date generated: 2024-12-16

Background

Mitch performs unidimensional and multidimensional gene set enrichment analysis. The concept behind this dates to work by Cox and Mann (https://doi.org/10.1186/1471-2105-13-S16-S12). This implementation is suited to R based workflows of multi-omics datasets. This software was developed by Antony Kaspi and Mark Ziemann. Learn more about Mitch at the website: https://github.com/markziemann/Mitch

Input profiles

Here is the first few lines of the input profile.

The profiling data being passed to mitch
cancer incidence
A1BG 1.256876 0.0020388
A1BG-AS1 -1.418138 0.0029418
A1CF 2.954785 -0.0015391
A2M -4.988589 -0.0004251
A2M-AS1 -2.232500 0.0057066
A2ML1 -3.565671 0.0000406

Here are some metrics about the input data profile:

Profiling data metrics
Profile metrics
num_genes_in_profile 21922
duplicated_genes_present 0
num_profile_genes_in_sets 17585
num_profile_genes_not_in_sets 4337
profile_pearson_correl 0.07271
profile_spearman_correl 0.07334

Here is a plot of the input profiles. Note the dynamic ranges.

Here is the contour plot of the profile including all detected genes.

Input genesets

Here are some metrics about the gene sets used:

GMT file of genesets:
Gene set metrics
Gene sets metrics
num_genesets 13188
num_genesets_excluded 4273
num_genesets_included 8915

Gene sets by quadrant


Number of significant gene sets (FDR<0.05)= 1327

Interactive enrichment scatterplot

All sets with FDR<0.05. Try hovering over the points.

Top N sets irrespective of FDR. Try hovering over the points.

A heatmap of S values for top results


A plot of effect size versus significance


Significance is the -log2(p.adjustMANOVA) and effect size is the s.dist which is the hypotenuse of the s scores.

Results table

Top N= 50 gene sets
set setSize pMANOVA p.adjustMANOVA s.dist s.cancer s.incidence p.cancer p.incidence
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB 5 8.68e-04 1.23e-02 1.000 -0.8080 -0.5940 1.75e-03 0.021500
GOMF LIPID ANTIGEN BINDING 5 8.68e-04 1.23e-02 1.000 -0.8080 -0.5940 1.75e-03 0.021500
GOBP FOREBRAIN NEURON FATE COMMITMENT 7 1.11e-04 2.36e-03 0.906 0.8410 -0.3380 1.16e-04 0.122000
GOBP SPINAL CORD OLIGODENDROCYTE CELL DIFFERENTIATION 5 1.60e-03 1.99e-02 0.893 0.7020 -0.5520 6.59e-03 0.032500
GOMF HEMOGLOBIN ALPHA BINDING 5 2.80e-03 3.05e-02 0.886 -0.8850 -0.0367 6.10e-04 0.887000
GOBP MESENCHYME MIGRATION 5 2.83e-03 3.07e-02 0.867 0.8420 -0.2070 1.11e-03 0.422000
GOMF 3 KETO STEROL REDUCTASE ACTIVITY 5 4.76e-03 4.57e-02 0.822 0.2970 -0.7660 2.49e-01 0.003000
Beta defensins 26 3.88e-11 3.50e-09 0.809 -0.6940 -0.4160 9.13e-10 0.000243
GOMF CCR6 CHEMOKINE RECEPTOR BINDING 5 1.11e-02 8.46e-02 0.798 -0.6980 -0.3870 6.85e-03 0.134000
GOMF OLFACTORY RECEPTOR ACTIVITY 338 0.00e+00 0.00e+00 0.794 -0.7880 -0.0975 0.00e+00 0.002060
GOMF TYPE I INTERFERON RECEPTOR BINDING 14 1.39e-06 5.09e-05 0.791 -0.7840 0.1100 3.81e-07 0.474000
GOBP NEURAL PLATE REGIONALIZATION 6 4.32e-03 4.25e-02 0.790 0.7640 0.1990 1.18e-03 0.399000
GOMF ODORANT BINDING 99 4.05e-40 2.93e-37 0.787 -0.7800 -0.1060 3.39e-41 0.069400
GOBP CARDIAC SEPTUM CELL DIFFERENTIATION 5 1.12e-02 8.53e-02 0.784 0.7650 0.1740 3.06e-03 0.501000
Expression and translocation of olfactory receptors 339 0.00e+00 0.00e+00 0.783 -0.7770 -0.0930 0.00e+00 0.003260
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION 5 1.25e-02 9.22e-02 0.782 0.7270 0.2880 4.86e-03 0.265000
GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY 7 2.58e-03 2.87e-02 0.775 0.6910 0.3500 1.54e-03 0.109000
GOMF ARYL SULFOTRANSFERASE ACTIVITY 7 2.64e-03 2.93e-02 0.774 0.6830 0.3650 1.76e-03 0.094800
GOBP NORADRENERGIC NEURON DIFFERENTIATION 10 1.16e-04 2.44e-03 0.771 0.7700 -0.0531 2.50e-05 0.771000
Olfactory Signaling Pathway 346 0.00e+00 0.00e+00 0.771 -0.7670 -0.0834 0.00e+00 0.007690
GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY 9 3.97e-04 6.51e-03 0.769 -0.7580 -0.1340 8.26e-05 0.488000
GOBP REGULATION OF GLUCOSYLCERAMIDE CATABOLIC PROCESS 5 1.57e-02 1.09e-01 0.760 0.2560 0.7160 3.22e-01 0.005590
GOBP NEURAL FOLD FORMATION 7 2.55e-03 2.85e-02 0.756 -0.0528 -0.7540 8.09e-01 0.000549
GOMF HISTONE H3K36 TRIMETHYLTRANSFERASE ACTIVITY 5 1.76e-02 1.16e-01 0.753 0.6850 0.3130 7.97e-03 0.226000
GOMF AMINOACYL TRNA HYDROLASE ACTIVITY 5 1.74e-02 1.15e-01 0.753 -0.2800 -0.6990 2.79e-01 0.006820
GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX 6 5.94e-03 5.37e-02 0.749 -0.0561 0.7470 8.12e-01 0.001540
GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT 7 3.86e-03 3.86e-02 0.748 0.3350 0.6690 1.25e-01 0.002180
GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION 8 1.15e-03 1.54e-02 0.746 0.7450 -0.0379 2.61e-04 0.853000
GOMF HEXOKINASE ACTIVITY 5 1.17e-02 8.83e-02 0.746 -0.3370 0.6660 1.92e-01 0.009950
Developmental Cell Lineages 5 1.88e-02 1.22e-01 0.746 0.6880 0.2880 7.73e-03 0.265000
Developmental Lineage of Pancreatic Acinar Cells 5 1.88e-02 1.22e-01 0.746 0.6880 0.2880 7.73e-03 0.265000
GOCC OUTER DENSE FIBER 6 4.69e-03 4.51e-02 0.745 -0.4020 0.6280 8.78e-02 0.007770
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS 5 1.95e-02 1.24e-01 0.745 0.6700 0.3240 9.45e-03 0.209000
GOBP SENSORY PERCEPTION OF SMELL 364 0.00e+00 0.00e+00 0.742 -0.7360 -0.0943 0.00e+00 0.001990
GOBP CEREBRAL CORTEX REGIONALIZATION 7 3.27e-03 3.42e-02 0.738 0.7370 0.0165 7.27e-04 0.940000
GOBP REGULATION OF OOCYTE MATURATION 7 5.17e-03 4.86e-02 0.732 0.4380 0.5870 4.48e-02 0.007150
GOBP EPOXIDE METABOLIC PROCESS 5 2.35e-02 1.43e-01 0.732 0.5890 0.4350 2.27e-02 0.092400
GOBP MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION 6 1.12e-02 8.54e-02 0.731 0.5590 0.4710 1.76e-02 0.045700
GOBP PROTEIN O LINKED FUCOSYLATION 5 1.69e-02 1.13e-01 0.730 -0.0774 0.7260 7.64e-01 0.004920
GOBP FAS SIGNALING PATHWAY 8 1.08e-03 1.46e-02 0.730 0.6380 -0.3540 1.76e-03 0.082500
GOBP ALANINE METABOLIC PROCESS 5 1.41e-02 1.01e-01 0.726 -0.4800 0.5450 6.30e-02 0.034900
GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY 10 6.35e-04 9.59e-03 0.725 0.5600 0.4620 2.18e-03 0.011500
GOBP GLIAL CELL FATE SPECIFICATION 7 2.68e-03 2.96e-02 0.724 0.5890 -0.4220 6.97e-03 0.053400
GOBP NEURAL PLATE PATTERN SPECIFICATION 8 2.37e-03 2.68e-02 0.721 0.6980 0.1790 6.28e-04 0.380000
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX 5 2.15e-02 1.33e-01 0.719 -0.0715 -0.7150 7.82e-01 0.005590
GOMF TYPE 2 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 5 2.63e-02 1.54e-01 0.718 0.6170 0.3680 1.69e-02 0.154000
Ficolins bind to repetitive carbohydrate structures on the target cell surface 5 1.91e-02 1.23e-01 0.717 -0.7090 0.1040 6.00e-03 0.688000
GOCC INNER DYNEIN ARM 5 2.73e-02 1.57e-01 0.716 0.4090 0.5880 1.13e-01 0.022800
GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER 5 2.77e-02 1.59e-01 0.712 0.3450 0.6230 1.82e-01 0.015800
GOBP REGULATION OF LUNG BLOOD PRESSURE 5 2.78e-02 1.59e-01 0.712 0.6180 0.3540 1.66e-02 0.171000


Results (complete table)


Click HERE to show results for all gene sets

Complete results
set setSize pMANOVA p.adjustMANOVA s.dist s.cancer s.incidence p.cancer p.incidence
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB 5 8.68e-04 1.23e-02 1.000000 -8.08e-01 -5.94e-01 1.75e-03 2.15e-02
GOMF LIPID ANTIGEN BINDING 5 8.68e-04 1.23e-02 1.000000 -8.08e-01 -5.94e-01 1.75e-03 2.15e-02
GOBP FOREBRAIN NEURON FATE COMMITMENT 7 1.11e-04 2.36e-03 0.906000 8.41e-01 -3.38e-01 1.16e-04 1.22e-01
GOBP SPINAL CORD OLIGODENDROCYTE CELL DIFFERENTIATION 5 1.60e-03 1.99e-02 0.893000 7.02e-01 -5.52e-01 6.59e-03 3.25e-02
GOMF HEMOGLOBIN ALPHA BINDING 5 2.80e-03 3.05e-02 0.886000 -8.85e-01 -3.67e-02 6.10e-04 8.87e-01
GOBP MESENCHYME MIGRATION 5 2.83e-03 3.07e-02 0.867000 8.42e-01 -2.07e-01 1.11e-03 4.22e-01
GOMF 3 KETO STEROL REDUCTASE ACTIVITY 5 4.76e-03 4.57e-02 0.822000 2.97e-01 -7.66e-01 2.49e-01 3.00e-03
Beta defensins 26 3.88e-11 3.50e-09 0.809000 -6.94e-01 -4.16e-01 9.13e-10 2.43e-04
GOMF CCR6 CHEMOKINE RECEPTOR BINDING 5 1.11e-02 8.46e-02 0.798000 -6.98e-01 -3.87e-01 6.85e-03 1.34e-01
GOMF OLFACTORY RECEPTOR ACTIVITY 338 1.22e-137 1.49e-133 0.794000 -7.88e-01 -9.75e-02 8.66e-139 2.06e-03
GOMF TYPE I INTERFERON RECEPTOR BINDING 14 1.39e-06 5.09e-05 0.791000 -7.84e-01 1.10e-01 3.81e-07 4.74e-01
GOBP NEURAL PLATE REGIONALIZATION 6 4.32e-03 4.25e-02 0.790000 7.64e-01 1.99e-01 1.18e-03 3.99e-01
GOMF ODORANT BINDING 99 4.05e-40 2.93e-37 0.787000 -7.80e-01 -1.06e-01 3.39e-41 6.94e-02
GOBP CARDIAC SEPTUM CELL DIFFERENTIATION 5 1.12e-02 8.53e-02 0.784000 7.65e-01 1.74e-01 3.06e-03 5.01e-01
Expression and translocation of olfactory receptors 339 3.53e-134 2.17e-130 0.783000 -7.77e-01 -9.30e-02 2.20e-135 3.26e-03
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION 5 1.25e-02 9.22e-02 0.782000 7.27e-01 2.88e-01 4.86e-03 2.65e-01
GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY 7 2.58e-03 2.87e-02 0.775000 6.91e-01 3.50e-01 1.54e-03 1.09e-01
GOMF ARYL SULFOTRANSFERASE ACTIVITY 7 2.64e-03 2.93e-02 0.774000 6.83e-01 3.65e-01 1.76e-03 9.48e-02
GOBP NORADRENERGIC NEURON DIFFERENTIATION 10 1.16e-04 2.44e-03 0.771000 7.70e-01 -5.31e-02 2.50e-05 7.71e-01
Olfactory Signaling Pathway 346 4.94e-133 2.02e-129 0.771000 -7.67e-01 -8.34e-02 2.34e-134 7.69e-03
GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY 9 3.97e-04 6.51e-03 0.769000 -7.58e-01 -1.34e-01 8.26e-05 4.88e-01
GOBP REGULATION OF GLUCOSYLCERAMIDE CATABOLIC PROCESS 5 1.57e-02 1.09e-01 0.760000 2.56e-01 7.16e-01 3.22e-01 5.59e-03
GOBP NEURAL FOLD FORMATION 7 2.55e-03 2.85e-02 0.756000 -5.28e-02 -7.54e-01 8.09e-01 5.49e-04
GOMF HISTONE H3K36 TRIMETHYLTRANSFERASE ACTIVITY 5 1.76e-02 1.16e-01 0.753000 6.85e-01 3.13e-01 7.97e-03 2.26e-01
GOMF AMINOACYL TRNA HYDROLASE ACTIVITY 5 1.74e-02 1.15e-01 0.753000 -2.80e-01 -6.99e-01 2.79e-01 6.82e-03
GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX 6 5.94e-03 5.37e-02 0.749000 -5.61e-02 7.47e-01 8.12e-01 1.54e-03
GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT 7 3.86e-03 3.86e-02 0.748000 3.35e-01 6.69e-01 1.25e-01 2.18e-03
GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION 8 1.15e-03 1.54e-02 0.746000 7.45e-01 -3.79e-02 2.61e-04 8.53e-01
GOMF HEXOKINASE ACTIVITY 5 1.17e-02 8.83e-02 0.746000 -3.37e-01 6.66e-01 1.92e-01 9.95e-03
Developmental Cell Lineages 5 1.88e-02 1.22e-01 0.746000 6.88e-01 2.88e-01 7.73e-03 2.65e-01
Developmental Lineage of Pancreatic Acinar Cells 5 1.88e-02 1.22e-01 0.746000 6.88e-01 2.88e-01 7.73e-03 2.65e-01
GOCC OUTER DENSE FIBER 6 4.69e-03 4.51e-02 0.745000 -4.02e-01 6.28e-01 8.78e-02 7.77e-03
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS 5 1.95e-02 1.24e-01 0.745000 6.70e-01 3.24e-01 9.45e-03 2.09e-01
GOBP SENSORY PERCEPTION OF SMELL 364 5.20e-129 1.59e-125 0.742000 -7.36e-01 -9.43e-02 4.18e-130 1.99e-03
GOBP CEREBRAL CORTEX REGIONALIZATION 7 3.27e-03 3.42e-02 0.738000 7.37e-01 1.65e-02 7.27e-04 9.40e-01
GOBP REGULATION OF OOCYTE MATURATION 7 5.17e-03 4.86e-02 0.732000 4.38e-01 5.87e-01 4.48e-02 7.15e-03
GOBP EPOXIDE METABOLIC PROCESS 5 2.35e-02 1.43e-01 0.732000 5.89e-01 4.35e-01 2.27e-02 9.24e-02
GOBP MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION 6 1.12e-02 8.54e-02 0.731000 5.59e-01 4.71e-01 1.76e-02 4.57e-02
GOBP PROTEIN O LINKED FUCOSYLATION 5 1.69e-02 1.13e-01 0.730000 -7.74e-02 7.26e-01 7.64e-01 4.92e-03
GOBP FAS SIGNALING PATHWAY 8 1.08e-03 1.46e-02 0.730000 6.38e-01 -3.54e-01 1.76e-03 8.25e-02
GOBP ALANINE METABOLIC PROCESS 5 1.41e-02 1.01e-01 0.726000 -4.80e-01 5.45e-01 6.30e-02 3.49e-02
GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY 10 6.35e-04 9.59e-03 0.725000 5.60e-01 4.62e-01 2.18e-03 1.15e-02
GOBP GLIAL CELL FATE SPECIFICATION 7 2.68e-03 2.96e-02 0.724000 5.89e-01 -4.22e-01 6.97e-03 5.34e-02
GOBP NEURAL PLATE PATTERN SPECIFICATION 8 2.37e-03 2.68e-02 0.721000 6.98e-01 1.79e-01 6.28e-04 3.80e-01
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX 5 2.15e-02 1.33e-01 0.719000 -7.15e-02 -7.15e-01 7.82e-01 5.59e-03
GOMF TYPE 2 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 5 2.63e-02 1.54e-01 0.718000 6.17e-01 3.68e-01 1.69e-02 1.54e-01
Ficolins bind to repetitive carbohydrate structures on the target cell surface 5 1.91e-02 1.23e-01 0.717000 -7.09e-01 1.04e-01 6.00e-03 6.88e-01
GOCC INNER DYNEIN ARM 5 2.73e-02 1.57e-01 0.716000 4.09e-01 5.88e-01 1.13e-01 2.28e-02
GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER 5 2.77e-02 1.59e-01 0.712000 3.45e-01 6.23e-01 1.82e-01 1.58e-02
GOBP REGULATION OF LUNG BLOOD PRESSURE 5 2.78e-02 1.59e-01 0.712000 6.18e-01 3.54e-01 1.66e-02 1.71e-01
Defensins 32 9.93e-11 8.52e-09 0.712000 -6.42e-01 -3.08e-01 3.27e-10 2.58e-03
Regulation of gene expression in early pancreatic precursor cells 8 1.88e-03 2.25e-02 0.710000 6.93e-01 -1.56e-01 6.89e-04 4.45e-01
Free fatty acid receptors 5 1.93e-02 1.24e-01 0.709000 -6.81e-01 2.00e-01 8.39e-03 4.38e-01
GOBP SERINE PHOSPHORYLATION OF STAT PROTEIN 20 2.90e-07 1.29e-05 0.709000 -7.08e-01 -2.72e-02 4.16e-08 8.33e-01
GOBP FORMATION OF ANATOMICAL BOUNDARY 7 3.74e-03 3.77e-02 0.704000 5.67e-01 -4.17e-01 9.40e-03 5.62e-02
GOBP POSITIVE REGULATION OF INTERLEUKIN 23 PRODUCTION 7 4.26e-03 4.20e-02 0.702000 -6.54e-01 2.55e-01 2.72e-03 2.43e-01
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION 6 1.08e-02 8.33e-02 0.700000 9.76e-02 -6.93e-01 6.79e-01 3.27e-03
GOBP REACTIVE GLIOSIS 6 1.66e-02 1.12e-01 0.698000 5.51e-01 4.29e-01 1.95e-02 6.86e-02
GOBP CELL MOTILITY INVOLVED IN CEREBRAL CORTEX RADIAL GLIA GUIDED MIGRATION 6 1.74e-02 1.15e-01 0.695000 5.22e-01 4.59e-01 2.67e-02 5.16e-02
Signaling by membrane-tethered fusions of PDGFRA or PDGFRB 5 3.06e-02 1.68e-01 0.695000 6.61e-01 2.15e-01 1.05e-02 4.05e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY 8 4.63e-03 4.47e-02 0.693000 5.04e-01 4.77e-01 1.37e-02 1.95e-02
Activated NTRK2 signals through PI3K 7 5.95e-03 5.37e-02 0.688000 6.75e-01 -1.29e-01 1.97e-03 5.55e-01
GOBP FORMATION OF TRANSLATION PREINITIATION COMPLEX 6 1.42e-02 1.01e-01 0.686000 -6.31e-04 -6.86e-01 9.98e-01 3.62e-03
GOBP THYROID STIMULATING HORMONE SECRETING CELL DIFFERENTIATION 6 1.90e-02 1.22e-01 0.685000 5.82e-01 3.62e-01 1.36e-02 1.25e-01
STAT5 Activation 7 5.15e-03 4.84e-02 0.682000 4.88e-01 -4.76e-01 2.54e-02 2.90e-02
GOCC R2TP COMPLEX 5 2.36e-02 1.44e-01 0.682000 3.93e-01 -5.57e-01 1.29e-01 3.09e-02
GOBP REDUCTION OF FOOD INTAKE IN RESPONSE TO DIETARY EXCESS 6 1.73e-02 1.15e-01 0.681000 -6.63e-01 -1.58e-01 4.94e-03 5.03e-01
GOMF SEROTONIN RECEPTOR ACTIVITY 6 1.23e-02 9.07e-02 0.681000 -6.34e-01 2.48e-01 7.17e-03 2.93e-01
GOCC TRAMP COMPLEX 5 2.68e-02 1.56e-01 0.680000 6.54e-01 -1.87e-01 1.13e-02 4.69e-01
GOMF CARBOHYDRATE PROTON SYMPORTER ACTIVITY 7 6.05e-03 5.43e-02 0.676000 -3.06e-01 6.03e-01 1.61e-01 5.75e-03
GOBP THELARCHE 5 3.66e-02 1.88e-01 0.675000 -1.80e-01 -6.51e-01 4.85e-01 1.17e-02
GOMF TYPE 1 ANGIOTENSIN RECEPTOR BINDING 6 2.11e-02 1.31e-01 0.675000 5.82e-01 3.42e-01 1.35e-02 1.47e-01
GOCC SEROTONIN RECEPTOR COMPLEX 5 2.96e-02 1.65e-01 0.671000 -6.50e-01 1.70e-01 1.19e-02 5.11e-01
GOMF SEROTONIN GATED MONOATOMIC CATION CHANNEL ACTIVITY 5 2.96e-02 1.65e-01 0.671000 -6.50e-01 1.70e-01 1.19e-02 5.11e-01
GOBP POSITIVE REGULATION OF BASEMENT MEMBRANE ASSEMBLY INVOLVED IN EMBRYONIC BODY MORPHOGENESIS 5 4.22e-02 2.04e-01 0.671000 5.57e-01 3.75e-01 3.10e-02 1.47e-01
GOMF ACTIVIN RECEPTOR ACTIVITY TYPE I 5 4.07e-02 2.00e-01 0.671000 6.04e-01 2.93e-01 1.94e-02 2.56e-01
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 7 8.66e-03 7.10e-02 0.671000 3.72e-03 -6.71e-01 9.86e-01 2.12e-03
GOCC CYTOPLASMIC SIDE OF ROUGH ENDOPLASMIC RETICULUM MEMBRANE 5 3.91e-02 1.95e-01 0.670000 -2.08e-01 -6.37e-01 4.20e-01 1.36e-02
GOBP POSITIVE REGULATION OF KERATINOCYTE APOPTOTIC PROCESS 5 3.68e-02 1.89e-01 0.669000 6.61e-01 1.01e-01 1.04e-02 6.95e-01
GOBP REGULATION OF TERMINATION OF DNA TEMPLATED TRANSCRIPTION 5 2.79e-02 1.59e-01 0.668000 5.82e-01 -3.28e-01 2.41e-02 2.04e-01
GOBP CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR 7 1.36e-02 9.88e-02 0.662000 5.26e-01 4.02e-01 1.60e-02 6.55e-02
FasL/ CD95L signaling 5 3.11e-02 1.70e-01 0.662000 2.49e-01 -6.13e-01 3.35e-01 1.76e-02
GOBP PH REDUCTION 6 1.69e-02 1.13e-01 0.660000 -1.59e-01 6.41e-01 5.00e-01 6.54e-03
Interleukin-36 pathway 7 7.39e-03 6.34e-02 0.658000 -4.92e-01 4.38e-01 2.43e-02 4.49e-02
GOBP POSITIVE REGULATION OF INTRACELLULAR LIPID TRANSPORT 5 3.39e-02 1.79e-01 0.656000 -2.05e-01 6.23e-01 4.27e-01 1.59e-02
GOBP PEPTIDE MODIFICATION 5 4.97e-02 2.25e-01 0.655000 4.44e-01 4.82e-01 8.53e-02 6.21e-02
GOBP NUCLEAR MIGRATION ALONG MICROTUBULE 5 4.93e-02 2.24e-01 0.655000 3.75e-01 5.37e-01 1.47e-01 3.76e-02
GOMF INOSITOL 1 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY 6 2.58e-02 1.52e-01 0.653000 6.01e-01 2.55e-01 1.08e-02 2.79e-01
POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation 10 1.49e-03 1.89e-02 0.653000 6.49e-01 -6.38e-02 3.76e-04 7.27e-01
GOBP GLUCOSYLCERAMIDE CATABOLIC PROCESS 8 7.90e-03 6.65e-02 0.652000 2.68e-01 5.94e-01 1.90e-01 3.61e-03
GOCC TROPONIN COMPLEX 9 2.11e-03 2.46e-02 0.651000 -3.94e-01 5.18e-01 4.05e-02 7.10e-03
GOCC MANNOSYLTRANSFERASE COMPLEX 5 4.92e-02 2.23e-01 0.649000 -2.44e-01 -6.01e-01 3.44e-01 1.99e-02
Defective CSF2RA causes SMDP4 7 8.75e-03 7.15e-02 0.647000 -4.92e-01 4.21e-01 2.43e-02 5.40e-02
Defective CSF2RB causes SMDP5 7 8.75e-03 7.15e-02 0.647000 -4.92e-01 4.21e-01 2.43e-02 5.40e-02
GOMF INSULIN BINDING 5 4.30e-02 2.07e-01 0.646000 6.46e-01 1.55e-04 1.24e-02 1.00e+00
GOBP POSITIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION 6 2.88e-02 1.62e-01 0.645000 2.87e-01 5.78e-01 2.24e-01 1.42e-02
GOBP RNA 3 URIDYLATION 5 4.81e-02 2.21e-01 0.645000 6.28e-01 1.45e-01 1.49e-02 5.75e-01
GOCC EARP COMPLEX 5 5.33e-02 2.35e-01 0.644000 5.59e-01 3.21e-01 3.04e-02 2.14e-01
GOBP SENSORY PERCEPTION OF CHEMICAL STIMULUS 439 2.97e-117 7.28e-114 0.644000 -6.41e-01 -6.23e-02 1.18e-118 2.53e-02
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY 5 4.18e-02 2.03e-01 0.643000 6.37e-01 -8.65e-02 1.37e-02 7.38e-01
GOMF HMG BOX DOMAIN BINDING 13 2.29e-04 4.22e-03 0.640000 6.09e-01 -1.97e-01 1.43e-04 2.18e-01
GOBP REGULATION OF BLOOD VOLUME BY RENIN ANGIOTENSIN 5 5.02e-02 2.26e-01 0.640000 6.24e-01 1.40e-01 1.56e-02 5.86e-01
GOBP REGULATION OF RAB PROTEIN SIGNAL TRANSDUCTION 7 1.76e-02 1.16e-01 0.638000 5.68e-01 2.90e-01 9.25e-03 1.84e-01
GOMF CYTOSKELETON NUCLEAR MEMBRANE ANCHOR ACTIVITY 5 5.11e-02 2.28e-01 0.637000 1.28e-01 6.24e-01 6.21e-01 1.56e-02
FLT3 signaling through SRC family kinases 6 2.27e-02 1.39e-01 0.637000 1.38e-01 -6.22e-01 5.59e-01 8.32e-03
GOBP INTERNAL PEPTIDYL LYSINE ACETYLATION 8 8.22e-03 6.85e-02 0.636000 6.32e-01 7.22e-02 1.96e-03 7.24e-01
GOBP REGULATION OF FAS SIGNALING PATHWAY 6 2.19e-02 1.35e-01 0.636000 6.03e-01 -2.03e-01 1.06e-02 3.89e-01
GOMF PHOSPHATIDYLINOSITOL TRANSFER ACTIVITY 10 2.95e-03 3.18e-02 0.636000 6.03e-01 2.03e-01 9.64e-04 2.67e-01
GOBP REGULATION OF PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS 5 6.03e-02 2.52e-01 0.633000 3.88e-01 5.01e-01 1.33e-01 5.25e-02
GOBP EXOCRINE PANCREAS DEVELOPMENT 7 1.08e-02 8.30e-02 0.632000 4.59e-01 -4.35e-01 3.55e-02 4.61e-02
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION 456 4.81e-117 9.84e-114 0.632000 -6.28e-01 -6.97e-02 2.42e-118 1.07e-02
GOBP INTERKINETIC NUCLEAR MIGRATION 5 4.11e-02 2.01e-01 0.632000 5.59e-01 -2.94e-01 3.03e-02 2.55e-01
GOBP REGULATION OF CHRONIC INFLAMMATORY RESPONSE 8 1.01e-02 7.92e-02 0.630000 -1.74e-01 -6.05e-01 3.93e-01 3.04e-03
GOBP ADULT FEEDING BEHAVIOR 9 5.85e-03 5.32e-02 0.629000 6.00e-01 1.89e-01 1.83e-03 3.26e-01
GOBP MEMBRANE TUBULATION 5 6.09e-02 2.54e-01 0.629000 5.56e-01 2.94e-01 3.14e-02 2.55e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF CYTOSKELETON POLARITY 7 1.72e-02 1.15e-01 0.628000 6.19e-01 1.04e-01 4.55e-03 6.33e-01
GOBP STEM CELL FATE SPECIFICATION 6 2.73e-02 1.58e-01 0.628000 6.26e-01 -4.46e-02 7.92e-03 8.50e-01
Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells 5 4.25e-02 2.05e-01 0.627000 5.33e-01 -3.31e-01 3.91e-02 2.01e-01
GOMF LYSINE N ACETYLTRANSFERASE ACTIVITY ACTING ON ACETYL PHOSPHATE AS DONOR 6 3.26e-02 1.75e-01 0.626000 6.07e-01 1.55e-01 1.00e-02 5.11e-01
GOCC DEUTEROSOME 6 3.83e-02 1.93e-01 0.624000 -4.18e-01 -4.63e-01 7.63e-02 4.96e-02
GOBP PARATHYROID GLAND DEVELOPMENT 7 1.54e-02 1.07e-01 0.623000 6.16e-01 -8.94e-02 4.75e-03 6.82e-01
GOMF COMPLEMENT RECEPTOR ACTIVITY 11 2.00e-03 2.36e-02 0.623000 -6.06e-01 -1.43e-01 5.02e-04 4.11e-01
GOMF INOSITOL POLYPHOSPHATE 5 PHOSPHATASE ACTIVITY 6 3.88e-02 1.94e-01 0.621000 5.10e-01 3.54e-01 3.05e-02 1.33e-01
GOMF GUANINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 6.37e-02 2.62e-01 0.621000 2.43e-01 5.71e-01 3.46e-01 2.70e-02
GOCC SPERM HEAD PLASMA MEMBRANE 6 2.94e-02 1.65e-01 0.619000 -6.14e-01 7.72e-02 9.19e-03 7.43e-01
GOBP CARDIAC PACEMAKER CELL DEVELOPMENT 8 8.53e-03 7.04e-02 0.618000 6.02e-01 -1.41e-01 3.19e-03 4.89e-01
GOBP OTOLITH MORPHOGENESIS 5 6.58e-02 2.67e-01 0.618000 5.62e-01 2.58e-01 2.96e-02 3.17e-01
GOCC CD95 DEATH INDUCING SIGNALING COMPLEX 6 2.49e-02 1.48e-01 0.618000 5.03e-01 -3.58e-01 3.27e-02 1.29e-01
GOBP THYMOCYTE MIGRATION 7 1.34e-02 9.70e-02 0.618000 -4.73e-01 3.98e-01 3.04e-02 6.85e-02
GOBP POSITIVE REGULATION OF CONNECTIVE TISSUE REPLACEMENT 12 1.11e-03 1.49e-02 0.617000 6.15e-01 5.07e-02 2.25e-04 7.61e-01
FLT3 signaling by CBL mutants 7 1.49e-02 1.05e-01 0.615000 2.41e-01 -5.66e-01 2.70e-01 9.50e-03
GOMF DOUBLE STRANDED RNA ADENOSINE DEAMINASE ACTIVITY 6 2.60e-02 1.53e-01 0.614000 -4.84e-01 3.78e-01 4.02e-02 1.09e-01
GOBP POSITIVE REGULATION OF NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY 7 1.80e-02 1.18e-01 0.612000 6.09e-01 -6.23e-02 5.24e-03 7.75e-01
Diseases associated with surfactant metabolism 9 4.48e-03 4.36e-02 0.610000 -4.85e-01 3.70e-01 1.18e-02 5.43e-02
Lectin pathway of complement activation 8 9.64e-03 7.67e-02 0.608000 -5.79e-01 1.84e-01 4.55e-03 3.68e-01
GOBP REGULATION OF SNRNA TRANSCRIPTION BY RNA POLYMERASE II 5 5.04e-02 2.26e-01 0.608000 4.10e-01 -4.49e-01 1.13e-01 8.22e-02
GOBP ATRIOVENTRICULAR NODE DEVELOPMENT 9 8.45e-03 6.99e-02 0.607000 5.72e-01 2.04e-01 2.96e-03 2.89e-01
GOBP SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION 12 1.05e-03 1.43e-02 0.606000 5.92e-01 -1.30e-01 3.81e-04 4.35e-01
GOCC POSTSYNAPTIC ENDOCYTIC ZONE 5 6.26e-02 2.59e-01 0.606000 6.06e-01 -1.21e-03 1.89e-02 9.96e-01
GOMF PYRUVATE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 7.08e-02 2.79e-01 0.606000 -5.75e-01 -1.91e-01 2.59e-02 4.60e-01
GOBP CENTRAL NERVOUS SYSTEM MYELIN MAINTENANCE 5 7.60e-02 2.91e-01 0.606000 4.95e-01 3.50e-01 5.52e-02 1.76e-01
GOBP SPERM MITOCHONDRIAL SHEATH ASSEMBLY 6 4.54e-02 2.13e-01 0.605000 -5.09e-01 -3.28e-01 3.09e-02 1.64e-01
Zinc efflux and compartmentalization by the SLC30 family 5 6.81e-02 2.72e-01 0.605000 -1.08e-01 -5.95e-01 6.75e-01 2.12e-02
GOMF HISTONE DEACETYLASE REGULATOR ACTIVITY 6 4.56e-02 2.14e-01 0.605000 5.10e-01 3.25e-01 3.04e-02 1.69e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION 5 7.44e-02 2.87e-01 0.604000 2.55e-01 5.48e-01 3.23e-01 3.39e-02
GOCC BASAL CORTEX 5 7.47e-02 2.88e-01 0.603000 5.54e-01 2.37e-01 3.19e-02 3.58e-01
GOBP ETHANOL METABOLIC PROCESS 11 3.63e-03 3.69e-02 0.602000 3.12e-01 5.15e-01 7.32e-02 3.10e-03
GOBP COMPLEMENT ACTIVATION LECTIN PATHWAY 11 1.84e-03 2.21e-02 0.602000 -5.61e-01 2.17e-01 1.27e-03 2.13e-01
GOBP TRANSDIFFERENTIATION 7 2.40e-02 1.45e-01 0.601000 5.95e-01 8.49e-02 6.42e-03 6.97e-01
RUNX3 regulates BCL2L11 (BIM) transcription 5 6.80e-02 2.72e-01 0.601000 5.99e-01 4.57e-02 2.04e-02 8.60e-01
GOBP POSITIVE REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION 6 3.18e-02 1.72e-01 0.597000 4.92e-01 -3.38e-01 3.67e-02 1.52e-01
GOCC VOLTAGE GATED SODIUM CHANNEL COMPLEX 14 6.57e-04 9.81e-03 0.597000 -5.88e-01 -1.05e-01 1.41e-04 4.98e-01
GOBP ERK5 CASCADE 5 7.96e-02 2.99e-01 0.596000 5.44e-01 2.44e-01 3.53e-02 3.44e-01
GOMF RNA POLYMERASE II INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING 8 1.84e-02 1.20e-01 0.596000 5.06e-01 3.14e-01 1.32e-02 1.24e-01
GOCC GARP COMPLEX 5 8.40e-02 3.11e-01 0.595000 3.91e-01 4.49e-01 1.30e-01 8.24e-02
GOBP OPTIC CUP MORPHOGENESIS INVOLVED IN CAMERA TYPE EYE DEVELOPMENT 7 2.04e-02 1.28e-01 0.595000 5.65e-01 -1.84e-01 9.59e-03 3.98e-01
GOBP SEPTUM PRIMUM DEVELOPMENT 5 6.91e-02 2.75e-01 0.593000 5.93e-01 -2.84e-02 2.17e-02 9.12e-01
GOBP REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY 6 3.74e-02 1.90e-01 0.593000 5.77e-01 -1.36e-01 1.43e-02 5.64e-01
GOBP TELENCEPHALON REGIONALIZATION 13 1.22e-03 1.61e-02 0.593000 5.83e-01 1.08e-01 2.73e-04 4.99e-01
GOBP REGULATION OF LIPOPHAGY 5 8.56e-02 3.13e-01 0.593000 4.64e-01 3.68e-01 7.21e-02 1.54e-01
GOBP POSITIVE REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 9 1.03e-02 8.03e-02 0.592000 5.72e-01 1.53e-01 2.97e-03 4.27e-01
GOMF CYCLASE INHIBITOR ACTIVITY 5 6.08e-02 2.54e-01 0.592000 -2.78e-01 5.22e-01 2.81e-01 4.31e-02
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 2.85e-03 3.09e-02 0.591000 4.23e-01 4.14e-01 1.12e-02 1.31e-02
GOMF HISTONE H3K4 MONOMETHYLTRANSFERASE ACTIVITY 8 2.01e-02 1.27e-01 0.591000 4.49e-01 3.84e-01 2.78e-02 5.99e-02
GOBP REGULATION OF BASEMENT MEMBRANE ORGANIZATION 11 4.42e-03 4.33e-02 0.590000 5.16e-01 2.88e-01 3.06e-03 9.86e-02
Metal sequestration by antimicrobial proteins 6 3.52e-02 1.83e-01 0.590000 -5.18e-01 2.84e-01 2.81e-02 2.29e-01
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 5 6.57e-02 2.67e-01 0.590000 1.64e-01 -5.66e-01 5.26e-01 2.83e-02
GOBP SKELETAL MUSCLE ATROPHY 5 6.49e-02 2.65e-01 0.589000 1.86e-01 -5.59e-01 4.70e-01 3.04e-02
GOBP ANGIOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS 5 8.70e-02 3.16e-01 0.588000 5.04e-01 3.04e-01 5.09e-02 2.40e-01
GOBP MUCOCILIARY CLEARANCE 8 2.09e-02 1.30e-01 0.588000 -4.55e-01 -3.73e-01 2.60e-02 6.78e-02
GOBP MYOBLAST FATE COMMITMENT 6 4.37e-02 2.08e-01 0.587000 5.87e-01 -1.93e-02 1.28e-02 9.35e-01
GOMF CCR1 CHEMOKINE RECEPTOR BINDING 5 8.44e-02 3.12e-01 0.587000 -2.06e-01 -5.50e-01 4.26e-01 3.33e-02
Regulation of cytoskeletal remodeling and cell spreading by IPP complex components 7 3.44e-02 1.81e-01 0.585000 4.89e-01 3.21e-01 2.50e-02 1.41e-01
GOBP REGULATION OF GROWTH RATE 5 8.99e-02 3.21e-01 0.585000 5.00e-01 3.03e-01 5.29e-02 2.41e-01
GOMF O PALMITOYLTRANSFERASE ACTIVITY 5 7.76e-02 2.95e-01 0.584000 5.84e-01 2.65e-02 2.38e-02 9.18e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY 8 1.26e-02 9.27e-02 0.583000 3.05e-01 -4.97e-01 1.35e-01 1.49e-02
Post-transcriptional silencing by small RNAs 7 2.88e-02 1.62e-01 0.583000 5.81e-01 4.68e-02 7.72e-03 8.30e-01
GOCC PTW PP1 PHOSPHATASE COMPLEX 7 2.32e-02 1.41e-01 0.583000 5.45e-01 -2.07e-01 1.25e-02 3.43e-01
GOBP ESTABLISHMENT OF MITOTIC SISTER CHROMATID COHESION 5 6.46e-02 2.64e-01 0.583000 4.65e-01 -3.51e-01 7.18e-02 1.74e-01
Classical antibody-mediated complement activation 6 5.78e-02 2.46e-01 0.583000 -4.53e-01 -3.66e-01 5.46e-02 1.20e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE ADAPTATION 8 1.83e-02 1.20e-01 0.582000 5.76e-01 8.72e-02 4.81e-03 6.69e-01
GOBP SENSORY PERCEPTION OF UMAMI TASTE 7 2.55e-02 1.50e-01 0.582000 -5.70e-01 1.15e-01 9.01e-03 5.97e-01
GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE REMODELING 6 4.34e-02 2.07e-01 0.581000 -5.71e-01 1.06e-01 1.54e-02 6.52e-01
Regulation of NPAS4 mRNA translation 9 1.01e-02 7.91e-02 0.581000 5.80e-01 -2.28e-02 2.58e-03 9.06e-01
GOBP GASTRIC MOTILITY 5 8.68e-02 3.15e-01 0.580000 5.59e-01 1.55e-01 3.03e-02 5.49e-01
GOBP BRANCH ELONGATION INVOLVED IN MAMMARY GLAND DUCT BRANCHING 5 9.07e-02 3.22e-01 0.580000 -2.35e-01 -5.31e-01 3.64e-01 3.99e-02
GOMF MHC CLASS IB RECEPTOR ACTIVITY 7 3.73e-02 1.90e-01 0.580000 -4.05e-01 -4.15e-01 6.36e-02 5.71e-02
GOBP DEVELOPMENT OF SECONDARY FEMALE SEXUAL CHARACTERISTICS 7 2.94e-02 1.65e-01 0.580000 -2.44e-02 -5.79e-01 9.11e-01 7.95e-03
GOBP METANEPHRIC GLOMERULUS VASCULATURE DEVELOPMENT 9 8.40e-03 6.96e-02 0.579000 5.38e-01 -2.14e-01 5.19e-03 2.65e-01
GOBP POSITIVE REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY 6 5.07e-02 2.27e-01 0.579000 5.75e-01 6.53e-02 1.47e-02 7.82e-01
GOBP REGULATION OF MACROPHAGE FUSION 5 7.98e-02 2.99e-01 0.579000 -5.79e-01 3.81e-03 2.50e-02 9.88e-01
GOMF NITRITE REDUCTASE ACTIVITY 7 2.83e-02 1.61e-01 0.579000 5.78e-01 -3.43e-02 8.13e-03 8.75e-01
GOMF INOSITOL 1 3 4 5 6 PENTAKISPHOSPHATE KINASE ACTIVITY 5 7.38e-02 2.86e-01 0.578000 5.60e-01 -1.42e-01 3.01e-02 5.81e-01
GOBP REGULATION OF MAINTENANCE OF SISTER CHROMATID COHESION 7 2.42e-02 1.46e-01 0.578000 5.21e-01 -2.49e-01 1.69e-02 2.54e-01
GOCC TRANSCRIPTION FACTOR AP 1 COMPLEX 5 9.71e-02 3.34e-01 0.577000 -3.55e-01 -4.55e-01 1.70e-01 7.78e-02
GOMF N ACETYLLACTOSAMINIDE BETA 1 3 N ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY 6 4.25e-02 2.05e-01 0.576000 -2.18e-01 5.34e-01 3.56e-01 2.36e-02
GOBP REGULATION OF VITAMIN D RECEPTOR SIGNALING PATHWAY 10 5.34e-03 4.95e-02 0.576000 5.45e-01 -1.87e-01 2.83e-03 3.07e-01
GOBP LNCRNA MEDIATED POST TRANSCRIPTIONAL GENE SILENCING 8 1.39e-02 1.00e-01 0.575000 4.36e-01 -3.75e-01 3.27e-02 6.63e-02
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION 5 6.94e-02 2.75e-01 0.575000 -4.56e-01 3.50e-01 7.75e-02 1.75e-01
GOMF MOLYBDOPTERIN COFACTOR BINDING 6 5.61e-02 2.42e-01 0.575000 5.56e-01 1.43e-01 1.82e-02 5.45e-01
GOMF PROSTAGLANDIN E RECEPTOR ACTIVITY 5 9.61e-02 3.32e-01 0.573000 -2.24e-01 -5.27e-01 3.87e-01 4.11e-02
GOBP BRONCHIOLE DEVELOPMENT 6 4.14e-02 2.01e-01 0.573000 4.00e-01 -4.10e-01 9.01e-02 8.17e-02
Signaling by LTK in cancer 7 3.03e-02 1.67e-01 0.572000 5.71e-01 -4.19e-02 8.89e-03 8.48e-01
GOBP HINDBRAIN TANGENTIAL CELL MIGRATION 5 7.45e-02 2.87e-01 0.572000 5.28e-01 -2.20e-01 4.08e-02 3.94e-01
Antimicrobial peptides 74 5.21e-16 1.33e-13 0.572000 -5.54e-01 -1.42e-01 1.54e-16 3.53e-02
GOBP NEGATIVE REGULATION OF MAST CELL DEGRANULATION 5 7.16e-02 2.81e-01 0.572000 4.56e-01 -3.44e-01 7.73e-02 1.83e-01
GOMF L GLUTAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY 8 1.96e-02 1.25e-01 0.571000 -3.63e-03 -5.71e-01 9.86e-01 5.15e-03
GOBP EMBRYONIC NEUROCRANIUM MORPHOGENESIS 8 2.42e-02 1.46e-01 0.571000 5.25e-01 2.24e-01 1.01e-02 2.72e-01
GOBP REGULATION OF HEPATIC STELLATE CELL ACTIVATION 7 3.74e-02 1.90e-01 0.570000 5.43e-01 1.76e-01 1.29e-02 4.21e-01
GOCC ENDOLYSOSOME LUMEN 5 1.03e-01 3.45e-01 0.570000 3.88e-01 4.18e-01 1.33e-01 1.06e-01
GOBP REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS 7 3.25e-02 1.75e-01 0.570000 -1.11e-03 -5.70e-01 9.96e-01 9.02e-03
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS NAD OR NADP AS ACCEPTOR 6 5.06e-02 2.27e-01 0.569000 -6.88e-02 5.65e-01 7.71e-01 1.65e-02
GOMF CYTOCHROME B5 REDUCTASE ACTIVITY ACTING ON NAD P H 6 6.52e-02 2.66e-01 0.569000 3.26e-01 4.67e-01 1.67e-01 4.77e-02
GOBP POSITIVE REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION 6 5.76e-02 2.46e-01 0.569000 5.60e-01 9.92e-02 1.75e-02 6.74e-01
GOBP METANEPHRIC COLLECTING DUCT DEVELOPMENT 10 1.10e-02 8.42e-02 0.568000 4.00e-01 4.03e-01 2.85e-02 2.72e-02
GOMF INTEGRIN BINDING INVOLVED IN CELL MATRIX ADHESION 5 1.01e-01 3.41e-01 0.568000 5.16e-01 2.37e-01 4.57e-02 3.58e-01
GOBP REGULATION OF CEREBELLAR GRANULE CELL PRECURSOR PROLIFERATION 9 1.64e-02 1.12e-01 0.567000 5.12e-01 2.43e-01 7.83e-03 2.07e-01
GOCC OUTER DYNEIN ARM 10 6.89e-03 6.02e-02 0.566000 -5.55e-01 1.13e-01 2.37e-03 5.35e-01
GOBP TYPE II HYPERSENSITIVITY 5 7.97e-02 2.99e-01 0.566000 -5.34e-01 1.89e-01 3.86e-02 4.65e-01
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION 7 3.05e-02 1.67e-01 0.563000 1.78e-01 -5.34e-01 4.14e-01 1.44e-02
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 5 PHOSPHATASE ACTIVITY 6 6.69e-02 2.70e-01 0.562000 5.15e-01 2.27e-01 2.91e-02 3.37e-01
HDL clearance 5 8.51e-02 3.12e-01 0.562000 -1.37e-01 5.45e-01 5.96e-01 3.48e-02
GOBP CELLULAR RESPONSE TO TEMPERATURE STIMULUS 5 1.05e-01 3.49e-01 0.562000 5.17e-01 2.21e-01 4.54e-02 3.92e-01
GOMF OPSONIN RECEPTOR ACTIVITY 5 1.07e-01 3.53e-01 0.562000 -4.94e-01 -2.67e-01 5.56e-02 3.01e-01
GOMF HISTONE H3K36 DEMETHYLASE ACTIVITY 9 1.88e-02 1.22e-01 0.561000 3.24e-01 4.58e-01 9.22e-02 1.73e-02
Specification of the neural plate border 16 3.81e-04 6.31e-03 0.560000 5.37e-01 -1.60e-01 2.01e-04 2.67e-01
GOBP GABAERGIC NEURON DIFFERENTIATION 18 1.19e-04 2.49e-03 0.560000 4.90e-01 -2.71e-01 3.16e-04 4.67e-02
GOCC GROWTH CONE MEMBRANE 8 3.02e-02 1.66e-01 0.560000 3.84e-01 4.07e-01 6.02e-02 4.59e-02
GOBP REGULATION OF CONNECTIVE TISSUE REPLACEMENT 15 1.03e-03 1.41e-02 0.560000 5.48e-01 1.13e-01 2.36e-04 4.50e-01
GOBP CHONDROBLAST DIFFERENTIATION 5 1.12e-01 3.63e-01 0.560000 3.84e-01 4.07e-01 1.37e-01 1.15e-01
Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA 8 2.70e-02 1.56e-01 0.559000 -1.70e-01 -5.33e-01 4.05e-01 9.05e-03
GOBP DENTINOGENESIS 6 5.75e-02 2.46e-01 0.559000 -3.54e-02 5.58e-01 8.81e-01 1.79e-02
GOCC MICROTUBULE MINUS END 7 3.31e-02 1.77e-01 0.559000 5.43e-01 -1.33e-01 1.29e-02 5.43e-01
GOBP REGULATION OF NATURAL KILLER CELL CHEMOTAXIS 8 2.50e-02 1.49e-01 0.558000 -7.18e-02 -5.54e-01 7.25e-01 6.69e-03
GOBP VOLUNTARY SKELETAL MUSCLE CONTRACTION 5 1.05e-01 3.49e-01 0.558000 1.61e-01 5.35e-01 5.34e-01 3.84e-02
GOMF SUMO POLYMER BINDING 5 9.91e-02 3.37e-01 0.558000 5.55e-01 5.96e-02 3.16e-02 8.18e-01
GOBP CITRATE METABOLIC PROCESS 5 1.04e-01 3.47e-01 0.558000 5.41e-01 1.35e-01 3.61e-02 6.02e-01
GOMF HEMOGLOBIN BINDING 9 1.51e-02 1.05e-01 0.558000 -5.57e-01 -2.18e-02 3.80e-03 9.10e-01
GOBP ISOCITRATE METABOLIC PROCESS 5 8.66e-02 3.15e-01 0.557000 1.87e-01 -5.25e-01 4.70e-01 4.22e-02
RSK activation 5 1.14e-01 3.66e-01 0.557000 4.50e-01 3.28e-01 8.16e-02 2.03e-01
GOBP CALCITONIN FAMILY RECEPTOR SIGNALING PATHWAY 8 2.98e-02 1.66e-01 0.556000 -5.01e-01 -2.40e-01 1.41e-02 2.39e-01
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY TYPE I 5 1.14e-01 3.67e-01 0.556000 4.53e-01 3.22e-01 7.93e-02 2.13e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL CHEMOTAXIS 5 1.16e-01 3.69e-01 0.555000 -3.59e-01 -4.23e-01 1.64e-01 1.01e-01
SARS-CoV-1 modulates host translation machinery 33 4.01e-07 1.73e-05 0.554000 -1.41e-01 -5.36e-01 1.62e-01 9.67e-08
GOBP MINERALOCORTICOID SECRETION 7 3.92e-02 1.95e-01 0.554000 5.54e-01 -1.81e-03 1.11e-02 9.93e-01
GOBP ATRIAL SEPTUM MORPHOGENESIS 15 9.56e-04 1.33e-02 0.554000 5.54e-01 -8.62e-03 2.04e-04 9.54e-01
Melanin biosynthesis 5 9.71e-02 3.35e-01 0.554000 -5.53e-01 3.21e-02 3.23e-02 9.01e-01
GOBP APOPTOTIC CHROMOSOME CONDENSATION 6 7.35e-02 2.86e-01 0.554000 4.94e-01 2.51e-01 3.62e-02 2.88e-01
GOMF ALCOHOL DEHYDROGENASE NADPLUS ACTIVITY ZINC DEPENDENT 7 3.13e-02 1.70e-01 0.554000 3.40e-01 -4.37e-01 1.20e-01 4.52e-02
GOBP LEUKOTRIENE B4 METABOLIC PROCESS 5 8.46e-02 3.12e-01 0.553000 3.34e-01 -4.41e-01 1.96e-01 8.74e-02
GOBP COMPLEMENT RECEPTOR MEDIATED SIGNALING PATHWAY 14 1.92e-03 2.29e-02 0.553000 -5.40e-01 -1.22e-01 4.72e-04 4.31e-01
Formation of the posterior neural plate 10 1.09e-02 8.39e-02 0.552000 5.48e-01 6.39e-02 2.68e-03 7.26e-01
GOBP INTERLEUKIN 11 MEDIATED SIGNALING PATHWAY 6 7.56e-02 2.90e-01 0.552000 4.81e-01 2.70e-01 4.11e-02 2.52e-01
GOMF NADPLUS PROTEIN ASPARTATE ADP RIBOSYLTRANSFERASE ACTIVITY 5 1.19e-01 3.75e-01 0.552000 4.29e-01 3.48e-01 9.69e-02 1.78e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON DIPHENOLS AND RELATED SUBSTANCES AS DONORS 8 3.27e-02 1.75e-01 0.552000 -3.10e-01 -4.56e-01 1.29e-01 2.54e-02
GOBP NEGATIVE REGULATION OF INTERFERON ALPHA PRODUCTION 6 7.50e-02 2.89e-01 0.551000 -4.95e-01 -2.42e-01 3.57e-02 3.04e-01
GOBP NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION 8 1.96e-02 1.25e-01 0.551000 3.91e-01 -3.88e-01 5.52e-02 5.75e-02
Synthesis of PIPs at the late endosome membrane 10 9.73e-03 7.72e-02 0.551000 5.49e-01 -4.83e-02 2.66e-03 7.92e-01
GOBP EMBRYONIC CAMERA TYPE EYE FORMATION 11 5.90e-03 5.35e-02 0.550000 5.44e-01 -8.13e-02 1.77e-03 6.41e-01
GOBP CELL CELL JUNCTION DISASSEMBLY 5 1.10e-01 3.58e-01 0.550000 5.36e-01 1.24e-01 3.80e-02 6.31e-01
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II 5 1.21e-01 3.79e-01 0.550000 -4.00e-01 -3.77e-01 1.22e-01 1.44e-01
GOBP RESPONSE TO ACTINOMYCIN D 5 8.81e-02 3.17e-01 0.549000 3.18e-01 -4.48e-01 2.19e-01 8.30e-02
GOMF ACTIVIN RECEPTOR ACTIVITY 9 2.16e-02 1.33e-01 0.548000 4.91e-01 2.43e-01 1.07e-02 2.07e-01
GOBP MOTOR LEARNING 8 2.14e-02 1.33e-01 0.547000 4.76e-01 -2.71e-01 1.98e-02 1.84e-01
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPTIC ACTIN CYTOSKELETON 7 4.37e-02 2.08e-01 0.547000 -5.46e-01 -3.35e-02 1.23e-02 8.78e-01
GOBP REGULATION OF CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP 5 9.74e-02 3.35e-01 0.547000 5.32e-01 -1.26e-01 3.93e-02 6.26e-01
Regulation of FOXO transcriptional activity by acetylation 9 1.49e-02 1.05e-01 0.546000 5.25e-01 -1.51e-01 6.36e-03 4.34e-01
GOBP NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 11 5.81e-03 5.29e-02 0.546000 5.24e-01 -1.56e-01 2.64e-03 3.70e-01
GOBP BRADYKININ CATABOLIC PROCESS 7 4.62e-02 2.15e-01 0.546000 5.39e-01 8.56e-02 1.35e-02 6.95e-01
Highly calcium permeable nicotinic acetylcholine receptors 9 1.99e-02 1.26e-01 0.546000 -5.33e-01 -1.16e-01 5.60e-03 5.48e-01
Formation of the anterior neural plate 10 9.01e-03 7.31e-02 0.546000 5.08e-01 -1.98e-01 5.37e-03 2.79e-01
GOBP G1 TO G0 TRANSITION INVOLVED IN CELL DIFFERENTIATION 6 7.05e-02 2.78e-01 0.545000 4.59e-02 5.43e-01 8.46e-01 2.13e-02
GOMF VINCULIN BINDING 11 9.24e-03 7.42e-02 0.545000 5.12e-01 1.86e-01 3.30e-03 2.85e-01
GOMF UBIQUITIN LIGASE INHIBITOR ACTIVITY 9 2.37e-02 1.44e-01 0.544000 -3.00e-01 -4.54e-01 1.19e-01 1.85e-02
GOBP POSITIVE REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION 5 1.24e-01 3.84e-01 0.543000 4.77e-01 2.61e-01 6.49e-02 3.13e-01
GOBP ENDOCARDIAL CELL DIFFERENTIATION 6 6.43e-02 2.64e-01 0.543000 5.33e-01 -1.05e-01 2.38e-02 6.55e-01
GOBP POSITIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY 5 1.11e-01 3.60e-01 0.543000 5.42e-01 3.60e-02 3.59e-02 8.89e-01
PTK6 Regulates Cell Cycle 6 8.42e-02 3.12e-01 0.543000 -4.16e-01 -3.49e-01 7.75e-02 1.39e-01
GOBP NEGATIVE REGULATION OF CELL MATURATION 8 3.72e-02 1.90e-01 0.542000 3.44e-01 4.20e-01 9.24e-02 3.99e-02
GOBP RECEPTOR MEDIATED ENDOCYTOSIS INVOLVED IN CHOLESTEROL TRANSPORT 9 1.49e-02 1.05e-01 0.542000 -2.18e-01 4.97e-01 2.58e-01 9.88e-03
GOBP POSITIVE REGULATION OF PROSTAGLANDIN BIOSYNTHETIC PROCESS 6 8.48e-02 3.12e-01 0.542000 4.21e-01 3.42e-01 7.43e-02 1.47e-01
GOMF LYSOZYME ACTIVITY 9 2.28e-02 1.39e-01 0.542000 -2.05e-01 -5.02e-01 2.86e-01 9.17e-03
GOBP NEURON FATE DETERMINATION 10 1.03e-02 8.07e-02 0.541000 5.24e-01 -1.35e-01 4.10e-03 4.60e-01
GOBP SOMATIC MOTOR NEURON DIFFERENTIATION 5 1.20e-01 3.76e-01 0.541000 5.22e-01 1.41e-01 4.32e-02 5.84e-01
GOMF XMP 5 NUCLEOSIDASE ACTIVITY 6 7.23e-02 2.82e-01 0.541000 2.45e-02 5.40e-01 9.17e-01 2.19e-02
GOMF ANGIOTENSIN RECEPTOR BINDING 9 2.52e-02 1.49e-01 0.541000 4.22e-01 3.38e-01 2.83e-02 7.95e-02
GOBP PROTEIN LOCALIZATION TO CELL LEADING EDGE 5 1.29e-01 3.92e-01 0.540000 3.23e-01 4.33e-01 2.12e-01 9.32e-02
GOCC INTRACELLULAR CYCLIC NUCLEOTIDE ACTIVATED CATION CHANNEL COMPLEX 5 9.46e-02 3.29e-01 0.540000 -3.56e-01 4.06e-01 1.68e-01 1.16e-01
GOCC ACTIVIN RECEPTOR COMPLEX 6 8.57e-02 3.13e-01 0.539000 4.57e-01 2.87e-01 5.27e-02 2.24e-01
Signaling by LTK 10 1.20e-02 8.93e-02 0.539000 5.38e-01 -3.64e-02 3.23e-03 8.42e-01
GOBP MYOSIN FILAMENT ORGANIZATION 6 8.52e-02 3.13e-01 0.539000 2.60e-01 4.72e-01 2.71e-01 4.53e-02
GOBP NEURAL CREST CELL MIGRATION INVOLVED IN AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 6 6.71e-02 2.70e-01 0.538000 5.25e-01 -1.17e-01 2.58e-02 6.20e-01
GOBP REGULATION OF GAMMA DELTA T CELL DIFFERENTIATION 9 1.65e-02 1.12e-01 0.538000 1.78e-01 -5.08e-01 3.55e-01 8.36e-03
GOBP OTIC VESICLE FORMATION 8 3.84e-02 1.93e-01 0.537000 4.70e-01 2.59e-01 2.13e-02 2.05e-01
GOBP SYMPATHETIC GANGLION DEVELOPMENT 9 1.73e-02 1.15e-01 0.537000 5.15e-01 -1.50e-01 7.43e-03 4.37e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF LIPID ANTIGEN VIA MHC CLASS IB 7 6.03e-02 2.52e-01 0.535000 -4.16e-01 -3.37e-01 5.65e-02 1.23e-01
MET Receptor Activation 6 7.61e-02 2.91e-01 0.535000 -5.35e-01 -2.47e-02 2.33e-02 9.16e-01
GOBP HARD PALATE DEVELOPMENT 8 3.47e-02 1.82e-01 0.535000 5.25e-01 1.04e-01 1.01e-02 6.09e-01
GOMF BH3 DOMAIN BINDING 6 8.05e-02 3.01e-01 0.535000 -1.02e-01 -5.25e-01 6.64e-01 2.59e-02
GOBP NEGATIVE REGULATION OF PLASMINOGEN ACTIVATION 8 3.62e-02 1.87e-01 0.535000 1.44e-01 5.15e-01 4.81e-01 1.16e-02
GOMF HISTONE H2A DEUBIQUITINASE ACTIVITY 5 1.21e-01 3.79e-01 0.535000 5.29e-01 7.98e-02 4.06e-02 7.57e-01
Activation of C3 and C5 6 8.26e-02 3.07e-01 0.535000 1.34e-01 5.18e-01 5.69e-01 2.81e-02
GOBP EMBRYONIC VISCEROCRANIUM MORPHOGENESIS 10 1.25e-02 9.20e-02 0.534000 5.30e-01 -6.73e-02 3.70e-03 7.12e-01
GOMF MHC CLASS IB PROTEIN BINDING 7 6.15e-02 2.55e-01 0.533000 -4.23e-01 -3.25e-01 5.26e-02 1.37e-01
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux 43 3.43e-08 1.85e-06 0.532000 4.61e-01 2.66e-01 1.65e-07 2.56e-03
GOBP ELASTIN CATABOLIC PROCESS 5 1.26e-01 3.86e-01 0.532000 -5.21e-01 -1.09e-01 4.36e-02 6.73e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED PTERIDINE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN 7 5.62e-02 2.42e-01 0.532000 -5.14e-01 -1.37e-01 1.85e-02 5.30e-01
GOBP CARDIAC FIBROBLAST CELL DIFFERENTIATION 5 1.02e-01 3.43e-01 0.532000 3.29e-01 -4.18e-01 2.02e-01 1.06e-01
TGFBR3 expression 28 1.17e-05 3.29e-04 0.532000 4.98e-01 1.88e-01 5.15e-06 8.50e-02
GOMF HISTONE H3K9ME2 METHYLTRANSFERASE ACTIVITY 7 6.13e-02 2.55e-01 0.532000 4.56e-01 2.74e-01 3.67e-02 2.10e-01
GOBP SUCKLING BEHAVIOR 12 4.94e-03 4.69e-02 0.532000 5.12e-01 -1.44e-01 2.13e-03 3.88e-01
GOBP G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY 10 1.21e-02 8.96e-02 0.532000 -5.13e-01 1.40e-01 4.97e-03 4.45e-01
GOMF G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR ACTIVITY 10 1.21e-02 8.96e-02 0.532000 -5.13e-01 1.40e-01 4.97e-03 4.45e-01
GOBP PENETRATION OF ZONA PELLUCIDA 9 2.86e-02 1.62e-01 0.532000 -3.96e-01 -3.54e-01 3.95e-02 6.57e-02
GOBP MITOCHONDRIAL RNA CATABOLIC PROCESS 6 8.47e-02 3.12e-01 0.532000 -1.26e-01 -5.16e-01 5.92e-01 2.85e-02
GOMF LIPOTEICHOIC ACID BINDING 5 1.26e-01 3.87e-01 0.531000 -5.21e-01 -1.01e-01 4.34e-02 6.95e-01
GOBP NEGATIVE REGULATION OF MYOFIBROBLAST DIFFERENTIATION 6 7.23e-02 2.82e-01 0.531000 5.18e-01 -1.16e-01 2.81e-02 6.22e-01
GOBP VENTRICULAR COMPACT MYOCARDIUM MORPHOGENESIS 8 4.08e-02 2.00e-01 0.531000 4.78e-01 2.30e-01 1.92e-02 2.59e-01
GOBP CARDIAC PACEMAKER CELL DIFFERENTIATION 10 1.47e-02 1.04e-01 0.530000 5.30e-01 1.84e-02 3.70e-03 9.20e-01
Estrogen-stimulated signaling through PRKCZ 6 9.08e-02 3.23e-01 0.530000 4.79e-01 2.27e-01 4.21e-02 3.36e-01
GOMF HISTONE H3 ACETYLTRANSFERASE ACTIVITY 15 1.55e-03 1.94e-02 0.530000 5.26e-01 -6.91e-02 4.24e-04 6.43e-01
LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production 5 1.10e-01 3.59e-01 0.530000 5.05e-01 -1.58e-01 5.03e-02 5.40e-01
GOBP CYTOPLASMIC SEQUESTERING OF PROTEIN 13 5.96e-03 5.37e-02 0.530000 4.41e-01 2.93e-01 5.92e-03 6.70e-02
GOBP URETERIC BUD FORMATION 7 4.45e-02 2.11e-01 0.529000 4.88e-01 -2.04e-01 2.53e-02 3.49e-01
GOBP POSITIVE REGULATION OF FIBROBLAST MIGRATION 15 2.05e-03 2.40e-02 0.529000 5.23e-01 7.63e-02 4.48e-04 6.09e-01
GOBP POSITIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS 6 7.39e-02 2.86e-01 0.528000 5.15e-01 -1.19e-01 2.91e-02 6.12e-01
Creation of C4 and C2 activators 14 3.04e-03 3.24e-02 0.528000 -5.25e-01 -5.20e-02 6.65e-04 7.36e-01
Synthesis of PIPs at the early endosome membrane 15 2.48e-03 2.78e-02 0.528000 4.96e-01 1.80e-01 8.81e-04 2.27e-01
GOMF INTERLEUKIN 2 RECEPTOR BINDING 5 1.09e-01 3.56e-01 0.527000 -2.46e-01 4.66e-01 3.40e-01 7.13e-02
GOBP REGULATION OF INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY 11 1.41e-02 1.01e-01 0.526000 3.32e-01 4.08e-01 5.66e-02 1.91e-02
GOBP FC RECEPTOR MEDIATED INHIBITORY SIGNALING PATHWAY 5 1.24e-01 3.84e-01 0.526000 -5.26e-01 1.89e-03 4.17e-02 9.94e-01
GOMF CCR2 CHEMOKINE RECEPTOR BINDING 5 1.38e-01 4.08e-01 0.525000 -1.84e-01 -4.92e-01 4.76e-01 5.68e-02
GOBP ROSTROCAUDAL NEURAL TUBE PATTERNING 10 1.68e-02 1.13e-01 0.524000 5.22e-01 5.42e-02 4.28e-03 7.67e-01
GOMF BMP RECEPTOR ACTIVITY 8 4.62e-02 2.15e-01 0.524000 3.95e-01 3.45e-01 5.30e-02 9.13e-02
GOMF MHC CLASS I RECEPTOR ACTIVITY 13 4.97e-03 4.71e-02 0.524000 -5.22e-01 -4.73e-02 1.13e-03 7.68e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 5 PRODUCTION 7 4.49e-02 2.12e-01 0.523000 -3.88e-01 3.51e-01 7.54e-02 1.07e-01
GOMF SPHINGOMYELIN PHOSPHODIESTERASE ACTIVITY 7 4.53e-02 2.13e-01 0.523000 -3.13e-01 4.20e-01 1.52e-01 5.45e-02
Signaling by FGFR4 in disease 11 1.21e-02 9.00e-02 0.523000 5.13e-01 1.04e-01 3.21e-03 5.51e-01
GOMF RETROMER COMPLEX BINDING 9 1.88e-02 1.22e-01 0.523000 4.21e-01 -3.10e-01 2.87e-02 1.07e-01
GOBP INTERLEUKIN 23 PRODUCTION 10 1.34e-02 9.71e-02 0.523000 -4.89e-01 1.84e-01 7.39e-03 3.15e-01
GOBP REGULATION OF ASYMMETRIC CELL DIVISION 5 1.22e-01 3.81e-01 0.522000 5.15e-01 -8.32e-02 4.60e-02 7.47e-01
GOMF HISTONE H3K27 METHYLTRANSFERASE ACTIVITY 6 8.91e-02 3.19e-01 0.522000 5.18e-01 6.44e-02 2.81e-02 7.85e-01
GOCC SIGNAL RECOGNITION PARTICLE 8 4.43e-02 2.10e-01 0.522000 -1.92e-01 -4.85e-01 3.47e-01 1.75e-02
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY NOREPINEPHRINE EPINEPHRINE 6 7.22e-02 2.82e-01 0.521000 4.26e-01 -3.00e-01 7.06e-02 2.03e-01
GOBP CIRCADIAN SLEEP WAKE CYCLE NON REM SLEEP 6 8.54e-02 3.13e-01 0.521000 5.21e-01 -2.10e-03 2.70e-02 9.93e-01
GOBP DEVELOPMENT OF SECONDARY SEXUAL CHARACTERISTICS 10 1.83e-02 1.20e-01 0.521000 -8.48e-02 -5.14e-01 6.42e-01 4.86e-03
Activation of RAC1 downstream of NMDARs 7 7.01e-02 2.77e-01 0.521000 3.32e-01 4.02e-01 1.28e-01 6.58e-02
GOCC NPBAF COMPLEX 14 4.09e-03 4.06e-02 0.520000 5.02e-01 1.38e-01 1.15e-03 3.73e-01
GOBP CHITIN METABOLIC PROCESS 6 7.70e-02 2.93e-01 0.520000 -4.89e-01 1.77e-01 3.79e-02 4.54e-01
GOMF CHITINASE ACTIVITY 6 7.70e-02 2.93e-01 0.520000 -4.89e-01 1.77e-01 3.79e-02 4.54e-01
GOMF GLYCOLIPID MANNOSYLTRANSFERASE ACTIVITY 5 1.48e-01 4.25e-01 0.519000 -2.33e-01 -4.64e-01 3.67e-01 7.26e-02
GOBP NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS 7 6.12e-02 2.55e-01 0.519000 5.16e-01 5.70e-02 1.82e-02 7.94e-01
GOBP POSITIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION 7 6.76e-02 2.71e-01 0.518000 1.87e-01 4.83e-01 3.91e-01 2.68e-02
GOBP CARDIAC MUSCLE CELL FATE COMMITMENT 8 3.60e-02 1.86e-01 0.518000 5.09e-01 -9.51e-02 1.26e-02 6.41e-01
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY 5 1.19e-01 3.75e-01 0.518000 -4.73e-01 2.12e-01 6.72e-02 4.13e-01
GOBP REGULATION OF FEAR RESPONSE 10 1.49e-02 1.05e-01 0.518000 4.94e-01 -1.56e-01 6.88e-03 3.93e-01
GOBP MESENDODERM DEVELOPMENT 9 2.55e-02 1.51e-01 0.517000 5.15e-01 -4.34e-02 7.46e-03 8.22e-01
GOBP NEGATIVE REGULATION OF FEEDING BEHAVIOR 6 8.74e-02 3.16e-01 0.517000 -3.16e-02 5.16e-01 8.93e-01 2.87e-02
GOBP REGULATION OF MYOFIBROBLAST DIFFERENTIATION 9 2.06e-02 1.29e-01 0.517000 3.94e-01 -3.34e-01 4.09e-02 8.23e-02
GOBP RESPONSE TO YEAST 7 5.00e-02 2.26e-01 0.516000 -4.43e-01 2.66e-01 4.25e-02 2.24e-01
Chylomicron remodeling 10 1.69e-02 1.13e-01 0.516000 -5.13e-01 5.59e-02 4.95e-03 7.59e-01
GOBP KERATINIZATION 77 2.60e-14 4.26e-12 0.516000 -5.14e-01 4.89e-02 6.25e-15 4.58e-01
GOMF HISTONE DEUBIQUITINASE ACTIVITY 7 6.96e-02 2.76e-01 0.516000 4.79e-01 1.92e-01 2.82e-02 3.80e-01
GOMF SEROTONIN BINDING 10 2.41e-02 1.46e-01 0.516000 4.09e-01 3.14e-01 2.51e-02 8.57e-02
GOBP REGULATION OF MONOATOMIC ANION TRANSMEMBRANE TRANSPORT 5 1.55e-01 4.35e-01 0.515000 4.28e-01 2.86e-01 9.70e-02 2.68e-01
GOBP POSITIVE REGULATION OF PODOSOME ASSEMBLY 10 1.40e-02 1.00e-01 0.515000 -2.83e-01 4.31e-01 1.22e-01 1.83e-02
GOCC CYTOSOLIC SMALL RIBOSOMAL SUBUNIT 38 3.71e-07 1.63e-05 0.515000 -9.05e-02 -5.07e-01 3.34e-01 6.24e-08
GOBP POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS 10 1.40e-02 1.00e-01 0.515000 -4.29e-01 2.84e-01 1.88e-02 1.19e-01
GOBP POSITIVE REGULATION OF FEAR RESPONSE 7 6.01e-02 2.52e-01 0.515000 5.15e-01 -1.75e-02 1.84e-02 9.36e-01
Synthesis of pyrophosphates in the cytosol 8 4.22e-02 2.04e-01 0.515000 5.14e-01 3.14e-02 1.19e-02 8.78e-01
GOMF KERATIN FILAMENT BINDING 6 8.52e-02 3.13e-01 0.515000 -1.01e-01 5.04e-01 6.67e-01 3.24e-02
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 SIGNALING PATHWAY 6 1.08e-01 3.55e-01 0.514000 3.15e-01 4.07e-01 1.82e-01 8.44e-02
Negative regulation of FLT3 15 1.64e-03 2.03e-02 0.514000 3.70e-01 -3.57e-01 1.32e-02 1.66e-02
Viral mRNA Translation 83 1.87e-14 3.18e-12 0.514000 -1.49e-01 -4.92e-01 1.88e-02 9.35e-15
GOBP DETECTION OF VIRUS 6 7.73e-02 2.94e-01 0.514000 3.34e-01 -3.90e-01 1.56e-01 9.79e-02
GOMF STRUCTURAL CONSTITUENT OF SKIN EPIDERMIS 36 2.18e-07 1.01e-05 0.514000 -3.94e-01 3.29e-01 4.23e-05 6.30e-04
GOBP NEUROENDOCRINE CELL DIFFERENTIATION 16 1.66e-03 2.04e-02 0.513000 5.13e-01 -2.49e-02 3.82e-04 8.63e-01
Peptide chain elongation 83 2.12e-14 3.57e-12 0.513000 -1.55e-01 -4.89e-01 1.49e-02 1.26e-14
GOMF HISTONE H3K14 ACETYLTRANSFERASE ACTIVITY 9 2.75e-02 1.58e-01 0.513000 5.12e-01 -2.64e-02 7.82e-03 8.91e-01
GOBP FOREBRAIN DORSAL VENTRAL PATTERN FORMATION 7 5.53e-02 2.40e-01 0.513000 4.86e-01 -1.62e-01 2.59e-02 4.57e-01
GOBP CELLULAR DETOXIFICATION OF ALDEHYDE 9 2.99e-02 1.66e-01 0.512000 5.10e-01 5.29e-02 8.10e-03 7.84e-01
GOBP NEGATIVE REGULATION OF VITAMIN D BIOSYNTHETIC PROCESS 5 1.28e-01 3.90e-01 0.512000 1.44e-01 -4.92e-01 5.76e-01 5.70e-02
GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION 5 1.56e-01 4.36e-01 0.512000 -2.34e-01 -4.56e-01 3.65e-01 7.77e-02
GOBP SPHINGOMYELIN CATABOLIC PROCESS 8 3.44e-02 1.81e-01 0.512000 -2.72e-01 4.34e-01 1.83e-01 3.37e-02
GOBP GLUCOSYLCERAMIDE METABOLIC PROCESS 11 1.77e-02 1.17e-01 0.512000 3.09e-01 4.08e-01 7.62e-02 1.91e-02
GOBP GANGLION DEVELOPMENT 17 1.00e-03 1.38e-02 0.512000 5.01e-01 -1.05e-01 3.51e-04 4.52e-01
GOBP POSITIVE REGULATION OF AMYLOID FIBRIL FORMATION 5 1.59e-01 4.41e-01 0.512000 4.25e-01 2.85e-01 1.00e-01 2.69e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED ASCORBATE AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN 5 1.21e-01 3.79e-01 0.511000 -3.67e-01 3.55e-01 1.55e-01 1.69e-01
GOBP REGULATION OF HEART RATE BY CHEMICAL SIGNAL 6 1.08e-01 3.54e-01 0.511000 4.65e-01 2.10e-01 4.85e-02 3.72e-01
GOCC LAMININ COMPLEX 9 3.61e-02 1.87e-01 0.510000 4.52e-01 2.38e-01 1.89e-02 2.17e-01
GOCC MLL3 4 COMPLEX 10 1.96e-02 1.24e-01 0.510000 5.10e-01 -6.68e-03 5.20e-03 9.71e-01
GOBP PURINE NUCLEOSIDE TRANSMEMBRANE TRANSPORT 5 1.61e-01 4.45e-01 0.510000 4.07e-01 3.07e-01 1.15e-01 2.34e-01
GOCC POLAR MICROTUBULE 5 1.60e-01 4.43e-01 0.510000 2.73e-01 4.31e-01 2.90e-01 9.54e-02
GOBP REGULATION OF SERINE TYPE PEPTIDASE ACTIVITY 6 1.12e-01 3.63e-01 0.510000 -4.01e-01 -3.15e-01 8.90e-02 1.81e-01
GOCC SIGNAL PEPTIDASE COMPLEX 5 1.37e-01 4.07e-01 0.510000 4.18e-02 -5.08e-01 8.71e-01 4.90e-02
GOCC AP 2 ADAPTOR COMPLEX 11 1.49e-02 1.05e-01 0.510000 5.03e-01 8.60e-02 3.89e-03 6.21e-01
GOBP EPIDERMAL CELL FATE SPECIFICATION 5 1.47e-01 4.22e-01 0.509000 5.05e-01 6.55e-02 5.04e-02 8.00e-01
GOMF ALKANE 1 MONOOXYGENASE ACTIVITY 5 1.26e-01 3.87e-01 0.509000 2.23e-01 -4.58e-01 3.88e-01 7.61e-02
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE SIGNAL SEQUENCE RECOGNITION 6 1.07e-01 3.53e-01 0.509000 -1.69e-01 -4.80e-01 4.74e-01 4.17e-02
Sensory Perception 550 1.61e-91 2.47e-88 0.509000 -5.07e-01 -3.54e-02 6.26e-93 1.55e-01
GOBP GLUTAMATE REUPTAKE 6 1.08e-01 3.54e-01 0.509000 1.76e-01 4.77e-01 4.54e-01 4.31e-02
GOBP REGULATION OF 3 UTR MEDIATED MRNA STABILIZATION 7 7.55e-02 2.90e-01 0.508000 4.68e-01 1.98e-01 3.19e-02 3.65e-01
GOBP REGULATION OF SOMITOGENESIS 6 8.16e-02 3.04e-01 0.508000 -3.27e-01 3.89e-01 1.66e-01 9.85e-02
GOCC PARASPECKLES 8 3.99e-02 1.97e-01 0.508000 1.24e-01 -4.93e-01 5.42e-01 1.58e-02
GOCC DEATH INDUCING SIGNALING COMPLEX 9 2.46e-02 1.47e-01 0.508000 4.53e-01 -2.29e-01 1.86e-02 2.34e-01
Fructose catabolism 5 1.49e-01 4.26e-01 0.508000 7.01e-02 5.03e-01 7.86e-01 5.16e-02
GOCC KAINATE SELECTIVE GLUTAMATE RECEPTOR COMPLEX 5 1.43e-01 4.15e-01 0.508000 -5.07e-01 7.22e-03 4.94e-02 9.78e-01
GOMF KAINATE SELECTIVE GLUTAMATE RECEPTOR ACTIVITY 5 1.43e-01 4.15e-01 0.508000 -5.07e-01 7.22e-03 4.94e-02 9.78e-01
GOMF 7SK SNRNA BINDING 9 2.61e-02 1.53e-01 0.507000 1.69e-01 -4.78e-01 3.81e-01 1.30e-02
GOBP REGULATION OF GLUCOKINASE ACTIVITY 5 1.65e-01 4.49e-01 0.507000 -4.16e-01 -2.89e-01 1.07e-01 2.63e-01
GOMF S METHYLTRANSFERASE ACTIVITY 10 2.31e-02 1.41e-01 0.506000 4.99e-01 8.09e-02 6.24e-03 6.58e-01
Signaling by cytosolic FGFR1 fusion mutants 18 1.15e-03 1.53e-02 0.505000 4.99e-01 7.84e-02 2.45e-04 5.65e-01
GOCC WEIBEL PALADE BODY 5 1.41e-01 4.12e-01 0.505000 5.01e-01 -6.82e-02 5.26e-02 7.92e-01
YAP1- and WWTR1 (TAZ)-stimulated gene expression 14 5.31e-03 4.93e-02 0.505000 4.97e-01 8.85e-02 1.29e-03 5.66e-01
GOCC 3M COMPLEX 5 1.69e-01 4.54e-01 0.505000 3.43e-01 3.70e-01 1.84e-01 1.52e-01
GOBP GLIAL CELL FATE COMMITMENT 13 4.78e-03 4.58e-02 0.504000 3.87e-01 -3.23e-01 1.56e-02 4.36e-02
GOBP RESPONSE TO L LEUCINE 15 2.94e-03 3.17e-02 0.504000 5.02e-01 -4.87e-02 7.62e-04 7.44e-01
GOBP NEGATIVE REGULATION OF TYPE B PANCREATIC CELL APOPTOTIC PROCESS 6 9.40e-02 3.28e-01 0.504000 4.95e-01 -9.74e-02 3.58e-02 6.79e-01
Removal of aminoterminal propeptides from gamma-carboxylated proteins 8 4.13e-02 2.01e-01 0.504000 -1.41e-01 4.84e-01 4.89e-01 1.78e-02
GOBP SUGAR MEDIATED SIGNALING PATHWAY 9 2.99e-02 1.66e-01 0.504000 5.00e-01 -6.39e-02 9.39e-03 7.40e-01
GOBP GAP JUNCTION MEDIATED INTERCELLULAR TRANSPORT 6 8.68e-02 3.15e-01 0.504000 -4.32e-01 2.60e-01 6.71e-02 2.71e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C 12 1.16e-02 8.74e-02 0.503000 -9.80e-02 -4.94e-01 5.57e-01 3.05e-03
GOBP LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS 6 8.64e-02 3.14e-01 0.503000 -2.83e-01 4.16e-01 2.30e-01 7.74e-02
Eukaryotic Translation Termination 86 2.68e-14 4.34e-12 0.503000 -1.62e-01 -4.76e-01 9.41e-03 2.23e-14
GOBP DETECTION OF STIMULUS 574 9.85e-93 1.73e-89 0.503000 -5.00e-01 -5.29e-02 4.75e-94 3.04e-02
GOBP SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 22 2.63e-04 4.68e-03 0.502000 5.00e-01 4.42e-02 4.90e-05 7.20e-01
GOBP RESOLUTION OF DNA RECOMBINATION INTERMEDIATES 6 1.21e-01 3.79e-01 0.502000 3.27e-01 3.81e-01 1.66e-01 1.06e-01
GOBP MAINTENANCE OF SISTER CHROMATID COHESION 11 1.58e-02 1.09e-01 0.502000 5.01e-01 2.26e-02 4.00e-03 8.97e-01
GOBP NEURON CELL CELL ADHESION 13 7.26e-03 6.28e-02 0.502000 -5.02e-01 -3.70e-03 1.74e-03 9.82e-01
GOBP RESPONSE TO PHEROMONE 7 6.80e-02 2.72e-01 0.501000 -4.99e-01 4.74e-02 2.22e-02 8.28e-01
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT PHOSPHATASE ACTIVITY 7 8.56e-02 3.13e-01 0.501000 3.86e-01 3.19e-01 7.68e-02 1.44e-01
Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells 15 2.40e-03 2.71e-02 0.500000 4.28e-01 -2.60e-01 4.12e-03 8.15e-02
GOBP POSITIVE REGULATION OF NEUROEPITHELIAL CELL DIFFERENTIATION 8 6.06e-02 2.53e-01 0.500000 3.92e-01 3.11e-01 5.50e-02 1.27e-01
GOBP REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY 7 6.50e-02 2.65e-01 0.500000 4.84e-01 -1.26e-01 2.66e-02 5.63e-01
GOBP IRON ION IMPORT ACROSS PLASMA MEMBRANE 5 1.74e-01 4.60e-01 0.500000 -3.99e-01 -3.01e-01 1.22e-01 2.43e-01
GOCC CALCINEURIN COMPLEX 6 9.32e-02 3.27e-01 0.500000 1.84e-01 -4.65e-01 4.35e-01 4.87e-02
GOCC CLATHRIN COAT OF COATED PIT 18 1.30e-03 1.70e-02 0.500000 4.95e-01 6.45e-02 2.73e-04 6.36e-01
GOBP VASCULOGENESIS INVOLVED IN CORONARY VASCULAR MORPHOGENESIS 5 1.75e-01 4.61e-01 0.499000 3.00e-01 3.99e-01 2.46e-01 1.23e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE INHIBITOR ACTIVITY 12 1.54e-02 1.07e-01 0.499000 -3.22e-01 -3.81e-01 5.33e-02 2.25e-02
GOBP PEPTIDYL LYSINE DIMETHYLATION 5 1.69e-01 4.54e-01 0.498000 4.63e-01 1.84e-01 7.30e-02 4.75e-01
Eukaryotic Translation Elongation 87 3.16e-14 4.97e-12 0.498000 -1.55e-01 -4.74e-01 1.24e-02 2.16e-14
APOBEC3G mediated resistance to HIV-1 infection 5 1.73e-01 4.59e-01 0.498000 -4.37e-01 -2.40e-01 9.07e-02 3.53e-01
GOCC CDC73 PAF1 COMPLEX 7 7.90e-02 2.98e-01 0.498000 4.86e-01 1.07e-01 2.58e-02 6.24e-01
GOBP OLFACTORY NERVE DEVELOPMENT 6 1.09e-01 3.56e-01 0.498000 3.65e-02 4.97e-01 8.77e-01 3.52e-02
Multifunctional anion exchangers 9 2.80e-02 1.60e-01 0.497000 -4.24e-01 2.60e-01 2.75e-02 1.77e-01
Uptake of dietary cobalamins into enterocytes 9 2.88e-02 1.62e-01 0.497000 -2.17e-01 4.48e-01 2.60e-01 2.00e-02
GOMF TELOMERASE INHIBITOR ACTIVITY 5 1.48e-01 4.24e-01 0.497000 4.89e-01 -8.87e-02 5.82e-02 7.31e-01
GOMF MELANOCORTIN RECEPTOR BINDING 5 1.72e-01 4.58e-01 0.497000 2.08e-01 4.52e-01 4.21e-01 8.03e-02
GOBP INDUCTION OF BACTERIAL AGGLUTINATION 6 1.19e-01 3.76e-01 0.497000 -4.66e-01 -1.72e-01 4.81e-02 4.65e-01
Regulation of TP53 Activity through Association with Co-factors 14 8.07e-03 6.75e-02 0.496000 3.42e-01 3.60e-01 2.69e-02 1.96e-02
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 5 PHOSPHATASE ACTIVITY 12 1.44e-02 1.02e-01 0.496000 4.64e-01 1.76e-01 5.38e-03 2.91e-01
GOBP LIPOPHAGY 7 8.99e-02 3.21e-01 0.496000 3.64e-01 3.37e-01 9.51e-02 1.23e-01
GOBP REGULATION OF CORTICOTROPIN SECRETION 5 1.71e-01 4.56e-01 0.496000 4.68e-01 1.63e-01 6.98e-02 5.28e-01
GOCC SPERM MITOCHONDRIAL SHEATH 6 1.02e-01 3.44e-01 0.496000 -4.88e-01 8.58e-02 3.83e-02 7.16e-01
GOCC CYTOSOLIC LARGE RIBOSOMAL SUBUNIT 51 1.30e-08 7.83e-07 0.495000 -1.27e-01 -4.79e-01 1.18e-01 3.25e-09
GOBP B CELL LINEAGE COMMITMENT 6 1.27e-01 3.88e-01 0.495000 4.13e-01 2.73e-01 8.01e-02 2.47e-01
LDL remodeling 6 1.29e-01 3.93e-01 0.494000 -3.50e-01 -3.49e-01 1.38e-01 1.39e-01
GOMF INTRONIC TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING 11 2.26e-02 1.38e-01 0.494000 4.30e-01 2.44e-01 1.36e-02 1.61e-01
GOBP RESPONSE TO FUNGICIDE 7 8.86e-02 3.18e-01 0.494000 2.14e-01 4.45e-01 3.26e-01 4.16e-02
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS 5 1.64e-01 4.48e-01 0.494000 4.91e-01 4.89e-02 5.72e-02 8.50e-01
GOCC EXTRINSIC COMPONENT OF PRESYNAPTIC MEMBRANE 6 1.29e-01 3.92e-01 0.494000 3.98e-01 2.92e-01 9.14e-02 2.15e-01
GOMF NEUROLIGIN FAMILY PROTEIN BINDING 5 1.59e-01 4.41e-01 0.493000 -4.93e-01 1.18e-02 5.61e-02 9.64e-01
GOBP BASEMENT MEMBRANE ASSEMBLY 9 4.53e-02 2.13e-01 0.493000 4.32e-01 2.38e-01 2.49e-02 2.16e-01
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM 5 1.64e-01 4.48e-01 0.493000 -4.33e-02 -4.91e-01 8.67e-01 5.73e-02
GOBP MEIOTIC METAPHASE CHROMOSOME ALIGNMENT 5 1.50e-01 4.28e-01 0.493000 1.28e-01 -4.76e-01 6.19e-01 6.54e-02
GOMF TRAIL BINDING 5 1.53e-01 4.31e-01 0.492000 -1.00e-01 4.82e-01 6.99e-01 6.20e-02
GOMF METAL ION SEQUESTERING ACTIVITY 5 1.43e-01 4.14e-01 0.492000 -4.13e-01 2.67e-01 1.09e-01 3.01e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE 4 PHOSPHATASE ACTIVITY 8 5.98e-02 2.52e-01 0.492000 4.77e-01 1.23e-01 1.96e-02 5.48e-01
GOBP GAMMA AMINOBUTYRIC ACID BIOSYNTHETIC PROCESS 6 1.03e-01 3.46e-01 0.492000 4.73e-01 -1.34e-01 4.47e-02 5.71e-01
Reversal of alkylation damage by DNA dioxygenases 7 9.38e-02 3.28e-01 0.492000 3.82e-01 3.09e-01 7.99e-02 1.57e-01
GOBP CORNIFIED ENVELOPE ASSEMBLY 6 1.13e-01 3.65e-01 0.491000 4.91e-01 8.40e-03 3.71e-02 9.72e-01
GOBP DIET INDUCED THERMOGENESIS 13 1.03e-02 8.03e-02 0.491000 4.79e-01 1.11e-01 2.80e-03 4.90e-01
GOBP POSITIVE REGULATION OF CHONDROCYTE PROLIFERATION 8 4.47e-02 2.11e-01 0.491000 2.76e-01 -4.06e-01 1.76e-01 4.67e-02
GOBP PROTEIN POLYUFMYLATION 5 1.42e-01 4.14e-01 0.491000 3.15e-01 -3.76e-01 2.22e-01 1.45e-01
GOCC ANKYRIN 1 COMPLEX 7 9.46e-02 3.29e-01 0.491000 -3.70e-01 -3.22e-01 8.99e-02 1.40e-01
GOBP P BODY ASSEMBLY 22 2.77e-04 4.87e-03 0.491000 4.83e-01 -8.64e-02 8.71e-05 4.83e-01
GOBP GLYCOSYLCERAMIDE CATABOLIC PROCESS 10 3.14e-02 1.71e-01 0.491000 1.67e-01 4.62e-01 3.61e-01 1.15e-02
Metallothioneins bind metals 11 1.46e-02 1.03e-01 0.490000 -4.37e-01 2.22e-01 1.20e-02 2.02e-01
GOBP PROTEIN LOCALIZATION TO CILIARY MEMBRANE 11 1.57e-02 1.09e-01 0.490000 1.45e-01 -4.68e-01 4.04e-01 7.15e-03
GOBP COLLATERAL SPROUTING IN ABSENCE OF INJURY 5 1.61e-01 4.45e-01 0.490000 4.90e-01 -2.10e-02 5.78e-02 9.35e-01
GOBP PANCREATIC A CELL DIFFERENTIATION 10 2.51e-02 1.49e-01 0.490000 4.86e-01 -6.24e-02 7.79e-03 7.33e-01
GOMF INOSITOL TETRAKISPHOSPHATE PHOSPHATASE ACTIVITY 7 8.89e-02 3.19e-01 0.490000 4.65e-01 1.52e-01 3.30e-02 4.87e-01
GOBP ENDOTHELIN RECEPTOR SIGNALING PATHWAY 11 1.76e-02 1.16e-01 0.489000 4.86e-01 -5.90e-02 5.27e-03 7.35e-01
GOBP VESICLE TETHERING TO GOLGI 5 1.48e-01 4.25e-01 0.489000 4.42e-01 -2.09e-01 8.67e-02 4.18e-01
GOBP POSITIVE REGULATION OF CHROMATIN ORGANIZATION 14 4.44e-03 4.34e-02 0.489000 3.44e-01 -3.48e-01 2.58e-02 2.43e-02
GOBP POSITIVE REGULATION OF HEPATOCYTE PROLIFERATION 10 3.00e-02 1.66e-01 0.489000 -9.09e-02 -4.80e-01 6.19e-01 8.51e-03
RHO GTPases activate PAKs 19 1.26e-03 1.65e-02 0.489000 4.82e-01 8.41e-02 2.78e-04 5.26e-01
GOBP NEGATIVE REGULATION OF SCHWANN CELL PROLIFERATION 8 6.70e-02 2.70e-01 0.488000 4.33e-01 2.27e-01 3.41e-02 2.67e-01
GOBP POSITIVE REGULATION OF AGGREPHAGY 6 9.88e-02 3.37e-01 0.488000 3.29e-01 -3.61e-01 1.62e-01 1.26e-01
GOMF ATP DEPENDENT CHROMATIN REMODELER ACTIVITY 33 1.50e-05 4.09e-04 0.488000 4.27e-01 2.37e-01 2.18e-05 1.86e-02
Signaling by PDGFRA extracellular domain mutants 12 1.19e-02 8.90e-02 0.488000 4.79e-01 -9.50e-02 4.09e-03 5.69e-01
Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants 12 1.19e-02 8.90e-02 0.488000 4.79e-01 -9.50e-02 4.09e-03 5.69e-01
Formation of a pool of free 40S subunits 93 1.06e-14 1.86e-12 0.488000 -1.15e-01 -4.74e-01 5.50e-02 2.61e-15
PI-3K cascade:FGFR3 17 3.08e-03 3.28e-02 0.488000 4.51e-01 1.85e-01 1.27e-03 1.87e-01
CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde 8 5.93e-02 2.50e-01 0.488000 5.07e-02 4.85e-01 8.04e-01 1.75e-02
GOBP PURINE RIBONUCLEOSIDE SALVAGE 6 1.07e-01 3.53e-01 0.488000 1.28e-01 -4.71e-01 5.88e-01 4.59e-02
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE 7 8.72e-02 3.16e-01 0.487000 -8.56e-02 -4.79e-01 6.95e-01 2.80e-02
GOBP CHEMOKINE C X C MOTIF LIGAND 1 PRODUCTION 6 1.04e-01 3.46e-01 0.487000 -4.36e-01 2.17e-01 6.46e-02 3.57e-01
GOBP RETINAL CELL PROGRAMMED CELL DEATH 6 1.01e-01 3.41e-01 0.487000 3.85e-01 -2.97e-01 1.02e-01 2.08e-01
GOMF ARMADILLO REPEAT DOMAIN BINDING 8 5.63e-02 2.43e-01 0.487000 4.86e-01 -2.64e-02 1.73e-02 8.97e-01
GOBP AMP CATABOLIC PROCESS 5 1.87e-01 4.78e-01 0.487000 2.28e-01 4.30e-01 3.76e-01 9.62e-02
GOBP REGULATION OF NEUTROPHIL EXTRAVASATION 5 1.50e-01 4.29e-01 0.486000 -4.27e-01 2.34e-01 9.85e-02 3.66e-01
GOMF PYRIMIDINE NUCLEOTIDE BINDING 5 1.91e-01 4.82e-01 0.486000 -3.87e-01 -2.95e-01 1.34e-01 2.53e-01
GOMF FATTY ACYL COA SYNTHASE ACTIVITY 7 9.37e-02 3.28e-01 0.486000 -4.50e-01 -1.83e-01 3.91e-02 4.01e-01
GOBP PHARYNGEAL SYSTEM DEVELOPMENT 31 1.36e-05 3.78e-04 0.486000 4.84e-01 -4.93e-02 3.13e-06 6.35e-01
GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DEVELOPMENT 5 1.63e-01 4.46e-01 0.486000 4.81e-01 -6.72e-02 6.23e-02 7.95e-01
GOMF INOSITOL PHOSPHATE PHOSPHATASE ACTIVITY 18 2.32e-03 2.62e-02 0.486000 4.47e-01 1.91e-01 1.03e-03 1.61e-01
GOBP POSITIVE REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION 11 1.52e-02 1.06e-01 0.485000 3.17e-01 -3.67e-01 6.89e-02 3.48e-02
GOCC MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX III 12 1.53e-02 1.07e-01 0.485000 -6.18e-02 -4.81e-01 7.11e-01 3.90e-03
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS DISULFIDE AS ACCEPTOR 7 8.58e-02 3.13e-01 0.485000 3.58e-02 4.84e-01 8.70e-01 2.67e-02
Signaling by PDGFR in disease 20 7.81e-04 1.13e-02 0.485000 4.84e-01 -3.15e-02 1.79e-04 8.07e-01
Tyrosine catabolism 5 1.76e-01 4.62e-01 0.485000 6.11e-02 4.81e-01 8.13e-01 6.26e-02
GOMF LIPOPEPTIDE BINDING 10 3.74e-02 1.90e-01 0.484000 -3.92e-01 -2.84e-01 3.18e-02 1.20e-01
GOBP MACROPHAGE INFLAMMATORY PROTEIN 1 ALPHA PRODUCTION 6 1.39e-01 4.09e-01 0.484000 -2.65e-01 -4.05e-01 2.61e-01 8.58e-02
GOBP OLIGOPEPTIDE IMPORT ACROSS PLASMA MEMBRANE 5 1.84e-01 4.74e-01 0.484000 4.64e-01 1.38e-01 7.25e-02 5.94e-01
GOMF HISTONE H3K4 METHYLTRANSFERASE ACTIVITY 19 1.94e-03 2.30e-02 0.484000 4.05e-01 2.64e-01 2.25e-03 4.60e-02
GOCC BOX H ACA RNP COMPLEX 7 7.75e-02 2.94e-01 0.483000 4.63e-01 -1.36e-01 3.38e-02 5.32e-01
GOBP REGULATION OF RNA BINDING 6 1.11e-01 3.61e-01 0.483000 4.60e-01 -1.47e-01 5.12e-02 5.32e-01
GOBP RESPONSE TO THYROGLOBULIN TRIIODOTHYRONINE 5 1.53e-01 4.31e-01 0.483000 3.84e-01 -2.92e-01 1.37e-01 2.58e-01
IkBA variant leads to EDA-ID 6 1.32e-01 3.96e-01 0.482000 4.65e-01 1.28e-01 4.85e-02 5.87e-01
RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) 9 4.96e-02 2.24e-01 0.482000 -4.51e-01 -1.71e-01 1.91e-02 3.73e-01
GOBP CELLULAR RESPONSE TO L LEUCINE 12 1.72e-02 1.15e-01 0.482000 4.68e-01 1.17e-01 5.00e-03 4.82e-01
Activated NTRK2 signals through RAS 9 3.79e-02 1.91e-01 0.482000 4.66e-01 -1.26e-01 1.56e-02 5.13e-01
GOBP REGULATION OF CELL FATE SPECIFICATION 23 5.13e-04 8.03e-03 0.482000 4.28e-01 2.22e-01 3.80e-04 6.52e-02
GOMF HISTONE H3K9 METHYLTRANSFERASE ACTIVITY 12 1.65e-02 1.12e-01 0.482000 4.76e-01 7.52e-02 4.30e-03 6.52e-01
GOBP CORTISOL SECRETION 5 1.67e-01 4.51e-01 0.482000 4.74e-01 -8.39e-02 6.63e-02 7.45e-01
GOMF 4 GALACTOSYL N ACETYLGLUCOSAMINIDE 3 ALPHA L FUCOSYLTRANSFERASE ACTIVITY 6 1.06e-01 3.52e-01 0.481000 -3.97e-01 2.72e-01 9.19e-02 2.49e-01
GOBP FATTY ACYL COA CATABOLIC PROCESS 5 1.98e-01 4.92e-01 0.481000 -3.36e-01 -3.45e-01 1.94e-01 1.82e-01
GOBP RIBOSOME ASSOCIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 7 1.00e-01 3.40e-01 0.481000 4.34e-01 2.06e-01 4.67e-02 3.44e-01
GOMF SIALIC ACID BINDING 22 3.88e-04 6.40e-03 0.481000 -4.73e-01 8.74e-02 1.24e-04 4.78e-01
DNA Damage Reversal 8 7.56e-02 2.90e-01 0.480000 3.13e-01 3.65e-01 1.26e-01 7.40e-02
Formation of the ternary complex, and subsequently, the 43S complex 45 2.31e-07 1.06e-05 0.480000 -7.71e-02 -4.74e-01 3.71e-01 3.66e-08
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 7 9.80e-02 3.36e-01 0.480000 1.61e-01 4.53e-01 4.61e-01 3.81e-02
GOBP CYCLIC NUCLEOTIDE TRANSPORT 11 2.88e-02 1.62e-01 0.480000 3.20e-01 3.59e-01 6.63e-02 3.95e-02
GOBP RETINAL BLOOD VESSEL MORPHOGENESIS 5 1.68e-01 4.53e-01 0.480000 4.73e-01 -8.49e-02 6.72e-02 7.42e-01
GOBP POSITIVE REGULATION OF HEPATIC STELLATE CELL ACTIVATION 5 1.90e-01 4.80e-01 0.480000 4.57e-01 1.47e-01 7.68e-02 5.68e-01
APC truncation mutants have impaired AXIN binding 13 1.15e-02 8.67e-02 0.480000 4.79e-01 3.57e-02 2.80e-03 8.24e-01
AXIN missense mutants destabilize the destruction complex 13 1.15e-02 8.67e-02 0.480000 4.79e-01 3.57e-02 2.80e-03 8.24e-01
Signaling by AMER1 mutants 13 1.15e-02 8.67e-02 0.480000 4.79e-01 3.57e-02 2.80e-03 8.24e-01
Signaling by APC mutants 13 1.15e-02 8.67e-02 0.480000 4.79e-01 3.57e-02 2.80e-03 8.24e-01
Signaling by AXIN mutants 13 1.15e-02 8.67e-02 0.480000 4.79e-01 3.57e-02 2.80e-03 8.24e-01
Truncations of AMER1 destabilize the destruction complex 13 1.15e-02 8.67e-02 0.480000 4.79e-01 3.57e-02 2.80e-03 8.24e-01
GOBP CELLULAR RESPONSE TO WATER STIMULUS 6 1.25e-01 3.85e-01 0.480000 4.80e-01 5.29e-03 4.17e-02 9.82e-01
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY 9 3.73e-02 1.90e-01 0.480000 -4.41e-01 1.88e-01 2.19e-02 3.28e-01
GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR ACTIVITY 9 3.73e-02 1.90e-01 0.480000 -4.41e-01 1.88e-01 2.19e-02 3.28e-01
GOBP UMP CATABOLIC PROCESS 5 1.97e-01 4.90e-01 0.480000 -4.11e-01 -2.47e-01 1.11e-01 3.38e-01
GOCC RIPOPTOSOME 6 1.08e-01 3.54e-01 0.480000 3.82e-01 -2.89e-01 1.05e-01 2.20e-01
Selenocysteine synthesis 86 4.17e-13 5.38e-11 0.479000 -1.41e-01 -4.58e-01 2.35e-02 1.99e-13
GOBP GROWTH INVOLVED IN HEART MORPHOGENESIS 5 2.02e-01 4.96e-01 0.478000 3.55e-01 3.20e-01 1.69e-01 2.16e-01
GOBP NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 14 5.72e-03 5.22e-02 0.478000 3.71e-01 -3.01e-01 1.61e-02 5.15e-02
GOBP PROTEIN RETENTION IN GOLGI APPARATUS 5 1.99e-01 4.92e-01 0.478000 4.18e-01 2.31e-01 1.05e-01 3.72e-01
Arachidonate production from DAG 5 2.01e-01 4.94e-01 0.478000 3.95e-01 2.69e-01 1.26e-01 2.98e-01
GOBP EMBRYONIC RETINA MORPHOGENESIS IN CAMERA TYPE EYE 6 1.25e-01 3.86e-01 0.478000 4.77e-01 -1.90e-02 4.29e-02 9.36e-01
GOBP NEGATIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE 6 1.30e-01 3.93e-01 0.478000 3.27e-02 4.76e-01 8.90e-01 4.33e-02
GOBP REGULATION OF SPONTANEOUS SYNAPTIC TRANSMISSION 6 1.47e-01 4.23e-01 0.477000 2.98e-01 3.73e-01 2.06e-01 1.14e-01
GOMF ADRENERGIC RECEPTOR ACTIVITY 10 2.66e-02 1.55e-01 0.477000 2.04e-01 -4.31e-01 2.64e-01 1.82e-02
GOBP PROTEIN LOCALIZATION TO CENP A CONTAINING CHROMATIN 16 3.65e-03 3.71e-02 0.477000 7.69e-02 -4.71e-01 5.94e-01 1.12e-03
GOBP PHOSPHATIDYLSERINE EXPOSURE ON APOPTOTIC CELL SURFACE 8 5.37e-02 2.36e-01 0.477000 -4.01e-01 2.58e-01 4.95e-02 2.06e-01
GOBP REGULATION OF LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR 5 1.90e-01 4.81e-01 0.477000 4.66e-01 1.00e-01 7.11e-02 6.97e-01
GOBP RESPONSE TO OXYGEN GLUCOSE DEPRIVATION 9 4.34e-02 2.07e-01 0.476000 4.72e-01 -6.18e-02 1.41e-02 7.48e-01
GOBP AORTA SMOOTH MUSCLE TISSUE MORPHOGENESIS 6 1.17e-01 3.71e-01 0.476000 4.47e-01 -1.64e-01 5.81e-02 4.86e-01
GOCC APICAL CORTEX 8 7.93e-02 2.99e-01 0.476000 3.00e-01 3.70e-01 1.42e-01 7.03e-02
GOBP PROTEIN UFMYLATION 6 1.16e-01 3.69e-01 0.476000 1.84e-01 -4.39e-01 4.35e-01 6.27e-02
GOBP ELASTIC FIBER ASSEMBLY 9 5.74e-02 2.46e-01 0.476000 3.86e-01 2.78e-01 4.48e-02 1.49e-01
GOCC NEUROFILAMENT 10 4.14e-02 2.01e-01 0.476000 4.02e-01 2.54e-01 2.76e-02 1.65e-01
GOBP SYMPATHETIC NEURON PROJECTION EXTENSION 5 1.97e-01 4.90e-01 0.476000 4.47e-01 1.63e-01 8.37e-02 5.27e-01
GOMF CARNITINE O ACYLTRANSFERASE ACTIVITY 6 1.16e-01 3.70e-01 0.476000 4.38e-01 -1.85e-01 6.30e-02 4.34e-01
GOCC CATALYTIC STEP 1 SPLICEOSOME 12 1.49e-02 1.05e-01 0.475000 4.64e-01 -1.01e-01 5.36e-03 5.44e-01
GOBP NEURAL PLATE MORPHOGENESIS 5 1.62e-01 4.45e-01 0.475000 3.78e-01 -2.87e-01 1.43e-01 2.66e-01
NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis 9 5.23e-02 2.32e-01 0.475000 4.60e-01 1.15e-01 1.68e-02 5.49e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR LIPID TRANSPORT 5 1.66e-01 4.50e-01 0.474000 -2.15e-01 4.23e-01 4.05e-01 1.02e-01
GOBP INTERLEUKIN 17 MEDIATED SIGNALING PATHWAY 12 2.05e-02 1.29e-01 0.474000 1.51e-01 4.50e-01 3.66e-01 6.99e-03
GOMF MICROTUBULE PLUS END BINDING 21 7.59e-04 1.11e-02 0.474000 4.73e-01 -3.22e-02 1.75e-04 7.98e-01
NFE2L2 regulating MDR associated enzymes 8 7.95e-02 2.99e-01 0.474000 2.43e-01 4.07e-01 2.35e-01 4.62e-02
GOMF HAPTOGLOBIN BINDING 10 3.70e-02 1.90e-01 0.473000 -4.67e-01 -7.19e-02 1.05e-02 6.94e-01
GOBP CORTICOTROPIN SECRETION 7 1.06e-01 3.52e-01 0.473000 4.40e-01 1.74e-01 4.39e-02 4.26e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN MITOCHONDRION 5 1.86e-01 4.76e-01 0.472000 -5.48e-03 4.72e-01 9.83e-01 6.75e-02
GOMF HISTONE H3K36 METHYLTRANSFERASE ACTIVITY 13 1.42e-02 1.01e-01 0.472000 4.65e-01 8.45e-02 3.73e-03 5.98e-01
GOBP BEHAVIORAL RESPONSE TO NICOTINE 8 5.62e-02 2.42e-01 0.472000 -3.46e-01 3.21e-01 9.04e-02 1.16e-01
GOMF EPOXIDE HYDROLASE ACTIVITY 8 8.21e-02 3.06e-01 0.471000 3.94e-01 2.58e-01 5.33e-02 2.06e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I 8 8.01e-02 3.00e-01 0.471000 4.23e-01 2.08e-01 3.82e-02 3.09e-01
Glucocorticoid biosynthesis 10 4.34e-02 2.07e-01 0.471000 -4.11e-01 -2.30e-01 2.44e-02 2.08e-01
GOBP NEGATIVE REGULATION OF MUSCLE ADAPTATION 11 2.66e-02 1.55e-01 0.471000 4.69e-01 4.41e-02 7.09e-03 8.00e-01
GOBP REGULATION OF NAD P H OXIDASE ACTIVITY 5 1.87e-01 4.78e-01 0.471000 -7.35e-03 4.71e-01 9.77e-01 6.83e-02
SRP-dependent cotranslational protein targeting to membrane 105 2.31e-15 4.69e-13 0.471000 -1.18e-01 -4.56e-01 3.63e-02 7.00e-16
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR 5 2.12e-01 5.08e-01 0.471000 -2.98e-01 -3.64e-01 2.48e-01 1.59e-01
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MAINTENANCE 5 2.12e-01 5.07e-01 0.470000 2.67e-01 3.87e-01 3.01e-01 1.34e-01
GOMF TYPE 1 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 5 2.13e-01 5.08e-01 0.470000 3.62e-01 3.00e-01 1.61e-01 2.45e-01
Response of EIF2AK4 (GCN2) to amino acid deficiency 94 1.18e-13 1.66e-11 0.470000 -1.61e-01 -4.42e-01 6.81e-03 1.32e-13
GOMF LARGE RIBOSOMAL SUBUNIT RRNA BINDING 5 1.90e-01 4.81e-01 0.470000 -5.85e-03 -4.70e-01 9.82e-01 6.88e-02
PDH complex synthesizes acetyl-CoA from PYR 5 1.73e-01 4.59e-01 0.470000 -1.88e-01 4.30e-01 4.66e-01 9.56e-02
GOMF PYRUVATE DEHYDROGENASE ACTIVITY 5 1.73e-01 4.59e-01 0.470000 -1.88e-01 4.30e-01 4.66e-01 9.56e-02
GOBP POSITIVE REGULATION OF CYTOPLASMIC MRNA PROCESSING BODY ASSEMBLY 6 1.36e-01 4.03e-01 0.469000 4.69e-01 -6.87e-03 4.64e-02 9.77e-01
GOBP SEGMENT SPECIFICATION 16 4.41e-03 4.32e-02 0.469000 4.65e-01 -6.75e-02 1.29e-03 6.40e-01
GOBP XENOBIOTIC TRANSPORT ACROSS BLOOD BRAIN BARRIER 6 1.57e-01 4.39e-01 0.469000 3.68e-01 2.91e-01 1.19e-01 2.16e-01
GOBP GLOMERULAR ENDOTHELIUM DEVELOPMENT 5 1.97e-01 4.90e-01 0.469000 4.64e-01 7.05e-02 7.25e-02 7.85e-01
GOBP TACHYKININ RECEPTOR SIGNALING PATHWAY 8 7.84e-02 2.97e-01 0.469000 4.49e-01 1.35e-01 2.78e-02 5.08e-01
GOCC NEUROFIBRILLARY TANGLE 5 2.10e-01 5.06e-01 0.469000 4.17e-01 2.14e-01 1.06e-01 4.07e-01
GOBP REGULATION OF ENTRY OF BACTERIUM INTO HOST CELL 7 1.16e-01 3.70e-01 0.469000 2.84e-01 3.73e-01 1.94e-01 8.74e-02
GOMF RETINYL PALMITATE ESTERASE ACTIVITY 6 1.19e-01 3.75e-01 0.469000 -3.48e-01 3.14e-01 1.40e-01 1.83e-01
L13a-mediated translational silencing of Ceruloplasmin expression 102 6.71e-15 1.21e-12 0.468000 -9.69e-02 -4.58e-01 9.08e-02 1.22e-15
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY 8 8.57e-02 3.13e-01 0.468000 2.89e-01 3.69e-01 1.57e-01 7.11e-02
Loss of MECP2 binding ability to the NCoR/SMRT complex 5 2.08e-01 5.03e-01 0.468000 4.37e-01 1.67e-01 9.03e-02 5.19e-01
Role of LAT2/NTAL/LAB on calcium mobilization 16 4.45e-03 4.34e-02 0.468000 4.61e-01 -8.01e-02 1.40e-03 5.79e-01
GOBP PROTEIN TARGETING TO PEROXISOME 9 4.19e-02 2.03e-01 0.468000 2.73e-01 -3.80e-01 1.56e-01 4.86e-02
GOBP GLUTAMATE SECRETION NEUROTRANSMISSION 8 8.51e-02 3.12e-01 0.468000 3.97e-01 2.47e-01 5.18e-02 2.26e-01
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN TRANSCRIPTION OF P21 CLASS MEDIATOR 6 1.54e-01 4.33e-01 0.468000 -1.82e-01 -4.31e-01 4.40e-01 6.77e-02
GTP hydrolysis and joining of the 60S ribosomal subunit 103 5.16e-15 9.75e-13 0.468000 -9.03e-02 -4.59e-01 1.13e-01 8.28e-16
GOCC SODIUM CHANNEL COMPLEX 24 4.20e-04 6.83e-03 0.468000 -4.65e-01 -5.18e-02 8.12e-05 6.61e-01
Scavenging by Class F Receptors 6 1.60e-01 4.43e-01 0.467000 -3.39e-01 -3.22e-01 1.51e-01 1.72e-01
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS 5 2.15e-01 5.10e-01 0.467000 -3.98e-01 -2.44e-01 1.23e-01 3.45e-01
GOBP POSITIVE REGULATION OF GASTRULATION 6 1.25e-01 3.85e-01 0.467000 1.94e-01 -4.25e-01 4.10e-01 7.17e-02
GOMF G PROTEIN COUPLED RECEPTOR KINASE ACTIVITY 7 9.53e-02 3.31e-01 0.467000 -7.26e-02 4.61e-01 7.40e-01 3.46e-02
GOMF INOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY 12 2.56e-02 1.51e-01 0.466000 3.88e-01 2.58e-01 1.98e-02 1.22e-01
Cohesin Loading onto Chromatin 8 6.93e-02 2.75e-01 0.466000 4.62e-01 -5.92e-02 2.35e-02 7.72e-01
GOBP CELLULAR RESPONSE TO X RAY 11 2.43e-02 1.46e-01 0.466000 4.53e-01 -1.10e-01 9.35e-03 5.26e-01
GOBP OTIC VESICLE DEVELOPMENT 15 9.18e-03 7.41e-02 0.466000 4.42e-01 1.45e-01 3.01e-03 3.29e-01
GOBP CARDIAC NEURAL CREST CELL MIGRATION INVOLVED IN OUTFLOW TRACT MORPHOGENESIS 11 2.51e-02 1.49e-01 0.466000 4.59e-01 -8.03e-02 8.44e-03 6.45e-01
GOMF UBIQUINOL CYTOCHROME C REDUCTASE ACTIVITY 5 2.13e-01 5.08e-01 0.465000 -1.81e-01 -4.28e-01 4.83e-01 9.72e-02
GOBP REGULATION OF MITOCHONDRIAL RNA CATABOLIC PROCESS 5 2.04e-01 4.98e-01 0.465000 -7.95e-02 -4.58e-01 7.58e-01 7.61e-02
GOCC TOM COMPLEX 7 1.20e-01 3.77e-01 0.465000 -2.77e-01 -3.73e-01 2.04e-01 8.74e-02
GOCC H3 HISTONE ACETYLTRANSFERASE COMPLEX 8 7.37e-02 2.86e-01 0.465000 4.64e-01 -6.74e-03 2.29e-02 9.74e-01
Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus 7 9.75e-02 3.35e-01 0.464000 -7.28e-02 4.59e-01 7.39e-01 3.56e-02
GOMF CCR5 CHEMOKINE RECEPTOR BINDING 7 1.01e-01 3.41e-01 0.464000 2.33e-02 -4.64e-01 9.15e-01 3.36e-02
GOBP IMMUNE RESPONSE INHIBITING CELL SURFACE RECEPTOR SIGNALING PATHWAY 9 5.27e-02 2.33e-01 0.464000 -4.64e-01 2.11e-02 1.60e-02 9.13e-01
Constitutive Signaling by EGFRvIII 15 5.80e-03 5.28e-02 0.464000 4.17e-01 -2.03e-01 5.14e-03 1.73e-01
Signaling by EGFRvIII in Cancer 15 5.80e-03 5.28e-02 0.464000 4.17e-01 -2.03e-01 5.14e-03 1.73e-01
GOBP POSITIVE REGULATION OF RECEPTOR RECYCLING 13 1.95e-02 1.24e-01 0.464000 2.44e-01 3.94e-01 1.27e-01 1.38e-02
GOBP HEMIDESMOSOME ASSEMBLY 6 1.57e-01 4.39e-01 0.464000 4.32e-01 1.69e-01 6.68e-02 4.74e-01
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE RAFT 5 2.14e-01 5.09e-01 0.463000 -1.60e-01 -4.35e-01 5.35e-01 9.23e-02
GOBP GLUTAMINE TRANSPORT 9 5.57e-02 2.42e-01 0.463000 -2.66e-02 -4.62e-01 8.90e-01 1.63e-02
GOBP MYCOTOXIN METABOLIC PROCESS 7 1.14e-01 3.65e-01 0.462000 1.16e-01 4.48e-01 5.94e-01 4.03e-02
GOBP REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION 17 2.82e-03 3.07e-02 0.462000 3.57e-01 -2.93e-01 1.07e-02 3.63e-02
Histidine catabolism 8 6.33e-02 2.61e-01 0.462000 -2.83e-01 3.65e-01 1.65e-01 7.37e-02
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 1.36e-01 4.05e-01 0.462000 4.51e-01 -9.91e-02 5.55e-02 6.74e-01
GOBP CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION 7 1.23e-01 3.83e-01 0.462000 3.62e-01 2.87e-01 9.69e-02 1.89e-01
RUNX3 regulates NOTCH signaling 13 1.30e-02 9.48e-02 0.462000 4.44e-01 -1.28e-01 5.60e-03 4.23e-01
GOBP PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION 26 3.28e-04 5.60e-03 0.462000 4.43e-01 1.30e-01 9.18e-05 2.51e-01
GOMF SINGLE STRANDED DNA 3 5 DNA EXONUCLEASE ACTIVITY 6 1.65e-01 4.49e-01 0.461000 3.93e-01 2.42e-01 9.59e-02 3.04e-01
GOBP CARBON DIOXIDE TRANSPORT 15 9.05e-03 7.33e-02 0.461000 -4.56e-01 -7.06e-02 2.23e-03 6.36e-01
GOBP KETONE BODY BIOSYNTHETIC PROCESS 6 1.64e-01 4.48e-01 0.461000 2.09e-01 4.11e-01 3.76e-01 8.11e-02
GOBP POSITIVE REGULATION OF EPITHELIAL TUBE FORMATION 8 7.50e-02 2.89e-01 0.461000 4.60e-01 -3.38e-02 2.43e-02 8.69e-01
GOBP MYOFIBROBLAST DIFFERENTIATION 14 8.15e-03 6.80e-02 0.461000 3.47e-01 -3.03e-01 2.44e-02 4.96e-02
GOMF OLFACTORY RECEPTOR BINDING 6 1.28e-01 3.91e-01 0.461000 -3.83e-01 2.57e-01 1.05e-01 2.75e-01
GOBP NEGATIVE REGULATION OF NEUROBLAST PROLIFERATION 12 1.92e-02 1.23e-01 0.461000 4.52e-01 -9.11e-02 6.73e-03 5.85e-01
GOBP POSITIVE REGULATION OF PINOCYTOSIS 7 9.85e-02 3.37e-01 0.460000 4.43e-01 -1.23e-01 4.22e-02 5.74e-01
GOCC CENTRIOLAR SUBDISTAL APPENDAGE 9 5.81e-02 2.47e-01 0.460000 4.59e-01 2.82e-02 1.71e-02 8.84e-01
GOBP VESICLE MEDIATED CHOLESTEROL TRANSPORT 9 7.00e-02 2.77e-01 0.460000 3.16e-01 3.34e-01 1.01e-01 8.24e-02
GOCC IKAPPAB KINASE COMPLEX 7 1.16e-01 3.70e-01 0.460000 4.46e-01 1.13e-01 4.11e-02 6.05e-01
Erythrocytes take up oxygen and release carbon dioxide 8 9.42e-02 3.29e-01 0.460000 -3.34e-01 -3.16e-01 1.02e-01 1.22e-01
GOBP NEGATIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 5 2.29e-01 5.26e-01 0.460000 3.41e-01 3.08e-01 1.87e-01 2.33e-01
PI-3K cascade:FGFR2 22 1.28e-03 1.68e-02 0.459000 4.30e-01 1.63e-01 4.85e-04 1.86e-01
GOBP SCHWANN CELL PROLIFERATION 9 7.04e-02 2.78e-01 0.459000 3.45e-01 3.03e-01 7.30e-02 1.15e-01
GOBP SNORNA LOCALIZATION 6 1.31e-01 3.96e-01 0.459000 3.96e-01 -2.33e-01 9.33e-02 3.23e-01
SHC-related events triggered by IGF1R 9 5.22e-02 2.31e-01 0.459000 4.48e-01 -1.03e-01 2.01e-02 5.93e-01
GOMF 5 DEOXYRIBOSE 5 PHOSPHATE LYASE ACTIVITY 7 1.20e-01 3.78e-01 0.459000 4.30e-01 1.62e-01 4.91e-02 4.57e-01
GOBP LENS MORPHOGENESIS IN CAMERA TYPE EYE 21 2.05e-03 2.40e-02 0.459000 2.84e-01 3.61e-01 2.44e-02 4.20e-03
GOBP PERIPHERAL NERVOUS SYSTEM AXON ENSHEATHMENT 29 1.79e-04 3.46e-03 0.459000 4.01e-01 2.22e-01 1.83e-04 3.81e-02
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT INTO CELL 8 9.42e-02 3.29e-01 0.459000 2.58e-01 3.79e-01 2.06e-01 6.34e-02
GOBP MIDBRAIN HINDBRAIN BOUNDARY DEVELOPMENT 7 1.21e-01 3.79e-01 0.458000 4.27e-01 1.66e-01 5.02e-02 4.47e-01
GOBP REGULATION OF FOCAL ADHESION DISASSEMBLY 6 1.72e-01 4.58e-01 0.458000 3.06e-01 3.41e-01 1.94e-01 1.47e-01
AKT phosphorylates targets in the nucleus 9 7.04e-02 2.78e-01 0.458000 2.61e-01 3.76e-01 1.74e-01 5.06e-02
GOBP REGULATION OF ARTERY MORPHOGENESIS 13 1.92e-02 1.23e-01 0.458000 -4.40e-01 -1.27e-01 5.99e-03 4.27e-01
GOMF TRACE AMINE RECEPTOR ACTIVITY 7 9.54e-02 3.31e-01 0.458000 -2.18e-01 4.03e-01 3.18e-01 6.49e-02
GOBP MIDGUT DEVELOPMENT 11 2.87e-02 1.62e-01 0.458000 4.53e-01 -6.60e-02 9.25e-03 7.04e-01
GOBP POSITIVE REGULATION OF PROTEOGLYCAN BIOSYNTHETIC PROCESS 5 2.31e-01 5.29e-01 0.458000 3.16e-01 3.32e-01 2.22e-01 1.99e-01
GOBP PROTEIN INSERTION INTO MEMBRANE FROM INNER SIDE 5 2.10e-01 5.05e-01 0.458000 -3.31e-02 -4.56e-01 8.98e-01 7.71e-02
GOMF CHROMO SHADOW DOMAIN BINDING 5 2.03e-01 4.96e-01 0.458000 4.56e-01 -3.35e-02 7.72e-02 8.97e-01
GOBP POSITIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION 5 2.04e-01 4.99e-01 0.458000 1.84e-02 -4.57e-01 9.43e-01 7.67e-02
Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) 88 2.86e-12 3.22e-10 0.457000 -1.27e-01 -4.39e-01 3.98e-02 1.03e-12
GOBP NEGATIVE REGULATION OF VITAMIN METABOLIC PROCESS 7 1.07e-01 3.52e-01 0.457000 4.71e-02 -4.55e-01 8.29e-01 3.72e-02
RHO GTPases Activate Rhotekin and Rhophilins 9 6.73e-02 2.71e-01 0.457000 -4.28e-01 -1.60e-01 2.61e-02 4.07e-01
Respiratory syncytial virus (RSV) genome replication, transcription and translation 16 5.43e-03 5.01e-02 0.457000 1.15e-01 -4.42e-01 4.27e-01 2.18e-03
GOMF PHOSPHOLIPASE INHIBITOR ACTIVITY 13 1.65e-02 1.12e-01 0.457000 -1.44e-02 4.57e-01 9.29e-01 4.37e-03
GOMF THIAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 1.01e-01 3.41e-01 0.457000 4.36e-01 -1.37e-01 4.60e-02 5.30e-01
GOMF BUBBLE DNA BINDING 8 9.47e-02 3.30e-01 0.457000 3.97e-01 2.25e-01 5.17e-02 2.70e-01
GOBP CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION 9 4.85e-02 2.22e-01 0.457000 3.67e-01 -2.72e-01 5.68e-02 1.57e-01
GOBP DIRECT OSSIFICATION 7 1.25e-01 3.86e-01 0.457000 1.89e-01 4.16e-01 3.87e-01 5.69e-02
GOBP REGULATION OF COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY 5 2.08e-01 5.03e-01 0.456000 -4.56e-01 2.80e-03 7.71e-02 9.91e-01
GOBP DENTATE GYRUS DEVELOPMENT 24 3.12e-04 5.37e-03 0.456000 3.58e-01 -2.83e-01 2.40e-03 1.63e-02
Tachykinin receptors bind tachykinins 5 1.90e-01 4.80e-01 0.456000 4.06e-01 -2.08e-01 1.16e-01 4.21e-01
GOCC BBAF COMPLEX 10 4.76e-02 2.20e-01 0.456000 4.46e-01 9.35e-02 1.45e-02 6.09e-01
GOBP CARDIAC CHAMBER FORMATION 12 2.81e-02 1.60e-01 0.456000 4.23e-01 1.70e-01 1.11e-02 3.09e-01
NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake 5 2.28e-01 5.25e-01 0.456000 4.13e-01 1.93e-01 1.10e-01 4.54e-01
GOBP PATTERN SPECIFICATION INVOLVED IN KIDNEY DEVELOPMENT 8 8.08e-02 3.02e-01 0.456000 4.56e-01 -1.11e-02 2.56e-02 9.57e-01
GOMF MICROTUBULE MINUS END BINDING 13 2.23e-02 1.37e-01 0.456000 3.88e-01 2.38e-01 1.53e-02 1.37e-01
Serotonin receptors 11 4.11e-02 2.01e-01 0.456000 3.11e-01 3.33e-01 7.38e-02 5.60e-02
TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling 11 3.67e-02 1.89e-01 0.456000 -1.31e-01 -4.36e-01 4.52e-01 1.22e-02
Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation 11 2.50e-02 1.49e-01 0.455000 3.41e-01 -3.02e-01 5.04e-02 8.26e-02
GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS 5 2.31e-01 5.28e-01 0.455000 -2.16e-01 -4.01e-01 4.03e-01 1.21e-01
GOBP RNA SECONDARY STRUCTURE UNWINDING 8 8.95e-02 3.20e-01 0.455000 4.43e-01 1.05e-01 3.01e-02 6.08e-01
GOMF PYRIMIDINE NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 8 9.91e-02 3.37e-01 0.455000 3.28e-01 3.15e-01 1.08e-01 1.23e-01
GOBP CLEARANCE OF FOREIGN INTRACELLULAR NUCLEIC ACIDS 6 1.55e-01 4.36e-01 0.455000 4.55e-01 1.41e-02 5.38e-02 9.52e-01
GOBP REGULATION OF PROTEIN OLIGOMERIZATION 5 2.06e-01 5.01e-01 0.455000 -4.53e-01 3.74e-02 7.93e-02 8.85e-01
GOCC SMAD PROTEIN COMPLEX 9 6.00e-02 2.52e-01 0.455000 4.54e-01 -1.02e-02 1.82e-02 9.58e-01
GOBP REGULATION OF HETEROCHROMATIN FORMATION 22 6.81e-04 1.01e-02 0.455000 3.90e-01 -2.34e-01 1.55e-03 5.78e-02
GOBP NEGATIVE REGULATION OF ASTROCYTE ACTIVATION 5 2.29e-01 5.27e-01 0.454000 -4.16e-01 -1.83e-01 1.07e-01 4.79e-01
GOBP VITAMIN D RECEPTOR SIGNALING PATHWAY 12 1.92e-02 1.23e-01 0.454000 4.06e-01 -2.04e-01 1.49e-02 2.20e-01
GOBP MONOCYTE EXTRAVASATION 11 3.11e-02 1.70e-01 0.454000 -4.47e-02 4.52e-01 7.97e-01 9.42e-03
GOBP RHOMBOMERE DEVELOPMENT 8 8.00e-02 3.00e-01 0.454000 4.51e-01 -5.29e-02 2.73e-02 7.95e-01
GOBP SENSORY PERCEPTION OF SWEET TASTE 7 1.04e-01 3.48e-01 0.454000 -4.34e-01 1.34e-01 4.70e-02 5.40e-01
GOCC MYELIN SHEATH ABAXONAL REGION 6 1.78e-01 4.65e-01 0.454000 3.34e-01 3.07e-01 1.57e-01 1.93e-01
GOCC NUCLEAR PORE OUTER RING 10 4.44e-02 2.10e-01 0.454000 1.25e-02 -4.54e-01 9.45e-01 1.30e-02
GOBP CHROMATIN LOOPING 15 6.85e-03 6.00e-02 0.453000 2.98e-01 -3.42e-01 4.60e-02 2.18e-02
GOCC SMC5 SMC6 COMPLEX 9 5.02e-02 2.26e-01 0.453000 3.07e-01 -3.33e-01 1.11e-01 8.32e-02
Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells 30 1.57e-04 3.12e-03 0.453000 4.11e-01 1.92e-01 9.92e-05 6.87e-02
GOBP MESONEPHRIC TUBULE FORMATION 10 3.64e-02 1.87e-01 0.453000 3.39e-01 -3.00e-01 6.36e-02 1.00e-01
GOMF TORC2 COMPLEX BINDING 5 2.39e-01 5.36e-01 0.453000 -3.17e-01 -3.23e-01 2.20e-01 2.11e-01
GOCC ANNULATE LAMELLAE 5 2.18e-01 5.14e-01 0.453000 4.50e-01 4.38e-02 8.11e-02 8.65e-01
GOBP SOFT PALATE DEVELOPMENT 5 2.30e-01 5.27e-01 0.453000 4.25e-01 1.56e-01 1.00e-01 5.45e-01
FGFR3 mutant receptor activation 11 4.29e-02 2.06e-01 0.452000 2.89e-01 3.48e-01 9.66e-02 4.58e-02
Signaling by activated point mutants of FGFR3 11 4.29e-02 2.06e-01 0.452000 2.89e-01 3.48e-01 9.66e-02 4.58e-02
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 10 5.74e-02 2.46e-01 0.452000 3.33e-01 3.07e-01 6.86e-02 9.33e-02
GOBP HORMONE MEDIATED APOPTOTIC SIGNALING PATHWAY 5 1.94e-01 4.87e-01 0.452000 -3.93e-01 2.23e-01 1.28e-01 3.88e-01
GOBP MIDDLE EAR MORPHOGENESIS 21 1.17e-03 1.56e-02 0.452000 4.30e-01 -1.41e-01 6.53e-04 2.65e-01
GOCC ENDOPLASMIC RETICULUM PLASMA MEMBRANE CONTACT SITE 12 3.25e-02 1.75e-01 0.452000 3.08e-01 3.31e-01 6.44e-02 4.74e-02
GOBP CELLULAR RESPONSE TO PEPTIDOGLYCAN 6 1.65e-01 4.49e-01 0.452000 -4.46e-01 -7.49e-02 5.86e-02 7.51e-01
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN 7 1.35e-01 4.02e-01 0.452000 -2.56e-01 -3.72e-01 2.40e-01 8.84e-02
GOCC MITOCHONDRIAL PERMEABILITY TRANSITION PORE COMPLEX 6 1.38e-01 4.08e-01 0.452000 -3.24e-01 3.14e-01 1.69e-01 1.83e-01
GOCC RSC TYPE COMPLEX 15 9.22e-03 7.41e-02 0.451000 4.48e-01 -5.41e-02 2.65e-03 7.17e-01
GOMF THYROID HORMONE BINDING 6 1.62e-01 4.45e-01 0.451000 4.50e-01 3.07e-02 5.62e-02 8.96e-01
GOCC PLATELET DENSE TUBULAR NETWORK MEMBRANE 9 7.67e-02 2.92e-01 0.451000 2.67e-01 3.64e-01 1.65e-01 5.89e-02
GOBP GALACTOSE CATABOLIC PROCESS VIA UDP GALACTOSE 5 2.24e-01 5.19e-01 0.451000 7.28e-02 4.45e-01 7.78e-01 8.48e-02
GOMF DEAD H BOX RNA HELICASE BINDING 8 9.73e-02 3.35e-01 0.451000 4.20e-01 1.65e-01 3.97e-02 4.20e-01
GOMF P TYPE CALCIUM TRANSPORTER ACTIVITY 8 1.03e-01 3.45e-01 0.451000 3.52e-01 2.81e-01 8.43e-02 1.68e-01
CTNNB1 S33 mutants aren’t phosphorylated 14 1.40e-02 1.00e-01 0.451000 4.51e-01 1.63e-02 3.51e-03 9.16e-01
CTNNB1 S37 mutants aren’t phosphorylated 14 1.40e-02 1.00e-01 0.451000 4.51e-01 1.63e-02 3.51e-03 9.16e-01
CTNNB1 S45 mutants aren’t phosphorylated 14 1.40e-02 1.00e-01 0.451000 4.51e-01 1.63e-02 3.51e-03 9.16e-01
CTNNB1 T41 mutants aren’t phosphorylated 14 1.40e-02 1.00e-01 0.451000 4.51e-01 1.63e-02 3.51e-03 9.16e-01
Signaling by CTNNB1 phospho-site mutants 14 1.40e-02 1.00e-01 0.451000 4.51e-01 1.63e-02 3.51e-03 9.16e-01
Signaling by GSK3beta mutants 14 1.40e-02 1.00e-01 0.451000 4.51e-01 1.63e-02 3.51e-03 9.16e-01
GOBP REGULATION OF SYNAPTIC VESICLE PRIMING 8 1.01e-01 3.41e-01 0.451000 3.92e-01 2.23e-01 5.50e-02 2.75e-01
GOCC PICLN SM PROTEIN COMPLEX 6 1.79e-01 4.67e-01 0.450000 -2.19e-01 -3.93e-01 3.52e-01 9.51e-02
GOBP POSITIVE REGULATION OF ODONTOGENESIS 8 8.52e-02 3.13e-01 0.450000 4.50e-01 -1.88e-02 2.75e-02 9.27e-01
GOBP NEGATIVE REGULATION OF TROPHOBLAST CELL MIGRATION 7 1.01e-01 3.41e-01 0.450000 2.96e-01 -3.40e-01 1.76e-01 1.20e-01
GOBP DETOXIFICATION OF COPPER ION 15 9.22e-03 7.41e-02 0.450000 -4.45e-01 7.07e-02 2.87e-03 6.35e-01
GOBP SNRNA CATABOLIC PROCESS 5 2.07e-01 5.02e-01 0.450000 4.40e-01 -9.62e-02 8.86e-02 7.10e-01
GOBP SKELETAL MUSCLE SATELLITE CELL MAINTENANCE INVOLVED IN SKELETAL MUSCLE REGENERATION 5 2.37e-01 5.33e-01 0.450000 1.97e-01 4.05e-01 4.46e-01 1.17e-01
GOBP OSMOSENSORY SIGNALING PATHWAY 7 1.30e-01 3.93e-01 0.450000 -1.44e-01 -4.26e-01 5.10e-01 5.08e-02
Cap-dependent Translation Initiation 110 6.62e-15 1.21e-12 0.450000 -7.53e-02 -4.44e-01 1.72e-01 8.75e-16
Eukaryotic Translation Initiation 110 6.62e-15 1.21e-12 0.450000 -7.53e-02 -4.44e-01 1.72e-01 8.75e-16
GOCC CORVET COMPLEX 7 1.34e-01 4.01e-01 0.450000 4.00e-01 2.06e-01 6.69e-02 3.45e-01
GOBP PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION 15 8.99e-03 7.30e-02 0.450000 4.39e-01 -9.82e-02 3.26e-03 5.10e-01
GOBP GAMMA AMINOBUTYRIC ACID METABOLIC PROCESS 8 7.53e-02 2.90e-01 0.450000 3.96e-01 -2.12e-01 5.23e-02 2.99e-01
GOBP RESPONSE TO NEMATODE 7 1.32e-01 3.98e-01 0.449000 -1.68e-01 -4.17e-01 4.43e-01 5.61e-02
Mineralocorticoid biosynthesis 6 1.58e-01 4.39e-01 0.449000 -4.48e-01 3.55e-02 5.74e-02 8.80e-01
GOMF EUKARYOTIC INITIATION FACTOR 4E BINDING 9 6.13e-02 2.55e-01 0.449000 4.45e-01 -6.32e-02 2.09e-02 7.43e-01
Defective LFNG causes SCDO3 5 1.99e-01 4.92e-01 0.449000 -2.24e-01 3.89e-01 3.86e-01 1.32e-01
GOBP AUTOPHAGOSOME LYSOSOME FUSION 12 3.10e-02 1.70e-01 0.449000 4.22e-01 1.53e-01 1.13e-02 3.60e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS 5 2.35e-01 5.32e-01 0.449000 4.21e-01 1.56e-01 1.03e-01 5.46e-01
Role of ABL in ROBO-SLIT signaling 8 8.50e-02 3.12e-01 0.448000 4.46e-01 -5.04e-02 2.91e-02 8.05e-01
GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY 7 1.16e-01 3.70e-01 0.448000 4.46e-01 -4.45e-02 4.10e-02 8.38e-01
GOBP IMMUNE RESPONSE INHIBITING SIGNAL TRANSDUCTION 11 3.01e-02 1.66e-01 0.448000 -4.12e-01 1.75e-01 1.79e-02 3.14e-01
GOBP POLYKETIDE METABOLIC PROCESS 10 5.49e-02 2.39e-01 0.448000 4.29e-01 1.28e-01 1.88e-02 4.82e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS ENZYMATIC MODIFICATION 11 4.60e-02 2.14e-01 0.448000 3.11e-01 3.22e-01 7.43e-02 6.42e-02
Adrenoceptors 9 5.94e-02 2.50e-01 0.448000 1.25e-01 -4.30e-01 5.17e-01 2.55e-02
GOBP DIACYLGLYCEROL CATABOLIC PROCESS 5 2.31e-01 5.29e-01 0.447000 9.37e-02 4.38e-01 7.17e-01 9.02e-02
GOBP NATURAL KILLER CELL CHEMOTAXIS 10 5.78e-02 2.46e-01 0.447000 -1.84e-01 -4.08e-01 3.13e-01 2.56e-02
GOBP DEADENYLATION DEPENDENT DECAPPING OF NUCLEAR TRANSCRIBED MRNA 11 2.85e-02 1.62e-01 0.447000 2.86e-01 -3.44e-01 1.01e-01 4.82e-02
GOMF G PROTEIN BETA SUBUNIT BINDING 21 2.62e-03 2.90e-02 0.447000 -3.95e-01 -2.09e-01 1.71e-03 9.68e-02
SARS-CoV-2 modulates host translation machinery 45 2.01e-06 7.00e-05 0.447000 -9.62e-02 -4.36e-01 2.64e-01 4.03e-07
GOMF 5S RRNA BINDING 9 5.76e-02 2.46e-01 0.447000 1.77e-01 -4.10e-01 3.57e-01 3.31e-02
GOCC FLOTILLIN COMPLEX 9 6.58e-02 2.67e-01 0.447000 4.46e-01 -1.49e-02 2.04e-02 9.39e-01
GOCC SEX CHROMATIN 6 1.81e-01 4.70e-01 0.447000 4.12e-01 1.72e-01 8.02e-02 4.67e-01
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME MATURATION 7 1.12e-01 3.63e-01 0.447000 4.29e-01 -1.25e-01 4.95e-02 5.66e-01
GOBP SIRNA PROCESSING 8 7.80e-02 2.95e-01 0.447000 -2.07e-01 3.96e-01 3.11e-01 5.25e-02
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 7 1.40e-01 4.11e-01 0.446000 -2.35e-01 -3.80e-01 2.82e-01 8.18e-02
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE 6 1.62e-01 4.45e-01 0.446000 4.45e-01 -3.12e-02 5.89e-02 8.95e-01
GOBP HEAT ACCLIMATION 5 2.15e-01 5.10e-01 0.446000 7.49e-02 -4.40e-01 7.72e-01 8.85e-02
GOCC THO COMPLEX 5 2.24e-01 5.19e-01 0.446000 -5.30e-03 -4.46e-01 9.84e-01 8.41e-02
Maturation of hRSV A proteins 13 1.61e-02 1.10e-01 0.446000 2.03e-01 -3.97e-01 2.06e-01 1.31e-02
GOBP OTOLITH DEVELOPMENT 10 5.99e-02 2.52e-01 0.446000 2.12e-01 3.92e-01 2.46e-01 3.16e-02
GOMF PROTEIN PHOSPHATASE 2B BINDING 6 1.53e-01 4.31e-01 0.446000 4.23e-01 -1.42e-01 7.30e-02 5.46e-01
GOBP TRYPTOPHAN CATABOLIC PROCESS TO KYNURENINE 5 2.41e-01 5.37e-01 0.446000 -4.13e-01 -1.69e-01 1.10e-01 5.13e-01
Alpha-defensins 6 1.52e-01 4.30e-01 0.446000 -4.16e-01 1.60e-01 7.78e-02 4.96e-01
GOBP METANEPHRIC PART OF URETERIC BUD DEVELOPMENT 6 1.59e-01 4.42e-01 0.446000 4.40e-01 -6.85e-02 6.18e-02 7.71e-01
GOBP REGULATION OF MYELOID DENDRITIC CELL ACTIVATION 5 2.37e-01 5.34e-01 0.445000 -1.22e-01 -4.28e-01 6.35e-01 9.72e-02
GOBP OMEGA HYDROXYLASE P450 PATHWAY 11 3.69e-02 1.89e-01 0.445000 9.68e-03 -4.45e-01 9.56e-01 1.06e-02
NR1H2 and NR1H3-mediated signaling 53 3.83e-07 1.67e-05 0.445000 3.78e-01 2.36e-01 1.94e-06 3.02e-03
GOBP GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT 10 5.06e-02 2.27e-01 0.445000 4.45e-01 2.04e-03 1.48e-02 9.91e-01
GOMF P TYPE POTASSIUM TRANSMEMBRANE TRANSPORTER ACTIVITY 8 8.50e-02 3.12e-01 0.445000 -4.33e-01 1.00e-01 3.37e-02 6.23e-01
GOCC PROTEASE INHIBITOR COMPLEX 8 1.09e-01 3.57e-01 0.445000 2.89e-01 3.38e-01 1.57e-01 9.75e-02
GOMF GLUTAMATE SODIUM SYMPORTER ACTIVITY 5 2.35e-01 5.32e-01 0.445000 9.31e-02 4.35e-01 7.19e-01 9.21e-02
GOBP PRIMITIVE STREAK FORMATION 10 4.28e-02 2.06e-01 0.445000 1.90e-01 -4.02e-01 2.97e-01 2.78e-02
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 8 1.07e-01 3.53e-01 0.445000 3.89e-01 2.16e-01 5.68e-02 2.91e-01
CD22 mediated BCR regulation 5 2.14e-01 5.09e-01 0.445000 1.10e-01 -4.31e-01 6.70e-01 9.54e-02
GOBP SNRNA MODIFICATION 6 1.48e-01 4.25e-01 0.444000 3.71e-01 -2.44e-01 1.15e-01 3.00e-01
GOBP AXONOGENESIS INVOLVED IN INNERVATION 9 7.22e-02 2.82e-01 0.444000 4.41e-01 5.83e-02 2.21e-02 7.62e-01
Downstream signal transduction 29 1.65e-04 3.24e-03 0.444000 4.44e-01 -2.87e-02 3.56e-05 7.89e-01
GOBP NEGATIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 6 1.88e-01 4.79e-01 0.444000 3.84e-01 2.24e-01 1.04e-01 3.42e-01
GOCC MICROVESICLE 9 6.19e-02 2.57e-01 0.444000 1.22e-01 -4.27e-01 5.25e-01 2.65e-02
SUMOylation of transcription factors 20 2.30e-03 2.61e-02 0.444000 4.39e-01 -6.74e-02 6.75e-04 6.02e-01
Activated NTRK3 signals through PI3K 6 1.71e-01 4.57e-01 0.444000 4.43e-01 3.15e-02 6.02e-02 8.94e-01
GOBP ISOLEUCINE METABOLIC PROCESS 6 1.55e-01 4.35e-01 0.444000 1.47e-01 -4.19e-01 5.32e-01 7.57e-02
GOBP BONE MARROW DEVELOPMENT 9 5.68e-02 2.44e-01 0.444000 3.22e-01 -3.06e-01 9.48e-02 1.12e-01
FGFRL1 modulation of FGFR1 signaling 13 2.82e-02 1.61e-01 0.443000 3.26e-01 3.01e-01 4.21e-02 6.03e-02
GAB1 signalosome 17 4.53e-03 4.40e-02 0.443000 3.41e-01 -2.83e-01 1.49e-02 4.33e-02
GOBP CHORIONIC TROPHOBLAST CELL DIFFERENTIATION 7 1.08e-01 3.55e-01 0.443000 -3.01e-01 3.25e-01 1.68e-01 1.36e-01
GOMF FUCOSE BINDING 8 9.54e-02 3.31e-01 0.443000 -4.42e-01 -2.19e-02 3.02e-02 9.14e-01
GOMF IMMUNOGLOBULIN RECEPTOR BINDING 10 4.75e-02 2.19e-01 0.443000 -4.33e-01 9.35e-02 1.77e-02 6.09e-01
GOMF FATZ BINDING 5 2.35e-01 5.31e-01 0.443000 4.39e-01 5.82e-02 8.91e-02 8.22e-01
FGFR2b ligand binding and activation 10 5.78e-02 2.46e-01 0.443000 4.28e-01 1.12e-01 1.90e-02 5.40e-01
Relaxin receptors 8 8.19e-02 3.05e-01 0.443000 -3.97e-01 1.96e-01 5.17e-02 3.38e-01
GOCC NF KAPPAB COMPLEX 5 2.05e-01 4.99e-01 0.443000 3.07e-01 -3.19e-01 2.34e-01 2.17e-01
Signaling by FGFR3 in disease 21 2.96e-03 3.18e-02 0.443000 3.91e-01 2.07e-01 1.91e-03 1.01e-01
GOMF BRANCHED CHAIN AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 9 8.45e-02 3.12e-01 0.443000 3.57e-01 2.62e-01 6.39e-02 1.74e-01
GOMF CLATHRIN HEAVY CHAIN BINDING 11 3.90e-02 1.95e-01 0.442000 4.42e-01 2.41e-03 1.10e-02 9.89e-01
Ribosomal scanning and start codon recognition 52 2.62e-07 1.18e-05 0.442000 -3.42e-02 -4.41e-01 6.69e-01 3.69e-08
Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) 8 1.06e-01 3.52e-01 0.442000 -1.63e-01 -4.11e-01 4.26e-01 4.39e-02
GOBP NEGATIVE REGULATION OF RIG I SIGNALING PATHWAY 8 1.07e-01 3.53e-01 0.442000 4.09e-01 1.67e-01 4.49e-02 4.14e-01
GOBP NEGATIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 5 2.14e-01 5.10e-01 0.442000 4.16e-01 -1.48e-01 1.07e-01 5.67e-01
GOBP MEDIUM CHAIN FATTY ACYL COA METABOLIC PROCESS 6 1.94e-01 4.87e-01 0.442000 -2.81e-01 -3.41e-01 2.34e-01 1.48e-01
GOBP SECRETION OF LYSOSOMAL ENZYMES 7 1.13e-01 3.65e-01 0.442000 1.93e-01 -3.97e-01 3.77e-01 6.87e-02
GOBP INTERNAL PROTEIN AMINO ACID ACETYLATION 10 5.44e-02 2.38e-01 0.441000 4.41e-01 2.66e-02 1.58e-02 8.84e-01
GOBP POSITIVE REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY 11 4.59e-02 2.14e-01 0.441000 4.17e-01 1.44e-01 1.66e-02 4.07e-01
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 6 1.84e-01 4.75e-01 0.441000 4.24e-01 1.23e-01 7.23e-02 6.02e-01
FGFR3 ligand binding and activation 12 3.76e-02 1.91e-01 0.441000 2.47e-01 3.66e-01 1.39e-01 2.83e-02
FGFR3c ligand binding and activation 12 3.76e-02 1.91e-01 0.441000 2.47e-01 3.66e-01 1.39e-01 2.83e-02
GOMF RETINOIC ACID RESPONSIVE ELEMENT BINDING 6 1.87e-01 4.78e-01 0.441000 4.14e-01 1.51e-01 7.87e-02 5.23e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 5 PRODUCTION 10 6.25e-02 2.58e-01 0.441000 1.78e-01 4.03e-01 3.29e-01 2.72e-02
GOBP ENTERIC NERVOUS SYSTEM DEVELOPMENT 12 3.16e-02 1.71e-01 0.441000 4.38e-01 5.10e-02 8.62e-03 7.60e-01
GOBP INTERLEUKIN 3 MEDIATED SIGNALING PATHWAY 6 1.62e-01 4.45e-01 0.441000 -1.16e-01 4.25e-01 6.22e-01 7.13e-02
GOBP REGULATION OF ASTROCYTE ACTIVATION 8 1.14e-01 3.66e-01 0.441000 -3.40e-01 -2.81e-01 9.63e-02 1.69e-01
Regulation of signaling by CBL 22 1.00e-03 1.38e-02 0.441000 3.20e-01 -3.03e-01 9.31e-03 1.40e-02
GOMF U6 SNRNA BINDING 14 1.54e-02 1.07e-01 0.441000 4.37e-01 -5.87e-02 4.67e-03 7.04e-01
GOBP REGULATION OF MESONEPHROS DEVELOPMENT 5 2.16e-01 5.11e-01 0.440000 4.13e-01 -1.54e-01 1.10e-01 5.52e-01
Regulation of NPAS4 gene transcription 5 2.56e-01 5.53e-01 0.440000 -2.30e-01 -3.75e-01 3.73e-01 1.46e-01
GOBP ATRIAL SEPTUM DEVELOPMENT 23 8.77e-04 1.24e-02 0.440000 4.09e-01 -1.62e-01 6.91e-04 1.78e-01
GOBP POSITIVE REGULATION OF GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION 5 2.40e-01 5.36e-01 0.440000 4.35e-01 6.47e-02 9.22e-02 8.02e-01
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants 19 2.69e-03 2.96e-02 0.440000 3.52e-01 -2.63e-01 7.90e-03 4.70e-02
Signaling by Ligand-Responsive EGFR Variants in Cancer 19 2.69e-03 2.96e-02 0.440000 3.52e-01 -2.63e-01 7.90e-03 4.70e-02
GOBP STOMACH DEVELOPMENT 5 2.19e-01 5.15e-01 0.439000 4.17e-01 -1.37e-01 1.06e-01 5.96e-01
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION 15 1.62e-02 1.11e-01 0.439000 4.01e-01 1.80e-01 7.23e-03 2.26e-01
GOBP PROXIMAL DISTAL PATTERN FORMATION INVOLVED IN NEPHRON DEVELOPMENT 5 2.29e-01 5.26e-01 0.439000 4.37e-01 -4.40e-02 9.05e-02 8.65e-01
GOCC HEMIDESMOSOME 8 1.16e-01 3.69e-01 0.439000 3.21e-01 3.00e-01 1.16e-01 1.42e-01
GOBP NEGATIVE REGULATION OF MEIOTIC CHROMOSOME SEPARATION 5 2.42e-01 5.39e-01 0.439000 4.33e-01 6.84e-02 9.33e-02 7.91e-01
GOCC CLATHRIN SCULPTED GAMMA AMINOBUTYRIC ACID TRANSPORT VESICLE 8 8.43e-02 3.12e-01 0.439000 3.72e-01 -2.33e-01 6.87e-02 2.54e-01
GOBP DORSAL SPINAL CORD DEVELOPMENT 20 2.74e-03 3.01e-02 0.439000 4.35e-01 -5.47e-02 7.55e-04 6.72e-01
GOBP AUTOCRINE SIGNALING 7 1.38e-01 4.08e-01 0.438000 -4.32e-01 -7.24e-02 4.75e-02 7.40e-01
Physiological factors 14 1.97e-02 1.25e-01 0.438000 4.28e-01 9.33e-02 5.53e-03 5.46e-01
GOBP POSITIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 9 7.89e-02 2.98e-01 0.438000 -7.56e-02 -4.32e-01 6.94e-01 2.49e-02
Nef Mediated CD8 Down-regulation 7 1.50e-01 4.28e-01 0.438000 3.78e-01 2.21e-01 8.32e-02 3.11e-01
GOMF ACTIVIN BINDING 11 4.85e-02 2.22e-01 0.438000 4.10e-01 1.55e-01 1.86e-02 3.74e-01
GOBP REGULATION OF ENDOCYTIC RECYCLING 19 6.10e-03 5.46e-02 0.438000 3.42e-01 2.73e-01 9.75e-03 3.93e-02
Pre-NOTCH Processing in the Endoplasmic Reticulum 6 1.67e-01 4.52e-01 0.438000 -1.00e-01 4.26e-01 6.70e-01 7.08e-02
GOBP REGULATION OF INTRACELLULAR LIPID TRANSPORT 13 1.83e-02 1.20e-01 0.438000 -2.37e-01 3.68e-01 1.38e-01 2.17e-02
GOBP DNA REPLICATION DEPENDENT CHROMATIN ASSEMBLY 6 1.57e-01 4.39e-01 0.438000 2.44e-01 -3.63e-01 3.01e-01 1.23e-01
GOBP REGULATION OF PROTEIN DEUBIQUITINATION 10 4.61e-02 2.15e-01 0.437000 2.44e-01 -3.63e-01 1.82e-01 4.69e-02
Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S 53 2.86e-07 1.28e-05 0.437000 -3.55e-02 -4.36e-01 6.55e-01 4.03e-08
Acrosome Reaction and Sperm:Oocyte Membrane Binding 6 2.01e-01 4.95e-01 0.437000 -2.96e-01 -3.22e-01 2.09e-01 1.73e-01
GOBP L LEUCINE IMPORT ACROSS PLASMA MEMBRANE 5 2.63e-01 5.60e-01 0.437000 2.89e-01 3.28e-01 2.63e-01 2.04e-01
GOCC CHROMAFFIN GRANULE MEMBRANE 9 7.36e-02 2.86e-01 0.437000 -2.29e-02 4.36e-01 9.05e-01 2.34e-02
Translation initiation complex formation 52 3.99e-07 1.73e-05 0.437000 -3.99e-02 -4.35e-01 6.18e-01 5.72e-08
GOBP THYROID GLAND DEVELOPMENT 31 1.94e-04 3.67e-03 0.437000 4.18e-01 1.25e-01 5.50e-05 2.29e-01
GOMF DENEDDYLASE ACTIVITY 6 1.72e-01 4.58e-01 0.436000 6.89e-02 -4.30e-01 7.70e-01 6.79e-02
GOBP REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT 9 7.42e-02 2.87e-01 0.436000 4.35e-01 -2.85e-02 2.39e-02 8.82e-01
GOMF COENZYME A DIPHOSPHATASE ACTIVITY 5 2.66e-01 5.62e-01 0.436000 -2.94e-01 -3.21e-01 2.54e-01 2.14e-01
GOMF C X C CHEMOKINE BINDING 5 2.17e-01 5.12e-01 0.435000 -2.66e-01 3.44e-01 3.02e-01 1.82e-01
GOCC CHROMOSOME CENTROMERIC CORE DOMAIN 17 6.58e-03 5.81e-02 0.435000 1.08e-01 -4.21e-01 4.39e-01 2.62e-03
GOBP SENSORY PERCEPTION OF TOUCH 5 2.16e-01 5.11e-01 0.435000 2.95e-01 -3.20e-01 2.53e-01 2.16e-01
Chylomicron assembly 10 5.97e-02 2.51e-01 0.435000 -4.34e-01 -3.56e-02 1.76e-02 8.45e-01
GOMF POTASSIUM CHANNEL ACTIVATOR ACTIVITY 5 2.43e-01 5.39e-01 0.435000 -1.96e-02 -4.34e-01 9.39e-01 9.26e-02
GOBP PROTEIN AUTO ADP RIBOSYLATION 11 5.03e-02 2.26e-01 0.435000 4.10e-01 1.44e-01 1.85e-02 4.09e-01
Regulation of glycolysis by fructose 2,6-bisphosphate metabolism 11 5.47e-02 2.39e-01 0.435000 3.30e-01 2.83e-01 5.82e-02 1.04e-01
GOCC SPERM FIBROUS SHEATH 6 2.06e-01 5.00e-01 0.434000 -3.34e-01 -2.77e-01 1.56e-01 2.40e-01
GOBP ENDOCARDIUM MORPHOGENESIS 6 1.67e-01 4.51e-01 0.434000 4.01e-01 -1.66e-01 8.90e-02 4.81e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYDROGEN PEROXIDE 9 8.51e-02 3.12e-01 0.434000 4.20e-01 1.08e-01 2.90e-02 5.75e-01
GOBP GLUCOSAMINE CONTAINING COMPOUND CATABOLIC PROCESS 9 6.53e-02 2.66e-01 0.434000 -3.58e-01 2.45e-01 6.26e-02 2.04e-01
GOBP GLUTAMATE CATABOLIC PROCESS 7 1.27e-01 3.89e-01 0.434000 4.17e-01 -1.19e-01 5.61e-02 5.86e-01
GOBP NECROPTOTIC SIGNALING PATHWAY 8 9.28e-02 3.27e-01 0.434000 1.55e-01 -4.05e-01 4.46e-01 4.75e-02
GOCC CILIARY TRANSITION FIBER 8 1.18e-01 3.75e-01 0.433000 3.88e-01 1.94e-01 5.75e-02 3.43e-01
GOMF NADPH OXIDASE H202 FORMING ACTIVITY 5 2.69e-01 5.66e-01 0.433000 2.80e-01 3.30e-01 2.78e-01 2.01e-01
GOCC LARGE RIBOSOMAL SUBUNIT 107 1.38e-13 1.91e-11 0.433000 -5.48e-02 -4.30e-01 3.27e-01 1.54e-14
STAT3 nuclear events downstream of ALK signaling 10 5.80e-02 2.47e-01 0.433000 4.33e-01 -2.07e-02 1.78e-02 9.10e-01
GOBP CORPUS CALLOSUM MORPHOGENESIS 6 1.65e-01 4.50e-01 0.433000 3.81e-01 -2.06e-01 1.06e-01 3.82e-01
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION 15 1.38e-02 9.99e-02 0.433000 3.23e-02 -4.32e-01 8.29e-01 3.80e-03
GOBP PHOTORECEPTOR CELL MORPHOGENESIS 5 2.70e-01 5.66e-01 0.433000 2.71e-01 3.37e-01 2.94e-01 1.92e-01
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY 15 1.61e-02 1.10e-01 0.433000 4.27e-01 7.18e-02 4.22e-03 6.30e-01
GOMF SULFURTRANSFERASE ACTIVITY 11 5.02e-02 2.26e-01 0.433000 -4.18e-01 -1.11e-01 1.63e-02 5.26e-01
Amino Acid conjugation 9 8.72e-02 3.16e-01 0.433000 -4.16e-01 -1.20e-01 3.08e-02 5.34e-01
Conjugation of carboxylic acids 9 8.72e-02 3.16e-01 0.433000 -4.16e-01 -1.20e-01 3.08e-02 5.34e-01
GOMF CALCIUM POTASSIUM SODIUM ANTIPORTER ACTIVITY 5 2.21e-01 5.17e-01 0.432000 -3.35e-01 2.74e-01 1.95e-01 2.89e-01
RUNX3 regulates YAP1-mediated transcription 7 1.51e-01 4.29e-01 0.432000 4.13e-01 1.27e-01 5.83e-02 5.61e-01
GOCC TRANSLATION PREINITIATION COMPLEX 16 1.12e-02 8.53e-02 0.432000 -6.90e-03 -4.32e-01 9.62e-01 2.77e-03
NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose 5 2.56e-01 5.54e-01 0.432000 4.20e-01 1.00e-01 1.04e-01 6.99e-01
GOBP RESPONSE TO ZINC ION STARVATION 9 9.47e-02 3.30e-01 0.432000 2.46e-01 3.55e-01 2.01e-01 6.53e-02
GOMF ACETYLCHOLINE BINDING 10 7.39e-02 2.86e-01 0.432000 -3.12e-01 -2.99e-01 8.79e-02 1.02e-01
GOBP PHOSPHATIDYLSERINE ACYL CHAIN REMODELING 9 8.86e-02 3.18e-01 0.432000 4.12e-01 1.30e-01 3.24e-02 5.00e-01
GOMF STRUCTURAL CONSTITUENT OF RIBOSOME 154 8.31e-19 2.55e-16 0.431000 -9.03e-02 -4.21e-01 5.32e-02 1.64e-19
GDP-fucose biosynthesis 6 1.68e-01 4.53e-01 0.431000 -2.06e-01 3.79e-01 3.83e-01 1.08e-01
GOBP TYPE III INTERFERON PRODUCTION 5 2.24e-01 5.19e-01 0.431000 2.52e-01 -3.49e-01 3.28e-01 1.76e-01
Condensation of Prometaphase Chromosomes 11 4.51e-02 2.12e-01 0.431000 2.20e-02 -4.30e-01 8.99e-01 1.35e-02
GOBP OTIC VESICLE MORPHOGENESIS 10 7.19e-02 2.81e-01 0.431000 3.86e-01 1.91e-01 3.46e-02 2.95e-01
GOBP REGULATION OF ADIPONECTIN SECRETION 7 1.59e-01 4.41e-01 0.430000 3.85e-01 1.93e-01 7.81e-02 3.76e-01
GOBP AXONEMAL CENTRAL APPARATUS ASSEMBLY 6 1.72e-01 4.58e-01 0.430000 -1.60e-01 3.99e-01 4.98e-01 9.02e-02
GOMF PROTEASOME ACTIVATING ACTIVITY 6 1.66e-01 4.50e-01 0.430000 3.11e-01 -2.97e-01 1.87e-01 2.08e-01
GOCC CORTICAL ENDOPLASMIC RETICULUM 6 2.05e-01 4.99e-01 0.430000 3.95e-01 1.72e-01 9.42e-02 4.67e-01
GOMF CO SMAD BINDING 9 7.73e-02 2.94e-01 0.430000 4.26e-01 -5.74e-02 2.68e-02 7.66e-01
GOBP POSITIVE REGULATION OF ENAMEL MINERALIZATION 5 2.74e-01 5.72e-01 0.430000 -3.11e-01 -2.97e-01 2.28e-01 2.50e-01
GOBP ENDODERMAL CELL FATE SPECIFICATION 8 1.05e-01 3.49e-01 0.430000 4.29e-01 -3.14e-02 3.57e-02 8.78e-01
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY 9 8.84e-02 3.18e-01 0.430000 4.19e-01 9.53e-02 2.95e-02 6.21e-01
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 1 SIGNALING PATHWAY 7 1.41e-01 4.12e-01 0.430000 4.29e-01 -1.80e-02 4.92e-02 9.34e-01
GOBP CELL PROLIFERATION IN HINDBRAIN 14 2.71e-02 1.57e-01 0.430000 3.17e-01 2.90e-01 3.99e-02 6.06e-02
GOBP INNER CELL MASS CELL DIFFERENTIATION 8 1.04e-01 3.48e-01 0.429000 4.27e-01 -4.72e-02 3.65e-02 8.17e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 19 6.96e-03 6.06e-02 0.429000 3.83e-01 1.94e-01 3.82e-03 1.44e-01
GOBP REGULATION OF RIBONUCLEASE ACTIVITY 9 7.16e-02 2.81e-01 0.429000 1.74e-01 -3.93e-01 3.67e-01 4.13e-02
GOBP METANEPHRIC S SHAPED BODY MORPHOGENESIS 5 2.56e-01 5.54e-01 0.429000 4.25e-01 6.05e-02 9.98e-02 8.15e-01
GOBP DISTAL TUBULE DEVELOPMENT 12 3.87e-02 1.94e-01 0.429000 4.23e-01 7.16e-02 1.11e-02 6.68e-01
GOMF SODIUM BICARBONATE SYMPORTER ACTIVITY 6 1.69e-01 4.54e-01 0.429000 -2.47e-01 3.51e-01 2.95e-01 1.37e-01
GOMF MAP KINASE KINASE KINASE ACTIVITY 24 1.56e-03 1.96e-02 0.429000 4.20e-01 8.69e-02 3.67e-04 4.61e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL 5 2.76e-01 5.74e-01 0.429000 3.32e-01 2.72e-01 1.99e-01 2.92e-01
GOBP REGULATION OF VITAMIN METABOLIC PROCESS 12 3.78e-02 1.91e-01 0.429000 -4.67e-02 -4.26e-01 7.79e-01 1.05e-02
Synthesis of IP2, IP, and Ins in the cytosol 13 3.07e-02 1.69e-01 0.429000 4.17e-01 1.02e-01 9.31e-03 5.23e-01
GOBP MEIOTIC SISTER CHROMATID COHESION 13 2.46e-02 1.47e-01 0.429000 4.20e-01 -8.45e-02 8.67e-03 5.98e-01
GOMF PHOSPHOFRUCTOKINASE ACTIVITY 6 2.14e-01 5.09e-01 0.429000 3.21e-01 2.84e-01 1.73e-01 2.29e-01
GOBP REGULATION OF OPSONIZATION 10 5.14e-02 2.29e-01 0.429000 -3.33e-01 2.70e-01 6.83e-02 1.39e-01
GOBP IRON COORDINATION ENTITY TRANSPORT 11 4.95e-02 2.24e-01 0.429000 3.81e-02 4.27e-01 8.27e-01 1.42e-02
GOMF PRIMARY AMINE OXIDASE ACTIVITY 7 1.63e-01 4.47e-01 0.429000 2.17e-01 3.69e-01 3.20e-01 9.05e-02
GOMF DOUBLE STRANDED TELOMERIC DNA BINDING 9 6.91e-02 2.75e-01 0.428000 2.83e-01 -3.21e-01 1.41e-01 9.51e-02
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX 6 2.14e-01 5.09e-01 0.428000 3.43e-01 2.56e-01 1.45e-01 2.77e-01
GOBP REGULATION OF AGGREPHAGY 7 1.26e-01 3.87e-01 0.428000 2.41e-01 -3.54e-01 2.69e-01 1.05e-01
GOBP REGULATION OF LIPID TRANSPORTER ACTIVITY 6 2.09e-01 5.04e-01 0.428000 1.82e-01 3.87e-01 4.39e-01 1.00e-01
GOBP HEPATIC STELLATE CELL ACTIVATION 9 9.17e-02 3.25e-01 0.428000 4.11e-01 1.18e-01 3.26e-02 5.38e-01
GOBP LATERAL MESODERM MORPHOGENESIS 5 2.39e-01 5.36e-01 0.428000 4.14e-01 -1.09e-01 1.09e-01 6.72e-01
GOBP NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION 16 1.52e-02 1.06e-01 0.428000 1.60e-01 3.97e-01 2.67e-01 6.01e-03
GOBP MESANGIAL CELL DIFFERENTIATION 7 1.39e-01 4.09e-01 0.428000 4.22e-01 -6.75e-02 5.29e-02 7.57e-01
GOBP UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY 5 2.78e-01 5.75e-01 0.428000 -3.39e-01 -2.62e-01 1.90e-01 3.11e-01
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE PHOSPHATASE ACTIVITY 11 4.94e-02 2.24e-01 0.428000 4.27e-01 2.29e-02 1.42e-02 8.95e-01
GOBP PRIMITIVE HEMOPOIESIS 8 9.56e-02 3.31e-01 0.428000 3.65e-01 -2.23e-01 7.39e-02 2.75e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA SYNTHESIS DEPENDENT STRAND ANNEALING 8 1.07e-01 3.53e-01 0.427000 4.25e-01 -4.42e-02 3.73e-02 8.28e-01
GOCC PWP2P CONTAINING SUBCOMPLEX OF 90S PRERIBOSOME 5 2.45e-01 5.40e-01 0.427000 6.78e-02 -4.22e-01 7.93e-01 1.02e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 8 1.30e-01 3.93e-01 0.427000 -3.20e-01 -2.83e-01 1.17e-01 1.66e-01
GOBP TRYPTOPHAN TRANSPORT 5 2.72e-01 5.69e-01 0.427000 3.93e-01 1.67e-01 1.28e-01 5.17e-01
GOMF POLY ADP D RIBOSE BINDING 5 2.65e-01 5.62e-01 0.427000 1.05e-01 4.14e-01 6.84e-01 1.09e-01
GOBP POSITIVE REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 9 7.04e-02 2.78e-01 0.427000 -2.84e-01 3.19e-01 1.40e-01 9.77e-02
PKMTs methylate histone lysines 42 1.44e-05 3.95e-04 0.427000 4.16e-01 9.47e-02 3.06e-06 2.88e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION 17 1.32e-02 9.59e-02 0.427000 3.33e-01 2.66e-01 1.73e-02 5.74e-02
GOBP 4FE 4S CLUSTER ASSEMBLY 5 2.33e-01 5.31e-01 0.426000 2.05e-01 -3.74e-01 4.28e-01 1.47e-01
GOBP ELASTIN METABOLIC PROCESS 8 1.26e-01 3.86e-01 0.426000 -3.91e-01 -1.70e-01 5.55e-02 4.04e-01
GOMF INOSITOL 1 3 4 5 TETRAKISPHOSPHATE BINDING 5 2.49e-01 5.46e-01 0.426000 -4.09e-02 4.24e-01 8.74e-01 1.00e-01
GOMF UBIQUITIN LIKE MODIFIER ACTIVATING ENZYME ACTIVITY 9 7.14e-02 2.80e-01 0.426000 2.59e-01 -3.38e-01 1.78e-01 7.87e-02
GOBP SMOOTH MUSCLE CELL MATRIX ADHESION 6 2.18e-01 5.13e-01 0.426000 2.82e-01 3.20e-01 2.32e-01 1.75e-01
GOCC MICROTUBULE BUNDLE 6 2.17e-01 5.13e-01 0.426000 2.66e-01 3.33e-01 2.60e-01 1.57e-01
GOMF RIBOSOMAL SMALL SUBUNIT BINDING 16 1.48e-02 1.05e-01 0.426000 -1.13e-01 -4.11e-01 4.35e-01 4.44e-03
GOMF 11 CIS RETINAL BINDING 7 1.29e-01 3.93e-01 0.426000 -3.49e-01 2.44e-01 1.10e-01 2.63e-01
GOMF U4 SNRNA BINDING 6 1.73e-01 4.59e-01 0.426000 3.33e-01 -2.66e-01 1.58e-01 2.60e-01
GOBP NEUROBLAST DIFFERENTIATION 8 1.18e-01 3.75e-01 0.426000 -7.02e-02 -4.20e-01 7.31e-01 3.97e-02
Phospholipase C-mediated cascade; FGFR3 12 4.74e-02 2.19e-01 0.426000 2.46e-01 3.47e-01 1.40e-01 3.73e-02
RUNX3 regulates CDKN1A transcription 7 1.40e-01 4.10e-01 0.426000 4.16e-01 -8.76e-02 5.64e-02 6.88e-01
GOMF CHITIN BINDING 8 1.06e-01 3.52e-01 0.426000 -4.18e-01 7.92e-02 4.06e-02 6.98e-01
GOBP CELL MIGRATION INVOLVED IN HEART DEVELOPMENT 20 4.67e-03 4.50e-02 0.425000 4.23e-01 4.73e-02 1.06e-03 7.14e-01
GOMF ARYLESTERASE ACTIVITY 6 1.82e-01 4.71e-01 0.425000 -4.06e-01 1.28e-01 8.53e-02 5.87e-01
GOMF EXTRACELLULAR MATRIX PROTEIN BINDING 6 2.15e-01 5.11e-01 0.425000 2.05e-01 3.73e-01 3.84e-01 1.14e-01
GOBP TYROSINE CATABOLIC PROCESS 6 2.09e-01 5.04e-01 0.425000 1.28e-01 4.05e-01 5.88e-01 8.54e-02
GOBP POSITIVE REGULATION OF SULFUR METABOLIC PROCESS 5 2.64e-01 5.61e-01 0.425000 4.20e-01 6.72e-02 1.04e-01 7.95e-01
GOMF DIPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 2.79e-01 5.76e-01 0.425000 3.70e-01 2.08e-01 1.51e-01 4.20e-01
GOBP RESPONSE TO PHORBOL 13 ACETATE 12 MYRISTATE 10 7.70e-02 2.93e-01 0.425000 -3.82e-01 -1.87e-01 3.67e-02 3.06e-01
GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN THERMOCEPTION 5 2.34e-01 5.31e-01 0.425000 -2.34e-01 3.54e-01 3.64e-01 1.70e-01
Recycling of eIF2:GDP 7 1.46e-01 4.21e-01 0.425000 3.03e-02 -4.24e-01 8.89e-01 5.22e-02
GOBP REGULATION OF HEXOKINASE ACTIVITY 6 2.21e-01 5.17e-01 0.425000 -3.14e-01 -2.85e-01 1.82e-01 2.26e-01
GOBP POSITIVE REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 7 1.65e-01 4.49e-01 0.424000 3.92e-01 1.62e-01 7.22e-02 4.58e-01
RNA Polymerase I Promoter Opening 26 6.57e-04 9.81e-03 0.424000 1.17e-01 -4.08e-01 3.02e-01 3.17e-04
GOMF OXYGEN SENSOR ACTIVITY 5 2.51e-01 5.48e-01 0.424000 4.20e-01 -5.51e-02 1.03e-01 8.31e-01
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 6 1.96e-01 4.89e-01 0.424000 4.24e-01 -6.39e-03 7.21e-02 9.78e-01
GOBP REGULATION OF BRANCHING MORPHOGENESIS OF A NERVE 5 2.43e-01 5.39e-01 0.424000 4.02e-01 -1.35e-01 1.20e-01 6.02e-01
GOBP REGULATION OF TRANSLATION AT POSTSYNAPSE 6 2.22e-01 5.17e-01 0.424000 3.05e-01 2.95e-01 1.96e-01 2.11e-01
Highly calcium permeable postsynaptic nicotinic acetylcholine receptors 11 5.53e-02 2.40e-01 0.424000 -4.16e-01 -8.28e-02 1.70e-02 6.34e-01
GOBP ENDOCARDIUM DEVELOPMENT 12 3.24e-02 1.74e-01 0.424000 3.82e-01 -1.82e-01 2.18e-02 2.74e-01
GOBP LIPOXIN METABOLIC PROCESS 5 2.55e-01 5.52e-01 0.424000 4.22e-01 -3.29e-02 1.02e-01 8.99e-01
GOCC AP 3 ADAPTOR COMPLEX 11 4.16e-02 2.02e-01 0.423000 3.39e-01 -2.54e-01 5.15e-02 1.45e-01
GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 6 2.23e-01 5.18e-01 0.423000 3.08e-01 2.90e-01 1.91e-01 2.18e-01
GOBP SPLICEOSOMAL CONFORMATIONAL CHANGES TO GENERATE CATALYTIC CONFORMATION 5 2.71e-01 5.68e-01 0.423000 4.12e-01 9.62e-02 1.11e-01 7.10e-01
GOMF UBIQUITIN LIGASE COMPLEX SCAFFOLD ACTIVITY 6 2.21e-01 5.17e-01 0.423000 3.51e-01 2.36e-01 1.36e-01 3.17e-01
GOBP MITRAL VALVE DEVELOPMENT 14 2.93e-02 1.65e-01 0.423000 3.61e-01 2.21e-01 1.95e-02 1.52e-01
GOBP MRNA METHYLGUANOSINE CAP DECAPPING 16 9.81e-03 7.76e-02 0.423000 2.76e-01 -3.20e-01 5.55e-02 2.67e-02
GOBP RESPONSE TO COBALT ION 9 1.01e-01 3.42e-01 0.422000 3.87e-01 1.70e-01 4.45e-02 3.77e-01
GOBP FUSED ANTRUM STAGE 6 2.24e-01 5.19e-01 0.422000 2.67e-01 3.27e-01 2.57e-01 1.65e-01
GOMF PEPTIDE ALPHA N ACETYLTRANSFERASE ACTIVITY 7 1.72e-01 4.58e-01 0.422000 -2.10e-01 -3.66e-01 3.35e-01 9.36e-02
GOCC SWI SNF COMPLEX 30 4.88e-04 7.71e-03 0.422000 3.89e-01 1.64e-01 2.26e-04 1.21e-01
GOMF HISTONE H3 METHYLTRANSFERASE ACTIVITY 42 2.21e-05 5.79e-04 0.422000 3.96e-01 1.47e-01 9.15e-06 9.93e-02
GOBP IRIS MORPHOGENESIS 9 9.29e-02 3.27e-01 0.422000 4.19e-01 4.61e-02 2.94e-02 8.11e-01
GOMF C3HC4 TYPE RING FINGER DOMAIN BINDING 6 1.85e-01 4.75e-01 0.422000 1.46e-01 -3.96e-01 5.36e-01 9.32e-02
Conjugation of salicylate with glycine 8 1.30e-01 3.93e-01 0.422000 -3.97e-01 -1.43e-01 5.20e-02 4.85e-01
GOBP TELOMERIC LOOP DISASSEMBLY 9 1.05e-01 3.49e-01 0.421000 2.09e-01 3.66e-01 2.78e-01 5.74e-02
FGFR1 mutant receptor activation 31 3.55e-04 5.97e-03 0.421000 4.02e-01 1.25e-01 1.06e-04 2.28e-01
GOMF GANGLIOSIDE BINDING 5 2.79e-01 5.76e-01 0.421000 1.40e-01 3.97e-01 5.87e-01 1.24e-01
GOBP POSITIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 1.08e-01 3.54e-01 0.421000 3.10e-01 2.85e-01 1.07e-01 1.39e-01
Ketone body metabolism 9 1.08e-01 3.54e-01 0.421000 3.12e-01 2.83e-01 1.05e-01 1.42e-01
GOBP REGULATION OF AXON GUIDANCE 11 5.48e-02 2.39e-01 0.421000 4.20e-01 2.99e-02 1.60e-02 8.63e-01
GOBP MACROPHAGE FUSION 6 1.94e-01 4.87e-01 0.420000 -4.13e-01 7.78e-02 7.97e-02 7.41e-01
GOBP TRANSEPITHELIAL CHLORIDE TRANSPORT 8 1.23e-01 3.83e-01 0.420000 5.02e-02 4.17e-01 8.06e-01 4.11e-02
GOMF ALPHA N ACETYLNEURAMINATE ALPHA 2 8 SIALYLTRANSFERASE ACTIVITY 6 1.82e-01 4.71e-01 0.420000 3.49e-01 -2.33e-01 1.38e-01 3.22e-01
GOBP REGULATION OF NK T CELL PROLIFERATION 7 1.47e-01 4.23e-01 0.420000 -8.60e-02 4.11e-01 6.93e-01 5.96e-02
GOMF HYDROLASE ACTIVITY ACTING ON ETHER BONDS 10 8.48e-02 3.12e-01 0.420000 3.31e-01 2.58e-01 6.95e-02 1.58e-01
GOBP FOREGUT MORPHOGENESIS 10 7.57e-02 2.90e-01 0.420000 4.11e-01 8.34e-02 2.43e-02 6.48e-01
GOBP PML BODY ORGANIZATION 7 1.78e-01 4.65e-01 0.420000 3.35e-01 2.52e-01 1.24e-01 2.47e-01
GOBP REGULATION OF PANCREATIC JUICE SECRETION 7 1.58e-01 4.39e-01 0.420000 4.19e-01 1.78e-02 5.47e-02 9.35e-01
GOMF SOMATOSTATIN RECEPTOR ACTIVITY 5 2.45e-01 5.41e-01 0.419000 -2.07e-01 3.64e-01 4.23e-01 1.58e-01
GOBP ORNITHINE TRANSPORT 6 2.29e-01 5.27e-01 0.419000 3.16e-01 2.75e-01 1.80e-01 2.44e-01
Signaling by FGFR1 in disease 38 6.94e-05 1.57e-03 0.419000 3.96e-01 1.35e-01 2.36e-05 1.50e-01
GOBP REGULATION OF ADHERENS JUNCTION ORGANIZATION 5 2.73e-01 5.70e-01 0.419000 4.88e-02 4.16e-01 8.50e-01 1.07e-01
MET activates PI3K/AKT signaling 6 1.86e-01 4.77e-01 0.418000 3.65e-01 -2.05e-01 1.22e-01 3.86e-01
GOBP ACETYLCHOLINE SECRETION 5 2.85e-01 5.82e-01 0.418000 3.94e-01 1.40e-01 1.27e-01 5.88e-01
GOBP COBALT ION TRANSPORT 6 1.84e-01 4.74e-01 0.418000 2.52e-01 -3.34e-01 2.85e-01 1.57e-01
GOCC BBSOME 8 1.05e-01 3.49e-01 0.418000 2.48e-01 -3.36e-01 2.25e-01 9.95e-02
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR ACTIVITY 13 3.85e-02 1.93e-01 0.418000 3.93e-01 1.43e-01 1.43e-02 3.73e-01
GOMF BICARBONATE MONOATOMIC ANION ANTIPORTER ACTIVITY 12 3.77e-02 1.91e-01 0.417000 -4.00e-01 1.20e-01 1.65e-02 4.71e-01
GOBP TRNA THIO MODIFICATION 5 2.57e-01 5.54e-01 0.417000 -1.09e-01 4.03e-01 6.74e-01 1.19e-01
RHOU GTPase cycle 37 9.77e-05 2.11e-03 0.417000 3.93e-01 1.39e-01 3.52e-05 1.44e-01
GOBP MESANGIAL CELL DEVELOPMENT 6 1.89e-01 4.80e-01 0.416000 3.61e-01 -2.07e-01 1.26e-01 3.79e-01
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING 12 4.87e-02 2.22e-01 0.416000 4.03e-01 1.05e-01 1.57e-02 5.29e-01
GOCC PRESYNAPTIC ENDOCYTIC ZONE 9 1.13e-01 3.65e-01 0.416000 2.83e-01 3.05e-01 1.41e-01 1.13e-01
GOBP TRICUSPID VALVE DEVELOPMENT 7 1.82e-01 4.71e-01 0.416000 3.49e-01 2.27e-01 1.10e-01 2.99e-01
GOBP PERICARDIUM DEVELOPMENT 19 7.67e-03 6.51e-02 0.416000 4.13e-01 4.98e-02 1.82e-03 7.07e-01
GOBP POSITIVE REGULATION OF TRANSLATION IN RESPONSE TO STRESS 5 2.80e-01 5.77e-01 0.416000 4.11e-01 6.61e-02 1.12e-01 7.98e-01
GOBP ENTRY OF BACTERIUM INTO HOST CELL 9 1.14e-01 3.67e-01 0.415000 3.06e-01 2.81e-01 1.12e-01 1.44e-01
GOBP REGULATION OF PHENOTYPIC SWITCHING 6 2.32e-01 5.30e-01 0.415000 3.61e-01 2.05e-01 1.26e-01 3.83e-01
GOBP POSITIVE REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY 5 2.93e-01 5.90e-01 0.415000 3.77e-01 1.73e-01 1.44e-01 5.04e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 11 6.37e-02 2.62e-01 0.415000 1.05e-01 4.02e-01 5.47e-01 2.11e-02
Molybdenum cofactor biosynthesis 6 2.32e-01 5.30e-01 0.415000 -3.60e-01 -2.07e-01 1.27e-01 3.80e-01
GOBP PROSTHETIC GROUP METABOLIC PROCESS 6 2.32e-01 5.30e-01 0.415000 -3.60e-01 -2.07e-01 1.27e-01 3.80e-01
GOBP GUANINE NUCLEOTIDE TRANSPORT 11 6.83e-02 2.73e-01 0.415000 1.91e-01 3.68e-01 2.72e-01 3.45e-02
GOMF CALCIUM DEPENDENT PROTEIN SERINE THREONINE PHOSPHATASE REGULATOR ACTIVITY 5 2.76e-01 5.74e-01 0.415000 -2.31e-02 -4.14e-01 9.29e-01 1.09e-01
GOBP CHORIO ALLANTOIC FUSION 7 1.77e-01 4.64e-01 0.415000 -1.40e-01 -3.90e-01 5.21e-01 7.37e-02
GOBP REGULATION OF INOSITOL 1 4 5 TRISPHOSPHATE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 5 2.97e-01 5.94e-01 0.414000 3.64e-01 1.98e-01 1.58e-01 4.44e-01
GOBP NATURAL KILLER CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 30 4.44e-04 7.15e-03 0.414000 -4.14e-01 -1.34e-02 8.63e-05 8.99e-01
GOMF INTERLEUKIN 1 RECEPTOR ACTIVITY 6 1.92e-01 4.83e-01 0.414000 -3.56e-01 2.12e-01 1.31e-01 3.69e-01
GOBP DEFENSE RESPONSE TO TUMOR CELL 13 4.42e-02 2.10e-01 0.414000 -3.14e-01 -2.70e-01 4.97e-02 9.23e-02
PI-3K cascade:FGFR1 21 5.96e-03 5.37e-02 0.414000 3.76e-01 1.75e-01 2.89e-03 1.66e-01
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 6 1.90e-01 4.81e-01 0.414000 2.52e-01 -3.28e-01 2.84e-01 1.64e-01
GOBP REGULATION OF FEMALE RECEPTIVITY 8 1.47e-01 4.23e-01 0.414000 2.81e-01 3.04e-01 1.69e-01 1.36e-01
GOBP RESPONSE TO GRAM POSITIVE BACTERIUM 6 1.97e-01 4.90e-01 0.414000 1.41e-01 -3.89e-01 5.49e-01 9.88e-02
GOBP CARDIAC NEURAL CREST CELL DEVELOPMENT INVOLVED IN OUTFLOW TRACT MORPHOGENESIS 13 3.10e-02 1.70e-01 0.414000 4.01e-01 -1.03e-01 1.23e-02 5.22e-01
GOBP REGULATION OF MESODERM DEVELOPMENT 6 1.94e-01 4.87e-01 0.414000 -3.70e-01 1.85e-01 1.16e-01 4.33e-01
Organic anion transport 5 2.59e-01 5.56e-01 0.413000 -3.87e-01 1.45e-01 1.34e-01 5.74e-01
GOBP POSITIVE REGULATION OF MICROTUBULE NUCLEATION 7 1.64e-01 4.48e-01 0.413000 4.13e-01 -5.21e-03 5.82e-02 9.81e-01
GOBP PLASMA MEMBRANE TUBULATION 19 1.05e-02 8.18e-02 0.413000 3.38e-01 2.39e-01 1.09e-02 7.17e-02
Tie2 Signaling 18 7.19e-03 6.23e-02 0.413000 3.55e-01 -2.12e-01 9.11e-03 1.20e-01
GOBP REGULATION OF BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS 5 2.94e-01 5.91e-01 0.413000 -1.50e-01 -3.85e-01 5.62e-01 1.36e-01
GOBP ENDOTHELIAL CELL ACTIVATION 11 4.82e-02 2.21e-01 0.413000 2.76e-01 -3.08e-01 1.14e-01 7.74e-02
GOBP EMBRYONIC SKELETAL JOINT MORPHOGENESIS 11 4.81e-02 2.21e-01 0.413000 2.98e-01 -2.86e-01 8.67e-02 1.01e-01
TGFBR3 regulates TGF-beta signaling 8 1.15e-01 3.68e-01 0.413000 3.81e-01 -1.58e-01 6.20e-02 4.38e-01
GOBP CYCLIC GMP AMP TRANSMEMBRANE IMPORT ACROSS PLASMA MEMBRANE 8 1.49e-01 4.26e-01 0.413000 2.69e-01 3.13e-01 1.88e-01 1.25e-01
GOBP RNA IMPORT INTO MITOCHONDRION 5 2.98e-01 5.94e-01 0.413000 -3.76e-01 -1.70e-01 1.45e-01 5.11e-01
GOBP OXALATE TRANSPORT 12 3.79e-02 1.91e-01 0.412000 -3.58e-01 2.05e-01 3.19e-02 2.18e-01
GOBP NEURAL PLATE DEVELOPMENT 8 1.14e-01 3.67e-01 0.412000 3.72e-01 -1.79e-01 6.87e-02 3.81e-01
GOCC MULTIVESICULAR BODY INTERNAL VESICLE 6 1.92e-01 4.84e-01 0.412000 2.62e-01 -3.18e-01 2.66e-01 1.77e-01
GOBP REGULATION OF EATING BEHAVIOR 7 1.86e-01 4.76e-01 0.412000 3.61e-01 1.99e-01 9.77e-02 3.63e-01
GOCC BCL 2 FAMILY PROTEIN COMPLEX 10 6.78e-02 2.72e-01 0.412000 1.56e-01 -3.82e-01 3.94e-01 3.67e-02
GOBP POSITIVE REGULATION OF MONOCYTE EXTRAVASATION 5 2.77e-01 5.74e-01 0.412000 -8.61e-03 4.12e-01 9.73e-01 1.11e-01
GOBP ERBB4 SIGNALING PATHWAY 10 8.14e-02 3.04e-01 0.412000 -4.08e-01 -5.50e-02 2.54e-02 7.63e-01
GOCC TRANSCRIPTION EXPORT COMPLEX 11 4.92e-02 2.23e-01 0.412000 2.55e-01 -3.23e-01 1.43e-01 6.32e-02
GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION 6 2.20e-01 5.16e-01 0.412000 3.67e-02 4.10e-01 8.76e-01 8.21e-02
GOCC SEMAPHORIN RECEPTOR COMPLEX 11 7.16e-02 2.81e-01 0.411000 1.92e-01 3.64e-01 2.69e-01 3.67e-02
GOMF SODIUM CHANNEL INHIBITOR ACTIVITY 8 1.50e-01 4.29e-01 0.411000 3.19e-01 2.60e-01 1.19e-01 2.02e-01
Transcriptional regulation of brown and beige adipocyte differentiation 29 9.50e-04 1.32e-02 0.411000 3.70e-01 1.79e-01 5.62e-04 9.49e-02
Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 29 9.50e-04 1.32e-02 0.411000 3.70e-01 1.79e-01 5.62e-04 9.49e-02
Loss of Function of SMAD2/3 in Cancer 7 1.51e-01 4.29e-01 0.411000 3.62e-01 -1.94e-01 9.68e-02 3.75e-01
GOMF NEDD8 TRANSFERASE ACTIVITY 7 1.53e-01 4.33e-01 0.411000 1.61e-01 -3.78e-01 4.62e-01 8.32e-02
GOBP OVULATION FROM OVARIAN FOLLICLE 9 1.12e-01 3.63e-01 0.411000 3.88e-01 1.34e-01 4.36e-02 4.87e-01
GOBP DTMP METABOLIC PROCESS 6 2.42e-01 5.38e-01 0.411000 -2.36e-01 -3.36e-01 3.17e-01 1.54e-01
RUNX3 regulates WNT signaling 8 1.22e-01 3.81e-01 0.411000 9.48e-02 -3.99e-01 6.42e-01 5.04e-02
Butyrophilin (BTN) family interactions 12 3.80e-02 1.92e-01 0.411000 3.08e-01 -2.71e-01 6.45e-02 1.04e-01
GOMF NEUROTROPHIN TRK RECEPTOR BINDING 6 2.27e-01 5.23e-01 0.411000 4.04e-01 7.51e-02 8.69e-02 7.50e-01
GOBP REGULATION OF ISOTYPE SWITCHING TO IGE ISOTYPES 6 2.43e-01 5.39e-01 0.410000 3.14e-01 2.64e-01 1.82e-01 2.63e-01
GOBP SULFATION 20 8.95e-03 7.29e-02 0.410000 3.28e-01 2.46e-01 1.10e-02 5.70e-02
GOBP ER OVERLOAD RESPONSE 11 5.32e-02 2.35e-01 0.410000 1.55e-01 -3.80e-01 3.75e-01 2.91e-02
GOMF AMINE BINDING 12 5.95e-02 2.51e-01 0.410000 3.02e-01 2.77e-01 6.97e-02 9.63e-02
Synthesis of Ketone Bodies 8 1.52e-01 4.30e-01 0.410000 3.21e-01 2.56e-01 1.16e-01 2.10e-01
GOBP REGULATION OF NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY 14 2.62e-02 1.54e-01 0.410000 4.03e-01 -7.44e-02 8.99e-03 6.30e-01
GOBP REGULATION OF MONOCYTE EXTRAVASATION 7 1.79e-01 4.67e-01 0.410000 8.12e-02 4.02e-01 7.10e-01 6.57e-02
GOCC MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O 10 8.09e-02 3.02e-01 0.410000 -1.48e-02 -4.09e-01 9.35e-01 2.50e-02
GOBP POLY A PLUS MRNA EXPORT FROM NUCLEUS 18 9.90e-03 7.82e-02 0.410000 4.08e-01 -4.01e-02 2.75e-03 7.68e-01
GOBP NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM 10 9.01e-02 3.21e-01 0.410000 -1.44e-01 -3.84e-01 4.32e-01 3.57e-02
GOBP MICROGLIAL CELL MEDIATED CYTOTOXICITY 5 2.96e-01 5.93e-01 0.409000 -3.96e-01 -1.05e-01 1.25e-01 6.85e-01
GOMF NUCLEAR EXPORT SIGNAL RECEPTOR ACTIVITY 12 3.94e-02 1.96e-01 0.409000 3.38e-01 -2.31e-01 4.27e-02 1.66e-01
GOCC NUCLEAR PORE CENTRAL TRANSPORT CHANNEL 5 3.03e-01 5.97e-01 0.409000 3.74e-01 1.65e-01 1.47e-01 5.24e-01
GOMF L LEUCINE TRANSMEMBRANE TRANSPORTER ACTIVITY 6 2.43e-01 5.39e-01 0.409000 3.47e-01 2.16e-01 1.41e-01 3.59e-01
Activated point mutants of FGFR2 16 2.38e-02 1.44e-01 0.409000 3.10e-01 2.66e-01 3.18e-02 6.51e-02
GOBP RESPONSE TO LUTEINIZING HORMONE 7 1.80e-01 4.68e-01 0.409000 4.02e-01 7.47e-02 6.56e-02 7.32e-01
GOBP DE NOVO CENTRIOLE ASSEMBLY INVOLVED IN MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION 5 3.09e-01 6.03e-01 0.409000 -3.40e-01 -2.27e-01 1.88e-01 3.79e-01
GOCC RNA N6 METHYLADENOSINE METHYLTRANSFERASE COMPLEX 9 1.04e-01 3.48e-01 0.409000 -2.50e-03 -4.08e-01 9.90e-01 3.38e-02
Beta oxidation of butanoyl-CoA to acetyl-CoA 5 3.09e-01 6.03e-01 0.409000 3.42e-01 2.24e-01 1.86e-01 3.86e-01
Scavenging by Class A Receptors 19 1.20e-02 8.91e-02 0.408000 -3.01e-01 -2.76e-01 2.31e-02 3.73e-02
Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation 35 1.89e-04 3.60e-03 0.408000 -6.97e-02 -4.02e-01 4.75e-01 3.79e-05
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN 6 2.36e-01 5.32e-01 0.408000 -1.18e-01 -3.90e-01 6.15e-01 9.77e-02
GOBP FUNGIFORM PAPILLA DEVELOPMENT 6 2.09e-01 5.04e-01 0.408000 3.90e-01 -1.18e-01 9.77e-02 6.17e-01
GOBP DE NOVO CENTRIOLE ASSEMBLY 6 2.47e-01 5.44e-01 0.408000 -3.22e-01 -2.50e-01 1.72e-01 2.89e-01
GOBP CARTILAGE MORPHOGENESIS 10 7.22e-02 2.82e-01 0.408000 3.81e-01 -1.46e-01 3.71e-02 4.24e-01
GOCC CLATHRIN SCULPTED VESICLE 12 4.32e-02 2.07e-01 0.408000 3.85e-01 -1.35e-01 2.11e-02 4.18e-01
Synthesis of wybutosine at G37 of tRNA(Phe) 6 2.01e-01 4.94e-01 0.407000 3.23e-01 -2.48e-01 1.71e-01 2.92e-01
GOCC PROTEIN COMPLEX INVOLVED IN CELL CELL ADHESION 5 2.75e-01 5.72e-01 0.407000 3.96e-01 -9.45e-02 1.25e-01 7.14e-01
Activated NTRK2 signals through FRS2 and FRS3 11 6.00e-02 2.52e-01 0.407000 4.02e-01 -6.60e-02 2.10e-02 7.05e-01
GOBP POSITIVE REGULATION OF GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT 5 2.68e-01 5.65e-01 0.407000 3.73e-01 -1.62e-01 1.48e-01 5.30e-01
GOBP BRANCHIOMOTOR NEURON AXON GUIDANCE 6 2.42e-01 5.39e-01 0.407000 3.73e-01 1.64e-01 1.14e-01 4.87e-01
GOBP REGULATION OF CARDIOBLAST DIFFERENTIATION 5 2.80e-01 5.77e-01 0.407000 4.03e-01 -5.61e-02 1.18e-01 8.28e-01
GOBP LYMPHOCYTE ANERGY 7 1.69e-01 4.54e-01 0.407000 4.32e-02 -4.05e-01 8.43e-01 6.37e-02
GOBP POSITIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 6 2.47e-01 5.44e-01 0.407000 -2.27e-01 -3.38e-01 3.37e-01 1.51e-01
Bicarbonate transporters 10 6.88e-02 2.74e-01 0.407000 -2.64e-01 3.10e-01 1.48e-01 9.00e-02
Initial triggering of complement 21 4.58e-03 4.42e-02 0.407000 -3.99e-01 8.01e-02 1.55e-03 5.25e-01
GOMF ATP ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY 6 2.02e-01 4.95e-01 0.407000 -2.33e-01 3.34e-01 3.23e-01 1.57e-01
Transport and synthesis of PAPS 6 2.02e-01 4.95e-01 0.407000 -2.34e-01 3.33e-01 3.20e-01 1.58e-01
TICAM1-dependent activation of IRF3/IRF7 13 3.10e-02 1.70e-01 0.407000 2.56e-01 -3.16e-01 1.09e-01 4.87e-02
GOBP RESPONSE TO IRON II ION 6 2.33e-01 5.31e-01 0.407000 3.99e-01 7.75e-02 9.04e-02 7.42e-01
Transcriptional regulation of pluripotent stem cells 28 9.92e-04 1.37e-02 0.407000 4.06e-01 2.34e-02 2.00e-04 8.30e-01
GOBP NEGATIVE REGULATION OF RESPIRATORY BURST 6 2.49e-01 5.46e-01 0.407000 2.48e-01 3.22e-01 2.93e-01 1.72e-01
GOCC SARCOPLASMIC RETICULUM LUMEN 9 1.07e-01 3.53e-01 0.407000 -7.28e-03 -4.07e-01 9.70e-01 3.47e-02
GOBP POSITIVE REGULATION OF LAMELLIPODIUM MORPHOGENESIS 7 1.92e-01 4.84e-01 0.407000 3.71e-01 1.67e-01 8.95e-02 4.44e-01
GOBP PROTEIN UNFOLDING 5 2.81e-01 5.78e-01 0.406000 5.20e-02 -4.03e-01 8.40e-01 1.19e-01
GOBP PLASMA MEMBRANE TO ENDOSOME TRANSPORT 8 1.54e-01 4.33e-01 0.406000 3.62e-01 1.85e-01 7.64e-02 3.65e-01
GOBP MESENCHYMAL STEM CELL MAINTENANCE INVOLVED IN NEPHRON MORPHOGENESIS 6 2.15e-01 5.10e-01 0.406000 8.00e-02 -3.98e-01 7.34e-01 9.10e-02
GOCC RIBOSOMAL SUBUNIT 174 4.66e-19 1.51e-16 0.406000 -5.20e-02 -4.03e-01 2.37e-01 4.57e-20
GOMF ATP DEPENDENT PROTEIN DISAGGREGASE ACTIVITY 6 2.18e-01 5.13e-01 0.406000 4.01e-01 -6.17e-02 8.87e-02 7.93e-01
GOBP KILLING BY HOST OF SYMBIONT CELLS 24 2.07e-03 2.43e-02 0.406000 -3.92e-01 1.06e-01 8.91e-04 3.68e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS 8 1.56e-01 4.36e-01 0.406000 3.49e-01 2.07e-01 8.73e-02 3.11e-01
GOMF CALCIUM ACTIVATED POTASSIUM CHANNEL ACTIVITY 13 4.17e-02 2.02e-01 0.406000 -4.04e-01 -3.94e-02 1.17e-02 8.06e-01
Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 29 5.07e-04 7.96e-03 0.406000 1.70e-01 -3.68e-01 1.13e-01 6.01e-04
GOBP EMBRYONIC BODY MORPHOGENESIS 11 6.87e-02 2.74e-01 0.405000 4.03e-01 4.80e-02 2.08e-02 7.83e-01
GOBP RESPONSE TO FOLIC ACID 9 9.72e-02 3.35e-01 0.405000 1.37e-01 -3.81e-01 4.77e-01 4.76e-02
GOBP INTRACELLULAR PH ELEVATION 7 1.74e-01 4.60e-01 0.405000 -3.38e-02 4.03e-01 8.77e-01 6.46e-02
GOBP REGULATION OF LAMELLIPODIUM MORPHOGENESIS 11 7.85e-02 2.97e-01 0.405000 3.52e-01 2.00e-01 4.35e-02 2.50e-01
GOMF C PALMITOYLTRANSFERASE ACTIVITY 5 3.18e-01 6.10e-01 0.405000 2.53e-01 3.16e-01 3.28e-01 2.21e-01
GOBP EPINEPHRINE SECRETION 7 1.83e-01 4.73e-01 0.405000 -4.51e-02 -4.02e-01 8.36e-01 6.55e-02
GOBP BLOOD VESSEL MATURATION 8 1.22e-01 3.80e-01 0.404000 3.36e-01 -2.25e-01 1.00e-01 2.70e-01
GOBP IMMATURE B CELL DIFFERENTIATION 12 4.92e-02 2.23e-01 0.404000 4.01e-01 -5.27e-02 1.62e-02 7.52e-01
GOBP REGULATION OF HOMOPHILIC CELL ADHESION 5 3.17e-01 6.10e-01 0.404000 2.18e-01 3.40e-01 3.98e-01 1.88e-01
GOBP NOSE DEVELOPMENT 16 1.65e-02 1.12e-01 0.404000 3.84e-01 -1.27e-01 7.91e-03 3.79e-01
GOBP EXOCYST LOCALIZATION 5 3.20e-01 6.11e-01 0.404000 2.62e-01 3.07e-01 3.10e-01 2.34e-01
GOBP REGULATION OF TRANSLATION AT SYNAPSE 8 1.49e-01 4.26e-01 0.404000 3.93e-01 9.18e-02 5.41e-02 6.53e-01
GOMF INOSITOL PHOSPHATE KINASE ACTIVITY 11 6.22e-02 2.58e-01 0.404000 3.96e-01 -7.78e-02 2.29e-02 6.55e-01
GOMF OXALATE TRANSMEMBRANE TRANSPORTER ACTIVITY 10 7.80e-02 2.95e-01 0.404000 -3.88e-01 1.10e-01 3.35e-02 5.45e-01
GOBP MAINTENANCE OF CENTROSOME LOCATION 6 2.09e-01 5.04e-01 0.404000 1.93e-01 -3.54e-01 4.12e-01 1.33e-01
GOCC TRANSLOCON COMPLEX 5 3.04e-01 5.98e-01 0.403000 -7.92e-02 -3.96e-01 7.59e-01 1.26e-01
GOBP RESPONSE TO EPINEPHRINE 14 3.96e-02 1.97e-01 0.403000 3.59e-01 1.85e-01 2.02e-02 2.32e-01
GOBP PRIMARY ALCOHOL CATABOLIC PROCESS 13 4.79e-02 2.21e-01 0.403000 1.38e-01 3.79e-01 3.91e-01 1.79e-02
GOBP RESPONSE TO INTERLEUKIN 17 18 1.67e-02 1.12e-01 0.403000 3.09e-01 2.59e-01 2.32e-02 5.70e-02
Defective F9 activation 5 3.02e-01 5.97e-01 0.403000 6.50e-02 3.98e-01 8.01e-01 1.23e-01
GOBP PYRUVATE TRANSPORT 7 2.01e-01 4.94e-01 0.403000 -3.49e-01 -2.01e-01 1.10e-01 3.57e-01
TICAM1,TRAF6-dependent induction of TAK1 complex 10 7.29e-02 2.84e-01 0.403000 2.46e-01 -3.19e-01 1.78e-01 8.09e-02
GOBP INTESTINAL STEM CELL HOMEOSTASIS 6 2.21e-01 5.17e-01 0.403000 3.94e-01 -8.11e-02 9.44e-02 7.31e-01
GOMF U2 SNRNA BINDING 6 2.12e-01 5.07e-01 0.402000 3.60e-01 -1.80e-01 1.27e-01 4.46e-01
GOBP REGULATION OF PINOCYTOSIS 12 5.10e-02 2.28e-01 0.402000 4.00e-01 -4.47e-02 1.65e-02 7.89e-01
GOBP CORTISOL METABOLIC PROCESS 12 4.46e-02 2.11e-01 0.402000 -3.52e-01 1.94e-01 3.46e-02 2.44e-01
GOCC TRANSCRIPTION FACTOR TFIIA COMPLEX 5 3.18e-01 6.10e-01 0.402000 -1.88e-01 -3.55e-01 4.66e-01 1.69e-01
GOCC TRNA SPLICING LIGASE COMPLEX 8 1.29e-01 3.92e-01 0.402000 1.43e-01 -3.76e-01 4.84e-01 6.55e-02
GOBP CORONARY ARTERY MORPHOGENESIS 9 1.24e-01 3.84e-01 0.402000 3.76e-01 1.44e-01 5.10e-02 4.54e-01
GOBP PEPTIDYL LYSINE ACETYLATION 22 5.50e-03 5.04e-02 0.402000 3.94e-01 8.34e-02 1.40e-03 4.98e-01
GOBP FATTY ACID OMEGA OXIDATION 5 2.70e-01 5.67e-01 0.402000 3.01e-01 -2.66e-01 2.43e-01 3.02e-01
GOBP TELOMERASE HOLOENZYME COMPLEX ASSEMBLY 6 2.36e-01 5.32e-01 0.402000 -3.11e-02 -4.01e-01 8.95e-01 8.91e-02
GOMF DNA RNA HYBRID BINDING 5 2.83e-01 5.80e-01 0.402000 3.89e-01 -1.00e-01 1.32e-01 6.98e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO LYSOSOME 5 3.22e-01 6.13e-01 0.402000 2.20e-01 3.36e-01 3.95e-01 1.93e-01
GOBP DUMP METABOLIC PROCESS 7 2.05e-01 4.99e-01 0.401000 -3.27e-01 -2.32e-01 1.34e-01 2.87e-01
GOMF SPHINGOSINE 1 PHOSPHATE RECEPTOR ACTIVITY 8 1.56e-01 4.36e-01 0.401000 -1.26e-01 -3.81e-01 5.38e-01 6.19e-02
GOBP SUCCINATE METABOLIC PROCESS 7 1.81e-01 4.71e-01 0.401000 4.01e-01 -1.22e-02 6.60e-02 9.55e-01
GOCC HAPTOGLOBIN HEMOGLOBIN COMPLEX 11 6.87e-02 2.74e-01 0.401000 -4.01e-01 9.54e-03 2.12e-02 9.56e-01
GOBP POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION 6 2.34e-01 5.31e-01 0.401000 4.01e-01 8.81e-03 8.90e-02 9.70e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE BINDING 36 2.29e-04 4.22e-03 0.401000 3.87e-01 1.05e-01 5.94e-05 2.75e-01
GOBP REGULATION BY VIRUS OF VIRAL PROTEIN LEVELS IN HOST CELL 7 1.62e-01 4.46e-01 0.401000 2.74e-01 -2.92e-01 2.09e-01 1.81e-01
Signaling by TGF-beta Receptor Complex in Cancer 8 1.33e-01 3.99e-01 0.400000 3.80e-01 -1.26e-01 6.28e-02 5.37e-01
GOBP NOTOCHORD MORPHOGENESIS 8 1.62e-01 4.46e-01 0.400000 -1.79e-01 -3.58e-01 3.81e-01 7.95e-02
GOBP DETOXIFICATION OF NITROGEN COMPOUND 5 3.15e-01 6.08e-01 0.400000 3.80e-01 1.24e-01 1.41e-01 6.31e-01
GOCC NUCLEAR STRESS GRANULE 6 2.57e-01 5.54e-01 0.400000 1.83e-01 3.56e-01 4.37e-01 1.31e-01
GOMF INSULIN RECEPTOR SUBSTRATE BINDING 13 4.74e-02 2.19e-01 0.400000 3.93e-01 7.23e-02 1.41e-02 6.52e-01
Sensory perception of salty taste 6 2.13e-01 5.08e-01 0.400000 -3.19e-01 2.41e-01 1.76e-01 3.08e-01
GOBP HYDROGEN SULFIDE METABOLIC PROCESS 5 2.88e-01 5.85e-01 0.400000 9.59e-02 -3.88e-01 7.10e-01 1.33e-01
GOBP BRANCHED CHAIN AMINO ACID BIOSYNTHETIC PROCESS 5 2.75e-01 5.72e-01 0.400000 2.57e-01 -3.06e-01 3.20e-01 2.36e-01
Signaling by activated point mutants of FGFR1 11 8.60e-02 3.14e-01 0.400000 2.70e-01 2.94e-01 1.21e-01 9.09e-02
GOBP ADENOSINE METABOLIC PROCESS 10 1.07e-01 3.53e-01 0.399000 2.48e-01 3.13e-01 1.75e-01 8.61e-02
GOBP REGULATION OF GLUTAMATE RECEPTOR CLUSTERING 6 2.15e-01 5.10e-01 0.399000 3.30e-01 -2.24e-01 1.61e-01 3.41e-01
GOMF FATTY ACID OMEGA HYDROXYLASE ACTIVITY 7 1.77e-01 4.64e-01 0.399000 8.01e-02 -3.91e-01 7.14e-01 7.32e-02
GOBP PEPTIDYL LYSINE OXIDATION 5 3.11e-01 6.04e-01 0.399000 7.49e-02 3.92e-01 7.72e-01 1.29e-01
GOMF PROTEIN LYSINE 6 OXIDASE ACTIVITY 5 3.11e-01 6.04e-01 0.399000 7.49e-02 3.92e-01 7.72e-01 1.29e-01
GOBP REGULATION OF LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE 6 2.54e-01 5.51e-01 0.399000 1.37e-01 3.75e-01 5.60e-01 1.12e-01
Regulation of TP53 Activity through Methylation 19 7.58e-03 6.45e-02 0.399000 3.12e-01 -2.48e-01 1.85e-02 6.10e-02
GOCC FEMALE PRONUCLEUS 10 1.01e-01 3.42e-01 0.399000 -1.30e-01 -3.77e-01 4.76e-01 3.90e-02
Interleukin-15 signaling 13 3.73e-02 1.90e-01 0.399000 3.63e-01 -1.65e-01 2.35e-02 3.02e-01
p75NTR negatively regulates cell cycle via SC1 6 2.54e-01 5.52e-01 0.399000 3.74e-01 1.39e-01 1.13e-01 5.55e-01
GOBP RECOGNITION OF APOPTOTIC CELL 7 1.83e-01 4.73e-01 0.399000 -3.97e-01 3.39e-02 6.88e-02 8.77e-01
GOMF CELL MATRIX ADHESION MEDIATOR ACTIVITY 9 1.30e-01 3.93e-01 0.399000 3.68e-01 1.53e-01 5.59e-02 4.27e-01
GOBP NEGATIVE REGULATION OF TELOMERE CAPPING 8 1.31e-01 3.95e-01 0.399000 3.51e-01 -1.88e-01 8.53e-02 3.56e-01
GOBP HIS PURKINJE SYSTEM DEVELOPMENT 7 1.67e-01 4.51e-01 0.399000 2.32e-01 -3.24e-01 2.88e-01 1.38e-01
GOBP REGULATION OF GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS 7 1.74e-01 4.60e-01 0.399000 1.24e-01 -3.79e-01 5.71e-01 8.26e-02
Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) 107 1.55e-11 1.56e-09 0.398000 -6.89e-02 -3.92e-01 2.18e-01 2.24e-12
Nonsense-Mediated Decay (NMD) 107 1.55e-11 1.56e-09 0.398000 -6.89e-02 -3.92e-01 2.18e-01 2.24e-12
GOBP REGULATION OF MESODERMAL CELL FATE SPECIFICATION 6 2.64e-01 5.61e-01 0.398000 2.60e-01 3.02e-01 2.71e-01 2.00e-01
GOBP XENOPHAGY 14 4.47e-02 2.11e-01 0.398000 3.15e-01 2.44e-01 4.14e-02 1.14e-01
GOBP DNA STRAND RESECTION INVOLVED IN REPLICATION FORK PROCESSING 10 9.60e-02 3.32e-01 0.398000 -5.37e-02 -3.95e-01 7.69e-01 3.07e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS OXYGEN AS ACCEPTOR 14 4.42e-02 2.10e-01 0.398000 2.20e-01 3.32e-01 1.54e-01 3.15e-02
GOBP REGULATION OF HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS 7 1.67e-01 4.52e-01 0.398000 3.24e-01 -2.31e-01 1.37e-01 2.90e-01
Glycine degradation 6 2.20e-01 5.16e-01 0.398000 3.59e-01 -1.71e-01 1.27e-01 4.69e-01
GOCC NURD COMPLEX 15 3.43e-02 1.80e-01 0.398000 3.60e-01 1.70e-01 1.59e-02 2.54e-01
GOBP RESPONSE TO L GLUTAMATE 15 2.27e-02 1.39e-01 0.398000 1.80e-01 -3.55e-01 2.28e-01 1.74e-02
GOMF ADENOSINE DEAMINASE ACTIVITY 12 4.66e-02 2.16e-01 0.398000 -3.05e-01 2.56e-01 6.77e-02 1.25e-01
GOBP 7 METHYLGUANOSINE CAP HYPERMETHYLATION 8 1.70e-01 4.56e-01 0.398000 -2.50e-01 -3.09e-01 2.21e-01 1.30e-01
GOBP REGULATION OF LYSOSOME ORGANIZATION 12 5.59e-02 2.42e-01 0.398000 3.97e-01 -2.44e-02 1.73e-02 8.84e-01
GOBP CHIASMA ASSEMBLY 6 2.19e-01 5.15e-01 0.397000 3.44e-01 -1.99e-01 1.45e-01 3.98e-01
NR1H2 & NR1H3 regulate gene expression linked to lipogenesis 9 1.37e-01 4.06e-01 0.397000 3.02e-01 2.58e-01 1.16e-01 1.80e-01
Negative regulation of activity of TFAP2 (AP-2) family transcription factors 10 9.64e-02 3.33e-01 0.397000 3.95e-01 4.71e-02 3.07e-02 7.97e-01
GOBP POSITIVE REGULATION OF CORTICOSTEROID HORMONE SECRETION 7 2.01e-01 4.94e-01 0.397000 3.83e-01 1.05e-01 7.91e-02 6.31e-01
GOCC ZONULA ADHERENS 8 1.56e-01 4.36e-01 0.397000 3.92e-01 6.10e-02 5.46e-02 7.65e-01
GOBP REGULATION OF NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY 10 8.22e-02 3.06e-01 0.397000 3.69e-01 -1.48e-01 4.35e-02 4.19e-01
GOBP REGULATION OF POTASSIUM ION IMPORT 5 2.80e-01 5.77e-01 0.397000 3.16e-01 -2.40e-01 2.20e-01 3.53e-01
GOBP POSITIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT 10 1.07e-01 3.53e-01 0.397000 3.53e-01 1.82e-01 5.34e-02 3.19e-01
Regulation of TP53 Activity through Acetylation 28 1.82e-03 2.19e-02 0.397000 3.70e-01 1.43e-01 7.02e-04 1.90e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 5 PHOSPHATASE ACTIVITY 5 3.27e-01 6.18e-01 0.397000 3.56e-01 1.75e-01 1.68e-01 4.97e-01
GOBP ADAPTIVE IMMUNE MEMORY RESPONSE 5 2.83e-01 5.80e-01 0.397000 3.39e-01 -2.05e-01 1.89e-01 4.27e-01
GOMF INOSITOL BISPHOSPHATE PHOSPHATASE ACTIVITY 7 2.11e-01 5.06e-01 0.397000 3.49e-01 1.88e-01 1.10e-01 3.89e-01
GOBP REGULATION OF INTESTINAL LIPID ABSORPTION 10 8.01e-02 3.00e-01 0.396000 -2.13e-01 3.34e-01 2.43e-01 6.75e-02
GOBP CLATHRIN COAT ASSEMBLY 19 1.29e-02 9.43e-02 0.396000 3.86e-01 8.86e-02 3.56e-03 5.04e-01
GOCC CYTOSKELETON OF PRESYNAPTIC ACTIVE ZONE 8 1.44e-01 4.18e-01 0.396000 -3.91e-01 6.08e-02 5.52e-02 7.66e-01
Synthesis of 5-eicosatetraenoic acids 9 1.19e-01 3.75e-01 0.396000 -3.96e-01 1.86e-03 3.97e-02 9.92e-01
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM CALCIUM ION CONCENTRATION 6 2.66e-01 5.62e-01 0.396000 3.38e-01 2.07e-01 1.52e-01 3.80e-01
GOBP 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS 15 3.69e-02 1.89e-01 0.396000 3.27e-01 2.23e-01 2.82e-02 1.36e-01
Inhibition of Signaling by Overexpressed EGFR 8 1.47e-01 4.22e-01 0.396000 4.57e-02 -3.93e-01 8.23e-01 5.42e-02
Signaling by Overexpressed Wild-Type EGFR in Cancer 8 1.47e-01 4.22e-01 0.396000 4.57e-02 -3.93e-01 8.23e-01 5.42e-02
GOCC SPERM HEAD 17 1.70e-02 1.14e-01 0.396000 -3.93e-01 4.29e-02 4.99e-03 7.59e-01
GOBP PURINE NUCLEOBASE TRANSMEMBRANE TRANSPORT 8 1.66e-01 4.50e-01 0.396000 1.41e-01 3.69e-01 4.88e-01 7.04e-02
GOBP SEMINIFEROUS TUBULE DEVELOPMENT 14 3.12e-02 1.70e-01 0.396000 3.68e-01 -1.44e-01 1.70e-02 3.50e-01
GOBP LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR 11 6.68e-02 2.70e-01 0.396000 3.76e-01 -1.21e-01 3.06e-02 4.86e-01
GOMF TFIID CLASS TRANSCRIPTION FACTOR COMPLEX BINDING 10 8.16e-02 3.04e-01 0.395000 3.41e-01 -2.00e-01 6.21e-02 2.72e-01
GOMF SUPERCOILED DNA BINDING 6 2.20e-01 5.15e-01 0.395000 2.58e-01 -2.99e-01 2.74e-01 2.04e-01
GOBP METANEPHRIC DISTAL TUBULE DEVELOPMENT 7 2.14e-01 5.09e-01 0.395000 3.42e-01 1.98e-01 1.17e-01 3.65e-01
GOBP COMPLEMENT ACTIVATION ALTERNATIVE PATHWAY 16 2.09e-02 1.30e-01 0.395000 -3.86e-01 8.16e-02 7.50e-03 5.72e-01
GOMF MIRNA INHIBITOR ACTIVITY VIA BASE PAIRING 7 1.79e-01 4.67e-01 0.394000 3.69e-01 -1.38e-01 9.05e-02 5.27e-01
GOBP MEMBRANE DEPOLARIZATION DURING SA NODE CELL ACTION POTENTIAL 5 3.06e-01 5.99e-01 0.394000 -3.94e-01 2.34e-02 1.27e-01 9.28e-01
GOMF ABC TYPE GLUTATHIONE S CONJUGATE TRANSPORTER ACTIVITY 8 1.74e-01 4.60e-01 0.394000 2.16e-01 3.30e-01 2.89e-01 1.06e-01
Regulation of KIT signaling 16 1.79e-02 1.18e-01 0.394000 2.76e-01 -2.81e-01 5.56e-02 5.17e-02
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY 12 5.53e-02 2.40e-01 0.394000 8.66e-02 -3.84e-01 6.04e-01 2.12e-02
GOBP NEGATIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION 9 1.39e-01 4.10e-01 0.394000 -3.42e-01 -1.95e-01 7.54e-02 3.11e-01
MAP3K8 (TPL2)-dependent MAPK1/3 activation 15 2.38e-02 1.44e-01 0.394000 3.33e-01 -2.10e-01 2.55e-02 1.59e-01
GOBP POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION 27 1.58e-03 1.98e-02 0.394000 3.89e-01 -6.10e-02 4.67e-04 5.83e-01
GOMF G PROTEIN COUPLED RECEPTOR ACTIVITY 743 3.59e-74 4.89e-71 0.394000 -3.94e-01 1.67e-04 3.92e-75 9.94e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MICROTUBULE 5 3.35e-01 6.25e-01 0.394000 1.99e-01 3.40e-01 4.41e-01 1.88e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS 8 1.37e-01 4.06e-01 0.394000 -2.00e-01 3.39e-01 3.28e-01 9.66e-02
GOBP REGULATION OF CENTROMERE COMPLEX ASSEMBLY 6 2.62e-01 5.59e-01 0.394000 3.72e-01 1.29e-01 1.15e-01 5.85e-01
GOBP NEGATIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 7 1.77e-01 4.64e-01 0.393000 3.47e-01 -1.85e-01 1.12e-01 3.96e-01
GOBP CGMP BIOSYNTHETIC PROCESS 10 1.06e-01 3.51e-01 0.393000 3.79e-01 1.04e-01 3.77e-02 5.70e-01
GOCC BRCA1 A COMPLEX 7 1.82e-01 4.71e-01 0.393000 3.73e-01 -1.26e-01 8.77e-02 5.65e-01
GOBP RESPONSE TO MUSCLE INACTIVITY 9 1.23e-01 3.82e-01 0.393000 2.21e-03 3.93e-01 9.91e-01 4.11e-02
GOBP PEPTIDE CATABOLIC PROCESS 19 1.59e-02 1.09e-01 0.393000 3.40e-01 1.98e-01 1.03e-02 1.36e-01
GOBP RESPONSE TO PEPTIDOGLYCAN 13 4.88e-02 2.23e-01 0.393000 -3.93e-01 -7.59e-03 1.41e-02 9.62e-01
GOCC RNA POLYMERASE I COMPLEX 13 5.03e-02 2.26e-01 0.393000 -3.41e-02 -3.92e-01 8.31e-01 1.45e-02
SIRT1 negatively regulates rRNA expression 30 8.54e-04 1.21e-02 0.393000 3.28e-02 -3.92e-01 7.56e-01 2.05e-04
GOBP CORONARY VASCULATURE MORPHOGENESIS 19 1.65e-02 1.12e-01 0.393000 3.02e-01 2.52e-01 2.28e-02 5.73e-02
Regulation of CDH11 mRNA translation by microRNAs 11 8.37e-02 3.10e-01 0.393000 3.84e-01 8.53e-02 2.76e-02 6.24e-01
GOBP CARDIAC CELL FATE COMMITMENT 13 4.72e-02 2.19e-01 0.393000 3.92e-01 -2.41e-02 1.43e-02 8.80e-01
GOBP VITAMIN E METABOLIC PROCESS 6 2.61e-01 5.58e-01 0.393000 1.07e-01 3.78e-01 6.50e-01 1.09e-01
Downstream signaling of activated FGFR3 24 4.80e-03 4.59e-02 0.393000 3.73e-01 1.22e-01 1.54e-03 3.01e-01
GOBP REGULATION OF BINDING OF SPERM TO ZONA PELLUCIDA 5 2.89e-01 5.86e-01 0.393000 -2.26e-01 3.21e-01 3.82e-01 2.13e-01
GOBP REGULATION OF DNA LIGATION 6 2.73e-01 5.70e-01 0.393000 2.27e-01 3.20e-01 3.35e-01 1.74e-01
FLT3 Signaling 38 8.22e-05 1.81e-03 0.392000 3.29e-01 -2.14e-01 4.54e-04 2.21e-02
GOBP RIBONUCLEOPROTEIN COMPLEX LOCALIZATION 11 6.79e-02 2.72e-01 0.392000 3.60e-01 -1.55e-01 3.85e-02 3.72e-01
GOBP ISOLEUCINE TRANSPORT 5 3.35e-01 6.25e-01 0.392000 1.70e-01 3.54e-01 5.11e-01 1.71e-01
GOBP NEGATIVE REGULATION OF HEPATOCYTE APOPTOTIC PROCESS 7 2.19e-01 5.15e-01 0.392000 3.39e-01 1.97e-01 1.21e-01 3.66e-01
GOBP REGULATION OF INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY 11 7.01e-02 2.77e-01 0.392000 1.20e-01 -3.73e-01 4.90e-01 3.21e-02
GOBP FEMALE MEIOSIS CHROMOSOME SEGREGATION 6 2.59e-01 5.56e-01 0.392000 3.85e-01 7.15e-02 1.02e-01 7.62e-01
GOBP REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE 17 2.60e-02 1.53e-01 0.392000 2.99e-01 2.53e-01 3.27e-02 7.10e-02
GOBP ANTIFUNGAL INNATE IMMUNE RESPONSE 19 1.53e-02 1.07e-01 0.392000 -3.66e-01 -1.40e-01 5.75e-03 2.92e-01
GOCC CBM COMPLEX 5 2.90e-01 5.86e-01 0.392000 -2.51e-01 3.00e-01 3.31e-01 2.45e-01
GOMF MHC CLASS II PROTEIN BINDING 7 1.86e-01 4.76e-01 0.392000 3.75e-01 -1.12e-01 8.55e-02 6.09e-01
GOBP POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS 14 4.80e-02 2.21e-01 0.391000 -3.45e-01 -1.84e-01 2.52e-02 2.33e-01
Cardiogenesis 26 1.85e-03 2.22e-02 0.391000 3.66e-01 -1.38e-01 1.23e-03 2.22e-01
GOBP DORSAL ROOT GANGLION DEVELOPMENT 7 1.99e-01 4.92e-01 0.391000 3.91e-01 1.22e-03 7.29e-02 9.96e-01
GOBP HYPERSENSITIVITY 12 5.13e-02 2.29e-01 0.391000 -2.51e-01 3.00e-01 1.31e-01 7.21e-02
GOBP COLLECTING DUCT DEVELOPMENT 15 4.01e-02 1.97e-01 0.391000 2.35e-01 3.13e-01 1.16e-01 3.58e-02
GOBP POSITIVE REGULATION OF SISTER CHROMATID COHESION 9 1.08e-01 3.54e-01 0.391000 2.47e-01 -3.03e-01 1.99e-01 1.15e-01
GOBP CARBOHYDRATE MEDIATED SIGNALING 11 7.91e-02 2.98e-01 0.391000 3.91e-01 -5.39e-05 2.47e-02 1.00e+00
GOBP POSITIVE REGULATION OF PYROPTOSIS 5 2.98e-01 5.94e-01 0.391000 3.63e-01 -1.46e-01 1.60e-01 5.72e-01
Oncogene Induced Senescence 35 1.83e-04 3.51e-03 0.391000 3.15e-01 -2.30e-01 1.24e-03 1.83e-02
SHC-mediated cascade:FGFR3 17 2.53e-02 1.50e-01 0.391000 3.48e-01 1.78e-01 1.30e-02 2.04e-01
GOMF POTASSIUM CHANNEL INHIBITOR ACTIVITY 5 2.94e-01 5.91e-01 0.391000 1.96e-01 -3.38e-01 4.47e-01 1.91e-01
STAT5 activation downstream of FLT3 ITD mutants 10 9.19e-02 3.25e-01 0.391000 1.06e-01 -3.76e-01 5.63e-01 3.95e-02
GOBP REGULATION OF COLLAGEN FIBRIL ORGANIZATION 9 1.15e-01 3.68e-01 0.391000 -1.25e-01 3.70e-01 5.17e-01 5.45e-02
rRNA modification in the mitochondrion 6 2.78e-01 5.76e-01 0.390000 3.03e-01 2.46e-01 1.99e-01 2.97e-01
GOBP TRNA THREONYLCARBAMOYLADENOSINE MODIFICATION 5 3.04e-01 5.98e-01 0.390000 1.11e-01 -3.74e-01 6.68e-01 1.48e-01
GOCC HEMOGLOBIN COMPLEX 12 6.89e-02 2.74e-01 0.390000 -3.83e-01 -7.47e-02 2.17e-02 6.54e-01
GOBP NEGATIVE REGULATION OF CYTOKINESIS 7 2.12e-01 5.07e-01 0.390000 -3.79e-01 -9.02e-02 8.23e-02 6.80e-01
GOBP IMP CATABOLIC PROCESS 5 3.04e-01 5.98e-01 0.390000 3.75e-01 -1.07e-01 1.47e-01 6.77e-01
GOMF INTRACELLULARLY CAMP ACTIVATED CATION CHANNEL ACTIVITY 8 1.41e-01 4.12e-01 0.390000 -3.19e-01 2.24e-01 1.18e-01 2.73e-01
GOBP REGULATION OF GLUCOCORTICOID RECEPTOR SIGNALING PATHWAY 7 2.14e-01 5.09e-01 0.390000 3.77e-01 9.92e-02 8.44e-02 6.50e-01
GOBP ADENOSINE TO INOSINE EDITING 6 2.33e-01 5.31e-01 0.390000 -3.39e-01 1.91e-01 1.50e-01 4.17e-01
Signaling by ERBB2 ECD mutants 16 2.24e-02 1.37e-01 0.389000 3.74e-01 -1.09e-01 9.59e-03 4.52e-01
GOBP REGULATION OF POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE 8 1.61e-01 4.44e-01 0.389000 3.89e-01 3.72e-03 5.65e-02 9.85e-01
Deactivation of the beta-catenin transactivating complex 39 7.92e-05 1.76e-03 0.389000 3.44e-01 -1.83e-01 2.05e-04 4.78e-02
GOBP CELL DIFFERENTIATION IN SPINAL CORD 49 1.42e-05 3.90e-04 0.389000 3.89e-01 2.87e-03 2.42e-06 9.72e-01
GOBP BRANCHING MORPHOGENESIS OF A NERVE 10 9.34e-02 3.28e-01 0.389000 3.74e-01 -1.06e-01 4.03e-02 5.61e-01
GOBP RESPONSE TO INDOLE 3 METHANOL 6 2.37e-01 5.33e-01 0.389000 3.61e-01 -1.46e-01 1.26e-01 5.36e-01
NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis 5 3.20e-01 6.11e-01 0.389000 3.89e-01 1.56e-03 1.32e-01 9.95e-01
GOCC EUKARYOTIC 48S PREINITIATION COMPLEX 14 3.95e-02 1.96e-01 0.389000 3.51e-02 -3.87e-01 8.20e-01 1.21e-02
Formation of the Editosome 8 1.43e-01 4.14e-01 0.389000 3.18e-01 -2.23e-01 1.19e-01 2.74e-01
mRNA Editing: C to U Conversion 8 1.43e-01 4.14e-01 0.389000 3.18e-01 -2.23e-01 1.19e-01 2.74e-01
GOBP STEM CELL FATE COMMITMENT 10 9.44e-02 3.29e-01 0.388000 3.74e-01 -1.04e-01 4.04e-02 5.70e-01
GOBP N ACETYLNEURAMINATE CATABOLIC PROCESS 6 2.58e-01 5.55e-01 0.388000 2.17e-02 3.88e-01 9.27e-01 1.00e-01
Phospholipase C-mediated cascade; FGFR2 17 2.78e-02 1.59e-01 0.388000 2.78e-01 2.71e-01 4.68e-02 5.33e-02
GOBP REGULATION OF SNARE COMPLEX ASSEMBLY 14 4.09e-02 2.00e-01 0.388000 3.88e-01 -1.28e-02 1.19e-02 9.34e-01
Downstream signaling of activated FGFR2 29 1.82e-03 2.19e-02 0.388000 3.70e-01 1.16e-01 5.54e-04 2.79e-01
GOBP CELLULAR RESPONSE TO FRUCTOSE STIMULUS 5 2.96e-01 5.93e-01 0.388000 -2.90e-01 2.58e-01 2.61e-01 3.18e-01
GOCC SWR1 COMPLEX 13 4.92e-02 2.23e-01 0.388000 3.84e-01 -5.56e-02 1.65e-02 7.29e-01
GOBP AMMONIUM HOMEOSTASIS 5 3.48e-01 6.38e-01 0.388000 -3.15e-01 -2.26e-01 2.22e-01 3.81e-01
GOBP NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 11 9.90e-02 3.37e-01 0.388000 -2.57e-01 -2.91e-01 1.40e-01 9.52e-02
GOBP POSITIVE REGULATION OF MAST CELL ACTIVATION 6 2.62e-01 5.58e-01 0.388000 -3.78e-02 -3.86e-01 8.73e-01 1.02e-01
GOMF PHOSPHOTRANSFERASE ACTIVITY NITROGENOUS GROUP AS ACCEPTOR 6 2.74e-01 5.71e-01 0.388000 3.64e-01 1.33e-01 1.22e-01 5.73e-01
Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex 32 4.78e-04 7.59e-03 0.387000 1.66e-01 -3.50e-01 1.03e-01 6.12e-04
Acyl chain remodeling of DAG and TAG 5 3.23e-01 6.14e-01 0.387000 2.80e-03 3.87e-01 9.91e-01 1.34e-01
GOCC CHROMAFFIN GRANULE 14 4.18e-02 2.03e-01 0.387000 -7.83e-03 3.87e-01 9.60e-01 1.21e-02
Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) 12 5.83e-02 2.47e-01 0.387000 1.35e-01 -3.63e-01 4.19e-01 2.94e-02
GOBP TERMINATION OF RNA POLYMERASE II TRANSCRIPTION 10 9.23e-02 3.26e-01 0.387000 3.53e-01 -1.58e-01 5.31e-02 3.86e-01
Disorders of Developmental Biology 11 9.30e-02 3.27e-01 0.387000 3.68e-01 1.19e-01 3.45e-02 4.94e-01
Disorders of Nervous System Development 11 9.30e-02 3.27e-01 0.387000 3.68e-01 1.19e-01 3.45e-02 4.94e-01
Loss of function of MECP2 in Rett syndrome 11 9.30e-02 3.27e-01 0.387000 3.68e-01 1.19e-01 3.45e-02 4.94e-01
Pervasive developmental disorders 11 9.30e-02 3.27e-01 0.387000 3.68e-01 1.19e-01 3.45e-02 4.94e-01
GOMF FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVITY 5 3.14e-01 6.07e-01 0.387000 -6.96e-02 3.81e-01 7.88e-01 1.41e-01
GOBP DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION 20 1.12e-02 8.52e-02 0.387000 -3.87e-01 -8.63e-03 2.75e-03 9.47e-01
GOMF METAL DEPENDENT DEUBIQUITINASE ACTIVITY 11 8.73e-02 3.16e-01 0.387000 3.84e-01 4.18e-02 2.73e-02 8.10e-01
GOCC G PROTEIN COUPLED RECEPTOR DIMERIC COMPLEX 7 1.87e-01 4.77e-01 0.387000 -1.97e-01 3.33e-01 3.67e-01 1.27e-01
NFE2L2 regulating inflammation associated genes 5 3.26e-01 6.18e-01 0.387000 3.86e-01 1.54e-02 1.35e-01 9.53e-01
GOBP REGULATION OF PHOSPHATIDYLCHOLINE METABOLIC PROCESS 10 1.22e-01 3.80e-01 0.386000 1.97e-01 3.32e-01 2.80e-01 6.89e-02
GOBP NUCLEOPHAGY 21 1.23e-02 9.10e-02 0.386000 3.12e-01 2.27e-01 1.32e-02 7.14e-02
GOBP RESPONSE TO SODIUM PHOSPHATE 9 1.22e-01 3.80e-01 0.386000 3.69e-01 -1.14e-01 5.51e-02 5.55e-01
GOBP MITOCHONDRIAL RNA MODIFICATION 8 1.54e-01 4.33e-01 0.386000 1.16e-01 -3.68e-01 5.72e-01 7.12e-02
GOCC CYTOSOLIC RIBOSOME 107 6.05e-11 5.30e-09 0.386000 -4.74e-02 -3.83e-01 3.97e-01 7.32e-12
GOBP METANEPHRIC GLOMERULUS DEVELOPMENT 16 2.46e-02 1.47e-01 0.386000 3.76e-01 -8.69e-02 9.21e-03 5.47e-01
FGFR2 ligand binding and activation 19 1.86e-02 1.21e-01 0.385000 3.33e-01 1.93e-01 1.19e-02 1.45e-01
FGFR1c ligand binding and activation 13 6.70e-02 2.70e-01 0.385000 3.13e-01 2.25e-01 5.10e-02 1.60e-01
GOCC PROTEIN PHOSPHATASE 4 COMPLEX 5 3.04e-01 5.98e-01 0.385000 3.27e-01 -2.03e-01 2.05e-01 4.32e-01
GOBP ALKALOID METABOLIC PROCESS 7 2.08e-01 5.03e-01 0.385000 -1.43e-02 3.85e-01 9.48e-01 7.81e-02
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS BY CYTOCHROME C 5 3.24e-01 6.15e-01 0.385000 2.87e-02 -3.84e-01 9.11e-01 1.37e-01
GOBP MICROGLIAL CELL PROLIFERATION 8 1.90e-01 4.80e-01 0.385000 3.17e-01 2.18e-01 1.21e-01 2.85e-01
GOBP AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 45 6.13e-05 1.42e-03 0.385000 3.75e-01 8.76e-02 1.37e-05 3.10e-01
Regulation of PTEN localization 8 1.47e-01 4.23e-01 0.385000 2.86e-01 -2.57e-01 1.61e-01 2.08e-01
GOBP REGULATION OF MICROGLIAL CELL ACTIVATION 20 1.58e-02 1.09e-01 0.385000 -2.27e-01 -3.10e-01 7.87e-02 1.63e-02
GOCC GID COMPLEX 5 3.48e-01 6.38e-01 0.384000 1.46e-01 3.56e-01 5.71e-01 1.68e-01
GOMF TRNA SPECIFIC ADENOSINE DEAMINASE ACTIVITY 8 1.48e-01 4.24e-01 0.384000 -2.98e-01 2.43e-01 1.44e-01 2.34e-01
GOBP VITAMIN B6 METABOLIC PROCESS 5 3.30e-01 6.20e-01 0.384000 3.84e-01 6.45e-03 1.37e-01 9.80e-01
GOBP MOTOR NEURON MIGRATION 13 4.52e-02 2.13e-01 0.384000 3.07e-01 -2.31e-01 5.55e-02 1.49e-01
Interaction between L1 and Ankyrins 30 1.61e-03 2.00e-02 0.384000 -3.72e-01 -9.60e-02 4.22e-04 3.63e-01
GOBP SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION 23 4.56e-03 4.42e-02 0.384000 3.51e-01 -1.56e-01 3.57e-03 1.95e-01
Noncanonical activation of NOTCH3 8 1.76e-01 4.63e-01 0.384000 -6.38e-02 -3.79e-01 7.55e-01 6.36e-02
FLT3 signaling in disease 28 1.31e-03 1.70e-02 0.384000 3.18e-01 -2.15e-01 3.57e-03 4.90e-02
GOBP SPLEEN DEVELOPMENT 38 1.60e-04 3.17e-03 0.384000 3.69e-01 -1.04e-01 8.24e-05 2.65e-01
SHC-mediated cascade:FGFR2 22 1.00e-02 7.88e-02 0.383000 3.50e-01 1.57e-01 4.52e-03 2.02e-01
GOBP COMPARTMENT PATTERN SPECIFICATION 5 3.46e-01 6.36e-01 0.383000 1.16e-01 3.65e-01 6.52e-01 1.57e-01
GOMF FERRIC IRON BINDING 9 1.25e-01 3.85e-01 0.383000 -3.62e-01 1.26e-01 6.03e-02 5.12e-01
GOCC MITOCHONDRIAL LARGE RIBOSOMAL SUBUNIT 56 4.07e-06 1.31e-04 0.383000 1.08e-02 -3.83e-01 8.89e-01 7.16e-07
GOBP PROGESTERONE BIOSYNTHETIC PROCESS 6 2.56e-01 5.53e-01 0.383000 -3.76e-01 7.35e-02 1.11e-01 7.55e-01
GOBP REGULATION OF ODONTOGENESIS 19 1.95e-02 1.24e-01 0.383000 3.37e-01 1.82e-01 1.10e-02 1.71e-01
GOBP IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION 10 9.38e-02 3.28e-01 0.383000 2.94e-01 -2.45e-01 1.07e-01 1.80e-01
GOBP CYTOSOL TO ENDOPLASMIC RETICULUM TRANSPORT 5 3.52e-01 6.42e-01 0.383000 1.57e-01 3.49e-01 5.44e-01 1.76e-01
Dopamine receptors 5 3.47e-01 6.37e-01 0.383000 3.65e-01 1.14e-01 1.57e-01 6.60e-01
GOMF DOPAMINE NEUROTRANSMITTER RECEPTOR ACTIVITY 5 3.47e-01 6.37e-01 0.383000 3.65e-01 1.14e-01 1.57e-01 6.60e-01
GOBP CILIARY NEUROTROPHIC FACTOR MEDIATED SIGNALING PATHWAY 5 3.58e-01 6.47e-01 0.383000 3.10e-01 2.24e-01 2.29e-01 3.86e-01
GOBP POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY 21 7.04e-03 6.12e-02 0.383000 2.30e-01 -3.06e-01 6.80e-02 1.53e-02
GOBP LUNG SECRETORY CELL DIFFERENTIATION 11 7.44e-02 2.87e-01 0.382000 2.49e-01 -2.90e-01 1.53e-01 9.53e-02
GOMF AZOLE TRANSMEMBRANE TRANSPORTER ACTIVITY 13 4.96e-02 2.25e-01 0.382000 3.57e-01 -1.37e-01 2.60e-02 3.91e-01
GOBP DCMP CATABOLIC PROCESS 6 2.94e-01 5.91e-01 0.382000 -2.69e-01 -2.71e-01 2.54e-01 2.50e-01
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX CATALYTIC CORE F 1 6 2.42e-01 5.39e-01 0.382000 2.80e-01 -2.60e-01 2.35e-01 2.70e-01
GOMF LONG CHAIN FATTY ACID BINDING 17 2.24e-02 1.38e-01 0.382000 -4.23e-02 3.80e-01 7.63e-01 6.74e-03
GOBP NEGATIVE REGULATION OF CENTROSOME DUPLICATION 12 5.99e-02 2.52e-01 0.382000 2.10e-01 -3.19e-01 2.08e-01 5.56e-02
GOBP METANEPHRIC GLOMERULAR MESANGIUM DEVELOPMENT 5 3.32e-01 6.23e-01 0.382000 3.82e-01 -6.78e-03 1.39e-01 9.79e-01
GOBP CEMENTUM MINERALIZATION 5 3.56e-01 6.45e-01 0.382000 3.40e-01 1.73e-01 1.88e-01 5.03e-01
GOBP HEME TRANSPORT 8 1.89e-01 4.80e-01 0.382000 1.44e-01 3.54e-01 4.81e-01 8.33e-02
GOMF HEME TRANSMEMBRANE TRANSPORTER ACTIVITY 8 1.89e-01 4.80e-01 0.382000 1.44e-01 3.54e-01 4.81e-01 8.33e-02
GOBP MALE MATING BEHAVIOR 7 2.09e-01 5.03e-01 0.382000 3.78e-01 -5.22e-02 8.32e-02 8.11e-01
GOBP CELLULAR RESPONSE TO PEPTIDE 13 5.35e-02 2.35e-01 0.381000 -7.24e-02 3.75e-01 6.51e-01 1.94e-02
GOBP POSITIVE REGULATION OF T CELL TOLERANCE INDUCTION 8 1.76e-01 4.63e-01 0.381000 -2.45e-02 -3.81e-01 9.04e-01 6.23e-02
GOBP LAMELLIPODIUM MORPHOGENESIS 18 2.19e-02 1.35e-01 0.381000 3.72e-01 8.30e-02 6.26e-03 5.42e-01
Orexin and neuropeptides FF and QRFP bind to their respective receptors 8 1.89e-01 4.80e-01 0.381000 1.42e-01 3.54e-01 4.86e-01 8.31e-02
GOBP PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 18 2.01e-02 1.27e-01 0.381000 3.81e-01 2.21e-02 5.18e-03 8.71e-01
GOBP TRNA TRANSPORT 6 2.87e-01 5.84e-01 0.381000 -1.39e-01 -3.55e-01 5.55e-01 1.32e-01
GOBP FATTY ACID ALPHA OXIDATION 8 1.67e-01 4.52e-01 0.381000 5.62e-02 -3.77e-01 7.83e-01 6.49e-02
GOBP REGULATION OF INTESTINAL ABSORPTION 12 6.75e-02 2.71e-01 0.381000 -6.97e-02 3.75e-01 6.76e-01 2.46e-02
Formation of the cornified envelope 124 7.29e-13 9.05e-11 0.381000 -3.70e-01 9.05e-02 1.06e-12 8.17e-02
GOMF 5ALPHA ANDROSTANE 3BETA 17BETA DIOL DEHYDROGENASE ACTIVITY 6 2.45e-01 5.40e-01 0.381000 2.87e-01 -2.51e-01 2.24e-01 2.87e-01
GOBP NEGATIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 7 2.10e-01 5.06e-01 0.381000 4.83e-02 -3.78e-01 8.25e-01 8.35e-02
GOBP FOREBRAIN REGIONALIZATION 24 5.87e-03 5.33e-02 0.381000 3.77e-01 5.02e-02 1.37e-03 6.70e-01
GOCC ISWI TYPE COMPLEX 11 7.64e-02 2.92e-01 0.381000 3.03e-01 -2.31e-01 8.23e-02 1.85e-01
GOBP NEGATIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY 9 1.62e-01 4.45e-01 0.381000 -2.89e-01 -2.47e-01 1.33e-01 1.99e-01
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY 14 5.42e-02 2.37e-01 0.380000 3.60e-01 1.24e-01 1.98e-02 4.23e-01
GOBP POSITIVE REGULATION OF FEEDING BEHAVIOR 10 1.31e-01 3.96e-01 0.380000 3.07e-01 2.24e-01 9.26e-02 2.19e-01
GOBP ACYLGLYCEROL TRANSPORT 8 1.55e-01 4.35e-01 0.380000 2.29e-01 -3.04e-01 2.62e-01 1.37e-01
GOCC MUSCLE MYOSIN COMPLEX 15 3.25e-02 1.75e-01 0.380000 -3.56e-01 1.33e-01 1.69e-02 3.73e-01
GOMF PYRIMIDINE NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 2.26e-01 5.22e-01 0.380000 6.31e-02 3.75e-01 7.73e-01 8.58e-02
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN 6 2.79e-01 5.77e-01 0.380000 -6.55e-02 -3.75e-01 7.81e-01 1.12e-01
DCC mediated attractive signaling 14 4.59e-02 2.14e-01 0.380000 3.79e-01 -2.79e-02 1.40e-02 8.56e-01
GOBP RESPONSE TO UV C 14 4.88e-02 2.23e-01 0.380000 3.79e-01 2.14e-02 1.40e-02 8.90e-01
HDR through MMEJ (alt-NHEJ) 12 6.47e-02 2.64e-01 0.380000 3.55e-01 -1.36e-01 3.33e-02 4.16e-01
GOCC BETA CATENIN TCF COMPLEX 13 4.86e-02 2.22e-01 0.379000 2.72e-01 -2.64e-01 8.90e-02 9.96e-02
GOMF 1 ACYLGLYCEROPHOSPHOCHOLINE O ACYLTRANSFERASE ACTIVITY 7 2.45e-01 5.41e-01 0.379000 2.66e-01 2.70e-01 2.23e-01 2.16e-01
GOMF THYROID HORMONE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 2.40e-01 5.36e-01 0.379000 1.68e-01 3.40e-01 4.42e-01 1.20e-01
GOBP PIECEMEAL MICROAUTOPHAGY OF THE NUCLEUS 17 3.22e-02 1.74e-01 0.379000 3.23e-01 1.98e-01 2.11e-02 1.58e-01
Assembly of the ORC complex at the origin of replication 32 7.15e-04 1.05e-02 0.379000 1.34e-01 -3.54e-01 1.89e-01 5.28e-04
GOBP POSITIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY 19 2.20e-02 1.36e-01 0.379000 3.06e-01 2.23e-01 2.08e-02 9.31e-02
GOCC PLATELET DENSE GRANULE MEMBRANE 5 3.16e-01 6.09e-01 0.378000 -3.20e-01 2.02e-01 2.15e-01 4.34e-01
Downstream signaling of activated FGFR1 31 1.63e-03 2.01e-02 0.378000 3.63e-01 1.07e-01 4.69e-04 3.02e-01
GOBP AZOLE TRANSMEMBRANE TRANSPORT 14 4.23e-02 2.04e-01 0.378000 3.54e-01 -1.32e-01 2.16e-02 3.92e-01
GOBP REGULATION OF GAMMA DELTA T CELL ACTIVATION 11 8.82e-02 3.17e-01 0.378000 6.25e-02 -3.73e-01 7.20e-01 3.22e-02
GOBP NEGATIVE REGULATION OF IMMATURE T CELL PROLIFERATION 5 3.14e-01 6.07e-01 0.378000 -2.78e-01 2.57e-01 2.82e-01 3.20e-01
GOBP INDUCTION OF POSITIVE CHEMOTAXIS 13 6.58e-02 2.67e-01 0.378000 7.56e-02 3.71e-01 6.37e-01 2.07e-02
GOMF MANNOSYL OLIGOSACCHARIDE MANNOSIDASE ACTIVITY 9 1.55e-01 4.36e-01 0.378000 1.08e-01 3.62e-01 5.76e-01 5.97e-02
GOBP REGULATION OF ESTABLISHMENT OF T CELL POLARITY 6 2.91e-01 5.88e-01 0.378000 3.57e-01 1.25e-01 1.30e-01 5.95e-01
GOMF SEMAPHORIN RECEPTOR ACTIVITY 10 1.27e-01 3.88e-01 0.378000 1.11e-01 3.61e-01 5.44e-01 4.78e-02
GOCC PYRUVATE DEHYDROGENASE COMPLEX 5 3.39e-01 6.28e-01 0.378000 -1.50e-02 3.77e-01 9.54e-01 1.44e-01
Signaling by CSF1 (M-CSF) in myeloid cells 30 1.17e-03 1.56e-02 0.378000 3.56e-01 -1.28e-01 7.50e-04 2.26e-01
GOBP FUNGIFORM PAPILLA MORPHOGENESIS 5 3.36e-01 6.26e-01 0.378000 3.76e-01 -3.67e-02 1.46e-01 8.87e-01
GOMF NADPLUS NUCLEOSIDASE ACTIVITY 9 1.34e-01 4.01e-01 0.377000 -3.63e-01 1.04e-01 5.95e-02 5.88e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 17 3.40e-02 1.79e-01 0.377000 -2.63e-01 -2.71e-01 6.05e-02 5.33e-02
GOBP PROGESTERONE RECEPTOR SIGNALING PATHWAY 11 9.02e-02 3.22e-01 0.377000 3.74e-01 -4.96e-02 3.17e-02 7.76e-01
GOBP SEQUESTERING OF METAL ION 10 1.04e-01 3.48e-01 0.377000 -3.44e-01 1.54e-01 5.95e-02 3.99e-01
GOBP REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 5 3.38e-01 6.28e-01 0.377000 3.76e-01 -3.06e-02 1.46e-01 9.06e-01
GOBP RESPONSE TO LIPOTEICHOIC ACID 10 1.29e-01 3.92e-01 0.377000 -3.57e-01 -1.21e-01 5.06e-02 5.07e-01
tRNA modification in the mitochondrion 8 1.85e-01 4.75e-01 0.377000 -3.96e-02 -3.75e-01 8.46e-01 6.64e-02
Modulation by Mtb of host immune system 6 2.74e-01 5.72e-01 0.377000 2.02e-02 -3.76e-01 9.32e-01 1.11e-01
GOBP REGULATION OF NEUTROPHIL MEDIATED CYTOTOXICITY 5 3.72e-01 6.58e-01 0.376000 2.63e-01 2.69e-01 3.08e-01 2.97e-01
GOBP POSITIVE REGULATION OF TOOTH MINERALIZATION 7 2.33e-01 5.31e-01 0.376000 -6.86e-02 -3.70e-01 7.53e-01 8.99e-02
CaMK IV-mediated phosphorylation of CREB 10 1.21e-01 3.79e-01 0.376000 2.80e-02 3.75e-01 8.78e-01 3.98e-02
Miro GTPase Cycle 8 1.60e-01 4.43e-01 0.376000 2.78e-01 -2.54e-01 1.74e-01 2.14e-01
GOBP REGULATION OF T HELPER 2 CELL DIFFERENTIATION 12 8.82e-02 3.18e-01 0.376000 1.46e-01 3.47e-01 3.83e-01 3.73e-02
GOBP NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION 13 7.61e-02 2.91e-01 0.376000 2.92e-01 2.37e-01 6.80e-02 1.39e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 18 PRODUCTION 8 1.98e-01 4.92e-01 0.376000 -3.47e-01 -1.45e-01 8.90e-02 4.78e-01
GOCC 9PLUS0 MOTILE CILIUM 5 3.36e-01 6.25e-01 0.376000 -3.72e-01 5.66e-02 1.50e-01 8.26e-01
GOBP FOREBRAIN RADIAL GLIAL CELL DIFFERENTIATION 7 2.44e-01 5.40e-01 0.376000 -1.59e-01 -3.41e-01 4.65e-01 1.18e-01
GOBP LEUKOTRIENE CATABOLIC PROCESS 6 2.68e-01 5.65e-01 0.376000 3.69e-01 -7.43e-02 1.18e-01 7.52e-01
Activated NTRK3 signals through RAS 8 1.73e-01 4.59e-01 0.376000 3.68e-01 -7.91e-02 7.18e-02 6.98e-01
GOMF METALLODIPEPTIDASE ACTIVITY 8 2.01e-01 4.94e-01 0.376000 1.66e-01 3.37e-01 4.16e-01 9.88e-02
GOBP REGULATION OF CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 14 5.12e-02 2.28e-01 0.376000 3.76e-01 5.65e-03 1.49e-02 9.71e-01
GOBP NEGATIVE REGULATION OF CYTOPLASMIC TRANSLATION 9 1.49e-01 4.26e-01 0.376000 3.75e-01 1.61e-02 5.12e-02 9.33e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE LIPASE ACTIVITY 8 1.96e-01 4.89e-01 0.376000 -3.58e-01 -1.14e-01 7.96e-02 5.77e-01
Activation of the phototransduction cascade 11 9.60e-02 3.32e-01 0.375000 -6.11e-03 3.75e-01 9.72e-01 3.11e-02
GOBP NEGATIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS 5 3.66e-01 6.53e-01 0.375000 -1.48e-01 -3.45e-01 5.67e-01 1.82e-01
GOBP LIMB BUD FORMATION 9 1.69e-01 4.54e-01 0.375000 3.09e-01 2.13e-01 1.08e-01 2.69e-01
CLEC7A/inflammasome pathway 6 2.55e-01 5.52e-01 0.375000 2.83e-01 -2.46e-01 2.30e-01 2.96e-01
Toxicity of botulinum toxin type D (botD) 5 3.58e-01 6.47e-01 0.375000 -8.36e-02 -3.66e-01 7.46e-01 1.57e-01
Toxicity of botulinum toxin type F (botF) 5 3.58e-01 6.47e-01 0.375000 -8.36e-02 -3.66e-01 7.46e-01 1.57e-01
GOMF LAMININ 1 BINDING 7 2.24e-01 5.20e-01 0.375000 -1.66e-02 3.75e-01 9.39e-01 8.59e-02
GOBP THYROID HORMONE MEDIATED SIGNALING PATHWAY 8 2.00e-01 4.93e-01 0.375000 1.41e-01 3.48e-01 4.91e-01 8.87e-02
GOCC NSL COMPLEX 9 1.67e-01 4.52e-01 0.375000 3.30e-01 1.78e-01 8.65e-02 3.55e-01
GOBP MITOCHONDRIAL DNA REPAIR 6 2.58e-01 5.55e-01 0.375000 2.02e-01 -3.16e-01 3.92e-01 1.80e-01
GOBP CEREBELLAR GRANULAR LAYER FORMATION 6 2.59e-01 5.56e-01 0.375000 -1.85e-01 3.26e-01 4.32e-01 1.67e-01
GOBP MITOTIC DNA REPLICATION CHECKPOINT SIGNALING 11 1.01e-01 3.41e-01 0.375000 -3.45e-02 -3.73e-01 8.43e-01 3.22e-02
GOBP NUCLEAR MIGRATION 25 6.67e-03 5.87e-02 0.374000 3.47e-01 1.41e-01 2.67e-03 2.23e-01
Regulation of TLR by endogenous ligand 21 9.72e-03 7.71e-02 0.374000 -3.55e-01 1.20e-01 4.91e-03 3.40e-01
GOMF RNA POLYMERASE II C TERMINAL DOMAIN BINDING 10 1.34e-01 4.01e-01 0.374000 3.50e-01 1.32e-01 5.52e-02 4.69e-01
GOBP REGULATION OF DENDRITIC SPINE MAINTENANCE 12 9.52e-02 3.31e-01 0.374000 2.36e-01 2.90e-01 1.56e-01 8.17e-02
GOCC WASH COMPLEX 13 5.28e-02 2.33e-01 0.374000 2.38e-01 -2.89e-01 1.37e-01 7.14e-02
GOBP NEGATIVE REGULATION OF DENDRITIC CELL APOPTOTIC PROCESS 8 1.89e-01 4.80e-01 0.374000 -3.35e-02 -3.73e-01 8.70e-01 6.79e-02
GOBP MONOCYTE AGGREGATION 5 3.23e-01 6.14e-01 0.374000 3.02e-01 -2.21e-01 2.42e-01 3.92e-01
GOBP REGULATION OF CHROMATIN ORGANIZATION 32 8.39e-04 1.20e-02 0.374000 3.48e-01 -1.38e-01 6.61e-04 1.78e-01
GOBP POSITIVE REGULATION OF MICROGLIAL CELL ACTIVATION 10 1.41e-01 4.13e-01 0.374000 -2.90e-01 -2.36e-01 1.13e-01 1.95e-01
GOBP AMYGDALA DEVELOPMENT 5 3.64e-01 6.51e-01 0.374000 3.58e-01 1.08e-01 1.66e-01 6.76e-01
GOBP FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS 13 5.48e-02 2.39e-01 0.374000 1.75e-01 -3.31e-01 2.76e-01 3.90e-02
GOCC BRCA1 C COMPLEX 6 2.69e-01 5.66e-01 0.374000 1.06e-01 -3.58e-01 6.53e-01 1.29e-01
Sema4D induced cell migration and growth-cone collapse 20 1.62e-02 1.11e-01 0.373000 3.70e-01 4.95e-02 4.16e-03 7.02e-01
GOBP TOOTH ERUPTION 5 3.31e-01 6.22e-01 0.373000 -1.49e-01 3.42e-01 5.63e-01 1.85e-01
GOBP RESPONSE TO PEPTIDE 20 1.57e-02 1.09e-01 0.373000 2.49e-02 3.72e-01 8.47e-01 3.94e-03
GOBP RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION 15 3.70e-02 1.90e-01 0.373000 -3.50e-01 1.29e-01 1.89e-02 3.88e-01
GOBP REGULATION OF TRANSLATION AT SYNAPSE MODULATING SYNAPTIC TRANSMISSION 5 3.44e-01 6.33e-01 0.373000 3.70e-01 -4.66e-02 1.52e-01 8.57e-01
GOBP MANNOSE METABOLIC PROCESS 9 1.73e-01 4.59e-01 0.373000 3.04e-01 2.16e-01 1.14e-01 2.62e-01
Proton-coupled monocarboxylate transport 6 3.03e-01 5.97e-01 0.373000 -3.46e-01 -1.38e-01 1.42e-01 5.59e-01
GOBP REGULATION OF MACROPHAGE PROLIFERATION 7 2.51e-01 5.48e-01 0.373000 3.37e-01 1.59e-01 1.23e-01 4.67e-01
GOBP MAMMALIAN OOGENESIS STAGE 12 9.73e-02 3.35e-01 0.373000 2.91e-01 2.32e-01 8.06e-02 1.64e-01
GOBP L HISTIDINE TRANSMEMBRANE TRANSPORT 5 3.27e-01 6.18e-01 0.372000 3.04e-01 -2.15e-01 2.39e-01 4.04e-01
GOCC JUNCTIONAL MEMBRANE COMPLEX 6 2.79e-01 5.77e-01 0.372000 -3.70e-01 4.09e-02 1.16e-01 8.62e-01
GOBP PANCREATIC JUICE SECRETION 11 1.10e-01 3.59e-01 0.372000 3.56e-01 1.10e-01 4.10e-02 5.28e-01
GOBP CRANIAL GANGLION DEVELOPMENT 5 3.50e-01 6.40e-01 0.372000 3.72e-01 -9.02e-03 1.49e-01 9.72e-01
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE 8 2.12e-01 5.08e-01 0.372000 2.73e-01 2.53e-01 1.80e-01 2.16e-01
GOMF GLUCOSE BINDING 10 1.15e-01 3.68e-01 0.372000 -9.32e-02 3.60e-01 6.10e-01 4.85e-02
GOBP PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS 21 1.07e-02 8.26e-02 0.372000 3.58e-01 -9.92e-02 4.46e-03 4.31e-01
Cytosolic sulfonation of small molecules 22 1.39e-02 1.00e-01 0.372000 2.07e-01 3.09e-01 9.26e-02 1.21e-02
GOBP LYMPHATIC ENDOTHELIAL CELL DIFFERENTIATION 8 2.10e-01 5.05e-01 0.372000 3.23e-01 1.85e-01 1.14e-01 3.65e-01
GOMF CHLORIDE CHANNEL INHIBITOR ACTIVITY 7 2.20e-01 5.16e-01 0.372000 3.59e-01 -9.62e-02 9.98e-02 6.59e-01
GOBP URETER DEVELOPMENT 18 2.13e-02 1.32e-01 0.372000 3.65e-01 -7.09e-02 7.37e-03 6.03e-01
GOMF FRUCTOSE TRANSMEMBRANE TRANSPORTER ACTIVITY 9 1.34e-01 4.00e-01 0.372000 -2.67e-01 2.58e-01 1.65e-01 1.79e-01
GOCC PLATELET DENSE TUBULAR NETWORK 11 1.20e-01 3.77e-01 0.371000 2.63e-01 2.62e-01 1.31e-01 1.32e-01
GOBP REGULATION OF VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 5 3.57e-01 6.46e-01 0.371000 -3.71e-01 -2.37e-02 1.51e-01 9.27e-01
HDMs demethylate histones 18 2.90e-02 1.63e-01 0.371000 3.41e-01 1.46e-01 1.22e-02 2.82e-01
GOCC RPAP3 R2TP PREFOLDIN LIKE COMPLEX 10 1.14e-01 3.67e-01 0.371000 1.20e-01 -3.51e-01 5.12e-01 5.45e-02
GOCC SPERM PLASMA MEMBRANE 14 5.62e-02 2.43e-01 0.371000 -3.70e-01 -2.20e-02 1.64e-02 8.87e-01
GOMF DEATH RECEPTOR BINDING 19 1.64e-02 1.12e-01 0.371000 3.52e-01 -1.18e-01 7.94e-03 3.75e-01
GOBP POSITIVE REGULATION OF OPSONIZATION 8 1.70e-01 4.54e-01 0.371000 -2.96e-01 2.23e-01 1.47e-01 2.75e-01
GOBP MITOCHONDRIAL TRANSLATIONAL ELONGATION 5 3.29e-01 6.20e-01 0.371000 2.55e-01 -2.69e-01 3.24e-01 2.97e-01
GOBP CARDIAC VENTRICLE FORMATION 8 2.11e-01 5.06e-01 0.371000 3.27e-01 1.74e-01 1.09e-01 3.94e-01
GOMF CARBOHYDRATE KINASE ACTIVITY 20 2.02e-02 1.27e-01 0.371000 1.59e-01 3.35e-01 2.19e-01 9.52e-03
GOCC PHAGOCYTIC VESICLE LUMEN 5 3.50e-01 6.40e-01 0.371000 -3.38e-02 3.69e-01 8.96e-01 1.53e-01
GOMF MIRNA BINDING 38 2.76e-04 4.87e-03 0.371000 3.52e-01 -1.15e-01 1.71e-04 2.21e-01
FRS-mediated FGFR3 signaling 19 2.52e-02 1.49e-01 0.370000 3.23e-01 1.81e-01 1.47e-02 1.73e-01
GOCC PROTEASOME CORE COMPLEX ALPHA SUBUNIT COMPLEX 8 1.92e-01 4.83e-01 0.370000 -1.57e-03 -3.70e-01 9.94e-01 6.98e-02
GOBP REGULATION OF DNA STRAND ELONGATION 17 2.65e-02 1.55e-01 0.370000 3.59e-01 -8.88e-02 1.03e-02 5.26e-01
GOBP ACTIN FILAMENT NETWORK FORMATION 8 2.07e-01 5.01e-01 0.370000 3.50e-01 1.19e-01 8.62e-02 5.60e-01
GOMF DISACCHARIDE BINDING 5 3.45e-01 6.35e-01 0.370000 -8.39e-02 3.60e-01 7.45e-01 1.63e-01
FBXW7 Mutants and NOTCH1 in Cancer 5 3.52e-01 6.42e-01 0.370000 3.68e-01 -3.18e-02 1.54e-01 9.02e-01
Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling 5 3.52e-01 6.42e-01 0.370000 3.68e-01 -3.18e-02 1.54e-01 9.02e-01
GOBP NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 12 9.06e-02 3.22e-01 0.370000 3.62e-01 7.26e-02 2.97e-02 6.63e-01
Trafficking of GluR2-containing AMPA receptors 15 5.62e-02 2.42e-01 0.370000 2.05e-01 3.07e-01 1.69e-01 3.92e-02
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION 11 9.86e-02 3.37e-01 0.369000 -6.07e-02 3.64e-01 7.27e-01 3.64e-02
GOBP CELL FATE SPECIFICATION 107 2.61e-10 2.12e-08 0.369000 3.69e-01 -1.82e-02 4.29e-11 7.45e-01
Gamma-carboxylation, transport, and amino-terminal cleavage of proteins 9 1.52e-01 4.31e-01 0.369000 -4.53e-02 3.66e-01 8.14e-01 5.70e-02
GOBP PROTEIN NEDDYLATION 28 2.12e-03 2.46e-02 0.369000 2.37e-01 -2.83e-01 3.01e-02 9.54e-03
GOBP CHONDROCYTE HYPERTROPHY 6 2.68e-01 5.64e-01 0.369000 2.23e-01 -2.94e-01 3.45e-01 2.12e-01
Signaling by EGFR in Cancer 25 4.11e-03 4.08e-02 0.369000 2.32e-01 -2.86e-01 4.42e-02 1.32e-02
GOCC RNA POLYMERASE I TRANSCRIPTION REGULATOR COMPLEX 6 3.16e-01 6.09e-01 0.369000 -3.17e-01 -1.89e-01 1.79e-01 4.23e-01
GOBP PROTEIN LOCALIZATION TO ADHERENS JUNCTION 6 3.20e-01 6.11e-01 0.369000 2.65e-01 2.56e-01 2.60e-01 2.77e-01
GOBP PROLACTIN SECRETION 5 3.41e-01 6.31e-01 0.369000 3.43e-01 -1.35e-01 1.84e-01 6.00e-01
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION 6 2.73e-01 5.70e-01 0.368000 -3.29e-01 1.65e-01 1.62e-01 4.84e-01
GOCC BRISC COMPLEX 5 3.52e-01 6.42e-01 0.368000 3.64e-01 -5.40e-02 1.58e-01 8.34e-01
GOBP D ASPARTATE TRANSMEMBRANE TRANSPORT 5 3.61e-01 6.49e-01 0.368000 5.25e-03 3.68e-01 9.84e-01 1.54e-01
GOMF HISTONE H3K4 DEMETHYLASE ACTIVITY 6 3.13e-01 6.06e-01 0.368000 3.39e-01 1.45e-01 1.51e-01 5.39e-01
GOBP MIRNA CATABOLIC PROCESS 17 3.53e-02 1.84e-01 0.368000 3.55e-01 9.68e-02 1.12e-02 4.90e-01
GOBP POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY 10 1.43e-01 4.15e-01 0.368000 -1.33e-01 -3.43e-01 4.68e-01 6.00e-02
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE ACTIVITY 9 1.81e-01 4.71e-01 0.368000 2.32e-01 2.86e-01 2.29e-01 1.37e-01
Signaling by FLT3 fusion proteins 19 1.91e-02 1.23e-01 0.368000 3.65e-01 -5.09e-02 5.93e-03 7.01e-01
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE 5 3.88e-01 6.72e-01 0.368000 2.71e-01 2.49e-01 2.95e-01 3.34e-01
GOBP TAURINE METABOLIC PROCESS 9 1.40e-01 4.11e-01 0.368000 2.12e-01 -3.01e-01 2.70e-01 1.18e-01
GOBP TRUNK SEGMENTATION 5 3.87e-01 6.71e-01 0.368000 2.21e-01 2.94e-01 3.92e-01 2.54e-01
GOBP SIGNAL COMPLEX ASSEMBLY 8 1.77e-01 4.64e-01 0.368000 3.21e-01 -1.80e-01 1.16e-01 3.79e-01
GOBP NUCLEUS LOCALIZATION 32 2.09e-03 2.44e-02 0.368000 3.37e-01 1.47e-01 9.64e-04 1.50e-01
GOBP PHASIC SMOOTH MUSCLE CONTRACTION 24 5.40e-03 5.00e-02 0.368000 3.06e-01 -2.04e-01 9.46e-03 8.37e-02
FRS-mediated FGFR2 signaling 24 1.01e-02 7.91e-02 0.367000 3.30e-01 1.61e-01 5.11e-03 1.72e-01
GOBP MUSCLE ATROPHY 11 9.32e-02 3.27e-01 0.367000 3.24e-01 -1.73e-01 6.26e-02 3.21e-01
GOCC MEIOTIC COHESIN COMPLEX 6 2.95e-01 5.92e-01 0.367000 1.86e-03 -3.67e-01 9.94e-01 1.19e-01
GOBP LEUKOTRIENE D4 METABOLIC PROCESS 8 2.09e-01 5.03e-01 0.367000 9.41e-02 3.55e-01 6.45e-01 8.21e-02
GOBP DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM 86 8.48e-08 4.27e-06 0.367000 -3.12e-01 -1.94e-01 5.79e-07 1.86e-03
GOBP MAINTENANCE OF ORGANELLE LOCATION 12 8.55e-02 3.13e-01 0.367000 3.66e-01 -2.45e-02 2.81e-02 8.83e-01
GOBP REGULATION OF DEVELOPMENT HETEROCHRONIC 13 6.00e-02 2.52e-01 0.367000 3.05e-01 -2.04e-01 5.70e-02 2.03e-01
Replacement of protamines by nucleosomes in the male pronucleus 22 1.28e-02 9.38e-02 0.367000 -5.58e-02 -3.62e-01 6.50e-01 3.26e-03
GOBP PROLINE METABOLIC PROCESS 10 1.15e-01 3.68e-01 0.367000 -2.07e-01 3.03e-01 2.58e-01 9.74e-02
GOBP NEGATIVE REGULATION OF CENTRIOLE REPLICATION 7 2.21e-01 5.17e-01 0.367000 1.88e-01 -3.15e-01 3.89e-01 1.49e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CILIUM 7 2.55e-01 5.53e-01 0.366000 3.55e-01 9.13e-02 1.04e-01 6.76e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL 6 3.03e-01 5.97e-01 0.366000 3.75e-02 3.64e-01 8.74e-01 1.22e-01
GOBP POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 30 3.10e-03 3.28e-02 0.366000 -1.21e-01 -3.45e-01 2.51e-01 1.06e-03
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH 12 7.43e-02 2.87e-01 0.366000 2.71e-01 -2.46e-01 1.04e-01 1.40e-01
GOCC SERINE TYPE PEPTIDASE COMPLEX 13 6.38e-02 2.62e-01 0.366000 -3.42e-01 1.31e-01 3.30e-02 4.13e-01
GOMF 5 3 DNA HELICASE ACTIVITY 9 1.85e-01 4.75e-01 0.366000 2.97e-01 2.13e-01 1.23e-01 2.68e-01
GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY 23 1.00e-02 7.90e-02 0.366000 -3.65e-01 -1.92e-02 2.42e-03 8.73e-01
GOBP DETOXIFICATION OF INORGANIC COMPOUND 22 1.07e-02 8.26e-02 0.366000 -3.61e-01 5.92e-02 3.38e-03 6.31e-01
GOBP CARDIAC ATRIUM MORPHOGENESIS 29 3.36e-03 3.49e-02 0.366000 3.60e-01 6.18e-02 7.82e-04 5.65e-01
GOBP PROTEIN LOCALIZATION TO CILIARY TRANSITION ZONE 8 1.78e-01 4.65e-01 0.366000 2.30e-01 -2.84e-01 2.60e-01 1.64e-01
GOBP LEUKOTRIENE TRANSPORT 7 2.71e-01 5.68e-01 0.366000 2.51e-01 2.66e-01 2.51e-01 2.23e-01
Germ layer formation at gastrulation 16 3.42e-02 1.80e-01 0.365000 3.42e-01 -1.28e-01 1.77e-02 3.75e-01
GOCC SMALL RIBOSOMAL SUBUNIT 70 1.00e-06 3.78e-05 0.365000 -4.35e-02 -3.63e-01 5.29e-01 1.51e-07
GOBP POSITIVE REGULATION OF GAMMA DELTA T CELL ACTIVATION 9 1.59e-01 4.41e-01 0.365000 3.68e-02 -3.64e-01 8.49e-01 5.89e-02
GOMF GUANYLATE CYCLASE ACTIVITY 7 2.65e-01 5.61e-01 0.365000 3.31e-01 1.54e-01 1.29e-01 4.81e-01
GOBP PURINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS 6 2.96e-01 5.93e-01 0.365000 -2.60e-02 3.64e-01 9.12e-01 1.22e-01
GOBP REELIN MEDIATED SIGNALING PATHWAY 8 1.79e-01 4.68e-01 0.365000 2.93e-01 -2.18e-01 1.52e-01 2.85e-01
GOMF UBIQUITIN LIGASE ACTIVATOR ACTIVITY 10 1.53e-01 4.31e-01 0.365000 -1.80e-01 -3.17e-01 3.24e-01 8.25e-02
MET activates PTPN11 5 3.42e-01 6.32e-01 0.365000 2.16e-01 -2.94e-01 4.04e-01 2.55e-01
GOCC PROTEASOME REGULATORY PARTICLE BASE SUBCOMPLEX 11 9.59e-02 3.32e-01 0.365000 3.16e-01 -1.82e-01 6.97e-02 2.95e-01
FGFR2c ligand binding and activation 12 1.07e-01 3.53e-01 0.365000 2.86e-01 2.26e-01 8.59e-02 1.76e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 19 2.92e-02 1.64e-01 0.365000 2.86e-01 2.27e-01 3.12e-02 8.71e-02
GOMF MAP KINASE KINASE KINASE KINASE ACTIVITY 6 3.23e-01 6.14e-01 0.364000 3.26e-01 1.62e-01 1.66e-01 4.91e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS OXYGEN AS ACCEPTOR 5 3.57e-01 6.46e-01 0.364000 -3.56e-01 7.67e-02 1.68e-01 7.66e-01
GOBP URIDINE TRANSMEMBRANE TRANSPORT 6 3.27e-01 6.18e-01 0.364000 2.06e-01 3.00e-01 3.82e-01 2.03e-01
GOBP NEUTROPHIL MEDIATED KILLING OF GRAM NEGATIVE BACTERIUM 7 2.42e-01 5.38e-01 0.364000 -3.62e-01 3.85e-02 9.72e-02 8.60e-01
GOMF HISTONE H3K9 MONOMETHYLTRANSFERASE ACTIVITY 6 3.03e-01 5.97e-01 0.364000 3.64e-01 9.86e-03 1.23e-01 9.67e-01
GOMF SPLICING FACTOR BINDING 6 2.91e-01 5.88e-01 0.364000 7.53e-02 -3.56e-01 7.49e-01 1.31e-01
GOBP DNA LIGATION INVOLVED IN DNA REPAIR 5 3.70e-01 6.57e-01 0.364000 7.18e-03 3.64e-01 9.78e-01 1.59e-01
GOBP PITUITARY GLAND DEVELOPMENT 40 2.77e-04 4.87e-03 0.364000 3.57e-01 -7.13e-02 9.48e-05 4.35e-01
GOBP ENDOSOME TO PLASMA MEMBRANE PROTEIN TRANSPORT 16 4.57e-02 2.14e-01 0.364000 8.25e-02 3.54e-01 5.68e-01 1.42e-02
GOBP KIDNEY MESENCHYME DEVELOPMENT 16 3.27e-02 1.75e-01 0.364000 2.71e-01 -2.43e-01 6.10e-02 9.24e-02
GOMF RNA POLYMERASE I GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY 5 3.76e-01 6.62e-01 0.364000 4.90e-02 3.60e-01 8.50e-01 1.63e-01
GOBP NEUTROPHIL EXTRAVASATION 11 9.74e-02 3.35e-01 0.364000 -3.18e-01 1.76e-01 6.79e-02 3.11e-01
GOBP REGULATION OF PEPTIDYL SERINE DEPHOSPHORYLATION 7 2.29e-01 5.26e-01 0.363000 3.24e-01 -1.65e-01 1.38e-01 4.49e-01
GOMF DNA DNA TETHERING ACTIVITY 7 2.33e-01 5.31e-01 0.363000 3.42e-01 -1.22e-01 1.17e-01 5.75e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY ENDOTHELIN 6 2.80e-01 5.77e-01 0.363000 1.99e-01 -3.04e-01 3.99e-01 1.97e-01
GOBP GPI ANCHOR METABOLIC PROCESS 32 2.66e-03 2.94e-02 0.363000 -2.00e-01 -3.03e-01 4.97e-02 3.01e-03
Wax and plasmalogen biosynthesis 5 3.50e-01 6.40e-01 0.363000 3.31e-01 -1.50e-01 2.00e-01 5.60e-01
Digestion of dietary carbohydrate 6 2.85e-01 5.82e-01 0.363000 -3.36e-01 1.38e-01 1.54e-01 5.57e-01
GOBP MICROGLIAL CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 5 3.75e-01 6.61e-01 0.363000 -3.47e-02 -3.62e-01 8.93e-01 1.62e-01
GOBP CELL ADHESION INVOLVED IN HEART MORPHOGENESIS 8 2.23e-01 5.19e-01 0.363000 3.31e-01 1.49e-01 1.05e-01 4.66e-01
RAS signaling downstream of NF1 loss-of-function variants 7 2.57e-01 5.54e-01 0.363000 3.59e-01 5.40e-02 1.00e-01 8.05e-01
GOBP MITOCHONDRIAL TRNA PROCESSING 13 6.74e-02 2.71e-01 0.363000 1.20e-01 -3.42e-01 4.55e-01 3.25e-02
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX 13 6.60e-02 2.68e-01 0.363000 1.46e-01 -3.32e-01 3.62e-01 3.81e-02
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING 16 3.35e-02 1.78e-01 0.363000 2.19e-01 -2.89e-01 1.30e-01 4.52e-02
FGFR1b ligand binding and activation 8 2.22e-01 5.17e-01 0.363000 3.37e-01 1.33e-01 9.84e-02 5.15e-01
GOBP NEGATIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 5 3.88e-01 6.72e-01 0.362000 -1.15e-01 -3.44e-01 6.56e-01 1.83e-01
Activation of Matrix Metalloproteinases 30 1.96e-03 2.33e-02 0.362000 -3.37e-01 1.34e-01 1.40e-03 2.05e-01
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 5 3.72e-01 6.59e-01 0.362000 3.62e-01 3.35e-03 1.60e-01 9.90e-01
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 25 6.69e-03 5.89e-02 0.362000 3.61e-01 -3.13e-02 1.78e-03 7.87e-01
GOBP MAST CELL PROLIFERATION 7 2.50e-01 5.47e-01 0.362000 3.62e-01 -1.40e-03 9.69e-02 9.95e-01
GOMF SUMO BINDING 16 5.19e-02 2.31e-01 0.362000 3.12e-01 1.84e-01 3.08e-02 2.02e-01
Presynaptic depolarization and calcium channel opening 12 8.17e-02 3.04e-01 0.362000 -3.25e-01 1.58e-01 5.10e-02 3.42e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS POLYSACCHARIDE CHAIN BIOSYNTHETIC PROCESS 8 2.27e-01 5.24e-01 0.362000 3.18e-01 1.73e-01 1.19e-01 3.98e-01
RORA activates gene expression 17 4.10e-02 2.01e-01 0.362000 3.40e-01 1.23e-01 1.52e-02 3.79e-01
GOMF TITIN BINDING 13 9.06e-02 3.22e-01 0.362000 1.80e-01 3.14e-01 2.62e-01 5.00e-02
GOBP POSITIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS 9 1.83e-01 4.73e-01 0.362000 1.10e-01 3.45e-01 5.69e-01 7.34e-02
DAP12 signaling 27 3.68e-03 3.73e-02 0.362000 1.44e-01 -3.32e-01 1.96e-01 2.84e-03
GOBP POSITIVE REGULATION OF MYOBLAST PROLIFERATION 14 7.04e-02 2.78e-01 0.362000 3.48e-01 9.82e-02 2.41e-02 5.25e-01
GOMF PROTEIN ARGININE OMEGA N MONOMETHYLTRANSFERASE ACTIVITY 5 3.79e-01 6.65e-01 0.361000 3.59e-01 4.03e-02 1.64e-01 8.76e-01
GOBP REGULATION OF CALCIDIOL 1 MONOOXYGENASE ACTIVITY 7 2.39e-01 5.36e-01 0.361000 9.83e-02 -3.48e-01 6.53e-01 1.11e-01
Regulation of MECP2 expression and activity 30 3.57e-03 3.65e-02 0.361000 3.42e-01 1.18e-01 1.20e-03 2.65e-01
GOBP CUT METABOLIC PROCESS 5 3.87e-01 6.71e-01 0.361000 3.50e-01 9.11e-02 1.76e-01 7.24e-01
GOCC AMINOACYL TRNA SYNTHETASE MULTIENZYME COMPLEX 10 1.24e-01 3.84e-01 0.361000 3.21e-01 -1.66e-01 7.86e-02 3.65e-01
GOMF NAD P H DEHYDROGENASE QUINONE ACTIVITY 5 3.48e-01 6.38e-01 0.361000 2.62e-01 -2.48e-01 3.10e-01 3.36e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT TO PLASMA MEMBRANE 16 4.75e-02 2.19e-01 0.361000 7.79e-02 3.53e-01 5.90e-01 1.46e-02
Cellular response to mitochondrial stress 8 2.16e-01 5.11e-01 0.361000 -6.31e-02 -3.55e-01 7.57e-01 8.17e-02
GOCC CARDIAC MYOFIBRIL 6 2.86e-01 5.83e-01 0.361000 -1.74e-01 3.16e-01 4.61e-01 1.80e-01
GOBP PROTEIN DEUBIQUITINATION INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 5 3.87e-01 6.71e-01 0.361000 3.51e-01 8.58e-02 1.75e-01 7.40e-01
GOBP NEGATIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 6 2.86e-01 5.83e-01 0.361000 3.13e-01 -1.79e-01 1.84e-01 4.48e-01
Type I hemidesmosome assembly 11 1.26e-01 3.87e-01 0.361000 9.89e-02 3.47e-01 5.70e-01 4.64e-02
GOBP FUCOSE METABOLIC PROCESS 16 3.57e-02 1.85e-01 0.360000 -1.81e-01 3.11e-01 2.09e-01 3.10e-02
GOBP RESPONSE TO HEPARIN 6 3.20e-01 6.11e-01 0.360000 -3.52e-01 -7.78e-02 1.36e-01 7.41e-01
GOBP POSITIVE REGULATION OF GAP JUNCTION ASSEMBLY 6 2.99e-01 5.95e-01 0.360000 3.54e-01 -6.79e-02 1.33e-01 7.73e-01
Intestinal absorption 5 3.71e-01 6.58e-01 0.360000 -3.42e-02 3.59e-01 8.95e-01 1.65e-01
GOBP REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY 11 1.19e-01 3.76e-01 0.360000 -3.12e-02 -3.59e-01 8.58e-01 3.92e-02
GOBP POLAR BODY EXTRUSION AFTER MEIOTIC DIVISIONS 5 3.55e-01 6.44e-01 0.360000 3.21e-01 -1.64e-01 2.14e-01 5.25e-01
GOCC UBIQUINONE BIOSYNTHESIS COMPLEX 6 2.95e-01 5.92e-01 0.360000 9.91e-02 -3.46e-01 6.74e-01 1.42e-01
GOBP PIRNA PROCESSING 21 1.38e-02 9.98e-02 0.360000 -3.43e-01 1.09e-01 6.44e-03 3.87e-01
GOMF BIOTIN BINDING 5 3.93e-01 6.76e-01 0.360000 1.20e-01 3.40e-01 6.43e-01 1.88e-01
GOMF PH DOMAIN BINDING 8 2.33e-01 5.31e-01 0.360000 2.06e-01 2.95e-01 3.12e-01 1.48e-01
GOBP FRUCTOSE TRANSMEMBRANE TRANSPORT 10 1.24e-01 3.84e-01 0.360000 -3.04e-01 1.94e-01 9.65e-02 2.88e-01
GOBP TRNA SURVEILLANCE 8 1.91e-01 4.83e-01 0.360000 3.25e-01 -1.54e-01 1.11e-01 4.50e-01
GOBP EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 44 1.29e-04 2.65e-03 0.360000 3.44e-01 -1.08e-01 7.98e-05 2.16e-01
GOBP NEGATIVE REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY 9 1.81e-01 4.70e-01 0.360000 6.86e-02 3.54e-01 7.22e-01 6.62e-02
Glycoprotein hormones 9 1.54e-01 4.33e-01 0.360000 -3.10e-01 1.83e-01 1.07e-01 3.42e-01
GOBP REGULATION OF PROTEIN KINASE C ACTIVITY 5 3.74e-01 6.60e-01 0.360000 3.60e-01 -1.66e-02 1.64e-01 9.49e-01
GOBP CDP DIACYLGLYCEROL BIOSYNTHETIC PROCESS 12 1.08e-01 3.55e-01 0.360000 3.34e-01 1.35e-01 4.52e-02 4.19e-01
GOBP N ACETYLNEURAMINATE METABOLIC PROCESS 11 1.27e-01 3.88e-01 0.360000 9.71e-02 3.47e-01 5.77e-01 4.65e-02
GOMF PHOSPHATASE ACTIVATOR ACTIVITY 19 2.74e-02 1.58e-01 0.360000 3.52e-01 7.61e-02 7.92e-03 5.66e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME 7 2.67e-01 5.64e-01 0.360000 3.49e-01 8.83e-02 1.10e-01 6.86e-01
GOCC SPHERICAL HIGH DENSITY LIPOPROTEIN PARTICLE 8 1.89e-01 4.80e-01 0.360000 -2.00e-01 2.99e-01 3.27e-01 1.43e-01
MET activates RAP1 and RAC1 11 1.10e-01 3.58e-01 0.360000 3.53e-01 -7.11e-02 4.28e-02 6.83e-01
GOBP NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 14 7.43e-02 2.87e-01 0.360000 1.27e-01 3.37e-01 4.10e-01 2.92e-02
GOBP MRNA 3 END PROCESSING BY STEM LOOP BINDING AND CLEAVAGE 6 3.13e-01 6.07e-01 0.360000 -2.16e-02 -3.59e-01 9.27e-01 1.28e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I 10 1.64e-01 4.48e-01 0.360000 2.65e-01 2.43e-01 1.46e-01 1.84e-01
GOBP TUBULIN COMPLEX ASSEMBLY 8 1.96e-01 4.89e-01 0.359000 3.39e-01 -1.21e-01 9.73e-02 5.55e-01
GOBP MEMBRANE REPOLARIZATION DURING ATRIAL CARDIAC MUSCLE CELL ACTION POTENTIAL 6 3.32e-01 6.24e-01 0.359000 3.24e-01 1.55e-01 1.69e-01 5.10e-01
GOBP PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE 15 6.11e-02 2.54e-01 0.359000 3.42e-01 1.09e-01 2.17e-02 4.65e-01
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY 13 9.28e-02 3.27e-01 0.359000 1.67e-01 3.18e-01 2.98e-01 4.69e-02
GOMF MUSCLE ALPHA ACTININ BINDING 15 6.29e-02 2.60e-01 0.359000 1.39e-01 3.31e-01 3.51e-01 2.63e-02
GOBP NEGATIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION 18 2.98e-02 1.66e-01 0.359000 7.94e-03 -3.59e-01 9.54e-01 8.32e-03
GOBP OUTFLOW TRACT SEPTUM MORPHOGENESIS 26 7.24e-03 6.27e-02 0.359000 3.54e-01 6.32e-02 1.80e-03 5.77e-01
GOBP REGULATION OF HELICASE ACTIVITY 9 1.60e-01 4.43e-01 0.359000 3.40e-01 -1.17e-01 7.77e-02 5.43e-01
GOBP NADH OXIDATION 6 3.39e-01 6.28e-01 0.359000 2.24e-01 2.81e-01 3.43e-01 2.33e-01
GOBP CORTISOL BIOSYNTHETIC PROCESS 10 1.24e-01 3.84e-01 0.359000 -2.72e-01 2.35e-01 1.37e-01 1.99e-01
GOBP HOST MEDIATED REGULATION OF INTESTINAL MICROBIOTA COMPOSITION 9 1.57e-01 4.39e-01 0.359000 -3.24e-01 1.55e-01 9.28e-02 4.19e-01
GOBP CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES 16 5.02e-02 2.26e-01 0.359000 3.47e-01 9.31e-02 1.64e-02 5.19e-01
GOBP RESPONSE TO HYDROXYUREA 11 1.28e-01 3.90e-01 0.359000 3.47e-01 9.19e-02 4.64e-02 5.98e-01
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 2B COMPLEX 5 3.59e-01 6.47e-01 0.359000 1.55e-01 -3.23e-01 5.48e-01 2.10e-01
Selenoamino acid metabolism 108 1.54e-09 1.09e-07 0.359000 -6.81e-02 -3.52e-01 2.21e-01 2.53e-10
GOBP TRNA DECAY 16 4.84e-02 2.22e-01 0.359000 3.54e-01 5.75e-02 1.42e-02 6.91e-01
GOMF OLIGOSACCHARYL TRANSFERASE ACTIVITY 5 3.76e-01 6.62e-01 0.359000 2.34e-02 -3.58e-01 9.28e-01 1.66e-01
GOBP EOSINOPHIL ACTIVATION 8 2.05e-01 4.99e-01 0.358000 -3.54e-01 5.91e-02 8.33e-02 7.72e-01
GOMF DYNACTIN BINDING 12 1.14e-01 3.66e-01 0.358000 3.06e-01 1.86e-01 6.63e-02 2.64e-01
SHC1 events in EGFR signaling 14 5.48e-02 2.39e-01 0.358000 2.21e-01 -2.82e-01 1.52e-01 6.76e-02
GOBP NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION 19 1.99e-02 1.26e-01 0.358000 -3.06e-01 1.86e-01 2.07e-02 1.61e-01
GOBP CELL SUBSTRATE JUNCTION DISASSEMBLY 8 2.38e-01 5.34e-01 0.358000 2.64e-01 2.42e-01 1.96e-01 2.35e-01
GOBP NEGATIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 6 3.05e-01 5.98e-01 0.358000 3.54e-01 -5.77e-02 1.34e-01 8.07e-01
GOBP REGULATION OF NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION 7 2.81e-01 5.78e-01 0.358000 1.73e-01 3.13e-01 4.27e-01 1.51e-01
GOCC VARICOSITY 9 1.89e-01 4.80e-01 0.358000 3.43e-01 1.01e-01 7.46e-02 5.98e-01
GOBP PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING 9 2.00e-01 4.93e-01 0.358000 2.48e-01 2.58e-01 1.98e-01 1.80e-01
GOMF HISTONE H2AX KINASE ACTIVITY 5 3.86e-01 6.70e-01 0.358000 3.56e-01 3.50e-02 1.68e-01 8.92e-01
GOBP REGULATION OF PODOSOME ASSEMBLY 13 6.96e-02 2.76e-01 0.358000 -1.77e-01 3.11e-01 2.70e-01 5.22e-02
GOBP NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 9 1.58e-01 4.39e-01 0.358000 1.85e-01 -3.06e-01 3.38e-01 1.12e-01
GOBP CRANIAL NERVE FORMATION 10 1.41e-01 4.13e-01 0.358000 3.55e-01 -3.88e-02 5.16e-02 8.32e-01
GOBP NEGATIVE REGULATION OF MUSCLE HYPERTROPHY 36 1.13e-03 1.52e-02 0.358000 3.54e-01 5.27e-02 2.40e-04 5.85e-01
Calcitonin-like ligand receptors 10 1.68e-01 4.53e-01 0.357000 -2.61e-01 -2.45e-01 1.54e-01 1.80e-01
GOBP VITAMIN D BIOSYNTHETIC PROCESS 10 1.38e-01 4.08e-01 0.357000 6.81e-02 -3.51e-01 7.09e-01 5.46e-02
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 6 3.12e-01 6.06e-01 0.357000 3.57e-01 -1.99e-02 1.30e-01 9.33e-01
Acetylcholine regulates insulin secretion 10 1.66e-01 4.50e-01 0.357000 3.01e-01 1.92e-01 9.91e-02 2.92e-01
GOBP NUCLEAR PORE ORGANIZATION 15 4.90e-02 2.23e-01 0.357000 3.37e-01 -1.19e-01 2.40e-02 4.24e-01
GOBP SIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION 10 1.28e-01 3.90e-01 0.357000 -2.90e-01 2.09e-01 1.13e-01 2.53e-01
GOBP CYTOPLASMIC TRANSLATION 147 6.56e-13 8.30e-11 0.357000 -2.94e-03 -3.57e-01 9.51e-01 7.75e-14
GOBP REGULATION OF TRANSCRIPTION BY GLUCOSE 8 1.99e-01 4.92e-01 0.357000 1.36e-01 -3.30e-01 5.04e-01 1.06e-01
GOBP CARDIAC LEFT VENTRICLE MORPHOGENESIS 16 4.10e-02 2.01e-01 0.357000 3.41e-01 -1.05e-01 1.83e-02 4.66e-01
GOCC INTERCHROMATIN GRANULE 5 3.92e-01 6.75e-01 0.357000 -5.81e-02 -3.52e-01 8.22e-01 1.73e-01
EGR2 and SOX10-mediated initiation of Schwann cell myelination 27 7.55e-03 6.44e-02 0.356000 3.26e-01 1.44e-01 3.37e-03 1.95e-01
GOMF VIRION BINDING 10 1.59e-01 4.41e-01 0.356000 -3.42e-01 -1.00e-01 6.11e-02 5.83e-01
GOCC TETRASPANIN ENRICHED MICRODOMAIN 10 1.69e-01 4.54e-01 0.356000 2.87e-01 2.11e-01 1.16e-01 2.48e-01
GOBP POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION 8 2.06e-01 5.01e-01 0.356000 3.47e-01 -7.97e-02 8.91e-02 6.96e-01
GOBP CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT 16 4.58e-02 2.14e-01 0.356000 3.55e-01 -2.09e-02 1.38e-02 8.85e-01
GOBP REGULATION OF NUCLEOTIDE EXCISION REPAIR 28 4.75e-03 4.56e-02 0.356000 3.56e-01 -1.52e-03 1.11e-03 9.89e-01
GOCC COPI VESICLE COAT 13 7.34e-02 2.86e-01 0.356000 3.29e-01 -1.36e-01 3.98e-02 3.98e-01
GOMF RISC COMPLEX BINDING 5 3.98e-01 6.80e-01 0.356000 3.46e-01 8.51e-02 1.81e-01 7.42e-01
B-WICH complex positively regulates rRNA expression 54 2.65e-05 6.85e-04 0.356000 5.78e-02 -3.51e-01 4.62e-01 8.00e-06
GOCC CORNIFIED ENVELOPE 57 1.27e-05 3.55e-04 0.356000 -3.43e-01 9.62e-02 7.68e-06 2.09e-01
GOBP NEGATIVE REGULATION OF MYOBLAST PROLIFERATION 9 1.60e-01 4.43e-01 0.356000 -2.02e-01 2.93e-01 2.94e-01 1.28e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT SUCCINATE TO UBIQUINONE 5 3.63e-01 6.51e-01 0.355000 3.07e-01 -1.79e-01 2.34e-01 4.89e-01
GOCC INO80 COMPLEX 16 4.11e-02 2.01e-01 0.355000 3.33e-01 -1.25e-01 2.12e-02 3.86e-01
GOBP OPSONIZATION 16 3.87e-02 1.94e-01 0.355000 -2.92e-01 2.02e-01 4.30e-02 1.61e-01
GOCC MRE11 COMPLEX 5 3.71e-01 6.58e-01 0.355000 3.39e-01 -1.06e-01 1.89e-01 6.82e-01
GOBP ERBB2 ERBB4 SIGNALING PATHWAY 5 4.13e-01 6.93e-01 0.355000 -2.08e-01 -2.88e-01 4.21e-01 2.64e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE P38 BINDING 7 2.88e-01 5.85e-01 0.355000 1.77e-01 3.08e-01 4.17e-01 1.59e-01
GOCC ENDOLYSOSOME 26 1.01e-02 7.91e-02 0.355000 2.93e-01 2.00e-01 9.59e-03 7.80e-02
GOBP REGULATION OF INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION 9 1.65e-01 4.49e-01 0.355000 -1.47e-01 3.23e-01 4.46e-01 9.31e-02
GOBP NEURON FATE SPECIFICATION 36 1.07e-03 1.45e-02 0.355000 3.55e-01 -4.92e-03 2.28e-04 9.59e-01
GOMF CONNEXIN BINDING 5 3.62e-01 6.49e-01 0.355000 2.82e-01 -2.16e-01 2.75e-01 4.03e-01
FGFR1 ligand binding and activation 17 5.02e-02 2.26e-01 0.355000 2.64e-01 2.37e-01 5.95e-02 9.05e-02
GOBP CORNIFICATION 9 1.67e-01 4.52e-01 0.355000 -1.21e-01 3.34e-01 5.30e-01 8.30e-02
GOMF GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR ACTIVITY 5 3.97e-01 6.79e-01 0.355000 -6.14e-02 -3.49e-01 8.12e-01 1.76e-01
GOBP NEGATIVE REGULATION OF T CELL MIGRATION 6 3.43e-01 6.32e-01 0.354000 1.61e-01 3.16e-01 4.96e-01 1.80e-01
GOBP NEGATIVE REGULATION OF NEUTROPHIL MIGRATION 5 3.63e-01 6.51e-01 0.354000 -2.11e-01 2.85e-01 4.15e-01 2.70e-01
GOCC DYSTROGLYCAN COMPLEX 7 2.47e-01 5.43e-01 0.354000 -1.51e-01 3.21e-01 4.89e-01 1.42e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE A2 ACTIVITY 5 3.64e-01 6.51e-01 0.354000 2.83e-01 -2.13e-01 2.73e-01 4.10e-01
GOBP SPERMIDINE TRANSPORT 5 3.69e-01 6.57e-01 0.354000 3.24e-01 -1.42e-01 2.09e-01 5.83e-01
TP53 Regulates Transcription of Death Receptors and Ligands 12 1.21e-01 3.79e-01 0.354000 2.87e-01 2.08e-01 8.56e-02 2.13e-01
Influenza Viral RNA Transcription and Replication 130 3.65e-11 3.37e-09 0.354000 -3.99e-02 -3.52e-01 4.32e-01 4.29e-12
GOBP RIBOSOMAL LARGE SUBUNIT EXPORT FROM NUCLEUS 7 2.51e-01 5.48e-01 0.354000 1.17e-01 -3.34e-01 5.91e-01 1.26e-01
GOBP EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS 17 3.23e-02 1.74e-01 0.354000 2.87e-01 -2.08e-01 4.07e-02 1.38e-01
GOMF CARGO ADAPTOR ACTIVITY 20 3.04e-02 1.67e-01 0.354000 2.57e-01 2.43e-01 4.67e-02 5.98e-02
Phospholipase C-mediated cascade: FGFR1 16 6.02e-02 2.52e-01 0.354000 1.98e-01 2.93e-01 1.70e-01 4.25e-02
GOBP 2FE 2S CLUSTER ASSEMBLY 9 1.69e-01 4.54e-01 0.354000 1.24e-01 -3.31e-01 5.19e-01 8.55e-02
GOMF SUPEROXIDE DISMUTASE ACTIVITY 5 3.91e-01 6.74e-01 0.353000 3.53e-01 2.29e-03 1.71e-01 9.93e-01
Interleukin-37 signaling 20 2.99e-02 1.66e-01 0.353000 2.98e-01 1.90e-01 2.12e-02 1.41e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON OTHER NITROGENOUS COMPOUNDS AS DONORS 12 9.85e-02 3.37e-01 0.353000 3.47e-01 -6.58e-02 3.73e-02 6.93e-01
Signaling by MST1 5 3.74e-01 6.60e-01 0.353000 -3.33e-01 1.17e-01 1.97e-01 6.50e-01
GOBP SPERM EJACULATION 6 3.25e-01 6.16e-01 0.353000 3.53e-01 8.87e-03 1.34e-01 9.70e-01
GOCC EXTRINSIC COMPONENT OF MITOCHONDRIAL INNER MEMBRANE 6 3.03e-01 5.97e-01 0.353000 1.65e-01 -3.12e-01 4.83e-01 1.86e-01
GOBP EYELID DEVELOPMENT IN CAMERA TYPE EYE 13 8.61e-02 3.14e-01 0.353000 3.52e-01 -1.47e-02 2.78e-02 9.27e-01
GOCC MHC CLASS I PROTEIN COMPLEX 10 1.37e-01 4.06e-01 0.353000 1.65e-01 -3.11e-01 3.66e-01 8.81e-02
GOBP SPINAL CORD MOTOR NEURON DIFFERENTIATION 28 5.29e-03 4.92e-02 0.352000 3.52e-01 -2.17e-03 1.25e-03 9.84e-01
GOMF RNA POLYMERASE I TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING 9 1.92e-01 4.84e-01 0.352000 3.49e-01 5.02e-02 7.01e-02 7.94e-01
Synthesis of PIPs at the ER membrane 5 4.07e-01 6.89e-01 0.352000 9.67e-02 3.39e-01 7.08e-01 1.90e-01
GOBP ARGININE CATABOLIC PROCESS 10 1.51e-01 4.29e-01 0.352000 3.51e-01 -3.05e-02 5.47e-02 8.68e-01
GOBP REGULATION OF SYNAPTIC VESICLE TRANSPORT 5 3.91e-01 6.74e-01 0.352000 -3.52e-01 1.07e-02 1.73e-01 9.67e-01
GOBP TONGUE MORPHOGENESIS 10 1.48e-01 4.23e-01 0.352000 3.47e-01 -5.93e-02 5.74e-02 7.45e-01
GOBP ABSCISSION 6 3.52e-01 6.42e-01 0.352000 -1.92e-01 -2.95e-01 4.14e-01 2.11e-01
GOBP HISTIDINE METABOLIC PROCESS 9 1.65e-01 4.49e-01 0.352000 -2.71e-01 2.25e-01 1.59e-01 2.43e-01
GOBP REGULATION OF BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 9 1.65e-01 4.49e-01 0.352000 2.66e-01 -2.31e-01 1.68e-01 2.31e-01
GOBP GLYCINE IMPORT ACROSS PLASMA MEMBRANE 5 4.21e-01 7.00e-01 0.352000 2.78e-01 2.15e-01 2.81e-01 4.05e-01
Glucuronidation 24 9.18e-03 7.41e-02 0.352000 1.26e-01 -3.28e-01 2.85e-01 5.37e-03
GOBP CONNECTIVE TISSUE REPLACEMENT 21 1.80e-02 1.18e-01 0.352000 3.45e-01 -6.64e-02 6.15e-03 5.98e-01
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 5 4.15e-01 6.96e-01 0.352000 -1.49e-01 -3.18e-01 5.63e-01 2.18e-01
GOBP FOREBRAIN MORPHOGENESIS 13 7.95e-02 2.99e-01 0.352000 3.32e-01 -1.16e-01 3.83e-02 4.69e-01
GOMF CALMODULIN DEPENDENT PROTEIN PHOSPHATASE ACTIVITY 5 3.86e-01 6.70e-01 0.351000 3.46e-01 -5.72e-02 1.80e-01 8.25e-01
GOBP POSITIVE REGULATION OF HIPPO SIGNALING 11 1.42e-01 4.14e-01 0.351000 3.32e-01 1.14e-01 5.67e-02 5.11e-01
Influenza Infection 149 1.62e-12 1.92e-10 0.351000 -3.28e-02 -3.49e-01 4.90e-01 1.75e-13
GOBP ESTABLISHMENT OF GOLGI LOCALIZATION 8 2.51e-01 5.48e-01 0.351000 2.88e-01 2.00e-01 1.58e-01 3.27e-01
GOBP PHAGOCYTOSIS RECOGNITION 27 5.59e-03 5.11e-02 0.351000 -3.39e-01 9.04e-02 2.30e-03 4.16e-01
GOBP REGULATION OF CAVEOLIN MEDIATED ENDOCYTOSIS 6 3.15e-01 6.08e-01 0.351000 3.38e-01 -9.31e-02 1.51e-01 6.93e-01
GOMF ANKYRIN BINDING 19 3.40e-02 1.79e-01 0.351000 -3.36e-01 -1.00e-01 1.12e-02 4.50e-01
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS 17 4.03e-02 1.98e-01 0.351000 3.47e-01 -4.81e-02 1.32e-02 7.31e-01
GOMF MEMBRANE INSERTASE ACTIVITY 16 4.24e-02 2.05e-01 0.351000 1.90e-01 -2.95e-01 1.88e-01 4.14e-02
GOBP NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM 8 2.51e-01 5.48e-01 0.350000 -1.87e-01 -2.96e-01 3.59e-01 1.47e-01
GOMF ACETYLATION DEPENDENT PROTEIN BINDING 25 1.14e-02 8.67e-02 0.350000 3.41e-01 8.12e-02 3.17e-03 4.82e-01
GOMF LYSOPHOSPHOLIPID ACYLTRANSFERASE ACTIVITY 20 3.09e-02 1.69e-01 0.350000 1.58e-01 3.13e-01 2.22e-01 1.55e-02
GOBP TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS 14 6.92e-02 2.75e-01 0.350000 7.91e-02 -3.41e-01 6.08e-01 2.71e-02
GOBP REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION 10 1.38e-01 4.08e-01 0.350000 2.73e-01 -2.20e-01 1.35e-01 2.29e-01
Phosphorylation of Emi1 6 3.25e-01 6.16e-01 0.350000 -3.48e-01 3.46e-02 1.40e-01 8.83e-01
GOMF L ARGININE TRANSMEMBRANE TRANSPORTER ACTIVITY 12 1.11e-01 3.59e-01 0.350000 3.50e-01 1.19e-02 3.60e-02 9.43e-01
GOMF GAMMA CATENIN BINDING 12 9.58e-02 3.32e-01 0.349000 3.06e-01 -1.69e-01 6.66e-02 3.10e-01
GOMF HISTONE H4 ACETYLTRANSFERASE ACTIVITY 21 1.60e-02 1.10e-01 0.349000 2.80e-01 -2.09e-01 2.64e-02 9.70e-02
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE 20 2.49e-02 1.48e-01 0.349000 3.49e-01 -1.01e-02 6.86e-03 9.38e-01
GOBP AROMATIC AMINO ACID TRANSPORT 10 1.56e-01 4.36e-01 0.349000 3.49e-01 -2.40e-02 5.63e-02 8.95e-01
GOBP MEIOTIC ATTACHMENT OF TELOMERE TO NUCLEAR ENVELOPE 5 4.23e-01 7.02e-01 0.349000 2.97e-01 1.85e-01 2.51e-01 4.75e-01
GOBP NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING 32 2.38e-03 2.69e-02 0.349000 3.43e-01 -6.74e-02 7.95e-04 5.09e-01
GOBP POSITIVE REGULATION OF DNA DAMAGE CHECKPOINT 5 4.25e-01 7.03e-01 0.349000 2.86e-01 2.00e-01 2.68e-01 4.38e-01
GOCC PHOTORECEPTOR DISC MEMBRANE 19 2.37e-02 1.44e-01 0.349000 -2.53e-01 2.41e-01 5.65e-02 6.93e-02
GOBP MAST CELL DIFFERENTIATION 6 3.59e-01 6.47e-01 0.349000 2.03e-01 2.84e-01 3.89e-01 2.29e-01
GOBP SCHWANN CELL DIFFERENTIATION 48 2.56e-04 4.62e-03 0.349000 3.11e-01 1.59e-01 1.97e-04 5.67e-02
GOBP PUTRESCINE BIOSYNTHETIC PROCESS 5 3.77e-01 6.62e-01 0.349000 -2.97e-01 1.82e-01 2.50e-01 4.80e-01
GOBP UV DAMAGE EXCISION REPAIR 12 1.30e-01 3.93e-01 0.349000 2.79e-01 2.09e-01 9.45e-02 2.09e-01
GOBP RESPONSE TO 2 3 7 8 TETRACHLORODIBENZODIOXINE 5 3.96e-01 6.78e-01 0.349000 -3.47e-01 2.84e-02 1.79e-01 9.12e-01
GOBP NEGATIVE REGULATION OF TUBULIN DEACETYLATION 5 3.82e-01 6.67e-01 0.348000 -1.28e-01 3.24e-01 6.21e-01 2.09e-01
Transport of RCbl within the body 8 2.52e-01 5.49e-01 0.348000 3.10e-01 1.60e-01 1.29e-01 4.34e-01
GOCC PINOSOME 9 2.05e-01 5.00e-01 0.348000 3.35e-01 9.42e-02 8.16e-02 6.25e-01
GOCC TORC2 COMPLEX 9 2.16e-01 5.11e-01 0.348000 1.97e-01 2.87e-01 3.07e-01 1.36e-01
GOCC CONE PHOTORECEPTOR OUTER SEGMENT 8 2.12e-01 5.07e-01 0.348000 -1.66e-01 3.06e-01 4.15e-01 1.34e-01
Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) 9 1.96e-01 4.89e-01 0.348000 -1.89e-02 -3.48e-01 9.22e-01 7.10e-02
GOCC INSULIN LIKE GROWTH FACTOR BINDING PROTEIN COMPLEX 5 4.08e-01 6.89e-01 0.348000 3.46e-01 4.11e-02 1.81e-01 8.74e-01
GOMF ADP D RIBOSE MODIFICATION DEPENDENT PROTEIN BINDING 6 3.62e-01 6.50e-01 0.348000 2.36e-01 2.56e-01 3.18e-01 2.77e-01
GOBP PEPTIDYL LYSINE TRIMETHYLATION 9 1.72e-01 4.58e-01 0.348000 2.67e-01 -2.23e-01 1.65e-01 2.47e-01
GOMF NEUROTROPHIN RECEPTOR BINDING 11 1.36e-01 4.05e-01 0.348000 3.47e-01 1.59e-02 4.60e-02 9.27e-01
Mitotic Telophase/Cytokinesis 11 1.30e-01 3.93e-01 0.348000 3.45e-01 -4.52e-02 4.77e-02 7.95e-01
GOBP PROSTATE GLANDULAR ACINUS MORPHOGENESIS 6 3.18e-01 6.10e-01 0.348000 3.25e-01 -1.23e-01 1.68e-01 6.03e-01
GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE CLEARANCE 7 2.98e-01 5.94e-01 0.348000 -1.32e-01 -3.22e-01 5.47e-01 1.41e-01
GOMF TRANSPORTER ACTIVATOR ACTIVITY 8 2.30e-01 5.28e-01 0.348000 1.86e-02 -3.47e-01 9.27e-01 8.92e-02
GOCC INO80 TYPE COMPLEX 27 6.26e-03 5.57e-02 0.347000 3.38e-01 -8.01e-02 2.35e-03 4.71e-01
rRNA processing in the mitochondrion 9 2.04e-01 4.99e-01 0.347000 3.40e-01 7.31e-02 7.77e-02 7.04e-01
GOBP TELOMERIC D LOOP DISASSEMBLY 7 3.07e-01 6.00e-01 0.347000 2.55e-01 2.36e-01 2.43e-01 2.80e-01
SARS-CoV-1 targets host intracellular signalling and regulatory pathways 16 5.03e-02 2.26e-01 0.347000 3.41e-01 -6.68e-02 1.82e-02 6.44e-01
GOBP DNA PROTECTION 5 4.26e-01 7.04e-01 0.347000 -1.67e-01 -3.04e-01 5.17e-01 2.39e-01
GOMF HISTONE H4K20 METHYLTRANSFERASE ACTIVITY 10 1.84e-01 4.75e-01 0.347000 2.81e-01 2.04e-01 1.24e-01 2.64e-01
GOBP CLATHRIN COATED VESICLE CARGO LOADING 7 2.56e-01 5.54e-01 0.347000 2.79e-01 -2.07e-01 2.01e-01 3.43e-01
GOCC WNT SIGNALOSOME 13 1.07e-01 3.53e-01 0.347000 3.19e-01 1.38e-01 4.68e-02 3.89e-01
GOBP COPPER ION IMPORT 6 3.11e-01 6.04e-01 0.347000 -2.21e-01 2.68e-01 3.49e-01 2.56e-01
Complex III assembly 24 1.15e-02 8.67e-02 0.347000 6.21e-02 -3.41e-01 5.98e-01 3.78e-03
GOBP POSITIVE REGULATION OF LEUKOCYTE TETHERING OR ROLLING 13 7.98e-02 2.99e-01 0.347000 -2.58e-01 2.32e-01 1.07e-01 1.48e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H HEME PROTEIN AS ACCEPTOR 10 1.85e-01 4.75e-01 0.347000 1.99e-01 2.84e-01 2.75e-01 1.20e-01
GOCC DYNACTIN COMPLEX 8 2.35e-01 5.32e-01 0.347000 3.47e-01 1.88e-03 8.95e-02 9.93e-01
GOBP VAGINA DEVELOPMENT 10 1.43e-01 4.15e-01 0.347000 2.32e-01 -2.58e-01 2.04e-01 1.58e-01
GOBP CELLULAR RESPONSE TO IRON ION 7 2.82e-01 5.79e-01 0.347000 -2.99e-03 -3.47e-01 9.89e-01 1.12e-01
GOMF ANKYRIN REPEAT BINDING 6 3.22e-01 6.14e-01 0.346000 3.30e-01 -1.05e-01 1.62e-01 6.55e-01
GOBP CELL MIGRATION IN HINDBRAIN 16 5.20e-02 2.31e-01 0.346000 3.42e-01 -5.46e-02 1.79e-02 7.05e-01
Coenzyme A biosynthesis 7 2.58e-01 5.55e-01 0.346000 2.68e-01 -2.19e-01 2.19e-01 3.16e-01
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 9 2.00e-01 4.93e-01 0.346000 -3.45e-01 -2.44e-02 7.28e-02 8.99e-01
GOMF G PROTEIN COUPLED OPIOID RECEPTOR ACTIVITY 7 2.58e-01 5.55e-01 0.346000 -2.59e-01 2.30e-01 2.36e-01 2.92e-01
GOBP INSULIN PROCESSING 8 2.62e-01 5.59e-01 0.346000 -2.49e-01 -2.41e-01 2.23e-01 2.39e-01
GOMF HISTONE METHYLTRANSFERASE ACTIVITY 69 6.26e-06 1.92e-04 0.346000 3.35e-01 8.55e-02 1.47e-06 2.19e-01
GOCC MALE PRONUCLEUS 8 2.49e-01 5.46e-01 0.346000 -8.58e-02 -3.35e-01 6.74e-01 1.01e-01
GOBP ANTRAL OVARIAN FOLLICLE GROWTH 12 1.35e-01 4.02e-01 0.346000 2.41e-01 2.48e-01 1.48e-01 1.37e-01
GOMF SECONDARY ACTIVE SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY 11 1.20e-01 3.77e-01 0.346000 -2.71e-01 2.15e-01 1.20e-01 2.17e-01
Keratinization 209 1.78e-17 4.87e-15 0.346000 -3.37e-01 7.81e-02 4.57e-17 5.17e-02
GOBP BODY MORPHOGENESIS 47 2.50e-04 4.53e-03 0.346000 3.43e-01 4.34e-02 4.77e-05 6.07e-01
GOCC BRAHMA COMPLEX 14 8.78e-02 3.17e-01 0.346000 3.35e-01 8.36e-02 2.99e-02 5.88e-01
GOBP CYTOPLASMIC TRANSLATIONAL ELONGATION 5 3.83e-01 6.67e-01 0.346000 2.91e-01 -1.86e-01 2.60e-01 4.71e-01
GOBP NK T CELL PROLIFERATION 8 2.25e-01 5.21e-01 0.346000 -8.73e-02 3.34e-01 6.69e-01 1.02e-01
GOMF DEHYDROASCORBIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 8 2.47e-01 5.43e-01 0.345000 -3.39e-01 -6.61e-02 9.67e-02 7.46e-01
GOBP REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY 19 3.76e-02 1.91e-01 0.345000 3.31e-01 9.72e-02 1.24e-02 4.63e-01
GOMF INTERLEUKIN 1 RECEPTOR BINDING 17 3.78e-02 1.91e-01 0.345000 -2.16e-01 2.69e-01 1.22e-01 5.46e-02
GOBP RENAL WATER TRANSPORT 9 2.20e-01 5.16e-01 0.345000 2.98e-01 1.75e-01 1.22e-01 3.63e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 BISPHOSPHATE BINDING 26 1.22e-02 9.05e-02 0.345000 3.11e-01 1.49e-01 5.98e-03 1.87e-01
GOMF RRNA BINDING 62 1.55e-05 4.20e-04 0.345000 -1.07e-02 -3.45e-01 8.84e-01 2.57e-06
GOBP INOSITOL METABOLIC PROCESS 8 2.23e-01 5.19e-01 0.345000 3.29e-01 -1.06e-01 1.08e-01 6.02e-01
GOCC SERINE TYPE ENDOPEPTIDASE COMPLEX 11 1.21e-01 3.79e-01 0.345000 -2.79e-01 2.03e-01 1.09e-01 2.44e-01
GOBP VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION 13 1.03e-01 3.46e-01 0.345000 3.39e-01 6.37e-02 3.42e-02 6.91e-01
Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant 7 3.08e-01 6.01e-01 0.345000 1.65e-01 3.03e-01 4.49e-01 1.65e-01
Signaling by NOTCH1 t(7;9)(NOTCH1:M1580 K2555) Translocation Mutant 7 3.08e-01 6.01e-01 0.345000 1.65e-01 3.03e-01 4.49e-01 1.65e-01
Packaging Of Telomere Ends 29 5.26e-03 4.91e-02 0.345000 2.34e-02 -3.44e-01 8.28e-01 1.34e-03
GOBP MARGINAL ZONE B CELL DIFFERENTIATION 8 2.63e-01 5.59e-01 0.345000 1.91e-01 2.87e-01 3.50e-01 1.59e-01
GOBP NEGATIVE REGULATION OF PINOCYTOSIS 5 4.18e-01 6.99e-01 0.345000 3.39e-01 6.44e-02 1.90e-01 8.03e-01
GOBP NERVE GROWTH FACTOR SIGNALING PATHWAY 14 7.13e-02 2.80e-01 0.345000 3.16e-01 -1.37e-01 4.05e-02 3.74e-01
GOBP ACETATE ESTER TRANSPORT 9 2.10e-01 5.05e-01 0.345000 3.36e-01 7.71e-02 8.10e-02 6.89e-01
GOBP CHROMOSOME ATTACHMENT TO THE NUCLEAR ENVELOPE 7 2.86e-01 5.83e-01 0.345000 3.45e-01 5.54e-04 1.14e-01 9.98e-01
GOMF LEUKOTRIENE C4 SYNTHASE ACTIVITY 5 3.88e-01 6.72e-01 0.345000 1.51e-01 -3.10e-01 5.58e-01 2.31e-01
GOBP POSITIVE REGULATION OF DNA LIGATION 5 4.36e-01 7.10e-01 0.344000 2.16e-01 2.69e-01 4.04e-01 2.98e-01
GOBP PEPTIDYL ARGININE METHYLATION TO ASYMMETRICAL DIMETHYL ARGININE 8 2.57e-01 5.54e-01 0.344000 3.21e-01 1.24e-01 1.16e-01 5.43e-01
GOBP MATERNAL PROCESS INVOLVED IN PARTURITION 5 3.84e-01 6.68e-01 0.344000 2.15e-01 -2.69e-01 4.06e-01 2.97e-01
Eicosanoids 12 1.15e-01 3.68e-01 0.344000 1.74e-02 -3.44e-01 9.17e-01 3.91e-02
GOCC SWI SNF SUPERFAMILY TYPE COMPLEX 90 1.42e-07 6.82e-06 0.344000 3.42e-01 3.84e-02 2.01e-08 5.28e-01
GOBP L LEUCINE TRANSPORT 10 1.91e-01 4.83e-01 0.344000 2.62e-01 2.23e-01 1.52e-01 2.21e-01
GOBP CARDIAC MUSCLE MYOBLAST PROLIFERATION 7 2.99e-01 5.94e-01 0.344000 -3.35e-01 -7.93e-02 1.25e-01 7.17e-01
GOBP G0 TO G1 TRANSITION 36 1.64e-03 2.02e-02 0.344000 3.44e-01 -8.12e-05 3.54e-04 9.99e-01
Transport of fatty acids 8 2.28e-01 5.26e-01 0.344000 -8.73e-02 3.33e-01 6.69e-01 1.03e-01
GOMF PHOSPHATIDIC ACID BINDING 23 2.17e-02 1.34e-01 0.344000 2.95e-01 1.76e-01 1.43e-02 1.43e-01
GOBP BERGMANN GLIAL CELL DIFFERENTIATION 11 1.49e-01 4.25e-01 0.344000 3.38e-01 6.34e-02 5.24e-02 7.16e-01
GOMF ADENYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 15 8.11e-02 3.03e-01 0.344000 -1.56e-01 -3.06e-01 2.94e-01 4.01e-02
Synthesis of Leukotrienes (LT) and Eoxins (EX) 20 2.21e-02 1.36e-01 0.344000 2.08e-01 -2.74e-01 1.08e-01 3.41e-02
GOMF TRANSCRIPTION REGULATOR INHIBITOR ACTIVITY 27 5.85e-03 5.32e-02 0.344000 2.73e-01 -2.09e-01 1.41e-02 6.04e-02
GOBP PHOSPHOLIPID DEPHOSPHORYLATION 40 1.33e-03 1.72e-02 0.343000 2.87e-01 1.88e-01 1.65e-03 3.97e-02
GOBP NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY 15 5.89e-02 2.49e-01 0.343000 3.00e-01 -1.67e-01 4.43e-02 2.62e-01
GOBP DISTAL CONVOLUTED TUBULE DEVELOPMENT 5 4.22e-01 7.01e-01 0.343000 3.36e-01 7.23e-02 1.94e-01 7.79e-01
GOBP RENAL PROTEIN ABSORPTION 9 2.19e-01 5.14e-01 0.343000 1.23e-01 3.21e-01 5.22e-01 9.59e-02
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR 16 5.88e-02 2.49e-01 0.343000 -6.45e-03 -3.43e-01 9.64e-01 1.74e-02
Signaling by KIT in disease 20 2.44e-02 1.47e-01 0.343000 3.24e-01 -1.13e-01 1.21e-02 3.83e-01
Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants 20 2.44e-02 1.47e-01 0.343000 3.24e-01 -1.13e-01 1.21e-02 3.83e-01
GOBP MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION 17 4.53e-02 2.13e-01 0.343000 3.37e-01 -6.25e-02 1.60e-02 6.56e-01
GOMF BETA 2 MICROGLOBULIN BINDING 9 1.85e-01 4.75e-01 0.343000 1.50e-01 -3.09e-01 4.37e-01 1.09e-01
GOBP NEGATIVE REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE 5 4.36e-01 7.10e-01 0.343000 1.76e-01 2.94e-01 4.95e-01 2.54e-01
GOBP POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE 18 5.08e-02 2.27e-01 0.343000 -1.81e-01 -2.91e-01 1.84e-01 3.24e-02
GOBP RAB PROTEIN SIGNAL TRANSDUCTION 17 6.12e-02 2.55e-01 0.343000 2.24e-01 2.60e-01 1.11e-01 6.35e-02
Signaling by TGFBR3 48 2.38e-04 4.34e-03 0.343000 3.40e-01 3.95e-02 4.47e-05 6.36e-01
GOBP CARBOHYDRATE PHOSPHORYLATION 22 2.52e-02 1.49e-01 0.343000 1.39e-01 3.13e-01 2.59e-01 1.10e-02
GOBP NEGATIVE REGULATION OF GLYCOGEN METABOLIC PROCESS 10 1.91e-01 4.83e-01 0.343000 2.91e-01 1.81e-01 1.11e-01 3.21e-01
GOMF TELOMERIC DNA BINDING 38 7.79e-04 1.13e-02 0.343000 2.91e-01 -1.80e-01 1.88e-03 5.44e-02
GOBP DEFENSE RESPONSE TO FUNGUS 50 1.83e-04 3.51e-03 0.343000 -3.37e-01 -6.01e-02 3.70e-05 4.62e-01
P2Y receptors 9 1.87e-01 4.77e-01 0.342000 -3.11e-01 1.43e-01 1.06e-01 4.56e-01
GOBP MONOTERPENOID METABOLIC PROCESS 6 3.21e-01 6.12e-01 0.342000 -2.14e-01 2.67e-01 3.65e-01 2.57e-01
GOCC POSTSYNAPTIC CYTOSKELETON 13 1.02e-01 3.43e-01 0.342000 3.42e-01 1.23e-02 3.27e-02 9.39e-01
Activation of the TFAP2 (AP-2) family of transcription factors 11 1.39e-01 4.09e-01 0.342000 3.40e-01 -3.94e-02 5.09e-02 8.21e-01
GOMF HISTONE H4K5 ACETYLTRANSFERASE ACTIVITY 11 1.46e-01 4.21e-01 0.342000 3.42e-01 1.94e-02 4.98e-02 9.11e-01
SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion 13 1.19e-01 3.75e-01 0.342000 2.70e-01 2.11e-01 9.24e-02 1.89e-01
GOBP MITOTIC SISTER CHROMATID COHESION 26 8.24e-03 6.86e-02 0.342000 3.22e-01 -1.17e-01 4.54e-03 3.03e-01
GOBP HINDLIMB MORPHOGENESIS 35 2.61e-03 2.90e-02 0.342000 3.31e-01 8.57e-02 6.97e-04 3.80e-01
GOBP GLYCOSYLCERAMIDE METABOLIC PROCESS 20 3.63e-02 1.87e-01 0.342000 1.56e-01 3.05e-01 2.28e-01 1.83e-02
RHOBTB1 GTPase cycle 22 2.41e-02 1.46e-01 0.342000 3.28e-01 9.62e-02 7.70e-03 4.35e-01
GOBP NAD TRANSPORT 5 4.07e-01 6.89e-01 0.342000 -3.39e-01 4.88e-02 1.90e-01 8.50e-01
GOBP REGULATION OF PROTEIN NEDDYLATION 19 2.79e-02 1.59e-01 0.342000 2.78e-01 -1.99e-01 3.57e-02 1.34e-01
GOBP GOLGI VESICLE BUDDING 10 1.80e-01 4.69e-01 0.342000 3.36e-01 6.43e-02 6.60e-02 7.25e-01
GOBP ACTIN POLYMERIZATION DEPENDENT CELL MOTILITY 7 2.74e-01 5.71e-01 0.342000 1.28e-01 -3.17e-01 5.57e-01 1.47e-01
Phase 1 - inactivation of fast Na+ channels 6 3.34e-01 6.24e-01 0.342000 -3.29e-01 9.20e-02 1.63e-01 6.96e-01
GOBP CYTOLYSIS 7 3.18e-01 6.11e-01 0.342000 2.67e-01 2.13e-01 2.21e-01 3.28e-01
GOBP HYPOTHALAMUS DEVELOPMENT 26 8.64e-03 7.10e-02 0.342000 3.28e-01 -9.43e-02 3.74e-03 4.05e-01
Defective pyroptosis 34 1.82e-03 2.19e-02 0.342000 1.42e-01 -3.11e-01 1.52e-01 1.72e-03
GOBP G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY 15 6.30e-02 2.60e-01 0.342000 -3.20e-01 1.19e-01 3.18e-02 4.24e-01
GOMF TRNA CYTIDINE METHYLTRANSFERASE ACTIVITY 9 1.92e-01 4.83e-01 0.342000 3.24e-01 -1.07e-01 9.19e-02 5.79e-01
GOBP PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION 38 8.53e-04 1.21e-02 0.341000 1.54e-01 -3.05e-01 9.94e-02 1.16e-03
GOBP NEGATIVE REGULATION OF B CELL DIFFERENTIATION 6 3.73e-01 6.59e-01 0.341000 -2.90e-01 -1.80e-01 2.19e-01 4.44e-01
GOMF RAGE RECEPTOR BINDING 10 1.95e-01 4.88e-01 0.341000 -2.75e-01 -2.02e-01 1.32e-01 2.68e-01
GOBP SUPPRESSION OF VIRAL RELEASE BY HOST 15 7.80e-02 2.95e-01 0.341000 3.33e-01 7.64e-02 2.56e-02 6.08e-01
Presynaptic nicotinic acetylcholine receptors 12 1.42e-01 4.13e-01 0.341000 -2.50e-01 -2.33e-01 1.34e-01 1.63e-01
Signaling by FLT3 ITD and TKD mutants 16 4.90e-02 2.23e-01 0.341000 2.47e-01 -2.36e-01 8.77e-02 1.02e-01
GOBP RESPONSE TO BACTERIAL LIPOPROTEIN 10 1.96e-01 4.89e-01 0.341000 -2.54e-01 -2.28e-01 1.64e-01 2.13e-01
GOBP VENTRAL SPINAL CORD DEVELOPMENT 45 3.64e-04 6.09e-03 0.341000 3.41e-01 -1.14e-02 7.60e-05 8.94e-01
GOCC B CELL RECEPTOR COMPLEX 5 4.02e-01 6.84e-01 0.341000 9.66e-02 -3.27e-01 7.08e-01 2.05e-01
Paracetamol ADME 26 1.43e-02 1.02e-01 0.341000 1.85e-01 2.87e-01 1.03e-01 1.14e-02
GOBP REGULATION OF PENTOSE PHOSPHATE SHUNT 6 3.77e-01 6.63e-01 0.341000 2.45e-01 2.37e-01 2.98e-01 3.15e-01
GOBP PRONEPHROS DEVELOPMENT 9 1.92e-01 4.84e-01 0.341000 3.21e-01 -1.15e-01 9.56e-02 5.50e-01
GOBP NEGATIVE REGULATION OF HYPOXIA INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 6 3.25e-01 6.16e-01 0.341000 2.00e-01 -2.76e-01 3.97e-01 2.41e-01
GOCC CORE MEDIATOR COMPLEX 25 9.39e-03 7.52e-02 0.341000 1.86e-01 -2.85e-01 1.07e-01 1.35e-02
SMAC (DIABLO) binds to IAPs 6 3.28e-01 6.19e-01 0.341000 1.62e-01 -3.00e-01 4.92e-01 2.04e-01
SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes 6 3.28e-01 6.19e-01 0.341000 1.62e-01 -3.00e-01 4.92e-01 2.04e-01
SMAC, XIAP-regulated apoptotic response 6 3.28e-01 6.19e-01 0.341000 1.62e-01 -3.00e-01 4.92e-01 2.04e-01
GOCC CYTOLYTIC GRANULE 14 1.01e-01 3.42e-01 0.341000 -1.80e-01 -2.90e-01 2.45e-01 6.07e-02
Gain-of-function MRAS complexes activate RAF signaling 7 2.72e-01 5.69e-01 0.341000 2.96e-01 -1.69e-01 1.75e-01 4.40e-01
SHOC2 M1731 mutant abolishes MRAS complex function 7 2.72e-01 5.69e-01 0.341000 2.96e-01 -1.69e-01 1.75e-01 4.40e-01
Signaling by MRAS-complex mutants 7 2.72e-01 5.69e-01 0.341000 2.96e-01 -1.69e-01 1.75e-01 4.40e-01
GOBP POSITIVE REGULATION OF MAST CELL CHEMOTAXIS 5 4.26e-01 7.04e-01 0.341000 6.01e-02 3.35e-01 8.16e-01 1.94e-01
GOBP LOBAR BRONCHUS EPITHELIUM DEVELOPMENT 5 4.41e-01 7.13e-01 0.341000 -1.71e-01 -2.94e-01 5.07e-01 2.54e-01
GOMF K63 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING 24 1.97e-02 1.25e-01 0.341000 2.94e-01 1.71e-01 1.25e-02 1.46e-01
GOMF EXTRACELLULAR MATRIX CONSTITUENT CONFERRING ELASTICITY 10 1.72e-01 4.58e-01 0.341000 3.40e-01 -1.89e-02 6.26e-02 9.18e-01
GOBP RANDOM INACTIVATION OF X CHROMOSOME 6 3.41e-01 6.31e-01 0.340000 3.34e-01 -6.57e-02 1.57e-01 7.80e-01
GOBP TELOMERE TETHERING AT NUCLEAR PERIPHERY 6 3.69e-01 6.57e-01 0.340000 3.17e-01 1.22e-01 1.78e-01 6.03e-01
GOBP NEGATIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION 5 4.21e-01 7.00e-01 0.340000 3.40e-01 1.66e-02 1.88e-01 9.49e-01
GOMF TRANSLATION INITIATION FACTOR ACTIVITY 44 3.73e-04 6.21e-03 0.340000 7.39e-02 -3.32e-01 3.96e-01 1.40e-04
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE III PROMOTER 8 2.32e-01 5.30e-01 0.340000 3.18e-01 -1.19e-01 1.19e-01 5.60e-01
GOBP NUCLEAR PORE COMPLEX ASSEMBLY 11 1.33e-01 4.00e-01 0.340000 3.14e-01 -1.30e-01 7.14e-02 4.55e-01
GOBP MINERALOCORTICOID BIOSYNTHETIC PROCESS 12 1.09e-01 3.57e-01 0.340000 -3.01e-01 1.58e-01 7.12e-02 3.44e-01
GOBP DRINKING BEHAVIOR 9 2.08e-01 5.03e-01 0.340000 3.40e-01 -7.03e-03 7.77e-02 9.71e-01
GOMF 3 HYDROXYACYL COA DEHYDRATASE ACTIVITY 7 2.78e-01 5.76e-01 0.340000 1.25e-01 -3.16e-01 5.67e-01 1.48e-01
GOBP RESPONSE TO L ASCORBIC ACID 5 4.41e-01 7.13e-01 0.340000 -1.50e-01 -3.05e-01 5.61e-01 2.38e-01
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING 15 7.32e-02 2.85e-01 0.340000 3.39e-01 -7.26e-03 2.28e-02 9.61e-01
GOBP SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION 10 1.64e-01 4.48e-01 0.339000 3.23e-01 -1.03e-01 7.65e-02 5.73e-01
Specification of primordial germ cells 11 1.37e-01 4.06e-01 0.339000 3.26e-01 -9.62e-02 6.15e-02 5.81e-01
GOBP NEGATIVE REGULATION OF NEURON DIFFERENTIATION 71 2.31e-06 7.86e-05 0.339000 3.09e-01 -1.41e-01 6.73e-06 4.06e-02
GOBP VENOUS BLOOD VESSEL DEVELOPMENT 16 7.22e-02 2.82e-01 0.339000 3.11e-01 1.35e-01 3.11e-02 3.48e-01
GOMF D LOOP DNA BINDING 5 4.47e-01 7.17e-01 0.339000 2.48e-01 2.31e-01 3.36e-01 3.70e-01
GOBP NEGATIVE REGULATION OF METALLOPEPTIDASE ACTIVITY 8 2.47e-01 5.44e-01 0.339000 3.39e-01 -1.47e-02 9.69e-02 9.43e-01
GOCC CLATHRIN ADAPTOR COMPLEX 26 1.23e-02 9.10e-02 0.339000 3.34e-01 5.72e-02 3.17e-03 6.13e-01
GOBP FACE MORPHOGENESIS 31 4.75e-03 4.56e-02 0.339000 3.39e-01 8.45e-03 1.09e-03 9.35e-01
GOMF L LACTATE DEHYDROGENASE ACTIVITY 5 4.02e-01 6.85e-01 0.339000 1.25e-01 -3.15e-01 6.27e-01 2.22e-01
SUMOylation of transcription cofactors 44 5.82e-04 8.94e-03 0.339000 3.35e-01 4.81e-02 1.18e-04 5.81e-01
Creatine metabolism 8 2.54e-01 5.51e-01 0.339000 3.38e-01 2.28e-02 9.78e-02 9.11e-01
PRC2 methylates histones and DNA 35 1.62e-03 2.00e-02 0.339000 1.65e-01 -2.96e-01 9.07e-02 2.46e-03
GOBP REGULATION OF CENTRIOLE REPLICATION 22 2.51e-02 1.49e-01 0.339000 -7.49e-02 -3.30e-01 5.43e-01 7.30e-03
GOMF PROMOTER ENHANCER LOOP ANCHORING ACTIVITY 6 3.54e-01 6.44e-01 0.339000 3.39e-01 2.49e-03 1.51e-01 9.92e-01
GOMF DESUMOYLASE ACTIVITY 7 3.01e-01 5.96e-01 0.339000 -1.81e-02 -3.38e-01 9.34e-01 1.21e-01
GOBP TYPE II PNEUMOCYTE DIFFERENTIATION 6 3.35e-01 6.25e-01 0.339000 3.12e-01 -1.33e-01 1.86e-01 5.73e-01
GOBP REGULATION OF KIDNEY SIZE 5 3.96e-01 6.78e-01 0.339000 2.20e-01 -2.57e-01 3.93e-01 3.20e-01
GOBP NEGATIVE REGULATION OF MIRNA PROCESSING 9 1.89e-01 4.80e-01 0.339000 2.52e-01 -2.26e-01 1.90e-01 2.41e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE BINDING 27 1.06e-02 8.22e-02 0.338000 3.34e-01 5.52e-02 2.67e-03 6.19e-01
GOBP REGULATION OF PROTEIN AUTOUBIQUITINATION 5 4.49e-01 7.19e-01 0.338000 2.59e-01 2.18e-01 3.15e-01 4.00e-01
GOMF C2H2 ZINC FINGER DOMAIN BINDING 12 1.32e-01 3.96e-01 0.338000 3.35e-01 5.06e-02 4.47e-02 7.61e-01
GOCC MESSENGER RIBONUCLEOPROTEIN COMPLEX 6 3.31e-01 6.22e-01 0.338000 2.80e-01 -1.90e-01 2.35e-01 4.19e-01
GOBP INTERMEDIATE FILAMENT BUNDLE ASSEMBLY 8 2.62e-01 5.59e-01 0.338000 3.31e-01 7.11e-02 1.05e-01 7.28e-01
GOCC ENDOLYSOSOME MEMBRANE 17 5.85e-02 2.48e-01 0.338000 3.30e-01 7.40e-02 1.85e-02 5.97e-01
GOCC SUMO LIGASE COMPLEX 13 9.64e-02 3.33e-01 0.338000 3.21e-01 -1.07e-01 4.53e-02 5.03e-01
GOBP TRANSCRIPTION ELONGATION BY RNA POLYMERASE I 7 3.20e-01 6.11e-01 0.338000 -1.45e-01 -3.06e-01 5.08e-01 1.61e-01
Nef Mediated CD4 Down-regulation 9 2.34e-01 5.31e-01 0.338000 2.92e-01 1.70e-01 1.29e-01 3.77e-01
GOBP QUINONE METABOLIC PROCESS 23 1.48e-02 1.04e-01 0.338000 2.92e-01 -1.71e-01 1.55e-02 1.56e-01
GOMF HISTONE H4K16 ACETYLTRANSFERASE ACTIVITY 8 2.43e-01 5.39e-01 0.338000 3.32e-01 -6.48e-02 1.04e-01 7.51e-01
Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 14 7.61e-02 2.91e-01 0.338000 2.75e-01 -1.96e-01 7.50e-02 2.03e-01
GOBP L LYSINE TRANSMEMBRANE TRANSPORT 7 3.17e-01 6.10e-01 0.338000 3.18e-01 1.14e-01 1.45e-01 6.03e-01
GOMF L LYSINE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 3.17e-01 6.10e-01 0.338000 3.18e-01 1.14e-01 1.45e-01 6.03e-01
GOBP REGULATION OF FAT CELL PROLIFERATION 10 2.02e-01 4.96e-01 0.338000 2.08e-01 2.66e-01 2.55e-01 1.45e-01
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL OUTER MEMBRANE 15 9.04e-02 3.22e-01 0.338000 -1.90e-01 -2.79e-01 2.02e-01 6.11e-02
GOMF TELOMERASE RNA BINDING 21 2.25e-02 1.38e-01 0.338000 3.14e-01 -1.26e-01 1.29e-02 3.19e-01
GOBP PIRNA MEDIATED RETROTRANSPOSON SILENCING BY HETEROCHROMATIN FORMATION 5 4.19e-01 6.99e-01 0.338000 -3.37e-01 2.82e-02 1.92e-01 9.13e-01
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING TENSILE STRENGTH 42 5.00e-04 7.87e-03 0.338000 -3.08e-01 1.38e-01 5.44e-04 1.23e-01
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT MODIFYING ACTIVITY 17 6.26e-02 2.59e-01 0.338000 3.13e-01 1.26e-01 2.54e-02 3.68e-01
GOMF HETEROTRIMERIC G PROTEIN BINDING 5 4.51e-01 7.20e-01 0.338000 -2.29e-01 -2.48e-01 3.75e-01 3.38e-01
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I 10 1.75e-01 4.61e-01 0.337000 3.36e-01 -3.51e-02 6.61e-02 8.48e-01
GOBP PARAXIAL MESODERM FORMATION 7 2.85e-01 5.82e-01 0.337000 1.15e-01 -3.17e-01 5.99e-01 1.46e-01
FGFR3b ligand binding and activation 7 3.22e-01 6.14e-01 0.337000 1.45e-01 3.05e-01 5.08e-01 1.63e-01
GOBP RETINOIC ACID RECEPTOR SIGNALING PATHWAY 32 5.02e-03 4.75e-02 0.337000 3.28e-01 7.97e-02 1.34e-03 4.35e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 46 6.08e-04 9.27e-03 0.337000 3.01e-01 1.51e-01 4.07e-04 7.60e-02
SHC-mediated cascade:FGFR1 21 3.45e-02 1.81e-01 0.337000 2.92e-01 1.69e-01 2.06e-02 1.81e-01
GOBP EMBRYONIC HEART TUBE LEFT RIGHT PATTERN FORMATION 6 3.83e-01 6.67e-01 0.337000 2.88e-01 1.75e-01 2.22e-01 4.57e-01
WNT5A-dependent internalization of FZD4 15 7.86e-02 2.97e-01 0.337000 3.36e-01 1.92e-02 2.41e-02 8.98e-01
GOCC SET1C COMPASS COMPLEX 14 1.02e-01 3.44e-01 0.337000 3.16e-01 1.16e-01 4.05e-02 4.53e-01
GOBP ENDODERMAL CELL FATE COMMITMENT 15 7.37e-02 2.86e-01 0.337000 3.34e-01 -4.01e-02 2.49e-02 7.88e-01
GOBP CARDIAC ATRIUM DEVELOPMENT 37 1.63e-03 2.01e-02 0.337000 3.35e-01 -3.82e-02 4.29e-04 6.87e-01
GOMF ENONE REDUCTASE ACTIVITY 5 4.20e-01 6.99e-01 0.337000 -3.34e-01 3.83e-02 1.95e-01 8.82e-01
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 7 2.78e-01 5.75e-01 0.336000 2.15e-01 -2.59e-01 3.25e-01 2.36e-01
GOBP OBSERVATIONAL LEARNING 7 2.93e-01 5.90e-01 0.336000 -6.62e-02 3.30e-01 7.62e-01 1.31e-01
GOBP NEGATIVE REGULATION OF MUSCLE ORGAN DEVELOPMENT 9 2.12e-01 5.07e-01 0.336000 3.36e-01 -2.34e-02 8.13e-02 9.03e-01
GOBP UBIQUINONE METABOLIC PROCESS 18 3.76e-02 1.91e-01 0.336000 2.74e-01 -1.95e-01 4.40e-02 1.53e-01
GOMF HISTONE H4K20 MONOMETHYLTRANSFERASE ACTIVITY 6 3.64e-01 6.51e-01 0.336000 3.35e-01 2.44e-02 1.55e-01 9.18e-01
CREB3 factors activate genes 8 2.39e-01 5.35e-01 0.336000 1.27e-01 -3.11e-01 5.33e-01 1.28e-01
GOBP NEGATIVE REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE 5 4.01e-01 6.83e-01 0.336000 2.24e-01 -2.50e-01 3.85e-01 3.32e-01
RHOT2 GTPase cycle 7 2.79e-01 5.76e-01 0.336000 2.59e-01 -2.14e-01 2.35e-01 3.27e-01
GOCC PARANODAL JUNCTION 8 2.61e-01 5.58e-01 0.336000 3.27e-02 3.34e-01 8.73e-01 1.02e-01
GOBP VIRAL TRANSLATIONAL TERMINATION REINITIATION 5 4.05e-01 6.88e-01 0.336000 1.60e-01 -2.95e-01 5.35e-01 2.53e-01
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING 8 2.81e-01 5.78e-01 0.336000 1.75e-01 2.86e-01 3.91e-01 1.61e-01
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL REPOLARIZATION 14 9.72e-02 3.35e-01 0.336000 4.56e-02 3.33e-01 7.68e-01 3.12e-02
GOCC DNA DEPENDENT PROTEIN KINASE DNA LIGASE 4 COMPLEX 7 3.28e-01 6.19e-01 0.336000 2.93e-01 1.64e-01 1.79e-01 4.54e-01
GOBP ALPHA LINOLENIC ACID METABOLIC PROCESS 9 2.42e-01 5.39e-01 0.336000 2.59e-01 2.13e-01 1.78e-01 2.69e-01
GOBP REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH 12 1.51e-01 4.30e-01 0.335000 2.16e-01 2.57e-01 1.96e-01 1.23e-01
GOBP FOLATE TRANSMEMBRANE TRANSPORT 5 4.40e-01 7.13e-01 0.335000 7.55e-02 3.27e-01 7.70e-01 2.06e-01
GOBP PODOSOME ASSEMBLY 21 3.12e-02 1.70e-01 0.335000 5.93e-02 3.30e-01 6.38e-01 8.84e-03
GOBP PROTEIN INSERTION INTO ER MEMBRANE BY STOP TRANSFER MEMBRANE ANCHOR SEQUENCE 10 1.62e-01 4.46e-01 0.335000 2.32e-01 -2.42e-01 2.04e-01 1.85e-01
Negative feedback regulation of MAPK pathway 6 3.78e-01 6.64e-01 0.335000 3.19e-01 1.02e-01 1.76e-01 6.65e-01
GOBP DTTP METABOLIC PROCESS 5 4.20e-01 6.99e-01 0.335000 -3.30e-01 5.59e-02 2.01e-01 8.29e-01
DNA methylation 28 7.79e-03 6.58e-02 0.335000 5.82e-02 -3.30e-01 5.94e-01 2.50e-03
GOMF ATP DEPENDENT PROTEIN FOLDING CHAPERONE 35 3.07e-03 3.26e-02 0.335000 -5.06e-02 -3.31e-01 6.04e-01 6.96e-04
GOCC VCP NPL4 UFD1 AAA ATPASE COMPLEX 8 2.45e-01 5.41e-01 0.335000 3.21e-01 -9.50e-02 1.16e-01 6.42e-01
Phase 3 - rapid repolarisation 8 2.58e-01 5.55e-01 0.335000 -4.48e-03 3.35e-01 9.82e-01 1.01e-01
GOMF ADENOSINE 3 5 BISPHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 4.50e-01 7.19e-01 0.335000 -1.35e-01 -3.06e-01 6.00e-01 2.36e-01
GOBP CELL PROLIFERATION IN FOREBRAIN 26 1.03e-02 8.07e-02 0.335000 3.19e-01 -1.01e-01 4.84e-03 3.74e-01
Beta-catenin phosphorylation cascade 16 6.99e-02 2.77e-01 0.334000 3.33e-01 3.11e-02 2.11e-02 8.29e-01
GOBP NEGATIVE REGULATION OF ANOIKIS 18 3.91e-02 1.95e-01 0.334000 2.75e-01 -1.90e-01 4.31e-02 1.63e-01
GOCC SMOOTH ENDOPLASMIC RETICULUM MEMBRANE 7 3.28e-01 6.19e-01 0.334000 -1.43e-01 -3.02e-01 5.12e-01 1.66e-01
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS III 8 2.40e-01 5.36e-01 0.334000 2.98e-01 -1.52e-01 1.45e-01 4.55e-01
GOBP MITOCHONDRION ENDOPLASMIC RETICULUM MEMBRANE TETHERING 7 3.19e-01 6.11e-01 0.334000 3.27e-01 7.10e-02 1.34e-01 7.45e-01
GOBP CGMP CATABOLIC PROCESS 5 4.26e-01 7.04e-01 0.334000 -3.33e-01 2.86e-02 1.97e-01 9.12e-01
GOBP REGULATION OF GASTRIC ACID SECRETION 6 3.84e-01 6.69e-01 0.334000 1.34e-01 3.06e-01 5.70e-01 1.94e-01
GOBP BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY 6 3.87e-01 6.71e-01 0.334000 2.96e-01 1.56e-01 2.10e-01 5.09e-01
GOBP RIBOSOMAL SMALL SUBUNIT EXPORT FROM NUCLEUS 8 2.56e-01 5.53e-01 0.334000 2.80e-02 -3.33e-01 8.91e-01 1.03e-01
GOBP POSITIVE REGULATION OF MEMBRANE DEPOLARIZATION 11 1.41e-01 4.12e-01 0.334000 2.99e-01 -1.50e-01 8.63e-02 3.90e-01
GOMF DEATH DOMAIN BINDING 11 1.39e-01 4.09e-01 0.334000 1.79e-01 -2.82e-01 3.04e-01 1.05e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS 11 1.47e-01 4.22e-01 0.334000 3.21e-01 -9.07e-02 6.49e-02 6.03e-01
GOCC DENSE CORE GRANULE MEMBRANE 7 3.03e-01 5.97e-01 0.334000 -3.41e-02 3.32e-01 8.76e-01 1.28e-01
GOBP REGULATION OF MITOCHONDRIAL MRNA STABILITY 7 3.23e-01 6.15e-01 0.334000 -9.61e-02 -3.20e-01 6.60e-01 1.43e-01
GOBP REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS 17 5.99e-02 2.52e-01 0.334000 3.32e-01 3.29e-02 1.77e-02 8.14e-01
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 10 1.66e-01 4.50e-01 0.334000 2.62e-01 -2.07e-01 1.52e-01 2.57e-01
GOBP CD40 SIGNALING PATHWAY 15 6.79e-02 2.72e-01 0.334000 2.72e-01 -1.94e-01 6.86e-02 1.94e-01
GOBP FACULTATIVE HETEROCHROMATIN FORMATION 40 1.05e-03 1.43e-02 0.333000 3.29e-01 -5.60e-02 3.20e-04 5.40e-01
GOBP MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL 16 6.59e-02 2.68e-01 0.333000 -3.28e-02 3.32e-01 8.20e-01 2.16e-02
GOBP ENDOSOMAL LUMEN ACIDIFICATION 12 1.42e-01 4.14e-01 0.333000 -7.15e-02 -3.26e-01 6.68e-01 5.08e-02
GOBP RETINAL METABOLIC PROCESS 18 4.18e-02 2.03e-01 0.333000 1.32e-01 -3.06e-01 3.33e-01 2.45e-02
GOBP PROTEIN DENEDDYLATION 11 1.38e-01 4.08e-01 0.333000 2.39e-01 -2.32e-01 1.69e-01 1.83e-01
GOMF SULFATE TRANSMEMBRANE TRANSPORTER ACTIVITY 16 6.42e-02 2.63e-01 0.333000 -3.28e-01 5.76e-02 2.30e-02 6.90e-01
GOBP VESICLE FUSION WITH GOLGI APPARATUS 9 2.40e-01 5.36e-01 0.333000 -1.30e-01 -3.07e-01 5.00e-01 1.11e-01
GOBP ENDOCARDIAL CUSHION FUSION 5 4.45e-01 7.17e-01 0.333000 3.24e-01 7.66e-02 2.09e-01 7.67e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR PRODUCTION 6 3.84e-01 6.69e-01 0.333000 -1.16e-01 -3.12e-01 6.21e-01 1.85e-01
Notch-HLH transcription pathway 24 2.07e-02 1.29e-01 0.333000 3.24e-01 7.84e-02 6.03e-03 5.06e-01
GOBP NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY 15 7.97e-02 2.99e-01 0.333000 3.33e-01 -1.87e-02 2.57e-02 9.00e-01
Regulation of CDH11 Expression and Function 29 9.45e-03 7.55e-02 0.333000 3.21e-01 8.98e-02 2.79e-03 4.02e-01
Mitochondrial translation initiation 87 5.52e-07 2.30e-05 0.333000 -1.46e-02 -3.33e-01 8.14e-01 8.04e-08
GOBP MAINTENANCE OF PRESYNAPTIC ACTIVE ZONE STRUCTURE 5 4.26e-01 7.04e-01 0.333000 -3.29e-01 4.80e-02 2.02e-01 8.52e-01
GOBP CELLULAR RESPONSE TO SALT 6 3.48e-01 6.38e-01 0.333000 1.31e-01 -3.06e-01 5.77e-01 1.95e-01
GOBP TELOMERE MAINTENANCE VIA RECOMBINATION 14 8.93e-02 3.20e-01 0.333000 3.24e-01 -7.76e-02 3.60e-02 6.15e-01
GOMF NAD P H OXIDASE H2O2 FORMING ACTIVITY 8 2.89e-01 5.86e-01 0.333000 2.01e-01 2.65e-01 3.25e-01 1.94e-01
GOBP NEGATIVE REGULATION OF CELL FATE COMMITMENT 10 2.09e-01 5.04e-01 0.333000 2.89e-01 1.65e-01 1.13e-01 3.67e-01
GOBP DNA TEMPLATED TRANSCRIPTION TERMINATION 24 1.43e-02 1.02e-01 0.333000 2.93e-01 -1.59e-01 1.31e-02 1.79e-01
GOCC RIBONUCLEASE P COMPLEX 13 1.02e-01 3.43e-01 0.333000 1.27e-01 -3.07e-01 4.27e-01 5.49e-02
GOBP HEME A METABOLIC PROCESS 10 1.70e-01 4.55e-01 0.333000 1.66e-01 -2.88e-01 3.63e-01 1.14e-01
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY 9 2.26e-01 5.23e-01 0.332000 -1.87e-02 -3.32e-01 9.22e-01 8.46e-02
GOBP REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY 7 3.13e-01 6.07e-01 0.332000 3.32e-01 9.73e-03 1.28e-01 9.64e-01
GOBP RESPONSE TO CYCLOHEXIMIDE 5 4.53e-01 7.21e-01 0.332000 -1.20e-01 -3.10e-01 6.42e-01 2.30e-01
LTC4-CYSLTR mediated IL4 production 5 4.39e-01 7.13e-01 0.332000 2.88e-02 3.31e-01 9.11e-01 2.00e-01
GOBP SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE 20 3.89e-02 1.94e-01 0.332000 3.28e-01 5.61e-02 1.12e-02 6.64e-01
GOMF PHOSPHOSERINE RESIDUE BINDING 10 1.82e-01 4.71e-01 0.332000 5.83e-02 -3.27e-01 7.50e-01 7.33e-02
GOCC DOPAMINERGIC SYNAPSE 15 8.64e-02 3.14e-01 0.332000 -3.30e-01 -4.10e-02 2.71e-02 7.83e-01
Digestion of dietary lipid 7 2.95e-01 5.92e-01 0.332000 -3.10e-01 1.20e-01 1.56e-01 5.83e-01
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 10 2.14e-01 5.09e-01 0.332000 -2.11e-01 -2.56e-01 2.48e-01 1.60e-01
GOBP POSITIVE REGULATION OF CELLULAR SENESCENCE 17 5.69e-02 2.44e-01 0.332000 3.64e-02 -3.30e-01 7.95e-01 1.85e-02
Scavenging by Class B Receptors 6 3.60e-01 6.49e-01 0.332000 -3.27e-01 5.67e-02 1.65e-01 8.10e-01
SARS-CoV-2 modulates autophagy 11 1.55e-01 4.36e-01 0.332000 3.28e-01 -4.81e-02 5.94e-02 7.82e-01
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 33 2.95e-03 3.18e-02 0.332000 1.71e-01 -2.84e-01 8.85e-02 4.74e-03
GOBP TONGUE DEVELOPMENT 21 2.61e-02 1.53e-01 0.332000 3.11e-01 -1.16e-01 1.37e-02 3.57e-01
GOBP PEPTIDYL SERINE AUTOPHOSPHORYLATION 8 2.75e-01 5.72e-01 0.332000 3.26e-01 6.23e-02 1.11e-01 7.60e-01
GOMF UBIQUITIN LIKE PROTEIN SPECIFIC ENDOPEPTIDASE ACTIVITY 5 4.18e-01 6.99e-01 0.332000 3.06e-01 -1.27e-01 2.36e-01 6.23e-01
GOBP N GLYCAN PROCESSING 17 6.74e-02 2.71e-01 0.332000 3.16e-01 9.95e-02 2.40e-02 4.78e-01
Interleukin-2 signaling 11 1.48e-01 4.24e-01 0.331000 1.21e-01 -3.08e-01 4.86e-01 7.67e-02
GOMF 2 ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY 6 3.60e-01 6.48e-01 0.331000 -7.22e-02 3.23e-01 7.60e-01 1.70e-01
GOBP REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL 12 1.57e-01 4.38e-01 0.331000 -1.72e-01 -2.83e-01 3.02e-01 9.00e-02
GOBP SEROTONIN RECEPTOR SIGNALING PATHWAY 8 2.43e-01 5.39e-01 0.331000 -2.45e-01 2.23e-01 2.31e-01 2.76e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL 10 2.00e-01 4.93e-01 0.331000 5.26e-02 3.27e-01 7.73e-01 7.37e-02
Interaction With Cumulus Cells And The Zona Pellucida 11 1.86e-01 4.77e-01 0.331000 -2.27e-01 -2.41e-01 1.93e-01 1.67e-01
Gamma-carboxylation of protein precursors 8 2.72e-01 5.69e-01 0.331000 2.67e-02 3.30e-01 8.96e-01 1.06e-01
GOMF HISTAMINE RECEPTOR ACTIVITY 6 3.47e-01 6.37e-01 0.331000 -1.89e-01 2.71e-01 4.22e-01 2.50e-01
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION BY CHEMICAL SIGNAL 6 3.50e-01 6.40e-01 0.331000 1.60e-01 -2.89e-01 4.97e-01 2.20e-01
GOMF PROFILIN BINDING 10 2.17e-01 5.12e-01 0.331000 2.16e-01 2.50e-01 2.36e-01 1.71e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY GLUCOSE 6 3.56e-01 6.46e-01 0.331000 1.04e-01 -3.14e-01 6.60e-01 1.83e-01
GOBP CGAS STING SIGNALING PATHWAY 17 6.02e-02 2.52e-01 0.331000 3.30e-01 -9.09e-03 1.83e-02 9.48e-01
VEGF binds to VEGFR leading to receptor dimerization 7 3.03e-01 5.97e-01 0.331000 -8.51e-02 3.19e-01 6.97e-01 1.43e-01
VEGF ligand-receptor interactions 7 3.03e-01 5.97e-01 0.331000 -8.51e-02 3.19e-01 6.97e-01 1.43e-01
GOBP MAINTENANCE OF ANIMAL ORGAN IDENTITY 5 4.48e-01 7.17e-01 0.330000 -5.37e-02 -3.26e-01 8.35e-01 2.07e-01
GOBP POSITIVE REGULATION OF RNA SPLICING 41 7.38e-04 1.08e-02 0.330000 2.63e-01 -1.99e-01 3.51e-03 2.72e-02
GOBP CILIUM DISASSEMBLY 5 4.66e-01 7.28e-01 0.330000 2.51e-01 2.15e-01 3.31e-01 4.06e-01
PI-3K cascade:FGFR4 19 5.12e-02 2.28e-01 0.330000 3.10e-01 1.14e-01 1.94e-02 3.88e-01
GOBP URINARY BLADDER SMOOTH MUSCLE CONTRACTION 7 3.33e-01 6.24e-01 0.330000 3.14e-01 1.02e-01 1.50e-01 6.41e-01
GOBP DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION 14 8.71e-02 3.16e-01 0.330000 2.89e-01 -1.59e-01 6.11e-02 3.02e-01
GOBP REGULATION OF MRNA EXPORT FROM NUCLEUS 9 2.13e-01 5.08e-01 0.330000 3.10e-01 -1.15e-01 1.08e-01 5.51e-01
Branched-chain ketoacid dehydrogenase kinase deficiency 5 4.47e-01 7.17e-01 0.330000 3.27e-01 4.40e-02 2.05e-01 8.65e-01
GOCC IRON SULFUR CLUSTER ASSEMBLY COMPLEX 10 1.91e-01 4.83e-01 0.330000 2.21e-02 -3.29e-01 9.04e-01 7.15e-02
GOBP MESENCHYMAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 6 3.52e-01 6.42e-01 0.330000 2.90e-01 -1.57e-01 2.19e-01 5.05e-01
Termination of translesion DNA synthesis 32 3.63e-03 3.69e-02 0.330000 2.13e-01 -2.52e-01 3.74e-02 1.36e-02
RUNX3 regulates p14-ARF 10 1.74e-01 4.60e-01 0.330000 2.74e-01 -1.83e-01 1.33e-01 3.17e-01
GOCC FACIT COLLAGEN TRIMER 6 3.60e-01 6.48e-01 0.330000 -3.16e-01 9.34e-02 1.80e-01 6.92e-01
GOCC PODOSOME 33 6.72e-03 5.91e-02 0.329000 2.56e-01 2.07e-01 1.08e-02 3.98e-02
GOBP EPIGENETIC PROGRAMING OF MALE PRONUCLEUS 5 4.19e-01 6.99e-01 0.329000 1.69e-01 -2.83e-01 5.13e-01 2.74e-01
GOMF IGG BINDING 7 3.05e-01 5.99e-01 0.329000 -3.18e-01 8.67e-02 1.46e-01 6.91e-01
GOBP BEHAVIORAL RESPONSE TO ETHANOL 9 2.34e-01 5.31e-01 0.329000 2.68e-02 3.28e-01 8.89e-01 8.84e-02
GOCC ER UBIQUITIN LIGASE COMPLEX 5 4.65e-01 7.28e-01 0.329000 2.87e-01 1.61e-01 2.66e-01 5.34e-01
GOBP HYPEROSMOTIC RESPONSE 25 1.33e-02 9.70e-02 0.329000 2.94e-01 -1.48e-01 1.10e-02 1.99e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 29 8.52e-03 7.03e-02 0.329000 3.28e-01 -2.03e-02 2.22e-03 8.50e-01
GOBP NEGATIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT 5 4.19e-01 6.99e-01 0.329000 1.83e-01 -2.73e-01 4.78e-01 2.90e-01
GOMF L GLUTAMATE TRANSMEMBRANE TRANSPORTER ACTIVITY 14 1.19e-01 3.76e-01 0.329000 2.75e-01 1.80e-01 7.47e-02 2.44e-01
GOBP REGULATION OF CELL FATE COMMITMENT 43 1.43e-03 1.84e-02 0.329000 2.85e-01 1.64e-01 1.24e-03 6.22e-02
GOMF PEPTIDOGLYCAN MURALYTIC ACTIVITY 13 1.40e-01 4.10e-01 0.329000 -1.99e-01 -2.61e-01 2.14e-01 1.03e-01
GOBP REPLICATIVE SENESCENCE 17 5.28e-02 2.33e-01 0.329000 2.86e-01 -1.61e-01 4.09e-02 2.50e-01
GOBP CELLULAR RESPONSE TO L GLUTAMATE 6 3.51e-01 6.41e-01 0.329000 2.59e-01 -2.02e-01 2.71e-01 3.92e-01
GOBP REGULATION OF NON MOTILE CILIUM ASSEMBLY 10 1.77e-01 4.64e-01 0.329000 2.85e-01 -1.64e-01 1.19e-01 3.69e-01
Translation 277 5.66e-20 1.93e-17 0.329000 -1.40e-02 -3.28e-01 6.89e-01 4.95e-21
GOBP G PROTEIN COUPLED SEROTONIN RECEPTOR SIGNALING PATHWAY 22 3.23e-02 1.74e-01 0.328000 9.44e-02 3.15e-01 4.43e-01 1.06e-02
Acyl chain remodelling of PS 22 2.58e-02 1.52e-01 0.328000 3.24e-01 -5.36e-02 8.53e-03 6.64e-01
GOBP NEGATIVE REGULATION OF CGAS STING SIGNALING PATHWAY 12 1.38e-01 4.08e-01 0.328000 3.26e-01 -3.68e-02 5.04e-02 8.25e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PEROXISOME 19 3.71e-02 1.90e-01 0.328000 1.85e-01 -2.71e-01 1.62e-01 4.09e-02
GOBP MICROAUTOPHAGY 22 3.61e-02 1.87e-01 0.328000 2.67e-01 1.90e-01 2.99e-02 1.22e-01
GOCC TOR COMPLEX 12 1.64e-01 4.48e-01 0.328000 2.06e-01 2.55e-01 2.16e-01 1.26e-01
GOCC DNA DEPENDENT PROTEIN KINASE COMPLEX 5 4.55e-01 7.22e-01 0.328000 3.22e-01 6.27e-02 2.13e-01 8.08e-01
GOBP KERATINOCYTE APOPTOTIC PROCESS 8 2.52e-01 5.49e-01 0.328000 2.87e-01 -1.58e-01 1.59e-01 4.39e-01
GOBP RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE 9 2.31e-01 5.29e-01 0.328000 3.28e-01 -8.47e-03 8.86e-02 9.65e-01
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY 12 1.26e-01 3.86e-01 0.328000 2.72e-01 -1.83e-01 1.03e-01 2.72e-01
GOBP RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 19 4.27e-02 2.05e-01 0.328000 3.22e-01 -5.99e-02 1.51e-02 6.51e-01
Drug-mediated inhibition of CDK4/CDK6 activity 5 4.45e-01 7.17e-01 0.328000 1.72e-03 -3.27e-01 9.95e-01 2.05e-01
GOBP REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION 66 4.53e-05 1.09e-03 0.327000 2.90e-01 1.52e-01 4.58e-05 3.28e-02
GOBP REGULATION OF CYTOPLASMIC TRANSLATIONAL INITIATION 7 3.43e-01 6.32e-01 0.327000 3.00e-01 1.31e-01 1.70e-01 5.47e-01
GOBP TRANSITION BETWEEN FAST AND SLOW FIBER 9 2.24e-01 5.20e-01 0.327000 -6.47e-02 3.21e-01 7.37e-01 9.56e-02
GOBP TRNA AMINOACYLATION FOR MITOCHONDRIAL PROTEIN TRANSLATION 8 2.65e-01 5.62e-01 0.327000 6.24e-02 -3.21e-01 7.60e-01 1.16e-01
Sodium-coupled phosphate cotransporters 5 4.22e-01 7.00e-01 0.327000 -1.94e-01 2.63e-01 4.52e-01 3.08e-01
GOBP GLOMERULAR MESANGIAL CELL DEVELOPMENT 5 4.29e-01 7.06e-01 0.327000 3.05e-01 -1.17e-01 2.37e-01 6.51e-01
Nucleotide-like (purinergic) receptors 13 1.08e-01 3.54e-01 0.327000 -2.85e-01 1.61e-01 7.54e-02 3.16e-01
GOBP NEGATIVE REGULATION OF ADIPOSE TISSUE DEVELOPMENT 5 4.74e-01 7.34e-01 0.327000 2.12e-01 2.49e-01 4.12e-01 3.35e-01
GOBP C21 STEROID HORMONE BIOSYNTHETIC PROCESS 20 3.21e-02 1.74e-01 0.327000 -2.73e-01 1.80e-01 3.45e-02 1.64e-01
GOMF NUCLEASE INHIBITOR ACTIVITY 6 3.55e-01 6.44e-01 0.327000 2.04e-01 -2.55e-01 3.86e-01 2.79e-01
GOBP HEAD MORPHOGENESIS 36 3.40e-03 3.52e-02 0.327000 3.24e-01 4.20e-02 7.62e-04 6.63e-01
GOBP ONE CARBON COMPOUND TRANSPORT 26 1.54e-02 1.07e-01 0.327000 -3.27e-01 -3.64e-03 3.92e-03 9.74e-01
GOBP PYRIMIDINE DIMER REPAIR 9 2.17e-01 5.12e-01 0.327000 2.97e-01 -1.37e-01 1.23e-01 4.77e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE PHOSPHATASE ACTIVITY 26 1.92e-02 1.23e-01 0.327000 3.00e-01 1.30e-01 8.15e-03 2.52e-01
GOMF STRUCTURAL CONSTITUENT OF CHROMATIN 78 3.37e-06 1.11e-04 0.327000 1.65e-02 -3.26e-01 8.01e-01 6.29e-07
Response of EIF2AK1 (HRI) to heme deficiency 14 1.10e-01 3.59e-01 0.327000 -3.23e-01 -4.51e-02 3.61e-02 7.70e-01
GOBP ERROR FREE TRANSLESION SYNTHESIS 5 4.22e-01 7.01e-01 0.326000 2.33e-01 -2.29e-01 3.68e-01 3.75e-01
GOBP DIPEPTIDE TRANSMEMBRANE TRANSPORT 8 3.03e-01 5.98e-01 0.326000 2.10e-01 2.50e-01 3.03e-01 2.21e-01
GOCC ATPASE DEPENDENT TRANSMEMBRANE TRANSPORT COMPLEX 24 1.89e-02 1.22e-01 0.326000 -6.73e-02 3.19e-01 5.68e-01 6.75e-03
GOMF EXTRACELLULARLY ATP GATED MONOATOMIC CATION CHANNEL ACTIVITY 7 3.44e-01 6.33e-01 0.326000 3.03e-01 1.20e-01 1.65e-01 5.81e-01
GOBP HINDBRAIN MATURATION 5 4.67e-01 7.29e-01 0.326000 3.02e-01 1.24e-01 2.43e-01 6.30e-01
GOBP NEPHRON TUBULE FORMATION 20 3.29e-02 1.75e-01 0.326000 2.80e-01 -1.67e-01 3.00e-02 1.96e-01
GOBP POSITIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING 11 1.61e-01 4.43e-01 0.326000 3.15e-01 -8.43e-02 7.03e-02 6.28e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL ANTIGEN PROCESSING AND PRESENTATION 7 3.10e-01 6.04e-01 0.326000 9.81e-02 -3.11e-01 6.53e-01 1.54e-01
GOBP POSITIVE REGULATION OF ENDOCYTIC RECYCLING 8 2.94e-01 5.91e-01 0.326000 1.09e-01 3.07e-01 5.93e-01 1.32e-01
GOBP CENTROMERIC SISTER CHROMATID COHESION 10 1.99e-01 4.93e-01 0.326000 3.26e-01 -1.41e-02 7.45e-02 9.38e-01
GOMF SMALL RIBOSOMAL SUBUNIT RRNA BINDING 8 2.59e-01 5.56e-01 0.326000 1.29e-01 -2.99e-01 5.27e-01 1.43e-01
GOBP CARDIOBLAST DIFFERENTIATION 17 5.80e-02 2.47e-01 0.326000 3.07e-01 -1.10e-01 2.84e-02 4.34e-01
GOBP PROTEIN DEMETHYLATION 8 3.02e-01 5.97e-01 0.326000 2.77e-01 1.72e-01 1.76e-01 3.98e-01
GOMF G PROTEIN COUPLED ADENOSINE RECEPTOR ACTIVITY 5 4.31e-01 7.06e-01 0.326000 -3.01e-01 1.25e-01 2.44e-01 6.28e-01
GOBP REGULATION OF GLUCAGON SECRETION 8 2.56e-01 5.53e-01 0.326000 1.70e-01 -2.78e-01 4.05e-01 1.74e-01
GOBP NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS 23 2.86e-02 1.62e-01 0.326000 -7.58e-02 -3.17e-01 5.29e-01 8.52e-03
Deposition of new CENPA-containing nucleosomes at the centromere 46 4.47e-04 7.17e-03 0.326000 1.19e-01 -3.03e-01 1.64e-01 3.69e-04
Nucleosome assembly 46 4.47e-04 7.17e-03 0.326000 1.19e-01 -3.03e-01 1.64e-01 3.69e-04
GOBP POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS 14 9.25e-02 3.26e-01 0.326000 2.83e-01 -1.62e-01 6.71e-02 2.94e-01
GOMF INTRACELLULARLY CGMP ACTIVATED CATION CHANNEL ACTIVITY 6 3.63e-01 6.51e-01 0.326000 -1.35e-01 2.96e-01 5.66e-01 2.09e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR 43 6.36e-04 9.59e-03 0.326000 2.51e-01 -2.08e-01 4.41e-03 1.85e-02
CYP2E1 reactions 10 1.94e-01 4.87e-01 0.326000 -3.21e-01 5.53e-02 7.89e-02 7.62e-01
GOCC TRAPPII PROTEIN COMPLEX 11 1.53e-01 4.31e-01 0.326000 2.65e-01 -1.89e-01 1.28e-01 2.77e-01
FRS-mediated FGFR1 signaling 23 3.24e-02 1.75e-01 0.325000 2.76e-01 1.72e-01 2.17e-02 1.54e-01
GOBP ADP BIOSYNTHETIC PROCESS 5 4.59e-01 7.24e-01 0.325000 5.49e-02 3.21e-01 8.32e-01 2.14e-01
Major pathway of rRNA processing in the nucleolus and cytosol 172 2.03e-12 2.38e-10 0.325000 -2.92e-02 -3.24e-01 5.09e-01 2.19e-13
GOBP SINOATRIAL NODE CELL DIFFERENTIATION 5 4.30e-01 7.06e-01 0.325000 2.95e-01 -1.37e-01 2.53e-01 5.95e-01
VEGFR2 mediated cell proliferation 19 6.03e-02 2.52e-01 0.325000 2.24e-01 2.36e-01 9.03e-02 7.55e-02
GOBP REGULATION OF ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE 9 2.27e-01 5.24e-01 0.325000 7.16e-02 -3.17e-01 7.10e-01 9.92e-02
GOMF I SMAD BINDING 16 8.71e-02 3.16e-01 0.325000 3.09e-01 9.98e-02 3.21e-02 4.90e-01
GOBP POSITIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 6 3.75e-01 6.61e-01 0.325000 -3.20e-01 5.71e-02 1.74e-01 8.09e-01
Activation of HOX genes during differentiation 83 7.24e-07 2.88e-05 0.325000 2.50e-01 -2.07e-01 7.98e-05 1.09e-03
Activation of anterior HOX genes in hindbrain development during early embryogenesis 83 7.24e-07 2.88e-05 0.325000 2.50e-01 -2.07e-01 7.98e-05 1.09e-03
Inactivation of CDC42 and RAC1 8 3.02e-01 5.97e-01 0.325000 2.88e-01 1.50e-01 1.58e-01 4.61e-01
GOBP PYRIMIDINE NUCLEOBASE CATABOLIC PROCESS 8 2.69e-01 5.66e-01 0.325000 -7.11e-02 3.17e-01 7.28e-01 1.20e-01
GOMF NADPLUS PROTEIN CYSTEINE ADP RIBOSYLTRANSFERASE ACTIVITY 6 3.92e-01 6.75e-01 0.325000 3.22e-01 4.28e-02 1.72e-01 8.56e-01
Metabolism of amine-derived hormones 17 6.44e-02 2.64e-01 0.325000 -3.23e-01 3.24e-02 2.10e-02 8.17e-01
Mitochondrial translation elongation 87 9.82e-07 3.74e-05 0.325000 6.06e-03 -3.25e-01 9.22e-01 1.63e-07
GOBP DOPAMINERGIC NEURON DIFFERENTIATION 39 1.82e-03 2.19e-02 0.325000 3.22e-01 -4.16e-02 4.99e-04 6.53e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 33 4.54e-03 4.40e-02 0.325000 6.54e-02 -3.18e-01 5.16e-01 1.56e-03
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT ENDOSOME TO POSTSYNAPTIC MEMBRANE 10 2.03e-01 4.97e-01 0.325000 -3.64e-03 3.25e-01 9.84e-01 7.54e-02
GOMF MRNA METHYLTRANSFERASE ACTIVITY 13 1.09e-01 3.57e-01 0.325000 2.46e-01 -2.12e-01 1.24e-01 1.86e-01
Formation of the nephric duct 17 5.72e-02 2.45e-01 0.325000 2.89e-01 -1.48e-01 3.92e-02 2.91e-01
GOCC ROD PHOTORECEPTOR OUTER SEGMENT 7 3.03e-01 5.98e-01 0.325000 -2.16e-01 2.42e-01 3.22e-01 2.68e-01
GOCC T CELL RECEPTOR COMPLEX 16 7.56e-02 2.90e-01 0.325000 3.69e-02 -3.22e-01 7.98e-01 2.55e-02
GOBP CONVERGENT EXTENSION INVOLVED IN GASTRULATION 9 2.61e-01 5.58e-01 0.324000 -1.52e-01 -2.86e-01 4.29e-01 1.37e-01
GOBP DNA DOUBLE STRAND BREAK PROCESSING 20 3.33e-02 1.77e-01 0.324000 2.15e-01 -2.43e-01 9.66e-02 5.95e-02
GOBP NEGATIVE REGULATION OF MACROPHAGE DIFFERENTIATION 8 2.69e-01 5.66e-01 0.324000 -3.15e-01 7.69e-02 1.23e-01 7.07e-01
GOBP L METHIONINE SALVAGE FROM METHYLTHIOADENOSINE 5 4.36e-01 7.10e-01 0.324000 -3.05e-01 1.10e-01 2.37e-01 6.69e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE 8 3.06e-01 5.99e-01 0.324000 -1.76e-01 -2.72e-01 3.89e-01 1.82e-01
TP53 Regulates Transcription of Caspase Activators and Caspases 12 1.70e-01 4.55e-01 0.324000 2.68e-01 1.82e-01 1.08e-01 2.74e-01
GOBP GLUCOSE 6 PHOSPHATE METABOLIC PROCESS 27 1.37e-02 9.94e-02 0.324000 -8.23e-03 3.24e-01 9.41e-01 3.57e-03
GOBP REGULATION OF SREBP SIGNALING PATHWAY 8 2.58e-01 5.55e-01 0.324000 2.62e-01 -1.91e-01 2.00e-01 3.49e-01
GOBP CEREBELLAR PURKINJE CELL LAYER FORMATION 14 1.19e-01 3.75e-01 0.324000 3.12e-01 8.66e-02 4.31e-02 5.75e-01
GOBP CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION 10 1.99e-01 4.92e-01 0.324000 5.18e-02 -3.20e-01 7.77e-01 8.01e-02
GOBP REGULATION OF BONE DEVELOPMENT 9 2.52e-01 5.49e-01 0.324000 6.80e-02 3.16e-01 7.24e-01 1.00e-01
GOBP FACE DEVELOPMENT 50 4.42e-04 7.13e-03 0.324000 3.21e-01 4.46e-02 8.79e-05 5.85e-01
GOBP FOREBRAIN NEURON DIFFERENTIATION 42 1.20e-03 1.59e-02 0.324000 3.22e-01 -3.44e-02 3.08e-04 7.00e-01
GOMF OLIGOPEPTIDE BINDING 11 1.88e-01 4.79e-01 0.323000 3.13e-01 8.18e-02 7.23e-02 6.39e-01
mRNA decay by 5’ to 3’ exoribonuclease 15 8.24e-02 3.07e-01 0.323000 2.93e-01 -1.37e-01 4.98e-02 3.57e-01
Release of Hh-Np from the secreting cell 8 2.66e-01 5.62e-01 0.323000 -3.00e-01 1.20e-01 1.42e-01 5.57e-01
GOBP NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 35 2.78e-03 3.04e-02 0.323000 2.62e-01 -1.90e-01 7.40e-03 5.21e-02
GOMF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 13 1.12e-01 3.62e-01 0.323000 -2.40e-01 2.16e-01 1.34e-01 1.77e-01
GOCC SORTING ENDOSOME 6 3.95e-01 6.77e-01 0.323000 3.21e-01 3.37e-02 1.73e-01 8.86e-01
GOMF HEPARAN SULFATE BINDING 7 3.61e-01 6.49e-01 0.323000 -2.32e-01 -2.24e-01 2.87e-01 3.04e-01
GOMF BETA GALACTOSIDE CMP ALPHA 2 3 SIALYLTRANSFERASE ACTIVITY 7 3.07e-01 6.00e-01 0.323000 -2.31e-01 2.25e-01 2.89e-01 3.02e-01
GOBP SUBTELOMERIC HETEROCHROMATIN FORMATION 8 3.04e-01 5.98e-01 0.323000 -1.21e-01 -2.99e-01 5.55e-01 1.43e-01
GOBP POSITIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 1.40e-01 4.10e-01 0.323000 3.04e-01 -1.07e-01 6.79e-02 5.21e-01
GOMF BETA GLUCOSIDASE ACTIVITY 6 4.11e-01 6.93e-01 0.323000 1.36e-01 2.92e-01 5.64e-01 2.15e-01
EGFR Transactivation by Gastrin 9 2.28e-01 5.25e-01 0.322000 3.02e-01 -1.12e-01 1.16e-01 5.60e-01
GOMF ATP GATED ION CHANNEL ACTIVITY 9 2.43e-01 5.39e-01 0.322000 3.22e-01 -6.11e-03 9.40e-02 9.75e-01
GOMF GLUCOSYLTRANSFERASE ACTIVITY 19 5.88e-02 2.49e-01 0.322000 3.02e-01 1.12e-01 2.26e-02 3.97e-01
GOBP MACROPHAGE PROLIFERATION 12 1.71e-01 4.57e-01 0.322000 2.85e-01 1.50e-01 8.73e-02 3.67e-01
GOBP INTERNEURON MIGRATION FROM THE SUBPALLIUM TO THE CORTEX 6 3.70e-01 6.58e-01 0.322000 1.39e-01 -2.91e-01 5.56e-01 2.17e-01
Defective factor IX causes hemophilia B 7 3.42e-01 6.32e-01 0.322000 4.69e-02 3.19e-01 8.30e-01 1.44e-01
GOBP PEPTIDE CROSS LINKING 26 1.90e-02 1.23e-01 0.322000 -3.17e-01 -5.70e-02 5.13e-03 6.15e-01
GOBP POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION 10 2.11e-01 5.06e-01 0.322000 3.22e-01 1.05e-02 7.79e-02 9.54e-01
Constitutive Signaling by AKT1 E17K in Cancer 25 2.66e-02 1.55e-01 0.322000 2.52e-01 2.00e-01 2.90e-02 8.31e-02
GOBP LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE 19 4.22e-02 2.04e-01 0.322000 -2.71e-01 1.74e-01 4.07e-02 1.90e-01
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 36 3.51e-03 3.59e-02 0.322000 3.22e-01 -1.28e-02 8.35e-04 8.94e-01
GOBP MATURE CONVENTIONAL DENDRITIC CELL DIFFERENTIATION 5 4.61e-01 7.25e-01 0.322000 -3.21e-01 -2.03e-02 2.13e-01 9.37e-01
RHOJ GTPase cycle 50 4.84e-04 7.68e-03 0.322000 3.19e-01 4.54e-02 9.71e-05 5.78e-01
GOBP CLEAVAGE FURROW FORMATION 7 3.29e-01 6.20e-01 0.322000 3.19e-01 -3.96e-02 1.43e-01 8.56e-01
GOBP NEGATIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY 5 4.52e-01 7.20e-01 0.322000 3.19e-01 -4.03e-02 2.17e-01 8.76e-01
GOBP INTERLEUKIN 5 PRODUCTION 19 4.75e-02 2.19e-01 0.322000 -6.55e-02 3.15e-01 6.21e-01 1.75e-02
GOMF ALPHA ADRENERGIC RECEPTOR ACTIVITY 6 4.00e-01 6.82e-01 0.322000 -4.60e-02 -3.18e-01 8.45e-01 1.77e-01
GOBP REGULATION OF CELL CHEMOTAXIS TO FIBROBLAST GROWTH FACTOR 8 3.14e-01 6.07e-01 0.322000 2.49e-01 2.04e-01 2.23e-01 3.18e-01
GOBP ACTIVATION OF PROTEIN KINASE C ACTIVITY 5 4.33e-01 7.08e-01 0.322000 2.43e-01 -2.10e-01 3.46e-01 4.16e-01
GOBP REGULATION OF GLUTAMATE SECRETION NEUROTRANSMISSION 5 4.58e-01 7.23e-01 0.321000 3.21e-01 -7.84e-03 2.13e-01 9.76e-01
GOBP POSITIVE REGULATION OF CELL PROLIFERATION IN BONE MARROW 6 3.86e-01 6.70e-01 0.321000 3.18e-01 -4.41e-02 1.77e-01 8.51e-01
Binding of TCF/LEF:CTNNB1 to target gene promoters 8 2.73e-01 5.70e-01 0.321000 1.01e-01 -3.05e-01 6.22e-01 1.35e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO HYPOXIA 9 2.23e-01 5.19e-01 0.321000 2.50e-01 -2.02e-01 1.95e-01 2.93e-01
GOBP POSITIVE REGULATION OF GLUTAMATE SECRETION 11 1.93e-01 4.85e-01 0.321000 8.75e-02 3.09e-01 6.15e-01 7.60e-02
GOBP SENSORY PERCEPTION 871 8.02e-57 9.84e-54 0.321000 -3.20e-01 -2.78e-02 4.05e-58 1.64e-01
GOBP REGULATION OF RESPONSE TO NUTRIENT LEVELS 30 7.18e-03 6.23e-02 0.321000 2.86e-01 -1.46e-01 6.74e-03 1.65e-01
Impaired BRCA2 binding to PALB2 24 1.84e-02 1.20e-01 0.321000 2.51e-01 -2.00e-01 3.34e-02 8.93e-02
GOBP RESPONSE TO METHIONINE 5 4.48e-01 7.17e-01 0.321000 3.11e-01 -7.98e-02 2.29e-01 7.57e-01
GOCC RIBOSOME 221 2.17e-15 4.60e-13 0.321000 -1.69e-02 -3.20e-01 6.65e-01 2.11e-16
Sema4D in semaphorin signaling 24 2.66e-02 1.55e-01 0.321000 3.16e-01 5.81e-02 7.44e-03 6.22e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 12 1.52e-01 4.30e-01 0.321000 -2.64e-02 3.20e-01 8.74e-01 5.51e-02
GOBP CONSTITUTIVE SECRETORY PATHWAY 7 3.33e-01 6.24e-01 0.321000 2.45e-02 -3.20e-01 9.10e-01 1.43e-01
Negative regulators of DDX58/IFIH1 signaling 34 3.49e-03 3.58e-02 0.321000 2.27e-01 -2.26e-01 2.18e-02 2.23e-02
GOMF HISTONE CHAPERONE ACTIVITY 12 1.36e-01 4.04e-01 0.321000 2.43e-01 -2.10e-01 1.46e-01 2.08e-01
GOBP POSITIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS 9 2.40e-01 5.36e-01 0.321000 4.98e-02 -3.17e-01 7.96e-01 9.98e-02
Crosslinking of collagen fibrils 16 8.02e-02 3.00e-01 0.321000 -3.86e-02 3.18e-01 7.89e-01 2.75e-02
GOCC NBAF COMPLEX 16 9.38e-02 3.28e-01 0.321000 3.03e-01 1.04e-01 3.57e-02 4.71e-01
GOCC PSEUDOPODIUM 16 9.91e-02 3.37e-01 0.321000 2.69e-01 1.74e-01 6.26e-02 2.27e-01
GOMF FIBROBLAST GROWTH FACTOR RECEPTOR BINDING 24 3.17e-02 1.72e-01 0.320000 2.58e-01 1.90e-01 2.88e-02 1.06e-01
Loss of Function of TGFBR1 in Cancer 7 3.35e-01 6.25e-01 0.320000 3.20e-01 -1.73e-02 1.43e-01 9.37e-01
GOBP DNA LIGATION 16 9.92e-02 3.37e-01 0.320000 1.71e-01 2.71e-01 2.37e-01 6.05e-02
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN SALIVARY GLAND MORPHOGENESIS 5 4.48e-01 7.18e-01 0.320000 3.09e-01 -8.40e-02 2.31e-01 7.45e-01
GOBP NEURON FATE COMMITMENT 74 1.01e-05 2.91e-04 0.320000 3.20e-01 -1.71e-02 1.96e-06 8.00e-01
GOBP NUCLEAR MRNA SURVEILLANCE 11 1.69e-01 4.54e-01 0.320000 1.02e-01 -3.04e-01 5.58e-01 8.13e-02
GOBP NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY 30 1.28e-02 9.38e-02 0.320000 2.85e-01 1.46e-01 6.85e-03 1.68e-01
GOBP REGULATION OF ADIPOSE TISSUE DEVELOPMENT 16 9.87e-02 3.37e-01 0.320000 2.78e-01 1.59e-01 5.42e-02 2.71e-01
GOBP DUCTUS ARTERIOSUS CLOSURE 5 4.49e-01 7.19e-01 0.320000 3.10e-01 -7.88e-02 2.30e-01 7.60e-01
GOMF EPINEPHRINE BINDING 6 3.85e-01 6.69e-01 0.320000 3.14e-01 -6.47e-02 1.84e-01 7.84e-01
GOCC GOLGI CIS CISTERNA 13 1.55e-01 4.35e-01 0.320000 2.56e-01 1.92e-01 1.10e-01 2.30e-01
Cell-extracellular matrix interactions 16 9.56e-02 3.31e-01 0.320000 2.98e-01 1.17e-01 3.90e-02 4.20e-01
GOBP REGULATION OF PIGMENT CELL DIFFERENTIATION 8 2.77e-01 5.74e-01 0.320000 3.08e-01 -8.84e-02 1.32e-01 6.65e-01
GOBP ATRIOVENTRICULAR CANAL DEVELOPMENT 13 1.34e-01 4.00e-01 0.320000 3.20e-01 -5.98e-03 4.58e-02 9.70e-01
GOBP NEGATIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND METHYLATION 14 1.02e-01 3.43e-01 0.320000 2.87e-01 -1.42e-01 6.33e-02 3.58e-01
GOCC ELONGIN COMPLEX 5 4.42e-01 7.14e-01 0.320000 -2.85e-01 1.45e-01 2.70e-01 5.75e-01
GOBP NEGATIVE REGULATION OF TELOMERE MAINTENANCE 33 5.22e-03 4.88e-02 0.320000 3.10e-01 -7.65e-02 2.02e-03 4.47e-01
GOBP ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 23 2.38e-02 1.44e-01 0.320000 -2.92e-01 1.31e-01 1.54e-02 2.77e-01
GOBP SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY 12 1.40e-01 4.10e-01 0.320000 1.62e-01 -2.76e-01 3.31e-01 9.84e-02
RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function 59 6.91e-05 1.57e-03 0.320000 2.90e-01 -1.34e-01 1.15e-04 7.50e-02
Mitochondrial translation 93 6.67e-07 2.71e-05 0.320000 -7.60e-03 -3.19e-01 8.99e-01 1.00e-07
GOBP REGULATION OF MITOCHONDRIAL ATP SYNTHESIS COUPLED ELECTRON TRANSPORT 7 3.38e-01 6.28e-01 0.320000 -3.19e-01 1.24e-02 1.44e-01 9.55e-01
Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template 38 1.90e-03 2.27e-02 0.319000 2.19e-01 -2.32e-01 1.93e-02 1.32e-02
Formation of ATP by chemiosmotic coupling 18 6.51e-02 2.65e-01 0.319000 -2.75e-02 -3.18e-01 8.40e-01 1.94e-02
GOBP REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 30 7.13e-03 6.19e-02 0.319000 2.07e-01 -2.44e-01 5.01e-02 2.09e-02
GOCC DENDRITIC SPINE HEAD 7 3.68e-01 6.55e-01 0.319000 1.95e-01 2.53e-01 3.72e-01 2.46e-01
Regulation of TP53 Degradation 36 3.76e-03 3.78e-02 0.319000 3.19e-01 -2.17e-02 9.37e-04 8.22e-01
GOBP CELL FATE COMMITMENT INVOLVED IN PATTERN SPECIFICATION 11 2.01e-01 4.94e-01 0.319000 2.96e-01 1.21e-01 8.97e-02 4.87e-01
GOBP PURINE RIBONUCLEOSIDE CATABOLIC PROCESS 5 4.51e-01 7.19e-01 0.319000 3.08e-01 -8.40e-02 2.33e-01 7.45e-01
GOMF OXO ACID LYASE ACTIVITY 7 3.53e-01 6.42e-01 0.319000 6.88e-02 3.12e-01 7.52e-01 1.53e-01
GOBP CELLULAR HYPEROSMOTIC RESPONSE 19 4.74e-02 2.19e-01 0.319000 3.02e-01 -1.04e-01 2.27e-02 4.34e-01
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 8 3.16e-01 6.09e-01 0.319000 -1.52e-01 -2.80e-01 4.55e-01 1.70e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS IB 18 5.50e-02 2.40e-01 0.319000 1.18e-01 -2.97e-01 3.88e-01 2.94e-02
Formation of the active cofactor, UDP-glucuronate 5 4.39e-01 7.13e-01 0.319000 2.18e-01 -2.33e-01 3.98e-01 3.68e-01
GOCC DNA REPLICATION FACTOR A COMPLEX 12 1.80e-01 4.70e-01 0.319000 2.63e-01 1.80e-01 1.14e-01 2.82e-01
GOBP CELLULAR RESPONSE TO EPINEPHRINE STIMULUS 11 2.08e-01 5.03e-01 0.319000 2.62e-01 1.82e-01 1.33e-01 2.96e-01
GOBP MUSCLE CELL FATE COMMITMENT 17 7.17e-02 2.81e-01 0.319000 3.17e-01 -2.85e-02 2.35e-02 8.39e-01
GOMF PHOSPHATIDYLINOSITOL TRISPHOSPHATE PHOSPHATASE ACTIVITY 9 2.79e-01 5.76e-01 0.319000 2.23e-01 2.27e-01 2.46e-01 2.38e-01
GOBP NEGATIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 21 4.92e-02 2.23e-01 0.319000 2.79e-01 1.54e-01 2.70e-02 2.21e-01
GOBP SKIN MORPHOGENESIS 13 1.33e-01 4.00e-01 0.319000 -2.86e-02 3.17e-01 8.58e-01 4.76e-02
GOCC CLATHRIN VESICLE COAT 34 6.89e-03 6.02e-02 0.319000 3.04e-01 9.57e-02 2.16e-03 3.34e-01
GOBP PROTEIN LOCALIZATION TO SITE OF DOUBLE STRAND BREAK 14 1.14e-01 3.67e-01 0.319000 2.77e-02 -3.17e-01 8.57e-01 3.98e-02
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA 6 3.83e-01 6.67e-01 0.319000 3.01e-01 -1.06e-01 2.02e-01 6.54e-01
GOMF PROTON TRANSPORTING ATP SYNTHASE ACTIVITY ROTATIONAL MECHANISM 16 7.58e-02 2.90e-01 0.319000 1.30e-01 -2.91e-01 3.70e-01 4.39e-02
GOBP SNO S RNA PROCESSING 12 1.68e-01 4.53e-01 0.319000 3.12e-01 6.41e-02 6.13e-02 7.01e-01
GOBP ADENYLATE CYCLASE ACTIVATING ADRENERGIC RECEPTOR SIGNALING PATHWAY 23 2.38e-02 1.44e-01 0.318000 2.76e-01 -1.60e-01 2.21e-02 1.85e-01
GOMF TYPE II TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 11 2.03e-01 4.97e-01 0.318000 2.94e-01 1.23e-01 9.14e-02 4.81e-01
GOBP FOREBRAIN NEURON DEVELOPMENT 23 3.56e-02 1.85e-01 0.318000 2.96e-01 1.17e-01 1.40e-02 3.29e-01
GOBP COMMISSURAL NEURON AXON GUIDANCE 13 1.39e-01 4.10e-01 0.318000 3.18e-01 1.64e-02 4.71e-02 9.18e-01
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell 124 1.79e-08 1.05e-06 0.318000 -2.91e-01 -1.28e-01 2.06e-08 1.38e-02
GOBP INOSITOL TRISPHOSPHATE BIOSYNTHETIC PROCESS 6 3.84e-01 6.68e-01 0.318000 -3.02e-01 1.01e-01 2.00e-01 6.69e-01
GOBP SKELETAL MUSCLE THIN FILAMENT ASSEMBLY 7 3.71e-01 6.58e-01 0.318000 2.35e-01 2.15e-01 2.82e-01 3.25e-01
RNA Polymerase I Promoter Escape 53 2.84e-04 4.97e-03 0.318000 2.29e-02 -3.18e-01 7.73e-01 6.35e-05
GOBP EPITHELIAL CELL FATE COMMITMENT 14 1.33e-01 4.00e-01 0.318000 2.86e-01 1.39e-01 6.37e-02 3.66e-01
mRNA Editing 10 1.99e-01 4.93e-01 0.318000 2.89e-01 -1.33e-01 1.14e-01 4.65e-01
GOMF NUCLEAR ESTROGEN RECEPTOR BINDING 39 2.02e-03 2.38e-02 0.318000 3.02e-01 -9.97e-02 1.09e-03 2.81e-01
GOBP AXON MIDLINE CHOICE POINT RECOGNITION 5 4.56e-01 7.22e-01 0.318000 3.12e-01 -6.23e-02 2.27e-01 8.09e-01
GOMF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR BINDING 10 2.02e-01 4.95e-01 0.318000 2.97e-01 -1.15e-01 1.04e-01 5.28e-01
GOBP REGULATION OF T CELL DIFFERENTIATION IN THYMUS 26 1.45e-02 1.03e-01 0.318000 -1.85e-01 2.59e-01 1.02e-01 2.25e-02
GOMF NUCLEOCYTOPLASMIC CARRIER ACTIVITY 32 6.01e-03 5.39e-02 0.318000 2.96e-01 -1.15e-01 3.72e-03 2.59e-01
GOBP REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION 7 3.21e-01 6.12e-01 0.318000 1.67e-01 -2.71e-01 4.45e-01 2.15e-01
GOCC EXOCYST 16 9.98e-02 3.39e-01 0.318000 2.90e-01 1.29e-01 4.43e-02 3.71e-01
GOBP REGULATION OF PHOSPHOLIPASE A2 ACTIVITY 7 3.21e-01 6.12e-01 0.318000 2.70e-01 -1.68e-01 2.16e-01 4.43e-01
GOBP PINOCYTOSIS 22 3.24e-02 1.75e-01 0.318000 3.13e-01 -5.30e-02 1.09e-02 6.67e-01
GOMF MEDIUM CHAIN FATTY ACID COA LIGASE ACTIVITY 10 2.44e-01 5.40e-01 0.318000 -2.06e-01 -2.42e-01 2.60e-01 1.85e-01
GOBP AMINOGLYCOSIDE ANTIBIOTIC METABOLIC PROCESS 10 2.30e-01 5.27e-01 0.318000 3.09e-01 7.38e-02 9.07e-02 6.86e-01
GOMF VASOPRESSIN RECEPTOR ACTIVITY 6 4.27e-01 7.05e-01 0.318000 1.81e-01 2.61e-01 4.43e-01 2.68e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE 33 8.13e-03 6.79e-02 0.318000 3.05e-01 9.02e-02 2.46e-03 3.70e-01
GOMF NAADP SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 5 4.90e-01 7.47e-01 0.318000 2.81e-01 1.47e-01 2.76e-01 5.68e-01
GOMF FOUR WAY JUNCTION DNA BINDING 16 9.13e-02 3.24e-01 0.317000 3.16e-01 3.34e-02 2.88e-02 8.17e-01
GOMF RNA POLYMERASE I ACTIVITY 10 2.11e-01 5.06e-01 0.317000 5.61e-02 -3.12e-01 7.59e-01 8.71e-02
GOBP REGULATION OF COMPLEMENT ACTIVATION CLASSICAL PATHWAY 9 2.61e-01 5.57e-01 0.317000 -3.15e-01 -3.57e-02 1.01e-01 8.53e-01
Regulation of TP53 Expression and Degradation 37 3.36e-03 3.49e-02 0.317000 3.16e-01 -3.32e-02 8.92e-04 7.27e-01
GOCC ROUGH ENDOPLASMIC RETICULUM MEMBRANE 23 3.26e-02 1.75e-01 0.317000 -4.05e-02 -3.15e-01 7.36e-01 8.97e-03
GOBP N ACYLETHANOLAMINE METABOLIC PROCESS 5 4.79e-01 7.39e-01 0.317000 -6.94e-02 -3.10e-01 7.88e-01 2.31e-01
WNT mediated activation of DVL 8 2.87e-01 5.85e-01 0.317000 3.11e-01 -6.03e-02 1.27e-01 7.68e-01
RHOQ GTPase cycle 57 2.92e-04 5.08e-03 0.317000 2.87e-01 1.34e-01 1.74e-04 8.04e-02
GOBP POSITIVE REGULATION OF RIG I SIGNALING PATHWAY 9 2.67e-01 5.63e-01 0.317000 3.09e-01 6.90e-02 1.08e-01 7.20e-01
GOBP CYCLOOXYGENASE PATHWAY 9 2.39e-01 5.36e-01 0.317000 -1.15e-01 2.96e-01 5.51e-01 1.25e-01
GOMF GTPASE ACTIVATING PROTEIN BINDING 11 1.69e-01 4.54e-01 0.317000 1.68e-01 -2.69e-01 3.36e-01 1.22e-01
GOBP REGULATION OF STORE OPERATED CALCIUM CHANNEL ACTIVITY 6 4.10e-01 6.91e-01 0.317000 3.15e-01 3.89e-02 1.82e-01 8.69e-01
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEDIFFERENTIATION 5 4.51e-01 7.19e-01 0.317000 2.92e-01 -1.24e-01 2.59e-01 6.31e-01
GOMF MITOCHONDRION TARGETING SEQUENCE BINDING 6 4.15e-01 6.96e-01 0.317000 -6.93e-02 -3.09e-01 7.69e-01 1.90e-01
GOBP ACTIVATION OF MEIOSIS 6 4.29e-01 7.06e-01 0.317000 1.72e-01 2.66e-01 4.66e-01 2.59e-01
GOBP DEOXYRIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 5 4.46e-01 7.17e-01 0.317000 -2.65e-01 1.73e-01 3.04e-01 5.03e-01
GOBP PROTEIN MATURATION BY 4FE 4S CLUSTER TRANSFER 8 3.13e-01 6.06e-01 0.317000 -3.05e-01 -8.61e-02 1.36e-01 6.73e-01
GOCC EARLY PHAGOSOME 12 1.73e-01 4.59e-01 0.317000 -7.10e-02 -3.09e-01 6.70e-01 6.42e-02
Formation of intermediate mesoderm 8 2.98e-01 5.94e-01 0.317000 3.16e-01 -3.80e-03 1.21e-01 9.85e-01
GOBP ACTIN MYOSIN FILAMENT SLIDING 16 9.19e-02 3.25e-01 0.316000 -3.15e-01 -2.40e-02 2.89e-02 8.68e-01
GOMF BHLH TRANSCRIPTION FACTOR BINDING 31 1.11e-02 8.51e-02 0.316000 3.05e-01 8.36e-02 3.28e-03 4.20e-01
GOBP POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION 12 1.76e-01 4.63e-01 0.316000 3.03e-01 9.01e-02 6.91e-02 5.89e-01
GOBP REGULATION PROTEIN CATABOLIC PROCESS AT SYNAPSE 5 4.57e-01 7.22e-01 0.316000 -9.00e-02 3.03e-01 7.27e-01 2.41e-01
GOBP POSITIVE REGULATION OF VACUOLE ORGANIZATION 24 3.43e-02 1.81e-01 0.316000 2.65e-01 1.72e-01 2.44e-02 1.46e-01
GOBP REGULATION OF PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION 5 4.51e-01 7.20e-01 0.316000 2.85e-01 -1.37e-01 2.70e-01 5.95e-01
GOMF IODIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 4.97e-01 7.52e-01 0.316000 -2.41e-01 -2.05e-01 3.51e-01 4.28e-01
DNA Damage Recognition in GG-NER 36 3.00e-03 3.21e-02 0.316000 2.37e-01 -2.09e-01 1.40e-02 2.96e-02
GOCC N TERMINAL PROTEIN ACETYLTRANSFERASE COMPLEX 9 2.72e-01 5.69e-01 0.316000 -8.57e-02 -3.04e-01 6.56e-01 1.14e-01
GOBP NEUROEPITHELIAL CELL DIFFERENTIATION 42 1.60e-03 1.99e-02 0.316000 3.13e-01 -4.33e-02 4.49e-04 6.27e-01
GOCC INNER ACROSOMAL MEMBRANE 5 4.70e-01 7.31e-01 0.316000 -3.16e-01 6.62e-03 2.21e-01 9.80e-01
GOBP PROTEIN O LINKED GLYCOSYLATION VIA THREONINE 10 2.47e-01 5.43e-01 0.316000 1.85e-01 2.56e-01 3.12e-01 1.61e-01
Signaling by WNT in cancer 32 8.96e-03 7.29e-02 0.316000 3.13e-01 4.15e-02 2.17e-03 6.85e-01
GOBP NITRIC OXIDE CGMP MEDIATED SIGNALING 9 2.72e-01 5.69e-01 0.316000 3.05e-01 8.20e-02 1.13e-01 6.70e-01
GOBP NEGATIVE REGULATION OF ACTION POTENTIAL 6 4.10e-01 6.91e-01 0.316000 2.34e-02 3.15e-01 9.21e-01 1.82e-01
GOBP BRANCHED CHAIN AMINO ACID TRANSPORT 13 1.62e-01 4.45e-01 0.316000 2.65e-01 1.72e-01 9.79e-02 2.84e-01
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK 27 1.48e-02 1.04e-01 0.316000 3.02e-01 -9.07e-02 6.54e-03 4.14e-01
GOBP DIENCEPHALON DEVELOPMENT 75 1.01e-05 2.91e-04 0.316000 3.11e-01 -5.21e-02 3.13e-06 4.35e-01
GOCC MICROTUBULE ORGANIZING CENTER ATTACHMENT SITE 11 1.73e-01 4.59e-01 0.316000 -1.57e-01 2.74e-01 3.68e-01 1.16e-01
GOBP INNER DYNEIN ARM ASSEMBLY 15 1.08e-01 3.54e-01 0.316000 2.10e-02 3.15e-01 8.88e-01 3.47e-02
GOBP REGULATION OF AUTOPHAGOSOME ASSEMBLY 45 1.45e-03 1.86e-02 0.316000 3.08e-01 6.78e-02 3.47e-04 4.31e-01
GOBP POSITIVE REGULATION OF VASCULOGENESIS 12 1.67e-01 4.52e-01 0.316000 3.15e-01 1.46e-02 5.87e-02 9.30e-01
GOBP HAIR CYCLE PHASE 9 2.35e-01 5.32e-01 0.316000 2.17e-01 -2.29e-01 2.60e-01 2.34e-01
GOBP THIAMINE TRANSPORT 8 2.89e-01 5.86e-01 0.315000 3.06e-01 -7.51e-02 1.33e-01 7.13e-01
rRNA processing in the nucleus and cytosol 181 2.74e-12 3.12e-10 0.315000 -2.74e-02 -3.14e-01 5.26e-01 2.96e-13
GOBP MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER 13 1.35e-01 4.02e-01 0.315000 3.10e-01 -5.85e-02 5.30e-02 7.15e-01
GOBP REGULATION OF ENDOTHELIAL CELL DEVELOPMENT 18 7.67e-02 2.92e-01 0.315000 2.96e-01 1.10e-01 2.99e-02 4.19e-01
GRB2 events in EGFR signaling 13 1.24e-01 3.84e-01 0.315000 1.91e-01 -2.51e-01 2.34e-01 1.17e-01
GOBP REGULATION OF DNA TOPOISOMERASE ATP HYDROLYZING ACTIVITY 5 4.59e-01 7.24e-01 0.315000 -3.01e-01 9.30e-02 2.44e-01 7.19e-01
GOBP TRANS SYNAPTIC SIGNALING BY TRANS SYNAPTIC COMPLEX 7 3.75e-01 6.61e-01 0.315000 2.71e-01 1.61e-01 2.14e-01 4.62e-01
GOBP FIBROBLAST ACTIVATION 15 1.16e-01 3.70e-01 0.315000 3.00e-01 9.55e-02 4.40e-02 5.22e-01
GOMF DOUBLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY 6 4.28e-01 7.05e-01 0.315000 -1.31e-01 -2.87e-01 5.78e-01 2.24e-01
GOBP INTESTINE SMOOTH MUSCLE CONTRACTION 8 2.88e-01 5.85e-01 0.315000 3.02e-01 -9.05e-02 1.39e-01 6.58e-01
GOBP MICROTUBULE ANCHORING 23 3.32e-02 1.77e-01 0.315000 3.14e-01 2.09e-02 9.06e-03 8.62e-01
Hormone ligand-binding receptors 13 1.27e-01 3.89e-01 0.315000 -2.76e-01 1.51e-01 8.47e-02 3.45e-01
GOBP MITOCHONDRIAL ATP TRANSMEMBRANE TRANSPORT 6 4.27e-01 7.04e-01 0.315000 -2.92e-01 -1.17e-01 2.15e-01 6.20e-01
GOBP WOUND HEALING INVOLVED IN INFLAMMATORY RESPONSE 8 3.22e-01 6.14e-01 0.315000 -1.23e-01 -2.90e-01 5.47e-01 1.56e-01
GOMF PHOSPHOLIPASE ACTIVATOR ACTIVITY 15 1.08e-01 3.55e-01 0.315000 -1.74e-02 -3.14e-01 9.07e-01 3.50e-02
GOBP HYPOTHALAMUS CELL MIGRATION 6 4.35e-01 7.10e-01 0.315000 1.88e-01 2.52e-01 4.24e-01 2.85e-01
GOBP ATTACHMENT OF GPI ANCHOR TO PROTEIN 6 4.31e-01 7.07e-01 0.315000 -2.76e-01 -1.51e-01 2.41e-01 5.22e-01
Downregulation of SMAD2/3:SMAD4 transcriptional activity 29 1.19e-02 8.90e-02 0.315000 3.10e-01 -5.39e-02 3.86e-03 6.16e-01
Vitamin B1 (thiamin) metabolism 5 4.56e-01 7.22e-01 0.314000 1.23e-01 -2.89e-01 6.33e-01 2.63e-01
GOBP THIAMINE DIPHOSPHATE METABOLIC PROCESS 5 4.56e-01 7.22e-01 0.314000 1.23e-01 -2.89e-01 6.33e-01 2.63e-01
GOBP PROTEASOME ASSEMBLY 12 1.82e-01 4.71e-01 0.314000 -1.02e-01 -2.97e-01 5.42e-01 7.46e-02
GOBP DNA METHYLATION DEPENDENT HETEROCHROMATIN FORMATION 32 7.39e-03 6.34e-02 0.314000 3.06e-01 -7.02e-02 2.72e-03 4.92e-01
GOCC U12 TYPE SPLICEOSOMAL COMPLEX 25 2.64e-02 1.54e-01 0.314000 -4.61e-02 -3.11e-01 6.90e-01 7.17e-03
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PIGMENTATION 9 2.38e-01 5.35e-01 0.314000 2.47e-01 -1.94e-01 2.00e-01 3.13e-01
GOBP NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS 9 2.41e-01 5.38e-01 0.314000 2.66e-01 -1.66e-01 1.67e-01 3.89e-01
GOBP REGULATION OF ENDOTHELIAL TUBE MORPHOGENESIS 6 4.07e-01 6.89e-01 0.313000 2.57e-02 -3.12e-01 9.13e-01 1.85e-01
GOBP MORPHOGENESIS OF AN EPITHELIAL FOLD 23 2.62e-02 1.53e-01 0.313000 1.92e-01 -2.48e-01 1.11e-01 3.97e-02
GOBP NEURON PROJECTION MAINTENANCE 11 2.16e-01 5.11e-01 0.313000 2.82e-01 1.36e-01 1.05e-01 4.36e-01
GOCC CCR4 NOT CORE COMPLEX 6 4.20e-01 6.99e-01 0.313000 3.10e-01 4.40e-02 1.89e-01 8.52e-01
GOBP ESTROGEN BIOSYNTHETIC PROCESS 11 1.77e-01 4.64e-01 0.313000 1.61e-01 -2.69e-01 3.56e-01 1.23e-01
GOBP NEGATIVE REGULATION OF POST TRANSCRIPTIONAL GENE SILENCING 13 1.50e-01 4.28e-01 0.313000 3.12e-01 2.45e-02 5.14e-02 8.79e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA SINGLE STRAND ANNEALING 6 3.95e-01 6.77e-01 0.313000 1.14e-01 -2.92e-01 6.30e-01 2.16e-01
GOBP CELLULAR RESPONSE TO COLD 13 1.65e-01 4.49e-01 0.313000 2.77e-01 1.45e-01 8.33e-02 3.65e-01
Regulated proteolysis of p75NTR 11 1.75e-01 4.61e-01 0.313000 2.13e-01 -2.29e-01 2.21e-01 1.88e-01
GOBP PURINE NUCLEOBASE BIOSYNTHETIC PROCESS 8 3.27e-01 6.19e-01 0.313000 -1.27e-01 -2.86e-01 5.34e-01 1.61e-01
GOBP COBALAMIN TRANSPORT 8 3.09e-01 6.03e-01 0.313000 1.34e-02 3.13e-01 9.48e-01 1.26e-01
GOBP PHENYLPROPANOID METABOLIC PROCESS 6 3.88e-01 6.72e-01 0.313000 -2.51e-01 1.86e-01 2.87e-01 4.29e-01
GOMF NEUROTRANSMITTER RECEPTOR REGULATOR ACTIVITY 13 1.30e-01 3.94e-01 0.313000 -2.73e-01 1.53e-01 8.83e-02 3.41e-01
GOBP ZYMOGEN INHIBITION 7 3.37e-01 6.27e-01 0.313000 1.22e-01 -2.88e-01 5.76e-01 1.87e-01
GOBP METANEPHRIC MESENCHYME DEVELOPMENT 14 1.10e-01 3.58e-01 0.313000 2.42e-01 -1.98e-01 1.17e-01 1.99e-01
GOBP NEGATIVE REGULATION OF GRANULOCYTE DIFFERENTIATION 8 2.91e-01 5.87e-01 0.313000 -1.10e-01 2.93e-01 5.89e-01 1.52e-01
GOBP POSITIVE REGULATION OF CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION 11 1.89e-01 4.80e-01 0.312000 5.96e-02 -3.07e-01 7.32e-01 7.81e-02
GOMF DIPEPTIDASE ACTIVITY 16 1.13e-01 3.64e-01 0.312000 2.40e-01 2.00e-01 9.59e-02 1.67e-01
Sema4D mediated inhibition of cell attachment and migration 8 3.19e-01 6.11e-01 0.312000 3.06e-01 6.15e-02 1.34e-01 7.63e-01
GOCC ACETYLCHOLINE GATED CHANNEL COMPLEX 17 9.86e-02 3.37e-01 0.312000 -2.34e-01 -2.07e-01 9.47e-02 1.40e-01
GOBP POSITIVE REGULATION OF PROTEIN ACETYLATION 14 1.15e-01 3.67e-01 0.312000 2.88e-01 -1.22e-01 6.24e-02 4.30e-01
GOMF VOLTAGE GATED SODIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL 5 4.67e-01 7.29e-01 0.312000 -3.03e-01 7.56e-02 2.41e-01 7.70e-01
EGFR interacts with phospholipase C-gamma 9 2.64e-01 5.61e-01 0.312000 1.53e-02 -3.12e-01 9.36e-01 1.05e-01
GOBP REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS 8 3.33e-01 6.24e-01 0.312000 2.70e-01 1.56e-01 1.86e-01 4.45e-01
GOCC PIP BODY 5 4.55e-01 7.22e-01 0.312000 -2.14e-01 2.27e-01 4.07e-01 3.80e-01
GOBP NEGATIVE REGULATION OF CELL KILLING 28 2.21e-02 1.36e-01 0.312000 -2.49e-01 -1.88e-01 2.25e-02 8.58e-02
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 19 5.04e-02 2.26e-01 0.312000 2.21e-01 -2.20e-01 9.56e-02 9.66e-02
Peptide hormone biosynthesis 11 1.83e-01 4.73e-01 0.312000 -2.86e-01 1.24e-01 1.01e-01 4.75e-01
GOMF MYRISTOYLTRANSFERASE ACTIVITY 10 2.40e-01 5.36e-01 0.312000 3.07e-01 5.48e-02 9.30e-02 7.64e-01
GOBP ALDITOL CATABOLIC PROCESS 6 4.36e-01 7.10e-01 0.312000 -2.83e-01 -1.30e-01 2.30e-01 5.81e-01
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC DEPRESSION 6 4.13e-01 6.94e-01 0.312000 -3.11e-01 1.49e-02 1.87e-01 9.49e-01
GOBP MEIOTIC CHROMOSOME SEPARATION 10 2.38e-01 5.34e-01 0.311000 3.09e-01 3.81e-02 9.05e-02 8.35e-01
GOBP POSITIVE REGULATION OF NON MOTILE CILIUM ASSEMBLY 7 3.33e-01 6.24e-01 0.311000 2.22e-01 -2.18e-01 3.08e-01 3.18e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION INDEPENDENT DECAY 7 3.34e-01 6.25e-01 0.311000 2.47e-01 -1.89e-01 2.57e-01 3.86e-01
GOCC PROTEIN PHOSPHATASE TYPE 2A COMPLEX 17 9.56e-02 3.31e-01 0.311000 2.84e-01 1.27e-01 4.24e-02 3.66e-01
GOBP PERISTALSIS 12 1.55e-01 4.36e-01 0.311000 2.72e-01 -1.52e-01 1.03e-01 3.62e-01
GOMF PHOSPHATIDATE PHOSPHATASE ACTIVITY 14 1.21e-01 3.79e-01 0.311000 -7.22e-02 3.03e-01 6.40e-01 4.98e-02
GOMF LIPASE BINDING 7 3.69e-01 6.57e-01 0.311000 -3.06e-01 -5.48e-02 1.60e-01 8.02e-01
GOMF FILAMIN BINDING 14 1.46e-01 4.21e-01 0.311000 2.78e-01 1.39e-01 7.14e-02 3.68e-01
GOBP RESPONSE TO INTERLEUKIN 13 5 5.07e-01 7.58e-01 0.311000 -2.55e-01 -1.79e-01 3.24e-01 4.89e-01
GOBP REGULATION OF ENAMEL MINERALIZATION 8 3.38e-01 6.28e-01 0.311000 -2.42e-01 -1.96e-01 2.37e-01 3.37e-01
GOBP ERYTHROSE 4 PHOSPHATE PHOSPHOENOLPYRUVATE FAMILY AMINO ACID METABOLIC PROCESS 18 6.44e-02 2.64e-01 0.311000 -1.01e-01 2.94e-01 4.58e-01 3.07e-02
GOBP POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 20 5.03e-02 2.26e-01 0.311000 3.06e-01 -5.55e-02 1.78e-02 6.67e-01
GOMF MYOSIN II BINDING 12 1.97e-01 4.90e-01 0.311000 1.85e-01 2.50e-01 2.66e-01 1.34e-01
GOBP REGULATION OF CORTICOSTEROID HORMONE SECRETION 16 1.00e-01 3.40e-01 0.311000 3.09e-01 2.97e-02 3.21e-02 8.37e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE REGULATOR ACTIVITY 31 1.40e-02 1.00e-01 0.311000 -1.24e-01 -2.85e-01 2.32e-01 6.01e-03
GOBP RIG I SIGNALING PATHWAY 27 1.75e-02 1.16e-01 0.311000 3.04e-01 -6.40e-02 6.23e-03 5.65e-01
GOBP RESPONSE TO CELL CYCLE CHECKPOINT SIGNALING 8 2.90e-01 5.86e-01 0.311000 2.69e-01 -1.56e-01 1.88e-01 4.44e-01
GOMF AMINOPEPTIDASE ACTIVITY 38 5.99e-03 5.39e-02 0.311000 2.10e-01 2.29e-01 2.50e-02 1.46e-02
GOBP REGULATION OF CELL PROLIFERATION IN BONE MARROW 8 2.87e-01 5.85e-01 0.311000 1.93e-01 -2.43e-01 3.44e-01 2.34e-01
Fatty acids 15 1.27e-01 3.89e-01 0.311000 -1.26e-01 -2.84e-01 3.98e-01 5.69e-02
GOMF G PROTEIN COUPLED SEROTONIN RECEPTOR ACTIVITY 21 5.44e-02 2.38e-01 0.311000 1.03e-01 2.93e-01 4.14e-01 2.01e-02
GOBP RESPONSE TO SALT 22 3.74e-02 1.90e-01 0.310000 3.04e-01 -6.11e-02 1.34e-02 6.20e-01
GOBP REGULATION OF RIG I SIGNALING PATHWAY 19 6.80e-02 2.72e-01 0.310000 3.06e-01 5.33e-02 2.10e-02 6.87e-01
Collagen chain trimerization 42 1.70e-03 2.08e-02 0.310000 -2.92e-01 1.06e-01 1.07e-03 2.36e-01
GOCC CLATHRIN COATED PIT 75 3.46e-05 8.68e-04 0.310000 2.85e-01 1.23e-01 2.02e-05 6.45e-02
Interleukin-12 signaling 43 2.35e-03 2.66e-02 0.310000 -6.05e-02 -3.04e-01 4.92e-01 5.55e-04
GOBP REGULATION OF TYPE B PANCREATIC CELL DEVELOPMENT 9 2.89e-01 5.86e-01 0.310000 2.90e-01 1.10e-01 1.32e-01 5.68e-01
GOBP AGGREPHAGY 16 8.48e-02 3.12e-01 0.310000 2.67e-01 -1.58e-01 6.44e-02 2.75e-01
GOBP PROTEIN FOLDING IN ENDOPLASMIC RETICULUM 12 2.00e-01 4.93e-01 0.310000 -2.29e-01 -2.09e-01 1.70e-01 2.10e-01
GOCC CALCITONIN FAMILY RECEPTOR COMPLEX 5 4.74e-01 7.34e-01 0.310000 -3.02e-01 7.01e-02 2.42e-01 7.86e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE 18 8.72e-02 3.16e-01 0.310000 1.53e-01 2.69e-01 2.61e-01 4.78e-02
GOBP BRANCH ELONGATION OF AN EPITHELIUM 20 5.87e-02 2.49e-01 0.310000 -4.13e-02 -3.07e-01 7.49e-01 1.75e-02
RHOT1 GTPase cycle 5 4.60e-01 7.24e-01 0.310000 2.31e-01 -2.06e-01 3.71e-01 4.25e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB 25 2.85e-02 1.62e-01 0.310000 -3.19e-02 -3.08e-01 7.82e-01 7.68e-03
GOBP THERMOCEPTION 8 2.92e-01 5.89e-01 0.310000 -2.64e-01 1.62e-01 1.97e-01 4.26e-01
GOBP NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 25 2.86e-02 1.62e-01 0.310000 3.08e-01 3.21e-02 7.69e-03 7.81e-01
GOMF LIPASE INHIBITOR ACTIVITY 17 7.70e-02 2.93e-01 0.310000 -9.86e-02 2.93e-01 4.81e-01 3.62e-02
Regulation of MITF-M-dependent genes involved in apoptosis 19 6.70e-02 2.70e-01 0.310000 3.08e-01 3.12e-02 2.01e-02 8.14e-01
GOBP PROTEIN LOCALIZATION TO PRESYNAPSE 11 1.84e-01 4.74e-01 0.310000 -1.61e-01 2.64e-01 3.55e-01 1.29e-01
GOBP RESPONSE TO X RAY 27 1.70e-02 1.14e-01 0.310000 2.93e-01 -1.01e-01 8.49e-03 3.64e-01
GOCC ESC E Z COMPLEX 15 1.00e-01 3.40e-01 0.309000 2.71e-01 -1.49e-01 6.91e-02 3.16e-01
GOBP REGULATION OF RENAL SODIUM EXCRETION 8 2.90e-01 5.87e-01 0.309000 2.47e-01 -1.86e-01 2.26e-01 3.63e-01
GOBP SERINE FAMILY AMINO ACID CATABOLIC PROCESS 11 1.96e-01 4.89e-01 0.309000 3.03e-01 -6.01e-02 8.13e-02 7.30e-01
GOMF CYCLASE ACTIVITY 20 6.88e-02 2.74e-01 0.309000 2.37e-01 1.99e-01 6.66e-02 1.24e-01
GOBP REGULATION OF CAMP MEDIATED SIGNALING 21 5.51e-02 2.40e-01 0.309000 -2.95e-01 -9.47e-02 1.95e-02 4.53e-01
GOBP RESPONSE TO INTERLEUKIN 9 5 4.63e-01 7.27e-01 0.309000 2.58e-01 -1.70e-01 3.17e-01 5.10e-01
GOBP SPONTANEOUS SYNAPTIC TRANSMISSION 14 1.51e-01 4.30e-01 0.309000 2.68e-01 1.54e-01 8.24e-02 3.18e-01
GOBP REGULATION OF HYALURONAN BIOSYNTHETIC PROCESS 8 2.90e-01 5.87e-01 0.309000 2.37e-01 -1.99e-01 2.47e-01 3.29e-01
GOBP POSITIVE REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT 8 3.34e-01 6.24e-01 0.309000 2.90e-01 1.07e-01 1.56e-01 5.99e-01
GOCC CIS GOLGI NETWORK MEMBRANE 10 2.14e-01 5.09e-01 0.309000 1.88e-01 -2.46e-01 3.04e-01 1.79e-01
VLDLR internalisation and degradation 16 9.39e-02 3.28e-01 0.309000 3.03e-01 -6.00e-02 3.58e-02 6.78e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS 15 1.35e-01 4.03e-01 0.309000 2.16e-01 2.20e-01 1.47e-01 1.39e-01
Carnitine shuttle 13 1.75e-01 4.61e-01 0.309000 2.61e-01 1.65e-01 1.03e-01 3.03e-01
GOBP L GLUTAMATE IMPORT 39 5.45e-03 5.02e-02 0.309000 2.53e-01 1.77e-01 6.25e-03 5.58e-02
GOMF TRANSCRIPTION REGULATOR ACTIVATOR ACTIVITY 7 3.40e-01 6.29e-01 0.309000 2.25e-01 -2.11e-01 3.02e-01 3.33e-01
GOBP NEGATIVE REGULATION OF VASOCONSTRICTION 12 1.81e-01 4.70e-01 0.309000 3.08e-01 1.54e-02 6.44e-02 9.26e-01
GOBP CATECHOL CONTAINING COMPOUND CATABOLIC PROCESS 6 4.01e-01 6.83e-01 0.309000 -1.49e-01 2.70e-01 5.28e-01 2.52e-01
GOBP WYBUTOSINE METABOLIC PROCESS 6 4.18e-01 6.99e-01 0.309000 3.07e-01 -2.78e-02 1.92e-01 9.06e-01
GOBP HEMATOPOIETIC STEM CELL PROLIFERATION 33 8.52e-03 7.03e-02 0.308000 3.08e-01 -1.71e-02 2.20e-03 8.65e-01
GOBP NEGATIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT 12 1.98e-01 4.92e-01 0.308000 2.74e-01 1.41e-01 1.00e-01 3.97e-01
GOMF ANNEALING ACTIVITY 8 3.23e-01 6.15e-01 0.308000 3.07e-01 3.28e-02 1.33e-01 8.72e-01
RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known 37 5.95e-03 5.37e-02 0.308000 3.00e-01 6.92e-02 1.56e-03 4.66e-01
GOBP NATURAL KILLER CELL CYTOKINE PRODUCTION 9 2.82e-01 5.79e-01 0.308000 -3.70e-02 -3.06e-01 8.47e-01 1.12e-01
GOMF SODIUM CHANNEL ACTIVITY 47 1.09e-03 1.47e-02 0.308000 -3.07e-01 3.17e-02 2.77e-04 7.07e-01
GOBP DENDRITIC CELL APOPTOTIC PROCESS 11 1.88e-01 4.79e-01 0.308000 1.45e-01 -2.72e-01 4.05e-01 1.18e-01
GOBP POSITIVE REGULATION OF HEMOGLOBIN BIOSYNTHETIC PROCESS 6 4.51e-01 7.20e-01 0.308000 1.94e-01 2.39e-01 4.10e-01 3.11e-01
GOBP POSITIVE REGULATION OF PHOSPHOLIPID TRANSLOCATION 5 5.14e-01 7.61e-01 0.308000 -1.86e-01 -2.46e-01 4.72e-01 3.41e-01
GOBP HYPOTHALAMUS CELL DIFFERENTIATION 12 1.59e-01 4.42e-01 0.308000 2.47e-01 -1.83e-01 1.38e-01 2.71e-01
GOBP REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY 7 3.95e-01 6.78e-01 0.308000 2.08e-01 2.27e-01 3.40e-01 2.98e-01
GOBP PHAGOSOME ACIDIFICATION 7 3.79e-01 6.65e-01 0.308000 6.41e-02 3.01e-01 7.69e-01 1.68e-01
Aspartate and asparagine metabolism 11 2.29e-01 5.27e-01 0.307000 2.74e-01 1.40e-01 1.16e-01 4.20e-01
GOBP POSITIVE REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION 9 2.54e-01 5.52e-01 0.307000 1.73e-01 -2.54e-01 3.68e-01 1.87e-01
GOBP CO TRANSCRIPTIONAL RNA 3 END PROCESSING CLEAVAGE AND POLYADENYLATION PATHWAY 10 2.20e-01 5.15e-01 0.307000 1.60e-01 -2.63e-01 3.82e-01 1.51e-01
GOBP REGULATION OF VACUOLE ORGANIZATION 56 4.49e-04 7.20e-03 0.307000 3.00e-01 6.50e-02 1.02e-04 4.00e-01
GOBP NEGATIVE REGULATION OF AMYLOID FIBRIL FORMATION 12 1.89e-01 4.80e-01 0.307000 -5.00e-02 -3.03e-01 7.64e-01 6.91e-02
GOBP REGULATION OF SULFUR METABOLIC PROCESS 13 1.59e-01 4.42e-01 0.307000 3.07e-01 1.27e-02 5.54e-02 9.37e-01
GOBP APICAL PROTEIN LOCALIZATION 14 1.40e-01 4.10e-01 0.307000 3.06e-01 2.17e-02 4.72e-02 8.88e-01
GOBP FORMATE METABOLIC PROCESS 6 4.05e-01 6.88e-01 0.307000 -2.73e-01 1.40e-01 2.46e-01 5.54e-01
GOBP REGULATION OF MAST CELL DEGRANULATION 24 2.70e-02 1.56e-01 0.307000 2.72e-01 -1.43e-01 2.12e-02 2.25e-01
GOMF RNA POLYMERASE II ACTIVITY 9 2.54e-01 5.52e-01 0.307000 2.43e-01 -1.87e-01 2.06e-01 3.31e-01
GOBP POSITIVE REGULATION OF ACROSOME REACTION 11 1.87e-01 4.78e-01 0.307000 -2.27e-01 2.07e-01 1.93e-01 2.35e-01
GOBP REGULATION OF RESTING MEMBRANE POTENTIAL 10 2.33e-01 5.31e-01 0.307000 -3.01e-01 5.76e-02 9.89e-02 7.53e-01
GOBP REGULATION OF PROSTATIC BUD FORMATION 5 5.08e-01 7.59e-01 0.307000 -2.90e-01 -1.00e-01 2.62e-01 6.98e-01
N-Glycan antennae elongation 15 1.39e-01 4.10e-01 0.307000 2.15e-01 2.19e-01 1.50e-01 1.42e-01
GOBP POSITIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 9 2.94e-01 5.91e-01 0.307000 -8.51e-02 -2.95e-01 6.58e-01 1.26e-01
GOBP GLUCOCORTICOID BIOSYNTHETIC PROCESS 16 9.40e-02 3.28e-01 0.307000 -2.92e-01 9.41e-02 4.33e-02 5.15e-01
Regulation of gene expression by Hypoxia-inducible Factor 10 2.34e-01 5.31e-01 0.306000 3.02e-01 -5.31e-02 9.84e-02 7.71e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT POSTSYNAPTIC ENDOSOME TO LYSOSOME 7 3.51e-01 6.41e-01 0.306000 -2.79e-01 1.27e-01 2.02e-01 5.59e-01
GOBP NEGATIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 6 4.08e-01 6.90e-01 0.306000 1.29e-01 -2.78e-01 5.86e-01 2.38e-01
H139Hfs13* PPM1K causes a mild variant of MSUD 5 4.88e-01 7.46e-01 0.306000 3.05e-01 -2.78e-02 2.37e-01 9.14e-01
Maple Syrup Urine Disease 5 4.88e-01 7.46e-01 0.306000 3.05e-01 -2.78e-02 2.37e-01 9.14e-01
GOBP RAP PROTEIN SIGNAL TRANSDUCTION 12 1.66e-01 4.50e-01 0.306000 2.73e-01 -1.38e-01 1.01e-01 4.07e-01
GOMF G RICH STRAND TELOMERIC DNA BINDING 10 2.22e-01 5.18e-01 0.306000 1.55e-01 -2.64e-01 3.97e-01 1.48e-01
GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS 10 2.23e-01 5.19e-01 0.306000 -1.44e-01 2.70e-01 4.31e-01 1.39e-01
GOBP NEUTROPHIL MEDIATED KILLING OF SYMBIONT CELL 13 1.45e-01 4.18e-01 0.306000 -2.83e-01 1.17e-01 7.74e-02 4.65e-01
GOBP TRANSCRIPTION DEPENDENT TETHERING OF RNA POLYMERASE II GENE DNA AT NUCLEAR PERIPHERY 7 3.46e-01 6.36e-01 0.306000 2.32e-01 -2.00e-01 2.89e-01 3.59e-01
GOBP ASYMMETRIC NEUROBLAST DIVISION 5 5.18e-01 7.63e-01 0.306000 2.50e-01 1.77e-01 3.34e-01 4.93e-01
Signaling by FGFR in disease 62 2.42e-04 4.41e-03 0.306000 2.88e-01 1.03e-01 8.67e-05 1.62e-01
GOBP POSITIVE REGULATION OF RECEPTOR BINDING 5 4.71e-01 7.31e-01 0.306000 1.70e-01 -2.55e-01 5.11e-01 3.24e-01
GOBP NEGATIVE REGULATION OF MEMBRANE POTENTIAL 13 1.68e-01 4.53e-01 0.306000 -6.07e-02 -3.00e-01 7.05e-01 6.12e-02
GOBP REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I 15 1.40e-01 4.11e-01 0.306000 2.43e-01 1.85e-01 1.03e-01 2.14e-01
Formation of definitive endoderm 16 9.42e-02 3.29e-01 0.306000 2.87e-01 -1.05e-01 4.67e-02 4.67e-01
GOBP REGULATION OF KERATINOCYTE MIGRATION 14 1.61e-01 4.43e-01 0.306000 2.18e-01 2.14e-01 1.57e-01 1.65e-01
GOBP REGULATION OF FEEDING BEHAVIOR 27 2.91e-02 1.63e-01 0.306000 1.80e-01 2.47e-01 1.06e-01 2.61e-02
PI5P Regulates TP53 Acetylation 8 3.33e-01 6.24e-01 0.306000 3.01e-01 5.51e-02 1.41e-01 7.87e-01
GOBP SPERM DNA CONDENSATION 17 8.66e-02 3.15e-01 0.306000 -3.02e-01 4.58e-02 3.09e-02 7.44e-01
Meiotic recombination 52 4.74e-04 7.54e-03 0.306000 1.05e-01 -2.87e-01 1.92e-01 3.41e-04
GOBP NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING 6 4.41e-01 7.13e-01 0.306000 2.99e-01 6.35e-02 2.05e-01 7.88e-01
Hyaluronan biosynthesis and export 5 5.11e-01 7.60e-01 0.306000 9.84e-02 2.89e-01 7.03e-01 2.63e-01
GOCC PML BODY 103 4.98e-07 2.12e-05 0.306000 3.05e-01 -1.10e-02 8.53e-08 8.47e-01
GOBP POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION 31 1.74e-02 1.16e-01 0.305000 2.45e-01 1.83e-01 1.83e-02 7.82e-02
GOMF CASPASE BINDING 13 1.73e-01 4.60e-01 0.305000 -9.04e-02 -2.92e-01 5.72e-01 6.85e-02
GOCC EMC COMPLEX 9 2.60e-01 5.57e-01 0.305000 1.66e-01 -2.56e-01 3.88e-01 1.84e-01
GOCC PROTEASOME CORE COMPLEX BETA SUBUNIT COMPLEX 11 2.38e-01 5.35e-01 0.305000 -1.89e-01 -2.40e-01 2.79e-01 1.68e-01
GOBP SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY 19 8.43e-02 3.12e-01 0.305000 2.34e-01 1.95e-01 7.69e-02 1.40e-01
Regulation of PTEN mRNA translation 25 3.28e-02 1.75e-01 0.305000 3.00e-01 5.36e-02 9.32e-03 6.43e-01
Regulation of expression of SLITs and ROBOs 149 1.21e-09 8.82e-08 0.305000 -2.51e-02 -3.04e-01 5.97e-01 1.47e-10
SOS-mediated signalling 7 3.94e-01 6.76e-01 0.305000 2.83e-01 1.13e-01 1.94e-01 6.04e-01
GOBP MYELOID PROGENITOR CELL DIFFERENTIATION 9 2.63e-01 5.59e-01 0.305000 1.38e-01 -2.72e-01 4.73e-01 1.58e-01
GOBP POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS 17 7.75e-02 2.94e-01 0.305000 2.16e-01 -2.15e-01 1.23e-01 1.24e-01
SUMOylation of DNA methylation proteins 16 1.24e-01 3.83e-01 0.305000 1.67e-01 2.55e-01 2.49e-01 7.70e-02
GOBP PHOSPHATIDYLSERINE METABOLIC PROCESS 23 4.73e-02 2.19e-01 0.305000 2.81e-01 1.18e-01 1.97e-02 3.26e-01
GOBP REGULATION OF MONOATOMIC ANION TRANSPORT 13 1.74e-01 4.60e-01 0.305000 2.93e-01 8.27e-02 6.70e-02 6.06e-01
GRB7 events in ERBB2 signaling 5 4.94e-01 7.51e-01 0.305000 -1.14e-02 3.05e-01 9.65e-01 2.38e-01
GOBP RESPONSE TO SYMBIONT 6 4.43e-01 7.15e-01 0.305000 -2.98e-01 -6.51e-02 2.07e-01 7.82e-01
GOMF MANNOSE BINDING 24 2.89e-02 1.63e-01 0.305000 -2.78e-01 1.26e-01 1.86e-02 2.85e-01
GOCC NEURONAL DENSE CORE VESICLE MEMBRANE 5 4.87e-01 7.45e-01 0.305000 -5.99e-02 2.99e-01 8.17e-01 2.47e-01
GOBP MESONEPHRIC DUCT DEVELOPMENT 8 3.02e-01 5.97e-01 0.305000 1.83e-01 -2.44e-01 3.70e-01 2.33e-01
GOMF SYNDECAN BINDING 5 5.18e-01 7.63e-01 0.305000 -2.70e-01 -1.41e-01 2.95e-01 5.85e-01
Mitochondrial translation termination 87 5.54e-06 1.72e-04 0.305000 -5.51e-03 -3.05e-01 9.29e-01 8.99e-07
GOBP MICTURITION 8 3.03e-01 5.97e-01 0.305000 -2.55e-01 1.66e-01 2.11e-01 4.15e-01
GOBP CONDITIONED PLACE PREFERENCE 5 4.82e-01 7.41e-01 0.305000 -9.47e-02 2.89e-01 7.14e-01 2.62e-01
GOBP NEGATIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE 8 3.04e-01 5.98e-01 0.304000 -1.56e-01 2.62e-01 4.46e-01 2.00e-01
GOMF INTERLEUKIN 1 BINDING 9 2.83e-01 5.80e-01 0.304000 -3.04e-01 8.19e-03 1.14e-01 9.66e-01
GOBP REGULATION OF PHOSPHOLIPID TRANSPORT 15 1.42e-01 4.14e-01 0.304000 -1.70e-01 -2.52e-01 2.53e-01 9.08e-02
GOBP REGULATION OF GAMMA AMINOBUTYRIC ACID SECRETION 8 3.56e-01 6.45e-01 0.304000 2.15e-01 2.16e-01 2.93e-01 2.91e-01
GOBP REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 35 1.05e-02 8.18e-02 0.304000 2.58e-01 1.61e-01 8.21e-03 9.97e-02
GOBP REGULATION OF CELLULAR RESPONSE TO OSMOTIC STRESS 13 1.74e-01 4.60e-01 0.304000 2.95e-01 7.55e-02 6.60e-02 6.37e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY 34 9.15e-03 7.41e-02 0.304000 -3.04e-01 -1.63e-02 2.19e-03 8.69e-01
GOCC RIBBON SYNAPSE 15 1.31e-01 3.95e-01 0.304000 5.38e-02 2.99e-01 7.18e-01 4.49e-02
GOBP MEIOTIC CYTOKINESIS 8 3.03e-01 5.97e-01 0.304000 2.01e-01 -2.27e-01 3.24e-01 2.65e-01
GOBP GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT 42 2.79e-03 3.05e-02 0.304000 3.03e-01 -1.90e-02 6.77e-04 8.31e-01
GOBP DEHYDROASCORBIC ACID TRANSPORT 9 2.89e-01 5.86e-01 0.304000 -3.03e-01 -1.56e-02 1.15e-01 9.35e-01
GOBP CENTRAL NERVOUS SYSTEM MYELIN FORMATION 8 3.05e-01 5.98e-01 0.304000 -2.45e-01 1.79e-01 2.30e-01 3.81e-01
GOBP NEGATIVE REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 9 3.14e-01 6.07e-01 0.303000 2.21e-01 2.08e-01 2.51e-01 2.79e-01
GOBP REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT 10 2.28e-01 5.26e-01 0.303000 1.52e-01 -2.63e-01 4.06e-01 1.50e-01
GOMF RETINOIC ACID 4 HYDROXYLASE ACTIVITY 10 2.75e-01 5.72e-01 0.303000 2.40e-01 1.85e-01 1.88e-01 3.10e-01
GOMF SEQUENCE SPECIFIC MRNA BINDING 12 1.89e-01 4.80e-01 0.303000 3.03e-01 -6.92e-04 6.88e-02 9.97e-01
GOBP REGULATION OF AUTOPHAGOSOME MATURATION 16 9.59e-02 3.32e-01 0.303000 2.73e-01 -1.31e-01 5.84e-02 3.63e-01
GOBP MUSCULAR SEPTUM MORPHOGENESIS 5 5.09e-01 7.59e-01 0.303000 5.39e-02 2.98e-01 8.35e-01 2.48e-01
GOCC INTERPHOTORECEPTOR MATRIX 6 4.11e-01 6.92e-01 0.303000 -1.81e-01 2.43e-01 4.42e-01 3.03e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION 23 4.81e-02 2.21e-01 0.303000 2.85e-01 1.03e-01 1.79e-02 3.93e-01
GOBP CELLULAR RESPONSE TO ALDEHYDE 16 1.20e-01 3.76e-01 0.303000 2.90e-01 8.90e-02 4.48e-02 5.38e-01
GOBP INTERCELLULAR TRANSPORT 10 2.34e-01 5.31e-01 0.303000 -1.09e-01 2.83e-01 5.51e-01 1.21e-01
GOBP NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY 28 1.80e-02 1.18e-01 0.303000 2.93e-01 -7.79e-02 7.30e-03 4.75e-01
GOBP PROTEIN DESUMOYLATION 9 2.75e-01 5.72e-01 0.303000 8.02e-02 -2.92e-01 6.77e-01 1.29e-01
VLDL assembly 5 5.05e-01 7.57e-01 0.303000 -3.02e-01 -2.74e-02 2.43e-01 9.15e-01
GOMF THIOL OXIDASE ACTIVITY 6 4.22e-01 7.01e-01 0.303000 -8.28e-02 2.91e-01 7.25e-01 2.16e-01
GOBP LIPID GLYCOSYLATION 12 1.76e-01 4.63e-01 0.303000 -1.00e-01 2.86e-01 5.47e-01 8.66e-02
GOBP ICOSANOID CATABOLIC PROCESS 9 2.66e-01 5.62e-01 0.303000 2.58e-01 -1.58e-01 1.80e-01 4.11e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H OXYGEN AS ACCEPTOR 12 2.15e-01 5.10e-01 0.303000 2.31e-01 1.95e-01 1.65e-01 2.42e-01
GOBP NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING 15 1.10e-01 3.59e-01 0.303000 2.61e-01 -1.54e-01 8.04e-02 3.03e-01
GOBP BOX C D SNORNP ASSEMBLY 10 2.32e-01 5.30e-01 0.303000 1.35e-01 -2.71e-01 4.60e-01 1.38e-01
Regulation of NFE2L2 gene expression 8 3.49e-01 6.38e-01 0.302000 2.87e-01 9.61e-02 1.60e-01 6.38e-01
GOCC COLLAGEN TRIMER 83 5.23e-06 1.64e-04 0.302000 -2.56e-01 1.62e-01 5.66e-05 1.10e-02
TRAF6 mediated IRF7 activation 26 3.53e-02 1.84e-01 0.302000 -2.56e-01 -1.61e-01 2.38e-02 1.56e-01
GOBP VESICLE TETHERING INVOLVED IN EXOCYTOSIS 9 3.13e-01 6.06e-01 0.302000 2.63e-01 1.48e-01 1.71e-01 4.41e-01
BBSome-mediated cargo-targeting to cilium 23 3.64e-02 1.87e-01 0.302000 1.03e-01 -2.84e-01 3.92e-01 1.83e-02
GOMF PEPTIDE LYSINE N ACETYLTRANSFERASE ACTIVITY 43 2.25e-03 2.58e-02 0.302000 2.95e-01 -6.63e-02 8.21e-04 4.52e-01
GOBP POSITIVE REGULATION OF RESPIRATORY BURST 7 3.59e-01 6.47e-01 0.302000 -2.60e-01 1.53e-01 2.33e-01 4.82e-01
GOBP MRNA MODIFICATION 19 6.60e-02 2.68e-01 0.302000 8.67e-02 -2.89e-01 5.13e-01 2.90e-02
GOBP DNA TOPOLOGICAL CHANGE 9 3.00e-01 5.95e-01 0.302000 2.97e-01 5.52e-02 1.23e-01 7.74e-01
GOCC PHOTORECEPTOR OUTER SEGMENT MEMBRANE 16 1.23e-01 3.82e-01 0.302000 1.02e-01 2.84e-01 4.80e-01 4.91e-02
GOMF CHOLINE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 3.58e-01 6.47e-01 0.302000 2.51e-01 -1.67e-01 2.50e-01 4.43e-01
GOBP REGULATION OF NMDA RECEPTOR ACTIVITY 14 1.63e-01 4.47e-01 0.302000 -1.30e-01 -2.72e-01 3.99e-01 7.78e-02
GOBP FOREBRAIN VENTRICULAR ZONE PROGENITOR CELL DIVISION 6 4.44e-01 7.16e-01 0.302000 3.00e-01 3.04e-02 2.03e-01 8.97e-01
GOBP POSITIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY 7 4.06e-01 6.88e-01 0.302000 2.67e-01 1.41e-01 2.22e-01 5.18e-01
GOBP CRD MEDIATED MRNA STABILIZATION 11 2.11e-01 5.07e-01 0.302000 6.41e-02 -2.95e-01 7.13e-01 9.05e-02
GOBP BONE TRABECULA FORMATION 11 2.16e-01 5.11e-01 0.302000 2.99e-01 -3.59e-02 8.56e-02 8.37e-01
GOMF NUCLEOSIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 10 2.78e-01 5.75e-01 0.302000 2.57e-01 1.57e-01 1.59e-01 3.89e-01
Diseases of Base Excision Repair 5 4.99e-01 7.53e-01 0.301000 -2.83e-02 3.00e-01 9.13e-01 2.45e-01
GOBP POSITIVE REGULATION OF PROTEIN NEDDYLATION 5 5.15e-01 7.62e-01 0.301000 2.94e-01 6.61e-02 2.55e-01 7.98e-01
GOBP REGULATION OF MUSCLE HYPERTROPHY 71 5.86e-05 1.36e-03 0.301000 3.01e-01 -1.02e-02 1.14e-05 8.81e-01
CD209 (DC-SIGN) signaling 20 5.56e-02 2.41e-01 0.301000 2.73e-01 -1.27e-01 3.44e-02 3.25e-01
GOMF DIACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY 5 4.99e-01 7.53e-01 0.301000 -3.33e-02 2.99e-01 8.97e-01 2.46e-01
Ciprofloxacin ADME 5 5.13e-01 7.61e-01 0.301000 -2.97e-01 -5.15e-02 2.51e-01 8.42e-01
GOBP REGULATION OF MITOTIC RECOMBINATION 7 3.58e-01 6.47e-01 0.301000 2.33e-01 -1.91e-01 2.86e-01 3.82e-01
GOBP REGULATION OF CYTOKINETIC PROCESS 7 3.92e-01 6.75e-01 0.301000 4.68e-02 2.97e-01 8.30e-01 1.73e-01
GOCC GLYCOSYLPHOSPHATIDYLINOSITOL N ACETYLGLUCOSAMINYLTRANSFERASE GPI GNT COMPLEX 6 4.55e-01 7.22e-01 0.301000 -2.89e-01 -8.41e-02 2.20e-01 7.21e-01
GOBP NOREPINEPHRINE BIOSYNTHETIC PROCESS 8 3.16e-01 6.09e-01 0.301000 -1.19e-01 2.77e-01 5.61e-01 1.75e-01
GOMF GLUTAMATE RECEPTOR ACTIVITY 25 3.29e-02 1.75e-01 0.301000 -3.01e-01 2.16e-03 9.19e-03 9.85e-01
Dissolution of Fibrin Clot 13 1.61e-01 4.44e-01 0.301000 -6.16e-02 2.94e-01 7.01e-01 6.60e-02
GOBP ECTODERM DEVELOPMENT 20 7.55e-02 2.90e-01 0.301000 2.78e-01 1.14e-01 3.13e-02 3.75e-01
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING TO IGG ISOTYPES 11 2.07e-01 5.01e-01 0.301000 1.16e-01 -2.77e-01 5.05e-01 1.11e-01
GOMF ICOSANOID BINDING 8 3.11e-01 6.05e-01 0.301000 -2.41e-01 1.80e-01 2.38e-01 3.79e-01
GOCC METHYLOSOME 13 1.88e-01 4.79e-01 0.301000 -1.24e-01 -2.74e-01 4.40e-01 8.72e-02
Antigen Presentation: Folding, assembly and peptide loading of class I MHC 29 1.53e-02 1.07e-01 0.301000 1.34e-01 -2.69e-01 2.12e-01 1.21e-02
GOMF SNRNA BINDING 48 9.71e-04 1.34e-02 0.301000 1.48e-01 -2.62e-01 7.61e-02 1.71e-03
GOBP SPINAL CORD DEVELOPMENT 96 2.43e-06 8.25e-05 0.301000 3.00e-01 1.58e-02 3.69e-07 7.89e-01
GOBP EPINEPHRINE TRANSPORT 11 2.21e-01 5.17e-01 0.301000 1.86e-02 -3.00e-01 9.15e-01 8.49e-02
GOBP MITOCHONDRIAL PROTEIN CATABOLIC PROCESS 10 2.63e-01 5.60e-01 0.300000 4.10e-02 2.98e-01 8.22e-01 1.03e-01
GOBP LIPID HYDROXYLATION 7 3.84e-01 6.69e-01 0.300000 3.00e-01 -6.90e-03 1.69e-01 9.75e-01
GOBP ADHERENS JUNCTION ASSEMBLY 13 1.84e-01 4.74e-01 0.300000 2.86e-01 9.26e-02 7.44e-02 5.63e-01
GOBP AIM2 INFLAMMASOME COMPLEX ASSEMBLY 5 4.94e-01 7.50e-01 0.300000 -7.93e-02 2.90e-01 7.59e-01 2.62e-01
Cellular response to starvation 144 6.43e-09 4.03e-07 0.300000 -6.76e-02 -2.93e-01 1.61e-01 1.31e-09
GOBP REGULATION OF T CIRCLE FORMATION 5 5.32e-01 7.72e-01 0.300000 2.37e-01 1.84e-01 3.58e-01 4.75e-01
GOBP ERBB4 ERBB4 SIGNALING PATHWAY 6 4.65e-01 7.28e-01 0.300000 -2.64e-01 -1.43e-01 2.63e-01 5.43e-01
GOBP POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION 44 3.11e-03 3.29e-02 0.300000 2.92e-01 7.03e-02 8.06e-04 4.20e-01
Interleukin-6 signaling 11 2.20e-01 5.15e-01 0.300000 2.99e-01 -2.94e-02 8.62e-02 8.66e-01
GOBP ORGAN INDUCTION 21 6.05e-02 2.53e-01 0.300000 2.98e-01 3.33e-02 1.80e-02 7.92e-01
GOBP RADIAL GLIA GUIDED PYRAMIDAL NEURON MIGRATION 6 4.47e-01 7.17e-01 0.300000 2.99e-01 2.23e-02 2.04e-01 9.25e-01
GOBP NEGATIVE REGULATION OF KERATINOCYTE DIFFERENTIATION 8 3.19e-01 6.11e-01 0.300000 -2.77e-01 1.16e-01 1.75e-01 5.69e-01
GOBP LYSOSOMAL MEMBRANE ORGANIZATION 15 1.38e-01 4.08e-01 0.300000 -5.49e-02 -2.95e-01 7.13e-01 4.79e-02
SMAD2/3 Phosphorylation Motif Mutants in Cancer 6 4.30e-01 7.06e-01 0.300000 2.90e-01 -7.80e-02 2.19e-01 7.41e-01
TGFBR1 KD Mutants in Cancer 6 4.30e-01 7.06e-01 0.300000 2.90e-01 -7.80e-02 2.19e-01 7.41e-01
GOMF CARBOXYLESTERASE ACTIVITY 6 4.52e-01 7.21e-01 0.300000 -2.95e-01 -5.17e-02 2.10e-01 8.27e-01
GOBP FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX 13 1.54e-01 4.35e-01 0.300000 1.37e-01 -2.67e-01 3.94e-01 9.55e-02
GOBP PROTEIN SIDE CHAIN DEGLUTAMYLATION 5 5.25e-01 7.67e-01 0.300000 -2.78e-01 -1.12e-01 2.82e-01 6.63e-01
GOMF HISTONE H4K12 ACETYLTRANSFERASE ACTIVITY 12 1.85e-01 4.75e-01 0.300000 2.90e-01 -7.74e-02 8.22e-02 6.42e-01
GOBP RENAL SODIUM EXCRETION 12 1.77e-01 4.64e-01 0.300000 2.58e-01 -1.54e-01 1.22e-01 3.57e-01
Abacavir transmembrane transport 5 5.28e-01 7.69e-01 0.300000 2.71e-01 1.28e-01 2.94e-01 6.21e-01
GOCC NUCLEOLAR RIBONUCLEASE P COMPLEX 7 3.77e-01 6.62e-01 0.300000 6.12e-02 -2.93e-01 7.79e-01 1.79e-01
Negative regulation of FGFR2 signaling 33 1.34e-02 9.73e-02 0.300000 2.91e-01 7.27e-02 3.83e-03 4.70e-01
GOBP FUCOSYLATION 17 8.80e-02 3.17e-01 0.300000 -1.26e-01 2.72e-01 3.68e-01 5.23e-02
GOMF NUCLEAR GLUCOCORTICOID RECEPTOR BINDING 12 1.88e-01 4.80e-01 0.300000 2.94e-01 -5.67e-02 7.75e-02 7.34e-01
GOCC CCR4 NOT COMPLEX 16 1.03e-01 3.45e-01 0.300000 2.78e-01 -1.12e-01 5.42e-02 4.39e-01
GOMF ACYLGLYCEROL O ACYLTRANSFERASE ACTIVITY 26 3.42e-02 1.80e-01 0.300000 8.54e-02 2.87e-01 4.51e-01 1.12e-02
Translesion synthesis by POLI 17 8.48e-02 3.12e-01 0.300000 2.09e-01 -2.15e-01 1.36e-01 1.25e-01
GOBP POSITIVE REGULATION OF MESENCHYMAL STEM CELL PROLIFERATION 6 4.70e-01 7.31e-01 0.300000 -2.44e-01 -1.74e-01 3.00e-01 4.62e-01
GOMF NEUREGULIN BINDING 5 5.20e-01 7.63e-01 0.300000 2.92e-01 6.71e-02 2.58e-01 7.95e-01
GOBP PEPTIDYL ARGININE MODIFICATION 13 1.58e-01 4.40e-01 0.299000 2.79e-01 -1.09e-01 8.14e-02 4.98e-01
NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 12 1.80e-01 4.70e-01 0.299000 2.72e-01 -1.26e-01 1.03e-01 4.50e-01
CDC42 GTPase cycle 143 9.30e-09 5.74e-07 0.299000 2.89e-01 7.95e-02 2.51e-09 1.01e-01
GOBP NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION 17 1.13e-01 3.65e-01 0.299000 1.13e-01 2.77e-01 4.21e-01 4.78e-02
GOBP GOLGI TO PLASMA MEMBRANE TRANSPORT 64 2.24e-04 4.15e-03 0.299000 2.95e-01 5.26e-02 4.55e-05 4.67e-01
GOBP EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 26 2.86e-02 1.62e-01 0.299000 2.98e-01 -2.73e-02 8.53e-03 8.10e-01
GOBP EMBRYONIC BRAIN DEVELOPMENT 16 1.14e-01 3.66e-01 0.299000 2.99e-01 -1.44e-02 3.85e-02 9.21e-01
GOBP DENDRITIC SPINE MAINTENANCE 21 7.13e-02 2.80e-01 0.299000 2.48e-01 1.67e-01 4.88e-02 1.86e-01
GOBP POSITIVE REGULATION OF FOCAL ADHESION ASSEMBLY 26 3.80e-02 1.92e-01 0.299000 2.50e-01 1.64e-01 2.72e-02 1.48e-01
GOBP N TERMINAL PROTEIN AMINO ACID ACETYLATION 14 1.32e-01 3.96e-01 0.299000 2.06e-01 -2.17e-01 1.82e-01 1.60e-01
GOBP CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT 22 4.75e-02 2.19e-01 0.299000 2.94e-01 -5.59e-02 1.70e-02 6.50e-01
Fertilization 26 3.88e-02 1.94e-01 0.299000 -2.02e-01 -2.20e-01 7.43e-02 5.16e-02
GOBP PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING 6 4.68e-01 7.29e-01 0.299000 2.63e-01 1.43e-01 2.65e-01 5.44e-01
GOBP POSITIVE REGULATION OF T HELPER 17 CELL DIFFERENTIATION 12 1.84e-01 4.75e-01 0.299000 2.83e-01 -9.62e-02 8.93e-02 5.64e-01
GOBP RNA DECAPPING 19 6.40e-02 2.63e-01 0.299000 2.16e-01 -2.07e-01 1.02e-01 1.19e-01
GOBP REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS 13 1.58e-01 4.40e-01 0.299000 -2.76e-01 1.15e-01 8.47e-02 4.73e-01
Translesion synthesis by POLK 17 8.55e-02 3.13e-01 0.299000 2.07e-01 -2.16e-01 1.40e-01 1.23e-01
GOBP PERICENTRIC HETEROCHROMATIN FORMATION 5 5.35e-01 7.75e-01 0.299000 -2.22e-01 -2.00e-01 3.89e-01 4.39e-01
GOCC UNCONVENTIONAL MYOSIN COMPLEX 9 3.04e-01 5.98e-01 0.299000 2.97e-01 3.69e-02 1.23e-01 8.48e-01
GOMF L LEUCINE BINDING 6 4.36e-01 7.10e-01 0.299000 2.94e-01 -5.45e-02 2.12e-01 8.17e-01
Regulation of NPAS4 gene expression 13 1.60e-01 4.43e-01 0.299000 2.81e-01 -1.02e-01 7.94e-02 5.25e-01
GOCC GTPASE ACTIVATOR COMPLEX 11 2.16e-01 5.11e-01 0.299000 2.90e-01 -7.13e-02 9.56e-02 6.82e-01
GOBP NEGATIVE REGULATION OF MEIOTIC NUCLEAR DIVISION 10 2.87e-01 5.85e-01 0.299000 -2.03e-01 -2.19e-01 2.66e-01 2.30e-01
GOBP ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE 24 4.69e-02 2.18e-01 0.299000 2.77e-01 1.13e-01 1.90e-02 3.39e-01
GOBP MITOCHONDRIAL RNA PROCESSING 21 5.78e-02 2.46e-01 0.299000 2.00e-02 -2.98e-01 8.74e-01 1.81e-02
GOBP POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION 14 1.72e-01 4.58e-01 0.299000 2.58e-01 1.51e-01 9.47e-02 3.29e-01
GOCC RETROMER COMPLEX 20 6.13e-02 2.55e-01 0.299000 2.87e-01 -8.19e-02 2.62e-02 5.26e-01
GOBP REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY 15 1.16e-01 3.69e-01 0.299000 2.40e-01 -1.78e-01 1.08e-01 2.33e-01
GOMF PROTEIN PRENYLTRANSFERASE ACTIVITY 6 4.30e-01 7.06e-01 0.299000 2.83e-01 -9.64e-02 2.31e-01 6.83e-01
GOMF PROTEIN CARRIER CHAPERONE 34 7.44e-03 6.36e-02 0.299000 2.18e-01 -2.04e-01 2.79e-02 3.93e-02
GOBP OOCYTE CONSTRUCTION 8 3.17e-01 6.10e-01 0.299000 -2.50e-01 1.63e-01 2.21e-01 4.24e-01
GOBP ARTERIAL ENDOTHELIAL CELL DIFFERENTIATION 6 4.29e-01 7.06e-01 0.298000 -1.06e-01 2.79e-01 6.53e-01 2.37e-01
GOBP 3 UTR MEDIATED MRNA DESTABILIZATION 19 6.61e-02 2.68e-01 0.298000 2.55e-01 -1.55e-01 5.40e-02 2.43e-01
GOBP NEGATIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY 16 1.35e-01 4.02e-01 0.298000 -2.50e-01 -1.62e-01 8.30e-02 2.61e-01
GOMF PYRUVATE DEHYDROGENASE ACETYL TRANSFERRING PHOSPHATASE ACTIVITY 5 4.96e-01 7.51e-01 0.298000 9.96e-02 -2.81e-01 7.00e-01 2.76e-01
GOMF NMDA GLUTAMATE RECEPTOR ACTIVITY 7 4.02e-01 6.84e-01 0.298000 -5.64e-02 -2.93e-01 7.96e-01 1.80e-01
Ethanol oxidation 12 1.84e-01 4.74e-01 0.298000 2.74e-01 -1.17e-01 1.00e-01 4.83e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE BINDING 16 1.25e-01 3.86e-01 0.298000 2.91e-01 6.35e-02 4.37e-02 6.60e-01
GOBP ANAGEN 5 4.91e-01 7.49e-01 0.298000 1.40e-01 -2.63e-01 5.88e-01 3.08e-01
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION 9 2.89e-01 5.86e-01 0.298000 -6.38e-02 2.91e-01 7.40e-01 1.30e-01
GOBP RETINAL BIPOLAR NEURON DIFFERENTIATION 7 4.08e-01 6.90e-01 0.298000 9.39e-02 2.83e-01 6.67e-01 1.95e-01
GOMF GLUTAMATE BINDING 8 3.37e-01 6.26e-01 0.298000 2.96e-01 -3.35e-02 1.47e-01 8.70e-01
GOBP REGULATION OF SECONDARY HEART FIELD CARDIOBLAST PROLIFERATION 10 2.51e-01 5.48e-01 0.298000 2.89e-01 -7.01e-02 1.13e-01 7.01e-01
GOMF NUCLEAR VITAMIN D RECEPTOR BINDING 13 1.57e-01 4.39e-01 0.298000 1.50e-01 -2.57e-01 3.48e-01 1.09e-01
GOCC CYTOPLASMIC UBIQUITIN LIGASE COMPLEX 8 3.70e-01 6.58e-01 0.298000 2.38e-01 1.79e-01 2.45e-01 3.79e-01
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 11 2.54e-01 5.52e-01 0.298000 2.46e-01 1.67e-01 1.57e-01 3.37e-01
SUMO E3 ligases SUMOylate target proteins 164 3.85e-10 3.01e-08 0.298000 2.98e-01 8.97e-03 4.76e-11 8.43e-01
GOBP RNA GUANINE N7 METHYLATION 6 4.66e-01 7.28e-01 0.298000 -1.02e-01 -2.80e-01 6.65e-01 2.36e-01
Defective factor VIII causes hemophilia A 5 5.15e-01 7.61e-01 0.298000 8.77e-03 2.97e-01 9.73e-01 2.49e-01
GOMF SEQUENCE SPECIFIC SINGLE STRANDED DNA BINDING 14 1.35e-01 4.03e-01 0.297000 1.82e-01 -2.35e-01 2.37e-01 1.28e-01
GOBP C TERMINAL PROTEIN LIPIDATION 8 3.44e-01 6.33e-01 0.297000 2.97e-01 -4.45e-04 1.45e-01 9.98e-01
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) 52 1.24e-03 1.63e-02 0.297000 2.89e-01 6.83e-02 3.05e-04 3.94e-01
GOBP ENDOCARDIAL CUSHION TO MESENCHYMAL TRANSITION 6 4.67e-01 7.29e-01 0.297000 2.78e-01 1.06e-01 2.39e-01 6.53e-01
GOMF PHOSPHATIDYLINOSITOL 3 4 5 TRISPHOSPHATE 3 PHOSPHATASE ACTIVITY 5 5.03e-01 7.55e-01 0.297000 -6.65e-02 2.90e-01 7.97e-01 2.62e-01
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN 11 2.08e-01 5.03e-01 0.297000 2.01e-01 -2.19e-01 2.48e-01 2.09e-01
GOBP GLIAL CELL PROLIFERATION 55 8.41e-04 1.20e-02 0.297000 2.90e-01 6.39e-02 1.97e-04 4.12e-01
GOBP SEROTONIN SECRETION 9 3.24e-01 6.15e-01 0.297000 2.64e-01 1.37e-01 1.71e-01 4.76e-01
GOBP MRNA 3 SPLICE SITE RECOGNITION 6 4.25e-01 7.03e-01 0.297000 2.34e-01 -1.83e-01 3.21e-01 4.37e-01
GOMF SOLUTE INORGANIC ANION ANTIPORTER ACTIVITY 31 1.22e-02 9.05e-02 0.297000 -2.39e-01 1.77e-01 2.14e-02 8.86e-02
GOCC MCRD MEDIATED MRNA STABILITY COMPLEX 5 4.98e-01 7.52e-01 0.297000 2.77e-01 -1.07e-01 2.84e-01 6.78e-01
Activation of caspases through apoptosome-mediated cleavage 5 4.90e-01 7.48e-01 0.297000 1.89e-01 -2.29e-01 4.65e-01 3.75e-01
RHOC GTPase cycle 70 1.42e-04 2.88e-03 0.297000 2.81e-01 9.51e-02 4.73e-05 1.69e-01
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE PHOSPHATASE ACTIVITY 12 1.83e-01 4.73e-01 0.297000 2.54e-01 -1.53e-01 1.27e-01 3.59e-01
GOBP REGULATION OF T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL 6 4.36e-01 7.10e-01 0.297000 -9.13e-02 2.82e-01 6.99e-01 2.31e-01
GOCC SERINE PROTEASE INHIBITOR COMPLEX 6 4.74e-01 7.34e-01 0.297000 1.42e-01 2.61e-01 5.47e-01 2.69e-01
GOBP ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS 25 4.35e-02 2.08e-01 0.297000 2.72e-01 1.18e-01 1.85e-02 3.09e-01
GOMF CYTOSKELETAL ANCHOR ACTIVITY 23 5.93e-02 2.50e-01 0.296000 1.93e-01 2.25e-01 1.08e-01 6.21e-02
GOBP RECEPTOR DIFFUSION TRAPPING 10 2.72e-01 5.69e-01 0.296000 -2.94e-01 -3.58e-02 1.07e-01 8.44e-01
GOCC CELL TIP 7 4.24e-01 7.02e-01 0.296000 2.09e-01 2.10e-01 3.38e-01 3.36e-01
GOBP SPINAL CORD PATTERNING 18 1.08e-01 3.55e-01 0.296000 2.52e-01 1.56e-01 6.43e-02 2.52e-01
GOCC ENDOPLASMIC RETICULUM TUBULAR NETWORK MEMBRANE 5 4.94e-01 7.51e-01 0.296000 1.50e-01 -2.55e-01 5.60e-01 3.23e-01
GOBP PEROXISOMAL TRANSPORT 20 5.91e-02 2.50e-01 0.296000 1.71e-01 -2.42e-01 1.84e-01 6.14e-02
GOBP CALCIUM ION IMPORT INTO SARCOPLASMIC RETICULUM 5 5.35e-01 7.75e-01 0.296000 1.22e-01 2.70e-01 6.37e-01 2.96e-01
GOBP URETERIC BUD ELONGATION 8 3.34e-01 6.25e-01 0.296000 2.87e-01 -7.35e-02 1.60e-01 7.19e-01
RHO GTPases Activate ROCKs 19 8.49e-02 3.12e-01 0.296000 2.94e-01 3.76e-02 2.66e-02 7.77e-01
rRNA processing 190 1.67e-11 1.66e-09 0.296000 -9.85e-03 -2.96e-01 8.15e-01 1.93e-12
GOBP GASTRULATION WITH MOUTH FORMING SECOND 26 2.63e-02 1.54e-01 0.296000 2.64e-01 -1.33e-01 1.96e-02 2.39e-01
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CONTRACTION 9 2.99e-01 5.95e-01 0.296000 -2.75e-02 2.95e-01 8.86e-01 1.26e-01
GOBP POSITIVE REGULATION OF SODIUM PROTON ANTIPORTER ACTIVITY 5 5.40e-01 7.79e-01 0.296000 2.44e-01 1.67e-01 3.44e-01 5.17e-01
GOBP CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS 24 4.63e-02 2.15e-01 0.296000 2.89e-01 6.29e-02 1.41e-02 5.94e-01
GOBP REGULATION OF PEPTIDYL LYSINE ACETYLATION 10 2.83e-01 5.80e-01 0.296000 2.81e-01 9.36e-02 1.24e-01 6.08e-01
GOBP PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS 7 4.05e-01 6.87e-01 0.296000 2.93e-01 4.35e-02 1.80e-01 8.42e-01
GOBP PROTEIN TO MEMBRANE DOCKING 5 5.03e-01 7.55e-01 0.296000 8.74e-02 -2.83e-01 7.35e-01 2.74e-01
GOMF MRNA 5 UTR BINDING 22 4.99e-02 2.25e-01 0.296000 6.95e-02 -2.88e-01 5.73e-01 1.96e-02
GOMF RIBONUCLEASE P ACTIVITY 12 1.90e-01 4.81e-01 0.296000 1.08e-01 -2.75e-01 5.18e-01 9.86e-02
GOBP GLYCINE BIOSYNTHETIC PROCESS 5 5.16e-01 7.62e-01 0.296000 -2.96e-01 8.11e-03 2.52e-01 9.75e-01
GOMF NITRIC OXIDE SYNTHASE BINDING 10 2.45e-01 5.41e-01 0.296000 1.57e-01 -2.51e-01 3.91e-01 1.70e-01
GOMF LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL 15 1.48e-01 4.25e-01 0.296000 -2.87e-01 -7.07e-02 5.42e-02 6.36e-01
GOBP POSITIVE REGULATION OF METALLOPEPTIDASE ACTIVITY 8 3.75e-01 6.61e-01 0.296000 -2.45e-01 -1.65e-01 2.30e-01 4.19e-01
GOBP POST CHAPERONIN TUBULIN FOLDING PATHWAY 6 4.60e-01 7.24e-01 0.296000 2.93e-01 3.50e-02 2.13e-01 8.82e-01
GOBP POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION 17 1.08e-01 3.55e-01 0.295000 1.20e-02 2.95e-01 9.32e-01 3.51e-02
SUMOylation 170 2.29e-10 1.90e-08 0.295000 2.95e-01 1.79e-03 2.97e-11 9.68e-01
Signaling by FGFR3 39 6.84e-03 6.00e-02 0.295000 2.90e-01 5.52e-02 1.71e-03 5.51e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME 12 2.32e-01 5.30e-01 0.295000 1.93e-01 2.23e-01 2.47e-01 1.80e-01
GOCC CHAPERONIN CONTAINING T COMPLEX 10 2.89e-01 5.86e-01 0.295000 -1.21e-01 -2.69e-01 5.08e-01 1.40e-01
GOMF HISTONE H4 METHYLTRANSFERASE ACTIVITY 17 1.19e-01 3.76e-01 0.295000 2.78e-01 9.92e-02 4.72e-02 4.79e-01
GOBP RESPONSE TO GROWTH HORMONE 35 1.35e-02 9.77e-02 0.295000 2.60e-01 1.40e-01 7.80e-03 1.53e-01
GOBP NEUROFILAMENT CYTOSKELETON ORGANIZATION 10 2.62e-01 5.58e-01 0.295000 2.92e-01 -4.49e-02 1.10e-01 8.06e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION 12 1.97e-01 4.90e-01 0.295000 2.87e-01 -6.92e-02 8.54e-02 6.78e-01
GOBP NUCLEOBASE CATABOLIC PROCESS 10 2.68e-01 5.64e-01 0.295000 -1.10e-02 2.95e-01 9.52e-01 1.07e-01
MET activates RAS signaling 11 2.21e-01 5.17e-01 0.295000 2.78e-01 -9.91e-02 1.11e-01 5.69e-01
GOBP REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 36 6.40e-03 5.69e-02 0.295000 1.85e-01 -2.30e-01 5.54e-02 1.69e-02
GOMF RIBOSOMAL LARGE SUBUNIT BINDING 14 1.57e-01 4.38e-01 0.295000 2.29e-02 -2.94e-01 8.82e-01 5.69e-02
Synthesis of Dolichyl-phosphate 6 4.45e-01 7.17e-01 0.295000 -2.88e-01 6.34e-02 2.22e-01 7.88e-01
GOBP MESENCHYME MORPHOGENESIS 61 2.28e-04 4.22e-03 0.295000 2.72e-01 -1.14e-01 2.44e-04 1.22e-01
IRS activation 5 5.02e-01 7.55e-01 0.295000 -1.16e-01 2.71e-01 6.54e-01 2.94e-01
GOBP POSITIVE REGULATION OF CHROMATIN BINDING 9 2.83e-01 5.80e-01 0.295000 -2.02e-01 2.15e-01 2.95e-01 2.65e-01
IGF1R signaling cascade 51 1.56e-03 1.96e-02 0.295000 2.88e-01 5.99e-02 3.67e-04 4.59e-01
GOBP NEGATIVE REGULATION OF MICROGLIAL CELL ACTIVATION 7 4.26e-01 7.04e-01 0.294000 -2.49e-01 -1.58e-01 2.54e-01 4.70e-01
GOBP REGULATION OF T HELPER 17 CELL LINEAGE COMMITMENT 10 2.78e-01 5.76e-01 0.294000 2.92e-01 3.98e-02 1.10e-01 8.27e-01
GOBP NEGATIVE REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS 5 5.13e-01 7.61e-01 0.294000 2.91e-01 -4.45e-02 2.60e-01 8.63e-01
GOCC FAR SIN STRIPAK COMPLEX 16 1.34e-01 4.00e-01 0.294000 2.85e-01 7.38e-02 4.85e-02 6.09e-01
NFE2L2 regulating ER-stress associated genes 5 5.45e-01 7.81e-01 0.294000 2.37e-01 1.75e-01 3.60e-01 4.98e-01
GOMF 2 ACYLGLYCEROL 3 PHOSPHATE O ACYLTRANSFERASE ACTIVITY 9 3.19e-01 6.11e-01 0.294000 5.59e-02 2.89e-01 7.71e-01 1.34e-01
GOBP SKELETAL MUSCLE TISSUE GROWTH 10 2.95e-01 5.92e-01 0.294000 -2.55e-01 -1.46e-01 1.63e-01 4.23e-01
GOBP PROTEIN LIPOYLATION 5 5.43e-01 7.80e-01 0.294000 -2.57e-01 -1.43e-01 3.20e-01 5.80e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS 7 3.98e-01 6.80e-01 0.294000 2.94e-01 -1.73e-02 1.79e-01 9.37e-01
GOBP CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS 20 8.72e-02 3.16e-01 0.294000 2.55e-01 1.47e-01 4.87e-02 2.54e-01
GOBP CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 40 4.55e-03 4.40e-02 0.294000 2.84e-01 -7.43e-02 1.85e-03 4.16e-01
GOBP POSITIVE REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 18 9.72e-02 3.35e-01 0.294000 2.94e-01 1.13e-02 3.09e-02 9.34e-01
GOMF ATPASE COUPLED INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 10 2.99e-01 5.94e-01 0.294000 2.31e-01 1.82e-01 2.07e-01 3.18e-01
GOBP DNA REPAIR DEPENDENT CHROMATIN REMODELING 20 7.96e-02 2.99e-01 0.294000 2.89e-01 5.55e-02 2.55e-02 6.67e-01
GOBP CELLULAR GLUCURONIDATION 19 7.93e-02 2.99e-01 0.294000 5.18e-02 -2.89e-01 6.96e-01 2.91e-02
GOBP REGULATION OF HYPERSENSITIVITY 7 3.84e-01 6.69e-01 0.294000 -1.08e-01 2.73e-01 6.22e-01 2.11e-01
GOMF METALLOAMINOPEPTIDASE ACTIVITY 24 5.46e-02 2.39e-01 0.294000 2.45e-01 1.61e-01 3.74e-02 1.71e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION 15 1.45e-01 4.18e-01 0.294000 2.93e-01 1.81e-02 4.94e-02 9.04e-01
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 9 2.85e-01 5.82e-01 0.294000 1.93e-01 -2.21e-01 3.16e-01 2.51e-01
GOCC CYTOSOLIC PROTEASOME COMPLEX 5 5.01e-01 7.53e-01 0.294000 2.51e-01 -1.53e-01 3.32e-01 5.54e-01
GOMF 3 HYDROXYACYL COA DEHYDROGENASE ACTIVITY 5 5.01e-01 7.53e-01 0.294000 1.53e-01 -2.51e-01 5.54e-01 3.32e-01
Integration of provirus 9 3.27e-01 6.19e-01 0.293000 -9.33e-02 -2.78e-01 6.28e-01 1.48e-01
GOBP PHAGOSOME LYSOSOME FUSION 13 1.97e-01 4.90e-01 0.293000 2.84e-01 7.54e-02 7.66e-02 6.38e-01
RUNX1 regulates transcription of genes involved in differentiation of myeloid cells 6 4.50e-01 7.19e-01 0.293000 -5.03e-02 2.89e-01 8.31e-01 2.20e-01
GOBP VENOUS BLOOD VESSEL MORPHOGENESIS 9 3.34e-01 6.25e-01 0.293000 2.57e-01 1.41e-01 1.81e-01 4.65e-01
GOBP NEGATIVE REGULATION OF NOREPINEPHRINE SECRETION 6 4.47e-01 7.17e-01 0.293000 7.24e-02 -2.84e-01 7.59e-01 2.28e-01
GOBP ANTIBACTERIAL HUMORAL RESPONSE 58 9.27e-04 1.30e-02 0.293000 -1.70e-01 -2.39e-01 2.50e-02 1.65e-03
Reactions specific to the complex N-glycan synthesis pathway 10 2.56e-01 5.53e-01 0.293000 -1.14e-01 2.70e-01 5.33e-01 1.39e-01
GOBP MEMBRANOUS SEPTUM MORPHOGENESIS 8 3.60e-01 6.48e-01 0.293000 2.92e-01 2.73e-02 1.53e-01 8.94e-01
RHOB GTPase cycle 66 2.83e-04 4.96e-03 0.293000 2.80e-01 8.78e-02 8.50e-05 2.17e-01
GOBP ENDOTHELIAL CELL CHEMOTAXIS 28 3.47e-02 1.82e-01 0.293000 1.90e-01 2.23e-01 8.15e-02 4.11e-02
GOCC INTRACILIARY TRANSPORT PARTICLE A 8 3.82e-01 6.67e-01 0.293000 2.32e-01 1.79e-01 2.57e-01 3.79e-01
GOBP REGULATION OF OSTEOCLAST PROLIFERATION 6 4.54e-01 7.21e-01 0.293000 -2.91e-01 3.67e-02 2.18e-01 8.76e-01
GOMF ALDOSE REDUCTASE NADPH ACTIVITY 12 2.36e-01 5.32e-01 0.293000 1.67e-01 2.41e-01 3.17e-01 1.49e-01
GOCC EXTRINSIC COMPONENT OF SYNAPTIC MEMBRANE 13 2.11e-01 5.06e-01 0.293000 2.29e-01 1.82e-01 1.53e-01 2.55e-01
GOBP CELL PROLIFERATION IN BONE MARROW 10 2.51e-01 5.48e-01 0.293000 2.26e-01 -1.85e-01 2.15e-01 3.10e-01
GOMF TRANSFERRIN RECEPTOR BINDING 10 3.02e-01 5.97e-01 0.293000 1.97e-01 2.17e-01 2.82e-01 2.35e-01
GOBP CORTICOSTEROID HORMONE SECRETION 19 9.41e-02 3.29e-01 0.292000 2.84e-01 7.13e-02 3.23e-02 5.91e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 11 2.69e-01 5.66e-01 0.292000 -2.06e-01 -2.07e-01 2.36e-01 2.34e-01
GOBP NATURAL KILLER CELL DIFFERENTIATION 23 4.19e-02 2.03e-01 0.292000 1.80e-01 -2.31e-01 1.36e-01 5.56e-02
GOBP DAMP METABOLIC PROCESS 7 3.92e-01 6.75e-01 0.292000 2.82e-01 -7.67e-02 1.96e-01 7.25e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY 27 3.55e-02 1.85e-01 0.292000 -8.23e-02 -2.80e-01 4.59e-01 1.16e-02
Negative epigenetic regulation of rRNA expression 70 8.52e-05 1.87e-03 0.292000 8.83e-02 -2.79e-01 2.02e-01 5.54e-05
GOBP CORTICOSTERONE SECRETION 6 4.37e-01 7.11e-01 0.292000 -1.80e-01 2.30e-01 4.45e-01 3.29e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 18 1.16e-01 3.70e-01 0.292000 1.73e-01 2.35e-01 2.03e-01 8.39e-02
GOBP REGULATION OF DNA DAMAGE CHECKPOINT 20 6.32e-02 2.61e-01 0.292000 2.05e-01 -2.08e-01 1.13e-01 1.07e-01
GOBP PROTEIN LOCALIZATION TO GOLGI MEMBRANE 5 5.49e-01 7.84e-01 0.292000 -1.62e-01 -2.43e-01 5.30e-01 3.47e-01
GOCC CLATHRIN COAT 50 2.08e-03 2.43e-02 0.292000 2.81e-01 7.93e-02 5.82e-04 3.32e-01
GOBP REGULATION OF STRIATED MUSCLE TISSUE DEVELOPMENT 19 9.96e-02 3.38e-01 0.292000 2.65e-01 1.22e-01 4.53e-02 3.56e-01
RHOV GTPase cycle 36 1.14e-02 8.67e-02 0.292000 2.84e-01 6.66e-02 3.15e-03 4.89e-01
GOCC MEMBRANE ATTACK COMPLEX 7 4.09e-01 6.91e-01 0.292000 -2.92e-01 -1.60e-02 1.82e-01 9.42e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE PHOSPHATASE ACTIVITY 11 2.66e-01 5.62e-01 0.292000 2.54e-01 1.44e-01 1.45e-01 4.07e-01
GOBP 7 METHYLGUANOSINE RNA CAPPING 7 3.83e-01 6.68e-01 0.292000 1.53e-01 -2.49e-01 4.84e-01 2.54e-01
GOBP NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 13 2.12e-01 5.07e-01 0.292000 1.77e-01 2.32e-01 2.69e-01 1.47e-01
GOMF PEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 9 3.42e-01 6.32e-01 0.292000 2.03e-01 2.10e-01 2.91e-01 2.76e-01
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 47 2.02e-03 2.38e-02 0.292000 2.86e-01 -5.98e-02 7.02e-04 4.78e-01
GOBP POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 15 1.55e-01 4.36e-01 0.292000 2.84e-01 6.87e-02 5.71e-02 6.45e-01
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION 18 9.79e-02 3.36e-01 0.292000 2.92e-01 -1.15e-02 3.22e-02 9.33e-01
Digestion 17 1.09e-01 3.56e-01 0.292000 -2.90e-01 3.48e-02 3.87e-02 8.04e-01
GOBP ETHANOLAMINE CONTAINING COMPOUND METABOLIC PROCESS 8 3.78e-01 6.64e-01 0.292000 -2.69e-01 -1.13e-01 1.88e-01 5.80e-01
GOMF CORTICOTROPIN RELEASING HORMONE RECEPTOR BINDING 6 4.78e-01 7.37e-01 0.292000 2.79e-01 8.51e-02 2.37e-01 7.18e-01
GOBP OVIDUCT DEVELOPMENT 6 4.39e-01 7.13e-01 0.292000 -2.33e-01 1.75e-01 3.22e-01 4.59e-01
IRS-related events triggered by IGF1R 50 2.11e-03 2.45e-02 0.292000 2.82e-01 7.49e-02 5.66e-04 3.60e-01
GOBP PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY 30 2.54e-02 1.50e-01 0.292000 2.77e-01 9.13e-02 8.67e-03 3.87e-01
GOBP ENDOCARDIAL CUSHION DEVELOPMENT 54 8.07e-04 1.16e-02 0.291000 2.84e-01 -6.58e-02 3.07e-04 4.03e-01
WNT5A-dependent internalization of FZD2, FZD5 and ROR2 13 2.13e-01 5.08e-01 0.291000 2.37e-01 1.69e-01 1.38e-01 2.91e-01
GOBP POSITIVE REGULATION OF UTERINE SMOOTH MUSCLE CONTRACTION 8 3.43e-01 6.32e-01 0.291000 2.75e-01 -9.50e-02 1.77e-01 6.42e-01
Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion 8 3.68e-01 6.55e-01 0.291000 4.71e-02 2.87e-01 8.17e-01 1.59e-01
GOBP REGULATION OF CELL PROJECTION SIZE 11 2.25e-01 5.22e-01 0.291000 -1.33e-01 2.59e-01 4.45e-01 1.37e-01
GOMF MRNA REGULATORY ELEMENT BINDING TRANSLATION REPRESSOR ACTIVITY 15 1.35e-01 4.03e-01 0.291000 2.76e-01 -9.22e-02 6.41e-02 5.36e-01
GOBP REGULATION OF MITOCHONDRIAL TRANSCRIPTION 8 3.48e-01 6.38e-01 0.291000 6.47e-02 -2.84e-01 7.51e-01 1.65e-01
GOMF GLYCOSPHINGOLIPID BINDING 10 2.84e-01 5.82e-01 0.291000 2.93e-02 2.90e-01 8.73e-01 1.13e-01
GOCC ORGANELLAR RIBOSOME 89 1.17e-05 3.29e-04 0.291000 5.96e-03 -2.91e-01 9.23e-01 2.08e-06
GOBP MRNA EXPORT FROM NUCLEUS 64 1.79e-04 3.46e-03 0.291000 2.60e-01 -1.30e-01 3.16e-04 7.22e-02
GOBP NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 36 8.52e-03 7.03e-02 0.291000 2.80e-01 -8.01e-02 3.68e-03 4.05e-01
GOBP ADHESION OF SYMBIONT TO HOST CELL 8 3.86e-01 6.70e-01 0.291000 -2.42e-01 -1.62e-01 2.37e-01 4.27e-01
Maturation of TCA enzymes and regulation of TCA cycle 20 6.81e-02 2.72e-01 0.291000 1.17e-01 -2.66e-01 3.65e-01 3.92e-02
Collagen degradation 61 2.58e-04 4.63e-03 0.291000 -2.50e-01 1.48e-01 7.15e-04 4.57e-02
GOBP ACINAR CELL DIFFERENTIATION 5 5.44e-01 7.80e-01 0.291000 2.76e-01 9.14e-02 2.85e-01 7.23e-01
GOBP REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 18 8.59e-02 3.14e-01 0.291000 1.76e-01 -2.32e-01 1.97e-01 8.89e-02
GOBP L PHENYLALANINE METABOLIC PROCESS 8 3.70e-01 6.58e-01 0.291000 5.03e-02 2.86e-01 8.05e-01 1.61e-01
GOMF ER RETENTION SEQUENCE BINDING 5 5.45e-01 7.81e-01 0.291000 9.60e-02 2.74e-01 7.10e-01 2.88e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH2 GROUP OF DONORS 17 1.34e-01 4.01e-01 0.291000 1.86e-01 2.23e-01 1.84e-01 1.11e-01
Chromatin modifications during the maternal to zygotic transition (MZT) 32 1.66e-02 1.12e-01 0.291000 1.26e-02 -2.90e-01 9.02e-01 4.47e-03
GOMF CALCIUM DEPENDENT PHOSPHOLIPASE A2 ACTIVITY 17 1.02e-01 3.43e-01 0.291000 2.65e-01 -1.19e-01 5.84e-02 3.96e-01
GOBP LYMPH VESSEL DEVELOPMENT 31 2.59e-02 1.52e-01 0.291000 2.16e-01 1.94e-01 3.70e-02 6.17e-02
GOCC ELASTIC FIBER 5 5.48e-01 7.84e-01 0.290000 2.64e-01 1.21e-01 3.07e-01 6.38e-01
GOMF PROLINE RICH REGION BINDING 17 9.95e-02 3.38e-01 0.290000 1.62e-01 -2.41e-01 2.49e-01 8.48e-02
GOMF NF KAPPAB BINDING 28 2.84e-02 1.61e-01 0.290000 2.90e-01 -2.52e-03 7.80e-03 9.82e-01
Transcriptional Regulation by MECP2 60 5.28e-04 8.21e-03 0.290000 2.90e-01 1.71e-02 1.03e-04 8.18e-01
GOBP RESPONSE TO GONADOTROPIN RELEASING HORMONE 6 4.77e-01 7.37e-01 0.290000 6.19e-02 2.84e-01 7.93e-01 2.29e-01
GOBP FOREBRAIN GENERATION OF NEURONS 52 1.02e-03 1.40e-02 0.290000 2.76e-01 -9.04e-02 5.76e-04 2.59e-01
GOBP SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION 10 2.87e-01 5.85e-01 0.290000 2.88e-01 3.62e-02 1.15e-01 8.43e-01
GOBP NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION 14 1.68e-01 4.53e-01 0.290000 2.90e-01 -4.36e-03 6.00e-02 9.77e-01
GOBP KINETOCHORE ORGANIZATION 20 6.64e-02 2.69e-01 0.290000 1.62e-01 -2.41e-01 2.10e-01 6.23e-02
Interleukin-23 signaling 9 3.18e-01 6.10e-01 0.290000 -3.96e-03 2.90e-01 9.84e-01 1.32e-01
GOBP ENDOTHELIAL CELL MATRIX ADHESION 8 3.77e-01 6.62e-01 0.290000 -8.02e-02 -2.79e-01 6.94e-01 1.72e-01
GOBP OOCYTE ANTERIOR POSTERIOR AXIS SPECIFICATION 6 4.42e-01 7.14e-01 0.290000 -2.05e-01 2.06e-01 3.85e-01 3.83e-01
GOCC EXORIBONUCLEASE COMPLEX 24 3.93e-02 1.95e-01 0.290000 1.46e-01 -2.51e-01 2.17e-01 3.34e-02
GOBP ADENOHYPOPHYSIS DEVELOPMENT 16 1.21e-01 3.79e-01 0.290000 2.77e-01 -8.60e-02 5.50e-02 5.51e-01
GOBP REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 78 9.70e-05 2.10e-03 0.290000 2.53e-01 1.41e-01 1.11e-04 3.09e-02
GOBP GALACTOSE CATABOLIC PROCESS 6 4.90e-01 7.47e-01 0.290000 1.38e-01 2.55e-01 5.58e-01 2.80e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 11 2.26e-01 5.22e-01 0.290000 1.65e-01 -2.38e-01 3.44e-01 1.71e-01
GOMF GROWTH HORMONE RECEPTOR BINDING 8 3.59e-01 6.47e-01 0.290000 -2.23e-02 2.89e-01 9.13e-01 1.57e-01
GOBP CEREBROSPINAL FLUID CIRCULATION 15 1.53e-01 4.31e-01 0.290000 -2.89e-01 -2.01e-02 5.25e-02 8.93e-01
GOBP NEGATIVE REGULATION OF MYELINATION 9 2.94e-01 5.92e-01 0.290000 2.09e-01 -2.01e-01 2.78e-01 2.97e-01
GOMF JUN KINASE KINASE KINASE ACTIVITY 11 2.73e-01 5.71e-01 0.290000 2.38e-01 1.65e-01 1.72e-01 3.42e-01
GOBP CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION 8 3.75e-01 6.61e-01 0.290000 -2.83e-01 -6.24e-02 1.66e-01 7.60e-01
GOBP NEGATIVE T CELL SELECTION 13 2.03e-01 4.96e-01 0.290000 -2.84e-01 -5.82e-02 7.65e-02 7.16e-01
GOBP MICROTUBULE BASED PROTEIN TRANSPORT 14 1.74e-01 4.60e-01 0.290000 2.06e-02 2.89e-01 8.94e-01 6.13e-02
GOBP GLUCOSE IMPORT IN RESPONSE TO INSULIN STIMULUS 6 4.68e-01 7.30e-01 0.290000 -2.37e-03 2.90e-01 9.92e-01 2.19e-01
GOBP NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION 14 1.68e-01 4.53e-01 0.289000 1.72e-02 -2.89e-01 9.11e-01 6.12e-02
GOMF MINUS END DIRECTED MICROTUBULE MOTOR ACTIVITY 17 1.03e-01 3.46e-01 0.289000 -1.31e-01 2.58e-01 3.51e-01 6.53e-02
GOBP NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 49 1.36e-03 1.75e-02 0.289000 2.33e-01 -1.71e-01 4.72e-03 3.83e-02
GOBP ARF PROTEIN SIGNAL TRANSDUCTION 21 8.53e-02 3.13e-01 0.289000 2.33e-01 1.71e-01 6.46e-02 1.74e-01
Complement cascade 54 1.18e-03 1.57e-02 0.289000 -2.89e-01 -1.67e-02 2.41e-04 8.32e-01
GOBP CAVEOLIN MEDIATED ENDOCYTOSIS 11 2.52e-01 5.49e-01 0.289000 2.89e-01 1.14e-02 9.70e-02 9.48e-01
Maturation of nucleoprotein 9694631 15 1.65e-01 4.49e-01 0.289000 2.72e-01 9.79e-02 6.80e-02 5.11e-01
GOBP THREONINE METABOLIC PROCESS 5 5.09e-01 7.59e-01 0.289000 1.77e-01 -2.29e-01 4.93e-01 3.76e-01
GOBP ENDOCRINE SYSTEM DEVELOPMENT 134 3.25e-08 1.78e-06 0.289000 2.84e-01 -5.53e-02 1.43e-08 2.69e-01
GOBP NEGATIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION 8 3.80e-01 6.65e-01 0.289000 -8.09e-02 -2.77e-01 6.92e-01 1.74e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 6 4.76e-01 7.35e-01 0.289000 -2.87e-01 -3.21e-02 2.23e-01 8.92e-01
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE II 16 1.16e-01 3.70e-01 0.289000 2.36e-01 -1.67e-01 1.03e-01 2.47e-01
GOBP GLYOXYLATE METABOLIC PROCESS 8 3.54e-01 6.43e-01 0.289000 -6.71e-02 2.81e-01 7.42e-01 1.69e-01
GOBP INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY 25 5.35e-02 2.35e-01 0.289000 2.40e-01 1.61e-01 3.79e-02 1.64e-01
GOBP CLATHRIN DEPENDENT ENDOCYTOSIS 48 3.01e-03 3.21e-02 0.289000 2.79e-01 7.39e-02 8.18e-04 3.76e-01
Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA 17 1.14e-01 3.66e-01 0.289000 3.43e-02 -2.87e-01 8.07e-01 4.08e-02
GOMF INSULIN LIKE GROWTH FACTOR II BINDING 8 3.42e-01 6.32e-01 0.289000 2.42e-01 -1.57e-01 2.36e-01 4.41e-01
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN 17 1.38e-01 4.08e-01 0.289000 -2.23e-01 -1.83e-01 1.11e-01 1.92e-01
GOMF SMALL PROTEIN ACTIVATING ENZYME BINDING 5 5.13e-01 7.61e-01 0.289000 2.49e-01 -1.46e-01 3.35e-01 5.72e-01
GOBP EARLY ENDOSOME TO RECYCLING ENDOSOME TRANSPORT 7 4.41e-01 7.13e-01 0.289000 2.37e-01 1.65e-01 2.78e-01 4.51e-01
GOCC DENDRITE TERMINUS 12 2.01e-01 4.94e-01 0.289000 2.48e-01 -1.47e-01 1.37e-01 3.78e-01
GOMF MYOSIN HEAVY CHAIN BINDING 13 1.81e-01 4.70e-01 0.289000 -1.03e-01 2.69e-01 5.19e-01 9.26e-02
GOMF LIGAND GATED SODIUM CHANNEL ACTIVITY 16 1.27e-01 3.88e-01 0.288000 -2.82e-01 5.86e-02 5.05e-02 6.85e-01
GOBP ION CHANNEL MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 8 3.49e-01 6.39e-01 0.288000 -1.03e-01 2.69e-01 6.14e-01 1.87e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY 61 2.88e-04 5.03e-03 0.288000 2.38e-01 -1.63e-01 1.31e-03 2.77e-02
GOMF TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 26 4.52e-02 2.13e-01 0.288000 2.69e-01 1.03e-01 1.74e-02 3.64e-01
GOBP NEGATIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE 8 3.73e-01 6.59e-01 0.288000 2.87e-01 3.22e-02 1.61e-01 8.75e-01
GOBP REGULATION OF CHONDROCYTE DEVELOPMENT 6 4.69e-01 7.30e-01 0.288000 -2.88e-01 1.18e-02 2.22e-01 9.60e-01
GOBP PHOSPHOLIPID EFFLUX 14 1.70e-01 4.55e-01 0.288000 -2.87e-01 2.13e-02 6.25e-02 8.90e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 34 1.73e-02 1.15e-01 0.288000 2.71e-01 9.69e-02 6.16e-03 3.28e-01
NoRC negatively regulates rRNA expression 68 1.45e-04 2.93e-03 0.288000 8.39e-02 -2.76e-01 2.31e-01 8.44e-05
GOBP EMBRYONIC HINDLIMB MORPHOGENESIS 27 3.90e-02 1.94e-01 0.288000 2.77e-01 7.98e-02 1.28e-02 4.73e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 66 1.53e-04 3.06e-03 0.288000 1.56e-01 -2.42e-01 2.83e-02 6.70e-04
GOBP NEGATIVE REGULATION BY HOST OF VIRAL PROCESS 14 1.97e-01 4.90e-01 0.288000 -1.74e-01 -2.30e-01 2.60e-01 1.37e-01
GOCC VESICLE COAT 62 4.86e-04 7.69e-03 0.288000 2.87e-01 2.72e-02 9.41e-05 7.12e-01
GOBP RNA CAPPING 15 1.63e-01 4.46e-01 0.288000 -6.22e-02 -2.81e-01 6.77e-01 5.94e-02
GOBP REGULATION OF PROTEIN ACETYLATION 20 7.42e-02 2.87e-01 0.288000 2.75e-01 -8.58e-02 3.34e-02 5.06e-01
GOBP KINETOCHORE ASSEMBLY 16 1.18e-01 3.73e-01 0.288000 2.23e-01 -1.83e-01 1.23e-01 2.06e-01
GOMF TRANSFORMING GROWTH FACTOR BETA BINDING 23 6.14e-02 2.55e-01 0.288000 2.82e-01 5.56e-02 1.90e-02 6.45e-01
GOMF DYNEIN COMPLEX BINDING 23 5.16e-02 2.29e-01 0.288000 2.80e-01 -6.67e-02 2.01e-02 5.80e-01
Negative regulation of FGFR3 signaling 28 3.43e-02 1.81e-01 0.288000 2.79e-01 7.00e-02 1.06e-02 5.21e-01
GOBP SOMATOSTATIN RECEPTOR SIGNALING PATHWAY 6 4.57e-01 7.22e-01 0.288000 -9.57e-02 2.71e-01 6.85e-01 2.50e-01
GOMF HISTONE H3K9 DEMETHYLASE ACTIVITY 12 2.34e-01 5.31e-01 0.288000 2.81e-01 6.10e-02 9.17e-02 7.15e-01
GOMF MINOR GROOVE OF ADENINE THYMINE RICH DNA BINDING 10 2.65e-01 5.62e-01 0.288000 2.49e-01 -1.44e-01 1.73e-01 4.29e-01
GOBP NEGATIVE REGULATION OF ORGANELLE ASSEMBLY 44 2.82e-03 3.07e-02 0.288000 2.26e-01 -1.78e-01 9.60e-03 4.07e-02
GOMF AROMATIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 9 3.13e-01 6.06e-01 0.288000 2.78e-01 -7.26e-02 1.48e-01 7.06e-01
GOBP TRICARBOXYLIC ACID METABOLIC PROCESS 15 1.35e-01 4.03e-01 0.288000 2.33e-01 -1.68e-01 1.17e-01 2.60e-01
DNA Damage Bypass 46 2.15e-03 2.49e-02 0.288000 2.09e-01 -1.98e-01 1.42e-02 2.04e-02
Regulation of beta-cell development 41 4.49e-03 4.36e-02 0.288000 2.56e-01 -1.30e-01 4.52e-03 1.48e-01
GOBP MEMBRANE RAFT ASSEMBLY 12 2.02e-01 4.96e-01 0.287000 -1.66e-01 2.35e-01 3.19e-01 1.60e-01
GOMF NAD DEPENDENT HISTONE DEACETYLASE ACTIVITY 5 5.54e-01 7.87e-01 0.287000 -1.08e-01 -2.66e-01 6.77e-01 3.02e-01
GOCC TRAPP COMPLEX 16 1.19e-01 3.75e-01 0.287000 2.29e-01 -1.73e-01 1.12e-01 2.30e-01
G2/M DNA replication checkpoint 5 5.43e-01 7.80e-01 0.287000 -2.85e-01 -3.48e-02 2.69e-01 8.93e-01
GOMF DOPAMINE BINDING 6 4.96e-01 7.52e-01 0.287000 2.52e-01 1.39e-01 2.86e-01 5.56e-01
GOBP NEURONAL ACTION POTENTIAL PROPAGATION 10 2.64e-01 5.60e-01 0.287000 -2.23e-01 1.81e-01 2.23e-01 3.20e-01
GOBP CEREBRAL CORTEX NEURON DIFFERENTIATION 23 4.84e-02 2.22e-01 0.287000 2.55e-01 -1.32e-01 3.41e-02 2.75e-01
GOBP RESPONSE TO SORBITOL 6 4.49e-01 7.19e-01 0.287000 2.10e-01 -1.96e-01 3.72e-01 4.07e-01
GOMF PHOSPHATIDYLGLYCEROL BINDING 15 1.75e-01 4.61e-01 0.287000 2.48e-01 1.45e-01 9.68e-02 3.30e-01
GOMF K48 LINKED DEUBIQUITINASE ACTIVITY 14 1.76e-01 4.62e-01 0.287000 2.87e-01 1.51e-03 6.29e-02 9.92e-01
Inhibition of DNA recombination at telomere 43 4.17e-03 4.11e-02 0.287000 5.38e-02 -2.82e-01 5.41e-01 1.37e-03
GOBP NEGATIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION 6 4.77e-01 7.37e-01 0.287000 -1.50e-02 -2.87e-01 9.49e-01 2.24e-01
GOBP INTERLEUKIN 21 PRODUCTION 5 5.62e-01 7.92e-01 0.287000 -2.24e-01 -1.80e-01 3.86e-01 4.86e-01
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE 22 7.35e-02 2.86e-01 0.287000 2.72e-01 9.15e-02 2.72e-02 4.58e-01
GOCC HISTONE METHYLTRANSFERASE COMPLEX 63 3.63e-04 6.08e-03 0.287000 2.85e-01 -2.99e-02 8.94e-05 6.81e-01
GOBP AMINOACYL TRNA METABOLISM INVOLVED IN TRANSLATIONAL FIDELITY 13 1.92e-01 4.84e-01 0.287000 2.84e-01 -4.39e-02 7.67e-02 7.84e-01
GOMF AMINOACYL TRNA EDITING ACTIVITY 13 1.92e-01 4.84e-01 0.287000 2.84e-01 -4.39e-02 7.67e-02 7.84e-01
Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) 14 1.89e-01 4.80e-01 0.287000 8.01e-02 2.75e-01 6.04e-01 7.44e-02
GOBP NEGATIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 14 1.99e-01 4.93e-01 0.287000 -1.69e-01 -2.31e-01 2.72e-01 1.34e-01
GOBP NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING 9 3.35e-01 6.25e-01 0.287000 -2.84e-01 -3.62e-02 1.40e-01 8.51e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 6 4.94e-01 7.50e-01 0.287000 1.05e-01 2.67e-01 6.55e-01 2.58e-01
GOCC ASTER 10 2.65e-01 5.62e-01 0.287000 1.81e-01 -2.23e-01 3.23e-01 2.23e-01
GOBP SUBPALLIUM DEVELOPMENT 26 3.27e-02 1.75e-01 0.287000 2.49e-01 -1.43e-01 2.83e-02 2.08e-01
GOMF SELENIUM BINDING 9 3.27e-01 6.19e-01 0.287000 2.87e-01 -4.26e-03 1.37e-01 9.82e-01
GOMF HEPARAN SULFATE GLUCOSAMINE 3 SULFOTRANSFERASE 1 ACTIVITY 7 4.22e-01 7.00e-01 0.286000 2.86e-01 5.74e-03 1.89e-01 9.79e-01
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function 25 3.63e-02 1.87e-01 0.286000 2.12e-01 -1.93e-01 6.71e-02 9.46e-02
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function 25 3.63e-02 1.87e-01 0.286000 2.12e-01 -1.93e-01 6.71e-02 9.46e-02
Defective homologous recombination repair (HRR) due to BRCA1 loss of function 25 3.63e-02 1.87e-01 0.286000 2.12e-01 -1.93e-01 6.71e-02 9.46e-02
Defective homologous recombination repair (HRR) due to PALB2 loss of function 25 3.63e-02 1.87e-01 0.286000 2.12e-01 -1.93e-01 6.71e-02 9.46e-02
HDR through Single Strand Annealing (SSA) 37 7.40e-03 6.34e-02 0.286000 1.99e-01 -2.06e-01 3.59e-02 3.03e-02
GOBP CELLULAR RESPONSE TO DSRNA 22 6.11e-02 2.54e-01 0.286000 5.65e-02 -2.81e-01 6.47e-01 2.26e-02
GOBP INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 52 1.69e-03 2.06e-02 0.286000 2.86e-01 8.96e-03 3.56e-04 9.11e-01
GOBP METANEPHRIC MESENCHYMAL CELL DIFFERENTIATION 5 5.39e-01 7.78e-01 0.286000 2.86e-01 -2.31e-03 2.68e-01 9.93e-01
GOBP EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 37 9.54e-03 7.61e-02 0.286000 2.84e-01 -3.71e-02 2.81e-03 6.96e-01
GOBP STRIATED MUSCLE CELL APOPTOTIC PROCESS 58 9.43e-04 1.32e-02 0.286000 2.82e-01 5.05e-02 2.06e-04 5.06e-01
GOBP REGULATION OF MITOCHONDRIAL DNA METABOLIC PROCESS 6 4.68e-01 7.29e-01 0.286000 5.04e-02 -2.82e-01 8.31e-01 2.32e-01
GOBP COLLAGEN CATABOLIC PROCESS 44 3.41e-03 3.53e-02 0.286000 -2.68e-01 1.00e-01 2.09e-03 2.51e-01
GOCC ACTOMYOSIN 91 2.73e-05 7.01e-04 0.286000 2.53e-01 1.34e-01 3.04e-05 2.75e-02
Cleavage of the damaged purine 33 1.73e-02 1.15e-01 0.286000 -4.80e-03 -2.86e-01 9.62e-01 4.46e-03
Depurination 33 1.73e-02 1.15e-01 0.286000 -4.80e-03 -2.86e-01 9.62e-01 4.46e-03
Recognition and association of DNA glycosylase with site containing an affected purine 33 1.73e-02 1.15e-01 0.286000 -4.80e-03 -2.86e-01 9.62e-01 4.46e-03
GOBP LACRIMAL GLAND DEVELOPMENT 7 4.49e-01 7.19e-01 0.286000 2.17e-01 1.86e-01 3.19e-01 3.94e-01
Downstream signaling of activated FGFR4 26 4.57e-02 2.14e-01 0.286000 2.76e-01 7.53e-02 1.49e-02 5.07e-01
GOBP ERROR PRONE TRANSLESION SYNTHESIS 12 2.20e-01 5.16e-01 0.286000 2.82e-01 -4.45e-02 9.02e-02 7.89e-01
GOBP NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 40 1.03e-02 8.07e-02 0.286000 2.23e-01 1.80e-01 1.49e-02 4.93e-02
GOCC SYNAPSE ASSOCIATED EXTRACELLULAR MATRIX 12 2.23e-01 5.19e-01 0.286000 -2.85e-01 2.66e-02 8.77e-02 8.73e-01
Retrograde neurotrophin signalling 14 2.01e-01 4.94e-01 0.286000 2.29e-01 1.71e-01 1.38e-01 2.67e-01
GOMF APOLIPOPROTEIN RECEPTOR BINDING 7 4.00e-01 6.82e-01 0.286000 -2.46e-01 1.45e-01 2.59e-01 5.06e-01
GOBP POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST 14 2.00e-01 4.94e-01 0.286000 2.38e-01 1.59e-01 1.24e-01 3.04e-01
GOBP NON PROTEINOGENIC AMINO ACID BIOSYNTHETIC PROCESS 16 1.21e-01 3.79e-01 0.286000 2.18e-01 -1.85e-01 1.31e-01 2.01e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY 8 3.86e-01 6.70e-01 0.286000 -6.93e-02 -2.77e-01 7.34e-01 1.75e-01
GOMF TRANSCRIPTION COACTIVATOR BINDING 42 7.40e-03 6.34e-02 0.286000 2.66e-01 1.04e-01 2.83e-03 2.44e-01
GOBP FOCAL ADHESION ASSEMBLY 83 6.98e-05 1.57e-03 0.286000 2.54e-01 1.31e-01 6.40e-05 3.89e-02
GOBP PEPTIDYL ARGININE METHYLATION 10 2.88e-01 5.86e-01 0.286000 2.85e-01 -2.24e-02 1.19e-01 9.02e-01
GOBP LEPTIN MEDIATED SIGNALING PATHWAY 10 2.78e-01 5.75e-01 0.286000 2.72e-01 -8.61e-02 1.36e-01 6.37e-01
GOBP MULTI CILIATED EPITHELIAL CELL DIFFERENTIATION 9 3.39e-01 6.28e-01 0.286000 -2.82e-01 -4.40e-02 1.43e-01 8.19e-01
GOMF RRNA ADENINE METHYLTRANSFERASE ACTIVITY 8 3.70e-01 6.58e-01 0.286000 1.99e-02 -2.85e-01 9.22e-01 1.63e-01
GOBP RESPONSE TO PROSTAGLANDIN D 5 5.17e-01 7.63e-01 0.286000 2.22e-01 -1.80e-01 3.91e-01 4.86e-01
GOBP L ARGININE TRANSMEMBRANE TRANSPORT 14 1.71e-01 4.57e-01 0.286000 2.81e-01 -5.00e-02 6.86e-02 7.46e-01
ALK mutants bind TKIs 12 2.06e-01 5.00e-01 0.286000 1.85e-01 -2.18e-01 2.68e-01 1.92e-01
GOCC PHAGOPHORE ASSEMBLY SITE MEMBRANE 20 1.02e-01 3.42e-01 0.285000 2.34e-01 1.63e-01 6.99e-02 2.06e-01
GOMF RNA POLYMERASE III ACTIVITY 10 2.87e-01 5.84e-01 0.285000 3.42e-02 -2.83e-01 8.52e-01 1.21e-01
GOMF PROTEINASE ACTIVATED RECEPTOR ACTIVITY 5 5.51e-01 7.85e-01 0.285000 5.36e-02 2.80e-01 8.36e-01 2.78e-01
GOCC CELL CORTEX REGION 35 1.85e-02 1.21e-01 0.285000 1.66e-01 2.32e-01 8.84e-02 1.77e-02
PTK6 promotes HIF1A stabilization 7 4.35e-01 7.10e-01 0.285000 -2.79e-01 -5.70e-02 2.01e-01 7.94e-01
GOBP CHEMOKINE C X C MOTIF LIGAND 12 SIGNALING PATHWAY 7 4.30e-01 7.06e-01 0.285000 -2.92e-02 -2.84e-01 8.94e-01 1.94e-01
GOMF TRNA GUANINE METHYLTRANSFERASE ACTIVITY 11 2.49e-01 5.46e-01 0.285000 6.41e-02 -2.78e-01 7.13e-01 1.11e-01
GOMF CARBOHYDRATE MONOATOMIC CATION SYMPORTER ACTIVITY 16 1.31e-01 3.95e-01 0.285000 -8.09e-02 2.73e-01 5.75e-01 5.85e-02
GOBP METANEPHRIC RENAL VESICLE MORPHOGENESIS 14 1.63e-01 4.47e-01 0.285000 2.56e-01 -1.26e-01 9.76e-02 4.16e-01
GOBP NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 22 5.58e-02 2.42e-01 0.285000 2.08e-01 -1.95e-01 9.16e-02 1.14e-01
Gastrulation 116 3.22e-07 1.43e-05 0.285000 2.55e-01 -1.27e-01 2.13e-06 1.79e-02
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION 25 3.79e-02 1.91e-01 0.285000 2.22e-01 -1.78e-01 5.44e-02 1.24e-01
GOBP INNERVATION 27 3.88e-02 1.94e-01 0.285000 2.83e-01 2.85e-02 1.08e-02 7.98e-01
GOBP POSITIVE REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY 5 5.22e-01 7.65e-01 0.285000 2.44e-01 -1.47e-01 3.45e-01 5.70e-01
GOCC STEREOCILIUM BASE 8 3.51e-01 6.40e-01 0.285000 -2.12e-01 1.89e-01 2.98e-01 3.54e-01
Regulation of IFNA/IFNB signaling 22 7.92e-02 2.99e-01 0.285000 -2.59e-01 -1.17e-01 3.52e-02 3.42e-01
GOBP NEUROTRANSMITTER RECEPTOR TRANSPORT 25 4.51e-02 2.12e-01 0.284000 -3.31e-02 2.83e-01 7.75e-01 1.45e-02
GOBP LOOP OF HENLE DEVELOPMENT 12 2.55e-01 5.52e-01 0.284000 2.41e-01 1.52e-01 1.49e-01 3.63e-01
GOBP RESPONSE TO FLUID SHEAR STRESS 35 1.93e-02 1.23e-01 0.284000 1.99e-01 2.03e-01 4.11e-02 3.79e-02
GOBP RNA POLYMERASE I PREINITIATION COMPLEX ASSEMBLY 9 3.41e-01 6.31e-01 0.284000 2.82e-01 3.68e-02 1.43e-01 8.49e-01
GOBP METANEPHRIC LOOP OF HENLE DEVELOPMENT 6 5.08e-01 7.59e-01 0.284000 1.93e-01 2.09e-01 4.13e-01 3.76e-01
GOCC MITOTIC SPINDLE MIDZONE 13 1.83e-01 4.73e-01 0.284000 2.16e-01 -1.84e-01 1.77e-01 2.50e-01
Antigen activates B Cell Receptor (BCR) leading to generation of second messengers 28 2.68e-02 1.56e-01 0.284000 2.48e-01 -1.39e-01 2.32e-02 2.02e-01
GOBP FIBROBLAST MIGRATION 54 1.87e-03 2.24e-02 0.284000 2.71e-01 8.72e-02 5.84e-04 2.68e-01
GOCC JUNCTIONAL SARCOPLASMIC RETICULUM MEMBRANE 9 3.42e-01 6.32e-01 0.284000 -2.81e-01 -4.16e-02 1.44e-01 8.29e-01
IRS-mediated signalling 47 4.16e-03 4.11e-02 0.284000 2.72e-01 8.22e-02 1.25e-03 3.29e-01
GOMF RNA STEM LOOP BINDING 14 2.04e-01 4.99e-01 0.284000 2.36e-01 1.59e-01 1.27e-01 3.04e-01
Signaling by Hippo 19 9.15e-02 3.25e-01 0.284000 2.76e-01 -6.92e-02 3.76e-02 6.01e-01
Spry regulation of FGF signaling 16 1.26e-01 3.87e-01 0.284000 2.44e-01 -1.45e-01 9.05e-02 3.17e-01
GOBP SYNAPTIC SIGNALING VIA NEUROPEPTIDE 6 4.60e-01 7.24e-01 0.284000 2.43e-01 -1.47e-01 3.02e-01 5.34e-01
GOBP CELLULAR RESPONSE TO INDOLE 3 METHANOL 5 5.34e-01 7.74e-01 0.284000 2.77e-01 -6.23e-02 2.83e-01 8.09e-01
GOMF RNA POLYMERASE CORE ENZYME BINDING 42 7.02e-03 6.11e-02 0.284000 2.79e-01 5.33e-02 1.76e-03 5.50e-01
GOBP POSITIVE REGULATION OF THE FORCE OF HEART CONTRACTION 5 5.67e-01 7.96e-01 0.284000 -2.37e-01 -1.56e-01 3.59e-01 5.45e-01
GOBP NEUTROPHIL APOPTOTIC PROCESS 7 4.02e-01 6.84e-01 0.284000 1.86e-01 -2.14e-01 3.93e-01 3.27e-01
GOBP CELLULAR RESPONSE TO FLUID SHEAR STRESS 21 9.21e-02 3.25e-01 0.284000 2.43e-01 1.46e-01 5.35e-02 2.46e-01
GOBP B CELL CHEMOTAXIS 7 4.40e-01 7.13e-01 0.284000 6.69e-02 2.76e-01 7.59e-01 2.06e-01
GOBP POSITIVE REGULATION OF CHROMOSOME ORGANIZATION 105 1.25e-06 4.64e-05 0.284000 1.69e-01 -2.28e-01 2.77e-03 5.38e-05
GOBP RENAL SYSTEM VASCULATURE MORPHOGENESIS 8 3.81e-01 6.66e-01 0.284000 2.83e-01 1.43e-02 1.65e-01 9.44e-01
GOBP CYTOPLASM ORGANIZATION 15 1.68e-01 4.53e-01 0.284000 3.94e-02 2.81e-01 7.92e-01 5.94e-02
GOBP REGULATION OF STEM CELL DIVISION 12 2.48e-01 5.45e-01 0.284000 2.70e-01 8.80e-02 1.06e-01 5.98e-01
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain 13 2.21e-01 5.17e-01 0.284000 2.70e-01 8.83e-02 9.23e-02 5.82e-01
GOMF ACYLTRANSFERASE ACTIVITY ACYL GROUPS CONVERTED INTO ALKYL ON TRANSFER 5 5.56e-01 7.89e-01 0.284000 2.76e-01 6.51e-02 2.85e-01 8.01e-01
GOBP REGULATION OF HEPATOCYTE PROLIFERATION 16 1.46e-01 4.21e-01 0.284000 -1.80e-02 -2.83e-01 9.01e-01 4.99e-02
SUMOylation of DNA damage response and repair proteins 74 1.12e-04 2.40e-03 0.284000 2.82e-01 -3.01e-02 2.71e-05 6.54e-01
GOBP DISRUPTION OF ANATOMICAL STRUCTURE IN ANOTHER ORGANISM 86 5.38e-05 1.27e-03 0.283000 -2.60e-01 -1.13e-01 3.06e-05 7.03e-02
GOBP POSITIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE 11 2.48e-01 5.45e-01 0.283000 -9.48e-02 2.67e-01 5.86e-01 1.25e-01
GOBP INTESTINAL CHOLESTEROL ABSORPTION 18 9.74e-02 3.35e-01 0.283000 -2.31e-01 1.64e-01 8.95e-02 2.29e-01
GOMF CCR3 CHEMOKINE RECEPTOR BINDING 5 5.56e-01 7.89e-01 0.283000 6.28e-02 2.76e-01 8.08e-01 2.85e-01
GOBP INTERLEUKIN 5 MEDIATED SIGNALING PATHWAY 6 4.63e-01 7.26e-01 0.283000 -2.50e-01 1.34e-01 2.89e-01 5.70e-01
Alpha-protein kinase 1 signaling pathway 10 2.74e-01 5.71e-01 0.283000 2.28e-01 -1.68e-01 2.12e-01 3.57e-01
GOBP DIAPEDESIS 6 4.86e-01 7.45e-01 0.283000 1.18e-02 2.83e-01 9.60e-01 2.30e-01
GOMF OLIGOSACCHARIDE BINDING 17 1.30e-01 3.94e-01 0.283000 -2.83e-01 -1.36e-02 4.35e-02 9.22e-01
GOBP CHOLINE TRANSPORT 9 3.35e-01 6.25e-01 0.283000 2.83e-01 -1.26e-02 1.42e-01 9.48e-01
GOBP NUCLEOLAR CHROMATIN ORGANIZATION 9 3.57e-01 6.47e-01 0.283000 2.61e-01 1.10e-01 1.76e-01 5.67e-01
GOBP REGULATION OF FIBROBLAST MIGRATION 40 9.64e-03 7.67e-02 0.283000 2.73e-01 7.44e-02 2.81e-03 4.16e-01
GOMF GAMMA AMINOBUTYRIC ACID SODIUM CHLORIDE SYMPORTER ACTIVITY 5 5.51e-01 7.86e-01 0.283000 -2.82e-01 -2.65e-02 2.75e-01 9.18e-01
GOCC CHROMATOID BODY 13 1.89e-01 4.80e-01 0.283000 -1.35e-01 2.49e-01 3.99e-01 1.21e-01
Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) 18 9.75e-02 3.35e-01 0.283000 1.85e-01 -2.14e-01 1.74e-01 1.16e-01
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression 38 7.38e-03 6.34e-02 0.283000 2.16e-01 -1.83e-01 2.12e-02 5.13e-02
GOBP DEFINITIVE HEMOPOIESIS 19 8.81e-02 3.17e-01 0.283000 2.50e-01 -1.32e-01 5.92e-02 3.18e-01
GOBP DENDRITE SELF AVOIDANCE 14 1.93e-01 4.85e-01 0.283000 -2.78e-01 -5.07e-02 7.15e-02 7.43e-01
GOCC SNO S RNA CONTAINING RIBONUCLEOPROTEIN COMPLEX 26 3.48e-02 1.82e-01 0.283000 2.11e-01 -1.88e-01 6.20e-02 9.76e-02
GOBP VESICLE TETHERING 31 2.28e-02 1.39e-01 0.283000 2.82e-01 -2.53e-02 6.66e-03 8.07e-01
Regulation of CDH11 gene transcription 10 3.13e-01 6.06e-01 0.283000 2.74e-01 6.94e-02 1.33e-01 7.04e-01
GOBP DORSAL VENTRAL AXIS SPECIFICATION 14 2.09e-01 5.04e-01 0.283000 2.25e-01 1.72e-01 1.46e-01 2.66e-01
GOMF STEROL ESTERASE ACTIVITY 7 4.22e-01 7.00e-01 0.283000 -4.75e-02 2.79e-01 8.28e-01 2.02e-01
GOBP VESTIBULOCOCHLEAR NERVE DEVELOPMENT 11 2.75e-01 5.72e-01 0.283000 2.78e-01 4.91e-02 1.10e-01 7.78e-01
APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway 7 4.56e-01 7.22e-01 0.283000 1.64e-01 2.30e-01 4.53e-01 2.91e-01
GOBP NUCLEOLUS ORGANIZATION 16 1.62e-01 4.45e-01 0.283000 2.58e-01 1.14e-01 7.34e-02 4.29e-01
GOBP PROTEIN SUMOYLATION 64 3.43e-04 5.80e-03 0.283000 2.72e-01 -7.57e-02 1.65e-04 2.95e-01
GOMF UBIQUITIN PROTEIN TRANSFERASE ACTIVATOR ACTIVITY 16 1.48e-01 4.24e-01 0.283000 -1.52e-02 -2.82e-01 9.16e-01 5.07e-02
GOBP ENDOCYTIC RECYCLING 83 9.56e-05 2.08e-03 0.283000 2.25e-01 1.70e-01 3.87e-04 7.25e-03
GOCC SMN COMPLEX 9 3.14e-01 6.07e-01 0.283000 2.30e-01 -1.64e-01 2.32e-01 3.95e-01
GOMF MONOAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY 12 2.36e-01 5.32e-01 0.282000 2.82e-01 -4.43e-03 9.03e-02 9.79e-01
GOCC PROTEASOME CORE COMPLEX 20 1.03e-01 3.46e-01 0.282000 -1.17e-01 -2.57e-01 3.65e-01 4.67e-02
GOBP APOPTOTIC PROCESS INVOLVED IN HEART MORPHOGENESIS 7 4.07e-01 6.89e-01 0.282000 2.34e-01 -1.57e-01 2.83e-01 4.71e-01
GOBP SEROTONIN UPTAKE 12 2.16e-01 5.11e-01 0.282000 2.43e-01 -1.44e-01 1.46e-01 3.87e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN 32 2.05e-02 1.29e-01 0.282000 2.30e-02 -2.81e-01 8.22e-01 5.88e-03
GOCC P BODY 99 3.42e-06 1.12e-04 0.282000 2.46e-01 -1.39e-01 2.40e-05 1.69e-02
GOCC ARP2 3 PROTEIN COMPLEX 9 3.32e-01 6.22e-01 0.282000 4.32e-02 -2.79e-01 8.23e-01 1.48e-01
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation 9 3.29e-01 6.20e-01 0.282000 2.76e-01 -6.03e-02 1.52e-01 7.54e-01
Signaling by FGFR1 51 2.53e-03 2.83e-02 0.282000 2.79e-01 3.94e-02 5.61e-04 6.26e-01
GOBP RESPONSE TO HYPEROXIA 17 1.38e-01 4.08e-01 0.282000 2.76e-01 5.62e-02 4.86e-02 6.88e-01
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY 7 4.13e-01 6.93e-01 0.282000 1.16e-01 -2.57e-01 5.94e-01 2.39e-01
GOBP FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 81 1.06e-04 2.29e-03 0.282000 2.58e-01 1.15e-01 6.11e-05 7.46e-02
GOMF ATP DEPENDENT ACTIVITY ACTING ON DNA 117 1.47e-06 5.34e-05 0.282000 2.72e-01 7.52e-02 3.82e-07 1.60e-01
Beta-oxidation of pristanoyl-CoA 9 3.55e-01 6.44e-01 0.282000 2.71e-01 7.83e-02 1.60e-01 6.84e-01
GOCC DNA REPAIR COMPLEX 22 7.31e-02 2.85e-01 0.282000 2.82e-01 1.28e-02 2.22e-02 9.18e-01
GOBP PROTEIN GERANYLGERANYLATION 6 4.70e-01 7.30e-01 0.282000 1.09e-01 -2.60e-01 6.44e-01 2.70e-01
GOCC CAMP DEPENDENT PROTEIN KINASE COMPLEX 7 4.58e-01 7.23e-01 0.282000 1.55e-01 2.36e-01 4.79e-01 2.80e-01
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION 34 1.66e-02 1.12e-01 0.282000 2.81e-01 -1.85e-02 4.57e-03 8.52e-01
Formation of WDR5-containing histone-modifying complexes 38 1.14e-02 8.67e-02 0.282000 2.80e-01 2.77e-02 2.79e-03 7.68e-01
GOBP RESPONSE TO ETHER 15 1.55e-01 4.35e-01 0.282000 8.29e-02 -2.69e-01 5.79e-01 7.11e-02
GOBP HIPPO SIGNALING 52 2.26e-03 2.58e-02 0.282000 2.79e-01 3.41e-02 4.89e-04 6.71e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX 14 1.69e-01 4.54e-01 0.282000 1.35e-01 -2.47e-01 3.83e-01 1.09e-01
GOBP NUCLEAR PORE LOCALIZATION 5 5.32e-01 7.73e-01 0.282000 2.56e-01 -1.16e-01 3.21e-01 6.53e-01
GOBP TRNA 3 END PROCESSING 6 4.95e-01 7.51e-01 0.282000 2.79e-01 3.52e-02 2.36e-01 8.81e-01
GOBP OLFACTORY BEHAVIOR 11 2.92e-01 5.89e-01 0.281000 2.45e-01 1.38e-01 1.59e-01 4.28e-01
DAP12 interactions 38 1.28e-02 9.38e-02 0.281000 -7.79e-02 -2.71e-01 4.06e-01 3.90e-03
GOBP POSITIVE REGULATION OF NEURON MIGRATION 16 1.57e-01 4.39e-01 0.281000 2.75e-01 6.22e-02 5.73e-02 6.67e-01
GOMF CAMP RESPONSE ELEMENT BINDING 12 2.34e-01 5.31e-01 0.281000 2.80e-01 -2.64e-02 9.28e-02 8.74e-01
GOBP REGULATION OF ANOIKIS 23 5.46e-02 2.39e-01 0.281000 2.51e-01 -1.28e-01 3.74e-02 2.88e-01
GOCC RNA POLYMERASE TRANSCRIPTION FACTOR SL1 COMPLEX 5 5.69e-01 7.97e-01 0.281000 -2.56e-01 -1.17e-01 3.22e-01 6.50e-01
GOBP MITOTIC RECOMBINATION 25 4.84e-02 2.22e-01 0.281000 2.80e-01 -3.00e-02 1.54e-02 7.95e-01
GOBP NEGATIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION 5 5.29e-01 7.71e-01 0.281000 2.34e-01 -1.57e-01 3.65e-01 5.44e-01
Assembly of collagen fibrils and other multimeric structures 59 5.43e-04 8.41e-03 0.281000 -1.68e-01 2.25e-01 2.52e-02 2.76e-03
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 4F COMPLEX 13 1.91e-01 4.82e-01 0.281000 1.64e-01 -2.29e-01 3.06e-01 1.53e-01
GOMF MUTLALPHA COMPLEX BINDING 7 4.61e-01 7.25e-01 0.281000 2.11e-01 1.86e-01 3.33e-01 3.95e-01
GOBP CXCL12 ACTIVATED CXCR4 SIGNALING PATHWAY 5 5.60e-01 7.91e-01 0.281000 -4.98e-02 -2.77e-01 8.47e-01 2.84e-01
GOBP PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY 23 5.88e-02 2.49e-01 0.281000 2.73e-01 -6.84e-02 2.36e-02 5.70e-01
GOBP CRANIAL SKELETAL SYSTEM DEVELOPMENT 71 1.63e-04 3.23e-03 0.281000 2.73e-01 -6.60e-02 6.83e-05 3.36e-01
GOCC SPERMATOPROTEASOME COMPLEX 5 5.75e-01 8.00e-01 0.281000 -1.75e-01 -2.20e-01 4.98e-01 3.94e-01
GOBP LUTEOLYSIS 6 4.68e-01 7.30e-01 0.281000 -1.33e-01 2.47e-01 5.71e-01 2.94e-01
GOBP RESPONSE TO MUSCLE STRETCH 24 6.38e-02 2.62e-01 0.281000 2.72e-01 7.16e-02 2.12e-02 5.44e-01
Synthesis of active ubiquitin: roles of E1 and E2 enzymes 27 3.19e-02 1.73e-01 0.281000 1.84e-01 -2.13e-01 9.87e-02 5.57e-02
GOBP LENS FIBER CELL DEVELOPMENT 14 1.79e-01 4.66e-01 0.281000 -6.81e-02 2.73e-01 6.59e-01 7.74e-02
GOBP DITERPENOID BIOSYNTHETIC PROCESS 10 2.85e-01 5.82e-01 0.281000 1.16e-01 -2.56e-01 5.26e-01 1.61e-01
GOCC GAMMA SECRETASE COMPLEX 7 4.09e-01 6.91e-01 0.281000 2.00e-01 -1.97e-01 3.60e-01 3.66e-01
GOBP MAMMARY GLAND INVOLUTION 8 3.73e-01 6.59e-01 0.281000 2.71e-01 -7.47e-02 1.85e-01 7.14e-01
GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DEVELOPMENT 5 5.57e-01 7.89e-01 0.281000 -2.66e-02 -2.79e-01 9.18e-01 2.79e-01
GOBP PERIPHERAL NERVOUS SYSTEM MYELIN MAINTENANCE 9 3.64e-01 6.51e-01 0.281000 2.57e-01 1.14e-01 1.83e-01 5.54e-01
GOBP POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY 19 9.61e-02 3.32e-01 0.281000 7.83e-02 -2.69e-01 5.54e-01 4.20e-02
GOBP CITRULLINE METABOLIC PROCESS 7 4.33e-01 7.08e-01 0.281000 2.80e-01 -1.60e-02 1.99e-01 9.42e-01
GOBP EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 93 1.10e-05 3.14e-04 0.281000 2.70e-01 -7.53e-02 6.63e-06 2.09e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION 6 4.95e-01 7.51e-01 0.281000 -2.58e-02 -2.79e-01 9.13e-01 2.36e-01
RUNX1 regulates transcription of genes involved in differentiation of HSCs 79 5.04e-05 1.19e-03 0.281000 1.27e-01 -2.50e-01 5.18e-02 1.19e-04
GOBP RIBOSOMAL SMALL SUBUNIT ASSEMBLY 19 9.32e-02 3.27e-01 0.280000 1.12e-01 -2.57e-01 3.99e-01 5.22e-02
ROBO receptors bind AKAP5 9 3.65e-01 6.53e-01 0.280000 2.54e-01 1.20e-01 1.88e-01 5.34e-01
GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS 5 5.51e-01 7.85e-01 0.280000 2.80e-01 -1.15e-02 2.78e-01 9.64e-01
GOMF MHC CLASS II RECEPTOR ACTIVITY 9 3.29e-01 6.20e-01 0.280000 -2.68e-01 8.28e-02 1.64e-01 6.67e-01
GOMF LNCRNA BINDING 23 6.87e-02 2.74e-01 0.280000 2.79e-01 3.12e-02 2.07e-02 7.96e-01
GOBP VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE 150 5.44e-08 2.79e-06 0.280000 2.58e-01 1.10e-01 4.99e-08 2.00e-02
GOBP PROTEIN DEGLYCOSYLATION 15 1.93e-01 4.85e-01 0.280000 2.02e-01 1.94e-01 1.75e-01 1.93e-01
GOBP EOSINOPHIL MEDIATED IMMUNITY 8 3.62e-01 6.49e-01 0.280000 -1.96e-01 2.01e-01 3.38e-01 3.25e-01
PI3K Cascade 43 7.67e-03 6.51e-02 0.280000 2.68e-01 8.29e-02 2.39e-03 3.47e-01
Transport of organic anions 10 3.06e-01 5.99e-01 0.280000 -4.57e-03 2.80e-01 9.80e-01 1.25e-01
GOCC PRERIBOSOME LARGE SUBUNIT PRECURSOR 18 1.28e-01 3.90e-01 0.280000 -6.43e-02 -2.73e-01 6.37e-01 4.53e-02
GOBP SEMICIRCULAR CANAL DEVELOPMENT 9 3.24e-01 6.15e-01 0.280000 2.49e-01 -1.27e-01 1.95e-01 5.08e-01
GOBP REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION 12 2.19e-01 5.15e-01 0.280000 1.64e-01 -2.27e-01 3.25e-01 1.74e-01
GOMF DIHYDROPYRIMIDINASE ACTIVITY 6 5.12e-01 7.60e-01 0.280000 1.14e-01 2.56e-01 6.29e-01 2.78e-01
GOBP AUTOPHAGIC CELL DEATH 9 3.35e-01 6.25e-01 0.280000 5.75e-02 -2.74e-01 7.65e-01 1.55e-01
Fructose metabolism 7 4.56e-01 7.22e-01 0.280000 1.02e-01 2.61e-01 6.40e-01 2.32e-01
GOBP HEMATOPOIETIC STEM CELL DIFFERENTIATION 36 1.18e-02 8.88e-02 0.280000 2.65e-01 -8.98e-02 5.91e-03 3.51e-01
GOBP REGULATION OF PRE MIRNA PROCESSING 6 4.69e-01 7.30e-01 0.280000 2.29e-01 -1.60e-01 3.31e-01 4.96e-01
GOBP CELLULAR RESPONSE TO GAMMA RADIATION 26 4.07e-02 2.00e-01 0.280000 2.65e-01 -8.95e-02 1.93e-02 4.29e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE KINASE BINDING 10 3.33e-01 6.24e-01 0.280000 2.29e-01 1.60e-01 2.10e-01 3.80e-01
GOBP NEGATIVE REGULATION OF JUN KINASE ACTIVITY 12 2.20e-01 5.16e-01 0.280000 1.64e-01 -2.27e-01 3.27e-01 1.74e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY 33 2.49e-02 1.48e-01 0.279000 -9.81e-02 -2.62e-01 3.29e-01 9.27e-03
Diseases associated with visual transduction 11 2.99e-01 5.94e-01 0.279000 1.50e-01 2.36e-01 3.89e-01 1.76e-01
Diseases of the neuronal system 11 2.99e-01 5.94e-01 0.279000 1.50e-01 2.36e-01 3.89e-01 1.76e-01
Retinoid cycle disease events 11 2.99e-01 5.94e-01 0.279000 1.50e-01 2.36e-01 3.89e-01 1.76e-01
GOMF LONG CHAIN FATTY ACYL COA HYDROLASE ACTIVITY 12 2.67e-01 5.63e-01 0.279000 2.40e-01 1.44e-01 1.51e-01 3.88e-01
Establishment of Sister Chromatid Cohesion 9 3.21e-01 6.12e-01 0.279000 1.84e-01 -2.10e-01 3.39e-01 2.74e-01
Conjugation of benzoate with glycine 6 4.70e-01 7.30e-01 0.279000 -1.68e-01 2.23e-01 4.76e-01 3.43e-01
GOBP REGULATION OF DNA CATABOLIC PROCESS 11 2.52e-01 5.49e-01 0.279000 2.41e-01 -1.41e-01 1.66e-01 4.17e-01
GOBP POSITIVE REGULATION OF SODIUM ION TRANSPORT 28 4.24e-02 2.05e-01 0.279000 2.68e-01 7.94e-02 1.42e-02 4.67e-01
GOBP VITAMIN BIOSYNTHETIC PROCESS 24 4.86e-02 2.22e-01 0.279000 2.16e-01 -1.77e-01 6.70e-02 1.33e-01
GOMF NFAT PROTEIN BINDING 5 5.32e-01 7.73e-01 0.279000 -2.13e-01 1.81e-01 4.10e-01 4.84e-01
GOBP NEGATIVE REGULATION OF HIPPO SIGNALING 21 9.01e-02 3.21e-01 0.279000 2.75e-01 4.65e-02 2.90e-02 7.12e-01
GOBP ECTODERMAL PLACODE DEVELOPMENT 13 1.97e-01 4.90e-01 0.279000 2.36e-01 -1.49e-01 1.41e-01 3.53e-01
GOBP FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA 13 2.40e-01 5.36e-01 0.279000 2.41e-01 1.40e-01 1.32e-01 3.81e-01
Attachment of GPI anchor to uPAR 7 4.66e-01 7.28e-01 0.279000 -1.74e-01 -2.18e-01 4.25e-01 3.18e-01
GOBP POSITIVE REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 5 5.75e-01 8.00e-01 0.279000 1.16e-01 2.54e-01 6.52e-01 3.26e-01
GOBP PROTEIN LOCALIZATION TO MEMBRANE RAFT 9 3.53e-01 6.43e-01 0.279000 -2.77e-02 -2.78e-01 8.85e-01 1.49e-01
Modulation of host responses by IFN-stimulated genes 18 1.11e-01 3.61e-01 0.279000 2.67e-01 -8.01e-02 4.97e-02 5.56e-01
GOBP REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 49 2.20e-03 2.55e-02 0.279000 1.49e-01 -2.36e-01 7.07e-02 4.32e-03
GOBP STRESS GRANULE DISASSEMBLY 7 4.17e-01 6.98e-01 0.279000 1.45e-01 -2.38e-01 5.05e-01 2.76e-01
HuR (ELAVL1) binds and stabilizes mRNA 10 2.93e-01 5.90e-01 0.279000 2.62e-01 -9.67e-02 1.52e-01 5.96e-01
GOMF STORE OPERATED CALCIUM CHANNEL ACTIVITY 9 3.38e-01 6.27e-01 0.279000 5.57e-02 -2.73e-01 7.72e-01 1.56e-01
GOMF LIPID PHOSPHATASE ACTIVITY 19 1.09e-01 3.57e-01 0.279000 6.66e-03 2.79e-01 9.60e-01 3.55e-02
GOBP RENAL ALBUMIN ABSORPTION 6 5.09e-01 7.59e-01 0.279000 7.47e-02 2.69e-01 7.51e-01 2.55e-01
GOBP NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY 25 4.98e-02 2.25e-01 0.279000 2.74e-01 -5.02e-02 1.77e-02 6.64e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN WOUND HEALING 10 2.85e-01 5.82e-01 0.279000 -1.76e-01 2.16e-01 3.35e-01 2.37e-01
GOBP CELLULAR RESPONSE TO INTERFERON ALPHA 7 4.20e-01 6.99e-01 0.279000 1.31e-01 -2.46e-01 5.50e-01 2.60e-01
GOBP SATELLITE CELL ACTIVATION INVOLVED IN SKELETAL MUSCLE REGENERATION 6 5.06e-01 7.58e-01 0.279000 5.87e-02 2.72e-01 8.03e-01 2.48e-01
GOBP MULTI PASS TRANSMEMBRANE PROTEIN INSERTION INTO ER MEMBRANE 6 5.11e-01 7.60e-01 0.279000 -2.65e-01 -8.47e-02 2.60e-01 7.19e-01
GOCC MULTI PASS TRANSLOCON COMPLEX 6 5.11e-01 7.60e-01 0.279000 -2.65e-01 -8.47e-02 2.60e-01 7.19e-01
GOBP NADPH REGENERATION 21 9.61e-02 3.32e-01 0.278000 9.07e-02 2.63e-01 4.72e-01 3.68e-02
GOMF PHOSPHATIDIC ACID TRANSFER ACTIVITY 7 4.49e-01 7.19e-01 0.278000 -2.75e-01 -4.21e-02 2.07e-01 8.47e-01
GOBP CERAMIDE CATABOLIC PROCESS 24 6.70e-02 2.70e-01 0.278000 6.83e-02 2.70e-01 5.62e-01 2.21e-02
GOBP ADRENERGIC RECEPTOR SIGNALING PATHWAY 33 2.07e-02 1.29e-01 0.278000 2.78e-01 -1.38e-02 5.71e-03 8.91e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY 13 2.30e-01 5.28e-01 0.278000 2.71e-01 6.20e-02 9.03e-02 6.99e-01
GOBP CONSTITUTIVE HETEROCHROMATIN FORMATION 10 3.35e-01 6.25e-01 0.278000 -1.33e-01 -2.44e-01 4.66e-01 1.81e-01
GOMF RETINAL DEHYDROGENASE ACTIVITY 9 3.61e-01 6.49e-01 0.278000 2.72e-01 5.90e-02 1.58e-01 7.59e-01
GOBP NUCLEOTIDE EXCISION REPAIR 79 1.13e-04 2.41e-03 0.278000 2.77e-01 2.05e-02 2.02e-05 7.52e-01
GOMF INTERMEDIATE FILAMENT BINDING 10 3.34e-01 6.25e-01 0.278000 1.24e-01 2.49e-01 4.95e-01 1.73e-01
GOBP MEIOTIC DNA DOUBLE STRAND BREAK FORMATION 8 3.94e-01 6.76e-01 0.278000 -2.78e-01 7.19e-04 1.73e-01 9.97e-01
GOCC ACTIN FILAMENT BUNDLE 92 4.61e-05 1.10e-03 0.278000 2.37e-01 1.45e-01 8.25e-05 1.65e-02
GOMF COPPER CHAPERONE ACTIVITY 6 5.18e-01 7.63e-01 0.278000 -1.26e-01 -2.48e-01 5.93e-01 2.93e-01
GOBP AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM 24 7.38e-02 2.86e-01 0.278000 1.51e-01 2.33e-01 2.01e-01 4.77e-02
GOMF ALPHA 1 3 FUCOSYLTRANSFERASE ACTIVITY 8 3.68e-01 6.55e-01 0.278000 -1.95e-01 1.98e-01 3.39e-01 3.32e-01
GOBP INNER EAR RECEPTOR CELL FATE COMMITMENT 5 5.53e-01 7.87e-01 0.278000 -3.59e-02 2.76e-01 8.90e-01 2.86e-01
GOBP RESPONSE TO LAMINAR FLUID SHEAR STRESS 15 1.88e-01 4.79e-01 0.278000 2.65e-01 8.48e-02 7.60e-02 5.70e-01
GOBP SEMICIRCULAR CANAL MORPHOGENESIS 7 4.32e-01 7.08e-01 0.278000 2.72e-01 -5.64e-02 2.13e-01 7.96e-01
PINK1-PRKN Mediated Mitophagy 31 2.59e-02 1.52e-01 0.278000 2.76e-02 -2.76e-01 7.90e-01 7.74e-03
Formation of Senescence-Associated Heterochromatin Foci (SAHF) 17 1.48e-01 4.25e-01 0.278000 2.70e-01 6.59e-02 5.41e-02 6.38e-01
GOBP POSITIVE REGULATION OF FERTILIZATION 5 5.68e-01 7.96e-01 0.278000 -4.92e-02 -2.73e-01 8.49e-01 2.90e-01
GOBP PROTEIN DESTABILIZATION 47 5.66e-03 5.17e-02 0.278000 2.57e-01 1.05e-01 2.30e-03 2.13e-01
GOBP POINTED END ACTIN FILAMENT CAPPING 7 4.20e-01 6.99e-01 0.278000 1.53e-01 -2.32e-01 4.83e-01 2.89e-01
GOBP REGULATION OF HIPPO SIGNALING 35 1.91e-02 1.23e-01 0.278000 2.73e-01 4.82e-02 5.14e-03 6.21e-01
GOBP REGULATION OF NEURON MATURATION 8 4.01e-01 6.83e-01 0.278000 2.76e-01 2.86e-02 1.76e-01 8.89e-01
GOBP CRANIAL NERVE DEVELOPMENT 62 8.65e-04 1.23e-02 0.278000 2.75e-01 3.43e-02 1.76e-04 6.40e-01
GOBP PROTOPORPHYRINOGEN IX METABOLIC PROCESS 10 2.93e-01 5.90e-01 0.277000 2.49e-01 -1.22e-01 1.72e-01 5.05e-01
GOBP POSITIVE REGULATION OF CHROMOSOME CONDENSATION 8 3.69e-01 6.57e-01 0.277000 2.03e-01 -1.89e-01 3.20e-01 3.54e-01
GOCC CONDENSIN COMPLEX 8 3.69e-01 6.57e-01 0.277000 2.03e-01 -1.89e-01 3.20e-01 3.54e-01
NOSTRIN mediated eNOS trafficking 5 5.79e-01 8.02e-01 0.277000 2.51e-01 1.19e-01 3.32e-01 6.46e-01
GOBP POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 14 2.22e-01 5.18e-01 0.277000 2.09e-01 1.82e-01 1.75e-01 2.39e-01
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS 17 1.56e-01 4.36e-01 0.277000 2.51e-01 1.17e-01 7.29e-02 4.02e-01
GOBP MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS 11 2.56e-01 5.53e-01 0.277000 2.24e-01 -1.64e-01 1.99e-01 3.46e-01
GOCC FANCONI ANAEMIA NUCLEAR COMPLEX 11 3.07e-01 6.00e-01 0.277000 1.91e-01 2.01e-01 2.73e-01 2.48e-01
GOBP WHITE FAT CELL DIFFERENTIATION 17 1.61e-01 4.44e-01 0.277000 1.78e-01 2.13e-01 2.04e-01 1.29e-01
GOMF NUCLEOSIDE BINDING 8 3.80e-01 6.65e-01 0.277000 9.03e-02 -2.62e-01 6.58e-01 1.99e-01
PP2A-mediated dephosphorylation of key metabolic factors 6 5.15e-01 7.61e-01 0.277000 2.63e-01 8.64e-02 2.64e-01 7.14e-01
GOBP MYOBLAST MIGRATION 13 2.26e-01 5.23e-01 0.277000 2.76e-01 2.27e-02 8.47e-02 8.87e-01
GOBP TRANSFERRIN TRANSPORT 10 3.04e-01 5.98e-01 0.277000 2.72e-01 -5.50e-02 1.37e-01 7.63e-01
GOCC LATE ENDOSOME LUMEN 8 4.24e-01 7.02e-01 0.277000 -2.13e-01 -1.77e-01 2.97e-01 3.86e-01
GOBP REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING 6 5.08e-01 7.59e-01 0.277000 -4.83e-02 -2.73e-01 8.38e-01 2.47e-01
GOMF BICARBONATE TRANSMEMBRANE TRANSPORTER ACTIVITY 32 1.89e-02 1.22e-01 0.277000 -2.03e-01 1.88e-01 4.66e-02 6.55e-02
GOMF TRIGLYCERIDE LIPASE ACTIVITY 24 5.36e-02 2.36e-01 0.277000 -1.16e-01 2.51e-01 3.25e-01 3.30e-02
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL FUSION 7 4.52e-01 7.21e-01 0.277000 2.75e-01 3.46e-02 2.08e-01 8.74e-01
GOMF 3 5 DNA EXONUCLEASE ACTIVITY 14 2.22e-01 5.18e-01 0.277000 2.27e-01 1.58e-01 1.42e-01 3.05e-01
GOBP POST EMBRYONIC HEMOPOIESIS 5 5.39e-01 7.78e-01 0.277000 -1.81e-01 2.09e-01 4.83e-01 4.19e-01
GOMF CADMIUM ION BINDING 5 5.80e-01 8.03e-01 0.276000 -2.51e-01 -1.15e-01 3.31e-01 6.55e-01
GOBP ENTRAINMENT OF CIRCADIAN CLOCK 29 3.83e-02 1.93e-01 0.276000 2.73e-01 4.38e-02 1.09e-02 6.83e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDES 15 1.99e-01 4.92e-01 0.276000 2.39e-01 1.39e-01 1.09e-01 3.52e-01
GOBP NEGATIVE REGULATION OF PROTEIN SUMOYLATION 8 3.78e-01 6.63e-01 0.276000 1.21e-01 -2.48e-01 5.53e-01 2.24e-01
RAC3 GTPase cycle 85 5.61e-05 1.31e-03 0.276000 2.76e-01 -8.58e-03 1.08e-05 8.91e-01
GOBP CHRONIC INFLAMMATORY RESPONSE 18 1.47e-01 4.23e-01 0.276000 -2.06e-01 -1.84e-01 1.30e-01 1.77e-01
GOMF VOLUME SENSITIVE ANION CHANNEL ACTIVITY 9 3.76e-01 6.61e-01 0.276000 1.08e-01 2.54e-01 5.76e-01 1.87e-01
GOMF COLLAGEN BINDING INVOLVED IN CELL MATRIX ADHESION 5 5.84e-01 8.05e-01 0.276000 2.37e-01 1.42e-01 3.59e-01 5.83e-01
GOBP TRNA 5 END PROCESSING 15 1.67e-01 4.51e-01 0.276000 7.75e-02 -2.65e-01 6.03e-01 7.56e-02
GOMF PEPTIDOGLYCAN IMMUNE RECEPTOR ACTIVITY 5 5.43e-01 7.80e-01 0.276000 -2.38e-01 1.40e-01 3.57e-01 5.88e-01
TLR3-mediated TICAM1-dependent programmed cell death 6 4.78e-01 7.37e-01 0.276000 1.66e-01 -2.21e-01 4.82e-01 3.49e-01
GOBP PLATELET DEGRANULATION 7 4.23e-01 7.01e-01 0.276000 1.74e-01 -2.14e-01 4.24e-01 3.27e-01
GOBP CORONARY VASCULATURE DEVELOPMENT 48 6.00e-03 5.39e-02 0.276000 1.61e-01 2.24e-01 5.43e-02 7.16e-03
GOMF CLATHRIN LIGHT CHAIN BINDING 7 4.65e-01 7.28e-01 0.276000 2.60e-01 9.13e-02 2.33e-01 6.76e-01
GOMF PHOSPHATIDYLINOSITOL MONOPHOSPHATE PHOSPHATASE ACTIVITY 11 3.03e-01 5.97e-01 0.276000 2.53e-01 1.11e-01 1.47e-01 5.23e-01
GOBP REGULATION OF NEUTROPHIL ACTIVATION 6 4.94e-01 7.50e-01 0.276000 2.72e-01 -4.83e-02 2.49e-01 8.38e-01
GOBP MAINTENANCE OF GASTROINTESTINAL EPITHELIUM 23 5.93e-02 2.50e-01 0.276000 -2.06e-01 1.83e-01 8.75e-02 1.28e-01
GOBP TERPENOID CATABOLIC PROCESS 8 4.04e-01 6.87e-01 0.276000 2.16e-02 2.75e-01 9.16e-01 1.78e-01
GOBP REGULATION OF TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE 19 1.05e-01 3.49e-01 0.276000 2.65e-01 -7.41e-02 4.51e-02 5.76e-01
Signaling by NTRK2 (TRKB) 25 5.32e-02 2.35e-01 0.276000 2.71e-01 -4.86e-02 1.89e-02 6.74e-01
Cross-presentation of particulate exogenous antigens (phagosomes) 6 4.96e-01 7.51e-01 0.276000 2.72e-01 -4.26e-02 2.48e-01 8.56e-01
GOBP U4 SNRNA 3 END PROCESSING 8 3.86e-01 6.70e-01 0.276000 7.54e-02 -2.65e-01 7.12e-01 1.94e-01
GOBP MUSCLE HYPERTROPHY 106 8.61e-06 2.53e-04 0.275000 2.68e-01 6.48e-02 1.92e-06 2.49e-01
GOBP SOMATIC STEM CELL DIVISION 12 2.39e-01 5.36e-01 0.275000 2.62e-01 -8.60e-02 1.17e-01 6.06e-01
Interleukin-18 signaling 8 3.76e-01 6.62e-01 0.275000 -1.65e-01 2.21e-01 4.20e-01 2.80e-01
GOBP REGULATION OF CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION 8 3.91e-01 6.74e-01 0.275000 2.70e-01 -5.31e-02 1.86e-01 7.95e-01
GOCC LOW DENSITY LIPOPROTEIN PARTICLE 14 1.96e-01 4.89e-01 0.275000 -2.73e-01 3.78e-02 7.73e-02 8.07e-01
GOMF TRNA METHYLTRANSFERASE ACTIVITY 32 2.06e-02 1.29e-01 0.275000 2.39e-01 -1.37e-01 1.94e-02 1.80e-01
Regulation of endogenous retroelements 103 7.39e-06 2.22e-04 0.275000 2.75e-01 -1.66e-02 1.45e-06 7.71e-01
Signaling by FGFR2 in disease 42 1.02e-02 7.99e-02 0.275000 2.62e-01 8.31e-02 3.26e-03 3.51e-01
Maturation of nucleoprotein 9683610 11 3.04e-01 5.98e-01 0.275000 2.56e-01 9.93e-02 1.41e-01 5.69e-01
GOBP CRANIAL NERVE STRUCTURAL ORGANIZATION 10 3.42e-01 6.32e-01 0.275000 2.46e-01 1.23e-01 1.78e-01 4.99e-01
GOCC CANONICAL INFLAMMASOME COMPLEX 17 1.25e-01 3.86e-01 0.275000 -1.97e-01 1.92e-01 1.59e-01 1.71e-01
GOMF UREA TRANSMEMBRANE TRANSPORTER ACTIVITY 7 4.32e-01 7.07e-01 0.275000 -1.07e-01 2.53e-01 6.25e-01 2.46e-01
GOMF NUCLEAR IMPORT SIGNAL RECEPTOR ACTIVITY 20 9.71e-02 3.34e-01 0.275000 2.71e-01 -4.60e-02 3.59e-02 7.22e-01
Deadenylation of mRNA 22 7.79e-02 2.95e-01 0.275000 2.72e-01 -3.65e-02 2.69e-02 7.67e-01
GOBP LYMPH VESSEL MORPHOGENESIS 23 8.77e-02 3.17e-01 0.275000 2.19e-01 1.66e-01 6.86e-02 1.69e-01
GOMF COMPLEMENT COMPONENT C1Q COMPLEX BINDING 8 4.30e-01 7.06e-01 0.275000 -1.81e-01 -2.07e-01 3.76e-01 3.11e-01
RAF activation 32 3.00e-02 1.66e-01 0.275000 2.65e-01 7.14e-02 9.37e-03 4.84e-01
AMPK inhibits chREBP transcriptional activation activity 8 3.81e-01 6.65e-01 0.275000 -2.43e-01 1.29e-01 2.34e-01 5.29e-01
GOMF 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE BINDING 9 3.86e-01 6.70e-01 0.275000 1.72e-01 2.14e-01 3.72e-01 2.65e-01
GOBP CONNECTIVE TISSUE REPLACEMENT INVOLVED IN INFLAMMATORY RESPONSE WOUND HEALING 6 5.20e-01 7.64e-01 0.275000 -8.49e-02 -2.61e-01 7.19e-01 2.68e-01
GOMF NEUTRAL L AMINO ACID SODIUM SYMPORTER ACTIVITY 8 3.78e-01 6.64e-01 0.275000 1.51e-01 -2.29e-01 4.59e-01 2.61e-01
GOBP REGULATION OF POSTSYNAPSE ASSEMBLY 6 5.29e-01 7.71e-01 0.275000 1.53e-01 2.28e-01 5.15e-01 3.34e-01
GOBP POSITIVE REGULATION OF GONAD DEVELOPMENT 8 3.84e-01 6.69e-01 0.275000 -1.01e-01 2.55e-01 6.20e-01 2.11e-01
GOBP DIGESTIVE TRACT MORPHOGENESIS 48 3.17e-03 3.34e-02 0.275000 2.50e-01 -1.14e-01 2.75e-03 1.71e-01
GOBP NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 26 5.28e-02 2.33e-01 0.275000 -2.75e-01 -9.10e-03 1.54e-02 9.36e-01
GOBP CELLULAR RESPONSE TO LUTEINIZING HORMONE STIMULUS 5 5.45e-01 7.81e-01 0.275000 2.28e-01 -1.53e-01 3.78e-01 5.53e-01
GOBP CELL SUBSTRATE JUNCTION ORGANIZATION 101 2.11e-05 5.58e-04 0.274000 2.46e-01 1.21e-01 1.87e-05 3.57e-02
RUNX2 regulates chondrocyte maturation 5 5.44e-01 7.80e-01 0.274000 -1.76e-01 2.10e-01 4.95e-01 4.15e-01
Acetylcholine binding and downstream events 14 2.29e-01 5.27e-01 0.274000 -1.98e-01 -1.90e-01 2.00e-01 2.18e-01
Postsynaptic nicotinic acetylcholine receptors 14 2.29e-01 5.27e-01 0.274000 -1.98e-01 -1.90e-01 2.00e-01 2.18e-01
GOBP NEGATIVE REGULATION OF CHOLESTEROL EFFLUX 22 9.90e-02 3.37e-01 0.274000 2.12e-01 1.74e-01 8.53e-02 1.58e-01
GOBP REGULATION OF SOMATIC STEM CELL POPULATION MAINTENANCE 12 2.35e-01 5.32e-01 0.274000 2.34e-01 -1.43e-01 1.61e-01 3.91e-01
GOBP PRE MIRNA PROCESSING 17 1.52e-01 4.30e-01 0.274000 2.72e-01 3.55e-02 5.25e-02 8.00e-01
GOCC GPI ANCHOR TRANSAMIDASE COMPLEX 5 5.72e-01 7.99e-01 0.274000 -2.73e-01 -2.23e-02 2.90e-01 9.31e-01
GOBP AORTA MORPHOGENESIS 38 1.52e-02 1.06e-01 0.274000 2.70e-01 4.68e-02 3.98e-03 6.18e-01
Processing of DNA double-strand break ends 75 1.20e-04 2.52e-03 0.274000 1.49e-01 -2.30e-01 2.58e-02 5.75e-04
GOBP NEGATIVE REGULATION OF INTERLEUKIN 13 PRODUCTION 7 4.30e-01 7.06e-01 0.274000 -2.31e-01 1.47e-01 2.90e-01 4.99e-01
GOBP D AMINO ACID TRANSPORT 6 4.96e-01 7.51e-01 0.274000 -6.78e-02 2.65e-01 7.74e-01 2.60e-01
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE MEMBRANE 19 1.34e-01 4.01e-01 0.274000 2.36e-01 1.39e-01 7.50e-02 2.94e-01
GOCC JUXTAPARANODE REGION OF AXON 12 2.33e-01 5.31e-01 0.274000 -1.94e-01 1.93e-01 2.45e-01 2.46e-01
GOBP HEPARIN BIOSYNTHETIC PROCESS 11 3.15e-01 6.08e-01 0.274000 2.16e-01 1.68e-01 2.15e-01 3.33e-01
Signaling by SCF-KIT 42 6.47e-03 5.73e-02 0.274000 2.33e-01 -1.43e-01 8.83e-03 1.10e-01
GOMF HISTONE METHYLTRANSFERASE BINDING 14 1.84e-01 4.74e-01 0.273000 2.08e-01 -1.78e-01 1.78e-01 2.50e-01
GOBP ROOF OF MOUTH DEVELOPMENT 90 3.83e-05 9.46e-04 0.273000 2.73e-01 -1.05e-02 7.40e-06 8.63e-01
PECAM1 interactions 12 2.35e-01 5.32e-01 0.273000 2.18e-01 -1.65e-01 1.91e-01 3.23e-01
GOBP POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION 39 1.19e-02 8.90e-02 0.273000 2.73e-01 -1.99e-02 3.22e-03 8.30e-01
GOBP MEIOTIC CHROMOSOME CONDENSATION 6 4.88e-01 7.46e-01 0.273000 2.41e-01 -1.29e-01 3.06e-01 5.86e-01
GOBP CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY 23 9.04e-02 3.22e-01 0.273000 -1.68e-01 -2.15e-01 1.62e-01 7.39e-02
GOCC CYTOPLASMIC SIDE OF ENDOSOME MEMBRANE 6 4.89e-01 7.47e-01 0.273000 2.45e-01 -1.20e-01 2.98e-01 6.10e-01
Translesion synthesis by REV1 16 1.45e-01 4.18e-01 0.273000 1.95e-01 -1.92e-01 1.77e-01 1.84e-01
GOBP CELL FATE COMMITMENT 284 2.23e-14 3.70e-12 0.273000 2.73e-01 9.85e-03 2.31e-15 7.75e-01
GOCC CHOLINERGIC SYNAPSE 10 2.99e-01 5.95e-01 0.273000 -1.98e-01 1.88e-01 2.78e-01 3.03e-01
GOBP POSITIVE REGULATION OF SARCOMERE ORGANIZATION 6 4.88e-01 7.46e-01 0.273000 -2.35e-01 1.40e-01 3.19e-01 5.54e-01
GOMF 1 PHOSPHATIDYLINOSITOL BINDING 15 2.01e-01 4.94e-01 0.273000 2.57e-01 9.28e-02 8.51e-02 5.34e-01
GOBP PHOSPHATIDYLINOSITOL PHOSPHATE BIOSYNTHETIC PROCESS 63 6.50e-04 9.73e-03 0.273000 2.62e-01 -7.61e-02 3.19e-04 2.96e-01
GOBP ATP EXPORT 6 4.86e-01 7.44e-01 0.273000 -1.72e-01 2.12e-01 4.66e-01 3.68e-01
GOMF NEUROTRANSMITTER TRANSMEMBRANE TRANSPORTER ACTIVITY 20 1.04e-01 3.47e-01 0.273000 2.72e-01 -1.91e-02 3.51e-02 8.83e-01
GOBP POSITIVE REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 9 3.89e-01 6.72e-01 0.273000 -1.39e-01 -2.35e-01 4.70e-01 2.22e-01
GOMF CELL ADHESIVE PROTEIN BINDING INVOLVED IN BUNDLE OF HIS CELL PURKINJE MYOCYTE COMMUNICATION 5 5.51e-01 7.85e-01 0.273000 -2.39e-01 1.32e-01 3.55e-01 6.10e-01
GOBP NOREPINEPHRINE METABOLIC PROCESS 13 2.22e-01 5.17e-01 0.273000 -6.34e-02 2.65e-01 6.92e-01 9.76e-02
GOBP GOLGI TO ENDOSOME TRANSPORT 17 1.62e-01 4.45e-01 0.273000 2.58e-01 8.75e-02 6.51e-02 5.32e-01
Inositol phosphate metabolism 45 7.30e-03 6.30e-02 0.273000 2.69e-01 4.24e-02 1.77e-03 6.22e-01
Surfactant metabolism 27 4.13e-02 2.01e-01 0.273000 -2.49e-01 1.11e-01 2.50e-02 3.20e-01
GOBP MALONYL COA METABOLIC PROCESS 6 5.09e-01 7.59e-01 0.273000 1.05e-02 -2.72e-01 9.65e-01 2.48e-01
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY 8 4.02e-01 6.84e-01 0.272000 -2.70e-01 3.42e-02 1.86e-01 8.67e-01
GOBP ANTERIOR POSTERIOR AXON GUIDANCE 7 4.53e-01 7.21e-01 0.272000 2.71e-01 -2.31e-02 2.14e-01 9.16e-01
GOBP NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 22 9.38e-02 3.28e-01 0.272000 2.63e-01 7.24e-02 3.30e-02 5.57e-01
GOBP ATRIAL CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 9 3.89e-01 6.72e-01 0.272000 2.40e-01 1.28e-01 2.12e-01 5.06e-01
GOBP RESPONSE TO HUMAN CHORIONIC GONADOTROPIN 5 5.79e-01 8.02e-01 0.272000 2.69e-01 4.06e-02 2.97e-01 8.75e-01
GOBP REGULATION OF TRANSLATIONAL ELONGATION 11 2.82e-01 5.80e-01 0.272000 5.40e-02 -2.67e-01 7.57e-01 1.25e-01
Regulation of Expression and Function of Type II Classical Cadherins 32 3.27e-02 1.75e-01 0.272000 2.59e-01 8.35e-02 1.12e-02 4.14e-01
Regulation of Homotypic Cell-Cell Adhesion 32 3.27e-02 1.75e-01 0.272000 2.59e-01 8.35e-02 1.12e-02 4.14e-01
GOMF TRANSLATION INITIATION FACTOR BINDING 28 3.49e-02 1.83e-01 0.272000 1.95e-01 -1.90e-01 7.47e-02 8.12e-02
Insulin receptor signalling cascade 53 3.45e-03 3.56e-02 0.272000 2.61e-01 7.83e-02 1.03e-03 3.24e-01
GOCC PEPTIDASE INHIBITOR COMPLEX 11 3.15e-01 6.08e-01 0.272000 1.22e-01 2.43e-01 4.82e-01 1.63e-01
GOBP MACROPINOCYTOSIS 10 3.46e-01 6.36e-01 0.272000 2.53e-01 9.99e-02 1.66e-01 5.84e-01
GOMF SODIUM ION BINDING 8 4.31e-01 7.06e-01 0.272000 1.18e-01 2.45e-01 5.63e-01 2.30e-01
GOMF PROTEIN DEMETHYLASE ACTIVITY 26 6.37e-02 2.62e-01 0.272000 2.53e-01 9.95e-02 2.54e-02 3.80e-01
GOBP ANTERIOR HEAD DEVELOPMENT 7 4.62e-01 7.26e-01 0.272000 2.71e-01 2.30e-02 2.14e-01 9.16e-01
GOBP POSITIVE REGULATION OF VIRAL GENOME REPLICATION 30 2.78e-02 1.59e-01 0.272000 1.99e-01 -1.85e-01 5.88e-02 7.96e-02
GOBP REGULATION OF NEUROMUSCULAR JUNCTION DEVELOPMENT 8 4.30e-01 7.06e-01 0.272000 2.49e-01 1.09e-01 2.23e-01 5.93e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL CALCIUM ION CONCENTRATION 9 3.94e-01 6.76e-01 0.272000 2.17e-01 1.63e-01 2.59e-01 3.96e-01
GOBP PRIMARY AMINO COMPOUND BIOSYNTHETIC PROCESS 6 5.11e-01 7.60e-01 0.272000 -2.71e-01 1.04e-02 2.50e-01 9.65e-01
GOMF ARP2 3 COMPLEX BINDING 14 2.18e-01 5.14e-01 0.272000 2.68e-01 4.17e-02 8.21e-02 7.87e-01
GOBP POST GOLGI VESICLE MEDIATED TRANSPORT 108 8.03e-06 2.39e-04 0.272000 2.69e-01 3.52e-02 1.32e-06 5.27e-01
Regulation of endogenous retroelements by KRAB-ZFP proteins 70 3.03e-04 5.25e-03 0.272000 2.58e-01 -8.51e-02 1.90e-04 2.18e-01
GOBP REGULATION OF SISTER CHROMATID COHESION 15 1.72e-01 4.58e-01 0.271000 2.46e-01 -1.15e-01 9.94e-02 4.39e-01
GOCC COP9 SIGNALOSOME 34 1.79e-02 1.18e-01 0.271000 1.52e-01 -2.24e-01 1.24e-01 2.36e-02
GOMF PROTEIN ARGININE N METHYLTRANSFERASE ACTIVITY 12 2.45e-01 5.41e-01 0.271000 2.46e-01 -1.15e-01 1.41e-01 4.90e-01
GOCC MLL1 2 COMPLEX 28 4.64e-02 2.16e-01 0.271000 2.71e-01 1.72e-02 1.32e-02 8.75e-01
GOMF E BOX BINDING 58 1.63e-03 2.02e-02 0.271000 2.71e-01 -1.56e-03 3.55e-04 9.84e-01
GOMF CENTROMERIC DNA BINDING 6 5.21e-01 7.64e-01 0.271000 2.69e-01 3.49e-02 2.54e-01 8.82e-01
GOCC MEDIATOR COMPLEX 34 1.77e-02 1.17e-01 0.271000 1.81e-01 -2.02e-01 6.76e-02 4.19e-02
GOBP ASPARAGINE METABOLIC PROCESS 5 5.59e-01 7.91e-01 0.271000 -2.51e-01 1.01e-01 3.31e-01 6.95e-01
GOMF MAP KINASE SCAFFOLD ACTIVITY 12 2.82e-01 5.79e-01 0.271000 2.56e-01 8.93e-02 1.25e-01 5.92e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN 25 5.24e-02 2.32e-01 0.271000 1.51e-01 -2.25e-01 1.92e-01 5.16e-02
GOBP NEUROBLAST DIVISION 14 2.30e-01 5.28e-01 0.271000 2.51e-01 1.02e-01 1.04e-01 5.10e-01
GOBP BLASTOCYST GROWTH 21 8.40e-02 3.11e-01 0.271000 2.24e-01 -1.52e-01 7.57e-02 2.27e-01
GOBP SYNAPTIC VESICLE BUDDING 12 2.76e-01 5.74e-01 0.271000 2.65e-01 5.49e-02 1.12e-01 7.42e-01
Formation of apoptosome 10 3.06e-01 5.99e-01 0.271000 1.85e-01 -1.97e-01 3.11e-01 2.80e-01
Regulation of the apoptosome activity 10 3.06e-01 5.99e-01 0.271000 1.85e-01 -1.97e-01 3.11e-01 2.80e-01
GOBP DNA STRAND ELONGATION 36 1.75e-02 1.16e-01 0.271000 2.68e-01 -3.46e-02 5.31e-03 7.19e-01
GOBP NEGATIVE REGULATION OF EPINEPHRINE SECRETION 5 5.90e-01 8.09e-01 0.271000 -8.64e-02 -2.57e-01 7.38e-01 3.21e-01
GOBP SPERMIDINE METABOLIC PROCESS 6 4.94e-01 7.51e-01 0.271000 -2.34e-01 1.35e-01 3.20e-01 5.66e-01
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 22 7.92e-02 2.99e-01 0.271000 8.74e-02 -2.56e-01 4.78e-01 3.76e-02
GOBP STRESS GRANULE ASSEMBLY 32 2.63e-02 1.54e-01 0.271000 2.64e-01 -5.80e-02 9.66e-03 5.70e-01
GOBP INTRACELLULAR MRNA LOCALIZATION 15 1.72e-01 4.58e-01 0.271000 1.33e-01 -2.36e-01 3.72e-01 1.14e-01
GOBP DIACYLGLYCEROL BIOSYNTHETIC PROCESS 9 3.98e-01 6.80e-01 0.271000 1.85e-01 1.97e-01 3.35e-01 3.06e-01
GOMF REGULATORY RNA BINDING 50 3.21e-03 3.37e-02 0.270000 2.57e-01 -8.39e-02 1.66e-03 3.05e-01
GOBP ACTIN CROSSLINK FORMATION 13 2.64e-01 5.61e-01 0.270000 2.12e-01 1.68e-01 1.85e-01 2.95e-01
GOBP REGULATION OF GASTRULATION 16 1.53e-01 4.31e-01 0.270000 2.29e-01 -1.44e-01 1.13e-01 3.19e-01
GOBP NEGATIVE REGULATION OF MYOSIN LIGHT CHAIN PHOSPHATASE ACTIVITY 5 5.59e-01 7.91e-01 0.270000 2.43e-01 -1.19e-01 3.47e-01 6.46e-01
GOBP REGULATION OF TELOMERE MAINTENANCE 100 8.24e-06 2.44e-04 0.270000 2.23e-01 -1.53e-01 1.18e-04 8.29e-03
GOBP APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS 26 5.70e-02 2.45e-01 0.270000 2.70e-01 -4.97e-03 1.72e-02 9.65e-01
GOBP LEUKOTRIENE D4 BIOSYNTHETIC PROCESS 6 5.16e-01 7.62e-01 0.270000 -3.27e-03 2.70e-01 9.89e-01 2.52e-01
GOBP MITOCHONDRIAL TRANSLATION 130 5.58e-07 2.32e-05 0.270000 2.34e-02 -2.69e-01 6.45e-01 1.17e-07
GOBP HEMATOPOIETIC OR LYMPHOID ORGAN DEVELOPMENT 99 1.20e-05 3.38e-04 0.270000 2.55e-01 -8.81e-02 1.14e-05 1.30e-01
Transcriptional Regulation by VENTX 41 1.01e-02 7.94e-02 0.270000 2.67e-01 -3.89e-02 3.08e-03 6.67e-01
GOBP HINDGUT DEVELOPMENT 8 4.10e-01 6.91e-01 0.270000 -2.68e-01 2.91e-02 1.89e-01 8.87e-01
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 14 1.97e-01 4.90e-01 0.270000 2.44e-01 -1.15e-01 1.14e-01 4.58e-01
GOBP REGULATION OF PROTEIN TARGETING TO MEMBRANE 31 3.92e-02 1.95e-01 0.270000 8.80e-02 2.55e-01 3.96e-01 1.41e-02
GOMF SINGLE STRANDED DNA EXODEOXYRIBONUCLEASE ACTIVITY 10 3.58e-01 6.47e-01 0.270000 2.36e-01 1.31e-01 1.97e-01 4.73e-01
Prednisone ADME 10 3.25e-01 6.16e-01 0.270000 5.16e-02 -2.65e-01 7.78e-01 1.47e-01
GOBP MACROPHAGE COLONY STIMULATING FACTOR SIGNALING PATHWAY 7 4.55e-01 7.22e-01 0.269000 -2.65e-01 4.93e-02 2.25e-01 8.21e-01
GOBP CARDIAC RIGHT VENTRICLE MORPHOGENESIS 21 1.12e-01 3.62e-01 0.269000 2.55e-01 8.85e-02 4.35e-02 4.83e-01
GOMF TRANSLATION TERMINATION FACTOR ACTIVITY 6 4.96e-01 7.51e-01 0.269000 1.50e-01 -2.24e-01 5.25e-01 3.42e-01
GOBP BRAINSTEM DEVELOPMENT 7 4.62e-01 7.26e-01 0.269000 1.45e-02 -2.69e-01 9.47e-01 2.18e-01
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE 13 2.65e-01 5.61e-01 0.269000 2.30e-01 1.41e-01 1.51e-01 3.80e-01
GOBP COENZYME A METABOLIC PROCESS 18 1.45e-01 4.18e-01 0.269000 -3.33e-02 -2.67e-01 8.07e-01 4.96e-02
NF-kB is activated and signals survival 12 2.50e-01 5.48e-01 0.269000 2.44e-01 -1.15e-01 1.44e-01 4.92e-01
GOCC HISTONE DEACETYLASE COMPLEX 76 2.03e-04 3.80e-03 0.269000 2.64e-01 -5.10e-02 6.77e-05 4.42e-01
Defective CHSY1 causes TPBS 7 4.72e-01 7.33e-01 0.269000 2.67e-01 3.22e-02 2.21e-01 8.83e-01
GOBP REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY 33 2.14e-02 1.33e-01 0.269000 2.14e-01 -1.62e-01 3.32e-02 1.06e-01
GOBP INTERMEDIATE FILAMENT ORGANIZATION 72 2.37e-04 4.34e-03 0.269000 -2.26e-01 1.46e-01 9.14e-04 3.26e-02
GOBP TRNA METHYLATION 38 1.19e-02 8.90e-02 0.269000 2.09e-01 -1.69e-01 2.60e-02 7.06e-02
RIPK1-mediated regulated necrosis 29 3.86e-02 1.94e-01 0.269000 5.88e-02 -2.62e-01 5.84e-01 1.45e-02
Regulation of necroptotic cell death 29 3.86e-02 1.94e-01 0.269000 5.88e-02 -2.62e-01 5.84e-01 1.45e-02
GOBP PROTEIN LOCALIZATION TO NUCLEAR BODY 11 2.90e-01 5.87e-01 0.269000 6.22e-02 -2.61e-01 7.21e-01 1.33e-01
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION 9 3.60e-01 6.48e-01 0.269000 2.55e-01 -8.57e-02 1.86e-01 6.56e-01
GOBP PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE 7 4.56e-01 7.22e-01 0.269000 5.89e-02 -2.62e-01 7.87e-01 2.30e-01
GOBP REGULATION OF SKELETAL MUSCLE TISSUE GROWTH 6 5.44e-01 7.80e-01 0.269000 -2.25e-01 -1.47e-01 3.41e-01 5.32e-01
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 16 1.81e-01 4.71e-01 0.269000 2.66e-01 3.55e-02 6.51e-02 8.06e-01
GOBP INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY 49 3.59e-03 3.67e-02 0.269000 2.42e-01 -1.17e-01 3.41e-03 1.56e-01
GOBP ARTICULAR CARTILAGE DEVELOPMENT 5 5.59e-01 7.91e-01 0.269000 2.22e-01 -1.52e-01 3.91e-01 5.57e-01
GOBP URINARY TRACT SMOOTH MUSCLE CONTRACTION 9 3.78e-01 6.64e-01 0.269000 2.68e-01 1.14e-02 1.63e-01 9.53e-01
GOCC GEMINI OF COILED BODIES 11 2.78e-01 5.76e-01 0.269000 2.16e-01 -1.59e-01 2.14e-01 3.60e-01
GOBP EMBRYONIC EYE MORPHOGENESIS 35 2.24e-02 1.37e-01 0.268000 2.68e-01 -5.31e-04 5.98e-03 9.96e-01
GOBP RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION 14 1.99e-01 4.92e-01 0.268000 1.32e-01 -2.33e-01 3.91e-01 1.30e-01
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION 13 2.29e-01 5.26e-01 0.268000 2.53e-01 -8.83e-02 1.14e-01 5.81e-01
GOBP SMOOTH MUSCLE CELL CHEMOTAXIS 9 3.82e-01 6.67e-01 0.268000 2.67e-01 2.70e-02 1.65e-01 8.88e-01
GOMF BASAL TRANSCRIPTION MACHINERY BINDING 58 1.76e-03 2.13e-02 0.268000 2.68e-01 -1.67e-02 4.18e-04 8.26e-01
GOBP DGMP METABOLIC PROCESS 6 5.33e-01 7.73e-01 0.268000 6.43e-02 2.60e-01 7.85e-01 2.69e-01
GOMF ACETYLCHOLINE GATED MONOATOMIC CATION SELECTIVE CHANNEL ACTIVITY 17 1.80e-01 4.70e-01 0.268000 -2.12e-01 -1.64e-01 1.29e-01 2.42e-01
Positive epigenetic regulation of rRNA expression 68 4.01e-04 6.55e-03 0.268000 1.33e-01 -2.33e-01 5.75e-02 9.00e-04
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE 34 3.13e-02 1.70e-01 0.268000 -1.20e-01 -2.40e-01 2.25e-01 1.56e-02
GOBP AXON CHOICE POINT RECOGNITION 7 4.57e-01 7.23e-01 0.268000 2.61e-01 -5.94e-02 2.31e-01 7.86e-01
Opsins 7 4.54e-01 7.21e-01 0.268000 -2.56e-01 7.95e-02 2.41e-01 7.16e-01
GOMF TUMOR NECROSIS FACTOR RECEPTOR BINDING 29 3.50e-02 1.83e-01 0.268000 1.49e-01 -2.23e-01 1.64e-01 3.79e-02
GOBP PROTEIN POLY ADP RIBOSYLATION 10 3.49e-01 6.39e-01 0.268000 2.62e-01 5.51e-02 1.51e-01 7.63e-01
GOCC CMG COMPLEX 11 3.08e-01 6.01e-01 0.268000 2.67e-01 2.02e-02 1.25e-01 9.08e-01
GOMF STRUCTURAL MOLECULE ACTIVITY CONFERRING ELASTICITY 12 2.75e-01 5.72e-01 0.268000 2.68e-01 1.39e-02 1.08e-01 9.33e-01
GOBP GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT 11 3.10e-01 6.04e-01 0.268000 2.66e-01 3.03e-02 1.26e-01 8.62e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 10 3.66e-01 6.53e-01 0.268000 2.15e-01 1.60e-01 2.39e-01 3.82e-01
GOBP INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY 7 4.95e-01 7.51e-01 0.268000 2.00e-01 1.78e-01 3.58e-01 4.15e-01
GOBP PROTEIN MATURATION BY PROTEIN FOLDING 7 4.56e-01 7.22e-01 0.268000 6.92e-02 -2.59e-01 7.51e-01 2.36e-01
GOMF UBIQUITIN MODIFIED HISTONE READER ACTIVITY 7 4.46e-01 7.17e-01 0.268000 2.27e-01 -1.42e-01 2.97e-01 5.16e-01
GOCC CYTOCHROME COMPLEX 35 2.45e-02 1.47e-01 0.268000 -3.56e-02 -2.65e-01 7.16e-01 6.56e-03
GOBP TRIGLYCERIDE RICH LIPOPROTEIN PARTICLE REMODELING 12 2.51e-01 5.48e-01 0.268000 -2.29e-01 1.39e-01 1.70e-01 4.04e-01
GOMF MACROLIDE BINDING 12 2.92e-01 5.90e-01 0.268000 -2.47e-01 -1.03e-01 1.38e-01 5.37e-01
GOBP TELENCEPHALON GLIAL CELL MIGRATION 26 6.75e-02 2.71e-01 0.268000 2.57e-01 7.52e-02 2.33e-02 5.07e-01
GOCC OLIGOSACCHARYLTRANSFERASE COMPLEX 13 2.37e-01 5.33e-01 0.268000 4.94e-02 -2.63e-01 7.58e-01 1.00e-01
GOMF MHC CLASS I PROTEIN BINDING 18 1.40e-01 4.10e-01 0.268000 2.20e-02 -2.67e-01 8.72e-01 5.00e-02
GOCC TRAPPIII PROTEIN COMPLEX 11 2.80e-01 5.77e-01 0.268000 1.78e-01 -2.00e-01 3.06e-01 2.51e-01
GOBP NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS 14 2.42e-01 5.38e-01 0.268000 1.27e-01 2.36e-01 4.12e-01 1.27e-01
GOMF LYSINE N METHYLTRANSFERASE ACTIVITY 62 1.67e-03 2.04e-02 0.268000 2.55e-01 8.13e-02 5.14e-04 2.68e-01
GOBP POLY A DEPENDENT SNORNA 3 END PROCESSING 8 4.21e-01 7.00e-01 0.268000 2.68e-01 -9.93e-04 1.90e-01 9.96e-01
GOCC MYOSIN FILAMENT 24 6.55e-02 2.67e-01 0.268000 -1.04e-01 2.46e-01 3.76e-01 3.66e-02
GOBP NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION 13 2.54e-01 5.51e-01 0.268000 2.64e-01 4.23e-02 9.90e-02 7.92e-01
RAC2 GTPase cycle 81 1.86e-04 3.54e-03 0.267000 2.66e-01 2.48e-02 3.41e-05 6.99e-01
GOMF BASIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 17 1.59e-01 4.42e-01 0.267000 2.67e-01 -3.35e-03 5.62e-02 9.81e-01
GOCC MICROTUBULE PLUS END 24 8.08e-02 3.02e-01 0.267000 2.63e-01 5.02e-02 2.59e-02 6.70e-01
GOBP POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS 34 2.68e-02 1.56e-01 0.267000 2.67e-01 2.16e-02 7.14e-03 8.28e-01
GOBP DEDIFFERENTIATION 11 2.97e-01 5.94e-01 0.267000 2.64e-01 -4.44e-02 1.30e-01 7.99e-01
GOBP CARBON CATABOLITE REGULATION OF TRANSCRIPTION 7 4.46e-01 7.17e-01 0.267000 2.10e-01 -1.66e-01 3.37e-01 4.48e-01
GOBP PRIMARY ALCOHOL BIOSYNTHETIC PROCESS 14 2.00e-01 4.93e-01 0.267000 -1.56e-01 2.17e-01 3.11e-01 1.60e-01
GOMF NAD DEPENDENT PROTEIN LYSINE DEACETYLASE ACTIVITY 7 4.68e-01 7.29e-01 0.267000 1.77e-02 -2.67e-01 9.35e-01 2.22e-01
GOBP COMMA SHAPED BODY MORPHOGENESIS 5 5.69e-01 7.97e-01 0.267000 -9.36e-02 2.50e-01 7.17e-01 3.33e-01
GOBP PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER 37 2.42e-02 1.46e-01 0.267000 2.32e-01 1.32e-01 1.45e-02 1.65e-01
Transcriptional regulation by RUNX3 84 6.42e-05 1.48e-03 0.267000 1.98e-01 -1.79e-01 1.70e-03 4.55e-03
SARS-CoV-1-host interactions 91 4.74e-05 1.13e-03 0.267000 4.09e-02 -2.64e-01 5.00e-01 1.36e-05
GOBP GEPHYRIN CLUSTERING INVOLVED IN POSTSYNAPTIC DENSITY ASSEMBLY 5 5.66e-01 7.94e-01 0.267000 -2.36e-01 1.25e-01 3.61e-01 6.28e-01
GOMF PEPTIDASE ACTIVATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 23 7.92e-02 2.99e-01 0.267000 2.62e-01 -5.16e-02 2.97e-02 6.69e-01
GOBP REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY 16 1.90e-01 4.81e-01 0.267000 2.60e-01 6.13e-02 7.21e-02 6.71e-01
GOMF RNA POLYMERASE III TYPE 3 PROMOTER SEQUENCE SPECIFIC DNA BINDING 6 5.44e-01 7.81e-01 0.267000 2.42e-01 1.11e-01 3.04e-01 6.37e-01
Deadenylation-dependent mRNA decay 53 2.59e-03 2.89e-02 0.267000 2.49e-01 -9.63e-02 1.73e-03 2.25e-01
GOBP CARDIAC VASCULAR SMOOTH MUSCLE CELL DIFFERENTIATION 10 3.19e-01 6.11e-01 0.267000 -1.42e-01 2.25e-01 4.35e-01 2.17e-01
GOBP REGULATION OF EXCRETION 11 2.84e-01 5.81e-01 0.267000 2.19e-01 -1.52e-01 2.08e-01 3.83e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN 6 5.40e-01 7.79e-01 0.267000 -8.03e-02 -2.54e-01 7.33e-01 2.81e-01
GOBP T CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE 5 5.91e-01 8.10e-01 0.267000 -3.43e-02 -2.64e-01 8.94e-01 3.06e-01
GOBP VIRAL TRANSLATION 19 1.19e-01 3.76e-01 0.267000 8.46e-02 -2.53e-01 5.23e-01 5.63e-02
GOBP DEVELOPMENTAL INDUCTION 32 3.82e-02 1.92e-01 0.267000 2.51e-01 9.10e-02 1.41e-02 3.73e-01
GOBP C X C CHEMOKINE RECEPTOR CXCR4 SIGNALING PATHWAY 6 5.16e-01 7.62e-01 0.267000 5.47e-02 -2.61e-01 8.16e-01 2.68e-01
GOCC PERINUCLEAR ENDOPLASMIC RETICULUM 19 1.37e-01 4.06e-01 0.267000 2.63e-01 4.20e-02 4.70e-02 7.52e-01
GOBP REGULATION OF MAST CELL CHEMOTAXIS 7 4.99e-01 7.53e-01 0.267000 2.01e-01 1.75e-01 3.58e-01 4.22e-01
GOBP L ASPARTATE TRANSMEMBRANE TRANSPORT 11 3.35e-01 6.25e-01 0.267000 2.13e-01 1.60e-01 2.21e-01 3.58e-01
GOBP CELLULAR RESPONSE TO SALT STRESS 14 2.09e-01 5.04e-01 0.266000 2.52e-01 -8.55e-02 1.02e-01 5.80e-01
GOBP PYRUVATE FAMILY AMINO ACID CATABOLIC PROCESS 10 3.18e-01 6.10e-01 0.266000 -1.61e-01 2.12e-01 3.78e-01 2.45e-01
Early Phase of HIV Life Cycle 14 2.40e-01 5.36e-01 0.266000 -9.08e-02 -2.50e-01 5.57e-01 1.05e-01
GOMF MICROTUBULE SEVERING ATPASE ACTIVITY 9 3.81e-01 6.67e-01 0.266000 -2.66e-01 2.41e-03 1.66e-01 9.90e-01
GOBP MEDIUM CHAIN FATTY ACID CATABOLIC PROCESS 5 5.80e-01 8.03e-01 0.266000 -3.39e-02 2.64e-01 8.95e-01 3.06e-01
GOBP NEGATIVE REGULATION OF FIBRINOLYSIS 13 2.75e-01 5.72e-01 0.266000 1.58e-01 2.14e-01 3.23e-01 1.81e-01
Caspase-mediated cleavage of cytoskeletal proteins 12 2.93e-01 5.90e-01 0.266000 2.54e-01 7.96e-02 1.28e-01 6.33e-01
GOBP MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION 21 1.25e-01 3.86e-01 0.266000 1.75e-01 2.01e-01 1.65e-01 1.12e-01
GOBP MODULATION BY VIRUS OF HOST PROCESS 6 5.52e-01 7.87e-01 0.266000 1.92e-01 1.84e-01 4.15e-01 4.35e-01
Telomere Extension By Telomerase 22 9.21e-02 3.25e-01 0.266000 2.64e-01 -3.05e-02 3.19e-02 8.05e-01
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 79 1.24e-04 2.58e-03 0.266000 1.58e-01 -2.14e-01 1.50e-02 1.02e-03
GOBP BASE EXCISION REPAIR GAP FILLING 14 2.39e-01 5.36e-01 0.266000 7.95e-02 2.54e-01 6.07e-01 1.00e-01
GOBP PHARYNGEAL ARCH ARTERY MORPHOGENESIS 10 3.42e-01 6.32e-01 0.266000 2.66e-01 -1.08e-02 1.46e-01 9.53e-01
GOMF LACTATE TRANSMEMBRANE TRANSPORTER ACTIVITY 6 5.31e-01 7.72e-01 0.266000 -2.65e-01 -1.96e-02 2.60e-01 9.34e-01
RHO GTPases activate PKNs 56 1.67e-03 2.04e-02 0.266000 1.97e-01 -1.79e-01 1.09e-02 2.05e-02
GOMF NATURAL KILLER CELL LECTIN LIKE RECEPTOR BINDING 8 4.15e-01 6.96e-01 0.266000 5.73e-02 -2.60e-01 7.79e-01 2.03e-01
GOMF POLYAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY 10 3.21e-01 6.12e-01 0.266000 2.24e-01 -1.43e-01 2.20e-01 4.33e-01
GOMF SUPEROXIDE GENERATING NAD P H OXIDASE ACTIVITY 7 5.00e-01 7.53e-01 0.266000 1.64e-01 2.09e-01 4.53e-01 3.37e-01
GOBP SKELETAL MYOFIBRIL ASSEMBLY 10 3.69e-01 6.56e-01 0.266000 2.30e-01 1.33e-01 2.07e-01 4.68e-01
GOBP T HELPER CELL LINEAGE COMMITMENT 23 8.78e-02 3.17e-01 0.266000 2.66e-01 1.32e-02 2.75e-02 9.13e-01
GOBP SENSORY PERCEPTION OF SOUR TASTE 9 3.59e-01 6.47e-01 0.266000 -2.22e-01 1.47e-01 2.49e-01 4.46e-01
GOBP COMPLEMENT ACTIVATION 56 2.61e-03 2.90e-02 0.266000 -2.66e-01 -2.31e-03 5.78e-04 9.76e-01
TNFR1-induced NF-kappa-B signaling pathway 30 3.25e-02 1.75e-01 0.266000 1.84e-01 -1.91e-01 8.04e-02 6.95e-02
GOMF ACETYLCHOLINE RECEPTOR ACTIVITY 22 1.07e-01 3.53e-01 0.266000 -2.52e-01 -8.53e-02 4.10e-02 4.88e-01
IRAK1 recruits IKK complex 12 2.62e-01 5.58e-01 0.266000 9.75e-02 -2.47e-01 5.59e-01 1.38e-01
IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation 12 2.62e-01 5.58e-01 0.266000 9.75e-02 -2.47e-01 5.59e-01 1.38e-01
GOBP ALLANTOIN METABOLIC PROCESS 9 4.10e-01 6.91e-01 0.266000 1.52e-01 2.18e-01 4.29e-01 2.58e-01
GOBP REGULATION OF RESPONSE TO FOOD 16 1.72e-01 4.58e-01 0.266000 2.57e-01 -6.83e-02 7.55e-02 6.36e-01
GOBP DIACYLGLYCEROL METABOLIC PROCESS 26 7.71e-02 2.93e-01 0.266000 1.71e-01 2.03e-01 1.31e-01 7.31e-02
GOBP LYMPHOCYTE MIGRATION INTO LYMPHOID ORGANS 9 3.63e-01 6.50e-01 0.266000 -1.23e-01 2.35e-01 5.23e-01 2.22e-01
GOBP RIGHTING REFLEX 8 4.53e-01 7.21e-01 0.266000 2.19e-01 1.51e-01 2.84e-01 4.60e-01
Elevation of cytosolic Ca2+ levels 16 1.98e-01 4.91e-01 0.265000 2.50e-01 8.97e-02 8.36e-02 5.34e-01
GOBP ATRIOVENTRICULAR VALVE DEVELOPMENT 30 4.12e-02 2.01e-01 0.265000 2.65e-01 -4.15e-03 1.19e-02 9.69e-01
GOBP TRANSFORMING GROWTH FACTOR BETA2 PRODUCTION 8 4.02e-01 6.84e-01 0.265000 1.85e-01 -1.90e-01 3.65e-01 3.52e-01
Constitutive Signaling by Overexpressed ERBB2 11 3.01e-01 5.96e-01 0.265000 2.60e-01 -5.52e-02 1.36e-01 7.51e-01
GOMF PHOSPHATIDYLINOSITOL 3 5 BISPHOSPHATE 3 PHOSPHATASE ACTIVITY 8 4.54e-01 7.21e-01 0.265000 2.17e-01 1.52e-01 2.87e-01 4.56e-01
GOBP SPINDLE ASSEMBLY INVOLVED IN FEMALE MEIOSIS 9 4.09e-01 6.91e-01 0.265000 -1.37e-01 -2.27e-01 4.78e-01 2.38e-01
GOBP NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY 33 3.81e-02 1.92e-01 0.265000 2.26e-01 1.38e-01 2.45e-02 1.69e-01
GOBP SOMITE DEVELOPMENT 81 2.23e-04 4.15e-03 0.265000 2.63e-01 3.32e-02 4.22e-05 6.06e-01
IRAK2 mediated activation of TAK1 complex 9 3.60e-01 6.48e-01 0.265000 1.98e-01 -1.76e-01 3.04e-01 3.60e-01
GOBP REGULATION OF CARDIOCYTE DIFFERENTIATION 32 4.34e-02 2.07e-01 0.265000 1.92e-01 1.83e-01 6.02e-02 7.35e-02
GOCC MPP7 DLG1 LIN7 COMPLEX 5 6.02e-01 8.17e-01 0.265000 7.58e-02 2.54e-01 7.69e-01 3.25e-01
GOBP INTRACELLULAR GLUTAMATE HOMEOSTASIS 6 5.30e-01 7.71e-01 0.265000 1.23e-03 2.65e-01 9.96e-01 2.61e-01
GOMF INTERLEUKIN 6 RECEPTOR BINDING 7 4.66e-01 7.28e-01 0.265000 2.58e-01 -5.87e-02 2.36e-01 7.88e-01
GOCC CYTOPLASMIC STRESS GRANULE 86 7.60e-05 1.70e-03 0.265000 2.50e-01 -8.66e-02 5.95e-05 1.65e-01
GOBP GENERAL ADAPTATION SYNDROME BEHAVIORAL PROCESS 5 6.10e-01 8.22e-01 0.265000 2.26e-01 1.38e-01 3.81e-01 5.94e-01
GOMF SUMO TRANSFERASE ACTIVITY 25 8.04e-02 3.01e-01 0.265000 2.50e-01 8.78e-02 3.05e-02 4.47e-01
GOBP POSITIVE REGULATION OF ACTIN NUCLEATION 14 2.27e-01 5.23e-01 0.265000 2.65e-01 -4.41e-03 8.62e-02 9.77e-01
NFE2L2 regulating anti-oxidant/detoxification enzymes 19 1.41e-01 4.12e-01 0.265000 2.61e-01 4.46e-02 4.88e-02 7.36e-01
GOMF TRANSCRIPTION COREPRESSOR BINDING 45 1.07e-02 8.26e-02 0.265000 2.51e-01 8.31e-02 3.53e-03 3.35e-01
GOBP REGULATION OF EMBRYONIC DEVELOPMENT 88 6.76e-05 1.55e-03 0.265000 2.56e-01 -6.81e-02 3.35e-05 2.70e-01
GOBP NEGATIVE REGULATION OF TRANSLATIONAL INITIATION 21 9.29e-02 3.27e-01 0.265000 1.68e-01 -2.05e-01 1.84e-01 1.04e-01
GOBP WATER SOLUBLE VITAMIN BIOSYNTHETIC PROCESS 11 3.14e-01 6.07e-01 0.265000 2.65e-01 4.43e-03 1.29e-01 9.80e-01
GOMF GTPASE ACTIVATOR ACTIVITY 243 2.46e-11 2.36e-09 0.265000 2.55e-01 7.15e-02 7.73e-12 5.50e-02
GOBP ACTIVATION INDUCED CELL DEATH OF T CELLS 8 4.25e-01 7.03e-01 0.265000 2.58e-02 -2.63e-01 8.99e-01 1.97e-01
GOCC MYOFILAMENT 26 5.67e-02 2.44e-01 0.265000 -9.04e-02 2.49e-01 4.25e-01 2.82e-02
GOBP REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 46 9.45e-03 7.55e-02 0.265000 2.55e-01 7.08e-02 2.78e-03 4.06e-01
GOMF SH2 DOMAIN BINDING 41 1.12e-02 8.52e-02 0.265000 2.53e-01 -7.67e-02 5.03e-03 3.95e-01
GOBP ENDOCARDIAL CUSHION MORPHOGENESIS 44 8.34e-03 6.93e-02 0.265000 2.57e-01 -6.09e-02 3.13e-03 4.84e-01
GOCC INSULIN RESPONSIVE COMPARTMENT 7 5.03e-01 7.55e-01 0.264000 1.51e-01 2.17e-01 4.88e-01 3.20e-01
Role of second messengers in netrin-1 signaling 9 3.81e-01 6.67e-01 0.264000 2.84e-02 -2.63e-01 8.83e-01 1.72e-01
GOCC PROCENTRIOLE REPLICATION COMPLEX 5 6.05e-01 8.19e-01 0.264000 -8.44e-02 -2.50e-01 7.44e-01 3.32e-01
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 5 6.09e-01 8.21e-01 0.264000 2.39e-01 1.12e-01 3.54e-01 6.63e-01
GOMF MONOATOMIC CATION BICARBONATE SYMPORTER ACTIVITY 13 2.31e-01 5.28e-01 0.264000 -1.72e-01 2.00e-01 2.83e-01 2.11e-01
GOBP ADIPOSE TISSUE DEVELOPMENT 60 2.28e-03 2.60e-02 0.264000 2.56e-01 6.38e-02 5.93e-04 3.93e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 18 PRODUCTION 5 6.12e-01 8.23e-01 0.264000 2.23e-01 1.41e-01 3.88e-01 5.84e-01
GOMF TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY BINDING 47 5.47e-03 5.03e-02 0.264000 2.40e-01 -1.10e-01 4.43e-03 1.91e-01
GOBP REGULATION OF MDA 5 SIGNALING PATHWAY 6 5.57e-01 7.89e-01 0.264000 1.65e-01 2.06e-01 4.84e-01 3.82e-01
GOBP OUTER EAR MORPHOGENESIS 8 4.34e-01 7.09e-01 0.264000 2.64e-01 1.34e-02 1.96e-01 9.48e-01
GOMF ALL TRANS RETINAL BINDING 5 5.97e-01 8.14e-01 0.264000 3.34e-02 2.62e-01 8.97e-01 3.10e-01
GOMF NUCLEOBASE TRANSMEMBRANE TRANSPORTER ACTIVITY 10 3.61e-01 6.49e-01 0.264000 5.31e-02 2.59e-01 7.71e-01 1.57e-01
GOMF U1 SNRNA BINDING 8 4.06e-01 6.88e-01 0.264000 1.87e-01 -1.86e-01 3.60e-01 3.61e-01
GOBP SEMAPHORIN PLEXIN SIGNALING PATHWAY 43 1.52e-02 1.06e-01 0.264000 1.64e-01 2.07e-01 6.29e-02 1.89e-02
GOBP POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 28 5.91e-02 2.50e-01 0.264000 2.55e-01 6.68e-02 1.94e-02 5.41e-01
GOBP VITAMIN K METABOLIC PROCESS 11 2.90e-01 5.87e-01 0.264000 1.83e-01 -1.90e-01 2.94e-01 2.75e-01
GOBP LOBAR BRONCHUS DEVELOPMENT 6 5.54e-01 7.87e-01 0.264000 -2.33e-01 -1.24e-01 3.23e-01 6.00e-01
GOMF ATPASE COUPLED LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY 8 4.07e-01 6.89e-01 0.264000 -1.95e-01 1.77e-01 3.39e-01 3.86e-01
GOBP POSITIVE REGULATION OF PLASMINOGEN ACTIVATION 8 4.22e-01 7.01e-01 0.264000 -2.58e-01 5.42e-02 2.06e-01 7.91e-01
GOBP PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 85 2.04e-04 3.82e-03 0.264000 2.51e-01 7.91e-02 6.14e-05 2.07e-01
GOBP REGULATION OF CHROMOSOME CONDENSATION 13 2.34e-01 5.31e-01 0.264000 2.22e-01 -1.41e-01 1.65e-01 3.78e-01
GOBP PANTOTHENATE METABOLIC PROCESS 7 5.07e-01 7.58e-01 0.264000 -1.65e-01 -2.06e-01 4.50e-01 3.46e-01
DNA replication initiation 7 4.60e-01 7.24e-01 0.263000 1.25e-01 -2.32e-01 5.67e-01 2.88e-01
GOMF AP 2 ADAPTOR COMPLEX BINDING 10 3.29e-01 6.20e-01 0.263000 2.29e-01 -1.29e-01 2.09e-01 4.78e-01
GOBP CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING 32 3.39e-02 1.79e-01 0.263000 2.31e-02 -2.62e-01 8.21e-01 1.02e-02
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE 6 5.54e-01 7.87e-01 0.263000 -2.37e-01 -1.14e-01 3.14e-01 6.28e-01
GOBP REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION 10 3.57e-01 6.46e-01 0.263000 -2.62e-01 -2.27e-02 1.51e-01 9.01e-01
GOBP POSITIVE REGULATION OF TISSUE REMODELING 23 1.05e-01 3.50e-01 0.263000 2.31e-01 1.27e-01 5.55e-02 2.93e-01
GOBP POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 103 2.16e-05 5.70e-04 0.263000 2.63e-01 -6.25e-03 3.96e-06 9.13e-01
GOMF INSULIN LIKE GROWTH FACTOR RECEPTOR BINDING 16 1.81e-01 4.71e-01 0.263000 2.60e-01 -4.14e-02 7.20e-02 7.74e-01
GOBP POSTREPLICATION REPAIR 35 2.04e-02 1.28e-01 0.263000 2.16e-01 -1.50e-01 2.71e-02 1.24e-01
GOBP UTERUS MORPHOGENESIS 6 5.41e-01 7.79e-01 0.263000 3.09e-02 2.61e-01 8.96e-01 2.68e-01
GOBP GLUCOCORTICOID METABOLIC PROCESS 24 7.17e-02 2.81e-01 0.263000 -2.39e-01 1.10e-01 4.28e-02 3.53e-01
GOBP ENDOCARDIAL CUSHION FORMATION 31 3.52e-02 1.83e-01 0.263000 2.52e-01 -7.36e-02 1.51e-02 4.78e-01
Negative regulation of FGFR1 signaling 32 4.13e-02 2.01e-01 0.263000 2.51e-01 7.76e-02 1.40e-02 4.48e-01
GOBP NEGATIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS 6 5.12e-01 7.61e-01 0.263000 1.97e-01 -1.74e-01 4.03e-01 4.61e-01
GOBP RESPONSE TO GAMMA RADIATION 51 3.43e-03 3.55e-02 0.263000 1.71e-01 -1.99e-01 3.49e-02 1.37e-02
GOBP POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 22 1.09e-01 3.57e-01 0.263000 -5.59e-02 -2.57e-01 6.50e-01 3.72e-02
GOBP CYTOPLASMIC TRANSLATIONAL INITIATION 38 1.56e-02 1.08e-01 0.263000 1.09e-01 -2.39e-01 2.46e-01 1.08e-02
GOBP RESPONSE TO CORTICOSTERONE 15 2.04e-01 4.98e-01 0.262000 4.09e-02 -2.59e-01 7.84e-01 8.21e-02
GOMF ESTROGEN 16 ALPHA HYDROXYLASE ACTIVITY 8 4.33e-01 7.08e-01 0.262000 2.62e-01 -1.61e-02 2.00e-01 9.37e-01
GOBP INSULIN RECEPTOR SIGNALING PATHWAY 128 3.59e-06 1.17e-04 0.262000 2.43e-01 9.99e-02 2.11e-06 5.10e-02
GOMF INTRACILIARY TRANSPORT PARTICLE B BINDING 5 5.89e-01 8.09e-01 0.262000 -2.60e-01 3.53e-02 3.14e-01 8.91e-01
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS 18 1.57e-01 4.38e-01 0.262000 -2.62e-01 -1.38e-02 5.43e-02 9.19e-01
Defective CHST3 causes SEDCJD 7 4.80e-01 7.39e-01 0.262000 2.62e-01 -1.89e-02 2.31e-01 9.31e-01
GOBP PROTEIN DE ADP RIBOSYLATION 5 5.83e-01 8.05e-01 0.262000 -7.30e-02 2.52e-01 7.77e-01 3.29e-01
GOCC SIN3 TYPE COMPLEX 20 1.10e-01 3.58e-01 0.262000 1.41e-01 -2.21e-01 2.74e-01 8.74e-02
GOBP ERBB3 SIGNALING PATHWAY 10 3.72e-01 6.59e-01 0.262000 2.48e-01 8.43e-02 1.74e-01 6.44e-01
GOBP PEPTIDYL SERINE DEPHOSPHORYLATION 14 2.21e-01 5.17e-01 0.262000 2.51e-01 -7.61e-02 1.04e-01 6.22e-01
Phosphate bond hydrolysis by NUDT proteins 7 5.05e-01 7.57e-01 0.262000 -1.13e-01 -2.37e-01 6.06e-01 2.78e-01
GOBP REGULATION OF GAP JUNCTION ASSEMBLY 9 3.93e-01 6.75e-01 0.262000 2.62e-01 -6.27e-03 1.74e-01 9.74e-01
GOBP TRANSLESION SYNTHESIS 26 5.76e-02 2.46e-01 0.262000 2.30e-01 -1.26e-01 4.26e-02 2.66e-01
Ubiquinol biosynthesis 13 2.36e-01 5.33e-01 0.262000 1.69e-01 -2.00e-01 2.92e-01 2.11e-01
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY 23 7.84e-02 2.97e-01 0.262000 2.08e-01 -1.59e-01 8.40e-02 1.87e-01
GOMF MANNOSIDASE ACTIVITY 15 2.34e-01 5.31e-01 0.262000 1.29e-01 2.28e-01 3.88e-01 1.26e-01
GOMF RNA POLYMERASE II CTD HEPTAPEPTIDE REPEAT KINASE ACTIVITY 10 3.54e-01 6.43e-01 0.262000 2.62e-01 -9.10e-03 1.52e-01 9.60e-01
GOBP REGULATION OF CARDIAC MUSCLE ADAPTATION 18 1.69e-01 4.54e-01 0.262000 2.49e-01 8.17e-02 6.77e-02 5.48e-01
GOBP RIBOSOMAL SUBUNIT EXPORT FROM NUCLEUS 15 2.04e-01 4.98e-01 0.262000 4.75e-02 -2.57e-01 7.50e-01 8.42e-02
GOMF PROTEIN METHYLTRANSFERASE ACTIVITY 95 6.20e-05 1.43e-03 0.262000 2.61e-01 1.67e-02 1.07e-05 7.78e-01
GOBP REGULATION OF CRISTAE FORMATION 5 5.76e-01 8.00e-01 0.262000 2.16e-01 -1.48e-01 4.04e-01 5.65e-01
GOBP REGULATION OF HEPATOCYTE APOPTOTIC PROCESS 9 4.18e-01 6.99e-01 0.262000 2.31e-01 1.23e-01 2.30e-01 5.22e-01
GOCC DNA REPLICATION PREINITIATION COMPLEX 13 2.52e-01 5.49e-01 0.262000 2.57e-01 -5.12e-02 1.09e-01 7.49e-01
VxPx cargo-targeting to cilium 20 1.41e-01 4.13e-01 0.262000 9.90e-02 2.42e-01 4.44e-01 6.08e-02
GOBP CRANIAL NERVE MORPHOGENESIS 30 4.82e-02 2.21e-01 0.262000 2.59e-01 3.51e-02 1.40e-02 7.40e-01
Formation of the beta-catenin:TCF transactivating complex 55 2.30e-03 2.61e-02 0.262000 1.73e-01 -1.96e-01 2.67e-02 1.18e-02
GOCC GBAF COMPLEX 14 2.57e-01 5.54e-01 0.261000 2.34e-01 1.18e-01 1.30e-01 4.46e-01
Senescence-Associated Secretory Phenotype (SASP) 74 3.15e-04 5.42e-03 0.261000 1.21e-01 -2.32e-01 7.13e-02 5.70e-04
GOBP LIVER MORPHOGENESIS 25 6.78e-02 2.72e-01 0.261000 8.68e-02 -2.47e-01 4.52e-01 3.28e-02
GOBP NEGATIVE REGULATION OF CELL VOLUME 5 5.80e-01 8.03e-01 0.261000 2.37e-01 -1.10e-01 3.59e-01 6.70e-01
GOBP INTRACELLULAR WATER HOMEOSTASIS 6 5.21e-01 7.64e-01 0.261000 2.37e-01 -1.09e-01 3.14e-01 6.42e-01
GOMF 14 3 3 PROTEIN BINDING 31 5.08e-02 2.27e-01 0.261000 2.23e-01 1.35e-01 3.13e-02 1.92e-01
GOBP FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS 12 2.73e-01 5.70e-01 0.261000 -1.02e-01 2.41e-01 5.42e-01 1.49e-01
GOBP POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION 16 2.04e-01 4.98e-01 0.261000 2.54e-01 6.29e-02 7.91e-02 6.63e-01
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 11 2.97e-01 5.94e-01 0.261000 -1.94e-01 1.75e-01 2.66e-01 3.14e-01
GOMF NUCLEAR RECEPTOR COACTIVATOR ACTIVITY 52 3.64e-03 3.70e-02 0.261000 2.41e-01 -1.01e-01 2.65e-03 2.08e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 37 1.70e-02 1.14e-01 0.261000 1.85e-01 -1.84e-01 5.10e-02 5.29e-02
GOMF VERY LONG CHAIN FATTY ACID COA LIGASE ACTIVITY 9 4.10e-01 6.91e-01 0.261000 6.58e-02 2.53e-01 7.32e-01 1.89e-01
GOBP AMIDE CATABOLIC PROCESS 16 1.77e-01 4.64e-01 0.261000 -2.38e-01 1.07e-01 9.93e-02 4.57e-01
PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases 14 2.58e-01 5.55e-01 0.261000 2.34e-01 1.16e-01 1.30e-01 4.53e-01
Transcriptional and post-translational regulation of MITF-M expression and activity 60 1.43e-03 1.84e-02 0.261000 2.21e-01 -1.39e-01 3.11e-03 6.22e-02
GOBP SULFATE TRANSPORT 17 1.74e-01 4.60e-01 0.261000 -2.61e-01 5.52e-03 6.27e-02 9.69e-01
GOBP REGULATION OF T CELL EXTRAVASATION 5 5.79e-01 8.02e-01 0.261000 -2.24e-01 1.34e-01 3.86e-01 6.04e-01
Metalloprotease DUBs 27 5.16e-02 2.29e-01 0.261000 1.65e-01 -2.02e-01 1.38e-01 6.93e-02
GOMF CUPROUS ION BINDING 8 4.59e-01 7.24e-01 0.261000 2.41e-01 9.87e-02 2.37e-01 6.29e-01
GOCC AP 1 ADAPTOR COMPLEX 11 3.47e-01 6.37e-01 0.261000 2.29e-01 1.24e-01 1.88e-01 4.76e-01
GOBP CELLULAR RESPONSE TO VITAMIN D 21 1.05e-01 3.49e-01 0.261000 2.43e-01 -9.40e-02 5.37e-02 4.56e-01
GOBP REGULATION OF GLIAL CELL PROLIFERATION 38 2.38e-02 1.44e-01 0.261000 2.51e-01 7.09e-02 7.47e-03 4.49e-01
Phase 0 - rapid depolarisation 31 3.98e-02 1.97e-01 0.261000 -2.59e-01 3.04e-02 1.26e-02 7.70e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS 5 5.77e-01 8.01e-01 0.261000 1.86e-01 -1.83e-01 4.72e-01 4.79e-01
GOBP POSITIVE REGULATION OF HAIR FOLLICLE MATURATION 5 5.78e-01 8.02e-01 0.261000 2.02e-01 -1.65e-01 4.35e-01 5.23e-01
RA biosynthesis pathway 22 9.09e-02 3.23e-01 0.261000 2.21e-01 -1.39e-01 7.32e-02 2.61e-01
GOBP POSITIVE REGULATION OF TOLERANCE INDUCTION 10 3.69e-01 6.57e-01 0.260000 -4.57e-02 -2.56e-01 8.03e-01 1.60e-01
GOBP NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 48 5.25e-03 4.90e-02 0.260000 2.04e-01 -1.62e-01 1.46e-02 5.21e-02
GOBP REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION 20 1.50e-01 4.27e-01 0.260000 -1.57e-01 -2.08e-01 2.25e-01 1.08e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 101 1.77e-05 4.77e-04 0.260000 2.24e-01 -1.32e-01 9.71e-05 2.18e-02
Formyl peptide receptors bind formyl peptides and many other ligands 8 4.26e-01 7.04e-01 0.260000 -7.96e-02 2.48e-01 6.97e-01 2.25e-01
GOMF PEPTIDOGLYCAN BINDING 18 1.42e-01 4.14e-01 0.260000 -2.29e-01 1.23e-01 9.19e-02 3.66e-01
GOBP CELLULAR RESPONSE TO ZINC ION 23 9.23e-02 3.26e-01 0.260000 -2.59e-01 2.86e-02 3.18e-02 8.13e-01
GOBP OUTFLOW TRACT MORPHOGENESIS 82 2.09e-04 3.89e-03 0.260000 2.59e-01 -2.90e-02 5.17e-05 6.50e-01
GOBP REGULATION OF LUTEINIZING HORMONE SECRETION 7 5.05e-01 7.57e-01 0.260000 2.48e-01 7.97e-02 2.57e-01 7.15e-01
GOBP POSITIVE REGULATION OF PROTEIN KINASE C SIGNALING 9 4.11e-01 6.92e-01 0.260000 -5.49e-02 -2.54e-01 7.75e-01 1.87e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPIRATION 13 2.59e-01 5.56e-01 0.260000 3.45e-02 -2.58e-01 8.30e-01 1.08e-01
GOBP CELL CELL ADHESION MEDIATED BY INTEGRIN 18 1.42e-01 4.14e-01 0.260000 2.23e-01 -1.34e-01 1.02e-01 3.24e-01
Response to metal ions 14 2.17e-01 5.12e-01 0.260000 -1.99e-01 1.67e-01 1.97e-01 2.79e-01
GOBP REGULATION OF SYNAPTIC VESICLE CLUSTERING 6 5.29e-01 7.71e-01 0.260000 -7.86e-02 2.48e-01 7.39e-01 2.93e-01
Zygotic genome activation (ZGA) 13 2.83e-01 5.80e-01 0.260000 -8.50e-02 -2.46e-01 5.96e-01 1.25e-01
GOMF URIDYLYLTRANSFERASE ACTIVITY 7 5.04e-01 7.56e-01 0.260000 6.85e-02 2.51e-01 7.54e-01 2.51e-01
Transcriptional regulation by small RNAs 70 5.06e-04 7.95e-03 0.260000 1.50e-01 -2.12e-01 2.96e-02 2.19e-03
GOBP SNO S RNA METABOLIC PROCESS 15 2.34e-01 5.31e-01 0.260000 2.45e-01 8.63e-02 1.01e-01 5.63e-01
GOBP NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 21 1.38e-01 4.08e-01 0.260000 -1.74e-01 -1.93e-01 1.67e-01 1.26e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 31 3.61e-02 1.87e-01 0.260000 2.36e-01 -1.08e-01 2.30e-02 2.97e-01
RHO GTPases Activate WASPs and WAVEs 34 2.62e-02 1.53e-01 0.259000 2.34e-01 -1.12e-01 1.81e-02 2.60e-01
TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation 5 5.99e-01 8.15e-01 0.259000 1.97e-02 -2.59e-01 9.39e-01 3.16e-01
GOBP REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 32 4.07e-02 2.00e-01 0.259000 2.58e-01 2.33e-02 1.14e-02 8.19e-01
GOMF PHOSPHATIDYLCHOLINE STEROL O ACYLTRANSFERASE ACTIVATOR ACTIVITY 6 5.22e-01 7.65e-01 0.259000 -2.11e-01 1.51e-01 3.72e-01 5.21e-01
GOBP FIBROBLAST APOPTOTIC PROCESS 25 7.46e-02 2.88e-01 0.259000 2.56e-01 -4.37e-02 2.69e-02 7.05e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION 18 1.84e-01 4.74e-01 0.259000 1.67e-01 1.99e-01 2.20e-01 1.45e-01
GOBP NEGATIVE REGULATION OF AUTOPHAGOSOME MATURATION 5 5.82e-01 8.04e-01 0.259000 1.50e-01 -2.12e-01 5.62e-01 4.12e-01
GOBP LIVER REGENERATION 30 5.52e-02 2.40e-01 0.259000 -8.78e-02 -2.44e-01 4.05e-01 2.07e-02
GOBP POSITIVE REGULATION OF RECEPTOR CLUSTERING 10 3.90e-01 6.73e-01 0.259000 2.06e-01 1.58e-01 2.60e-01 3.87e-01
GOMF OXYGEN CARRIER ACTIVITY 14 2.61e-01 5.57e-01 0.259000 -2.39e-01 -1.00e-01 1.21e-01 5.17e-01
GOCC NASCENT POLYPEPTIDE ASSOCIATED COMPLEX 5 5.81e-01 8.04e-01 0.259000 -1.66e-01 1.99e-01 5.20e-01 4.41e-01
GOBP NEGATIVE REGULATION OF DNA TEMPLATED DNA REPLICATION 10 3.38e-01 6.27e-01 0.259000 1.81e-01 -1.85e-01 3.22e-01 3.10e-01
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 31 4.99e-02 2.25e-01 0.259000 2.47e-01 7.90e-02 1.74e-02 4.46e-01
GOBP NEGATIVE REGULATION OF BLOOD CIRCULATION 24 9.91e-02 3.37e-01 0.259000 8.75e-02 2.44e-01 4.58e-01 3.87e-02
Activation of SMO 18 1.80e-01 4.69e-01 0.259000 2.34e-01 1.11e-01 8.59e-02 4.14e-01
GOBP MESENCHYMAL CELL MIGRATION 59 2.45e-03 2.75e-02 0.259000 2.58e-01 -1.91e-02 6.04e-04 7.99e-01
GOMF U3 SNORNA BINDING 10 3.92e-01 6.75e-01 0.259000 2.01e-01 1.63e-01 2.71e-01 3.72e-01
Nephron development 13 2.69e-01 5.65e-01 0.259000 2.59e-01 -3.67e-03 1.06e-01 9.82e-01
GOBP ONCOGENE INDUCED CELL SENESCENCE 6 5.28e-01 7.69e-01 0.259000 -2.34e-01 1.10e-01 3.21e-01 6.40e-01
GOBP CELLULAR RESPONSE TO IONIZING RADIATION 70 5.26e-04 8.18e-03 0.259000 1.99e-01 -1.65e-01 3.96e-03 1.69e-02
GOBP PROTEIN TARGETING TO LYSOSOME 31 4.21e-02 2.04e-01 0.259000 2.57e-01 -2.46e-02 1.31e-02 8.13e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 7 4.73e-01 7.33e-01 0.259000 2.26e-01 -1.26e-01 3.00e-01 5.65e-01
GOBP GLIAL CELL APOPTOTIC PROCESS 16 1.99e-01 4.92e-01 0.259000 2.59e-01 -3.89e-03 7.33e-02 9.79e-01
GOBP CELLULAR RESPONSE TO EXOGENOUS DSRNA 16 1.78e-01 4.66e-01 0.259000 1.50e-01 -2.11e-01 2.99e-01 1.45e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 36 3.31e-02 1.76e-01 0.259000 -1.17e-01 -2.31e-01 2.24e-01 1.67e-02
GOMF ACYL COA BINDING 19 1.45e-01 4.18e-01 0.259000 1.85e-02 -2.58e-01 8.89e-01 5.17e-02
GOMF CXCR3 CHEMOKINE RECEPTOR BINDING 5 5.95e-01 8.13e-01 0.259000 5.77e-02 -2.52e-01 8.23e-01 3.29e-01
GOBP EPITHELIAL FLUID TRANSPORT 12 3.19e-01 6.11e-01 0.259000 2.36e-01 1.07e-01 1.58e-01 5.23e-01
GOBP INTERLEUKIN 17A MEDIATED SIGNALING PATHWAY 6 5.65e-01 7.94e-01 0.258000 1.05e-01 2.36e-01 6.57e-01 3.16e-01
GOBP MAINTENANCE OF LENS TRANSPARENCY 7 4.97e-01 7.52e-01 0.258000 2.58e-01 1.32e-02 2.37e-01 9.52e-01
GOMF DNA DNA ANNEALING ACTIVITY 7 5.11e-01 7.60e-01 0.258000 2.42e-01 9.11e-02 2.68e-01 6.77e-01
Pre-NOTCH Transcription and Translation 68 6.82e-04 1.01e-02 0.258000 1.43e-01 -2.15e-01 4.11e-02 2.16e-03
GOBP POSITIVE REGULATION OF G0 TO G1 TRANSITION 5 5.89e-01 8.09e-01 0.258000 9.62e-02 -2.40e-01 7.10e-01 3.53e-01
GOBP L GLUTAMATE TRANSMEMBRANE TRANSPORT 29 6.55e-02 2.67e-01 0.258000 2.21e-01 1.33e-01 3.91e-02 2.14e-01
GOBP EMBRYONIC HEMOPOIESIS 23 8.41e-02 3.11e-01 0.258000 2.03e-01 -1.60e-01 9.21e-02 1.85e-01
GOBP AUTOPHAGY OF PEROXISOME 15 2.43e-01 5.39e-01 0.258000 2.27e-01 1.24e-01 1.28e-01 4.07e-01
GOBP RNA EXPORT FROM NUCLEUS 84 1.29e-04 2.65e-03 0.258000 2.21e-01 -1.33e-01 4.58e-04 3.49e-02
Uptake and function of diphtheria toxin 6 5.70e-01 7.97e-01 0.258000 -1.37e-01 -2.19e-01 5.61e-01 3.53e-01
Interleukin-12 family signaling 53 5.20e-03 4.87e-02 0.258000 -1.70e-02 -2.58e-01 8.30e-01 1.18e-03
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION 15 2.43e-01 5.39e-01 0.258000 2.30e-01 1.17e-01 1.23e-01 4.34e-01
GOCC MKS COMPLEX 13 2.61e-01 5.57e-01 0.258000 5.59e-02 -2.52e-01 7.27e-01 1.16e-01
GOMF STRUCTURAL CONSTITUENT OF NUCLEAR PORE 23 9.65e-02 3.33e-01 0.258000 2.57e-01 -2.49e-02 3.30e-02 8.37e-01
GOBP MYELIN MAINTENANCE 17 1.93e-01 4.84e-01 0.258000 2.51e-01 6.09e-02 7.36e-02 6.64e-01
GOCC PRONUCLEUS 14 2.72e-01 5.69e-01 0.258000 -1.63e-01 -2.00e-01 2.91e-01 1.95e-01
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX COUPLING FACTOR F O 12 3.00e-01 5.95e-01 0.258000 3.27e-03 -2.58e-01 9.84e-01 1.22e-01
Folding of actin by CCT/TriC 10 3.82e-01 6.67e-01 0.258000 -7.24e-02 -2.47e-01 6.92e-01 1.76e-01
GOBP POSITIVE REGULATION OF TROPHOBLAST CELL MIGRATION 7 5.18e-01 7.63e-01 0.258000 1.20e-01 2.28e-01 5.82e-01 2.96e-01
GOBP NEGATIVE REGULATION OF NEURON MIGRATION 9 4.33e-01 7.08e-01 0.258000 2.03e-01 1.58e-01 2.91e-01 4.11e-01
GOBP CARDIAC MUSCLE CELL CARDIAC MUSCLE CELL ADHESION 7 4.84e-01 7.42e-01 0.258000 -2.49e-01 6.76e-02 2.55e-01 7.57e-01
GOBP MRNA 5 SPLICE SITE RECOGNITION 10 3.55e-01 6.45e-01 0.258000 2.50e-01 -6.16e-02 1.71e-01 7.36e-01
GOBP POSITIVE REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION 8 4.76e-01 7.36e-01 0.258000 -1.86e-01 -1.79e-01 3.63e-01 3.82e-01
GOBP SEX DETERMINATION 18 1.86e-01 4.77e-01 0.258000 2.19e-01 1.35e-01 1.07e-01 3.21e-01
GOBP AXIS ELONGATION 29 5.66e-02 2.43e-01 0.258000 -1.52e-02 -2.57e-01 8.87e-01 1.66e-02
GOCC NUCLEAR REPLICATION FORK 39 2.03e-02 1.28e-01 0.258000 2.58e-01 -1.27e-03 5.38e-03 9.89e-01
Anchoring fibril formation 13 2.84e-01 5.82e-01 0.257000 5.73e-02 2.51e-01 7.21e-01 1.17e-01
GOBP T HELPER 17 CELL LINEAGE COMMITMENT 19 1.37e-01 4.06e-01 0.257000 2.42e-01 -8.88e-02 6.82e-02 5.03e-01
GOCC PERINEURONAL NET 10 3.53e-01 6.42e-01 0.257000 -2.45e-01 7.81e-02 1.79e-01 6.69e-01
GOMF GLYCOGEN BINDING 7 4.72e-01 7.32e-01 0.257000 -1.82e-01 1.82e-01 4.04e-01 4.05e-01
GOBP CYTOCHROME METABOLIC PROCESS 5 5.91e-01 8.10e-01 0.257000 -1.03e-01 2.36e-01 6.90e-01 3.61e-01
GOCC AP TYPE MEMBRANE COAT ADAPTOR COMPLEX 40 1.70e-02 1.14e-01 0.257000 2.55e-01 -3.73e-02 5.32e-03 6.83e-01
GOCC MULTIVESICULAR BODY LUMEN 6 5.69e-01 7.97e-01 0.257000 -1.17e-01 -2.29e-01 6.19e-01 3.31e-01
GOBP POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS 17 2.04e-01 4.98e-01 0.257000 1.26e-01 2.24e-01 3.68e-01 1.09e-01
GOBP HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 51 7.38e-03 6.34e-02 0.257000 -2.50e-01 -6.05e-02 2.00e-03 4.55e-01
GOBP NEUROTRANSMITTER LOADING INTO SYNAPTIC VESICLE 7 4.97e-01 7.52e-01 0.257000 2.57e-01 -3.15e-03 2.39e-01 9.88e-01
GOBP AXO DENDRITIC PROTEIN TRANSPORT 9 3.96e-01 6.78e-01 0.257000 -5.95e-02 2.50e-01 7.57e-01 1.94e-01
GOBP CARTILAGE CONDENSATION 19 1.52e-01 4.30e-01 0.257000 7.36e-03 2.57e-01 9.56e-01 5.24e-02
Downregulation of ERBB4 signaling 9 3.82e-01 6.67e-01 0.257000 1.60e-01 -2.01e-01 4.06e-01 2.96e-01
GOBP PYRIMIDINE RIBONUCLEOTIDE CATABOLIC PROCESS 8 4.69e-01 7.30e-01 0.257000 -2.40e-01 -9.22e-02 2.40e-01 6.52e-01
GOMF SMAD BINDING 74 6.15e-04 9.34e-03 0.257000 2.57e-01 -9.39e-03 1.32e-04 8.89e-01
GOMF GAP JUNCTION HEMI CHANNEL ACTIVITY 6 5.62e-01 7.92e-01 0.257000 -6.71e-02 -2.48e-01 7.76e-01 2.92e-01
NRAGE signals death through JNK 53 7.42e-03 6.34e-02 0.257000 2.09e-01 1.50e-01 8.60e-03 5.85e-02
GOBP REGULATION OF SMOOTHENED SIGNALING PATHWAY 85 2.84e-04 4.97e-03 0.257000 2.50e-01 5.79e-02 6.56e-05 3.56e-01
PKA activation in glucagon signalling 17 2.06e-01 5.00e-01 0.257000 1.34e-01 2.19e-01 3.37e-01 1.18e-01
GOBP POSITIVE REGULATION OF GLOMERULAR MESANGIAL CELL PROLIFERATION 7 5.24e-01 7.66e-01 0.257000 -1.97e-01 -1.65e-01 3.67e-01 4.49e-01
GOBP POSITIVE REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION 6 5.45e-01 7.81e-01 0.257000 -2.83e-02 2.55e-01 9.05e-01 2.79e-01
GOBP REGULATION OF LYMPHOCYTE CHEMOTAXIS 25 7.49e-02 2.89e-01 0.257000 7.91e-02 -2.44e-01 4.94e-01 3.44e-02
GOMF CLATHRIN BINDING 55 6.22e-03 5.54e-02 0.257000 2.10e-01 1.48e-01 7.07e-03 5.78e-02
GOBP POSITIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 23 9.18e-02 3.25e-01 0.257000 8.51e-02 -2.42e-01 4.80e-01 4.43e-02
GOMF L ASPARTATE TRANSMEMBRANE TRANSPORTER ACTIVITY 9 4.36e-01 7.10e-01 0.257000 2.01e-01 1.60e-01 2.97e-01 4.06e-01
GOBP CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 55 4.12e-03 4.08e-02 0.257000 2.56e-01 -1.45e-02 1.01e-03 8.52e-01
GOBP VESICLE CARGO LOADING 31 3.99e-02 1.97e-01 0.257000 2.40e-01 -9.04e-02 2.07e-02 3.84e-01
GOBP NEGATIVE REGULATION OF MOTOR NEURON APOPTOTIC PROCESS 11 3.10e-01 6.04e-01 0.256000 1.92e-01 -1.70e-01 2.70e-01 3.29e-01
CLEC7A (Dectin-1) induces NFAT activation 11 3.44e-01 6.33e-01 0.256000 2.54e-01 3.73e-02 1.45e-01 8.30e-01
GOBP REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 28 7.60e-02 2.91e-01 0.256000 1.52e-01 2.07e-01 1.64e-01 5.86e-02
GOBP CELLULAR RESPONSE TO MANGANESE ION 10 3.99e-01 6.82e-01 0.256000 -1.76e-01 -1.87e-01 3.36e-01 3.06e-01
GOBP REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 105 1.78e-05 4.79e-04 0.256000 1.09e-01 -2.32e-01 5.32e-02 4.04e-05
Stabilization of p53 43 1.08e-02 8.32e-02 0.256000 1.35e-01 -2.18e-01 1.26e-01 1.35e-02
Passive transport by Aquaporins 13 2.82e-01 5.79e-01 0.256000 2.71e-02 2.55e-01 8.66e-01 1.12e-01
GOBP PROTEIN RNA COMPLEX DISASSEMBLY 10 3.46e-01 6.36e-01 0.256000 1.78e-01 -1.85e-01 3.31e-01 3.12e-01
GOBP NEGATIVE REGULATION OF MONOCYTE DIFFERENTIATION 8 4.80e-01 7.39e-01 0.256000 -1.95e-01 -1.66e-01 3.39e-01 4.16e-01
GOCC OMEGASOME 5 5.97e-01 8.14e-01 0.256000 2.44e-01 -7.82e-02 3.45e-01 7.62e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS 10 3.92e-01 6.75e-01 0.256000 2.36e-01 9.87e-02 1.96e-01 5.89e-01
Acyl chain remodelling of PG 18 1.69e-01 4.54e-01 0.256000 2.56e-01 1.03e-03 6.00e-02 9.94e-01
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 70 6.10e-04 9.29e-03 0.256000 1.72e-01 -1.89e-01 1.26e-02 6.20e-03
GOBP OLFACTORY BULB INTERNEURON DEVELOPMENT 7 5.19e-01 7.63e-01 0.256000 -2.37e-01 -9.70e-02 2.78e-01 6.57e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 24 8.84e-02 3.18e-01 0.256000 2.52e-01 -4.24e-02 3.23e-02 7.19e-01
GOBP V D J RECOMBINATION 19 1.56e-01 4.36e-01 0.256000 2.55e-01 1.53e-02 5.39e-02 9.08e-01
GOMF DISORDERED DOMAIN SPECIFIC BINDING 29 4.86e-02 2.22e-01 0.256000 2.30e-01 -1.12e-01 3.18e-02 2.99e-01
GOBP POSITIVE REGULATION OF MUCUS SECRETION 6 5.77e-01 8.01e-01 0.256000 1.67e-01 1.93e-01 4.78e-01 4.12e-01
Digestion and absorption 22 1.01e-01 3.42e-01 0.256000 -2.32e-01 1.08e-01 6.00e-02 3.78e-01
Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks 55 3.00e-03 3.21e-02 0.256000 1.72e-01 -1.89e-01 2.70e-02 1.54e-02
Regulation of PTEN gene transcription 59 3.32e-03 3.46e-02 0.256000 2.54e-01 2.88e-02 7.34e-04 7.02e-01
Josephin domain DUBs 10 3.78e-01 6.64e-01 0.256000 -2.42e-02 -2.55e-01 8.95e-01 1.63e-01
GOCC SYNAPTOBREVIN 2 SNAP 25 SYNTAXIN 1A COMPLEX 5 6.33e-01 8.36e-01 0.256000 1.90e-01 1.71e-01 4.62e-01 5.07e-01
GOBP ASPARTATE TRANSMEMBRANE TRANSPORT 20 1.59e-01 4.41e-01 0.256000 1.32e-01 2.19e-01 3.06e-01 9.03e-02
GOBP ISG15 PROTEIN CONJUGATION 6 5.45e-01 7.81e-01 0.256000 4.68e-02 -2.51e-01 8.43e-01 2.87e-01
GOBP POSITIVE REGULATION OF AXON EXTENSION 33 4.74e-02 2.19e-01 0.256000 2.26e-01 1.19e-01 2.46e-02 2.36e-01
The activation of arylsulfatases 8 4.30e-01 7.06e-01 0.255000 2.01e-01 -1.58e-01 3.25e-01 4.39e-01
Defective CFTR causes cystic fibrosis 48 6.84e-03 6.00e-02 0.255000 1.12e-01 -2.30e-01 1.81e-01 5.87e-03
GOMF 7S RNA BINDING 7 4.88e-01 7.46e-01 0.255000 7.85e-02 -2.43e-01 7.19e-01 2.65e-01
GOBP ASYMMETRIC CELL DIVISION 18 1.80e-01 4.69e-01 0.255000 2.49e-01 5.55e-02 6.71e-02 6.83e-01
GOBP CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS 18 1.81e-01 4.70e-01 0.255000 2.49e-01 5.82e-02 6.78e-02 6.69e-01
GOBP FACIAL NERVE MORPHOGENESIS 10 3.85e-01 6.69e-01 0.255000 2.50e-01 5.13e-02 1.71e-01 7.79e-01
GOMF VOLTAGE GATED CHLORIDE CHANNEL ACTIVITY 9 4.41e-01 7.13e-01 0.255000 1.75e-01 1.86e-01 3.63e-01 3.34e-01
GOCC PRE SNORNP COMPLEX 7 4.79e-01 7.38e-01 0.255000 2.07e-01 -1.50e-01 3.44e-01 4.92e-01
GOBP SOMATIC STEM CELL POPULATION MAINTENANCE 64 1.30e-03 1.69e-02 0.255000 2.26e-01 -1.18e-01 1.75e-03 1.02e-01
GOMF COLLAGEN RECEPTOR ACTIVITY 6 5.33e-01 7.73e-01 0.255000 -1.49e-01 2.07e-01 5.27e-01 3.80e-01
GOBP MITOCHONDRIAL GENE EXPRESSION 166 7.43e-08 3.77e-06 0.255000 2.57e-02 -2.54e-01 5.67e-01 1.66e-08
Removal of the Flap Intermediate 13 2.55e-01 5.52e-01 0.255000 1.92e-01 -1.68e-01 2.30e-01 2.95e-01
GOMF TESTOSTERONE DEHYDROGENASE NADPLUS ACTIVITY 7 4.83e-01 7.42e-01 0.255000 -2.27e-01 1.16e-01 2.98e-01 5.95e-01
GOBP SECONDARY PALATE DEVELOPMENT 26 7.87e-02 2.97e-01 0.255000 2.55e-01 3.77e-03 2.44e-02 9.73e-01
GOMF 2 IRON 2 SULFUR CLUSTER BINDING 24 8.05e-02 3.01e-01 0.255000 1.61e-01 -1.98e-01 1.72e-01 9.36e-02
GOBP CELLULAR LIPID BIOSYNTHETIC PROCESS 12 3.22e-01 6.13e-01 0.255000 -6.44e-02 -2.47e-01 6.99e-01 1.39e-01
GOBP PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS 10 3.51e-01 6.40e-01 0.255000 1.52e-01 -2.04e-01 4.04e-01 2.63e-01
PI Metabolism 78 5.68e-04 8.74e-03 0.255000 2.53e-01 3.33e-02 1.14e-04 6.11e-01
GOCC AXON HILLOCK 7 5.05e-01 7.57e-01 0.255000 5.07e-03 2.55e-01 9.81e-01 2.43e-01
GOBP REGULATION OF RESPIRATORY SYSTEM PROCESS 14 2.77e-01 5.74e-01 0.255000 2.22e-01 1.25e-01 1.51e-01 4.17e-01
GOMF GLUTAMATE GATED CALCIUM ION CHANNEL ACTIVITY 7 4.96e-01 7.51e-01 0.255000 4.43e-02 -2.51e-01 8.39e-01 2.50e-01
GOBP MODULATION OF INHIBITORY POSTSYNAPTIC POTENTIAL 7 4.86e-01 7.45e-01 0.255000 -1.03e-01 2.33e-01 6.36e-01 2.86e-01
Metabolism of nitric oxide: NOS3 activation and regulation 17 1.83e-01 4.73e-01 0.255000 2.51e-01 -4.06e-02 7.27e-02 7.72e-01
GOBP ANTEROGRADE NEURONAL DENSE CORE VESICLE TRANSPORT 6 5.69e-01 7.97e-01 0.255000 -2.45e-01 -6.88e-02 2.98e-01 7.70e-01
GOMF TRANSLATION FACTOR ACTIVITY RNA BINDING 75 4.26e-04 6.90e-03 0.255000 1.23e-01 -2.23e-01 6.50e-02 8.49e-04
GOMF SULFATIDE BINDING 6 5.53e-01 7.87e-01 0.254000 2.16e-02 -2.54e-01 9.27e-01 2.82e-01
GOBP EXCITATORY CHEMICAL SYNAPTIC TRANSMISSION 10 3.72e-01 6.59e-01 0.254000 2.12e-02 -2.54e-01 9.07e-01 1.65e-01
GOCC PROTEIN PHOSPHATASE TYPE 1 COMPLEX 18 1.65e-01 4.49e-01 0.254000 2.50e-01 -4.48e-02 6.59e-02 7.42e-01
GOBP METANEPHROS DEVELOPMENT 89 1.32e-04 2.69e-03 0.254000 2.48e-01 -5.82e-02 5.39e-05 3.43e-01
GOBP REGULATION OF NEURON PROJECTION ARBORIZATION 14 2.75e-01 5.72e-01 0.254000 2.33e-01 1.02e-01 1.31e-01 5.09e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA ALTERNATIVE NONHOMOLOGOUS END JOINING 8 4.37e-01 7.11e-01 0.254000 1.20e-01 -2.24e-01 5.56e-01 2.72e-01
GOBP REGULATION OF ASPARTIC TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 6 5.74e-01 8.00e-01 0.254000 9.57e-02 2.36e-01 6.85e-01 3.18e-01
GOBP MAINTENANCE OF CELL NUMBER 179 2.04e-08 1.17e-06 0.254000 2.51e-01 -4.10e-02 7.02e-09 3.45e-01
GOBP REGULATION OF VOLTAGE GATED SODIUM CHANNEL ACTIVITY 8 4.83e-01 7.42e-01 0.254000 2.18e-01 1.31e-01 2.86e-01 5.21e-01
Diseases of programmed cell death 66 1.08e-03 1.46e-02 0.254000 1.37e-01 -2.14e-01 5.44e-02 2.63e-03
GOBP PROTEIN HISTIDYL MODIFICATION TO DIPHTHAMIDE 7 5.01e-01 7.53e-01 0.254000 2.73e-02 -2.53e-01 9.00e-01 2.47e-01
GOBP REGULATION OF THYROID HORMONE GENERATION 7 5.14e-01 7.61e-01 0.254000 2.51e-01 3.88e-02 2.50e-01 8.59e-01
GOBP REGULATION OF APOPTOTIC DNA FRAGMENTATION 10 3.55e-01 6.45e-01 0.254000 2.20e-01 -1.28e-01 2.29e-01 4.85e-01
Activation of PUMA and translocation to mitochondria 9 4.42e-01 7.15e-01 0.254000 2.09e-01 1.45e-01 2.78e-01 4.52e-01
GOMF PHOSPHORUS OXYGEN LYASE ACTIVITY 22 1.38e-01 4.07e-01 0.254000 1.65e-01 1.93e-01 1.81e-01 1.16e-01
GOBP FUCOSE CATABOLIC PROCESS 9 3.92e-01 6.75e-01 0.254000 -1.51e-01 2.04e-01 4.32e-01 2.89e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO ENDOSOME 12 3.19e-01 6.11e-01 0.254000 3.45e-02 2.52e-01 8.36e-01 1.31e-01
GOBP REGULATION OF SALIVA SECRETION 7 5.09e-01 7.59e-01 0.254000 2.54e-01 1.20e-02 2.45e-01 9.56e-01
GOBP REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 15 2.33e-01 5.31e-01 0.254000 2.54e-01 -3.37e-03 8.91e-02 9.82e-01
GOMF ADP TRANSMEMBRANE TRANSPORTER ACTIVITY 9 4.22e-01 7.00e-01 0.254000 -2.53e-01 -1.67e-02 1.89e-01 9.31e-01
p75NTR regulates axonogenesis 9 3.94e-01 6.76e-01 0.254000 -1.44e-01 2.09e-01 4.54e-01 2.79e-01
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY 19 1.41e-01 4.12e-01 0.253000 -2.15e-01 1.34e-01 1.04e-01 3.13e-01
GOMF ABC TYPE XENOBIOTIC TRANSPORTER ACTIVITY 14 2.40e-01 5.36e-01 0.253000 -1.01e-01 2.32e-01 5.13e-01 1.32e-01
GOBP POSITIVE REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY 8 4.44e-01 7.16e-01 0.253000 2.36e-01 -9.27e-02 2.48e-01 6.50e-01
The NLRP3 inflammasome 16 1.98e-01 4.92e-01 0.253000 8.53e-02 -2.38e-01 5.54e-01 9.86e-02
GOBP ENDOSOMAL VESICLE FUSION 15 2.37e-01 5.33e-01 0.253000 2.53e-01 9.45e-03 8.98e-02 9.49e-01
GOMF NUCLEOSIDE TRIPHOSPHATE DIPHOSPHATASE ACTIVITY 9 4.36e-01 7.10e-01 0.253000 -2.40e-01 -7.95e-02 2.12e-01 6.80e-01
GOCC MITOCHONDRIAL CRISTA 8 4.48e-01 7.17e-01 0.253000 2.42e-01 -7.30e-02 2.35e-01 7.21e-01
GOBP TONIC SMOOTH MUSCLE CONTRACTION 11 3.29e-01 6.19e-01 0.253000 8.88e-02 -2.37e-01 6.10e-01 1.73e-01
Maturation of protein 3a 9683673 9 4.33e-01 7.08e-01 0.253000 6.55e-02 2.44e-01 7.34e-01 2.04e-01
Maturation of protein 3a 9694719 9 4.33e-01 7.08e-01 0.253000 6.55e-02 2.44e-01 7.34e-01 2.04e-01
GOCC U4 SNRNP 10 3.94e-01 6.76e-01 0.253000 -6.12e-02 -2.46e-01 7.38e-01 1.79e-01
GOBP NEGATIVE REGULATION OF GONADOTROPIN SECRETION 8 4.70e-01 7.31e-01 0.253000 -4.02e-02 -2.50e-01 8.44e-01 2.21e-01
GOMF CALCIUM DEPENDENT CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 16 2.12e-01 5.07e-01 0.253000 -8.15e-03 2.53e-01 9.55e-01 7.99e-02
GOBP BRAIN MORPHOGENESIS 38 2.80e-02 1.60e-01 0.253000 2.50e-01 4.00e-02 7.71e-03 6.70e-01
GOBP REGULATION OF CELLULAR RESPONSE TO HEAT 16 1.94e-01 4.87e-01 0.253000 2.21e-01 -1.23e-01 1.26e-01 3.92e-01
GOBP S ADENOSYLMETHIONINE CYCLE 7 5.13e-01 7.61e-01 0.253000 2.00e-02 2.52e-01 9.27e-01 2.48e-01
Condensation of Prophase Chromosomes 36 2.78e-02 1.59e-01 0.253000 5.92e-02 -2.46e-01 5.39e-01 1.07e-02
GOBP REGULATION OF MYOBLAST PROLIFERATION 25 1.07e-01 3.53e-01 0.253000 1.87e-01 1.70e-01 1.05e-01 1.41e-01
GOBP RESPONSE TO FUNGUS 60 3.48e-03 3.58e-02 0.253000 -2.51e-01 -3.34e-02 7.83e-04 6.55e-01
GOBP POST EMBRYONIC EYE MORPHOGENESIS 7 5.11e-01 7.60e-01 0.253000 2.53e-01 7.41e-03 2.47e-01 9.73e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN 15 2.61e-01 5.57e-01 0.253000 -1.45e-01 -2.07e-01 3.31e-01 1.65e-01
GOBP VIRAL RNA GENOME REPLICATION 29 6.63e-02 2.69e-01 0.253000 2.48e-01 4.87e-02 2.08e-02 6.50e-01
GOBP RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY 52 4.72e-03 4.55e-02 0.253000 1.60e-01 -1.96e-01 4.60e-02 1.47e-02
GOBP GLYCOSIDE METABOLIC PROCESS 20 1.66e-01 4.50e-01 0.253000 2.11e-01 1.39e-01 1.02e-01 2.83e-01
GOBP BASIC AMINO ACID TRANSPORT 21 1.29e-01 3.92e-01 0.253000 2.51e-01 -2.57e-02 4.61e-02 8.38e-01
GOBP THYMUS DEVELOPMENT 49 8.03e-03 6.73e-02 0.253000 2.49e-01 -4.36e-02 2.58e-03 5.97e-01
GOBP INTERLEUKIN 10 MEDIATED SIGNALING PATHWAY 12 3.26e-01 6.17e-01 0.253000 -2.48e-01 -4.98e-02 1.37e-01 7.65e-01
GOBP CELL AGGREGATION 23 1.11e-01 3.60e-01 0.253000 9.33e-03 2.52e-01 9.38e-01 3.61e-02
GOBP NEGATIVE REGULATION OF BONE MINERALIZATION 18 1.84e-01 4.74e-01 0.253000 -2.50e-01 -3.91e-02 6.68e-02 7.74e-01
N-glycan antennae elongation in the medial/trans-Golgi 26 9.14e-02 3.25e-01 0.253000 7.65e-02 2.41e-01 5.00e-01 3.36e-02
GOMF CDP ALCOHOL PHOSPHATIDYLTRANSFERASE ACTIVITY 8 4.57e-01 7.22e-01 0.252000 3.45e-02 -2.50e-01 8.66e-01 2.21e-01
GOBP POSITIVE REGULATION OF PROTEIN DEUBIQUITINATION 5 5.98e-01 8.14e-01 0.252000 1.56e-01 -1.99e-01 5.46e-01 4.42e-01
Competing endogenous RNAs (ceRNAs) regulate PTEN translation 16 2.15e-01 5.10e-01 0.252000 2.52e-01 -1.40e-03 8.04e-02 9.92e-01
Pyrimidine catabolism 12 3.42e-01 6.32e-01 0.252000 -2.07e-01 -1.44e-01 2.14e-01 3.86e-01
GOBP NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT 13 2.63e-01 5.60e-01 0.252000 -1.99e-01 1.56e-01 2.15e-01 3.31e-01
GOBP PHAGOLYSOSOME ASSEMBLY 17 1.98e-01 4.92e-01 0.252000 2.52e-01 1.36e-02 7.22e-02 9.22e-01
Chromatin modifying enzymes 216 7.45e-10 5.61e-08 0.252000 2.49e-01 -4.11e-02 2.87e-10 2.98e-01
Chromatin organization 216 7.45e-10 5.61e-08 0.252000 2.49e-01 -4.11e-02 2.87e-10 2.98e-01
Phase 2 - plateau phase 14 2.51e-01 5.48e-01 0.252000 -5.44e-02 2.46e-01 7.24e-01 1.11e-01
GOBP CELLULAR RESPONSE TO INSULIN STIMULUS 210 6.50e-09 4.05e-07 0.252000 2.29e-01 1.05e-01 1.02e-08 8.60e-03
GOMF ACTIVIN RECEPTOR BINDING 9 4.19e-01 6.99e-01 0.252000 2.52e-01 -1.31e-02 1.91e-01 9.46e-01
G2/M DNA damage checkpoint 72 6.82e-04 1.01e-02 0.252000 1.16e-01 -2.24e-01 8.82e-02 1.03e-03
Activation of RAS in B cells 5 6.06e-01 8.20e-01 0.252000 2.38e-01 -8.21e-02 3.56e-01 7.50e-01
GOBP PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES 20 1.49e-01 4.26e-01 0.252000 2.52e-01 9.10e-03 5.12e-02 9.44e-01
GOBP SOMITOGENESIS 63 2.99e-03 3.20e-02 0.252000 2.45e-01 5.92e-02 7.73e-04 4.16e-01
GOBP INTRACELLULAR STEROL TRANSPORT 37 3.20e-02 1.73e-01 0.252000 4.71e-02 2.48e-01 6.20e-01 9.17e-03
GOBP METANEPHRIC NEPHRON DEVELOPMENT 40 2.15e-02 1.33e-01 0.252000 2.52e-01 -8.91e-03 5.86e-03 9.22e-01
GOBP CELL FATE DETERMINATION 42 1.66e-02 1.12e-01 0.252000 2.49e-01 -3.71e-02 5.21e-03 6.77e-01
GOBP BICARBONATE TRANSPORT 37 2.25e-02 1.38e-01 0.252000 -1.84e-01 1.72e-01 5.24e-02 7.08e-02
PKA-mediated phosphorylation of CREB 19 1.82e-01 4.71e-01 0.252000 1.18e-01 2.23e-01 3.74e-01 9.31e-02
GOMF INSULIN LIKE GROWTH FACTOR I BINDING 13 2.79e-01 5.76e-01 0.252000 2.47e-01 -5.03e-02 1.23e-01 7.54e-01
GOBP PYRIMIDINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT 16 2.42e-01 5.39e-01 0.252000 1.94e-01 1.60e-01 1.79e-01 2.67e-01
GOBP CEREBRAL CORTEX DEVELOPMENT 119 9.44e-06 2.75e-04 0.252000 2.49e-01 -3.92e-02 2.78e-06 4.60e-01
GOMF NETRIN RECEPTOR ACTIVITY 5 6.00e-01 8.16e-01 0.252000 -1.50e-01 2.02e-01 5.61e-01 4.34e-01
GOBP PARAXIAL MESODERM DEVELOPMENT 18 1.78e-01 4.65e-01 0.252000 2.51e-01 -1.05e-02 6.48e-02 9.38e-01
GOMF DEUBIQUITINASE ACTIVITY 88 2.06e-04 3.85e-03 0.252000 2.50e-01 -2.44e-02 4.88e-05 6.92e-01
GOMF GLUTATHIONE TRANSFERASE ACTIVITY 24 8.58e-02 3.13e-01 0.252000 1.88e-01 -1.67e-01 1.10e-01 1.58e-01
GOBP MAMMARY GLAND ALVEOLUS DEVELOPMENT 19 1.60e-01 4.43e-01 0.252000 1.69e-02 -2.51e-01 8.99e-01 5.82e-02
GOCC U1 SNRNP 19 1.69e-01 4.54e-01 0.252000 -3.51e-02 -2.49e-01 7.91e-01 6.01e-02
GOCC EXON EXON JUNCTION COMPLEX 19 1.43e-01 4.15e-01 0.252000 1.91e-01 -1.64e-01 1.50e-01 2.16e-01
GOBP RESPONSE TO ANGIOTENSIN 41 2.49e-02 1.48e-01 0.252000 2.30e-01 1.02e-01 1.08e-02 2.60e-01
GOBP POSITIVE REGULATION OF MRNA PROCESSING 30 4.75e-02 2.19e-01 0.252000 2.13e-01 -1.34e-01 4.37e-02 2.04e-01
GOBP CARDIAC CONDUCTION SYSTEM DEVELOPMENT 36 2.64e-02 1.54e-01 0.252000 2.23e-01 -1.15e-01 2.03e-02 2.30e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION 49 1.06e-02 8.25e-02 0.251000 2.48e-01 4.43e-02 2.72e-03 5.92e-01
GOBP INHIBITION OF NEUROEPITHELIAL CELL DIFFERENTIATION 6 5.53e-01 7.87e-01 0.251000 2.43e-01 -6.54e-02 3.03e-01 7.81e-01
GOBP POSITIVE REGULATION OF COMPLEMENT ACTIVATION 7 5.19e-01 7.63e-01 0.251000 -2.50e-01 -2.86e-02 2.52e-01 8.96e-01
GOBP ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE 9 3.99e-01 6.81e-01 0.251000 -1.67e-01 1.88e-01 3.86e-01 3.30e-01
Synthesis of glycosylphosphatidylinositol (GPI) 17 2.17e-01 5.12e-01 0.251000 -1.05e-01 -2.28e-01 4.54e-01 1.03e-01
GOMF SPHINGOSINE N ACYLTRANSFERASE ACTIVITY 7 5.35e-01 7.75e-01 0.251000 1.17e-01 2.22e-01 5.91e-01 3.09e-01
GOMF 3 5 DNA HELICASE ACTIVITY 15 2.61e-01 5.58e-01 0.251000 2.25e-01 1.12e-01 1.32e-01 4.52e-01
GOBP GLOMERULUS VASCULATURE MORPHOGENESIS 6 5.61e-01 7.92e-01 0.251000 2.50e-01 -2.00e-02 2.88e-01 9.32e-01
GOBP GALACTOSYLCERAMIDE BIOSYNTHETIC PROCESS 6 5.87e-01 8.07e-01 0.251000 2.14e-01 1.31e-01 3.63e-01 5.80e-01
Kidney development 45 1.08e-02 8.29e-02 0.251000 2.21e-01 -1.19e-01 1.03e-02 1.67e-01
GOBP MUSCLE HYPERTROPHY IN RESPONSE TO STRESS 32 5.99e-02 2.52e-01 0.251000 1.82e-01 1.73e-01 7.41e-02 9.11e-02
GOMF HELICASE ACTIVITY 149 1.47e-06 5.34e-05 0.251000 2.37e-01 8.22e-02 5.76e-07 8.33e-02
GOMF GLUTATHIONE DISULFIDE OXIDOREDUCTASE ACTIVITY 5 6.43e-01 8.42e-01 0.251000 -2.01e-01 -1.50e-01 4.36e-01 5.61e-01
GOBP URONIC ACID METABOLIC PROCESS 24 9.35e-02 3.28e-01 0.251000 7.17e-02 -2.41e-01 5.43e-01 4.13e-02
GOBP DNA ALKYLATION REPAIR 11 3.74e-01 6.61e-01 0.251000 2.23e-01 1.15e-01 2.00e-01 5.08e-01
GOBP POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 34 5.01e-02 2.26e-01 0.251000 1.58e-01 1.95e-01 1.11e-01 4.91e-02
GOBP REGULATION OF T CELL APOPTOTIC PROCESS 39 3.22e-02 1.74e-01 0.251000 -1.53e-01 -1.99e-01 9.86e-02 3.15e-02
GOMF IMMUNOGLOBULIN BINDING 22 1.26e-01 3.86e-01 0.251000 -2.51e-01 -1.14e-02 4.18e-02 9.26e-01
GOBP REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH 15 2.33e-01 5.31e-01 0.251000 2.48e-01 -3.89e-02 9.65e-02 7.94e-01
GOBP GLYCOLYTIC PROCESS THROUGH GLUCOSE 6 PHOSPHATE 19 1.51e-01 4.29e-01 0.251000 -9.05e-02 2.34e-01 4.95e-01 7.74e-02
HDL assembly 8 4.76e-01 7.36e-01 0.251000 3.93e-02 2.48e-01 8.47e-01 2.25e-01
GOBP REGULATION OF COPII VESICLE COATING 5 6.29e-01 8.34e-01 0.251000 -2.48e-01 -3.70e-02 3.37e-01 8.86e-01
GOCC SAGA COMPLEX 23 9.65e-02 3.33e-01 0.251000 1.92e-01 -1.62e-01 1.12e-01 1.79e-01
GOBP REGULATION OF MICROTUBULE NUCLEATION 17 1.82e-01 4.72e-01 0.251000 2.28e-01 -1.04e-01 1.03e-01 4.56e-01
Glycosphingolipid transport 8 4.45e-01 7.17e-01 0.251000 1.35e-01 -2.12e-01 5.10e-01 3.00e-01
GOBP CARDIOLIPIN METABOLIC PROCESS 14 2.62e-01 5.59e-01 0.251000 1.60e-02 -2.50e-01 9.18e-01 1.05e-01
Urea cycle 9 4.04e-01 6.87e-01 0.251000 2.19e-01 -1.22e-01 2.55e-01 5.27e-01
GOBP TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY 64 1.54e-03 1.94e-02 0.251000 2.01e-01 -1.49e-01 5.32e-03 3.89e-02
GOBP MICROGLIAL CELL MIGRATION 8 4.84e-01 7.43e-01 0.251000 -2.39e-01 -7.66e-02 2.42e-01 7.07e-01
GOBP PROTEIN LOCALIZATION TO NUCLEOPLASM 13 2.71e-01 5.68e-01 0.251000 1.17e-01 -2.22e-01 4.66e-01 1.66e-01
Mitophagy 37 2.65e-02 1.55e-01 0.251000 6.61e-02 -2.42e-01 4.86e-01 1.09e-02
Vitamin C (ascorbate) metabolism 8 4.61e-01 7.25e-01 0.251000 3.74e-02 -2.48e-01 8.55e-01 2.25e-01
GOBP SEQUESTERING OF IRON ION 6 5.45e-01 7.81e-01 0.251000 -2.05e-01 1.44e-01 3.85e-01 5.40e-01
GOMF THIOREDOXIN DISULFIDE REDUCTASE NADPH ACTIVITY 7 5.15e-01 7.62e-01 0.250000 -3.53e-03 2.50e-01 9.87e-01 2.51e-01
GOMF STRUCTURAL CONSTITUENT OF MUSCLE 41 2.07e-02 1.29e-01 0.250000 -3.27e-03 2.50e-01 9.71e-01 5.53e-03
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS WITH A FLAVIN AS ACCEPTOR 13 3.20e-01 6.11e-01 0.250000 1.82e-01 1.72e-01 2.55e-01 2.84e-01
GOBP MITOCHONDRIAL RNA METABOLIC PROCESS 55 5.11e-03 4.82e-02 0.250000 3.05e-02 -2.48e-01 6.95e-01 1.44e-03
GOBP NEGATIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION 7 5.15e-01 7.62e-01 0.250000 2.50e-01 -5.55e-03 2.52e-01 9.80e-01
GOMF HISTONE MODIFYING ACTIVITY 197 1.30e-08 7.83e-07 0.250000 2.49e-01 2.78e-02 1.72e-09 5.02e-01
RUNX2 regulates genes involved in cell migration 8 4.46e-01 7.17e-01 0.250000 -1.48e-01 2.02e-01 4.68e-01 3.23e-01
Regulation of RUNX3 expression and activity 45 1.09e-02 8.37e-02 0.250000 1.31e-01 -2.14e-01 1.30e-01 1.32e-02
GOMF UBIQUITIN LIKE PROTEIN READER ACTIVITY 20 1.70e-01 4.55e-01 0.250000 2.21e-01 1.18e-01 8.76e-02 3.61e-01
GOBP POSITIVE REGULATION OF MIRNA TRANSCRIPTION 54 5.91e-03 5.35e-02 0.250000 2.50e-01 -1.63e-02 1.51e-03 8.36e-01
MECP2 regulates neuronal receptors and channels 17 1.88e-01 4.79e-01 0.250000 2.37e-01 -8.04e-02 9.10e-02 5.66e-01
GOMF PROTEIN PHOSPHATASE 2A BINDING 27 7.07e-02 2.79e-01 0.250000 2.39e-01 -7.48e-02 3.19e-02 5.01e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 17 2.22e-01 5.18e-01 0.250000 1.18e-01 2.21e-01 4.01e-01 1.15e-01
GOMF PROTEIN GLUTAMIC ACID LIGASE ACTIVITY 10 4.07e-01 6.89e-01 0.250000 -7.98e-02 -2.37e-01 6.62e-01 1.95e-01
GOMF UDP XYLOSYLTRANSFERASE ACTIVITY 11 3.80e-01 6.65e-01 0.250000 2.11e-01 1.34e-01 2.26e-01 4.41e-01
GOBP L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE 17 2.27e-01 5.24e-01 0.250000 1.74e-01 1.79e-01 2.14e-01 2.01e-01
GOBP BONE TRABECULA MORPHOGENESIS 14 2.65e-01 5.61e-01 0.250000 2.49e-01 -1.59e-02 1.06e-01 9.18e-01
GOBP PLATELET ACTIVATING FACTOR METABOLIC PROCESS 8 4.86e-01 7.45e-01 0.250000 -7.40e-02 -2.39e-01 7.17e-01 2.43e-01
MET interacts with TNS proteins 5 6.18e-01 8.27e-01 0.250000 -4.18e-02 2.46e-01 8.72e-01 3.40e-01
Activation of RAC1 12 3.43e-01 6.32e-01 0.250000 2.32e-01 9.35e-02 1.65e-01 5.75e-01
RHO GTPases activate CIT 19 1.77e-01 4.64e-01 0.250000 2.44e-01 5.32e-02 6.56e-02 6.88e-01
GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT 7 5.07e-01 7.58e-01 0.250000 2.43e-01 -5.74e-02 2.66e-01 7.93e-01
alpha-linolenic (omega3) and linoleic (omega6) acid metabolism 12 3.51e-01 6.40e-01 0.250000 2.01e-01 1.48e-01 2.27e-01 3.76e-01
alpha-linolenic acid (ALA) metabolism 12 3.51e-01 6.40e-01 0.250000 2.01e-01 1.48e-01 2.27e-01 3.76e-01
Signal attenuation 10 4.15e-01 6.95e-01 0.250000 2.19e-01 1.19e-01 2.30e-01 5.13e-01
GOCC SCAR COMPLEX 12 3.01e-01 5.96e-01 0.250000 1.38e-01 -2.08e-01 4.09e-01 2.12e-01
GOCC MEIOTIC SPINDLE 14 2.96e-01 5.93e-01 0.249000 -1.62e-01 -1.89e-01 2.93e-01 2.20e-01
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE C END DEGRON RULE PATHWAY 12 3.29e-01 6.20e-01 0.249000 -1.97e-02 -2.49e-01 9.06e-01 1.36e-01
GOBP POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY 41 2.38e-02 1.44e-01 0.249000 -4.48e-02 -2.45e-01 6.20e-01 6.57e-03
GOBP NEGATIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE 6 5.48e-01 7.84e-01 0.249000 -1.41e-01 2.05e-01 5.49e-01 3.84e-01
GOBP SYNAPTIC VESICLE ENDOSOMAL PROCESSING 8 4.73e-01 7.33e-01 0.249000 2.49e-01 1.89e-03 2.22e-01 9.93e-01
GOMF HEPARAN SULFATE SULFOTRANSFERASE ACTIVITY 14 2.95e-01 5.92e-01 0.249000 2.03e-01 1.45e-01 1.89e-01 3.49e-01
GOCC MICROVILLUS MEMBRANE 32 4.53e-02 2.13e-01 0.249000 -6.04e-02 2.42e-01 5.54e-01 1.79e-02
Organic anion transporters 12 3.06e-01 5.99e-01 0.249000 1.06e-01 -2.25e-01 5.25e-01 1.76e-01
GOBP PURINE RIBONUCLEOTIDE SALVAGE 7 5.39e-01 7.78e-01 0.249000 1.04e-01 2.26e-01 6.33e-01 3.00e-01
GOBP NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY 15 2.31e-01 5.29e-01 0.249000 8.26e-02 -2.35e-01 5.80e-01 1.15e-01
GOBP POSITIVE REGULATION OF MUSCLE HYPERTROPHY 37 2.71e-02 1.57e-01 0.249000 2.35e-01 -8.12e-02 1.32e-02 3.93e-01
Signaling by MAPK mutants 6 5.91e-01 8.10e-01 0.249000 2.19e-01 1.18e-01 3.53e-01 6.15e-01
GOBP COPI COATED VESICLE BUDDING 6 5.87e-01 8.07e-01 0.249000 2.33e-01 8.86e-02 3.24e-01 7.07e-01
GOBP HEPOXILIN METABOLIC PROCESS 8 4.92e-01 7.50e-01 0.249000 2.30e-01 9.54e-02 2.60e-01 6.40e-01
GOMF NARROW PORE CHANNEL ACTIVITY 19 1.63e-01 4.47e-01 0.249000 -2.46e-01 3.84e-02 6.35e-02 7.72e-01
GOBP CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION 35 4.43e-02 2.10e-01 0.249000 2.35e-01 8.09e-02 1.60e-02 4.07e-01
Protein lipoylation 10 3.75e-01 6.61e-01 0.249000 9.17e-02 -2.31e-01 6.16e-01 2.05e-01
GOCC U2 TYPE CATALYTIC STEP 2 SPLICEOSOME 30 5.03e-02 2.26e-01 0.249000 1.42e-01 -2.05e-01 1.79e-01 5.24e-02
GOMF K63 LINKED DEUBIQUITINASE ACTIVITY 11 3.37e-01 6.26e-01 0.249000 2.19e-01 -1.18e-01 2.08e-01 4.99e-01
GOMF STEROID HORMONE BINDING 6 5.86e-01 8.06e-01 0.249000 -2.36e-01 -7.88e-02 3.17e-01 7.38e-01
GOMF FK506 BINDING 10 4.21e-01 7.00e-01 0.249000 -1.61e-01 -1.90e-01 3.79e-01 2.99e-01
Citric acid cycle (TCA cycle) 32 4.09e-02 2.00e-01 0.249000 1.85e-01 -1.66e-01 6.96e-02 1.05e-01
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE 29 5.52e-02 2.40e-01 0.249000 1.77e-01 -1.74e-01 9.87e-02 1.04e-01
GOBP LINOLEIC ACID METABOLIC PROCESS 19 1.50e-01 4.28e-01 0.249000 1.92e-01 -1.57e-01 1.47e-01 2.35e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III 17 2.17e-01 5.12e-01 0.249000 2.41e-01 5.94e-02 8.49e-02 6.72e-01
GOMF MONOCARBOXYLATE SODIUM SYMPORTER ACTIVITY 13 2.89e-01 5.86e-01 0.249000 -2.45e-01 4.45e-02 1.27e-01 7.81e-01
GOCC REPLICATION FORK 72 1.18e-03 1.56e-02 0.248000 2.48e-01 -1.56e-02 2.73e-04 8.19e-01
Signaling by NTRK3 (TRKC) 17 1.92e-01 4.84e-01 0.248000 2.37e-01 -7.49e-02 9.09e-02 5.93e-01
GOBP T CELL TOLERANCE INDUCTION 14 2.98e-01 5.94e-01 0.248000 -1.48e-01 -1.99e-01 3.37e-01 1.97e-01
GOCC PERINUCLEOLAR COMPARTMENT 5 6.29e-01 8.34e-01 0.248000 2.48e-01 7.05e-03 3.36e-01 9.78e-01
NADE modulates death signalling 5 6.45e-01 8.42e-01 0.248000 2.23e-01 1.09e-01 3.88e-01 6.72e-01
Signaling by BMP 30 7.25e-02 2.83e-01 0.248000 2.23e-01 1.09e-01 3.46e-02 2.99e-01
GOMF BMP BINDING 20 1.76e-01 4.63e-01 0.248000 1.29e-01 2.12e-01 3.18e-01 1.00e-01
GOBP TROPHOBLAST CELL MIGRATION 17 2.08e-01 5.03e-01 0.248000 2.48e-01 7.41e-03 7.65e-02 9.58e-01
Signaling by EGFR 52 6.10e-03 5.46e-02 0.248000 2.23e-01 -1.09e-01 5.40e-03 1.74e-01
GOBP CELLULAR RESPONSE TO MURAMYL DIPEPTIDE 8 4.70e-01 7.31e-01 0.248000 2.47e-01 -2.58e-02 2.27e-01 8.99e-01
GOBP FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE 12 3.48e-01 6.38e-01 0.248000 2.29e-01 9.57e-02 1.70e-01 5.66e-01
GOBP FRUCTOSE METABOLIC PROCESS 13 3.24e-01 6.15e-01 0.248000 1.29e-01 2.12e-01 4.20e-01 1.86e-01
GOCC LIPOPOLYSACCHARIDE RECEPTOR COMPLEX 5 6.31e-01 8.34e-01 0.248000 -1.12e-02 -2.48e-01 9.65e-01 3.37e-01
GOBP REGULATION OF VASCULOGENESIS 16 2.37e-01 5.33e-01 0.248000 2.43e-01 4.94e-02 9.23e-02 7.32e-01
RAC1 GTPase cycle 171 1.97e-07 9.21e-06 0.248000 2.46e-01 3.39e-02 2.93e-08 4.45e-01
GOBP ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT 27 7.52e-02 2.89e-01 0.248000 5.98e-02 -2.41e-01 5.91e-01 3.04e-02
GOBP ARGININE METABOLIC PROCESS 18 1.77e-01 4.64e-01 0.248000 2.39e-01 -6.68e-02 7.93e-02 6.24e-01
GOCC FASCIA ADHERENS 9 4.56e-01 7.22e-01 0.248000 2.20e-01 1.14e-01 2.52e-01 5.54e-01
E3 ubiquitin ligases ubiquitinate target proteins 55 4.36e-03 4.28e-02 0.248000 1.39e-01 -2.06e-01 7.50e-02 8.37e-03
GOBP MONOACYLGLYCEROL CATABOLIC PROCESS 7 5.47e-01 7.82e-01 0.248000 1.42e-01 2.03e-01 5.14e-01 3.52e-01
GOCC CEREBELLAR CLIMBING FIBER TO PURKINJE CELL SYNAPSE 7 5.06e-01 7.57e-01 0.248000 2.30e-01 -9.21e-02 2.92e-01 6.73e-01
GOMF G QUADRUPLEX RNA BINDING 6 5.66e-01 7.95e-01 0.248000 2.45e-01 -4.01e-02 3.00e-01 8.65e-01
GOCC CELL TRAILING EDGE 14 2.65e-01 5.61e-01 0.248000 2.44e-01 -4.46e-02 1.14e-01 7.73e-01
Impaired BRCA2 binding to RAD51 35 3.15e-02 1.71e-01 0.248000 1.42e-01 -2.03e-01 1.46e-01 3.77e-02
GOBP POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION 15 2.37e-01 5.34e-01 0.248000 6.48e-02 -2.39e-01 6.64e-01 1.09e-01
Integrin signaling 27 7.55e-02 2.90e-01 0.248000 2.40e-01 -6.16e-02 3.09e-02 5.79e-01
Voltage gated Potassium channels 42 1.60e-02 1.10e-01 0.248000 -1.34e-01 2.08e-01 1.34e-01 1.95e-02
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 23 1.40e-01 4.10e-01 0.248000 1.67e-01 1.83e-01 1.65e-01 1.29e-01
GOBP TRANSCYTOSIS 21 1.63e-01 4.46e-01 0.248000 1.24e-01 2.14e-01 3.25e-01 8.92e-02
Calcineurin activates NFAT 9 4.14e-01 6.94e-01 0.248000 2.17e-01 -1.20e-01 2.60e-01 5.34e-01
GOBP XENOBIOTIC GLUCURONIDATION 6 5.75e-01 8.00e-01 0.248000 1.83e-04 -2.48e-01 9.99e-01 2.94e-01
GOBP AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS 25 9.81e-02 3.36e-01 0.247000 -2.47e-01 1.14e-02 3.24e-02 9.22e-01
GOBP EPITHELIAL CELL CELL ADHESION 15 2.70e-01 5.66e-01 0.247000 2.28e-01 9.71e-02 1.27e-01 5.15e-01
GOBP NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING 16 2.22e-01 5.17e-01 0.247000 2.45e-01 -3.56e-02 8.99e-02 8.05e-01
GOBP SNARE COMPLEX ASSEMBLY 22 1.26e-01 3.87e-01 0.247000 2.45e-01 -3.37e-02 4.65e-02 7.85e-01
GOBP REGULATION OF ICOSANOID SECRETION 21 1.26e-01 3.86e-01 0.247000 1.49e-01 -1.97e-01 2.36e-01 1.18e-01
GOMF L PROLINE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 5.00e-01 7.53e-01 0.247000 -1.68e-01 1.81e-01 4.41e-01 4.06e-01
GOBP APPENDAGE MORPHOGENESIS 147 1.50e-06 5.38e-05 0.247000 2.47e-01 7.10e-03 2.30e-07 8.82e-01
GOBP IODIDE TRANSPORT 9 4.52e-01 7.20e-01 0.247000 -7.43e-02 -2.36e-01 7.00e-01 2.21e-01
GOMF MOLECULAR TRANSDUCER ACTIVITY 1364 2.86e-52 3.19e-49 0.247000 -2.47e-01 2.64e-03 3.42e-53 8.70e-01
IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation 14 2.51e-01 5.48e-01 0.247000 1.80e-01 -1.69e-01 2.42e-01 2.74e-01
GOBP REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT 18 1.96e-01 4.89e-01 0.247000 2.46e-01 2.57e-02 7.10e-02 8.50e-01
Glycogen breakdown (glycogenolysis) 11 3.88e-01 6.72e-01 0.247000 1.30e-01 2.10e-01 4.57e-01 2.27e-01
GOBP HEAT GENERATION 18 1.69e-01 4.54e-01 0.247000 1.77e-01 -1.72e-01 1.93e-01 2.06e-01
Class I peroxisomal membrane protein import 19 1.64e-01 4.48e-01 0.247000 5.82e-02 -2.40e-01 6.61e-01 7.00e-02
GOBP POSITIVE REGULATION OF MIRNA METABOLIC PROCESS 63 2.89e-03 3.13e-02 0.247000 2.46e-01 -1.80e-02 7.17e-04 8.05e-01
GOMF DEUBIQUITINASE ACTIVATOR ACTIVITY 7 5.02e-01 7.54e-01 0.247000 1.97e-01 -1.49e-01 3.66e-01 4.95e-01
GOBP NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS 12 3.45e-01 6.35e-01 0.247000 -2.38e-01 -6.50e-02 1.53e-01 6.96e-01
GOBP CELLULAR RESPONSE TO INSULIN LIKE GROWTH FACTOR STIMULUS 8 4.79e-01 7.39e-01 0.247000 2.47e-01 1.39e-03 2.26e-01 9.95e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 13 3.02e-01 5.97e-01 0.247000 -3.51e-03 2.47e-01 9.82e-01 1.23e-01
Erythropoietin activates Phospholipase C gamma (PLCG) 7 5.02e-01 7.55e-01 0.247000 -1.50e-01 1.96e-01 4.91e-01 3.69e-01
GABA synthesis, release, reuptake and degradation 19 1.55e-01 4.35e-01 0.247000 1.44e-01 -2.01e-01 2.78e-01 1.30e-01
GOCC RAGULATOR COMPLEX 6 5.62e-01 7.92e-01 0.247000 2.33e-01 -8.21e-02 3.23e-01 7.28e-01
GOBP SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION 10 3.80e-01 6.65e-01 0.247000 2.25e-01 -1.01e-01 2.17e-01 5.81e-01
GOBP CORPUS CALLOSUM DEVELOPMENT 26 9.43e-02 3.29e-01 0.247000 2.46e-01 1.55e-02 2.98e-02 8.91e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION 24 1.30e-01 3.93e-01 0.247000 1.50e-01 1.96e-01 2.03e-01 9.68e-02
GOBP PARAXIAL MESODERM MORPHOGENESIS 10 3.80e-01 6.65e-01 0.247000 2.25e-01 -1.00e-01 2.17e-01 5.84e-01
GOBP DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM 107 1.18e-04 2.47e-03 0.247000 -1.76e-01 -1.72e-01 1.61e-03 2.09e-03
GOBP BLASTOCYST FORMATION 45 1.30e-02 9.50e-02 0.246000 2.25e-01 -1.02e-01 9.15e-03 2.38e-01
GOBP NOTOCHORD DEVELOPMENT 19 1.72e-01 4.58e-01 0.246000 1.92e-02 -2.46e-01 8.85e-01 6.37e-02
GOCC U2 SNRNP 23 1.22e-01 3.81e-01 0.246000 -7.56e-04 -2.46e-01 9.95e-01 4.08e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH OXIDATION OF A PAIR OF DONORS RESULTING IN THE REDUCTION OF MOLECULAR OXYGEN TO TWO MOLECULES OF WATER 10 3.84e-01 6.68e-01 0.246000 -8.39e-02 2.32e-01 6.46e-01 2.05e-01
GOMF RNA CAP BINDING 19 1.74e-01 4.60e-01 0.246000 2.46e-01 -1.24e-02 6.34e-02 9.25e-01
GOCC TRANS GOLGI NETWORK TRANSPORT VESICLE 36 4.73e-02 2.19e-01 0.246000 1.57e-01 1.90e-01 1.03e-01 4.87e-02
GOCC MICROTUBULE END 34 4.31e-02 2.07e-01 0.246000 2.45e-01 -2.10e-02 1.33e-02 8.32e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MATRIX ADHESION VIA FIBRONECTIN 5 6.44e-01 8.42e-01 0.246000 -6.22e-02 -2.38e-01 8.10e-01 3.56e-01
GOBP NEGATIVE REGULATION OF THYMOCYTE APOPTOTIC PROCESS 9 4.66e-01 7.28e-01 0.246000 -1.44e-01 -2.00e-01 4.55e-01 3.00e-01
GOBP EMBRYONIC FORELIMB MORPHOGENESIS 33 4.04e-02 1.99e-01 0.246000 2.09e-01 -1.30e-01 3.80e-02 1.95e-01
GOBP INFLAMMATORY RESPONSE TO WOUNDING 27 8.43e-02 3.12e-01 0.246000 8.01e-03 -2.46e-01 9.43e-01 2.70e-02
GOBP PROXIMAL TUBULE DEVELOPMENT 10 4.12e-01 6.93e-01 0.246000 4.85e-02 2.41e-01 7.91e-01 1.87e-01
GOBP AMINO SUGAR CATABOLIC PROCESS 14 2.59e-01 5.56e-01 0.246000 -1.11e-01 2.20e-01 4.74e-01 1.55e-01
Defective homologous recombination repair (HRR) due to BRCA2 loss of function 41 1.84e-02 1.20e-01 0.246000 1.50e-01 -1.95e-01 9.65e-02 3.08e-02
Diseases of DNA Double-Strand Break Repair 41 1.84e-02 1.20e-01 0.246000 1.50e-01 -1.95e-01 9.65e-02 3.08e-02
Methionine salvage pathway 6 5.63e-01 7.93e-01 0.246000 -2.29e-01 9.05e-02 3.32e-01 7.01e-01
GOBP REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT 17 2.38e-01 5.34e-01 0.246000 1.88e-01 1.58e-01 1.79e-01 2.59e-01
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS 7 5.44e-01 7.80e-01 0.246000 2.33e-01 7.68e-02 2.85e-01 7.25e-01
GOBP CILIARY BASAL BODY ORGANIZATION 5 6.45e-01 8.42e-01 0.246000 2.38e-01 6.29e-02 3.58e-01 8.08e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I 37 2.91e-02 1.63e-01 0.246000 2.27e-01 -9.44e-02 1.69e-02 3.21e-01
Signaling by LRP5 mutants 6 5.60e-01 7.91e-01 0.246000 2.13e-01 -1.22e-01 3.66e-01 6.04e-01
GOBP MIRNA METABOLIC PROCESS 104 1.01e-04 2.17e-03 0.246000 2.43e-01 3.91e-02 1.92e-05 4.91e-01
GOBP PROTEIN REFOLDING 26 8.47e-02 3.12e-01 0.246000 7.94e-02 -2.32e-01 4.83e-01 4.02e-02
GOBP TYPE B PANCREATIC CELL PROLIFERATION 26 8.79e-02 3.17e-01 0.246000 2.40e-01 -5.08e-02 3.40e-02 6.54e-01
NRIF signals cell death from the nucleus 16 2.15e-01 5.10e-01 0.246000 1.08e-01 -2.21e-01 4.57e-01 1.26e-01
GOCC GLYCOGEN GRANULE 6 5.57e-01 7.89e-01 0.245000 -1.60e-01 1.86e-01 4.97e-01 4.30e-01
GOBP ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION 40 2.82e-02 1.61e-01 0.245000 2.44e-01 2.66e-02 7.58e-03 7.71e-01
GOBP POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE 19 1.80e-01 4.68e-01 0.245000 6.18e-03 2.45e-01 9.63e-01 6.41e-02
GOCC CENTRAL ELEMENT 7 5.36e-01 7.75e-01 0.245000 2.85e-02 2.44e-01 8.96e-01 2.64e-01
GOBP REGULATION OF TETRAPYRROLE METABOLIC PROCESS 8 4.59e-01 7.24e-01 0.245000 1.57e-01 -1.88e-01 4.41e-01 3.56e-01
GOBP LIMBIC SYSTEM DEVELOPMENT 120 1.06e-05 3.04e-04 0.245000 2.22e-01 -1.05e-01 2.76e-05 4.63e-02
GOBP T HELPER 2 CELL DIFFERENTIATION 18 2.21e-01 5.17e-01 0.245000 1.73e-01 1.74e-01 2.04e-01 2.01e-01
GOBP SNRNA METABOLIC PROCESS 55 5.03e-03 4.76e-02 0.245000 2.10e-01 -1.26e-01 7.06e-03 1.05e-01
GOBP MUSCLE ADAPTATION 120 2.91e-05 7.43e-04 0.245000 2.38e-01 5.91e-02 6.75e-06 2.63e-01
Suppression of phagosomal maturation 13 2.83e-01 5.80e-01 0.245000 1.59e-01 -1.86e-01 3.21e-01 2.44e-01
GOBP POSITIVE REGULATION OF ANTIBACTERIAL PEPTIDE PRODUCTION 5 6.16e-01 8.26e-01 0.245000 1.42e-01 -2.00e-01 5.83e-01 4.39e-01
GOMF T CELL RECEPTOR BINDING 11 3.48e-01 6.38e-01 0.245000 1.13e-01 -2.18e-01 5.18e-01 2.12e-01
GOBP REGULATION OF PROSTAGLANDIN SECRETION 14 2.57e-01 5.54e-01 0.245000 1.63e-01 -1.83e-01 2.92e-01 2.36e-01
GOMF TRANSCRIPTION COREGULATOR BINDING 110 7.98e-05 1.76e-03 0.245000 2.30e-01 8.33e-02 3.01e-05 1.31e-01
GOMF MYOSIN V BINDING 16 2.59e-01 5.56e-01 0.245000 -1.29e-01 -2.08e-01 3.71e-01 1.50e-01
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM EXIT SITE 6 6.05e-01 8.19e-01 0.245000 1.81e-01 1.65e-01 4.42e-01 4.85e-01
GOBP REGULATION OF CD40 SIGNALING PATHWAY 6 5.79e-01 8.03e-01 0.245000 1.08e-02 -2.45e-01 9.63e-01 3.00e-01
GOBP NEGATIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS 62 2.50e-03 2.80e-02 0.245000 1.87e-01 -1.58e-01 1.10e-02 3.10e-02
GOMF OLIGOPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 14 3.08e-01 6.02e-01 0.245000 1.99e-01 1.43e-01 1.98e-01 3.55e-01
GOCC UBIQUITIN CONJUGATING ENZYME COMPLEX 7 5.40e-01 7.78e-01 0.245000 -4.12e-02 -2.41e-01 8.50e-01 2.69e-01
GOBP REGULATION OF FIBROBLAST APOPTOTIC PROCESS 19 1.65e-01 4.49e-01 0.245000 2.28e-01 -8.99e-02 8.59e-02 4.98e-01
GOCC NUCLEAR EXOSOME RNASE COMPLEX 16 2.12e-01 5.08e-01 0.245000 1.72e-01 -1.74e-01 2.33e-01 2.29e-01
GOBP ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM 15 2.70e-01 5.67e-01 0.245000 2.39e-01 5.45e-02 1.10e-01 7.15e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION 21 1.60e-01 4.43e-01 0.245000 5.70e-02 2.38e-01 6.51e-01 5.91e-02
GOBP INTRACELLULAR TRIGLYCERIDE HOMEOSTASIS 9 4.24e-01 7.03e-01 0.245000 -2.22e-01 1.03e-01 2.49e-01 5.94e-01
Acetylcholine inhibits contraction of outer hair cells 5 6.52e-01 8.46e-01 0.245000 9.33e-02 2.26e-01 7.18e-01 3.81e-01
GOMF RNA METHYLTRANSFERASE ACTIVITY 62 2.51e-03 2.81e-02 0.245000 1.66e-01 -1.80e-01 2.42e-02 1.42e-02
GOBP SEROTONERGIC NEURON AXON GUIDANCE 5 6.50e-01 8.45e-01 0.245000 7.75e-02 2.32e-01 7.64e-01 3.69e-01
GOBP CELLULAR RESPONSE TO NITROSATIVE STRESS 6 5.69e-01 7.97e-01 0.245000 7.27e-02 -2.33e-01 7.58e-01 3.22e-01
GOBP MRNA CIS SPLICING VIA SPLICEOSOME 30 5.71e-02 2.45e-01 0.245000 2.17e-01 -1.12e-01 3.92e-02 2.89e-01
GOBP STRIATUM DEVELOPMENT 20 1.56e-01 4.36e-01 0.245000 2.38e-01 -5.56e-02 6.52e-02 6.67e-01
GOBP NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 9 4.69e-01 7.30e-01 0.245000 -2.06e-01 -1.32e-01 2.85e-01 4.94e-01
G2 Phase 5 6.22e-01 8.29e-01 0.244000 9.93e-02 -2.23e-01 7.01e-01 3.87e-01
GOBP NEGATIVE REGULATION OF PROTEIN ACETYLATION 6 5.82e-01 8.04e-01 0.244000 2.44e-01 -1.89e-03 3.00e-01 9.94e-01
GOBP THYROID HORMONE TRANSPORT 10 4.24e-01 7.02e-01 0.244000 8.27e-02 2.30e-01 6.51e-01 2.08e-01
DAG and IP3 signaling 40 3.33e-02 1.77e-01 0.244000 9.77e-02 2.24e-01 2.85e-01 1.42e-02
FGFR4 ligand binding and activation 13 3.32e-01 6.23e-01 0.244000 1.07e-01 2.20e-01 5.03e-01 1.71e-01
GOBP INDOLE CONTAINING COMPOUND BIOSYNTHETIC PROCESS 5 6.29e-01 8.34e-01 0.244000 -2.38e-01 5.34e-02 3.56e-01 8.36e-01
GOBP CENP A CONTAINING CHROMATIN ASSEMBLY 9 4.53e-01 7.21e-01 0.244000 2.42e-01 3.61e-02 2.09e-01 8.51e-01
MAPK6/MAPK4 signaling 78 5.81e-04 8.93e-03 0.244000 1.27e-01 -2.09e-01 5.22e-02 1.45e-03
Signaling by FGFR4 40 2.85e-02 1.62e-01 0.244000 2.44e-01 1.54e-02 7.63e-03 8.66e-01
GOBP NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 10 4.25e-01 7.03e-01 0.244000 8.44e-02 2.29e-01 6.44e-01 2.10e-01
GOBP CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS 13 2.88e-01 5.85e-01 0.244000 -2.05e-01 1.33e-01 2.01e-01 4.07e-01
GOBP REGULATION OF MEMBRANE INVAGINATION 15 2.86e-01 5.83e-01 0.244000 -1.94e-01 -1.49e-01 1.94e-01 3.18e-01
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY 36 3.23e-02 1.74e-01 0.244000 2.12e-01 -1.20e-01 2.74e-02 2.12e-01
GOCC NONHOMOLOGOUS END JOINING COMPLEX 9 4.73e-01 7.33e-01 0.244000 1.74e-01 1.71e-01 3.65e-01 3.75e-01
Synthesis of PI 5 6.56e-01 8.48e-01 0.244000 2.17e-01 1.12e-01 4.02e-01 6.63e-01
GOBP PROTEOGLYCAN CATABOLIC PROCESS 9 4.57e-01 7.23e-01 0.244000 -2.38e-01 -5.41e-02 2.16e-01 7.79e-01
GOBP MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION 7 5.10e-01 7.60e-01 0.244000 1.77e-01 -1.68e-01 4.17e-01 4.41e-01
GOBP GLYCOLIPID TRANSPORT 8 4.87e-01 7.46e-01 0.244000 2.44e-01 -2.60e-03 2.32e-01 9.90e-01
GOBP BLOOD VESSEL REMODELING 46 2.17e-02 1.34e-01 0.244000 1.97e-01 1.44e-01 2.08e-02 9.12e-02
GOMF MORPHOGEN ACTIVITY 8 4.94e-01 7.51e-01 0.244000 -2.78e-02 -2.42e-01 8.92e-01 2.35e-01
GOBP ESTROGEN METABOLIC PROCESS 37 2.87e-02 1.62e-01 0.244000 1.57e-01 -1.87e-01 9.88e-02 4.95e-02
GOBP POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC 54 6.06e-03 5.43e-02 0.244000 2.19e-01 -1.06e-01 5.29e-03 1.77e-01
GOBP SALIVARY GLAND DEVELOPMENT 36 4.01e-02 1.98e-01 0.244000 2.44e-01 2.47e-03 1.14e-02 9.80e-01
GOBP REGULATION OF ISOMERASE ACTIVITY 7 5.16e-01 7.62e-01 0.244000 -2.20e-01 1.05e-01 3.14e-01 6.29e-01
GOBP T CELL LINEAGE COMMITMENT 35 4.91e-02 2.23e-01 0.244000 2.35e-01 6.33e-02 1.60e-02 5.17e-01
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION 21 1.33e-01 3.99e-01 0.244000 1.71e-01 -1.73e-01 1.74e-01 1.69e-01
GOBP NEGATIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS 10 4.36e-01 7.10e-01 0.244000 1.84e-01 1.60e-01 3.14e-01 3.81e-01
GOBP SYNAPTIC VESICLE DOCKING 9 4.23e-01 7.02e-01 0.243000 -1.41e-01 1.98e-01 4.63e-01 3.03e-01
GOBP POSITIVE REGULATION OF DEOXYRIBONUCLEASE ACTIVITY 5 6.25e-01 8.32e-01 0.243000 -9.45e-02 2.24e-01 7.14e-01 3.85e-01
GOBP GLYCOSYLCERAMIDE BIOSYNTHETIC PROCESS 8 5.02e-01 7.55e-01 0.243000 2.35e-01 6.25e-02 2.49e-01 7.59e-01
GOBP REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION 12 3.24e-01 6.15e-01 0.243000 9.27e-02 -2.25e-01 5.78e-01 1.77e-01
Linoleic acid (LA) metabolism 7 5.57e-01 7.89e-01 0.243000 1.21e-01 2.11e-01 5.78e-01 3.34e-01
RNA Polymerase I Transcription Termination 29 7.54e-02 2.90e-01 0.243000 -1.63e-03 -2.43e-01 9.88e-01 2.33e-02
Phenylalanine and tyrosine metabolism 11 3.71e-01 6.58e-01 0.243000 -1.75e-02 2.43e-01 9.20e-01 1.63e-01
GOBP INTESTINAL EPITHELIAL STRUCTURE MAINTENANCE 8 4.80e-01 7.39e-01 0.243000 -2.38e-01 4.91e-02 2.43e-01 8.10e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE ACTIVATION 15 2.89e-01 5.86e-01 0.243000 -1.70e-01 -1.74e-01 2.55e-01 2.42e-01
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER SECRETION 6 6.08e-01 8.21e-01 0.243000 -1.92e-01 -1.49e-01 4.15e-01 5.27e-01
GOBP POSITIVE REGULATION OF STEM CELL POPULATION MAINTENANCE 46 1.52e-02 1.06e-01 0.243000 2.40e-01 -3.73e-02 4.79e-03 6.62e-01
GOBP POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS 13 2.97e-01 5.94e-01 0.243000 8.71e-02 -2.27e-01 5.87e-01 1.56e-01
GOMF SIGNAL RECOGNITION PARTICLE BINDING 8 4.78e-01 7.37e-01 0.243000 6.04e-02 -2.36e-01 7.67e-01 2.49e-01
GOBP ADRENAL GLAND DEVELOPMENT 26 9.36e-02 3.28e-01 0.243000 2.40e-01 -3.87e-02 3.41e-02 7.33e-01
GOBP POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY 26 9.17e-02 3.25e-01 0.243000 2.37e-01 -5.41e-02 3.64e-02 6.33e-01
GOBP ISOPENTENYL DIPHOSPHATE BIOSYNTHETIC PROCESS 5 6.59e-01 8.50e-01 0.243000 -2.10e-01 -1.23e-01 4.16e-01 6.35e-01
GOBP REGULATION OF MUSCLE ADAPTATION 95 2.96e-04 5.13e-03 0.243000 2.35e-01 6.29e-02 7.61e-05 2.89e-01
Signaling by ALK fusions and activated point mutants 91 1.91e-04 3.61e-03 0.243000 2.15e-01 -1.13e-01 3.81e-04 6.35e-02
Signaling by ALK in cancer 91 1.91e-04 3.61e-03 0.243000 2.15e-01 -1.13e-01 3.81e-04 6.35e-02
GOMF PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE BINDING 80 1.36e-03 1.75e-02 0.243000 1.47e-01 1.93e-01 2.28e-02 2.77e-03
Interleukin-3, Interleukin-5 and GM-CSF signaling 44 1.50e-02 1.05e-01 0.243000 1.73e-01 -1.71e-01 4.75e-02 4.96e-02
Signaling by CSF3 (G-CSF) 30 5.75e-02 2.46e-01 0.243000 1.94e-01 -1.46e-01 6.57e-02 1.66e-01
GOCC PRP19 COMPLEX 14 2.74e-01 5.71e-01 0.243000 2.33e-01 -6.88e-02 1.31e-01 6.56e-01
GOBP FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS 44 2.58e-02 1.52e-01 0.243000 2.08e-01 1.25e-01 1.69e-02 1.50e-01
GOBP REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 83 9.52e-04 1.32e-02 0.243000 2.21e-01 1.00e-01 4.92e-04 1.14e-01
Phospholipase C-mediated cascade; FGFR4 14 3.05e-01 5.99e-01 0.243000 8.34e-02 2.28e-01 5.89e-01 1.39e-01
GOMF ADENYLATE CYCLASE ACTIVITY 15 2.90e-01 5.87e-01 0.243000 1.82e-01 1.61e-01 2.23e-01 2.81e-01
GOBP GLUTAMATERGIC NEURON DIFFERENTIATION 15 2.82e-01 5.79e-01 0.243000 8.80e-02 2.26e-01 5.55e-01 1.29e-01
RND2 GTPase cycle 41 2.88e-02 1.62e-01 0.243000 2.39e-01 4.09e-02 8.03e-03 6.51e-01
GOMF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 5 6.59e-01 8.50e-01 0.243000 2.16e-01 1.11e-01 4.04e-01 6.67e-01
Apoptotic cleavage of cellular proteins 35 4.58e-02 2.14e-01 0.243000 2.42e-01 9.91e-03 1.31e-02 9.19e-01
GOBP NEGATIVE REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS 5 6.63e-01 8.51e-01 0.243000 1.87e-01 1.54e-01 4.68e-01 5.51e-01
Signalling to p38 via RIT and RIN 5 6.47e-01 8.44e-01 0.243000 -3.17e-02 -2.40e-01 9.02e-01 3.52e-01
Glutamate binding, activation of AMPA receptors and synaptic plasticity 29 9.15e-02 3.25e-01 0.242000 1.39e-01 1.99e-01 1.95e-01 6.39e-02
Trafficking of AMPA receptors 29 9.15e-02 3.25e-01 0.242000 1.39e-01 1.99e-01 1.95e-01 6.39e-02
SHC-mediated cascade:FGFR4 19 2.05e-01 4.99e-01 0.242000 2.17e-01 1.08e-01 1.01e-01 4.15e-01
GOBP POSITIVE REGULATION OF PROTEIN KINASE A SIGNALING 12 3.73e-01 6.59e-01 0.242000 -1.64e-01 -1.79e-01 3.26e-01 2.84e-01
GOMF PEPTIDE N ACETYLTRANSFERASE ACTIVITY 47 1.26e-02 9.27e-02 0.242000 2.24e-01 -9.30e-02 7.92e-03 2.70e-01
GOBP MRNA TRANSPORT 118 1.55e-05 4.20e-04 0.242000 2.08e-01 -1.24e-01 9.40e-05 1.97e-02
GOBP PUTRESCINE METABOLIC PROCESS 7 5.14e-01 7.61e-01 0.242000 -1.61e-01 1.81e-01 4.61e-01 4.06e-01
GOBP NEUROBLAST PROLIFERATION 82 8.61e-04 1.22e-02 0.242000 2.39e-01 4.14e-02 1.85e-04 5.17e-01
GOBP REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 67 1.97e-03 2.34e-02 0.242000 2.23e-01 -9.53e-02 1.61e-03 1.77e-01
GOBP ALDEHYDE CATABOLIC PROCESS 14 3.14e-01 6.07e-01 0.242000 1.23e-01 2.09e-01 4.27e-01 1.76e-01
Activation of Ca-permeable Kainate Receptor 9 4.27e-01 7.05e-01 0.242000 -2.02e-01 1.34e-01 2.94e-01 4.87e-01
Ionotropic activity of kainate receptors 9 4.27e-01 7.05e-01 0.242000 -2.02e-01 1.34e-01 2.94e-01 4.87e-01
GOMF PROLINE SODIUM SYMPORTER ACTIVITY 5 6.44e-01 8.42e-01 0.242000 2.42e-01 6.36e-03 3.48e-01 9.80e-01
Rap1 signalling 16 2.42e-01 5.38e-01 0.242000 2.42e-01 -6.18e-03 9.36e-02 9.66e-01
GOBP NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS 17 2.44e-01 5.39e-01 0.242000 1.11e-01 2.15e-01 4.26e-01 1.25e-01
Acetylcholine Neurotransmitter Release Cycle 17 2.22e-01 5.18e-01 0.242000 2.42e-01 -2.66e-03 8.39e-02 9.85e-01
GOBP RNA LOCALIZATION 187 2.33e-08 1.31e-06 0.242000 1.89e-01 -1.52e-01 8.67e-06 3.42e-04
Prolonged ERK activation events 14 3.10e-01 6.04e-01 0.242000 2.23e-01 9.52e-02 1.49e-01 5.38e-01
Presynaptic phase of homologous DNA pairing and strand exchange 40 2.27e-02 1.39e-01 0.242000 1.63e-01 -1.79e-01 7.53e-02 4.96e-02
GOBP MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 16 2.20e-01 5.16e-01 0.242000 1.88e-01 -1.52e-01 1.93e-01 2.91e-01
GOBP POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION 13 3.06e-01 5.99e-01 0.242000 -5.58e-02 2.35e-01 7.28e-01 1.42e-01
GOBP EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 33 5.00e-02 2.26e-01 0.242000 2.36e-01 -5.20e-02 1.88e-02 6.05e-01
GOBP REGULATION OF PROTEIN GLYCOSYLATION 11 3.79e-01 6.64e-01 0.242000 -2.19e-03 2.42e-01 9.90e-01 1.65e-01
GOBP SNRNA TRANSCRIPTION BY RNA POLYMERASE III 9 4.47e-01 7.17e-01 0.242000 2.41e-01 -2.39e-02 2.11e-01 9.01e-01
GOBP FERMENTATION 5 6.56e-01 8.49e-01 0.242000 -7.73e-02 -2.29e-01 7.65e-01 3.75e-01
GOBP ANOIKIS 32 5.64e-02 2.43e-01 0.242000 2.39e-01 -3.40e-02 1.91e-02 7.39e-01
GOCC RISC LOADING COMPLEX 8 5.10e-01 7.60e-01 0.242000 2.29e-01 7.60e-02 2.61e-01 7.10e-01
Diseases of hemostasis 17 2.30e-01 5.28e-01 0.242000 3.07e-02 2.40e-01 8.27e-01 8.71e-02
GOBP REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION 29 7.08e-02 2.79e-01 0.242000 2.32e-01 -6.62e-02 3.04e-02 5.37e-01
GOBP PROTEIN RETENTION IN ER LUMEN 8 4.97e-01 7.52e-01 0.241000 -2.41e-01 -1.17e-02 2.37e-01 9.54e-01
Translesion Synthesis by POLH 18 1.84e-01 4.73e-01 0.241000 1.58e-01 -1.82e-01 2.46e-01 1.80e-01
Circadian Clock 65 3.90e-03 3.89e-02 0.241000 2.37e-01 4.42e-02 9.34e-04 5.38e-01
Acyl chain remodelling of PI 17 2.03e-01 4.97e-01 0.241000 1.33e-01 -2.01e-01 3.41e-01 1.51e-01
DNA Double Strand Break Response 56 5.16e-03 4.85e-02 0.241000 1.60e-01 -1.81e-01 3.86e-02 1.92e-02
GOBP TYPE I PNEUMOCYTE DIFFERENTIATION 8 5.21e-01 7.64e-01 0.241000 1.90e-01 1.49e-01 3.53e-01 4.65e-01
GOBP POSITIVE REGULATION OF APOPTOTIC CELL CLEARANCE 8 5.11e-01 7.60e-01 0.241000 -2.30e-01 -7.44e-02 2.61e-01 7.16e-01
GOBP MIRNA PROCESSING 44 1.80e-02 1.18e-01 0.241000 2.30e-01 -7.20e-02 8.21e-03 4.09e-01
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 43 2.16e-02 1.34e-01 0.241000 2.39e-01 -2.96e-02 6.60e-03 7.37e-01
GOBP NEGATIVE REGULATION OF AMINE METABOLIC PROCESS 6 5.77e-01 8.01e-01 0.241000 7.52e-02 -2.29e-01 7.50e-01 3.31e-01
GOBP MIDBODY ABSCISSION 17 2.46e-01 5.42e-01 0.241000 -1.10e-01 -2.15e-01 4.32e-01 1.26e-01
TFAP2 (AP-2) family regulates transcription of cell cycle factors 5 6.32e-01 8.35e-01 0.241000 8.35e-02 -2.26e-01 7.47e-01 3.81e-01
GOBP MITOCHONDRIAL RNA 3 END PROCESSING 6 5.86e-01 8.07e-01 0.241000 2.77e-02 -2.39e-01 9.06e-01 3.10e-01
GOBP REGULATION OF CELL MATRIX ADHESION 121 4.01e-05 9.85e-04 0.241000 2.31e-01 6.82e-02 1.12e-05 1.95e-01
GOBP MELANOSOME ASSEMBLY 18 2.31e-01 5.29e-01 0.241000 1.37e-01 1.98e-01 3.13e-01 1.46e-01
GOBP OLEFINIC COMPOUND BIOSYNTHETIC PROCESS 28 7.26e-02 2.83e-01 0.241000 -1.86e-01 1.53e-01 8.78e-02 1.62e-01
GOBP PANCREAS DEVELOPMENT 77 7.97e-04 1.15e-02 0.241000 2.10e-01 -1.18e-01 1.43e-03 7.42e-02
GOBP SERINE TRANSPORT 9 4.38e-01 7.12e-01 0.241000 8.64e-02 -2.25e-01 6.54e-01 2.43e-01
GOBP CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 172 3.59e-07 1.59e-05 0.241000 2.41e-01 9.96e-03 5.18e-08 8.22e-01
GOMF PRIMARY MIRNA BINDING 9 4.35e-01 7.10e-01 0.241000 2.15e-01 -1.08e-01 2.63e-01 5.75e-01
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE REGULATOR ACTIVITY 47 1.83e-02 1.20e-01 0.241000 -3.88e-02 -2.38e-01 6.45e-01 4.83e-03
GOBP SNRNA TRANSCRIPTION 20 1.54e-01 4.33e-01 0.241000 1.66e-01 -1.75e-01 2.00e-01 1.76e-01
Negative regulation of MAPK pathway 41 2.63e-02 1.54e-01 0.241000 2.39e-01 -2.89e-02 8.11e-03 7.49e-01
Processing of Capped Intron-Containing Pre-mRNA 265 2.18e-11 2.10e-09 0.241000 1.66e-01 -1.74e-01 3.25e-06 1.06e-06
GOBP POSITIVE REGULATION OF JUN KINASE ACTIVITY 28 7.84e-02 2.97e-01 0.241000 2.29e-01 -7.42e-02 3.61e-02 4.97e-01
GOBP TELOMERE ORGANIZATION 181 4.98e-08 2.59e-06 0.241000 1.79e-01 -1.61e-01 3.25e-05 1.93e-04
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex 13 3.20e-01 6.11e-01 0.241000 9.42e-03 -2.40e-01 9.53e-01 1.34e-01
GOBP REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 13 2.96e-01 5.94e-01 0.240000 1.73e-01 -1.67e-01 2.79e-01 2.98e-01
EGFR downregulation 30 6.07e-02 2.54e-01 0.240000 1.81e-01 -1.58e-01 8.62e-02 1.34e-01
GOMF CGMP BINDING 15 2.47e-01 5.43e-01 0.240000 -1.47e-01 1.90e-01 3.25e-01 2.02e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS DISULFIDE AS ACCEPTOR 9 4.74e-01 7.34e-01 0.240000 -8.55e-02 -2.25e-01 6.57e-01 2.43e-01
Striated Muscle Contraction 35 4.00e-02 1.97e-01 0.240000 -1.05e-01 2.16e-01 2.82e-01 2.69e-02
GOBP REGULATION OF CHROMOSOME ORGANIZATION 240 3.09e-10 2.46e-08 0.240000 2.15e-01 -1.08e-01 9.71e-09 4.11e-03
GOBP APOPTOTIC DNA FRAGMENTATION 19 1.71e-01 4.57e-01 0.240000 2.00e-01 -1.32e-01 1.30e-01 3.18e-01
GOBP IRON IMPORT INTO CELL 10 4.41e-01 7.13e-01 0.240000 -2.14e-01 -1.09e-01 2.41e-01 5.51e-01
GOMF UBIQUITIN LIKE PROTEIN PEPTIDASE ACTIVITY 101 1.14e-04 2.43e-03 0.240000 2.32e-01 -6.30e-02 5.66e-05 2.74e-01
GOMF CATECHOLAMINE BINDING 12 3.35e-01 6.25e-01 0.240000 2.25e-01 -8.30e-02 1.76e-01 6.19e-01
TNFR1-induced proapoptotic signaling 24 1.07e-01 3.53e-01 0.240000 1.43e-01 -1.93e-01 2.26e-01 1.01e-01
MAPK1 (ERK2) activation 9 4.69e-01 7.30e-01 0.240000 2.34e-01 5.54e-02 2.25e-01 7.74e-01
GOBP CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT 29 8.45e-02 3.12e-01 0.240000 2.38e-01 3.13e-02 2.65e-02 7.71e-01
GOBP GLUTAMATE SECRETION 28 1.05e-01 3.49e-01 0.240000 1.55e-01 1.84e-01 1.57e-01 9.25e-02
GOBP NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 7 5.62e-01 7.92e-01 0.240000 -9.19e-02 -2.22e-01 6.74e-01 3.10e-01
GOBP NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 56 9.22e-03 7.41e-02 0.240000 2.33e-01 5.84e-02 2.57e-03 4.50e-01
GOBP NEGATIVE REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 8 4.86e-01 7.45e-01 0.240000 2.32e-01 -6.30e-02 2.57e-01 7.58e-01
GOBP ANTIMICROBIAL HUMORAL RESPONSE 139 1.31e-05 3.65e-04 0.240000 -2.07e-01 -1.21e-01 2.45e-05 1.37e-02
GOBP NEGATIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION 7 5.27e-01 7.69e-01 0.240000 9.46e-02 -2.20e-01 6.65e-01 3.12e-01
GOBP KYNURENINE METABOLIC PROCESS 11 3.96e-01 6.79e-01 0.240000 -2.34e-01 -5.07e-02 1.78e-01 7.71e-01
GOCC FILTRATION DIAPHRAGM 9 4.36e-01 7.10e-01 0.240000 1.18e-01 -2.09e-01 5.39e-01 2.78e-01
GOMF TRANSLATION REGULATOR ACTIVITY NUCLEIC ACID BINDING 95 1.54e-04 3.09e-03 0.240000 1.39e-01 -1.95e-01 1.89e-02 1.01e-03
GOBP ESTABLISHMENT OF SKIN BARRIER 34 4.58e-02 2.14e-01 0.240000 -2.25e-01 8.31e-02 2.32e-02 4.02e-01
GOBP DNA DEMETHYLATION 22 1.58e-01 4.40e-01 0.240000 2.34e-01 5.03e-02 5.71e-02 6.83e-01
Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane 18 2.08e-01 5.03e-01 0.240000 -2.39e-01 1.17e-02 7.87e-02 9.31e-01
GOBP POSITIVE REGULATION OF WNT SIGNALING PATHWAY 139 7.60e-06 2.28e-04 0.240000 2.38e-01 2.40e-02 1.21e-06 6.25e-01
GOMF DOUBLE STRANDED METHYLATED DNA BINDING 5 6.58e-01 8.50e-01 0.240000 2.33e-01 5.42e-02 3.66e-01 8.34e-01
GOMF CARBON NITROGEN LIGASE ACTIVITY WITH GLUTAMINE AS AMIDO N DONOR 10 4.46e-01 7.17e-01 0.240000 2.01e-01 1.31e-01 2.72e-01 4.74e-01
GOMF COMPLEMENT COMPONENT C3B BINDING 8 5.27e-01 7.69e-01 0.240000 -1.75e-01 -1.63e-01 3.91e-01 4.23e-01
Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) 60 4.92e-03 4.69e-02 0.240000 2.36e-01 -4.33e-02 1.59e-03 5.62e-01
GOMF MOLECULAR TAG ACTIVITY 13 2.99e-01 5.95e-01 0.240000 1.78e-01 -1.60e-01 2.66e-01 3.18e-01
GOBP CELLULAR RESPONSE TO GLUCOCORTICOID STIMULUS 54 6.73e-03 5.91e-02 0.239000 1.70e-01 -1.69e-01 3.06e-02 3.21e-02
GOBP PROTEIN LOCALIZATION TO ENDOSOME 27 1.05e-01 3.49e-01 0.239000 5.65e-02 2.33e-01 6.11e-01 3.64e-02
GOBP MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION 16 2.53e-01 5.50e-01 0.239000 2.39e-01 8.31e-03 9.75e-02 9.54e-01
GOBP ENDODERM DEVELOPMENT 84 6.74e-04 1.00e-02 0.239000 2.39e-01 -1.75e-02 1.56e-04 7.81e-01
GOMF GTPASE BINDING 298 1.81e-11 1.80e-09 0.239000 2.35e-01 4.35e-02 2.76e-12 1.97e-01
GOMF U1 SNRNP BINDING 6 5.74e-01 7.99e-01 0.239000 1.64e-01 -1.74e-01 4.87e-01 4.60e-01
GOBP TELOMERE LOCALIZATION 12 3.30e-01 6.21e-01 0.239000 1.51e-01 -1.85e-01 3.64e-01 2.66e-01
GOMF BETA N ACETYLHEXOSAMINIDASE ACTIVITY 5 6.33e-01 8.35e-01 0.239000 1.15e-01 -2.10e-01 6.56e-01 4.17e-01
GOBP PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING 11 3.71e-01 6.58e-01 0.239000 2.26e-01 -7.72e-02 1.94e-01 6.58e-01
Laminin interactions 28 1.06e-01 3.50e-01 0.239000 1.98e-01 1.34e-01 7.00e-02 2.19e-01
VEGFR2 mediated vascular permeability 26 1.25e-01 3.86e-01 0.239000 1.75e-01 1.63e-01 1.22e-01 1.51e-01
GOMF FUCOSYLTRANSFERASE ACTIVITY 13 3.05e-01 5.98e-01 0.239000 -1.12e-01 2.12e-01 4.86e-01 1.87e-01
GOBP RESPONSE TO FRUCTOSE 10 4.06e-01 6.88e-01 0.239000 -7.89e-02 2.26e-01 6.66e-01 2.16e-01
GOBP MITOCHONDRIAL PROTEIN PROCESSING 13 3.20e-01 6.11e-01 0.239000 2.37e-01 -2.94e-02 1.39e-01 8.54e-01
Regulation of NF-kappa B signaling 17 2.08e-01 5.03e-01 0.239000 1.65e-01 -1.73e-01 2.40e-01 2.16e-01
GOBP SUCCINYL COA CATABOLIC PROCESS 6 6.14e-01 8.24e-01 0.239000 -1.00e-01 -2.17e-01 6.72e-01 3.57e-01
GOCC PCG PROTEIN COMPLEX 46 1.56e-02 1.08e-01 0.239000 2.20e-01 -9.33e-02 9.82e-03 2.73e-01
GOBP DNA SYNTHESIS INVOLVED IN DNA REPAIR 41 2.45e-02 1.47e-01 0.239000 2.20e-01 -9.29e-02 1.47e-02 3.03e-01
GOBP PEPTIDYL LYSINE DEACETYLATION 5 6.31e-01 8.34e-01 0.239000 1.41e-01 -1.93e-01 5.86e-01 4.54e-01
GOCC GOLGI TRANSPORT COMPLEX 10 4.10e-01 6.91e-01 0.239000 6.33e-02 -2.30e-01 7.29e-01 2.07e-01
GOBP LUNG MORPHOGENESIS 55 9.55e-03 7.61e-02 0.239000 2.38e-01 2.49e-02 2.30e-03 7.50e-01
GOBP NEGATIVE REGULATION OF CELL MATRIX ADHESION 37 4.92e-02 2.23e-01 0.239000 2.20e-01 9.22e-02 2.04e-02 3.32e-01
NFE2L2 regulating tumorigenic genes 11 3.68e-01 6.56e-01 0.239000 2.16e-01 -1.02e-01 2.15e-01 5.59e-01
GOMF PROTEIN TRANSMEMBRANE TRANSPORTER ACTIVITY 26 1.05e-01 3.50e-01 0.239000 1.24e-02 -2.38e-01 9.13e-01 3.53e-02
GOBP EAR MORPHOGENESIS 125 2.10e-05 5.57e-04 0.239000 2.38e-01 -1.24e-02 4.12e-06 8.11e-01
GOMF N METHYLTRANSFERASE ACTIVITY 97 2.59e-04 4.63e-03 0.239000 2.39e-01 8.87e-03 4.88e-05 8.80e-01
GOBP NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE 16 2.68e-01 5.65e-01 0.239000 2.27e-01 7.24e-02 1.15e-01 6.16e-01
GOBP REGULATION OF COMPLEMENT ACTIVATION 22 1.46e-01 4.22e-01 0.239000 -2.37e-01 2.92e-02 5.45e-02 8.12e-01
GOCC KERATIN FILAMENT 87 3.62e-04 6.06e-03 0.239000 -2.04e-01 1.23e-01 9.88e-04 4.68e-02
GOBP MIDBRAIN DEVELOPMENT 85 6.00e-04 9.15e-03 0.239000 2.36e-01 -3.34e-02 1.66e-04 5.94e-01
GOBP HISTONE MRNA CATABOLIC PROCESS 15 2.59e-01 5.56e-01 0.239000 2.22e-01 -8.72e-02 1.36e-01 5.59e-01
Mitochondrial RNA degradation 10 4.31e-01 7.07e-01 0.239000 -3.16e-02 -2.36e-01 8.63e-01 1.95e-01
GOMF DNA TOPOISOMERASE ACTIVITY 7 5.36e-01 7.75e-01 0.238000 2.28e-01 -7.03e-02 2.97e-01 7.48e-01
Homologous DNA Pairing and Strand Exchange 43 1.93e-02 1.23e-01 0.238000 1.68e-01 -1.69e-01 5.69e-02 5.47e-02
GOBP RESPONSE TO SODIUM ARSENITE 6 5.76e-01 8.00e-01 0.238000 1.77e-01 -1.60e-01 4.53e-01 4.98e-01
GOBP CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION 12 3.34e-01 6.25e-01 0.238000 2.02e-01 -1.27e-01 2.26e-01 4.46e-01
GOBP DNA INTEGRATION 8 5.07e-01 7.58e-01 0.238000 2.38e-01 1.38e-02 2.44e-01 9.46e-01
GOBP RESPONSE TO HEPATOCYTE GROWTH FACTOR 18 2.13e-01 5.08e-01 0.238000 2.38e-01 -6.57e-03 8.02e-02 9.61e-01
GOBP EXTRAEMBRYONIC MEMBRANE DEVELOPMENT 13 3.45e-01 6.34e-01 0.238000 -2.27e-01 -7.33e-02 1.57e-01 6.47e-01
GOBP OVULATION 16 2.55e-01 5.52e-01 0.238000 2.38e-01 1.06e-03 9.89e-02 9.94e-01
GOBP PROTEIN LOCALIZATION TO CONDENSED CHROMOSOME 15 2.54e-01 5.51e-01 0.238000 1.38e-01 -1.94e-01 3.55e-01 1.93e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 8 4.92e-01 7.49e-01 0.238000 2.30e-01 -6.12e-02 2.59e-01 7.64e-01
GOBP POSITIVE REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS 15 2.98e-01 5.94e-01 0.238000 9.90e-02 2.17e-01 5.07e-01 1.46e-01
FRS-mediated FGFR4 signaling 21 1.86e-01 4.76e-01 0.238000 2.07e-01 1.17e-01 9.99e-02 3.53e-01
GOMF RACEMASE AND EPIMERASE ACTIVITY ACTING ON CARBOHYDRATES AND DERIVATIVES 10 4.42e-01 7.14e-01 0.238000 2.25e-01 7.76e-02 2.18e-01 6.71e-01
TICAM1, RIP1-mediated IKK complex recruitment 18 1.97e-01 4.90e-01 0.238000 1.01e-01 -2.16e-01 4.59e-01 1.13e-01
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 20 1.64e-01 4.48e-01 0.238000 2.13e-01 -1.06e-01 9.89e-02 4.11e-01
GOMF GUANYLATE CYCLASE REGULATOR ACTIVITY 8 4.94e-01 7.51e-01 0.238000 -2.32e-01 5.30e-02 2.56e-01 7.95e-01
GOCC GATOR1 COMPLEX 5 6.66e-01 8.53e-01 0.238000 2.24e-01 8.00e-02 3.85e-01 7.57e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL DEPOLARIZATION 9 4.40e-01 7.13e-01 0.238000 1.95e-01 -1.36e-01 3.10e-01 4.80e-01
GOBP RESPIRATORY BURST INVOLVED IN DEFENSE RESPONSE 16 2.71e-01 5.67e-01 0.238000 -2.27e-01 -7.27e-02 1.17e-01 6.15e-01
Purine ribonucleoside monophosphate biosynthesis 9 4.54e-01 7.22e-01 0.238000 4.54e-02 -2.34e-01 8.14e-01 2.25e-01
GOBP DOLICHYL DIPHOSPHATE METABOLIC PROCESS 5 6.46e-01 8.43e-01 0.238000 -2.35e-01 3.79e-02 3.63e-01 8.83e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION 12 3.39e-01 6.28e-01 0.238000 1.02e-01 -2.15e-01 5.39e-01 1.98e-01
GOMF THIOREDOXIN DEPENDENT PEROXIREDOXIN ACTIVITY 5 6.48e-01 8.44e-01 0.238000 2.59e-02 -2.36e-01 9.20e-01 3.60e-01
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 28 8.09e-02 3.02e-01 0.238000 9.68e-02 -2.17e-01 3.75e-01 4.66e-02
GOBP POSITIVE REGULATION OF STEM CELL PROLIFERATION 54 7.92e-03 6.66e-02 0.238000 2.18e-01 -9.41e-02 5.51e-03 2.32e-01
TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain 19 1.78e-01 4.66e-01 0.238000 2.02e-01 -1.25e-01 1.28e-01 3.44e-01
GOBP MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 24 1.13e-01 3.65e-01 0.238000 1.99e-01 -1.30e-01 9.10e-02 2.72e-01
GOMF O ACETYLTRANSFERASE ACTIVITY 9 4.44e-01 7.16e-01 0.238000 2.12e-01 -1.07e-01 2.70e-01 5.78e-01
GOBP POSITIVE REGULATION OF CAMP MEDIATED SIGNALING 9 4.89e-01 7.46e-01 0.238000 -1.99e-01 -1.30e-01 3.00e-01 5.01e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION IMPORT 18 2.40e-01 5.36e-01 0.238000 -1.94e-01 -1.38e-01 1.55e-01 3.11e-01
GOCC POSTSYNAPTIC RECYCLING ENDOSOME 7 5.56e-01 7.89e-01 0.238000 2.35e-02 2.36e-01 9.14e-01 2.79e-01
GOBP NEGATIVE REGULATION OF ERAD PATHWAY 7 5.70e-01 7.97e-01 0.238000 -9.95e-02 -2.16e-01 6.49e-01 3.23e-01
GOBP NERVE DEVELOPMENT 95 3.20e-04 5.48e-03 0.238000 2.38e-01 9.82e-04 6.27e-05 9.87e-01
GOBP AORTA DEVELOPMENT 65 5.21e-03 4.88e-02 0.238000 2.23e-01 8.08e-02 1.84e-03 2.60e-01
GOBP POSITIVE REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 6 5.91e-01 8.10e-01 0.237000 2.32e-01 -5.18e-02 3.26e-01 8.26e-01
GOBP RESPONSE TO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR 9 4.90e-01 7.47e-01 0.237000 1.30e-01 1.99e-01 4.99e-01 3.02e-01
Transport of connexons to the plasma membrane 19 2.00e-01 4.94e-01 0.237000 -2.37e-01 -7.02e-03 7.33e-02 9.58e-01
GOBP NEGATIVE REGULATION OF FERTILIZATION 7 5.74e-01 7.99e-01 0.237000 1.26e-01 2.01e-01 5.65e-01 3.56e-01
Metabolism of RNA 677 1.75e-26 8.60e-24 0.237000 1.10e-01 -2.10e-01 9.72e-07 9.98e-21
GOMF ESTRADIOL 17 BETA DEHYDROGENASE NAD P ACTIVITY 18 2.05e-01 4.99e-01 0.237000 2.29e-01 -6.36e-02 9.29e-02 6.41e-01
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION 26 9.77e-02 3.35e-01 0.237000 9.50e-02 -2.18e-01 4.02e-01 5.48e-02
GOBP HYALURONAN BIOSYNTHETIC PROCESS 14 3.14e-01 6.07e-01 0.237000 2.34e-01 4.13e-02 1.30e-01 7.89e-01
GOBP MYELOID DENDRITIC CELL CYTOKINE PRODUCTION 7 5.65e-01 7.94e-01 0.237000 -6.65e-02 -2.28e-01 7.61e-01 2.97e-01
GOBP POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT 21 1.48e-01 4.24e-01 0.237000 1.72e-01 -1.63e-01 1.72e-01 1.96e-01
GOBP POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY 18 1.97e-01 4.90e-01 0.237000 1.21e-01 -2.04e-01 3.73e-01 1.34e-01
GOBP HEPARIN METABOLIC PROCESS 17 2.62e-01 5.59e-01 0.237000 1.81e-01 1.54e-01 1.97e-01 2.72e-01
GOBP PROTEIN LOCALIZATION TO CYTOSKELETON 59 9.70e-03 7.71e-02 0.237000 1.84e-01 1.49e-01 1.43e-02 4.74e-02
GOBP REGULATION OF TORC2 SIGNALING 5 6.34e-01 8.36e-01 0.237000 1.68e-01 -1.67e-01 5.16e-01 5.17e-01
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 1173 6.33e-42 4.86e-39 0.237000 -2.37e-01 5.88e-03 9.12e-43 7.34e-01
Sensing of DNA Double Strand Breaks 6 5.81e-01 8.04e-01 0.237000 1.34e-01 -1.96e-01 5.71e-01 4.06e-01
GOCC LATERAL PART OF CELL 5 6.72e-01 8.57e-01 0.237000 1.13e-01 2.08e-01 6.62e-01 4.20e-01
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY 12 3.41e-01 6.31e-01 0.237000 1.12e-01 -2.09e-01 5.03e-01 2.10e-01
GOMF FRUCTOSE BINDING 6 5.87e-01 8.07e-01 0.237000 -8.66e-02 2.20e-01 7.13e-01 3.50e-01
GOBP CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE 40 2.78e-02 1.59e-01 0.237000 -2.10e-01 1.10e-01 2.17e-02 2.28e-01
GOBP POSITIVE REGULATION OF CHROMOSOME SEGREGATION 27 8.66e-02 3.15e-01 0.237000 1.53e-01 -1.80e-01 1.67e-01 1.05e-01
Platelet calcium homeostasis 27 1.19e-01 3.76e-01 0.237000 1.96e-01 1.33e-01 7.75e-02 2.33e-01
GOMF OSMOSENSOR ACTIVITY 5 6.70e-01 8.56e-01 0.237000 -2.17e-01 -9.54e-02 4.01e-01 7.12e-01
GOBP SYNAPTIC TRANSMISSION GLYCINERGIC 5 6.63e-01 8.51e-01 0.237000 2.33e-01 4.41e-02 3.68e-01 8.65e-01
Terminal pathway of complement 8 4.94e-01 7.50e-01 0.237000 -2.24e-01 7.58e-02 2.72e-01 7.10e-01
GOBP NATURAL KILLER CELL PROLIFERATION 14 3.26e-01 6.16e-01 0.237000 8.83e-02 2.20e-01 5.67e-01 1.55e-01
GOBP CARDIOLIPIN ACYL CHAIN REMODELING 5 6.40e-01 8.40e-01 0.237000 9.82e-02 -2.15e-01 7.04e-01 4.04e-01
RHOA GTPase cycle 140 1.16e-05 3.28e-04 0.237000 2.30e-01 5.52e-02 2.56e-06 2.60e-01
GOCC NUCLEOSOME 114 4.21e-05 1.03e-03 0.237000 8.91e-02 -2.19e-01 1.00e-01 5.23e-05
GOBP RESPONSE TO STEROL DEPLETION 18 2.17e-01 5.12e-01 0.237000 2.37e-01 -8.51e-03 8.23e-02 9.50e-01
HATs acetylate histones 97 1.57e-04 3.12e-03 0.237000 1.69e-01 -1.66e-01 4.05e-03 4.76e-03
GOBP RESPONSE TO IRON ION 27 8.91e-02 3.19e-01 0.237000 2.07e-01 -1.14e-01 6.20e-02 3.06e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE POTENTIAL 7 5.78e-01 8.02e-01 0.237000 1.70e-01 1.64e-01 4.36e-01 4.51e-01
tRNA Aminoacylation 40 2.95e-02 1.65e-01 0.237000 2.24e-01 -7.65e-02 1.43e-02 4.02e-01
GOMF OXIDOREDUCTION DRIVEN ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 53 9.79e-03 7.76e-02 0.237000 6.08e-02 -2.29e-01 4.44e-01 3.98e-03
Erythropoietin activates RAS 14 2.94e-01 5.91e-01 0.237000 2.28e-01 -6.25e-02 1.39e-01 6.85e-01
GOBP RESPONSE TO CORTISOL 6 5.84e-01 8.05e-01 0.237000 2.04e-01 -1.20e-01 3.86e-01 6.12e-01
GOBP POSITIVE REGULATION OF VASCULAR WOUND HEALING 6 5.82e-01 8.04e-01 0.237000 1.93e-01 -1.37e-01 4.14e-01 5.61e-01
Defective GALNT3 causes HFTC 18 2.06e-01 5.01e-01 0.237000 -2.26e-01 6.84e-02 9.63e-02 6.15e-01
GOCC HISTONE PRE MRNA 3 END PROCESSING COMPLEX 6 6.22e-01 8.29e-01 0.236000 -1.11e-01 -2.09e-01 6.39e-01 3.75e-01
GOMF RNA DNA HYBRID RIBONUCLEASE ACTIVITY 6 6.20e-01 8.28e-01 0.236000 -9.76e-02 -2.15e-01 6.79e-01 3.61e-01
GOBP RETROGRADE AXONAL TRANSPORT 21 1.51e-01 4.30e-01 0.236000 1.97e-01 -1.31e-01 1.19e-01 2.98e-01
Downregulation of TGF-beta receptor signaling 26 9.55e-02 3.31e-01 0.236000 1.72e-01 -1.62e-01 1.29e-01 1.52e-01
GOBP EMBRYONIC PROCESS INVOLVED IN FEMALE PREGNANCY 6 6.02e-01 8.17e-01 0.236000 9.89e-03 -2.36e-01 9.67e-01 3.17e-01
GOBP MESONEPHRIC TUBULE MORPHOGENESIS 65 3.44e-03 3.55e-02 0.236000 2.26e-01 -6.72e-02 1.59e-03 3.49e-01
Assembly of the pre-replicative complex 96 1.97e-04 3.71e-03 0.236000 1.12e-01 -2.08e-01 5.90e-02 4.24e-04
GOBP CRISTAE FORMATION 17 2.26e-01 5.22e-01 0.236000 2.25e-01 -7.06e-02 1.08e-01 6.15e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 19 2.09e-01 5.03e-01 0.236000 -2.88e-02 -2.34e-01 8.28e-01 7.70e-02
GOCC ENDOPLASMIC RETICULUM QUALITY CONTROL COMPARTMENT 15 2.62e-01 5.58e-01 0.236000 1.20e-01 -2.03e-01 4.22e-01 1.73e-01
Norepinephrine Neurotransmitter Release Cycle 17 2.61e-01 5.57e-01 0.236000 2.12e-01 1.03e-01 1.30e-01 4.60e-01
GOBP REGULATION OF MALE GONAD DEVELOPMENT 8 5.04e-01 7.56e-01 0.236000 -3.26e-02 2.34e-01 8.73e-01 2.52e-01
GOBP COENZYME A BIOSYNTHETIC PROCESS 10 4.08e-01 6.89e-01 0.236000 1.91e-01 -1.38e-01 2.95e-01 4.50e-01
GOMF TRANSCRIPTION COACTIVATOR ACTIVITY 257 6.93e-10 5.28e-08 0.236000 2.35e-01 1.78e-02 8.32e-11 6.23e-01
GOBP INTESTINAL EPITHELIAL CELL MATURATION 6 5.88e-01 8.07e-01 0.236000 -2.13e-01 1.02e-01 3.67e-01 6.67e-01
RHOBTB GTPase Cycle 34 6.17e-02 2.56e-01 0.236000 2.33e-01 3.53e-02 1.86e-02 7.22e-01
CaM pathway 34 6.56e-02 2.67e-01 0.236000 7.30e-02 2.24e-01 4.61e-01 2.36e-02
Calmodulin induced events 34 6.56e-02 2.67e-01 0.236000 7.30e-02 2.24e-01 4.61e-01 2.36e-02
GOBP CARDIAC SEPTUM DEVELOPMENT 109 1.24e-04 2.58e-03 0.236000 2.35e-01 1.78e-02 2.22e-05 7.48e-01
GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CARDIAC CONDUCTION ELECTRICAL COUPLING 5 6.42e-01 8.41e-01 0.236000 2.13e-01 -1.01e-01 4.09e-01 6.96e-01
mRNA Splicing 199 1.93e-08 1.12e-06 0.236000 1.69e-01 -1.64e-01 3.92e-05 6.35e-05
GOBP RESPONSE TO BILE ACID 7 5.62e-01 7.92e-01 0.236000 2.93e-02 2.34e-01 8.93e-01 2.84e-01
Synthesis of PIPs at the plasma membrane 48 2.14e-02 1.33e-01 0.236000 2.25e-01 6.91e-02 6.93e-03 4.07e-01
GOBP ANTEROGRADE DENDRITIC TRANSPORT OF NEUROTRANSMITTER RECEPTOR COMPLEX 5 6.62e-01 8.51e-01 0.236000 2.59e-02 2.34e-01 9.20e-01 3.64e-01
SUMOylation of intracellular receptors 29 1.03e-01 3.46e-01 0.236000 2.03e-01 1.20e-01 5.91e-02 2.62e-01
GOBP INDOLE CONTAINING COMPOUND CATABOLIC PROCESS 9 4.78e-01 7.37e-01 0.236000 -2.33e-01 -3.21e-02 2.25e-01 8.68e-01
GOBP REGULATION OF STEM CELL POPULATION MAINTENANCE 71 2.29e-03 2.60e-02 0.236000 2.31e-01 -4.36e-02 7.43e-04 5.26e-01
GOBP POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE 23 1.60e-01 4.43e-01 0.236000 -2.21e-01 -8.10e-02 6.63e-02 5.02e-01
GOMF POLY PYRIMIDINE TRACT BINDING 26 1.33e-01 4.00e-01 0.236000 1.58e-01 1.75e-01 1.64e-01 1.22e-01
GOMF POTASSIUM ION LEAK CHANNEL ACTIVITY 16 2.44e-01 5.40e-01 0.235000 -2.15e-01 9.52e-02 1.36e-01 5.10e-01
GOBP REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE 22 1.40e-01 4.11e-01 0.235000 1.36e-01 -1.92e-01 2.70e-01 1.18e-01
GOBP RENAL WATER HOMEOSTASIS 24 1.52e-01 4.31e-01 0.235000 2.08e-01 1.10e-01 7.76e-02 3.50e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE 6 5.84e-01 8.05e-01 0.235000 -1.80e-01 1.52e-01 4.46e-01 5.19e-01
GOBP INTERMEMBRANE LIPID TRANSFER 34 6.42e-02 2.63e-01 0.235000 2.29e-01 5.24e-02 2.06e-02 5.97e-01
p75NTR signals via NF-kB 15 2.61e-01 5.58e-01 0.235000 1.74e-01 -1.58e-01 2.42e-01 2.89e-01
GOBP CELLULAR RESPONSE TO UV C 5 6.72e-01 8.57e-01 0.235000 2.21e-01 7.98e-02 3.91e-01 7.57e-01
GOCC ENDOPLASMIC RETICULUM CHAPERONE COMPLEX 11 4.09e-01 6.90e-01 0.235000 -4.16e-02 -2.32e-01 8.11e-01 1.83e-01
Signaling by FGFR2 72 2.42e-03 2.73e-02 0.235000 2.35e-01 -7.73e-03 5.57e-04 9.10e-01
GOCC ATPASE COMPLEX 142 7.25e-06 2.19e-04 0.235000 2.35e-01 -6.75e-03 1.30e-06 8.90e-01
GOBP OUTER DYNEIN ARM ASSEMBLY 22 1.48e-01 4.24e-01 0.235000 -2.24e-01 7.14e-02 6.87e-02 5.62e-01
GOBP MESENCHYMAL CELL DEVELOPMENT 6 6.18e-01 8.27e-01 0.235000 6.22e-02 2.27e-01 7.92e-01 3.36e-01
Binding and Uptake of Ligands by Scavenger Receptors 41 4.14e-02 2.01e-01 0.235000 -1.95e-01 -1.31e-01 3.04e-02 1.47e-01
GOBP REGULATION OF MIRNA CATABOLIC PROCESS 8 4.93e-01 7.50e-01 0.235000 2.07e-01 -1.11e-01 3.10e-01 5.87e-01
Cytosolic tRNA aminoacylation 22 1.52e-01 4.31e-01 0.235000 2.31e-01 -4.28e-02 6.04e-02 7.28e-01
GOBP BASE EXCISION REPAIR 42 3.87e-02 1.94e-01 0.235000 1.90e-01 1.39e-01 3.32e-02 1.20e-01
GOBP GLANDULAR EPITHELIAL CELL MATURATION 9 4.95e-01 7.51e-01 0.235000 1.17e-01 2.04e-01 5.42e-01 2.90e-01
GOBP REGULATION OF PRO B CELL DIFFERENTIATION 8 5.38e-01 7.78e-01 0.235000 1.42e-01 1.87e-01 4.86e-01 3.59e-01
GOBP SMOOTH MUSCLE ADAPTATION 5 6.80e-01 8.61e-01 0.235000 -1.66e-01 -1.67e-01 5.21e-01 5.19e-01
Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol 23 1.70e-01 4.55e-01 0.235000 1.60e-01 1.72e-01 1.84e-01 1.53e-01
GOBP POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 8 4.92e-01 7.49e-01 0.235000 1.26e-01 -1.98e-01 5.36e-01 3.32e-01
GOBP POSITIVE REGULATION OF STRESS GRANULE ASSEMBLY 7 5.39e-01 7.78e-01 0.235000 1.14e-01 -2.06e-01 6.03e-01 3.46e-01
GOBP TRIGEMINAL NERVE DEVELOPMENT 12 3.60e-01 6.49e-01 0.235000 2.32e-01 -3.60e-02 1.64e-01 8.29e-01
GOBP DNA REPLICATION CHECKPOINT SIGNALING 20 1.74e-01 4.61e-01 0.235000 8.71e-02 -2.18e-01 5.00e-01 9.12e-02
GOBP RESPONSE TO POTASSIUM ION 18 2.04e-01 4.99e-01 0.235000 -2.07e-01 1.11e-01 1.29e-01 4.14e-01
GOBP ESTABLISHMENT OF LEFT RIGHT ASYMMETRY 6 5.87e-01 8.07e-01 0.235000 -1.34e-01 1.93e-01 5.71e-01 4.13e-01
GOBP REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 10 4.62e-01 7.26e-01 0.235000 1.81e-01 1.49e-01 3.21e-01 4.14e-01
GOBP REGULATION OF LAMELLIPODIUM ORGANIZATION 49 1.95e-02 1.24e-01 0.235000 2.29e-01 5.02e-02 5.49e-03 5.43e-01
GOBP MICROVILLUS ASSEMBLY 20 1.89e-01 4.80e-01 0.235000 2.35e-01 -6.39e-03 6.94e-02 9.61e-01
GOBP UBIQUITIN DEPENDENT GLYCOPROTEIN ERAD PATHWAY 7 5.58e-01 7.90e-01 0.235000 -9.26e-03 2.34e-01 9.66e-01 2.83e-01
GOMF MANNOSYL OLIGOSACCHARIDE 1 2 ALPHA MANNOSIDASE ACTIVITY 7 5.58e-01 7.90e-01 0.235000 -9.26e-03 2.34e-01 9.66e-01 2.83e-01
GOBP PHOSPHATIDYLINOSITOL MEDIATED SIGNALING 23 1.47e-01 4.23e-01 0.235000 2.34e-01 -7.06e-03 5.16e-02 9.53e-01
GOBP MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 18 2.46e-01 5.41e-01 0.235000 -2.09e-01 -1.05e-01 1.24e-01 4.38e-01
NCAM1 interactions 41 2.86e-02 1.62e-01 0.235000 -2.20e-01 8.04e-02 1.47e-02 3.73e-01
Role of phospholipids in phagocytosis 24 1.49e-01 4.26e-01 0.234000 7.21e-02 2.23e-01 5.41e-01 5.85e-02
Signaling by NODAL 20 2.00e-01 4.93e-01 0.234000 2.30e-01 4.25e-02 7.44e-02 7.42e-01
Co-inhibition by CTLA4 21 1.82e-01 4.72e-01 0.234000 2.32e-01 3.33e-02 6.57e-02 7.91e-01
GOBP NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION 21 1.67e-01 4.52e-01 0.234000 4.86e-02 -2.29e-01 7.00e-01 6.90e-02
GOBP ACTIVATION OF GTPASE ACTIVITY 82 1.59e-03 1.98e-02 0.234000 2.20e-01 8.07e-02 5.72e-04 2.06e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION 46 2.76e-02 1.59e-01 0.234000 2.13e-01 9.68e-02 1.23e-02 2.56e-01
MECP2 regulates transcription of neuronal ligands 7 5.57e-01 7.89e-01 0.234000 2.34e-01 -1.83e-02 2.85e-01 9.33e-01
GOMF LIPOPROTEIN LIPASE ACTIVITY 9 4.50e-01 7.19e-01 0.234000 -1.46e-01 1.83e-01 4.48e-01 3.42e-01
GOCC SM LIKE PROTEIN FAMILY COMPLEX 89 3.83e-04 6.34e-03 0.234000 1.81e-01 -1.49e-01 3.14e-03 1.54e-02
GOBP PROTEIN TARGETING TO VACUOLE 46 2.45e-02 1.47e-01 0.234000 2.31e-01 3.80e-02 6.67e-03 6.56e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 64 6.63e-03 5.85e-02 0.234000 2.18e-01 8.56e-02 2.56e-03 2.36e-01
Export of Viral Ribonucleoproteins from Nucleus 33 5.53e-02 2.40e-01 0.234000 2.05e-01 -1.13e-01 4.16e-02 2.59e-01
GOMF SNRNP BINDING 9 4.53e-01 7.21e-01 0.234000 1.17e-01 -2.03e-01 5.45e-01 2.92e-01
GOBP TRANSLATIONAL INITIATION 109 1.09e-04 2.33e-03 0.234000 2.85e-02 -2.32e-01 6.08e-01 2.76e-05
GOBP RESPONSE TO WATER DEPRIVATION 5 6.73e-01 8.58e-01 0.234000 2.23e-01 7.00e-02 3.87e-01 7.86e-01
GOBP G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY 11 3.77e-01 6.63e-01 0.234000 -1.67e-01 1.64e-01 3.37e-01 3.46e-01
SUMOylation of chromatin organization proteins 57 1.02e-02 7.95e-02 0.234000 2.31e-01 3.66e-02 2.54e-03 6.33e-01
GOCC INTRACILIARY TRANSPORT PARTICLE B 19 2.12e-01 5.07e-01 0.234000 -1.54e-02 -2.33e-01 9.07e-01 7.81e-02
GOMF CHLORIDE CHANNEL REGULATOR ACTIVITY 14 3.02e-01 5.97e-01 0.234000 2.26e-01 -6.10e-02 1.43e-01 6.93e-01
GOBP WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY 5 6.43e-01 8.42e-01 0.234000 1.81e-01 -1.48e-01 4.83e-01 5.66e-01
GOBP CORNEA DEVELOPMENT IN CAMERA TYPE EYE 12 3.83e-01 6.67e-01 0.234000 2.29e-01 4.70e-02 1.69e-01 7.78e-01
GOBP INTRACELLULAR CORTICOSTEROID RECEPTOR SIGNALING PATHWAY 14 3.09e-01 6.03e-01 0.234000 2.32e-01 -2.92e-02 1.33e-01 8.50e-01
GOCC CHROMOSOME TELOMERIC REGION 166 4.71e-07 2.01e-05 0.234000 1.76e-01 -1.53e-01 8.75e-05 6.52e-04
GOBP CIRCADIAN REGULATION OF GENE EXPRESSION 66 3.88e-03 3.88e-02 0.234000 2.30e-01 -3.94e-02 1.21e-03 5.80e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION 57 6.85e-03 6.00e-02 0.234000 2.01e-01 -1.19e-01 8.68e-03 1.19e-01
GOBP REGULATION OF MAST CELL ACTIVATION 18 2.24e-01 5.19e-01 0.234000 2.01e-02 -2.33e-01 8.83e-01 8.74e-02
GOMF FOLIC ACID BINDING 13 3.18e-01 6.10e-01 0.233000 -1.77e-01 1.53e-01 2.70e-01 3.41e-01
GOBP NAIL DEVELOPMENT 11 4.17e-01 6.98e-01 0.233000 5.35e-02 2.27e-01 7.59e-01 1.92e-01
Synthesis of PIPs at the Golgi membrane 17 2.37e-01 5.33e-01 0.233000 2.27e-01 -5.40e-02 1.05e-01 7.00e-01
GOMF ANAPHASE PROMOTING COMPLEX BINDING 9 5.04e-01 7.56e-01 0.233000 -1.76e-01 -1.53e-01 3.59e-01 4.28e-01
GOBP BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS 13 3.63e-01 6.50e-01 0.233000 -8.34e-02 -2.18e-01 6.03e-01 1.74e-01
GOBP ESTABLISHMENT OF RNA LOCALIZATION 150 2.05e-06 7.10e-05 0.233000 1.82e-01 -1.46e-01 1.19e-04 2.05e-03
Signaling by ALK 27 9.39e-02 3.28e-01 0.233000 1.89e-01 -1.37e-01 8.97e-02 2.18e-01
GOMF ADENYLATE CYCLASE BINDING 12 3.96e-01 6.78e-01 0.233000 -9.98e-02 -2.11e-01 5.50e-01 2.06e-01
GOBP ANTIBACTERIAL INNATE IMMUNE RESPONSE 10 4.57e-01 7.22e-01 0.233000 2.22e-01 7.11e-02 2.24e-01 6.97e-01
Interleukin-7 signaling 21 1.60e-01 4.43e-01 0.233000 1.25e-01 -1.96e-01 3.20e-01 1.19e-01
GOCC COPII VESICLE COAT 16 2.69e-01 5.66e-01 0.233000 2.33e-01 -3.23e-03 1.07e-01 9.82e-01
GOBP REGULATION OF PRESYNAPSE ORGANIZATION 30 1.03e-01 3.45e-01 0.233000 1.66e-01 1.63e-01 1.15e-01 1.22e-01
Ub-specific processing proteases 162 7.22e-07 2.88e-05 0.233000 1.62e-01 -1.68e-01 3.74e-04 2.33e-04
mitochondrial fatty acid beta-oxidation of saturated fatty acids 11 4.17e-01 6.98e-01 0.233000 2.28e-01 4.61e-02 1.90e-01 7.91e-01
GOBP REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY 26 1.17e-01 3.71e-01 0.233000 2.32e-01 -1.72e-02 4.03e-02 8.80e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 32 7.68e-02 2.93e-01 0.233000 2.31e-01 2.90e-02 2.37e-02 7.76e-01
GOBP HIPPOCAMPUS DEVELOPMENT 91 3.78e-04 6.28e-03 0.233000 2.03e-01 -1.15e-01 8.30e-04 5.87e-02
DNA Replication Pre-Initiation 111 6.63e-05 1.52e-03 0.233000 1.21e-01 -1.99e-01 2.75e-02 2.94e-04
GOBP HRI MEDIATED SIGNALING 6 6.35e-01 8.37e-01 0.233000 -1.47e-01 -1.80e-01 5.33e-01 4.44e-01
GOBP IMMUNOGLOBULIN V D J RECOMBINATION 8 5.46e-01 7.82e-01 0.233000 1.64e-01 1.65e-01 4.23e-01 4.18e-01
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) 110 6.83e-05 1.56e-03 0.233000 1.54e-01 -1.75e-01 5.36e-03 1.54e-03
Homology Directed Repair 116 4.04e-05 9.89e-04 0.233000 1.67e-01 -1.62e-01 1.88e-03 2.58e-03
GOBP NEGATIVE REGULATION OF PLATELET ACTIVATION 18 2.22e-01 5.18e-01 0.233000 2.30e-01 -3.83e-02 9.18e-02 7.78e-01
GOBP PALLIUM DEVELOPMENT 182 2.33e-07 1.07e-05 0.233000 2.25e-01 -5.92e-02 1.63e-07 1.68e-01
Formation of TC-NER Pre-Incision Complex 49 1.39e-02 1.00e-01 0.233000 1.51e-01 -1.77e-01 6.77e-02 3.21e-02
Nef and signal transduction 8 5.47e-01 7.82e-01 0.233000 -1.68e-01 -1.61e-01 4.11e-01 4.31e-01
GOBP ADENOSINE TRANSPORT 5 6.77e-01 8.60e-01 0.232000 7.04e-02 2.22e-01 7.85e-01 3.91e-01
GOBP T HELPER 1 CELL CYTOKINE PRODUCTION 8 5.20e-01 7.64e-01 0.232000 -6.19e-03 2.32e-01 9.76e-01 2.55e-01
GOBP LONG CHAIN FATTY ACID CATABOLIC PROCESS 8 5.18e-01 7.63e-01 0.232000 2.32e-01 -1.69e-02 2.56e-01 9.34e-01
GOMF DNA SECONDARY STRUCTURE BINDING 36 5.50e-02 2.39e-01 0.232000 2.32e-01 1.31e-02 1.60e-02 8.92e-01
GOBP POSITIVE REGULATION OF SYNAPTIC PLASTICITY 10 4.71e-01 7.31e-01 0.232000 1.61e-01 1.67e-01 3.77e-01 3.60e-01
Apoptotic execution phase 49 1.72e-02 1.15e-01 0.232000 2.29e-01 -3.62e-02 5.47e-03 6.61e-01
GOMF 1 PHOSPHATIDYLINOSITOL 4 PHOSPHATE 3 KINASE ACTIVITY 7 5.44e-01 7.81e-01 0.232000 1.33e-01 -1.90e-01 5.43e-01 3.83e-01
Activation of the pre-replicative complex 31 6.97e-02 2.76e-01 0.232000 2.07e-01 -1.05e-01 4.59e-02 3.13e-01
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM 13 3.59e-01 6.47e-01 0.232000 -2.28e-01 -4.40e-02 1.55e-01 7.83e-01
GOMF CYCLIC NUCLEOTIDE ACTIVATED MONOATOMIC ION CHANNEL ACTIVITY 10 4.30e-01 7.06e-01 0.232000 -2.21e-01 6.90e-02 2.25e-01 7.06e-01
GOCC GROWTH FACTOR COMPLEX 8 5.03e-01 7.55e-01 0.232000 2.08e-01 -1.02e-01 3.08e-01 6.16e-01
GOBP NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 35 5.12e-02 2.28e-01 0.232000 2.17e-01 -8.17e-02 2.63e-02 4.03e-01
GOBP SKELETAL MUSCLE SATELLITE CELL ACTIVATION 9 4.65e-01 7.28e-01 0.232000 -8.58e-02 2.15e-01 6.56e-01 2.63e-01
GOBP CELLULAR RESPONSE TO ESTRADIOL STIMULUS 37 5.10e-02 2.28e-01 0.232000 2.32e-01 9.33e-03 1.48e-02 9.22e-01
Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) 27 9.77e-02 3.35e-01 0.232000 1.99e-01 -1.18e-01 7.28e-02 2.88e-01
GOCC SAGA TYPE COMPLEX 35 4.92e-02 2.23e-01 0.232000 2.00e-01 -1.17e-01 4.05e-02 2.31e-01
GOBP RESPONSE TO NITRIC OXIDE 19 2.07e-01 5.01e-01 0.232000 2.28e-01 -3.98e-02 8.49e-02 7.64e-01
Protein ubiquitination 73 1.82e-03 2.19e-02 0.232000 1.39e-01 -1.86e-01 4.03e-02 6.11e-03
Lipid particle organization 6 6.05e-01 8.19e-01 0.232000 2.24e-01 -5.75e-02 3.41e-01 8.07e-01
GOBP REGULATION OF CHLORIDE TRANSPORT 6 5.94e-01 8.12e-01 0.232000 1.72e-01 -1.56e-01 4.67e-01 5.09e-01
GOBP RNA 5 END PROCESSING 36 5.42e-02 2.37e-01 0.232000 4.50e-03 -2.32e-01 9.63e-01 1.62e-02
GOBP CELLULAR RESPONSE TO ETHER 6 6.15e-01 8.26e-01 0.232000 1.31e-03 -2.32e-01 9.96e-01 3.26e-01
GOBP REGULATION OF MITOCHONDRIAL FUSION 13 3.59e-01 6.47e-01 0.232000 2.28e-01 3.96e-02 1.54e-01 8.05e-01
RNA Polymerase I Promoter Clearance 71 2.22e-03 2.56e-02 0.231000 1.31e-01 -1.91e-01 5.68e-02 5.38e-03
RNA Polymerase I Transcription 71 2.22e-03 2.56e-02 0.231000 1.31e-01 -1.91e-01 5.68e-02 5.38e-03
Ubiquitin-dependent degradation of Cyclin D 39 4.03e-02 1.98e-01 0.231000 3.31e-02 -2.29e-01 7.20e-01 1.33e-02
GOBP NEGATIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION 5 6.77e-01 8.60e-01 0.231000 -2.25e-01 -5.45e-02 3.84e-01 8.33e-01
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS 6 6.00e-01 8.16e-01 0.231000 2.12e-01 -9.34e-02 3.69e-01 6.92e-01
GOBP INTERLEUKIN 12 MEDIATED SIGNALING PATHWAY 9 4.62e-01 7.25e-01 0.231000 -1.15e-01 2.01e-01 5.51e-01 2.96e-01
GOBP POSITIVE REGULATION OF CELL FATE COMMITMENT 17 2.79e-01 5.76e-01 0.231000 1.93e-01 1.28e-01 1.69e-01 3.61e-01
GOBP TELOMERASE RNA LOCALIZATION 18 2.12e-01 5.07e-01 0.231000 1.88e-01 -1.35e-01 1.67e-01 3.22e-01
GOBP PROXIMAL DISTAL PATTERN FORMATION 34 5.29e-02 2.33e-01 0.231000 1.57e-01 -1.70e-01 1.14e-01 8.59e-02
GOBP ACIDIC AMINO ACID TRANSPORT 66 7.23e-03 6.26e-02 0.231000 1.80e-01 1.45e-01 1.15e-02 4.12e-02
GOMF TOXIC SUBSTANCE BINDING 10 4.21e-01 7.00e-01 0.231000 1.46e-01 -1.79e-01 4.24e-01 3.26e-01
GOBP THIAMINE CONTAINING COMPOUND METABOLIC PROCESS 6 5.95e-01 8.13e-01 0.231000 1.55e-01 -1.71e-01 5.10e-01 4.68e-01
GOBP POSITIVE REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE 8 5.18e-01 7.63e-01 0.231000 -2.28e-01 3.50e-02 2.63e-01 8.64e-01
PKA activation 18 2.57e-01 5.54e-01 0.231000 1.10e-01 2.03e-01 4.20e-01 1.35e-01
GOBP CELLULAR RESPONSE TO VITAMIN 28 8.91e-02 3.19e-01 0.231000 1.62e-01 -1.65e-01 1.38e-01 1.31e-01
GOBP MESODERMAL CELL MIGRATION 5 6.89e-01 8.65e-01 0.231000 1.54e-01 1.72e-01 5.50e-01 5.05e-01
GOBP NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 24 1.37e-01 4.05e-01 0.231000 -2.25e-01 5.08e-02 5.60e-02 6.66e-01
GOMF GLYCEROL CHANNEL ACTIVITY 5 6.50e-01 8.45e-01 0.231000 -1.40e-01 1.84e-01 5.89e-01 4.76e-01
Fibronectin matrix formation 6 5.97e-01 8.14e-01 0.231000 1.92e-01 -1.29e-01 4.16e-01 5.85e-01
GOMF BILE ACID SODIUM SYMPORTER ACTIVITY 5 6.52e-01 8.46e-01 0.231000 -1.98e-01 1.19e-01 4.43e-01 6.45e-01
GOBP POSITIVE REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION 23 1.64e-01 4.48e-01 0.231000 -2.28e-01 -3.45e-02 5.79e-02 7.75e-01
GOBP POST EMBRYONIC ANIMAL MORPHOGENESIS 5 6.75e-01 8.58e-01 0.231000 -3.36e-02 -2.29e-01 8.97e-01 3.76e-01
Gap junction degradation 12 3.89e-01 6.72e-01 0.231000 2.29e-01 3.20e-02 1.70e-01 8.48e-01
GOCC CHYLOMICRON 13 3.64e-01 6.51e-01 0.231000 -2.25e-01 -5.35e-02 1.61e-01 7.38e-01
GOBP MEGAKARYOCYTE DEVELOPMENT 22 1.85e-01 4.75e-01 0.231000 2.19e-01 7.29e-02 7.53e-02 5.54e-01
GOMF 2 OXOGLUTARATE DEPENDENT DIOXYGENASE ACTIVITY 54 1.65e-02 1.12e-01 0.231000 2.13e-01 8.81e-02 6.67e-03 2.63e-01
HDACs deacetylate histones 54 9.86e-03 7.79e-02 0.231000 1.26e-01 -1.93e-01 1.08e-01 1.41e-02
GOBP POSITIVE REGULATION OF PROTEIN MONOUBIQUITINATION 5 6.89e-01 8.65e-01 0.231000 1.45e-01 1.79e-01 5.73e-01 4.88e-01
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING 10 4.43e-01 7.15e-01 0.231000 -2.43e-02 2.29e-01 8.94e-01 2.09e-01
GOBP REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS 13 3.47e-01 6.37e-01 0.231000 2.57e-02 -2.29e-01 8.72e-01 1.52e-01
GOBP LIPID TRANSPORT ACROSS BLOOD BRAIN BARRIER 6 6.38e-01 8.38e-01 0.231000 -1.99e-01 -1.16e-01 3.98e-01 6.23e-01
GOBP FACIAL NERVE STRUCTURAL ORGANIZATION 8 5.49e-01 7.84e-01 0.230000 1.99e-01 1.17e-01 3.31e-01 5.67e-01
TGF-beta receptor signaling activates SMADs 47 1.84e-02 1.20e-01 0.230000 1.99e-01 -1.17e-01 1.84e-02 1.67e-01
GOBP CAMP BIOSYNTHETIC PROCESS 10 4.74e-01 7.34e-01 0.230000 1.29e-01 1.91e-01 4.79e-01 2.97e-01
GOCC ATAC COMPLEX 13 3.28e-01 6.19e-01 0.230000 1.81e-01 -1.42e-01 2.57e-01 3.75e-01
GOCC HOPS COMPLEX 14 3.27e-01 6.18e-01 0.230000 2.30e-01 3.18e-03 1.36e-01 9.84e-01
GOBP NUCLEOSIDE SALVAGE 11 3.90e-01 6.73e-01 0.230000 1.39e-01 -1.84e-01 4.25e-01 2.91e-01
GOBP ZINC ION IMPORT INTO ORGANELLE 11 3.92e-01 6.75e-01 0.230000 1.16e-01 -1.99e-01 5.04e-01 2.54e-01
GOMF INOSITOL TETRAKISPHOSPHATE KINASE ACTIVITY 5 6.51e-01 8.46e-01 0.230000 1.71e-01 -1.54e-01 5.08e-01 5.50e-01
GOBP NEURAL CREST CELL DIFFERENTIATION 92 5.98e-04 9.14e-03 0.230000 2.29e-01 -2.05e-02 1.43e-04 7.34e-01
GOBP CELL CELL ADHESION INVOLVED IN GASTRULATION 11 4.26e-01 7.04e-01 0.230000 4.44e-02 2.26e-01 7.99e-01 1.95e-01
GOBP PROTEIN DNA COMPLEX ASSEMBLY 201 3.80e-08 2.04e-06 0.230000 1.69e-01 -1.56e-01 3.42e-05 1.41e-04
GOMF PROTEIN TRANSPORTER ACTIVITY 40 3.85e-02 1.93e-01 0.230000 3.41e-02 -2.28e-01 7.09e-01 1.27e-02
GOMF DINUCLEOTIDE PHOSPHATASE ACTIVITY 8 5.52e-01 7.87e-01 0.230000 1.37e-01 1.85e-01 5.02e-01 3.65e-01
GOMF P53 BINDING 65 5.44e-03 5.01e-02 0.230000 2.30e-01 -1.20e-02 1.36e-03 8.68e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS 7 5.58e-01 7.90e-01 0.230000 -7.72e-02 2.17e-01 7.24e-01 3.21e-01
AUF1 (hnRNP D0) binds and destabilizes mRNA 42 3.03e-02 1.67e-01 0.230000 7.74e-02 -2.16e-01 3.85e-01 1.52e-02
GOCC ENZYME ACTIVATOR COMPLEX 13 3.37e-01 6.26e-01 0.230000 2.14e-01 -8.49e-02 1.82e-01 5.96e-01
GOBP NEGATIVE REGULATION OF VIRAL TRANSCRIPTION 14 3.04e-01 5.98e-01 0.230000 1.91e-01 -1.28e-01 2.16e-01 4.06e-01
GOBP ESTABLISHMENT OF MEIOTIC SPINDLE LOCALIZATION 6 6.09e-01 8.22e-01 0.230000 2.22e-01 -6.08e-02 3.47e-01 7.96e-01
GOBP G2 MI TRANSITION OF MEIOTIC CELL CYCLE 6 6.41e-01 8.41e-01 0.230000 -1.33e-01 -1.87e-01 5.72e-01 4.27e-01
GOBP RESPONSE TO GRAVITY 9 5.15e-01 7.61e-01 0.230000 -1.58e-01 -1.67e-01 4.12e-01 3.86e-01
GOCC SYMMETRIC SYNAPSE 8 5.47e-01 7.82e-01 0.230000 8.95e-02 2.12e-01 6.61e-01 3.00e-01
GOBP RESPONSE TO NERVE GROWTH FACTOR 51 1.90e-02 1.22e-01 0.230000 2.27e-01 3.40e-02 4.98e-03 6.74e-01
SUMOylation of ubiquitinylation proteins 39 3.88e-02 1.94e-01 0.230000 2.15e-01 -8.00e-02 1.99e-02 3.87e-01
GOMF CALCIUM INDEPENDENT PHOSPHOLIPASE A2 ACTIVITY 9 4.98e-01 7.52e-01 0.230000 -4.13e-02 -2.26e-01 8.30e-01 2.40e-01
GOMF HISTONE DEACETYLASE BINDING 109 1.12e-04 2.38e-03 0.230000 2.11e-01 -9.10e-02 1.41e-04 1.01e-01
GOBP EXOCRINE SYSTEM DEVELOPMENT 48 2.06e-02 1.29e-01 0.230000 2.28e-01 -2.93e-02 6.31e-03 7.26e-01
GOBP DE NOVO NAD BIOSYNTHETIC PROCESS 8 5.30e-01 7.71e-01 0.230000 -2.30e-01 -2.42e-03 2.61e-01 9.91e-01
GOCC U2 TYPE SPLICEOSOMAL COMPLEX 91 4.55e-04 7.28e-03 0.230000 1.90e-01 -1.28e-01 1.70e-03 3.43e-02
GOMF NUCLEAR RECEPTOR BINDING 131 2.08e-05 5.52e-04 0.230000 2.19e-01 -6.85e-02 1.49e-05 1.76e-01
Oxidative Stress Induced Senescence 88 5.69e-04 8.75e-03 0.229000 1.65e-01 -1.60e-01 7.50e-03 9.66e-03
GOBP REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 21 2.12e-01 5.07e-01 0.229000 1.27e-01 1.91e-01 3.15e-01 1.29e-01
GOBP METANEPHRIC PROXIMAL TUBULE DEVELOPMENT 5 6.92e-01 8.67e-01 0.229000 1.38e-01 1.83e-01 5.93e-01 4.78e-01
GOBP ACETATE ESTER METABOLIC PROCESS 6 6.03e-01 8.17e-01 0.229000 2.00e-01 -1.12e-01 3.96e-01 6.33e-01
GOBP POSITIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 8 5.49e-01 7.84e-01 0.229000 9.58e-02 2.08e-01 6.39e-01 3.07e-01
GOBP REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS 11 4.20e-01 6.99e-01 0.229000 2.29e-01 8.29e-03 1.88e-01 9.62e-01
GOMF ARYL HYDROCARBON RECEPTOR BINDING 8 5.15e-01 7.61e-01 0.229000 2.15e-01 -7.85e-02 2.91e-01 7.01e-01
GOBP MONOUBIQUITINATED PROTEIN DEUBIQUITINATION 8 5.12e-01 7.61e-01 0.229000 2.10e-01 -9.26e-02 3.04e-01 6.50e-01
GOBP TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION 11 3.94e-01 6.76e-01 0.229000 -1.87e-01 1.32e-01 2.82e-01 4.48e-01
GOMF ARACHIDONIC ACID MONOOXYGENASE ACTIVITY 17 2.87e-01 5.84e-01 0.229000 -1.73e-01 -1.50e-01 2.17e-01 2.83e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CILIUM 11 4.17e-01 6.98e-01 0.229000 2.29e-01 -5.04e-03 1.88e-01 9.77e-01
GOBP MESENCHYMAL TO EPITHELIAL TRANSITION 18 2.36e-01 5.32e-01 0.229000 2.28e-01 -2.14e-02 9.37e-02 8.75e-01
GOBP ALDITOL BIOSYNTHETIC PROCESS 5 6.85e-01 8.64e-01 0.229000 -2.16e-01 -7.70e-02 4.03e-01 7.66e-01
GOBP EXTRACELLULAR MATRIX CONSTITUENT SECRETION 13 3.42e-01 6.32e-01 0.229000 2.18e-01 -7.08e-02 1.74e-01 6.58e-01
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY 9 4.69e-01 7.30e-01 0.229000 1.14e-01 -1.99e-01 5.55e-01 3.01e-01
GOBP EMBRYONIC DIGIT MORPHOGENESIS 58 8.98e-03 7.30e-02 0.229000 2.24e-01 -4.60e-02 3.11e-03 5.45e-01
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX 29 8.76e-02 3.16e-01 0.229000 1.12e-01 -2.00e-01 2.97e-01 6.25e-02
GOBP REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY 36 6.93e-02 2.75e-01 0.229000 -2.02e-01 -1.08e-01 3.62e-02 2.60e-01
GOBP REGULATION OF PROTEIN MONOUBIQUITINATION 6 6.39e-01 8.39e-01 0.229000 2.09e-01 9.30e-02 3.75e-01 6.93e-01
GOBP PEPTIDYL GLUTAMIC ACID MODIFICATION 26 1.29e-01 3.92e-01 0.229000 -4.14e-03 -2.29e-01 9.71e-01 4.34e-02
GOCC MCM COMPLEX 11 4.25e-01 7.03e-01 0.229000 2.28e-01 2.38e-02 1.91e-01 8.91e-01
GOBP SPHINGOID BIOSYNTHETIC PROCESS 14 3.33e-01 6.24e-01 0.229000 9.21e-03 2.29e-01 9.52e-01 1.38e-01
GOBP FEMALE GENITALIA DEVELOPMENT 19 2.28e-01 5.25e-01 0.229000 2.28e-01 2.08e-02 8.55e-02 8.75e-01
GOCC U6 SNRNP 8 5.08e-01 7.59e-01 0.229000 1.73e-01 -1.49e-01 3.96e-01 4.65e-01
GOBP REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS 57 1.50e-02 1.05e-01 0.229000 -1.15e-01 -1.98e-01 1.32e-01 9.89e-03
GOCC PROTON TRANSPORTING ATP SYNTHASE COMPLEX 21 1.83e-01 4.73e-01 0.229000 3.82e-02 -2.26e-01 7.62e-01 7.35e-02
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC 6 6.45e-01 8.42e-01 0.229000 1.69e-01 1.54e-01 4.73e-01 5.14e-01
GOBP NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION 22 1.66e-01 4.50e-01 0.229000 2.21e-01 -5.92e-02 7.29e-02 6.31e-01
GOBP REGULATION OF CHROMATIN BINDING 11 4.03e-01 6.86e-01 0.229000 -7.87e-02 2.15e-01 6.51e-01 2.18e-01
GOBP C4 DICARBOXYLATE TRANSPORT 28 1.29e-01 3.92e-01 0.229000 1.37e-01 1.83e-01 2.09e-01 9.39e-02
GOMF SPHINGOSINE 1 PHOSPHATE PHOSPHATASE ACTIVITY 7 5.75e-01 8.00e-01 0.229000 -5.38e-03 2.29e-01 9.80e-01 2.95e-01
Regulation of TNFR1 signaling 46 2.08e-02 1.30e-01 0.229000 1.82e-01 -1.38e-01 3.25e-02 1.05e-01
GOBP POSITIVE REGULATION OF NEURON DIFFERENTIATION 89 1.15e-03 1.53e-02 0.229000 2.23e-01 4.85e-02 2.71e-04 4.29e-01
GOBP PROTEIN LOCALIZATION TO MOTILE CILIUM 6 6.33e-01 8.35e-01 0.229000 -4.85e-02 -2.23e-01 8.37e-01 3.44e-01
GOBP CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 82 1.62e-03 2.01e-02 0.228000 2.28e-01 1.93e-03 3.47e-04 9.76e-01
GOBP PURINE NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS 5 6.73e-01 8.57e-01 0.228000 -2.28e-01 1.21e-02 3.77e-01 9.63e-01
GOBP FOREBRAIN DEVELOPMENT 393 2.90e-14 4.62e-12 0.228000 2.25e-01 -3.92e-02 1.82e-14 1.82e-01
GOBP DNA CATABOLIC PROCESS 29 9.73e-02 3.35e-01 0.228000 2.26e-01 -3.56e-02 3.55e-02 7.40e-01
GOBP REGULATION OF MEIOSIS I 6 6.42e-01 8.41e-01 0.228000 1.07e-01 2.02e-01 6.50e-01 3.92e-01
ER Quality Control Compartment (ERQC) 21 1.87e-01 4.78e-01 0.228000 2.27e-01 -2.45e-02 7.18e-02 8.46e-01
GOMF RECEPTOR SIGNALING PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY 5 6.89e-01 8.65e-01 0.228000 8.84e-02 2.10e-01 7.32e-01 4.15e-01
Unwinding of DNA 12 3.83e-01 6.67e-01 0.228000 2.26e-01 -3.09e-02 1.75e-01 8.53e-01
GOBP REGULATION OF CORTISOL BIOSYNTHETIC PROCESS 7 5.81e-01 8.03e-01 0.228000 1.64e-02 2.28e-01 9.40e-01 2.97e-01
GOBP CAMP PKA SIGNAL TRANSDUCTION 5 6.64e-01 8.51e-01 0.228000 -7.41e-02 2.16e-01 7.74e-01 4.03e-01
GOBP EMBRYONIC HEART TUBE DEVELOPMENT 84 1.26e-03 1.65e-02 0.228000 2.26e-01 -2.70e-02 3.32e-04 6.69e-01
GOBP CELL COMMUNICATION BY ELECTRICAL COUPLING 33 6.29e-02 2.60e-01 0.228000 1.35e-01 -1.84e-01 1.78e-01 6.81e-02
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 33 6.53e-02 2.66e-01 0.228000 2.07e-01 -9.66e-02 4.00e-02 3.37e-01
TRAF3-dependent IRF activation pathway 15 2.83e-01 5.80e-01 0.228000 1.62e-01 -1.60e-01 2.76e-01 2.83e-01
GOBP CELLULAR RESPONSE TO HYDROPEROXIDE 9 5.20e-01 7.64e-01 0.228000 -1.53e-01 -1.69e-01 4.26e-01 3.81e-01
GOBP GLOMERULAR EPITHELIUM DEVELOPMENT 26 1.33e-01 3.98e-01 0.228000 2.28e-01 1.10e-02 4.45e-02 9.22e-01
GOBP BLEB ASSEMBLY 11 4.45e-01 7.17e-01 0.228000 2.02e-01 1.06e-01 2.46e-01 5.43e-01
GOCC LAMELLAR BODY 18 2.25e-01 5.21e-01 0.228000 -2.02e-01 1.05e-01 1.37e-01 4.41e-01
SUMOylation of SUMOylation proteins 35 5.65e-02 2.43e-01 0.228000 2.12e-01 -8.35e-02 3.00e-02 3.92e-01
GOBP NEGATIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION 5 6.61e-01 8.51e-01 0.228000 9.76e-02 -2.06e-01 7.05e-01 4.25e-01
GOBP POSITIVE REGULATION OF FATTY ACID TRANSPORT 24 1.34e-01 4.00e-01 0.228000 1.68e-01 -1.54e-01 1.54e-01 1.92e-01
GOBP POSITIVE REGULATION OF AMINO ACID TRANSPORT 22 2.03e-01 4.96e-01 0.228000 1.38e-01 1.81e-01 2.62e-01 1.42e-01
GOBP CENTROMERE COMPLEX ASSEMBLY 28 1.03e-01 3.46e-01 0.228000 2.19e-01 -6.12e-02 4.46e-02 5.75e-01
Advanced glycosylation endproduct receptor signaling 13 3.84e-01 6.69e-01 0.228000 2.05e-01 9.98e-02 2.02e-01 5.33e-01
Nectin/Necl trans heterodimerization 7 5.99e-01 8.15e-01 0.228000 -2.00e-01 -1.08e-01 3.59e-01 6.20e-01
Interleukin-9 signaling 7 5.65e-01 7.94e-01 0.228000 2.16e-01 -7.12e-02 3.22e-01 7.44e-01
Reduction of cytosolic Ca++ levels 11 4.48e-01 7.18e-01 0.228000 1.18e-01 1.94e-01 4.98e-01 2.64e-01
GOMF PHOSPHATIDYLSERINE 1 ACYLHYDROLASE ACTIVITY 11 4.31e-01 7.07e-01 0.227000 -2.96e-02 -2.26e-01 8.65e-01 1.95e-01
GOMF TRNA CYTIDINE 5 METHYLTRANSFERASE ACTIVITY 5 6.83e-01 8.63e-01 0.227000 2.25e-01 3.58e-02 3.84e-01 8.90e-01
GOBP NUCLEAR EXPORT 157 2.20e-06 7.55e-05 0.227000 1.80e-01 -1.39e-01 9.77e-05 2.68e-03
activated TAK1 mediates p38 MAPK activation 20 1.92e-01 4.84e-01 0.227000 1.00e-01 -2.04e-01 4.37e-01 1.14e-01
Dectin-2 family 28 1.12e-01 3.63e-01 0.227000 -2.27e-01 6.71e-03 3.74e-02 9.51e-01
GOBP SISTER CHROMATID COHESION 53 1.61e-02 1.10e-01 0.227000 2.27e-01 -3.70e-03 4.20e-03 9.63e-01
GOBP PURKINJE MYOCYTE TO VENTRICULAR CARDIAC MUSCLE CELL COMMUNICATION 6 6.06e-01 8.19e-01 0.227000 1.44e-01 -1.76e-01 5.41e-01 4.56e-01
GOBP REGULATION OF TELOMERE CAPPING 26 1.16e-01 3.69e-01 0.227000 1.22e-01 -1.91e-01 2.80e-01 9.10e-02
GOBP PROTOPORPHYRINOGEN IX BIOSYNTHETIC PROCESS 8 5.14e-01 7.61e-01 0.227000 1.87e-01 -1.29e-01 3.59e-01 5.27e-01
GOBP RESPONSE TO INTERLEUKIN 12 12 3.67e-01 6.55e-01 0.227000 -1.45e-01 1.75e-01 3.83e-01 2.95e-01
GOBP NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 15 2.92e-01 5.89e-01 0.227000 2.07e-01 -9.48e-02 1.66e-01 5.25e-01
GOBP NUCLEOSIDE TRANSPORT 10 4.86e-01 7.44e-01 0.227000 1.79e-01 1.40e-01 3.28e-01 4.42e-01
Activation of NOXA and translocation to mitochondria 5 6.73e-01 8.58e-01 0.227000 2.68e-02 -2.26e-01 9.17e-01 3.83e-01
GOBP RESPONSE TO DISACCHARIDE 8 5.42e-01 7.80e-01 0.227000 -2.26e-01 -2.35e-02 2.69e-01 9.08e-01
GOMF BIOACTIVE LIPID RECEPTOR ACTIVITY 14 3.60e-01 6.49e-01 0.227000 -2.01e-01 -1.06e-01 1.94e-01 4.91e-01
GOBP REGULATION OF ANTIGEN PROCESSING AND PRESENTATION 18 2.34e-01 5.31e-01 0.227000 6.56e-02 -2.17e-01 6.30e-01 1.11e-01
Transcriptional Regulation by E2F6 32 8.59e-02 3.14e-01 0.227000 2.26e-01 1.74e-02 2.67e-02 8.65e-01
GOCC SMALL SUBUNIT PROCESSOME 69 3.45e-03 3.56e-02 0.227000 1.07e-01 -2.00e-01 1.24e-01 4.05e-03
GOCC CHITOSOME 20 1.94e-01 4.87e-01 0.227000 -2.05e-01 9.76e-02 1.13e-01 4.50e-01
GOBP ADIPONECTIN ACTIVATED SIGNALING PATHWAY 7 6.02e-01 8.17e-01 0.227000 1.91e-01 1.23e-01 3.83e-01 5.72e-01
GOCC PROTEIN FOLDING CHAPERONE COMPLEX 40 4.77e-02 2.20e-01 0.227000 -2.78e-02 -2.25e-01 7.61e-01 1.37e-02
GOBP PHENOL CONTAINING COMPOUND CATABOLIC PROCESS 8 5.18e-01 7.63e-01 0.227000 -1.03e-01 2.02e-01 6.14e-01 3.22e-01
GOBP INTRA GOLGI VESICLE MEDIATED TRANSPORT 32 7.03e-02 2.78e-01 0.227000 1.73e-01 -1.46e-01 9.00e-02 1.52e-01
GOMF PROTEIN PHOSPHORYLATED AMINO ACID BINDING 58 8.29e-03 6.89e-02 0.227000 1.85e-01 -1.31e-01 1.47e-02 8.48e-02
GOCC BASEMENT MEMBRANE COLLAGEN TRIMER 6 6.12e-01 8.23e-01 0.227000 -2.06e-01 9.51e-02 3.83e-01 6.87e-01
GOBP GENERAL ADAPTATION SYNDROME 6 6.50e-01 8.45e-01 0.227000 1.76e-01 1.42e-01 4.54e-01 5.46e-01
GOBP DIAPHRAGM DEVELOPMENT 9 4.74e-01 7.34e-01 0.227000 1.79e-01 -1.39e-01 3.53e-01 4.69e-01
GOMF BH DOMAIN BINDING 11 4.12e-01 6.93e-01 0.227000 6.61e-02 -2.17e-01 7.04e-01 2.13e-01
GOBP POSITIVE REGULATION OF PROTEIN GLYCOSYLATION 7 6.03e-01 8.17e-01 0.227000 1.23e-01 1.90e-01 5.74e-01 3.83e-01
Defective C1GALT1C1 causes TNPS 18 2.37e-01 5.33e-01 0.226000 -2.19e-01 5.85e-02 1.08e-01 6.68e-01
GOBP DNA TEMPLATED TRANSCRIPTION INITIATION 188 1.90e-07 8.96e-06 0.226000 1.55e-01 -1.65e-01 2.37e-04 9.89e-05
GOBP REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY 47 2.08e-02 1.30e-01 0.226000 1.86e-01 -1.29e-01 2.71e-02 1.27e-01
GOBP T CELL MEDIATED CYTOTOXICITY 59 1.38e-02 9.98e-02 0.226000 -1.01e-01 -2.03e-01 1.80e-01 7.08e-03
GOMF DEOXYNUCLEOSIDE KINASE ACTIVITY 5 6.68e-01 8.54e-01 0.226000 7.21e-02 -2.15e-01 7.80e-01 4.06e-01
eNOS activation 13 3.48e-01 6.38e-01 0.226000 2.10e-01 -8.34e-02 1.89e-01 6.03e-01
GOBP T FOLLICULAR HELPER CELL DIFFERENTIATION 7 5.64e-01 7.93e-01 0.226000 2.02e-01 -1.03e-01 3.56e-01 6.37e-01
CASP8 activity is inhibited 11 4.06e-01 6.89e-01 0.226000 1.05e-01 -2.01e-01 5.48e-01 2.49e-01
Dimerization of procaspase-8 11 4.06e-01 6.89e-01 0.226000 1.05e-01 -2.01e-01 5.48e-01 2.49e-01
Regulation by c-FLIP 11 4.06e-01 6.89e-01 0.226000 1.05e-01 -2.01e-01 5.48e-01 2.49e-01
GOCC CAJAL BODY 78 2.23e-03 2.57e-02 0.226000 2.25e-01 -2.64e-02 6.00e-04 6.87e-01
Signaling by ROBO receptors 194 2.22e-07 1.03e-05 0.226000 4.95e-02 -2.21e-01 2.35e-01 1.13e-07
GOMF ATP DEPENDENT PROTEIN BINDING 6 6.13e-01 8.24e-01 0.226000 2.05e-01 -9.49e-02 3.84e-01 6.87e-01
GOMF PROMOTER SPECIFIC CHROMATIN BINDING 64 7.42e-03 6.34e-02 0.226000 2.26e-01 6.82e-03 1.76e-03 9.25e-01
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 12 3.77e-01 6.62e-01 0.226000 2.06e-01 -9.38e-02 2.17e-01 5.74e-01
GOMF PHOSPHATIDYLINOSITOL KINASE ACTIVITY 26 1.40e-01 4.10e-01 0.226000 2.25e-01 2.58e-02 4.74e-02 8.20e-01
GOBP BASEMENT MEMBRANE ORGANIZATION 38 6.46e-02 2.64e-01 0.226000 1.96e-01 1.13e-01 3.68e-02 2.27e-01
GOBP RNA TEMPLATED DNA BIOSYNTHETIC PROCESS 70 3.23e-03 3.38e-02 0.226000 1.91e-01 -1.21e-01 5.80e-03 7.88e-02
GOBP CELLULAR RESPONSE TO STEROL DEPLETION 16 2.98e-01 5.94e-01 0.226000 2.25e-01 2.51e-02 1.20e-01 8.62e-01
GOBP NEGATIVE REGULATION OF NUCLEASE ACTIVITY 7 5.70e-01 7.97e-01 0.226000 7.01e-02 -2.15e-01 7.48e-01 3.25e-01
GOBP POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEPARATION 18 2.52e-01 5.49e-01 0.226000 2.26e-01 6.08e-03 9.70e-02 9.64e-01
Mitochondrial tRNA aminoacylation 20 1.93e-01 4.85e-01 0.226000 1.84e-01 -1.31e-01 1.54e-01 3.11e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE PRODUCTION 29 1.12e-01 3.63e-01 0.226000 3.10e-02 2.24e-01 7.73e-01 3.69e-02
GOMF NEUROPEPTIDE ACTIVITY 29 1.20e-01 3.78e-01 0.226000 2.10e-01 8.36e-02 5.04e-02 4.36e-01
GOBP RISC COMPLEX ASSEMBLY 10 4.84e-01 7.43e-01 0.226000 2.03e-01 9.95e-02 2.67e-01 5.86e-01
GOBP SEROTONIN TRANSPORT 20 2.14e-01 5.09e-01 0.226000 2.26e-01 -5.28e-03 8.04e-02 9.67e-01
GOBP GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION 12 3.93e-01 6.76e-01 0.226000 2.25e-01 -1.73e-02 1.77e-01 9.17e-01
Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA 17 2.57e-01 5.54e-01 0.226000 6.35e-02 -2.17e-01 6.50e-01 1.22e-01
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR ACTIVITY 7 5.62e-01 7.93e-01 0.226000 1.83e-01 -1.33e-01 4.03e-01 5.43e-01
GOMF N ACETYLTRANSFERASE ACTIVITY 62 7.82e-03 6.59e-02 0.226000 2.24e-01 -3.19e-02 2.33e-03 6.64e-01
GOBP LYSINE METABOLIC PROCESS 8 5.61e-01 7.92e-01 0.226000 -1.99e-01 -1.07e-01 3.30e-01 6.02e-01
Acyl chain remodelling of PC 27 1.30e-01 3.93e-01 0.226000 2.25e-01 2.34e-02 4.34e-02 8.34e-01
GOBP ERBB2 EGFR SIGNALING PATHWAY 8 5.43e-01 7.80e-01 0.226000 -7.20e-03 -2.26e-01 9.72e-01 2.69e-01
GOMF TRNA SPECIFIC RIBONUCLEASE ACTIVITY 16 2.68e-01 5.65e-01 0.226000 1.76e-01 -1.42e-01 2.24e-01 3.27e-01
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING 14 3.20e-01 6.11e-01 0.226000 1.06e-01 -1.99e-01 4.92e-01 1.97e-01
GOBP DENDRITIC TRANSPORT 12 3.73e-01 6.59e-01 0.226000 1.73e-01 -1.45e-01 3.00e-01 3.85e-01
GOMF SH3 DOMAIN BINDING 114 2.71e-04 4.79e-03 0.226000 2.04e-01 9.60e-02 1.66e-04 7.66e-02
GOBP AMINO ACID ACTIVATION 43 3.13e-02 1.70e-01 0.226000 2.09e-01 -8.59e-02 1.79e-02 3.30e-01
GOBP OPTIC NERVE DEVELOPMENT 20 2.17e-01 5.12e-01 0.226000 2.26e-01 5.12e-03 8.08e-02 9.68e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR 81 1.32e-03 1.71e-02 0.226000 1.37e-01 -1.79e-01 3.36e-02 5.23e-03
GOBP IMMATURE T CELL PROLIFERATION 12 3.75e-01 6.61e-01 0.226000 -1.90e-01 1.22e-01 2.55e-01 4.66e-01
GOBP CEREBELLAR GRANULAR LAYER MORPHOGENESIS 8 5.23e-01 7.66e-01 0.225000 -2.04e-01 9.59e-02 3.18e-01 6.39e-01
GOBP PYRIMIDINE CONTAINING COMPOUND SALVAGE 7 5.68e-01 7.96e-01 0.225000 2.06e-01 -9.17e-02 3.45e-01 6.75e-01
GOBP PROTEIN LOCALIZATION TO NUCLEOLUS 17 2.49e-01 5.46e-01 0.225000 1.85e-01 -1.29e-01 1.86e-01 3.59e-01
GOBP GLUCOSE IMPORT ACROSS PLASMA MEMBRANE 5 6.63e-01 8.51e-01 0.225000 1.67e-01 -1.52e-01 5.19e-01 5.56e-01
RNA Polymerase III Transcription Initiation From Type 3 Promoter 28 1.07e-01 3.53e-01 0.225000 6.71e-02 -2.15e-01 5.39e-01 4.87e-02
GOBP CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS 15 3.00e-01 5.95e-01 0.225000 2.10e-01 -8.14e-02 1.59e-01 5.85e-01
GOBP PROTEIN POLYGLUTAMYLATION 12 3.93e-01 6.75e-01 0.225000 2.67e-02 -2.24e-01 8.73e-01 1.80e-01
GOBP REGULATION OF MORPHOGENESIS OF AN EPITHELIUM 63 6.12e-03 5.46e-02 0.225000 1.02e-01 -2.01e-01 1.60e-01 5.84e-03
GOBP TRNA 5 LEADER REMOVAL 13 3.61e-01 6.49e-01 0.225000 4.04e-02 -2.22e-01 8.01e-01 1.66e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDINES 11 4.47e-01 7.17e-01 0.225000 7.02e-02 2.14e-01 6.87e-01 2.19e-01
Complex I biogenesis 58 1.07e-02 8.26e-02 0.225000 4.02e-02 -2.22e-01 5.97e-01 3.52e-03
GOBP NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 54 1.89e-02 1.22e-01 0.225000 2.17e-01 5.82e-02 5.70e-03 4.59e-01
GOMF PROTEIN FOLDING CHAPERONE 67 6.39e-03 5.68e-02 0.225000 -1.60e-02 -2.25e-01 8.21e-01 1.48e-03
GOBP ENTEROENDOCRINE CELL DIFFERENTIATION 35 6.35e-02 2.62e-01 0.225000 2.19e-01 -5.12e-02 2.48e-02 6.00e-01
GOBP CELL DIFFERENTIATION IN HINDBRAIN 21 2.06e-01 5.00e-01 0.225000 2.24e-01 2.18e-02 7.55e-02 8.63e-01
GOBP RNA SURVEILLANCE 18 2.37e-01 5.33e-01 0.225000 7.95e-02 -2.11e-01 5.59e-01 1.22e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION REGENERATION 10 4.93e-01 7.50e-01 0.225000 1.69e-01 1.49e-01 3.55e-01 4.16e-01
GOBP NUCLEOSOME ORGANIZATION 119 6.18e-05 1.43e-03 0.225000 1.62e-01 -1.56e-01 2.32e-03 3.22e-03
GOBP POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 60 1.43e-02 1.02e-01 0.225000 1.84e-01 1.29e-01 1.35e-02 8.47e-02
GOBP NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING 22 1.72e-01 4.58e-01 0.225000 2.10e-01 -8.14e-02 8.88e-02 5.09e-01
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE II PROMOTER 150 5.06e-06 1.60e-04 0.225000 1.63e-01 -1.55e-01 5.69e-04 1.06e-03
GOMF INTERLEUKIN 17 RECEPTOR ACTIVITY 8 5.68e-01 7.96e-01 0.225000 1.53e-01 1.65e-01 4.53e-01 4.20e-01
GOBP PHOSPHOLIPASE C ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY 9 5.09e-01 7.59e-01 0.225000 2.24e-01 2.27e-02 2.45e-01 9.06e-01
GOMF FATTY ACID DERIVATIVE BINDING 18 2.54e-01 5.52e-01 0.225000 -8.17e-04 -2.25e-01 9.95e-01 9.87e-02
GOBP MATURATION OF LSU RRNA 23 1.60e-01 4.43e-01 0.225000 7.52e-02 -2.12e-01 5.32e-01 7.87e-02
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 18 2.81e-01 5.78e-01 0.225000 -1.47e-01 -1.70e-01 2.80e-01 2.12e-01
GOBP REGULATION OF MELANOCYTE DIFFERENTIATION 6 6.38e-01 8.38e-01 0.225000 2.24e-01 2.27e-02 3.43e-01 9.23e-01
Collagen formation 88 7.86e-04 1.14e-02 0.225000 -1.42e-01 1.74e-01 2.11e-02 4.81e-03
GOBP NEGATIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION 7 5.75e-01 8.00e-01 0.225000 2.15e-01 -6.46e-02 3.24e-01 7.67e-01
GOBP LEUKOCYTE CHEMOTAXIS INVOLVED IN INFLAMMATORY RESPONSE 8 5.21e-01 7.64e-01 0.225000 -1.50e-01 1.68e-01 4.64e-01 4.12e-01
GOCC MIB COMPLEX 11 4.58e-01 7.23e-01 0.225000 1.22e-01 1.89e-01 4.85e-01 2.78e-01
GOMF CYCLIC NUCLEOTIDE DEPENDENT PROTEIN KINASE ACTIVITY 7 5.74e-01 7.99e-01 0.225000 2.13e-01 -7.22e-02 3.30e-01 7.41e-01
GOBP INDOLALKYLAMINE METABOLIC PROCESS 11 4.60e-01 7.24e-01 0.224000 -1.81e-01 -1.33e-01 2.99e-01 4.45e-01
GOBP SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING 13 3.58e-01 6.47e-01 0.224000 -6.32e-02 2.15e-01 6.93e-01 1.79e-01
GOBP COPPER ION TRANSMEMBRANE TRANSPORT 7 5.66e-01 7.95e-01 0.224000 -1.82e-01 1.31e-01 4.05e-01 5.47e-01
GOBP AUTOPHAGOSOME ORGANIZATION 118 1.34e-04 2.72e-03 0.224000 2.24e-01 -2.44e-04 2.53e-05 9.96e-01
GOBP PROTEIN ACETYLATION 53 1.72e-02 1.15e-01 0.224000 2.24e-01 -1.84e-02 4.85e-03 8.17e-01
GOBP BRONCHUS DEVELOPMENT 11 4.52e-01 7.20e-01 0.224000 -2.10e-01 -7.88e-02 2.28e-01 6.51e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO TYPE II INTERFERON 7 6.05e-01 8.19e-01 0.224000 2.06e-01 8.99e-02 3.46e-01 6.81e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ADAPTOR ACTIVITY 17 2.53e-01 5.51e-01 0.224000 1.91e-01 -1.18e-01 1.73e-01 4.02e-01
GOBP OOCYTE MATURATION 35 8.58e-02 3.13e-01 0.224000 1.59e-01 1.58e-01 1.03e-01 1.06e-01
GOMF ADENOSINE RECEPTOR BINDING 8 5.35e-01 7.75e-01 0.224000 -2.19e-01 4.81e-02 2.83e-01 8.14e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS 5 6.82e-01 8.62e-01 0.224000 -2.24e-01 1.46e-02 3.86e-01 9.55e-01
GOBP CELLULAR RESPONSE TO ANGIOTENSIN 34 8.42e-02 3.12e-01 0.224000 2.16e-01 6.14e-02 2.95e-02 5.36e-01
GOMF CUPRIC ION BINDING 5 6.97e-01 8.68e-01 0.224000 2.12e-01 7.39e-02 4.12e-01 7.75e-01
GOBP U2 TYPE PRESPLICEOSOME ASSEMBLY 23 1.72e-01 4.58e-01 0.224000 1.87e-02 -2.23e-01 8.77e-01 6.36e-02
GOMF G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR ACTIVITY 7 5.73e-01 7.99e-01 0.224000 -2.09e-01 8.19e-02 3.39e-01 7.07e-01
GOCC VESICLE TETHERING COMPLEX 65 7.33e-03 6.31e-02 0.224000 2.24e-01 -1.27e-03 1.77e-03 9.86e-01
GOMF INTERLEUKIN 12 RECEPTOR BINDING 5 6.85e-01 8.64e-01 0.224000 -2.24e-01 -1.03e-03 3.85e-01 9.97e-01
GOBP REGULATION OF ANIMAL ORGAN FORMATION 27 1.29e-01 3.92e-01 0.224000 2.24e-01 -4.05e-03 4.38e-02 9.71e-01
GOMF GALACTOSIDASE ACTIVITY 6 6.20e-01 8.27e-01 0.224000 2.06e-01 -8.82e-02 3.82e-01 7.08e-01
GOBP POSITIVE REGULATION OF CELL MATURATION 9 4.83e-01 7.42e-01 0.224000 -1.29e-01 1.83e-01 5.02e-01 3.41e-01
Regulation of activated PAK-2p34 by proteasome mediated degradation 37 5.47e-02 2.39e-01 0.224000 6.15e-02 -2.16e-01 5.17e-01 2.33e-02
Defective CHST14 causes EDS, musculocontractural type 7 6.06e-01 8.19e-01 0.224000 2.05e-01 8.98e-02 3.47e-01 6.81e-01
Regulation of pyruvate dehydrogenase (PDH) complex 13 3.66e-01 6.53e-01 0.224000 -3.55e-02 2.21e-01 8.24e-01 1.67e-01
GOBP RENAL SYSTEM VASCULATURE DEVELOPMENT 33 7.50e-02 2.89e-01 0.224000 2.15e-01 -6.16e-02 3.22e-02 5.40e-01
GOMF SIGNALING RECEPTOR COMPLEX ADAPTOR ACTIVITY 51 2.12e-02 1.32e-01 0.224000 2.24e-01 -1.18e-03 5.65e-03 9.88e-01
Signaling by Insulin receptor 79 3.29e-03 3.44e-02 0.224000 2.15e-01 6.27e-02 9.56e-04 3.35e-01
Cytochrome c-mediated apoptotic response 12 3.82e-01 6.67e-01 0.224000 1.97e-01 -1.06e-01 2.37e-01 5.24e-01
PLC beta mediated events 48 3.40e-02 1.79e-01 0.224000 1.18e-01 1.90e-01 1.57e-01 2.26e-02
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS 9 4.97e-01 7.52e-01 0.224000 2.19e-01 -4.53e-02 2.55e-01 8.14e-01
GOBP INTEGRIN MEDIATED SIGNALING PATHWAY 110 3.29e-04 5.61e-03 0.224000 2.19e-01 4.71e-02 7.34e-05 3.93e-01
GOBP AMINO ACID NEUROTRANSMITTER REUPTAKE 10 4.66e-01 7.28e-01 0.224000 -1.79e-02 2.23e-01 9.22e-01 2.22e-01
GOMF PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ACTIVITY 9 4.93e-01 7.50e-01 0.224000 -2.14e-01 6.66e-02 2.67e-01 7.30e-01
GOBP AMPA GLUTAMATE RECEPTOR CLUSTERING 10 4.47e-01 7.17e-01 0.224000 1.87e-01 -1.22e-01 3.05e-01 5.04e-01
mRNA Splicing - Major Pathway 189 2.60e-07 1.17e-05 0.224000 1.71e-01 -1.44e-01 4.95e-05 6.41e-04
GOBP NEGATIVE REGULATION OF MATRIX METALLOPEPTIDASE SECRETION 6 6.24e-01 8.31e-01 0.224000 -6.73e-02 2.13e-01 7.75e-01 3.66e-01
GOBP REGULATION OF INSULIN RECEPTOR SIGNALING PATHWAY 72 6.12e-03 5.46e-02 0.224000 2.01e-01 9.84e-02 3.22e-03 1.49e-01
Ribavirin ADME 11 4.36e-01 7.10e-01 0.223000 2.23e-01 -5.59e-03 1.99e-01 9.74e-01
Transcriptional regulation of granulopoiesis 53 1.66e-02 1.12e-01 0.223000 4.74e-02 -2.18e-01 5.50e-01 5.97e-03
TGFBR3 PTM regulation 10 4.50e-01 7.19e-01 0.223000 1.08e-01 -1.95e-01 5.54e-01 2.85e-01
CD28 dependent Vav1 pathway 11 4.14e-01 6.95e-01 0.223000 1.16e-01 -1.91e-01 5.07e-01 2.72e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 20 2.41e-01 5.37e-01 0.223000 2.05e-01 8.77e-02 1.12e-01 4.97e-01
GOMF DYNEIN HEAVY CHAIN BINDING 16 3.10e-01 6.04e-01 0.223000 3.91e-02 2.20e-01 7.87e-01 1.28e-01
GOBP REGULATION OF GTP BINDING 9 5.18e-01 7.63e-01 0.223000 -2.19e-01 -4.15e-02 2.54e-01 8.29e-01
GOBP LYMPHANGIOGENESIS 19 2.60e-01 5.57e-01 0.223000 2.04e-01 9.10e-02 1.24e-01 4.92e-01
GOBP DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION 14 3.57e-01 6.46e-01 0.223000 2.21e-01 3.07e-02 1.52e-01 8.43e-01
GOBP CEREBRAL CORTEX CELL MIGRATION 45 3.74e-02 1.90e-01 0.223000 2.19e-01 4.05e-02 1.09e-02 6.39e-01
GOMF PROTEIN TYROSINE KINASE INHIBITOR ACTIVITY 7 6.13e-01 8.24e-01 0.223000 -1.27e-01 -1.83e-01 5.59e-01 4.01e-01
p75NTR recruits signalling complexes 12 3.95e-01 6.77e-01 0.223000 4.77e-02 -2.18e-01 7.75e-01 1.91e-01
ISG15 antiviral mechanism 74 2.64e-03 2.93e-02 0.223000 1.45e-01 -1.69e-01 3.09e-02 1.17e-02
GOMF ADENYLATE CYCLASE REGULATOR ACTIVITY 8 5.59e-01 7.91e-01 0.223000 4.76e-02 2.18e-01 8.16e-01 2.86e-01
GOBP ESCRT COMPLEX DISASSEMBLY 10 4.86e-01 7.45e-01 0.223000 -2.14e-01 -6.13e-02 2.40e-01 7.37e-01
GOBP PHOTOPERIODISM 27 1.44e-01 4.18e-01 0.223000 2.12e-01 6.96e-02 5.67e-02 5.31e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION 8 5.73e-01 7.99e-01 0.223000 1.71e-01 1.43e-01 4.01e-01 4.85e-01
GOBP ADHESION OF SYMBIONT TO HOST 12 4.33e-01 7.08e-01 0.223000 -1.80e-01 -1.32e-01 2.80e-01 4.30e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE MIGRATION 14 3.73e-01 6.59e-01 0.223000 1.01e-01 1.99e-01 5.14e-01 1.98e-01
Collagen biosynthesis and modifying enzymes 65 5.47e-03 5.02e-02 0.223000 -1.72e-01 1.42e-01 1.66e-02 4.76e-02
GOBP REGULATION OF STRESS GRANULE ASSEMBLY 11 4.13e-01 6.94e-01 0.223000 1.52e-01 -1.63e-01 3.84e-01 3.48e-01
GOBP REGULATION OF ENDOSOME ORGANIZATION 5 6.98e-01 8.70e-01 0.223000 2.13e-01 6.59e-02 4.10e-01 7.98e-01
GOBP FLUID TRANSPORT 38 7.10e-02 2.80e-01 0.223000 1.28e-01 1.82e-01 1.71e-01 5.19e-02
GOBP EPITHELIAL STRUCTURE MAINTENANCE 35 6.03e-02 2.52e-01 0.223000 -1.56e-01 1.59e-01 1.11e-01 1.03e-01
GOBP SOMATOTROPIN SECRETING CELL DIFFERENTIATION 5 6.71e-01 8.56e-01 0.223000 1.85e-01 -1.24e-01 4.74e-01 6.31e-01
GOBP GLOSSOPHARYNGEAL NERVE DEVELOPMENT 5 7.00e-01 8.70e-01 0.223000 2.09e-01 7.69e-02 4.18e-01 7.66e-01
GOBP NUCLEOBASE TRANSPORT 12 4.20e-01 7.00e-01 0.223000 5.46e-02 2.16e-01 7.43e-01 1.95e-01
GOBP INTRACELLULAR DISTRIBUTION OF MITOCHONDRIA 7 5.76e-01 8.00e-01 0.223000 -9.00e-02 2.04e-01 6.80e-01 3.50e-01
mRNA decay by 3’ to 5’ exoribonuclease 16 2.78e-01 5.75e-01 0.223000 1.74e-01 -1.39e-01 2.29e-01 3.35e-01
GOBP VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS 14 3.79e-01 6.64e-01 0.223000 1.73e-01 1.40e-01 2.62e-01 3.64e-01
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY 13 4.04e-01 6.86e-01 0.223000 -1.19e-01 -1.88e-01 4.57e-01 2.40e-01
GOBP REFLEX 22 1.85e-01 4.76e-01 0.223000 3.91e-02 -2.19e-01 7.51e-01 7.51e-02
GOCC PROTEIN DNA COMPLEX 1362 8.68e-44 7.61e-41 0.223000 2.16e-01 -5.28e-02 4.84e-41 1.09e-03
GOBP NEGATIVE REGULATION OF AUTOPHAGY 87 1.46e-03 1.86e-02 0.223000 2.22e-01 -1.43e-02 3.43e-04 8.18e-01
GOBP REGULATION OF MEGAKARYOCYTE DIFFERENTIATION 35 7.32e-02 2.85e-01 0.222000 4.65e-03 -2.22e-01 9.62e-01 2.28e-02
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 34 7.68e-02 2.93e-01 0.222000 2.04e-02 -2.21e-01 8.37e-01 2.54e-02
Nonhomologous End-Joining (NHEJ) 46 2.55e-02 1.51e-01 0.222000 1.38e-01 -1.74e-01 1.06e-01 4.06e-02
GOBP REGULATION OF NEURON DIFFERENTIATION 186 1.09e-06 4.10e-05 0.222000 2.22e-01 3.28e-03 1.69e-07 9.39e-01
GOMF CARDIOLIPIN BINDING 11 4.67e-01 7.28e-01 0.222000 1.30e-01 1.80e-01 4.56e-01 3.00e-01
GOBP REGULATION OF RECEPTOR CATABOLIC PROCESS 11 4.24e-01 7.03e-01 0.222000 -7.43e-02 2.10e-01 6.70e-01 2.29e-01
XBP1(S) activates chaperone genes 43 4.62e-02 2.15e-01 0.222000 2.14e-01 6.02e-02 1.52e-02 4.95e-01
GOBP THALAMUS DEVELOPMENT 11 4.65e-01 7.28e-01 0.222000 1.16e-01 1.90e-01 5.06e-01 2.76e-01
GOBP DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE 46 2.57e-02 1.51e-01 0.222000 -1.69e-01 1.44e-01 4.72e-02 9.11e-02
GOBP GAMMA AMINOBUTYRIC ACID SECRETION 13 4.08e-01 6.90e-01 0.222000 1.42e-01 1.71e-01 3.77e-01 2.85e-01
GOBP APPENDAGE DEVELOPMENT 182 1.47e-06 5.34e-05 0.222000 2.22e-01 -3.47e-04 2.36e-07 9.94e-01
GOBP INFLAMMATORY CELL APOPTOTIC PROCESS 23 1.61e-01 4.43e-01 0.222000 1.37e-01 -1.75e-01 2.55e-01 1.47e-01
GOBP RIBOFLAVIN TRANSPORT 6 6.60e-01 8.50e-01 0.222000 1.20e-01 1.87e-01 6.12e-01 4.28e-01
GOMF RIBOFLAVIN TRANSMEMBRANE TRANSPORTER ACTIVITY 6 6.60e-01 8.50e-01 0.222000 1.20e-01 1.87e-01 6.12e-01 4.28e-01
G2/M Checkpoints 132 3.27e-05 8.29e-04 0.222000 1.01e-01 -1.97e-01 4.44e-02 8.94e-05
GOBP EMBRYONIC APPENDAGE MORPHOGENESIS 121 1.15e-04 2.43e-03 0.222000 2.21e-01 -2.25e-02 2.73e-05 6.69e-01
GOBP TELOMERE MAINTENANCE 152 6.29e-06 1.92e-04 0.222000 1.83e-01 -1.25e-01 9.80e-05 7.63e-03
GOBP REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 10 5.02e-01 7.55e-01 0.222000 1.37e-01 1.74e-01 4.52e-01 3.40e-01
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE 9 5.16e-01 7.62e-01 0.222000 -1.15e-02 -2.22e-01 9.52e-01 2.50e-01
GOBP RNA SPLICING VIA TRANSESTERIFICATION REACTIONS 289 1.47e-10 1.24e-08 0.222000 1.82e-01 -1.27e-01 1.08e-07 1.93e-04
GOBP STEM CELL DIVISION 32 1.02e-01 3.44e-01 0.222000 2.13e-01 6.08e-02 3.68e-02 5.52e-01
Synthesis of PG 8 5.74e-01 7.99e-01 0.222000 1.10e-01 1.93e-01 5.91e-01 3.45e-01
GOMF N ACETYLLACTOSAMINE SYNTHASE ACTIVITY 5 7.03e-01 8.72e-01 0.222000 2.06e-01 8.12e-02 4.25e-01 7.53e-01
GOCC ATG1 ULK1 KINASE COMPLEX 9 5.14e-01 7.61e-01 0.222000 2.22e-01 3.48e-03 2.50e-01 9.86e-01
GOBP REGULATION OF ODONTOBLAST DIFFERENTIATION 10 5.00e-01 7.53e-01 0.222000 1.93e-01 1.09e-01 2.91e-01 5.51e-01
GOBP POSITIVE REGULATION OF FIBROBLAST APOPTOTIC PROCESS 10 4.53e-01 7.21e-01 0.222000 1.40e-01 -1.71e-01 4.42e-01 3.48e-01
GOBP NEGATIVE REGULATION OF MAST CELL ACTIVATION 10 4.70e-01 7.31e-01 0.222000 3.11e-02 -2.19e-01 8.65e-01 2.30e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX CONSTITUENT SECRETION 9 5.01e-01 7.54e-01 0.221000 2.13e-01 -6.08e-02 2.69e-01 7.52e-01
Regulation of mRNA stability by proteins that bind AU-rich elements 76 2.77e-03 3.04e-02 0.221000 8.30e-02 -2.05e-01 2.11e-01 1.97e-03
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY 5 6.92e-01 8.67e-01 0.221000 -2.21e-01 -5.12e-03 3.91e-01 9.84e-01
Diseases of Mismatch Repair (MMR) 5 6.82e-01 8.62e-01 0.221000 5.40e-02 -2.15e-01 8.34e-01 4.06e-01
GOBP NAD CATABOLIC PROCESS 20 2.05e-01 4.99e-01 0.221000 -1.39e-01 1.72e-01 2.81e-01 1.83e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS 123 6.91e-05 1.57e-03 0.221000 1.98e-01 -9.96e-02 1.51e-04 5.64e-02
GOBP METHYLGLYOXAL METABOLIC PROCESS 6 6.56e-01 8.48e-01 0.221000 7.65e-02 2.08e-01 7.46e-01 3.78e-01
Cleavage of the damaged pyrimidine 38 5.62e-02 2.42e-01 0.221000 4.07e-02 -2.18e-01 6.64e-01 2.03e-02
Depyrimidination 38 5.62e-02 2.42e-01 0.221000 4.07e-02 -2.18e-01 6.64e-01 2.03e-02
Recognition and association of DNA glycosylase with site containing an affected pyrimidine 38 5.62e-02 2.42e-01 0.221000 4.07e-02 -2.18e-01 6.64e-01 2.03e-02
GOBP POSITIVE REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT 8 5.78e-01 8.02e-01 0.221000 1.55e-01 1.58e-01 4.47e-01 4.39e-01
GOMF GALACTOSYLCERAMIDASE ACTIVITY 5 7.04e-01 8.72e-01 0.221000 7.77e-02 2.07e-01 7.63e-01 4.22e-01
GOBP MEMBRANE DEPOLARIZATION DURING AV NODE CELL ACTION POTENTIAL 6 6.24e-01 8.31e-01 0.221000 -1.90e-01 1.14e-01 4.21e-01 6.29e-01
Myoclonic epilepsy of Lafora 9 5.01e-01 7.54e-01 0.221000 6.16e-02 -2.13e-01 7.49e-01 2.69e-01
GOMF ALKALI METAL ION BINDING 19 2.71e-01 5.68e-01 0.221000 1.26e-01 1.82e-01 3.43e-01 1.69e-01
GOBP REGULATION OF APPETITE 21 2.35e-01 5.32e-01 0.221000 1.89e-01 1.15e-01 1.34e-01 3.60e-01
RET signaling 41 5.41e-02 2.37e-01 0.221000 2.15e-01 5.34e-02 1.74e-02 5.54e-01
GOCC CYCLIN CDK POSITIVE TRANSCRIPTION ELONGATION FACTOR COMPLEX 8 5.33e-01 7.73e-01 0.221000 1.90e-01 -1.14e-01 3.53e-01 5.76e-01
GOCC LAMIN FILAMENT 5 7.06e-01 8.73e-01 0.221000 -9.31e-02 -2.01e-01 7.18e-01 4.37e-01
Prevention of phagosomal-lysosomal fusion 9 4.91e-01 7.48e-01 0.221000 1.36e-01 -1.75e-01 4.80e-01 3.64e-01
GOBP DE NOVO PYRIMIDINE NUCLEOBASE BIOSYNTHETIC PROCESS 6 6.36e-01 8.38e-01 0.221000 2.18e-01 -3.48e-02 3.54e-01 8.82e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY 6 6.40e-01 8.40e-01 0.221000 2.21e-01 -1.09e-02 3.49e-01 9.63e-01
GOCC B WICH COMPLEX 7 5.84e-01 8.05e-01 0.221000 2.11e-01 -6.61e-02 3.34e-01 7.62e-01
GOBP DICARBOXYLIC ACID CATABOLIC PROCESS 17 3.06e-01 5.99e-01 0.221000 2.03e-01 8.84e-02 1.48e-01 5.28e-01
GOBP POSITIVE REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY 5 6.99e-01 8.70e-01 0.221000 -2.17e-01 -4.23e-02 4.01e-01 8.70e-01
GOBP MULTICELLULAR ORGANISM GROWTH 146 1.48e-05 4.07e-04 0.221000 2.12e-01 -6.20e-02 9.52e-06 1.96e-01
GOMF BILE ACID BINDING 10 4.88e-01 7.46e-01 0.221000 2.17e-01 4.15e-02 2.34e-01 8.20e-01
GOCC PERICILIARY MEMBRANE COMPARTMENT 5 6.79e-01 8.61e-01 0.221000 -2.04e-01 8.46e-02 4.29e-01 7.43e-01
Caspase activation via Death Receptors in the presence of ligand 16 2.85e-01 5.82e-01 0.221000 1.18e-01 -1.87e-01 4.12e-01 1.96e-01
Phosphate bond hydrolysis by NTPDase proteins 8 5.55e-01 7.88e-01 0.221000 -2.21e-01 -2.77e-03 2.79e-01 9.89e-01
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION 8 5.62e-01 7.92e-01 0.221000 -2.19e-01 -3.12e-02 2.84e-01 8.78e-01
GOBP RESPONSE TO VITAMIN A 15 3.58e-01 6.47e-01 0.221000 1.76e-01 1.34e-01 2.39e-01 3.69e-01
GOBP EMBRYONIC HEART TUBE MORPHOGENESIS 70 5.21e-03 4.88e-02 0.221000 2.18e-01 -3.44e-02 1.58e-03 6.18e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 73 6.95e-03 6.06e-02 0.221000 1.44e-01 1.68e-01 3.36e-02 1.32e-02
GOBP REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY 17 2.88e-01 5.86e-01 0.221000 8.47e-03 2.21e-01 9.52e-01 1.15e-01
GOCC CUL4B RING E3 UBIQUITIN LIGASE COMPLEX 5 6.85e-01 8.64e-01 0.221000 4.28e-02 -2.17e-01 8.69e-01 4.01e-01
Synthesis of PA 38 5.39e-02 2.37e-01 0.221000 2.08e-01 -7.49e-02 2.67e-02 4.24e-01
Processive synthesis on the lagging strand 14 3.34e-01 6.24e-01 0.221000 1.85e-01 -1.21e-01 2.32e-01 4.33e-01
SUMOylation of immune response proteins 11 4.56e-01 7.22e-01 0.221000 2.16e-01 4.39e-02 2.14e-01 8.01e-01
GOCC AXOLEMMA 15 3.12e-01 6.05e-01 0.221000 -9.83e-02 1.98e-01 5.10e-01 1.85e-01
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY 21 2.30e-01 5.27e-01 0.221000 -2.08e-01 -7.29e-02 9.84e-02 5.63e-01
Regulation of TP53 Activity through Phosphorylation 89 1.12e-03 1.51e-02 0.221000 6.74e-02 -2.10e-01 2.72e-01 6.09e-04
GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 6 6.26e-01 8.32e-01 0.221000 1.89e-01 -1.14e-01 4.23e-01 6.28e-01
Repression of WNT target genes 14 3.32e-01 6.23e-01 0.221000 1.57e-01 -1.55e-01 3.08e-01 3.16e-01
GOBP HEMATOPOIETIC STEM CELL MIGRATION 8 5.33e-01 7.73e-01 0.221000 1.44e-01 -1.67e-01 4.80e-01 4.13e-01
GOBP CYTIDINE TO URIDINE EDITING 12 4.23e-01 7.01e-01 0.221000 2.18e-01 3.34e-02 1.91e-01 8.41e-01
GOBP TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 78 2.21e-03 2.56e-02 0.221000 1.73e-01 -1.37e-01 8.35e-03 3.61e-02
GOBP SIALYLATION 10 4.85e-01 7.43e-01 0.221000 1.79e-02 2.20e-01 9.22e-01 2.29e-01
Protein repair 6 6.65e-01 8.52e-01 0.221000 -1.59e-01 -1.53e-01 5.01e-01 5.16e-01
GOBP NEGATIVE REGULATION OF DNA BINDING 29 1.29e-01 3.92e-01 0.221000 2.14e-01 5.41e-02 4.63e-02 6.14e-01
GOMF NUCLEOTIDE RECEPTOR ACTIVITY 17 2.64e-01 5.60e-01 0.221000 -1.77e-01 1.32e-01 2.07e-01 3.47e-01
GOMF SALT TRANSMEMBRANE TRANSPORTER ACTIVITY 9 4.95e-01 7.51e-01 0.220000 -1.23e-01 1.83e-01 5.23e-01 3.42e-01
GOMF DNA BINDING TRANSCRIPTION ACTIVATOR ACTIVITY 456 2.16e-15 4.60e-13 0.220000 2.15e-01 -4.70e-02 3.10e-15 8.51e-02
GOMF C4 DICARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY 15 3.60e-01 6.49e-01 0.220000 1.76e-01 1.33e-01 2.39e-01 3.72e-01
GOBP TORC2 SIGNALING 11 4.68e-01 7.30e-01 0.220000 1.98e-01 9.61e-02 2.55e-01 5.81e-01
GOCC CYTOPLASMIC EXOSOME RNASE COMPLEX 16 2.88e-01 5.86e-01 0.220000 1.07e-01 -1.93e-01 4.59e-01 1.82e-01
FCERI mediated Ca+2 mobilization 30 9.62e-02 3.32e-01 0.220000 1.82e-01 -1.24e-01 8.46e-02 2.39e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MEMBRANE 6 6.25e-01 8.32e-01 0.220000 1.33e-01 -1.75e-01 5.72e-01 4.57e-01
GOBP CELLULAR RESPONSE TO ACID CHEMICAL 89 1.49e-03 1.90e-02 0.220000 2.20e-01 -5.38e-03 3.30e-04 9.30e-01
GOBP REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 42 5.80e-02 2.47e-01 0.220000 1.72e-01 1.38e-01 5.38e-02 1.23e-01
GOCC MITOTIC SPINDLE POLE 36 7.12e-02 2.80e-01 0.220000 2.20e-01 -8.26e-03 2.23e-02 9.32e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS 14 3.82e-01 6.67e-01 0.220000 1.01e-01 1.95e-01 5.11e-01 2.06e-01
GOMF LAMIN BINDING 16 3.18e-01 6.10e-01 0.220000 2.18e-01 2.98e-02 1.31e-01 8.37e-01
GOMF 1 PHOSPHATIDYLINOSITOL 4 5 BISPHOSPHATE 3 KINASE ACTIVITY 7 6.07e-01 8.21e-01 0.220000 -3.72e-02 -2.17e-01 8.65e-01 3.20e-01
Heme biosynthesis 13 3.65e-01 6.52e-01 0.220000 1.07e-01 -1.92e-01 5.02e-01 2.30e-01
DNA Damage/Telomere Stress Induced Senescence 57 1.22e-02 9.04e-02 0.220000 1.05e-01 -1.94e-01 1.72e-01 1.14e-02
GOBP POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS 65 9.31e-03 7.47e-02 0.220000 2.19e-01 1.85e-02 2.23e-03 7.96e-01
Activation of AMPK downstream of NMDARs 27 1.26e-01 3.87e-01 0.220000 -2.04e-01 8.17e-02 6.60e-02 4.63e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 32 8.89e-02 3.19e-01 0.220000 2.12e-01 -5.77e-02 3.76e-02 5.72e-01
GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 42 3.97e-02 1.97e-01 0.220000 8.79e-02 -2.02e-01 3.24e-01 2.37e-02
GOMF GPI ANCHOR BINDING 8 5.82e-01 8.04e-01 0.220000 -1.41e-01 -1.69e-01 4.90e-01 4.08e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 129 1.68e-04 3.29e-03 0.220000 1.73e-01 1.36e-01 7.13e-04 7.46e-03
GOBP CHORION DEVELOPMENT 10 4.58e-01 7.23e-01 0.220000 -1.71e-01 1.39e-01 3.50e-01 4.48e-01
GOBP AXIAL MESODERM DEVELOPMENT 8 5.37e-01 7.77e-01 0.220000 1.86e-01 -1.17e-01 3.63e-01 5.66e-01
Attachment and Entry 9694614 16 2.89e-01 5.86e-01 0.220000 -1.86e-01 1.17e-01 1.98e-01 4.16e-01
GOBP POSITIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE 15 3.24e-01 6.15e-01 0.220000 2.14e-01 -4.83e-02 1.50e-01 7.46e-01
GOBP TELENCEPHALON DEVELOPMENT 266 3.64e-09 2.41e-07 0.220000 2.19e-01 -2.15e-02 8.06e-10 5.46e-01
GOBP POSITIVE REGULATION OF BEHAVIOR 24 1.97e-01 4.90e-01 0.220000 1.79e-01 1.28e-01 1.29e-01 2.79e-01
GOMF RNA POLYMERASE BINDING 58 1.64e-02 1.12e-01 0.220000 2.17e-01 3.54e-02 4.28e-03 6.41e-01
GOBP OLIGODENDROCYTE DEVELOPMENT 45 4.48e-02 2.12e-01 0.220000 2.04e-01 8.07e-02 1.77e-02 3.49e-01
GOMF DNA REPLICATION ORIGIN BINDING 15 3.26e-01 6.17e-01 0.220000 2.16e-01 -4.25e-02 1.48e-01 7.76e-01
GOBP POSITIVE REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 10 4.58e-01 7.23e-01 0.220000 1.51e-01 -1.60e-01 4.09e-01 3.81e-01
Epigenetic regulation of gene expression 269 3.11e-09 2.10e-07 0.220000 2.19e-01 -1.93e-02 6.46e-10 5.86e-01
GOBP CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS 310 6.90e-10 5.28e-08 0.220000 2.03e-01 8.32e-02 7.52e-10 1.18e-02
GOBP ACTIN FILAMENT BASED TRANSPORT 10 4.96e-01 7.52e-01 0.220000 2.13e-01 5.48e-02 2.44e-01 7.64e-01
OAS antiviral response 8 5.39e-01 7.78e-01 0.220000 1.09e-01 -1.90e-01 5.93e-01 3.51e-01
GOBP REGULATION OF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 6 6.36e-01 8.38e-01 0.220000 2.12e-01 -5.81e-02 3.69e-01 8.05e-01
GOBP MRNA SPLICE SITE RECOGNITION 35 6.60e-02 2.68e-01 0.219000 1.75e-01 -1.32e-01 7.26e-02 1.77e-01
Apoptosis induced DNA fragmentation 13 3.63e-01 6.51e-01 0.219000 1.65e-01 -1.44e-01 3.02e-01 3.68e-01
Respiratory Syncytial Virus Infection Pathway 110 3.08e-04 5.31e-03 0.219000 2.53e-02 -2.18e-01 6.46e-01 7.79e-05
GOBP SPHINGOID METABOLIC PROCESS 22 2.17e-01 5.12e-01 0.219000 6.83e-02 2.09e-01 5.79e-01 9.04e-02
Autodegradation of the E3 ubiquitin ligase COP1 38 5.59e-02 2.42e-01 0.219000 7.41e-02 -2.07e-01 4.29e-01 2.75e-02
Protein methylation 15 3.12e-01 6.05e-01 0.219000 1.70e-01 -1.39e-01 2.55e-01 3.52e-01
GOBP ISOTYPE SWITCHING TO IGG ISOTYPES 15 3.17e-01 6.09e-01 0.219000 9.59e-02 -1.97e-01 5.20e-01 1.86e-01
GOBP DORSAL AORTA MORPHOGENESIS 8 5.74e-01 7.99e-01 0.219000 6.56e-02 2.09e-01 7.48e-01 3.05e-01
GOMF PHOSPHATIDYLINOSITOL BISPHOSPHATE BINDING 103 1.01e-03 1.39e-02 0.219000 1.45e-01 1.64e-01 1.08e-02 3.96e-03
GOMF MELANOCORTIN RECEPTOR ACTIVITY 6 6.66e-01 8.53e-01 0.219000 -1.86e-01 -1.16e-01 4.30e-01 6.22e-01
Ubiquitin Mediated Degradation of Phosphorylated Cdc25A 39 5.29e-02 2.33e-01 0.219000 6.40e-02 -2.10e-01 4.89e-01 2.34e-02
p53-Independent DNA Damage Response 39 5.29e-02 2.33e-01 0.219000 6.40e-02 -2.10e-01 4.89e-01 2.34e-02
p53-Independent G1/S DNA damage checkpoint 39 5.29e-02 2.33e-01 0.219000 6.40e-02 -2.10e-01 4.89e-01 2.34e-02
GOBP RELAXATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE 6 6.44e-01 8.42e-01 0.219000 -2.19e-01 1.61e-02 3.54e-01 9.46e-01
GOBP GERM CELL PROLIFERATION 10 4.85e-01 7.43e-01 0.219000 2.19e-01 1.15e-03 2.30e-01 9.95e-01
GOBP ENDOPLASMIC RETICULUM MEMBRANE ORGANIZATION 12 3.94e-01 6.76e-01 0.219000 1.37e-01 -1.71e-01 4.11e-01 3.05e-01
GOBP REGULATION OF SKELETAL MUSCLE ADAPTATION 14 3.62e-01 6.50e-01 0.219000 -3.64e-03 2.19e-01 9.81e-01 1.56e-01
Metabolism of ingested SeMet, Sec, MeSec into H2Se 7 6.23e-01 8.30e-01 0.219000 1.13e-01 1.88e-01 6.04e-01 3.90e-01
GOMF ACTININ BINDING 36 8.92e-02 3.19e-01 0.219000 1.73e-01 1.34e-01 7.18e-02 1.64e-01
GOMF LIGASE ACTIVITY FORMING CARBON OXYGEN BONDS 39 5.18e-02 2.30e-01 0.219000 2.04e-01 -8.08e-02 2.78e-02 3.82e-01
GOBP RRNA BASE METHYLATION 8 5.39e-01 7.78e-01 0.219000 1.23e-01 -1.81e-01 5.47e-01 3.75e-01
GOBP SPECIFICATION OF ANIMAL ORGAN IDENTITY 36 7.78e-02 2.95e-01 0.219000 2.17e-01 2.71e-02 2.40e-02 7.78e-01
GOMF UNMETHYLATED CPG BINDING 9 5.45e-01 7.81e-01 0.219000 1.82e-01 1.21e-01 3.43e-01 5.29e-01
Postmitotic nuclear pore complex (NPC) reformation 27 1.27e-01 3.89e-01 0.219000 1.98e-01 -9.36e-02 7.50e-02 4.00e-01
GOBP CHROMOSOME MOVEMENT TOWARDS SPINDLE POLE 7 5.87e-01 8.07e-01 0.219000 8.75e-02 -2.01e-01 6.88e-01 3.58e-01
MyD88 deficiency (TLR2/4) 16 3.38e-01 6.27e-01 0.219000 -1.93e-01 -1.04e-01 1.82e-01 4.72e-01
GOBP CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER 33 8.50e-02 3.12e-01 0.219000 2.12e-01 -5.33e-02 3.47e-02 5.96e-01
Androgen biosynthesis 11 4.29e-01 7.06e-01 0.219000 -1.09e-01 1.90e-01 5.30e-01 2.76e-01
GOCC MEMBRANE COAT 96 9.68e-04 1.34e-02 0.219000 2.19e-01 -6.38e-03 2.10e-04 9.14e-01
GOBP REGULATION OF LENS FIBER CELL DIFFERENTIATION 8 5.55e-01 7.88e-01 0.219000 2.17e-01 -2.98e-02 2.88e-01 8.84e-01
GOBP BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS 22 2.28e-01 5.25e-01 0.219000 1.82e-01 1.22e-01 1.40e-01 3.21e-01
GOBP NEURAL TUBE PATTERNING 31 1.11e-01 3.61e-01 0.219000 2.17e-01 2.53e-02 3.62e-02 8.08e-01
Beta oxidation of octanoyl-CoA to hexanoyl-CoA 5 6.84e-01 8.63e-01 0.219000 2.03e-01 -8.23e-02 4.32e-01 7.50e-01
GOBP MEIOTIC SPINDLE ASSEMBLY 12 4.29e-01 7.06e-01 0.219000 -3.57e-02 -2.16e-01 8.30e-01 1.95e-01
GOBP REGULATION OF NEUROBLAST PROLIFERATION 54 2.18e-02 1.35e-01 0.219000 2.17e-01 2.40e-02 5.71e-03 7.60e-01
GOBP EMBRYONIC ORGAN MORPHOGENESIS 293 6.14e-10 4.74e-08 0.219000 2.17e-01 -2.43e-02 1.52e-10 4.74e-01
GOBP ESTABLISHMENT OF SPINDLE ORIENTATION 42 5.59e-02 2.42e-01 0.219000 2.07e-01 7.09e-02 2.04e-02 4.26e-01
Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha 52 2.07e-02 1.29e-01 0.219000 5.92e-02 -2.10e-01 4.61e-01 8.68e-03
GOBP EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS 30 1.19e-01 3.75e-01 0.219000 2.18e-01 1.95e-02 3.91e-02 8.53e-01
GOBP RENAL VESICLE DEVELOPMENT 18 2.53e-01 5.50e-01 0.219000 1.91e-01 -1.07e-01 1.61e-01 4.34e-01
GOBP LONG CHAIN FATTY ACYL COA METABOLIC PROCESS 24 2.02e-01 4.95e-01 0.218000 1.48e-01 1.60e-01 2.08e-01 1.74e-01
GOBP LIPID DROPLET FORMATION 13 4.16e-01 6.97e-01 0.218000 1.05e-01 1.91e-01 5.10e-01 2.32e-01
GOMF GLUTAMATE GATED RECEPTOR ACTIVITY 15 3.65e-01 6.52e-01 0.218000 -1.85e-01 -1.16e-01 2.15e-01 4.35e-01
GOMF LAMININ BINDING 29 1.24e-01 3.84e-01 0.218000 -2.50e-03 2.18e-01 9.81e-01 4.18e-02
GOBP MESODERM MORPHOGENESIS 77 3.33e-03 3.48e-02 0.218000 2.12e-01 -5.12e-02 1.28e-03 4.38e-01
GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 5 7.14e-01 8.77e-01 0.218000 1.07e-01 1.90e-01 6.78e-01 4.61e-01
GOCC REPLISOME 22 2.11e-01 5.06e-01 0.218000 2.17e-01 2.33e-02 7.80e-02 8.50e-01
GOBP REGULATION OF LONG TERM SYNAPTIC DEPRESSION 12 4.01e-01 6.83e-01 0.218000 -1.03e-01 1.92e-01 5.36e-01 2.48e-01
GOBP EGG ACTIVATION 11 4.65e-01 7.28e-01 0.218000 4.56e-02 2.13e-01 7.94e-01 2.20e-01
GOBP REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 59 1.10e-02 8.43e-02 0.218000 1.84e-01 -1.17e-01 1.45e-02 1.19e-01
GOBP NEURONAL DENSE CORE VESICLE EXOCYTOSIS 7 5.83e-01 8.05e-01 0.218000 -1.56e-01 1.52e-01 4.73e-01 4.86e-01
RHOF GTPase cycle 40 5.45e-02 2.38e-01 0.218000 2.17e-01 -2.37e-02 1.76e-02 7.95e-01
Nucleotide Excision Repair 105 3.36e-04 5.70e-03 0.218000 1.82e-01 -1.19e-01 1.23e-03 3.46e-02
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 19 2.83e-01 5.80e-01 0.218000 1.48e-01 1.60e-01 2.64e-01 2.27e-01
GOMF ICOSANOID TRANSMEMBRANE TRANSPORTER ACTIVITY 13 3.93e-01 6.76e-01 0.218000 -3.65e-03 2.18e-01 9.82e-01 1.73e-01
GOBP POSITIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY 12 3.99e-01 6.82e-01 0.218000 1.81e-01 -1.21e-01 2.77e-01 4.68e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DEVELOPMENT 12 4.50e-01 7.19e-01 0.218000 1.78e-01 1.25e-01 2.85e-01 4.53e-01
GOBP DENSE CORE GRANULE TRANSPORT 10 4.99e-01 7.53e-01 0.218000 -2.14e-01 -4.30e-02 2.42e-01 8.14e-01
GOBP PLUS END DIRECTED ORGANELLE TRANSPORT ALONG MICROTUBULE 7 5.85e-01 8.06e-01 0.218000 1.35e-01 -1.71e-01 5.36e-01 4.34e-01
GOBP CHOLESTEROL IMPORT 9 5.22e-01 7.65e-01 0.218000 -2.17e-01 1.53e-02 2.59e-01 9.37e-01
GOCC SMALL NUCLEAR RIBONUCLEOPROTEIN COMPLEX 79 2.44e-03 2.74e-02 0.218000 1.80e-01 -1.23e-01 5.73e-03 5.88e-02
GOBP VESICLE TRANSPORT ALONG MICROTUBULE 46 2.96e-02 1.65e-01 0.218000 1.67e-01 -1.40e-01 5.02e-02 1.01e-01
GOBP POSITIVE REGULATION OF COLLATERAL SPROUTING 9 5.15e-01 7.62e-01 0.218000 2.13e-01 -4.53e-02 2.68e-01 8.14e-01
Regulation of MITF-M-dependent genes involved in cell cycle and proliferation 18 2.78e-01 5.76e-01 0.218000 -7.54e-03 -2.18e-01 9.56e-01 1.10e-01
CDH11 homotypic and heterotypic interactions 7 6.25e-01 8.32e-01 0.217000 9.59e-02 1.95e-01 6.60e-01 3.71e-01
GOMF MACROMOLECULE TRANSMEMBRANE TRANSPORTER ACTIVITY 31 9.55e-02 3.31e-01 0.217000 1.09e-01 -1.88e-01 2.95e-01 6.95e-02
GOMF PHOSPHATIDYLINOSITOL BINDING 263 2.67e-08 1.48e-06 0.217000 1.94e-01 9.83e-02 6.13e-08 6.04e-03
GOBP PORE COMPLEX ASSEMBLY 19 2.53e-01 5.50e-01 0.217000 2.16e-01 -2.49e-02 1.03e-01 8.51e-01
GOBP PROTON MOTIVE FORCE DRIVEN ATP SYNTHESIS 65 8.63e-03 7.10e-02 0.217000 4.40e-02 -2.13e-01 5.40e-01 2.99e-03
GOBP POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 70 9.36e-03 7.50e-02 0.217000 1.92e-01 1.01e-01 5.41e-03 1.42e-01
GOCC CHROMOSOME PASSENGER COMPLEX 6 6.43e-01 8.42e-01 0.217000 -5.16e-02 2.11e-01 8.27e-01 3.71e-01
GOBP NEGATIVE REGULATION OF GTPASE ACTIVITY 17 3.17e-01 6.10e-01 0.217000 8.14e-02 2.01e-01 5.61e-01 1.50e-01
GOMF N6 METHYLADENOSINE CONTAINING RNA READER ACTIVITY 11 4.44e-01 7.16e-01 0.217000 2.10e-01 -5.68e-02 2.28e-01 7.44e-01
GOMF ADP BINDING 36 8.29e-02 3.08e-01 0.217000 2.13e-01 4.10e-02 2.67e-02 6.70e-01
GOMF NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 450 9.24e-14 1.32e-11 0.217000 2.06e-01 6.88e-02 6.57e-14 1.24e-02
GOBP NEGATIVE REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE 7 5.91e-01 8.10e-01 0.217000 1.97e-01 -9.21e-02 3.68e-01 6.73e-01
Plasma lipoprotein assembly 19 2.45e-01 5.40e-01 0.217000 -2.06e-01 6.82e-02 1.20e-01 6.07e-01
GOBP PROTEIN LOCALIZATION TO NON MOTILE CILIUM 12 4.54e-01 7.21e-01 0.217000 -1.60e-01 -1.47e-01 3.38e-01 3.78e-01
GOBP T CELL APOPTOTIC PROCESS 57 2.19e-02 1.35e-01 0.217000 -8.85e-02 -1.98e-01 2.48e-01 9.63e-03
GOBP REGULATION OF T CELL MEDIATED CYTOTOXICITY 50 3.51e-02 1.83e-01 0.217000 -8.90e-02 -1.98e-01 2.76e-01 1.54e-02
GOBP MYOTUBE DIFFERENTIATION INVOLVED IN SKELETAL MUSCLE REGENERATION 8 5.50e-01 7.85e-01 0.217000 2.00e-01 -8.33e-02 3.26e-01 6.83e-01
GOBP REGULATION OF ERYTHROCYTE DIFFERENTIATION 44 3.53e-02 1.84e-01 0.217000 1.39e-01 -1.67e-01 1.11e-01 5.55e-02
Telomere Maintenance 86 1.46e-03 1.86e-02 0.217000 1.51e-01 -1.56e-01 1.58e-02 1.23e-02
GOMF TYPE I TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 11 4.76e-01 7.36e-01 0.217000 2.03e-01 7.71e-02 2.44e-01 6.58e-01
GOMF ACETYLESTERASE ACTIVITY 5 7.01e-01 8.70e-01 0.217000 -5.85e-03 2.17e-01 9.82e-01 4.01e-01
Phosphorylation of CD3 and TCR zeta chains 20 2.32e-01 5.29e-01 0.217000 4.96e-02 -2.11e-01 7.01e-01 1.02e-01
mRNA Splicing - Minor Pathway 52 2.08e-02 1.30e-01 0.217000 8.50e-02 -1.99e-01 2.89e-01 1.28e-02
GOBP LACTATE TRANSMEMBRANE TRANSPORT 8 5.76e-01 8.01e-01 0.217000 -2.13e-01 -4.25e-02 2.98e-01 8.35e-01
GOBP POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 14 3.74e-01 6.60e-01 0.217000 2.16e-01 1.13e-02 1.61e-01 9.42e-01
GOBP BINDING OF SPERM TO ZONA PELLUCIDA 38 7.61e-02 2.91e-01 0.217000 -2.07e-01 -6.46e-02 2.73e-02 4.91e-01
GOBP NEPHRON MORPHOGENESIS 78 3.24e-03 3.40e-02 0.217000 2.07e-01 -6.31e-02 1.54e-03 3.36e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION 34 9.40e-02 3.28e-01 0.217000 2.15e-01 2.49e-02 2.98e-02 8.02e-01
Ca-dependent events 36 8.86e-02 3.18e-01 0.217000 7.54e-02 2.03e-01 4.34e-01 3.49e-02
GOBP ANIMAL ORGAN FORMATION 68 8.23e-03 6.86e-02 0.217000 2.17e-01 4.94e-04 2.00e-03 9.94e-01
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY INVOLVED IN REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 53 2.95e-02 1.65e-01 0.217000 -1.94e-01 -9.55e-02 1.44e-02 2.29e-01
GOCC SPLICEOSOMAL COMPLEX 186 8.38e-07 3.28e-05 0.217000 1.66e-01 -1.39e-01 9.67e-05 1.04e-03
GOMF NUCLEAR THYROID HORMONE RECEPTOR BINDING 27 1.34e-01 4.00e-01 0.217000 1.97e-01 -8.95e-02 7.62e-02 4.21e-01
GOCC ASYMMETRIC GLUTAMATERGIC EXCITATORY SYNAPSE 13 3.73e-01 6.59e-01 0.217000 1.46e-01 -1.60e-01 3.63e-01 3.18e-01
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION MICROTUBULE MEDIATED 24 1.71e-01 4.57e-01 0.216000 2.06e-01 -6.60e-02 8.04e-02 5.75e-01
GOBP POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY 36 9.03e-02 3.22e-01 0.216000 1.99e-01 8.47e-02 3.87e-02 3.79e-01
Synthesis of UDP-N-acetyl-glucosamine 7 5.94e-01 8.12e-01 0.216000 -1.97e-01 8.94e-02 3.67e-01 6.82e-01
GOBP GERM CELL MIGRATION 9 5.50e-01 7.85e-01 0.216000 -9.46e-02 -1.95e-01 6.23e-01 3.12e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE CYTOKINE PRODUCTION 12 4.56e-01 7.22e-01 0.216000 1.42e-01 1.63e-01 3.95e-01 3.27e-01
GOBP LIPID DROPLET DISASSEMBLY 6 6.75e-01 8.59e-01 0.216000 1.40e-01 1.65e-01 5.51e-01 4.85e-01
GOBP MUSCLE CELL APOPTOTIC PROCESS 98 1.29e-03 1.69e-02 0.216000 2.10e-01 5.16e-02 3.26e-04 3.77e-01
GOBP COLLAGEN ACTIVATED SIGNALING PATHWAY 13 3.82e-01 6.67e-01 0.216000 -2.01e-01 7.90e-02 2.09e-01 6.22e-01
GOBP POSITIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS 14 3.79e-01 6.65e-01 0.216000 -2.59e-02 -2.15e-01 8.67e-01 1.64e-01
Interleukin-10 signaling 42 6.24e-02 2.58e-01 0.216000 -1.04e-01 -1.90e-01 2.45e-01 3.33e-02
GOBP MITOCHONDRIAL DNA REPLICATION 14 3.96e-01 6.78e-01 0.216000 -9.97e-02 -1.92e-01 5.18e-01 2.14e-01
GOBP SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 170 2.91e-06 9.69e-05 0.216000 1.33e-01 -1.70e-01 2.71e-03 1.28e-04
GOCC LAMELLIPODIUM 196 1.51e-06 5.40e-05 0.216000 2.14e-01 3.24e-02 2.44e-07 4.34e-01
GOBP ADULT LOCOMOTORY BEHAVIOR 80 3.07e-03 3.26e-02 0.216000 2.12e-01 -4.47e-02 1.07e-03 4.90e-01
Extension of Telomeres 49 2.94e-02 1.65e-01 0.216000 2.14e-01 -3.39e-02 9.71e-03 6.81e-01
GOBP NEUTROPHIL MEDIATED CYTOTOXICITY 15 3.26e-01 6.17e-01 0.216000 -1.90e-01 1.04e-01 2.03e-01 4.87e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING ONE CARBON GROUPS 206 3.69e-07 1.62e-05 0.216000 2.12e-01 -4.40e-02 1.62e-07 2.76e-01
GOBP INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION 35 7.80e-02 2.95e-01 0.216000 -2.09e-01 5.57e-02 3.25e-02 5.69e-01
GOCC AXONEMAL DYNEIN COMPLEX 21 2.09e-01 5.04e-01 0.216000 -1.92e-01 9.99e-02 1.28e-01 4.28e-01
GOBP POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 24 1.64e-01 4.48e-01 0.216000 1.29e-01 -1.73e-01 2.72e-01 1.42e-01
Pentose phosphate pathway 12 4.14e-01 6.94e-01 0.216000 -7.24e-02 2.03e-01 6.64e-01 2.22e-01
GOBP RESPONSE TO SELENIUM ION 9 5.07e-01 7.58e-01 0.216000 1.51e-01 -1.54e-01 4.32e-01 4.23e-01
GOBP MEMBRANE RAFT LOCALIZATION 7 6.32e-01 8.35e-01 0.216000 1.81e-01 1.18e-01 4.07e-01 5.90e-01
GOBP LATERAL VENTRICLE DEVELOPMENT 12 4.20e-01 6.99e-01 0.216000 2.12e-01 -4.31e-02 2.04e-01 7.96e-01
GOBP SPHINGOMYELIN BIOSYNTHETIC PROCESS 11 4.36e-01 7.10e-01 0.216000 1.59e-01 -1.46e-01 3.60e-01 4.03e-01
GOBP SMAD PROTEIN SIGNAL TRANSDUCTION 94 1.53e-03 1.94e-02 0.216000 2.15e-01 2.25e-02 3.20e-04 7.06e-01
GOBP NERVOUS SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 10 4.87e-01 7.46e-01 0.216000 3.52e-02 -2.13e-01 8.47e-01 2.44e-01
GOBP REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 286 6.39e-09 4.02e-07 0.216000 2.01e-01 7.75e-02 4.53e-09 2.41e-02
GOBP RESPONSE TO GLYCOPROTEIN 11 4.60e-01 7.24e-01 0.216000 -9.71e-03 2.16e-01 9.56e-01 2.16e-01
GOBP REGULATION OF SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING 7 6.28e-01 8.33e-01 0.216000 8.40e-02 1.99e-01 7.01e-01 3.63e-01
GOBP NEGATIVE REGULATION OF HYDROGEN PEROXIDE MEDIATED PROGRAMMED CELL DEATH 12 4.14e-01 6.94e-01 0.216000 2.02e-01 -7.63e-02 2.26e-01 6.47e-01
GOBP REGULATION OF CALCIUM IMPORT INTO THE MITOCHONDRION 6 6.73e-01 8.58e-01 0.216000 1.90e-01 1.02e-01 4.20e-01 6.66e-01
Lewis blood group biosynthesis 18 2.60e-01 5.57e-01 0.216000 -1.19e-01 1.80e-01 3.84e-01 1.86e-01
GOBP SKELETAL MUSCLE SATELLITE CELL PROLIFERATION 17 3.07e-01 6.00e-01 0.216000 -1.30e-02 -2.15e-01 9.26e-01 1.24e-01
GOMF FAD BINDING 39 6.76e-02 2.71e-01 0.216000 1.94e-02 2.15e-01 8.34e-01 2.03e-02
DARPP-32 events 24 1.79e-01 4.68e-01 0.216000 2.13e-01 -3.40e-02 7.10e-02 7.73e-01
GOBP NEGATIVE REGULATION OF MONOOXYGENASE ACTIVITY 12 4.16e-01 6.97e-01 0.216000 2.05e-01 -6.72e-02 2.19e-01 6.87e-01
GOBP HUMORAL IMMUNE RESPONSE 255 4.70e-08 2.46e-06 0.216000 -2.04e-01 -6.97e-02 2.03e-08 5.52e-02
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) 16 3.06e-01 5.99e-01 0.216000 1.94e-01 -9.45e-02 1.80e-01 5.13e-01
GOBP NEGATIVE REGULATION OF DENDRITIC CELL DIFFERENTIATION 5 6.90e-01 8.66e-01 0.215000 -1.90e-01 1.02e-01 4.63e-01 6.92e-01
GOBP NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 67 1.07e-02 8.28e-02 0.215000 2.11e-01 4.51e-02 2.87e-03 5.23e-01
GOBP RELAXATION OF SMOOTH MUSCLE 9 5.09e-01 7.59e-01 0.215000 -1.54e-01 1.50e-01 4.22e-01 4.36e-01
GOBP NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS 47 3.94e-02 1.96e-01 0.215000 2.14e-01 2.07e-02 1.10e-02 8.06e-01
Axonal growth inhibition (RHOA activation) 8 5.50e-01 7.85e-01 0.215000 -1.27e-01 1.74e-01 5.34e-01 3.94e-01
GOBP REGULATION OF IRON ION TRANSPORT 7 6.12e-01 8.23e-01 0.215000 5.08e-03 -2.15e-01 9.81e-01 3.24e-01
Chromosome Maintenance 109 2.92e-04 5.08e-03 0.215000 1.49e-01 -1.56e-01 7.33e-03 4.97e-03
GOBP PHOTOTRANSDUCTION 41 4.76e-02 2.20e-01 0.215000 -1.11e-01 1.85e-01 2.21e-01 4.07e-02
MicroRNA (miRNA) biogenesis 26 1.49e-01 4.25e-01 0.215000 2.00e-01 -8.00e-02 7.78e-02 4.80e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION 36 8.98e-02 3.21e-01 0.215000 -6.15e-02 -2.06e-01 5.23e-01 3.22e-02
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 20 2.30e-01 5.27e-01 0.215000 1.98e-01 -8.49e-02 1.26e-01 5.11e-01
GOMF NUCLEAR LOCALIZATION SEQUENCE BINDING 24 1.66e-01 4.50e-01 0.215000 1.69e-01 -1.34e-01 1.53e-01 2.57e-01
GOBP G QUADRUPLEX DNA UNWINDING 7 6.26e-01 8.32e-01 0.215000 6.26e-02 2.06e-01 7.74e-01 3.45e-01
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION INVOLVED IN INACTIVATION OF PROTEIN KINASE ACTIVITY 8 5.54e-01 7.87e-01 0.215000 -9.30e-02 1.94e-01 6.49e-01 3.42e-01
GOBP PRESYNAPTIC MEMBRANE ORGANIZATION 6 6.64e-01 8.51e-01 0.215000 -2.13e-01 -3.03e-02 3.66e-01 8.98e-01
GOBP RESPONSE TO LECTIN 21 2.19e-01 5.15e-01 0.215000 5.69e-02 -2.07e-01 6.52e-01 9.99e-02
GOMF SULFOTRANSFERASE ACTIVITY 49 4.24e-02 2.05e-01 0.215000 1.63e-01 1.40e-01 4.78e-02 9.06e-02
GOBP POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE 27 1.68e-01 4.53e-01 0.215000 7.89e-02 2.00e-01 4.78e-01 7.21e-02
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN EXECUTION PHASE OF APOPTOSIS 5 7.23e-01 8.81e-01 0.215000 1.73e-01 1.27e-01 5.02e-01 6.23e-01
Intrinsic Pathway of Fibrin Clot Formation 21 2.24e-01 5.20e-01 0.215000 -3.45e-02 2.12e-01 7.84e-01 9.23e-02
GOBP RENAL SODIUM ION ABSORPTION 12 4.34e-01 7.09e-01 0.215000 2.15e-01 -4.72e-04 1.97e-01 9.98e-01
GOBP L AMINO ACID TRANSPORT 90 2.86e-03 3.09e-02 0.215000 1.89e-01 1.01e-01 1.89e-03 9.70e-02
GOBP RESPONSE TO IONIZING RADIATION 138 3.73e-05 9.25e-04 0.215000 1.77e-01 -1.22e-01 3.32e-04 1.36e-02
GOBP NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS 44 3.77e-02 1.91e-01 0.215000 1.56e-01 -1.48e-01 7.39e-02 8.96e-02
Activated NTRK2 signals through CDK5 6 6.39e-01 8.40e-01 0.215000 -1.47e-01 1.56e-01 5.32e-01 5.07e-01
Neurotransmitter clearance 9 5.50e-01 7.85e-01 0.215000 2.03e-01 7.02e-02 2.92e-01 7.15e-01
GOBP RNA METHYLATION 75 3.98e-03 3.96e-02 0.215000 1.08e-01 -1.86e-01 1.07e-01 5.39e-03
Oncogenic MAPK signaling 78 4.79e-03 4.59e-02 0.215000 2.14e-01 1.68e-02 1.08e-03 7.98e-01
GOBP TRANS SYNAPTIC SIGNALING BY LIPID 7 6.02e-01 8.17e-01 0.215000 -2.03e-01 6.87e-02 3.52e-01 7.53e-01
GOBP RENAL TUBULE DEVELOPMENT 100 9.41e-04 1.32e-02 0.215000 2.14e-01 -1.06e-02 2.11e-04 8.54e-01
GOMF PROTEIN SERINE THREONINE PHOSPHATASE INHIBITOR ACTIVITY 12 4.20e-01 6.99e-01 0.215000 6.42e-02 -2.05e-01 7.00e-01 2.19e-01
UCH proteinases 80 2.67e-03 2.95e-02 0.215000 1.28e-01 -1.72e-01 4.76e-02 7.78e-03
GOBP NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY 17 3.29e-01 6.20e-01 0.215000 9.37e-02 1.93e-01 5.03e-01 1.68e-01
mTORC1-mediated signalling 23 1.81e-01 4.70e-01 0.215000 1.45e-01 -1.58e-01 2.28e-01 1.90e-01
GOBP MITOTIC DNA REPLICATION 16 3.43e-01 6.33e-01 0.214000 2.07e-01 5.51e-02 1.51e-01 7.03e-01
GOMF DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY 12 4.12e-01 6.93e-01 0.214000 1.17e-01 -1.80e-01 4.83e-01 2.81e-01
GOMF SERINE TYPE CARBOXYPEPTIDASE ACTIVITY 5 6.95e-01 8.68e-01 0.214000 2.00e-01 -7.65e-02 4.38e-01 7.67e-01
GOBP RRNA 3 END PROCESSING 10 4.77e-01 7.36e-01 0.214000 1.72e-01 -1.28e-01 3.46e-01 4.85e-01
Sphingolipid catabolism 12 4.44e-01 7.16e-01 0.214000 3.32e-02 2.12e-01 8.42e-01 2.04e-01
GOBP PEPTIDYL THREONINE MODIFICATION 103 1.31e-03 1.71e-02 0.214000 1.82e-01 1.12e-01 1.38e-03 4.87e-02
Regulation of Apoptosis 40 5.41e-02 2.37e-01 0.214000 8.87e-02 -1.95e-01 3.32e-01 3.28e-02
GOMF IMMUNOGLOBULIN RECEPTOR ACTIVITY 9 5.18e-01 7.63e-01 0.214000 -1.93e-01 9.23e-02 3.15e-01 6.32e-01
GOBP HYDROGEN PEROXIDE CATABOLIC PROCESS 30 1.11e-01 3.61e-01 0.214000 -1.91e-01 9.69e-02 7.01e-02 3.58e-01
GOBP GROWTH HORMONE SECRETION 13 3.87e-01 6.71e-01 0.214000 1.94e-01 -9.11e-02 2.26e-01 5.70e-01
Deubiquitination 231 4.37e-08 2.32e-06 0.214000 1.68e-01 -1.32e-01 1.04e-05 5.28e-04
GOBP GLOMERULAR EPITHELIAL CELL DEVELOPMENT 12 4.22e-01 7.01e-01 0.214000 2.05e-01 -6.06e-02 2.18e-01 7.16e-01
GOMF NUCLEAR RETINOID X RECEPTOR BINDING 17 3.12e-01 6.06e-01 0.214000 2.14e-01 1.37e-02 1.27e-01 9.22e-01
GOBP MAINTENANCE OF CELL POLARITY 17 2.84e-01 5.82e-01 0.214000 1.69e-01 -1.31e-01 2.27e-01 3.50e-01
GOBP POSITIVE REGULATION OF NK T CELL ACTIVATION 9 5.15e-01 7.61e-01 0.214000 -1.21e-01 1.76e-01 5.28e-01 3.60e-01
GOBP PROTEIN OXIDATION 12 4.59e-01 7.24e-01 0.214000 9.93e-02 1.90e-01 5.51e-01 2.55e-01
GOBP REGULATION OF SODIUM DEPENDENT PHOSPHATE TRANSPORT 5 7.08e-01 8.74e-01 0.214000 -1.72e-03 -2.14e-01 9.95e-01 4.07e-01
GOMF METHYLATION DEPENDENT PROTEIN BINDING 69 1.22e-02 9.05e-02 0.214000 1.59e-01 1.44e-01 2.27e-02 3.90e-02
GOMF GLUTATHIONE HYDROLASE ACTIVITY 5 7.00e-01 8.70e-01 0.214000 -5.09e-02 2.08e-01 8.44e-01 4.21e-01
GOBP REGULATION OF MICROTUBULE DEPOLYMERIZATION 27 1.44e-01 4.16e-01 0.214000 2.04e-01 -6.44e-02 6.64e-02 5.62e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO HYPOXIA 10 4.77e-01 7.36e-01 0.214000 1.56e-01 -1.47e-01 3.94e-01 4.22e-01
NOTCH4 Activation and Transmission of Signal to the Nucleus 11 4.65e-01 7.28e-01 0.214000 1.44e-02 -2.13e-01 9.34e-01 2.20e-01
GOBP PROTEIN LOCALIZATION TO BASOLATERAL PLASMA MEMBRANE 7 6.38e-01 8.39e-01 0.214000 -1.71e-01 -1.29e-01 4.34e-01 5.54e-01
GOBP POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION 51 2.43e-02 1.46e-01 0.214000 1.91e-01 -9.69e-02 1.85e-02 2.31e-01
GOMF HISTONE READER ACTIVITY 17 3.33e-01 6.24e-01 0.214000 1.04e-01 1.87e-01 4.59e-01 1.82e-01
GOMF PROTEIN ARGININE OMEGA N ASYMMETRIC METHYLTRANSFERASE ACTIVITY 7 6.09e-01 8.22e-01 0.214000 2.10e-01 -3.98e-02 3.36e-01 8.55e-01
GOCC APICAL DENDRITE 16 3.58e-01 6.47e-01 0.214000 1.20e-01 1.77e-01 4.04e-01 2.21e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 66 8.26e-03 6.87e-02 0.214000 1.92e-01 -9.31e-02 6.86e-03 1.91e-01
GOBP NK T CELL DIFFERENTIATION 11 4.80e-01 7.39e-01 0.214000 -4.66e-02 -2.09e-01 7.89e-01 2.31e-01
GOCC CORTICAL GRANULE 6 6.54e-01 8.47e-01 0.214000 -3.88e-02 2.10e-01 8.69e-01 3.73e-01
GOBP PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION 13 3.90e-01 6.74e-01 0.214000 -8.04e-02 1.98e-01 6.16e-01 2.16e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 28 1.43e-01 4.14e-01 0.214000 1.68e-02 -2.13e-01 8.78e-01 5.10e-02
GOMF PHOSPHOPROTEIN BINDING 87 1.86e-03 2.23e-02 0.214000 1.96e-01 -8.58e-02 1.61e-03 1.67e-01
GOMF SULFUR AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 11 4.79e-01 7.38e-01 0.214000 4.10e-02 2.10e-01 8.14e-01 2.29e-01
GOMF CIS REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING 1143 8.12e-34 4.98e-31 0.214000 2.12e-01 -2.76e-02 1.14e-33 1.15e-01
GOBP REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE 6 6.44e-01 8.42e-01 0.214000 1.77e-01 -1.20e-01 4.53e-01 6.12e-01
GOMF WATER TRANSMEMBRANE TRANSPORTER ACTIVITY 18 3.17e-01 6.10e-01 0.213000 1.29e-01 1.70e-01 3.44e-01 2.11e-01
GOBP ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE 12 4.66e-01 7.28e-01 0.213000 1.63e-01 1.38e-01 3.29e-01 4.07e-01
GOBP NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION 89 1.52e-03 1.93e-02 0.213000 1.83e-01 -1.11e-01 2.91e-03 7.14e-02
Activation of BAD and translocation to mitochondria 15 3.36e-01 6.25e-01 0.213000 1.89e-01 -9.94e-02 2.05e-01 5.05e-01
GOBP RIBOSOME DISASSEMBLY 40 5.28e-02 2.33e-01 0.213000 1.61e-01 -1.40e-01 7.77e-02 1.26e-01
GOBP REGULATION OF BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 19 2.47e-01 5.43e-01 0.213000 1.55e-01 -1.47e-01 2.43e-01 2.67e-01
Activation of TRKA receptors 6 6.45e-01 8.42e-01 0.213000 -1.82e-01 1.11e-01 4.40e-01 6.36e-01
GOBP RESPONSE TO INTERLEUKIN 15 11 4.46e-01 7.17e-01 0.213000 1.34e-01 -1.66e-01 4.40e-01 3.41e-01
GOBP HAIR FOLLICLE MATURATION 15 3.58e-01 6.47e-01 0.213000 2.13e-01 1.38e-03 1.53e-01 9.93e-01
GOBP POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 17 3.10e-01 6.04e-01 0.213000 -7.80e-03 2.13e-01 9.56e-01 1.28e-01
GOBP POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION 19 2.51e-01 5.49e-01 0.213000 1.89e-01 -9.91e-02 1.54e-01 4.55e-01
GOMF ALDEHYDE LYASE ACTIVITY 9 5.21e-01 7.64e-01 0.213000 -9.35e-02 1.92e-01 6.27e-01 3.19e-01
GOBP RESPONSE TO INSULIN 269 3.82e-08 2.04e-06 0.213000 1.85e-01 1.06e-01 1.67e-07 2.89e-03
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE 9 5.27e-01 7.69e-01 0.213000 5.94e-02 -2.05e-01 7.58e-01 2.87e-01
GOCC MYELIN SHEATH 43 6.50e-02 2.65e-01 0.213000 1.70e-01 1.29e-01 5.43e-02 1.43e-01
GOBP RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM 50 3.23e-02 1.74e-01 0.213000 2.13e-01 -6.18e-03 9.14e-03 9.40e-01
GOBP RESPONSE TO MURAMYL DIPEPTIDE 20 2.80e-01 5.77e-01 0.213000 1.72e-01 1.26e-01 1.82e-01 3.31e-01
GOBP NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 5 7.12e-01 8.76e-01 0.213000 -2.13e-01 -1.11e-02 4.10e-01 9.66e-01
GOCC ORIGIN RECOGNITION COMPLEX 8 6.02e-01 8.17e-01 0.213000 1.65e-01 1.35e-01 4.19e-01 5.09e-01
Pre-NOTCH Processing in Golgi 18 2.74e-01 5.71e-01 0.213000 -7.96e-02 1.98e-01 5.59e-01 1.47e-01
GOCC SCHMIDT LANTERMAN INCISURE 11 4.98e-01 7.52e-01 0.213000 1.41e-01 1.59e-01 4.17e-01 3.60e-01
GOBP DOPAMINE BIOSYNTHETIC PROCESS 12 4.33e-01 7.08e-01 0.213000 -2.97e-02 2.11e-01 8.59e-01 2.06e-01
SCF(Skp2)-mediated degradation of p27/p21 50 3.41e-02 1.79e-01 0.213000 -1.51e-02 -2.13e-01 8.53e-01 9.33e-03
GOBP REGULATION OF GENE SILENCING BY REGULATORY NCRNA 27 1.60e-01 4.43e-01 0.213000 2.13e-01 9.49e-03 5.56e-02 9.32e-01
RHO GTPase cycle 419 9.62e-13 1.17e-10 0.213000 2.12e-01 2.50e-02 1.07e-13 3.79e-01
GOBP TENDON DEVELOPMENT 5 7.26e-01 8.82e-01 0.213000 1.85e-01 1.05e-01 4.73e-01 6.84e-01
GOBP LAMELLIPODIUM ORGANIZATION 86 3.15e-03 3.32e-02 0.213000 2.12e-01 2.38e-02 6.94e-04 7.03e-01
GOBP PHOSPHATIDYLCHOLINE CATABOLIC PROCESS 16 3.32e-01 6.22e-01 0.213000 1.47e-02 -2.12e-01 9.19e-01 1.41e-01
GOBP RETINAL CELL APOPTOTIC PROCESS 7 6.00e-01 8.16e-01 0.213000 1.16e-01 -1.78e-01 5.94e-01 4.14e-01
GOMF ACIDIC AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 18 3.05e-01 5.98e-01 0.213000 2.07e-01 4.89e-02 1.28e-01 7.19e-01
GOBP HISTAMINE METABOLIC PROCESS 6 6.50e-01 8.45e-01 0.213000 -7.62e-02 1.99e-01 7.46e-01 3.99e-01
GOBP FATTY ACID DERIVATIVE CATABOLIC PROCESS 16 3.23e-01 6.14e-01 0.213000 5.24e-02 -2.06e-01 7.17e-01 1.53e-01
GOBP REGULATION OF PLASMINOGEN ACTIVATION 18 2.82e-01 5.79e-01 0.213000 -4.28e-02 2.09e-01 7.53e-01 1.26e-01
GOCC AMPHISOME 13 4.38e-01 7.12e-01 0.213000 -1.70e-01 -1.28e-01 2.88e-01 4.24e-01
Processing and activation of SUMO 10 4.92e-01 7.50e-01 0.213000 2.05e-01 -5.61e-02 2.61e-01 7.59e-01
GOBP CELL MIGRATION INVOLVED IN KIDNEY DEVELOPMENT 6 6.74e-01 8.58e-01 0.213000 2.05e-01 5.69e-02 3.84e-01 8.09e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A HEME GROUP OF DONORS 12 4.26e-01 7.04e-01 0.213000 6.09e-02 -2.04e-01 7.15e-01 2.21e-01
GOBP BLOOD COAGULATION INTRINSIC PATHWAY 6 6.80e-01 8.61e-01 0.213000 9.61e-02 1.90e-01 6.84e-01 4.20e-01
GOBP REGULATION OF ANIMAL ORGAN MORPHOGENESIS 86 2.44e-03 2.74e-02 0.213000 2.09e-01 -4.12e-02 8.14e-04 5.09e-01
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN NEURAL TUBE CLOSURE 10 5.14e-01 7.61e-01 0.213000 2.09e-01 3.84e-02 2.52e-01 8.34e-01
GOBP RESPONSE TO DEXAMETHASONE 44 4.41e-02 2.10e-01 0.213000 2.03e-01 -6.30e-02 1.97e-02 4.70e-01
GOMF NADH DEHYDROGENASE UBIQUINONE ACTIVITY 33 9.07e-02 3.22e-01 0.213000 1.16e-01 -1.78e-01 2.48e-01 7.65e-02
GOBP STRIATED MUSCLE ADAPTATION 56 2.84e-02 1.61e-01 0.213000 1.81e-01 1.12e-01 1.93e-02 1.46e-01
GOBP DERMATAN SULFATE BIOSYNTHETIC PROCESS 5 7.26e-01 8.82e-01 0.213000 1.02e-01 1.86e-01 6.92e-01 4.70e-01
GOBP INTRACELLULAR SODIUM ION HOMEOSTASIS 22 2.07e-01 5.03e-01 0.213000 -1.98e-01 7.82e-02 1.09e-01 5.25e-01
GOBP NEGATIVE REGULATION OF LENS FIBER CELL DIFFERENTIATION 6 6.53e-01 8.47e-01 0.213000 2.02e-01 -6.57e-02 3.91e-01 7.81e-01
GOBP SEGMENTATION 99 1.52e-03 1.93e-02 0.212000 2.07e-01 4.98e-02 3.82e-04 3.92e-01
GOBP POSITIVE REGULATION OF ISOTYPE SWITCHING 28 1.30e-01 3.93e-01 0.212000 1.67e-01 -1.31e-01 1.25e-01 2.30e-01
GOMF SECONDARY ACTIVE MONOCARBOXYLATE TRANSMEMBRANE TRANSPORTER ACTIVITY 17 3.16e-01 6.09e-01 0.212000 -2.12e-01 -5.85e-03 1.29e-01 9.67e-01
GOBP REGULATION OF NODAL SIGNALING PATHWAY 5 6.94e-01 8.68e-01 0.212000 -1.40e-01 1.60e-01 5.88e-01 5.36e-01
STING mediated induction of host immune responses 16 3.59e-01 6.47e-01 0.212000 1.92e-01 9.13e-02 1.84e-01 5.27e-01
Synthesis of IP3 and IP4 in the cytosol 25 1.94e-01 4.87e-01 0.212000 2.06e-01 5.33e-02 7.52e-02 6.44e-01
GOBP ISOTYPE SWITCHING TO IGA ISOTYPES 7 6.01e-01 8.16e-01 0.212000 1.62e-01 -1.37e-01 4.58e-01 5.30e-01
Global Genome Nucleotide Excision Repair (GG-NER) 81 2.89e-03 3.13e-02 0.212000 1.80e-01 -1.13e-01 5.17e-03 7.89e-02
GOMF BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY 14 4.13e-01 6.93e-01 0.212000 1.75e-01 1.19e-01 2.56e-01 4.39e-01
GOBP POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 62 1.15e-02 8.70e-02 0.212000 1.04e-01 -1.85e-01 1.57e-01 1.18e-02
GOMF NUCLEAR RETINOIC ACID RECEPTOR BINDING 25 1.78e-01 4.65e-01 0.212000 2.10e-01 -2.72e-02 6.86e-02 8.14e-01
GOBP REGULATION OF MUCUS SECRETION 9 5.45e-01 7.81e-01 0.212000 9.95e-03 2.12e-01 9.59e-01 2.71e-01
GOBP POSITIVE REGULATION OF PHAGOCYTOSIS 66 1.07e-02 8.26e-02 0.212000 -2.11e-01 2.35e-02 3.06e-03 7.41e-01
GOCC CTF18 RFC LIKE COMPLEX 8 5.59e-01 7.91e-01 0.212000 -1.57e-01 1.43e-01 4.43e-01 4.83e-01
Gluconeogenesis 25 1.71e-01 4.57e-01 0.212000 -2.02e-01 6.43e-02 8.04e-02 5.78e-01
GOBP FAT CELL PROLIFERATION 15 3.75e-01 6.61e-01 0.212000 5.05e-02 2.06e-01 7.35e-01 1.67e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION 7 6.41e-01 8.41e-01 0.212000 -1.87e-01 -9.98e-02 3.92e-01 6.47e-01
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer 49 3.01e-02 1.66e-01 0.212000 1.90e-01 -9.31e-02 2.11e-02 2.60e-01
GOBP PROTEIN EXPORT FROM NUCLEUS 57 1.60e-02 1.10e-01 0.212000 1.54e-01 -1.45e-01 4.37e-02 5.81e-02
NOTCH2 intracellular domain regulates transcription 11 4.55e-01 7.22e-01 0.212000 1.89e-01 -9.54e-02 2.77e-01 5.84e-01
GOBP CELLULAR DEFENSE RESPONSE 48 4.53e-02 2.13e-01 0.212000 -2.00e-01 -6.87e-02 1.63e-02 4.10e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 71 1.12e-02 8.51e-02 0.212000 1.87e-01 9.92e-02 6.40e-03 1.48e-01
GOBP PROTEIN LOCALIZATION TO MICROTUBULE 17 3.34e-01 6.24e-01 0.212000 2.01e-01 6.77e-02 1.52e-01 6.29e-01
Glycerophospholipid catabolism 7 6.43e-01 8.42e-01 0.212000 -1.82e-01 -1.08e-01 4.05e-01 6.20e-01
GOBP ASTROCYTE CELL MIGRATION 9 5.68e-01 7.96e-01 0.212000 1.70e-01 1.26e-01 3.77e-01 5.12e-01
GOBP POSITIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY 5 6.96e-01 8.68e-01 0.212000 1.59e-01 -1.40e-01 5.39e-01 5.87e-01
GOBP INTERSTRAND CROSS LINK REPAIR 40 7.98e-02 2.99e-01 0.212000 1.85e-01 1.03e-01 4.28e-02 2.62e-01
NGF-stimulated transcription 38 7.56e-02 2.90e-01 0.212000 1.33e-02 -2.11e-01 8.87e-01 2.43e-02
GOBP NEGATIVE REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY 9 5.68e-01 7.96e-01 0.211000 1.13e-01 1.79e-01 5.58e-01 3.53e-01
NIK–>noncanonical NF-kB signaling 46 3.76e-02 1.91e-01 0.211000 9.75e-02 -1.88e-01 2.53e-01 2.77e-02
GOMF DIACYLGLYCEROL BINDING 13 4.28e-01 7.06e-01 0.211000 4.72e-02 2.06e-01 7.68e-01 1.98e-01
GOBP REGULATION OF MIRNA METABOLIC PROCESS 87 2.99e-03 3.21e-02 0.211000 2.11e-01 6.93e-03 6.58e-04 9.11e-01
GOBP SYNAPTIC VESICLE PRIMING 19 3.06e-01 5.99e-01 0.211000 1.53e-01 1.45e-01 2.48e-01 2.72e-01
POLB-Dependent Long Patch Base Excision Repair 8 5.71e-01 7.98e-01 0.211000 2.03e-01 -5.99e-02 3.21e-01 7.69e-01
GOBP EOSINOPHIL DIFFERENTIATION 6 6.60e-01 8.50e-01 0.211000 4.56e-02 -2.06e-01 8.47e-01 3.82e-01
GOMF S ADENOSYLMETHIONINE DEPENDENT METHYLTRANSFERASE ACTIVITY 159 1.90e-05 5.09e-04 0.211000 2.08e-01 -3.38e-02 5.68e-06 4.63e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 ALPHA PRODUCTION 5 7.31e-01 8.84e-01 0.211000 1.72e-01 1.22e-01 5.04e-01 6.37e-01
GOBP NEGATIVE REGULATION OF DOPAMINE SECRETION 5 7.12e-01 8.76e-01 0.211000 -2.10e-01 1.91e-02 4.16e-01 9.41e-01
GOBP MATURATION OF SSU RRNA 52 2.49e-02 1.48e-01 0.211000 9.52e-02 -1.88e-01 2.35e-01 1.88e-02
GOBP NEGATIVE REGULATION OF TELOMERASE ACTIVITY 9 5.56e-01 7.89e-01 0.211000 2.06e-01 4.46e-02 2.84e-01 8.17e-01
GOBP CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS 10 4.86e-01 7.45e-01 0.211000 1.44e-01 -1.54e-01 4.29e-01 3.99e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY 130 2.63e-04 4.68e-03 0.211000 1.96e-01 7.87e-02 1.15e-04 1.21e-01
GOMF GAMMA TUBULIN BINDING 30 1.53e-01 4.33e-01 0.211000 1.74e-01 1.20e-01 9.96e-02 2.56e-01
GOBP HEAD DEVELOPMENT 734 1.09e-21 4.20e-19 0.211000 2.10e-01 -1.57e-02 2.51e-22 4.69e-01
GOMF CCR CHEMOKINE RECEPTOR BINDING 39 8.86e-02 3.18e-01 0.211000 -1.43e-01 -1.55e-01 1.21e-01 9.42e-02
Phase 4 - resting membrane potential 19 2.57e-01 5.54e-01 0.211000 -1.09e-01 1.81e-01 4.10e-01 1.73e-01
GOBP LEYDIG CELL DIFFERENTIATION 9 5.51e-01 7.85e-01 0.211000 2.10e-01 1.83e-02 2.75e-01 9.24e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 15 3.50e-01 6.40e-01 0.211000 -2.00e-01 6.80e-02 1.81e-01 6.48e-01
GOBP STEM CELL DEVELOPMENT 86 3.34e-03 3.48e-02 0.211000 2.11e-01 1.01e-02 7.35e-04 8.71e-01
TAK1-dependent IKK and NF-kappa-B activation 41 5.64e-02 2.43e-01 0.211000 1.97e-01 -7.46e-02 2.89e-02 4.09e-01
GOBP INNER CELL MASS CELL PROLIFERATION 14 3.67e-01 6.55e-01 0.211000 1.22e-01 -1.72e-01 4.29e-01 2.66e-01
Methylation 14 3.93e-01 6.75e-01 0.211000 -3.67e-03 -2.11e-01 9.81e-01 1.72e-01
GOMF POTASSIUM ION BINDING 13 4.29e-01 7.06e-01 0.211000 4.09e-02 2.07e-01 7.98e-01 1.97e-01
GOMF IMMUNE RECEPTOR ACTIVITY 134 1.54e-04 3.08e-03 0.211000 -2.09e-01 -2.31e-02 2.82e-05 6.44e-01
Response of endothelial cells to shear stress 92 3.20e-03 3.36e-02 0.211000 1.83e-01 1.05e-01 2.43e-03 8.28e-02
GOBP PEPTIDYL PROLINE HYDROXYLATION 11 4.54e-01 7.21e-01 0.211000 1.50e-01 -1.47e-01 3.88e-01 3.97e-01
GOBP EQUILIBRIOCEPTION 8 6.08e-01 8.21e-01 0.211000 -1.65e-01 -1.31e-01 4.20e-01 5.20e-01
CREB phosphorylation 6 6.85e-01 8.64e-01 0.211000 1.88e-01 9.49e-02 4.25e-01 6.87e-01
GOBP RNA SPLICING 423 1.23e-13 1.72e-11 0.211000 1.71e-01 -1.23e-01 1.53e-09 1.48e-05
Thyroxine biosynthesis 10 5.13e-01 7.61e-01 0.211000 -2.11e-01 -1.63e-03 2.49e-01 9.93e-01
Dectin-1 mediated noncanonical NF-kB signaling 49 3.12e-02 1.70e-01 0.211000 9.65e-02 -1.87e-01 2.42e-01 2.34e-02
GOBP LENS FIBER CELL MORPHOGENESIS 6 6.84e-01 8.63e-01 0.211000 8.64e-02 1.92e-01 7.14e-01 4.15e-01
MAPK3 (ERK1) activation 10 4.88e-01 7.46e-01 0.211000 1.62e-01 -1.35e-01 3.76e-01 4.60e-01
GOMF ROUNDABOUT BINDING 8 5.79e-01 8.02e-01 0.211000 -2.08e-01 3.14e-02 3.08e-01 8.78e-01
GOBP REGULATION OF SISTER CHROMATID SEGREGATION 104 7.98e-04 1.15e-02 0.211000 2.06e-01 -4.46e-02 2.87e-04 4.32e-01
Post-translational modification: synthesis of GPI-anchored proteins 91 3.48e-03 3.58e-02 0.211000 -1.79e-01 -1.11e-01 3.16e-03 6.79e-02
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE 67 8.42e-03 6.97e-02 0.210000 1.29e-01 -1.66e-01 6.74e-02 1.87e-02
GOMF PHOSPHOTYROSINE RESIDUE BINDING 46 3.94e-02 1.96e-01 0.210000 1.91e-01 -8.77e-02 2.49e-02 3.03e-01
GOBP RIBOSOME ASSEMBLY 57 2.05e-02 1.29e-01 0.210000 3.61e-02 -2.07e-01 6.37e-01 6.81e-03
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II 1191 1.64e-34 1.12e-31 0.210000 2.05e-01 -4.71e-02 7.92e-33 6.23e-03
Nicotinamide salvaging 19 3.02e-01 5.97e-01 0.210000 8.54e-02 1.92e-01 5.20e-01 1.47e-01
GOCC COMPACT MYELIN 14 4.22e-01 7.00e-01 0.210000 1.52e-01 1.45e-01 3.25e-01 3.47e-01
GOBP REGULATION OF CD4 POSITIVE CD25 POSITIVE ALPHA BETA REGULATORY T CELL DIFFERENTIATION 5 7.32e-01 8.85e-01 0.210000 -1.04e-01 -1.83e-01 6.88e-01 4.79e-01
GOCC BARR BODY 7 6.09e-01 8.22e-01 0.210000 1.83e-01 -1.03e-01 4.02e-01 6.37e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION 17 3.02e-01 5.97e-01 0.210000 1.89e-01 -9.25e-02 1.78e-01 5.09e-01
GOBP REGULATION OF XENOPHAGY 9 5.63e-01 7.93e-01 0.210000 2.01e-01 6.06e-02 2.96e-01 7.53e-01
GOBP MANCHETTE ASSEMBLY 9 5.42e-01 7.80e-01 0.210000 -3.40e-02 2.07e-01 8.60e-01 2.81e-01
GOBP POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 35 8.26e-02 3.07e-01 0.210000 1.61e-01 -1.35e-01 9.87e-02 1.68e-01
GOMF 3 5 RNA HELICASE ACTIVITY 6 6.88e-01 8.65e-01 0.210000 1.81e-01 1.06e-01 4.42e-01 6.53e-01
Transcription of E2F targets under negative control by DREAM complex 19 2.59e-01 5.56e-01 0.210000 1.27e-01 -1.67e-01 3.37e-01 2.07e-01
Cobalamin (Cbl, vitamin B12) transport and metabolism 21 2.53e-01 5.51e-01 0.210000 2.34e-02 2.09e-01 8.53e-01 9.77e-02
GOBP MHC CLASS I BIOSYNTHETIC PROCESS 8 6.03e-01 8.17e-01 0.210000 -1.97e-01 -7.28e-02 3.35e-01 7.21e-01
GOMF COMPLEMENT BINDING 23 2.34e-01 5.31e-01 0.210000 -1.96e-01 -7.43e-02 1.03e-01 5.37e-01
GOBP CYTOLYSIS BY HOST OF SYMBIONT CELLS 6 6.57e-01 8.49e-01 0.210000 -1.91e-01 8.64e-02 4.17e-01 7.14e-01
GOBP REGULATION OF HIPPOCAMPAL NEURON APOPTOTIC PROCESS 5 7.19e-01 8.79e-01 0.210000 -2.10e-01 -8.04e-03 4.17e-01 9.75e-01
GOBP DENDRITIC TRANSPORT OF RIBONUCLEOPROTEIN COMPLEX 5 7.10e-01 8.75e-01 0.210000 4.77e-02 -2.04e-01 8.53e-01 4.29e-01
GOBP REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 11 4.97e-01 7.52e-01 0.210000 2.00e-01 6.34e-02 2.50e-01 7.16e-01
GOBP REGULATION OF ACTIN NUCLEATION 38 7.66e-02 2.92e-01 0.210000 2.08e-01 -2.93e-02 2.67e-02 7.55e-01
GOBP CARDIAC SEPTUM MORPHOGENESIS 73 7.64e-03 6.49e-02 0.210000 2.09e-01 -1.37e-02 1.98e-03 8.39e-01
GOCC FHF COMPLEX 5 7.01e-01 8.71e-01 0.210000 -1.71e-01 1.22e-01 5.08e-01 6.37e-01
GOBP OLFACTORY BULB INTERNEURON DIFFERENTIATION 12 4.26e-01 7.04e-01 0.210000 1.49e-01 -1.47e-01 3.70e-01 3.77e-01
GOBP FOLIC ACID CONTAINING COMPOUND CATABOLIC PROCESS 5 7.02e-01 8.71e-01 0.210000 -1.77e-01 1.13e-01 4.93e-01 6.63e-01
GOBP NEGATIVE REGULATION OF TRANSLATIONAL ELONGATION 5 7.09e-01 8.75e-01 0.210000 5.80e-02 -2.01e-01 8.22e-01 4.35e-01
GOBP DOUBLE STRAND BREAK REPAIR 304 1.37e-09 9.85e-08 0.210000 2.06e-01 -3.78e-02 6.14e-10 2.57e-01
GOBP REGULATION OF T CELL COSTIMULATION 5 7.01e-01 8.70e-01 0.210000 -1.56e-01 1.39e-01 5.45e-01 5.89e-01
GOMF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 217 1.29e-06 4.78e-05 0.210000 1.97e-01 7.27e-02 5.99e-07 6.48e-02
Transcription-Coupled Nucleotide Excision Repair (TC-NER) 74 5.32e-03 4.94e-02 0.210000 1.61e-01 -1.35e-01 1.70e-02 4.52e-02
GOBP RESPONSE TO TYPE III INTERFERON 10 4.92e-01 7.49e-01 0.209000 -1.61e-01 1.33e-01 3.77e-01 4.65e-01
GOMF DEMETHYLASE ACTIVITY 35 1.14e-01 3.67e-01 0.209000 1.84e-01 1.00e-01 5.98e-02 3.05e-01
Na+/Cl- dependent neurotransmitter transporters 18 3.30e-01 6.21e-01 0.209000 1.18e-01 1.73e-01 3.87e-01 2.04e-01
GOBP DOPAMINERGIC NEURON AXON GUIDANCE 6 6.75e-01 8.59e-01 0.209000 1.36e-02 2.09e-01 9.54e-01 3.76e-01
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I 43 6.71e-02 2.70e-01 0.209000 1.96e-01 7.24e-02 2.58e-02 4.11e-01
Small interfering RNA (siRNA) biogenesis 9 5.73e-01 7.99e-01 0.209000 1.83e-01 1.01e-01 3.41e-01 5.99e-01
GOBP CELLULAR RESPONSE TO HEAT 63 1.19e-02 8.88e-02 0.209000 1.22e-01 -1.70e-01 9.52e-02 1.94e-02
GOBP DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT 8 6.13e-01 8.23e-01 0.209000 1.68e-01 1.25e-01 4.12e-01 5.41e-01
GOBP RETROGRADE TRANS SYNAPTIC SIGNALING BY LIPID 5 7.02e-01 8.71e-01 0.209000 -1.46e-01 1.49e-01 5.71e-01 5.63e-01
GOMF MHC PROTEIN BINDING 32 1.15e-01 3.68e-01 0.209000 3.86e-02 -2.05e-01 7.06e-01 4.43e-02
GOBP CELLULAR RESPONSE TO PROGESTERONE STIMULUS 7 6.52e-01 8.46e-01 0.209000 1.63e-01 1.31e-01 4.55e-01 5.49e-01
GOCC PHOSPHATASE COMPLEX 52 3.03e-02 1.67e-01 0.209000 2.06e-01 -3.51e-02 1.02e-02 6.62e-01
Frs2-mediated activation 12 4.73e-01 7.33e-01 0.209000 1.95e-01 7.59e-02 2.43e-01 6.49e-01
Transport of vitamins, nucleosides, and related molecules 38 7.44e-02 2.87e-01 0.209000 -6.27e-02 1.99e-01 5.04e-01 3.36e-02
GOBP FLAVIN CONTAINING COMPOUND METABOLIC PROCESS 6 6.93e-01 8.68e-01 0.209000 1.24e-01 1.68e-01 6.00e-01 4.75e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 104 1.48e-03 1.89e-02 0.209000 1.99e-01 6.38e-02 4.60e-04 2.61e-01
GOBP REGULATION OF PROTEIN EXPORT FROM NUCLEUS 32 1.06e-01 3.51e-01 0.209000 1.23e-01 -1.69e-01 2.28e-01 9.89e-02
Triglyceride catabolism 23 2.34e-01 5.31e-01 0.209000 2.01e-01 5.56e-02 9.48e-02 6.44e-01
GOBP MICROTUBULE NUCLEATION 42 6.96e-02 2.76e-01 0.209000 2.03e-01 4.77e-02 2.27e-02 5.93e-01
GOBP REGULATION OF GOLGI ORGANIZATION 17 3.04e-01 5.98e-01 0.209000 1.73e-01 -1.17e-01 2.17e-01 4.05e-01
GOMF SEQUENCE SPECIFIC DNA BINDING 1564 3.29e-43 2.70e-40 0.209000 2.06e-01 -3.10e-02 2.08e-42 4.10e-02
Triglyceride biosynthesis 12 4.32e-01 7.07e-01 0.209000 -1.13e-01 1.75e-01 4.98e-01 2.93e-01
FGFR2 mutant receptor activation 32 1.39e-01 4.09e-01 0.209000 1.87e-01 9.29e-02 6.75e-02 3.63e-01
GOBP CHROMATIN REMODELING 630 6.52e-19 2.05e-16 0.209000 1.99e-01 -6.23e-02 1.43e-17 7.63e-03
Interleukin-21 signaling 9 5.41e-01 7.79e-01 0.208000 6.22e-02 -1.99e-01 7.47e-01 3.01e-01
GOBP MOLTING CYCLE PROCESS 95 2.00e-03 2.36e-02 0.208000 2.08e-01 -2.98e-03 4.45e-04 9.60e-01
GOCC RIBONUCLEASE MRP COMPLEX 9 5.47e-01 7.83e-01 0.208000 3.25e-02 -2.06e-01 8.66e-01 2.85e-01
GOBP TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE 32 1.06e-01 3.51e-01 0.208000 1.60e-01 -1.33e-01 1.17e-01 1.92e-01
Signaling by TGFB family members 157 3.32e-05 8.38e-04 0.208000 2.08e-01 -1.43e-02 6.91e-06 7.58e-01
GOBP POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE 18 2.92e-01 5.89e-01 0.208000 -1.97e-01 6.77e-02 1.48e-01 6.19e-01
GOMF MONOATOMIC ION GATED CHANNEL ACTIVITY 30 1.40e-01 4.10e-01 0.208000 -2.08e-01 5.90e-03 4.84e-02 9.55e-01
GOCC METHYLTRANSFERASE COMPLEX 94 1.43e-03 1.84e-02 0.208000 1.70e-01 -1.20e-01 4.31e-03 4.46e-02
Orc1 removal from chromatin 58 1.75e-02 1.16e-01 0.208000 1.20e-01 -1.70e-01 1.14e-01 2.49e-02
GOMF BENZODIAZEPINE RECEPTOR ACTIVITY 9 5.44e-01 7.80e-01 0.208000 5.39e-02 -2.01e-01 7.79e-01 2.96e-01
GOBP POSITIVE REGULATION OF CELL MATRIX ADHESION 56 3.02e-02 1.66e-01 0.208000 1.99e-01 6.10e-02 9.98e-03 4.30e-01
GOBP REGULATION OF HEMATOPOIETIC STEM CELL PROLIFERATION 15 3.54e-01 6.43e-01 0.208000 9.93e-02 -1.83e-01 5.06e-01 2.20e-01
GOBP T CELL HOMEOSTASIS 45 4.51e-02 2.12e-01 0.208000 8.98e-02 -1.88e-01 2.97e-01 2.93e-02
GOBP CARDIAC MYOFIBRIL ASSEMBLY 19 3.14e-01 6.07e-01 0.208000 1.77e-01 1.10e-01 1.82e-01 4.08e-01
GOBP ENGULFMENT OF APOPTOTIC CELL 15 3.61e-01 6.49e-01 0.208000 -1.98e-01 6.36e-02 1.84e-01 6.70e-01
GOMF AMINOACYLASE ACTIVITY 5 7.05e-01 8.72e-01 0.208000 -1.44e-01 1.50e-01 5.78e-01 5.60e-01
GOBP NEGATIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY 7 6.47e-01 8.44e-01 0.208000 -1.96e-01 -7.06e-02 3.70e-01 7.46e-01
GOBP NEGATIVE REGULATION OF BMP SIGNALING PATHWAY 70 1.40e-02 1.00e-01 0.208000 1.81e-01 1.02e-01 8.68e-03 1.41e-01
Activation of PPARGC1A (PGC-1alpha) by phosphorylation 10 5.21e-01 7.64e-01 0.208000 -2.08e-01 6.48e-04 2.55e-01 9.97e-01
PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 9 5.34e-01 7.73e-01 0.208000 1.25e-01 -1.66e-01 5.16e-01 3.88e-01
GOBP POSITIVE REGULATION OF GLIAL CELL PROLIFERATION 20 2.58e-01 5.55e-01 0.208000 1.98e-01 -6.17e-02 1.24e-01 6.33e-01
Heme signaling 45 6.14e-02 2.55e-01 0.208000 1.96e-01 6.91e-02 2.29e-02 4.22e-01
GOBP POSITIVE REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 6 6.63e-01 8.51e-01 0.208000 -8.39e-02 1.90e-01 7.22e-01 4.20e-01
GOBP RESPONSE TO OZONE 5 7.36e-01 8.86e-01 0.208000 9.29e-02 1.86e-01 7.19e-01 4.72e-01
GOBP POSITIVE REGULATION OF DOPAMINE SECRETION 6 6.96e-01 8.68e-01 0.208000 1.33e-01 1.59e-01 5.72e-01 4.99e-01
GOBP REGULATION OF PROTEIN LIPIDATION 11 4.66e-01 7.28e-01 0.208000 1.74e-01 -1.14e-01 3.18e-01 5.13e-01
GOMF MITOGEN ACTIVATED PROTEIN KINASE BINDING 29 1.34e-01 4.01e-01 0.208000 1.78e-01 -1.08e-01 9.77e-02 3.16e-01
GOBP DNA CONFORMATION CHANGE 87 3.87e-03 3.87e-02 0.208000 2.07e-01 2.15e-02 8.65e-04 7.28e-01
GOBP HYPEROSMOTIC SALINITY RESPONSE 10 4.99e-01 7.53e-01 0.208000 1.72e-01 -1.16e-01 3.46e-01 5.24e-01
GOBP THROMBOPOIETIN MEDIATED SIGNALING PATHWAY 5 7.20e-01 8.79e-01 0.208000 -2.07e-01 1.63e-02 4.23e-01 9.50e-01
GOBP REGULATION OF RELAXATION OF CARDIAC MUSCLE 6 6.69e-01 8.55e-01 0.208000 4.21e-02 -2.03e-01 8.58e-01 3.88e-01
Adenylate cyclase activating pathway 10 5.41e-01 7.79e-01 0.208000 8.36e-02 1.90e-01 6.47e-01 2.98e-01
GOMF PROTEASOME BINDING 17 3.29e-01 6.20e-01 0.208000 -9.67e-03 2.07e-01 9.45e-01 1.39e-01
Malate-aspartate shuttle 9 5.52e-01 7.86e-01 0.208000 2.06e-01 -2.55e-02 2.85e-01 8.94e-01
GOBP POSITIVE REGULATION OF MYELINATION 18 3.33e-01 6.24e-01 0.208000 9.03e-02 1.87e-01 5.07e-01 1.70e-01
GOCC CILIARY MEMBRANE 74 1.09e-02 8.37e-02 0.208000 1.88e-01 8.88e-02 5.27e-03 1.87e-01
GOBP DEFENSE RESPONSE TO BACTERIUM 296 1.82e-08 1.07e-06 0.208000 -1.83e-01 -9.79e-02 6.07e-08 3.75e-03
LGI-ADAM interactions 14 3.77e-01 6.63e-01 0.207000 -1.52e-01 1.41e-01 3.25e-01 3.61e-01
GOBP POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION 26 2.08e-01 5.03e-01 0.207000 1.73e-01 1.15e-01 1.28e-01 3.10e-01
GOBP POSITIVE REGULATION OF MELANOCYTE DIFFERENTIATION 5 7.14e-01 8.77e-01 0.207000 1.99e-01 -5.92e-02 4.42e-01 8.19e-01
GOCC BOX C D RNP COMPLEX 6 6.85e-01 8.64e-01 0.207000 2.04e-01 3.90e-02 3.88e-01 8.69e-01
GOMF TESTOSTERONE 17 BETA DEHYDROGENASE NADPPLUS ACTIVITY 9 5.51e-01 7.85e-01 0.207000 -3.11e-02 2.05e-01 8.72e-01 2.87e-01
GOBP NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY 42 6.43e-02 2.64e-01 0.207000 2.07e-01 -1.36e-02 2.03e-02 8.79e-01
GOCC MULTIMERIC RIBONUCLEASE P COMPLEX 10 5.15e-01 7.61e-01 0.207000 3.66e-02 -2.04e-01 8.41e-01 2.64e-01
GOMF RIBONUCLEASE P RNA BINDING 10 5.15e-01 7.61e-01 0.207000 3.66e-02 -2.04e-01 8.41e-01 2.64e-01
GOBP REGULATION OF GLYCOGEN BIOSYNTHETIC PROCESS 29 1.75e-01 4.61e-01 0.207000 1.60e-01 1.31e-01 1.35e-01 2.21e-01
GOBP NEGATIVE REGULATION OF DNA REPAIR 37 9.31e-02 3.27e-01 0.207000 2.07e-01 1.05e-02 2.94e-02 9.12e-01
GOBP LIPOPROTEIN LOCALIZATION 24 2.03e-01 4.97e-01 0.207000 -2.04e-01 3.70e-02 8.38e-02 7.54e-01
GOBP HORMONE CATABOLIC PROCESS 12 4.80e-01 7.39e-01 0.207000 1.90e-01 8.30e-02 2.55e-01 6.19e-01
GOBP STEROID HORMONE MEDIATED SIGNALING PATHWAY 129 2.20e-04 4.09e-03 0.207000 2.06e-01 -2.05e-02 5.24e-05 6.88e-01
GOBP STORE OPERATED CALCIUM ENTRY 22 2.59e-01 5.56e-01 0.207000 1.93e-01 7.54e-02 1.17e-01 5.40e-01
TCF dependent signaling in response to WNT 180 4.63e-06 1.48e-04 0.207000 1.81e-01 -1.02e-01 2.94e-05 1.87e-02
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY 118 3.65e-04 6.09e-03 0.207000 1.98e-01 -6.23e-02 2.10e-04 2.42e-01
GOBP REGULATION OF MYOBLAST DIFFERENTIATION 73 9.18e-03 7.41e-02 0.207000 2.07e-01 4.86e-03 2.22e-03 9.43e-01
GOBP NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT 8 6.17e-01 8.26e-01 0.207000 -1.12e-01 -1.74e-01 5.82e-01 3.94e-01
GOCC MITOCHONDRIAL PROTEIN CONTAINING COMPLEX 263 4.47e-08 2.37e-06 0.207000 9.20e-03 -2.07e-01 7.97e-01 7.58e-09
GOBP RESPONSE TO EPIDERMAL GROWTH FACTOR 46 4.44e-02 2.10e-01 0.207000 1.93e-01 -7.52e-02 2.36e-02 3.78e-01
GOBP DE NOVO PROTEIN FOLDING 42 6.68e-02 2.70e-01 0.207000 -9.14e-04 -2.07e-01 9.92e-01 2.03e-02
GOBP REGULATION OF RECEPTOR CLUSTERING 16 3.77e-01 6.63e-01 0.207000 1.87e-01 8.87e-02 1.95e-01 5.39e-01
GOBP CELLULAR RESPONSE TO POTASSIUM ION 12 4.39e-01 7.13e-01 0.207000 -1.82e-01 9.82e-02 2.74e-01 5.56e-01
Regulation of Complement cascade 43 6.79e-02 2.72e-01 0.207000 -2.03e-01 -4.11e-02 2.14e-02 6.41e-01
GOMF N ACETYLGALACTOSAMINE 4 O SULFOTRANSFERASE ACTIVITY 5 7.21e-01 8.80e-01 0.207000 -2.06e-01 1.80e-02 4.25e-01 9.44e-01
GOBP CELLULAR RESPONSE TO HISTAMINE 6 6.64e-01 8.51e-01 0.207000 9.53e-02 -1.84e-01 6.86e-01 4.36e-01
GOBP NEGATIVE REGULATION OF CELL SIZE 9 5.75e-01 8.00e-01 0.207000 1.95e-01 6.78e-02 3.10e-01 7.25e-01
GOBP CENTRIOLE CENTRIOLE COHESION 15 3.78e-01 6.64e-01 0.207000 2.07e-01 -8.76e-03 1.66e-01 9.53e-01
GOBP NEUROTROPHIN SIGNALING PATHWAY 39 8.50e-02 3.12e-01 0.207000 2.05e-01 2.49e-02 2.66e-02 7.88e-01
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN 9 5.64e-01 7.93e-01 0.207000 -2.06e-01 -1.64e-02 2.84e-01 9.32e-01
GOBP REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION 54 2.46e-02 1.47e-01 0.207000 1.14e-01 -1.73e-01 1.49e-01 2.82e-02
DNA Double-Strand Break Repair 146 4.69e-05 1.12e-03 0.207000 1.74e-01 -1.12e-01 2.87e-04 1.97e-02
p75 NTR receptor-mediated signalling 90 4.14e-03 4.09e-02 0.207000 1.93e-01 7.45e-02 1.57e-03 2.22e-01
GOBP CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT 9 5.37e-01 7.77e-01 0.207000 1.47e-01 -1.46e-01 4.46e-01 4.49e-01
GOBP POSITIVE REGULATION OF DNA REPAIR 129 1.81e-04 3.48e-03 0.207000 1.96e-01 -6.46e-02 1.18e-04 2.05e-01
GOBP VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS 47 5.64e-02 2.43e-01 0.207000 1.94e-01 7.10e-02 2.14e-02 4.00e-01
Resolution of D-loop Structures through Holliday Junction Intermediates 34 1.01e-01 3.41e-01 0.207000 1.91e-01 -7.79e-02 5.36e-02 4.32e-01
GOBP RESPONSE TO INACTIVITY 12 4.59e-01 7.24e-01 0.206000 -1.31e-02 2.06e-01 9.38e-01 2.16e-01
ERBB2 Activates PTK6 Signaling 13 4.61e-01 7.25e-01 0.206000 -1.48e-01 -1.44e-01 3.56e-01 3.68e-01
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN PHAGOCYTOSIS 22 2.35e-01 5.32e-01 0.206000 2.03e-01 -3.48e-02 9.85e-02 7.78e-01
GOBP REGULATION OF JUN KINASE ACTIVITY 40 6.47e-02 2.64e-01 0.206000 1.73e-01 -1.12e-01 5.79e-02 2.19e-01
GOBP HEMATOPOIETIC STEM CELL HOMEOSTASIS 20 2.87e-01 5.85e-01 0.206000 4.14e-02 2.02e-01 7.49e-01 1.17e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY 6 6.62e-01 8.51e-01 0.206000 1.30e-01 -1.60e-01 5.80e-01 4.98e-01
GOBP REGULATION OF GLYCOGEN CATABOLIC PROCESS 6 6.63e-01 8.51e-01 0.206000 -1.75e-01 1.09e-01 4.57e-01 6.44e-01
GOBP POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION 17 3.57e-01 6.46e-01 0.206000 8.37e-02 1.89e-01 5.50e-01 1.78e-01
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN 10 5.38e-01 7.78e-01 0.206000 -2.00e-01 -5.03e-02 2.73e-01 7.83e-01
GOCC NUCLEAR PORE NUCLEAR BASKET 11 4.89e-01 7.46e-01 0.206000 2.05e-01 -2.02e-02 2.38e-01 9.08e-01
GOBP ORNITHINE METABOLIC PROCESS 9 5.46e-01 7.82e-01 0.206000 7.43e-02 -1.92e-01 7.00e-01 3.18e-01
p53-Dependent G1 DNA Damage Response 52 2.94e-02 1.65e-01 0.206000 9.65e-02 -1.82e-01 2.29e-01 2.30e-02
p53-Dependent G1/S DNA damage checkpoint 52 2.94e-02 1.65e-01 0.206000 9.65e-02 -1.82e-01 2.29e-01 2.30e-02
GOBP MIRNA MEDIATED GENE SILENCING BY MRNA DESTABILIZATION 96 2.86e-03 3.09e-02 0.206000 6.49e-02 1.96e-01 2.71e-01 9.22e-04
Translation of Replicase and Assembly of the Replication Transcription Complex 9694676 14 3.82e-01 6.67e-01 0.206000 1.47e-01 -1.44e-01 3.40e-01 3.50e-01
NOTCH4 Intracellular Domain Regulates Transcription 19 2.99e-01 5.94e-01 0.206000 2.06e-01 1.01e-02 1.20e-01 9.39e-01
Regulation of FZD by ubiquitination 21 2.44e-01 5.40e-01 0.206000 1.92e-01 -7.48e-02 1.28e-01 5.53e-01
GOBP ZINC ION IMPORT ACROSS PLASMA MEMBRANE 10 5.37e-01 7.76e-01 0.206000 -2.02e-01 -3.88e-02 2.68e-01 8.32e-01
GOBP CARDIOBLAST PROLIFERATION 12 4.39e-01 7.13e-01 0.206000 1.60e-01 -1.30e-01 3.38e-01 4.35e-01
Transcriptional regulation of testis differentiation 12 4.84e-01 7.43e-01 0.206000 8.51e-02 1.88e-01 6.10e-01 2.60e-01
GOBP EPIGENETIC REGULATION OF GENE EXPRESSION 265 1.59e-08 9.45e-07 0.206000 1.58e-01 -1.32e-01 9.04e-06 2.25e-04
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 14 4.26e-01 7.04e-01 0.206000 1.94e-01 6.99e-02 2.10e-01 6.51e-01
GOCC MANCHETTE 21 2.39e-01 5.36e-01 0.206000 -1.71e-01 1.14e-01 1.74e-01 3.65e-01
GOBP REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION 77 7.31e-03 6.30e-02 0.206000 2.06e-01 -4.09e-03 1.79e-03 9.50e-01
GOMF C X3 C CHEMOKINE BINDING 5 7.11e-01 8.75e-01 0.206000 1.67e-01 -1.20e-01 5.17e-01 6.43e-01
GOBP FORELIMB MORPHOGENESIS 40 7.13e-02 2.80e-01 0.206000 2.00e-01 -5.03e-02 2.89e-02 5.82e-01
GOBP REGULATION OF ATP BIOSYNTHETIC PROCESS 14 4.34e-01 7.09e-01 0.206000 -1.10e-01 -1.74e-01 4.75e-01 2.60e-01
GOCC PRESYNAPTIC ACTIVE ZONE CYTOPLASMIC COMPONENT 17 3.14e-01 6.07e-01 0.206000 -1.14e-01 1.72e-01 4.17e-01 2.21e-01
GOBP REGULATION OF RNA EXPORT FROM NUCLEUS 15 3.71e-01 6.58e-01 0.206000 1.99e-01 -5.17e-02 1.82e-01 7.29e-01
GOBP PROTEIN STABILIZATION 203 1.02e-06 3.84e-05 0.206000 1.42e-01 -1.49e-01 5.05e-04 2.43e-04
GOBP NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II 841 5.08e-24 2.23e-21 0.206000 1.99e-01 -5.39e-02 1.27e-22 7.99e-03
GOBP INNATE IMMUNE RESPONSE IN MUCOSA 22 2.68e-01 5.64e-01 0.206000 -9.46e-02 -1.83e-01 4.42e-01 1.38e-01
GOMF DNA HELICASE ACTIVITY 59 2.69e-02 1.56e-01 0.206000 1.99e-01 5.33e-02 8.32e-03 4.79e-01
Degradation of beta-catenin by the destruction complex 71 7.93e-03 6.67e-02 0.206000 1.60e-01 -1.30e-01 2.00e-02 5.90e-02
GOBP PLANAR CELL POLARITY PATHWAY INVOLVED IN AXIS ELONGATION 6 6.99e-01 8.70e-01 0.206000 -1.05e-01 -1.77e-01 6.57e-01 4.53e-01
RNA Polymerase III Chain Elongation 18 3.11e-01 6.04e-01 0.206000 2.75e-02 -2.04e-01 8.40e-01 1.34e-01
GOCC RNA POLYMERASE III COMPLEX 18 3.11e-01 6.04e-01 0.206000 2.75e-02 -2.04e-01 8.40e-01 1.34e-01
GOBP REGULATION OF ACROSOME REACTION 18 3.28e-01 6.19e-01 0.206000 -2.01e-01 -4.13e-02 1.39e-01 7.62e-01
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR 88 2.99e-03 3.20e-02 0.206000 1.97e-01 -5.93e-02 1.41e-03 3.37e-01
G-protein mediated events 53 4.27e-02 2.06e-01 0.206000 1.04e-01 1.77e-01 1.91e-01 2.55e-02
GOBP NADH DEHYDROGENASE COMPLEX ASSEMBLY 52 3.57e-02 1.85e-01 0.206000 1.21e-02 -2.05e-01 8.80e-01 1.05e-02
GOBP REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 26 1.87e-01 4.78e-01 0.206000 2.05e-01 -1.77e-02 7.07e-02 8.76e-01
GOBP REGULATION OF LIPOPROTEIN METABOLIC PROCESS 17 3.13e-01 6.07e-01 0.205000 1.55e-01 -1.35e-01 2.69e-01 3.35e-01
GOBP MINERALOCORTICOID METABOLIC PROCESS 14 3.85e-01 6.69e-01 0.205000 -1.61e-01 1.28e-01 2.98e-01 4.06e-01
GOBP ENDOTHELIAL CELL FATE COMMITMENT 8 6.13e-01 8.24e-01 0.205000 5.71e-02 1.97e-01 7.80e-01 3.34e-01
GOBP PROTEIN DNA COMPLEX ORGANIZATION 851 2.08e-24 9.48e-22 0.205000 1.94e-01 -6.70e-02 6.04e-22 9.08e-04
GOBP REGULATION OF CILIUM ASSEMBLY 95 2.64e-03 2.93e-02 0.205000 2.04e-01 1.93e-02 5.72e-04 7.45e-01
GOBP EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 126 2.50e-04 4.53e-03 0.205000 1.96e-01 -5.97e-02 1.39e-04 2.47e-01
GOBP POSITIVE REGULATION OF DNA TEMPLATED DNA REPLICATION 13 4.12e-01 6.93e-01 0.205000 -1.57e-01 1.33e-01 3.28e-01 4.07e-01
GOBP DORSAL VENTRAL PATTERN FORMATION 90 3.50e-03 3.59e-02 0.205000 2.05e-01 1.09e-02 7.72e-04 8.58e-01
GOBP OLFACTORY LOBE DEVELOPMENT 36 9.94e-02 3.38e-01 0.205000 2.05e-01 -1.45e-02 3.34e-02 8.80e-01
GOBP REGULATION OF KILLING OF CELLS OF ANOTHER ORGANISM 9 5.74e-01 7.99e-01 0.205000 -2.01e-01 -4.02e-02 2.96e-01 8.35e-01
GOBP RIBOSOMAL SMALL SUBUNIT BIOGENESIS 101 1.30e-03 1.69e-02 0.205000 5.93e-02 -1.96e-01 3.03e-01 6.43e-04
Cell death signalling via NRAGE, NRIF and NADE 69 1.50e-02 1.05e-01 0.205000 1.98e-01 5.52e-02 4.53e-03 4.28e-01
GOBP MITOCHONDRIAL CALCIUM ION HOMEOSTASIS 23 2.26e-01 5.23e-01 0.205000 2.03e-01 -2.63e-02 9.12e-02 8.27e-01
Beta oxidation of hexanoyl-CoA to butanoyl-CoA 5 7.23e-01 8.81e-01 0.205000 2.03e-01 -2.96e-02 4.32e-01 9.09e-01
GOBP METANEPHRIC TUBULE MORPHOGENESIS 10 5.08e-01 7.59e-01 0.205000 -1.15e-01 1.70e-01 5.28e-01 3.53e-01
GOBP POSITIVE REGULATION OF CGMP MEDIATED SIGNALING 5 7.40e-01 8.87e-01 0.205000 7.33e-02 1.92e-01 7.76e-01 4.58e-01
GOBP POSITIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS 9 5.69e-01 7.96e-01 0.205000 2.05e-01 1.51e-02 2.88e-01 9.37e-01
TNF signaling 54 2.73e-02 1.57e-01 0.205000 1.87e-01 -8.38e-02 1.74e-02 2.87e-01
GOMF GABA RECEPTOR BINDING 18 2.96e-01 5.93e-01 0.205000 1.17e-01 -1.68e-01 3.90e-01 2.16e-01
GOBP POSITIVE REGULATION OF TELOMERE CAPPING 17 3.43e-01 6.32e-01 0.205000 -7.33e-03 -2.05e-01 9.58e-01 1.44e-01
GOBP REVERSE CHOLESTEROL TRANSPORT 20 2.85e-01 5.82e-01 0.205000 1.05e-02 2.05e-01 9.35e-01 1.13e-01
GOBP AGGRESOME ASSEMBLY 5 7.12e-01 8.76e-01 0.205000 -1.57e-01 1.32e-01 5.43e-01 6.10e-01
GOBP MICROTUBULE ORGANIZING CENTER LOCALIZATION 32 1.34e-01 4.00e-01 0.205000 2.05e-01 8.04e-03 4.50e-02 9.37e-01
GOBP ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE 53 2.77e-02 1.59e-01 0.205000 1.24e-01 -1.63e-01 1.18e-01 4.01e-02
Ca2+ activated K+ channels 9 5.79e-01 8.02e-01 0.205000 -1.96e-01 -5.99e-02 3.09e-01 7.56e-01
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS 18 3.25e-01 6.16e-01 0.205000 1.93e-02 2.04e-01 8.87e-01 1.34e-01
GOBP ATP BIOSYNTHETIC PROCESS 86 4.08e-03 4.06e-02 0.205000 2.01e-02 -2.04e-01 7.48e-01 1.08e-03
GOBP RESPONSE TO CORTICOTROPIN RELEASING HORMONE 5 7.45e-01 8.91e-01 0.205000 1.65e-01 1.21e-01 5.22e-01 6.40e-01
GOBP ENDOTHELIAL CELL APOPTOTIC PROCESS 68 1.23e-02 9.07e-02 0.205000 2.01e-01 -3.81e-02 4.12e-03 5.87e-01
GOBP NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY 10 5.54e-01 7.87e-01 0.205000 1.76e-01 1.05e-01 3.35e-01 5.66e-01
GOBP PERICARDIUM MORPHOGENESIS 8 5.83e-01 8.05e-01 0.205000 1.68e-01 -1.17e-01 4.12e-01 5.65e-01
GOBP POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION 25 1.87e-01 4.78e-01 0.205000 1.77e-01 -1.03e-01 1.26e-01 3.72e-01
SUMO is conjugated to E1 (UBA2:SAE1) 5 7.17e-01 8.78e-01 0.205000 1.88e-01 -8.03e-02 4.66e-01 7.56e-01
GOMF RIBOSOME BINDING 94 2.48e-03 2.78e-02 0.205000 2.25e-02 -2.03e-01 7.07e-01 6.57e-04
GOBP PROPIONATE METABOLIC PROCESS 5 7.42e-01 8.89e-01 0.204000 -1.89e-01 -7.85e-02 4.65e-01 7.61e-01
GOCC POST MRNA RELEASE SPLICEOSOMAL COMPLEX 11 5.15e-01 7.62e-01 0.204000 1.94e-01 6.36e-02 2.64e-01 7.15e-01
GOBP REGULATION OF POSITIVE CHEMOTAXIS 25 2.10e-01 5.06e-01 0.204000 1.26e-02 2.04e-01 9.13e-01 7.74e-02
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 45 4.82e-02 2.21e-01 0.204000 1.27e-01 -1.60e-01 1.41e-01 6.29e-02
GOBP REGULATION OF ANTIMICROBIAL HUMORAL RESPONSE 12 4.91e-01 7.48e-01 0.204000 -1.83e-01 -9.11e-02 2.72e-01 5.85e-01
GOBP NEPHRON EPITHELIUM DEVELOPMENT 118 6.11e-04 9.30e-03 0.204000 2.04e-01 -7.16e-04 1.25e-04 9.89e-01
Transport of Ribonucleoproteins into the Host Nucleus 32 1.18e-01 3.75e-01 0.204000 1.80e-01 -9.60e-02 7.74e-02 3.47e-01
GOBP REGULATION OF LEUKOCYTE TETHERING OR ROLLING 18 2.97e-01 5.94e-01 0.204000 -1.47e-01 1.42e-01 2.79e-01 2.98e-01
Signaling by MET 78 7.95e-03 6.67e-02 0.204000 2.04e-01 1.68e-02 1.87e-03 7.98e-01
GOBP PROTEIN IMPORT 9 5.85e-01 8.06e-01 0.204000 -1.87e-01 -8.20e-02 3.31e-01 6.70e-01
NOTCH1 Intracellular Domain Regulates Transcription 44 5.63e-02 2.43e-01 0.204000 1.95e-01 -6.08e-02 2.53e-02 4.85e-01
GOBP PYRUVATE FAMILY AMINO ACID METABOLIC PROCESS 12 4.45e-01 7.17e-01 0.204000 -1.52e-01 1.36e-01 3.61e-01 4.14e-01
GOMF NEUROPEPTIDE RECEPTOR BINDING 34 1.34e-01 4.01e-01 0.204000 9.15e-02 1.83e-01 3.56e-01 6.55e-02
GOBP POSITIVE REGULATION OF CELL KILLING 75 1.23e-02 9.07e-02 0.204000 -1.01e-01 -1.78e-01 1.31e-01 7.86e-03
RHOD GTPase cycle 49 5.01e-02 2.26e-01 0.204000 2.01e-01 3.59e-02 1.50e-02 6.64e-01
GOCC PAR POLARITY COMPLEX 6 7.05e-01 8.73e-01 0.204000 1.53e-01 1.36e-01 5.18e-01 5.65e-01
GOBP MAINTENANCE OF DNA REPEAT ELEMENTS 7 6.46e-01 8.43e-01 0.204000 2.04e-01 8.49e-03 3.50e-01 9.69e-01
GOCC PARALLEL FIBER TO PURKINJE CELL SYNAPSE 17 3.67e-01 6.55e-01 0.204000 -9.65e-02 -1.80e-01 4.91e-01 1.99e-01
GOBP FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY 31 1.37e-01 4.06e-01 0.204000 2.01e-01 -3.28e-02 5.23e-02 7.52e-01
GOBP PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS 28 1.91e-01 4.83e-01 0.204000 1.84e-01 8.85e-02 9.22e-02 4.18e-01
GOBP REGULATION OF CIRCADIAN RHYTHM 109 1.11e-03 1.49e-02 0.204000 2.04e-01 1.87e-04 2.34e-04 9.97e-01
GOMF CD4 RECEPTOR BINDING 8 5.98e-01 8.15e-01 0.204000 2.01e-01 -3.35e-02 3.24e-01 8.70e-01
GOBP NUCLEAR BODY ORGANIZATION 17 3.34e-01 6.24e-01 0.204000 1.99e-01 -4.27e-02 1.55e-01 7.60e-01
GOBP PROTEIN LOCALIZATION TO CHROMOSOME 122 2.87e-04 5.01e-03 0.204000 1.33e-01 -1.55e-01 1.13e-02 3.17e-03
Initiation of Nuclear Envelope (NE) Reformation 18 3.01e-01 5.96e-01 0.204000 1.10e-01 -1.72e-01 4.21e-01 2.07e-01
CREB1 phosphorylation through the activation of Adenylate Cyclase 11 5.22e-01 7.65e-01 0.204000 8.63e-02 1.85e-01 6.20e-01 2.89e-01
GOBP RAS PROTEIN SIGNAL TRANSDUCTION 116 8.06e-04 1.16e-02 0.204000 2.03e-01 1.91e-02 1.61e-04 7.22e-01
GOBP MORPHOGENESIS OF AN ENDOTHELIUM 17 3.23e-01 6.14e-01 0.204000 1.03e-01 -1.76e-01 4.62e-01 2.10e-01
GOMF OMEGA PEPTIDASE ACTIVITY 12 4.74e-01 7.34e-01 0.204000 6.63e-03 2.04e-01 9.68e-01 2.22e-01
GOMF TRANSCRIPTION REGULATOR ACTIVITY 1836 1.11e-47 1.14e-44 0.204000 2.01e-01 -3.16e-02 1.50e-46 2.50e-02
GOBP AMINO ACID BETAINE BIOSYNTHETIC PROCESS 5 7.25e-01 8.82e-01 0.204000 -1.99e-01 4.12e-02 4.40e-01 8.73e-01
GOMF BETA GALACTOSIDASE ACTIVITY 5 7.15e-01 8.77e-01 0.204000 1.28e-01 -1.59e-01 6.21e-01 5.39e-01
GOBP AXONAL TRANSPORT OF MITOCHONDRION 16 3.54e-01 6.43e-01 0.204000 1.95e-01 -5.75e-02 1.76e-01 6.90e-01
Negative regulation of FGFR4 signaling 30 1.61e-01 4.43e-01 0.204000 2.01e-01 3.30e-02 5.68e-02 7.55e-01
GOBP RESPONSE TO STIMULUS INVOLVED IN REGULATION OF MUSCLE ADAPTATION 14 4.44e-01 7.16e-01 0.204000 1.27e-01 1.59e-01 4.09e-01 3.04e-01
GOBP SECONDARY HEART FIELD SPECIFICATION 11 4.83e-01 7.42e-01 0.204000 -1.81e-01 9.23e-02 2.97e-01 5.96e-01
GOBP RESPONSE TO L PHENYLALANINE DERIVATIVE 6 6.81e-01 8.62e-01 0.204000 -3.75e-02 2.00e-01 8.74e-01 3.96e-01
GOBP PLASMINOGEN ACTIVATION 26 1.76e-01 4.62e-01 0.203000 -1.37e-01 1.50e-01 2.25e-01 1.86e-01
GOBP MOTOR NEURON AXON GUIDANCE 25 2.34e-01 5.31e-01 0.203000 1.70e-01 1.11e-01 1.41e-01 3.35e-01
GOBP ORGANELLE TRANSPORT ALONG MICROTUBULE 86 4.46e-03 4.35e-02 0.203000 2.03e-01 -1.76e-02 1.16e-03 7.78e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION 84 6.15e-03 5.48e-02 0.203000 2.00e-01 3.50e-02 1.50e-03 5.79e-01
GOBP NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 95 1.97e-03 2.34e-02 0.203000 1.85e-01 -8.48e-02 1.85e-03 1.53e-01
GOMF C C CHEMOKINE BINDING 23 2.51e-01 5.48e-01 0.203000 -1.97e-01 -4.99e-02 1.02e-01 6.78e-01
GOMF ACYL COA OXIDASE ACTIVITY 7 6.51e-01 8.45e-01 0.203000 1.98e-02 2.02e-01 9.28e-01 3.54e-01
GOBP RIBOFLAVIN METABOLIC PROCESS 5 7.46e-01 8.91e-01 0.203000 8.91e-02 1.83e-01 7.30e-01 4.79e-01
GOMF OPSONIN BINDING 18 3.54e-01 6.44e-01 0.203000 -1.41e-01 -1.47e-01 3.01e-01 2.82e-01
Prostanoid ligand receptors 9 5.79e-01 8.02e-01 0.203000 -3.58e-02 -2.00e-01 8.53e-01 2.99e-01
GOBP CARDIOCYTE DIFFERENTIATION 161 7.50e-05 1.68e-03 0.203000 1.92e-01 6.69e-02 2.66e-05 1.43e-01
GOBP CATECHOL CONTAINING COMPOUND METABOLIC PROCESS 49 5.62e-02 2.42e-01 0.203000 8.15e-02 1.86e-01 3.24e-01 2.42e-02
Signaling by FGFR 87 4.89e-03 4.66e-02 0.203000 2.02e-01 1.88e-02 1.11e-03 7.62e-01
GOBP REGULATION OF INCLUSION BODY ASSEMBLY 17 3.48e-01 6.38e-01 0.203000 1.06e-03 2.03e-01 9.94e-01 1.47e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 9 5.91e-01 8.10e-01 0.203000 -9.47e-02 -1.80e-01 6.23e-01 3.51e-01
GOBP MEMBRANE DISASSEMBLY 13 4.52e-01 7.20e-01 0.203000 2.02e-01 2.40e-02 2.08e-01 8.81e-01
GOBP REGULATION OF HUMORAL IMMUNE RESPONSE 46 6.75e-02 2.71e-01 0.203000 -1.85e-01 -8.44e-02 3.02e-02 3.22e-01
GOMF HYDROXYMETHYL FORMYL AND RELATED TRANSFERASE ACTIVITY 8 6.19e-01 8.27e-01 0.203000 -5.09e-02 -1.97e-01 8.03e-01 3.36e-01
GOBP T CELL RECEPTOR SIGNALING PATHWAY 136 1.22e-04 2.55e-03 0.203000 1.31e-01 -1.55e-01 8.29e-03 1.80e-03
APC-Cdc20 mediated degradation of Nek2A 26 1.88e-01 4.79e-01 0.203000 5.33e-02 -1.96e-01 6.38e-01 8.39e-02
GOBP OXIDATIVE PHOSPHORYLATION 125 4.36e-04 7.04e-03 0.203000 4.53e-03 -2.03e-01 9.30e-01 9.01e-05
GOMF NAD BINDING 55 3.07e-02 1.68e-01 0.203000 2.00e-01 -3.31e-02 1.03e-02 6.71e-01
GOMF PROTON CHANNEL ACTIVITY 25 2.18e-01 5.13e-01 0.203000 -2.13e-02 -2.02e-01 8.54e-01 8.09e-02
GOBP NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT 23 2.66e-01 5.62e-01 0.203000 1.61e-01 1.23e-01 1.81e-01 3.07e-01
GOCC SMN SM PROTEIN COMPLEX 16 3.64e-01 6.51e-01 0.203000 2.79e-02 -2.01e-01 8.47e-01 1.64e-01
GOBP POSITIVE REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY 8 6.29e-01 8.34e-01 0.203000 9.96e-02 1.76e-01 6.26e-01 3.87e-01
GOBP DIGESTIVE SYSTEM DEVELOPMENT 140 1.55e-04 3.09e-03 0.203000 2.01e-01 -2.59e-02 4.04e-05 5.96e-01
GOMF AMIDINE LYASE ACTIVITY 7 6.57e-01 8.49e-01 0.203000 4.18e-02 1.98e-01 8.48e-01 3.64e-01
GOBP VESTIBULOCOCHLEAR NERVE MORPHOGENESIS 7 6.61e-01 8.51e-01 0.203000 1.92e-01 6.34e-02 3.78e-01 7.72e-01
GOMF ALPHA N ACETYLGALACTOSAMINIDE ALPHA 2 6 SIALYLTRANSFERASE ACTIVITY 6 7.01e-01 8.70e-01 0.203000 6.20e-02 1.93e-01 7.92e-01 4.13e-01
Formation of annular gap junctions 11 5.11e-01 7.60e-01 0.203000 2.02e-01 1.67e-02 2.46e-01 9.24e-01
GOBP POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 13 4.71e-01 7.31e-01 0.202000 1.77e-01 9.83e-02 2.69e-01 5.40e-01
GOCC SPLICEOSOMAL TRI SNRNP COMPLEX 40 7.58e-02 2.90e-01 0.202000 1.91e-01 -6.72e-02 3.66e-02 4.62e-01
GOBP STRIATED MUSCLE ATROPHY 7 6.29e-01 8.34e-01 0.202000 1.30e-01 -1.55e-01 5.51e-01 4.77e-01
GOCC POSTSYNAPTIC ENDOSOME 13 4.46e-01 7.17e-01 0.202000 -8.69e-03 2.02e-01 9.57e-01 2.07e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT 11 4.83e-01 7.42e-01 0.202000 -1.51e-01 1.34e-01 3.85e-01 4.41e-01
GOMF PROTEIN CYSTEINE S STEAROYLTRANSFERASE ACTIVITY 6 7.03e-01 8.71e-01 0.202000 1.90e-01 6.96e-02 4.20e-01 7.68e-01
GOCC TRANSCRIPTION REGULATOR COMPLEX 488 4.23e-14 6.57e-12 0.202000 1.91e-01 -6.58e-02 4.56e-13 1.27e-02
GOBP REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS 79 5.46e-03 5.02e-02 0.202000 1.43e-01 -1.43e-01 2.77e-02 2.83e-02
GOBP NEGATIVE REGULATION OF BEHAVIOR 12 5.00e-01 7.53e-01 0.202000 1.78e-01 9.66e-02 2.87e-01 5.62e-01
GOMF SUMO LIGASE ACTIVITY 13 4.75e-01 7.35e-01 0.202000 1.25e-01 1.59e-01 4.34e-01 3.22e-01
PTEN Regulation 139 1.72e-04 3.34e-03 0.202000 2.00e-01 -2.60e-02 4.50e-05 5.96e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE 5 7.24e-01 8.81e-01 0.202000 1.88e-01 -7.53e-02 4.68e-01 7.71e-01
GOMF TRANSCRIPTION COREGULATOR ACTIVITY 467 3.60e-13 4.70e-11 0.202000 2.01e-01 -2.38e-02 1.06e-13 3.79e-01
GOBP ENDOCRINE HORMONE SECRETION 57 3.78e-02 1.91e-01 0.202000 1.75e-01 1.02e-01 2.26e-02 1.84e-01
Phospholipid metabolism 200 6.28e-06 1.92e-04 0.202000 2.00e-01 2.54e-02 1.02e-06 5.35e-01
GOBP INTERFERON ALPHA PRODUCTION 27 2.14e-01 5.09e-01 0.202000 -1.25e-01 -1.58e-01 2.59e-01 1.55e-01
GOBP IP 10 PRODUCTION 5 7.23e-01 8.81e-01 0.202000 1.84e-01 -8.22e-02 4.75e-01 7.50e-01
NEP/NS2 Interacts with the Cellular Export Machinery 32 1.25e-01 3.85e-01 0.202000 1.81e-01 -8.97e-02 7.65e-02 3.80e-01
GOBP ACTIVIN RECEPTOR SIGNALING PATHWAY 46 6.61e-02 2.68e-01 0.202000 1.95e-01 5.37e-02 2.24e-02 5.28e-01
GOBP HETEROCHROMATIN ORGANIZATION 13 4.37e-01 7.10e-01 0.202000 1.95e-01 -5.37e-02 2.24e-01 7.38e-01
Interactions of Rev with host cellular proteins 37 9.17e-02 3.25e-01 0.202000 1.86e-01 -7.90e-02 5.05e-02 4.06e-01
GOBP COMPLEMENT ACTIVATION CLASSICAL PATHWAY 34 1.19e-01 3.75e-01 0.202000 -1.99e-01 3.12e-02 4.42e-02 7.53e-01
Defective ST3GAL3 causes MCT12 and EIEE15 8 6.34e-01 8.36e-01 0.202000 1.58e-01 1.25e-01 4.38e-01 5.40e-01
GOMF NADH DEHYDROGENASE ACTIVITY 8 6.31e-01 8.35e-01 0.202000 1.75e-01 9.97e-02 3.90e-01 6.25e-01
GOMF CXCR CHEMOKINE RECEPTOR BINDING 18 3.50e-01 6.40e-01 0.202000 7.35e-02 1.88e-01 5.89e-01 1.68e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 42 6.64e-02 2.69e-01 0.202000 1.85e-01 -8.15e-02 3.85e-02 3.61e-01
GOBP HYALOID VASCULAR PLEXUS REGRESSION 7 6.65e-01 8.52e-01 0.202000 -1.87e-01 -7.55e-02 3.91e-01 7.29e-01
Defective binding of VWF variant to GPIb:IX:V 7 6.47e-01 8.44e-01 0.202000 -1.80e-02 2.01e-01 9.34e-01 3.57e-01
Enhanced binding of GP1BA variant to VWF multimer:collagen 7 6.47e-01 8.44e-01 0.202000 -1.80e-02 2.01e-01 9.34e-01 3.57e-01
GOBP MICROVILLUS ORGANIZATION 28 1.75e-01 4.61e-01 0.202000 2.01e-01 -2.20e-02 6.63e-02 8.40e-01
GOBP RECOMBINATIONAL REPAIR 181 9.26e-06 2.71e-04 0.202000 1.86e-01 -7.73e-02 1.53e-05 7.30e-02
GOBP POSITIVE THYMIC T CELL SELECTION 15 4.15e-01 6.95e-01 0.202000 -6.11e-02 -1.92e-01 6.82e-01 1.97e-01
GOMF CHROMATIN BINDING 581 2.67e-16 6.98e-14 0.202000 1.97e-01 -4.50e-02 5.29e-16 6.41e-02
GOBP REGULATION OF ISOTYPE SWITCHING 36 9.48e-02 3.30e-01 0.202000 1.66e-01 -1.15e-01 8.50e-02 2.34e-01
GOMF S ADENOSYL L METHIONINE BINDING 18 3.26e-01 6.17e-01 0.202000 2.20e-02 -2.00e-01 8.72e-01 1.41e-01
GOBP ENDOCYTOSIS INVOLVED IN VIRAL ENTRY INTO HOST CELL 12 4.90e-01 7.48e-01 0.202000 4.33e-02 1.97e-01 7.95e-01 2.38e-01
Vpu mediated degradation of CD4 39 8.39e-02 3.11e-01 0.202000 5.54e-02 -1.94e-01 5.50e-01 3.62e-02
GOBP TRYPTOPHAN METABOLIC PROCESS 10 5.66e-01 7.94e-01 0.202000 -1.64e-01 -1.17e-01 3.70e-01 5.20e-01
GOBP POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION 14 4.06e-01 6.89e-01 0.202000 7.55e-02 -1.87e-01 6.25e-01 2.26e-01
GOMF TRANSCRIPTION FACTOR BINDING 570 1.33e-15 2.96e-13 0.202000 2.01e-01 -7.79e-03 1.95e-16 7.51e-01
GOBP DIOL BIOSYNTHETIC PROCESS 21 2.66e-01 5.62e-01 0.202000 -4.49e-02 1.96e-01 7.22e-01 1.19e-01
Signaling by the B Cell Receptor (BCR) 94 2.18e-03 2.53e-02 0.201000 1.64e-01 -1.16e-01 5.86e-03 5.11e-02
Disassembly of the destruction complex and recruitment of AXIN to the membrane 30 1.74e-01 4.60e-01 0.201000 1.90e-01 6.66e-02 7.15e-02 5.28e-01
GOBP REGULATION OF GLOMERULUS DEVELOPMENT 5 7.27e-01 8.82e-01 0.201000 6.21e-02 -1.92e-01 8.10e-01 4.58e-01
GOBP REGULATION OF CHROMOSOME SEGREGATION 129 3.26e-04 5.57e-03 0.201000 1.99e-01 -3.32e-02 9.79e-05 5.15e-01
GOBP KIDNEY MORPHOGENESIS 95 2.43e-03 2.73e-02 0.201000 1.93e-01 -5.85e-02 1.17e-03 3.25e-01
GOBP NON PROTEINOGENIC AMINO ACID CATABOLIC PROCESS 16 3.50e-01 6.40e-01 0.201000 -1.32e-01 1.52e-01 3.59e-01 2.94e-01
GOBP HISTAMINE SECRETION 12 5.03e-01 7.55e-01 0.201000 1.74e-01 1.01e-01 2.96e-01 5.46e-01
GOBP REGULATION OF STORE OPERATED CALCIUM ENTRY 15 4.28e-01 7.05e-01 0.201000 1.39e-01 1.46e-01 3.52e-01 3.28e-01
Leading Strand Synthesis 13 4.28e-01 7.05e-01 0.201000 1.19e-01 -1.62e-01 4.57e-01 3.11e-01
Polymerase switching 13 4.28e-01 7.05e-01 0.201000 1.19e-01 -1.62e-01 4.57e-01 3.11e-01
GOBP S SHAPED BODY MORPHOGENESIS 7 6.72e-01 8.57e-01 0.201000 1.61e-01 1.20e-01 4.60e-01 5.81e-01
GOBP RETINAL ROD CELL DEVELOPMENT 10 5.59e-01 7.91e-01 0.201000 -7.04e-02 -1.89e-01 7.00e-01 3.02e-01
GOBP LEUKOCYTE AGGREGATION 12 4.63e-01 7.27e-01 0.201000 1.87e-01 -7.51e-02 2.63e-01 6.52e-01
Transport of Mature mRNA derived from an Intron-Containing Transcript 69 1.12e-02 8.53e-02 0.201000 1.63e-01 -1.17e-01 1.89e-02 9.16e-02
GOCC CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX 52 4.13e-02 2.01e-01 0.201000 8.46e-03 -2.01e-01 9.16e-01 1.21e-02
GOMF ALKALINE PHOSPHATASE ACTIVITY 6 6.89e-01 8.65e-01 0.201000 -2.00e-01 2.53e-02 3.97e-01 9.15e-01
GOBP CELL KILLING 216 4.92e-06 1.56e-04 0.201000 -1.73e-01 -1.03e-01 1.18e-05 9.20e-03
GOMF LIPASE ACTIVATOR ACTIVITY 19 3.31e-01 6.22e-01 0.201000 -6.77e-02 -1.89e-01 6.10e-01 1.53e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT 24 2.58e-01 5.55e-01 0.201000 1.40e-01 1.44e-01 2.35e-01 2.21e-01
PERK regulates gene expression 31 1.48e-01 4.24e-01 0.201000 1.59e-02 -2.00e-01 8.78e-01 5.34e-02
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS VIA LACTOSYLCERAMIDE 6 6.75e-01 8.59e-01 0.201000 -1.44e-01 1.40e-01 5.41e-01 5.52e-01
GOBP RESPONSE TO FIBROBLAST GROWTH FACTOR 117 1.09e-03 1.47e-02 0.201000 1.93e-01 5.62e-02 3.08e-04 2.94e-01
rRNA modification in the nucleus and cytosol 57 2.89e-02 1.63e-01 0.201000 3.11e-02 -1.99e-01 6.84e-01 9.48e-03
GOBP SPERMATID NUCLEUS DIFFERENTIATION 27 2.13e-01 5.08e-01 0.201000 -1.78e-01 -9.38e-02 1.10e-01 3.99e-01
Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition 12 4.57e-01 7.22e-01 0.201000 1.53e-01 -1.30e-01 3.57e-01 4.36e-01
GOBP GAMMA DELTA T CELL DIFFERENTIATION 13 4.28e-01 7.06e-01 0.201000 1.22e-01 -1.60e-01 4.48e-01 3.18e-01
GOBP POSITIVE REGULATION OF DNA RECOMBINATION 73 8.91e-03 7.26e-02 0.201000 1.72e-01 -1.04e-01 1.09e-02 1.26e-01
GOMF LBD DOMAIN BINDING 6 7.12e-01 8.76e-01 0.201000 1.64e-01 1.16e-01 4.86e-01 6.23e-01
GOBP POSITIVE REGULATION OF RNA METABOLIC PROCESS 1835 3.03e-46 2.86e-43 0.201000 1.99e-01 -2.59e-02 1.14e-45 6.55e-02
GOBP MUCOSA ASSOCIATED LYMPHOID TISSUE DEVELOPMENT 8 6.31e-01 8.34e-01 0.201000 8.29e-02 1.83e-01 6.85e-01 3.70e-01
GOBP GENITALIA MORPHOGENESIS 11 5.37e-01 7.77e-01 0.201000 1.28e-01 1.55e-01 4.63e-01 3.73e-01
GOBP NUCLEAR RNA SURVEILLANCE 15 3.76e-01 6.61e-01 0.201000 1.36e-01 -1.48e-01 3.62e-01 3.21e-01
GOBP RESPONSE TO ERYTHROPOIETIN 7 6.67e-01 8.53e-01 0.201000 -7.37e-02 -1.87e-01 7.36e-01 3.92e-01
RMTs methylate histone arginines 43 6.37e-02 2.62e-01 0.201000 1.84e-01 -8.13e-02 3.71e-02 3.57e-01
GOBP G1 TO G0 TRANSITION 19 3.41e-01 6.31e-01 0.201000 1.15e-01 1.65e-01 3.85e-01 2.14e-01
GOBP T HELPER 17 CELL DIFFERENTIATION 34 1.09e-01 3.56e-01 0.201000 1.45e-01 -1.39e-01 1.45e-01 1.59e-01
GOBP POSITIVE REGULATION OF GLIAL CELL MIGRATION 11 5.34e-01 7.74e-01 0.201000 -1.76e-01 -9.70e-02 3.13e-01 5.77e-01
GOBP L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT 68 1.90e-02 1.23e-01 0.201000 1.93e-01 5.54e-02 5.92e-03 4.29e-01
GOBP STEM CELL PROLIFERATION 121 4.66e-04 7.42e-03 0.201000 1.88e-01 -7.05e-02 3.53e-04 1.81e-01
GOBP POSITIVE REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS 5 7.32e-01 8.84e-01 0.201000 -3.89e-02 1.97e-01 8.80e-01 4.46e-01
GOBP NEGATIVE REGULATION OF CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION 5 7.25e-01 8.82e-01 0.201000 8.51e-02 -1.82e-01 7.42e-01 4.81e-01
GOBP REGULATION OF T HELPER 17 CELL DIFFERENTIATION 23 2.24e-01 5.20e-01 0.201000 1.23e-01 -1.58e-01 3.05e-01 1.89e-01
Termination of O-glycan biosynthesis 25 1.97e-01 4.90e-01 0.201000 -1.64e-01 1.16e-01 1.56e-01 3.15e-01
GOMF DEAMINASE ACTIVITY 32 1.31e-01 3.96e-01 0.201000 -6.61e-02 1.89e-01 5.17e-01 6.36e-02
GOCC DNA POLYMERASE COMPLEX 19 2.98e-01 5.94e-01 0.201000 1.86e-01 -7.62e-02 1.61e-01 5.65e-01
Cargo recognition for clathrin-mediated endocytosis 100 1.75e-03 2.13e-02 0.201000 1.86e-01 -7.54e-02 1.32e-03 1.93e-01
GOBP VITAMIN D METABOLIC PROCESS 21 3.02e-01 5.97e-01 0.201000 -9.01e-02 -1.79e-01 4.75e-01 1.55e-01
GOBP RESPONSE TO BMP 173 4.67e-05 1.12e-03 0.200000 1.92e-01 5.89e-02 1.38e-05 1.81e-01
Base-Excision Repair, AP Site Formation 40 8.70e-02 3.16e-01 0.200000 1.34e-02 -2.00e-01 8.83e-01 2.86e-02
GOBP INSEMINATION 13 4.66e-01 7.28e-01 0.200000 1.96e-01 4.15e-02 2.21e-01 7.96e-01
GOBP MATURATION OF 5 8S RRNA 34 1.10e-01 3.59e-01 0.200000 1.29e-01 -1.53e-01 1.91e-01 1.23e-01
GOBP MESENCHYME DEVELOPMENT 322 3.60e-09 2.40e-07 0.200000 2.00e-01 -1.60e-02 7.14e-10 6.22e-01
GOCC PERICENTRIOLAR MATERIAL 22 2.46e-01 5.42e-01 0.200000 1.83e-01 -8.06e-02 1.37e-01 5.13e-01
GOBP POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE 46 5.19e-02 2.30e-01 0.200000 -1.04e-01 1.71e-01 2.20e-01 4.50e-02
GOMF MODIFICATION DEPENDENT PROTEIN BINDING 169 6.98e-05 1.57e-03 0.200000 1.81e-01 8.61e-02 4.97e-05 5.36e-02
GOBP POSITIVE REGULATION OF STRESS FIBER ASSEMBLY 51 5.74e-02 2.46e-01 0.200000 1.56e-01 1.26e-01 5.41e-02 1.20e-01
GOBP REGULATION OF MYELOID CELL APOPTOTIC PROCESS 30 1.59e-01 4.41e-01 0.200000 1.99e-01 -2.04e-02 5.89e-02 8.47e-01
GOCC PRECATALYTIC SPLICEOSOME 50 3.95e-02 1.96e-01 0.200000 1.23e-01 -1.58e-01 1.32e-01 5.33e-02
GOBP NEURONAL STEM CELL POPULATION MAINTENANCE 25 2.20e-01 5.15e-01 0.200000 2.00e-01 -5.41e-03 8.32e-02 9.63e-01
MITF-M-regulated melanocyte development 155 6.57e-05 1.51e-03 0.200000 1.94e-01 -4.91e-02 3.03e-05 2.91e-01
GOBP ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 182 8.59e-06 2.53e-04 0.200000 1.15e-01 -1.64e-01 7.61e-03 1.34e-04
GOMF LIGAND ACTIVATED TRANSCRIPTION FACTOR ACTIVITY 52 5.03e-02 2.26e-01 0.200000 1.89e-01 6.72e-02 1.87e-02 4.02e-01
Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes 94 2.80e-03 3.05e-02 0.200000 1.92e-01 -5.62e-02 1.29e-03 3.46e-01
Epigenetic regulation of gene expression by MLL3 and MLL4 complexes 94 2.80e-03 3.05e-02 0.200000 1.92e-01 -5.62e-02 1.29e-03 3.46e-01
MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis 94 2.80e-03 3.05e-02 0.200000 1.92e-01 -5.62e-02 1.29e-03 3.46e-01
GOBP EPITHELIAL CELL MATURATION 27 2.21e-01 5.17e-01 0.200000 1.29e-01 1.53e-01 2.46e-01 1.69e-01
GOMF N ACYLTRANSFERASE ACTIVITY 86 5.34e-03 4.95e-02 0.200000 2.00e-01 -1.54e-02 1.38e-03 8.05e-01
GOMF CHONDROITIN SULFATE BINDING 9 6.04e-01 8.18e-01 0.200000 -1.21e-01 -1.60e-01 5.31e-01 4.07e-01
GOBP PROTEIN N LINKED GLYCOSYLATION VIA ASPARAGINE 23 2.47e-01 5.43e-01 0.200000 1.39e-02 -1.99e-01 9.08e-01 9.78e-02
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CONTRACTION 8 6.05e-01 8.19e-01 0.200000 -6.07e-02 1.90e-01 7.66e-01 3.51e-01
GOBP REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 13 4.80e-01 7.39e-01 0.200000 1.74e-01 9.91e-02 2.79e-01 5.36e-01
GOBP SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE 182 8.72e-06 2.56e-04 0.200000 1.57e-01 -1.23e-01 2.52e-04 4.11e-03
GOMF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 157 4.74e-05 1.13e-03 0.200000 -1.77e-01 9.28e-02 1.29e-04 4.48e-02
GOBP ANTEROGRADE DENDRITIC TRANSPORT 9 5.63e-01 7.93e-01 0.200000 1.76e-01 -9.43e-02 3.60e-01 6.24e-01
GOCC CD40 RECEPTOR COMPLEX 11 5.28e-01 7.70e-01 0.200000 1.93e-01 5.04e-02 2.67e-01 7.72e-01
GOBP REGULATION OF GLYCOGEN METABOLIC PROCESS 35 1.42e-01 4.14e-01 0.200000 1.37e-01 1.46e-01 1.61e-01 1.36e-01
GOBP REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS 17 3.35e-01 6.25e-01 0.200000 1.57e-01 -1.24e-01 2.63e-01 3.78e-01
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants 54 3.72e-02 1.90e-01 0.200000 1.99e-01 -2.11e-02 1.16e-02 7.89e-01
Constitutive Signaling by NOTCH1 PEST Domain Mutants 54 3.72e-02 1.90e-01 0.200000 1.99e-01 -2.11e-02 1.16e-02 7.89e-01
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer 54 3.72e-02 1.90e-01 0.200000 1.99e-01 -2.11e-02 1.16e-02 7.89e-01
Signaling by NOTCH1 PEST Domain Mutants in Cancer 54 3.72e-02 1.90e-01 0.200000 1.99e-01 -2.11e-02 1.16e-02 7.89e-01
Signaling by NOTCH1 in Cancer 54 3.72e-02 1.90e-01 0.200000 1.99e-01 -2.11e-02 1.16e-02 7.89e-01
GOBP POSITIVE REGULATION OF MAPKKK CASCADE BY FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 5 7.25e-01 8.82e-01 0.200000 -1.22e-01 1.58e-01 6.37e-01 5.40e-01
Gastrin-CREB signalling pathway via PKC and MAPK 17 3.59e-01 6.47e-01 0.200000 2.00e-01 -3.02e-03 1.54e-01 9.83e-01
GOBP GASTRIC ACID SECRETION 13 4.65e-01 7.28e-01 0.200000 2.63e-02 1.98e-01 8.70e-01 2.17e-01
GOMF MRNA 3 UTR AU RICH REGION BINDING 29 1.63e-01 4.47e-01 0.200000 5.96e-02 -1.91e-01 5.79e-01 7.57e-02
GOBP REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY 10 5.34e-01 7.73e-01 0.200000 1.88e-01 -6.67e-02 3.03e-01 7.15e-01
GOCC PARANODE REGION OF AXON 12 5.12e-01 7.61e-01 0.200000 1.58e-01 1.22e-01 3.43e-01 4.65e-01
GOBP NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION 14 4.46e-01 7.17e-01 0.200000 5.53e-02 1.92e-01 7.20e-01 2.14e-01
GOBP SYNAPTIC MEMBRANE ADHESION 26 2.23e-01 5.19e-01 0.200000 1.92e-01 5.38e-02 9.00e-02 6.35e-01
GOBP REGULATION OF OVARIAN FOLLICLE DEVELOPMENT 6 7.12e-01 8.76e-01 0.200000 1.79e-01 8.73e-02 4.47e-01 7.11e-01
GOBP MUSCLE CELL MIGRATION 102 3.09e-03 3.28e-02 0.199000 1.85e-01 7.51e-02 1.26e-03 1.90e-01
GOMF POTASSIUM CHLORIDE SYMPORTER ACTIVITY 9 5.80e-01 8.03e-01 0.199000 -1.10e-02 1.99e-01 9.54e-01 3.01e-01
GOBP REGULATION OF MIRNA TRANSCRIPTION 74 1.23e-02 9.07e-02 0.199000 1.99e-01 7.32e-03 3.03e-03 9.13e-01
Nuclear import of Rev protein 34 1.15e-01 3.68e-01 0.199000 1.73e-01 -9.83e-02 8.00e-02 3.21e-01
GOBP REGULATION OF STEM CELL PROLIFERATION 92 2.78e-03 3.04e-02 0.199000 1.54e-01 -1.26e-01 1.04e-02 3.68e-02
IRF3 mediated activation of type 1 IFN 5 7.32e-01 8.85e-01 0.199000 -1.91e-01 5.70e-02 4.60e-01 8.25e-01
GOBP REGULATION OF CYTOPLASMIC TRANSLATION 32 1.42e-01 4.13e-01 0.199000 1.97e-01 -3.10e-02 5.41e-02 7.61e-01
GOMF DNA BINDING TRANSCRIPTION FACTOR BINDING 451 2.60e-12 2.99e-10 0.199000 1.99e-01 -1.18e-02 4.47e-13 6.68e-01
GOCC POSTSYNAPTIC CYTOSOL 13 4.86e-01 7.45e-01 0.199000 1.54e-01 1.27e-01 3.37e-01 4.29e-01
Cellular response to hypoxia 61 2.06e-02 1.29e-01 0.199000 1.09e-01 -1.67e-01 1.41e-01 2.44e-02
GOBP SEX CHROMOSOME DOSAGE COMPENSATION 15 3.94e-01 6.76e-01 0.199000 1.91e-01 -5.57e-02 2.00e-01 7.09e-01
GOMF PRE MRNA 5 SPLICE SITE BINDING 6 6.84e-01 8.63e-01 0.199000 1.77e-01 -9.02e-02 4.52e-01 7.02e-01
GOMF DOLICHYL PHOSPHATE MANNOSE PROTEIN MANNOSYLTRANSFERASE ACTIVITY 8 6.38e-01 8.39e-01 0.199000 9.23e-02 1.76e-01 6.51e-01 3.88e-01
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 14 4.56e-01 7.22e-01 0.199000 1.75e-01 9.45e-02 2.56e-01 5.40e-01
GOMF PROTEIN SERINE THREONINE KINASE BINDING 10 5.54e-01 7.87e-01 0.199000 1.99e-01 1.31e-02 2.77e-01 9.43e-01
GOMF NUCLEOSIDE KINASE ACTIVITY 9 5.73e-01 7.99e-01 0.199000 1.91e-01 -5.43e-02 3.20e-01 7.78e-01
GOCC STRIATED MUSCLE THIN FILAMENT 22 2.52e-01 5.49e-01 0.199000 -7.65e-02 1.84e-01 5.34e-01 1.36e-01
GOBP SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT 19 3.06e-01 5.99e-01 0.199000 6.80e-02 -1.87e-01 6.08e-01 1.58e-01
GOCC MITOCHONDRIAL CRISTA JUNCTION 6 7.02e-01 8.71e-01 0.199000 1.98e-01 1.43e-02 4.00e-01 9.52e-01
GOMF POTASSIUM CHANNEL ACTIVITY 123 4.64e-04 7.41e-03 0.199000 -1.83e-01 7.70e-02 4.46e-04 1.40e-01
GOBP REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 26 2.21e-01 5.17e-01 0.199000 1.96e-01 3.52e-02 8.42e-02 7.56e-01
GOBP POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 105 2.06e-03 2.41e-02 0.199000 1.99e-01 8.59e-03 4.38e-04 8.79e-01
GOBP TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 240 1.07e-06 4.02e-05 0.199000 1.95e-01 3.86e-02 1.96e-07 3.02e-01
Negative regulation of TCF-dependent signaling by WNT ligand antagonists 15 4.27e-01 7.04e-01 0.199000 1.88e-01 6.51e-02 2.08e-01 6.63e-01
GOBP REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS 115 7.35e-04 1.07e-02 0.199000 1.77e-01 -9.11e-02 1.07e-03 9.15e-02
GOBP PROTEIN RNA COMPLEX ORGANIZATION 201 3.00e-06 9.95e-05 0.199000 1.40e-01 -1.40e-01 5.97e-04 6.00e-04
Dual incision in TC-NER 61 2.07e-02 1.29e-01 0.199000 1.29e-01 -1.51e-01 8.05e-02 4.20e-02
GOBP REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS 15 4.13e-01 6.94e-01 0.199000 -1.98e-01 -1.11e-02 1.84e-01 9.41e-01
GOBP SNRNA PROCESSING 26 1.95e-01 4.87e-01 0.199000 1.76e-01 -9.16e-02 1.20e-01 4.19e-01
CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling 25 2.48e-01 5.44e-01 0.198000 1.77e-01 9.04e-02 1.26e-01 4.34e-01
Diseases associated with glycosylation precursor biosynthesis 15 4.35e-01 7.10e-01 0.198000 -1.68e-01 -1.05e-01 2.59e-01 4.80e-01
GOBP FOREBRAIN CELL MIGRATION 62 2.43e-02 1.46e-01 0.198000 1.98e-01 -1.71e-02 7.10e-03 8.16e-01
GOBP PEPTIDYL LYSINE MODIFICATION 141 1.84e-04 3.52e-03 0.198000 1.93e-01 -4.71e-02 7.76e-05 3.35e-01
GOCC INTEGRATOR COMPLEX 17 3.61e-01 6.49e-01 0.198000 1.98e-01 -1.46e-02 1.58e-01 9.17e-01
GOBP BRUSH BORDER ASSEMBLY 8 6.06e-01 8.20e-01 0.198000 -1.81e-01 8.05e-02 3.75e-01 6.93e-01
G1/S DNA Damage Checkpoints 54 3.35e-02 1.78e-01 0.198000 9.63e-02 -1.73e-01 2.21e-01 2.75e-02
Signaling by TGF-beta Receptor Complex 92 3.29e-03 3.44e-02 0.198000 1.84e-01 -7.53e-02 2.35e-03 2.12e-01
GOBP TAIL ANCHORED MEMBRANE PROTEIN INSERTION INTO ER MEMBRANE 15 3.93e-01 6.75e-01 0.198000 7.78e-02 -1.82e-01 6.02e-01 2.22e-01
RAB GEFs exchange GTP for GDP on RABs 80 9.02e-03 7.32e-02 0.198000 1.98e-01 3.30e-03 2.19e-03 9.59e-01
FCGR3A-mediated phagocytosis 57 3.00e-02 1.66e-01 0.198000 1.89e-01 -5.99e-02 1.37e-02 4.34e-01
Leishmania phagocytosis 57 3.00e-02 1.66e-01 0.198000 1.89e-01 -5.99e-02 1.37e-02 4.34e-01
Parasite infection 57 3.00e-02 1.66e-01 0.198000 1.89e-01 -5.99e-02 1.37e-02 4.34e-01
GOBP ALDEHYDE BIOSYNTHETIC PROCESS 18 3.19e-01 6.11e-01 0.198000 -1.44e-01 1.36e-01 2.90e-01 3.18e-01
GOBP INHIBITORY SYNAPSE ASSEMBLY 23 2.49e-01 5.46e-01 0.198000 1.96e-01 -3.16e-02 1.05e-01 7.93e-01
GOBP MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL 29 1.96e-01 4.89e-01 0.198000 7.13e-02 1.85e-01 5.06e-01 8.51e-02
GOMF SINGLE STRANDED DNA ENDODEOXYRIBONUCLEASE ACTIVITY 11 4.98e-01 7.52e-01 0.198000 1.56e-01 -1.22e-01 3.70e-01 4.85e-01
GOBP PEROXISOME ORGANIZATION 34 1.19e-01 3.76e-01 0.198000 8.85e-02 -1.77e-01 3.72e-01 7.38e-02
GOBP HYDROCARBON METABOLIC PROCESS 7 6.82e-01 8.62e-01 0.198000 -1.41e-01 -1.39e-01 5.19e-01 5.24e-01
GOMF SERINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY 95 4.16e-03 4.11e-02 0.198000 -1.96e-01 -2.63e-02 9.49e-04 6.57e-01
GOMF RNA POLYMERASE II SPECIFIC DNA BINDING TRANSCRIPTION FACTOR BINDING 329 4.60e-09 2.98e-07 0.198000 1.98e-01 -2.27e-03 6.65e-10 9.44e-01
GOBP REGULATION OF AMINO ACID TRANSMEMBRANE TRANSPORT 14 4.65e-01 7.28e-01 0.198000 1.40e-01 1.40e-01 3.64e-01 3.66e-01
GOBP NEGATIVE REGULATION OF LIPOPROTEIN LIPASE ACTIVITY 7 6.58e-01 8.50e-01 0.198000 1.97e-01 -1.87e-02 3.67e-01 9.32e-01
Membrane binding and targetting of GAG proteins 14 4.18e-01 6.98e-01 0.198000 8.57e-02 -1.78e-01 5.79e-01 2.48e-01
Synthesis And Processing Of GAG, GAGPOL Polyproteins 14 4.18e-01 6.98e-01 0.198000 8.57e-02 -1.78e-01 5.79e-01 2.48e-01
GOBP RESPONSE TO FORSKOLIN 14 4.43e-01 7.15e-01 0.198000 1.82e-02 1.97e-01 9.06e-01 2.02e-01
GOBP RESPONSE TO PHENYLPROPANOID 5 7.59e-01 8.97e-01 0.198000 1.70e-01 1.01e-01 5.10e-01 6.96e-01
Inhibition of replication initiation of damaged DNA by RB1/E2F1 11 5.26e-01 7.68e-01 0.198000 1.97e-01 1.25e-02 2.57e-01 9.43e-01
GOBP REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS 15 4.41e-01 7.13e-01 0.198000 1.45e-01 1.34e-01 3.30e-01 3.69e-01
Azathioprine ADME 22 2.50e-01 5.48e-01 0.198000 1.58e-01 -1.19e-01 2.00e-01 3.34e-01
GOMF RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 19 3.11e-01 6.04e-01 0.198000 6.59e-02 -1.86e-01 6.19e-01 1.60e-01
IRAK4 deficiency (TLR2/4) 17 3.87e-01 6.71e-01 0.198000 -1.83e-01 -7.44e-02 1.91e-01 5.95e-01
Nuclear events stimulated by ALK signaling in cancer 34 1.17e-01 3.72e-01 0.198000 1.28e-01 -1.51e-01 1.98e-01 1.28e-01
SUMO is transferred from E1 to E2 (UBE2I, UBC9) 7 6.57e-01 8.49e-01 0.198000 1.96e-01 -2.69e-02 3.70e-01 9.02e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 7 6.45e-01 8.42e-01 0.197000 -1.07e-01 1.66e-01 6.25e-01 4.47e-01
GOBP KERATAN SULFATE METABOLIC PROCESS 18 3.30e-01 6.21e-01 0.197000 -6.92e-02 1.85e-01 6.11e-01 1.74e-01
CHL1 interactions 9 5.75e-01 8.00e-01 0.197000 6.72e-02 -1.86e-01 7.27e-01 3.35e-01
GOBP INTESTINAL ABSORPTION 41 9.35e-02 3.28e-01 0.197000 1.89e-02 1.96e-01 8.34e-01 2.95e-02
GOMF PRE MRNA INTRONIC BINDING 13 4.41e-01 7.13e-01 0.197000 1.48e-01 -1.31e-01 3.57e-01 4.14e-01
GOBP CENTRIOLE ELONGATION 7 6.78e-01 8.60e-01 0.197000 -7.65e-02 -1.82e-01 7.26e-01 4.05e-01
GOMF ACETYLTRANSFERASE ACTIVITY 89 4.42e-03 4.33e-02 0.197000 1.88e-01 -5.86e-02 2.12e-03 3.39e-01
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT CONFERRING COMPRESSION RESISTANCE 19 3.12e-01 6.05e-01 0.197000 -6.70e-02 1.86e-01 6.13e-01 1.61e-01
GOMF MOLECULAR CARRIER ACTIVITY 93 2.94e-03 3.17e-02 0.197000 1.34e-01 -1.44e-01 2.52e-02 1.61e-02
GOBP POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION 40 8.74e-02 3.16e-01 0.197000 1.89e-01 -5.73e-02 3.89e-02 5.30e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC 8 6.07e-01 8.21e-01 0.197000 -1.01e-01 1.69e-01 6.21e-01 4.07e-01
GOBP COPPER ION TRANSPORT 15 3.90e-01 6.74e-01 0.197000 -1.21e-01 1.56e-01 4.19e-01 2.96e-01
GOBP HINDBRAIN DEVELOPMENT 149 1.23e-04 2.57e-03 0.197000 1.90e-01 -5.28e-02 6.30e-05 2.66e-01
GOMF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 1370 2.87e-34 1.86e-31 0.197000 1.94e-01 -3.20e-02 1.22e-33 4.69e-02
GOBP ESTABLISHMENT OF CELL POLARITY 151 2.58e-04 4.63e-03 0.197000 1.76e-01 8.87e-02 1.90e-04 5.99e-02
GOMF TRANSPORTER INHIBITOR ACTIVITY 40 1.01e-01 3.41e-01 0.197000 1.96e-01 2.43e-02 3.24e-02 7.91e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 13 4.46e-01 7.17e-01 0.197000 9.60e-02 -1.72e-01 5.49e-01 2.83e-01
mRNA 3’-end processing 53 3.62e-02 1.87e-01 0.197000 1.27e-01 -1.50e-01 1.09e-01 5.82e-02
GOMF PROTEIN ARGININE DEIMINASE ACTIVITY 5 7.46e-01 8.91e-01 0.197000 -3.37e-03 1.97e-01 9.90e-01 4.46e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE 43 6.92e-02 2.75e-01 0.197000 1.00e-01 -1.69e-01 2.55e-01 5.46e-02
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE 6 7.17e-01 8.78e-01 0.197000 1.81e-01 7.66e-02 4.42e-01 7.45e-01
GOMF GPI LINKED EPHRIN RECEPTOR ACTIVITY 6 7.06e-01 8.73e-01 0.197000 6.54e-03 1.97e-01 9.78e-01 4.04e-01
GOMF UBIQUITIN LIKE PROTEIN LIGASE BINDING 306 9.59e-09 5.89e-07 0.197000 1.85e-01 -6.81e-02 2.79e-08 4.05e-02
GOBP REGULATION OF MUSCLE ORGAN DEVELOPMENT 24 2.71e-01 5.68e-01 0.197000 1.65e-01 1.07e-01 1.61e-01 3.64e-01
GOCC PI BODY 10 5.35e-01 7.75e-01 0.197000 -1.45e-01 1.32e-01 4.26e-01 4.68e-01
Epigenetic regulation by WDR5-containing histone modifying complexes 123 6.85e-04 1.01e-02 0.197000 1.95e-01 -2.79e-02 1.91e-04 5.93e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 32 1.35e-01 4.03e-01 0.197000 -1.33e-01 1.45e-01 1.94e-01 1.55e-01
GOMF FIBRONECTIN BINDING 30 1.94e-01 4.87e-01 0.197000 1.72e-01 9.51e-02 1.03e-01 3.67e-01
Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane 10 5.42e-01 7.80e-01 0.197000 -7.29e-02 1.83e-01 6.90e-01 3.17e-01
GOBP POSITIVE REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT 8 6.47e-01 8.43e-01 0.197000 1.04e-01 1.67e-01 6.09e-01 4.14e-01
GOCC MITOCHONDRIA ASSOCIATED ENDOPLASMIC RETICULUM MEMBRANE CONTACT SITE 19 3.31e-01 6.22e-01 0.197000 -3.68e-03 -1.97e-01 9.78e-01 1.38e-01
MAP2K and MAPK activation 38 9.42e-02 3.29e-01 0.197000 1.63e-01 -1.10e-01 8.15e-02 2.43e-01
GOCC RNA CAP BINDING COMPLEX 16 3.68e-01 6.55e-01 0.197000 1.44e-01 -1.34e-01 3.19e-01 3.53e-01
GOBP POSITIVE REGULATION OF BONE MINERALIZATION 43 9.84e-02 3.37e-01 0.197000 1.31e-01 1.46e-01 1.36e-01 9.71e-02
GOBP REGULATION OF VIRAL GENOME REPLICATION 83 5.82e-03 5.29e-02 0.197000 1.63e-01 -1.10e-01 1.04e-02 8.20e-02
GOBP REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY 11 5.50e-01 7.85e-01 0.196000 -1.67e-01 -1.03e-01 3.37e-01 5.54e-01
GOBP CYSTEINE METABOLIC PROCESS 10 5.70e-01 7.97e-01 0.196000 1.91e-01 4.63e-02 2.96e-01 8.00e-01
GOCC TRICARBOXYLIC ACID CYCLE HETEROMERIC ENZYME COMPLEX 17 3.80e-01 6.65e-01 0.196000 1.94e-01 2.95e-02 1.66e-01 8.33e-01
RHO GTPases activate KTN1 11 5.18e-01 7.63e-01 0.196000 1.92e-01 -3.99e-02 2.69e-01 8.19e-01
Activation of ATR in response to replication stress 37 9.99e-02 3.39e-01 0.196000 1.46e-01 -1.32e-01 1.25e-01 1.66e-01
GOBP INFLAMMASOME MEDIATED SIGNALING PATHWAY 41 1.03e-01 3.45e-01 0.196000 -1.87e-01 -6.08e-02 3.86e-02 5.01e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 17 PRODUCTION 22 2.99e-01 5.94e-01 0.196000 -1.79e-01 -7.98e-02 1.45e-01 5.17e-01
GOBP NEGATIVE REGULATION OF CGMP MEDIATED SIGNALING 6 6.94e-01 8.68e-01 0.196000 -1.85e-01 6.61e-02 4.33e-01 7.79e-01
GOCC CATALYTIC STEP 2 SPLICEOSOME 86 4.90e-03 4.67e-02 0.196000 1.61e-01 -1.12e-01 9.86e-03 7.20e-02
GOBP LIPID PHOSPHORYLATION 10 5.57e-01 7.89e-01 0.196000 1.96e-01 -1.26e-02 2.84e-01 9.45e-01
GOMF ATP DEPENDENT DIACYLGLYCEROL KINASE ACTIVITY 10 5.57e-01 7.89e-01 0.196000 1.96e-01 -1.26e-02 2.84e-01 9.45e-01
GOBP DISACCHARIDE METABOLIC PROCESS 10 5.62e-01 7.92e-01 0.196000 -1.96e-01 -7.87e-03 2.83e-01 9.66e-01
GOMF PEPTIDE HORMONE RECEPTOR BINDING 20 2.90e-01 5.86e-01 0.196000 1.12e-01 -1.61e-01 3.87e-01 2.12e-01
Aflatoxin activation and detoxification 18 3.72e-01 6.59e-01 0.196000 7.77e-02 1.80e-01 5.68e-01 1.86e-01
GOBP METHYLATION 209 3.44e-06 1.12e-04 0.196000 1.85e-01 -6.63e-02 4.19e-06 9.85e-02
GOBP GALACTOSE METABOLIC PROCESS 9 6.16e-01 8.26e-01 0.196000 1.33e-01 1.44e-01 4.88e-01 4.55e-01
GOBP NUCLEAR TRANSPORT 317 4.62e-09 2.98e-07 0.196000 1.76e-01 -8.70e-02 7.32e-08 7.76e-03
GOCC DENSE BODY 5 7.61e-01 8.98e-01 0.196000 -1.77e-01 -8.45e-02 4.93e-01 7.43e-01
GOBP POSITIVE REGULATION OF THYROID HORMONE GENERATION 5 7.59e-01 8.97e-01 0.196000 1.83e-01 7.08e-02 4.79e-01 7.84e-01
Regulation of lipid metabolism by PPARalpha 115 1.50e-03 1.90e-02 0.196000 1.94e-01 2.58e-02 3.17e-04 6.32e-01
GOBP MACROMOLECULE METHYLATION 123 4.95e-04 7.81e-03 0.196000 1.34e-01 -1.43e-01 1.00e-02 6.27e-03
GOBP POSITIVE REGULATION OF OSSIFICATION 53 5.75e-02 2.46e-01 0.196000 1.63e-01 1.09e-01 3.99e-02 1.71e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON METAL IONS 16 3.77e-01 6.63e-01 0.196000 -7.60e-02 1.81e-01 5.99e-01 2.11e-01
GOBP LENS FIBER CELL DIFFERENTIATION 36 1.45e-01 4.18e-01 0.196000 1.52e-01 1.24e-01 1.15e-01 1.98e-01
GOCC NUCLEAR BODY 812 5.70e-21 2.06e-18 0.196000 1.92e-01 -3.72e-02 1.09e-20 7.17e-02
GOBP SODIUM ION EXPORT ACROSS PLASMA MEMBRANE 15 4.08e-01 6.89e-01 0.196000 -4.63e-02 1.90e-01 7.56e-01 2.02e-01
GOBP POSITIVE REGULATION OF CHROMOSOME SEPARATION 29 1.75e-01 4.61e-01 0.196000 1.88e-01 -5.57e-02 8.00e-02 6.03e-01
GOMF PORIN ACTIVITY 6 6.93e-01 8.68e-01 0.196000 8.23e-02 -1.78e-01 7.27e-01 4.51e-01
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 13 4.67e-01 7.29e-01 0.196000 1.95e-01 -1.69e-02 2.23e-01 9.16e-01
GOBP INTRACELLULAR ZINC ION HOMEOSTASIS 36 1.35e-01 4.02e-01 0.196000 -1.89e-01 -4.97e-02 4.92e-02 6.06e-01
GOBP POSITIVE REGULATION OF MEMBRANE POTENTIAL 12 4.77e-01 7.36e-01 0.196000 1.62e-01 -1.10e-01 3.31e-01 5.10e-01
GOBP POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY 46 8.55e-02 3.13e-01 0.196000 1.32e-01 1.45e-01 1.21e-01 8.98e-02
GOBP REGULATION OF DOPAMINE SECRETION 25 2.16e-01 5.11e-01 0.196000 -9.68e-02 1.70e-01 4.02e-01 1.41e-01
GOCC CRD MEDIATED MRNA STABILITY COMPLEX 6 7.04e-01 8.72e-01 0.196000 1.61e-02 -1.95e-01 9.46e-01 4.08e-01
GOBP GLIAL CELL DEVELOPMENT 131 7.43e-04 1.08e-02 0.196000 1.87e-01 5.85e-02 2.24e-04 2.48e-01
GOBP G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY 21 2.99e-01 5.94e-01 0.196000 1.62e-03 1.96e-01 9.90e-01 1.21e-01
GOMF PEROXIREDOXIN ACTIVITY 7 6.50e-01 8.45e-01 0.196000 1.12e-01 -1.60e-01 6.06e-01 4.63e-01
GOBP NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS 1158 5.91e-29 3.15e-26 0.195000 1.92e-01 -3.56e-02 2.56e-28 4.13e-02
GOCC PHAGOPHORE ASSEMBLY SITE 37 1.29e-01 3.93e-01 0.195000 1.88e-01 5.38e-02 4.80e-02 5.71e-01
GOBP NEGATIVE REGULATION OF NATURAL KILLER CELL ACTIVATION 10 5.72e-01 7.99e-01 0.195000 -4.11e-02 -1.91e-01 8.22e-01 2.96e-01
GOCC CHROMOSOMAL REGION 384 8.22e-11 7.11e-09 0.195000 1.60e-01 -1.12e-01 6.93e-08 1.72e-04
GOBP REGULATION OF GRANULOCYTE DIFFERENTIATION 16 3.73e-01 6.59e-01 0.195000 -1.34e-01 1.42e-01 3.54e-01 3.24e-01
APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint 61 2.69e-02 1.56e-01 0.195000 4.57e-02 -1.90e-01 5.37e-01 1.03e-02
GOMF L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 63 3.11e-02 1.70e-01 0.195000 1.87e-01 5.48e-02 1.01e-02 4.52e-01
GOBP VASCULAR WOUND HEALING 23 2.85e-01 5.82e-01 0.195000 1.82e-01 7.08e-02 1.31e-01 5.57e-01
GOBP SMOOTH MUSCLE TISSUE DEVELOPMENT 27 2.11e-01 5.06e-01 0.195000 1.95e-01 -5.52e-03 7.92e-02 9.60e-01
GOBP ACTIN NUCLEATION 56 3.31e-02 1.76e-01 0.195000 1.71e-01 -9.44e-02 2.70e-02 2.22e-01
Interleukin-27 signaling 11 5.33e-01 7.73e-01 0.195000 1.95e-01 3.27e-03 2.62e-01 9.85e-01
GOCC PROTEASOME REGULATORY PARTICLE LID SUBCOMPLEX 7 6.62e-01 8.51e-01 0.195000 -3.35e-02 1.92e-01 8.78e-01 3.78e-01
GOBP CHROMOSOME SEPARATION 81 8.07e-03 6.75e-02 0.195000 1.87e-01 -5.43e-02 3.53e-03 3.98e-01
DNA strand elongation 31 1.53e-01 4.31e-01 0.195000 1.76e-01 -8.45e-02 9.00e-02 4.16e-01
GOBP POSITIVE REGULATION OF KIDNEY DEVELOPMENT 9 5.93e-01 8.12e-01 0.195000 1.42e-02 -1.95e-01 9.41e-01 3.12e-01
GOMF SINGLE STRANDED DNA HELICASE ACTIVITY 23 2.66e-01 5.62e-01 0.195000 1.95e-01 -4.79e-03 1.05e-01 9.68e-01
GOBP GRANULOCYTE COLONY STIMULATING FACTOR SIGNALING PATHWAY 5 7.65e-01 9.01e-01 0.195000 -1.07e-01 -1.63e-01 6.80e-01 5.27e-01
GOCC TELOMERASE HOLOENZYME COMPLEX 20 3.22e-01 6.14e-01 0.195000 1.94e-01 1.69e-02 1.32e-01 8.96e-01
GOBP UTERINE SMOOTH MUSCLE CONTRACTION 10 5.64e-01 7.93e-01 0.195000 1.95e-01 1.07e-03 2.86e-01 9.95e-01
GOBP NEUTROPHIL HOMEOSTASIS 19 3.18e-01 6.10e-01 0.195000 1.80e-01 -7.53e-02 1.75e-01 5.70e-01
GOBP LIPID MODIFICATION 187 4.98e-05 1.18e-03 0.195000 1.61e-01 1.10e-01 1.50e-04 9.18e-03
GOBP CELLULAR RESPONSE TO SODIUM ARSENITE 5 7.48e-01 8.91e-01 0.195000 2.00e-02 -1.94e-01 9.38e-01 4.53e-01
GOMF DYNEIN LIGHT INTERMEDIATE CHAIN BINDING 28 1.97e-01 4.90e-01 0.195000 -1.92e-02 1.94e-01 8.60e-01 7.56e-02
GOBP REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY 39 1.15e-01 3.68e-01 0.195000 -1.90e-01 -4.26e-02 3.98e-02 6.46e-01
GOBP VIRAL RELEASE FROM HOST CELL 28 2.27e-01 5.23e-01 0.195000 -1.35e-01 -1.41e-01 2.17e-01 1.97e-01
Synthesis of bile acids and bile salts 33 1.68e-01 4.53e-01 0.195000 1.77e-01 8.17e-02 7.85e-02 4.17e-01
GOCC MISMATCH REPAIR COMPLEX 10 5.84e-01 8.05e-01 0.195000 1.73e-01 8.97e-02 3.43e-01 6.23e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 89 5.21e-03 4.88e-02 0.195000 1.89e-01 -4.89e-02 2.10e-03 4.25e-01
GOBP EPITHELIAL TUBE FORMATION 134 3.90e-04 6.44e-03 0.195000 1.91e-01 -3.98e-02 1.38e-04 4.27e-01
GOBP ENDOCRINE PANCREAS DEVELOPMENT 44 6.79e-02 2.72e-01 0.195000 1.56e-01 -1.16e-01 7.29e-02 1.82e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 11 5.10e-01 7.60e-01 0.195000 1.58e-01 -1.14e-01 3.65e-01 5.11e-01
GOMF ALL TRANS RETINOL DEHYDROGENASE NADPPLUS ACTIVITY 13 4.57e-01 7.22e-01 0.195000 1.78e-01 -7.98e-02 2.67e-01 6.18e-01
GOBP RESPONSE TO PROSTAGLANDIN 32 1.41e-01 4.13e-01 0.195000 1.53e-01 -1.21e-01 1.35e-01 2.36e-01
GOBP NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION 22 3.05e-01 5.98e-01 0.195000 1.78e-01 7.82e-02 1.48e-01 5.26e-01
Defects of platelet adhesion to exposed collagen 8 6.25e-01 8.32e-01 0.195000 -3.61e-02 1.91e-01 8.60e-01 3.49e-01
DNA Repair 298 1.87e-08 1.08e-06 0.195000 1.74e-01 -8.67e-02 2.25e-07 1.00e-02
IRE1alpha activates chaperones 45 8.31e-02 3.08e-01 0.195000 1.90e-01 4.15e-02 2.73e-02 6.30e-01
GOBP REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY 52 6.41e-02 2.63e-01 0.195000 -1.40e-01 -1.35e-01 8.02e-02 9.22e-02
GOCC UNIPLEX COMPLEX 6 7.19e-01 8.79e-01 0.195000 1.88e-01 5.16e-02 4.26e-01 8.27e-01
GOBP NUCLEOSIDE BISPHOSPHATE CATABOLIC PROCESS 11 5.56e-01 7.89e-01 0.195000 -1.05e-01 -1.64e-01 5.46e-01 3.47e-01
Rev-mediated nuclear export of HIV RNA 35 1.27e-01 3.89e-01 0.195000 1.90e-01 -4.40e-02 5.23e-02 6.53e-01
Estrogen biosynthesis 6 7.02e-01 8.71e-01 0.195000 1.88e-01 -4.85e-02 4.24e-01 8.37e-01
GOCC NUCLEAR CYCLIN DEPENDENT PROTEIN KINASE HOLOENZYME COMPLEX 13 4.53e-01 7.21e-01 0.195000 1.64e-01 -1.05e-01 3.07e-01 5.10e-01
GOBP DNA REPLICATION SYNTHESIS OF PRIMER 6 7.10e-01 8.75e-01 0.195000 1.95e-01 -1.13e-03 4.09e-01 9.96e-01
GOCC CHROMATIN SILENCING COMPLEX 12 5.06e-01 7.57e-01 0.195000 1.94e-01 4.72e-03 2.43e-01 9.77e-01
GOBP EMBRYONIC PLACENTA MORPHOGENESIS 26 2.17e-01 5.12e-01 0.195000 4.13e-02 -1.90e-01 7.16e-01 9.34e-02
GOCC CCAAT BINDING FACTOR COMPLEX 5 7.64e-01 9.00e-01 0.194000 1.78e-01 7.89e-02 4.91e-01 7.60e-01
GOBP CARDIAC CELL DEVELOPMENT 92 6.47e-03 5.73e-02 0.194000 1.89e-01 4.70e-02 1.77e-03 4.36e-01
GOBP NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT 12 5.31e-01 7.72e-01 0.194000 1.24e-01 1.50e-01 4.58e-01 3.69e-01
GOCC MRNA CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR COMPLEX 17 4.05e-01 6.87e-01 0.194000 1.66e-01 1.02e-01 2.37e-01 4.68e-01
GOBP PEPTIDYL TYROSINE AUTOPHOSPHORYLATION 16 4.16e-01 6.97e-01 0.194000 1.88e-01 4.96e-02 1.93e-01 7.31e-01
GOBP NEGATIVE REGULATION OF GLIOGENESIS 44 9.79e-02 3.36e-01 0.194000 1.56e-01 1.16e-01 7.30e-02 1.85e-01
Signaling by Rho GTPases, Miro GTPases and RHOBTB3 643 2.29e-16 6.11e-14 0.194000 1.94e-01 -1.63e-02 5.18e-17 4.80e-01
Association of TriC/CCT with target proteins during biosynthesis 38 9.88e-02 3.37e-01 0.194000 1.48e-01 -1.26e-01 1.14e-01 1.79e-01
GOBP ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE 99 5.42e-03 5.01e-02 0.194000 -1.57e-01 -1.14e-01 6.78e-03 5.04e-02
GOCC COPI COATED VESICLE MEMBRANE 18 3.34e-01 6.24e-01 0.194000 1.44e-01 -1.30e-01 2.91e-01 3.38e-01
GOBP ATP SYNTHESIS COUPLED ELECTRON TRANSPORT 84 7.35e-03 6.32e-02 0.194000 4.43e-02 -1.89e-01 4.83e-01 2.74e-03
Signaling by BRAF and RAF1 fusions 63 2.99e-02 1.66e-01 0.194000 1.93e-01 2.25e-02 8.11e-03 7.58e-01
MET promotes cell motility 41 1.02e-01 3.43e-01 0.194000 1.93e-01 2.42e-02 3.28e-02 7.89e-01
GOBP ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY 17 3.55e-01 6.45e-01 0.194000 1.50e-01 -1.24e-01 2.85e-01 3.78e-01
GOBP CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 202 6.49e-06 1.98e-04 0.194000 1.80e-01 -7.19e-02 1.00e-05 7.81e-02
GOBP RIBOSOMAL LARGE SUBUNIT BIOGENESIS 66 2.33e-02 1.42e-01 0.194000 8.28e-03 -1.94e-01 9.07e-01 6.46e-03
Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal 91 4.48e-03 4.36e-02 0.194000 1.80e-01 -7.35e-02 3.07e-03 2.25e-01
Amplification of signal from the kinetochores 91 4.48e-03 4.36e-02 0.194000 1.80e-01 -7.35e-02 3.07e-03 2.25e-01
GOBP VACUOLE FUSION 12 5.32e-01 7.73e-01 0.194000 -1.41e-01 -1.33e-01 3.97e-01 4.25e-01
Class C/3 (Metabotropic glutamate/pheromone receptors) 39 9.37e-02 3.28e-01 0.194000 -1.23e-01 1.50e-01 1.83e-01 1.06e-01
GOMF POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING 52 5.66e-02 2.43e-01 0.194000 1.91e-01 3.23e-02 1.70e-02 6.87e-01
GOBP MESENCHYMAL CELL PROLIFERATION INVOLVED IN LUNG DEVELOPMENT 6 7.13e-01 8.76e-01 0.194000 1.94e-01 7.97e-03 4.11e-01 9.73e-01
GOBP NEUTROPHIL CLEARANCE 6 7.29e-01 8.84e-01 0.194000 1.27e-01 1.46e-01 5.90e-01 5.34e-01
GOBP RETROGRADE TRANSPORT VESICLE RECYCLING WITHIN GOLGI 9 5.89e-01 8.08e-01 0.194000 5.34e-02 -1.86e-01 7.81e-01 3.33e-01
GOBP POSITIVE REGULATION OF VESICLE FUSION 10 5.45e-01 7.81e-01 0.194000 -1.19e-01 1.53e-01 5.16e-01 4.01e-01
GOBP INCLUSION BODY ASSEMBLY 23 2.60e-01 5.57e-01 0.194000 -4.52e-02 1.89e-01 7.08e-01 1.17e-01
Signaling by Rho GTPases 629 6.26e-16 1.54e-13 0.194000 1.93e-01 -1.25e-02 1.15e-16 5.92e-01
GOBP EPOXYGENASE P450 PATHWAY 17 4.10e-01 6.91e-01 0.194000 -1.36e-01 -1.38e-01 3.32e-01 3.24e-01
GOBP NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING 8 6.50e-01 8.45e-01 0.194000 1.82e-01 6.61e-02 3.72e-01 7.46e-01
GOBP POSITIVE REGULATION OF ORGAN GROWTH 49 7.64e-02 2.92e-01 0.194000 1.52e-01 1.20e-01 6.49e-02 1.47e-01
GOBP REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY 15 4.10e-01 6.91e-01 0.194000 -7.30e-02 1.80e-01 6.25e-01 2.29e-01
GOBP POSITIVE REGULATION OF TORC1 SIGNALING 50 4.93e-02 2.24e-01 0.194000 1.65e-01 -1.02e-01 4.38e-02 2.13e-01
GOBP CARNITINE TRANSMEMBRANE TRANSPORT 6 7.17e-01 8.78e-01 0.194000 -2.57e-02 -1.92e-01 9.13e-01 4.15e-01
GOBP POSITIVE REGULATION OF PLATELET ACTIVATION 12 4.84e-01 7.42e-01 0.194000 -1.15e-01 1.56e-01 4.89e-01 3.51e-01
GOBP POSITIVE REGULATION OF DNA BINDING 37 1.12e-01 3.63e-01 0.194000 1.82e-01 -6.62e-02 5.53e-02 4.86e-01
GOBP RESCUE OF STALLED RIBOSOME 33 1.42e-01 4.14e-01 0.194000 1.82e-01 -6.64e-02 7.05e-02 5.09e-01
GOBP FIBRINOLYSIS 27 2.11e-01 5.06e-01 0.194000 -2.73e-02 1.92e-01 8.06e-01 8.47e-02
Hydrolysis of LPC 9 6.13e-01 8.24e-01 0.194000 1.87e-01 5.17e-02 3.32e-01 7.88e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL FISSION 21 3.33e-01 6.24e-01 0.194000 1.41e-01 1.32e-01 2.63e-01 2.93e-01
Hh mutants abrogate ligand secretion 46 7.13e-02 2.80e-01 0.194000 2.36e-02 -1.92e-01 7.82e-01 2.41e-02
Negative regulation of TCF-dependent signaling by DVL-interacting proteins 5 7.64e-01 9.00e-01 0.194000 1.82e-01 6.53e-02 4.81e-01 8.00e-01
GOBP ATRIAL CARDIAC MUSCLE TISSUE MORPHOGENESIS 6 7.02e-01 8.71e-01 0.194000 1.84e-01 -5.91e-02 4.34e-01 8.02e-01
GOBP NEGATIVE REGULATION OF CELLULAR EXTRAVASATION 9 6.22e-01 8.30e-01 0.193000 1.03e-01 1.64e-01 5.92e-01 3.95e-01
GOCC EXTRINSIC COMPONENT OF ORGANELLE MEMBRANE 23 2.49e-01 5.46e-01 0.193000 1.44e-01 -1.29e-01 2.31e-01 2.85e-01
GOBP ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION 21 2.84e-01 5.81e-01 0.193000 1.02e-01 -1.64e-01 4.18e-01 1.93e-01
GOBP REGULATION OF ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION 6 7.07e-01 8.73e-01 0.193000 1.90e-01 -3.68e-02 4.21e-01 8.76e-01
TFAP2 (AP-2) family regulates transcription of growth factors and their receptors 12 5.19e-01 7.63e-01 0.193000 1.89e-01 4.10e-02 2.57e-01 8.06e-01
GOBP INTRACELLULAR LIPID TRANSPORT 50 7.12e-02 2.80e-01 0.193000 8.82e-02 1.72e-01 2.80e-01 3.55e-02
BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members 9 5.81e-01 8.03e-01 0.193000 1.42e-01 -1.31e-01 4.60e-01 4.97e-01
GOBP NON LYTIC VIRAL RELEASE 14 4.74e-01 7.34e-01 0.193000 -1.78e-01 -7.62e-02 2.50e-01 6.22e-01
GOCC X CHROMOSOME 11 5.42e-01 7.80e-01 0.193000 1.93e-01 1.20e-02 2.68e-01 9.45e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME 11 5.32e-01 7.73e-01 0.193000 2.67e-02 -1.91e-01 8.78e-01 2.72e-01
GOMF NADPLUS NUCLEOTIDASE CYCLIC ADP RIBOSE GENERATING 14 4.40e-01 7.13e-01 0.193000 -1.83e-01 6.11e-02 2.35e-01 6.92e-01
GOBP NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION 23 2.52e-01 5.49e-01 0.193000 1.04e-01 -1.63e-01 3.89e-01 1.77e-01
GOBP GLYCEROL TRANSMEMBRANE TRANSPORT 7 6.95e-01 8.68e-01 0.193000 1.42e-01 1.31e-01 5.15e-01 5.49e-01
GOMF GLYCEROL TRANSMEMBRANE TRANSPORTER ACTIVITY 7 6.95e-01 8.68e-01 0.193000 1.42e-01 1.31e-01 5.15e-01 5.49e-01
GOBP AMP METABOLIC PROCESS 22 2.98e-01 5.94e-01 0.193000 2.79e-02 1.91e-01 8.21e-01 1.21e-01
GOBP PATTERN SPECIFICATION PROCESS 453 9.80e-12 1.04e-09 0.193000 1.92e-01 -2.08e-02 2.47e-12 4.48e-01
GOBP PROTEIN TRANSPORT WITHIN LIPID BILAYER 6 7.11e-01 8.76e-01 0.193000 1.55e-02 -1.92e-01 9.48e-01 4.14e-01
VEGFA-VEGFR2 Pathway 94 6.41e-03 5.69e-02 0.193000 1.85e-01 5.45e-02 1.92e-03 3.61e-01
GOBP NEGATIVE REGULATION OF DEPHOSPHORYLATION 31 1.69e-01 4.54e-01 0.193000 1.91e-01 -3.05e-02 6.63e-02 7.69e-01
GOBP POSITIVE REGULATION OF LIPID CATABOLIC PROCESS 26 2.40e-01 5.36e-01 0.193000 2.75e-02 1.91e-01 8.08e-01 9.19e-02
GOBP SYNAPTIC VESICLE UNCOATING 7 6.60e-01 8.50e-01 0.193000 -1.72e-01 8.73e-02 4.31e-01 6.89e-01
Diseases of DNA repair 51 4.69e-02 2.18e-01 0.193000 1.23e-01 -1.48e-01 1.28e-01 6.68e-02
GOBP REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY 35 1.30e-01 3.94e-01 0.193000 5.59e-02 -1.85e-01 5.67e-01 5.89e-02
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY 7 6.88e-01 8.65e-01 0.193000 -1.81e-01 -6.52e-02 4.06e-01 7.65e-01
GOBP NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 34 1.40e-01 4.12e-01 0.193000 1.88e-01 -4.31e-02 5.80e-02 6.64e-01
GOBP EMBRYONIC MORPHOGENESIS 605 2.32e-15 4.69e-13 0.193000 1.91e-01 -2.79e-02 1.08e-15 2.42e-01
GOBP GLUCOSE CATABOLIC PROCESS 25 2.34e-01 5.31e-01 0.193000 -5.01e-02 1.86e-01 6.65e-01 1.07e-01
GOBP REGULATION OF DEFENSE RESPONSE TO BACTERIUM 20 3.19e-01 6.11e-01 0.193000 2.75e-02 -1.91e-01 8.31e-01 1.40e-01
GOBP OLIGOPEPTIDE TRANSPORT 19 3.72e-01 6.59e-01 0.193000 1.58e-01 1.11e-01 2.34e-01 4.03e-01
GOBP AROMATIC AMINO ACID METABOLIC PROCESS 31 1.57e-01 4.38e-01 0.193000 -1.60e-01 1.08e-01 1.24e-01 2.99e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE CHEMOTAXIS 7 6.64e-01 8.51e-01 0.193000 -6.62e-02 1.81e-01 7.62e-01 4.07e-01
Signaling by ERBB2 KD Mutants 25 2.25e-01 5.21e-01 0.193000 1.58e-01 -1.11e-01 1.72e-01 3.39e-01
Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) 14 4.35e-01 7.10e-01 0.193000 1.65e-01 -9.85e-02 2.84e-01 5.23e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX RECEPTOR RECYCLING 6 7.01e-01 8.70e-01 0.193000 9.00e-02 -1.70e-01 7.03e-01 4.70e-01
GOBP NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 33 1.64e-01 4.48e-01 0.193000 1.91e-01 2.53e-02 5.78e-02 8.01e-01
GOBP NEURAL PRECURSOR CELL PROLIFERATION 165 1.27e-04 2.63e-03 0.192000 1.91e-01 2.66e-02 2.38e-05 5.56e-01
GOCC NEUROTRANSMITTER RECEPTOR COMPLEX 42 8.95e-02 3.20e-01 0.192000 -1.88e-01 4.21e-02 3.52e-02 6.37e-01
GOBP GAP JUNCTION ASSEMBLY 16 4.08e-01 6.89e-01 0.192000 1.92e-01 -7.22e-03 1.83e-01 9.60e-01
Defective GALNT12 causes CRCS1 18 3.55e-01 6.45e-01 0.192000 -1.87e-01 4.32e-02 1.69e-01 7.51e-01
Regulation of TP53 Activity 155 1.27e-04 2.63e-03 0.192000 1.82e-01 -6.24e-02 9.28e-05 1.80e-01
GOBP SPLICEOSOMAL COMPLEX ASSEMBLY 76 1.12e-02 8.54e-02 0.192000 1.66e-01 -9.62e-02 1.21e-02 1.47e-01
GOBP PROTEIN LOCALIZATION TO AXON 9 6.27e-01 8.33e-01 0.192000 1.09e-01 1.59e-01 5.72e-01 4.10e-01
GOMF LIM DOMAIN BINDING 5 7.63e-01 8.99e-01 0.192000 -3.81e-02 -1.88e-01 8.83e-01 4.66e-01
GOBP PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY 28 1.88e-01 4.79e-01 0.192000 -1.46e-01 1.24e-01 1.80e-01 2.54e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 4 PRODUCTION 7 6.94e-01 8.68e-01 0.192000 -1.67e-01 -9.44e-02 4.43e-01 6.65e-01
GOBP ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION 44 7.40e-02 2.87e-01 0.192000 1.65e-01 -9.91e-02 5.88e-02 2.55e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 6 7.20e-01 8.79e-01 0.192000 1.91e-01 2.01e-02 4.18e-01 9.32e-01
GOBP RESPONSE TO INCREASED OXYGEN LEVELS 23 2.79e-01 5.76e-01 0.192000 1.92e-01 9.15e-04 1.11e-01 9.94e-01
GOBP PROTEIN MONOUBIQUITINATION 46 7.98e-02 2.99e-01 0.192000 1.92e-01 1.35e-02 2.45e-02 8.74e-01
GOBP AMINO ACID BETAINE METABOLIC PROCESS 16 3.86e-01 6.70e-01 0.192000 1.54e-01 -1.14e-01 2.85e-01 4.29e-01
GOBP NEGATIVE REGULATION OF CIRCADIAN RHYTHM 11 5.19e-01 7.63e-01 0.192000 1.36e-01 -1.36e-01 4.36e-01 4.35e-01
GOBP POLARIZED EPITHELIAL CELL DIFFERENTIATION 25 2.36e-01 5.32e-01 0.192000 1.84e-01 -5.54e-02 1.12e-01 6.32e-01
SCF-beta-TrCP mediated degradation of Emi1 42 8.95e-02 3.20e-01 0.192000 4.89e-02 -1.86e-01 5.83e-01 3.74e-02
GOBP REGULATION OF TAU PROTEIN KINASE ACTIVITY 7 6.97e-01 8.69e-01 0.192000 1.17e-01 1.52e-01 5.93e-01 4.85e-01
GOBP NEGATIVE REGULATION OF SYNAPSE ASSEMBLY 8 6.32e-01 8.35e-01 0.192000 -4.59e-02 1.86e-01 8.22e-01 3.61e-01
GOBP REGULATION OF PHOSPHOLIPID TRANSLOCATION 6 7.34e-01 8.85e-01 0.192000 -1.53e-01 -1.16e-01 5.17e-01 6.21e-01
GOBP SHORT TERM MEMORY 10 5.53e-01 7.87e-01 0.192000 1.57e-01 -1.11e-01 3.91e-01 5.44e-01
GOBP EMBRYONIC ORGAN DEVELOPMENT 448 1.34e-11 1.38e-09 0.192000 1.89e-01 -3.54e-02 7.66e-12 1.99e-01
GOBP VITAMIN A METABOLIC PROCESS 8 6.49e-01 8.45e-01 0.192000 1.88e-01 3.60e-02 3.56e-01 8.60e-01
GOBP TRIGLYCERIDE CATABOLIC PROCESS 27 2.16e-01 5.11e-01 0.192000 -1.89e-01 3.13e-02 8.88e-02 7.79e-01
GOBP SEROTONIN METABOLIC PROCESS 10 5.90e-01 8.09e-01 0.192000 6.36e-02 1.81e-01 7.28e-01 3.22e-01
PPARA activates gene expression 113 2.28e-03 2.60e-02 0.192000 1.89e-01 2.98e-02 5.09e-04 5.84e-01
GOCC SPERM MIDPIECE 54 5.71e-02 2.45e-01 0.192000 -1.84e-01 -5.47e-02 1.96e-02 4.87e-01
Signaling by WNT 276 1.43e-07 6.85e-06 0.192000 1.82e-01 -6.06e-02 2.02e-07 8.29e-02
GOBP TRICARBOXYLIC ACID TRANSPORT 5 7.73e-01 9.05e-01 0.192000 -1.16e-01 -1.53e-01 6.54e-01 5.55e-01
GOBP REGULATION OF ELECTRON TRANSFER ACTIVITY 5 7.53e-01 8.94e-01 0.191000 3.28e-02 -1.89e-01 8.99e-01 4.65e-01
Neurofascin interactions 6 7.07e-01 8.73e-01 0.191000 -6.21e-02 1.81e-01 7.92e-01 4.42e-01
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS 80 8.89e-03 7.26e-02 0.191000 1.22e-01 -1.48e-01 5.98e-02 2.23e-02
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION INITIATION 15 4.19e-01 6.99e-01 0.191000 1.77e-01 -7.33e-02 2.36e-01 6.23e-01
GOCC PAM COMPLEX TIM23 ASSOCIATED IMPORT MOTOR 5 7.65e-01 9.01e-01 0.191000 -1.87e-01 -3.89e-02 4.68e-01 8.80e-01
GOBP HEART VALVE MORPHOGENESIS 61 4.01e-02 1.97e-01 0.191000 1.83e-01 5.63e-02 1.35e-02 4.47e-01
GOBP PROTEIN O LINKED GLYCOSYLATION VIA SERINE 10 5.93e-01 8.12e-01 0.191000 7.56e-02 1.76e-01 6.79e-01 3.36e-01
Nicotinate metabolism 31 2.04e-01 4.98e-01 0.191000 1.10e-01 1.56e-01 2.89e-01 1.32e-01
Sodium/Calcium exchangers 11 5.22e-01 7.65e-01 0.191000 -1.42e-01 1.28e-01 4.15e-01 4.62e-01
GOCC TORC1 COMPLEX 6 7.35e-01 8.86e-01 0.191000 1.57e-01 1.09e-01 5.06e-01 6.42e-01
Estrogen-dependent gene expression 113 1.33e-03 1.72e-02 0.191000 1.58e-01 -1.08e-01 3.71e-03 4.80e-02
GOBP REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS 13 5.14e-01 7.61e-01 0.191000 -1.14e-01 -1.53e-01 4.76e-01 3.38e-01
GOBP CELL MIGRATION INVOLVED IN METANEPHROS DEVELOPMENT 5 7.50e-01 8.92e-01 0.191000 1.82e-01 -5.80e-02 4.81e-01 8.22e-01
GOBP AMACRINE CELL DIFFERENTIATION 12 5.12e-01 7.61e-01 0.191000 1.90e-01 -1.61e-02 2.53e-01 9.23e-01
Formation of paraxial mesoderm 58 3.27e-02 1.75e-01 0.191000 1.45e-01 -1.25e-01 5.69e-02 9.93e-02
Formation of the ureteric bud 21 2.92e-01 5.88e-01 0.191000 1.02e-01 -1.61e-01 4.16e-01 2.01e-01
GOCC INTERMEDIATE FILAMENT CYTOSKELETON 237 9.59e-07 3.68e-05 0.191000 -1.43e-01 1.27e-01 1.48e-04 7.81e-04
Acyl chain remodelling of PE 29 1.91e-01 4.83e-01 0.191000 1.84e-01 -5.04e-02 8.58e-02 6.39e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION ELONGATION BY RNA POLYMERASE II 48 6.15e-02 2.55e-01 0.191000 1.72e-01 -8.37e-02 3.95e-02 3.16e-01
GOBP REGULATION OF BONE MINERALIZATION INVOLVED IN BONE MATURATION 7 6.62e-01 8.51e-01 0.191000 -1.26e-01 1.44e-01 5.65e-01 5.09e-01
TRAF6-mediated induction of TAK1 complex within TLR4 complex 15 4.13e-01 6.93e-01 0.191000 1.28e-01 -1.42e-01 3.91e-01 3.41e-01
RHOBTB3 ATPase cycle 8 6.64e-01 8.52e-01 0.191000 1.17e-01 1.51e-01 5.65e-01 4.60e-01
GOBP RHO PROTEIN SIGNAL TRANSDUCTION 137 7.97e-04 1.15e-02 0.191000 1.79e-01 6.69e-02 2.98e-04 1.77e-01
Metabolism of non-coding RNA 52 4.84e-02 2.22e-01 0.191000 8.89e-02 -1.69e-01 2.67e-01 3.49e-02
snRNP Assembly 52 4.84e-02 2.22e-01 0.191000 8.89e-02 -1.69e-01 2.67e-01 3.49e-02
GOCC APOLIPOPROTEIN B MRNA EDITING ENZYME COMPLEX 5 7.69e-01 9.03e-01 0.191000 1.80e-01 6.41e-02 4.86e-01 8.04e-01
Semaphorin interactions 61 3.58e-02 1.86e-01 0.191000 1.91e-01 7.16e-03 9.92e-03 9.23e-01
Cdc20:Phospho-APC/C mediated degradation of Cyclin A 60 3.25e-02 1.75e-01 0.191000 5.57e-02 -1.83e-01 4.56e-01 1.44e-02
GOBP POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY 14 4.40e-01 7.13e-01 0.191000 1.08e-01 -1.57e-01 4.83e-01 3.08e-01
GOMF ATP DEPENDENT DNA DAMAGE SENSOR ACTIVITY 19 3.63e-01 6.51e-01 0.191000 1.87e-01 3.99e-02 1.59e-01 7.64e-01
GOBP GOLGI LOCALIZATION 14 4.53e-01 7.21e-01 0.191000 1.87e-01 -4.00e-02 2.26e-01 7.95e-01
GOMF PHOSPHATIDYLINOSITOL PHOSPHATE BINDING 170 1.67e-04 3.28e-03 0.191000 1.67e-01 9.33e-02 1.78e-04 3.59e-02
GOMF FERROUS IRON TRANSMEMBRANE TRANSPORTER ACTIVITY 5 7.73e-01 9.05e-01 0.191000 9.60e-02 1.65e-01 7.10e-01 5.23e-01
GOBP POSITIVE REGULATION OF CELL MORPHOGENESIS 32 1.82e-01 4.72e-01 0.191000 3.99e-02 1.87e-01 6.96e-01 6.76e-02
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL 99 3.53e-03 3.61e-02 0.191000 1.82e-01 -5.78e-02 1.75e-03 3.20e-01
GOCC HOST CELLULAR COMPONENT 9 6.12e-01 8.23e-01 0.191000 -1.04e-02 -1.91e-01 9.57e-01 3.22e-01
GOMF MHC CLASS II PROTEIN COMPLEX BINDING 25 2.63e-01 5.60e-01 0.191000 -3.41e-02 -1.88e-01 7.68e-01 1.04e-01
Hh mutants are degraded by ERAD 43 8.54e-02 3.13e-01 0.191000 5.99e-02 -1.81e-01 4.97e-01 3.98e-02
GOMF TOXIN TRANSMEMBRANE TRANSPORTER ACTIVITY 9 6.24e-01 8.31e-01 0.191000 1.80e-01 6.35e-02 3.50e-01 7.42e-01
GOBP NEGATIVE REGULATION OF TYPE II INTERFERON PRODUCTION 40 9.74e-02 3.35e-01 0.191000 -9.23e-02 1.67e-01 3.12e-01 6.76e-02
GOBP NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 27 2.22e-01 5.17e-01 0.191000 1.89e-01 -2.29e-02 8.84e-02 8.37e-01
APC/C:Cdc20 mediated degradation of mitotic proteins 63 2.97e-02 1.65e-01 0.191000 2.67e-02 -1.89e-01 7.14e-01 9.51e-03
GOBP NEGATIVE REGULATION OF GLIAL CELL MIGRATION 6 7.03e-01 8.71e-01 0.191000 1.18e-01 -1.50e-01 6.17e-01 5.25e-01
GOBP REGULATION OF DIGESTIVE SYSTEM PROCESS 39 1.36e-01 4.04e-01 0.191000 1.62e-01 1.00e-01 7.94e-02 2.79e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN CYCLIC AMIDINES 34 1.41e-01 4.13e-01 0.191000 -7.12e-02 1.77e-01 4.72e-01 7.42e-02
Signaling by Erythropoietin 25 2.37e-01 5.34e-01 0.191000 1.77e-01 -6.98e-02 1.25e-01 5.46e-01
GOBP REGULATION OF WOUND HEALING SPREADING OF EPIDERMAL CELLS 10 5.95e-01 8.13e-01 0.191000 7.42e-02 1.76e-01 6.84e-01 3.36e-01
GOBP REGULATION OF AMYLOID FIBRIL FORMATION 16 4.05e-01 6.88e-01 0.191000 4.04e-02 -1.86e-01 7.80e-01 1.97e-01
GOCC MITOCHONDRIAL SMALL RIBOSOMAL SUBUNIT 32 1.71e-01 4.57e-01 0.191000 1.24e-02 -1.90e-01 9.04e-01 6.26e-02
GOBP PHENOTYPIC SWITCHING 16 4.31e-01 7.06e-01 0.191000 1.83e-01 5.26e-02 2.05e-01 7.16e-01
Cell Cycle Checkpoints 252 4.32e-07 1.86e-05 0.191000 1.33e-01 -1.37e-01 2.80e-04 1.88e-04
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION 5 7.54e-01 8.95e-01 0.191000 1.87e-01 -3.84e-02 4.70e-01 8.82e-01
GOBP VENTRICULAR SEPTUM DEVELOPMENT 75 1.70e-02 1.14e-01 0.191000 1.90e-01 4.93e-03 4.34e-03 9.41e-01
GOBP REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 5 7.64e-01 9.00e-01 0.191000 -2.38e-02 -1.89e-01 9.27e-01 4.64e-01
GOBP POSITIVE REGULATION OF T HELPER 2 CELL CYTOKINE PRODUCTION 9 5.98e-01 8.14e-01 0.190000 -6.26e-02 1.80e-01 7.45e-01 3.50e-01
GOCC CATION TRANSPORTING ATPASE COMPLEX 18 3.56e-01 6.45e-01 0.190000 -7.10e-02 1.77e-01 6.02e-01 1.94e-01
GOBP CELLULAR RESPONSE TO THYROID HORMONE STIMULUS 12 5.42e-01 7.80e-01 0.190000 1.61e-01 1.03e-01 3.36e-01 5.39e-01
GOBP TELOMERE CAPPING 39 1.02e-01 3.43e-01 0.190000 1.40e-01 -1.29e-01 1.30e-01 1.63e-01
RNA Polymerase III Abortive And Retractive Initiation 41 9.07e-02 3.22e-01 0.190000 1.44e-01 -1.25e-01 1.11e-01 1.66e-01
RNA Polymerase III Transcription 41 9.07e-02 3.22e-01 0.190000 1.44e-01 -1.25e-01 1.11e-01 1.66e-01
GOBP POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS 26 2.64e-01 5.61e-01 0.190000 1.65e-01 9.44e-02 1.44e-01 4.04e-01
GOBP SINGLE STRAND BREAK REPAIR 11 5.61e-01 7.92e-01 0.190000 1.84e-01 4.96e-02 2.91e-01 7.76e-01
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids 6 7.04e-01 8.72e-01 0.190000 -1.18e-01 1.49e-01 6.16e-01 5.27e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY 18 3.87e-01 6.71e-01 0.190000 -4.54e-02 -1.85e-01 7.39e-01 1.75e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 54 5.93e-02 2.50e-01 0.190000 -5.38e-02 -1.83e-01 4.94e-01 2.03e-02
GOBP ETHER BIOSYNTHETIC PROCESS 12 5.40e-01 7.78e-01 0.190000 -8.36e-02 -1.71e-01 6.16e-01 3.05e-01
GOBP REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION 17 3.85e-01 6.70e-01 0.190000 1.87e-01 -3.67e-02 1.83e-01 7.93e-01
GOBP INNER EAR MORPHOGENESIS 105 3.47e-03 3.57e-02 0.190000 1.90e-01 1.01e-02 7.66e-04 8.58e-01
GOBP SUBSTRATE INDEPENDENT TELENCEPHALIC TANGENTIAL MIGRATION 9 6.16e-01 8.26e-01 0.190000 -1.77e-02 -1.89e-01 9.27e-01 3.25e-01
Regulation of RUNX2 expression and activity 59 3.18e-02 1.72e-01 0.190000 1.33e-01 -1.36e-01 7.64e-02 7.14e-02
GOBP NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 123 1.73e-03 2.11e-02 0.190000 1.78e-01 6.65e-02 6.38e-04 2.03e-01
Signal regulatory protein family interactions 15 4.19e-01 6.99e-01 0.190000 -1.63e-01 9.78e-02 2.74e-01 5.12e-01
GOBP REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 182 2.77e-05 7.11e-04 0.190000 9.96e-02 -1.62e-01 2.04e-02 1.63e-04
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS 21 3.02e-01 5.97e-01 0.190000 6.35e-02 -1.79e-01 6.15e-01 1.55e-01
GOCC GUANYL NUCLEOTIDE EXCHANGE FACTOR COMPLEX 21 3.30e-01 6.21e-01 0.190000 1.85e-01 4.20e-02 1.41e-01 7.39e-01
GOBP TUBE FORMATION 148 2.70e-04 4.79e-03 0.190000 1.87e-01 -3.25e-02 8.32e-05 4.95e-01
GOBP RESPONSE TO INTERLEUKIN 7 15 4.68e-01 7.30e-01 0.190000 -1.47e-01 -1.21e-01 3.24e-01 4.18e-01
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS 22 3.29e-01 6.20e-01 0.190000 1.46e-01 1.22e-01 2.37e-01 3.21e-01
GOBP REGULATION OF PROTEIN STABILITY 308 2.23e-08 1.26e-06 0.190000 1.65e-01 -9.45e-02 6.34e-07 4.32e-03
GOBP RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR 17 3.84e-01 6.69e-01 0.190000 -1.85e-01 4.48e-02 1.87e-01 7.49e-01
GOBP POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION 26 2.69e-01 5.66e-01 0.190000 1.40e-01 1.29e-01 2.17e-01 2.56e-01
GOBP TRANSCRIPTION ELONGATION COUPLED CHROMATIN REMODELING 9 6.20e-01 8.27e-01 0.190000 1.88e-01 2.99e-02 3.30e-01 8.77e-01
RNA polymerase II transcribes snRNA genes 74 1.34e-02 9.75e-02 0.190000 1.33e-01 -1.36e-01 4.78e-02 4.37e-02
Co-stimulation by CD28 47 7.93e-02 2.99e-01 0.190000 1.90e-01 8.78e-03 2.44e-02 9.17e-01
GOBP RETROGRADE TRANSPORT ENDOSOME TO GOLGI 98 3.95e-03 3.94e-02 0.190000 1.81e-01 -5.78e-02 1.96e-03 3.23e-01
GOCC NUCLEAR SPECK 393 2.37e-10 1.96e-08 0.190000 1.74e-01 -7.72e-02 3.48e-09 8.61e-03
GOMF CHEMOREPELLENT ACTIVITY 28 2.44e-01 5.40e-01 0.190000 1.29e-01 1.39e-01 2.36e-01 2.03e-01
Calnexin/calreticulin cycle 26 2.25e-01 5.21e-01 0.190000 1.71e-01 -8.28e-02 1.32e-01 4.65e-01
SUMOylation of RNA binding proteins 47 8.03e-02 3.01e-01 0.190000 1.89e-01 1.36e-02 2.47e-02 8.72e-01
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY TRANSPOSING C C BONDS 15 4.55e-01 7.22e-01 0.190000 -4.42e-02 -1.85e-01 7.67e-01 2.16e-01
GOBP REGULATION OF TRANSLATIONAL FIDELITY 18 3.52e-01 6.42e-01 0.190000 1.58e-01 -1.06e-01 2.47e-01 4.37e-01
GOMF MAGNESIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 16 3.97e-01 6.79e-01 0.190000 1.64e-01 -9.64e-02 2.57e-01 5.04e-01
GOBP REGULATION OF CANONICAL WNT SIGNALING PATHWAY 255 6.85e-07 2.77e-05 0.190000 1.84e-01 -4.81e-02 4.42e-07 1.86e-01
Cation-coupled Chloride cotransporters 7 6.74e-01 8.58e-01 0.190000 -4.84e-02 1.83e-01 8.24e-01 4.01e-01
GOBP PROTEIN DNA COMPLEX DISASSEMBLY 23 2.66e-01 5.62e-01 0.190000 9.28e-02 -1.65e-01 4.41e-01 1.69e-01
GOMF PIRNA BINDING 5 7.57e-01 8.96e-01 0.190000 -3.61e-02 1.86e-01 8.89e-01 4.71e-01
Apoptotic cleavage of cell adhesion proteins 11 5.54e-01 7.87e-01 0.190000 1.89e-01 1.42e-02 2.77e-01 9.35e-01
Regulation of IFNG signaling 14 4.51e-01 7.20e-01 0.190000 6.63e-02 -1.78e-01 6.67e-01 2.50e-01
GOBP AXONAL FASCICULATION 20 3.66e-01 6.53e-01 0.190000 1.22e-01 1.45e-01 3.44e-01 2.62e-01
GOBP MORPHOGENESIS OF EMBRYONIC EPITHELIUM 148 2.53e-04 4.57e-03 0.190000 1.82e-01 -5.26e-02 1.30e-04 2.69e-01
GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION 15 4.48e-01 7.18e-01 0.190000 -1.89e-01 -1.47e-02 2.05e-01 9.22e-01
GOBP NEGATIVE REGULATION OF FATTY ACID BETA OXIDATION 6 7.21e-01 8.80e-01 0.190000 -8.50e-03 1.89e-01 9.71e-01 4.22e-01
GOBP POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION 46 9.85e-02 3.37e-01 0.190000 1.57e-01 1.06e-01 6.48e-02 2.15e-01
GOBP REGULATION OF MITOCHONDRIAL FISSION 30 2.22e-01 5.18e-01 0.190000 1.41e-01 1.26e-01 1.80e-01 2.32e-01
GOBP MESENCHYMAL CELL DIFFERENTIATION 267 6.10e-07 2.50e-05 0.189000 1.89e-01 -2.02e-03 9.77e-08 9.55e-01
GOBP AMINO ACID IMPORT ACROSS PLASMA MEMBRANE 45 1.05e-01 3.49e-01 0.189000 1.34e-01 1.34e-01 1.21e-01 1.19e-01
GOCC COPI COATED VESICLE 25 2.36e-01 5.32e-01 0.189000 1.55e-01 -1.09e-01 1.79e-01 3.48e-01
GOBP POSITIVE REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE 7 6.97e-01 8.69e-01 0.189000 6.65e-02 1.77e-01 7.61e-01 4.16e-01
GOBP LYMPH NODE DEVELOPMENT 19 3.35e-01 6.25e-01 0.189000 1.60e-01 -1.01e-01 2.26e-01 4.48e-01
Constitutive Signaling by NOTCH1 HD Domain Mutants 15 4.65e-01 7.28e-01 0.189000 1.73e-01 7.70e-02 2.46e-01 6.06e-01
Signaling by NOTCH1 HD Domain Mutants in Cancer 15 4.65e-01 7.28e-01 0.189000 1.73e-01 7.70e-02 2.46e-01 6.06e-01
GOBP PROTEIN K6 LINKED UBIQUITINATION 16 4.48e-01 7.17e-01 0.189000 -1.52e-01 -1.13e-01 2.92e-01 4.36e-01
GOBP REGULATION OF MEMBRANE TUBULATION 5 7.53e-01 8.94e-01 0.189000 1.77e-01 -6.72e-02 4.93e-01 7.95e-01
GOBP PLASMA MEMBRANE RAFT ASSEMBLY 8 6.31e-01 8.34e-01 0.189000 -1.03e-01 1.59e-01 6.13e-01 4.37e-01
GOBP RIBONUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS 10 5.99e-01 8.15e-01 0.189000 7.11e-02 1.75e-01 6.97e-01 3.37e-01
GOCC CIA COMPLEX 5 7.51e-01 8.92e-01 0.189000 -8.62e-02 1.69e-01 7.39e-01 5.14e-01
GOBP POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 20 3.54e-01 6.44e-01 0.189000 5.13e-02 1.82e-01 6.91e-01 1.58e-01
GOBP MYOTUBE CELL DEVELOPMENT 41 1.18e-01 3.75e-01 0.189000 1.83e-01 4.65e-02 4.20e-02 6.07e-01
Evasion by RSV of host interferon responses 31 2.11e-01 5.07e-01 0.189000 -1.50e-01 -1.15e-01 1.48e-01 2.67e-01
Formation of Incision Complex in GG-NER 40 9.99e-02 3.39e-01 0.189000 1.56e-01 -1.07e-01 8.84e-02 2.39e-01
GOBP REGULATION OF SMOOTH MUSCLE CELL CHEMOTAXIS 7 6.67e-01 8.53e-01 0.189000 1.24e-01 -1.43e-01 5.69e-01 5.13e-01
GOBP SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 471 3.72e-11 3.39e-09 0.189000 1.83e-01 4.72e-02 9.44e-12 7.93e-02
GOMF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY 97 3.72e-03 3.75e-02 0.189000 -1.37e-01 1.31e-01 1.99e-02 2.61e-02
Intrinsic Pathway for Apoptosis 53 5.33e-02 2.35e-01 0.189000 1.86e-01 -3.59e-02 1.93e-02 6.51e-01
GOCC PRERIBOSOME 102 3.07e-03 3.26e-02 0.189000 7.96e-02 -1.72e-01 1.65e-01 2.75e-03
GOBP REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 175 9.80e-05 2.12e-03 0.189000 1.88e-01 1.88e-02 1.75e-05 6.68e-01
GOMF MECHANOSENSITIVE MONOATOMIC ION CHANNEL ACTIVITY 17 3.98e-01 6.80e-01 0.189000 6.23e-03 -1.89e-01 9.65e-01 1.77e-01
GOCC NUCLEAR PROTEIN CONTAINING COMPLEX 1191 1.69e-28 8.64e-26 0.189000 1.76e-01 -6.90e-02 1.25e-24 5.97e-05
GOMF INTRAMOLECULAR PHOSPHOTRANSFERASE ACTIVITY 10 5.67e-01 7.96e-01 0.189000 7.13e-02 -1.75e-01 6.96e-01 3.38e-01
Receptor Mediated Mitophagy 10 6.00e-01 8.16e-01 0.189000 1.74e-01 7.32e-02 3.40e-01 6.89e-01
GOBP PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY 7 6.95e-01 8.68e-01 0.189000 -4.88e-02 -1.83e-01 8.23e-01 4.03e-01
GOBP TRANSLATIONAL TERMINATION 15 4.37e-01 7.10e-01 0.189000 3.35e-02 -1.86e-01 8.22e-01 2.12e-01
GOBP DEMETHYLATION 41 1.21e-01 3.79e-01 0.189000 1.80e-01 5.72e-02 4.59e-02 5.26e-01
GOBP REGULATION OF CELL CYCLE CHECKPOINT 43 8.63e-02 3.14e-01 0.189000 1.69e-01 -8.53e-02 5.56e-02 3.33e-01
GOBP REGULATION OF RNA SPLICING 168 7.06e-05 1.59e-03 0.189000 1.64e-01 -9.44e-02 2.50e-04 3.47e-02
GOBP KERATINOCYTE MIGRATION 20 3.69e-01 6.56e-01 0.189000 1.25e-01 1.42e-01 3.35e-01 2.72e-01
GOBP GASTRULATION 192 2.41e-05 6.27e-04 0.189000 1.82e-01 -5.09e-02 1.38e-05 2.24e-01
Aspirin ADME 41 1.23e-01 3.82e-01 0.189000 -6.39e-02 -1.78e-01 4.79e-01 4.89e-02
TBC/RABGAPs 41 1.29e-01 3.92e-01 0.189000 1.54e-01 1.10e-01 8.86e-02 2.24e-01
GOBP GLUTATHIONE CATABOLIC PROCESS 7 6.73e-01 8.58e-01 0.189000 -7.14e-02 1.75e-01 7.44e-01 4.23e-01
GOBP POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS 34 1.46e-01 4.22e-01 0.189000 1.74e-01 -7.35e-02 7.93e-02 4.58e-01
Signaling by ERBB2 in Cancer 26 2.27e-01 5.23e-01 0.189000 1.64e-01 -9.37e-02 1.48e-01 4.08e-01
GOBP REGULATION OF L GLUTAMATE IMPORT ACROSS PLASMA MEMBRANE 8 6.65e-01 8.52e-01 0.189000 1.75e-01 7.19e-02 3.93e-01 7.25e-01
GOBP PLASMA CELL DIFFERENTIATION 9 6.00e-01 8.16e-01 0.189000 1.71e-01 -7.92e-02 3.74e-01 6.81e-01
GOBP URATE TRANSPORT 11 5.34e-01 7.74e-01 0.189000 -1.64e-01 9.31e-02 3.46e-01 5.93e-01
GOBP NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS 106 2.30e-03 2.61e-02 0.189000 1.45e-01 -1.20e-01 9.78e-03 3.21e-02
GOBP REGULATION OF MICROTUBULE POLYMERIZATION 59 4.44e-02 2.10e-01 0.189000 1.88e-01 1.75e-02 1.26e-02 8.16e-01
GOBP VASCULOGENESIS 82 1.64e-02 1.12e-01 0.189000 1.66e-01 8.90e-02 9.27e-03 1.63e-01
CRMPs in Sema3A signaling 15 4.73e-01 7.33e-01 0.188000 1.55e-01 1.07e-01 2.98e-01 4.74e-01
GOBP CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION 12 5.16e-01 7.62e-01 0.188000 1.84e-01 -3.93e-02 2.69e-01 8.14e-01
GOMF SPHINGOLIPID TRANSPORTER ACTIVITY 20 3.68e-01 6.55e-01 0.188000 1.62e-01 9.70e-02 2.11e-01 4.53e-01
GOBP POSITIVE REGULATION OF GLIOGENESIS 70 2.86e-02 1.62e-01 0.188000 1.76e-01 6.69e-02 1.08e-02 3.33e-01
GOBP MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 53 4.80e-02 2.21e-01 0.188000 1.28e-01 -1.38e-01 1.06e-01 8.23e-02
GOBP PROTEOGLYCAN BIOSYNTHETIC PROCESS 63 4.43e-02 2.10e-01 0.188000 1.27e-01 1.39e-01 8.22e-02 5.55e-02
DNA Replication 146 2.58e-04 4.63e-03 0.188000 9.67e-02 -1.62e-01 4.37e-02 7.47e-04
GOBP PROTEIN LIPID COMPLEX ASSEMBLY 30 2.26e-01 5.23e-01 0.188000 1.42e-01 1.24e-01 1.79e-01 2.40e-01
GOBP 3 UTR MEDIATED MRNA STABILIZATION 21 3.18e-01 6.10e-01 0.188000 1.86e-01 -2.76e-02 1.40e-01 8.26e-01
GOBP NON MOTILE CILIUM ASSEMBLY 62 3.12e-02 1.70e-01 0.188000 1.75e-01 -6.85e-02 1.69e-02 3.51e-01
GOBP REGULATION OF NK T CELL DIFFERENTIATION 6 7.10e-01 8.75e-01 0.188000 1.53e-01 -1.10e-01 5.18e-01 6.40e-01
GOBP STEM CELL DIFFERENTIATION 243 2.08e-06 7.17e-05 0.188000 1.87e-01 -2.38e-02 5.31e-07 5.23e-01
GOCC DENDRITIC GROWTH CONE 8 6.61e-01 8.51e-01 0.188000 1.84e-01 4.15e-02 3.69e-01 8.39e-01
GOBP PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 26 2.77e-01 5.74e-01 0.188000 1.30e-01 1.36e-01 2.52e-01 2.29e-01
GOBP REGULATION OF CATECHOLAMINE METABOLIC PROCESS 16 4.53e-01 7.21e-01 0.188000 1.48e-01 1.16e-01 3.05e-01 4.22e-01
GOBP UREA TRANSMEMBRANE TRANSPORT 9 6.02e-01 8.17e-01 0.188000 -8.13e-02 1.70e-01 6.73e-01 3.78e-01
GOBP ASTRAL MICROTUBULE ORGANIZATION 9 6.28e-01 8.33e-01 0.188000 1.84e-01 4.10e-02 3.40e-01 8.31e-01
NOTCH3 Activation and Transmission of Signal to the Nucleus 25 2.39e-01 5.36e-01 0.188000 1.37e-01 -1.29e-01 2.37e-01 2.63e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS 27 2.14e-01 5.10e-01 0.188000 -1.12e-01 1.51e-01 3.15e-01 1.73e-01
GOBP NEGATIVE REGULATION OF COMPLEMENT ACTIVATION 12 5.26e-01 7.68e-01 0.188000 -1.88e-01 5.53e-03 2.60e-01 9.74e-01
Formation of the dystrophin-glycoprotein complex (DGC) 34 1.72e-01 4.58e-01 0.188000 1.85e-01 3.53e-02 6.24e-02 7.21e-01
Regulation of actin dynamics for phagocytic cup formation 58 3.99e-02 1.97e-01 0.188000 1.78e-01 -6.17e-02 1.93e-02 4.16e-01
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR 135 7.65e-04 1.11e-02 0.188000 1.88e-01 -4.79e-03 1.63e-04 9.24e-01
GOBP MESODERM DEVELOPMENT 126 9.89e-04 1.37e-02 0.188000 1.82e-01 -4.86e-02 4.32e-04 3.46e-01
GOBP POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION 31 1.70e-01 4.56e-01 0.188000 1.37e-01 -1.28e-01 1.86e-01 2.16e-01
GOBP SYNAPTONEMAL COMPLEX ORGANIZATION 26 2.46e-01 5.42e-01 0.188000 -1.75e-02 1.87e-01 8.77e-01 9.87e-02
GOBP REGULATION OF DNA BINDING 72 2.27e-02 1.39e-01 0.188000 1.87e-01 1.27e-02 5.94e-03 8.53e-01
HDR through Homologous Recombination (HRR) 68 2.08e-02 1.30e-01 0.188000 1.38e-01 -1.27e-01 4.83e-02 7.02e-02
GOCC OUTER KINETOCHORE 20 3.41e-01 6.31e-01 0.188000 1.37e-02 -1.87e-01 9.15e-01 1.47e-01
GOBP POLYAMINE BIOSYNTHETIC PROCESS 12 5.13e-01 7.61e-01 0.188000 -1.76e-01 6.52e-02 2.91e-01 6.96e-01
Diseases of signal transduction by growth factor receptors and second messengers 440 5.87e-11 5.18e-09 0.188000 1.85e-01 -3.41e-02 3.02e-11 2.21e-01
Nephrin family interactions 21 3.05e-01 5.99e-01 0.188000 1.62e-01 -9.50e-02 1.99e-01 4.51e-01
GOBP NEGATIVE REGULATION OF JNK CASCADE 35 1.36e-01 4.05e-01 0.188000 1.44e-01 -1.20e-01 1.40e-01 2.18e-01
GOCC FIBRINOGEN COMPLEX 8 6.40e-01 8.40e-01 0.188000 6.78e-02 -1.75e-01 7.40e-01 3.91e-01
GOBP DETECTION OF LIGHT STIMULUS 60 3.38e-02 1.79e-01 0.188000 -1.61e-01 9.69e-02 3.12e-02 1.94e-01
GOBP POSITIVE REGULATION OF AMINE TRANSPORT 39 1.41e-01 4.12e-01 0.188000 1.73e-01 7.29e-02 6.15e-02 4.31e-01
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS 6 7.13e-01 8.76e-01 0.188000 -9.02e-02 1.65e-01 7.02e-01 4.85e-01
GOBP DETECTION OF MUSCLE STRETCH 7 7.05e-01 8.73e-01 0.188000 1.65e-01 8.88e-02 4.49e-01 6.84e-01
GOBP REGULATION OF MRNA SPLICING VIA SPLICEOSOME 100 3.67e-03 3.72e-02 0.188000 1.66e-01 -8.77e-02 4.15e-03 1.30e-01
GOBP COMMON MYELOID PROGENITOR CELL PROLIFERATION 9 6.03e-01 8.17e-01 0.188000 1.67e-01 -8.60e-02 3.86e-01 6.55e-01
GOBP RESPONSE TO PEPTIDE HORMONE 427 8.06e-10 6.03e-08 0.188000 1.68e-01 8.36e-02 2.61e-09 3.05e-03
GOBP MRNA PROCESSING 455 1.09e-11 1.15e-09 0.188000 1.58e-01 -1.01e-01 7.29e-09 2.26e-04
GOBP NEGATIVE REGULATION OF MONOCYTE CHEMOTAXIS 6 7.12e-01 8.76e-01 0.188000 -1.00e-01 1.59e-01 6.71e-01 5.01e-01
Cyclin D associated events in G1 46 7.44e-02 2.87e-01 0.188000 1.03e-01 -1.57e-01 2.27e-01 6.60e-02
G1 Phase 46 7.44e-02 2.87e-01 0.188000 1.03e-01 -1.57e-01 2.27e-01 6.60e-02
GOMF UBIQUITIN LIKE PROTEIN BINDING 118 2.26e-03 2.59e-02 0.187000 1.86e-01 2.68e-02 4.99e-04 6.15e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE 59 5.36e-02 2.36e-01 0.187000 1.65e-01 8.94e-02 2.86e-02 2.35e-01
Regulation of MITF-M-dependent genes involved in pigmentation 41 1.24e-01 3.84e-01 0.187000 1.81e-01 4.90e-02 4.50e-02 5.87e-01
Negative regulation of MET activity 20 3.35e-01 6.25e-01 0.187000 1.83e-01 -4.19e-02 1.57e-01 7.45e-01
GOBP COLLATERAL SPROUTING 26 2.60e-01 5.57e-01 0.187000 1.85e-01 2.73e-02 1.02e-01 8.10e-01
GOBP RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES 15 4.38e-01 7.12e-01 0.187000 1.80e-01 -5.20e-02 2.27e-01 7.27e-01
GOCC NUCLEAR CHROMOSOME 221 4.88e-06 1.56e-04 0.187000 1.70e-01 -7.80e-02 1.27e-05 4.57e-02
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL CORTEX 9 6.43e-01 8.42e-01 0.187000 1.17e-01 1.46e-01 5.43e-01 4.47e-01
GOBP T CELL EXTRAVASATION 11 5.83e-01 8.05e-01 0.187000 -1.42e-01 -1.22e-01 4.14e-01 4.84e-01
GOBP GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION 18 3.71e-01 6.58e-01 0.187000 -1.79e-01 5.55e-02 1.89e-01 6.83e-01
GOBP COLLAGEN FIBRIL ORGANIZATION 65 3.60e-02 1.87e-01 0.187000 3.99e-02 1.83e-01 5.78e-01 1.07e-02
GOBP ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS 13 5.13e-01 7.61e-01 0.187000 -3.59e-02 -1.84e-01 8.23e-01 2.51e-01
GOBP POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION 15 4.38e-01 7.12e-01 0.187000 -1.78e-01 5.72e-02 2.32e-01 7.01e-01
GOBP PREPULSE INHIBITION 13 4.83e-01 7.42e-01 0.187000 -1.66e-01 8.67e-02 3.00e-01 5.88e-01
GOBP MONOSACCHARIDE CATABOLIC PROCESS 48 7.11e-02 2.80e-01 0.187000 -6.01e-02 1.77e-01 4.71e-01 3.36e-02
GOMF N ACYLSPHINGOSINE AMIDOHYDROLASE ACTIVITY 7 6.84e-01 8.63e-01 0.187000 -3.64e-02 1.84e-01 8.67e-01 4.00e-01
GOBP BLASTOCYST DEVELOPMENT 113 2.28e-03 2.60e-02 0.187000 1.85e-01 -3.09e-02 6.98e-04 5.71e-01
GOMF NEUROTROPHIN RECEPTOR ACTIVITY 5 7.68e-01 9.02e-01 0.187000 -1.87e-03 1.87e-01 9.94e-01 4.69e-01
GOBP FAT PAD DEVELOPMENT 9 6.17e-01 8.26e-01 0.187000 1.86e-01 -2.22e-02 3.34e-01 9.08e-01
GOBP POSITIVE REGULATION OF AXONOGENESIS 71 2.81e-02 1.60e-01 0.187000 1.78e-01 5.88e-02 9.64e-03 3.92e-01
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING 17 4.28e-01 7.05e-01 0.187000 7.34e-02 1.72e-01 6.00e-01 2.19e-01
GOCC CLATHRIN SCULPTED MONOAMINE TRANSPORT VESICLE 5 7.66e-01 9.01e-01 0.187000 1.86e-01 -1.44e-02 4.70e-01 9.56e-01
GOBP REPLICATION BORN DOUBLE STRAND BREAK REPAIR VIA SISTER CHROMATID EXCHANGE 6 7.14e-01 8.77e-01 0.187000 9.98e-02 -1.58e-01 6.72e-01 5.02e-01
GOBP FORMATION OF PRIMARY GERM LAYER 129 9.20e-04 1.29e-02 0.187000 1.82e-01 -4.42e-02 3.65e-04 3.86e-01
GOBP WATER TRANSPORT 28 2.50e-01 5.48e-01 0.187000 8.63e-02 1.66e-01 4.29e-01 1.29e-01
GOBP REGULATION OF REMOVAL OF SUPEROXIDE RADICALS 6 7.42e-01 8.89e-01 0.187000 -1.68e-01 -8.22e-02 4.76e-01 7.27e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION 16 4.32e-01 7.07e-01 0.187000 -2.69e-03 -1.87e-01 9.85e-01 1.96e-01
GOCC NADPH OXIDASE COMPLEX 13 5.09e-01 7.59e-01 0.187000 1.77e-02 1.86e-01 9.12e-01 2.45e-01
Rab regulation of trafficking 110 3.67e-03 3.72e-02 0.187000 1.83e-01 3.58e-02 8.88e-04 5.17e-01
Smooth Muscle Contraction 42 1.23e-01 3.81e-01 0.187000 1.75e-01 6.63e-02 5.01e-02 4.57e-01
Xenobiotics 23 2.76e-01 5.74e-01 0.187000 -1.61e-01 9.43e-02 1.81e-01 4.34e-01
GOBP LEFT RIGHT AXIS SPECIFICATION 13 5.11e-01 7.60e-01 0.187000 1.85e-01 2.28e-02 2.47e-01 8.87e-01
Negative regulation of NOTCH4 signaling 44 8.98e-02 3.21e-01 0.187000 5.72e-02 -1.78e-01 5.11e-01 4.13e-02
GOBP REGULATION OF POLYSACCHARIDE BIOSYNTHETIC PROCESS 37 1.56e-01 4.36e-01 0.187000 1.77e-01 5.98e-02 6.25e-02 5.29e-01
GOBP REGULATION OF RECEPTOR RECYCLING 24 2.97e-01 5.94e-01 0.187000 5.14e-02 1.80e-01 6.63e-01 1.28e-01
GOBP REGULATION OF CELLULAR EXTRAVASATION 39 1.16e-01 3.70e-01 0.187000 -7.10e-02 1.73e-01 4.43e-01 6.19e-02
Biosynthesis of maresin-like SPMs 6 7.14e-01 8.77e-01 0.187000 -1.54e-01 1.05e-01 5.13e-01 6.55e-01
GOBP NEGATIVE REGULATION OF BONE REMODELING 18 4.05e-01 6.87e-01 0.187000 -5.78e-02 -1.78e-01 6.71e-01 1.92e-01
GOBP NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION 33 1.62e-01 4.46e-01 0.187000 6.74e-02 -1.74e-01 5.03e-01 8.35e-02
GOBP GRANULOCYTE COLONY STIMULATING FACTOR PRODUCTION 5 7.55e-01 8.95e-01 0.187000 1.47e-01 -1.15e-01 5.70e-01 6.55e-01
GOBP REGULATION OF CELL MATURATION 22 3.20e-01 6.11e-01 0.187000 1.49e-02 1.86e-01 9.04e-01 1.31e-01
GOBP DETERMINATION OF DORSAL VENTRAL ASYMMETRY 11 5.69e-01 7.96e-01 0.187000 -2.83e-02 -1.84e-01 8.71e-01 2.89e-01
GOBP PEPTIDYL LYSINE HYDROXYLATION 8 6.77e-01 8.60e-01 0.187000 1.22e-01 1.41e-01 5.51e-01 4.89e-01
GOMF PRENYLTRANSFERASE ACTIVITY 16 4.13e-01 6.94e-01 0.187000 7.43e-02 -1.71e-01 6.07e-01 2.36e-01
Degradation of GLI1 by the proteasome 47 7.15e-02 2.80e-01 0.187000 1.18e-01 -1.44e-01 1.60e-01 8.75e-02
Degradation of the extracellular matrix 134 5.88e-04 9.00e-03 0.187000 -9.53e-02 1.60e-01 5.68e-02 1.35e-03
GOMF AXON GUIDANCE RECEPTOR ACTIVITY 10 5.73e-01 7.99e-01 0.187000 1.63e-01 -9.04e-02 3.72e-01 6.21e-01
GOBP MATING BEHAVIOR 36 1.74e-01 4.60e-01 0.187000 1.39e-01 1.24e-01 1.49e-01 1.96e-01
GOBP REGULATION OF CIRCULATING FIBRINOGEN LEVELS 5 7.73e-01 9.05e-01 0.186000 -1.85e-01 -2.54e-02 4.74e-01 9.22e-01
GOBP LABYRINTHINE LAYER DEVELOPMENT 44 9.24e-02 3.26e-01 0.186000 4.49e-02 -1.81e-01 6.07e-01 3.78e-02
Recognition of DNA damage by PCNA-containing replication complex 29 1.96e-01 4.89e-01 0.186000 1.32e-01 -1.32e-01 2.19e-01 2.19e-01
GOBP DNA DAMAGE RESPONSE 857 2.49e-20 8.75e-18 0.186000 1.77e-01 -5.89e-02 1.39e-18 3.43e-03
GOBP BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 153 2.59e-04 4.63e-03 0.186000 1.80e-01 -4.91e-02 1.24e-04 2.94e-01
GOMF NOTCH BINDING 23 3.20e-01 6.11e-01 0.186000 7.35e-02 1.71e-01 5.42e-01 1.55e-01
Lagging Strand Synthesis 19 3.44e-01 6.34e-01 0.186000 1.44e-01 -1.18e-01 2.77e-01 3.72e-01
GOBP REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY 28 2.45e-01 5.41e-01 0.186000 1.79e-01 5.28e-02 1.02e-01 6.29e-01
GOMF PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 13 4.90e-01 7.47e-01 0.186000 6.81e-02 -1.73e-01 6.71e-01 2.79e-01
GOBP ENUCLEATE ERYTHROCYTE DEVELOPMENT 6 7.14e-01 8.77e-01 0.186000 1.17e-01 -1.45e-01 6.21e-01 5.38e-01
GOMF ALCOHOL DEHYDROGENASE NAD P PLUS ACTIVITY 24 2.61e-01 5.57e-01 0.186000 1.46e-01 -1.16e-01 2.17e-01 3.24e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 32 1.96e-01 4.89e-01 0.186000 -3.18e-02 -1.84e-01 7.55e-01 7.23e-02
GOBP RESPONSE TO LIGHT INTENSITY 15 4.59e-01 7.24e-01 0.186000 8.42e-03 1.86e-01 9.55e-01 2.12e-01
GOBP EPIDERMIS MORPHOGENESIS 36 1.67e-01 4.51e-01 0.186000 6.35e-02 1.75e-01 5.10e-01 6.91e-02
GOMF SOLUTE PROTON SYMPORTER ACTIVITY 24 2.77e-01 5.75e-01 0.186000 -2.92e-02 1.84e-01 8.05e-01 1.19e-01
GOBP REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY 23 3.27e-01 6.19e-01 0.186000 1.13e-01 1.48e-01 3.49e-01 2.19e-01
GOBP NEUTROPHIL DIFFERENTIATION 11 5.64e-01 7.93e-01 0.186000 -3.76e-03 -1.86e-01 9.83e-01 2.85e-01
GOBP SENSORY PERCEPTION OF TASTE 66 2.52e-02 1.49e-01 0.186000 -1.50e-01 1.10e-01 3.51e-02 1.21e-01
GOBP SMOOTH MUSCLE CELL MIGRATION 88 1.34e-02 9.70e-02 0.186000 1.67e-01 8.26e-02 6.81e-03 1.80e-01
GOBP POSITIVE REGULATION OF PROTEIN SUMOYLATION 12 5.32e-01 7.73e-01 0.186000 1.86e-01 -7.72e-03 2.64e-01 9.63e-01
GOBP CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE 16 4.59e-01 7.24e-01 0.186000 -1.51e-01 -1.08e-01 2.94e-01 4.53e-01
GOMF INTERFERON RECEPTOR ACTIVITY 5 7.75e-01 9.06e-01 0.186000 1.83e-01 3.38e-02 4.78e-01 8.96e-01
GOBP NEGATIVE REGULATION OF AMYLOID BETA CLEARANCE 11 5.44e-01 7.81e-01 0.186000 8.52e-02 -1.65e-01 6.25e-01 3.42e-01
GOBP INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE 121 1.21e-03 1.59e-02 0.186000 -1.52e-01 1.08e-01 3.92e-03 4.08e-02
GOBP LEUKOCYTE HOMEOSTASIS 103 3.20e-03 3.36e-02 0.186000 1.37e-01 -1.26e-01 1.62e-02 2.74e-02
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION 9 6.04e-01 8.19e-01 0.186000 1.45e-01 -1.17e-01 4.52e-01 5.44e-01
Death Receptor Signaling 144 6.40e-04 9.62e-03 0.186000 1.85e-01 2.01e-02 1.27e-04 6.77e-01
GOBP B CELL RECEPTOR SIGNALING PATHWAY 61 3.82e-02 1.92e-01 0.186000 3.60e-02 -1.83e-01 6.27e-01 1.37e-02
GOBP OOCYTE DIFFERENTIATION 66 4.12e-02 2.01e-01 0.186000 1.17e-01 1.45e-01 1.01e-01 4.17e-02
GOCC CLATHRIN COMPLEX 8 6.52e-01 8.46e-01 0.186000 1.83e-01 -3.35e-02 3.70e-01 8.70e-01
GOMF PHOSPHATIDYLCHOLINE FLIPPASE ACTIVITY 5 7.85e-01 9.12e-01 0.186000 1.20e-01 1.42e-01 6.43e-01 5.82e-01
Infection with Mycobacterium tuberculosis 25 2.50e-01 5.48e-01 0.186000 1.61e-01 -9.28e-02 1.63e-01 4.22e-01
GOCC STEREOCILIUM TIP 20 3.67e-01 6.55e-01 0.186000 -5.14e-02 -1.79e-01 6.91e-01 1.66e-01
GOBP CELLULAR RESPONSE TO NUTRIENT 46 7.70e-02 2.93e-01 0.186000 1.46e-01 -1.15e-01 8.69e-02 1.76e-01
GOBP REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 121 1.74e-03 2.12e-02 0.186000 1.85e-01 -1.63e-02 4.34e-04 7.56e-01
Formation of Fibrin Clot (Clotting Cascade) 37 1.31e-01 3.95e-01 0.186000 -8.07e-02 1.67e-01 3.96e-01 7.80e-02
RNA Polymerase III Transcription Initiation 36 1.37e-01 4.05e-01 0.186000 9.38e-02 -1.60e-01 3.30e-01 9.58e-02
GOBP PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE 36 1.67e-01 4.52e-01 0.186000 -5.84e-02 -1.76e-01 5.44e-01 6.71e-02
Signaling by ERBB2 50 6.85e-02 2.73e-01 0.186000 1.81e-01 -4.32e-02 2.71e-02 5.97e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE REGULATOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 38 1.37e-01 4.05e-01 0.186000 1.85e-01 -1.17e-02 4.81e-02 9.01e-01
GOBP BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS 12 5.15e-01 7.62e-01 0.186000 9.41e-02 -1.60e-01 5.72e-01 3.37e-01
Mitotic Spindle Checkpoint 108 2.82e-03 3.07e-02 0.186000 1.72e-01 -7.00e-02 2.03e-03 2.09e-01
GOBP CRANIAL SUTURE MORPHOGENESIS 9 6.18e-01 8.27e-01 0.186000 1.81e-01 -4.02e-02 3.47e-01 8.34e-01
GOCC SITE OF DOUBLE STRAND BREAK 94 5.43e-03 5.01e-02 0.186000 1.28e-01 -1.35e-01 3.25e-02 2.40e-02
SARS-CoV-1 Infection 135 7.06e-04 1.04e-02 0.186000 5.48e-02 -1.77e-01 2.71e-01 3.76e-04
GOMF PRE MRNA BINDING 40 1.14e-01 3.66e-01 0.186000 6.62e-02 -1.73e-01 4.68e-01 5.79e-02
GOBP ANTIMICROBIAL PEPTIDE PRODUCTION 12 5.39e-01 7.78e-01 0.185000 -1.85e-01 -7.48e-03 2.66e-01 9.64e-01
GOBP REGULATION OF NEUROINFLAMMATORY RESPONSE 41 1.35e-01 4.02e-01 0.185000 -7.80e-02 -1.68e-01 3.88e-01 6.22e-02
GOBP NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY 18 3.76e-01 6.62e-01 0.185000 1.72e-01 -6.80e-02 2.05e-01 6.18e-01
GOCC TUBULAR ENDOSOME 5 7.77e-01 9.07e-01 0.185000 -3.39e-02 -1.82e-01 8.96e-01 4.80e-01
GOBP REGULATION OF EOSINOPHIL MIGRATION 5 7.60e-01 8.98e-01 0.185000 1.66e-01 -8.30e-02 5.21e-01 7.48e-01
GOMF ACROSIN BINDING 5 7.68e-01 9.02e-01 0.185000 2.39e-02 -1.84e-01 9.26e-01 4.77e-01
GOBP PROTEIN DEUBIQUITINATION 79 1.66e-02 1.12e-01 0.185000 1.85e-01 -6.55e-03 4.42e-03 9.20e-01
Synthesis of diphthamide-EEF2 8 6.63e-01 8.51e-01 0.185000 -1.14e-02 -1.85e-01 9.55e-01 3.65e-01
GOCC RNA POLYMERASE II CORE COMPLEX 13 4.86e-01 7.45e-01 0.185000 1.20e-01 -1.41e-01 4.53e-01 3.79e-01
Defective Intrinsic Pathway for Apoptosis 25 2.50e-01 5.48e-01 0.185000 1.41e-01 -1.20e-01 2.23e-01 2.97e-01
GOMF CATALYTIC ACTIVITY ACTING ON DNA 234 8.93e-06 2.62e-04 0.185000 1.81e-01 3.86e-02 1.79e-06 3.09e-01
GOBP MESODERMAL CELL DIFFERENTIATION 35 1.51e-01 4.29e-01 0.185000 1.74e-01 -6.22e-02 7.40e-02 5.24e-01
GOCC ACETYLTRANSFERASE COMPLEX 91 6.67e-03 5.87e-02 0.185000 1.52e-01 -1.05e-01 1.19e-02 8.30e-02
RNA Polymerase III Transcription Termination 23 2.79e-01 5.76e-01 0.185000 1.31e-01 -1.31e-01 2.78e-01 2.76e-01
GOBP N TERMINAL PROTEIN AMINO ACID MODIFICATION 26 2.37e-01 5.34e-01 0.185000 1.12e-01 -1.48e-01 3.24e-01 1.93e-01
GOBP REGULATION OF MYOTUBE DIFFERENTIATION 47 1.04e-01 3.48e-01 0.185000 1.03e-01 1.54e-01 2.24e-01 6.74e-02
GOBP REGULATION OF TELOMERASE ACTIVITY 43 9.37e-02 3.28e-01 0.185000 1.01e-01 -1.55e-01 2.51e-01 7.86e-02
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE 19 3.98e-01 6.80e-01 0.185000 -8.84e-02 -1.63e-01 5.05e-01 2.20e-01
Signaling by NOTCH4 71 1.98e-02 1.25e-01 0.185000 1.21e-01 -1.40e-01 7.82e-02 4.11e-02
GOBP PLATELET DENSE GRANULE ORGANIZATION 24 3.15e-01 6.07e-01 0.185000 1.56e-01 9.92e-02 1.85e-01 4.00e-01
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION 7 6.93e-01 8.68e-01 0.185000 1.84e-01 -1.86e-02 3.99e-01 9.32e-01
GOCC BLOOD MICROPARTICLE 111 3.10e-03 3.29e-02 0.185000 -1.84e-01 1.61e-02 7.93e-04 7.70e-01
GOBP BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS 36 1.56e-01 4.36e-01 0.185000 1.85e-01 -2.77e-03 5.47e-02 9.77e-01
GOBP GLYCERALDEHYDE 3 PHOSPHATE METABOLIC PROCESS 12 5.17e-01 7.63e-01 0.185000 -9.68e-02 1.58e-01 5.61e-01 3.44e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 61 4.42e-02 2.10e-01 0.185000 1.85e-01 7.86e-03 1.25e-02 9.15e-01
Assembly and cell surface presentation of NMDA receptors 40 1.27e-01 3.88e-01 0.185000 -1.85e-01 4.57e-03 4.31e-02 9.60e-01
GOBP POSITIVE REGULATION OF MACROAUTOPHAGY 83 1.66e-02 1.12e-01 0.185000 1.78e-01 5.16e-02 5.16e-03 4.17e-01
GOBP EMBRYONIC SKELETAL JOINT DEVELOPMENT 15 4.37e-01 7.11e-01 0.185000 1.42e-01 -1.18e-01 3.41e-01 4.28e-01
GOBP NK T CELL ACTIVATION 14 4.70e-01 7.31e-01 0.185000 -1.74e-01 6.28e-02 2.60e-01 6.84e-01
GOBP EMBRYONIC CLEAVAGE 8 6.67e-01 8.53e-01 0.185000 1.83e-01 2.29e-02 3.69e-01 9.11e-01
GOBP TYPE B PANCREATIC CELL APOPTOTIC PROCESS 10 5.76e-01 8.00e-01 0.185000 1.18e-01 -1.42e-01 5.17e-01 4.37e-01
GOBP FOREBRAIN NEUROBLAST DIVISION 6 7.18e-01 8.79e-01 0.185000 1.13e-01 -1.46e-01 6.31e-01 5.36e-01
GOBP CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS 63 3.11e-02 1.70e-01 0.185000 1.24e-01 -1.37e-01 8.86e-02 6.02e-02
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR BINDING 22 2.98e-01 5.94e-01 0.185000 1.43e-01 -1.17e-01 2.45e-01 3.43e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT BINDING 11 5.90e-01 8.09e-01 0.185000 1.53e-01 1.03e-01 3.79e-01 5.54e-01
GOBP SIGNAL PEPTIDE PROCESSING 13 5.06e-01 7.58e-01 0.185000 2.25e-02 -1.83e-01 8.88e-01 2.52e-01
GOCC FILOPODIUM MEMBRANE 17 4.06e-01 6.88e-01 0.185000 1.80e-01 -4.07e-02 1.98e-01 7.72e-01
GOBP AMYLOID BETA CLEARANCE BY CELLULAR CATABOLIC PROCESS 8 6.64e-01 8.52e-01 0.185000 -5.89e-03 -1.85e-01 9.77e-01 3.66e-01
GOBP POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS 35 1.67e-01 4.52e-01 0.185000 1.84e-01 5.65e-03 5.89e-02 9.54e-01
GOBP NEGATIVE REGULATION OF PLATELET AGGREGATION 11 5.86e-01 8.07e-01 0.185000 1.69e-01 7.42e-02 3.32e-01 6.70e-01
GOBP RESPONSE TO DIETARY EXCESS 35 1.72e-01 4.58e-01 0.185000 1.83e-01 2.59e-02 6.14e-02 7.91e-01
GOBP NERVOUS SYSTEM PROCESS 1383 1.16e-29 6.46e-27 0.185000 -1.85e-01 -2.06e-03 1.03e-30 8.98e-01
GOMF UNIPORTER ACTIVITY 9 6.49e-01 8.45e-01 0.184000 1.59e-01 9.40e-02 4.09e-01 6.25e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I 32 2.16e-01 5.11e-01 0.184000 1.59e-01 9.38e-02 1.20e-01 3.58e-01
Erythrocytes take up carbon dioxide and release oxygen 12 5.60e-01 7.91e-01 0.184000 -1.66e-01 -8.07e-02 3.20e-01 6.28e-01
O2/CO2 exchange in erythrocytes 12 5.60e-01 7.91e-01 0.184000 -1.66e-01 -8.07e-02 3.20e-01 6.28e-01
GOBP ANDROGEN RECEPTOR SIGNALING PATHWAY 45 9.88e-02 3.37e-01 0.184000 1.84e-01 -5.48e-03 3.24e-02 9.49e-01
GLI3 is processed to GLI3R by the proteasome 47 7.64e-02 2.92e-01 0.184000 1.05e-01 -1.52e-01 2.14e-01 7.18e-02
RSV-host interactions 88 1.18e-02 8.87e-02 0.184000 -1.62e-02 -1.84e-01 7.93e-01 2.89e-03
GOBP REGULATION OF T CELL CHEMOTAXIS 15 4.75e-01 7.34e-01 0.184000 -3.85e-02 -1.80e-01 7.96e-01 2.27e-01
GOMF PHOSPHORYLATION DEPENDENT PROTEIN BINDING 9 6.48e-01 8.44e-01 0.184000 -8.33e-02 -1.64e-01 6.65e-01 3.93e-01
Potassium Channels 102 3.79e-03 3.81e-02 0.184000 -1.18e-01 1.41e-01 3.92e-02 1.36e-02
GOMF 1 PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY 15 4.70e-01 7.31e-01 0.184000 -2.05e-02 -1.83e-01 8.91e-01 2.19e-01
GOBP REGULATION OF GLUTAMATE SECRETION 19 4.00e-01 6.82e-01 0.184000 7.80e-02 1.67e-01 5.56e-01 2.08e-01
GOBP SMOOTHENED SIGNALING PATHWAY 140 7.97e-04 1.15e-02 0.184000 1.84e-01 -3.25e-03 1.69e-04 9.47e-01
GOBP PARALLEL ACTIN FILAMENT BUNDLE ASSEMBLY 7 6.81e-01 8.62e-01 0.184000 1.30e-01 -1.31e-01 5.53e-01 5.49e-01
GOBP PULMONARY ARTERY MORPHOGENESIS 6 7.23e-01 8.81e-01 0.184000 -8.24e-02 1.65e-01 7.27e-01 4.85e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 30 2.25e-01 5.22e-01 0.184000 -3.45e-02 -1.81e-01 7.44e-01 8.64e-02
GOCC CIS GOLGI NETWORK 54 5.40e-02 2.37e-01 0.184000 1.64e-01 -8.39e-02 3.72e-02 2.86e-01
GOBP MONOACYLGLYCEROL METABOLIC PROCESS 14 5.09e-01 7.59e-01 0.184000 7.52e-02 1.68e-01 6.26e-01 2.76e-01
GOBP REGULATION OF FIBRINOLYSIS 18 4.25e-01 7.03e-01 0.184000 1.07e-01 1.50e-01 4.31e-01 2.71e-01
GOBP REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 101 6.54e-03 5.79e-02 0.184000 1.82e-01 2.69e-02 1.56e-03 6.41e-01
GOMF PHOSPHATIDYLCHOLINE TRANSFER ACTIVITY 5 7.73e-01 9.05e-01 0.184000 1.84e-01 -7.02e-03 4.76e-01 9.78e-01
GOBP PROTEIN LOCALIZATION TO CELL CELL JUNCTION 21 3.64e-01 6.51e-01 0.184000 1.67e-01 7.72e-02 1.85e-01 5.40e-01
GOBP RESPONSE TO THYROXINE 5 7.60e-01 8.98e-01 0.184000 -1.20e-01 1.39e-01 6.42e-01 5.89e-01
GOBP POSITIVE REGULATION OF ACTION POTENTIAL 8 6.84e-01 8.63e-01 0.184000 1.45e-01 1.14e-01 4.79e-01 5.77e-01
GOBP INTERMEDIATE FILAMENT BASED PROCESS 94 6.00e-03 5.39e-02 0.184000 -1.44e-01 1.14e-01 1.55e-02 5.64e-02
GOBP AMELOBLAST DIFFERENTIATION 5 7.89e-01 9.14e-01 0.184000 -1.09e-01 -1.48e-01 6.72e-01 5.67e-01
GOBP NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS 1386 2.18e-30 1.28e-27 0.184000 1.80e-01 -3.64e-02 1.96e-29 2.31e-02
GOBP REGULATION OF WNT SIGNALING PATHWAY 328 4.64e-08 2.44e-06 0.184000 1.81e-01 -3.09e-02 1.65e-08 3.35e-01
Receptor-type tyrosine-protein phosphatases 16 4.45e-01 7.17e-01 0.184000 1.84e-01 8.79e-03 2.03e-01 9.51e-01
GOBP REGULATION OF DNA REPAIR 215 1.41e-05 3.88e-04 0.184000 1.80e-01 -3.74e-02 5.38e-06 3.44e-01
GOBP TERMINAL BUTTON ORGANIZATION 6 7.39e-01 8.87e-01 0.184000 1.03e-02 1.84e-01 9.65e-01 4.36e-01
GOBP ANTERIOR POSTERIOR PATTERN SPECIFICATION 209 2.07e-05 5.50e-04 0.184000 1.82e-01 -2.87e-02 6.05e-06 4.74e-01
GOCC KATANIN COMPLEX 5 7.85e-01 9.12e-01 0.184000 -6.67e-02 -1.71e-01 7.96e-01 5.07e-01
GOBP PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING 24 2.85e-01 5.82e-01 0.184000 -1.80e-01 3.58e-02 1.26e-01 7.61e-01
GOBP MACROPHAGE CYTOKINE PRODUCTION 36 1.42e-01 4.14e-01 0.184000 1.01e-01 -1.54e-01 2.96e-01 1.11e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMATIN 9 6.50e-01 8.45e-01 0.184000 1.63e-01 8.43e-02 3.97e-01 6.61e-01
GOMF DNA BINDING TRANSCRIPTION REPRESSOR ACTIVITY 265 8.38e-07 3.28e-05 0.184000 1.71e-01 -6.74e-02 1.67e-06 5.90e-02
GOBP TRANSLATIONAL READTHROUGH 9 6.54e-01 8.47e-01 0.184000 1.41e-01 1.17e-01 4.62e-01 5.43e-01
GOMF HISTONE BINDING 217 3.23e-05 8.22e-04 0.184000 1.68e-01 7.32e-02 1.91e-05 6.32e-02
GOBP MRNA 3 END PROCESSING 38 1.27e-01 3.89e-01 0.184000 1.47e-01 -1.10e-01 1.18e-01 2.39e-01
GOCC KINOCILIUM 10 6.05e-01 8.19e-01 0.184000 -1.83e-01 -1.45e-02 3.16e-01 9.37e-01
GOCC DERLIN 1 RETROTRANSLOCATION COMPLEX 8 6.57e-01 8.49e-01 0.184000 1.78e-01 -4.46e-02 3.83e-01 8.27e-01
N-glycan trimming in the ER and Calnexin/Calreticulin cycle 35 1.60e-01 4.43e-01 0.184000 1.79e-01 -4.13e-02 6.72e-02 6.72e-01
Muscarinic acetylcholine receptors 5 7.71e-01 9.04e-01 0.183000 -1.81e-01 3.11e-02 4.84e-01 9.04e-01
GOMF HYDROPEROXY ICOSATETRAENOATE DEHYDRATASE ACTIVITY 7 6.95e-01 8.68e-01 0.183000 -1.80e-01 3.33e-02 4.09e-01 8.79e-01
GOBP REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT 20 3.87e-01 6.71e-01 0.183000 1.61e-01 8.67e-02 2.11e-01 5.02e-01
GOBP BIOLOGICAL PHASE 11 5.52e-01 7.86e-01 0.183000 1.52e-01 -1.02e-01 3.81e-01 5.59e-01
GOMF CALCIUM DEPENDENT PHOSPHOLIPID BINDING 53 6.68e-02 2.70e-01 0.183000 -1.33e-02 1.83e-01 8.67e-01 2.13e-02
GOBP SUBSTANTIA NIGRA DEVELOPMENT 40 1.15e-01 3.68e-01 0.183000 1.51e-01 -1.05e-01 9.95e-02 2.53e-01
Cellular Senescence 159 1.92e-04 3.64e-03 0.183000 1.48e-01 -1.09e-01 1.32e-03 1.80e-02
GOBP LONG TERM SYNAPTIC POTENTIATION 105 4.93e-03 4.69e-02 0.183000 1.83e-01 -5.14e-03 1.18e-03 9.28e-01
GOBP REGULATION OF BMP SIGNALING PATHWAY 117 3.86e-03 3.86e-02 0.183000 1.66e-01 7.84e-02 1.97e-03 1.43e-01
GOBP POSITIVE REGULATION OF MACROPHAGE ACTIVATION 30 2.45e-01 5.41e-01 0.183000 -1.36e-01 -1.23e-01 1.99e-01 2.43e-01
GOBP MOTOR NEURON APOPTOTIC PROCESS 21 3.25e-01 6.16e-01 0.183000 8.00e-02 -1.65e-01 5.26e-01 1.91e-01
GOBP RESPONSE TO SALT STRESS 24 2.74e-01 5.71e-01 0.183000 1.50e-01 -1.05e-01 2.04e-01 3.71e-01
tRNA processing in the nucleus 58 4.37e-02 2.08e-01 0.183000 1.48e-01 -1.08e-01 5.16e-02 1.54e-01
GOBP INTRACILIARY ANTEROGRADE TRANSPORT 19 3.89e-01 6.73e-01 0.183000 -2.09e-02 -1.82e-01 8.75e-01 1.70e-01
GOBP AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS 16 4.21e-01 7.00e-01 0.183000 -1.35e-01 1.23e-01 3.50e-01 3.93e-01
GOBP FATTY ACID ELONGATION 13 5.05e-01 7.57e-01 0.183000 1.73e-01 -5.74e-02 2.79e-01 7.20e-01
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 26 2.81e-01 5.78e-01 0.183000 -1.79e-01 -3.66e-02 1.14e-01 7.47e-01
GOCC FLEMMING BODY 34 1.73e-01 4.59e-01 0.183000 1.79e-01 -3.50e-02 7.03e-02 7.24e-01
GOBP NEGATIVE REGULATION OF MACROAUTOPHAGY 33 1.79e-01 4.68e-01 0.183000 1.77e-01 -4.59e-02 7.87e-02 6.48e-01
GOBP LAYER FORMATION IN CEREBRAL CORTEX 14 4.81e-01 7.40e-01 0.183000 1.75e-01 -5.08e-02 2.56e-01 7.42e-01
GOBP GOLGI VESICLE TRANSPORT 290 5.83e-07 2.40e-05 0.183000 1.83e-01 3.86e-03 8.74e-08 9.10e-01
GOBP GALACTOSE TRANSMEMBRANE TRANSPORT 5 7.82e-01 9.10e-01 0.183000 -1.80e-01 -3.04e-02 4.86e-01 9.06e-01
GOMF NEUREXIN FAMILY PROTEIN BINDING 9 6.56e-01 8.49e-01 0.183000 1.02e-01 1.51e-01 5.96e-01 4.32e-01
GOMF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY 27 2.34e-01 5.31e-01 0.183000 -1.25e-01 1.33e-01 2.59e-01 2.33e-01
GOMF DOUBLE STRANDED RNA BINDING 71 2.55e-02 1.51e-01 0.183000 1.78e-01 -3.97e-02 9.43e-03 5.63e-01
GOBP SPINDLE LOCALIZATION 62 4.33e-02 2.07e-01 0.183000 1.82e-01 -1.31e-02 1.32e-02 8.58e-01
GOBP NEURAL NUCLEUS DEVELOPMENT 61 4.00e-02 1.97e-01 0.183000 1.68e-01 -7.16e-02 2.33e-02 3.33e-01
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 190 1.26e-04 2.61e-03 0.183000 1.69e-01 6.87e-02 5.84e-05 1.02e-01
GOCC POLYPRENYL DIPHOSPHATE SYNTHASE COMPLEX 10 5.88e-01 8.08e-01 0.182000 1.65e-01 -7.83e-02 3.67e-01 6.68e-01
GOBP NUCLEOSIDE TRANSMEMBRANE TRANSPORT 8 6.88e-01 8.65e-01 0.182000 1.48e-01 1.07e-01 4.68e-01 6.02e-01
GOBP CAMP METABOLIC PROCESS 23 3.19e-01 6.11e-01 0.182000 9.99e-03 1.82e-01 9.34e-01 1.30e-01
GOBP LIPID DIGESTION 21 3.25e-01 6.16e-01 0.182000 -1.52e-01 1.01e-01 2.28e-01 4.23e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE DEGRANULATION 11 5.54e-01 7.87e-01 0.182000 1.17e-01 -1.40e-01 5.01e-01 4.22e-01
GOBP SNRNA 3 END PROCESSING 20 3.41e-01 6.31e-01 0.182000 1.26e-01 -1.32e-01 3.30e-01 3.07e-01
GOBP SENSORY PERCEPTION OF BITTER TASTE 44 9.40e-02 3.28e-01 0.182000 -1.29e-01 1.29e-01 1.40e-01 1.38e-01
GOMF GUANYLATE KINASE ACTIVITY 7 6.87e-01 8.65e-01 0.182000 -1.03e-01 1.51e-01 6.38e-01 4.90e-01
GOBP RESPONSE TO MUSCLE ACTIVITY 28 2.55e-01 5.52e-01 0.182000 3.21e-02 1.80e-01 7.69e-01 1.00e-01
GOMF PEPTIDYL PROLINE DIOXYGENASE ACTIVITY 12 5.29e-01 7.71e-01 0.182000 1.63e-01 -8.08e-02 3.27e-01 6.28e-01
GOMF ENDOPEPTIDASE REGULATOR ACTIVITY 177 1.50e-04 3.02e-03 0.182000 -1.82e-01 8.50e-04 2.87e-05 9.84e-01
GOCC NUCLEOTIDE EXCISION REPAIR COMPLEX 11 6.00e-01 8.16e-01 0.182000 1.30e-01 1.27e-01 4.54e-01 4.65e-01
GOBP KETONE BODY METABOLIC PROCESS 9 6.52e-01 8.46e-01 0.182000 6.98e-02 1.68e-01 7.17e-01 3.82e-01
GOBP PIGMENT GRANULE LOCALIZATION 23 2.91e-01 5.88e-01 0.182000 1.27e-01 -1.31e-01 2.93e-01 2.77e-01
GOBP ACUTE PHASE RESPONSE 45 1.15e-01 3.68e-01 0.182000 -1.76e-01 -4.73e-02 4.12e-02 5.83e-01
GOBP DNA REPAIR 579 2.26e-13 3.09e-11 0.182000 1.78e-01 -4.02e-02 2.72e-13 9.80e-02
Clathrin-mediated endocytosis 139 8.20e-04 1.18e-02 0.182000 1.78e-01 -3.67e-02 2.83e-04 4.55e-01
Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) 14 4.73e-01 7.33e-01 0.182000 1.14e-01 -1.42e-01 4.61e-01 3.57e-01
GOBP ISOPRENOID CATABOLIC PROCESS 10 6.21e-01 8.28e-01 0.182000 5.96e-02 1.72e-01 7.44e-01 3.46e-01
GOBP HEART VALVE DEVELOPMENT 73 2.71e-02 1.57e-01 0.182000 1.82e-01 9.75e-03 7.25e-03 8.85e-01
MITF-M-dependent gene expression 106 5.13e-03 4.84e-02 0.182000 1.82e-01 -7.93e-04 1.21e-03 9.89e-01
Glyoxylate metabolism and glycine degradation 18 3.93e-01 6.75e-01 0.182000 -5.34e-02 1.74e-01 6.95e-01 2.01e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE 171 3.47e-04 5.87e-03 0.182000 1.62e-01 8.33e-02 2.63e-04 6.03e-02
GOMF NUCLEAR STEROID RECEPTOR ACTIVITY 25 3.15e-01 6.08e-01 0.182000 1.31e-01 1.26e-01 2.57e-01 2.74e-01
SUMO is proteolytically processed 6 7.39e-01 8.87e-01 0.182000 1.81e-01 -1.44e-02 4.42e-01 9.51e-01
GOCC MICROBODY MEMBRANE 61 3.99e-02 1.97e-01 0.182000 8.69e-02 -1.60e-01 2.40e-01 3.09e-02
PI3K events in ERBB2 signaling 16 4.25e-01 7.03e-01 0.182000 1.37e-01 -1.19e-01 3.41e-01 4.09e-01
GOBP HEART GROWTH 96 1.10e-02 8.41e-02 0.182000 1.67e-01 7.21e-02 4.70e-03 2.22e-01
GOBP N TERMINAL PEPTIDYL METHIONINE ACETYLATION 5 7.78e-01 9.08e-01 0.182000 1.82e-01 -1.01e-02 4.82e-01 9.69e-01
GOBP PROTEIN PROCESSING INVOLVED IN PROTEIN TARGETING TO MITOCHONDRION 7 6.97e-01 8.68e-01 0.182000 1.76e-01 -4.72e-02 4.21e-01 8.29e-01
GOBP REGULATION OF MULTICELLULAR ORGANISM GROWTH 64 3.80e-02 1.92e-01 0.182000 1.78e-01 -3.52e-02 1.36e-02 6.27e-01
GOMF ALPHA KETOGLUTARATE TRANSMEMBRANE TRANSPORTER ACTIVITY 6 7.26e-01 8.82e-01 0.182000 -1.25e-01 1.32e-01 5.96e-01 5.75e-01
GOBP CELLULAR RESPONSE TO CHOLESTEROL 20 3.97e-01 6.79e-01 0.182000 1.44e-01 1.10e-01 2.64e-01 3.93e-01
GOBP MITOTIC SISTER CHROMATID SEPARATION 62 4.10e-02 2.01e-01 0.182000 1.75e-01 -4.79e-02 1.70e-02 5.14e-01
GOBP LEUKOTRIENE METABOLIC PROCESS 30 2.40e-01 5.36e-01 0.182000 1.73e-01 5.67e-02 1.02e-01 5.91e-01
GOBP REGULATION OF GLIAL CELL APOPTOTIC PROCESS 11 5.62e-01 7.92e-01 0.182000 1.66e-01 -7.40e-02 3.41e-01 6.71e-01
GOBP PRO B CELL DIFFERENTIATION 12 5.64e-01 7.93e-01 0.182000 1.74e-01 5.10e-02 2.96e-01 7.60e-01
GOCC FIBRILLAR COLLAGEN TRIMER 12 5.67e-01 7.95e-01 0.182000 -6.37e-02 -1.70e-01 7.02e-01 3.08e-01
GOCC TRANSCRIPTION PREINITIATION COMPLEX 13 5.21e-01 7.64e-01 0.182000 1.81e-01 -1.11e-02 2.58e-01 9.45e-01
GOBP REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY 18 4.27e-01 7.05e-01 0.182000 -6.38e-02 -1.70e-01 6.39e-01 2.12e-01
GOBP POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 16 4.66e-01 7.28e-01 0.182000 1.74e-01 5.10e-02 2.27e-01 7.24e-01
GOMF TPR DOMAIN BINDING 7 7.18e-01 8.79e-01 0.182000 -1.70e-01 -6.27e-02 4.35e-01 7.74e-01
GOBP GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS 25 3.01e-01 5.97e-01 0.181000 1.77e-01 4.20e-02 1.26e-01 7.16e-01
GOBP PHOSPHATIDYLINOSITOL METABOLIC PROCESS 155 3.31e-04 5.64e-03 0.181000 1.70e-01 -6.34e-02 2.58e-04 1.73e-01
GOBP RESPONSE TO ODORANT 5 7.66e-01 9.01e-01 0.181000 -1.19e-01 1.37e-01 6.44e-01 5.97e-01
Telomere C-strand synthesis initiation 12 5.28e-01 7.70e-01 0.181000 1.19e-01 -1.37e-01 4.75e-01 4.12e-01
GOMF WNT RECEPTOR ACTIVITY 17 4.57e-01 7.23e-01 0.181000 1.15e-01 1.40e-01 4.13e-01 3.16e-01
RNA Polymerase II Transcription Termination 62 3.79e-02 1.91e-01 0.181000 9.87e-02 -1.52e-01 1.79e-01 3.82e-02
GOBP SPINDLE ELONGATION 13 5.47e-01 7.82e-01 0.181000 1.58e-01 8.97e-02 3.25e-01 5.75e-01
Cellular responses to mechanical stimuli 102 8.98e-03 7.30e-02 0.181000 1.57e-01 9.13e-02 6.26e-03 1.11e-01
GOBP BONE MATURATION 26 2.66e-01 5.62e-01 0.181000 -3.52e-02 1.78e-01 7.56e-01 1.16e-01
Signaling by Activin 17 4.21e-01 7.00e-01 0.181000 1.78e-01 -3.52e-02 2.04e-01 8.02e-01
GOBP DICARBOXYLIC ACID TRANSPORT 100 9.36e-03 7.50e-02 0.181000 7.15e-02 1.67e-01 2.17e-01 3.99e-03
GOBP DIADENOSINE POLYPHOSPHATE METABOLIC PROCESS 6 7.32e-01 8.84e-01 0.181000 6.96e-02 -1.67e-01 7.68e-01 4.78e-01
GOBP RESPONSE TO LITHIUM ION 16 4.66e-01 7.28e-01 0.181000 4.50e-02 1.76e-01 7.55e-01 2.24e-01
GOCC CELL POLE 9 6.62e-01 8.51e-01 0.181000 1.27e-01 1.30e-01 5.10e-01 5.01e-01
GOCC MRNA CLEAVAGE FACTOR COMPLEX 22 3.47e-01 6.37e-01 0.181000 1.78e-01 3.33e-02 1.48e-01 7.87e-01
RHOH GTPase cycle 36 1.55e-01 4.36e-01 0.181000 1.71e-01 -6.05e-02 7.62e-02 5.30e-01
Apoptotic factor-mediated response 18 4.05e-01 6.87e-01 0.181000 1.80e-01 -1.96e-02 1.86e-01 8.86e-01
GOBP PEPTIDE METABOLIC PROCESS 72 3.71e-02 1.90e-01 0.181000 1.18e-01 1.38e-01 8.44e-02 4.33e-02
Metabolism of porphyrins 27 2.44e-01 5.40e-01 0.181000 7.79e-02 -1.63e-01 4.84e-01 1.41e-01
GOBP REGULATION OF LYMPHANGIOGENESIS 7 6.92e-01 8.67e-01 0.181000 -1.57e-01 8.95e-02 4.71e-01 6.82e-01
Adipogenesis 105 5.23e-03 4.89e-02 0.181000 1.80e-01 -2.09e-02 1.45e-03 7.12e-01
GOBP REGULATION OF TOLERANCE INDUCTION 18 4.31e-01 7.06e-01 0.181000 -7.01e-02 -1.67e-01 6.07e-01 2.20e-01
GOBP PURINE DEOXYRIBONUCLEOSIDE METABOLIC PROCESS 5 7.81e-01 9.10e-01 0.181000 1.81e-01 -7.76e-04 4.83e-01 9.98e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 25 3.11e-01 6.04e-01 0.181000 -1.66e-01 -7.11e-02 1.50e-01 5.38e-01
GOBP MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE 29 2.65e-01 5.62e-01 0.181000 1.41e-01 1.13e-01 1.88e-01 2.92e-01
TRAF6 mediated NF-kB activation 24 2.95e-01 5.92e-01 0.181000 1.76e-01 -4.20e-02 1.36e-01 7.21e-01
GOBP TRICARBOXYLIC ACID CYCLE 28 2.43e-01 5.39e-01 0.181000 1.78e-01 -3.07e-02 1.03e-01 7.79e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 72 2.95e-02 1.65e-01 0.181000 1.81e-01 4.98e-03 7.99e-03 9.42e-01
SUMOylation of DNA replication proteins 46 9.59e-02 3.32e-01 0.181000 1.75e-01 -4.58e-02 4.01e-02 5.91e-01
GOMF FOUR WAY JUNCTION HELICASE ACTIVITY 6 7.45e-01 8.91e-01 0.181000 1.81e-01 5.54e-03 4.43e-01 9.81e-01
GOBP REGULATION OF CILIUM BEAT FREQUENCY INVOLVED IN CILIARY MOTILITY 9 6.31e-01 8.34e-01 0.181000 1.74e-01 -5.01e-02 3.67e-01 7.95e-01
GOBP NETRIN ACTIVATED SIGNALING PATHWAY 9 6.22e-01 8.29e-01 0.181000 -1.45e-01 1.08e-01 4.51e-01 5.75e-01
GOBP POSITIVE REGULATION OF RRNA PROCESSING 10 6.17e-01 8.26e-01 0.181000 -2.37e-02 -1.79e-01 8.97e-01 3.26e-01
GOBP REGULATION OF STEM CELL DIFFERENTIATION 83 1.78e-02 1.17e-01 0.181000 1.80e-01 1.35e-02 4.54e-03 8.31e-01
GOBP LUNG LOBE DEVELOPMENT 7 6.99e-01 8.70e-01 0.181000 1.74e-01 -5.04e-02 4.27e-01 8.17e-01
GOBP LIMB JOINT MORPHOGENESIS 7 7.21e-01 8.80e-01 0.181000 1.67e-01 6.94e-02 4.45e-01 7.51e-01
GOMF NEUROPEPTIDE Y RECEPTOR ACTIVITY 9 6.23e-01 8.30e-01 0.181000 1.52e-01 -9.80e-02 4.30e-01 6.11e-01
GOBP CARDIAC MUSCLE TISSUE REGENERATION 8 6.67e-01 8.53e-01 0.181000 1.77e-01 -3.54e-02 3.86e-01 8.62e-01
GOBP PROTEIN LOCALIZATION TO POSTSYNAPSE 40 1.61e-01 4.45e-01 0.181000 1.14e-01 1.40e-01 2.11e-01 1.26e-01
GOBP REGULATION OF MATRIX METALLOPEPTIDASE SECRETION 10 5.94e-01 8.13e-01 0.181000 -7.98e-02 1.62e-01 6.62e-01 3.75e-01
GOBP HEME B METABOLIC PROCESS 9 6.26e-01 8.32e-01 0.181000 1.62e-01 -8.05e-02 4.01e-01 6.76e-01
GOBP RADIAL GLIAL CELL DIFFERENTIATION 14 5.17e-01 7.63e-01 0.181000 -5.13e-02 -1.73e-01 7.39e-01 2.62e-01
GOCC MYOSIN II COMPLEX 26 2.56e-01 5.54e-01 0.180000 -9.90e-02 1.51e-01 3.82e-01 1.83e-01
GOCC IMMUNOGLOBULIN COMPLEX 10 5.94e-01 8.12e-01 0.180000 -1.57e-01 8.82e-02 3.89e-01 6.29e-01
GOCC ORGANELLE MEMBRANE CONTACT SITE 46 1.13e-01 3.64e-01 0.180000 1.76e-01 3.82e-02 3.86e-02 6.54e-01
GOBP CELL SURFACE RECEPTOR PROTEIN TYROSINE PHOSPHATASE SIGNALING PATHWAY 6 7.37e-01 8.87e-01 0.180000 1.74e-01 -4.74e-02 4.61e-01 8.41e-01
GOBP NEGATIVE REGULATION OF P38MAPK CASCADE 8 6.86e-01 8.64e-01 0.180000 -5.11e-02 -1.73e-01 8.02e-01 3.97e-01
GOBP ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY 10 6.20e-01 8.27e-01 0.180000 2.91e-02 1.78e-01 8.73e-01 3.30e-01
GOMF POLY A SPECIFIC RIBONUCLEASE ACTIVITY 13 5.05e-01 7.57e-01 0.180000 1.30e-01 -1.25e-01 4.17e-01 4.36e-01
GOBP PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION 28 2.35e-01 5.32e-01 0.180000 1.61e-01 -8.07e-02 1.40e-01 4.60e-01
GOMF VOLTAGE GATED MONOATOMIC CATION CHANNEL ACTIVITY 141 6.38e-04 9.61e-03 0.180000 -1.36e-01 1.18e-01 5.32e-03 1.54e-02
GOBP POSITIVE REGULATION OF P38MAPK CASCADE 30 2.52e-01 5.49e-01 0.180000 1.59e-01 8.45e-02 1.31e-01 4.23e-01
GOBP MYELOID CELL APOPTOTIC PROCESS 37 1.49e-01 4.25e-01 0.180000 1.65e-01 -7.31e-02 8.31e-02 4.42e-01
GOMF ALPHA ACTININ BINDING 28 2.74e-01 5.71e-01 0.180000 7.34e-02 1.65e-01 5.02e-01 1.32e-01
GOBP NEGATIVE REGULATION OF SODIUM ION TRANSPORT 17 4.53e-01 7.21e-01 0.180000 1.70e-01 6.01e-02 2.26e-01 6.68e-01
GOBP LAMELLIPODIUM ASSEMBLY 67 3.69e-02 1.89e-01 0.180000 1.79e-01 -1.40e-02 1.11e-02 8.43e-01
GOMF MICROFILAMENT MOTOR ACTIVITY 37 1.83e-01 4.73e-01 0.180000 1.61e-01 8.08e-02 9.05e-02 3.95e-01
GOBP BUD ELONGATION INVOLVED IN LUNG BRANCHING 7 6.94e-01 8.68e-01 0.180000 1.05e-01 -1.46e-01 6.31e-01 5.03e-01
GOBP POSITIVE REGULATION OF HELICASE ACTIVITY 6 7.43e-01 8.89e-01 0.180000 1.79e-01 -1.87e-02 4.48e-01 9.37e-01
GOBP REGULATION OF MITOCHONDRIAL GENE EXPRESSION 33 1.86e-01 4.76e-01 0.180000 6.01e-02 -1.70e-01 5.50e-01 9.19e-02
GOBP PROTEASOME MEDIATED UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 387 5.52e-09 3.51e-07 0.180000 1.77e-01 -3.03e-02 2.11e-09 3.06e-01
GOBP NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 32 1.97e-01 4.90e-01 0.180000 1.71e-01 -5.47e-02 9.34e-02 5.93e-01
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY INTERCONVERTING ALDOSES AND KETOSES 6 7.34e-01 8.85e-01 0.180000 -1.60e-01 8.13e-02 4.96e-01 7.30e-01
GOBP REGULATION OF GLUCOCORTICOID SECRETION 10 6.26e-01 8.32e-01 0.180000 1.73e-01 4.87e-02 3.43e-01 7.90e-01
GOBP NON CANONICAL WNT SIGNALING PATHWAY 69 4.37e-02 2.08e-01 0.180000 1.53e-01 9.46e-02 2.81e-02 1.74e-01
GOCC CONTRACTILE RING 11 6.03e-01 8.17e-01 0.180000 1.64e-01 7.25e-02 3.45e-01 6.77e-01
GOBP NEGATIVE REGULATION OF CHEMOTAXIS 47 1.13e-01 3.65e-01 0.180000 1.69e-01 5.97e-02 4.44e-02 4.79e-01
GOBP RESPONSE TO ACID CHEMICAL 132 1.29e-03 1.69e-02 0.180000 1.72e-01 -5.26e-02 6.52e-04 2.97e-01
RND3 GTPase cycle 41 1.56e-01 4.36e-01 0.180000 1.51e-01 9.69e-02 9.37e-02 2.83e-01
GOBP ENERGY HOMEOSTASIS 81 2.15e-02 1.33e-01 0.180000 1.77e-01 2.83e-02 5.77e-03 6.59e-01
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS 37 1.64e-01 4.48e-01 0.180000 1.79e-01 -9.26e-03 5.90e-02 9.22e-01
GOBP NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 13 5.32e-01 7.73e-01 0.180000 1.80e-01 2.22e-03 2.62e-01 9.89e-01
GOMF JUN KINASE BINDING 11 6.09e-01 8.22e-01 0.180000 1.27e-01 1.26e-01 4.64e-01 4.68e-01
GOBP REGULATION OF RETROGRADE TRANSPORT ENDOSOME TO GOLGI 7 7.22e-01 8.80e-01 0.180000 5.36e-02 1.71e-01 8.06e-01 4.32e-01
TCR signaling 100 5.64e-03 5.16e-02 0.179000 1.08e-01 -1.43e-01 6.09e-02 1.35e-02
GOMF MICROFIBRIL BINDING 6 7.35e-01 8.86e-01 0.179000 -1.62e-01 7.70e-02 4.92e-01 7.44e-01
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY 77 2.15e-02 1.33e-01 0.179000 1.75e-01 -3.86e-02 7.86e-03 5.58e-01
GOBP NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 61 6.26e-02 2.59e-01 0.179000 1.59e-01 8.31e-02 3.18e-02 2.62e-01
GOBP RESPONSE TO MISFOLDED PROTEIN 18 4.19e-01 6.99e-01 0.179000 1.79e-01 1.89e-03 1.88e-01 9.89e-01
GOBP REGULATION OF TOOTH MINERALIZATION 11 5.84e-01 8.06e-01 0.179000 9.86e-03 -1.79e-01 9.55e-01 3.04e-01
IRF3-mediated induction of type I IFN 13 5.58e-01 7.90e-01 0.179000 1.22e-01 1.31e-01 4.46e-01 4.13e-01
GOBP REGULATION OF NOTCH SIGNALING PATHWAY 95 1.41e-02 1.01e-01 0.179000 1.05e-01 1.45e-01 7.64e-02 1.45e-02
GOMF TRANSCRIPTION COREPRESSOR ACTIVITY 183 1.17e-04 2.46e-03 0.179000 1.75e-01 -3.70e-02 4.27e-05 3.88e-01
GOBP DIOL METABOLIC PROCESS 30 2.33e-01 5.31e-01 0.179000 -3.40e-03 1.79e-01 9.74e-01 8.94e-02
GOBP PSEUDOPODIUM ORGANIZATION 15 4.61e-01 7.24e-01 0.179000 1.48e-01 -1.02e-01 3.22e-01 4.96e-01
GOBP NEGATIVE REGULATION OF CATECHOLAMINE SECRETION 13 5.58e-01 7.90e-01 0.179000 -1.23e-01 -1.30e-01 4.42e-01 4.17e-01
GOBP NOREPINEPHRINE UPTAKE 8 6.60e-01 8.51e-01 0.179000 1.37e-01 -1.15e-01 5.02e-01 5.72e-01
GOBP POSITIVE REGULATION OF TRANSPORTER ACTIVITY 82 1.81e-02 1.19e-01 0.179000 1.78e-01 -1.76e-02 5.26e-03 7.83e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING ALKYL OR ARYL OTHER THAN METHYL GROUPS 55 6.06e-02 2.53e-01 0.179000 7.70e-02 -1.62e-01 3.23e-01 3.81e-02
FOXO-mediated transcription of cell cycle genes 16 4.51e-01 7.20e-01 0.179000 1.75e-01 -3.73e-02 2.25e-01 7.96e-01
Regulation of innate immune responses to cytosolic DNA 15 4.62e-01 7.25e-01 0.179000 1.50e-01 -9.82e-02 3.16e-01 5.10e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 221 4.24e-05 1.03e-03 0.179000 1.68e-01 6.20e-02 1.69e-05 1.12e-01
GOMF RIBONUCLEOPROTEIN COMPLEX BINDING 154 3.94e-04 6.49e-03 0.179000 8.41e-02 -1.58e-01 7.15e-02 7.16e-04
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 23 3.04e-01 5.98e-01 0.179000 1.39e-01 -1.12e-01 2.47e-01 3.52e-01
GOMF PHOSPHATIDYLCHOLINE TRANSPORTER ACTIVITY 18 4.41e-01 7.13e-01 0.179000 1.62e-01 7.67e-02 2.35e-01 5.73e-01
GOBP NEGATIVE REGULATION OF PHAGOCYTOSIS 21 3.90e-01 6.73e-01 0.179000 -1.44e-01 -1.06e-01 2.54e-01 3.98e-01
GOBP NEGATIVE REGULATION OF T HELPER 2 CELL DIFFERENTIATION 5 7.97e-01 9.17e-01 0.179000 8.70e-02 1.56e-01 7.36e-01 5.45e-01
COPII-mediated vesicle transport 67 3.51e-02 1.83e-01 0.179000 1.72e-01 -4.84e-02 1.47e-02 4.94e-01
GOBP SYNAPSE PRUNING 14 5.20e-01 7.64e-01 0.179000 -1.74e-01 -4.01e-02 2.59e-01 7.95e-01
GOMF TELETHONIN BINDING 7 6.98e-01 8.70e-01 0.179000 -8.75e-02 1.56e-01 6.88e-01 4.75e-01
Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins 64 4.34e-02 2.07e-01 0.179000 2.39e-02 -1.77e-01 7.41e-01 1.42e-02
GOBP MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 28 2.73e-01 5.71e-01 0.179000 -1.72e-01 -4.89e-02 1.15e-01 6.54e-01
Tandem pore domain potassium channels 12 5.38e-01 7.77e-01 0.179000 -1.33e-01 1.20e-01 4.26e-01 4.72e-01
GOBP REGULATION OF ALDOSTERONE METABOLIC PROCESS 8 6.79e-01 8.61e-01 0.179000 -6.55e-03 1.79e-01 9.74e-01 3.82e-01
GOBP NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC 161 2.58e-04 4.63e-03 0.179000 1.31e-01 -1.22e-01 4.19e-03 7.65e-03
GOBP NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION 21 3.77e-01 6.62e-01 0.179000 1.74e-01 4.18e-02 1.68e-01 7.40e-01
GOMF MOLECULAR CONDENSATE SCAFFOLD ACTIVITY 36 1.61e-01 4.43e-01 0.179000 1.62e-01 -7.54e-02 9.25e-02 4.34e-01
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION 41 1.60e-01 4.43e-01 0.179000 1.42e-01 1.08e-01 1.15e-01 2.32e-01
GOBP PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS 9 6.28e-01 8.33e-01 0.179000 1.30e-01 -1.23e-01 5.01e-01 5.23e-01
GOCC SITE OF DNA DAMAGE 125 1.75e-03 2.12e-02 0.179000 1.57e-01 -8.43e-02 2.36e-03 1.03e-01
GOBP REGULATION OF MACROPHAGE ACTIVATION 60 6.41e-02 2.63e-01 0.179000 -5.98e-02 -1.68e-01 4.23e-01 2.41e-02
GOBP LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT 19 4.01e-01 6.83e-01 0.179000 1.04e-03 -1.79e-01 9.94e-01 1.78e-01
GOBP NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY 12 5.65e-01 7.94e-01 0.179000 1.17e-02 1.78e-01 9.44e-01 2.85e-01
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation 10 6.37e-01 8.38e-01 0.179000 -1.56e-01 -8.73e-02 3.94e-01 6.33e-01
GOBP LABYRINTHINE LAYER MORPHOGENESIS 22 3.53e-01 6.42e-01 0.179000 -1.67e-02 -1.78e-01 8.92e-01 1.49e-01
GOBP EPITHELIAL TUBE MORPHOGENESIS 326 1.26e-07 6.12e-06 0.179000 1.75e-01 -3.49e-02 5.40e-08 2.79e-01
GOBP HEMOGLOBIN BIOSYNTHETIC PROCESS 13 5.48e-01 7.84e-01 0.179000 1.72e-01 4.71e-02 2.82e-01 7.69e-01
GOBP BLOOD VESSEL ENDOTHELIAL CELL DIFFERENTIATION 14 4.98e-01 7.52e-01 0.178000 1.72e-01 -4.90e-02 2.66e-01 7.51e-01
GOCC RNA POLYMERASE III TRANSCRIPTION REGULATOR COMPLEX 9 6.45e-01 8.42e-01 0.178000 1.77e-01 -2.01e-02 3.57e-01 9.17e-01
Signaling by NOTCH1 69 3.63e-02 1.87e-01 0.178000 1.78e-01 -5.05e-03 1.04e-02 9.42e-01
ARMS-mediated activation 7 7.32e-01 8.85e-01 0.178000 1.22e-01 1.30e-01 5.76e-01 5.51e-01
Co-inhibition by PD-1 21 3.78e-01 6.64e-01 0.178000 -4.37e-02 -1.73e-01 7.29e-01 1.70e-01
GOMF NADPLUS PROTEIN ADP RIBOSYLTRANSFERASE ACTIVITY 28 2.81e-01 5.78e-01 0.178000 1.64e-01 7.05e-02 1.33e-01 5.18e-01
GOMF FLAVIN ADENINE DINUCLEOTIDE BINDING 84 1.89e-02 1.22e-01 0.178000 1.47e-02 1.78e-01 8.16e-01 4.86e-03
GOBP PROTEIN LOCALIZATION TO CHROMATIN 58 5.09e-02 2.27e-01 0.178000 1.24e-01 -1.28e-01 1.02e-01 9.21e-02
GOBP REGULATION OF LAMELLIPODIUM ASSEMBLY 37 1.75e-01 4.61e-01 0.178000 1.77e-01 1.75e-02 6.18e-02 8.54e-01
Pyrimidine salvage 10 6.13e-01 8.24e-01 0.178000 2.83e-02 -1.76e-01 8.77e-01 3.35e-01
GOMF TBP CLASS PROTEIN BINDING 24 2.95e-01 5.92e-01 0.178000 1.55e-01 -8.74e-02 1.88e-01 4.59e-01
GOBP REGULATION OF FOREBRAIN NEURON DIFFERENTIATION 5 7.74e-01 9.05e-01 0.178000 1.06e-01 -1.43e-01 6.81e-01 5.80e-01
GOBP NEGATIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION 37 1.79e-01 4.67e-01 0.178000 1.75e-01 3.26e-02 6.52e-02 7.32e-01
GOBP SYNAPTIC VESICLE CLUSTERING 15 4.70e-01 7.31e-01 0.178000 -1.64e-01 6.91e-02 2.71e-01 6.43e-01
Signal transduction by L1 20 3.76e-01 6.62e-01 0.178000 1.76e-01 -2.85e-02 1.73e-01 8.26e-01
GOMF GUANYLYLTRANSFERASE ACTIVITY 7 7.02e-01 8.71e-01 0.178000 1.62e-01 -7.45e-02 4.59e-01 7.33e-01
GOBP HISTONE MRNA METABOLIC PROCESS 24 2.93e-01 5.91e-01 0.178000 1.07e-01 -1.42e-01 3.65e-01 2.27e-01
GOBP MESENCHYMAL CELL PROLIFERATION 44 1.12e-01 3.62e-01 0.178000 1.69e-01 -5.71e-02 5.30e-02 5.12e-01
GOCC INTERCELLULAR CANALICULUS 6 7.50e-01 8.92e-01 0.178000 -7.21e-03 1.78e-01 9.76e-01 4.51e-01
GOBP TYPE B PANCREATIC CELL DIFFERENTIATION 29 2.41e-01 5.36e-01 0.178000 1.74e-01 -3.69e-02 1.05e-01 7.31e-01
GOCC RUFFLE 179 2.76e-04 4.87e-03 0.178000 1.73e-01 4.24e-02 6.62e-05 3.28e-01
GOCC POLE PLASM 24 2.97e-01 5.94e-01 0.178000 -1.56e-01 8.52e-02 1.85e-01 4.70e-01
Proteasome assembly 51 9.77e-02 3.35e-01 0.178000 -5.35e-02 -1.70e-01 5.08e-01 3.61e-02
GOBP POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 31 2.40e-01 5.36e-01 0.178000 4.06e-02 1.73e-01 6.95e-01 9.52e-02
GOBP REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 158 4.23e-04 6.86e-03 0.178000 1.71e-01 -4.97e-02 2.14e-04 2.81e-01
GOBP REGULATION OF PROTEIN FOLDING 9 6.41e-01 8.41e-01 0.178000 4.83e-02 -1.71e-01 8.02e-01 3.74e-01
GOBP REGULATION OF BARBED END ACTIN FILAMENT CAPPING 5 7.90e-01 9.14e-01 0.178000 1.77e-01 1.31e-02 4.93e-01 9.59e-01
GOMF LIGASE ACTIVITY FORMING PHOSPHORIC ESTER BONDS 6 7.50e-01 8.92e-01 0.178000 1.77e-01 -9.29e-03 4.52e-01 9.69e-01
GOBP POSITIVE REGULATION OF PROTEIN DEACETYLATION 6 7.55e-01 8.95e-01 0.178000 1.77e-01 1.90e-02 4.54e-01 9.36e-01
GOBP SENSORY ORGAN MORPHOGENESIS 274 3.80e-06 1.24e-04 0.178000 1.73e-01 3.79e-02 7.65e-07 2.81e-01
GOBP POSITIVE T CELL SELECTION 44 1.08e-01 3.54e-01 0.178000 1.50e-01 -9.56e-02 8.59e-02 2.73e-01
GOBP PROTEIN LOCALIZATION TO EARLY ENDOSOME 12 5.50e-01 7.85e-01 0.178000 -6.12e-02 1.67e-01 7.14e-01 3.17e-01
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT 9 6.33e-01 8.36e-01 0.178000 1.47e-01 -1.00e-01 4.47e-01 6.02e-01
GOBP S ADENOSYLMETHIONINE METABOLIC PROCESS 16 4.65e-01 7.28e-01 0.177000 1.77e-01 -9.63e-03 2.20e-01 9.47e-01
GOBP CHAPERONE MEDIATED PROTEIN FOLDING 75 2.64e-02 1.54e-01 0.177000 2.84e-02 -1.75e-01 6.70e-01 8.71e-03
GOMF ACYL COA HYDROLASE ACTIVITY 22 3.80e-01 6.65e-01 0.177000 1.19e-01 1.32e-01 3.34e-01 2.85e-01
GOBP OXYGEN TRANSPORT 15 5.11e-01 7.60e-01 0.177000 -1.61e-01 -7.52e-02 2.81e-01 6.14e-01
GOBP POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 18 4.41e-01 7.13e-01 0.177000 5.15e-02 1.70e-01 7.05e-01 2.12e-01
GOCC LSM1 7 PAT1 COMPLEX 5 7.90e-01 9.14e-01 0.177000 -5.67e-03 -1.77e-01 9.82e-01 4.92e-01
Viral Messenger RNA Synthesis 44 1.10e-01 3.59e-01 0.177000 1.59e-01 -7.92e-02 6.85e-02 3.63e-01
Signaling by Leptin 11 6.02e-01 8.17e-01 0.177000 1.74e-01 3.24e-02 3.17e-01 8.53e-01
GOMF ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY 14 5.40e-01 7.78e-01 0.177000 -1.43e-01 -1.04e-01 3.53e-01 4.99e-01
GOBP MYOBLAST DIFFERENTIATION 112 4.89e-03 4.66e-02 0.177000 1.77e-01 -8.66e-03 1.20e-03 8.74e-01
GOCC HFE TRANSFERRIN RECEPTOR COMPLEX 8 6.69e-01 8.55e-01 0.177000 8.57e-02 -1.55e-01 6.75e-01 4.47e-01
GOBP INTERLEUKIN 13 PRODUCTION 21 3.95e-01 6.77e-01 0.177000 9.50e-02 1.50e-01 4.51e-01 2.35e-01
Toll Like Receptor 9 (TLR9) Cascade 102 5.88e-03 5.33e-02 0.177000 1.48e-01 -9.80e-02 9.94e-03 8.72e-02
GOBP CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS 20 3.62e-01 6.50e-01 0.177000 1.21e-01 -1.30e-01 3.49e-01 3.16e-01
GOBP MESONEPHROS DEVELOPMENT 101 7.59e-03 6.45e-02 0.177000 1.75e-01 -3.05e-02 2.43e-03 5.96e-01
GOMF NADPLUS PROTEIN ARGININE ADP RIBOSYLTRANSFERASE ACTIVITY 6 7.38e-01 8.87e-01 0.177000 -1.38e-01 1.11e-01 5.59e-01 6.36e-01
Glycosphingolipid biosynthesis 19 4.04e-01 6.86e-01 0.177000 1.77e-01 -1.14e-02 1.82e-01 9.31e-01
GOBP VESICLE TARGETING 65 4.87e-02 2.22e-01 0.177000 1.76e-01 1.80e-02 1.40e-02 8.02e-01
GOBP CHOLESTEROL CATABOLIC PROCESS 9 6.69e-01 8.55e-01 0.177000 -1.61e-01 -7.46e-02 4.04e-01 6.98e-01
GOBP REGULATION OF NEUROTRANSMITTER UPTAKE 18 4.54e-01 7.21e-01 0.177000 1.08e-01 1.41e-01 4.29e-01 3.02e-01
Nucleotide biosynthesis 12 5.46e-01 7.82e-01 0.177000 9.86e-02 -1.47e-01 5.54e-01 3.78e-01
Resolution of D-Loop Structures 35 1.79e-01 4.67e-01 0.177000 1.69e-01 -5.29e-02 8.36e-02 5.88e-01
GOBP DNA STRAND INVASION 6 7.68e-01 9.02e-01 0.177000 1.42e-01 1.06e-01 5.47e-01 6.53e-01
Myogenesis 29 2.75e-01 5.72e-01 0.177000 1.60e-01 7.67e-02 1.37e-01 4.75e-01
GOBP RESPONSE TO VITAMIN 86 1.31e-02 9.52e-02 0.177000 1.37e-01 -1.12e-01 2.81e-02 7.24e-02
GOBP POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION 15 5.19e-01 7.63e-01 0.177000 -1.28e-01 -1.22e-01 3.91e-01 4.12e-01
GOBP POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT 42 1.59e-01 4.41e-01 0.177000 1.08e-01 1.40e-01 2.27e-01 1.16e-01
GOBP TETRAPYRROLE CATABOLIC PROCESS 13 5.23e-01 7.66e-01 0.177000 7.43e-02 -1.61e-01 6.43e-01 3.16e-01
GOBP REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY 43 1.15e-01 3.68e-01 0.177000 1.49e-01 -9.58e-02 9.14e-02 2.77e-01
GOBP POSITIVE REGULATION OF NEUROGENESIS 231 3.56e-05 8.93e-04 0.177000 1.64e-01 6.69e-02 1.79e-05 7.97e-02
GOMF PHOSPHATIDYLINOSITOL 4 PHOSPHATE BINDING 29 2.34e-01 5.31e-01 0.177000 8.40e-02 -1.56e-01 4.34e-01 1.47e-01
GOBP POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION 12 5.84e-01 8.05e-01 0.177000 1.65e-01 6.33e-02 3.22e-01 7.04e-01
GOBP REGULATION OF BEHAVIOR 73 3.99e-02 1.97e-01 0.177000 1.55e-01 8.55e-02 2.21e-02 2.07e-01
GOBP PROTEIN DNA COVALENT CROSS LINKING REPAIR 8 6.67e-01 8.53e-01 0.177000 1.31e-01 -1.19e-01 5.20e-01 5.62e-01
GOBP CARDIAC MUSCLE CELL DIFFERENTIATION 126 4.09e-03 4.06e-02 0.177000 1.43e-01 1.04e-01 5.50e-03 4.42e-02
APC/C:Cdc20 mediated degradation of Securin 55 6.81e-02 2.72e-01 0.177000 4.77e-02 -1.70e-01 5.41e-01 2.89e-02
GOBP GLOMERULUS DEVELOPMENT 71 3.13e-02 1.70e-01 0.177000 1.70e-01 -4.72e-02 1.30e-02 4.92e-01
ER-Phagosome pathway 76 2.95e-02 1.65e-01 0.177000 -1.62e-02 -1.76e-01 8.07e-01 7.96e-03
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription 36 1.62e-01 4.46e-01 0.177000 1.23e-01 -1.27e-01 2.03e-01 1.86e-01
Signaling by RNF43 mutants 8 7.01e-01 8.70e-01 0.177000 7.78e-02 1.59e-01 7.03e-01 4.37e-01
GOCC TRANSCRIPTION FACTOR TFTC COMPLEX 17 4.31e-01 7.06e-01 0.177000 1.63e-01 -6.87e-02 2.45e-01 6.24e-01
GOBP CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 47 1.06e-01 3.50e-01 0.177000 2.25e-02 -1.75e-01 7.90e-01 3.77e-02
GOBP CATECHOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS 22 3.35e-01 6.25e-01 0.177000 -7.89e-02 1.58e-01 5.22e-01 1.99e-01
GOMF UDP GALACTOSE BETA N ACETYLGLUCOSAMINE BETA 1 3 GALACTOSYLTRANSFERASE ACTIVITY 12 5.92e-01 8.10e-01 0.177000 1.43e-01 1.04e-01 3.93e-01 5.31e-01
NTRK2 activates RAC1 5 7.84e-01 9.12e-01 0.177000 -4.12e-02 1.72e-01 8.73e-01 5.06e-01
GOBP POSITIVE REGULATION OF REGULATORY T CELL DIFFERENTIATION 22 3.66e-01 6.53e-01 0.177000 -3.27e-02 -1.74e-01 7.90e-01 1.59e-01
GOBP POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 7 7.30e-01 8.84e-01 0.177000 1.67e-01 5.63e-02 4.43e-01 7.96e-01
GOBP CELL SURFACE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 401 1.55e-08 9.26e-07 0.177000 1.73e-01 3.52e-02 2.73e-09 2.27e-01
GOMF ANDROSTAN 3 ALPHA 17 BETA DIOL DEHYDROGENASE ACTIVITY 8 6.93e-01 8.68e-01 0.177000 1.74e-01 2.97e-02 3.94e-01 8.84e-01
Mitotic Prophase 104 5.43e-03 5.01e-02 0.176000 1.31e-01 -1.18e-01 2.12e-02 3.69e-02
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH 27 3.07e-01 6.00e-01 0.176000 1.49e-01 9.41e-02 1.80e-01 3.97e-01
GOBP DEPYRIMIDINATION 8 7.04e-01 8.72e-01 0.176000 9.30e-02 1.50e-01 6.49e-01 4.63e-01
GOBP POSITIVE REGULATION OF CALCIUM ION IMPORT 24 3.03e-01 5.97e-01 0.176000 1.55e-01 -8.36e-02 1.88e-01 4.79e-01
GOBP HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE 33 1.95e-01 4.88e-01 0.176000 1.59e-01 -7.65e-02 1.14e-01 4.47e-01
GOBP POLYAMINE METABOLIC PROCESS 15 4.74e-01 7.34e-01 0.176000 -1.54e-01 8.51e-02 3.00e-01 5.68e-01
GOBP TROPHECTODERMAL CELL DIFFERENTIATION 19 3.87e-01 6.71e-01 0.176000 1.50e-01 -9.26e-02 2.58e-01 4.85e-01
GOCC NADH DEHYDROGENASE COMPLEX 42 1.30e-01 3.93e-01 0.176000 4.80e-02 -1.70e-01 5.91e-01 5.71e-02
GOBP REGULATION OF RESPONSE TO OSMOTIC STRESS 16 4.76e-01 7.36e-01 0.176000 1.76e-01 1.21e-02 2.23e-01 9.33e-01
GOMF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY 27 2.64e-01 5.61e-01 0.176000 -7.17e-02 1.61e-01 5.19e-01 1.48e-01
GOBP POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION 63 5.64e-02 2.43e-01 0.176000 1.74e-01 2.82e-02 1.69e-02 6.99e-01
Effects of PIP2 hydrolysis 26 3.16e-01 6.09e-01 0.176000 1.62e-01 6.96e-02 1.53e-01 5.39e-01
GOBP LYMPHOCYTE APOPTOTIC PROCESS 79 2.78e-02 1.59e-01 0.176000 -3.40e-02 -1.73e-01 6.02e-01 7.89e-03
Nuclear events mediated by NFE2L2 85 1.42e-02 1.01e-01 0.176000 1.23e-01 -1.26e-01 5.03e-02 4.41e-02
Toll Like Receptor 3 (TLR3) Cascade 100 7.04e-03 6.12e-02 0.176000 1.51e-01 -9.02e-02 8.97e-03 1.19e-01
Dermatan sulfate biosynthesis 10 6.47e-01 8.43e-01 0.176000 1.47e-01 9.69e-02 4.21e-01 5.96e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL PROLIFERATION 10 6.11e-01 8.23e-01 0.176000 -6.97e-02 1.62e-01 7.03e-01 3.76e-01
GOBP XMP METABOLIC PROCESS 7 7.06e-01 8.73e-01 0.176000 8.70e-02 -1.53e-01 6.90e-01 4.83e-01
GOBP QUATERNARY AMMONIUM GROUP TRANSPORT 17 4.27e-01 7.05e-01 0.176000 1.27e-01 -1.22e-01 3.65e-01 3.85e-01
GOCC CHROMOSOME CENTROMERIC REGION 246 5.27e-06 1.65e-04 0.176000 1.40e-01 -1.06e-01 1.47e-04 4.25e-03
GOBP HEART MORPHOGENESIS 267 4.98e-06 1.58e-04 0.176000 1.76e-01 9.83e-03 7.78e-07 7.82e-01
GOCC CELL SUBSTRATE JUNCTION 419 3.82e-09 2.52e-07 0.176000 1.75e-01 -1.24e-02 7.17e-10 6.64e-01
GOBP POSITIVE REGULATION OF FIBROBLAST PROLIFERATION 54 7.20e-02 2.82e-01 0.176000 6.01e-02 -1.65e-01 4.45e-01 3.57e-02
HSF1 activation 26 2.86e-01 5.83e-01 0.176000 4.32e-02 -1.70e-01 7.03e-01 1.32e-01
GOBP RESPONSE TO PROSTAGLANDIN E 24 3.06e-01 5.99e-01 0.176000 7.94e-02 -1.57e-01 5.01e-01 1.83e-01
RUNX1 regulates transcription of genes involved in WNT signaling 5 7.82e-01 9.10e-01 0.176000 1.60e-01 -7.20e-02 5.35e-01 7.80e-01
Attenuation phase 24 3.22e-01 6.14e-01 0.176000 1.65e-02 -1.75e-01 8.89e-01 1.38e-01
GOBP NEURAL TUBE DEVELOPMENT 156 7.33e-04 1.07e-02 0.176000 1.76e-01 6.48e-06 1.51e-04 1.00e+00
GOCC NUCLEOID 43 1.52e-01 4.30e-01 0.176000 -7.30e-02 -1.60e-01 4.08e-01 6.98e-02
GOBP XYLULOSE 5 PHOSPHATE METABOLIC PROCESS 6 7.57e-01 8.96e-01 0.176000 1.76e-01 2.28e-03 4.56e-01 9.92e-01
GOBP REGULATION OF CELL JUNCTION ASSEMBLY 205 1.35e-04 2.74e-03 0.176000 1.58e-01 7.60e-02 9.27e-05 6.05e-02
GOBP EMBRYO DEVELOPMENT 1097 5.53e-22 2.19e-19 0.176000 1.75e-01 -8.77e-03 9.30e-23 6.24e-01
RUNX1 regulates transcription of genes involved in BCR signaling 6 7.41e-01 8.89e-01 0.176000 1.19e-01 -1.29e-01 6.14e-01 5.83e-01
Fc epsilon receptor (FCERI) signaling 115 3.51e-03 3.59e-02 0.176000 1.52e-01 -8.71e-02 4.74e-03 1.07e-01
GOMF TAU PROTEIN KINASE ACTIVITY 22 3.77e-01 6.63e-01 0.176000 1.66e-01 5.84e-02 1.79e-01 6.36e-01
Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) 8 6.95e-01 8.68e-01 0.176000 1.74e-01 2.49e-02 3.95e-01 9.03e-01
GOBP REGULATION OF POLYSACCHARIDE METABOLIC PROCESS 43 1.54e-01 4.33e-01 0.176000 1.56e-01 8.14e-02 7.76e-02 3.56e-01
GOBP NEGATIVE REGULATION OF HUMORAL IMMUNE RESPONSE 15 5.24e-01 7.66e-01 0.175000 -1.36e-01 -1.11e-01 3.62e-01 4.56e-01
GOMF CHROMATIN PROTEIN ADAPTOR ACTIVITY 28 2.90e-01 5.87e-01 0.175000 1.65e-01 5.99e-02 1.31e-01 5.83e-01
GOBP PENTOSE METABOLIC PROCESS 12 5.92e-01 8.11e-01 0.175000 -7.76e-02 -1.57e-01 6.42e-01 3.45e-01
GOBP WNT SIGNALING PATHWAY 446 1.22e-09 8.86e-08 0.175000 1.75e-01 -1.36e-02 2.38e-10 6.22e-01
GOBP PROTEIN K27 LINKED UBIQUITINATION 12 5.97e-01 8.14e-01 0.175000 -1.23e-01 -1.25e-01 4.59e-01 4.55e-01
GOMF OUTWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY 26 2.75e-01 5.72e-01 0.175000 -1.12e-01 1.35e-01 3.22e-01 2.34e-01
GOBP POST ANAL TAIL MORPHOGENESIS 18 4.56e-01 7.22e-01 0.175000 7.85e-02 1.57e-01 5.64e-01 2.49e-01
GOBP RETINOIC ACID METABOLIC PROCESS 33 1.95e-01 4.87e-01 0.175000 1.04e-01 -1.41e-01 3.01e-01 1.60e-01
GOBP RESPONSE TO INTERLEUKIN 2 9 6.42e-01 8.41e-01 0.175000 8.78e-02 -1.52e-01 6.48e-01 4.30e-01
RHO GTPase Effectors 273 1.80e-06 6.33e-05 0.175000 1.57e-01 -7.72e-02 7.55e-06 2.81e-02
Signaling by ERBB4 57 5.92e-02 2.50e-01 0.175000 1.18e-01 -1.30e-01 1.25e-01 8.97e-02
GOBP TRABECULA FORMATION 27 2.68e-01 5.64e-01 0.175000 1.60e-01 -7.25e-02 1.51e-01 5.14e-01
GOBP CANONICAL WNT SIGNALING PATHWAY 310 4.68e-07 2.01e-05 0.175000 1.71e-01 -3.67e-02 2.13e-07 2.67e-01
ChREBP activates metabolic gene expression 8 7.06e-01 8.73e-01 0.175000 1.58e-01 7.58e-02 4.40e-01 7.10e-01
GOBP CHROMOSOME ORGANIZATION 614 2.64e-13 3.57e-11 0.175000 1.64e-01 -6.21e-02 4.23e-12 8.59e-03
GOBP CELLULAR RESPONSE TO GLUCOSE STARVATION 44 1.14e-01 3.66e-01 0.175000 1.06e-01 -1.39e-01 2.23e-01 1.10e-01
GOBP PROTEIN CATABOLIC PROCESS IN THE VACUOLE 23 3.72e-01 6.59e-01 0.175000 1.45e-01 9.75e-02 2.28e-01 4.18e-01
GOBP IMMUNE SYSTEM DEVELOPMENT 197 7.77e-05 1.73e-03 0.175000 1.63e-01 -6.26e-02 7.63e-05 1.30e-01
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY 109 4.63e-03 4.47e-02 0.175000 1.21e-01 -1.26e-01 2.88e-02 2.28e-02
GOBP POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 16 5.00e-01 7.53e-01 0.175000 -8.16e-02 -1.55e-01 5.72e-01 2.84e-01
GOBP REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 25 2.91e-01 5.88e-01 0.175000 1.39e-01 -1.07e-01 2.30e-01 3.56e-01
GOCC CELL BODY FIBER 8 6.89e-01 8.65e-01 0.175000 -1.19e-02 1.75e-01 9.53e-01 3.93e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL DIFFERENTIATION 7 7.08e-01 8.73e-01 0.175000 1.10e-01 -1.36e-01 6.15e-01 5.33e-01
Activated NTRK2 signals through FYN 7 7.41e-01 8.88e-01 0.175000 1.07e-01 1.39e-01 6.25e-01 5.25e-01
Meiosis 82 1.84e-02 1.20e-01 0.175000 8.34e-02 -1.54e-01 1.92e-01 1.61e-02
Apoptosis 160 4.21e-04 6.84e-03 0.175000 1.54e-01 -8.35e-02 7.99e-04 6.84e-02
GOMF SIGNAL SEQUENCE BINDING 47 9.94e-02 3.38e-01 0.175000 1.45e-01 -9.71e-02 8.46e-02 2.49e-01
GOBP CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT 27 2.98e-01 5.94e-01 0.175000 1.72e-01 3.03e-02 1.22e-01 7.85e-01
GOBP SEQUESTERING OF BMP IN EXTRACELLULAR MATRIX 5 7.96e-01 9.17e-01 0.175000 -1.13e-02 -1.74e-01 9.65e-01 4.99e-01
GOBP NEGATIVE REGULATION OF MHC CLASS II BIOSYNTHETIC PROCESS 5 8.08e-01 9.21e-01 0.175000 1.32e-01 1.14e-01 6.08e-01 6.59e-01
GOMF GABA A RECEPTOR ACTIVITY 16 4.98e-01 7.52e-01 0.175000 -6.79e-02 -1.61e-01 6.38e-01 2.65e-01
GOBP SEQUESTERING OF ACTIN MONOMERS 6 7.71e-01 9.04e-01 0.175000 -1.58e-01 -7.46e-02 5.03e-01 7.52e-01
GOCC NLRP3 INFLAMMASOME COMPLEX 7 7.36e-01 8.86e-01 0.175000 1.64e-01 6.08e-02 4.53e-01 7.81e-01
GOBP LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS 18 4.64e-01 7.28e-01 0.175000 1.35e-01 1.11e-01 3.22e-01 4.15e-01
GOCC MITOTIC SPINDLE 175 3.41e-04 5.78e-03 0.175000 1.75e-01 -9.54e-04 6.80e-05 9.83e-01
GOBP POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 62 6.29e-02 2.60e-01 0.175000 1.72e-01 3.12e-02 1.94e-02 6.71e-01
GOBP RENAL VESICLE FORMATION 8 7.00e-01 8.70e-01 0.175000 1.71e-01 3.24e-02 4.01e-01 8.74e-01
GOBP TRABECULA MORPHOGENESIS 47 1.05e-01 3.50e-01 0.174000 1.65e-01 -5.77e-02 5.08e-02 4.94e-01
GOBP ACYLGLYCEROL HOMEOSTASIS 44 1.32e-01 3.96e-01 0.174000 -1.74e-01 7.06e-03 4.55e-02 9.35e-01
GOBP EPHRIN RECEPTOR SIGNALING PATHWAY 49 1.25e-01 3.86e-01 0.174000 1.19e-01 1.28e-01 1.50e-01 1.22e-01
Miscellaneous substrates 12 5.94e-01 8.12e-01 0.174000 -6.56e-02 -1.61e-01 6.94e-01 3.33e-01
MyD88-independent TLR4 cascade 104 6.45e-03 5.72e-02 0.174000 1.51e-01 -8.66e-02 7.69e-03 1.27e-01
TRIF (TICAM1)-mediated TLR4 signaling 104 6.45e-03 5.72e-02 0.174000 1.51e-01 -8.66e-02 7.69e-03 1.27e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY 12 5.97e-01 8.14e-01 0.174000 -7.89e-02 -1.55e-01 6.36e-01 3.51e-01
GOBP SKELETAL MUSCLE CELL PROLIFERATION 24 3.45e-01 6.35e-01 0.174000 -3.81e-02 -1.70e-01 7.47e-01 1.49e-01
cGMP effects 16 4.73e-01 7.33e-01 0.174000 -1.72e-01 2.90e-02 2.34e-01 8.41e-01
GOBP PROSTAGLANDIN SECRETION 18 4.22e-01 7.01e-01 0.174000 1.63e-01 -6.01e-02 2.30e-01 6.59e-01
GOBP POSITIVE REGULATION OF INTERFERON BETA PRODUCTION 37 1.88e-01 4.79e-01 0.174000 -1.29e-02 -1.74e-01 8.92e-01 6.75e-02
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY 23 3.76e-01 6.62e-01 0.174000 1.44e-01 9.85e-02 2.33e-01 4.14e-01
GOBP NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 159 7.33e-04 1.07e-02 0.174000 1.74e-01 -3.03e-04 1.51e-04 9.95e-01
GOMF NUCLEOTIDASE ACTIVITY 14 5.50e-01 7.85e-01 0.174000 9.05e-02 1.49e-01 5.58e-01 3.35e-01
Signaling by VEGF 102 1.22e-02 9.04e-02 0.174000 1.62e-01 6.29e-02 4.63e-03 2.72e-01
GOBP ENDOSOMAL TRANSPORT 276 6.05e-06 1.87e-04 0.174000 1.69e-01 4.30e-02 1.42e-06 2.19e-01
GOBP MORPHOGENESIS OF A BRANCHING STRUCTURE 200 8.16e-05 1.80e-03 0.174000 1.67e-01 -4.92e-02 4.69e-05 2.30e-01
GOBP KIDNEY EPITHELIUM DEVELOPMENT 148 1.24e-03 1.63e-02 0.174000 1.74e-01 3.81e-03 2.59e-04 9.36e-01
GOBP UREA TRANSPORT 11 5.86e-01 8.07e-01 0.174000 -1.50e-01 8.77e-02 3.88e-01 6.15e-01
GOBP PHOSPHATIDYLGLYCEROL METABOLIC PROCESS 33 2.04e-01 4.98e-01 0.174000 1.57e-01 -7.57e-02 1.19e-01 4.52e-01
CD163 mediating an anti-inflammatory response 9 6.81e-01 8.62e-01 0.174000 -1.51e-01 -8.64e-02 4.33e-01 6.54e-01
GOBP ER NUCLEUS SIGNALING PATHWAY 47 1.05e-01 3.49e-01 0.174000 1.60e-01 -6.82e-02 5.77e-02 4.18e-01
GOBP CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 37 1.89e-01 4.80e-01 0.174000 1.73e-01 1.24e-02 6.79e-02 8.96e-01
GOBP REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM 24 3.42e-01 6.32e-01 0.174000 -2.20e-02 -1.72e-01 8.52e-01 1.44e-01
GOBP REGULATION OF DENDRITIC CELL DIFFERENTIATION 13 5.63e-01 7.93e-01 0.174000 3.80e-02 1.70e-01 8.12e-01 2.90e-01
GOBP REGULATION OF STEROID HORMONE SECRETION 22 3.83e-01 6.68e-01 0.174000 1.65e-01 5.37e-02 1.79e-01 6.63e-01
GOBP COPII COATED VESICLE CARGO LOADING 18 4.30e-01 7.06e-01 0.174000 1.70e-01 -3.43e-02 2.11e-01 8.01e-01
GOMF RNA POLYMERASE ACTIVITY 30 2.38e-01 5.34e-01 0.174000 6.85e-02 -1.60e-01 5.16e-01 1.30e-01
GOBP REGULATION OF PIGMENTATION 17 4.36e-01 7.10e-01 0.174000 1.12e-01 -1.33e-01 4.26e-01 3.42e-01
GOBP REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 94 1.87e-02 1.22e-01 0.174000 9.30e-02 1.47e-01 1.19e-01 1.39e-02
GOCC SUPER ELONGATION COMPLEX 5 8.10e-01 9.22e-01 0.174000 1.10e-01 1.34e-01 6.70e-01 6.03e-01
Downstream TCR signaling 81 1.95e-02 1.24e-01 0.174000 1.13e-01 -1.32e-01 7.97e-02 3.96e-02
GOBP POLYAMINE TRANSPORT 16 4.59e-01 7.24e-01 0.174000 1.14e-01 -1.31e-01 4.30e-01 3.64e-01
GOBP CELLULAR RESPONSE TO CADMIUM ION 35 2.01e-01 4.94e-01 0.174000 -1.73e-01 1.24e-02 7.63e-02 8.99e-01
GOBP SUBSTRATE ADHESION DEPENDENT CELL SPREADING 99 1.14e-02 8.67e-02 0.174000 1.74e-01 1.63e-03 2.84e-03 9.78e-01
GOCC SODIUM POTASSIUM EXCHANGING ATPASE COMPLEX 11 5.86e-01 8.06e-01 0.174000 -1.36e-01 1.08e-01 4.36e-01 5.34e-01
Transport of Mature Transcript to Cytoplasm 78 2.30e-02 1.40e-01 0.174000 1.41e-01 -1.01e-01 3.12e-02 1.23e-01
GOBP REGULATION OF MITOTIC SPINDLE ASSEMBLY 22 3.73e-01 6.59e-01 0.173000 -1.33e-02 -1.73e-01 9.14e-01 1.60e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 17 4.74e-01 7.34e-01 0.173000 3.97e-02 1.69e-01 7.77e-01 2.28e-01
Synthesis of PC 27 2.70e-01 5.67e-01 0.173000 1.40e-01 -1.02e-01 2.08e-01 3.57e-01
GOBP ACTIN POLYMERIZATION OR DEPOLYMERIZATION 186 2.09e-04 3.89e-03 0.173000 1.73e-01 -1.57e-02 4.86e-05 7.12e-01
GOBP URETER MORPHOGENESIS 7 7.42e-01 8.89e-01 0.173000 1.54e-01 8.00e-02 4.81e-01 7.14e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL PROLIFERATION 8 6.86e-01 8.64e-01 0.173000 -1.67e-01 4.75e-02 4.14e-01 8.16e-01
GOBP TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY 28 2.57e-01 5.54e-01 0.173000 1.32e-01 -1.12e-01 2.27e-01 3.03e-01
GOBP T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 12 5.99e-01 8.15e-01 0.173000 1.57e-01 7.31e-02 3.46e-01 6.61e-01
GOBP REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 15 5.04e-01 7.56e-01 0.173000 1.31e-02 -1.73e-01 9.30e-01 2.47e-01
GOBP GDP MANNOSE METABOLIC PROCESS 8 6.87e-01 8.65e-01 0.173000 -1.68e-01 4.31e-02 4.11e-01 8.33e-01
GOBP ADAPTIVE THERMOGENESIS 166 7.07e-04 1.04e-02 0.173000 1.70e-01 3.29e-02 1.56e-04 4.64e-01
Nuclear Pore Complex (NPC) Disassembly 36 1.77e-01 4.64e-01 0.173000 1.50e-01 -8.73e-02 1.20e-01 3.65e-01
ESR-mediated signaling 183 1.64e-04 3.24e-03 0.173000 1.53e-01 -8.15e-02 3.61e-04 5.73e-02
GOBP BILE ACID AND BILE SALT TRANSPORT 29 2.61e-01 5.58e-01 0.173000 -2.85e-02 1.71e-01 7.90e-01 1.11e-01
Vitamin B5 (pantothenate) metabolism 19 4.51e-01 7.19e-01 0.173000 -1.10e-01 -1.34e-01 4.08e-01 3.11e-01
Hyaluronan uptake and degradation 12 5.59e-01 7.91e-01 0.173000 1.32e-01 -1.12e-01 4.28e-01 5.02e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY 10 6.16e-01 8.26e-01 0.173000 1.33e-01 -1.11e-01 4.67e-01 5.43e-01
GOBP REGULATION OF NUCLEASE ACTIVITY 21 3.61e-01 6.49e-01 0.173000 1.21e-01 -1.24e-01 3.38e-01 3.25e-01
GOBP REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 309 1.36e-06 5.01e-05 0.173000 1.72e-01 2.37e-02 2.14e-07 4.75e-01
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 44 1.37e-01 4.06e-01 0.173000 1.73e-01 -2.08e-04 4.69e-02 9.98e-01
GOBP POLY N ACETYLLACTOSAMINE METABOLIC PROCESS 10 6.43e-01 8.42e-01 0.173000 2.66e-02 1.71e-01 8.84e-01 3.49e-01
GOCC NMDA SELECTIVE GLUTAMATE RECEPTOR COMPLEX 9 6.68e-01 8.54e-01 0.173000 -1.01e-02 -1.73e-01 9.58e-01 3.69e-01
GOBP PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS 29 2.47e-01 5.43e-01 0.173000 1.43e-01 -9.81e-02 1.84e-01 3.60e-01
GOBP REGULATION OF CELL KILLING 111 9.80e-03 7.76e-02 0.173000 -1.20e-01 -1.25e-01 2.92e-02 2.30e-02
GOBP REGULATION OF TRANSLATIONAL TERMINATION 8 6.93e-01 8.68e-01 0.173000 2.00e-02 -1.72e-01 9.22e-01 4.00e-01
GOBP REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY 24 3.60e-01 6.48e-01 0.173000 1.57e-01 7.20e-02 1.82e-01 5.42e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION 19 4.10e-01 6.91e-01 0.173000 -5.08e-02 1.65e-01 7.02e-01 2.12e-01
GOBP TRACHEA MORPHOGENESIS 11 6.30e-01 8.34e-01 0.173000 1.40e-01 1.02e-01 4.21e-01 5.60e-01
GOBP POSITIVE REGULATION OF MRNA METABOLIC PROCESS 221 5.47e-05 1.28e-03 0.173000 1.73e-01 7.35e-03 9.50e-06 8.51e-01
GOBP HOMOLOGOUS RECOMBINATION 66 4.14e-02 2.01e-01 0.173000 1.24e-01 -1.20e-01 8.12e-02 9.07e-02
GOBP REGULATION OF B CELL APOPTOTIC PROCESS 19 4.41e-01 7.13e-01 0.173000 -5.34e-02 -1.64e-01 6.87e-01 2.15e-01
Platelet Adhesion to exposed collagen 16 5.13e-01 7.61e-01 0.173000 1.19e-01 1.25e-01 4.10e-01 3.85e-01
GOMF STRUCTURAL CONSTITUENT OF POSTSYNAPSE 18 4.72e-01 7.32e-01 0.173000 1.16e-01 1.28e-01 3.92e-01 3.48e-01
GOBP EPITHELIAL CELL APOPTOTIC PROCESS 146 1.01e-03 1.38e-02 0.173000 1.57e-01 -7.23e-02 1.05e-03 1.32e-01
GOBP CAMKK AMPK SIGNALING CASCADE 9 6.78e-01 8.60e-01 0.173000 4.97e-02 1.66e-01 7.96e-01 3.90e-01
GOBP REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION 98 9.71e-03 7.71e-02 0.173000 1.58e-01 -7.07e-02 6.99e-03 2.26e-01
GOMF ANTIGEN BINDING 66 5.93e-02 2.50e-01 0.173000 -1.63e-01 -5.74e-02 2.20e-02 4.20e-01
GOBP FERROPTOSIS 9 6.50e-01 8.45e-01 0.173000 -9.07e-02 1.47e-01 6.37e-01 4.45e-01
RHOG GTPase cycle 71 4.55e-02 2.13e-01 0.173000 1.69e-01 3.54e-02 1.38e-02 6.06e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE 101 1.50e-02 1.05e-01 0.173000 1.35e-01 1.08e-01 1.93e-02 6.04e-02
GOBP MORPHOGENESIS OF AN EPITHELIAL BUD 14 5.19e-01 7.63e-01 0.173000 1.65e-01 -5.17e-02 2.86e-01 7.38e-01
GOBP FEMALE MEIOSIS I 13 5.75e-01 8.00e-01 0.173000 -6.73e-02 -1.59e-01 6.74e-01 3.21e-01
GOCC MHC PROTEIN COMPLEX 24 3.19e-01 6.11e-01 0.173000 8.15e-02 -1.52e-01 4.90e-01 1.97e-01
GOBP INTEGRATED STRESS RESPONSE SIGNALING 48 1.31e-01 3.95e-01 0.173000 -7.12e-02 -1.57e-01 3.94e-01 5.95e-02
GOBP EXTRACELLULAR MATRIX ASSEMBLY 51 1.20e-01 3.78e-01 0.173000 1.18e-01 1.26e-01 1.46e-01 1.19e-01
GOBP HEXOSE PHOSPHATE TRANSPORT 7 7.23e-01 8.81e-01 0.172000 -1.67e-01 4.14e-02 4.43e-01 8.50e-01
GOBP HETEROCHROMATIN FORMATION 127 2.28e-03 2.60e-02 0.172000 1.21e-01 -1.23e-01 1.85e-02 1.68e-02
CDC6 association with the ORC:origin complex 8 6.81e-01 8.62e-01 0.172000 1.30e-01 -1.14e-01 5.25e-01 5.78e-01
GOCC HIGH DENSITY LIPOPROTEIN PARTICLE 25 3.17e-01 6.10e-01 0.172000 -3.07e-02 1.70e-01 7.90e-01 1.42e-01
GOBP CELLULAR RESPONSE TO CAMP 49 1.24e-01 3.84e-01 0.172000 1.62e-01 5.96e-02 5.00e-02 4.71e-01
GOCC CATION CHANNEL COMPLEX 200 8.82e-05 1.93e-03 0.172000 -1.60e-01 6.40e-02 9.47e-05 1.19e-01
GOBP NEGATIVE REGULATION OF RUFFLE ASSEMBLY 7 7.33e-01 8.85e-01 0.172000 -1.72e-01 -1.21e-02 4.31e-01 9.56e-01
GOBP SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 46 1.10e-01 3.59e-01 0.172000 1.10e-01 -1.33e-01 1.97e-01 1.19e-01
GOBP RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME 13 5.63e-01 7.93e-01 0.172000 -1.64e-02 -1.72e-01 9.18e-01 2.84e-01
GOMF DELTA CATENIN BINDING 9 6.86e-01 8.64e-01 0.172000 -8.64e-02 -1.49e-01 6.53e-01 4.39e-01
GOMF DNA DIRECTED DNA POLYMERASE ACTIVITY 22 3.62e-01 6.50e-01 0.172000 1.68e-01 -3.96e-02 1.73e-01 7.48e-01
GOMF C ACETYLTRANSFERASE ACTIVITY 7 7.48e-01 8.91e-01 0.172000 -1.27e-01 -1.17e-01 5.61e-01 5.93e-01
GOBP NEGATIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION 83 1.93e-02 1.24e-01 0.172000 9.24e-02 -1.45e-01 1.46e-01 2.20e-02
GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE ASSEMBLY 12 5.66e-01 7.94e-01 0.172000 8.38e-02 -1.50e-01 6.15e-01 3.67e-01
GOMF SOLUTE POTASSIUM ANTIPORTER ACTIVITY 17 4.44e-01 7.16e-01 0.172000 -9.45e-02 1.44e-01 5.00e-01 3.04e-01
GOBP VESICLE CYTOSKELETAL TRAFFICKING 58 6.24e-02 2.58e-01 0.172000 1.26e-01 -1.18e-01 9.80e-02 1.21e-01
GOBP MITOCHONDRIAL FUSION 34 2.15e-01 5.10e-01 0.172000 1.72e-01 -1.44e-02 8.34e-02 8.84e-01
PIP3 activates AKT signaling 273 5.30e-06 1.65e-04 0.172000 1.72e-01 -9.31e-03 1.01e-06 7.91e-01
Respiratory electron transport 142 1.58e-03 1.97e-02 0.172000 2.83e-02 -1.70e-01 5.61e-01 4.78e-04
GOBP NEGATIVE REGULATION OF STEM CELL POPULATION MAINTENANCE 24 3.19e-01 6.11e-01 0.172000 9.29e-02 -1.45e-01 4.31e-01 2.19e-01
GOBP TETRAPYRROLE BIOSYNTHETIC PROCESS 31 2.29e-01 5.27e-01 0.172000 9.03e-02 -1.46e-01 3.84e-01 1.58e-01
GOBP REGULATION OF CELL SUBSTRATE ADHESION 214 9.39e-05 2.04e-03 0.172000 1.70e-01 2.36e-02 1.73e-05 5.51e-01
GOMF CO RECEPTOR BINDING 13 5.37e-01 7.77e-01 0.172000 1.32e-01 -1.10e-01 4.10e-01 4.91e-01
GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 6 7.66e-01 9.01e-01 0.172000 1.72e-01 6.39e-03 4.66e-01 9.78e-01
GOBP MITOTIC G2 M TRANSITION CHECKPOINT 52 8.38e-02 3.11e-01 0.172000 1.34e-01 -1.08e-01 9.57e-02 1.77e-01
GOBP PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 57 8.88e-02 3.19e-01 0.172000 1.63e-01 5.53e-02 3.35e-02 4.70e-01
GOBP POSITIVE REGULATION OF STEROID HORMONE SECRETION 11 6.26e-01 8.32e-01 0.172000 1.63e-01 5.36e-02 3.48e-01 7.58e-01
Sensory perception of taste 47 1.06e-01 3.52e-01 0.172000 -1.16e-01 1.27e-01 1.69e-01 1.32e-01
GOMF TAT PROTEIN BINDING 10 6.30e-01 8.34e-01 0.172000 -4.44e-02 1.66e-01 8.08e-01 3.63e-01
GOBP POSITIVE REGULATION OF MEGAKARYOCYTE DIFFERENTIATION 10 6.29e-01 8.34e-01 0.172000 5.12e-02 -1.64e-01 7.79e-01 3.69e-01
GOBP REGULATION OF B CELL DIFFERENTIATION 33 2.45e-01 5.41e-01 0.172000 -4.97e-02 -1.64e-01 6.21e-01 1.02e-01
GOBP HEPARAN SULFATE PROTEOGLYCAN CATABOLIC PROCESS 8 7.05e-01 8.72e-01 0.172000 -1.71e-01 -1.98e-02 4.03e-01 9.23e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL APOPTOTIC PROCESS 9 6.51e-01 8.45e-01 0.172000 1.22e-01 -1.21e-01 5.27e-01 5.29e-01
GOMF K48 LINKED POLYUBIQUITIN MODIFICATION DEPENDENT PROTEIN BINDING 10 6.53e-01 8.47e-01 0.172000 1.64e-01 5.12e-02 3.70e-01 7.79e-01
2-LTR circle formation 7 7.38e-01 8.87e-01 0.172000 -2.81e-02 -1.69e-01 8.98e-01 4.38e-01
GOBP NEGATIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE 11 5.92e-01 8.11e-01 0.172000 -1.14e-01 1.28e-01 5.13e-01 4.61e-01
Amyloid fiber formation 73 3.18e-02 1.72e-01 0.172000 9.48e-02 -1.43e-01 1.61e-01 3.47e-02
HIV Transcription Initiation 43 1.33e-01 3.98e-01 0.172000 8.11e-02 -1.51e-01 3.57e-01 8.63e-02
RNA Polymerase II HIV Promoter Escape 43 1.33e-01 3.98e-01 0.172000 8.11e-02 -1.51e-01 3.57e-01 8.63e-02
RNA Polymerase II Promoter Escape 43 1.33e-01 3.98e-01 0.172000 8.11e-02 -1.51e-01 3.57e-01 8.63e-02
RNA Polymerase II Transcription Initiation 43 1.33e-01 3.98e-01 0.172000 8.11e-02 -1.51e-01 3.57e-01 8.63e-02
RNA Polymerase II Transcription Initiation And Promoter Clearance 43 1.33e-01 3.98e-01 0.172000 8.11e-02 -1.51e-01 3.57e-01 8.63e-02
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening 43 1.33e-01 3.98e-01 0.172000 8.11e-02 -1.51e-01 3.57e-01 8.63e-02
GOBP AMINE BIOSYNTHETIC PROCESS 37 1.72e-01 4.58e-01 0.172000 -1.14e-01 1.28e-01 2.32e-01 1.76e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS 13 5.81e-01 8.04e-01 0.172000 7.73e-02 1.53e-01 6.29e-01 3.39e-01
Resolution of AP sites via the multiple-nucleotide patch replacement pathway 25 3.08e-01 6.02e-01 0.171000 1.50e-01 -8.36e-02 1.95e-01 4.70e-01
SHC1 events in ERBB2 signaling 22 3.58e-01 6.47e-01 0.171000 1.58e-01 -6.73e-02 2.00e-01 5.85e-01
GOCC VOLTAGE GATED CALCIUM CHANNEL COMPLEX 44 1.38e-01 4.08e-01 0.171000 -1.70e-01 2.07e-02 5.08e-02 8.13e-01
GOBP POSITIVE REGULATION OF AMINE METABOLIC PROCESS 6 7.55e-01 8.95e-01 0.171000 -7.02e-02 1.56e-01 7.66e-01 5.07e-01
NOD1/2 Signaling Pathway 33 2.11e-01 5.06e-01 0.171000 1.47e-01 -8.84e-02 1.44e-01 3.79e-01
GOBP MAMMARY GLAND EPITHELIAL CELL PROLIFERATION 26 3.25e-01 6.16e-01 0.171000 -2.90e-02 -1.69e-01 7.98e-01 1.36e-01
GOBP MYOBLAST PROLIFERATION 34 2.46e-01 5.41e-01 0.171000 1.45e-01 9.17e-02 1.44e-01 3.55e-01
GOCC DNA RECOMBINASE MEDIATOR COMPLEX 7 7.25e-01 8.82e-01 0.171000 1.66e-01 -4.34e-02 4.47e-01 8.42e-01
GOBP POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION 44 1.29e-01 3.93e-01 0.171000 1.59e-01 -6.47e-02 6.86e-02 4.58e-01
GOBP ANTIBACTERIAL PEPTIDE PRODUCTION 10 6.57e-01 8.49e-01 0.171000 -6.52e-02 -1.58e-01 7.21e-01 3.85e-01
GOCC RNA POLYMERASE II TRANSCRIPTION REPRESSOR COMPLEX 15 4.96e-01 7.51e-01 0.171000 1.53e-01 -7.63e-02 3.04e-01 6.09e-01
GOBP VACUOLE ORGANIZATION 224 5.45e-05 1.28e-03 0.171000 1.71e-01 -8.95e-04 9.98e-06 9.82e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 14 5.17e-01 7.63e-01 0.171000 1.45e-01 -9.12e-02 3.48e-01 5.55e-01
GOCC HAUS COMPLEX 7 7.48e-01 8.91e-01 0.171000 -8.20e-02 -1.50e-01 7.07e-01 4.91e-01
GOBP CONVERGENT EXTENSION INVOLVED IN AXIS ELONGATION 5 8.00e-01 9.18e-01 0.171000 9.88e-03 -1.71e-01 9.69e-01 5.08e-01
GOBP NEPHRON DEVELOPMENT 156 8.46e-04 1.20e-02 0.171000 1.66e-01 -4.02e-02 3.34e-04 3.86e-01
Transcriptional regulation by RUNX1 192 1.66e-04 3.26e-03 0.171000 1.66e-01 -4.22e-02 7.37e-05 3.14e-01
GOBP VERY LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 7 7.50e-01 8.92e-01 0.171000 -1.06e-01 -1.35e-01 6.29e-01 5.37e-01
PIWI-interacting RNA (piRNA) biogenesis 29 2.76e-01 5.74e-01 0.171000 -1.71e-01 5.97e-03 1.11e-01 9.56e-01
GOBP REGULATION OF CELLULAR RESPONSE TO STRESS 499 1.20e-10 1.02e-08 0.171000 1.52e-01 -7.85e-02 5.95e-09 2.68e-03
Response of Mtb to phagocytosis 22 3.61e-01 6.49e-01 0.171000 1.60e-01 -6.17e-02 1.95e-01 6.16e-01
GOMF METALLOCHAPERONE ACTIVITY 12 6.08e-01 8.21e-01 0.171000 -8.19e-02 -1.50e-01 6.23e-01 3.68e-01
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH 31 2.32e-01 5.29e-01 0.171000 1.33e-01 -1.07e-01 1.98e-01 3.03e-01
GOBP TESTOSTERONE BIOSYNTHETIC PROCESS 11 5.99e-01 8.15e-01 0.171000 -7.40e-02 1.54e-01 6.71e-01 3.76e-01
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS 76 2.99e-02 1.66e-01 0.171000 1.58e-01 -6.48e-02 1.71e-02 3.29e-01
GOMF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY 68 5.67e-02 2.44e-01 0.171000 -1.64e-01 -4.81e-02 1.93e-02 4.92e-01
GOBP RENAL SYSTEM DEVELOPMENT 322 7.51e-07 2.97e-05 0.171000 1.71e-01 -9.68e-03 1.39e-07 7.65e-01
Signaling by NOTCH3 48 1.09e-01 3.57e-01 0.171000 1.59e-01 -6.23e-02 5.64e-02 4.55e-01
GOBP PHOSPHATE ION HOMEOSTASIS 20 4.42e-01 7.14e-01 0.171000 1.34e-01 1.06e-01 2.99e-01 4.13e-01
GOBP POSITIVE REGULATION OF CELL CYCLE CHECKPOINT 19 4.50e-01 7.19e-01 0.171000 1.62e-01 5.45e-02 2.22e-01 6.81e-01
GOBP REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 24 3.31e-01 6.22e-01 0.171000 1.60e-01 -5.91e-02 1.74e-01 6.17e-01
GOCC SPINDLE MIDZONE 36 2.11e-01 5.06e-01 0.171000 1.70e-01 1.78e-02 7.77e-02 8.54e-01
GOBP SKELETAL MUSCLE ADAPTATION 25 3.36e-01 6.26e-01 0.171000 1.71e-01 9.27e-03 1.40e-01 9.36e-01
Degradation of GLI2 by the proteasome 47 1.10e-01 3.58e-01 0.171000 1.01e-01 -1.38e-01 2.32e-01 1.02e-01
GOBP MUSCLE CELL DEVELOPMENT 199 3.18e-04 5.44e-03 0.171000 1.33e-01 1.07e-01 1.22e-03 9.15e-03
FCERI mediated MAPK activation 32 2.26e-01 5.23e-01 0.171000 1.53e-01 -7.64e-02 1.35e-01 4.54e-01
GOBP POSITIVE REGULATION OF MRNA CATABOLIC PROCESS 193 2.78e-04 4.89e-03 0.171000 1.68e-01 3.07e-02 5.77e-05 4.62e-01
GOBP POSITIVE REGULATION OF CELL SIZE 10 6.65e-01 8.52e-01 0.171000 -1.39e-01 -9.90e-02 4.47e-01 5.88e-01
KSRP (KHSRP) binds and destabilizes mRNA 17 4.82e-01 7.41e-01 0.170000 -2.25e-02 -1.69e-01 8.72e-01 2.28e-01
GOBP POSITIVE REGULATION OF CERAMIDE BIOSYNTHETIC PROCESS 7 7.23e-01 8.81e-01 0.170000 -1.54e-01 7.23e-02 4.79e-01 7.41e-01
GOBP PROTEIN LOCALIZATION TO CYTOPLASMIC STRESS GRANULE 7 7.21e-01 8.80e-01 0.170000 1.43e-01 -9.21e-02 5.11e-01 6.73e-01
GOBP NADH METABOLIC PROCESS 32 2.46e-01 5.41e-01 0.170000 -4.71e-03 1.70e-01 9.63e-01 9.55e-02
GOBP TOLERANCE INDUCTION 29 3.00e-01 5.95e-01 0.170000 -1.59e-01 -6.06e-02 1.38e-01 5.72e-01
GOBP REGULATION OF MUSCLE TISSUE DEVELOPMENT 44 1.55e-01 4.36e-01 0.170000 1.67e-01 3.57e-02 5.60e-02 6.82e-01
Cargo concentration in the ER 32 2.26e-01 5.23e-01 0.170000 8.34e-02 -1.48e-01 4.14e-01 1.46e-01
GOBP RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 302 2.51e-06 8.53e-05 0.170000 1.70e-01 1.23e-02 3.81e-07 7.13e-01
Incretin synthesis, secretion, and inactivation 23 3.47e-01 6.37e-01 0.170000 6.74e-02 -1.56e-01 5.76e-01 1.94e-01
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION 44 1.51e-01 4.30e-01 0.170000 1.69e-01 1.91e-02 5.22e-02 8.27e-01
GOBP PROTEIN LOCALIZATION TO LYSOSOME 57 8.74e-02 3.16e-01 0.170000 1.69e-01 2.26e-02 2.75e-02 7.68e-01
GOMF GLUCURONOSYLTRANSFERASE ACTIVITY 33 2.20e-01 5.15e-01 0.170000 6.64e-02 -1.57e-01 5.09e-01 1.19e-01
MAP kinase activation 58 6.80e-02 2.72e-01 0.170000 1.47e-01 -8.65e-02 5.35e-02 2.55e-01
GOBP POSITIVE REGULATION OF GLUCOSE IMPORT 35 2.43e-01 5.39e-01 0.170000 1.22e-01 1.18e-01 2.10e-01 2.27e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED IRON SULFUR PROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN 9 6.94e-01 8.68e-01 0.170000 -1.36e-01 -1.03e-01 4.81e-01 5.94e-01
GOBP SISTER CHROMATID SEGREGATION 226 3.65e-05 9.12e-04 0.170000 1.60e-01 -5.79e-02 3.43e-05 1.34e-01
GOBP REGULATION OF SODIUM ION TRANSPORT 79 2.83e-02 1.61e-01 0.170000 1.64e-01 -4.59e-02 1.19e-02 4.81e-01
GOBP REGULATION OF MACROAUTOPHAGY 174 5.67e-04 8.74e-03 0.170000 1.70e-01 8.40e-03 1.11e-04 8.48e-01
Glycerophospholipid biosynthesis 123 5.27e-03 4.91e-02 0.170000 1.69e-01 1.94e-02 1.21e-03 7.10e-01
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 BINDING 9 6.57e-01 8.50e-01 0.170000 9.86e-02 -1.39e-01 6.08e-01 4.72e-01
GOBP REGULATION OF MESODERMAL CELL DIFFERENTIATION 10 6.68e-01 8.54e-01 0.170000 1.18e-01 1.23e-01 5.20e-01 5.01e-01
GOBP ADP TRANSPORT 10 6.33e-01 8.36e-01 0.170000 -1.59e-01 6.03e-02 3.84e-01 7.41e-01
Golgi Associated Vesicle Biogenesis 51 9.52e-02 3.31e-01 0.170000 1.50e-01 -7.92e-02 6.31e-02 3.28e-01
GOBP MAST CELL ACTIVATION 65 5.06e-02 2.27e-01 0.170000 7.27e-02 -1.54e-01 3.10e-01 3.22e-02
GOMF G QUADRUPLEX DNA BINDING 11 6.34e-01 8.36e-01 0.170000 1.58e-01 6.19e-02 3.63e-01 7.22e-01
GOCC MICOS COMPLEX 7 7.45e-01 8.91e-01 0.170000 1.65e-01 4.19e-02 4.51e-01 8.48e-01
GOBP POSITIVE REGULATION OF GENE EXPRESSION VIA CHROMOSOMAL CPG ISLAND DEMETHYLATION 14 5.32e-01 7.72e-01 0.170000 1.64e-01 -4.50e-02 2.88e-01 7.71e-01
GOBP EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 662 7.17e-13 8.98e-11 0.170000 1.70e-01 8.66e-04 8.58e-14 9.70e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H QUINONE OR SIMILAR COMPOUND AS ACCEPTOR 50 9.88e-02 3.37e-01 0.170000 1.44e-01 -9.00e-02 7.79e-02 2.71e-01
Transcriptional activation of mitochondrial biogenesis 51 1.01e-01 3.41e-01 0.170000 1.64e-01 -4.34e-02 4.25e-02 5.92e-01
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY 42 1.42e-01 4.14e-01 0.170000 -1.39e-01 9.74e-02 1.19e-01 2.75e-01
GOBP FLAVONOID METABOLIC PROCESS 11 6.42e-01 8.41e-01 0.170000 1.08e-01 1.31e-01 5.36e-01 4.52e-01
GOMF THREONINE TYPE ENDOPEPTIDASE ACTIVITY 9 6.96e-01 8.68e-01 0.170000 -1.07e-01 -1.32e-01 5.79e-01 4.93e-01
Chaperone Mediated Autophagy 20 4.32e-01 7.07e-01 0.170000 -3.77e-02 -1.65e-01 7.70e-01 2.00e-01
HCMV Late Events 81 2.65e-02 1.55e-01 0.170000 4.35e-02 -1.64e-01 4.98e-01 1.07e-02
GOBP NEGATIVE REGULATION OF AMINO ACID TRANSPORT 15 5.41e-01 7.79e-01 0.170000 1.55e-01 6.98e-02 3.00e-01 6.40e-01
GOBP GLUCOCORTICOID SECRETION 12 6.17e-01 8.27e-01 0.170000 1.26e-01 1.14e-01 4.51e-01 4.95e-01
GOBP REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 67 4.48e-02 2.11e-01 0.170000 1.25e-01 -1.14e-01 7.58e-02 1.06e-01
GOMF AMP ACTIVATED PROTEIN KINASE ACTIVITY 8 6.90e-01 8.66e-01 0.170000 -1.04e-01 1.34e-01 6.12e-01 5.11e-01
GOCC EUKARYOTIC TRANSLATION INITIATION FACTOR 3 COMPLEX EIF3M 7 7.27e-01 8.83e-01 0.169000 6.18e-02 -1.58e-01 7.77e-01 4.70e-01
GOBP REGULATION OF NATURAL KILLER CELL ACTIVATION 38 2.10e-01 5.05e-01 0.169000 -6.03e-02 -1.58e-01 5.20e-01 9.12e-02
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS 9 6.95e-01 8.68e-01 0.169000 1.44e-01 8.96e-02 4.55e-01 6.42e-01
GOMF LONG CHAIN FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 15 5.06e-01 7.57e-01 0.169000 -6.48e-02 1.56e-01 6.64e-01 2.94e-01
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY 6 7.78e-01 9.07e-01 0.169000 1.66e-01 3.49e-02 4.82e-01 8.82e-01
GOBP RESPONSE TO PLATELET DERIVED GROWTH FACTOR 21 4.10e-01 6.91e-01 0.169000 1.68e-01 1.95e-02 1.82e-01 8.77e-01
FBXL7 down-regulates AURKA during mitotic entry and in early mitosis 42 1.57e-01 4.38e-01 0.169000 2.70e-02 -1.67e-01 7.62e-01 6.11e-02
GOBP NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY 25 3.68e-01 6.56e-01 0.169000 1.27e-01 1.12e-01 2.72e-01 3.34e-01
GOBP CELLULAR RESPONSE TO HORMONE STIMULUS 596 3.38e-11 3.19e-09 0.169000 1.63e-01 4.41e-02 9.60e-12 6.57e-02
GOBP REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 357 5.50e-07 2.30e-05 0.169000 1.58e-01 6.01e-02 2.88e-07 5.10e-02
Reproduction 119 5.05e-03 4.78e-02 0.169000 4.34e-02 -1.63e-01 4.13e-01 2.08e-03
GOBP GLIOGENESIS 338 8.64e-07 3.36e-05 0.169000 1.66e-01 3.17e-02 1.54e-07 3.16e-01
GOMF S100 PROTEIN BINDING 14 5.37e-01 7.77e-01 0.169000 -3.74e-02 1.65e-01 8.09e-01 2.86e-01
GOMF OXIDIZED DNA BINDING 11 6.43e-01 8.42e-01 0.169000 9.52e-02 1.40e-01 5.84e-01 4.23e-01
GOBP NUCLEAR MEMBRANE REASSEMBLY 25 3.65e-01 6.52e-01 0.169000 -8.38e-02 -1.47e-01 4.68e-01 2.04e-01
RHOBTB2 GTPase cycle 22 4.06e-01 6.88e-01 0.169000 1.59e-01 5.62e-02 1.96e-01 6.48e-01
Mitochondrial protein import 58 9.56e-02 3.31e-01 0.169000 -7.31e-02 -1.52e-01 3.36e-01 4.48e-02
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL APOPTOTIC PROCESS 18 4.70e-01 7.31e-01 0.169000 1.66e-01 2.89e-02 2.21e-01 8.32e-01
GOMF RNA 7 METHYLGUANOSINE CAP BINDING 13 5.89e-01 8.09e-01 0.169000 1.55e-01 6.68e-02 3.33e-01 6.77e-01
GOBP ANGIOGENESIS INVOLVED IN WOUND HEALING 32 2.67e-01 5.63e-01 0.169000 1.62e-01 4.76e-02 1.13e-01 6.41e-01
GOBP NEGATIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 9 6.93e-01 8.68e-01 0.169000 -6.74e-02 -1.55e-01 7.26e-01 4.21e-01
GOBP CENTRAL NERVOUS SYSTEM DEVELOPMENT 975 3.14e-18 8.97e-16 0.169000 1.69e-01 -4.90e-03 4.22e-19 7.95e-01
GOBP POSITIVE REGULATION OF CILIUM ASSEMBLY 30 2.78e-01 5.76e-01 0.169000 1.69e-01 7.32e-03 1.10e-01 9.45e-01
GOBP REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 41 1.77e-01 4.64e-01 0.169000 1.68e-01 1.76e-02 6.29e-02 8.45e-01
GOBP POSITIVE REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE 7 7.56e-01 8.95e-01 0.169000 1.38e-01 9.66e-02 5.26e-01 6.58e-01
GOBP POSITIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 63 5.53e-02 2.40e-01 0.169000 1.15e-01 -1.23e-01 1.14e-01 9.01e-02
GOBP AV NODE CELL TO BUNDLE OF HIS CELL SIGNALING 11 6.13e-01 8.24e-01 0.169000 -1.63e-01 4.50e-02 3.51e-01 7.96e-01
Maturation of spike protein 9683686 5 8.14e-01 9.25e-01 0.169000 -4.88e-02 -1.61e-01 8.50e-01 5.32e-01
RNA Polymerase I Transcription Initiation 45 1.31e-01 3.96e-01 0.169000 1.55e-01 -6.65e-02 7.21e-02 4.40e-01
GOBP MRNA METABOLIC PROCESS 778 2.33e-15 4.69e-13 0.169000 1.59e-01 -5.52e-02 3.90e-14 8.76e-03
GOBP REGULATION OF HAIR FOLLICLE DEVELOPMENT 20 3.99e-01 6.81e-01 0.169000 1.09e-01 -1.28e-01 3.97e-01 3.20e-01
Neurotransmitter release cycle 48 1.24e-01 3.83e-01 0.169000 1.67e-01 -2.13e-02 4.50e-02 7.98e-01
MyD88 cascade initiated on plasma membrane 91 1.65e-02 1.12e-01 0.169000 1.53e-01 -7.17e-02 1.19e-02 2.37e-01
Toll Like Receptor 10 (TLR10) Cascade 91 1.65e-02 1.12e-01 0.169000 1.53e-01 -7.17e-02 1.19e-02 2.37e-01
Toll Like Receptor 5 (TLR5) Cascade 91 1.65e-02 1.12e-01 0.169000 1.53e-01 -7.17e-02 1.19e-02 2.37e-01
Formation of tubulin folding intermediates by CCT/TriC 25 3.47e-01 6.36e-01 0.169000 -1.68e-01 -1.10e-02 1.45e-01 9.24e-01
Interferon alpha/beta signaling 74 3.53e-02 1.84e-01 0.169000 7.44e-02 -1.51e-01 2.69e-01 2.45e-02
GOBP PROLINE TRANSPORT 11 6.45e-01 8.42e-01 0.169000 9.95e-02 1.36e-01 5.68e-01 4.35e-01
GOBP PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING 14 5.37e-01 7.77e-01 0.168000 1.62e-01 -4.49e-02 2.93e-01 7.71e-01
GOBP REGULATION OF PROTEIN DEACETYLATION 26 3.54e-01 6.44e-01 0.168000 1.42e-01 9.13e-02 2.11e-01 4.21e-01
GOBP FEAR RESPONSE 47 1.17e-01 3.72e-01 0.168000 1.39e-01 -9.54e-02 9.95e-02 2.58e-01
GOBP C TERMINAL PROTEIN AMINO ACID MODIFICATION 15 5.23e-01 7.66e-01 0.168000 1.68e-01 -1.21e-02 2.60e-01 9.35e-01
GOBP SKELETAL MUSCLE TISSUE REGENERATION 42 1.82e-01 4.72e-01 0.168000 1.56e-01 6.25e-02 7.95e-02 4.83e-01
GOBP REGULATION OF CELLULAR RESPONSE TO HYPOXIA 20 4.13e-01 6.94e-01 0.168000 4.22e-02 -1.63e-01 7.44e-01 2.07e-01
GOBP PEPTIDYL LYSINE METHYLATION 23 3.74e-01 6.61e-01 0.168000 1.68e-01 -1.56e-03 1.62e-01 9.90e-01
Caspase activation via extrinsic apoptotic signalling pathway 25 3.18e-01 6.11e-01 0.168000 1.19e-01 -1.19e-01 3.03e-01 3.04e-01
GOBP INTESTINAL LIPID ABSORPTION 22 3.67e-01 6.54e-01 0.168000 -9.56e-02 1.38e-01 4.38e-01 2.61e-01
GOBP RESPIRATORY CHAIN COMPLEX III ASSEMBLY 12 6.02e-01 8.17e-01 0.168000 -1.68e-01 -1.01e-02 3.14e-01 9.52e-01
Adenylate cyclase inhibitory pathway 14 5.65e-01 7.94e-01 0.168000 5.48e-02 1.59e-01 7.23e-01 3.03e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION 27 2.93e-01 5.90e-01 0.168000 -9.44e-02 1.39e-01 3.96e-01 2.10e-01
GOBP KERATINOCYTE DIFFERENTIATION 171 6.65e-04 9.91e-03 0.168000 -1.68e-01 1.18e-02 1.53e-04 7.90e-01
GOBP GOLGI RIBBON FORMATION 11 6.37e-01 8.38e-01 0.168000 1.62e-01 4.57e-02 3.53e-01 7.93e-01
GOBP MITOCHONDRIAL RESPIRASOME ASSEMBLY 10 6.34e-01 8.36e-01 0.168000 -9.42e-02 1.39e-01 6.06e-01 4.46e-01
GOBP LENS DEVELOPMENT IN CAMERA TYPE EYE 85 3.46e-02 1.82e-01 0.168000 1.38e-01 9.57e-02 2.76e-02 1.27e-01
GOMF PEROXISOME TARGETING SEQUENCE BINDING 5 7.96e-01 9.17e-01 0.168000 1.32e-01 -1.04e-01 6.09e-01 6.87e-01
GOMF DIACYLGLYCEROL DEPENDENT SERINE THREONINE KINASE ACTIVITY 16 5.09e-01 7.59e-01 0.168000 1.68e-01 9.71e-03 2.45e-01 9.46e-01
GOBP NEUROMUSCULAR JUNCTION DEVELOPMENT 51 1.29e-01 3.92e-01 0.168000 1.54e-01 6.82e-02 5.76e-02 4.00e-01
GOBP REGULATION OF GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 7 7.49e-01 8.92e-01 0.168000 -1.65e-01 -3.43e-02 4.51e-01 8.75e-01
GOMF MECHANOSENSITIVE MONOATOMIC CATION CHANNEL ACTIVITY 6 7.76e-01 9.07e-01 0.168000 -6.66e-03 -1.68e-01 9.77e-01 4.76e-01
GOBP REGULATION OF LYSOSOME SIZE 8 6.94e-01 8.68e-01 0.168000 -1.34e-01 1.02e-01 5.12e-01 6.18e-01
GOCC BORC COMPLEX 8 6.94e-01 8.68e-01 0.168000 -1.34e-01 1.02e-01 5.12e-01 6.18e-01
Sperm Motility And Taxes 9 7.01e-01 8.70e-01 0.168000 -1.09e-01 -1.28e-01 5.70e-01 5.07e-01
GOBP NEGATIVE REGULATION OF CATABOLIC PROCESS 332 3.85e-07 1.67e-05 0.168000 1.49e-01 -7.81e-02 3.15e-06 1.45e-02
GOBP REGULATION OF POSTSYNAPTIC DENSITY ASSEMBLY 13 5.54e-01 7.87e-01 0.168000 -9.35e-02 1.40e-01 5.59e-01 3.83e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVATOR ACTIVITY 5 7.99e-01 9.17e-01 0.168000 -6.85e-02 1.53e-01 7.91e-01 5.52e-01
Interleukin-1 signaling 98 1.17e-02 8.82e-02 0.168000 1.33e-01 -1.03e-01 2.29e-02 7.90e-02
GOBP LYMPHOCYTE HOMEOSTASIS 73 3.72e-02 1.90e-01 0.168000 8.26e-02 -1.46e-01 2.22e-01 3.07e-02
GOMF VOLTAGE GATED CHANNEL ACTIVITY 168 5.13e-04 8.03e-03 0.168000 -1.40e-01 9.34e-02 1.80e-03 3.66e-02
GOMF SEMAPHORIN RECEPTOR BINDING 23 4.01e-01 6.83e-01 0.168000 1.45e-01 8.51e-02 2.29e-01 4.80e-01
GOBP REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 52 1.01e-01 3.42e-01 0.168000 1.62e-01 -4.45e-02 4.34e-02 5.79e-01
GOBP NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE 69 6.10e-02 2.54e-01 0.168000 1.60e-01 5.14e-02 2.17e-02 4.61e-01
GOBP VERY LONG CHAIN FATTY ACID METABOLIC PROCESS 34 2.62e-01 5.59e-01 0.168000 1.08e-01 1.28e-01 2.75e-01 1.95e-01
Signaling by high-kinase activity BRAF mutants 34 2.17e-01 5.12e-01 0.168000 1.49e-01 -7.80e-02 1.34e-01 4.31e-01
tRNA processing 105 8.77e-03 7.17e-02 0.168000 1.40e-01 -9.24e-02 1.31e-02 1.02e-01
GOBP NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY 43 1.85e-01 4.75e-01 0.168000 1.15e-01 1.23e-01 1.94e-01 1.64e-01
GOCC MITOTIC SPINDLE ASTRAL MICROTUBULE 7 7.34e-01 8.85e-01 0.168000 1.59e-01 -5.27e-02 4.66e-01 8.09e-01
GOBP ENSHEATHMENT OF NEURONS 154 2.23e-03 2.57e-02 0.168000 1.50e-01 7.56e-02 1.34e-03 1.05e-01
GOBP PROTEIN HYDROXYLATION 23 3.92e-01 6.75e-01 0.168000 1.61e-01 4.73e-02 1.82e-01 6.94e-01
TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation 95 1.39e-02 1.00e-01 0.168000 1.43e-01 -8.83e-02 1.63e-02 1.37e-01
GOBP REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 54 9.70e-02 3.34e-01 0.168000 1.66e-01 -2.52e-02 3.51e-02 7.49e-01
GOBP CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER 21 4.05e-01 6.87e-01 0.168000 -1.96e-02 1.66e-01 8.76e-01 1.87e-01
GOBP CORTICAL ACTIN CYTOSKELETON ORGANIZATION 43 1.81e-01 4.71e-01 0.168000 1.48e-01 7.78e-02 9.21e-02 3.78e-01
GOMF QUINONE BINDING 15 5.52e-01 7.87e-01 0.168000 1.44e-01 8.58e-02 3.35e-01 5.65e-01
G alpha (12/13) signalling events 74 5.41e-02 2.37e-01 0.168000 1.42e-01 8.85e-02 3.44e-02 1.88e-01
KEAP1-NFE2L2 pathway 113 6.23e-03 5.55e-02 0.167000 1.40e-01 -9.25e-02 1.03e-02 8.93e-02
GOBP PROTEIN TRIMERIZATION 17 4.76e-01 7.36e-01 0.167000 3.85e-02 -1.63e-01 7.83e-01 2.45e-01
GOBP FATTY ACYL COA BIOSYNTHETIC PROCESS 25 3.41e-01 6.31e-01 0.167000 1.66e-01 -2.21e-02 1.51e-01 8.49e-01
GOCC PHOTORECEPTOR OUTER SEGMENT 85 2.52e-02 1.49e-01 0.167000 -3.35e-02 1.64e-01 5.93e-01 8.96e-03
GOBP TRANSCRIPTION BY RNA POLYMERASE III 59 6.97e-02 2.76e-01 0.167000 1.31e-01 -1.04e-01 8.16e-02 1.67e-01
GOBP CELLULAR RESPONSE TO ANTIBIOTIC 11 6.19e-01 8.27e-01 0.167000 3.69e-02 -1.63e-01 8.32e-01 3.49e-01
GOBP GLAND DEVELOPMENT 435 5.84e-09 3.70e-07 0.167000 1.55e-01 -6.42e-02 3.23e-08 2.16e-02
GOBP NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS 18 4.45e-01 7.16e-01 0.167000 1.40e-01 -9.21e-02 3.05e-01 4.99e-01
GOBP REGULATION OF JNK CASCADE 134 3.02e-03 3.22e-02 0.167000 1.63e-01 -3.80e-02 1.13e-03 4.47e-01
GOBP ENDODERM FORMATION 59 7.60e-02 2.91e-01 0.167000 1.61e-01 -4.52e-02 3.24e-02 5.48e-01
GOBP DETERMINATION OF DIGESTIVE TRACT LEFT RIGHT ASYMMETRY 5 7.98e-01 9.17e-01 0.167000 -9.48e-02 1.38e-01 7.14e-01 5.94e-01
GOBP ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME 69 4.62e-02 2.15e-01 0.167000 1.48e-01 -7.73e-02 3.32e-02 2.67e-01
GOCC PHAGOLYSOSOME 7 7.57e-01 8.96e-01 0.167000 1.50e-01 7.28e-02 4.91e-01 7.39e-01
GOBP REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 177 4.90e-04 7.74e-03 0.167000 1.63e-01 -3.58e-02 1.80e-04 4.11e-01
GOCC SPECIFIC GRANULE LUMEN 60 6.71e-02 2.70e-01 0.167000 -1.15e-01 1.22e-01 1.25e-01 1.03e-01
GOBP REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 201 1.96e-04 3.69e-03 0.167000 1.66e-01 -2.17e-02 5.16e-05 5.96e-01
GOBP PHOSPHOLIPID HOMEOSTASIS 17 4.74e-01 7.34e-01 0.167000 5.39e-02 -1.58e-01 7.01e-01 2.59e-01
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 20 4.20e-01 7.00e-01 0.167000 1.63e-01 -3.76e-02 2.08e-01 7.71e-01
GOMF CARBOHYDRATE BINDING 264 7.87e-06 2.35e-04 0.167000 -1.30e-01 1.05e-01 2.77e-04 3.39e-03
GOBP GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE 22 3.73e-01 6.59e-01 0.167000 -9.38e-02 1.38e-01 4.46e-01 2.62e-01
GOMF ALDEHYDE DEHYDROGENASE NAD P PLUS ACTIVITY 17 5.16e-01 7.62e-01 0.167000 1.30e-01 1.05e-01 3.53e-01 4.55e-01
GOMF EPHRIN RECEPTOR ACTIVITY 18 4.64e-01 7.27e-01 0.167000 -1.92e-02 1.66e-01 8.88e-01 2.23e-01
GOCC FILOPODIUM 101 1.95e-02 1.24e-01 0.167000 1.39e-01 9.20e-02 1.56e-02 1.10e-01
GOBP HORMONE MEDIATED SIGNALING PATHWAY 185 5.57e-04 8.63e-03 0.167000 1.64e-01 3.18e-02 1.22e-04 4.56e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 24 3.92e-01 6.75e-01 0.167000 1.37e-01 9.56e-02 2.46e-01 4.18e-01
PCNA-Dependent Long Patch Base Excision Repair 21 3.93e-01 6.76e-01 0.167000 7.99e-02 -1.46e-01 5.26e-01 2.46e-01
GOBP REGULATION OF RIBOSOME BIOGENESIS 6 7.81e-01 9.10e-01 0.167000 1.65e-01 2.13e-02 4.83e-01 9.28e-01
GOBP RESPONSE TO STILBENOID 8 7.00e-01 8.70e-01 0.167000 -1.45e-01 8.21e-02 4.77e-01 6.88e-01
GOBP ACTIN FILAMENT SEVERING 16 5.22e-01 7.65e-01 0.167000 1.63e-01 3.59e-02 2.60e-01 8.03e-01
GOBP PROTEIN LOCALIZATION TO PHOTORECEPTOR OUTER SEGMENT 7 7.40e-01 8.88e-01 0.167000 -1.64e-01 3.15e-02 4.53e-01 8.85e-01
GOBP NATURAL KILLER CELL ACTIVATION 90 2.99e-02 1.66e-01 0.167000 -8.59e-02 -1.43e-01 1.59e-01 1.92e-02
GOBP RESPONSE TO IMMOBILIZATION STRESS 25 3.38e-01 6.28e-01 0.167000 1.61e-01 -4.22e-02 1.63e-01 7.15e-01
GOBP REGULATION OF TRANSLATIONAL INITIATION 77 3.35e-02 1.78e-01 0.167000 7.20e-02 -1.50e-01 2.75e-01 2.26e-02
Downstream signaling events of B Cell Receptor (BCR) 67 5.00e-02 2.26e-01 0.167000 1.32e-01 -1.01e-01 6.08e-02 1.52e-01
GOCC MITOCHONDRIAL INTERMEMBRANE SPACE PROTEIN TRANSPORTER COMPLEX 5 8.21e-01 9.27e-01 0.167000 -7.28e-02 -1.50e-01 7.78e-01 5.62e-01
GOBP PURINE NUCLEOSIDE CATABOLIC PROCESS 7 7.46e-01 8.91e-01 0.167000 1.67e-01 -2.41e-04 4.45e-01 9.99e-01
GOBP PERICYTE CELL DIFFERENTIATION 11 6.47e-01 8.44e-01 0.167000 6.80e-02 1.52e-01 6.96e-01 3.83e-01
GOBP REGULATION OF TESTOSTERONE BIOSYNTHETIC PROCESS 7 7.37e-01 8.86e-01 0.167000 -5.30e-02 1.58e-01 8.08e-01 4.70e-01
GOBP PEPTIDYL LYSINE MONOMETHYLATION 9 6.94e-01 8.68e-01 0.166000 1.63e-01 3.28e-02 3.97e-01 8.65e-01
Gap-filling DNA repair synthesis and ligation in TC-NER 60 6.85e-02 2.73e-01 0.166000 1.28e-01 -1.07e-01 8.68e-02 1.53e-01
GOMF 5 N 7 METHYLGUANOSINE 5 TRIPHOSPHO MRNA HYDROLASE ACTIVITY 10 6.40e-01 8.40e-01 0.166000 9.89e-02 -1.34e-01 5.88e-01 4.64e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 12 6.13e-01 8.24e-01 0.166000 1.64e-01 2.63e-02 3.24e-01 8.74e-01
Assembly Of The HIV Virion 16 5.09e-01 7.59e-01 0.166000 1.47e-02 -1.66e-01 9.19e-01 2.51e-01
Highly sodium permeable postsynaptic acetylcholine nicotinic receptors 7 7.50e-01 8.92e-01 0.166000 -1.91e-02 -1.65e-01 9.30e-01 4.49e-01
GOBP REPRODUCTIVE BEHAVIOR 44 1.82e-01 4.72e-01 0.166000 1.30e-01 1.04e-01 1.35e-01 2.35e-01
GOBP CALCIUM ACTIVATED PHOSPHOLIPID SCRAMBLING 5 8.21e-01 9.27e-01 0.166000 -6.10e-02 -1.55e-01 8.13e-01 5.49e-01
GOBP MYELOID LEUKOCYTE CYTOKINE PRODUCTION 49 1.17e-01 3.73e-01 0.166000 6.31e-02 -1.54e-01 4.45e-01 6.26e-02
GOBP INTRACELLULAR POTASSIUM ION HOMEOSTASIS 15 5.20e-01 7.63e-01 0.166000 -1.55e-01 5.92e-02 2.98e-01 6.92e-01
GOCC GOLGI LUMEN 93 1.62e-02 1.11e-01 0.166000 -9.52e-02 1.36e-01 1.12e-01 2.33e-02
GOBP REGULATION OF AXON EXTENSION INVOLVED IN AXON GUIDANCE 15 5.60e-01 7.92e-01 0.166000 1.29e-01 1.05e-01 3.88e-01 4.82e-01
Mismatch Repair 15 5.12e-01 7.61e-01 0.166000 1.25e-01 -1.09e-01 4.00e-01 4.65e-01
GOMF 1 4 ALPHA OLIGOGLUCAN PHOSPHORYLASE ACTIVITY 5 8.17e-01 9.26e-01 0.166000 -1.63e-01 -3.11e-02 5.28e-01 9.04e-01
GOBP SUCCINATE TRANSMEMBRANE TRANSPORT 6 7.93e-01 9.15e-01 0.166000 1.38e-01 9.29e-02 5.59e-01 6.94e-01
GOMF SUCCINATE TRANSMEMBRANE TRANSPORTER ACTIVITY 6 7.93e-01 9.15e-01 0.166000 1.38e-01 9.29e-02 5.59e-01 6.94e-01
GOMF CARBOHYDRATE DERIVATIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 54 1.23e-01 3.82e-01 0.166000 8.54e-02 1.42e-01 2.78e-01 7.02e-02
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS 19 4.30e-01 7.06e-01 0.166000 1.34e-01 -9.75e-02 3.11e-01 4.62e-01
GOMF CYCLIN BINDING 34 2.24e-01 5.19e-01 0.166000 8.01e-02 -1.45e-01 4.19e-01 1.42e-01
GOBP REGULATION OF PROTEIN SUMOYLATION 21 3.95e-01 6.77e-01 0.166000 1.39e-01 -9.00e-02 2.69e-01 4.75e-01
GOBP POSITIVE REGULATION OF METALLOENDOPEPTIDASE ACTIVITY 5 8.21e-01 9.27e-01 0.166000 -5.93e-02 -1.55e-01 8.18e-01 5.49e-01
GOMF NUCLEOSOME BINDING 89 1.99e-02 1.26e-01 0.166000 1.43e-01 -8.44e-02 1.99e-02 1.69e-01
GOBP MEIOTIC CELL CYCLE PHASE TRANSITION 14 5.64e-01 7.93e-01 0.166000 -1.29e-02 -1.65e-01 9.33e-01 2.84e-01
GOMF DNA NUCLEASE ACTIVITY 60 7.38e-02 2.86e-01 0.166000 1.53e-01 -6.26e-02 3.98e-02 4.02e-01
GOMF UBIQUITIN SPECIFIC PROTEASE BINDING 18 4.97e-01 7.52e-01 0.166000 1.44e-01 8.16e-02 2.89e-01 5.49e-01
GOBP RNA 3 END PROCESSING 84 2.69e-02 1.56e-01 0.166000 1.58e-01 -5.09e-02 1.24e-02 4.20e-01
NGF-independant TRKA activation 5 8.08e-01 9.21e-01 0.166000 -1.62e-01 3.69e-02 5.32e-01 8.87e-01
Free fatty acids regulate insulin secretion 10 6.61e-01 8.51e-01 0.166000 -1.34e-03 1.66e-01 9.94e-01 3.64e-01
GOBP REGULATION OF ATPASE COUPLED CALCIUM TRANSMEMBRANE TRANSPORTER ACTIVITY 5 8.21e-01 9.27e-01 0.166000 -1.57e-01 -5.34e-02 5.44e-01 8.36e-01
Sodium-coupled sulphate, di- and tri-carboxylate transporters 5 8.09e-01 9.22e-01 0.166000 -2.68e-02 1.63e-01 9.17e-01 5.27e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON NAD P H 75 4.79e-02 2.21e-01 0.166000 1.64e-01 2.05e-02 1.38e-02 7.59e-01
GOBP CARBOHYDRATE DERIVATIVE TRANSPORT 89 3.33e-02 1.77e-01 0.166000 1.08e-01 1.26e-01 7.86e-02 4.04e-02
GOBP POSITIVE REGULATION OF ANOIKIS 5 8.21e-01 9.27e-01 0.166000 1.57e-01 5.31e-02 5.43e-01 8.37e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS NAD OR NADP AS ACCEPTOR 32 2.43e-01 5.39e-01 0.166000 -1.04e-01 1.29e-01 3.08e-01 2.08e-01
GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 7 7.57e-01 8.96e-01 0.165000 -4.32e-02 -1.60e-01 8.43e-01 4.64e-01
GOMF PHOSPHOLIPID BINDING 463 2.42e-08 1.35e-06 0.165000 1.43e-01 8.24e-02 1.21e-07 2.38e-03
GOBP B CELL PROLIFERATION INVOLVED IN IMMUNE RESPONSE 6 7.87e-01 9.13e-01 0.165000 1.60e-01 4.07e-02 4.96e-01 8.63e-01
GOBP VASODILATION 49 1.15e-01 3.68e-01 0.165000 1.07e-01 -1.26e-01 1.95e-01 1.27e-01
GOBP POSITIVE REGULATION OF MITOTIC CELL CYCLE 127 4.94e-03 4.69e-02 0.165000 1.64e-01 -2.21e-02 1.42e-03 6.67e-01
GOMF ABC TYPE TRANSPORTER ACTIVITY 46 1.43e-01 4.15e-01 0.165000 -3.11e-02 1.62e-01 7.15e-01 5.66e-02
GOBP UV PROTECTION 12 6.20e-01 8.27e-01 0.165000 3.87e-02 1.61e-01 8.17e-01 3.35e-01
GOBP MYELIN ASSEMBLY 24 3.89e-01 6.73e-01 0.165000 5.41e-02 1.56e-01 6.46e-01 1.85e-01
GOBP NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 10 6.43e-01 8.42e-01 0.165000 1.32e-01 -9.97e-02 4.70e-01 5.85e-01
GOBP MICROTUBULE POLYMERIZATION 91 2.75e-02 1.58e-01 0.165000 1.59e-01 4.47e-02 8.69e-03 4.61e-01
GOBP HEART DEVELOPMENT 601 7.70e-11 6.70e-09 0.165000 1.61e-01 3.89e-02 1.71e-11 1.03e-01
GOBP MOLTING CYCLE 115 1.04e-02 8.13e-02 0.165000 1.61e-01 3.63e-02 2.83e-03 5.01e-01
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION 75 4.12e-02 2.01e-01 0.165000 1.60e-01 -4.29e-02 1.69e-02 5.20e-01
SARS-CoV-2-host interactions 189 3.95e-04 6.49e-03 0.165000 1.83e-02 -1.64e-01 6.65e-01 9.91e-05
GOBP ENDOPLASMIC RETICULUM LOCALIZATION 10 6.69e-01 8.55e-01 0.165000 1.63e-01 2.56e-02 3.72e-01 8.88e-01
GOBP ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE 25 3.34e-01 6.24e-01 0.165000 9.23e-02 -1.37e-01 4.25e-01 2.36e-01
GOBP NEGATIVE REGULATION OF PROTEIN UBIQUITINATION 69 4.95e-02 2.24e-01 0.165000 8.13e-02 -1.44e-01 2.43e-01 3.90e-02
Alpha-oxidation of phytanate 6 7.96e-01 9.16e-01 0.165000 -1.18e-01 -1.15e-01 6.16e-01 6.25e-01
GOBP TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION 9 7.01e-01 8.70e-01 0.165000 1.58e-01 4.64e-02 4.10e-01 8.09e-01
GOBP PYRAMIDAL NEURON DEVELOPMENT 9 6.94e-01 8.68e-01 0.165000 1.64e-01 1.48e-02 3.93e-01 9.39e-01
GOBP DNA TEMPLATED TRANSCRIPTION ELONGATION 132 3.47e-03 3.57e-02 0.165000 1.53e-01 -6.10e-02 2.34e-03 2.26e-01
GOBP DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 9 6.84e-01 8.63e-01 0.165000 -1.62e-01 3.30e-02 4.01e-01 8.64e-01
GOBP MYELOID CELL HOMEOSTASIS 169 6.98e-04 1.03e-02 0.165000 1.51e-01 -6.72e-02 7.21e-04 1.32e-01
GOBP POSITIVE REGULATION OF GTPASE ACTIVITY 187 6.16e-04 9.34e-03 0.165000 1.62e-01 3.26e-02 1.37e-04 4.42e-01
GOBP GLIAL CELL MIGRATION 58 1.10e-01 3.58e-01 0.165000 1.33e-01 9.73e-02 7.94e-02 2.00e-01
GOBP POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS 19 4.37e-01 7.11e-01 0.165000 8.06e-02 -1.44e-01 5.43e-01 2.78e-01
GOBP REGULATION OF GLUCOCORTICOID METABOLIC PROCESS 11 6.20e-01 8.27e-01 0.165000 -7.79e-02 1.45e-01 6.55e-01 4.04e-01
GOMF PHOSPHATIDYLINOSITOL 3 PHOSPHATE BINDING 43 1.86e-01 4.77e-01 0.165000 1.56e-01 5.25e-02 7.62e-02 5.52e-01
GOMF 5 3 DNA EXONUCLEASE ACTIVITY 9 6.98e-01 8.70e-01 0.165000 1.62e-01 2.81e-02 3.99e-01 8.84e-01
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 133 5.51e-03 5.05e-02 0.165000 1.58e-01 4.54e-02 1.61e-03 3.66e-01
GOBP LACTATION 38 1.92e-01 4.84e-01 0.165000 1.43e-01 -8.12e-02 1.26e-01 3.86e-01
trans-Golgi Network Vesicle Budding 67 5.58e-02 2.42e-01 0.165000 1.49e-01 -7.02e-02 3.50e-02 3.20e-01
GOBP REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN 48 1.22e-01 3.81e-01 0.165000 1.11e-01 -1.22e-01 1.83e-01 1.45e-01
GOCC SPERM ANNULUS 5 8.24e-01 9.28e-01 0.165000 6.34e-02 1.52e-01 8.06e-01 5.56e-01
Pexophagy 10 6.50e-01 8.45e-01 0.165000 6.65e-02 -1.51e-01 7.16e-01 4.09e-01
GOBP ESTABLISHMENT OF MITOCHONDRION LOCALIZATION 29 2.95e-01 5.92e-01 0.165000 1.61e-01 -3.59e-02 1.34e-01 7.38e-01
GOCC CELL LEADING EDGE 412 9.93e-08 4.89e-06 0.165000 1.62e-01 2.86e-02 1.61e-08 3.19e-01
GOBP ICOSANOID SECRETION 47 1.28e-01 3.91e-01 0.165000 1.29e-01 -1.02e-01 1.25e-01 2.26e-01
GOBP ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 71 4.60e-02 2.14e-01 0.165000 1.41e-01 -8.43e-02 3.94e-02 2.19e-01
GOBP NEGATIVE REGULATION OF ORGAN GROWTH 35 2.54e-01 5.51e-01 0.165000 1.58e-01 4.58e-02 1.05e-01 6.39e-01
GOBP DOUBLE STRAND BREAK REPAIR INVOLVED IN MEIOTIC RECOMBINATION 11 6.19e-01 8.27e-01 0.165000 8.93e-02 -1.38e-01 6.08e-01 4.27e-01
GOCC KINETOCHORE MICROTUBULE 20 4.36e-01 7.10e-01 0.165000 2.14e-02 -1.63e-01 8.68e-01 2.07e-01
GOBP POSITIVE REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE 11 6.18e-01 8.27e-01 0.165000 1.16e-01 -1.17e-01 5.06e-01 5.02e-01
GOBP TERTIARY ALCOHOL METABOLIC PROCESS 22 4.09e-01 6.90e-01 0.164000 2.90e-03 1.64e-01 9.81e-01 1.82e-01
GOMF IRON ION TRANSMEMBRANE TRANSPORTER ACTIVITY 9 6.89e-01 8.65e-01 0.164000 1.64e-01 -1.76e-02 3.96e-01 9.27e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 62 6.93e-02 2.75e-01 0.164000 1.47e-01 -7.38e-02 4.53e-02 3.15e-01
Degradation of AXIN 42 1.69e-01 4.54e-01 0.164000 4.84e-02 -1.57e-01 5.88e-01 7.80e-02
GOBP POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS 65 5.87e-02 2.49e-01 0.164000 1.14e-01 -1.18e-01 1.11e-01 9.92e-02
GOBP NEGATIVE REGULATION OF CHROMOSOME SEGREGATION 50 1.13e-01 3.65e-01 0.164000 1.29e-01 -1.02e-01 1.15e-01 2.11e-01
GOBP NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE 22 4.30e-01 7.06e-01 0.164000 1.48e-01 7.21e-02 2.30e-01 5.59e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 20 4.60e-01 7.24e-01 0.164000 1.55e-01 5.40e-02 2.29e-01 6.76e-01
GOBP POSITIVE REGULATION OF NECROPTOTIC PROCESS 7 7.67e-01 9.01e-01 0.164000 1.38e-01 8.95e-02 5.28e-01 6.82e-01
GOMF POLY G BINDING 7 7.59e-01 8.97e-01 0.164000 -3.96e-02 -1.59e-01 8.56e-01 4.65e-01
Toll Like Receptor 7/8 (TLR7/8) Cascade 98 1.46e-02 1.03e-01 0.164000 1.42e-01 -8.31e-02 1.53e-02 1.55e-01
GOBP CHORIONIC TROPHOBLAST CELL PROLIFERATION 5 8.15e-01 9.25e-01 0.164000 -1.64e-01 5.76e-03 5.25e-01 9.82e-01
GOBP GRANZYME MEDIATED PROGRAMMED CELL DEATH SIGNALING PATHWAY 8 7.39e-01 8.87e-01 0.164000 -1.03e-01 -1.28e-01 6.13e-01 5.31e-01
GOBP NEGATIVE REGULATION OF CHOLESTEROL STORAGE 11 6.60e-01 8.50e-01 0.164000 1.00e-01 1.30e-01 5.65e-01 4.55e-01
GOBP TORC1 SIGNALING 98 1.46e-02 1.03e-01 0.164000 1.41e-01 -8.36e-02 1.56e-02 1.53e-01
GOBP MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 34 2.30e-01 5.28e-01 0.164000 1.41e-01 -8.35e-02 1.54e-01 3.99e-01
GOBP VIRAL TRANSCRIPTION 50 1.14e-01 3.66e-01 0.164000 1.32e-01 -9.81e-02 1.07e-01 2.30e-01
GOBP LIPID IMPORT INTO CELL 21 4.53e-01 7.21e-01 0.164000 1.22e-01 1.10e-01 3.33e-01 3.83e-01
Ligand-receptor interactions 8 7.40e-01 8.88e-01 0.164000 1.17e-01 1.16e-01 5.68e-01 5.71e-01
GOBP LUNG CELL DIFFERENTIATION 29 2.84e-01 5.81e-01 0.164000 1.33e-01 -9.62e-02 2.15e-01 3.70e-01
GOMF HISTONE H2A UBIQUITIN LIGASE ACTIVITY 6 7.73e-01 9.05e-01 0.164000 1.49e-01 -6.98e-02 5.29e-01 7.67e-01
GOBP GLYCEROL 3 PHOSPHATE METABOLIC PROCESS 7 7.68e-01 9.02e-01 0.164000 1.32e-01 9.78e-02 5.46e-01 6.54e-01
GOBP SMOOTH MUSCLE CELL DIFFERENTIATION 75 4.90e-02 2.23e-01 0.164000 1.64e-01 6.42e-03 1.41e-02 9.23e-01
GOBP EXTRACELLULAR TRANSPORT 44 1.70e-01 4.55e-01 0.164000 -1.64e-01 -5.99e-03 5.99e-02 9.45e-01
GOBP CELLULAR RESPONSE TO RADIATION 171 6.44e-04 9.67e-03 0.164000 1.37e-01 -8.95e-02 1.93e-03 4.34e-02
GOBP CYTOSOLIC TRANSPORT 135 3.71e-03 3.74e-02 0.164000 1.61e-01 -3.21e-02 1.25e-03 5.19e-01
GOBP REGULATION OF SYNAPSE PRUNING 6 7.92e-01 9.15e-01 0.164000 -4.79e-02 -1.57e-01 8.39e-01 5.06e-01
GOBP CELL CYCLE G1 S PHASE TRANSITION 251 3.40e-05 8.56e-04 0.164000 1.62e-01 -2.53e-02 9.84e-06 4.90e-01
GOBP REGULATION OF CELLULAR PH REDUCTION 7 7.57e-01 8.96e-01 0.164000 1.63e-01 1.98e-02 4.56e-01 9.28e-01
GOBP CAMERA TYPE EYE MORPHOGENESIS 131 6.61e-03 5.83e-02 0.164000 1.53e-01 5.88e-02 2.49e-03 2.45e-01
GOBP SMOOTH MUSCLE CONTRACTION 109 1.15e-02 8.67e-02 0.164000 1.63e-01 -1.81e-02 3.29e-03 7.44e-01
GOMF CYCLASE REGULATOR ACTIVITY 16 5.01e-01 7.53e-01 0.164000 -9.22e-02 1.36e-01 5.23e-01 3.48e-01
Hedgehog ‘on’ state 73 5.03e-02 2.26e-01 0.164000 1.63e-01 -1.61e-02 1.60e-02 8.12e-01
Signaling by Nuclear Receptors 258 2.60e-05 6.74e-04 0.164000 1.62e-01 -2.49e-02 7.46e-06 4.91e-01
GOBP ACETYL COA BIOSYNTHETIC PROCESS 16 5.13e-01 7.61e-01 0.164000 -3.58e-02 1.60e-01 8.04e-01 2.68e-01
GOBP PROTEIN ACYLATION 87 3.07e-02 1.68e-01 0.164000 1.64e-01 7.76e-03 8.31e-03 9.00e-01
GOMF MYOSIN LIGHT CHAIN BINDING 8 7.34e-01 8.85e-01 0.164000 5.10e-02 1.56e-01 8.03e-01 4.46e-01
GP1b-IX-V activation signalling 11 6.62e-01 8.51e-01 0.164000 1.28e-01 1.03e-01 4.64e-01 5.55e-01
GOBP POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION 18 5.04e-01 7.56e-01 0.164000 7.46e-02 1.46e-01 5.84e-01 2.84e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 95 2.12e-02 1.32e-01 0.164000 1.64e-01 -8.48e-03 5.86e-03 8.86e-01
GOBP NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 27 3.24e-01 6.15e-01 0.164000 1.59e-01 -4.03e-02 1.54e-01 7.17e-01
Degradation of cysteine and homocysteine 14 5.52e-01 7.87e-01 0.164000 5.95e-02 -1.52e-01 7.00e-01 3.23e-01
GOMF BILE ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 20 4.43e-01 7.15e-01 0.164000 -1.00e-02 1.63e-01 9.38e-01 2.06e-01
GOBP REGULATION OF LEUKOCYTE DEGRANULATION 39 1.88e-01 4.79e-01 0.164000 1.41e-01 -8.26e-02 1.27e-01 3.72e-01
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 19 4.41e-01 7.13e-01 0.164000 9.07e-02 -1.36e-01 4.94e-01 3.04e-01
Intracellular signaling by second messengers 312 4.98e-06 1.58e-04 0.164000 1.62e-01 1.91e-02 7.94e-07 5.62e-01
GOMF DIOXYGENASE ACTIVITY 86 3.36e-02 1.78e-01 0.164000 1.62e-01 2.06e-02 9.28e-03 7.42e-01
GOBP POSITIVE REGULATION OF GLUCONEOGENESIS 20 4.54e-01 7.21e-01 0.163000 1.62e-01 2.20e-02 2.10e-01 8.64e-01
GOBP RESPONSE TO INTERLEUKIN 3 6 7.78e-01 9.08e-01 0.163000 -4.44e-02 1.57e-01 8.51e-01 5.05e-01
GOMF METAL ION SENSOR ACTIVITY 8 7.14e-01 8.77e-01 0.163000 -5.15e-02 1.55e-01 8.01e-01 4.47e-01
GOCC RNAI EFFECTOR COMPLEX 358 8.87e-07 3.44e-05 0.163000 1.92e-02 1.62e-01 5.32e-01 1.34e-07
GOBP POSITIVE REGULATION OF ASPARTIC TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 5 8.20e-01 9.27e-01 0.163000 1.33e-02 1.63e-01 9.59e-01 5.29e-01
GOBP CELL DIFFERENTIATION INVOLVED IN PHENOTYPIC SWITCHING 5 8.20e-01 9.27e-01 0.163000 1.28e-02 1.63e-01 9.60e-01 5.29e-01
Thrombin signalling through proteinase activated receptors (PARs) 32 2.99e-01 5.94e-01 0.163000 1.46e-01 7.22e-02 1.52e-01 4.79e-01
GOCC RESPIRASOME 88 3.10e-02 1.70e-01 0.163000 -1.43e-02 -1.63e-01 8.17e-01 8.39e-03
GOBP NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 23 3.80e-01 6.65e-01 0.163000 5.83e-02 -1.52e-01 6.29e-01 2.06e-01
GOBP LEUKOCYTE APOPTOTIC PROCESS 115 8.62e-03 7.10e-02 0.163000 4.03e-02 -1.58e-01 4.56e-01 3.40e-03
GOCC TRANSCRIPTION REPRESSOR COMPLEX 75 4.26e-02 2.05e-01 0.163000 1.51e-01 -6.20e-02 2.39e-02 3.53e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 24 4.07e-01 6.89e-01 0.163000 1.39e-01 8.48e-02 2.37e-01 4.72e-01
Dual Incision in GG-NER 39 1.87e-01 4.78e-01 0.163000 1.13e-01 -1.18e-01 2.23e-01 2.03e-01
GOBP POSITIVE REGULATION OF HEART GROWTH 39 2.35e-01 5.32e-01 0.163000 1.26e-01 1.03e-01 1.73e-01 2.65e-01
GOBP ANGIOTENSIN ACTIVATED SIGNALING PATHWAY 19 4.89e-01 7.46e-01 0.163000 1.45e-01 7.44e-02 2.74e-01 5.75e-01
Translation of Replicase and Assembly of the Replication Transcription Complex 9679504 13 5.72e-01 7.99e-01 0.163000 1.23e-01 -1.07e-01 4.43e-01 5.03e-01
GOMF ORGANOPHOSPHATE PHOSPHATE ANTIPORTER ACTIVITY 7 7.63e-01 8.99e-01 0.163000 3.96e-02 1.58e-01 8.56e-01 4.69e-01
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters 20 4.72e-01 7.32e-01 0.163000 1.43e-01 7.79e-02 2.68e-01 5.46e-01
GOBP REGULATION OF TYPE 2 IMMUNE RESPONSE 34 2.63e-01 5.60e-01 0.163000 2.15e-02 1.62e-01 8.28e-01 1.03e-01
GOBP REGULATION OF MITOPHAGY 35 2.71e-01 5.68e-01 0.163000 1.37e-01 8.86e-02 1.61e-01 3.64e-01
GOMF VITAMIN D BINDING 6 7.81e-01 9.10e-01 0.163000 3.05e-02 -1.60e-01 8.97e-01 4.97e-01
GOBP ANIMAL ORGAN MATURATION 30 2.99e-01 5.95e-01 0.163000 -5.99e-03 1.63e-01 9.55e-01 1.23e-01
GOMF DIPEPTIDYL PEPTIDASE ACTIVITY 12 6.08e-01 8.21e-01 0.163000 1.57e-01 -4.24e-02 3.45e-01 7.99e-01
GOBP DOPAMINE SECRETION 30 2.79e-01 5.76e-01 0.163000 -8.52e-02 1.39e-01 4.19e-01 1.88e-01
GOBP VASOCONSTRICTION 85 3.62e-02 1.87e-01 0.163000 1.61e-01 2.31e-02 1.02e-02 7.12e-01
Regulation of CDH19 Expression and Function 7 7.69e-01 9.03e-01 0.163000 7.62e-02 1.44e-01 7.27e-01 5.10e-01
GOBP CELLULAR RESPONSE TO COCAINE 10 6.79e-01 8.61e-01 0.163000 3.69e-02 1.59e-01 8.40e-01 3.85e-01
GOBP CELLULAR RESPONSE TO OSMOTIC STRESS 53 1.26e-01 3.86e-01 0.163000 1.61e-01 2.21e-02 4.22e-02 7.80e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS 153 1.76e-03 2.13e-02 0.163000 1.55e-01 -5.12e-02 9.65e-04 2.74e-01
GOBP LUNG ASSOCIATED MESENCHYME DEVELOPMENT 9 6.80e-01 8.61e-01 0.163000 1.07e-01 -1.23e-01 5.79e-01 5.23e-01
GOBP POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 19 4.87e-01 7.46e-01 0.163000 1.50e-01 6.31e-02 2.58e-01 6.34e-01
GOMF QUATERNARY AMMONIUM GROUP TRANSMEMBRANE TRANSPORTER ACTIVITY 13 5.73e-01 7.99e-01 0.163000 1.23e-01 -1.06e-01 4.41e-01 5.07e-01
GOBP TRIF DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 11 6.24e-01 8.31e-01 0.163000 1.06e-01 -1.24e-01 5.44e-01 4.77e-01
Fcgamma receptor (FCGR) dependent phagocytosis 83 3.56e-02 1.85e-01 0.163000 1.62e-01 -1.08e-02 1.05e-02 8.65e-01
GOMF STEROL TRANSFER ACTIVITY 24 3.67e-01 6.55e-01 0.163000 -5.52e-02 1.53e-01 6.40e-01 1.94e-01
GOMF KINESIN BINDING 42 2.05e-01 4.99e-01 0.163000 1.50e-01 6.33e-02 9.27e-02 4.78e-01
GOCC FC RECEPTOR COMPLEX 5 8.08e-01 9.21e-01 0.163000 -1.28e-01 1.00e-01 6.20e-01 6.98e-01
GOBP SMOOTH MUSCLE CELL PROLIFERATION 162 1.61e-03 2.00e-02 0.163000 1.63e-01 -2.18e-03 3.53e-04 9.62e-01
Activation of gene expression by SREBF (SREBP) 41 2.20e-01 5.16e-01 0.163000 1.17e-01 1.13e-01 1.95e-01 2.11e-01
GOBP MORPHOGENESIS OF AN EPITHELIAL SHEET 64 8.61e-02 3.14e-01 0.163000 1.57e-01 4.20e-02 2.97e-02 5.61e-01
GOCC GRANULAR COMPONENT 7 7.71e-01 9.04e-01 0.163000 -1.37e-01 -8.76e-02 5.30e-01 6.88e-01
GOBP NODAL SIGNALING PATHWAY 16 5.52e-01 7.86e-01 0.163000 1.36e-01 8.91e-02 3.46e-01 5.37e-01
GOBP GLYCOSIDE CATABOLIC PROCESS 8 7.42e-01 8.89e-01 0.163000 1.39e-01 8.39e-02 4.95e-01 6.81e-01
GOCC ALPHA KETOACID DEHYDROGENASE COMPLEX 14 5.96e-01 8.14e-01 0.163000 1.18e-01 1.12e-01 4.43e-01 4.70e-01
GOBP FATTY ACID ELONGATION SATURATED FATTY ACID 8 7.28e-01 8.83e-01 0.163000 1.63e-01 2.72e-03 4.26e-01 9.89e-01
GOBP NITRIC OXIDE TRANSPORT 5 8.25e-01 9.28e-01 0.163000 -3.65e-02 -1.58e-01 8.88e-01 5.40e-01
GOBP ANTERIOR COMMISSURE MORPHOGENESIS 7 7.52e-01 8.93e-01 0.163000 -2.27e-02 1.61e-01 9.17e-01 4.61e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL WATER HOMEOSTASIS 33 2.94e-01 5.91e-01 0.163000 1.36e-01 8.86e-02 1.75e-01 3.78e-01
GOCC STEREOCILIA ANKLE LINK COMPLEX 6 7.74e-01 9.05e-01 0.163000 1.02e-01 -1.26e-01 6.64e-01 5.93e-01
GOMF MOLECULAR ADAPTOR ACTIVITY 1097 9.38e-19 2.74e-16 0.163000 1.63e-01 1.94e-03 9.51e-20 9.14e-01
GOBP REGULATION OF METALLOENDOPEPTIDASE ACTIVITY 10 6.53e-01 8.47e-01 0.163000 1.30e-01 -9.76e-02 4.77e-01 5.93e-01
GOCC COSTAMERE 16 5.46e-01 7.82e-01 0.163000 1.51e-01 6.02e-02 2.96e-01 6.77e-01
GOMF PHOSPHOLIPASE A1 ACTIVITY 18 4.64e-01 7.27e-01 0.162000 1.07e-01 -1.22e-01 4.30e-01 3.71e-01
GOMF CHROMATIN DNA BINDING 135 3.80e-03 3.81e-02 0.162000 1.54e-01 -5.05e-02 1.95e-03 3.11e-01
GOMF INTRACELLULARLY GATED CALCIUM CHANNEL ACTIVITY 18 5.06e-01 7.57e-01 0.162000 5.76e-02 1.52e-01 6.72e-01 2.65e-01
EPH-Ephrin signaling 90 3.04e-02 1.67e-01 0.162000 1.61e-01 2.25e-02 8.35e-03 7.12e-01
GOMF RIBOSOMAL PROTEIN S6 KINASE ACTIVITY 5 8.20e-01 9.27e-01 0.162000 1.62e-01 1.18e-03 5.29e-01 9.96e-01
GOBP INOSITOL PHOSPHATE METABOLIC PROCESS 39 2.02e-01 4.96e-01 0.162000 1.58e-01 -3.61e-02 8.71e-02 6.97e-01
Generation of second messenger molecules 29 3.14e-01 6.07e-01 0.162000 6.47e-03 -1.62e-01 9.52e-01 1.31e-01
GOBP PEPTIDYL PROLINE MODIFICATION 29 2.91e-01 5.88e-01 0.162000 1.04e-01 -1.25e-01 3.34e-01 2.44e-01
GOBP REGULATION OF NEUROGENESIS 362 1.41e-06 5.16e-05 0.162000 1.52e-01 5.60e-02 6.39e-07 6.74e-02
GOBP NEGATIVE REGULATION OF RECEPTOR RECYCLING 5 8.27e-01 9.29e-01 0.162000 -5.12e-02 -1.54e-01 8.43e-01 5.51e-01
Cellular response to heat stress 97 1.63e-02 1.12e-01 0.162000 1.18e-01 -1.11e-01 4.41e-02 5.87e-02
GOBP REGULATION OF NATURAL KILLER CELL PROLIFERATION 12 6.17e-01 8.26e-01 0.162000 -1.56e-02 1.61e-01 9.25e-01 3.33e-01
GOMF TASTE RECEPTOR ACTIVITY 30 2.90e-01 5.86e-01 0.162000 -4.86e-02 1.55e-01 6.45e-01 1.42e-01
GOBP NEURAL TUBE FORMATION 101 1.59e-02 1.09e-01 0.162000 1.56e-01 -4.39e-02 6.68e-03 4.46e-01
GOMF CALCIUM CHANNEL INHIBITOR ACTIVITY 13 5.90e-01 8.09e-01 0.162000 1.60e-01 -2.54e-02 3.17e-01 8.74e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVATOR ACTIVITY 6 7.86e-01 9.13e-01 0.162000 -1.17e-02 1.62e-01 9.60e-01 4.93e-01
GOBP REGULATION OF BLOOD VESSEL REMODELING 12 6.02e-01 8.17e-01 0.162000 -1.37e-01 8.73e-02 4.12e-01 6.00e-01
GOBP REGULATION OF MOTOR NEURON APOPTOTIC PROCESS 15 5.31e-01 7.72e-01 0.162000 8.08e-02 -1.41e-01 5.88e-01 3.46e-01
GOBP RESPONSE TO INSECTICIDE 6 7.98e-01 9.17e-01 0.162000 -6.39e-02 -1.49e-01 7.86e-01 5.27e-01
GOMF MALATE DEHYDROGENASE ACTIVITY 8 7.12e-01 8.76e-01 0.162000 1.11e-01 -1.18e-01 5.85e-01 5.64e-01
GOBP REGULATION OF GLIOGENESIS 108 1.75e-02 1.16e-01 0.162000 1.51e-01 5.89e-02 6.69e-03 2.90e-01
MyD88 dependent cascade initiated on endosome 96 1.77e-02 1.17e-01 0.162000 1.36e-01 -8.82e-02 2.14e-02 1.35e-01
GOBP NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 74 4.64e-02 2.16e-01 0.162000 1.50e-01 -6.21e-02 2.61e-02 3.56e-01
GOBP INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 75 4.45e-02 2.11e-01 0.162000 -1.49e-01 6.37e-02 2.58e-02 3.40e-01
GOMF ATP DEPENDENT ACTIVITY ACTING ON RNA 75 5.80e-02 2.47e-01 0.162000 1.56e-01 4.19e-02 1.92e-02 5.30e-01
GOBP MECHANOSENSORY BEHAVIOR 14 5.65e-01 7.94e-01 0.162000 -3.74e-02 1.57e-01 8.09e-01 3.08e-01
EPHA-mediated growth cone collapse 29 3.46e-01 6.36e-01 0.162000 1.23e-01 1.05e-01 2.52e-01 3.26e-01
Unfolded Protein Response (UPR) 86 2.69e-02 1.56e-01 0.162000 1.32e-01 -9.29e-02 3.37e-02 1.36e-01
GOMF ACETYLCHOLINE RECEPTOR INHIBITOR ACTIVITY 7 7.44e-01 8.90e-01 0.162000 -1.33e-01 9.19e-02 5.42e-01 6.74e-01
GOBP MITOTIC G2 DNA DAMAGE CHECKPOINT SIGNALING 34 2.51e-01 5.48e-01 0.162000 1.58e-01 -3.59e-02 1.12e-01 7.17e-01
GOBP MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY 92 3.02e-02 1.67e-01 0.162000 -3.58e-02 -1.58e-01 5.53e-01 8.94e-03
GOMF RNA POLYMERASE III GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY 12 6.02e-01 8.17e-01 0.162000 1.16e-01 -1.13e-01 4.87e-01 4.99e-01
GOBP POSITIVE REGULATION OF INFLAMMASOME MEDIATED SIGNALING PATHWAY 19 4.97e-01 7.52e-01 0.162000 -1.38e-01 -8.36e-02 2.97e-01 5.28e-01
GOBP REGULATION OF POLYAMINE TRANSMEMBRANE TRANSPORT 5 8.19e-01 9.27e-01 0.162000 1.46e-02 -1.61e-01 9.55e-01 5.33e-01
GOMF ORNITHINE DECARBOXYLASE REGULATOR ACTIVITY 5 8.19e-01 9.27e-01 0.162000 1.46e-02 -1.61e-01 9.55e-01 5.33e-01
GOBP RESPONSE TO GROWTH FACTOR 752 8.06e-13 9.89e-11 0.162000 1.59e-01 3.06e-02 1.27e-13 1.53e-01
Aquaporin-mediated transport 51 1.45e-01 4.18e-01 0.162000 3.92e-02 1.57e-01 6.29e-01 5.28e-02
Signaling by NOTCH2 32 2.60e-01 5.57e-01 0.162000 1.27e-01 -9.95e-02 2.13e-01 3.30e-01
Pre-NOTCH Expression and Processing 84 2.94e-02 1.65e-01 0.162000 9.89e-02 -1.28e-01 1.17e-01 4.30e-02
GOBP MAGNESIUM ION TRANSPORT 17 4.96e-01 7.51e-01 0.162000 1.50e-01 -5.92e-02 2.83e-01 6.73e-01
GOBP CARDIAC MUSCLE CELL PROLIFERATION 58 1.20e-01 3.77e-01 0.162000 1.33e-01 9.13e-02 7.93e-02 2.29e-01
GOCC RNA POLYMERASE II HOLOENZYME 67 6.38e-02 2.62e-01 0.162000 1.52e-01 -5.54e-02 3.17e-02 4.33e-01
GOCC NODE OF RANVIER 16 5.28e-01 7.70e-01 0.161000 -1.61e-01 1.69e-02 2.66e-01 9.07e-01
Processive synthesis on the C-strand of the telomere 19 4.64e-01 7.28e-01 0.161000 1.58e-01 -3.20e-02 2.32e-01 8.09e-01
GOBP POST EMBRYONIC DEVELOPMENT 86 3.92e-02 1.95e-01 0.161000 1.56e-01 4.32e-02 1.27e-02 4.88e-01
GOBP POSITIVE REGULATION OF NEUROBLAST PROLIFERATION 37 2.44e-01 5.40e-01 0.161000 1.58e-01 3.16e-02 9.57e-02 7.39e-01
GOBP NEGATIVE REGULATION OF VIRAL GENOME REPLICATION 54 1.05e-01 3.49e-01 0.161000 1.38e-01 -8.37e-02 7.95e-02 2.87e-01
GOBP CELL CYCLE G2 M PHASE TRANSITION 148 2.13e-03 2.47e-02 0.161000 1.37e-01 -8.58e-02 4.12e-03 7.16e-02
GOBP IMPORT INTO NUCLEUS 165 1.23e-03 1.62e-02 0.161000 1.53e-01 -4.98e-02 6.71e-04 2.70e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL 35 2.35e-01 5.32e-01 0.161000 -6.70e-02 1.47e-01 4.93e-01 1.33e-01
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL SIGNALING 9 6.88e-01 8.65e-01 0.161000 -1.42e-01 7.61e-02 4.60e-01 6.92e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS 10 6.92e-01 8.67e-01 0.161000 7.42e-02 1.43e-01 6.84e-01 4.33e-01
GOBP PROTEIN AUTOUBIQUITINATION 72 6.02e-02 2.52e-01 0.161000 1.61e-01 1.13e-03 1.80e-02 9.87e-01
GOBP NEGATIVE REGULATION OF RNA CATABOLIC PROCESS 81 3.40e-02 1.79e-01 0.161000 1.32e-01 -9.22e-02 3.96e-02 1.51e-01
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 19 4.50e-01 7.19e-01 0.161000 1.15e-01 -1.13e-01 3.85e-01 3.94e-01
GOMF WNT PROTEIN BINDING 31 3.19e-01 6.11e-01 0.161000 1.46e-01 6.90e-02 1.60e-01 5.06e-01
GOBP CARDIAC CHAMBER DEVELOPMENT 169 1.43e-03 1.84e-02 0.161000 1.61e-01 3.81e-03 3.01e-04 9.32e-01
GOBP RNA STABILIZATION 68 5.83e-02 2.47e-01 0.161000 1.28e-01 -9.73e-02 6.69e-02 1.65e-01
GOBP AUTOPHAGOSOME MATURATION 64 6.84e-02 2.73e-01 0.161000 1.12e-01 -1.15e-01 1.20e-01 1.10e-01
GOMF APOLIPOPROTEIN A I BINDING 5 8.34e-01 9.31e-01 0.161000 1.15e-01 1.13e-01 6.56e-01 6.62e-01
Vpr-mediated nuclear import of PICs 34 2.40e-01 5.36e-01 0.161000 1.19e-01 -1.09e-01 2.30e-01 2.72e-01
Switching of origins to a post-replicative state 79 3.68e-02 1.89e-01 0.161000 1.02e-01 -1.25e-01 1.19e-01 5.47e-02
Ephrin signaling 17 5.40e-01 7.79e-01 0.161000 1.18e-01 1.10e-01 4.01e-01 4.33e-01
GOBP PROTEIN LOCALIZATION TO PLASMA MEMBRANE 275 4.28e-05 1.04e-03 0.161000 1.48e-01 6.32e-02 2.36e-05 7.14e-02
GOMF EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 156 1.51e-03 1.92e-02 0.161000 -1.08e-01 1.20e-01 2.01e-02 9.99e-03
GOBP NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY 21 4.16e-01 6.96e-01 0.161000 1.28e-01 -9.75e-02 3.10e-01 4.39e-01
GOCC STEREOCILIA COUPLING LINK 8 7.42e-01 8.89e-01 0.161000 1.52e-01 5.37e-02 4.57e-01 7.93e-01
GOCC LSM2 8 COMPLEX 7 7.50e-01 8.92e-01 0.161000 6.52e-02 -1.47e-01 7.65e-01 5.00e-01
GOBP PERK MEDIATED UNFOLDED PROTEIN RESPONSE 20 4.69e-01 7.30e-01 0.161000 -3.42e-02 -1.57e-01 7.91e-01 2.23e-01
GOCC ALVEOLAR LAMELLAR BODY 8 7.15e-01 8.77e-01 0.161000 -1.07e-01 1.20e-01 5.99e-01 5.57e-01
GOMF ENOYL COA HYDRATASE ACTIVITY 11 6.31e-01 8.34e-01 0.161000 1.20e-01 -1.08e-01 4.92e-01 5.37e-01
Recycling of bile acids and salts 18 5.07e-01 7.58e-01 0.161000 3.62e-02 1.57e-01 7.90e-01 2.50e-01
GPVI-mediated activation cascade 34 2.45e-01 5.41e-01 0.161000 7.97e-02 -1.40e-01 4.21e-01 1.59e-01
GOBP NEGATIVE REGULATION OF MONONUCLEAR CELL MIGRATION 35 2.80e-01 5.77e-01 0.161000 1.37e-01 8.49e-02 1.62e-01 3.84e-01
Removal of the Flap Intermediate from the C-strand 17 4.97e-01 7.52e-01 0.161000 1.46e-01 -6.62e-02 2.96e-01 6.37e-01
GOBP RETINAL PIGMENT EPITHELIUM DEVELOPMENT 6 8.04e-01 9.20e-01 0.161000 -1.32e-01 -9.09e-02 5.74e-01 7.00e-01
GOBP POSITIVE REGULATION OF HAIR FOLLICLE DEVELOPMENT 12 6.21e-01 8.29e-01 0.161000 2.20e-02 -1.59e-01 8.95e-01 3.40e-01
GOCC NUCLEAR INCLUSION BODY 12 6.08e-01 8.21e-01 0.161000 1.36e-01 -8.63e-02 4.16e-01 6.05e-01
GOBP REGULATION OF PHAGOCYTOSIS 95 2.95e-02 1.65e-01 0.161000 -1.53e-01 -4.96e-02 1.01e-02 4.03e-01
GOBP RESPONSE TO AMPHETAMINE 34 2.81e-01 5.78e-01 0.161000 1.54e-01 4.59e-02 1.20e-01 6.43e-01
GOCC EXTRINSIC COMPONENT OF SYNAPTIC VESICLE MEMBRANE 11 6.33e-01 8.35e-01 0.161000 1.28e-01 -9.71e-02 4.62e-01 5.77e-01
Formation of axial mesoderm 14 5.66e-01 7.94e-01 0.161000 1.51e-01 -5.51e-02 3.28e-01 7.21e-01
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION 190 4.36e-04 7.04e-03 0.161000 1.45e-01 -6.82e-02 5.48e-04 1.05e-01
GOBP NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 141 5.15e-03 4.84e-02 0.161000 1.56e-01 3.67e-02 1.35e-03 4.52e-01
GOBP REGULATION OF AMINO ACID TRANSPORT 40 2.37e-01 5.33e-01 0.161000 9.90e-02 1.26e-01 2.78e-01 1.67e-01
GOBP POSITIVE REGULATION OF PROTEIN K63 LINKED UBIQUITINATION 7 7.53e-01 8.94e-01 0.161000 4.94e-02 -1.53e-01 8.21e-01 4.84e-01
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) 32 2.68e-01 5.65e-01 0.160000 1.42e-01 -7.43e-02 1.64e-01 4.67e-01
Regulation of Glucokinase by Glucokinase Regulatory Protein 32 2.68e-01 5.65e-01 0.160000 1.42e-01 -7.43e-02 1.64e-01 4.67e-01
GOBP REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS 212 1.89e-04 3.59e-03 0.160000 1.48e-01 -6.20e-02 2.05e-04 1.20e-01
GOMF L SERINE TRANSMEMBRANE TRANSPORTER ACTIVITY 8 7.26e-01 8.82e-01 0.160000 3.60e-02 -1.56e-01 8.60e-01 4.44e-01
Blood group systems biosynthesis 22 4.11e-01 6.92e-01 0.160000 -4.90e-02 1.53e-01 6.91e-01 2.15e-01
GOBP POSITIVE REGULATION OF ORGANELLE ASSEMBLY 87 4.39e-02 2.09e-01 0.160000 1.31e-01 9.31e-02 3.54e-02 1.33e-01
GOBP LEUKOCYTE MEDIATED CYTOTOXICITY 139 6.95e-03 6.06e-02 0.160000 -1.26e-01 -9.89e-02 1.02e-02 4.42e-02
GOCC PHOTORECEPTOR CONNECTING CILIUM 39 2.10e-01 5.05e-01 0.160000 4.06e-02 -1.55e-01 6.61e-01 9.39e-02
GOBP STRESS FIBER ASSEMBLY 109 1.87e-02 1.22e-01 0.160000 1.47e-01 6.31e-02 7.88e-03 2.55e-01
GOBP PROTEIN DEPHOSPHORYLATION 199 3.52e-04 5.93e-03 0.160000 1.53e-01 -4.74e-02 1.97e-04 2.49e-01
GOBP NEGATIVE REGULATION OF TORC1 SIGNALING 47 1.43e-01 4.15e-01 0.160000 9.95e-02 -1.26e-01 2.38e-01 1.36e-01
GOBP REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS 24 4.16e-01 6.96e-01 0.160000 6.34e-02 1.47e-01 5.91e-01 2.12e-01
GOBP CEREBELLAR CORTEX FORMATION 24 4.19e-01 6.99e-01 0.160000 1.40e-01 7.73e-02 2.34e-01 5.12e-01
GOBP REGULATION OF EXTENT OF CELL GROWTH 87 3.98e-02 1.97e-01 0.160000 1.54e-01 4.32e-02 1.29e-02 4.86e-01
RND1 GTPase cycle 41 2.08e-01 5.03e-01 0.160000 1.60e-01 7.51e-03 7.64e-02 9.34e-01
Regulation of APC/C activators between G1/S and early anaphase 68 6.40e-02 2.63e-01 0.160000 5.79e-02 -1.49e-01 4.09e-01 3.33e-02
Diseases of branched-chain amino acid catabolism 13 5.98e-01 8.14e-01 0.160000 1.58e-01 -2.75e-02 3.25e-01 8.64e-01
G0 and Early G1 27 3.31e-01 6.22e-01 0.160000 7.66e-02 -1.41e-01 4.91e-01 2.06e-01
GOBP REGULATION OF TRANSMISSION OF NERVE IMPULSE 15 5.85e-01 8.06e-01 0.160000 1.14e-01 1.13e-01 4.46e-01 4.50e-01
GOBP REGULATION OF ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS 5 8.14e-01 9.25e-01 0.160000 -1.37e-01 8.24e-02 5.95e-01 7.50e-01
GOCC SITE OF POLARIZED GROWTH 159 3.32e-03 3.46e-02 0.160000 1.39e-01 8.00e-02 2.57e-03 8.16e-02
GOBP PROTEIN SULFATION 6 7.86e-01 9.12e-01 0.160000 -1.53e-01 4.69e-02 5.16e-01 8.42e-01
GOBP NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 30 2.89e-01 5.86e-01 0.160000 1.24e-01 -1.02e-01 2.41e-01 3.35e-01
GOMF GLUTAMATE RECEPTOR BINDING 44 1.64e-01 4.48e-01 0.160000 -8.88e-02 1.33e-01 3.08e-01 1.27e-01
GOMF PROTEIN SERINE THREONINE TYROSINE KINASE ACTIVITY 42 2.17e-01 5.12e-01 0.160000 1.46e-01 6.50e-02 1.01e-01 4.66e-01
GOBP RIBONUCLEOPROTEIN COMPLEX BIOGENESIS 437 2.13e-08 1.21e-06 0.160000 9.24e-02 -1.30e-01 9.20e-04 2.91e-06
GOBP SARCOMERE ORGANIZATION 51 1.25e-01 3.85e-01 0.160000 -7.69e-02 1.40e-01 3.42e-01 8.34e-02
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR ALPHA SIGNALING PATHWAY 5 8.15e-01 9.25e-01 0.160000 8.26e-02 -1.37e-01 7.49e-01 5.96e-01
GOMF SINGLE STRANDED DNA BINDING 115 9.20e-03 7.41e-02 0.160000 1.38e-01 -8.11e-02 1.08e-02 1.33e-01
GOBP NEUTRAL LIPID CATABOLIC PROCESS 37 2.21e-01 5.17e-01 0.160000 -1.41e-01 7.50e-02 1.37e-01 4.30e-01
GOBP NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS 111 1.32e-02 9.62e-02 0.160000 1.59e-01 -1.95e-02 3.90e-03 7.23e-01
GOMF PALMITOYLTRANSFERASE ACTIVITY 34 2.90e-01 5.86e-01 0.160000 1.48e-01 6.09e-02 1.36e-01 5.39e-01
GOMF INSULIN RECEPTOR BINDING 21 4.28e-01 7.06e-01 0.160000 1.49e-01 -5.83e-02 2.38e-01 6.44e-01
GOBP REGULATION OF DENDRITE MORPHOGENESIS 58 1.27e-01 3.88e-01 0.160000 1.03e-01 1.22e-01 1.73e-01 1.09e-01
GOBP CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS 29 3.04e-01 5.98e-01 0.160000 -1.31e-01 9.10e-02 2.21e-01 3.96e-01
GOCC RIBONUCLEOPROTEIN GRANULE 261 2.68e-05 6.91e-04 0.160000 1.41e-01 -7.47e-02 8.60e-05 3.78e-02
GOBP REGULATION OF AXON EXTENSION 71 7.60e-02 2.91e-01 0.160000 1.47e-01 6.30e-02 3.25e-02 3.58e-01
Synthesis of bile acids and bile salts via 27-hydroxycholesterol 14 6.01e-01 8.16e-01 0.160000 6.25e-02 1.47e-01 6.85e-01 3.41e-01
RNA Polymerase II Transcription 1287 1.21e-21 4.49e-19 0.160000 1.55e-01 -3.69e-02 7.27e-21 2.63e-02
GOBP INTRACELLULAR RECEPTOR SIGNALING PATHWAY 355 1.12e-06 4.19e-05 0.160000 1.58e-01 -2.39e-02 3.28e-07 4.40e-01
GOBP SULFUR AMINO ACID BIOSYNTHETIC PROCESS 15 5.39e-01 7.78e-01 0.160000 1.17e-01 -1.08e-01 4.32e-01 4.68e-01
GOMF SYNTAXIN BINDING 59 1.17e-01 3.71e-01 0.159000 1.50e-01 5.52e-02 4.69e-02 4.63e-01
GRB2:SOS provides linkage to MAPK signaling for Integrins 15 5.40e-01 7.79e-01 0.159000 1.01e-01 -1.24e-01 4.99e-01 4.07e-01
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS 31 2.82e-01 5.79e-01 0.159000 1.33e-01 -8.82e-02 2.01e-01 3.95e-01
Inflammasomes 21 4.39e-01 7.13e-01 0.159000 2.55e-02 -1.57e-01 8.39e-01 2.12e-01
GOBP AXON EXTENSION 96 2.96e-02 1.65e-01 0.159000 1.53e-01 4.43e-02 9.52e-03 4.53e-01
GOMF GTP DEPENDENT PROTEIN BINDING 20 4.41e-01 7.13e-01 0.159000 1.00e-01 -1.24e-01 4.39e-01 3.37e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL GENOME REPLICATION 10 6.67e-01 8.53e-01 0.159000 1.43e-01 -6.99e-02 4.33e-01 7.02e-01
GOBP REGULATION OF PROTEIN DEPOLYMERIZATION 83 3.84e-02 1.93e-01 0.159000 1.56e-01 -3.36e-02 1.42e-02 5.97e-01
GOBP NEGATIVE REGULATION OF TOR SIGNALING 68 6.57e-02 2.67e-01 0.159000 1.48e-01 -5.78e-02 3.42e-02 4.10e-01
GOBP CELL CELL JUNCTION MAINTENANCE 18 5.13e-01 7.61e-01 0.159000 3.41e-02 1.56e-01 8.02e-01 2.53e-01
GOBP NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY 139 3.83e-03 3.84e-02 0.159000 1.46e-01 -6.29e-02 2.90e-03 2.01e-01
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME ACTIVITY 36 2.30e-01 5.27e-01 0.159000 1.27e-01 -9.62e-02 1.88e-01 3.18e-01
GOBP STRESS INDUCED PREMATURE SENESCENCE 8 7.20e-01 8.79e-01 0.159000 1.05e-01 -1.20e-01 6.07e-01 5.57e-01
GOBP REGULATION OF AUTOPHAGY 349 2.01e-06 7.00e-05 0.159000 1.59e-01 2.03e-03 3.18e-07 9.48e-01
GOBP NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS 13 5.89e-01 8.08e-01 0.159000 -8.51e-02 1.35e-01 5.95e-01 4.01e-01
GOBP ACTOMYOSIN STRUCTURE ORGANIZATION 212 5.60e-04 8.65e-03 0.159000 1.33e-01 8.77e-02 8.53e-04 2.77e-02
GOBP REGULATION OF CELLULAR RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR STIMULUS 6 8.00e-01 9.18e-01 0.159000 -1.56e-01 -3.11e-02 5.08e-01 8.95e-01
Degradation of DVL 44 1.78e-01 4.66e-01 0.159000 3.09e-02 -1.56e-01 7.22e-01 7.31e-02
GOBP REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III 28 3.37e-01 6.27e-01 0.159000 1.58e-01 -1.92e-02 1.48e-01 8.60e-01
PTK6 Regulates Proteins Involved in RNA Processing 5 8.19e-01 9.27e-01 0.159000 5.54e-02 -1.49e-01 8.30e-01 5.63e-01
GOMF RETINAL BINDING 19 4.60e-01 7.24e-01 0.159000 -1.23e-01 1.01e-01 3.52e-01 4.48e-01
GOBP ACTIN FILAMENT BUNDLE ORGANIZATION 163 3.03e-03 3.24e-02 0.159000 1.40e-01 7.62e-02 2.08e-03 9.33e-02
GOBP REGULATION OF EXCITATORY SYNAPSE ASSEMBLY 17 4.99e-01 7.53e-01 0.159000 -1.09e-01 1.16e-01 4.38e-01 4.07e-01
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 8 7.23e-01 8.81e-01 0.159000 8.18e-02 -1.36e-01 6.89e-01 5.04e-01
GOMF SNAP RECEPTOR ACTIVITY 36 2.41e-01 5.37e-01 0.159000 1.53e-01 -4.28e-02 1.12e-01 6.57e-01
GOBP COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE 24 4.07e-01 6.89e-01 0.159000 -1.73e-02 -1.58e-01 8.84e-01 1.80e-01
GOBP NEGATIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 12 6.14e-01 8.24e-01 0.159000 -8.73e-02 1.33e-01 6.01e-01 4.25e-01
GOBP PROTEIN METHYLATION 50 1.32e-01 3.96e-01 0.159000 1.35e-01 -8.42e-02 9.90e-02 3.03e-01
GOBP CELL VOLUME HOMEOSTASIS 34 2.80e-01 5.77e-01 0.159000 1.58e-01 1.90e-02 1.11e-01 8.48e-01
GOBP HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN 47 1.80e-01 4.70e-01 0.159000 -1.52e-01 -4.69e-02 7.16e-02 5.78e-01
GOBP POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 31 2.82e-01 5.79e-01 0.159000 1.09e-01 -1.15e-01 2.92e-01 2.66e-01
GOBP REGULATION OF MITOTIC CELL CYCLE PHASE TRANSITION 348 1.72e-06 6.08e-05 0.159000 1.58e-01 -1.91e-02 4.25e-07 5.41e-01
GOBP FEEDING BEHAVIOR 104 2.02e-02 1.27e-01 0.159000 1.59e-01 9.54e-03 5.21e-03 8.66e-01
GOBP REGULATION OF NEURON APOPTOTIC PROCESS 235 1.45e-04 2.93e-03 0.159000 1.59e-01 7.38e-04 2.73e-05 9.84e-01
GOBP SYNAPTIC VESICLE COATING 5 8.15e-01 9.25e-01 0.159000 1.16e-01 -1.09e-01 6.54e-01 6.73e-01
GOCC ER TO GOLGI TRANSPORT VESICLE MEMBRANE 60 8.72e-02 3.16e-01 0.159000 1.03e-01 -1.20e-01 1.66e-01 1.07e-01
GOCC POTASSIUM CHANNEL COMPLEX 99 1.80e-02 1.18e-01 0.159000 -1.21e-01 1.02e-01 3.70e-02 7.83e-02
GOBP POSITIVE REGULATION OF PROTEIN POLYMERIZATION 89 3.18e-02 1.72e-01 0.159000 1.57e-01 -2.61e-02 1.07e-02 6.70e-01
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR BINDING 51 1.28e-01 3.90e-01 0.159000 1.35e-01 -8.26e-02 9.41e-02 3.08e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 81 5.76e-02 2.46e-01 0.159000 1.31e-01 8.99e-02 4.20e-02 1.62e-01
GOCC CILIARY BASAL BODY 162 1.91e-03 2.28e-02 0.159000 1.56e-01 -2.76e-02 5.99e-04 5.45e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN ANOTHER COMPOUND AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN 7 7.70e-01 9.03e-01 0.159000 -1.58e-01 -1.48e-02 4.69e-01 9.46e-01
GOBP REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 26 3.57e-01 6.47e-01 0.159000 1.50e-01 -5.18e-02 1.86e-01 6.48e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY 11 6.42e-01 8.41e-01 0.159000 -1.37e-01 7.95e-02 4.31e-01 6.48e-01
GOBP NADPH OXIDATION 6 8.09e-01 9.22e-01 0.159000 1.27e-01 9.43e-02 5.89e-01 6.89e-01
Inactivation of CSF3 (G-CSF) signaling 25 3.62e-01 6.50e-01 0.159000 1.05e-01 -1.19e-01 3.64e-01 3.04e-01
GOCC CONDENSED CHROMOSOME CENTROMERIC REGION 174 9.83e-04 1.36e-02 0.158000 1.42e-01 -7.11e-02 1.27e-03 1.06e-01
GOBP CENTROSOME DUPLICATION 73 5.66e-02 2.43e-01 0.158000 4.74e-02 -1.51e-01 4.83e-01 2.55e-02
Gap-filling DNA repair synthesis and ligation in GG-NER 25 3.65e-01 6.52e-01 0.158000 1.35e-01 -8.34e-02 2.44e-01 4.70e-01
GOBP STABILIZATION OF MEMBRANE POTENTIAL 17 5.21e-01 7.64e-01 0.158000 -1.57e-01 1.72e-02 2.61e-01 9.02e-01
GOBP CENTRIOLE ASSEMBLY 46 1.74e-01 4.60e-01 0.158000 9.37e-03 -1.58e-01 9.12e-01 6.36e-02
The role of GTSE1 in G2/M progression after G2 checkpoint 64 1.03e-01 3.46e-01 0.158000 -7.05e-02 -1.42e-01 3.29e-01 4.99e-02
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR BINDING 24 4.28e-01 7.06e-01 0.158000 8.03e-02 1.36e-01 4.96e-01 2.47e-01
GOBP NEURAL CREST CELL FATE COMMITMENT 6 7.94e-01 9.16e-01 0.158000 1.79e-02 -1.57e-01 9.40e-01 5.05e-01
Autodegradation of Cdh1 by Cdh1:APC/C 54 1.15e-01 3.68e-01 0.158000 7.48e-02 -1.40e-01 3.42e-01 7.61e-02
GOBP REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 28 3.49e-01 6.39e-01 0.158000 -4.75e-03 -1.58e-01 9.65e-01 1.47e-01
GOMF CALCITONIN FAMILY RECEPTOR ACTIVITY 6 7.84e-01 9.12e-01 0.158000 -1.13e-01 1.11e-01 6.31e-01 6.39e-01
Mitochondrial iron-sulfur cluster biogenesis 13 5.95e-01 8.13e-01 0.158000 7.20e-02 -1.41e-01 6.53e-01 3.79e-01
GOBP REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 90 3.47e-02 1.82e-01 0.158000 1.58e-01 7.37e-03 9.56e-03 9.04e-01
GOBP POSITIVE REGULATION OF TELOMERASE ACTIVITY 29 3.23e-01 6.14e-01 0.158000 3.91e-02 -1.53e-01 7.16e-01 1.53e-01
GOCC TIM22 MITOCHONDRIAL IMPORT INNER MEMBRANE INSERTION COMPLEX 7 7.59e-01 8.97e-01 0.158000 1.50e-01 -5.11e-02 4.93e-01 8.15e-01
GOBP L PROLINE BIOSYNTHETIC PROCESS 6 7.86e-01 9.12e-01 0.158000 -8.49e-02 1.33e-01 7.19e-01 5.72e-01
ERKs are inactivated 13 6.28e-01 8.33e-01 0.158000 1.48e-01 5.67e-02 3.57e-01 7.23e-01
GOBP POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION 22 4.64e-01 7.27e-01 0.158000 1.22e-01 1.00e-01 3.21e-01 4.15e-01
GOBP MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 22 4.37e-01 7.10e-01 0.158000 -1.58e-01 9.30e-04 1.99e-01 9.94e-01
Keratan sulfate biosynthesis 28 3.53e-01 6.42e-01 0.158000 1.06e-02 1.58e-01 9.23e-01 1.49e-01
GOMF ALPHA 2A ADRENERGIC RECEPTOR BINDING 5 8.21e-01 9.27e-01 0.158000 1.47e-01 -5.70e-02 5.68e-01 8.25e-01
GOMF HIGH DENSITY LIPOPROTEIN PARTICLE BINDING 13 6.27e-01 8.33e-01 0.158000 5.11e-02 1.49e-01 7.50e-01 3.51e-01
GOBP NATURAL KILLER CELL DEGRANULATION 10 7.06e-01 8.73e-01 0.158000 -1.07e-01 -1.16e-01 5.58e-01 5.25e-01
Sealing of the nuclear envelope (NE) by ESCRT-III 30 3.11e-01 6.04e-01 0.158000 -1.52e-01 4.19e-02 1.49e-01 6.91e-01
GOBP REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS 15 5.69e-01 7.97e-01 0.158000 -5.93e-04 1.58e-01 9.97e-01 2.90e-01
GOBP NUCLEOBASE CONTAINING COMPOUND TRANSPORT 214 2.32e-04 4.26e-03 0.158000 1.46e-01 -5.94e-02 2.27e-04 1.34e-01
GOBP MUSCLE STRUCTURE DEVELOPMENT 693 2.99e-11 2.84e-09 0.158000 1.52e-01 4.40e-02 1.02e-11 4.85e-02
GOMF GTPASE INHIBITOR ACTIVITY 12 6.29e-01 8.34e-01 0.158000 -3.13e-02 1.55e-01 8.51e-01 3.54e-01
GOBP CELLULAR RESPONSE TO COPPER ION 24 3.81e-01 6.65e-01 0.158000 -1.12e-01 1.11e-01 3.43e-01 3.45e-01
GOBP RESPONSE TO CADMIUM ION 57 1.12e-01 3.63e-01 0.158000 -1.55e-01 2.72e-02 4.24e-02 7.23e-01
Programmed Cell Death 190 5.15e-04 8.04e-03 0.158000 1.26e-01 -9.55e-02 2.83e-03 2.33e-02
GOMF POLY A BINDING 22 4.56e-01 7.22e-01 0.158000 1.48e-01 5.40e-02 2.29e-01 6.61e-01
ATF4 activates genes in response to endoplasmic reticulum stress 27 3.50e-01 6.40e-01 0.158000 4.42e-02 -1.51e-01 6.91e-01 1.73e-01
GOMF DICARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 31 3.00e-01 5.95e-01 0.158000 -4.23e-02 1.52e-01 6.83e-01 1.43e-01
GOBP POLYSACCHARIDE BIOSYNTHETIC PROCESS 64 1.01e-01 3.41e-01 0.158000 1.51e-01 4.68e-02 3.72e-02 5.18e-01
GOBP MITOTIC G1 S TRANSITION CHECKPOINT SIGNALING 30 3.00e-01 5.95e-01 0.158000 1.17e-01 -1.05e-01 2.67e-01 3.17e-01
GOBP DEOXYRIBONUCLEOSIDE CATABOLIC PROCESS 6 8.12e-01 9.24e-01 0.158000 9.70e-02 1.24e-01 6.81e-01 5.98e-01
GOBP GROWTH PLATE CARTILAGE CHONDROCYTE DIFFERENTIATION 9 7.02e-01 8.71e-01 0.158000 5.73e-02 -1.47e-01 7.66e-01 4.46e-01
GOBP NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 171 1.53e-03 1.94e-02 0.158000 1.56e-01 -2.14e-02 4.27e-04 6.30e-01
GOBP REGULATION OF MRNA CATABOLIC PROCESS 271 4.56e-05 1.09e-03 0.158000 1.58e-01 2.98e-03 8.02e-06 9.33e-01
GOBP RESPONSE TO RETINOIC ACID 105 1.66e-02 1.12e-01 0.158000 1.48e-01 -5.44e-02 8.86e-03 3.35e-01
GOMF NADPH BINDING 16 5.42e-01 7.80e-01 0.158000 -2.48e-02 1.56e-01 8.64e-01 2.81e-01
Transport of nucleotide sugars 8 7.26e-01 8.82e-01 0.158000 -9.14e-02 1.28e-01 6.54e-01 5.30e-01
GOBP NATURAL KILLER CELL MEDIATED IMMUNITY 81 6.11e-02 2.54e-01 0.157000 -1.16e-01 -1.06e-01 7.12e-02 9.75e-02
GOBP OXALOACETATE METABOLIC PROCESS 9 7.14e-01 8.76e-01 0.157000 4.52e-03 -1.57e-01 9.81e-01 4.14e-01
GOBP RESPONSE TO HEAT 99 1.93e-02 1.23e-01 0.157000 1.03e-01 -1.19e-01 7.68e-02 4.06e-02
GOBP ESTABLISHMENT OF EPITHELIAL CELL POLARITY 33 3.18e-01 6.11e-01 0.157000 1.26e-01 9.39e-02 2.09e-01 3.51e-01
GOBP REGULATION OF AMPA RECEPTOR ACTIVITY 18 5.23e-01 7.66e-01 0.157000 -1.52e-01 -3.92e-02 2.63e-01 7.73e-01
GOBP POSITIVE REGULATION OF VIRAL LIFE CYCLE 23 4.47e-01 7.17e-01 0.157000 1.38e-01 7.49e-02 2.51e-01 5.34e-01
GOBP NEGATIVE REGULATION OF GLUTAMATE SECRETION 5 8.19e-01 9.27e-01 0.157000 9.61e-02 -1.25e-01 7.10e-01 6.29e-01
GOBP HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE 17 5.40e-01 7.78e-01 0.157000 2.92e-02 1.55e-01 8.35e-01 2.70e-01
Synthesis of PE 13 5.94e-01 8.13e-01 0.157000 1.18e-01 -1.03e-01 4.60e-01 5.18e-01
Formation of xylulose-5-phosphate 5 8.22e-01 9.27e-01 0.157000 1.47e-01 -5.55e-02 5.69e-01 8.30e-01
GOBP GLUCURONATE CATABOLIC PROCESS TO XYLULOSE 5 PHOSPHATE 5 8.22e-01 9.27e-01 0.157000 1.47e-01 -5.55e-02 5.69e-01 8.30e-01
GOBP NEGATIVE REGULATION OF GLUCOCORTICOID METABOLIC PROCESS 5 8.24e-01 9.28e-01 0.157000 4.11e-02 -1.52e-01 8.73e-01 5.57e-01
Activation of BH3-only proteins 30 3.20e-01 6.11e-01 0.157000 1.56e-01 -2.17e-02 1.40e-01 8.37e-01
GOMF WD40 REPEAT DOMAIN BINDING 5 8.34e-01 9.31e-01 0.157000 2.92e-02 1.54e-01 9.10e-01 5.50e-01
Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding 31 3.37e-01 6.27e-01 0.157000 -1.42e-01 -6.84e-02 1.73e-01 5.10e-01
GOBP TRNA METABOLIC PROCESS 195 4.65e-04 7.41e-03 0.157000 1.33e-01 -8.40e-02 1.38e-03 4.32e-02
GOMF ARGININE BINDING 8 7.28e-01 8.83e-01 0.157000 7.99e-02 -1.35e-01 6.96e-01 5.08e-01
GOBP AGGRESSIVE BEHAVIOR 8 7.59e-01 8.97e-01 0.157000 1.03e-01 1.18e-01 6.13e-01 5.62e-01
TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway 16 5.31e-01 7.72e-01 0.157000 7.66e-02 -1.37e-01 5.96e-01 3.42e-01
GOBP GLYCOPHAGY 11 6.80e-01 8.61e-01 0.157000 6.71e-02 1.42e-01 7.00e-01 4.15e-01
Intra-Golgi traffic 43 2.11e-01 5.06e-01 0.157000 1.55e-01 2.75e-02 7.93e-02 7.55e-01
GOBP SULFUR AMINO ACID TRANSPORT 12 6.39e-01 8.40e-01 0.157000 -3.78e-03 1.57e-01 9.82e-01 3.46e-01
Biosynthesis of Lipoxins (LX) 6 7.99e-01 9.17e-01 0.157000 1.57e-01 -5.75e-03 5.06e-01 9.81e-01
GOBP GLYCOLIPID CATABOLIC PROCESS 25 4.23e-01 7.02e-01 0.157000 1.06e-01 1.16e-01 3.58e-01 3.17e-01
GOBP NEGATIVE REGULATION OF CILIUM ASSEMBLY 20 4.76e-01 7.36e-01 0.157000 1.57e-01 -5.21e-04 2.25e-01 9.97e-01
GOMF C METHYLTRANSFERASE ACTIVITY 6 7.89e-01 9.14e-01 0.157000 1.34e-01 -8.19e-02 5.71e-01 7.28e-01
GOBP PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS 123 7.81e-03 6.58e-02 0.157000 1.27e-01 -9.23e-02 1.52e-02 7.71e-02
GOBP REGULATION OF NATURAL KILLER CELL DIFFERENTIATION 12 6.26e-01 8.32e-01 0.157000 6.33e-02 -1.43e-01 7.04e-01 3.90e-01
GOBP POSITIVE REGULATION OF CELLULAR EXTRAVASATION 16 5.33e-01 7.73e-01 0.157000 -7.50e-02 1.38e-01 6.04e-01 3.40e-01
GOBP L CYSTINE TRANSPORT 6 7.89e-01 9.14e-01 0.157000 -1.30e-01 8.77e-02 5.81e-01 7.10e-01
GOBP NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS 15 5.85e-01 8.06e-01 0.157000 -3.88e-02 -1.52e-01 7.95e-01 3.08e-01
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 8 7.50e-01 8.92e-01 0.157000 -1.54e-01 -3.14e-02 4.52e-01 8.78e-01
GOBP METALLO SULFUR CLUSTER ASSEMBLY 26 3.88e-01 6.72e-01 0.157000 -1.70e-02 -1.56e-01 8.80e-01 1.69e-01
GOMF DNA ENDONUCLEASE ACTIVITY 39 2.13e-01 5.08e-01 0.157000 1.08e-01 -1.13e-01 2.43e-01 2.20e-01
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 31 3.15e-01 6.08e-01 0.157000 -1.56e-01 8.79e-03 1.32e-01 9.32e-01
GOBP INTERLEUKIN 10 PRODUCTION 58 1.13e-01 3.65e-01 0.157000 -1.55e-01 1.87e-02 4.06e-02 8.05e-01
GOBP NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 42 1.99e-01 4.92e-01 0.157000 1.49e-01 -4.72e-02 9.41e-02 5.96e-01
GOCC PRESYNAPTIC CYTOSKELETON 11 6.73e-01 8.58e-01 0.156000 -1.54e-01 -2.78e-02 3.77e-01 8.73e-01
GOBP CELLULAR RESPONSE TO UV 87 3.35e-02 1.78e-01 0.156000 1.37e-01 -7.49e-02 2.68e-02 2.27e-01
GOBP CORTICAL CYTOSKELETON ORGANIZATION 52 1.58e-01 4.41e-01 0.156000 1.51e-01 4.14e-02 5.99e-02 6.06e-01
GOBP REGULATION OF PROTEIN KINASE C SIGNALING 18 5.02e-01 7.55e-01 0.156000 4.17e-02 -1.51e-01 7.59e-01 2.68e-01
GOCC TRNA METHYLTRANSFERASE COMPLEX 6 7.91e-01 9.15e-01 0.156000 1.39e-01 -7.15e-02 5.55e-01 7.62e-01
Nitric oxide stimulates guanylate cyclase 21 4.41e-01 7.13e-01 0.156000 -1.38e-01 7.34e-02 2.74e-01 5.60e-01
GOBP KERATINOCYTE DEVELOPMENT 13 6.41e-01 8.41e-01 0.156000 -9.37e-02 -1.25e-01 5.59e-01 4.35e-01
GOBP COPULATION 19 5.23e-01 7.66e-01 0.156000 1.17e-01 1.03e-01 3.75e-01 4.37e-01
Meiotic synapsis 54 1.28e-01 3.89e-01 0.156000 4.32e-02 -1.50e-01 5.83e-01 5.64e-02
GOBP POSITIVE REGULATION OF CENTRIOLE REPLICATION 8 7.55e-01 8.95e-01 0.156000 -5.13e-02 -1.48e-01 8.02e-01 4.70e-01
GOBP CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS 28 3.35e-01 6.25e-01 0.156000 1.35e-01 -7.86e-02 2.17e-01 4.72e-01
GOBP RIBONUCLEOSIDE CATABOLIC PROCESS 20 4.69e-01 7.30e-01 0.156000 1.52e-01 -3.49e-02 2.39e-01 7.87e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT 10 6.93e-01 8.68e-01 0.156000 1.56e-01 2.03e-03 3.93e-01 9.91e-01
RUNX1 regulates estrogen receptor mediated transcription 6 7.90e-01 9.14e-01 0.156000 1.05e-01 -1.16e-01 6.57e-01 6.23e-01
GOBP MELANOCYTE PROLIFERATION 5 8.40e-01 9.34e-01 0.156000 -1.45e-01 -5.73e-02 5.74e-01 8.24e-01
GOMF SIGNALING ADAPTOR ACTIVITY 111 1.90e-02 1.23e-01 0.156000 1.54e-01 2.20e-02 4.97e-03 6.89e-01
GOMF HISTONE ACETYLTRANSFERASE BINDING 23 4.07e-01 6.89e-01 0.156000 8.69e-02 -1.29e-01 4.71e-01 2.83e-01
GOMF UBIQUITIN BINDING 100 2.72e-02 1.57e-01 0.156000 1.55e-01 1.22e-02 7.26e-03 8.33e-01
GOMF CTPASE ACTIVITY 5 8.23e-01 9.27e-01 0.156000 1.35e-01 -7.74e-02 6.00e-01 7.64e-01
Activated NOTCH1 Transmits Signal to the Nucleus 30 3.48e-01 6.38e-01 0.156000 1.51e-01 3.88e-02 1.53e-01 7.13e-01
GOCC NUCLEAR PORE 90 2.98e-02 1.66e-01 0.156000 1.22e-01 -9.64e-02 4.50e-02 1.14e-01
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 276 7.62e-05 1.70e-03 0.156000 1.46e-01 5.54e-02 3.15e-05 1.13e-01
Signalling to ERKs 34 2.85e-01 5.82e-01 0.156000 1.55e-01 -1.35e-02 1.18e-01 8.91e-01
GOCC PHOSPHATIDYLINOSITOL 3 KINASE COMPLEX CLASS I 9 7.17e-01 8.78e-01 0.156000 1.33e-02 -1.55e-01 9.45e-01 4.20e-01
GOBP PROTEIN LOCALIZATION TO VACUOLE 85 4.71e-02 2.19e-01 0.156000 1.55e-01 1.33e-02 1.34e-02 8.32e-01
GOBP REGULATION OF METAPHASE PLATE CONGRESSION 14 5.78e-01 8.02e-01 0.156000 1.21e-01 -9.78e-02 4.33e-01 5.26e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 46 1.66e-01 4.50e-01 0.156000 1.21e-01 -9.76e-02 1.55e-01 2.52e-01
GOBP TRANSLATIONAL ELONGATION 70 6.60e-02 2.68e-01 0.156000 1.31e-01 -8.40e-02 5.80e-02 2.24e-01
GOCC SNARE COMPLEX 49 1.51e-01 4.29e-01 0.156000 1.38e-01 -7.11e-02 9.38e-02 3.89e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS 19 5.11e-01 7.60e-01 0.156000 -3.37e-02 -1.52e-01 7.99e-01 2.52e-01
GOBP REGULATION OF REGULATORY NCRNA PROCESSING 16 5.35e-01 7.75e-01 0.156000 1.20e-01 -9.92e-02 4.07e-01 4.92e-01
GOMF CATALYTIC ACTIVITY ACTING ON A TRNA 134 5.44e-03 5.01e-02 0.156000 1.14e-01 -1.06e-01 2.24e-02 3.49e-02
Generic Transcription Pathway 1169 9.09e-19 2.72e-16 0.156000 1.53e-01 -2.97e-02 1.33e-18 8.75e-02
GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ASSEMBLY 5 8.45e-01 9.36e-01 0.155000 -1.15e-01 -1.05e-01 6.57e-01 6.84e-01
GOMF LIGAND GATED MONOATOMIC CATION CHANNEL ACTIVITY 134 7.07e-03 6.14e-02 0.155000 -1.54e-01 2.13e-02 2.08e-03 6.71e-01
GOBP RNA CATABOLIC PROCESS 382 9.93e-07 3.76e-05 0.155000 1.55e-01 -1.04e-02 1.92e-07 7.27e-01
RNA Polymerase III Transcription Initiation From Type 2 Promoter 27 3.59e-01 6.47e-01 0.155000 4.88e-02 -1.48e-01 6.61e-01 1.84e-01
GOBP REGULATION OF SPINDLE ASSEMBLY 31 3.12e-01 6.06e-01 0.155000 3.51e-02 -1.51e-01 7.35e-01 1.45e-01
GOBP POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 36 2.71e-01 5.68e-01 0.155000 1.55e-01 1.91e-03 1.07e-01 9.84e-01
GOBP MULTICELLULAR ORGANISMAL MOVEMENT 59 1.21e-01 3.79e-01 0.155000 1.64e-02 1.55e-01 8.28e-01 4.00e-02
GOCC INTEGRIN COMPLEX 30 3.53e-01 6.43e-01 0.155000 1.46e-01 5.27e-02 1.66e-01 6.18e-01
GOBP DNA MODIFICATION 43 2.25e-01 5.21e-01 0.155000 1.47e-01 5.05e-02 9.54e-02 5.67e-01
GOCC PROXIMAL DENDRITE 6 8.04e-01 9.20e-01 0.155000 -1.55e-01 1.10e-03 5.10e-01 9.96e-01
NFE2L2 regulates pentose phosphate pathway genes 7 7.90e-01 9.14e-01 0.155000 1.00e-01 1.19e-01 6.45e-01 5.87e-01
GOBP CELLULAR RESPONSE TO MINERALOCORTICOID STIMULUS 12 6.44e-01 8.42e-01 0.155000 1.55e-01 -1.02e-02 3.52e-01 9.51e-01
GOBP REGULATION OF FATTY ACID TRANSPORT 33 2.87e-01 5.84e-01 0.155000 1.48e-01 -4.61e-02 1.40e-01 6.47e-01
GOBP TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY 17 5.40e-01 7.79e-01 0.155000 -4.10e-03 -1.55e-01 9.77e-01 2.68e-01
GOBP NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS 15 5.99e-01 8.15e-01 0.155000 1.39e-01 7.02e-02 3.53e-01 6.38e-01
GOBP ACTIN FILAMENT DEPOLYMERIZATION 58 1.24e-01 3.84e-01 0.155000 1.55e-01 6.81e-03 4.10e-02 9.29e-01
GOMF GLUCURONOSYL N ACETYLGALACTOSAMINYL PROTEOGLYCAN 4 BETA N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY 6 7.98e-01 9.17e-01 0.155000 -3.71e-02 1.51e-01 8.75e-01 5.23e-01
GOBP MAMMARY GLAND EPITHELIUM DEVELOPMENT 68 8.14e-02 3.04e-01 0.155000 1.54e-01 -1.94e-02 2.81e-02 7.82e-01
GOBP REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 87 4.32e-02 2.07e-01 0.155000 -1.41e-03 -1.55e-01 9.82e-01 1.24e-02
GOBP RESPONSE TO INTERFERON ALPHA 17 5.29e-01 7.71e-01 0.155000 3.63e-02 -1.51e-01 7.96e-01 2.82e-01
GOCC EGG COAT 5 8.37e-01 9.32e-01 0.155000 -1.84e-02 -1.54e-01 9.43e-01 5.51e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION 54 1.42e-01 4.14e-01 0.155000 -2.15e-03 -1.55e-01 9.78e-01 4.87e-02
GOBP DOPAMINE METABOLIC PROCESS 35 2.86e-01 5.83e-01 0.155000 1.00e-02 1.55e-01 9.18e-01 1.13e-01
Metabolism of cofactors 25 3.96e-01 6.78e-01 0.155000 2.69e-02 -1.53e-01 8.16e-01 1.87e-01
GOBP GANGLIOSIDE BIOSYNTHETIC PROCESS 17 5.57e-01 7.89e-01 0.155000 1.46e-01 5.29e-02 2.99e-01 7.06e-01
GOBP CENTRAL NERVOUS SYSTEM MATURATION 6 7.97e-01 9.17e-01 0.155000 1.46e-01 -5.07e-02 5.35e-01 8.30e-01
GOMF MONOSACCHARIDE BINDING 72 6.72e-02 2.70e-01 0.155000 -4.43e-02 1.48e-01 5.16e-01 2.94e-02
Mitochondrial protein degradation 86 3.85e-02 1.93e-01 0.155000 5.84e-02 -1.43e-01 3.49e-01 2.15e-02
Nuclear Receptor transcription pathway 51 1.65e-01 4.49e-01 0.155000 1.53e-01 2.35e-02 5.86e-02 7.72e-01
GOBP NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVITY 23 4.12e-01 6.93e-01 0.155000 1.28e-01 -8.73e-02 2.88e-01 4.69e-01
GOBP ELECTRON TRANSPORT CHAIN 114 1.28e-02 9.36e-02 0.155000 7.77e-02 -1.34e-01 1.52e-01 1.35e-02
GOBP POLYOL CATABOLIC PROCESS 9 7.39e-01 8.87e-01 0.155000 -1.28e-01 -8.67e-02 5.06e-01 6.52e-01
GOBP MATURE B CELL DIFFERENTIATION 34 3.21e-01 6.12e-01 0.155000 1.13e-01 1.06e-01 2.53e-01 2.87e-01
GOBP GLANDULAR EPITHELIAL CELL DIFFERENTIATION 71 8.37e-02 3.10e-01 0.155000 1.51e-01 3.15e-02 2.73e-02 6.46e-01
GOBP REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION 17 5.19e-01 7.63e-01 0.155000 -1.26e-01 8.94e-02 3.67e-01 5.24e-01
GOBP EXPLORATION BEHAVIOR 32 3.21e-01 6.12e-01 0.155000 1.54e-01 1.50e-02 1.32e-01 8.83e-01
Regulation of HSF1-mediated heat shock response 80 4.57e-02 2.14e-01 0.155000 1.11e-01 -1.07e-01 8.54e-02 9.68e-02
GOCC OXOGLUTARATE DEHYDROGENASE COMPLEX 10 6.96e-01 8.68e-01 0.155000 1.54e-01 -6.41e-03 3.98e-01 9.72e-01
GOMF CARBOHYDRATE PHOSPHATASE ACTIVITY 9 7.38e-01 8.87e-01 0.155000 8.02e-02 1.32e-01 6.77e-01 4.92e-01
GOMF ACID AMINO ACID LIGASE ACTIVITY 23 4.62e-01 7.25e-01 0.155000 -8.36e-02 -1.30e-01 4.88e-01 2.80e-01
GOBP POSITIVE REGULATION OF TRANSLATION 119 1.06e-02 8.23e-02 0.155000 1.31e-01 -8.28e-02 1.39e-02 1.19e-01
Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways 53 1.30e-01 3.94e-01 0.155000 9.24e-02 -1.24e-01 2.45e-01 1.19e-01
Gene expression (Transcription) 1503 2.68e-23 1.14e-20 0.155000 1.51e-01 -3.08e-02 8.87e-23 4.62e-02
GOCC PHAGOCYTIC VESICLE MEMBRANE 73 6.10e-02 2.54e-01 0.155000 8.59e-02 -1.28e-01 2.04e-01 5.78e-02
GOBP POSITIVE REGULATION OF VIRAL PROCESS 62 9.97e-02 3.39e-01 0.155000 1.50e-01 -3.89e-02 4.17e-02 5.96e-01
GOBP ALDITOL METABOLIC PROCESS 22 4.74e-01 7.34e-01 0.154000 -1.39e-01 -6.64e-02 2.57e-01 5.90e-01
GOBP GLIAL CELL DIFFERENTIATION 256 1.15e-04 2.44e-03 0.154000 1.54e-01 4.49e-03 2.10e-05 9.02e-01
GOBP NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION 26 3.73e-01 6.59e-01 0.154000 1.39e-01 -6.65e-02 2.19e-01 5.57e-01
GOBP POSITIVE REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION 10 6.81e-01 8.62e-01 0.154000 1.25e-01 -9.01e-02 4.92e-01 6.22e-01
GOBP DETERMINATION OF ADULT LIFESPAN 35 2.79e-01 5.76e-01 0.154000 1.53e-01 -1.87e-02 1.17e-01 8.48e-01
GOCC NUCLEAR OUTER MEMBRANE 28 3.66e-01 6.53e-01 0.154000 -2.62e-03 1.54e-01 9.81e-01 1.58e-01
GOBP REGULATION OF GLUCONEOGENESIS 50 1.75e-01 4.62e-01 0.154000 2.94e-02 1.51e-01 7.19e-01 6.40e-02
GOBP PHOSPHATIDIC ACID METABOLIC PROCESS 36 2.95e-01 5.92e-01 0.154000 1.43e-01 5.88e-02 1.39e-01 5.41e-01
GOCC INTERSTITIAL MATRIX 11 6.61e-01 8.51e-01 0.154000 -5.60e-02 1.44e-01 7.48e-01 4.09e-01
GOCC PRESYNAPTIC CYTOSOL 12 6.37e-01 8.38e-01 0.154000 1.43e-01 -5.73e-02 3.91e-01 7.31e-01
GOBP POSITIVE REGULATION OF SYNAPTIC VESICLE RECYCLING 8 7.37e-01 8.87e-01 0.154000 -7.82e-02 1.33e-01 7.02e-01 5.16e-01
GOBP CATECHOLAMINE UPTAKE 18 5.03e-01 7.55e-01 0.154000 8.66e-02 -1.27e-01 5.25e-01 3.49e-01
GOBP NEGATIVE REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 14 5.91e-01 8.10e-01 0.154000 1.43e-01 -5.82e-02 3.55e-01 7.06e-01
GOBP RECEPTOR MEDIATED ENDOCYTOSIS OF VIRUS BY HOST CELL 10 6.98e-01 8.70e-01 0.154000 -3.84e-03 1.54e-01 9.83e-01 3.99e-01
GOCC SPERM CONNECTING PIECE 11 6.78e-01 8.60e-01 0.154000 1.54e-01 1.25e-02 3.78e-01 9.43e-01
GOBP METANEPHRIC NEPHRON TUBULE MORPHOGENESIS 8 7.38e-01 8.87e-01 0.154000 -7.15e-02 1.36e-01 7.26e-01 5.04e-01
GOBP DNA UNWINDING INVOLVED IN DNA REPLICATION 21 4.47e-01 7.17e-01 0.154000 1.13e-01 -1.05e-01 3.72e-01 4.05e-01
GOBP POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 84 6.24e-02 2.58e-01 0.154000 1.02e-01 1.16e-01 1.08e-01 6.67e-02
GOMF MHC PROTEIN COMPLEX BINDING 34 3.19e-01 6.11e-01 0.154000 -6.95e-02 -1.37e-01 4.83e-01 1.66e-01
GOMF CILIARY NEUROTROPHIC FACTOR RECEPTOR BINDING 6 8.20e-01 9.27e-01 0.154000 1.01e-01 1.16e-01 6.69e-01 6.21e-01
APC/C:Cdc20 mediated degradation of Cyclin B 24 4.11e-01 6.92e-01 0.154000 4.04e-02 -1.49e-01 7.32e-01 2.08e-01
GOBP EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 110 2.07e-02 1.29e-01 0.154000 1.54e-01 8.77e-03 5.35e-03 8.74e-01
GOCC ENDOCYTIC VESICLE LUMEN 23 4.53e-01 7.21e-01 0.154000 -1.49e-01 -3.86e-02 2.16e-01 7.49e-01
GOBP GOLGI TO LYSOSOME TRANSPORT 12 6.36e-01 8.38e-01 0.154000 1.39e-01 -6.54e-02 4.03e-01 6.95e-01
GOBP POSITIVE REGULATION OF DNA CATABOLIC PROCESS 5 8.29e-01 9.30e-01 0.154000 5.98e-02 -1.42e-01 8.17e-01 5.83e-01
GOBP VESICLE BUDDING FROM MEMBRANE 84 4.85e-02 2.22e-01 0.154000 1.53e-01 -1.35e-02 1.52e-02 8.30e-01
GOMF KINASE INHIBITOR ACTIVITY 79 4.92e-02 2.23e-01 0.154000 9.92e-02 -1.18e-01 1.27e-01 7.10e-02
GOBP RESPIRATORY SYSTEM DEVELOPMENT 217 4.85e-04 7.68e-03 0.154000 1.54e-01 4.77e-03 9.49e-05 9.04e-01
GOBP FLAVONE METABOLIC PROCESS 6 8.00e-01 9.18e-01 0.154000 4.70e-02 -1.46e-01 8.42e-01 5.35e-01
GOBP MACROPHAGE APOPTOTIC PROCESS 14 5.90e-01 8.09e-01 0.154000 1.38e-01 -6.72e-02 3.70e-01 6.63e-01
GOCC BRUSH BORDER MEMBRANE 57 1.20e-01 3.77e-01 0.154000 -5.03e-02 1.45e-01 5.11e-01 5.78e-02
GOBP RRNA PROCESSING 212 3.41e-04 5.78e-03 0.154000 8.20e-02 -1.30e-01 3.95e-02 1.10e-03
GOBP RESPONSE TO PROGESTERONE 44 1.87e-01 4.78e-01 0.154000 1.23e-01 -9.26e-02 1.59e-01 2.88e-01
GOMF ORGANOPHOSPHATE ESTER TRANSMEMBRANE TRANSPORTER ACTIVITY 35 2.85e-01 5.82e-01 0.154000 -9.80e-03 1.53e-01 9.20e-01 1.16e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE 63 1.13e-01 3.64e-01 0.154000 1.52e-01 2.56e-02 3.75e-02 7.25e-01
GOBP NEGATIVE REGULATION OF MRNA METABOLIC PROCESS 91 3.35e-02 1.78e-01 0.154000 1.41e-01 -6.05e-02 1.99e-02 3.19e-01
GOBP POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT 32 2.97e-01 5.94e-01 0.154000 8.84e-02 -1.26e-01 3.87e-01 2.19e-01
GOMF SERINE TYPE EXOPEPTIDASE ACTIVITY 12 6.49e-01 8.45e-01 0.154000 1.53e-01 -1.27e-02 3.59e-01 9.39e-01
GOMF MONOATOMIC CATION CHANNEL ACTIVITY 326 8.25e-06 2.44e-04 0.154000 -1.51e-01 2.57e-02 2.59e-06 4.25e-01
GOBP POSITIVE REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 7 7.89e-01 9.14e-01 0.154000 1.44e-01 5.25e-02 5.09e-01 8.10e-01
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY 309 9.97e-06 2.88e-04 0.154000 1.34e-01 -7.53e-02 5.23e-05 2.27e-02
GOMF ESTROGEN 2 HYDROXYLASE ACTIVITY 5 8.40e-01 9.33e-01 0.154000 1.98e-02 1.52e-01 9.39e-01 5.56e-01
GOBP REGULATION OF GTPASE ACTIVITY 249 2.37e-04 4.33e-03 0.153000 1.45e-01 5.05e-02 8.17e-05 1.70e-01
GOBP QUINOLINATE METABOLIC PROCESS 5 8.31e-01 9.30e-01 0.153000 -4.78e-02 1.46e-01 8.53e-01 5.72e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX CATALYTIC DOMAIN 19 4.88e-01 7.46e-01 0.153000 1.31e-01 -7.94e-02 3.22e-01 5.49e-01
GOBP HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS 14 5.88e-01 8.07e-01 0.153000 9.16e-02 -1.23e-01 5.53e-01 4.25e-01
GOBP RESPONSE TO MAGNESIUM ION 20 5.11e-01 7.60e-01 0.153000 1.42e-01 5.91e-02 2.73e-01 6.47e-01
GOCC HETEROCHROMATIN 77 5.84e-02 2.48e-01 0.153000 1.46e-01 -4.71e-02 2.67e-02 4.75e-01
GOBP REGULATION OF CALCIUM ION IMPORT ACROSS PLASMA MEMBRANE 14 6.23e-01 8.30e-01 0.153000 -1.44e-01 -5.34e-02 3.52e-01 7.29e-01
Regulation of commissural axon pathfinding by SLIT and ROBO 10 7.13e-01 8.76e-01 0.153000 -5.04e-02 -1.45e-01 7.83e-01 4.28e-01
GOCC TRANSCRIPTION ELONGATION FACTOR COMPLEX 51 1.88e-01 4.79e-01 0.153000 1.10e-01 1.07e-01 1.76e-01 1.85e-01
GOBP AEROBIC RESPIRATION 169 2.12e-03 2.46e-02 0.153000 3.80e-02 -1.49e-01 3.94e-01 8.62e-04
GOMF CATALYTIC ACTIVITY ACTING ON A GLYCOPROTEIN 22 4.39e-01 7.12e-01 0.153000 -6.70e-02 1.38e-01 5.87e-01 2.63e-01
GOBP REGULATION OF TRANSLATION IN RESPONSE TO STRESS 20 4.75e-01 7.34e-01 0.153000 1.41e-01 -5.98e-02 2.75e-01 6.43e-01
GOBP DORSAL AORTA DEVELOPMENT 10 7.20e-01 8.79e-01 0.153000 1.19e-01 9.63e-02 5.14e-01 5.98e-01
GOCC FILAMENTOUS ACTIN 32 3.24e-01 6.15e-01 0.153000 1.53e-01 2.30e-03 1.34e-01 9.82e-01
GOBP POSITIVE REGULATION OF RNA EXPORT FROM NUCLEUS 5 8.44e-01 9.36e-01 0.153000 4.58e-02 1.46e-01 8.59e-01 5.71e-01
GOMF ENZYME ACTIVATOR ACTIVITY 565 2.30e-09 1.59e-07 0.153000 1.52e-01 -2.13e-02 6.96e-10 3.87e-01
GOBP NEUROMUSCULAR PROCESS CONTROLLING BALANCE 52 1.71e-01 4.57e-01 0.153000 1.47e-01 4.15e-02 6.59e-02 6.05e-01
GOBP REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 30 3.37e-01 6.27e-01 0.153000 1.51e-01 -2.75e-02 1.53e-01 7.94e-01
Cristae formation 29 3.42e-01 6.32e-01 0.153000 5.34e-02 -1.44e-01 6.19e-01 1.81e-01
GOBP G PROTEIN COUPLED RECEPTOR INTERNALIZATION 10 7.19e-01 8.79e-01 0.153000 8.43e-02 1.28e-01 6.44e-01 4.84e-01
GOBP CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS 42 2.53e-01 5.50e-01 0.153000 1.18e-01 9.75e-02 1.86e-01 2.74e-01
GOBP UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS 9 7.16e-01 8.78e-01 0.153000 -1.42e-01 5.78e-02 4.62e-01 7.64e-01
GOBP EXTRINSIC APOPTOTIC SIGNALING PATHWAY 222 2.61e-04 4.66e-03 0.153000 1.33e-01 -7.51e-02 6.15e-04 5.40e-02
GOBP COCHLEA MORPHOGENESIS 23 4.20e-01 6.99e-01 0.153000 9.10e-02 -1.23e-01 4.50e-01 3.07e-01
GOBP FATTY ACID BETA OXIDATION 73 9.25e-02 3.26e-01 0.153000 1.06e-01 1.10e-01 1.17e-01 1.03e-01
RNA Polymerase III Transcription Initiation From Type 1 Promoter 28 3.53e-01 6.43e-01 0.153000 6.22e-02 -1.40e-01 5.69e-01 2.00e-01
GOBP NEURON MIGRATION 173 1.69e-03 2.07e-02 0.153000 1.41e-01 -6.05e-02 1.43e-03 1.70e-01
Suppression of apoptosis 7 7.81e-01 9.10e-01 0.153000 1.53e-01 -2.43e-03 4.83e-01 9.91e-01
GOMF CALCIUM SODIUM ANTIPORTER ACTIVITY 10 6.87e-01 8.64e-01 0.153000 -1.30e-01 8.10e-02 4.77e-01 6.58e-01
GOBP REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES 10 7.16e-01 8.77e-01 0.153000 -1.41e-01 -5.88e-02 4.39e-01 7.48e-01
GOBP MAINTENANCE OF POSTSYNAPTIC SPECIALIZATION STRUCTURE 8 7.69e-01 9.03e-01 0.153000 9.15e-02 1.23e-01 6.54e-01 5.48e-01
GOBP MAST CELL CHEMOTAXIS 11 6.63e-01 8.51e-01 0.153000 -7.21e-02 1.35e-01 6.79e-01 4.38e-01
GOBP REGULATION OF ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME 52 1.43e-01 4.15e-01 0.153000 1.34e-01 -7.43e-02 9.55e-02 3.54e-01
GOBP AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 67 8.75e-02 3.16e-01 0.153000 1.48e-01 -3.68e-02 3.56e-02 6.02e-01
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA 5 8.35e-01 9.31e-01 0.153000 1.51e-01 -2.33e-02 5.58e-01 9.28e-01
GOBP THYMOCYTE APOPTOTIC PROCESS 19 5.17e-01 7.63e-01 0.153000 -1.49e-02 -1.52e-01 9.11e-01 2.51e-01
Aberrant regulation of mitotic exit in cancer due to RB1 defects 20 5.04e-01 7.56e-01 0.153000 1.50e-01 2.71e-02 2.44e-01 8.34e-01
GOBP POSITIVE REGULATION OF CATABOLIC PROCESS 601 1.83e-09 1.28e-07 0.153000 1.51e-01 2.50e-02 2.68e-10 2.96e-01
GOBP VESICLE UNCOATING 9 7.12e-01 8.76e-01 0.153000 -1.19e-01 9.59e-02 5.37e-01 6.18e-01
GOMF PSEUDOURIDINE SYNTHASE ACTIVITY 12 6.69e-01 8.55e-01 0.153000 -5.36e-02 -1.43e-01 7.48e-01 3.91e-01
GOBP CYTOSOLIC RIBOSOME ASSEMBLY 8 7.40e-01 8.88e-01 0.153000 1.25e-01 -8.75e-02 5.40e-01 6.68e-01
Regulation of signaling by NODAL 9 7.17e-01 8.78e-01 0.153000 1.41e-01 -5.88e-02 4.64e-01 7.60e-01
GOMF NITRIC OXIDE SYNTHASE REGULATOR ACTIVITY 7 7.70e-01 9.03e-01 0.153000 7.38e-02 -1.34e-01 7.35e-01 5.40e-01
GOBP TYPE B PANCREATIC CELL DEVELOPMENT 24 4.45e-01 7.16e-01 0.153000 1.47e-01 4.22e-02 2.13e-01 7.20e-01
GOBP PROTEIN NITROSYLATION 15 5.97e-01 8.14e-01 0.153000 -1.51e-01 -2.07e-02 3.10e-01 8.90e-01
GOBP POSITIVE REGULATION OF MITOTIC CYTOKINESIS 13 6.51e-01 8.46e-01 0.153000 7.31e-02 1.34e-01 6.48e-01 4.03e-01
GOBP NEGATIVE REGULATION OF PROTEIN POLYMERIZATION 74 7.71e-02 2.93e-01 0.153000 1.52e-01 1.20e-02 2.36e-02 8.58e-01
Amine ligand-binding receptors 40 2.64e-01 5.60e-01 0.153000 5.58e-02 1.42e-01 5.41e-01 1.20e-01
GOBP IN UTERO EMBRYONIC DEVELOPMENT 389 9.41e-07 3.62e-05 0.153000 1.48e-01 -3.55e-02 4.98e-07 2.29e-01
GOBP HEART TRABECULA MORPHOGENESIS 32 3.03e-01 5.97e-01 0.153000 1.32e-01 -7.67e-02 1.96e-01 4.53e-01
GOBP REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 41 2.22e-01 5.17e-01 0.153000 1.43e-01 -5.31e-02 1.13e-01 5.56e-01
GOCC CENTRIOLE 155 4.88e-03 4.66e-02 0.153000 1.52e-01 1.59e-02 1.11e-03 7.33e-01
GOMF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 156 3.12e-03 3.29e-02 0.153000 -1.34e-01 7.29e-02 3.88e-03 1.16e-01
GOCC POSTSYNAPTIC DENSITY MEMBRANE 97 3.62e-02 1.87e-01 0.153000 -1.51e-01 -2.12e-02 1.01e-02 7.18e-01
GOBP POSITIVE REGULATION OF PLATELET AGGREGATION 12 6.45e-01 8.42e-01 0.153000 -1.45e-01 4.59e-02 3.83e-01 7.83e-01
GOBP ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 998 1.10e-14 1.91e-12 0.152000 1.46e-01 4.25e-02 4.71e-15 2.32e-02
Regulation of localization of FOXO transcription factors 11 6.89e-01 8.65e-01 0.152000 3.48e-02 1.48e-01 8.42e-01 3.94e-01
GOMF GLUTATHIONE PEROXIDASE ACTIVITY 21 4.99e-01 7.53e-01 0.152000 1.39e-01 6.28e-02 2.70e-01 6.18e-01
GOMF CALCIUM SENSITIVE GUANYLATE CYCLASE ACTIVATOR ACTIVITY 5 8.49e-01 9.37e-01 0.152000 -8.68e-02 -1.25e-01 7.37e-01 6.27e-01
GOBP AMINO ACID TRANSPORT 150 7.89e-03 6.64e-02 0.152000 1.14e-01 1.01e-01 1.61e-02 3.21e-02
TNFR2 non-canonical NF-kB pathway 83 4.46e-02 2.11e-01 0.152000 1.01e-01 -1.14e-01 1.11e-01 7.27e-02
GOMF PHOSPHATIDYLINOSITOL 3 KINASE BINDING 25 4.05e-01 6.87e-01 0.152000 1.48e-01 -3.55e-02 2.00e-01 7.59e-01
Displacement of DNA glycosylase by APEX1 9 7.24e-01 8.81e-01 0.152000 -1.50e-01 2.78e-02 4.36e-01 8.85e-01
GOBP MDA 5 SIGNALING PATHWAY 10 7.04e-01 8.72e-01 0.152000 1.52e-01 -1.52e-03 4.04e-01 9.93e-01
GOBP CELL CYCLE PHASE TRANSITION 539 4.86e-09 3.12e-07 0.152000 1.46e-01 -4.24e-02 6.11e-09 9.21e-02
GOBP NEGATIVE REGULATION OF CELL CYCLE PROCESS 304 1.39e-05 3.85e-04 0.152000 1.30e-01 -7.89e-02 9.24e-05 1.80e-02
GOBP PIGMENT ACCUMULATION 11 6.63e-01 8.51e-01 0.152000 8.27e-02 -1.28e-01 6.35e-01 4.63e-01
GOMF SINGLE STRANDED DNA 5 3 DNA EXONUCLEASE ACTIVITY 5 8.50e-01 9.38e-01 0.152000 9.14e-02 1.22e-01 7.24e-01 6.37e-01
GOBP POSITIVE REGULATION OF SYNAPSE MATURATION 8 7.42e-01 8.89e-01 0.152000 -1.26e-01 8.59e-02 5.38e-01 6.74e-01
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 150 3.85e-03 3.86e-02 0.152000 1.27e-01 -8.45e-02 7.41e-03 7.41e-02
GOBP CYCLIC NUCLEOTIDE METABOLIC PROCESS 40 2.70e-01 5.67e-01 0.152000 7.47e-02 1.33e-01 4.14e-01 1.47e-01
GOBP REGULATION OF CHOLESTEROL EFFLUX 54 1.70e-01 4.55e-01 0.152000 6.63e-02 1.37e-01 3.99e-01 8.15e-02
Asymmetric localization of PCP proteins 51 1.52e-01 4.30e-01 0.152000 7.29e-02 -1.34e-01 3.68e-01 9.89e-02
GOBP REGULATION OF CELL CYCLE PHASE TRANSITION 441 1.74e-07 8.27e-06 0.152000 1.48e-01 -3.34e-02 9.06e-08 2.29e-01
GOCC GOLGI CISTERNA 98 4.26e-02 2.05e-01 0.152000 1.01e-01 1.13e-01 8.32e-02 5.22e-02
GOBP COPII COATED VESICLE BUDDING 43 2.08e-01 5.03e-01 0.152000 1.42e-01 -5.40e-02 1.07e-01 5.40e-01
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 13 6.15e-01 8.26e-01 0.152000 -1.06e-01 1.10e-01 5.10e-01 4.94e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH SYMBIONT 110 2.76e-02 1.59e-01 0.152000 -1.35e-01 -6.96e-02 1.43e-02 2.07e-01
GOBP CHONDROCYTE PROLIFERATION 25 3.98e-01 6.80e-01 0.152000 1.37e-01 -6.68e-02 2.37e-01 5.63e-01
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 29 3.92e-01 6.75e-01 0.152000 9.49e-02 1.19e-01 3.77e-01 2.68e-01
Synthesis of Prostaglandins (PG) and Thromboxanes (TX) 15 5.71e-01 7.98e-01 0.152000 -1.17e-01 9.66e-02 4.31e-01 5.17e-01
GOMF AROMATASE ACTIVITY 26 3.81e-01 6.66e-01 0.152000 8.60e-02 -1.25e-01 4.48e-01 2.69e-01
GOMF LIPID KINASE ACTIVITY 40 2.56e-01 5.53e-01 0.152000 1.50e-01 2.07e-02 9.96e-02 8.21e-01
GOBP NEGATIVE REGULATION OF ACTIN NUCLEATION 9 7.28e-01 8.83e-01 0.152000 1.51e-01 -1.44e-02 4.32e-01 9.40e-01
Interleukin-6 family signaling 24 4.29e-01 7.06e-01 0.152000 1.51e-01 -1.63e-02 2.00e-01 8.90e-01
Transcriptional regulation of white adipocyte differentiation 81 5.16e-02 2.30e-01 0.152000 1.37e-01 -6.44e-02 3.24e-02 3.16e-01
GOBP SEBACEOUS GLAND DEVELOPMENT 10 6.91e-01 8.66e-01 0.152000 1.29e-01 -8.00e-02 4.80e-01 6.61e-01
Synthesis of DNA 107 1.88e-02 1.22e-01 0.152000 1.03e-01 -1.11e-01 6.48e-02 4.68e-02
GOBP ERYTHROCYTE HOMEOSTASIS 139 6.00e-03 5.39e-02 0.152000 1.29e-01 -8.02e-02 8.69e-03 1.03e-01
GOBP CELLULAR RESPONSE TO STRESS 1768 3.02e-26 1.43e-23 0.152000 1.46e-01 -4.06e-02 1.54e-24 4.57e-03
GOBP REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY 6 8.24e-01 9.28e-01 0.152000 9.28e-02 1.20e-01 6.94e-01 6.10e-01
IKK complex recruitment mediated by RIP1 22 4.48e-01 7.17e-01 0.152000 5.93e-02 -1.40e-01 6.30e-01 2.57e-01
NOTCH2 Activation and Transmission of Signal to the Nucleus 22 4.44e-01 7.16e-01 0.152000 1.31e-01 -7.64e-02 2.87e-01 5.35e-01
GOBP REGULATION OF MRNA PROCESSING 121 1.24e-02 9.12e-02 0.152000 1.40e-01 -5.79e-02 7.71e-03 2.72e-01
APC/C-mediated degradation of cell cycle proteins 75 6.75e-02 2.71e-01 0.152000 4.29e-02 -1.45e-01 5.20e-01 2.94e-02
Regulation of mitotic cell cycle 75 6.75e-02 2.71e-01 0.152000 4.29e-02 -1.45e-01 5.20e-01 2.94e-02
GOBP GERMINAL CENTER FORMATION 14 6.19e-01 8.27e-01 0.152000 1.51e-01 1.27e-02 3.28e-01 9.34e-01
Platelet Aggregation (Plug Formation) 39 2.61e-01 5.58e-01 0.152000 1.52e-01 4.47e-03 1.02e-01 9.61e-01
GOMF HSP90 PROTEIN BINDING 40 2.37e-01 5.33e-01 0.152000 1.45e-01 -4.41e-02 1.12e-01 6.29e-01
GOBP FILOPODIUM ASSEMBLY 64 1.26e-01 3.87e-01 0.152000 1.30e-01 7.74e-02 7.14e-02 2.84e-01
GOCC INCLUSION BODY 70 8.54e-02 3.13e-01 0.152000 1.50e-01 -1.87e-02 2.96e-02 7.87e-01
GOBP G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER 54 1.48e-01 4.25e-01 0.152000 -2.36e-02 1.50e-01 7.64e-01 5.71e-02
GOBP EMBRYONIC PATTERN SPECIFICATION 69 9.63e-02 3.32e-01 0.152000 1.50e-01 1.76e-02 3.07e-02 8.01e-01
GOBP NEGATIVE REGULATION OF RECEPTOR BINDING 12 6.65e-01 8.52e-01 0.151000 1.51e-01 1.62e-02 3.66e-01 9.22e-01
GOBP RESPONSE TO COLD 42 2.22e-01 5.18e-01 0.151000 1.46e-01 -3.97e-02 1.01e-01 6.56e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS 37 2.57e-01 5.54e-01 0.151000 1.31e-01 -7.54e-02 1.67e-01 4.28e-01
GOBP REGULATION OF COA TRANSFERASE ACTIVITY 10 6.98e-01 8.70e-01 0.151000 1.46e-01 -4.11e-02 4.25e-01 8.22e-01
GOBP CELLULAR RESPONSE TO ACIDIC PH 14 6.00e-01 8.16e-01 0.151000 -6.32e-02 1.38e-01 6.82e-01 3.73e-01
GOCC RNA POLYMERASE COMPLEX 96 2.91e-02 1.63e-01 0.151000 1.19e-01 -9.31e-02 4.32e-02 1.15e-01
GOMF NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY 12 6.71e-01 8.57e-01 0.151000 4.02e-02 1.46e-01 8.10e-01 3.81e-01
GOBP NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 232 2.00e-04 3.77e-03 0.151000 1.05e-01 -1.09e-01 5.96e-03 4.15e-03
GOBP FRUCTOSE 1 6 BISPHOSPHATE METABOLIC PROCESS 9 7.48e-01 8.91e-01 0.151000 8.01e-02 1.28e-01 6.77e-01 5.05e-01
GOBP RIBOSOME BIOGENESIS 298 2.21e-05 5.79e-04 0.151000 6.33e-02 -1.37e-01 6.00e-02 4.47e-05
GOMF RNA POLYMERASE II GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY 36 2.65e-01 5.61e-01 0.151000 9.00e-02 -1.22e-01 3.50e-01 2.06e-01
GOBP MITOTIC CELL CYCLE PHASE TRANSITION 441 2.18e-07 1.01e-05 0.151000 1.49e-01 -2.88e-02 8.78e-08 3.00e-01
GOMF PEPTIDE HORMONE BINDING 48 1.86e-01 4.76e-01 0.151000 1.50e-01 -1.89e-02 7.20e-02 8.21e-01
GOBP TOOTH MINERALIZATION 30 3.48e-01 6.38e-01 0.151000 1.50e-01 -2.12e-02 1.56e-01 8.41e-01
N-glycan trimming and elongation in the cis-Golgi 5 8.35e-01 9.31e-01 0.151000 1.44e-01 -4.55e-02 5.76e-01 8.60e-01
GOMF ALCOHOL DEHYDROGENASE NADPPLUS ACTIVITY 23 4.72e-01 7.32e-01 0.151000 1.40e-01 5.78e-02 2.46e-01 6.32e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO GROUP OF DONORS 47 2.23e-01 5.18e-01 0.151000 1.20e-01 9.23e-02 1.56e-01 2.73e-01
GOBP LOW DENSITY LIPOPROTEIN PARTICLE REMODELING 16 5.94e-01 8.12e-01 0.151000 1.38e-01 6.10e-02 3.38e-01 6.73e-01
GOBP NEURON MATURATION 46 2.13e-01 5.08e-01 0.151000 1.49e-01 2.45e-02 8.00e-02 7.74e-01
GOCC PHOTORECEPTOR INNER SEGMENT 69 7.95e-02 2.99e-01 0.151000 -1.25e-01 8.48e-02 7.23e-02 2.23e-01
Signaling by Retinoic Acid 39 2.57e-01 5.54e-01 0.151000 1.51e-01 -1.36e-02 1.04e-01 8.83e-01
GOBP SKELETAL SYSTEM MORPHOGENESIS 226 5.15e-04 8.04e-03 0.151000 1.50e-01 1.78e-02 1.01e-04 6.45e-01
GOBP RESPONSE TO BLUE LIGHT 6 8.26e-01 9.28e-01 0.151000 -9.68e-02 -1.16e-01 6.81e-01 6.23e-01
GOBP STRIATED MUSCLE CELL DIFFERENTIATION 305 6.78e-05 1.55e-03 0.151000 1.11e-01 1.03e-01 8.66e-04 2.05e-03
GOBP MITOTIC DNA INTEGRITY CHECKPOINT SIGNALING 85 4.44e-02 2.11e-01 0.151000 1.24e-01 -8.60e-02 4.78e-02 1.71e-01
Fanconi Anemia Pathway 34 3.10e-01 6.04e-01 0.151000 1.51e-01 -2.23e-03 1.28e-01 9.82e-01
Propionyl-CoA catabolism 5 8.52e-01 9.38e-01 0.151000 -7.88e-02 -1.29e-01 7.60e-01 6.18e-01
GOBP REGULATION OF PLASMA CELL DIFFERENTIATION 6 8.25e-01 9.28e-01 0.151000 -8.00e-02 -1.28e-01 7.34e-01 5.87e-01
GOBP ARTERY MORPHOGENESIS 82 5.57e-02 2.42e-01 0.151000 1.48e-01 -2.94e-02 2.04e-02 6.45e-01
GOBP LONG CHAIN FATTY ACID IMPORT ACROSS PLASMA MEMBRANE 10 6.94e-01 8.68e-01 0.151000 -7.50e-02 1.31e-01 6.81e-01 4.73e-01
GOBP REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY 23 4.76e-01 7.36e-01 0.151000 1.33e-01 7.12e-02 2.69e-01 5.55e-01
GOBP PROTEIN K48 LINKED UBIQUITINATION 98 3.68e-02 1.89e-01 0.151000 1.50e-01 1.58e-02 1.02e-02 7.87e-01
GOMF XENOBIOTIC TRANSMEMBRANE TRANSPORTER ACTIVITY 32 3.08e-01 6.01e-01 0.151000 -1.01e-01 1.12e-01 3.23e-01 2.72e-01
GOBP SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION 14 5.97e-01 8.14e-01 0.151000 9.62e-02 -1.16e-01 5.33e-01 4.51e-01
GOBP CELLULAR RESPONSE TO NITROGEN COMPOUND 626 1.61e-09 1.14e-07 0.151000 1.47e-01 3.35e-02 3.21e-10 1.52e-01
GOBP REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 46 2.32e-01 5.30e-01 0.151000 1.13e-01 1.00e-01 1.86e-01 2.40e-01
GOMF NUCLEOSIDE DIPHOSPHATE PHOSPHATASE ACTIVITY 17 5.83e-01 8.05e-01 0.151000 -1.13e-01 -1.00e-01 4.21e-01 4.75e-01
GOBP RRNA METHYLATION 23 4.30e-01 7.06e-01 0.151000 9.03e-02 -1.21e-01 4.54e-01 3.16e-01
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer’s disease models 22 4.47e-01 7.17e-01 0.151000 8.83e-02 -1.22e-01 4.73e-01 3.21e-01
Neurodegenerative Diseases 22 4.47e-01 7.17e-01 0.151000 8.83e-02 -1.22e-01 4.73e-01 3.21e-01
GOBP REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION 226 2.66e-04 4.73e-03 0.151000 1.05e-01 -1.08e-01 6.66e-03 4.97e-03
GOBP NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 58 1.47e-01 4.23e-01 0.151000 -1.47e-01 -3.46e-02 5.33e-02 6.49e-01
GOBP DEVELOPMENTAL CELL GROWTH 213 1.02e-03 1.40e-02 0.151000 1.41e-01 5.24e-02 3.77e-04 1.87e-01
GOBP CELL CELL ADHESION MEDIATED BY CADHERIN 49 1.80e-01 4.68e-01 0.151000 -1.48e-01 2.66e-02 7.24e-02 7.48e-01
GOBP MUSCLE CELL DIFFERENTIATION 417 2.05e-06 7.10e-05 0.151000 1.28e-01 7.92e-02 7.08e-06 5.50e-03
GOCC AXON CYTOPLASM 61 1.15e-01 3.68e-01 0.151000 1.45e-01 -4.06e-02 5.00e-02 5.84e-01
Platelet sensitization by LDL 17 5.49e-01 7.84e-01 0.151000 1.47e-01 -3.31e-02 2.94e-01 8.13e-01
GOBP POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING 37 2.74e-01 5.71e-01 0.151000 2.58e-02 -1.48e-01 7.86e-01 1.18e-01
GOBP REGULATION OF RESPIRATORY BURST 16 5.56e-01 7.89e-01 0.151000 -1.03e-01 1.09e-01 4.74e-01 4.49e-01
GOBP NEGATIVE REGULATION OF ORGANELLE ORGANIZATION 337 6.16e-06 1.90e-04 0.151000 1.35e-01 -6.56e-02 1.91e-05 3.84e-02
GOBP ALDITOL PHOSPHATE METABOLIC PROCESS 9 7.51e-01 8.92e-01 0.151000 1.24e-01 8.53e-02 5.20e-01 6.58e-01
GOBP POSITIVE REGULATION OF CARDIAC MUSCLE ADAPTATION 9 7.48e-01 8.92e-01 0.150000 1.36e-01 6.50e-02 4.81e-01 7.36e-01
GOBP TRANSLATION 704 2.10e-11 2.04e-09 0.150000 6.37e-02 -1.36e-01 3.96e-03 7.12e-10
GOMF R SMAD BINDING 25 4.30e-01 7.06e-01 0.150000 1.50e-01 1.08e-02 1.94e-01 9.25e-01
GOBP REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 47 2.22e-01 5.18e-01 0.150000 1.35e-01 6.68e-02 1.10e-01 4.28e-01
GOBP STRIATED MUSCLE TISSUE DEVELOPMENT 262 2.72e-04 4.81e-03 0.150000 1.24e-01 8.48e-02 5.49e-04 1.81e-02
GOBP PROTEIN LIPID COMPLEX ORGANIZATION 54 1.82e-01 4.72e-01 0.150000 9.01e-02 1.20e-01 2.52e-01 1.27e-01
GOBP RESPONSE TO AUDITORY STIMULUS 33 3.02e-01 5.97e-01 0.150000 -8.76e-02 1.22e-01 3.84e-01 2.25e-01
GOBP RETICULOPHAGY 21 4.71e-01 7.32e-01 0.150000 1.37e-01 -6.10e-02 2.76e-01 6.28e-01
GOBP REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY 13 6.55e-01 8.48e-01 0.150000 1.43e-01 4.56e-02 3.72e-01 7.76e-01
GOBP PRENYLATION 11 6.86e-01 8.64e-01 0.150000 1.08e-02 -1.50e-01 9.51e-01 3.90e-01
Vitamin B2 (riboflavin) metabolism 7 7.94e-01 9.16e-01 0.150000 3.24e-02 1.47e-01 8.82e-01 5.02e-01
GOMF PHOSPHOLIPID TRANSFER ACTIVITY 25 4.41e-01 7.13e-01 0.150000 1.46e-01 3.66e-02 2.08e-01 7.52e-01
Regulation of cholesterol biosynthesis by SREBP (SREBF) 53 1.84e-01 4.74e-01 0.150000 1.36e-01 6.44e-02 8.79e-02 4.17e-01
GOBP REGULATION OF ORGANELLE ASSEMBLY 239 3.02e-04 5.22e-03 0.150000 1.50e-01 -1.03e-02 6.71e-05 7.84e-01
GOBP GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS 39 2.77e-01 5.74e-01 0.150000 1.47e-01 2.96e-02 1.12e-01 7.49e-01
GOBP POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 26 3.97e-01 6.79e-01 0.150000 -5.49e-02 1.40e-01 6.28e-01 2.18e-01
RNA Pol II CTD phosphorylation and interaction with CE 26 3.89e-01 6.72e-01 0.150000 1.15e-01 -9.67e-02 3.12e-01 3.93e-01
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection 26 3.89e-01 6.72e-01 0.150000 1.15e-01 -9.67e-02 3.12e-01 3.93e-01
GOMF HORMONE BINDING 89 4.57e-02 2.14e-01 0.150000 1.47e-01 -2.74e-02 1.62e-02 6.55e-01
GOMF CATALYTIC ACTIVITY ACTING ON A NUCLEIC ACID 597 1.67e-09 1.17e-07 0.150000 1.47e-01 -2.69e-02 7.33e-10 2.62e-01
GOBP POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 32 3.36e-01 6.25e-01 0.150000 8.09e-03 -1.50e-01 9.37e-01 1.43e-01
GOBP CONVERGENT EXTENSION 15 5.91e-01 8.10e-01 0.150000 3.82e-02 -1.45e-01 7.98e-01 3.31e-01
GOBP VITAMIN TRANSPORT 50 1.75e-01 4.61e-01 0.150000 -3.37e-02 1.46e-01 6.81e-01 7.40e-02
TNFR1-mediated ceramide production 6 8.05e-01 9.20e-01 0.150000 9.12e-02 -1.19e-01 6.99e-01 6.14e-01
GOBP CGMP MEDIATED SIGNALING 32 3.52e-01 6.42e-01 0.150000 1.45e-01 3.68e-02 1.55e-01 7.18e-01
GOBP POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY 28 3.77e-01 6.62e-01 0.150000 3.25e-02 -1.46e-01 7.66e-01 1.80e-01
GOBP NEGATIVE REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION 6 8.06e-01 9.20e-01 0.150000 7.36e-02 -1.30e-01 7.55e-01 5.80e-01
GOBP PEPTIDE BIOSYNTHETIC PROCESS 25 4.20e-01 6.99e-01 0.150000 -3.12e-02 1.46e-01 7.87e-01 2.05e-01
GOCC RNA POLYMERASE II TRANSCRIPTION REGULATOR COMPLEX 236 2.43e-04 4.41e-03 0.150000 1.36e-01 -6.32e-02 3.32e-04 9.47e-02
GOMF TUMOR NECROSIS FACTOR BINDING 7 7.94e-01 9.16e-01 0.150000 -1.48e-01 -2.47e-02 4.99e-01 9.10e-01
GOBP PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX 19 5.46e-01 7.82e-01 0.150000 -1.36e-01 -6.14e-02 3.03e-01 6.43e-01
GOBP NUCLEIC ACID CATABOLIC PROCESS 755 4.91e-12 5.43e-10 0.150000 1.34e-01 -6.56e-02 3.23e-10 2.15e-03
GOMF VOLTAGE GATED MONOATOMIC ION CHANNEL ACTIVITY INVOLVED IN REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL 11 7.00e-01 8.70e-01 0.150000 4.13e-02 1.44e-01 8.12e-01 4.09e-01
GOBP TOLERANCE INDUCTION TO SELF ANTIGEN 5 8.35e-01 9.31e-01 0.150000 -1.09e-01 1.03e-01 6.73e-01 6.91e-01
GOBP STEROID HORMONE SECRETION 27 4.12e-01 6.93e-01 0.150000 1.47e-01 2.60e-02 1.85e-01 8.15e-01
GOBP MEIOTIC SPINDLE ORGANIZATION 18 5.27e-01 7.69e-01 0.150000 1.36e-01 -6.23e-02 3.18e-01 6.47e-01
High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells 69 1.17e-01 3.71e-01 0.149000 1.06e-01 1.05e-01 1.27e-01 1.31e-01
GOCC BLOC COMPLEX 20 5.31e-01 7.72e-01 0.149000 1.34e-01 6.61e-02 3.00e-01 6.09e-01
GOBP T CELL CHEMOTAXIS 24 4.65e-01 7.28e-01 0.149000 -5.51e-02 -1.39e-01 6.40e-01 2.39e-01
GOMF G PROTEIN COUPLED NEUROTRANSMITTER RECEPTOR ACTIVITY 12 6.58e-01 8.50e-01 0.149000 -1.44e-01 4.02e-02 3.88e-01 8.09e-01
Chylomicron clearance 5 8.45e-01 9.36e-01 0.149000 -1.71e-03 1.49e-01 9.95e-01 5.63e-01
GOBP POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 35 3.25e-01 6.16e-01 0.149000 1.42e-01 4.55e-02 1.45e-01 6.41e-01
GOBP PROTEASOMAL PROTEIN CATABOLIC PROCESS 507 2.85e-08 1.58e-06 0.149000 1.42e-01 -4.57e-02 4.25e-08 7.80e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS OXYGEN AS ACCEPTOR 10 7.20e-01 8.79e-01 0.149000 2.35e-02 1.47e-01 8.97e-01 4.20e-01
GOCC PHAGOCYTIC VESICLE 132 9.12e-03 7.39e-02 0.149000 1.27e-01 -7.78e-02 1.15e-02 1.23e-01
GOBP ANTEROGRADE AXONAL TRANSPORT OF MITOCHONDRION 6 8.06e-01 9.20e-01 0.149000 1.25e-01 -8.18e-02 5.96e-01 7.29e-01
GOBP POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS 37 3.10e-01 6.04e-01 0.149000 1.36e-01 6.25e-02 1.54e-01 5.11e-01
ABC transporter disorders 64 1.05e-01 3.49e-01 0.149000 5.62e-02 -1.38e-01 4.36e-01 5.58e-02
GOBP NUCLEOBASE BIOSYNTHETIC PROCESS 15 5.87e-01 8.07e-01 0.149000 6.90e-02 -1.32e-01 6.43e-01 3.75e-01
M-decay: degradation of maternal mRNAs by maternally stored factors 45 2.47e-01 5.43e-01 0.149000 1.17e-01 9.24e-02 1.74e-01 2.84e-01
GOBP DNA RECOMBINATION 327 9.96e-06 2.88e-04 0.149000 1.27e-01 -7.76e-02 7.49e-05 1.58e-02
GOBP INTERLEUKIN 4 PRODUCTION 32 3.70e-01 6.57e-01 0.149000 9.27e-02 1.17e-01 3.64e-01 2.53e-01
GOBP RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 55 1.62e-01 4.45e-01 0.149000 -1.02e-02 -1.49e-01 8.96e-01 5.63e-02
GOMF PHOSPHODIESTERASE I ACTIVITY 5 8.55e-01 9.40e-01 0.149000 -8.27e-02 -1.24e-01 7.49e-01 6.31e-01
GOBP RESPONSE TO ISCHEMIA 64 1.17e-01 3.71e-01 0.149000 1.49e-01 -3.38e-03 3.92e-02 9.63e-01
GOBP REGULATION OF CELLULAR CATABOLIC PROCESS 440 6.97e-07 2.81e-05 0.149000 1.48e-01 2.02e-02 1.07e-07 4.67e-01
GOMF PROTEIN RNA ADAPTOR ACTIVITY 19 5.14e-01 7.61e-01 0.149000 1.41e-01 -4.84e-02 2.87e-01 7.15e-01
GOBP DETECTION OF TEMPERATURE STIMULUS 26 4.21e-01 7.00e-01 0.149000 -1.49e-01 -6.12e-03 1.89e-01 9.57e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO EARLY ENDOSOME 8 7.68e-01 9.02e-01 0.149000 1.63e-02 1.48e-01 9.36e-01 4.68e-01
GOBP REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 45 2.19e-01 5.15e-01 0.149000 1.09e-02 -1.49e-01 8.99e-01 8.46e-02
GOMF PHOSPHATASE BINDING 185 1.79e-03 2.16e-02 0.149000 1.46e-01 -3.19e-02 6.41e-04 4.55e-01
GOBP BARBED END ACTIN FILAMENT CAPPING 25 4.61e-01 7.24e-01 0.149000 9.46e-02 1.15e-01 4.13e-01 3.19e-01
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 16 6.09e-01 8.22e-01 0.149000 9.67e-02 1.13e-01 5.03e-01 4.33e-01
GOBP POSITIVE REGULATION OF JNK CASCADE 91 4.93e-02 2.24e-01 0.149000 1.49e-01 7.44e-03 1.42e-02 9.02e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 47 2.33e-01 5.31e-01 0.149000 9.23e-02 1.17e-01 2.74e-01 1.66e-01
GOBP CELLULAR RESPONSE TO ELECTRICAL STIMULUS 12 6.73e-01 8.57e-01 0.149000 -1.12e-02 -1.48e-01 9.47e-01 3.73e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS 12 6.62e-01 8.51e-01 0.149000 1.46e-01 -2.88e-02 3.81e-01 8.63e-01
GOBP 5S CLASS RRNA TRANSCRIPTION BY RNA POLYMERASE III 6 8.21e-01 9.27e-01 0.149000 1.48e-01 1.57e-02 5.30e-01 9.47e-01
GOCC TRANSCRIPTION FACTOR TFIIIC COMPLEX 6 8.21e-01 9.27e-01 0.149000 1.48e-01 1.57e-02 5.30e-01 9.47e-01
GOBP ACID SECRETION 45 2.25e-01 5.22e-01 0.149000 6.68e-03 1.49e-01 9.38e-01 8.44e-02
GOBP NEGATIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 26 4.12e-01 6.93e-01 0.149000 -1.47e-01 2.40e-02 1.95e-01 8.32e-01
GOMF NADPLUS BINDING 18 5.25e-01 7.67e-01 0.149000 1.11e-01 -9.93e-02 4.16e-01 4.66e-01
GOBP NEGATIVE REGULATION OF CELL ADHESION MOLECULE PRODUCTION 10 7.30e-01 8.84e-01 0.149000 6.02e-02 1.36e-01 7.42e-01 4.56e-01
GOBP MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS 594 2.27e-09 1.57e-07 0.149000 1.45e-01 -3.28e-02 1.52e-09 1.72e-01
GOMF AP 1 ADAPTOR COMPLEX BINDING 5 8.47e-01 9.36e-01 0.149000 3.40e-03 1.49e-01 9.89e-01 5.65e-01
Regulation of RAS by GAPs 54 1.47e-01 4.23e-01 0.149000 1.24e-01 -8.18e-02 1.14e-01 2.98e-01
GOMF POLYOL TRANSMEMBRANE TRANSPORTER ACTIVITY 11 6.85e-01 8.64e-01 0.149000 1.45e-01 -3.40e-02 4.06e-01 8.45e-01
GOMF CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 40 2.40e-01 5.36e-01 0.149000 1.10e-01 -1.00e-01 2.30e-01 2.72e-01
GOBP POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION 15 5.87e-01 8.07e-01 0.149000 8.16e-02 -1.24e-01 5.84e-01 4.05e-01
GOBP MITOTIC NUCLEAR MEMBRANE DISASSEMBLY 8 7.80e-01 9.09e-01 0.149000 7.95e-02 1.26e-01 6.97e-01 5.39e-01
GOMF LIPOPOLYSACCHARIDE BINDING 39 2.99e-01 5.94e-01 0.149000 -1.24e-01 -8.15e-02 1.80e-01 3.78e-01
GOBP LEARNED VOCALIZATION BEHAVIOR OR VOCAL LEARNING 10 7.01e-01 8.70e-01 0.149000 -8.41e-02 1.22e-01 6.45e-01 5.02e-01
GOBP STEROL BIOSYNTHETIC PROCESS 63 1.23e-01 3.82e-01 0.149000 -2.65e-03 1.49e-01 9.71e-01 4.15e-02
GOBP NEGATIVE REGULATION OF CARDIAC MUSCLE CONTRACTION 7 7.96e-01 9.16e-01 0.149000 1.85e-02 1.47e-01 9.32e-01 5.00e-01
Glycogen storage diseases 15 6.28e-01 8.33e-01 0.149000 -8.39e-02 -1.23e-01 5.74e-01 4.11e-01
GOCC CATSPER COMPLEX 14 6.36e-01 8.38e-01 0.149000 -2.67e-02 -1.46e-01 8.63e-01 3.44e-01
GOBP 10 FORMYLTETRAHYDROFOLATE METABOLIC PROCESS 5 8.55e-01 9.40e-01 0.148000 6.17e-02 1.35e-01 8.11e-01 6.01e-01
GOBP MITOTIC CELL CYCLE PROCESS 746 1.87e-11 1.84e-09 0.148000 1.45e-01 -3.11e-02 1.44e-11 1.49e-01
GOBP POSITIVE REGULATION OF ORGANELLE ORGANIZATION 501 5.23e-08 2.71e-06 0.148000 1.45e-01 -3.06e-02 2.56e-08 2.41e-01
GOMF G PROTEIN COUPLED AMINE RECEPTOR ACTIVITY 39 2.99e-01 5.94e-01 0.148000 7.88e-02 1.26e-01 3.95e-01 1.74e-01
GOBP MUCUS SECRETION 19 5.24e-01 7.66e-01 0.148000 -2.87e-02 1.45e-01 8.28e-01 2.72e-01
GOBP POSITIVE REGULATION OF DNA METABOLIC PROCESS 289 4.04e-05 9.89e-04 0.148000 1.20e-01 -8.73e-02 4.57e-04 1.06e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN REDUCED FLAVIN OR FLAVOPROTEIN AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN 42 2.73e-01 5.70e-01 0.148000 -7.71e-02 -1.27e-01 3.87e-01 1.56e-01
GOBP PROTEIN DEACETYLATION 38 2.97e-01 5.94e-01 0.148000 1.44e-01 3.48e-02 1.24e-01 7.10e-01
GOBP CELL SURFACE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 630 4.24e-09 2.78e-07 0.148000 1.38e-01 5.40e-02 3.30e-09 2.06e-02
GOBP VITAMIN TRANSMEMBRANE TRANSPORT 19 5.53e-01 7.87e-01 0.148000 1.33e-01 6.57e-02 3.16e-01 6.20e-01
GOBP EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 10 7.24e-01 8.82e-01 0.148000 1.46e-01 2.64e-02 4.25e-01 8.85e-01
GOBP PROTEIN LOCALIZATION TO NUCLEUS 307 2.54e-05 6.59e-04 0.148000 1.35e-01 -6.11e-02 4.73e-05 6.54e-02
GOBP POSITIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS 21 5.20e-01 7.64e-01 0.148000 1.32e-01 6.63e-02 2.93e-01 5.99e-01
GOCC HIPPOCAMPAL MOSSY FIBER TO CA3 SYNAPSE 43 2.60e-01 5.57e-01 0.148000 1.36e-01 5.76e-02 1.22e-01 5.13e-01
GOMF EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY 68 1.23e-01 3.82e-01 0.148000 -1.27e-01 -7.55e-02 6.91e-02 2.82e-01
CDK-mediated phosphorylation and removal of Cdc6 60 1.24e-01 3.84e-01 0.148000 5.83e-02 -1.36e-01 4.35e-01 6.81e-02
GOMF PROTEIN DISULFIDE REDUCTASE NAD P H ACTIVITY 8 7.57e-01 8.96e-01 0.148000 -5.84e-02 1.36e-01 7.75e-01 5.05e-01
FOXO-mediated transcription of cell death genes 15 5.93e-01 8.11e-01 0.148000 1.35e-01 -6.04e-02 3.65e-01 6.85e-01
GOBP GLYCOSIDE TRANSPORT 5 8.57e-01 9.41e-01 0.148000 8.71e-02 1.20e-01 7.36e-01 6.43e-01
GOBP CALCIUM IMPORT INTO THE MITOCHONDRION 16 6.10e-01 8.22e-01 0.148000 1.29e-01 7.30e-02 3.72e-01 6.13e-01
GOBP POSITIVE REGULATION OF ORGANIC ACID TRANSPORT 45 2.26e-01 5.23e-01 0.148000 1.48e-01 -1.65e-03 8.59e-02 9.85e-01
InlA-mediated entry of Listeria monocytogenes into host cells 9 7.29e-01 8.84e-01 0.148000 7.11e-02 -1.30e-01 7.12e-01 5.00e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 15 6.31e-01 8.34e-01 0.148000 -8.68e-02 -1.20e-01 5.61e-01 4.22e-01
GOBP DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR RESULTING IN CELL CYCLE ARREST 19 5.36e-01 7.75e-01 0.148000 -4.60e-03 -1.48e-01 9.72e-01 2.65e-01
GOBP REGULATION OF T HELPER CELL DIFFERENTIATION 44 2.31e-01 5.29e-01 0.148000 1.48e-01 -1.03e-02 9.03e-02 9.06e-01
GOBP NEGATIVE REGULATION OF TRANSPORTER ACTIVITY 86 7.26e-02 2.83e-01 0.148000 1.15e-01 9.30e-02 6.53e-02 1.36e-01
GOBP DETECTION OF OTHER ORGANISM 19 5.25e-01 7.67e-01 0.148000 -1.45e-01 3.00e-02 2.75e-01 8.21e-01
GOCC CUL4 RING E3 UBIQUITIN LIGASE COMPLEX 33 3.16e-01 6.09e-01 0.148000 6.75e-02 -1.32e-01 5.02e-01 1.91e-01
GOBP AUTOPHAGY OF MITOCHONDRION 100 4.59e-02 2.14e-01 0.148000 1.31e-01 6.91e-02 2.39e-02 2.33e-01
Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 16 5.69e-01 7.96e-01 0.148000 9.50e-02 -1.13e-01 5.11e-01 4.33e-01
GOBP REGULATION OF ACTION POTENTIAL 57 1.52e-01 4.30e-01 0.148000 -7.61e-03 1.48e-01 9.21e-01 5.39e-02
GOBP SYNAPTIC VESICLE RECYCLING 77 9.63e-02 3.32e-01 0.148000 1.02e-01 1.07e-01 1.24e-01 1.03e-01
GOBP NEGATIVE REGULATION OF MUSCLE CONTRACTION 23 4.81e-01 7.41e-01 0.148000 3.40e-02 1.44e-01 7.78e-01 2.33e-01
GOBP INTRACELLULAR SPHINGOLIPID HOMEOSTASIS 5 8.43e-01 9.36e-01 0.148000 3.65e-02 -1.43e-01 8.88e-01 5.79e-01
GOMF PROTEIN PHOSPHATASE BINDING 140 8.66e-03 7.10e-02 0.148000 1.42e-01 -4.00e-02 3.69e-03 4.14e-01
GOBP POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 23 4.50e-01 7.19e-01 0.148000 1.31e-01 -6.76e-02 2.76e-01 5.75e-01
GOBP REGULATORY NCRNA MEDIATED HETEROCHROMATIN FORMATION 19 5.23e-01 7.65e-01 0.148000 -1.41e-01 4.32e-02 2.87e-01 7.44e-01
GOBP MORPHOGENESIS OF AN EPITHELIUM 489 1.18e-07 5.79e-06 0.148000 1.47e-01 -1.56e-02 2.73e-08 5.54e-01
GOBP CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 22 4.95e-01 7.51e-01 0.148000 1.45e-01 2.65e-02 2.39e-01 8.30e-01
GOMF SERINE HYDROLASE ACTIVITY 188 1.49e-03 1.89e-02 0.148000 -1.27e-01 7.53e-02 2.70e-03 7.50e-02
GOBP RECEPTOR LOCALIZATION TO SYNAPSE 57 1.68e-01 4.52e-01 0.148000 4.47e-02 1.41e-01 5.59e-01 6.64e-02
GOBP GAMMA AMINOBUTYRIC ACID TRANSPORT 20 5.43e-01 7.80e-01 0.148000 1.19e-01 8.68e-02 3.56e-01 5.01e-01
GOBP TRIPEPTIDE TRANSMEMBRANE TRANSPORT 10 7.38e-01 8.87e-01 0.148000 1.06e-01 1.03e-01 5.62e-01 5.74e-01
GOBP TISSUE MORPHOGENESIS 604 4.36e-09 2.84e-07 0.148000 1.47e-01 1.80e-03 5.88e-10 9.40e-01
GOCC CONDENSED CHROMOSOME 268 9.24e-05 2.01e-03 0.147000 1.20e-01 -8.55e-02 7.04e-04 1.60e-02
Serotonin Neurotransmitter Release Cycle 17 5.82e-01 8.04e-01 0.147000 1.44e-01 2.98e-02 3.03e-01 8.32e-01
GOBP REGULATION OF BRANCHING INVOLVED IN LUNG MORPHOGENESIS 6 8.30e-01 9.30e-01 0.147000 -6.01e-02 -1.35e-01 7.99e-01 5.68e-01
ERK/MAPK targets 20 5.39e-01 7.78e-01 0.147000 1.34e-01 6.14e-02 3.00e-01 6.34e-01
GOBP VESICLE COATING 38 2.75e-01 5.72e-01 0.147000 1.42e-01 -3.97e-02 1.30e-01 6.72e-01
TRIF-mediated programmed cell death 9 7.30e-01 8.84e-01 0.147000 1.22e-01 -8.33e-02 5.28e-01 6.65e-01
GOBP PYRAMIDAL NEURON DIFFERENTIATION 13 6.37e-01 8.38e-01 0.147000 1.32e-01 -6.48e-02 4.09e-01 6.86e-01
GOBP APOPTOTIC MITOCHONDRIAL CHANGES 103 4.05e-02 1.99e-01 0.147000 -4.77e-02 -1.39e-01 4.03e-01 1.45e-02
GOBP VIRAL GENOME REPLICATION 123 1.44e-02 1.02e-01 0.147000 1.32e-01 -6.57e-02 1.15e-02 2.08e-01
GOBP AMINOGLYCAN BIOSYNTHETIC PROCESS 75 1.03e-01 3.46e-01 0.147000 9.21e-02 1.15e-01 1.68e-01 8.50e-02
GOCC INNER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX 141 8.42e-03 6.97e-02 0.147000 4.36e-02 -1.41e-01 3.71e-01 3.91e-03
GOBP CONNECTIVE TISSUE DEVELOPMENT 281 1.79e-04 3.46e-03 0.147000 1.37e-01 5.35e-02 7.54e-05 1.22e-01
GOBP ANDROGEN CATABOLIC PROCESS 5 8.39e-01 9.33e-01 0.147000 9.28e-02 -1.14e-01 7.19e-01 6.58e-01
GOMF RNA EXONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS 40 2.49e-01 5.46e-01 0.147000 1.26e-01 -7.55e-02 1.66e-01 4.08e-01
GOBP NEURON APOPTOTIC PROCESS 279 1.15e-04 2.43e-03 0.147000 1.47e-01 -6.80e-03 2.34e-05 8.45e-01
GOBP LUNG VASCULATURE DEVELOPMENT 9 7.59e-01 8.97e-01 0.147000 7.12e-02 1.29e-01 7.12e-01 5.03e-01
GOMF DNA EXONUCLEASE ACTIVITY 24 4.63e-01 7.27e-01 0.147000 1.46e-01 1.77e-02 2.15e-01 8.81e-01
GOBP POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY 40 2.55e-01 5.53e-01 0.147000 4.94e-02 -1.39e-01 5.89e-01 1.29e-01
GOBP GAS TRANSPORT 22 5.06e-01 7.57e-01 0.147000 -1.37e-01 -5.45e-02 2.67e-01 6.58e-01
GOBP RESPONSE TO STEROID HORMONE 325 1.49e-05 4.08e-04 0.147000 1.28e-01 -7.21e-02 7.01e-05 2.55e-02
GOBP NEGATIVE REGULATION OF PHOSPHATASE ACTIVITY 20 5.07e-01 7.58e-01 0.147000 1.41e-01 -4.22e-02 2.75e-01 7.44e-01
GOCC CILIARY TRANSITION ZONE 72 8.62e-02 3.14e-01 0.147000 4.97e-02 -1.38e-01 4.66e-01 4.22e-02
GOBP PROTEIN K11 LINKED UBIQUITINATION 34 3.29e-01 6.20e-01 0.147000 1.47e-01 -4.98e-03 1.38e-01 9.60e-01
GOMF LIPOPOLYSACCHARIDE IMMUNE RECEPTOR ACTIVITY 6 8.34e-01 9.31e-01 0.147000 1.00e-01 1.07e-01 6.70e-01 6.48e-01
GOBP MALE SEX DETERMINATION 11 7.00e-01 8.70e-01 0.147000 1.47e-01 3.53e-03 3.99e-01 9.84e-01
GOBP REGULATION OF DNA METABOLIC PROCESS 494 5.68e-08 2.91e-06 0.147000 1.31e-01 -6.62e-02 5.77e-07 1.18e-02
GOBP CELLULAR RESPONSE TO LAMINAR FLUID SHEAR STRESS 8 7.84e-01 9.11e-01 0.147000 1.26e-01 7.54e-02 5.36e-01 7.12e-01
GOBP REGULATION OF ENDOCRINE PROCESS 40 2.97e-01 5.94e-01 0.147000 1.23e-01 8.02e-02 1.77e-01 3.80e-01
GOBP DENDRITIC CELL CYTOKINE PRODUCTION 18 5.74e-01 7.99e-01 0.147000 -5.52e-02 -1.36e-01 6.85e-01 3.17e-01
GOBP REGULATION OF GLOMERULAR FILTRATION 8 7.65e-01 9.01e-01 0.147000 2.99e-02 -1.44e-01 8.84e-01 4.81e-01
GOBP REGULATION OF CATABOLIC PROCESS 1061 4.12e-15 8.16e-13 0.147000 1.47e-01 -6.19e-03 6.21e-16 7.33e-01
GOBP ODONTOGENESIS 129 1.75e-02 1.16e-01 0.147000 1.44e-01 3.12e-02 4.87e-03 5.40e-01
Activation of NF-kappaB in B cells 53 1.58e-01 4.40e-01 0.147000 1.08e-01 -9.96e-02 1.74e-01 2.10e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 158 7.80e-03 6.58e-02 0.147000 1.37e-01 5.20e-02 2.89e-03 2.59e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE 17 5.60e-01 7.91e-01 0.147000 5.55e-02 -1.36e-01 6.92e-01 3.32e-01
GOBP POSITIVE REGULATION OF CILIUM MOVEMENT 13 6.45e-01 8.42e-01 0.147000 1.41e-01 -3.91e-02 3.77e-01 8.07e-01
GOBP REGULATION OF GONAD DEVELOPMENT 12 6.79e-01 8.61e-01 0.147000 6.06e-03 1.47e-01 9.71e-01 3.79e-01
GOMF PROTEIN DOMAIN SPECIFIC BINDING 622 2.72e-09 1.85e-07 0.147000 1.47e-01 -4.68e-03 4.22e-10 8.42e-01
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 123 1.72e-02 1.15e-01 0.147000 1.45e-01 -2.43e-02 5.58e-03 6.42e-01
GOBP RESPONSE TO TESTOSTERONE 41 2.64e-01 5.60e-01 0.147000 1.47e-01 -3.79e-03 1.04e-01 9.67e-01
GOBP RESPONSE TO DSRNA 53 1.99e-01 4.92e-01 0.147000 -1.31e-01 -6.56e-02 9.84e-02 4.09e-01
GOBP CHOLINE METABOLIC PROCESS 6 8.24e-01 9.28e-01 0.147000 -4.26e-03 -1.47e-01 9.86e-01 5.34e-01
GOBP REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION 46 2.29e-01 5.27e-01 0.147000 1.46e-01 1.01e-02 8.60e-02 9.06e-01
GOBP NOTCH RECEPTOR PROCESSING 9 7.32e-01 8.84e-01 0.147000 9.05e-02 -1.15e-01 6.38e-01 5.49e-01
GOBP SPLICEOSOMAL SNRNP ASSEMBLY 43 2.48e-01 5.45e-01 0.147000 1.47e-01 -1.65e-03 9.62e-02 9.85e-01
GOBP NEGATIVE REGULATION OF FAT CELL PROLIFERATION 5 8.44e-01 9.36e-01 0.147000 -1.38e-01 4.90e-02 5.93e-01 8.50e-01
GOBP VIRAL PROTEIN PROCESSING 31 3.86e-01 6.70e-01 0.147000 5.62e-02 1.35e-01 5.88e-01 1.92e-01
GOBP REGULATION OF MRNA METABOLIC PROCESS 375 5.43e-06 1.69e-04 0.147000 1.46e-01 -1.47e-02 1.23e-06 6.26e-01
GOBP SPERM EGG RECOGNITION 51 1.96e-01 4.90e-01 0.147000 -1.46e-01 -1.24e-02 7.12e-02 8.78e-01
Common Pathway of Fibrin Clot Formation 21 4.86e-01 7.44e-01 0.147000 -7.29e-02 1.27e-01 5.63e-01 3.13e-01
GOBP DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF SOUND 15 5.95e-01 8.13e-01 0.147000 1.19e-01 -8.57e-02 4.25e-01 5.66e-01
GOBP REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE 31 3.42e-01 6.32e-01 0.147000 -1.19e-01 8.50e-02 2.50e-01 4.13e-01
Viral Infection Pathways 743 3.63e-11 3.37e-09 0.147000 3.45e-02 -1.42e-01 1.09e-01 3.84e-11
GOBP MUSCLE CELL CELLULAR HOMEOSTASIS 23 4.89e-01 7.46e-01 0.146000 -3.90e-02 -1.41e-01 7.46e-01 2.41e-01
GOBP TOLL LIKE RECEPTOR 7 SIGNALING PATHWAY 8 7.74e-01 9.05e-01 0.146000 -1.46e-01 -7.34e-03 4.74e-01 9.71e-01
Cyclin A/B1/B2 associated events during G2/M transition 24 4.35e-01 7.10e-01 0.146000 1.10e-01 -9.66e-02 3.51e-01 4.13e-01
RUNX3 Regulates Immune Response and Cell Migration 6 8.13e-01 9.24e-01 0.146000 1.19e-01 -8.54e-02 6.14e-01 7.17e-01
Sensory perception of sweet, bitter, and umami (glutamate) taste 41 2.44e-01 5.40e-01 0.146000 -7.95e-02 1.23e-01 3.79e-01 1.73e-01
TP53 Regulates Transcription of Cell Death Genes 43 2.63e-01 5.60e-01 0.146000 1.41e-01 3.78e-02 1.09e-01 6.68e-01
GOMF SNARE BINDING 103 4.33e-02 2.07e-01 0.146000 1.35e-01 5.62e-02 1.78e-02 3.24e-01
GOCC SPECTRIN 9 7.62e-01 8.99e-01 0.146000 7.28e-02 1.27e-01 7.05e-01 5.10e-01
GOBP MITOTIC SISTER CHROMATID SEGREGATION 185 1.79e-03 2.16e-02 0.146000 1.22e-01 -8.05e-02 4.14e-03 5.90e-02
GOBP NEGATIVE REGULATION OF CELL CYCLE 391 1.99e-06 6.97e-05 0.146000 1.32e-01 -6.42e-02 8.01e-06 2.94e-02
GOBP WALKING BEHAVIOR 35 3.13e-01 6.07e-01 0.146000 1.43e-01 -2.96e-02 1.42e-01 7.62e-01
GOBP BONE MINERALIZATION INVOLVED IN BONE MATURATION 13 6.39e-01 8.39e-01 0.146000 -8.33e-02 1.20e-01 6.03e-01 4.53e-01
Activation of the AP-1 family of transcription factors 10 7.27e-01 8.82e-01 0.146000 -1.46e-01 -1.02e-02 4.24e-01 9.55e-01
GOBP NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY 38 3.02e-01 5.97e-01 0.146000 2.07e-02 1.45e-01 8.25e-01 1.22e-01
GOBP POSITIVE REGULATION OF AUTOPHAGY 151 7.69e-03 6.52e-02 0.146000 1.46e-01 -6.08e-03 1.94e-03 8.97e-01
GOBP REGULATION OF CHOLESTEROL METABOLIC PROCESS 40 2.88e-01 5.86e-01 0.146000 3.57e-02 1.42e-01 6.96e-01 1.21e-01
GOMF HISTONE KINASE ACTIVITY 23 4.69e-01 7.30e-01 0.146000 1.45e-01 -2.17e-02 2.30e-01 8.57e-01
GOBP REGULATION OF ACTIN FILAMENT LENGTH 148 7.46e-03 6.37e-02 0.146000 1.42e-01 -3.42e-02 2.83e-03 4.73e-01
GOBP POSITIVE REGULATION OF EXOSOMAL SECRETION 15 6.01e-01 8.16e-01 0.146000 -5.78e-02 1.34e-01 6.98e-01 3.68e-01
GOMF IGE BINDING 5 8.49e-01 9.37e-01 0.146000 -1.96e-02 1.45e-01 9.40e-01 5.75e-01
GOMF CAMP DEPENDENT PROTEIN KINASE REGULATOR ACTIVITY 12 6.62e-01 8.51e-01 0.146000 8.34e-02 -1.20e-01 6.17e-01 4.72e-01
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 489 2.35e-07 1.07e-05 0.146000 1.46e-01 8.75e-03 3.31e-08 7.40e-01
GOBP RESPONSE TO OXYGEN LEVELS 323 2.36e-05 6.18e-04 0.146000 1.40e-01 -4.15e-02 1.50e-05 2.00e-01
GOBP MODULATION BY HOST OF VIRAL PROCESS 45 2.61e-01 5.57e-01 0.146000 -8.27e-02 -1.20e-01 3.37e-01 1.63e-01
GOBP DNA INTEGRITY CHECKPOINT SIGNALING 132 1.09e-02 8.36e-02 0.146000 1.13e-01 -9.30e-02 2.56e-02 6.50e-02
GOMF CADHERIN BINDING 329 2.62e-05 6.78e-04 0.146000 1.45e-01 -1.24e-02 5.72e-06 7.00e-01
GOCC CARBOXY TERMINAL DOMAIN PROTEIN KINASE COMPLEX 18 5.42e-01 7.80e-01 0.146000 1.31e-01 -6.53e-02 3.37e-01 6.32e-01
GOMF NUCLEAR ANDROGEN RECEPTOR BINDING 25 4.58e-01 7.23e-01 0.146000 1.43e-01 2.68e-02 2.14e-01 8.16e-01
GOMF POLY PURINE TRACT BINDING 27 4.36e-01 7.10e-01 0.146000 1.40e-01 4.16e-02 2.08e-01 7.08e-01
NOTCH3 Intracellular Domain Regulates Transcription 24 4.59e-01 7.24e-01 0.146000 1.46e-01 -1.08e-02 2.17e-01 9.27e-01
GOBP PROTEIN CONTAINING COMPLEX DISASSEMBLY 248 2.29e-04 4.22e-03 0.146000 1.25e-01 -7.50e-02 6.87e-04 4.20e-02
GOBP LIPID DROPLET ORGANIZATION 35 3.24e-01 6.15e-01 0.146000 1.46e-01 -5.12e-03 1.36e-01 9.58e-01
GOBP METAPHASE ANAPHASE TRANSITION OF MEIOTIC CELL CYCLE 7 7.86e-01 9.13e-01 0.146000 1.18e-01 -8.56e-02 5.88e-01 6.95e-01
GOBP P38MAPK CASCADE 59 1.38e-01 4.08e-01 0.146000 1.36e-01 -5.19e-02 7.01e-02 4.91e-01
GOBP EPITHELIAL TO MESENCHYMAL TRANSITION 188 2.70e-03 2.97e-02 0.146000 1.45e-01 1.06e-02 5.82e-04 8.01e-01
Regulation of RUNX1 Expression and Activity 25 4.31e-01 7.06e-01 0.146000 1.34e-01 -5.65e-02 2.45e-01 6.25e-01
GOCC PLATELET DENSE GRANULE 20 5.15e-01 7.62e-01 0.146000 -3.69e-02 1.41e-01 7.75e-01 2.75e-01
GOBP MITOCHONDRIAL TRANSCRIPTION 22 4.78e-01 7.37e-01 0.146000 5.26e-02 -1.36e-01 6.69e-01 2.70e-01
GOBP WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 48 2.40e-01 5.36e-01 0.146000 1.17e-01 8.62e-02 1.59e-01 3.01e-01
GOBP MEMBRANE LIPID CATABOLIC PROCESS 52 2.05e-01 4.99e-01 0.146000 4.69e-02 1.38e-01 5.59e-01 8.53e-02
GOMF GATED CHANNEL ACTIVITY 307 4.57e-05 1.10e-03 0.146000 -1.42e-01 3.25e-02 1.88e-05 3.27e-01
BMAL1:CLOCK,NPAS2 activates circadian gene expression 24 4.92e-01 7.49e-01 0.146000 1.02e-01 1.04e-01 3.89e-01 3.76e-01
GOBP REGULATION OF RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE 7 7.95e-01 9.16e-01 0.146000 -2.78e-02 1.43e-01 8.98e-01 5.13e-01
GOBP NEGATIVE REGULATION OF B CELL MEDIATED IMMUNITY 13 6.60e-01 8.50e-01 0.146000 -1.46e-01 1.82e-03 3.63e-01 9.91e-01
GOBP GLUCAN BIOSYNTHETIC PROCESS 44 2.71e-01 5.68e-01 0.146000 1.16e-01 8.80e-02 1.83e-01 3.12e-01
Cyclin E associated events during G1/S transition 73 8.93e-02 3.20e-01 0.146000 4.04e-02 -1.40e-01 5.51e-01 3.88e-02
GOBP AMINO ACID TRANSMEMBRANE TRANSPORT 96 5.78e-02 2.46e-01 0.146000 1.23e-01 7.85e-02 3.79e-02 1.84e-01
GOBP PROTEIN LOCALIZATION TO CELL PERIPHERY 333 4.48e-05 1.08e-03 0.146000 1.38e-01 4.66e-02 1.52e-05 1.44e-01
GOBP POSITIVE REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY 9 7.63e-01 8.99e-01 0.146000 6.34e-02 1.31e-01 7.42e-01 4.96e-01
GOBP PARENTAL BEHAVIOR 13 6.52e-01 8.46e-01 0.146000 1.42e-01 -3.14e-02 3.75e-01 8.44e-01
GOBP POSITIVE REGULATION OF BMP SIGNALING PATHWAY 39 3.14e-01 6.07e-01 0.145000 1.21e-01 8.05e-02 1.90e-01 3.85e-01
GOCC NUCLEOLAR EXOSOME RNASE COMPLEX 10 7.10e-01 8.75e-01 0.145000 9.95e-02 -1.06e-01 5.86e-01 5.61e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION 12 6.72e-01 8.57e-01 0.145000 3.95e-02 -1.40e-01 8.13e-01 4.01e-01
GOBP CELLULAR RESPONSE TO STEROL 25 4.77e-01 7.37e-01 0.145000 9.03e-02 1.14e-01 4.34e-01 3.24e-01
GOMF ACETYLCHOLINE RECEPTOR BINDING 11 6.98e-01 8.70e-01 0.145000 -2.57e-02 1.43e-01 8.83e-01 4.11e-01
GOBP CELLULAR EXTRAVASATION 72 9.31e-02 3.27e-01 0.145000 -3.90e-02 1.40e-01 5.67e-01 3.99e-02
GOMF DAMAGED DNA BINDING 72 9.19e-02 3.25e-01 0.145000 1.38e-01 -4.59e-02 4.30e-02 5.01e-01
GOMF PURINE NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 25 4.43e-01 7.15e-01 0.145000 -2.31e-02 1.43e-01 8.42e-01 2.14e-01
GOCC ENDOPLASMIC RETICULUM PALMITOYLTRANSFERASE COMPLEX 8 7.74e-01 9.05e-01 0.145000 1.45e-01 -5.81e-03 4.77e-01 9.77e-01
Regulated Necrosis 56 1.58e-01 4.40e-01 0.145000 3.75e-02 -1.40e-01 6.27e-01 6.92e-02
TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest 14 6.26e-01 8.32e-01 0.145000 -1.33e-01 5.83e-02 3.89e-01 7.06e-01
GOBP POSITIVE REGULATION OF GRANULOCYTE DIFFERENTIATION 9 7.51e-01 8.92e-01 0.145000 -1.45e-01 1.86e-03 4.51e-01 9.92e-01
GOBP REGULATION OF MITOCHONDRIAL TRANSLATION 25 4.33e-01 7.08e-01 0.145000 5.86e-02 -1.33e-01 6.12e-01 2.50e-01
GOCC ESCRT I COMPLEX 12 7.02e-01 8.71e-01 0.145000 9.79e-02 1.07e-01 5.57e-01 5.20e-01
GOBP REGULATION OF FIBROBLAST PROLIFERATION 89 5.03e-02 2.26e-01 0.145000 7.03e-02 -1.27e-01 2.52e-01 3.84e-02
GOBP REGULATION OF HIGH DENSITY LIPOPROTEIN PARTICLE CLEARANCE 10 7.45e-01 8.91e-01 0.145000 1.09e-01 9.57e-02 5.50e-01 6.00e-01
GOBP NEGATIVE REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY 8 7.89e-01 9.14e-01 0.145000 1.25e-01 7.44e-02 5.42e-01 7.15e-01
GOBP TRACHEA CARTILAGE DEVELOPMENT 7 7.96e-01 9.16e-01 0.145000 1.42e-01 -3.01e-02 5.16e-01 8.90e-01
GOBP REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY 16 5.94e-01 8.12e-01 0.145000 2.74e-02 -1.42e-01 8.49e-01 3.24e-01
SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs 11 7.24e-01 8.81e-01 0.145000 -1.01e-01 -1.04e-01 5.60e-01 5.52e-01
GOBP PROTEIN EXIT FROM ENDOPLASMIC RETICULUM 47 2.05e-01 4.99e-01 0.145000 7.74e-02 -1.23e-01 3.58e-01 1.46e-01
GOBP OLIGODENDROCYTE DIFFERENTIATION 105 3.72e-02 1.90e-01 0.145000 1.45e-01 6.08e-03 1.03e-02 9.14e-01
GOBP CELLULAR RESPONSE TO OXYGEN LEVELS 161 4.36e-03 4.28e-02 0.145000 1.03e-01 -1.02e-01 2.43e-02 2.54e-02
S Phase 147 7.01e-03 6.11e-02 0.145000 9.38e-02 -1.10e-01 4.95e-02 2.08e-02
GOBP ESTABLISHMENT OF ENDOTHELIAL INTESTINAL BARRIER 14 6.35e-01 8.37e-01 0.145000 -1.43e-01 2.62e-02 3.56e-01 8.65e-01
GOBP POSITIVE REGULATION OF MITOPHAGY 14 6.37e-01 8.38e-01 0.145000 -1.75e-02 1.44e-01 9.10e-01 3.52e-01
GOBP DOPAMINE RECEPTOR SIGNALING PATHWAY 39 2.77e-01 5.74e-01 0.145000 1.38e-01 -4.42e-02 1.36e-01 6.33e-01
GOBP CIRCADIAN RHYTHM 198 1.65e-03 2.03e-02 0.145000 1.41e-01 -3.42e-02 6.45e-04 4.07e-01
GOBP ENDONUCLEOLYTIC CLEAVAGE IN ITS1 TO SEPARATE SSU RRNA FROM 5 8S RRNA AND LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 9 7.38e-01 8.87e-01 0.145000 7.87e-02 -1.21e-01 6.83e-01 5.28e-01
GOBP CELL MATRIX ADHESION 234 1.06e-03 1.44e-02 0.145000 1.25e-01 7.25e-02 9.65e-04 5.60e-02
GOBP ACTIN FILAMENT ORGANIZATION 442 1.74e-06 6.15e-05 0.145000 1.41e-01 3.14e-02 3.52e-07 2.58e-01
GOBP REGULATION OF KIDNEY DEVELOPMENT 33 3.28e-01 6.19e-01 0.145000 9.57e-02 -1.08e-01 3.41e-01 2.81e-01
GOBP REGULATION OF GLUCOSE METABOLIC PROCESS 97 5.84e-02 2.48e-01 0.145000 7.91e-02 1.21e-01 1.78e-01 3.94e-02
GOMF TELOMERASE ACTIVITY 6 8.17e-01 9.26e-01 0.145000 -8.07e-02 1.20e-01 7.32e-01 6.11e-01
Estrogen-dependent nuclear events downstream of ESR-membrane signaling 23 4.60e-01 7.24e-01 0.145000 1.03e-01 -1.01e-01 3.93e-01 3.99e-01
Regulation of PTEN stability and activity 55 1.59e-01 4.41e-01 0.144000 7.60e-02 -1.23e-01 3.30e-01 1.15e-01
GOBP MITOCHONDRIAL DNA METABOLIC PROCESS 22 4.87e-01 7.46e-01 0.144000 4.01e-02 -1.39e-01 7.45e-01 2.60e-01
GOBP POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY 40 2.65e-01 5.61e-01 0.144000 6.24e-02 -1.30e-01 4.95e-01 1.54e-01
GOBP LYTIC VACUOLE ORGANIZATION 105 3.38e-02 1.79e-01 0.144000 1.41e-01 -2.95e-02 1.23e-02 6.01e-01
GOBP ENDOCRINE PROCESS 87 7.93e-02 2.99e-01 0.144000 1.17e-01 8.51e-02 6.01e-02 1.70e-01
GOBP REGULATION OF PROTEIN POLYMERIZATION 194 2.25e-03 2.58e-02 0.144000 1.44e-01 -8.57e-03 5.37e-04 8.37e-01
GOBP RESPONSE TO VITAMIN D 37 2.88e-01 5.85e-01 0.144000 1.06e-01 -9.75e-02 2.63e-01 3.05e-01
GOBP REGULATION OF CATION CHANNEL ACTIVITY 106 4.27e-02 2.06e-01 0.144000 1.35e-01 5.10e-02 1.63e-02 3.64e-01
GOBP NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS 15 6.42e-01 8.41e-01 0.144000 -1.31e-01 -6.12e-02 3.81e-01 6.82e-01
GOBP NEGATIVE REGULATION OF STEM CELL PROLIFERATION 26 4.37e-01 7.11e-01 0.144000 1.66e-02 -1.43e-01 8.84e-01 2.06e-01
GOMF ACYLGLYCEROL LIPASE ACTIVITY 15 6.46e-01 8.43e-01 0.144000 8.27e-02 1.18e-01 5.79e-01 4.28e-01
GOBP PROTEIN O LINKED GLYCOSYLATION 99 4.95e-02 2.24e-01 0.144000 2.70e-02 1.42e-01 6.42e-01 1.49e-02
GOCC 9PLUS2 MOTILE CILIUM 180 3.60e-03 3.67e-02 0.144000 -1.44e-01 4.96e-03 8.53e-04 9.09e-01
GOBP CYTOCHROME COMPLEX ASSEMBLY 38 3.26e-01 6.17e-01 0.144000 -6.31e-02 -1.30e-01 5.01e-01 1.67e-01
Antiviral mechanism by IFN-stimulated genes 144 8.15e-03 6.80e-02 0.144000 1.08e-01 -9.51e-02 2.48e-02 4.87e-02
Hedgehog ligand biogenesis 52 2.00e-01 4.93e-01 0.144000 -7.86e-03 -1.44e-01 9.22e-01 7.26e-02
GOBP REGULATION OF GROWTH HORMONE RECEPTOR SIGNALING PATHWAY 6 8.29e-01 9.30e-01 0.144000 2.57e-03 1.44e-01 9.91e-01 5.41e-01
GOBP POSITIVE REGULATION OF CELLULAR CATABOLIC PROCESS 214 1.66e-03 2.04e-02 0.144000 1.40e-01 3.61e-02 4.35e-04 3.63e-01
GOCC TRANSFERASE COMPLEX 793 8.80e-12 9.40e-10 0.144000 1.25e-01 -7.09e-02 1.89e-09 6.81e-04
GOBP JNK CASCADE 163 5.33e-03 4.95e-02 0.144000 1.40e-01 -3.48e-02 2.08e-03 4.43e-01
GOBP REGULATION OF MUSCLE CELL DIFFERENTIATION 158 9.96e-03 7.86e-02 0.144000 1.28e-01 6.63e-02 5.58e-03 1.50e-01
GOBP AXO DENDRITIC TRANSPORT 75 8.48e-02 3.12e-01 0.144000 1.30e-01 -6.08e-02 5.07e-02 3.62e-01
GOBP REGULATION OF PLASMA MEMBRANE REPAIR 6 8.40e-01 9.34e-01 0.144000 9.52e-02 1.08e-01 6.86e-01 6.47e-01
GOCC CATALYTIC COMPLEX 1617 3.07e-22 1.26e-19 0.144000 1.30e-01 -6.14e-02 2.47e-18 3.90e-05
GOBP POSITIVE REGULATION OF CATION CHANNEL ACTIVITY 46 2.15e-01 5.10e-01 0.144000 1.09e-01 -9.39e-02 2.01e-01 2.70e-01
GOBP SPHINGOMYELIN METABOLIC PROCESS 20 5.23e-01 7.66e-01 0.144000 -4.16e-02 1.38e-01 7.47e-01 2.87e-01
GOBP CELL CYCLE CHECKPOINT SIGNALING 189 1.91e-03 2.28e-02 0.144000 1.09e-01 -9.31e-02 9.45e-03 2.73e-02
GOBP SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS 64 1.22e-01 3.81e-01 0.144000 1.29e-01 -6.39e-02 7.50e-02 3.76e-01
GOBP PULMONARY VALVE DEVELOPMENT 24 5.00e-01 7.53e-01 0.144000 1.11e-01 9.10e-02 3.46e-01 4.40e-01
HCMV Early Events 99 3.79e-02 1.91e-01 0.144000 7.95e-02 -1.20e-01 1.72e-01 3.97e-02
GOBP ANIMAL ORGAN MORPHOGENESIS 999 2.77e-13 3.69e-11 0.144000 1.41e-01 2.61e-02 4.11e-14 1.62e-01
GOBP DETECTION OF VISIBLE LIGHT 45 2.42e-01 5.39e-01 0.144000 -1.43e-01 1.46e-02 9.73e-02 8.66e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 7 8.06e-01 9.20e-01 0.144000 1.43e-01 9.73e-03 5.12e-01 9.64e-01
GOBP TRANSPOSITION 37 2.94e-01 5.91e-01 0.144000 -7.88e-02 1.20e-01 4.07e-01 2.07e-01
GOMF UBIQUITIN LIKE PROTEIN CONJUGATING ENZYME BINDING 37 3.17e-01 6.10e-01 0.144000 1.43e-01 -1.95e-03 1.31e-01 9.84e-01
GOBP REGULATION OF NERVOUS SYSTEM DEVELOPMENT 436 3.25e-06 1.07e-04 0.143000 1.35e-01 4.98e-02 1.44e-06 7.48e-02
Nuclear Envelope Breakdown 52 1.81e-01 4.70e-01 0.143000 1.26e-01 -6.93e-02 1.17e-01 3.87e-01
GOBP POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY 67 1.34e-01 4.01e-01 0.143000 -2.96e-02 -1.40e-01 6.75e-01 4.70e-02
Diseases associated with O-glycosylation of proteins 68 1.06e-01 3.50e-01 0.143000 -1.15e-01 8.55e-02 1.01e-01 2.23e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION 11 7.23e-01 8.81e-01 0.143000 -4.86e-02 -1.35e-01 7.80e-01 4.39e-01
GOBP MITOTIC CELL CYCLE CHECKPOINT SIGNALING 142 9.17e-03 7.41e-02 0.143000 1.05e-01 -9.73e-02 3.03e-02 4.53e-02
GOBP PROTEIN K63 LINKED DEUBIQUITINATION 26 4.70e-01 7.31e-01 0.143000 1.26e-01 6.82e-02 2.66e-01 5.47e-01
GOBP NEGATIVE REGULATION OF LIPID TRANSPORT 47 2.53e-01 5.50e-01 0.143000 1.32e-01 5.69e-02 1.19e-01 5.00e-01
GOMF L ASCORBIC ACID BINDING 20 5.41e-01 7.79e-01 0.143000 1.43e-01 8.64e-03 2.68e-01 9.47e-01
GOBP ACUTE INFLAMMATORY RESPONSE 100 4.34e-02 2.07e-01 0.143000 -1.42e-01 1.80e-02 1.41e-02 7.55e-01
GOBP REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION 23 4.79e-01 7.38e-01 0.143000 1.38e-01 -3.75e-02 2.51e-01 7.56e-01
GOBP ASTROCYTE DIFFERENTIATION 85 7.19e-02 2.81e-01 0.143000 1.43e-01 -5.91e-03 2.26e-02 9.25e-01
GOBP COMPLEMENT DEPENDENT CYTOTOXICITY 13 6.81e-01 8.62e-01 0.143000 -1.36e-01 -4.33e-02 3.95e-01 7.87e-01
GOCC BETA CATENIN DESTRUCTION COMPLEX 12 6.75e-01 8.59e-01 0.143000 6.78e-02 -1.26e-01 6.84e-01 4.50e-01
GOBP GOLGI TO VACUOLE TRANSPORT 20 5.42e-01 7.80e-01 0.143000 1.43e-01 7.01e-03 2.69e-01 9.57e-01
GOCC ENDOPLASMIC RETICULUM PROTEIN CONTAINING COMPLEX 118 2.27e-02 1.39e-01 0.143000 4.89e-02 -1.34e-01 3.59e-01 1.17e-02
GOMF BITTER TASTE RECEPTOR ACTIVITY 24 4.97e-01 7.52e-01 0.143000 5.70e-02 1.31e-01 6.29e-01 2.66e-01
GOBP PROTEIN AUTOPHOSPHORYLATION 179 5.55e-03 5.08e-02 0.143000 1.33e-01 5.29e-02 2.18e-03 2.22e-01
GOBP POSITIVE REGULATION OF MYOBLAST FUSION 15 6.26e-01 8.32e-01 0.143000 -1.42e-01 1.63e-02 3.41e-01 9.13e-01
GOBP REGULATION OF PROTEIN COMPLEX STABILITY 14 6.33e-01 8.36e-01 0.143000 1.27e-01 -6.62e-02 4.12e-01 6.68e-01
Interactions of Vpr with host cellular proteins 35 3.15e-01 6.08e-01 0.143000 9.89e-02 -1.03e-01 3.11e-01 2.91e-01
GOBP GROWTH PLATE CARTILAGE DEVELOPMENT 19 5.42e-01 7.80e-01 0.143000 5.03e-02 -1.34e-01 7.04e-01 3.13e-01
GOMF LONG CHAIN FATTY ACID COA LIGASE ACTIVITY 14 6.61e-01 8.51e-01 0.143000 3.77e-02 1.38e-01 8.07e-01 3.72e-01
tRNA modification in the nucleus and cytosol 41 2.76e-01 5.74e-01 0.143000 1.41e-01 -2.20e-02 1.18e-01 8.07e-01
GOBP REGULATION OF PLASMA MEMBRANE ORGANIZATION 16 6.30e-01 8.34e-01 0.143000 1.27e-01 6.43e-02 3.77e-01 6.56e-01
GOBP PRIMARY MIRNA PROCESSING 18 5.53e-01 7.87e-01 0.143000 9.50e-02 -1.07e-01 4.85e-01 4.34e-01
GOBP GLOMERULUS MORPHOGENESIS 9 7.60e-01 8.97e-01 0.143000 1.43e-01 4.81e-03 4.59e-01 9.80e-01
GOBP POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM 34 3.26e-01 6.18e-01 0.143000 1.04e-01 -9.73e-02 2.92e-01 3.26e-01
GOBP ERBB SIGNALING PATHWAY 131 1.83e-02 1.20e-01 0.143000 1.43e-01 -3.91e-04 4.78e-03 9.94e-01
GOBP OVULATION CYCLE PROCESS 50 2.34e-01 5.31e-01 0.143000 5.49e-02 1.32e-01 5.02e-01 1.07e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 44 2.65e-01 5.62e-01 0.143000 -1.42e-01 -1.51e-02 1.03e-01 8.62e-01
GOMF HYDROLASE ACTIVITY HYDROLYZING N GLYCOSYL COMPOUNDS 38 2.94e-01 5.91e-01 0.143000 -5.32e-02 1.32e-01 5.70e-01 1.58e-01
GOBP GOLGI ORGANIZATION 138 1.65e-02 1.12e-01 0.143000 1.41e-01 2.44e-02 4.37e-03 6.21e-01
Potential therapeutics for SARS 92 5.85e-02 2.48e-01 0.143000 1.42e-01 -9.79e-03 1.83e-02 8.71e-01
GOCC EPSILON DNA POLYMERASE COMPLEX 5 8.58e-01 9.41e-01 0.143000 -1.80e-03 -1.43e-01 9.94e-01 5.81e-01
GOBP REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY 13 6.59e-01 8.50e-01 0.143000 5.00e-02 -1.34e-01 7.55e-01 4.05e-01
GOBP TEMPERATURE HOMEOSTASIS 182 4.09e-03 4.06e-02 0.143000 1.42e-01 5.94e-03 9.17e-04 8.90e-01
GOBP PROTEOGLYCAN METABOLIC PROCESS 85 8.96e-02 3.20e-01 0.143000 8.64e-02 1.13e-01 1.69e-01 7.06e-02
GOMF CYSTEINE TYPE PEPTIDASE ACTIVITY 154 8.83e-03 7.21e-02 0.143000 1.42e-01 -9.11e-03 2.31e-03 8.45e-01
Transport of the SLBP independent Mature mRNA 35 3.24e-01 6.15e-01 0.142000 1.31e-01 -5.58e-02 1.80e-01 5.68e-01
DDX58/IFIH1-mediated induction of interferon-alpha/beta 76 8.47e-02 3.12e-01 0.142000 7.42e-02 -1.22e-01 2.63e-01 6.69e-02
GOBP MRNA TRANSCRIPTION 47 2.43e-01 5.39e-01 0.142000 1.42e-01 1.47e-02 9.29e-02 8.62e-01
GOBP ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE 8 7.88e-01 9.13e-01 0.142000 1.40e-01 2.57e-02 4.93e-01 9.00e-01
GOBP NEGATIVE REGULATION OF HORMONE METABOLIC PROCESS 12 6.94e-01 8.68e-01 0.142000 -1.85e-03 -1.42e-01 9.91e-01 3.93e-01
SARS-CoV-1 activates/modulates innate immune responses 39 2.81e-01 5.78e-01 0.142000 7.52e-02 -1.21e-01 4.16e-01 1.91e-01
GOMF ADRENERGIC RECEPTOR BINDING 18 5.79e-01 8.02e-01 0.142000 1.42e-01 6.09e-03 2.96e-01 9.64e-01
Paradoxical activation of RAF signaling by kinase inactive BRAF 42 2.69e-01 5.66e-01 0.142000 1.40e-01 -2.58e-02 1.17e-01 7.73e-01
Signaling by RAS mutants 42 2.69e-01 5.66e-01 0.142000 1.40e-01 -2.58e-02 1.17e-01 7.73e-01
Signaling by moderate kinase activity BRAF mutants 42 2.69e-01 5.66e-01 0.142000 1.40e-01 -2.58e-02 1.17e-01 7.73e-01
Signaling downstream of RAS mutants 42 2.69e-01 5.66e-01 0.142000 1.40e-01 -2.58e-02 1.17e-01 7.73e-01
GOBP POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 58 1.77e-01 4.64e-01 0.142000 1.41e-01 1.88e-02 6.32e-02 8.05e-01
GOBP MUSCLE TISSUE DEVELOPMENT 429 4.07e-06 1.31e-04 0.142000 1.38e-01 3.29e-02 8.83e-07 2.43e-01
GOBP FARNESYL DIPHOSPHATE METABOLIC PROCESS 6 8.25e-01 9.28e-01 0.142000 -1.33e-01 5.10e-02 5.73e-01 8.29e-01
GOBP POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION 179 5.08e-03 4.80e-02 0.142000 1.40e-01 2.36e-02 1.21e-03 5.86e-01
GOBP PARANODAL JUNCTION ASSEMBLY 6 8.37e-01 9.32e-01 0.142000 2.81e-02 1.39e-01 9.05e-01 5.54e-01
GOBP MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS 13 6.75e-01 8.59e-01 0.142000 -8.56e-03 -1.42e-01 9.57e-01 3.76e-01
GOBP G PROTEIN COUPLED OPIOID RECEPTOR SIGNALING PATHWAY 11 7.02e-01 8.71e-01 0.142000 -6.26e-02 1.28e-01 7.19e-01 4.64e-01
Telomere C-strand (Lagging Strand) Synthesis 33 3.52e-01 6.42e-01 0.142000 1.36e-01 -4.15e-02 1.77e-01 6.80e-01
GOBP REGULATION OF CENTROSOME CYCLE 53 1.99e-01 4.92e-01 0.142000 2.28e-03 -1.42e-01 9.77e-01 7.36e-02
GOBP REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS 15 6.34e-01 8.36e-01 0.142000 1.00e-04 -1.42e-01 9.99e-01 3.41e-01
GOBP DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING 69 1.23e-01 3.82e-01 0.142000 1.42e-01 -2.18e-03 4.14e-02 9.75e-01
GOBP REGULATION OF SECONDARY METABOLIC PROCESS 15 6.31e-01 8.34e-01 0.142000 9.70e-03 -1.42e-01 9.48e-01 3.42e-01
GOMF PROTEIN HETERODIMERIZATION ACTIVITY 308 5.49e-05 1.28e-03 0.142000 6.97e-02 -1.24e-01 3.53e-02 1.90e-04
GOBP POSITIVE REGULATION OF FATTY ACID BETA OXIDATION 10 7.37e-01 8.87e-01 0.142000 1.42e-01 -3.53e-03 4.37e-01 9.85e-01
GOBP TRANSEPITHELIAL TRANSPORT 35 3.54e-01 6.44e-01 0.142000 2.24e-02 1.40e-01 8.19e-01 1.51e-01
GOBP MYOTUBE DIFFERENTIATION 129 2.68e-02 1.56e-01 0.142000 1.12e-01 8.68e-02 2.76e-02 8.87e-02
Cholesterol biosynthesis 25 4.49e-01 7.19e-01 0.142000 -1.29e-01 5.93e-02 2.65e-01 6.08e-01
GOBP GERMINAL CENTER B CELL DIFFERENTIATION 8 7.98e-01 9.17e-01 0.142000 1.17e-01 8.06e-02 5.67e-01 6.93e-01
GOBP REGULATION OF COLLATERAL SPROUTING 19 5.74e-01 8.00e-01 0.142000 1.37e-01 3.74e-02 3.02e-01 7.78e-01
GOBP ENDONUCLEOLYTIC CLEAVAGE OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 16 6.11e-01 8.23e-01 0.142000 1.41e-01 -1.53e-02 3.29e-01 9.16e-01
PI3K events in ERBB4 signaling 10 7.55e-01 8.95e-01 0.142000 -8.84e-02 -1.11e-01 6.28e-01 5.44e-01
GOMF ENDODEOXYRIBONUCLEASE ACTIVITY PRODUCING 5 PHOSPHOMONOESTERS 11 7.34e-01 8.85e-01 0.142000 1.14e-01 8.47e-02 5.14e-01 6.27e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS DISULFIDE AS ACCEPTOR 5 8.54e-01 9.39e-01 0.142000 4.73e-02 -1.34e-01 8.55e-01 6.05e-01
GOBP TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY 9 7.49e-01 8.92e-01 0.142000 -1.25e-01 6.68e-02 5.17e-01 7.29e-01
GOMF POLYPEPTIDE N ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY 19 5.80e-01 8.03e-01 0.142000 5.14e-02 1.32e-01 6.98e-01 3.19e-01
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION 60 1.77e-01 4.64e-01 0.141000 1.35e-01 4.20e-02 7.03e-02 5.73e-01
GOBP CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND 14 6.62e-01 8.51e-01 0.141000 -1.40e-01 -2.32e-02 3.66e-01 8.80e-01
GOBP ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS 24 5.07e-01 7.58e-01 0.141000 1.24e-01 6.87e-02 2.94e-01 5.60e-01
Mitotic G1 phase and G1/S transition 136 1.25e-02 9.23e-02 0.141000 9.90e-02 -1.01e-01 4.62e-02 4.18e-02
GOBP NEGATIVE REGULATION OF PROTEIN KINASE ACTIVITY BY REGULATION OF PROTEIN PHOSPHORYLATION 6 8.33e-01 9.30e-01 0.141000 1.41e-01 -1.14e-02 5.50e-01 9.61e-01
GOBP BUNDLE OF HIS CELL TO PURKINJE MYOCYTE SIGNALING 7 8.15e-01 9.25e-01 0.141000 -1.38e-01 -3.08e-02 5.27e-01 8.88e-01
GOMF VITAMIN B6 BINDING 53 2.18e-01 5.13e-01 0.141000 4.47e-02 1.34e-01 5.73e-01 9.11e-02
GOBP O GLYCAN PROCESSING 42 2.89e-01 5.86e-01 0.141000 1.85e-02 1.40e-01 8.36e-01 1.16e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 29 4.45e-01 7.17e-01 0.141000 1.02e-01 9.82e-02 3.43e-01 3.60e-01
GOBP SEQUESTERING OF EXTRACELLULAR LIGAND FROM RECEPTOR 11 7.25e-01 8.82e-01 0.141000 -3.11e-02 -1.38e-01 8.58e-01 4.28e-01
Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding 38 3.12e-01 6.06e-01 0.141000 1.78e-02 -1.40e-01 8.49e-01 1.35e-01
GOCC POSTSYNAPTIC SPECIALIZATION MEMBRANE 124 2.69e-02 1.56e-01 0.141000 -1.39e-01 -2.60e-02 7.55e-03 6.17e-01
GOBP ATRIOVENTRICULAR VALVE FORMATION 8 7.99e-01 9.17e-01 0.141000 8.23e-02 1.15e-01 6.87e-01 5.74e-01
GOBP NITROGEN UTILIZATION 5 8.57e-01 9.41e-01 0.141000 -1.39e-01 2.22e-02 5.89e-01 9.31e-01
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON 5 8.69e-01 9.46e-01 0.141000 1.23e-01 6.93e-02 6.34e-01 7.89e-01
GOBP RRNA METABOLIC PROCESS 253 3.12e-04 5.37e-03 0.141000 9.91e-02 -1.01e-01 6.63e-03 5.88e-03
GOBP NEGATIVE REGULATION OF STEROL TRANSPORT 30 4.32e-01 7.07e-01 0.141000 7.94e-02 1.17e-01 4.52e-01 2.69e-01
GOBP PURINE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORT 37 3.44e-01 6.33e-01 0.141000 3.81e-02 1.36e-01 6.88e-01 1.52e-01
GOBP ESTROUS CYCLE 16 6.10e-01 8.22e-01 0.141000 1.38e-01 -2.74e-02 3.38e-01 8.49e-01
GOCC PALMITOYLTRANSFERASE COMPLEX 10 7.26e-01 8.82e-01 0.141000 1.18e-01 -7.70e-02 5.17e-01 6.73e-01
GOBP ACETYL COA METABOLIC PROCESS 31 3.83e-01 6.68e-01 0.141000 -3.06e-02 1.38e-01 7.68e-01 1.84e-01
GOBP CERAMIDE METABOLIC PROCESS 109 4.28e-02 2.06e-01 0.141000 3.24e-02 1.37e-01 5.59e-01 1.32e-02
ATF6 (ATF6-alpha) activates chaperones 11 7.07e-01 8.73e-01 0.141000 1.31e-01 -5.28e-02 4.52e-01 7.62e-01
GOBP POSITIVE REGULATION OF CATECHOLAMINE SECRETION 12 6.97e-01 8.69e-01 0.141000 1.41e-01 -3.58e-03 3.98e-01 9.83e-01
GOBP REGULATION OF HAIR CYCLE 29 4.37e-01 7.10e-01 0.141000 1.33e-01 4.72e-02 2.15e-01 6.60e-01
GOBP SENSORY ORGAN DEVELOPMENT 581 7.15e-08 3.64e-06 0.141000 1.38e-01 3.05e-02 1.39e-08 2.09e-01
GOBP MISMATCH REPAIR 34 3.82e-01 6.67e-01 0.141000 1.28e-01 5.90e-02 1.96e-01 5.52e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 14 6.71e-01 8.56e-01 0.141000 1.32e-01 4.99e-02 3.93e-01 7.46e-01
Nuclear Events (kinase and transcription factor activation) 59 1.55e-01 4.36e-01 0.141000 5.90e-02 -1.28e-01 4.33e-01 8.89e-02
GOBP REGULATION OF AMACRINE CELL DIFFERENTIATION 6 8.44e-01 9.36e-01 0.141000 -5.79e-02 -1.29e-01 8.06e-01 5.86e-01
GOBP DNA METABOLIC PROCESS 957 3.60e-13 4.70e-11 0.141000 1.34e-01 -4.40e-02 2.20e-12 2.12e-02
GOBP INTERNEURON MIGRATION 13 6.65e-01 8.52e-01 0.141000 1.31e-01 -5.18e-02 4.14e-01 7.46e-01
GOBP CAP DEPENDENT TRANSLATIONAL INITIATION 7 8.00e-01 9.18e-01 0.141000 7.19e-02 -1.21e-01 7.42e-01 5.79e-01
GOBP T HELPER 1 CELL DIFFERENTIATION 23 5.05e-01 7.57e-01 0.141000 1.41e-01 4.74e-03 2.43e-01 9.69e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS 23 5.23e-01 7.65e-01 0.141000 -1.28e-01 -5.83e-02 2.87e-01 6.29e-01
GOBP UROGENITAL SYSTEM DEVELOPMENT 65 1.38e-01 4.08e-01 0.141000 1.39e-01 -2.25e-02 5.27e-02 7.54e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 589 1.79e-08 1.05e-06 0.141000 1.34e-01 -4.26e-02 2.67e-08 7.76e-02
GOBP CELLULAR RESPONSE TO STARVATION 165 8.90e-03 7.26e-02 0.141000 1.37e-01 3.31e-02 2.45e-03 4.63e-01
Post-chaperonin tubulin folding pathway 22 4.96e-01 7.51e-01 0.141000 -1.11e-01 8.64e-02 3.68e-01 4.83e-01
Separation of Sister Chromatids 170 4.55e-03 4.40e-02 0.141000 1.04e-01 -9.41e-02 1.88e-02 3.42e-02
GOBP NEPHRIC DUCT DEVELOPMENT 14 6.58e-01 8.50e-01 0.141000 1.41e-01 -2.54e-03 3.63e-01 9.87e-01
GOBP REGULATION OF ERAD PATHWAY 22 4.97e-01 7.52e-01 0.141000 7.75e-02 -1.17e-01 5.29e-01 3.41e-01
GOBP REGULATION OF CGMP MEDIATED SIGNALING 11 7.07e-01 8.73e-01 0.140000 -6.75e-02 1.23e-01 6.98e-01 4.79e-01
GOMF LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY 18 6.07e-01 8.20e-01 0.140000 7.44e-02 1.19e-01 5.85e-01 3.82e-01
GOBP NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION 151 9.49e-03 7.58e-02 0.140000 1.33e-01 -4.52e-02 4.82e-03 3.37e-01
GOBP POSITIVE REGULATION OF GROWTH HORMONE SECRETION 9 7.56e-01 8.95e-01 0.140000 4.79e-02 -1.32e-01 8.03e-01 4.93e-01
GOBP MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION 129 2.47e-02 1.47e-01 0.140000 1.38e-01 2.79e-02 6.96e-03 5.85e-01
GOBP MEGAKARYOCYTE DIFFERENTIATION 62 1.42e-01 4.14e-01 0.140000 6.84e-02 -1.23e-01 3.51e-01 9.51e-02
GOBP REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT 112 2.98e-02 1.66e-01 0.140000 -1.23e-01 6.70e-02 2.42e-02 2.20e-01
GOBP POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET 7 8.09e-01 9.22e-01 0.140000 1.39e-01 -2.04e-02 5.25e-01 9.26e-01
GOBP NEGATIVE REGULATION OF OSTEOCLAST DEVELOPMENT 5 8.54e-01 9.40e-01 0.140000 6.52e-02 -1.24e-01 8.01e-01 6.31e-01
Integration of energy metabolism 105 5.04e-02 2.26e-01 0.140000 3.55e-02 1.36e-01 5.30e-01 1.63e-02
GOBP PLATELET MORPHOGENESIS 25 4.89e-01 7.46e-01 0.140000 1.36e-01 3.32e-02 2.38e-01 7.74e-01
Atorvastatin ADME 9 7.57e-01 8.96e-01 0.140000 -4.38e-02 1.33e-01 8.20e-01 4.89e-01
GOBP APOLIPOPROTEIN A I MEDIATED SIGNALING PATHWAY 7 8.18e-01 9.27e-01 0.140000 1.37e-01 2.83e-02 5.29e-01 8.97e-01
GOBP POSITIVE REGULATION OF B CELL DIFFERENTIATION 15 6.23e-01 8.30e-01 0.140000 7.75e-02 -1.17e-01 6.03e-01 4.34e-01
GOBP REGULATION OF SKELETAL MUSCLE FIBER DEVELOPMENT 11 7.06e-01 8.73e-01 0.140000 8.67e-02 -1.10e-01 6.19e-01 5.28e-01
GOBP PROTEIN LOCALIZATION TO CELL SURFACE 65 1.69e-01 4.54e-01 0.140000 8.62e-02 1.10e-01 2.29e-01 1.24e-01
GOMF GAP JUNCTION CHANNEL ACTIVITY INVOLVED IN CELL COMMUNICATION BY ELECTRICAL COUPLING 8 7.77e-01 9.07e-01 0.140000 1.19e-01 -7.45e-02 5.61e-01 7.15e-01
Inwardly rectifying K+ channels 35 3.35e-01 6.25e-01 0.140000 -6.55e-02 1.24e-01 5.03e-01 2.05e-01
GOBP REGULATION OF STEROL TRANSPORT 77 9.23e-02 3.26e-01 0.140000 -5.33e-02 1.29e-01 4.19e-01 4.96e-02
GOBP POSITIVE REGULATION OF HEART RATE 25 4.54e-01 7.21e-01 0.140000 9.00e-02 -1.07e-01 4.36e-01 3.53e-01
GOBP I KAPPAB PHOSPHORYLATION 14 6.69e-01 8.55e-01 0.140000 1.37e-01 2.71e-02 3.74e-01 8.61e-01
GOBP NEGATIVE REGULATION OF MITOTIC CELL CYCLE 243 5.38e-04 8.35e-03 0.140000 1.24e-01 -6.55e-02 9.02e-04 7.84e-02
GOBP SECRETORY GRANULE LOCALIZATION 22 5.21e-01 7.64e-01 0.140000 -1.40e-01 6.19e-03 2.57e-01 9.60e-01
GOBP RESPONSE TO STARVATION 204 3.13e-03 3.30e-02 0.140000 1.36e-01 3.17e-02 7.98e-04 4.35e-01
GOBP CELLULAR RESPONSE TO LEPTIN STIMULUS 17 5.85e-01 8.06e-01 0.140000 8.70e-02 -1.09e-01 5.35e-01 4.34e-01
GOBP DNA BIOSYNTHETIC PROCESS 187 3.10e-03 3.28e-02 0.140000 1.26e-01 -5.97e-02 2.87e-03 1.59e-01
Inactivation of APC/C via direct inhibition of the APC/C complex 21 5.18e-01 7.63e-01 0.140000 7.18e-02 -1.20e-01 5.69e-01 3.41e-01
Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components 21 5.18e-01 7.63e-01 0.140000 7.18e-02 -1.20e-01 5.69e-01 3.41e-01
Sialic acid metabolism 33 4.06e-01 6.89e-01 0.140000 1.10e-01 8.66e-02 2.76e-01 3.89e-01
GOBP PROTEIN HETEROTETRAMERIZATION 15 6.24e-01 8.31e-01 0.140000 1.14e-01 -8.09e-02 4.45e-01 5.87e-01
Reversible hydration of carbon dioxide 11 7.34e-01 8.85e-01 0.140000 1.33e-01 4.42e-02 4.47e-01 8.00e-01
GOBP INTERLEUKIN 4 MEDIATED SIGNALING PATHWAY 9 7.57e-01 8.96e-01 0.140000 1.28e-01 -5.48e-02 5.05e-01 7.76e-01
GOBP REGULATION OF ORGANELLE ORGANIZATION 1165 4.33e-15 8.44e-13 0.140000 1.39e-01 -1.74e-02 1.52e-15 3.16e-01
GOBP CELL PROLIFERATION IN MIDBRAIN 8 7.93e-01 9.15e-01 0.140000 1.39e-01 1.20e-02 4.96e-01 9.53e-01
Signaling by FGFR2 IIIa TM 19 5.55e-01 7.88e-01 0.140000 1.26e-01 -5.97e-02 3.41e-01 6.53e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 46 2.86e-01 5.83e-01 0.140000 9.14e-02 1.05e-01 2.83e-01 2.16e-01
GOBP PROTEIN LOCALIZATION TO CELL CORTEX 11 7.41e-01 8.88e-01 0.140000 1.11e-01 8.52e-02 5.26e-01 6.25e-01
O-glycosylation of TSR domain-containing proteins 38 3.17e-01 6.10e-01 0.140000 -1.36e-01 2.97e-02 1.46e-01 7.51e-01
GOMF PROTEIN SERINE THREONINE KINASE ACTIVITY 405 1.86e-05 4.97e-04 0.140000 1.17e-01 7.53e-02 4.98e-05 9.32e-03
GOBP REGULATION OF P38MAPK CASCADE 46 2.59e-01 5.56e-01 0.140000 1.39e-01 -2.80e-03 1.02e-01 9.74e-01
GOBP POSTSYNAPTIC DENSITY PROTEIN 95 CLUSTERING 10 7.61e-01 8.98e-01 0.140000 -1.13e-01 -8.12e-02 5.35e-01 6.57e-01
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE 37 3.40e-01 6.29e-01 0.139000 3.10e-03 1.39e-01 9.74e-01 1.42e-01
GOBP CELL ADHESION MEDIATED BY INTEGRIN 87 7.00e-02 2.77e-01 0.139000 1.31e-01 -4.81e-02 3.49e-02 4.38e-01
GOBP EYE MORPHOGENESIS 160 1.26e-02 9.27e-02 0.139000 1.23e-01 6.56e-02 7.27e-03 1.52e-01
GOBP L KYNURENINE METABOLIC PROCESS 7 8.10e-01 9.22e-01 0.139000 -1.36e-01 2.90e-02 5.32e-01 8.94e-01
GOBP GLYCEROPHOSPHOLIPID METABOLIC PROCESS 295 1.28e-04 2.64e-03 0.139000 1.29e-01 -5.24e-02 1.35e-04 1.22e-01
GOCC SEX CHROMOSOME 33 3.71e-01 6.58e-01 0.139000 1.37e-01 -2.55e-02 1.73e-01 8.00e-01
GOBP POSITIVE REGULATION OF GROWTH 240 1.54e-03 1.94e-02 0.139000 1.16e-01 7.78e-02 2.03e-03 3.80e-02
GOBP NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 68 1.56e-01 4.37e-01 0.139000 -1.20e-01 -7.11e-02 8.76e-02 3.11e-01
GOCC INTRACILIARY TRANSPORT PARTICLE 26 4.50e-01 7.19e-01 0.139000 5.11e-02 -1.30e-01 6.52e-01 2.53e-01
GOBP DENSE CORE GRANULE EXOCYTOSIS 10 7.33e-01 8.85e-01 0.139000 -1.21e-01 6.86e-02 5.07e-01 7.07e-01
GOBP REGULATION OF MITOTIC CELL CYCLE 515 2.54e-07 1.15e-05 0.139000 1.36e-01 -3.11e-02 1.34e-07 2.27e-01
GOBP SEMI LUNAR VALVE DEVELOPMENT 48 2.57e-01 5.54e-01 0.139000 1.36e-01 2.99e-02 1.03e-01 7.20e-01
GOBP VACUOLAR LOCALIZATION 80 8.76e-02 3.16e-01 0.139000 1.32e-01 -4.53e-02 4.18e-02 4.84e-01
GOBP RIBOSOMAL LARGE SUBUNIT ASSEMBLY 21 5.42e-01 7.80e-01 0.139000 -1.88e-03 -1.39e-01 9.88e-01 2.70e-01
GOBP RENAL ABSORPTION 34 3.99e-01 6.81e-01 0.139000 9.30e-02 1.04e-01 3.48e-01 2.96e-01
GOBP POSITIVE REGULATION OF LIPASE ACTIVITY 50 2.59e-01 5.56e-01 0.139000 -8.84e-02 -1.07e-01 2.79e-01 1.89e-01
GOBP PEPTIDYL THREONINE DEPHOSPHORYLATION 17 6.10e-01 8.22e-01 0.139000 1.39e-01 3.98e-03 3.21e-01 9.77e-01
GOBP PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS 5 8.69e-01 9.46e-01 0.139000 4.12e-02 1.33e-01 8.73e-01 6.07e-01
Cytoprotection by HMOX1 54 2.15e-01 5.10e-01 0.139000 1.38e-01 2.11e-02 8.04e-02 7.88e-01
GOBP TANGENTIAL MIGRATION FROM THE SUBVENTRICULAR ZONE TO THE OLFACTORY BULB 7 8.21e-01 9.27e-01 0.139000 -1.35e-01 -3.28e-02 5.36e-01 8.81e-01
GOBP RESPONSE TO TUMOR CELL 44 3.04e-01 5.98e-01 0.139000 -8.09e-02 -1.13e-01 3.53e-01 1.94e-01
GOBP GLYCOSPHINGOLIPID METABOLIC PROCESS 68 1.56e-01 4.36e-01 0.139000 1.24e-01 6.32e-02 7.73e-02 3.67e-01
GOBP OSTEOBLAST PROLIFERATION 36 3.64e-01 6.51e-01 0.139000 1.35e-01 3.41e-02 1.62e-01 7.23e-01
Defective B3GALTL causes PpS 37 3.37e-01 6.26e-01 0.139000 -1.38e-01 1.22e-02 1.45e-01 8.98e-01
GOMF CLASS I DNA APURINIC OR APYRIMIDINIC SITE ENDONUCLEASE ACTIVITY 8 7.82e-01 9.10e-01 0.139000 1.25e-01 -6.14e-02 5.42e-01 7.64e-01
Regulation of BACH1 activity 15 6.27e-01 8.33e-01 0.139000 8.81e-02 -1.07e-01 5.55e-01 4.72e-01
GOBP POSITIVE REGULATION OF ERAD PATHWAY 15 6.28e-01 8.33e-01 0.139000 1.13e-01 -8.04e-02 4.48e-01 5.90e-01
GOBP RESPONSE TO HYDROPEROXIDE 19 5.53e-01 7.87e-01 0.139000 -9.63e-02 1.00e-01 4.68e-01 4.50e-01
GOMF G PROTEIN ALPHA SUBUNIT BINDING 29 4.56e-01 7.22e-01 0.139000 1.18e-01 7.32e-02 2.72e-01 4.95e-01
GOBP SKELETAL MUSCLE ORGAN DEVELOPMENT 176 5.37e-03 4.97e-02 0.139000 1.36e-01 -2.92e-02 1.90e-03 5.04e-01
GOBP GLAND MORPHOGENESIS 124 2.18e-02 1.35e-01 0.139000 1.15e-01 -7.70e-02 2.64e-02 1.38e-01
GOCC PRERIBOSOME SMALL SUBUNIT PRECURSOR 15 6.29e-01 8.34e-01 0.139000 1.20e-01 -6.98e-02 4.21e-01 6.40e-01
Cell Cycle 620 7.94e-09 4.93e-07 0.139000 1.17e-01 -7.47e-02 6.77e-07 1.49e-03
GOBP L SERINE METABOLIC PROCESS 11 7.31e-01 8.84e-01 0.139000 1.38e-01 1.79e-02 4.30e-01 9.18e-01
GOBP CHROMOSOME SEGREGATION 409 7.28e-06 2.20e-04 0.139000 1.38e-01 -1.53e-02 1.73e-06 5.95e-01
GOBP VACUOLAR TRANSMEMBRANE TRANSPORT 8 7.97e-01 9.17e-01 0.139000 1.37e-01 1.95e-02 5.01e-01 9.24e-01
GOCC STEREOCILIUM BUNDLE 64 1.80e-01 4.69e-01 0.139000 -9.62e-02 -9.98e-02 1.83e-01 1.67e-01
GOBP ESTABLISHMENT OF LYMPHOCYTE POLARITY 16 6.42e-01 8.41e-01 0.139000 1.32e-01 4.33e-02 3.62e-01 7.64e-01
GOBP POSITIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH 10 7.48e-01 8.91e-01 0.139000 1.38e-01 -3.33e-03 4.48e-01 9.85e-01
Nucleotide catabolism 35 3.91e-01 6.74e-01 0.139000 -1.07e-01 -8.76e-02 2.72e-01 3.70e-01
GOBP STEROL TRANSPORT 128 2.50e-02 1.49e-01 0.138000 -2.14e-03 1.38e-01 9.67e-01 6.82e-03
GOBP POSITIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 17 6.32e-01 8.35e-01 0.138000 -7.45e-02 -1.17e-01 5.95e-01 4.05e-01
Gene Silencing by RNA 104 4.03e-02 1.98e-01 0.138000 9.95e-02 -9.62e-02 7.94e-02 9.01e-02
GOBP BEHAVIORAL RESPONSE TO PAIN 19 6.01e-01 8.16e-01 0.138000 8.26e-02 1.11e-01 5.33e-01 4.02e-01
Signaling by NTRK1 (TRKA) 113 3.35e-02 1.78e-01 0.138000 1.31e-01 -4.52e-02 1.63e-02 4.06e-01
GOBP GAMMA AMINOBUTYRIC ACID IMPORT 6 8.31e-01 9.30e-01 0.138000 8.19e-02 -1.11e-01 7.28e-01 6.36e-01
GOBP ERYTHROCYTE DEVELOPMENT 40 2.98e-01 5.94e-01 0.138000 5.39e-02 -1.27e-01 5.55e-01 1.64e-01
GOBP POSITIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS 104 5.47e-02 2.39e-01 0.138000 1.36e-01 2.47e-02 1.65e-02 6.64e-01
GOBP REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 43 2.78e-01 5.75e-01 0.138000 3.49e-02 -1.34e-01 6.92e-01 1.29e-01
GOCC MAIN AXON 68 1.47e-01 4.22e-01 0.138000 1.63e-02 1.37e-01 8.17e-01 5.03e-02
GOBP REGULATION OF CELL CYCLE 1072 5.39e-14 7.88e-12 0.138000 1.33e-01 -3.82e-02 1.98e-13 3.47e-02
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX PROTON TRANSPORTING DOMAIN 23 5.11e-01 7.60e-01 0.138000 1.29e-02 -1.38e-01 9.15e-01 2.53e-01
GOBP REGULATION OF MONOOXYGENASE ACTIVITY 37 3.55e-01 6.44e-01 0.138000 1.36e-01 2.39e-02 1.52e-01 8.02e-01
GOCC FIBRILLAR CENTER 144 1.69e-02 1.14e-01 0.138000 1.38e-01 8.87e-03 4.29e-03 8.54e-01
GOBP REGULATION OF THE FORCE OF HEART CONTRACTION 26 4.98e-01 7.52e-01 0.138000 -1.17e-01 -7.36e-02 3.02e-01 5.16e-01
GOMF LIGASE ACTIVITY FORMING CARBON CARBON BONDS 7 8.29e-01 9.29e-01 0.138000 1.18e-01 7.18e-02 5.89e-01 7.42e-01
GOBP MUSCLE ORGAN MORPHOGENESIS 82 1.14e-01 3.66e-01 0.138000 1.03e-01 9.21e-02 1.08e-01 1.49e-01
GOBP TUBE DEVELOPMENT 1135 6.01e-14 8.68e-12 0.138000 1.37e-01 1.53e-02 6.32e-15 3.84e-01
GOBP DEPHOSPHORYLATION 272 3.80e-04 6.30e-03 0.138000 1.36e-01 -2.02e-02 1.07e-04 5.66e-01
GOBP VENTRAL MIDLINE DEVELOPMENT 6 8.41e-01 9.34e-01 0.138000 -1.38e-01 4.94e-03 5.59e-01 9.83e-01
GOBP RESPONSE TO VITAMIN E 9 7.85e-01 9.12e-01 0.138000 -6.37e-02 -1.22e-01 7.41e-01 5.25e-01
GOBP PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 20 5.74e-01 7.99e-01 0.138000 -2.82e-02 -1.35e-01 8.27e-01 2.96e-01
GOMF IONOTROPIC GLUTAMATE RECEPTOR BINDING 23 4.98e-01 7.52e-01 0.138000 -6.09e-02 1.24e-01 6.13e-01 3.05e-01
HSF1-dependent transactivation 34 3.56e-01 6.46e-01 0.138000 6.48e-02 -1.22e-01 5.13e-01 2.20e-01
GOCC MITOTIC SPINDLE MICROTUBULE 13 6.79e-01 8.61e-01 0.138000 3.73e-02 -1.33e-01 8.16e-01 4.08e-01
Base Excision Repair 68 1.27e-01 3.89e-01 0.138000 6.53e-02 -1.21e-01 3.52e-01 8.35e-02
Gap junction assembly 35 3.43e-01 6.32e-01 0.138000 -1.14e-01 7.78e-02 2.44e-01 4.26e-01
GOBP CELLULAR RESPONSE TO NUTRIENT LEVELS 232 1.45e-03 1.86e-02 0.138000 1.38e-01 6.03e-03 3.02e-04 8.74e-01
GOBP NEGATIVE REGULATION OF AMIDE METABOLIC PROCESS 33 3.71e-01 6.58e-01 0.138000 5.42e-02 -1.27e-01 5.90e-01 2.08e-01
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT 142 1.55e-02 1.08e-01 0.138000 1.34e-01 -3.10e-02 5.77e-03 5.23e-01
GOMF HISTONE H3 KINASE ACTIVITY 11 7.47e-01 8.91e-01 0.138000 9.85e-02 9.62e-02 5.71e-01 5.81e-01
GOBP RAC PROTEIN SIGNAL TRANSDUCTION 48 2.52e-01 5.49e-01 0.138000 1.38e-01 -6.39e-03 9.92e-02 9.39e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 173 6.14e-03 5.48e-02 0.138000 1.32e-01 -3.74e-02 2.65e-03 3.96e-01
GOBP CELL RECOGNITION 154 1.24e-02 9.11e-02 0.138000 -1.38e-01 5.36e-03 3.22e-03 9.09e-01
GOMF LIPID TRANSMEMBRANE TRANSPORTER ACTIVITY 54 2.08e-01 5.03e-01 0.138000 -2.04e-02 1.36e-01 7.95e-01 8.36e-02
GOBP GENOMIC IMPRINTING 17 6.05e-01 8.19e-01 0.138000 1.33e-01 -3.45e-02 3.42e-01 8.05e-01
GOMF AMMONIA LYASE ACTIVITY 5 8.74e-01 9.48e-01 0.138000 -1.24e-01 -5.93e-02 6.31e-01 8.18e-01
LDL clearance 19 5.70e-01 7.97e-01 0.138000 1.32e-01 -3.77e-02 3.18e-01 7.76e-01
GOMF NUCLEOBASE CONTAINING COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY 52 2.45e-01 5.41e-01 0.138000 4.93e-02 1.28e-01 5.39e-01 1.09e-01
GOBP PROTEIN LOCALIZATION TO GOLGI APPARATUS 30 4.53e-01 7.21e-01 0.137000 1.05e-01 8.86e-02 3.19e-01 4.01e-01
InlB-mediated entry of Listeria monocytogenes into host cell 14 6.53e-01 8.47e-01 0.137000 7.86e-02 -1.13e-01 6.11e-01 4.65e-01
GOBP MEIOTIC CELL CYCLE CHECKPOINT SIGNALING 10 7.68e-01 9.02e-01 0.137000 8.36e-02 1.09e-01 6.47e-01 5.50e-01
GOBP CELLULAR RESPONSE TO RETINOIC ACID 67 1.40e-01 4.12e-01 0.137000 1.34e-01 -3.04e-02 5.78e-02 6.67e-01
GOBP POSITIVE REGULATION OF CELL CYCLE 323 7.99e-05 1.76e-03 0.137000 1.31e-01 -4.02e-02 4.91e-05 2.14e-01
GOBP ORGAN GROWTH 171 9.82e-03 7.77e-02 0.137000 1.31e-01 4.18e-02 3.15e-03 3.46e-01
GOBP ANATOMICAL STRUCTURE ARRANGEMENT 16 6.38e-01 8.38e-01 0.137000 1.37e-01 9.73e-03 3.43e-01 9.46e-01
GOMF CARBONATE DEHYDRATASE ACTIVITY 14 6.71e-01 8.57e-01 0.137000 1.37e-01 -1.62e-03 3.74e-01 9.92e-01
GOBP PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS 21 5.74e-01 8.00e-01 0.137000 -1.11e-01 -8.05e-02 3.78e-01 5.23e-01
GOBP REGULATION OF SYNAPTIC VESICLE MEMBRANE ORGANIZATION 12 7.15e-01 8.77e-01 0.137000 -1.45e-02 -1.37e-01 9.31e-01 4.13e-01
GOCC MIDBODY 199 3.57e-03 3.65e-02 0.137000 1.37e-01 -6.30e-03 8.59e-04 8.78e-01
GOMF PROTEIN SERINE THREONINE KINASE INHIBITOR ACTIVITY 39 3.34e-01 6.24e-01 0.137000 -6.19e-03 -1.37e-01 9.47e-01 1.39e-01
GOCC BASAL DENDRITE 6 8.47e-01 9.36e-01 0.137000 2.15e-02 1.35e-01 9.27e-01 5.66e-01
GOBP PENTOSE PHOSPHATE SHUNT NON OXIDATIVE BRANCH 6 8.53e-01 9.39e-01 0.137000 1.19e-01 6.78e-02 6.13e-01 7.74e-01
MAPK family signaling cascades 299 1.43e-04 2.89e-03 0.137000 1.23e-01 -6.13e-02 2.64e-04 6.83e-02
GOBP PROSTATE GLANDULAR ACINUS DEVELOPMENT 10 7.62e-01 8.99e-01 0.137000 1.32e-01 3.83e-02 4.71e-01 8.34e-01
GOBP REGULATION OF VIRAL TRANSCRIPTION 18 5.82e-01 8.04e-01 0.137000 1.18e-01 -6.92e-02 3.85e-01 6.11e-01
Translocation of ZAP-70 to Immunological synapse 17 6.23e-01 8.30e-01 0.137000 -1.62e-02 -1.36e-01 9.08e-01 3.31e-01
GOBP ACTIN MODIFICATION 5 8.62e-01 9.42e-01 0.137000 5.44e-02 -1.26e-01 8.33e-01 6.26e-01
Signaling by ERBB2 TMD/JMD mutants 22 5.16e-01 7.62e-01 0.137000 6.88e-02 -1.18e-01 5.76e-01 3.36e-01
GOBP INTERLEUKIN 18 PRODUCTION 14 6.88e-01 8.65e-01 0.137000 -1.25e-01 -5.60e-02 4.18e-01 7.17e-01
GOBP TISSUE REMODELING 183 8.39e-03 6.96e-02 0.137000 1.11e-01 7.96e-02 9.28e-03 6.33e-02
GOBP EMBRYONIC PLACENTA DEVELOPMENT 85 8.69e-02 3.15e-01 0.137000 1.87e-02 -1.36e-01 7.65e-01 3.06e-02
GOBP PROTEIN FOLDING 211 2.06e-03 2.41e-02 0.137000 4.59e-02 -1.29e-01 2.51e-01 1.23e-03
GOBP ANTIVIRAL INNATE IMMUNE RESPONSE 54 2.01e-01 4.94e-01 0.137000 1.26e-01 -5.29e-02 1.08e-01 5.01e-01
GOBP POSITIVE REGULATION OF CELL DEVELOPMENT 439 9.52e-06 2.76e-04 0.137000 1.28e-01 4.85e-02 4.27e-06 8.17e-02
GOBP NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS 53 2.44e-01 5.40e-01 0.137000 1.24e-01 5.80e-02 1.19e-01 4.65e-01
GOMF CATALYTIC ACTIVITY ACTING ON RNA 389 1.04e-05 2.97e-04 0.137000 1.19e-01 -6.82e-02 5.90e-05 2.10e-02
GOBP EAR DEVELOPMENT 221 2.28e-03 2.60e-02 0.137000 1.36e-01 1.40e-02 4.90e-04 7.20e-01
GOBP REGULATION OF APOPTOTIC SIGNALING PATHWAY 378 1.30e-05 3.63e-04 0.137000 9.74e-02 -9.60e-02 1.15e-03 1.35e-03
GOBP CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 23 5.18e-01 7.63e-01 0.137000 -1.36e-02 1.36e-01 9.10e-01 2.59e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS OXYGEN AS ACCEPTOR 11 7.44e-01 8.90e-01 0.137000 1.28e-01 4.67e-02 4.61e-01 7.88e-01
GOBP NEGATIVE REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS 5 8.60e-01 9.42e-01 0.137000 -7.56e-02 1.14e-01 7.70e-01 6.59e-01
GOCC RUFFLE MEMBRANE 99 6.82e-02 2.73e-01 0.137000 1.33e-01 3.11e-02 2.21e-02 5.93e-01
GOBP PYRIMIDINE RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 15 6.54e-01 8.47e-01 0.137000 6.03e-03 -1.36e-01 9.68e-01 3.60e-01
GOMF PROTEIN SERINE THREONINE PHOSPHATASE ACTIVITY 94 6.19e-02 2.57e-01 0.137000 1.23e-01 -5.91e-02 3.92e-02 3.22e-01
GOBP ANIMAL ORGAN REGENERATION 62 1.72e-01 4.58e-01 0.137000 1.21e-02 -1.36e-01 8.69e-01 6.40e-02
GOBP REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING 27 4.88e-01 7.46e-01 0.137000 1.25e-01 5.44e-02 2.60e-01 6.25e-01
GOMF ATPASE REGULATOR ACTIVITY 47 2.91e-01 5.87e-01 0.137000 -6.65e-02 -1.19e-01 4.30e-01 1.57e-01
GOBP EXIT FROM MITOSIS 31 4.27e-01 7.05e-01 0.136000 1.35e-01 2.02e-02 1.93e-01 8.46e-01
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION 52 2.37e-01 5.34e-01 0.136000 1.13e-02 1.36e-01 8.88e-01 8.99e-02
GOBP VESICLE TARGETING ROUGH ER TO CIS GOLGI 25 4.72e-01 7.32e-01 0.136000 1.02e-01 -9.02e-02 3.76e-01 4.35e-01
GOBP REGULATION OF DNA RECOMBINATION 135 1.91e-02 1.23e-01 0.136000 1.26e-01 -5.14e-02 1.13e-02 3.02e-01
GOBP SPINDLE MIDZONE ASSEMBLY 13 7.13e-01 8.76e-01 0.136000 9.30e-02 9.98e-02 5.62e-01 5.33e-01
GOBP INHIBITORY POSTSYNAPTIC POTENTIAL 16 6.19e-01 8.27e-01 0.136000 -1.10e-01 8.03e-02 4.45e-01 5.78e-01
GOBP TERPENOID BIOSYNTHETIC PROCESS 16 6.19e-01 8.27e-01 0.136000 7.76e-02 -1.12e-01 5.91e-01 4.37e-01
GOBP CANNABINOID SIGNALING PATHWAY 7 8.28e-01 9.29e-01 0.136000 3.58e-02 1.32e-01 8.70e-01 5.47e-01
GOMF TRIPEPTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 9 7.92e-01 9.15e-01 0.136000 9.00e-02 1.02e-01 6.40e-01 5.95e-01
GOBP INTRACELLULAR TRANSPORT OF VIRUS 10 7.69e-01 9.03e-01 0.136000 -6.46e-02 -1.20e-01 7.24e-01 5.11e-01
GOBP T TUBULE ORGANIZATION 6 8.42e-01 9.35e-01 0.136000 -2.29e-02 1.34e-01 9.23e-01 5.69e-01
GOBP PEPTIDYL HISTIDINE MODIFICATION 9 7.73e-01 9.05e-01 0.136000 2.06e-02 -1.35e-01 9.15e-01 4.84e-01
GOBP NEUROPEPTIDE SIGNALING PATHWAY 101 6.60e-02 2.68e-01 0.136000 1.32e-01 3.14e-02 2.14e-02 5.85e-01
GOMF SYMPORTER ACTIVITY 145 1.43e-02 1.02e-01 0.136000 -5.49e-02 1.25e-01 2.54e-01 9.58e-03
GOMF SODIUM CHANNEL REGULATOR ACTIVITY 38 3.50e-01 6.40e-01 0.136000 1.36e-01 9.17e-03 1.47e-01 9.22e-01
GOBP NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS 21 5.33e-01 7.73e-01 0.136000 9.62e-02 -9.63e-02 4.45e-01 4.45e-01
GOBP AMINO ACID BETAINE TRANSPORT 13 6.93e-01 8.68e-01 0.136000 8.98e-03 -1.36e-01 9.55e-01 3.96e-01
GOBP POSITIVE REGULATION OF STEROL TRANSPORT 36 3.41e-01 6.31e-01 0.136000 -1.04e-01 8.78e-02 2.80e-01 3.62e-01
GOMF OXYSTEROL BINDING 16 6.60e-01 8.50e-01 0.136000 1.10e-01 8.03e-02 4.47e-01 5.78e-01
PI3K/AKT Signaling in Cancer 111 4.56e-02 2.14e-01 0.136000 1.36e-01 -8.14e-04 1.32e-02 9.88e-01
GOMF PHOSPHOLIPASE A2 ACTIVITY 34 3.62e-01 6.49e-01 0.136000 1.01e-01 -9.16e-02 3.10e-01 3.55e-01
GOMF ZINC ION TRANSMEMBRANE TRANSPORTER ACTIVITY 24 4.90e-01 7.48e-01 0.136000 6.97e-02 -1.17e-01 5.54e-01 3.22e-01
GOBP VOCALIZATION BEHAVIOR 15 6.54e-01 8.47e-01 0.136000 -1.35e-01 1.43e-02 3.64e-01 9.24e-01
GOBP RESPONSE TO CGMP 8 7.88e-01 9.13e-01 0.136000 1.08e-01 -8.23e-02 5.96e-01 6.87e-01
GOMF LIPID TRANSFER ACTIVITY 56 2.35e-01 5.32e-01 0.136000 1.09e-01 8.07e-02 1.56e-01 2.96e-01
GOBP PROTEIN POLYUBIQUITINATION 264 6.34e-04 9.58e-03 0.136000 1.35e-01 -1.15e-02 1.51e-04 7.47e-01
GOBP LIPID DROPLET FUSION 5 8.71e-01 9.47e-01 0.136000 1.36e-01 1.03e-02 6.00e-01 9.68e-01
GOBP STEROL METABOLIC PROCESS 152 1.58e-02 1.09e-01 0.136000 1.25e-02 1.35e-01 7.91e-01 3.97e-03
GOBP RESPONSE TO NITROSATIVE STRESS 10 7.48e-01 8.91e-01 0.136000 4.31e-02 -1.29e-01 8.13e-01 4.80e-01
M Phase 354 3.15e-05 8.02e-04 0.136000 1.13e-01 -7.54e-02 2.56e-04 1.48e-02
GOBP POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 19 6.11e-01 8.22e-01 0.136000 1.14e-01 7.41e-02 3.90e-01 5.76e-01
GOBP DERMATAN SULFATE METABOLIC PROCESS 8 7.94e-01 9.16e-01 0.136000 -3.51e-02 1.31e-01 8.64e-01 5.20e-01
GOBP INTRACELLULAR TRANSPORT 1295 7.40e-16 1.78e-13 0.136000 1.34e-01 -2.43e-02 6.16e-16 1.41e-01
GOBP RNA PROCESSING 1247 5.43e-16 1.36e-13 0.136000 1.03e-01 -8.82e-02 8.30e-10 1.61e-07
GOBP POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS 20 5.86e-01 8.06e-01 0.136000 1.31e-01 3.66e-02 3.11e-01 7.77e-01
GOBP GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS 23 5.27e-01 7.69e-01 0.136000 1.36e-01 -2.98e-03 2.60e-01 9.80e-01
GOBP CELLULAR SENESCENCE 107 4.18e-02 2.03e-01 0.136000 1.04e-01 -8.76e-02 6.37e-02 1.17e-01
GOMF STRUCTURAL CONSTITUENT OF EYE LENS 22 5.68e-01 7.96e-01 0.136000 9.03e-02 1.01e-01 4.63e-01 4.11e-01
GOBP REGULATION OF NADP METABOLIC PROCESS 8 8.10e-01 9.22e-01 0.136000 1.26e-01 5.13e-02 5.38e-01 8.02e-01
GOMF SNORNA BINDING 31 3.98e-01 6.80e-01 0.136000 1.06e-01 -8.49e-02 3.08e-01 4.13e-01
GOMF PHOSPHATASE REGULATOR ACTIVITY 101 6.46e-02 2.64e-01 0.136000 1.35e-01 1.70e-02 1.94e-02 7.67e-01
GOCC HIPPOCAMPAL MOSSY FIBER 6 8.40e-01 9.33e-01 0.136000 -4.78e-02 1.27e-01 8.39e-01 5.90e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 61 1.75e-01 4.61e-01 0.136000 -1.32e-01 3.24e-02 7.52e-02 6.61e-01
GOBP NEUROTRANSMITTER REUPTAKE 34 3.86e-01 6.70e-01 0.136000 1.35e-01 -1.13e-02 1.73e-01 9.09e-01
GOBP CELLULAR RESPONSE TO ALDOSTERONE 7 8.25e-01 9.28e-01 0.136000 6.77e-03 1.35e-01 9.75e-01 5.35e-01
GOBP REGULATION OF RENAL SYSTEM PROCESS 21 5.38e-01 7.77e-01 0.136000 1.14e-01 -7.33e-02 3.65e-01 5.61e-01
GOBP INTRACILIARY RETROGRADE TRANSPORT 14 6.89e-01 8.65e-01 0.136000 1.31e-01 3.66e-02 3.98e-01 8.12e-01
GOBP POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION 21 5.66e-01 7.94e-01 0.136000 -1.97e-02 -1.34e-01 8.76e-01 2.87e-01
GOCC INNER KINETOCHORE 17 6.04e-01 8.18e-01 0.136000 8.22e-02 -1.08e-01 5.57e-01 4.42e-01
GOBP REGULATORY NCRNA MEDIATED GENE SILENCING 601 8.28e-08 4.18e-06 0.136000 -5.91e-03 1.35e-01 8.05e-01 1.41e-08
GOBP GLOMERULAR MESANGIUM DEVELOPMENT 18 6.05e-01 8.19e-01 0.136000 1.35e-01 -9.30e-03 3.21e-01 9.46e-01
GOBP REGULATION OF OSTEOBLAST PROLIFERATION 30 4.56e-01 7.22e-01 0.135000 1.24e-01 5.40e-02 2.39e-01 6.09e-01
GOMF ACTIN MONOMER BINDING 24 5.03e-01 7.55e-01 0.135000 3.35e-02 -1.31e-01 7.76e-01 2.66e-01
GOMF CADHERIN BINDING INVOLVED IN CELL CELL ADHESION 18 6.08e-01 8.21e-01 0.135000 1.32e-04 1.35e-01 9.99e-01 3.20e-01
GOBP NEGATIVE REGULATION OF FATTY ACID TRANSPORT 7 8.35e-01 9.31e-01 0.135000 7.54e-02 1.12e-01 7.30e-01 6.06e-01
GOBP REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION 10 7.74e-01 9.05e-01 0.135000 9.85e-02 9.30e-02 5.90e-01 6.11e-01
GOBP HEPATICOBILIARY SYSTEM DEVELOPMENT 142 1.52e-02 1.06e-01 0.135000 8.66e-02 -1.04e-01 7.49e-02 3.22e-02
GOBP NEGATIVE REGULATION OF SYNAPSE ORGANIZATION 11 7.54e-01 8.95e-01 0.135000 1.01e-01 8.99e-02 5.61e-01 6.06e-01
GOBP VESICLE TRANSPORT ALONG ACTIN FILAMENT 8 7.91e-01 9.15e-01 0.135000 1.19e-01 -6.42e-02 5.59e-01 7.53e-01
GOBP REGULATION OF KERATINOCYTE PROLIFERATION 48 2.43e-01 5.39e-01 0.135000 7.79e-02 -1.11e-01 3.50e-01 1.85e-01
GOMF NUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 29 4.40e-01 7.13e-01 0.135000 -2.45e-02 1.33e-01 8.19e-01 2.15e-01
GOBP NEGATIVE REGULATION OF SATELLITE CELL DIFFERENTIATION 5 8.71e-01 9.47e-01 0.135000 -1.00e-04 -1.35e-01 1.00e+00 6.00e-01
GOMF PROSTANOID RECEPTOR ACTIVITY 11 7.46e-01 8.91e-01 0.135000 -3.34e-02 -1.31e-01 8.48e-01 4.51e-01
GOMF NON MEMBRANE SPANNING PROTEIN TYROSINE KINASE ACTIVITY 43 2.94e-01 5.91e-01 0.135000 1.31e-01 -3.20e-02 1.36e-01 7.17e-01
GOBP CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 148 1.83e-02 1.20e-01 0.135000 1.35e-01 1.23e-02 4.67e-03 7.97e-01
GOBP PULMONARY VALVE MORPHOGENESIS 20 5.92e-01 8.11e-01 0.135000 4.90e-02 1.26e-01 7.04e-01 3.29e-01
GOBP CELL SUBSTRATE ADHESION 346 1.21e-04 2.54e-03 0.135000 1.30e-01 3.85e-02 3.42e-05 2.18e-01
GOBP RESPONSE TO CAMP 83 1.06e-01 3.52e-01 0.135000 1.34e-01 1.61e-02 3.45e-02 8.00e-01
GOBP CHROMOSOME LOCALIZATION 122 2.80e-02 1.60e-01 0.135000 1.11e-01 -7.78e-02 3.50e-02 1.38e-01
GOBP POSITIVE REGULATION OF MIRNA PROCESSING 5 8.78e-01 9.50e-01 0.135000 1.23e-01 5.68e-02 6.35e-01 8.26e-01
Sensory processing of sound by outer hair cells of the cochlea 50 2.80e-01 5.77e-01 0.135000 -9.62e-02 -9.50e-02 2.39e-01 2.45e-01
GOBP AMYLOID BETA METABOLIC PROCESS 64 1.58e-01 4.40e-01 0.135000 1.26e-01 -4.94e-02 8.17e-02 4.94e-01
Transcriptional Regulation by NPAS4 32 4.05e-01 6.87e-01 0.135000 1.33e-01 -2.65e-02 1.95e-01 7.95e-01
GOBP NEGATIVE REGULATION OF EXOCYTOSIS 31 4.16e-01 6.96e-01 0.135000 1.32e-01 -2.77e-02 2.02e-01 7.90e-01
GOBP NEGATIVE REGULATION OF MAP KINASE ACTIVITY 45 3.06e-01 5.99e-01 0.135000 1.29e-01 4.08e-02 1.35e-01 6.36e-01
GOBP PRESYNAPSE ORGANIZATION 48 2.95e-01 5.92e-01 0.135000 9.93e-02 9.16e-02 2.34e-01 2.72e-01
GOBP MUSCLE CELL PROLIFERATION 233 1.66e-03 2.04e-02 0.135000 1.35e-01 -8.18e-03 3.92e-04 8.30e-01
GOBP LIPID OXIDATION 111 5.78e-02 2.46e-01 0.135000 1.19e-01 6.41e-02 3.05e-02 2.43e-01
GOMF PROTEIN ANTIGEN BINDING 7 8.14e-01 9.25e-01 0.135000 -1.07e-01 8.20e-02 6.23e-01 7.07e-01
Transport of the SLBP Dependant Mature mRNA 36 3.49e-01 6.39e-01 0.135000 1.16e-01 -6.92e-02 2.29e-01 4.72e-01
GOBP MOTOR BEHAVIOR 22 5.36e-01 7.75e-01 0.135000 1.31e-01 -3.15e-02 2.86e-01 7.98e-01
GOCC ACTIN CYTOSKELETON 503 3.11e-06 1.03e-04 0.135000 1.19e-01 6.39e-02 4.96e-06 1.42e-02
GOBP SENSORY SYSTEM DEVELOPMENT 395 3.69e-05 9.18e-04 0.135000 1.29e-01 4.08e-02 1.14e-05 1.64e-01
Mitotic Anaphase 213 2.03e-03 2.39e-02 0.135000 1.09e-01 -7.99e-02 6.23e-03 4.44e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OR CH2 GROUPS 11 7.29e-01 8.84e-01 0.135000 1.27e-01 -4.50e-02 4.65e-01 7.96e-01
GOBP RESPONSE TO ZINC ION 48 2.54e-01 5.52e-01 0.135000 -1.29e-01 4.02e-02 1.23e-01 6.30e-01
GOBP MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 48 2.64e-01 5.61e-01 0.135000 1.34e-01 -1.24e-02 1.08e-01 8.82e-01
GOBP CADMIUM ION TRANSMEMBRANE TRANSPORT 6 8.59e-01 9.42e-01 0.135000 -8.72e-02 -1.03e-01 7.12e-01 6.63e-01
GOMF CALCIUM DEPENDENT PROTEIN KINASE ACTIVITY 10 7.52e-01 8.93e-01 0.135000 3.72e-02 -1.30e-01 8.38e-01 4.78e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION 33 4.26e-01 7.04e-01 0.135000 -5.30e-02 -1.24e-01 5.98e-01 2.18e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 81 1.27e-01 3.89e-01 0.135000 1.12e-01 7.48e-02 8.12e-02 2.44e-01
GOBP CELLULAR RESPONSE TO LEUCINE STARVATION 11 7.25e-01 8.82e-01 0.135000 7.33e-02 -1.13e-01 6.74e-01 5.16e-01
GOBP AXONAL TRANSPORT 63 1.71e-01 4.57e-01 0.135000 1.32e-01 -2.67e-02 7.01e-02 7.14e-01
GOBP REGULATION OF PROTEIN DEPHOSPHORYLATION 73 1.29e-01 3.93e-01 0.135000 1.32e-01 -2.70e-02 5.14e-02 6.90e-01
GOBP FEVER GENERATION 11 7.24e-01 8.82e-01 0.135000 9.26e-02 -9.77e-02 5.95e-01 5.75e-01
GOBP MITOTIC CELL CYCLE 893 3.51e-11 3.29e-09 0.135000 1.32e-01 -2.65e-02 2.24e-11 1.79e-01
Triglyceride metabolism 35 4.13e-01 6.94e-01 0.135000 9.35e-02 9.67e-02 3.38e-01 3.22e-01
GOCC TRANSFERASE COMPLEX TRANSFERRING PHOSPHORUS CONTAINING GROUPS 273 3.96e-04 6.50e-03 0.135000 1.15e-01 -6.91e-02 1.03e-03 4.93e-02
GOBP TRNA TRANSCRIPTION 13 6.87e-01 8.65e-01 0.134000 1.21e-01 -5.90e-02 4.51e-01 7.13e-01
GOCC TRIGLYCERIDE RICH PLASMA LIPOPROTEIN PARTICLE 19 5.93e-01 8.11e-01 0.134000 -1.34e-01 8.72e-03 3.11e-01 9.48e-01
Chemokine receptors bind chemokines 55 2.19e-01 5.15e-01 0.134000 -1.34e-01 1.39e-02 8.62e-02 8.58e-01
GOBP POSITIVE REGULATION OF LYSOSOMAL PROTEIN CATABOLIC PROCESS 5 8.73e-01 9.48e-01 0.134000 1.34e-01 2.36e-03 6.03e-01 9.93e-01
GOBP CELLULAR RESPIRATION 214 2.30e-03 2.61e-02 0.134000 5.16e-02 -1.24e-01 1.93e-01 1.75e-03
GOBP OLIGODENDROCYTE PROGENITOR PROLIFERATION 8 7.97e-01 9.17e-01 0.134000 1.28e-01 -4.01e-02 5.30e-01 8.44e-01
FCGR3A-mediated IL10 synthesis 36 4.00e-01 6.82e-01 0.134000 6.78e-02 1.16e-01 4.81e-01 2.28e-01
GOBP REGULATION OF PROTEIN UBIQUITINATION 177 5.99e-03 5.39e-02 0.134000 7.87e-02 -1.09e-01 7.08e-02 1.24e-02
Processing of Intronless Pre-mRNAs 19 5.77e-01 8.01e-01 0.134000 6.51e-02 -1.18e-01 6.23e-01 3.75e-01
GOBP CELLULAR RESPONSE TO CHEMICAL STRESS 307 2.32e-04 4.26e-03 0.134000 1.34e-01 -1.38e-02 5.62e-05 6.78e-01
GOCC AXONAL GROWTH CONE 25 5.31e-01 7.72e-01 0.134000 1.11e-01 7.52e-02 3.35e-01 5.15e-01
GOBP MAMMARY GLAND BRANCHING INVOLVED IN PREGNANCY 6 8.53e-01 9.39e-01 0.134000 -1.32e-01 -2.45e-02 5.75e-01 9.17e-01
Signaling by NOTCH 197 3.38e-03 3.51e-02 0.134000 1.05e-01 -8.36e-02 1.10e-02 4.31e-02
GOBP POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS 32 4.33e-01 7.08e-01 0.134000 3.45e-02 1.30e-01 7.35e-01 2.04e-01
GOCC RADIAL SPOKE HEAD 5 8.71e-01 9.47e-01 0.134000 -1.36e-02 1.34e-01 9.58e-01 6.05e-01
Cell Cycle, Mitotic 495 7.93e-07 3.12e-05 0.134000 1.11e-01 -7.48e-02 2.18e-05 4.35e-03
GOBP POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY 101 7.90e-02 2.98e-01 0.134000 1.06e-01 8.23e-02 6.56e-02 1.53e-01
GOBP AMEBOIDAL TYPE CELL MIGRATION 481 2.79e-06 9.39e-05 0.134000 1.34e-01 -1.15e-05 4.56e-07 1.00e+00
GOCC SPERM PRINCIPAL PIECE 33 4.14e-01 6.95e-01 0.134000 -1.34e-01 -1.38e-02 1.84e-01 8.91e-01
GOBP CELL GROWTH 460 6.78e-06 2.06e-04 0.134000 1.32e-01 2.51e-02 1.26e-06 3.57e-01
GOBP CERAMIDE 1 PHOSPHATE TRANSPORT 7 8.22e-01 9.27e-01 0.134000 2.70e-02 -1.31e-01 9.02e-01 5.47e-01
GOMF CERAMIDE 1 PHOSPHATE TRANSFER ACTIVITY 7 8.22e-01 9.27e-01 0.134000 2.70e-02 -1.31e-01 9.02e-01 5.47e-01
GOBP REGULATION OF CELL CYCLE PROCESS 718 3.27e-09 2.19e-07 0.134000 1.30e-01 -3.39e-02 3.10e-09 1.21e-01
Netrin-1 signaling 42 2.97e-01 5.94e-01 0.134000 7.25e-02 -1.13e-01 4.16e-01 2.06e-01
GOBP FATTY ACID HOMEOSTASIS 16 6.32e-01 8.35e-01 0.134000 -1.21e-01 5.77e-02 4.02e-01 6.89e-01
GOCC GOLGI CISTERNA MEMBRANE 74 1.56e-01 4.37e-01 0.134000 8.33e-02 1.05e-01 2.15e-01 1.18e-01
GOBP NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 68 1.42e-01 4.13e-01 0.134000 1.16e-01 -6.74e-02 9.85e-02 3.37e-01
Non-integrin membrane-ECM interactions 75 1.34e-01 4.01e-01 0.134000 1.34e-01 8.15e-03 4.52e-02 9.03e-01
GOBP POSITIVE REGULATION OF PSEUDOPODIUM ASSEMBLY 12 7.13e-01 8.76e-01 0.134000 3.99e-02 -1.28e-01 8.11e-01 4.43e-01
GOBP REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY 21 5.45e-01 7.81e-01 0.134000 7.98e-02 -1.08e-01 5.27e-01 3.93e-01
GOBP POSITIVE REGULATION OF MAST CELL DEGRANULATION 12 7.09e-01 8.75e-01 0.134000 6.02e-02 -1.20e-01 7.18e-01 4.73e-01
GOBP REGULATION OF METALLOPEPTIDASE ACTIVITY 17 6.18e-01 8.27e-01 0.134000 4.67e-02 -1.25e-01 7.39e-01 3.70e-01
GOCC F ACTIN CAPPING PROTEIN COMPLEX 8 7.95e-01 9.16e-01 0.134000 -6.38e-02 1.18e-01 7.55e-01 5.64e-01
GOBP NEUROMUSCULAR PROCESS 163 1.73e-02 1.15e-01 0.134000 1.05e-01 8.28e-02 2.05e-02 6.82e-02
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS NAD P AS ACCEPTOR 11 7.40e-01 8.87e-01 0.134000 -1.57e-02 1.33e-01 9.28e-01 4.46e-01
GOBP L ASPARTATE IMPORT ACROSS PLASMA MEMBRANE 6 8.60e-01 9.42e-01 0.134000 7.18e-02 1.13e-01 7.61e-01 6.32e-01
Processing of Capped Intronless Pre-mRNA 28 4.62e-01 7.26e-01 0.134000 2.17e-02 -1.32e-01 8.42e-01 2.27e-01
GOBP AXON DEVELOPMENT 489 4.14e-06 1.33e-04 0.134000 1.28e-01 3.72e-02 1.14e-06 1.59e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING SULPHUR CONTAINING GROUPS 66 1.91e-01 4.83e-01 0.134000 7.33e-02 1.12e-01 3.03e-01 1.16e-01
Vif-mediated degradation of APOBEC3G 41 3.28e-01 6.19e-01 0.134000 1.08e-02 -1.33e-01 9.05e-01 1.40e-01
Mitotic Metaphase and Anaphase 214 2.22e-03 2.56e-02 0.134000 1.06e-01 -8.11e-02 7.41e-03 4.09e-02
Cytosolic sensors of pathogen-associated DNA 63 1.69e-01 4.54e-01 0.134000 1.24e-01 -4.92e-02 8.82e-02 4.99e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS 13 7.20e-01 8.79e-01 0.134000 -6.46e-02 -1.17e-01 6.87e-01 4.65e-01
GOBP REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE 13 7.09e-01 8.75e-01 0.134000 1.33e-01 1.59e-02 4.08e-01 9.21e-01
GOBP REGULATION OF DEPHOSPHORYLATION 97 6.50e-02 2.65e-01 0.134000 1.23e-01 -5.22e-02 3.64e-02 3.74e-01
GOBP LYMPHOCYTE CHEMOTAXIS 42 2.99e-01 5.94e-01 0.133000 1.00e-01 -8.81e-02 2.61e-01 3.23e-01
GOBP BASOLATERAL PROTEIN SECRETION 5 8.68e-01 9.45e-01 0.133000 -5.61e-02 1.21e-01 8.28e-01 6.39e-01
GOBP REGULATION OF CELL SHAPE 132 3.20e-02 1.73e-01 0.133000 1.32e-01 2.15e-02 8.97e-03 6.69e-01
GOMF MYOSIN PHOSPHATASE ACTIVITY 73 1.23e-01 3.83e-01 0.133000 1.05e-01 -8.19e-02 1.20e-01 2.26e-01
Aerobic respiration and respiratory electron transport 236 1.58e-03 1.97e-02 0.133000 2.73e-02 -1.31e-01 4.70e-01 5.48e-04
GOBP REGULATION OF BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION 64 1.96e-01 4.89e-01 0.133000 4.65e-02 1.25e-01 5.20e-01 8.37e-02
GOBP NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL 22 5.41e-01 7.79e-01 0.133000 -3.92e-02 1.27e-01 7.50e-01 3.01e-01
GOBP MONOACYLGLYCEROL BIOSYNTHETIC PROCESS 7 8.30e-01 9.30e-01 0.133000 7.83e-03 1.33e-01 9.71e-01 5.42e-01
GOBP EPIBOLY 42 3.48e-01 6.38e-01 0.133000 6.32e-02 1.17e-01 4.78e-01 1.88e-01
GOBP R LOOP PROCESSING 9 7.72e-01 9.05e-01 0.133000 8.79e-02 -1.00e-01 6.48e-01 6.03e-01
GOBP REGULATION OF CELL CYCLE G2 M PHASE TRANSITION 112 4.30e-02 2.06e-01 0.133000 1.22e-01 -5.34e-02 2.55e-02 3.29e-01
GOMF SHORT CHAIN CARBOXYLESTERASE ACTIVITY 6 8.45e-01 9.36e-01 0.133000 -4.77e-02 1.24e-01 8.40e-01 5.98e-01
Cellular responses to stress 735 1.47e-09 1.05e-07 0.133000 7.46e-02 -1.10e-01 5.72e-04 3.41e-07
GOBP REGULATION OF PROTEIN CATABOLIC PROCESS 338 1.01e-04 2.17e-03 0.133000 1.30e-01 -3.02e-02 4.10e-05 3.40e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY 25 5.13e-01 7.61e-01 0.133000 1.33e-01 -3.01e-04 2.49e-01 9.98e-01
GOBP LUTEINIZING HORMONE SECRETION 11 7.48e-01 8.91e-01 0.133000 1.33e-01 1.16e-02 4.46e-01 9.47e-01
GOBP RESPONSE TO ENDOGENOUS STIMULUS 1659 5.67e-18 1.58e-15 0.133000 1.29e-01 3.15e-02 1.56e-18 3.27e-02
GOBP RESPONSE TO OSMOTIC STRESS 80 1.03e-01 3.46e-01 0.133000 1.14e-01 -6.91e-02 7.83e-02 2.86e-01
GOBP NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY 32 4.06e-01 6.88e-01 0.133000 1.21e-01 -5.63e-02 2.38e-01 5.82e-01
GOMF METAL CATION PROTON ANTIPORTER ACTIVITY 23 5.65e-01 7.94e-01 0.133000 -1.07e-01 -7.87e-02 3.73e-01 5.14e-01
GOBP REGULATION OF PHOSPHOLIPID METABOLIC PROCESS 31 4.65e-01 7.28e-01 0.133000 1.03e-01 8.47e-02 3.23e-01 4.14e-01
GOBP CELLULAR RESPONSE TO ABIOTIC STIMULUS 321 1.32e-04 2.69e-03 0.133000 1.19e-01 -5.88e-02 2.38e-04 7.00e-02
GOBP OPTIC NERVE MORPHOGENESIS 6 8.62e-01 9.43e-01 0.133000 9.64e-02 9.16e-02 6.83e-01 6.98e-01
GOBP TRNA PROCESSING 131 2.42e-02 1.46e-01 0.133000 8.69e-02 -1.01e-01 8.58e-02 4.69e-02
CLEC7A (Dectin-1) signaling 85 9.18e-02 3.25e-01 0.133000 1.19e-01 -5.93e-02 5.80e-02 3.44e-01
GOMF LIGAND GATED CHANNEL ACTIVITY 180 8.67e-03 7.11e-02 0.133000 -1.33e-01 -1.34e-03 2.10e-03 9.75e-01
GOBP CELLULAR RESPONSE TO OXIDATIVE STRESS 244 1.60e-03 1.99e-02 0.133000 1.33e-01 -3.54e-03 3.56e-04 9.24e-01
GOBP MUSCLE ORGAN DEVELOPMENT 348 1.48e-04 2.97e-03 0.133000 1.30e-01 2.86e-02 3.25e-05 3.60e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 30 4.29e-01 7.06e-01 0.133000 1.15e-01 -6.54e-02 2.74e-01 5.35e-01
GOBP GMP BIOSYNTHETIC PROCESS 13 7.13e-01 8.76e-01 0.133000 -1.95e-02 -1.31e-01 9.03e-01 4.13e-01
GOBP MEMBRANE HYPERPOLARIZATION 11 7.63e-01 8.99e-01 0.133000 9.01e-02 9.74e-02 6.05e-01 5.76e-01
GOMF SPHINGOLIPID TRANSFER ACTIVITY 9 7.79e-01 9.08e-01 0.133000 1.25e-01 -4.36e-02 5.15e-01 8.21e-01
GOBP REGULATION OF GERM CELL PROLIFERATION 7 8.30e-01 9.30e-01 0.133000 1.33e-01 -1.75e-03 5.43e-01 9.94e-01
GOBP T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE 85 1.04e-01 3.47e-01 0.133000 1.32e-01 -7.47e-03 3.48e-02 9.05e-01
FCERI mediated NF-kB activation 66 1.58e-01 4.40e-01 0.133000 1.20e-01 -5.60e-02 9.11e-02 4.31e-01
GOBP MONOCYTE ACTIVATION 12 7.19e-01 8.79e-01 0.133000 -1.28e-01 3.65e-02 4.44e-01 8.27e-01
GOCC PROTEASOME COMPLEX 61 1.94e-01 4.87e-01 0.133000 1.52e-02 -1.32e-01 8.38e-01 7.51e-02
GOBP REGULATION OF BILE ACID BIOSYNTHETIC PROCESS 12 7.18e-01 8.79e-01 0.133000 -1.27e-01 3.91e-02 4.47e-01 8.14e-01
GOBP REGULATION OF POSTSYNAPSE ORGANIZATION 100 8.44e-02 3.12e-01 0.133000 6.52e-02 1.15e-01 2.60e-01 4.61e-02
GOMF ACTIN BINDING 412 4.44e-05 1.07e-03 0.133000 1.14e-01 6.79e-02 7.34e-05 1.81e-02
Sodium/Proton exchangers 7 8.30e-01 9.30e-01 0.132000 -7.20e-03 1.32e-01 9.74e-01 5.44e-01
GOBP BASE EXCISION REPAIR AP SITE FORMATION 12 7.31e-01 8.84e-01 0.132000 1.03e-02 1.32e-01 9.51e-01 4.28e-01
GOBP RUFFLE ORGANIZATION 56 2.46e-01 5.41e-01 0.132000 1.23e-01 4.83e-02 1.10e-01 5.32e-01
GOBP PSEUDOURIDINE SYNTHESIS 17 6.43e-01 8.42e-01 0.132000 -1.49e-02 -1.32e-01 9.15e-01 3.48e-01
GOCC MONOATOMIC ION CHANNEL COMPLEX 327 1.27e-04 2.63e-03 0.132000 -1.22e-01 5.24e-02 1.57e-04 1.03e-01
Disinhibition of SNARE formation 5 8.78e-01 9.50e-01 0.132000 -1.18e-02 -1.32e-01 9.64e-01 6.10e-01
GOBP RESPIRATORY CHAIN COMPLEX IV ASSEMBLY 28 5.02e-01 7.54e-01 0.132000 -6.92e-02 -1.13e-01 5.26e-01 3.02e-01
GOBP VENTRICULAR SYSTEM DEVELOPMENT 32 4.14e-01 6.95e-01 0.132000 1.25e-01 -4.40e-02 2.22e-01 6.67e-01
GOBP HISTAMINE TRANSPORT 15 6.75e-01 8.58e-01 0.132000 1.32e-01 3.76e-03 3.75e-01 9.80e-01
Serine biosynthesis 9 7.87e-01 9.13e-01 0.132000 1.32e-01 -6.46e-03 4.93e-01 9.73e-01
APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 61 1.87e-01 4.78e-01 0.132000 4.29e-02 -1.25e-01 5.62e-01 9.11e-02
GOBP NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS 110 5.18e-02 2.30e-01 0.132000 2.43e-02 -1.30e-01 6.60e-01 1.85e-02
GOBP HEART VALVE FORMATION 15 6.60e-01 8.50e-01 0.132000 5.28e-02 -1.21e-01 7.23e-01 4.17e-01
GOBP ESTABLISHMENT OF BLOOD BRAIN BARRIER 14 7.10e-01 8.75e-01 0.132000 1.05e-01 8.02e-02 4.96e-01 6.03e-01
GOBP CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 509 1.47e-06 5.34e-05 0.132000 1.30e-01 -2.38e-02 5.16e-07 3.59e-01
GOBP REGULATION OF DNA REPLICATION 124 3.22e-02 1.74e-01 0.132000 1.18e-01 -5.98e-02 2.35e-02 2.50e-01
Transcriptional Regulation by TP53 347 9.20e-05 2.01e-03 0.132000 1.28e-01 -3.18e-02 4.06e-05 3.09e-01
Vasopressin regulates renal water homeostasis via Aquaporins 42 3.52e-01 6.42e-01 0.132000 5.04e-02 1.22e-01 5.72e-01 1.71e-01
GOCC GOLGI ASSOCIATED VESICLE MEMBRANE 55 2.62e-01 5.58e-01 0.132000 1.07e-01 7.73e-02 1.70e-01 3.22e-01
GOBP REGULATION OF OXIDOREDUCTASE ACTIVITY 62 1.93e-01 4.85e-01 0.132000 1.31e-01 -1.28e-02 7.38e-02 8.61e-01
GOBP NEPHRIC DUCT MORPHOGENESIS 10 7.76e-01 9.07e-01 0.132000 1.29e-01 2.88e-02 4.81e-01 8.75e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION 20 5.93e-01 8.11e-01 0.132000 -2.33e-03 -1.32e-01 9.86e-01 3.07e-01
GOBP GAMMA DELTA T CELL ACTIVATION 24 5.19e-01 7.63e-01 0.132000 3.95e-02 -1.26e-01 7.38e-01 2.86e-01
GOBP REGULATION OF NK T CELL ACTIVATION 11 7.34e-01 8.85e-01 0.132000 -1.04e-01 8.05e-02 5.49e-01 6.44e-01
Ovarian tumor domain proteases 36 3.65e-01 6.52e-01 0.132000 7.70e-02 -1.07e-01 4.24e-01 2.67e-01
GOCC CORTICAL ACTIN CYTOSKELETON 74 1.65e-01 4.49e-01 0.132000 1.11e-01 7.18e-02 1.00e-01 2.86e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION 24 5.11e-01 7.60e-01 0.132000 -1.07e-01 7.70e-02 3.64e-01 5.14e-01
GOBP GLYCOPROTEIN CATABOLIC PROCESS 33 4.19e-01 6.99e-01 0.132000 -1.32e-01 6.47e-03 1.91e-01 9.49e-01
GOBP REGULATION OF VASOCONSTRICTION 65 1.88e-01 4.79e-01 0.132000 1.31e-01 1.31e-02 6.76e-02 8.55e-01
GOBP FOLIC ACID TRANSPORT 10 7.62e-01 8.99e-01 0.132000 -3.80e-02 1.26e-01 8.35e-01 4.90e-01
Co-stimulation by ICOS 10 7.84e-01 9.11e-01 0.132000 -7.66e-02 -1.07e-01 6.75e-01 5.57e-01
GOBP GTP METABOLIC PROCESS 24 5.11e-01 7.60e-01 0.132000 1.05e-01 -8.00e-02 3.75e-01 4.98e-01
Keratan sulfate degradation 15 6.86e-01 8.64e-01 0.132000 1.27e-01 3.31e-02 3.93e-01 8.24e-01
DEx/H-box helicases activate type I IFN and inflammatory cytokines production 7 8.30e-01 9.30e-01 0.132000 1.64e-02 -1.31e-01 9.40e-01 5.50e-01
GOBP ENERGY RESERVE METABOLIC PROCESS 93 1.06e-01 3.51e-01 0.132000 1.02e-01 8.35e-02 9.00e-02 1.64e-01
GOCC ZYMOGEN GRANULE 19 6.15e-01 8.26e-01 0.132000 -1.30e-01 -1.84e-02 3.26e-01 8.90e-01
GOCC FICOLIN 1 RICH GRANULE MEMBRANE 59 1.94e-01 4.87e-01 0.132000 -1.10e-01 7.25e-02 1.45e-01 3.35e-01
GOBP SERTOLI CELL DEVELOPMENT 12 7.15e-01 8.77e-01 0.132000 9.29e-02 -9.31e-02 5.77e-01 5.77e-01
GOBP POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS 68 1.71e-01 4.57e-01 0.132000 -4.57e-04 -1.32e-01 9.95e-01 6.07e-02
GOBP NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS 11 7.59e-01 8.97e-01 0.131000 -1.27e-01 -3.39e-02 4.66e-01 8.46e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS 17 6.48e-01 8.44e-01 0.131000 1.83e-02 1.30e-01 8.96e-01 3.53e-01
GOBP DORSAL VENTRAL NEURAL TUBE PATTERNING 16 6.79e-01 8.61e-01 0.131000 1.05e-01 7.90e-02 4.67e-01 5.84e-01
GOBP LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL 6 8.64e-01 9.43e-01 0.131000 -6.32e-02 -1.15e-01 7.89e-01 6.25e-01
GOBP DEVELOPMENTAL GROWTH 631 1.27e-07 6.14e-06 0.131000 1.31e-01 5.64e-03 1.77e-08 8.09e-01
GOBP REGULATION OF THYMOCYTE APOPTOTIC PROCESS 13 7.27e-01 8.82e-01 0.131000 -1.18e-01 -5.78e-02 4.61e-01 7.18e-01
GOBP INTRACELLULAR PROTEIN TRANSPORT 646 3.24e-08 1.78e-06 0.131000 1.19e-01 -5.55e-02 2.41e-07 1.60e-02
GOBP PURINE DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 11 7.59e-01 8.97e-01 0.131000 1.27e-01 3.51e-02 4.67e-01 8.40e-01
GOBP MAMMARY GLAND FORMATION 7 8.41e-01 9.34e-01 0.131000 -4.41e-02 -1.24e-01 8.40e-01 5.71e-01
AKT phosphorylates targets in the cytosol 14 6.97e-01 8.69e-01 0.131000 1.31e-01 8.80e-03 3.96e-01 9.55e-01
GOBP ORGANELLE DISASSEMBLY 175 1.04e-02 8.07e-02 0.131000 1.31e-01 -1.10e-02 2.82e-03 8.02e-01
GOBP VACUOLAR PROTON TRANSPORTING V TYPE ATPASE COMPLEX ASSEMBLY 5 8.83e-01 9.52e-01 0.131000 -1.26e-01 -3.76e-02 6.26e-01 8.84e-01
GOBP SODIUM ION IMPORT ACROSS PLASMA MEMBRANE 23 5.33e-01 7.73e-01 0.131000 -1.20e-01 5.34e-02 3.19e-01 6.58e-01
GOBP RESPONSE TO NUTRIENT LEVELS 476 5.96e-06 1.84e-04 0.131000 1.31e-01 5.66e-03 9.44e-07 8.32e-01
GOBP POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 122 4.44e-02 2.10e-01 0.131000 1.31e-01 1.05e-02 1.26e-02 8.41e-01
GOBP NEGATIVE REGULATION OF NUCLEAR DIVISION 62 1.87e-01 4.77e-01 0.131000 4.28e-02 -1.24e-01 5.60e-01 9.11e-02
GOMF DOPAMINE RECEPTOR BINDING 14 7.14e-01 8.77e-01 0.131000 9.36e-02 9.20e-02 5.44e-01 5.51e-01
GOBP 2 OXOGLUTARATE METABOLIC PROCESS 16 6.58e-01 8.50e-01 0.131000 -7.88e-03 1.31e-01 9.56e-01 3.65e-01
GOBP POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 6 8.46e-01 9.36e-01 0.131000 -8.88e-02 9.65e-02 7.06e-01 6.82e-01
GOBP INTERLEUKIN 17 PRODUCTION 47 2.80e-01 5.77e-01 0.131000 -1.23e-01 4.49e-02 1.44e-01 5.94e-01
GOBP REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 102 8.62e-02 3.14e-01 0.131000 1.08e-01 7.46e-02 6.00e-02 1.93e-01
GOBP RHYTHMIC PROCESS 289 5.26e-04 8.18e-03 0.131000 1.30e-01 -1.91e-02 1.48e-04 5.76e-01
GOBP POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 11 7.37e-01 8.86e-01 0.131000 -9.65e-02 8.88e-02 5.80e-01 6.10e-01
GOBP REGULATION OF ORGANIC ACID TRANSPORT 76 1.59e-01 4.41e-01 0.131000 1.16e-01 6.18e-02 8.17e-02 3.52e-01
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT 22 5.43e-01 7.80e-01 0.131000 9.61e-02 -8.90e-02 4.35e-01 4.70e-01
GOBP SYNAPTIC VESICLE TRANSPORT 42 3.12e-01 6.06e-01 0.131000 8.86e-02 -9.64e-02 3.20e-01 2.80e-01
GOBP NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I 24 5.54e-01 7.87e-01 0.131000 1.23e-01 4.59e-02 2.98e-01 6.97e-01
GOBP OVULATION CYCLE 73 1.74e-01 4.60e-01 0.131000 1.07e-01 7.61e-02 1.15e-01 2.61e-01
GOBP STEROID HORMONE BIOSYNTHETIC PROCESS 44 3.24e-01 6.15e-01 0.131000 -1.31e-01 -6.03e-03 1.33e-01 9.45e-01
GOBP NEGATIVE REGULATION OF COLLATERAL SPROUTING 10 7.85e-01 9.12e-01 0.131000 6.81e-02 1.12e-01 7.09e-01 5.40e-01
ABC transporters in lipid homeostasis 17 6.36e-01 8.38e-01 0.131000 -1.28e-01 2.90e-02 3.62e-01 8.36e-01
GOMF TAP BINDING 7 8.45e-01 9.36e-01 0.131000 -6.86e-02 -1.11e-01 7.53e-01 6.10e-01
GOMF KINETOCHORE BINDING 6 8.62e-01 9.42e-01 0.131000 1.26e-01 3.55e-02 5.93e-01 8.80e-01
GOBP GLYCEROL ETHER METABOLIC PROCESS 21 5.96e-01 8.13e-01 0.131000 -4.11e-02 -1.24e-01 7.45e-01 3.24e-01
GOMF GLYCINE BINDING 10 7.85e-01 9.12e-01 0.131000 -5.92e-02 -1.17e-01 7.46e-01 5.23e-01
GOBP POTASSIUM ION HOMEOSTASIS 34 3.91e-01 6.74e-01 0.131000 -9.41e-02 9.09e-02 3.42e-01 3.59e-01
GOBP NEGATIVE REGULATION OF CELL GROWTH 161 1.46e-02 1.03e-01 0.131000 1.29e-01 -2.31e-02 4.82e-03 6.13e-01
Sphingolipid de novo biosynthesis 37 3.88e-01 6.72e-01 0.131000 1.31e-01 5.46e-03 1.69e-01 9.54e-01
GOBP ECTODERMAL CELL DIFFERENTIATION 6 8.47e-01 9.36e-01 0.131000 1.01e-01 -8.30e-02 6.68e-01 7.25e-01
Tryptophan catabolism 14 6.84e-01 8.63e-01 0.131000 -1.21e-01 4.96e-02 4.33e-01 7.48e-01
GOMF METALLOEXOPEPTIDASE ACTIVITY 64 2.17e-01 5.12e-01 0.131000 7.87e-02 1.04e-01 2.76e-01 1.49e-01
GOBP REGULATION OF LONG TERM SYNAPTIC POTENTIATION 47 3.06e-01 5.99e-01 0.131000 1.30e-01 1.65e-02 1.24e-01 8.44e-01
GOMF SPECTRIN BINDING 26 5.33e-01 7.73e-01 0.131000 1.17e-01 5.78e-02 3.01e-01 6.10e-01
GOMF PHOSPHATIDYLCHOLINE BINDING 28 5.07e-01 7.58e-01 0.131000 1.19e-01 5.45e-02 2.77e-01 6.18e-01
GOBP CARDIAC MUSCLE TISSUE MORPHOGENESIS 61 2.33e-01 5.31e-01 0.131000 7.76e-02 1.05e-01 2.94e-01 1.56e-01
Organic cation/anion/zwitterion transport 15 6.62e-01 8.51e-01 0.131000 -1.03e-01 8.06e-02 4.91e-01 5.89e-01
Sema3A PAK dependent Axon repulsion 14 6.83e-01 8.62e-01 0.131000 1.15e-01 -6.18e-02 4.56e-01 6.89e-01
GOBP OXYGEN METABOLIC PROCESS 6 8.49e-01 9.37e-01 0.131000 6.63e-02 -1.13e-01 7.79e-01 6.33e-01
GOBP LEUKOCYTE DEGRANULATION 74 1.45e-01 4.18e-01 0.131000 1.77e-02 -1.29e-01 7.92e-01 5.43e-02
GOBP GLYCINE METABOLIC PROCESS 13 7.23e-01 8.81e-01 0.131000 -2.58e-02 -1.28e-01 8.72e-01 4.24e-01
GOBP THIOESTER BIOSYNTHETIC PROCESS 43 3.58e-01 6.47e-01 0.131000 1.06e-01 7.64e-02 2.30e-01 3.86e-01
TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest 18 6.16e-01 8.26e-01 0.131000 4.76e-02 -1.22e-01 7.27e-01 3.72e-01
GOCC INTRACELLULAR PROTEIN CONTAINING COMPLEX 860 1.58e-10 1.33e-08 0.131000 1.14e-01 -6.32e-02 1.29e-08 1.65e-03
Resolution of Sister Chromatid Cohesion 119 3.92e-02 1.95e-01 0.131000 1.11e-01 -6.86e-02 3.64e-02 1.96e-01
GOCC ZONA PELLUCIDA RECEPTOR COMPLEX 8 8.04e-01 9.20e-01 0.130000 1.11e-01 -6.91e-02 5.88e-01 7.35e-01
GOMF CARBON OXYGEN LYASE ACTIVITY 74 1.73e-01 4.59e-01 0.130000 9.79e-02 8.62e-02 1.45e-01 2.00e-01
GOBP FLAVONOID GLUCURONIDATION 5 8.81e-01 9.51e-01 0.130000 -6.73e-03 -1.30e-01 9.79e-01 6.14e-01
GOBP INTERLEUKIN 2 MEDIATED SIGNALING PATHWAY 8 8.12e-01 9.24e-01 0.130000 1.42e-02 -1.30e-01 9.44e-01 5.26e-01
GOBP REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 108 5.42e-02 2.37e-01 0.130000 1.16e-01 -5.88e-02 3.67e-02 2.91e-01
GOMF PROTEIN SERINE KINASE ACTIVITY 342 2.93e-04 5.09e-03 0.130000 1.18e-01 5.57e-02 1.81e-04 7.65e-02
GOBP RENAL FILTRATION 27 4.88e-01 7.46e-01 0.130000 1.25e-01 -3.61e-02 2.60e-01 7.45e-01
Cross-presentation of soluble exogenous antigens (endosomes) 34 4.23e-01 7.01e-01 0.130000 -8.43e-03 -1.30e-01 9.32e-01 1.90e-01
GOCC PLATELET DENSE GRANULE LUMEN 14 7.08e-01 8.74e-01 0.130000 3.33e-02 1.26e-01 8.29e-01 4.15e-01
GOBP CD8 POSITIVE ALPHA BETA T CELL ACTIVATION 28 5.12e-01 7.61e-01 0.130000 -1.13e-01 -6.47e-02 3.01e-01 5.53e-01
GOBP POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 59 2.05e-01 4.99e-01 0.130000 1.19e-01 -5.26e-02 1.14e-01 4.84e-01
GOBP HEART FORMATION 34 4.39e-01 7.13e-01 0.130000 1.21e-01 4.81e-02 2.22e-01 6.27e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH NH GROUP OF DONORS NAD OR NADP AS ACCEPTOR 17 6.28e-01 8.33e-01 0.130000 -8.92e-02 9.48e-02 5.24e-01 4.99e-01
GOBP REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 33 4.56e-01 7.22e-01 0.130000 1.10e-01 6.88e-02 2.72e-01 4.94e-01
GOBP NADP METABOLIC PROCESS 42 3.43e-01 6.32e-01 0.130000 5.05e-04 1.30e-01 9.95e-01 1.44e-01
GOBP AUTOSOME GENOMIC IMPRINTING 5 8.75e-01 9.48e-01 0.130000 4.86e-02 -1.21e-01 8.51e-01 6.40e-01
GOBP HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 164 1.51e-02 1.05e-01 0.130000 1.30e-01 -8.62e-03 4.12e-03 8.49e-01
GOMF PATTERN RECOGNITION RECEPTOR ACTIVITY 32 4.37e-01 7.10e-01 0.130000 -1.29e-01 1.45e-02 2.06e-01 8.87e-01
Signaling by NTRKs 132 2.96e-02 1.65e-01 0.130000 1.20e-01 -4.99e-02 1.72e-02 3.22e-01
GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY 30 4.80e-01 7.39e-01 0.130000 -1.25e-01 -3.62e-02 2.37e-01 7.32e-01
GOBP AMYLOID BETA CLEARANCE BY TRANSCYTOSIS 7 8.47e-01 9.36e-01 0.130000 1.03e-01 7.99e-02 6.38e-01 7.14e-01
GOBP GENITALIA DEVELOPMENT 46 3.03e-01 5.97e-01 0.130000 1.29e-01 -1.81e-02 1.31e-01 8.32e-01
GOBP POSITIVE REGULATION OF FEVER GENERATION 7 8.34e-01 9.31e-01 0.130000 -1.29e-01 1.46e-02 5.54e-01 9.47e-01
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 19 5.97e-01 8.14e-01 0.130000 7.50e-02 -1.06e-01 5.72e-01 4.23e-01
GOBP NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION 93 8.27e-02 3.07e-01 0.130000 5.78e-02 -1.16e-01 3.36e-01 5.25e-02
GOBP MACROAUTOPHAGY 346 1.72e-04 3.34e-03 0.130000 1.30e-01 -8.04e-04 3.31e-05 9.79e-01
GOMF ASPARTIC ENDOPEPTIDASE ACTIVITY INTRAMEMBRANE CLEAVING 8 8.28e-01 9.29e-01 0.130000 1.03e-01 7.92e-02 6.14e-01 6.98e-01
GOBP REGULATION OF CYTOSKELETON ORGANIZATION 500 5.15e-06 1.62e-04 0.130000 1.29e-01 1.68e-02 8.36e-07 5.20e-01
The canonical retinoid cycle in rods (twilight vision) 22 5.53e-01 7.87e-01 0.130000 -6.14e-02 1.14e-01 6.18e-01 3.53e-01
GOBP CELLULAR RESPONSE TO AMYLOID BETA 44 3.35e-01 6.25e-01 0.130000 1.29e-01 1.63e-02 1.40e-01 8.52e-01
O-linked glycosylation of mucins 62 1.86e-01 4.76e-01 0.130000 -9.56e-02 8.76e-02 1.93e-01 2.33e-01
GOMF OXYGEN BINDING 32 4.63e-01 7.26e-01 0.130000 -1.22e-01 -4.49e-02 2.34e-01 6.60e-01
GOMF PRE MIRNA BINDING 9 7.89e-01 9.14e-01 0.130000 3.81e-02 -1.24e-01 8.43e-01 5.20e-01
GOMF ACETYLGLUCOSAMINYLTRANSFERASE ACTIVITY 42 3.31e-01 6.22e-01 0.130000 -3.80e-02 1.24e-01 6.70e-01 1.65e-01
GOBP REGULATION OF FATTY ACID METABOLIC PROCESS 94 1.11e-01 3.60e-01 0.130000 1.02e-01 7.94e-02 8.64e-02 1.83e-01
GOBP REGULATION OF CELLULAR SENESCENCE 53 2.39e-01 5.36e-01 0.129000 8.56e-02 -9.71e-02 2.81e-01 2.21e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION 41 3.37e-01 6.26e-01 0.129000 -1.19e-01 5.18e-02 1.89e-01 5.66e-01
GOBP POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS 21 5.71e-01 7.98e-01 0.129000 -1.16e-01 5.69e-02 3.57e-01 6.52e-01
EML4 and NUDC in mitotic spindle formation 112 5.11e-02 2.28e-01 0.129000 1.16e-01 -5.78e-02 3.45e-02 2.90e-01
GOMF ADENYLYLTRANSFERASE ACTIVITY 29 4.88e-01 7.46e-01 0.129000 1.28e-01 1.40e-02 2.31e-01 8.96e-01
GOMF ACETYLGALACTOSAMINYLTRANSFERASE ACTIVITY 34 4.53e-01 7.21e-01 0.129000 8.51e-02 9.72e-02 3.90e-01 3.27e-01
O-linked glycosylation 110 5.21e-02 2.31e-01 0.129000 -8.93e-02 9.32e-02 1.05e-01 9.12e-02
GOBP UTP METABOLIC PROCESS 12 7.32e-01 8.85e-01 0.129000 -1.26e-01 3.03e-02 4.52e-01 8.56e-01
GOBP CDP CHOLINE PATHWAY 6 8.55e-01 9.40e-01 0.129000 3.19e-02 -1.25e-01 8.92e-01 5.96e-01
GOMF PHOSPHOLIPASE BINDING 20 6.01e-01 8.16e-01 0.129000 1.33e-02 -1.28e-01 9.18e-01 3.20e-01
Transport of inorganic cations/anions and amino acids/oligopeptides 102 6.87e-02 2.74e-01 0.129000 -4.67e-02 1.20e-01 4.15e-01 3.57e-02
GOBP TOR SIGNALING 158 1.58e-02 1.09e-01 0.129000 1.19e-01 -4.96e-02 9.72e-03 2.82e-01
GOBP NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 64 2.06e-01 5.00e-01 0.129000 -1.18e-02 -1.29e-01 8.70e-01 7.54e-02
GOBP REGULATION OF ORGAN GROWTH 96 1.05e-01 3.49e-01 0.129000 1.13e-01 6.14e-02 5.47e-02 2.98e-01
GOBP REGULATION OF HEART RATE BY CARDIAC CONDUCTION 39 3.56e-01 6.45e-01 0.129000 -5.52e-02 1.17e-01 5.51e-01 2.08e-01
GOCC ASTROCYTE END FOOT 11 7.72e-01 9.04e-01 0.129000 5.92e-02 1.15e-01 7.34e-01 5.11e-01
GOBP RESPONSE TO NUTRIENT 157 1.76e-02 1.16e-01 0.129000 1.25e-01 -2.98e-02 6.65e-03 5.20e-01
GOCC NLRP1 INFLAMMASOME COMPLEX 6 8.51e-01 9.38e-01 0.129000 -7.43e-02 1.05e-01 7.53e-01 6.55e-01
GOBP KERATINOCYTE PROLIFERATION 60 2.14e-01 5.09e-01 0.129000 2.39e-02 -1.27e-01 7.49e-01 8.95e-02
GOBP NUCLEAR CHROMOSOME SEGREGATION 312 3.53e-04 5.94e-03 0.129000 1.26e-01 -2.74e-02 1.29e-04 4.06e-01
GOBP COPPER ION HOMEOSTASIS 18 6.17e-01 8.26e-01 0.129000 -1.01e-01 8.02e-02 4.58e-01 5.56e-01
GOBP ANDROGEN BIOSYNTHETIC PROCESS 10 7.79e-01 9.08e-01 0.129000 -1.29e-01 -2.88e-03 4.80e-01 9.87e-01
GOBP NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 14 7.11e-01 8.76e-01 0.129000 1.26e-01 2.57e-02 4.13e-01 8.68e-01
GOBP POSITIVE REGULATION OF FATTY ACID OXIDATION 14 6.88e-01 8.65e-01 0.129000 1.07e-01 -7.18e-02 4.88e-01 6.42e-01
GOCC ENDOPLASMIC RETICULUM EXIT SITE 29 4.66e-01 7.28e-01 0.129000 5.19e-02 -1.18e-01 6.28e-01 2.72e-01
GOBP FATTY ACID TRANSPORT 119 4.88e-02 2.23e-01 0.129000 1.28e-01 -1.64e-02 1.60e-02 7.57e-01
GOBP REGULATION OF SUPEROXIDE ANION GENERATION 20 6.01e-01 8.17e-01 0.129000 -1.28e-01 1.44e-02 3.21e-01 9.11e-01
GOBP RESPONSE TO HORMONE 854 2.46e-09 1.68e-07 0.129000 1.25e-01 3.22e-02 5.98e-10 1.10e-01
GOBP REGULATION OF PROTEIN ADP RIBOSYLATION 8 8.30e-01 9.30e-01 0.129000 7.75e-02 1.03e-01 7.04e-01 6.14e-01
GOBP NEGATIVE REGULATION OF MAPK CASCADE 159 1.77e-02 1.17e-01 0.129000 1.27e-01 -1.86e-02 5.55e-03 6.85e-01
GOCC CELL CORTEX 305 9.16e-04 1.28e-02 0.129000 1.03e-01 7.72e-02 1.95e-03 2.04e-02
GOMF SIALYLTRANSFERASE ACTIVITY 21 6.11e-01 8.22e-01 0.129000 5.94e-02 1.14e-01 6.37e-01 3.65e-01
GOBP T HELPER 2 CELL CYTOKINE PRODUCTION 13 7.07e-01 8.73e-01 0.129000 -7.04e-02 1.08e-01 6.60e-01 5.01e-01
GOBP EXTRACELLULAR EXOSOME ASSEMBLY 7 8.40e-01 9.33e-01 0.129000 -9.32e-04 1.29e-01 9.97e-01 5.55e-01
GOMF KINASE REGULATOR ACTIVITY 268 8.71e-04 1.23e-02 0.129000 6.78e-02 -1.09e-01 5.60e-02 2.06e-03
GOMF ATPASE BINDING 82 1.22e-01 3.81e-01 0.129000 2.77e-02 -1.26e-01 6.65e-01 4.92e-02
GOBP HOMEOSTASIS OF NUMBER OF CELLS 306 3.62e-04 6.06e-03 0.129000 1.19e-01 -4.94e-02 3.51e-04 1.38e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 129 3.40e-02 1.79e-01 0.129000 1.16e-01 -5.59e-02 2.31e-02 2.73e-01
HDL remodeling 10 7.94e-01 9.16e-01 0.129000 -8.50e-02 -9.65e-02 6.42e-01 5.97e-01
GOBP POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 25 5.50e-01 7.85e-01 0.129000 1.23e-01 3.59e-02 2.85e-01 7.56e-01
Lysosphingolipid and LPA receptors 14 7.13e-01 8.76e-01 0.129000 -1.26e-01 -2.63e-02 4.15e-01 8.65e-01
GOBP REGULATION OF CELL SIZE 163 2.05e-02 1.29e-01 0.129000 1.24e-01 3.34e-02 6.23e-03 4.62e-01
GOBP GANGLIOSIDE CATABOLIC PROCESS 7 8.30e-01 9.30e-01 0.129000 7.22e-02 -1.06e-01 7.41e-01 6.26e-01
GOBP NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION 16 6.90e-01 8.66e-01 0.129000 1.07e-01 7.08e-02 4.57e-01 6.24e-01
GOMF METALLOENDOPEPTIDASE ACTIVITY 106 6.01e-02 2.52e-01 0.129000 -1.05e-01 7.40e-02 6.14e-02 1.88e-01
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS 43 3.57e-01 6.47e-01 0.129000 -3.48e-02 -1.24e-01 6.93e-01 1.60e-01
GOMF EXONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 5 PHOSPHOMONOESTERS 60 2.12e-01 5.08e-01 0.129000 1.24e-01 -3.54e-02 9.78e-02 6.35e-01
Cyclin A:Cdk2-associated events at S phase entry 75 1.45e-01 4.18e-01 0.128000 3.51e-02 -1.24e-01 5.99e-01 6.42e-02
GOBP GLUTAMATE RECEPTOR SIGNALING PATHWAY 48 2.85e-01 5.82e-01 0.128000 -1.18e-01 5.14e-02 1.58e-01 5.38e-01
GOMF CALCIUM DEPENDENT PROTEIN BINDING 76 1.36e-01 4.04e-01 0.128000 -1.14e-01 5.85e-02 8.49e-02 3.78e-01
GOBP EMBRYO IMPLANTATION 58 2.38e-01 5.34e-01 0.128000 1.28e-01 2.18e-03 9.07e-02 9.77e-01
GOMF CYTIDYLYLTRANSFERASE ACTIVITY 9 8.11e-01 9.23e-01 0.128000 6.06e-02 1.13e-01 7.53e-01 5.57e-01
GOBP TUBE MORPHOGENESIS 928 3.75e-10 2.95e-08 0.128000 1.27e-01 1.47e-02 4.61e-11 4.49e-01
GOBP PEROXISOME FISSION 9 7.88e-01 9.13e-01 0.128000 1.07e-01 -7.01e-02 5.77e-01 7.16e-01
GOBP PROTEIN K63 LINKED UBIQUITINATION 67 1.97e-01 4.90e-01 0.128000 1.27e-01 1.70e-02 7.20e-02 8.10e-01
GOBP COBALAMIN METABOLIC PROCESS 9 7.95e-01 9.16e-01 0.128000 -2.32e-02 1.26e-01 9.04e-01 5.12e-01
GOCC PROTEIN KINASE COMPLEX 137 2.96e-02 1.65e-01 0.128000 1.21e-01 -4.14e-02 1.43e-02 4.02e-01
GOBP REGULATION OF PROTEIN KINASE A SIGNALING 20 6.30e-01 8.34e-01 0.128000 -6.69e-02 -1.09e-01 6.05e-01 3.98e-01
Glucagon-type ligand receptors 32 4.81e-01 7.40e-01 0.128000 -8.68e-02 -9.41e-02 3.95e-01 3.57e-01
GOBP DNA CYTOSINE DEAMINATION 9 8.10e-01 9.22e-01 0.128000 1.17e-01 5.14e-02 5.42e-01 7.89e-01
GOBP ORGANELLE LOCALIZATION 581 5.07e-07 2.15e-05 0.128000 1.24e-01 -3.30e-02 3.47e-07 1.74e-01
GOBP REGULATION OF DEVELOPMENTAL GROWTH 299 8.44e-04 1.20e-02 0.128000 1.25e-01 2.59e-02 1.92e-04 4.41e-01
GOBP REGULATION OF HEART MORPHOGENESIS 8 8.32e-01 9.30e-01 0.128000 7.28e-02 1.05e-01 7.21e-01 6.06e-01
GOBP RESPONSE TO TYPE II INTERFERON 115 4.82e-02 2.21e-01 0.128000 8.42e-02 -9.64e-02 1.19e-01 7.40e-02
GOMF FLOPPASE ACTIVITY 15 6.84e-01 8.63e-01 0.128000 -2.22e-02 1.26e-01 8.82e-01 3.98e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING 12 7.32e-01 8.84e-01 0.128000 5.50e-02 -1.15e-01 7.41e-01 4.89e-01
GOMF ARACHIDONATE COA LIGASE ACTIVITY 10 7.95e-01 9.16e-01 0.128000 7.37e-02 1.04e-01 6.86e-01 5.67e-01
GOBP PROTEIN O LINKED MANNOSYLATION 19 6.08e-01 8.21e-01 0.128000 -6.41e-02 1.11e-01 6.29e-01 4.04e-01
GOBP NOREPINEPHRINE SECRETION 14 7.19e-01 8.79e-01 0.128000 -3.92e-02 -1.22e-01 7.99e-01 4.31e-01
GOCC NUCLEOCYTOPLASMIC TRANSPORT COMPLEX 12 7.31e-01 8.84e-01 0.128000 6.10e-02 -1.12e-01 7.14e-01 5.01e-01
GOBP L ALANINE TRANSPORT 10 7.72e-01 9.05e-01 0.128000 -1.19e-01 4.78e-02 5.16e-01 7.94e-01
GOBP REGULATION OF FATTY ACID BETA OXIDATION 19 6.34e-01 8.36e-01 0.128000 1.26e-01 2.29e-02 3.43e-01 8.63e-01
GOBP RETINAL CONE CELL DEVELOPMENT 11 7.76e-01 9.07e-01 0.128000 1.12e-01 6.17e-02 5.21e-01 7.23e-01
GOBP CARDIAC CHAMBER MORPHOGENESIS 128 4.56e-02 2.14e-01 0.128000 1.27e-01 1.05e-02 1.29e-02 8.37e-01
GOBP PERIPHERAL NERVOUS SYSTEM AXON REGENERATION 8 8.31e-01 9.30e-01 0.128000 5.89e-02 1.13e-01 7.73e-01 5.79e-01
GOCC NUCLEAR PERIPHERY 142 2.44e-02 1.46e-01 0.128000 8.24e-02 -9.75e-02 9.02e-02 4.49e-02
GOBP POSITIVE REGULATION OF NEURON PROJECTION ARBORIZATION 8 8.31e-01 9.30e-01 0.128000 1.15e-01 5.54e-02 5.73e-01 7.86e-01
GOMF HYDRO LYASE ACTIVITY 56 2.79e-01 5.76e-01 0.128000 7.13e-02 1.06e-01 3.56e-01 1.71e-01
GOBP APOPTOTIC SIGNALING PATHWAY 597 2.49e-07 1.13e-05 0.128000 1.07e-01 -6.98e-02 8.34e-06 3.59e-03
GOBP GROWTH 881 1.29e-09 9.31e-08 0.128000 1.27e-01 1.17e-02 1.58e-10 5.55e-01
GOBP ATRIAL CARDIAC MUSCLE TISSUE DEVELOPMENT 20 6.32e-01 8.35e-01 0.127000 1.11e-01 6.36e-02 3.92e-01 6.23e-01
Ca2+ pathway 62 2.13e-01 5.08e-01 0.127000 1.26e-01 -1.90e-02 8.60e-02 7.95e-01
GOBP MEMBRANE PROTEIN PROTEOLYSIS 59 2.19e-01 5.15e-01 0.127000 1.17e-01 -5.05e-02 1.20e-01 5.02e-01
GOCC CUL3 RING UBIQUITIN LIGASE COMPLEX 37 4.23e-01 7.02e-01 0.127000 1.19e-01 4.67e-02 2.12e-01 6.23e-01
GOMF UNFOLDED PROTEIN BINDING 114 5.74e-02 2.46e-01 0.127000 2.54e-02 -1.25e-01 6.40e-01 2.12e-02
GOBP NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 19 6.49e-01 8.45e-01 0.127000 1.02e-01 7.59e-02 4.40e-01 5.67e-01
GOMF LIGASE ACTIVITY 161 1.59e-02 1.10e-01 0.127000 1.15e-01 -5.58e-02 1.21e-02 2.22e-01
GOBP REGULATION OF MITOTIC CYTOKINESIS 16 6.96e-01 8.68e-01 0.127000 8.96e-02 9.06e-02 5.35e-01 5.30e-01
GOCC PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX 48 2.93e-01 5.90e-01 0.127000 4.42e-02 -1.19e-01 5.96e-01 1.52e-01
GOBP VESICLE DOCKING 56 2.40e-01 5.36e-01 0.127000 1.21e-01 -4.05e-02 1.18e-01 6.00e-01
GOBP CARDIAC VENTRICLE DEVELOPMENT 128 4.56e-02 2.14e-01 0.127000 1.27e-01 6.57e-03 1.30e-02 8.98e-01
GOBP MITOCHONDRIAL FISSION 40 3.90e-01 6.73e-01 0.127000 1.23e-01 3.16e-02 1.77e-01 7.30e-01
GOBP ANATOMICAL STRUCTURE REGRESSION 15 6.95e-01 8.68e-01 0.127000 1.27e-01 4.90e-03 3.94e-01 9.74e-01
GOBP ACTIN FILAMENT BASED PROCESS 797 2.22e-08 1.26e-06 0.127000 1.11e-01 6.16e-02 8.75e-08 3.13e-03
GOCC CLATHRIN COATED VESICLE 208 7.79e-03 6.58e-02 0.127000 1.23e-01 3.24e-02 2.20e-03 4.21e-01
GOCC PROTEASOME ACCESSORY COMPLEX 23 5.48e-01 7.83e-01 0.127000 8.27e-02 -9.67e-02 4.92e-01 4.22e-01
Glutathione conjugation 33 4.39e-01 7.12e-01 0.127000 1.25e-01 -2.15e-02 2.13e-01 8.31e-01
GOCC SPINDLE POLE CENTROSOME 13 7.40e-01 8.87e-01 0.127000 -4.39e-02 -1.19e-01 7.84e-01 4.56e-01
GOMF ACYLTRANSFERASE ACTIVITY 677 1.02e-07 4.99e-06 0.127000 1.27e-01 -5.66e-03 1.74e-08 8.02e-01
GOMF DNA DAMAGE SENSOR ACTIVITY 23 5.74e-01 7.99e-01 0.127000 1.27e-01 6.43e-03 2.92e-01 9.57e-01
GOCC PROTEIN COMPLEX INVOLVED IN CELL ADHESION 56 2.65e-01 5.62e-01 0.127000 1.25e-01 2.13e-02 1.05e-01 7.83e-01
GOMF MONOOXYGENASE ACTIVITY 104 8.39e-02 3.11e-01 0.127000 -1.26e-01 -1.37e-02 2.61e-02 8.09e-01
GOMF ACTIN FILAMENT BINDING 203 1.07e-02 8.26e-02 0.127000 8.04e-02 9.83e-02 4.83e-02 1.58e-02
Budding and maturation of HIV virion 28 5.24e-01 7.66e-01 0.127000 -4.53e-02 -1.19e-01 6.78e-01 2.77e-01
GOCC LIPID DROPLET 96 1.16e-01 3.69e-01 0.127000 7.96e-02 9.89e-02 1.78e-01 9.40e-02
GOMF RNA EXONUCLEASE ACTIVITY 45 3.11e-01 6.04e-01 0.127000 7.65e-02 -1.01e-01 3.74e-01 2.40e-01
GOBP SYNAPSE MATURATION 33 4.47e-01 7.17e-01 0.127000 4.47e-03 -1.27e-01 9.65e-01 2.07e-01
GOBP REGULATION OF LIPID KINASE ACTIVITY 8 8.32e-01 9.30e-01 0.127000 1.17e-01 4.81e-02 5.65e-01 8.14e-01
GOBP CALCIUM ION TRANSPORT INTO CYTOSOL 28 4.96e-01 7.51e-01 0.127000 3.03e-02 -1.23e-01 7.81e-01 2.59e-01
GOBP NEGATIVE REGULATION OF DNA METABOLIC PROCESS 134 3.99e-02 1.97e-01 0.127000 1.27e-01 2.62e-03 1.13e-02 9.58e-01
GOBP INTESTINAL HEXOSE ABSORPTION 5 8.85e-01 9.54e-01 0.127000 -3.93e-03 1.27e-01 9.88e-01 6.24e-01
GOBP POSITIVE REGULATION OF CELL GROWTH 152 3.34e-02 1.78e-01 0.127000 9.81e-02 8.04e-02 3.69e-02 8.71e-02
GOBP RRNA TRANSCRIPTION 40 3.79e-01 6.64e-01 0.127000 1.27e-01 -1.86e-03 1.65e-01 9.84e-01
GOBP CENTROSOME SEPARATION 16 6.98e-01 8.70e-01 0.127000 9.11e-02 8.81e-02 5.28e-01 5.42e-01
GOBP IMPORT ACROSS PLASMA MEMBRANE 194 7.56e-03 6.44e-02 0.127000 -4.42e-02 1.19e-01 2.89e-01 4.31e-03
Interferon gamma signaling 92 1.00e-01 3.40e-01 0.127000 1.23e-01 -3.26e-02 4.22e-02 5.89e-01
GOMF PYRIMIDINE NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY 10 7.91e-01 9.15e-01 0.127000 1.24e-01 2.65e-02 4.97e-01 8.85e-01
GOMF AMINOACYLTRANSFERASE ACTIVITY 461 1.66e-05 4.49e-04 0.127000 1.27e-01 -5.75e-03 3.17e-06 8.32e-01
GOBP POSITIVE REGULATION OF URINE VOLUME 13 7.47e-01 8.91e-01 0.127000 9.11e-02 8.81e-02 5.70e-01 5.82e-01
GOBP ADULT BEHAVIOR 143 3.47e-02 1.82e-01 0.127000 1.25e-01 1.94e-02 9.75e-03 6.89e-01
GOCC RECYCLING ENDOSOME 198 1.18e-02 8.83e-02 0.127000 1.10e-01 6.27e-02 7.63e-03 1.28e-01
GOBP NEGATIVE REGULATION OF GLUCONEOGENESIS 18 6.38e-01 8.39e-01 0.127000 -3.05e-02 1.23e-01 8.23e-01 3.67e-01
GOBP REGULATION OF MYELINATION 46 3.58e-01 6.47e-01 0.127000 9.47e-02 8.39e-02 2.66e-01 3.25e-01
GOBP SCHWANN CELL MIGRATION 5 8.80e-01 9.51e-01 0.127000 1.11e-01 -6.08e-02 6.68e-01 8.14e-01
GOBP INTEGRIN ACTIVATION 26 5.12e-01 7.61e-01 0.126000 1.06e-01 -6.88e-02 3.49e-01 5.44e-01
GOBP REGULATION OF DNA BIOSYNTHETIC PROCESS 114 5.32e-02 2.35e-01 0.126000 9.26e-02 -8.61e-02 8.78e-02 1.12e-01
GOBP KETONE CATABOLIC PROCESS 15 6.79e-01 8.61e-01 0.126000 9.17e-02 -8.71e-02 5.39e-01 5.59e-01
GOBP MULTINUCLEAR OSTEOCLAST DIFFERENTIATION 8 8.14e-01 9.25e-01 0.126000 -1.05e-01 7.01e-02 6.07e-01 7.31e-01
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 55 2.49e-01 5.46e-01 0.126000 1.16e-01 -4.98e-02 1.36e-01 5.23e-01
GOBP GDP METABOLIC PROCESS 9 7.93e-01 9.15e-01 0.126000 -8.89e-02 8.98e-02 6.44e-01 6.41e-01
GOMF EPIDERMAL GROWTH FACTOR RECEPTOR BINDING 34 4.44e-01 7.16e-01 0.126000 -6.73e-03 -1.26e-01 9.46e-01 2.03e-01
GOBP CELLULAR COMPONENT MAINTENANCE 70 2.01e-01 4.95e-01 0.126000 4.19e-02 1.19e-01 5.44e-01 8.47e-02
GOCC ENDONUCLEASE COMPLEX 38 3.76e-01 6.62e-01 0.126000 1.00e-01 -7.70e-02 2.85e-01 4.11e-01
GOMF CATALYTIC ACTIVITY ACTING ON A RRNA 22 5.68e-01 7.96e-01 0.126000 1.02e-01 -7.46e-02 4.08e-01 5.45e-01
GOBP L ASCORBIC ACID METABOLIC PROCESS 10 7.78e-01 9.07e-01 0.126000 1.19e-01 -4.19e-02 5.14e-01 8.18e-01
GOBP CELLULAR PIGMENTATION 60 2.23e-01 5.18e-01 0.126000 1.20e-01 -4.06e-02 1.09e-01 5.87e-01
Biosynthesis of EPA-derived SPMs 6 8.70e-01 9.46e-01 0.126000 2.64e-02 1.23e-01 9.11e-01 6.01e-01
GOBP ACTIVATION OF PHOSPHOLIPASE C ACTIVITY 23 6.00e-01 8.16e-01 0.126000 -9.03e-02 -8.81e-02 4.53e-01 4.64e-01
GOBP PROTEIN POLYMERIZATION 272 1.55e-03 1.95e-02 0.126000 1.26e-01 -2.59e-03 3.42e-04 9.41e-01
GOBP CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE 76 1.65e-01 4.49e-01 0.126000 6.80e-03 1.26e-01 9.18e-01 5.76e-02
GOBP POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY 106 7.20e-02 2.82e-01 0.126000 1.21e-01 -3.59e-02 3.15e-02 5.24e-01
GOBP NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 30 4.86e-01 7.44e-01 0.126000 1.26e-01 -5.12e-03 2.32e-01 9.61e-01
GOMF COBALAMIN BINDING 9 8.14e-01 9.25e-01 0.126000 1.19e-01 4.03e-02 5.35e-01 8.34e-01
GOBP NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING 14 7.29e-01 8.83e-01 0.126000 5.10e-02 1.15e-01 7.41e-01 4.56e-01
GOBP REGULATION OF PROTEIN TARGETING 75 1.82e-01 4.71e-01 0.126000 1.19e-01 4.19e-02 7.54e-02 5.30e-01
GOBP GANGLIOSIDE METABOLIC PROCESS 28 5.30e-01 7.71e-01 0.126000 1.17e-01 4.61e-02 2.83e-01 6.73e-01
GOBP RESPONSE TO UV 150 2.34e-02 1.42e-01 0.126000 1.14e-01 -5.26e-02 1.56e-02 2.66e-01
GOBP AV NODE CELL TO BUNDLE OF HIS CELL COMMUNICATION 14 6.99e-01 8.70e-01 0.126000 -9.49e-02 8.26e-02 5.39e-01 5.93e-01
Bile acid and bile salt metabolism 44 3.74e-01 6.61e-01 0.126000 1.10e-01 6.14e-02 2.08e-01 4.81e-01
GOBP NEGATIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 63 2.27e-01 5.23e-01 0.126000 1.25e-01 8.38e-03 8.50e-02 9.08e-01
GOBP REGULATION OF ACTIN FILAMENT ORGANIZATION 259 2.37e-03 2.68e-02 0.126000 1.25e-01 8.46e-03 5.07e-04 8.15e-01
GOBP REGULATION OF SYNAPSE MATURATION 21 6.20e-01 8.27e-01 0.126000 1.20e-01 3.88e-02 3.43e-01 7.58e-01
Synthesis of GDP-mannose 6 8.64e-01 9.43e-01 0.126000 1.25e-01 -1.73e-02 5.97e-01 9.41e-01
Somitogenesis 45 3.20e-01 6.11e-01 0.126000 6.30e-02 -1.09e-01 4.64e-01 2.07e-01
GOBP BLASTODERM SEGMENTATION 25 5.65e-01 7.94e-01 0.126000 3.55e-02 1.21e-01 7.59e-01 2.97e-01
GOBP REGULATION OF EXECUTION PHASE OF APOPTOSIS 23 5.58e-01 7.90e-01 0.126000 6.61e-02 -1.07e-01 5.83e-01 3.75e-01
Zinc influx into cells by the SLC39 gene family 10 7.85e-01 9.12e-01 0.126000 -1.42e-02 1.25e-01 9.38e-01 4.94e-01
GOBP MELANOCYTE DIFFERENTIATION 24 5.87e-01 8.07e-01 0.126000 -6.97e-02 -1.05e-01 5.54e-01 3.75e-01
IL-6-type cytokine receptor ligand interactions 17 6.85e-01 8.64e-01 0.126000 1.09e-01 6.23e-02 4.36e-01 6.56e-01
GOBP POSITIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 76 1.85e-01 4.75e-01 0.126000 1.09e-01 6.30e-02 1.01e-01 3.43e-01
GOBP REGULATION OF SYNAPTIC VESICLE CYCLE 12 7.38e-01 8.87e-01 0.126000 -6.84e-02 1.05e-01 6.81e-01 5.28e-01
GOCC CALYX OF HELD 18 6.72e-01 8.57e-01 0.126000 7.32e-02 1.02e-01 5.91e-01 4.53e-01
GOBP FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE 12 7.57e-01 8.96e-01 0.126000 1.24e-01 2.24e-02 4.59e-01 8.93e-01
GOCC LATE ENDOSOME 295 1.04e-03 1.42e-02 0.126000 1.25e-01 6.91e-03 2.12e-04 8.38e-01
TRAIL signaling 8 8.22e-01 9.27e-01 0.126000 1.22e-01 -2.82e-02 5.49e-01 8.90e-01
GOBP POSITIVE REGULATION OF T HELPER 1 CELL DIFFERENTIATION 6 8.59e-01 9.42e-01 0.125000 -1.07e-01 6.58e-02 6.50e-01 7.80e-01
GOBP ORGANELLE FUSION 162 2.05e-02 1.29e-01 0.125000 1.24e-01 -1.57e-02 6.26e-03 7.31e-01
GOBP N ACYLPHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS 9 7.97e-01 9.17e-01 0.125000 6.09e-02 -1.10e-01 7.52e-01 5.69e-01
Protein localization 153 2.70e-02 1.56e-01 0.125000 1.61e-03 -1.25e-01 9.73e-01 7.43e-03
GOCC PHOTORECEPTOR RIBBON SYNAPSE 9 8.19e-01 9.27e-01 0.125000 1.07e-01 6.49e-02 5.77e-01 7.36e-01
Translation of Structural Proteins 9683701 29 5.11e-01 7.60e-01 0.125000 1.24e-01 1.84e-02 2.48e-01 8.64e-01
GOBP CHROMOSOME CONDENSATION 46 3.64e-01 6.51e-01 0.125000 9.91e-02 7.68e-02 2.45e-01 3.68e-01
GOBP REGULATION OF PLATELET ACTIVATION 51 3.20e-01 6.11e-01 0.125000 1.14e-01 5.19e-02 1.59e-01 5.22e-01
GOBP REGULATION OF CELL PROJECTION ASSEMBLY 217 6.69e-03 5.89e-02 0.125000 1.25e-01 1.41e-02 1.57e-03 7.20e-01
Antigen processing: Ubiquitination & Proteasome degradation 283 9.63e-04 1.34e-02 0.125000 1.17e-01 -4.54e-02 7.22e-04 1.88e-01
GOBP REGULATION OF AXONOGENESIS 129 5.81e-02 2.47e-01 0.125000 1.09e-01 6.22e-02 3.28e-02 2.23e-01
Regulation of ornithine decarboxylase (ODC) 38 3.94e-01 6.77e-01 0.125000 3.36e-02 -1.21e-01 7.20e-01 1.98e-01
GOCC CYTOSOLIC REGION 19 6.55e-01 8.48e-01 0.125000 1.13e-01 5.31e-02 3.92e-01 6.88e-01
Signaling by RAF1 mutants 39 3.90e-01 6.74e-01 0.125000 1.23e-01 -2.02e-02 1.82e-01 8.27e-01
GOBP REGULATION OF GUANYLATE CYCLASE ACTIVITY 6 8.60e-01 9.42e-01 0.125000 -6.83e-02 1.05e-01 7.72e-01 6.56e-01
GOBP PIGMENT BIOSYNTHETIC PROCESS 51 2.89e-01 5.86e-01 0.125000 3.06e-02 -1.21e-01 7.05e-01 1.34e-01
GOBP PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 23 5.66e-01 7.94e-01 0.125000 -4.56e-02 1.16e-01 7.05e-01 3.34e-01
GOBP NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 55 2.58e-01 5.55e-01 0.125000 1.18e-01 -4.20e-02 1.31e-01 5.90e-01
GOMF ACYLTRANSFERASE ACTIVITY TRANSFERRING GROUPS OTHER THAN AMINO ACYL GROUPS 208 7.35e-03 6.32e-02 0.125000 1.25e-01 -9.76e-03 1.94e-03 8.08e-01
GOBP PROTEIN LOCALIZATION TO PERINUCLEAR REGION OF CYTOPLASM 9 8.13e-01 9.24e-01 0.125000 -1.24e-01 -1.86e-02 5.21e-01 9.23e-01
Trafficking and processing of endosomal TLR 11 7.59e-01 8.97e-01 0.125000 1.07e-01 -6.41e-02 5.38e-01 7.13e-01
Vitamins 6 8.60e-01 9.42e-01 0.125000 1.00e-01 -7.49e-02 6.71e-01 7.51e-01
RHO GTPases Activate Formins 134 3.59e-02 1.86e-01 0.125000 1.10e-01 -5.96e-02 2.83e-02 2.33e-01
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS 85 1.57e-01 4.37e-01 0.125000 1.02e-01 7.14e-02 1.02e-01 2.55e-01
GOBP REGULATION OF CELLULAR COMPONENT BIOGENESIS 965 3.61e-10 2.86e-08 0.125000 1.25e-01 -1.06e-03 4.96e-11 9.55e-01
GOBP VITAMIN CATABOLIC PROCESS 15 7.09e-01 8.75e-01 0.125000 1.23e-01 2.13e-02 4.09e-01 8.87e-01
GOBP REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 345 3.99e-04 6.53e-03 0.125000 1.24e-01 1.68e-02 7.86e-05 5.91e-01
GOBP ICOSANOID TRANSPORT 64 2.18e-01 5.13e-01 0.125000 1.24e-01 -1.39e-02 8.61e-02 8.48e-01
GOMF LOW DENSITY LIPOPROTEIN PARTICLE BINDING 17 6.57e-01 8.49e-01 0.125000 -1.15e-01 4.80e-02 4.11e-01 7.32e-01
GOBP GLYCEROPHOSPHOLIPID BIOSYNTHETIC PROCESS 200 7.57e-03 6.45e-02 0.125000 1.16e-01 -4.50e-02 4.54e-03 2.73e-01
GOBP ESTABLISHMENT OF ORGANELLE LOCALIZATION 459 1.73e-05 4.68e-04 0.125000 1.20e-01 -3.43e-02 1.06e-05 2.08e-01
GOMF POLYSACCHARIDE BINDING 21 5.97e-01 8.14e-01 0.125000 -1.16e-01 4.48e-02 3.56e-01 7.22e-01
GOBP ALCOHOL CATABOLIC PROCESS 33 4.56e-01 7.22e-01 0.125000 -1.43e-02 1.24e-01 8.87e-01 2.18e-01
GOBP CELLULAR RESPONSE TO TYPE II INTERFERON 93 9.86e-02 3.37e-01 0.125000 1.04e-01 -6.86e-02 8.27e-02 2.53e-01
GOBP MITOCHONDRION LOCALIZATION 47 3.10e-01 6.04e-01 0.125000 1.05e-01 -6.66e-02 2.11e-01 4.30e-01
GOCC TERTIARY GRANULE MEMBRANE 69 1.94e-01 4.87e-01 0.125000 -1.24e-01 1.55e-02 7.57e-02 8.24e-01
GOBP POSTSYNAPSE ORGANIZATION 183 1.95e-02 1.24e-01 0.125000 9.28e-02 8.30e-02 3.03e-02 5.28e-02
GOBP POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS 192 1.23e-02 9.10e-02 0.124000 1.24e-01 9.57e-03 3.03e-03 8.19e-01
GOBP NEUROTRANSMITTER UPTAKE 44 3.82e-01 6.67e-01 0.124000 1.09e-01 5.96e-02 2.10e-01 4.94e-01
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling 112 7.26e-02 2.83e-01 0.124000 1.24e-01 -6.86e-03 2.31e-02 9.00e-01
GOBP REGULATION OF SMOOTH MUSCLE CONTRACTION 61 2.33e-01 5.31e-01 0.124000 1.22e-01 -2.33e-02 9.87e-02 7.53e-01
GOBP NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 92 1.20e-01 3.77e-01 0.124000 1.24e-01 5.54e-03 3.95e-02 9.27e-01
GOCC SPECTRIN ASSOCIATED CYTOSKELETON 9 8.17e-01 9.26e-01 0.124000 1.20e-01 3.40e-02 5.34e-01 8.60e-01
GOMF NEUROTROPHIN BINDING 10 7.89e-01 9.14e-01 0.124000 -1.23e-01 1.62e-02 5.00e-01 9.29e-01
GOBP TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY 18 6.64e-01 8.52e-01 0.124000 -1.23e-01 -1.98e-02 3.67e-01 8.84e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 161 1.91e-02 1.23e-01 0.124000 1.08e-01 -6.12e-02 1.79e-02 1.80e-01
GOBP FATTY ACID DERIVATIVE METABOLIC PROCESS 68 2.15e-01 5.11e-01 0.124000 1.22e-01 2.31e-02 8.17e-02 7.41e-01
GOCC GABA RECEPTOR COMPLEX 18 6.78e-01 8.61e-01 0.124000 -8.38e-02 -9.17e-02 5.38e-01 5.00e-01
GOBP REGULATION OF DNA DEMETHYLATION 7 8.51e-01 9.38e-01 0.124000 -8.56e-03 -1.24e-01 9.69e-01 5.70e-01
GOBP RESPONSE TO TEMPERATURE STIMULUS 166 1.66e-02 1.12e-01 0.124000 9.80e-02 -7.61e-02 2.93e-02 9.06e-02
GOCC PHOSPHOLIPID TRANSLOCATING ATPASE COMPLEX 13 7.24e-01 8.81e-01 0.124000 9.83e-02 -7.58e-02 5.39e-01 6.36e-01
GOBP REGULATION OF ENDODEOXYRIBONUCLEASE ACTIVITY 8 8.24e-01 9.28e-01 0.124000 -3.66e-02 1.19e-01 8.58e-01 5.61e-01
GOCC MICROFIBRIL 13 7.56e-01 8.95e-01 0.124000 9.90e-02 7.48e-02 5.37e-01 6.40e-01
GOBP SERINE FAMILY AMINO ACID METABOLIC PROCESS 30 4.82e-01 7.41e-01 0.124000 1.15e-01 -4.66e-02 2.76e-01 6.59e-01
GOBP GLANDULAR EPITHELIAL CELL DEVELOPMENT 36 4.46e-01 7.17e-01 0.124000 1.21e-01 2.78e-02 2.10e-01 7.73e-01
Plasma lipoprotein clearance 37 4.27e-01 7.05e-01 0.124000 1.24e-01 5.64e-03 1.92e-01 9.53e-01
GOBP L SERINE BIOSYNTHETIC PROCESS 6 8.74e-01 9.48e-01 0.124000 1.21e-01 2.53e-02 6.07e-01 9.15e-01
GOCC LUMENAL SIDE OF ENDOPLASMIC RETICULUM MEMBRANE 32 4.57e-01 7.22e-01 0.124000 1.12e-01 -5.40e-02 2.74e-01 5.97e-01
GOBP GENERATION OF NEURONS 1444 5.39e-14 7.88e-12 0.124000 1.22e-01 2.09e-02 7.26e-15 1.84e-01
GOBP REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION 153 2.85e-02 1.62e-01 0.124000 1.24e-01 -8.35e-03 8.26e-03 8.59e-01
GOBP SHORT CHAIN FATTY ACID CATABOLIC PROCESS 7 8.60e-01 9.42e-01 0.124000 -9.78e-02 -7.62e-02 6.54e-01 7.27e-01
GOCC LAMELLIPODIUM MEMBRANE 22 5.96e-01 8.13e-01 0.124000 1.23e-01 -1.44e-02 3.17e-01 9.07e-01
GOBP POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 197 1.18e-02 8.87e-02 0.124000 1.23e-01 1.59e-02 2.93e-03 7.00e-01
Zinc transporters 15 7.19e-01 8.79e-01 0.124000 -4.56e-02 -1.15e-01 7.60e-01 4.40e-01
GOBP REGULATION OF INWARD RECTIFIER POTASSIUM CHANNEL ACTIVITY 6 8.64e-01 9.43e-01 0.124000 -1.14e-01 4.96e-02 6.30e-01 8.33e-01
GOBP NEGATIVE REGULATION OF FERROPTOSIS 8 8.20e-01 9.27e-01 0.124000 -7.74e-02 9.67e-02 7.04e-01 6.36e-01
E2F mediated regulation of DNA replication 20 6.15e-01 8.26e-01 0.124000 1.15e-01 -4.61e-02 3.73e-01 7.21e-01
GOBP VIRAL GENE EXPRESSION 99 8.83e-02 3.18e-01 0.124000 1.07e-01 -6.25e-02 6.60e-02 2.82e-01
GOBP CEREBELLAR GRANULAR LAYER DEVELOPMENT 12 7.43e-01 8.89e-01 0.124000 -9.52e-02 7.91e-02 5.68e-01 6.35e-01
GOBP CELLULAR RESPONSE TO NITROGEN LEVELS 12 7.71e-01 9.04e-01 0.124000 5.72e-02 1.10e-01 7.31e-01 5.10e-01
GOMF O METHYLTRANSFERASE ACTIVITY 20 6.48e-01 8.44e-01 0.124000 -5.89e-02 -1.09e-01 6.48e-01 3.99e-01
GOBP POSITIVE REGULATION OF MONOATOMIC ION TRANSPORT 196 9.88e-03 7.81e-02 0.124000 1.21e-01 -2.49e-02 3.43e-03 5.48e-01
GOBP PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION 785 1.18e-08 7.17e-07 0.124000 1.18e-01 -3.87e-02 2.12e-08 6.48e-02
GOBP POSITIVE REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY 5 8.86e-01 9.54e-01 0.124000 -1.15e-01 4.57e-02 6.56e-01 8.59e-01
GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 15 7.25e-01 8.82e-01 0.124000 7.84e-02 9.57e-02 5.99e-01 5.21e-01
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS 10 8.07e-01 9.21e-01 0.124000 8.02e-02 9.42e-02 6.61e-01 6.06e-01
GOMF SODIUM PHOSPHATE SYMPORTER ACTIVITY 13 7.29e-01 8.83e-01 0.124000 -1.12e-01 5.18e-02 4.83e-01 7.46e-01
GOCC GLIAL CELL PROJECTION 38 3.92e-01 6.75e-01 0.124000 -8.30e-02 9.16e-02 3.76e-01 3.29e-01
GOMF FOLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 5 8.97e-01 9.59e-01 0.124000 4.99e-02 1.13e-01 8.47e-01 6.62e-01
GOBP PROTEIN TRANSMEMBRANE TRANSPORT 71 2.06e-01 5.00e-01 0.123000 -2.47e-02 -1.21e-01 7.18e-01 7.80e-02
GOBP LIPID EXPORT FROM CELL 50 3.08e-01 6.01e-01 0.123000 1.21e-01 -2.42e-02 1.39e-01 7.67e-01
GOBP REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION 371 2.38e-04 4.35e-03 0.123000 1.23e-01 3.86e-03 4.49e-05 8.98e-01
GOBP CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS 32 4.73e-01 7.33e-01 0.123000 1.22e-01 -1.84e-02 2.32e-01 8.57e-01
GOBP MODULATION BY HOST OF SYMBIONT PROCESS 81 1.75e-01 4.61e-01 0.123000 -5.44e-02 -1.11e-01 3.97e-01 8.49e-02
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE TO WOUNDING 9 8.19e-01 9.27e-01 0.123000 -2.78e-02 -1.20e-01 8.85e-01 5.32e-01
GOBP PROCESS UTILIZING AUTOPHAGIC MECHANISM 571 2.81e-06 9.43e-05 0.123000 1.23e-01 -1.22e-03 4.69e-07 9.60e-01
GOBP POSITIVE REGULATION OF TOR SIGNALING 68 1.92e-01 4.83e-01 0.123000 1.07e-01 -6.06e-02 1.26e-01 3.88e-01
GOBP POST TRANSLATIONAL PROTEIN MODIFICATION 918 8.28e-10 6.16e-08 0.123000 1.19e-01 -3.10e-02 8.61e-10 1.11e-01
GOBP REGULATION OF HEAT GENERATION 13 7.27e-01 8.82e-01 0.123000 9.89e-02 -7.37e-02 5.37e-01 6.46e-01
GOCC EUCHROMATIN 59 2.58e-01 5.55e-01 0.123000 1.23e-01 -4.29e-03 1.02e-01 9.55e-01
GOBP ARTERY DEVELOPMENT 113 7.84e-02 2.97e-01 0.123000 1.23e-01 1.01e-02 2.40e-02 8.53e-01
Keratan sulfate/keratin metabolism 36 4.50e-01 7.19e-01 0.123000 2.65e-02 1.20e-01 7.83e-01 2.11e-01
GOMF INOSITOL 1 4 5 TRISPHOSPHATE BINDING 11 7.91e-01 9.15e-01 0.123000 -7.28e-02 -9.95e-02 6.76e-01 5.68e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY 36 4.50e-01 7.19e-01 0.123000 2.44e-02 1.21e-01 8.00e-01 2.10e-01
Glycosphingolipid metabolism 52 3.09e-01 6.02e-01 0.123000 1.23e-01 7.56e-03 1.25e-01 9.25e-01
GOBP METANEPHRIC NEPHRON MORPHOGENESIS 24 5.73e-01 7.99e-01 0.123000 1.22e-01 -1.28e-02 2.99e-01 9.14e-01
GOMF HEPARAN SULFATE PROTEOGLYCAN BINDING 18 6.75e-01 8.58e-01 0.123000 -1.17e-01 -3.77e-02 3.89e-01 7.82e-01
GOBP NEGATIVE REGULATION OF OSSIFICATION 38 4.41e-01 7.13e-01 0.123000 -4.99e-02 -1.13e-01 5.95e-01 2.30e-01
EPHB-mediated forward signaling 41 3.76e-01 6.61e-01 0.123000 1.15e-01 -4.28e-02 2.01e-01 6.36e-01
GOBP REGULATION OF EXOSOMAL SECRETION 19 6.30e-01 8.34e-01 0.123000 -6.82e-02 1.02e-01 6.07e-01 4.40e-01
Mitotic Prometaphase 192 1.00e-02 7.88e-02 0.123000 1.09e-01 -5.64e-02 8.98e-03 1.78e-01
GOBP REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION 29 5.24e-01 7.66e-01 0.123000 -1.22e-01 -1.86e-02 2.57e-01 8.63e-01
GOMF PEPTIDASE REGULATOR ACTIVITY 221 7.27e-03 6.28e-02 0.123000 -1.22e-01 -1.13e-02 1.70e-03 7.73e-01
GOBP PROTEIN HETEROOLIGOMERIZATION 29 5.42e-01 7.80e-01 0.123000 8.66e-02 8.73e-02 4.19e-01 4.16e-01
GOBP REGULATION OF HEART GROWTH 70 2.28e-01 5.25e-01 0.123000 1.00e-01 7.16e-02 1.48e-01 3.00e-01
GOBP PEPTIDYL PROLINE HYDROXYLATION TO 4 HYDROXY L PROLINE 8 8.28e-01 9.29e-01 0.123000 1.20e-01 -2.83e-02 5.58e-01 8.90e-01
GOMF PEPTIDYL PROLINE 4 DIOXYGENASE ACTIVITY 8 8.28e-01 9.29e-01 0.123000 1.20e-01 -2.83e-02 5.58e-01 8.90e-01
GOBP TYPE II INTERFERON MEDIATED SIGNALING PATHWAY 26 5.33e-01 7.73e-01 0.123000 1.06e-01 -6.17e-02 3.48e-01 5.86e-01
GOBP CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 102 8.60e-02 3.14e-01 0.123000 1.09e-01 -5.68e-02 5.71e-02 3.22e-01
GOBP MANNOSYLATION 25 5.43e-01 7.80e-01 0.123000 -8.45e-02 8.92e-02 4.65e-01 4.40e-01
GOBP SURFACTANT HOMEOSTASIS 20 6.32e-01 8.35e-01 0.123000 -7.88e-03 1.23e-01 9.51e-01 3.42e-01
GOBP NEUROGENESIS 1676 1.32e-15 2.96e-13 0.123000 1.20e-01 2.46e-02 2.26e-16 9.39e-02
GOMF G PROTEIN ACTIVITY 46 3.27e-01 6.18e-01 0.123000 9.14e-02 -8.19e-02 2.83e-01 3.37e-01
GOBP POSITIVE REGULATION OF NUCLEAR DIVISION 61 2.40e-01 5.36e-01 0.123000 1.19e-01 -2.95e-02 1.08e-01 6.90e-01
GOMF MEMBRANE POTENTIAL DRIVEN UNIPORTER ACTIVITY 5 8.97e-01 9.59e-01 0.123000 1.16e-01 4.03e-02 6.54e-01 8.76e-01
RUNX1 regulates transcription of genes involved in interleukin signaling 5 8.94e-01 9.58e-01 0.123000 -1.22e-01 -1.07e-02 6.36e-01 9.67e-01
GOBP PROTEIN LOCALIZATION TO ORGANELLE 930 5.04e-10 3.92e-08 0.123000 1.10e-01 -5.44e-02 1.30e-08 4.93e-03
GOBP PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE 9 8.12e-01 9.24e-01 0.123000 1.22e-01 -1.66e-02 5.28e-01 9.31e-01
GOBP PROTEIN MATURATION BY IRON SULFUR CLUSTER TRANSFER 15 7.07e-01 8.73e-01 0.123000 -1.21e-01 1.76e-02 4.16e-01 9.06e-01
GOBP CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT 195 1.06e-02 8.23e-02 0.123000 1.18e-01 -3.22e-02 4.38e-03 4.38e-01
GOCC 90S PRERIBOSOME 27 5.43e-01 7.80e-01 0.123000 1.23e-01 2.29e-03 2.70e-01 9.84e-01
Cargo trafficking to the periciliary membrane 49 3.13e-01 6.06e-01 0.123000 1.15e-01 -4.31e-02 1.65e-01 6.01e-01
GOBP HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION 8 8.24e-01 9.28e-01 0.123000 1.03e-01 -6.69e-02 6.15e-01 7.43e-01
GOMF MANGANESE ION BINDING 64 2.31e-01 5.29e-01 0.123000 1.22e-01 -1.11e-02 9.13e-02 8.78e-01
GOCC NUCLEOTIDE ACTIVATED PROTEIN KINASE COMPLEX 10 7.88e-01 9.13e-01 0.123000 -1.12e-01 5.02e-02 5.40e-01 7.83e-01
GOBP POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION 102 8.80e-02 3.17e-01 0.122000 1.10e-01 -5.42e-02 5.53e-02 3.44e-01
GOBP PRESYNAPTIC ACTIVE ZONE ORGANIZATION 7 8.47e-01 9.36e-01 0.122000 -4.56e-02 1.14e-01 8.34e-01 6.03e-01
GOBP AXONEMAL DYNEIN COMPLEX ASSEMBLY 38 4.00e-01 6.82e-01 0.122000 -1.01e-01 6.91e-02 2.81e-01 4.61e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE 436 3.69e-05 9.18e-04 0.122000 1.11e-01 -5.23e-02 7.39e-05 6.12e-02
GOBP NEGATIVE REGULATION OF MIRNA METABOLIC PROCESS 28 5.24e-01 7.66e-01 0.122000 1.21e-01 -1.84e-02 2.68e-01 8.66e-01
Hyaluronan metabolism 17 6.83e-01 8.63e-01 0.122000 1.22e-01 6.03e-03 3.83e-01 9.66e-01
GOBP POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 119 6.25e-02 2.58e-01 0.122000 1.18e-01 -3.25e-02 2.62e-02 5.41e-01
GOBP REGULATION OF AMYLOID BETA CLEARANCE 19 6.42e-01 8.41e-01 0.122000 2.92e-02 -1.19e-01 8.26e-01 3.70e-01
Defective RIPK1-mediated regulated necrosis 7 8.44e-01 9.36e-01 0.122000 9.57e-02 -7.62e-02 6.61e-01 7.27e-01
PI3K/AKT activation 9 8.16e-01 9.25e-01 0.122000 1.22e-01 -3.05e-03 5.25e-01 9.87e-01
GOBP REGULATION OF ACUTE INFLAMMATORY RESPONSE 45 3.56e-01 6.45e-01 0.122000 -1.21e-01 1.67e-02 1.59e-01 8.47e-01
G1/S Transition 118 5.90e-02 2.49e-01 0.122000 6.95e-02 -1.01e-01 1.92e-01 5.90e-02
GOBP CELLULAR RESPONSE TO FOLLICLE STIMULATING HORMONE STIMULUS 9 8.05e-01 9.20e-01 0.122000 -9.38e-02 7.84e-02 6.26e-01 6.84e-01
GOBP REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 30 5.25e-01 7.67e-01 0.122000 4.21e-02 1.15e-01 6.90e-01 2.76e-01
GOCC INHIBITORY SYNAPSE 13 7.35e-01 8.86e-01 0.122000 4.70e-02 -1.13e-01 7.69e-01 4.81e-01
Transport of Mature mRNA Derived from an Intronless Transcript 42 3.82e-01 6.67e-01 0.122000 1.21e-01 -1.61e-02 1.74e-01 8.57e-01
GOBP IMMUNOLOGICAL MEMORY PROCESS 19 6.59e-01 8.50e-01 0.122000 1.21e-01 2.01e-02 3.63e-01 8.79e-01
GOCC PREFOLDIN COMPLEX 6 8.78e-01 9.50e-01 0.122000 -3.03e-02 -1.18e-01 8.98e-01 6.15e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 14 7.44e-01 8.90e-01 0.122000 1.06e-01 6.14e-02 4.94e-01 6.91e-01
GOBP STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 54 2.74e-01 5.71e-01 0.122000 1.01e-01 -6.86e-02 1.98e-01 3.83e-01
Peroxisomal protein import 62 2.25e-01 5.21e-01 0.122000 9.31e-02 -7.91e-02 2.05e-01 2.81e-01
GOCC COATED VESICLE MEMBRANE 194 1.07e-02 8.26e-02 0.122000 1.14e-01 -4.29e-02 5.99e-03 3.03e-01
GOBP REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY 50 3.01e-01 5.96e-01 0.122000 1.00e-01 -7.00e-02 2.20e-01 3.92e-01
GOMF TUMOR NECROSIS FACTOR RECEPTOR ACTIVITY 8 8.31e-01 9.30e-01 0.122000 1.20e-01 -2.52e-02 5.58e-01 9.02e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS 40 4.11e-01 6.92e-01 0.122000 1.22e-01 8.15e-03 1.82e-01 9.29e-01
Beta-catenin independent WNT signaling 133 4.47e-02 2.11e-01 0.122000 1.16e-01 -3.97e-02 2.14e-02 4.29e-01
GOBP PROTEIN TRANSPORT TO VACUOLE INVOLVED IN UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY 15 7.28e-01 8.83e-01 0.122000 5.53e-02 1.09e-01 7.11e-01 4.65e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION 61 2.81e-01 5.78e-01 0.122000 -8.26e-02 -9.00e-02 2.65e-01 2.24e-01
Negative regulation of the PI3K/AKT network 119 7.09e-02 2.79e-01 0.122000 1.22e-01 4.54e-03 2.15e-02 9.32e-01
GOBP CELL DIVISION 617 6.25e-07 2.55e-05 0.122000 1.09e-01 -5.52e-02 3.84e-06 1.92e-02
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN 20 6.59e-01 8.50e-01 0.122000 8.00e-02 9.22e-02 5.36e-01 4.75e-01
GOCC MYOSIN COMPLEX 57 3.01e-01 5.96e-01 0.122000 5.63e-02 1.08e-01 4.62e-01 1.57e-01
GOBP REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 44 3.67e-01 6.54e-01 0.122000 1.21e-01 -1.49e-02 1.65e-01 8.64e-01
GOBP BRANCHED CHAIN AMINO ACID METABOLIC PROCESS 27 5.26e-01 7.68e-01 0.122000 1.08e-01 -5.71e-02 3.32e-01 6.08e-01
GOCC GLYCOPROTEIN COMPLEX 21 6.11e-01 8.23e-01 0.122000 -4.12e-02 1.15e-01 7.44e-01 3.62e-01
NS1 Mediated Effects on Host Pathways 41 3.74e-01 6.60e-01 0.122000 9.04e-02 -8.18e-02 3.17e-01 3.64e-01
GOBP NEUROTRANSMITTER RECEPTOR INTERNALIZATION 33 4.90e-01 7.48e-01 0.122000 3.07e-02 1.18e-01 7.60e-01 2.41e-01
GOBP POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS 100 1.21e-01 3.79e-01 0.122000 1.12e-01 4.92e-02 5.39e-02 3.95e-01
GOMF SOLUTE MONOATOMIC CATION SYMPORTER ACTIVITY 114 7.45e-02 2.87e-01 0.122000 -1.83e-02 1.21e-01 7.36e-01 2.62e-02
GOBP CELL CYCLE 1601 1.26e-15 2.92e-13 0.122000 1.19e-01 -2.55e-02 1.72e-15 8.94e-02
GOBP POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 145 4.43e-02 2.10e-01 0.122000 -2.90e-02 -1.18e-01 5.46e-01 1.39e-02
Cellular response to chemical stress 188 1.20e-02 8.96e-02 0.122000 1.09e-01 -5.43e-02 9.87e-03 1.99e-01
GOBP NEGATIVE REGULATION OF B CELL ACTIVATION 29 5.48e-01 7.83e-01 0.122000 -9.63e-02 -7.46e-02 3.69e-01 4.87e-01
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY 8 8.29e-01 9.30e-01 0.122000 -4.33e-02 1.14e-01 8.32e-01 5.77e-01
GOBP POSITIVE REGULATION OF LIPID METABOLIC PROCESS 118 8.22e-02 3.06e-01 0.122000 4.33e-02 1.14e-01 4.16e-01 3.27e-02
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION 8 8.46e-01 9.36e-01 0.122000 -1.06e-01 -6.08e-02 6.05e-01 7.66e-01
GOCC EXTRINSIC COMPONENT OF POSTSYNAPTIC MEMBRANE 7 8.65e-01 9.44e-01 0.122000 8.38e-02 8.84e-02 7.01e-01 6.86e-01
GOMF MONOATOMIC ANION SODIUM SYMPORTER ACTIVITY 17 6.82e-01 8.62e-01 0.122000 -1.22e-01 7.19e-03 3.86e-01 9.59e-01
GOBP CELL CELL RECOGNITION 73 2.08e-01 5.03e-01 0.122000 -1.18e-01 -2.87e-02 8.05e-02 6.72e-01
GOBP CARDIAC VENTRICLE MORPHOGENESIS 72 2.19e-01 5.15e-01 0.122000 1.12e-01 4.65e-02 9.90e-02 4.95e-01
GOMF MONOCARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 68 2.06e-01 5.00e-01 0.122000 -4.06e-02 1.15e-01 5.63e-01 1.02e-01
GOBP HEART TRABECULA FORMATION 15 7.00e-01 8.70e-01 0.122000 6.62e-02 -1.02e-01 6.57e-01 4.94e-01
GOMF RETINOIC ACID BINDING 27 5.36e-01 7.75e-01 0.122000 1.17e-01 -3.34e-02 2.93e-01 7.64e-01
GOBP EARLY ENDOSOME TO GOLGI TRANSPORT 17 6.78e-01 8.60e-01 0.122000 1.19e-01 -2.30e-02 3.94e-01 8.70e-01
GOBP PROLINE TRANSMEMBRANE TRANSPORT 9 8.08e-01 9.21e-01 0.122000 -6.14e-02 1.05e-01 7.50e-01 5.86e-01
GOMF CERAMIDE 1 PHOSPHATE BINDING 7 8.59e-01 9.42e-01 0.121000 -2.27e-02 -1.19e-01 9.17e-01 5.85e-01
GOCC ENDODEOXYRIBONUCLEASE COMPLEX 5 8.95e-01 9.58e-01 0.121000 9.58e-04 -1.21e-01 9.97e-01 6.38e-01
Beta-oxidation of very long chain fatty acids 10 7.88e-01 9.13e-01 0.121000 9.40e-02 -7.68e-02 6.07e-01 6.74e-01
GOMF ENZYME SUBSTRATE ADAPTOR ACTIVITY 69 1.94e-01 4.87e-01 0.121000 9.51e-02 -7.54e-02 1.72e-01 2.79e-01
GOBP POSITIVE REGULATION BY HOST OF VIRAL PROCESS 20 6.57e-01 8.49e-01 0.121000 -4.91e-02 -1.11e-01 7.04e-01 3.90e-01
GOBP CELL CYCLE PROCESS 1244 2.22e-12 2.57e-10 0.121000 1.19e-01 -2.44e-02 1.73e-12 1.47e-01
GOBP ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 1235 1.29e-11 1.33e-09 0.121000 1.18e-01 2.63e-02 2.48e-12 1.20e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 36 4.25e-01 7.03e-01 0.121000 8.09e-02 -9.03e-02 4.01e-01 3.48e-01
GOMF OXIDATIVE RNA DEMETHYLASE ACTIVITY 5 9.01e-01 9.61e-01 0.121000 1.09e-01 5.26e-02 6.72e-01 8.38e-01
GOBP PROTEIN INSERTION INTO MEMBRANE 42 4.07e-01 6.89e-01 0.121000 -2.75e-02 -1.18e-01 7.58e-01 1.85e-01
GOMF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY 168 2.51e-02 1.49e-01 0.121000 1.21e-01 2.15e-03 6.71e-03 9.62e-01
GOBP NEGATIVE REGULATION OF HEART RATE 11 7.98e-01 9.17e-01 0.121000 8.91e-02 8.22e-02 6.09e-01 6.37e-01
GOBP REGULATION OF VASCULAR WOUND HEALING 14 7.18e-01 8.79e-01 0.121000 1.01e-01 -6.67e-02 5.12e-01 6.66e-01
GOMF CHOLESTEROL BINDING 52 3.39e-01 6.28e-01 0.121000 1.09e-01 5.31e-02 1.74e-01 5.08e-01
GOBP PIGMENT GRANULE MATURATION 10 7.94e-01 9.16e-01 0.121000 3.81e-02 -1.15e-01 8.35e-01 5.29e-01
GOCC LUMENAL SIDE OF MEMBRANE 42 3.77e-01 6.62e-01 0.121000 1.12e-01 -4.66e-02 2.10e-01 6.01e-01
GOMF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY INVOLVED IN CARDIAC MUSCLE CELL ACTION POTENTIAL 5 9.01e-01 9.61e-01 0.121000 -5.60e-02 -1.07e-01 8.28e-01 6.77e-01
GOBP CYTIDINE METABOLIC PROCESS 13 7.61e-01 8.98e-01 0.121000 1.13e-01 4.33e-02 4.80e-01 7.87e-01
GOBP METANEPHRIC TUBULE FORMATION 6 8.68e-01 9.46e-01 0.121000 -6.06e-02 1.05e-01 7.97e-01 6.57e-01
GOBP REGULATION OF CELL MORPHOGENESIS 231 8.63e-03 7.10e-02 0.121000 1.08e-01 5.49e-02 4.72e-03 1.51e-01
GOBP REGULATION OF OSSIFICATION 119 6.96e-02 2.76e-01 0.121000 1.20e-01 -1.58e-02 2.37e-02 7.65e-01
GOBP LONG TERM SYNAPTIC DEPRESSION 30 5.10e-01 7.60e-01 0.121000 -1.38e-02 1.20e-01 8.96e-01 2.54e-01
GOMF 4 IRON 4 SULFUR CLUSTER BINDING 45 3.97e-01 6.79e-01 0.121000 6.55e-02 1.02e-01 4.47e-01 2.38e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 80 1.61e-01 4.44e-01 0.121000 1.16e-01 -3.32e-02 7.21e-02 6.07e-01
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION 60 2.47e-01 5.43e-01 0.121000 -1.08e-01 5.44e-02 1.48e-01 4.66e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 40 4.37e-01 7.10e-01 0.121000 5.35e-02 1.08e-01 5.58e-01 2.35e-01
GOMF ASPARTIC TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY 7 8.62e-01 9.43e-01 0.121000 -3.36e-02 -1.16e-01 8.78e-01 5.95e-01
GOBP REGULATION OF CALCINEURIN MEDIATED SIGNALING 40 3.90e-01 6.73e-01 0.121000 7.44e-02 -9.53e-02 4.16e-01 2.97e-01
GOMF EXOPEPTIDASE ACTIVITY 100 1.31e-01 3.95e-01 0.121000 7.75e-02 9.27e-02 1.80e-01 1.09e-01
GOBP ALANINE TRANSPORT 16 6.97e-01 8.69e-01 0.121000 -1.19e-01 1.99e-02 4.09e-01 8.90e-01
GOBP DERMATAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS 8 8.47e-01 9.36e-01 0.121000 4.82e-02 1.11e-01 8.13e-01 5.87e-01
GOMF ORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 76 1.75e-01 4.61e-01 0.121000 1.14e-01 -4.04e-02 8.62e-02 5.42e-01
GOMF GLUCOSIDASE ACTIVITY 14 7.46e-01 8.91e-01 0.121000 4.16e-02 1.13e-01 7.88e-01 4.63e-01
GOBP TRIPEPTIDE TRANSPORT 12 7.72e-01 9.05e-01 0.121000 1.20e-01 1.48e-02 4.72e-01 9.29e-01
GOBP MUCOPOLYSACCHARIDE METABOLIC PROCESS 88 1.59e-01 4.42e-01 0.121000 4.07e-02 1.14e-01 5.09e-01 6.53e-02
GOMF STEROL BINDING 66 2.55e-01 5.52e-01 0.121000 1.10e-01 4.91e-02 1.21e-01 4.90e-01
GOBP NEGATIVE REGULATION OF MEMBRANE PERMEABILITY 21 6.17e-01 8.27e-01 0.121000 -4.01e-02 1.14e-01 7.50e-01 3.66e-01
GOMF PHOSPHATIDYLCHOLINE FLOPPASE ACTIVITY 8 8.44e-01 9.36e-01 0.121000 2.78e-02 1.17e-01 8.92e-01 5.65e-01
GOCC NLS DEPENDENT PROTEIN NUCLEAR IMPORT COMPLEX 10 7.91e-01 9.15e-01 0.121000 7.07e-02 -9.78e-02 6.99e-01 5.92e-01
GOMF STEROID HYDROXYLASE ACTIVITY 26 5.78e-01 8.02e-01 0.121000 -1.17e-01 -3.10e-02 3.04e-01 7.84e-01
GOBP METAPHASE CHROMOSOME ALIGNMENT 102 9.29e-02 3.27e-01 0.121000 9.95e-02 -6.80e-02 8.25e-02 2.35e-01
GOCC GOLGI STACK 129 7.41e-02 2.87e-01 0.120000 8.59e-02 8.45e-02 9.20e-02 9.75e-02
GOMF O ACYLTRANSFERASE ACTIVITY 50 3.57e-01 6.46e-01 0.120000 1.10e-01 4.96e-02 1.79e-01 5.44e-01
GOMF UBIQUITIN LIKE PROTEIN LIGASE ACTIVITY 343 6.95e-04 1.03e-02 0.120000 1.20e-01 1.26e-02 1.38e-04 6.89e-01
GOBP DNA REPLICATION INITIATION 35 4.48e-01 7.17e-01 0.120000 1.11e-01 -4.69e-02 2.56e-01 6.31e-01
GOBP POSITIVE REGULATION OF CALCIUM ION TRANSPORT 112 7.74e-02 2.94e-01 0.120000 1.12e-01 -4.51e-02 4.13e-02 4.10e-01
GOBP PROTEIN CONTAINING COMPLEX ASSEMBLY 1526 4.58e-15 8.78e-13 0.120000 1.05e-01 -5.94e-02 8.08e-12 1.07e-04
Synthesis of very long-chain fatty acyl-CoAs 23 6.11e-01 8.22e-01 0.120000 1.45e-02 1.19e-01 9.04e-01 3.21e-01
GOBP IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY 21 6.52e-01 8.46e-01 0.120000 -6.34e-02 -1.02e-01 6.15e-01 4.17e-01
GOBP REGULATION OF MEMBRANE PERMEABILITY 70 2.24e-01 5.19e-01 0.120000 -1.40e-02 -1.19e-01 8.40e-01 8.39e-02
GOBP THORAX AND ANTERIOR ABDOMEN DETERMINATION 5 9.01e-01 9.61e-01 0.120000 -3.85e-02 -1.14e-01 8.82e-01 6.59e-01
GOBP REGULATION OF WNT PROTEIN SECRETION 5 8.94e-01 9.58e-01 0.120000 1.19e-01 -1.97e-02 6.46e-01 9.39e-01
GOBP WNT PROTEIN SECRETION 5 8.94e-01 9.58e-01 0.120000 1.19e-01 -1.97e-02 6.46e-01 9.39e-01
GOBP POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY 23 6.21e-01 8.29e-01 0.120000 1.12e-01 4.42e-02 3.53e-01 7.14e-01
GOBP POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION 21 6.53e-01 8.47e-01 0.120000 -6.93e-02 -9.82e-02 5.83e-01 4.36e-01
Other interleukin signaling 24 5.88e-01 8.07e-01 0.120000 -1.41e-02 1.19e-01 9.05e-01 3.11e-01
GOCC TRANS GOLGI NETWORK 251 4.14e-03 4.09e-02 0.120000 1.19e-01 -1.27e-02 1.11e-03 7.28e-01
ATF6 (ATF6-alpha) activates chaperone genes 10 7.93e-01 9.16e-01 0.120000 6.14e-02 -1.03e-01 7.37e-01 5.72e-01
GOBP POST EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 8 8.51e-01 9.38e-01 0.120000 7.88e-02 9.07e-02 7.00e-01 6.57e-01
GOBP MITOTIC NUCLEAR DIVISION 274 1.84e-03 2.21e-02 0.120000 9.70e-02 -7.09e-02 5.74e-03 4.35e-02
Caspase activation via Dependence Receptors in the absence of ligand 9 8.23e-01 9.27e-01 0.120000 1.20e-01 1.76e-03 5.33e-01 9.93e-01
GOBP REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 54 3.00e-01 5.95e-01 0.120000 1.18e-01 -2.41e-02 1.35e-01 7.59e-01
Membrane Trafficking 604 2.85e-06 9.52e-05 0.120000 1.20e-01 -6.35e-04 4.72e-07 9.79e-01
GOBP NEUROBLAST MIGRATION 7 8.62e-01 9.43e-01 0.120000 1.19e-01 1.80e-02 5.87e-01 9.34e-01
CD28 dependent PI3K/Akt signaling 27 5.81e-01 8.04e-01 0.120000 9.12e-02 7.79e-02 4.12e-01 4.83e-01
GOBP INTERLEUKIN 18 MEDIATED SIGNALING PATHWAY 10 8.14e-01 9.25e-01 0.120000 4.68e-02 1.10e-01 7.98e-01 5.45e-01
GOBP DETECTION OF EXTERNAL BIOTIC STIMULUS 26 5.62e-01 7.92e-01 0.120000 -1.18e-01 2.03e-02 2.97e-01 8.58e-01
GOBP EXPORT ACROSS PLASMA MEMBRANE 79 1.97e-01 4.90e-01 0.120000 4.05e-02 1.13e-01 5.34e-01 8.30e-02
GOBP POSITIVE REGULATION OF RUFFLE ASSEMBLY 15 7.37e-01 8.87e-01 0.120000 1.05e-01 5.71e-02 4.80e-01 7.02e-01
GOBP REGULATION OF EXIT FROM MITOSIS 18 6.75e-01 8.59e-01 0.120000 1.20e-01 -7.25e-03 3.80e-01 9.58e-01
GOBP NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 146 5.39e-02 2.37e-01 0.120000 9.69e-02 7.04e-02 4.32e-02 1.42e-01
GOBP COLLAGEN METABOLIC PROCESS 104 9.05e-02 3.22e-01 0.120000 -7.71e-02 9.18e-02 1.75e-01 1.06e-01
GOBP REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN 20 6.41e-01 8.41e-01 0.120000 -1.17e-01 2.43e-02 3.64e-01 8.51e-01
GOCC RADIAL SPOKE 15 7.08e-01 8.74e-01 0.120000 -5.98e-02 1.04e-01 6.88e-01 4.87e-01
GOBP ERYTHROCYTE MATURATION 20 6.40e-01 8.40e-01 0.120000 1.17e-01 -2.71e-02 3.67e-01 8.34e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 35 4.91e-01 7.48e-01 0.120000 -1.07e-01 -5.28e-02 2.71e-01 5.89e-01
GOBP LEUKOCYTE TETHERING OR ROLLING 34 4.67e-01 7.29e-01 0.120000 -3.12e-02 1.16e-01 7.53e-01 2.44e-01
GOMF PROTEIN CONTAINING COMPLEX BINDING 1684 2.04e-15 4.47e-13 0.120000 1.20e-01 -4.58e-03 2.98e-16 7.55e-01
GOMF UBIQUITIN UBIQUITIN LIGASE ACTIVITY 14 7.32e-01 8.84e-01 0.120000 1.16e-01 -2.80e-02 4.51e-01 8.56e-01
GOBP REGULATION OF SEROTONIN SECRETION 6 8.77e-01 9.49e-01 0.120000 1.19e-01 -1.36e-02 6.14e-01 9.54e-01
GOBP AMIDE BIOSYNTHETIC PROCESS 150 5.07e-02 2.27e-01 0.120000 7.66e-02 9.19e-02 1.05e-01 5.21e-02
GOBP CELLULAR RESPONSE TO NICOTINE 9 8.32e-01 9.30e-01 0.120000 -1.10e-01 -4.72e-02 5.68e-01 8.06e-01
GOBP B CELL HOMEOSTASIS 31 4.92e-01 7.49e-01 0.120000 5.82e-02 -1.04e-01 5.75e-01 3.14e-01
GOBP REGULATION OF EPITHELIAL CELL PROLIFERATION 396 1.57e-04 3.12e-03 0.120000 1.13e-01 -3.82e-02 1.08e-04 1.92e-01
GOBP CHONDROCYTE DIFFERENTIATION 113 1.05e-01 3.49e-01 0.120000 7.02e-02 9.68e-02 1.97e-01 7.55e-02
GOBP RNA MODIFICATION 162 2.60e-02 1.53e-01 0.120000 4.64e-02 -1.10e-01 3.08e-01 1.55e-02
GOBP REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 42 3.97e-01 6.79e-01 0.120000 1.18e-01 -1.94e-02 1.86e-01 8.28e-01
Sphingolipid metabolism 101 1.24e-01 3.84e-01 0.120000 1.15e-01 3.12e-02 4.51e-02 5.88e-01
GOBP REGULATION OF ACTIN FILAMENT BASED PROCESS 370 5.58e-04 8.63e-03 0.120000 1.13e-01 3.82e-02 1.83e-04 2.07e-01
GOBP PROTEIN DEPALMITOYLATION 8 8.46e-01 9.36e-01 0.120000 -2.30e-02 -1.17e-01 9.10e-01 5.66e-01
GOBP REGULATION OF RESPONSE TO TYPE II INTERFERON 14 7.36e-01 8.86e-01 0.120000 1.19e-01 -1.27e-02 4.41e-01 9.34e-01
MET receptor recycling 10 7.96e-01 9.17e-01 0.119000 1.06e-01 -5.50e-02 5.62e-01 7.63e-01
GOBP SPECIFICATION OF SYMMETRY 138 5.38e-02 2.36e-01 0.119000 1.19e-01 7.67e-03 1.56e-02 8.76e-01
GOMF DYNEIN LIGHT CHAIN BINDING 9 8.18e-01 9.27e-01 0.119000 -3.17e-02 1.15e-01 8.69e-01 5.50e-01
GOCC ENDOSOME LUMEN 38 4.19e-01 6.99e-01 0.119000 -6.27e-02 1.02e-01 5.04e-01 2.78e-01
GOBP POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS 12 7.67e-01 9.01e-01 0.119000 -2.56e-02 1.17e-01 8.78e-01 4.84e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 71 2.07e-01 5.01e-01 0.119000 -1.15e-01 3.03e-02 9.25e-02 6.59e-01
GOBP GLUTATHIONE METABOLIC PROCESS 47 3.80e-01 6.65e-01 0.119000 1.14e-01 3.41e-02 1.75e-01 6.86e-01
GOBP HEPATOCYTE APOPTOTIC PROCESS 20 6.66e-01 8.53e-01 0.119000 4.65e-02 1.10e-01 7.19e-01 3.95e-01
GOBP NEGATIVE REGULATION OF TYPE 2 IMMUNE RESPONSE 15 7.30e-01 8.84e-01 0.119000 1.82e-02 1.18e-01 9.03e-01 4.29e-01
GOBP PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS 729 1.26e-07 6.14e-06 0.119000 1.11e-01 -4.43e-02 3.55e-07 4.17e-02
GOBP B CELL APOPTOTIC PROCESS 25 5.64e-01 7.93e-01 0.119000 7.29e-02 -9.43e-02 5.28e-01 4.14e-01
GOBP REGULATION OF TUBE SIZE 148 4.46e-02 2.11e-01 0.119000 1.19e-01 1.05e-02 1.26e-02 8.26e-01
GOBP NEGATIVE REGULATION OF PROGRAMMED CELL DEATH 877 5.08e-09 3.25e-07 0.119000 1.07e-01 -5.21e-02 7.03e-08 8.85e-03
GOBP CELL ADHESION MOLECULE PRODUCTION 18 6.67e-01 8.53e-01 0.119000 -4.65e-02 1.10e-01 7.33e-01 4.21e-01
GOBP PROTEIN INSERTION INTO MITOCHONDRIAL INNER MEMBRANE 12 7.88e-01 9.14e-01 0.119000 -8.40e-02 -8.44e-02 6.15e-01 6.13e-01
GOMF NUCLEOSOMAL DNA BINDING 60 2.54e-01 5.51e-01 0.119000 9.12e-02 -7.65e-02 2.22e-01 3.05e-01
GOCC OXIDOREDUCTASE COMPLEX 104 9.46e-02 3.29e-01 0.119000 6.36e-02 -1.01e-01 2.62e-01 7.63e-02
Infectious disease 925 2.37e-09 1.63e-07 0.119000 4.21e-02 -1.11e-01 3.01e-02 9.39e-09
GOMF MONOCARBOXYLIC ACID BINDING 87 1.75e-01 4.62e-01 0.119000 1.06e-01 5.42e-02 8.77e-02 3.82e-01
GOBP TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY 64 2.82e-01 5.79e-01 0.119000 9.69e-02 6.89e-02 1.80e-01 3.40e-01
GOBP DELAMINATION 7 8.55e-01 9.40e-01 0.119000 -1.09e-01 4.68e-02 6.16e-01 8.30e-01
RAF-independent MAPK1/3 activation 22 6.16e-01 8.26e-01 0.119000 1.16e-01 -2.69e-02 3.47e-01 8.27e-01
GOBP REGULATION OF PROGRAMMED CELL DEATH 1462 5.17e-14 7.83e-12 0.119000 1.11e-01 -4.38e-02 1.49e-12 5.05e-03
GOBP CELLULAR RESPONSE TO ATP 16 7.28e-01 8.83e-01 0.119000 7.16e-02 9.49e-02 6.20e-01 5.11e-01
GOBP REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 35 5.01e-01 7.54e-01 0.119000 8.26e-02 8.55e-02 3.98e-01 3.81e-01
GOBP POSITIVE REGULATION OF DENDRITIC CELL CYTOKINE PRODUCTION 12 7.66e-01 9.01e-01 0.119000 -1.13e-01 3.72e-02 4.98e-01 8.23e-01
GOMF RNA 2 O METHYLTRANSFERASE ACTIVITY 8 8.54e-01 9.39e-01 0.119000 -9.29e-02 -7.41e-02 6.49e-01 7.17e-01
GOMF PROTEIN KINASE ACTIVITY 551 2.11e-05 5.58e-04 0.119000 1.06e-01 5.31e-02 1.98e-05 3.31e-02
GOBP ENUCLEATE ERYTHROCYTE DIFFERENTIATION 13 7.48e-01 8.91e-01 0.119000 4.34e-02 -1.11e-01 7.86e-01 4.90e-01
GOBP PROTEIN LOCALIZATION TO SYNAPSE 73 2.15e-01 5.10e-01 0.119000 4.71e-03 1.19e-01 9.45e-01 7.96e-02
GOBP ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 79 1.85e-01 4.75e-01 0.119000 -7.66e-03 1.18e-01 9.06e-01 6.88e-02
mRNA Capping 28 5.29e-01 7.71e-01 0.119000 8.90e-02 -7.84e-02 4.15e-01 4.73e-01
GOBP SKELETAL SYSTEM DEVELOPMENT 510 4.35e-05 1.05e-03 0.119000 1.10e-01 4.36e-02 2.00e-05 9.21e-02
GOBP REGULATION OF COMPLEMENT DEPENDENT CYTOTOXICITY 11 8.01e-01 9.18e-01 0.119000 -1.11e-01 -4.03e-02 5.22e-01 8.17e-01
GOBP GOLGI LUMEN ACIDIFICATION 10 7.97e-01 9.17e-01 0.119000 6.83e-02 -9.69e-02 7.08e-01 5.96e-01
E2F-enabled inhibition of pre-replication complex formation 9 8.24e-01 9.28e-01 0.118000 1.42e-02 -1.18e-01 9.41e-01 5.41e-01
GOMF HORMONE RECEPTOR BINDING 31 5.11e-01 7.60e-01 0.118000 1.17e-01 -2.07e-02 2.61e-01 8.42e-01
GOMF ERBB 3 CLASS RECEPTOR BINDING 5 8.95e-01 9.58e-01 0.118000 4.58e-02 -1.09e-01 8.59e-01 6.72e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION 40 4.46e-01 7.17e-01 0.118000 -1.13e-01 -3.62e-02 2.17e-01 6.92e-01
GOMF FMN BINDING 15 7.20e-01 8.79e-01 0.118000 3.30e-02 -1.14e-01 8.25e-01 4.46e-01
GOMF NEUTRAL L AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 40 4.47e-01 7.17e-01 0.118000 3.91e-02 1.12e-01 6.68e-01 2.22e-01
GOCC DENDRITIC SPINE MEMBRANE 13 7.74e-01 9.06e-01 0.118000 -9.79e-02 -6.64e-02 5.41e-01 6.78e-01
GOBP NEGATIVE REGULATION OF AXONOGENESIS 45 3.96e-01 6.78e-01 0.118000 1.17e-01 1.76e-02 1.75e-01 8.38e-01
GOBP POSITIVE REGULATION OF MUSCLE CONTRACTION 49 3.49e-01 6.39e-01 0.118000 1.17e-01 -1.62e-02 1.56e-01 8.45e-01
Metabolism of lipids 722 6.13e-07 2.51e-05 0.118000 1.16e-01 2.39e-02 1.15e-07 2.74e-01
GOCC AMPA GLUTAMATE RECEPTOR COMPLEX 22 6.09e-01 8.22e-01 0.118000 -7.03e-02 9.51e-02 5.68e-01 4.40e-01
GOMF EXTRACELLULAR MATRIX BINDING 63 2.63e-01 5.60e-01 0.118000 -6.34e-03 1.18e-01 9.31e-01 1.05e-01
GOMF AMINE TRANSMEMBRANE TRANSPORTER ACTIVITY 6 8.86e-01 9.55e-01 0.118000 -3.94e-02 -1.11e-01 8.67e-01 6.36e-01
GOBP DNA REPLICATION 273 2.72e-03 2.99e-02 0.118000 1.13e-01 -3.34e-02 1.26e-03 3.43e-01
GOBP MAINTENANCE OF APICAL BASAL CELL POLARITY 10 8.18e-01 9.27e-01 0.118000 -4.12e-02 -1.11e-01 8.21e-01 5.44e-01
GOBP NEGATIVE REGULATION OF CELL DIFFERENTIATION 677 5.72e-07 2.36e-05 0.118000 1.13e-01 -3.34e-02 4.90e-07 1.39e-01
GOBP MACROMOLECULE CATABOLIC PROCESS 1407 4.44e-13 5.67e-11 0.118000 1.16e-01 -2.01e-02 2.43e-13 2.06e-01
GOMF KINASE ACTIVITY 706 1.49e-06 5.37e-05 0.118000 9.87e-02 6.49e-02 7.84e-06 3.29e-03
GOBP POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION 26 5.97e-01 8.14e-01 0.118000 1.07e-01 5.00e-02 3.45e-01 6.59e-01
GOBP LONG CHAIN FATTY ACID TRANSPORT 66 2.63e-01 5.59e-01 0.118000 1.15e-01 2.81e-02 1.07e-01 6.93e-01
Constitutive Signaling by Aberrant PI3K in Cancer 85 1.50e-01 4.29e-01 0.118000 1.02e-01 -5.97e-02 1.04e-01 3.41e-01
GOMF CYCLIN DEPENDENT PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY 15 7.43e-01 8.89e-01 0.118000 -4.87e-02 -1.08e-01 7.44e-01 4.71e-01
Prefoldin mediated transfer of substrate to CCT/TriC 26 5.96e-01 8.13e-01 0.118000 -1.09e-01 -4.41e-02 3.34e-01 6.97e-01
GOBP ASSOCIATIVE LEARNING 86 1.89e-01 4.80e-01 0.118000 8.06e-02 8.62e-02 1.96e-01 1.67e-01
Interferon Signaling 263 2.92e-03 3.15e-02 0.118000 9.68e-02 -6.75e-02 6.87e-03 5.94e-02
GOBP MICROGLIA DIFFERENTIATION 12 7.92e-01 9.15e-01 0.118000 8.88e-02 7.77e-02 5.94e-01 6.41e-01
GOMF TRNA PSEUDOURIDINE SYNTHASE ACTIVITY 8 8.53e-01 9.39e-01 0.118000 -4.96e-02 -1.07e-01 8.08e-01 6.00e-01
GOBP UBIQUITIN RECYCLING 13 7.54e-01 8.95e-01 0.118000 2.88e-02 -1.14e-01 8.57e-01 4.75e-01
GOMF STEROID DEHYDROGENASE ACTIVITY ACTING ON THE CH OH GROUP OF DONORS NAD OR NADP AS ACCEPTOR 29 5.21e-01 7.64e-01 0.118000 7.56e-02 -9.06e-02 4.81e-01 3.98e-01
GOBP POSITIVE REGULATION OF CELL DIFFERENTIATION 872 4.84e-08 2.53e-06 0.118000 1.12e-01 3.56e-02 1.71e-08 7.41e-02
GOBP SKELETAL MUSCLE CELL DIFFERENTIATION 78 1.92e-01 4.84e-01 0.118000 1.18e-01 -9.84e-03 7.26e-02 8.81e-01
GOBP LUNG GROWTH 6 8.75e-01 9.48e-01 0.118000 1.01e-01 -6.02e-02 6.67e-01 7.98e-01
GOBP RHODOPSIN MEDIATED SIGNALING PATHWAY 11 7.81e-01 9.10e-01 0.118000 -7.91e-02 8.75e-02 6.50e-01 6.15e-01
GOMF PROTEIN LYSINE DEACETYLASE ACTIVITY 21 6.47e-01 8.44e-01 0.118000 1.18e-01 8.65e-03 3.51e-01 9.45e-01
GOCC GINS COMPLEX 5 8.97e-01 9.59e-01 0.118000 3.63e-02 -1.12e-01 8.88e-01 6.64e-01
GOBP MITOTIC CHROMOSOME CONDENSATION 19 6.53e-01 8.47e-01 0.118000 7.56e-02 -9.04e-02 5.68e-01 4.95e-01
GOMF COPPER ION TRANSMEMBRANE TRANSPORTER ACTIVITY 6 8.74e-01 9.48e-01 0.118000 -8.78e-02 7.87e-02 7.10e-01 7.39e-01
GOBP SKELETAL MUSCLE CONTRACTION 44 3.73e-01 6.59e-01 0.118000 -7.85e-02 8.79e-02 3.67e-01 3.13e-01
GOBP MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON 11 8.01e-01 9.18e-01 0.118000 -2.88e-02 -1.14e-01 8.68e-01 5.12e-01
GOBP POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING 56 3.20e-01 6.11e-01 0.118000 -2.09e-02 -1.16e-01 7.87e-01 1.34e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION 21 6.27e-01 8.33e-01 0.118000 6.07e-02 -1.01e-01 6.30e-01 4.24e-01
GOCC ASTROCYTE PROJECTION 21 6.25e-01 8.32e-01 0.118000 -8.80e-02 7.80e-02 4.85e-01 5.36e-01
GOMF INTEGRIN BINDING 154 5.12e-02 2.28e-01 0.118000 9.69e-02 6.66e-02 3.79e-02 1.54e-01
GOBP POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY 14 7.62e-01 8.99e-01 0.118000 9.55e-02 6.87e-02 5.36e-01 6.56e-01
GOMF LYSOPHOSPHATIDIC ACID BINDING 7 8.71e-01 9.47e-01 0.118000 1.09e-01 4.36e-02 6.17e-01 8.42e-01
GOCC POSTSYNAPTIC ACTIN CYTOSKELETON 8 8.44e-01 9.36e-01 0.118000 1.57e-02 -1.17e-01 9.39e-01 5.68e-01
GOCC GOLGI MEDIAL CISTERNA 11 8.02e-01 9.18e-01 0.118000 3.05e-02 1.14e-01 8.61e-01 5.14e-01
GOBP EYE PHOTORECEPTOR CELL DEVELOPMENT 36 4.51e-01 7.20e-01 0.117000 -9.93e-02 6.27e-02 3.03e-01 5.15e-01
GLI proteins bind promoters of Hh responsive genes to promote transcription 7 8.68e-01 9.45e-01 0.117000 2.04e-02 1.16e-01 9.25e-01 5.97e-01
WNT ligand biogenesis and trafficking 25 5.81e-01 8.04e-01 0.117000 4.03e-02 -1.10e-01 7.27e-01 3.40e-01
GOBP REGULATION OF MONOCYTE DIFFERENTIATION 20 6.42e-01 8.41e-01 0.117000 9.57e-02 -6.78e-02 4.59e-01 6.00e-01
GOMF PLUS END DIRECTED MICROTUBULE MOTOR ACTIVITY 17 6.91e-01 8.67e-01 0.117000 4.01e-02 -1.10e-01 7.75e-01 4.31e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME 27 5.58e-01 7.90e-01 0.117000 1.11e-01 -3.80e-02 3.18e-01 7.33e-01
GOCC EXTERNAL ENCAPSULATING STRUCTURE 537 9.32e-06 2.72e-04 0.117000 -9.81e-02 6.42e-02 1.01e-04 1.10e-02
Recycling pathway of L1 42 4.09e-01 6.91e-01 0.117000 -2.44e-02 1.15e-01 7.85e-01 1.99e-01
GOBP NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT 11 7.83e-01 9.11e-01 0.117000 8.80e-02 -7.74e-02 6.13e-01 6.57e-01
GOBP REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 1767 9.08e-16 2.14e-13 0.117000 1.15e-01 -2.29e-02 9.91e-16 1.10e-01
GOBP NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION 14 7.52e-01 8.93e-01 0.117000 1.43e-02 1.16e-01 9.26e-01 4.51e-01
GOBP LOCOMOTORY BEHAVIOR 200 1.81e-02 1.19e-01 0.117000 1.16e-01 1.82e-02 4.78e-03 6.57e-01
GOBP POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 340 1.22e-03 1.61e-02 0.117000 1.14e-01 2.60e-02 2.95e-04 4.10e-01
GOBP REGULATION OF TRANSPORTER ACTIVITY 230 1.01e-02 7.90e-02 0.117000 1.16e-01 1.89e-02 2.52e-03 6.22e-01
GOMF PROTEIN KINASE A CATALYTIC SUBUNIT BINDING 14 7.37e-01 8.87e-01 0.117000 4.71e-02 -1.07e-01 7.60e-01 4.87e-01
GOMF L ALANINE TRANSMEMBRANE TRANSPORTER ACTIVITY 9 8.35e-01 9.31e-01 0.117000 -1.14e-01 -2.47e-02 5.52e-01 8.98e-01
GOBP REGULATION OF CELL DIVISION 180 2.05e-02 1.29e-01 0.117000 1.07e-01 -4.72e-02 1.32e-02 2.75e-01
Complex IV assembly 44 4.26e-01 7.04e-01 0.117000 -5.17e-02 -1.05e-01 5.53e-01 2.28e-01
GOBP REGULATION OF PHOSPHOLIPID CATABOLIC PROCESS 7 8.73e-01 9.48e-01 0.117000 -1.05e-01 -5.08e-02 6.29e-01 8.16e-01
GOBP CELLULAR RESPONSE TO EXTERNAL STIMULUS 72 2.09e-01 5.04e-01 0.117000 1.06e-01 -5.01e-02 1.21e-01 4.63e-01
GOBP TUBULIN DEACETYLATION 19 6.96e-01 8.68e-01 0.117000 8.30e-02 8.24e-02 5.31e-01 5.34e-01
GOBP NONASSOCIATIVE LEARNING 6 8.76e-01 9.49e-01 0.117000 6.95e-02 -9.40e-02 7.68e-01 6.90e-01
Extra-nuclear estrogen signaling 74 1.99e-01 4.92e-01 0.117000 1.01e-01 -5.82e-02 1.32e-01 3.87e-01
GOBP SPHINGOSINE 1 PHOSPHATE RECEPTOR SIGNALING PATHWAY 15 7.49e-01 8.92e-01 0.117000 -6.05e-02 -1.00e-01 6.85e-01 5.03e-01
GOBP INTERLEUKIN 8 PRODUCTION 97 1.41e-01 4.12e-01 0.117000 -1.16e-01 -9.25e-03 4.76e-02 8.75e-01
GOBP REGULATION OF SPINDLE CHECKPOINT 22 6.45e-01 8.42e-01 0.117000 1.14e-01 2.36e-02 3.54e-01 8.48e-01
GOMF RECEPTOR TYROSINE KINASE BINDING 79 1.83e-01 4.73e-01 0.117000 1.08e-01 -4.45e-02 9.75e-02 4.94e-01
GOBP RRNA MODIFICATION 31 5.06e-01 7.57e-01 0.117000 8.20e-02 -8.29e-02 4.29e-01 4.24e-01
GOMF STRUCTURAL CONSTITUENT OF SYNAPSE 23 6.24e-01 8.31e-01 0.117000 6.89e-04 1.17e-01 9.95e-01 3.33e-01
GOBP NEGATIVE REGULATION OF LIPID LOCALIZATION 65 2.91e-01 5.88e-01 0.117000 9.06e-02 7.35e-02 2.07e-01 3.06e-01
GOMF TRANSLATION REPRESSOR ACTIVITY 290 2.77e-03 3.04e-02 0.117000 -2.31e-03 1.17e-01 9.46e-01 6.34e-04
GOBP POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS 16 7.30e-01 8.84e-01 0.117000 1.12e-01 3.12e-02 4.37e-01 8.29e-01
GOMF TRANSLATION ELONGATION FACTOR ACTIVITY 18 6.76e-01 8.59e-01 0.117000 1.01e-01 -5.74e-02 4.56e-01 6.73e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY 33 5.35e-01 7.75e-01 0.117000 -8.00e-02 -8.48e-02 4.27e-01 3.99e-01
Electric Transmission Across Gap Junctions 5 8.97e-01 9.59e-01 0.117000 9.72e-02 -6.43e-02 7.07e-01 8.04e-01
Transmission across Electrical Synapses 5 8.97e-01 9.59e-01 0.117000 9.72e-02 -6.43e-02 7.07e-01 8.04e-01
GOBP NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORTER ACTIVITY 64 2.98e-01 5.94e-01 0.116000 8.25e-02 8.22e-02 2.54e-01 2.56e-01
GOBP NUCLEOTIDE TRANSMEMBRANE TRANSPORT 28 5.43e-01 7.80e-01 0.116000 -9.69e-02 6.45e-02 3.75e-01 5.54e-01
GOMF GDP PHOSPHATASE ACTIVITY 10 8.25e-01 9.28e-01 0.116000 -1.05e-01 -5.03e-02 5.65e-01 7.83e-01
GOMF PHOSPHATIDYLINOSITOL 5 PHOSPHATE BINDING 20 6.46e-01 8.43e-01 0.116000 6.61e-02 -9.58e-02 6.09e-01 4.58e-01
GOBP INTERLEUKIN 1 ALPHA PRODUCTION 11 7.87e-01 9.13e-01 0.116000 6.43e-02 -9.70e-02 7.12e-01 5.78e-01
GOBP ZYGOTIC DETERMINATION OF ANTERIOR POSTERIOR AXIS EMBRYO 6 8.78e-01 9.50e-01 0.116000 9.99e-02 -5.95e-02 6.72e-01 8.01e-01
GOBP NEGATIVE REGULATION OF FATTY ACID OXIDATION 14 7.54e-01 8.95e-01 0.116000 9.91e-03 1.16e-01 9.49e-01 4.53e-01
GOBP CIRCULATORY SYSTEM DEVELOPMENT 1190 2.43e-10 1.99e-08 0.116000 1.12e-01 2.99e-02 6.43e-11 8.28e-02
GOBP MODULATION BY SYMBIONT OF ENTRY INTO HOST 55 3.45e-01 6.34e-01 0.116000 3.96e-02 1.09e-01 6.12e-01 1.61e-01
GOBP REGULATION OF MACROPHAGE APOPTOTIC PROCESS 11 7.98e-01 9.17e-01 0.116000 1.16e-01 -5.70e-03 5.05e-01 9.74e-01
Regulation of CDH11 function 10 8.26e-01 9.28e-01 0.116000 1.01e-01 5.68e-02 5.79e-01 7.56e-01
GOCC UBIQUITIN LIGASE COMPLEX 298 2.14e-03 2.48e-02 0.116000 1.14e-01 -2.17e-02 6.99e-04 5.19e-01
GOBP RESPONSE TO ORGANOPHOSPHORUS 123 9.25e-02 3.26e-01 0.116000 1.10e-01 3.66e-02 3.47e-02 4.83e-01
GOBP FAT SOLUBLE VITAMIN CATABOLIC PROCESS 12 7.89e-01 9.14e-01 0.116000 1.14e-01 2.31e-02 4.95e-01 8.90e-01
GOBP DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 219 1.32e-02 9.59e-02 0.116000 1.15e-01 1.46e-02 3.29e-03 7.09e-01
Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy 15 7.36e-01 8.86e-01 0.116000 5.85e-03 -1.16e-01 9.69e-01 4.37e-01
GOMF TRNA BINDING 75 1.98e-01 4.91e-01 0.116000 9.59e-02 -6.53e-02 1.51e-01 3.28e-01
GOBP NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION 154 3.91e-02 1.95e-01 0.116000 1.10e-01 -3.81e-02 1.90e-02 4.15e-01
Sulfur amino acid metabolism 26 5.82e-01 8.04e-01 0.116000 2.38e-02 -1.13e-01 8.33e-01 3.17e-01
GOBP NEURON REMODELING 15 7.51e-01 8.92e-01 0.116000 1.05e-01 4.83e-02 4.80e-01 7.46e-01
GOBP REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION 18 6.79e-01 8.61e-01 0.116000 -5.83e-02 1.00e-01 6.69e-01 4.62e-01
GOBP NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 61 2.89e-01 5.86e-01 0.116000 -1.16e-01 6.74e-03 1.18e-01 9.27e-01
GOBP NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 170 3.35e-02 1.78e-01 0.116000 1.16e-01 3.70e-03 9.21e-03 9.34e-01
GOMF LYASE ACTIVITY 191 2.87e-02 1.62e-01 0.116000 7.95e-02 8.42e-02 5.82e-02 4.47e-02
Glutamate and glutamine metabolism 12 7.82e-01 9.10e-01 0.116000 1.08e-02 -1.15e-01 9.48e-01 4.89e-01
GOBP REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT 76 2.42e-01 5.39e-01 0.116000 7.95e-02 8.41e-02 2.31e-01 2.05e-01
Endosomal/Vacuolar pathway 12 7.71e-01 9.04e-01 0.116000 7.61e-02 -8.71e-02 6.48e-01 6.01e-01
Class I MHC mediated antigen processing & presentation 349 6.39e-04 9.61e-03 0.116000 1.01e-01 -5.58e-02 1.15e-03 7.31e-02
GOBP B CELL PROLIFERATION 97 1.39e-01 4.09e-01 0.116000 -1.15e-01 1.11e-02 5.01e-02 8.50e-01
GOMF MONOATOMIC ANION MONOATOMIC CATION SYMPORTER ACTIVITY 24 6.07e-01 8.20e-01 0.116000 -2.76e-02 1.12e-01 8.15e-01 3.41e-01
GOCC CILIARY TIP 47 3.63e-01 6.51e-01 0.116000 8.01e-02 -8.33e-02 3.42e-01 3.23e-01
GOBP TISSUE MIGRATION 369 5.85e-04 8.97e-03 0.116000 1.15e-01 -1.50e-02 1.57e-04 6.20e-01
Signal Transduction 2475 8.92e-20 2.96e-17 0.116000 1.15e-01 7.32e-03 7.54e-21 5.53e-01
GOCC NUCLEAR ENVELOPE LUMEN 11 8.01e-01 9.18e-01 0.115000 1.15e-01 -4.21e-03 5.07e-01 9.81e-01
GOBP NEURON PROJECTION REGENERATION 57 3.35e-01 6.25e-01 0.115000 3.47e-02 1.10e-01 6.50e-01 1.51e-01
GOBP VIRION ASSEMBLY 34 5.19e-01 7.63e-01 0.115000 -3.07e-02 -1.11e-01 7.57e-01 2.62e-01
GOBP GLUCOSE METABOLIC PROCESS 182 3.33e-02 1.77e-01 0.115000 5.36e-02 1.02e-01 2.12e-01 1.75e-02
GOMF CULLIN FAMILY PROTEIN BINDING 24 6.37e-01 8.38e-01 0.115000 1.01e-01 5.54e-02 3.91e-01 6.39e-01
SHC1 events in ERBB4 signaling 14 7.51e-01 8.92e-01 0.115000 1.65e-02 -1.14e-01 9.15e-01 4.60e-01
GOCC ORGANELLE INNER MEMBRANE 521 3.29e-05 8.32e-04 0.115000 1.12e-02 -1.15e-01 6.61e-01 7.52e-06
GOBP INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS 62 2.67e-01 5.63e-01 0.115000 6.67e-02 -9.39e-02 3.64e-01 2.01e-01
GOBP VASCULAR TRANSPORT 84 2.02e-01 4.96e-01 0.115000 3.70e-02 1.09e-01 5.58e-01 8.41e-02
GOBP AMINOPHOSPHOLIPID TRANSPORT 8 8.61e-01 9.42e-01 0.115000 1.00e-01 5.71e-02 6.24e-01 7.80e-01
GOBP TETRAHYDROFOLATE INTERCONVERSION 9 8.38e-01 9.33e-01 0.115000 1.14e-01 1.61e-02 5.54e-01 9.33e-01
GOCC DYNEIN AXONEMAL PARTICLE 20 6.73e-01 8.58e-01 0.115000 -1.15e-01 -7.07e-03 3.74e-01 9.56e-01
GOBP ARACHIDONIC ACID SECRETION 31 5.16e-01 7.62e-01 0.115000 9.16e-02 -6.97e-02 3.78e-01 5.02e-01
GOMF CARBONYL REDUCTASE NADPH ACTIVITY 9 8.47e-01 9.36e-01 0.115000 -8.66e-02 -7.57e-02 6.53e-01 6.94e-01
Metabolism of amino acids and derivatives 330 2.03e-03 2.39e-02 0.115000 -3.66e-02 -1.09e-01 2.53e-01 6.60e-04
Neddylation 221 9.26e-03 7.43e-02 0.115000 7.53e-02 -8.69e-02 5.36e-02 2.60e-02
GOBP INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY 32 5.16e-01 7.62e-01 0.115000 1.11e-01 -2.98e-02 2.77e-01 7.71e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE MIGRATION 54 3.67e-01 6.55e-01 0.115000 9.57e-02 6.37e-02 2.24e-01 4.18e-01
GOBP REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 98 1.65e-01 4.49e-01 0.115000 8.29e-02 7.95e-02 1.56e-01 1.74e-01
RUNX2 regulates bone development 29 5.85e-01 8.06e-01 0.115000 9.30e-02 6.74e-02 3.86e-01 5.30e-01
GOBP REGULATION OF MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE 6 8.86e-01 9.55e-01 0.115000 1.15e-01 -8.93e-03 6.27e-01 9.70e-01
GOBP MEMBRANE RAFT ORGANIZATION 26 6.09e-01 8.22e-01 0.115000 3.35e-02 1.10e-01 7.67e-01 3.32e-01
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY 33 5.12e-01 7.61e-01 0.115000 1.73e-02 -1.14e-01 8.64e-01 2.59e-01
GOBP PROSTAGLANDIN TRANSPORT 29 5.75e-01 8.00e-01 0.115000 1.10e-01 3.23e-02 3.04e-01 7.63e-01
GOCC CLEAVAGE FURROW 52 3.43e-01 6.32e-01 0.115000 1.10e-01 -3.13e-02 1.68e-01 6.96e-01
GOBP REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 24 6.43e-01 8.42e-01 0.115000 7.52e-02 8.66e-02 5.24e-01 4.62e-01
GOMF SULFURIC ESTER HYDROLASE ACTIVITY 11 7.91e-01 9.15e-01 0.115000 -8.70e-02 7.48e-02 6.18e-01 6.68e-01
MAPK1/MAPK3 signaling 258 5.01e-03 4.75e-02 0.115000 1.08e-01 -3.92e-02 2.88e-03 2.78e-01
GOMF LIPOPROTEIN PARTICLE RECEPTOR BINDING 29 5.73e-01 7.99e-01 0.115000 2.38e-02 1.12e-01 8.24e-01 2.96e-01
GOMF DNA POLYMERASE ACTIVITY 28 5.73e-01 7.99e-01 0.115000 1.14e-01 -5.41e-03 2.94e-01 9.61e-01
GOMF ALPHA GLUCOSIDASE ACTIVITY 6 8.82e-01 9.52e-01 0.115000 5.00e-02 -1.03e-01 8.32e-01 6.62e-01
GOBP REGULATION OF DNA DIRECTED DNA POLYMERASE ACTIVITY 9 8.43e-01 9.36e-01 0.115000 -1.10e-01 -3.31e-02 5.69e-01 8.63e-01
GOMF 3 CHLOROALLYL ALDEHYDE DEHYDROGENASE ACTIVITY 5 8.99e-01 9.61e-01 0.115000 -8.29e-02 7.91e-02 7.48e-01 7.60e-01
GOBP RESPONSE TO CORTICOSTEROID 152 4.25e-02 2.05e-01 0.115000 4.97e-02 -1.03e-01 2.90e-01 2.81e-02
GOBP METANEPHROS MORPHOGENESIS 30 5.63e-01 7.93e-01 0.115000 1.12e-01 2.43e-02 2.89e-01 8.17e-01
GOBP DNA TEMPLATED DNA REPLICATION MAINTENANCE OF FIDELITY 57 3.31e-01 6.22e-01 0.115000 1.14e-01 1.36e-02 1.38e-01 8.59e-01
FGFR2 alternative splicing 26 5.77e-01 8.01e-01 0.114000 8.52e-02 -7.65e-02 4.52e-01 5.00e-01
GOBP SPHINGOLIPID BIOSYNTHETIC PROCESS 111 1.32e-01 3.98e-01 0.114000 8.08e-02 8.11e-02 1.42e-01 1.40e-01
GOBP REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 121 9.91e-02 3.37e-01 0.114000 1.12e-01 2.14e-02 3.27e-02 6.84e-01
GOCC MICROTUBULE ORGANIZING CENTER 842 9.09e-08 4.52e-06 0.114000 1.14e-01 -1.08e-02 1.97e-08 5.94e-01
Retrograde transport at the Trans-Golgi-Network 47 3.74e-01 6.60e-01 0.114000 5.66e-02 -9.94e-02 5.02e-01 2.38e-01
GOMF PROTEIN TYROSINE KINASE ACTIVITY 140 7.58e-02 2.90e-01 0.114000 1.01e-01 5.31e-02 3.85e-02 2.78e-01
GOBP POSITIVE REGULATION OF SPROUTING ANGIOGENESIS 30 5.72e-01 7.99e-01 0.114000 4.66e-02 1.04e-01 6.58e-01 3.22e-01
GOBP ORGANELLE INHERITANCE 15 7.59e-01 8.97e-01 0.114000 6.17e-02 9.63e-02 6.79e-01 5.19e-01
GOBP CELL JUNCTION DISASSEMBLY 27 6.11e-01 8.22e-01 0.114000 8.71e-02 7.41e-02 4.33e-01 5.05e-01
GOBP REGULATION OF FEVER GENERATION 9 8.28e-01 9.29e-01 0.114000 5.68e-02 -9.93e-02 7.68e-01 6.06e-01
Synthesis of 12-eicosatetraenoic acid derivatives 7 8.62e-01 9.43e-01 0.114000 -7.60e-02 8.54e-02 7.28e-01 6.96e-01
GOCC ACTIN FILAMENT 108 1.30e-01 3.94e-01 0.114000 1.10e-01 3.01e-02 4.77e-02 5.89e-01
GOBP REGULATION OF LYMPHOID PROGENITOR CELL DIFFERENTIATION 12 7.82e-01 9.10e-01 0.114000 1.10e-01 -3.22e-02 5.11e-01 8.47e-01
GOBP NEGATIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS 15 7.47e-01 8.91e-01 0.114000 -9.30e-03 -1.14e-01 9.50e-01 4.45e-01
GOBP REGULATION OF ANATOMICAL STRUCTURE SIZE 476 1.07e-04 2.29e-03 0.114000 1.14e-01 2.38e-03 1.95e-05 9.29e-01
GOCC LEWY BODY 8 8.63e-01 9.43e-01 0.114000 -5.68e-02 -9.91e-02 7.81e-01 6.27e-01
GOBP REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 14 7.47e-01 8.91e-01 0.114000 5.40e-02 -1.01e-01 7.26e-01 5.14e-01
GOMF ELECTRON TRANSFER ACTIVITY 99 1.32e-01 3.96e-01 0.114000 3.70e-02 -1.08e-01 5.25e-01 6.31e-02
GOBP EPITHELIAL CELL PROLIFERATION 471 7.30e-05 1.64e-03 0.114000 1.06e-01 -4.19e-02 7.77e-05 1.19e-01
GOBP BILE ACID SIGNALING PATHWAY 11 8.01e-01 9.18e-01 0.114000 -2.14e-02 1.12e-01 9.02e-01 5.19e-01
GOCC DNA REPLICATION FACTOR C COMPLEX 5 9.03e-01 9.62e-01 0.114000 3.03e-02 -1.10e-01 9.07e-01 6.70e-01
GOBP RESPONSE TO COCAINE 54 3.75e-01 6.61e-01 0.114000 8.08e-02 8.07e-02 3.04e-01 3.05e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 139 5.60e-02 2.42e-01 0.114000 1.00e-01 -5.47e-02 4.14e-02 2.65e-01
Cellular responses to stimuli 844 3.71e-08 2.00e-06 0.114000 7.79e-02 -8.34e-02 1.21e-04 3.88e-05
GOBP REGULATION OF PRESYNAPTIC MEMBRANE POTENTIAL 28 5.67e-01 7.95e-01 0.114000 -1.11e-01 2.81e-02 3.11e-01 7.97e-01
GOMF PHOSPHOTRANSFERASE ACTIVITY FOR OTHER SUBSTITUTED PHOSPHATE GROUPS 22 6.30e-01 8.34e-01 0.114000 7.98e-02 -8.15e-02 5.17e-01 5.08e-01
GOBP MALE SEX DIFFERENTIATION 164 3.51e-02 1.83e-01 0.114000 1.06e-01 -4.13e-02 1.89e-02 3.61e-01
GOBP AMINOGLYCAN METABOLIC PROCESS 119 1.01e-01 3.42e-01 0.114000 1.06e-02 1.14e-01 8.42e-01 3.24e-02
GOMF INTRAMOLECULAR TRANSFERASE ACTIVITY 27 5.83e-01 8.05e-01 0.114000 1.58e-02 -1.13e-01 8.87e-01 3.10e-01
Carboxyterminal post-translational modifications of tubulin 43 4.56e-01 7.22e-01 0.114000 -9.64e-02 -6.07e-02 2.74e-01 4.91e-01
GOBP TRANSCRIPTION BY RNA POLYMERASE I 68 2.56e-01 5.53e-01 0.114000 1.12e-01 -2.13e-02 1.11e-01 7.61e-01
Signaling by Hedgehog 135 7.55e-02 2.90e-01 0.114000 1.13e-01 1.21e-02 2.31e-02 8.08e-01
GOBP PIGMENT METABOLIC PROCESS 74 2.13e-01 5.08e-01 0.114000 7.42e-02 -8.64e-02 2.70e-01 1.99e-01
GOMF HISTONE H3K9ME2 H3K9ME3 DEMETHYLASE ACTIVITY 5 9.07e-01 9.64e-01 0.114000 1.14e-01 5.08e-03 6.60e-01 9.84e-01
GOBP FREE UBIQUITIN CHAIN POLYMERIZATION 9 8.40e-01 9.33e-01 0.114000 -4.66e-03 -1.14e-01 9.81e-01 5.55e-01
RUNX2 regulates osteoblast differentiation 22 6.69e-01 8.55e-01 0.114000 5.68e-02 9.86e-02 6.44e-01 4.23e-01
GOCC NUCLEOLUS 1319 5.00e-12 5.48e-10 0.114000 8.21e-02 -7.88e-02 5.42e-07 1.54e-06
GOBP PEXOPHAGY 7 8.68e-01 9.46e-01 0.114000 -2.80e-02 1.10e-01 8.98e-01 6.13e-01
GOBP METENCEPHALON DEVELOPMENT 107 1.23e-01 3.83e-01 0.114000 1.14e-01 -5.41e-03 4.23e-02 9.23e-01
GOMF LACTATE DEHYDROGENASE ACTIVITY 6 8.90e-01 9.56e-01 0.114000 -4.85e-03 -1.14e-01 9.84e-01 6.30e-01
Regulation of gene expression in beta cells 21 6.46e-01 8.43e-01 0.114000 6.63e-02 -9.23e-02 5.99e-01 4.64e-01
GOBP ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE 36 4.92e-01 7.50e-01 0.114000 -1.13e-01 9.63e-03 2.40e-01 9.20e-01
GOBP MACROPHAGE CHEMOTAXIS 41 4.44e-01 7.16e-01 0.114000 1.13e-01 -1.44e-02 2.12e-01 8.73e-01
GOMF PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 485 7.20e-05 1.62e-03 0.114000 -1.11e-01 2.59e-02 2.99e-05 3.29e-01
GOBP REGULATION OF GROWTH 575 2.49e-05 6.48e-04 0.114000 1.12e-01 2.14e-02 4.83e-06 3.80e-01
Signaling by Receptor Tyrosine Kinases 514 5.40e-05 1.27e-03 0.114000 1.13e-01 -4.60e-03 1.06e-05 8.58e-01
GOMF ESTROGEN RESPONSE ELEMENT BINDING 10 8.26e-01 9.28e-01 0.114000 -1.27e-02 -1.13e-01 9.44e-01 5.37e-01
GOBP PIGMENT CELL DIFFERENTIATION 35 5.29e-01 7.71e-01 0.113000 -5.43e-02 -9.96e-02 5.78e-01 3.08e-01
Interleukin-20 family signaling 24 6.27e-01 8.33e-01 0.113000 -3.32e-03 1.13e-01 9.78e-01 3.36e-01
GOBP NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY 20 6.87e-01 8.65e-01 0.113000 1.11e-01 2.49e-02 3.92e-01 8.47e-01
GOMF 3 5 EXONUCLEASE ACTIVITY 59 3.14e-01 6.07e-01 0.113000 1.13e-01 -1.29e-02 1.35e-01 8.64e-01
GOBP VALINE METABOLIC PROCESS 7 8.82e-01 9.52e-01 0.113000 -7.68e-02 -8.33e-02 7.25e-01 7.03e-01
GOBP MONOSACCHARIDE BIOSYNTHETIC PROCESS 90 1.75e-01 4.61e-01 0.113000 -4.87e-03 1.13e-01 9.36e-01 6.35e-02
GOBP ESTABLISHMENT OF SISTER CHROMATID COHESION 8 8.48e-01 9.37e-01 0.113000 9.66e-02 -5.90e-02 6.36e-01 7.72e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 131 7.10e-02 2.80e-01 0.113000 1.05e-01 -4.16e-02 3.74e-02 4.10e-01
GOBP POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS 43 4.61e-01 7.25e-01 0.113000 6.16e-02 9.50e-02 4.85e-01 2.81e-01
GOBP SERTOLI CELL DIFFERENTIATION 17 7.25e-01 8.82e-01 0.113000 1.12e-01 1.56e-02 4.23e-01 9.11e-01
GOMF GLYCEROPHOSPHOLIPID FLIPPASE ACTIVITY 12 8.06e-01 9.20e-01 0.113000 6.49e-02 9.28e-02 6.97e-01 5.78e-01
GOBP REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY 405 4.11e-04 6.70e-03 0.113000 1.13e-01 -1.13e-02 1.00e-04 6.96e-01
GOBP NEUTRAL AMINO ACID TRANSPORT 54 3.79e-01 6.65e-01 0.113000 6.42e-02 9.32e-02 4.14e-01 2.36e-01
Antigen processing-Cross presentation 87 1.86e-01 4.77e-01 0.113000 2.69e-03 -1.13e-01 9.65e-01 6.81e-02
GOBP POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY 138 5.99e-02 2.52e-01 0.113000 9.87e-02 -5.53e-02 4.52e-02 2.62e-01
Interleukin-17 signaling 66 2.56e-01 5.54e-01 0.113000 8.86e-02 -7.04e-02 2.13e-01 3.22e-01
GOBP TYPE 2 IMMUNE RESPONSE 42 4.65e-01 7.28e-01 0.113000 4.59e-02 1.03e-01 6.07e-01 2.46e-01
GOMF RNA ENDONUCLEASE ACTIVITY 70 2.70e-01 5.67e-01 0.113000 1.11e-01 2.28e-02 1.09e-01 7.42e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN PHOSPHATASE ACTIVITY 17 7.18e-01 8.78e-01 0.113000 8.79e-03 -1.13e-01 9.50e-01 4.21e-01
GOBP POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN PROTEIN CATABOLIC PROCESS 124 8.74e-02 3.16e-01 0.113000 1.11e-01 -1.92e-02 3.20e-02 7.11e-01
GOMF TOLL LIKE RECEPTOR 4 BINDING 5 9.04e-01 9.63e-01 0.113000 -3.61e-02 1.07e-01 8.89e-01 6.78e-01
GOBP REGULATION OF CILIUM BEAT FREQUENCY 17 7.38e-01 8.87e-01 0.113000 -8.62e-02 -7.32e-02 5.38e-01 6.01e-01
GOBP NUCLEAR ENVELOPE ORGANIZATION 55 3.23e-01 6.14e-01 0.113000 6.32e-02 -9.38e-02 4.17e-01 2.29e-01
IFNG signaling activates MAPKs 8 8.58e-01 9.41e-01 0.113000 1.13e-01 5.59e-03 5.80e-01 9.78e-01
Cell junction organization 113 1.31e-01 3.96e-01 0.113000 9.85e-02 5.55e-02 7.05e-02 3.08e-01
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 940 1.84e-08 1.07e-06 0.113000 1.11e-01 -2.07e-02 7.67e-09 2.81e-01
Glycosaminoglycan metabolism 121 1.13e-01 3.65e-01 0.113000 5.13e-02 1.01e-01 3.30e-01 5.57e-02
Vitamin D (calciferol) metabolism 12 7.82e-01 9.10e-01 0.113000 5.65e-02 -9.78e-02 7.35e-01 5.57e-01
CS/DS degradation 12 7.81e-01 9.10e-01 0.113000 9.18e-02 -6.58e-02 5.82e-01 6.93e-01
GOBP MITOCHONDRIAL FRAGMENTATION INVOLVED IN APOPTOTIC PROCESS 10 8.37e-01 9.32e-01 0.113000 7.62e-02 8.33e-02 6.76e-01 6.48e-01
GOBP INTRACELLULAR OXYGEN HOMEOSTASIS 7 8.66e-01 9.44e-01 0.113000 8.12e-02 -7.83e-02 7.10e-01 7.20e-01
GOBP REGULATION OF FATTY ACID OXIDATION 33 5.55e-01 7.88e-01 0.113000 9.06e-02 6.72e-02 3.68e-01 5.04e-01
GOBP MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT 22 6.77e-01 8.60e-01 0.113000 7.87e-02 8.08e-02 5.23e-01 5.12e-01
GOBP PIGMENT GRANULE ORGANIZATION 37 4.82e-01 7.41e-01 0.113000 1.10e-01 -2.41e-02 2.46e-01 8.00e-01
GOBP NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 37 4.98e-01 7.52e-01 0.113000 1.08e-02 1.12e-01 9.10e-01 2.38e-01
GOMF NEUROTRANSMITTER RECEPTOR ACTIVITY 91 1.75e-01 4.61e-01 0.113000 -1.13e-01 3.22e-03 6.32e-02 9.58e-01
GOBP MITOTIC INTRA S DNA DAMAGE CHECKPOINT SIGNALING 17 7.06e-01 8.73e-01 0.113000 6.35e-02 -9.31e-02 6.50e-01 5.06e-01
GOBP SPROUTING ANGIOGENESIS 190 3.49e-02 1.83e-01 0.113000 9.09e-02 6.65e-02 3.06e-02 1.14e-01
GOBP CELLULAR RESPONSE TO LIGHT STIMULUS 113 1.06e-01 3.51e-01 0.113000 1.07e-01 -3.51e-02 4.93e-02 5.19e-01
GOBP MYELOID CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 94 1.51e-01 4.30e-01 0.113000 4.51e-02 -1.03e-01 4.50e-01 8.37e-02
GOBP POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION 52 3.45e-01 6.35e-01 0.113000 7.03e-02 -8.80e-02 3.80e-01 2.73e-01
GOBP CELLULAR RESPONSE TO VIRUS 79 2.39e-01 5.36e-01 0.113000 -1.05e-01 -4.13e-02 1.07e-01 5.26e-01
GOBP REGULATION OF RELAXATION OF MUSCLE 14 7.65e-01 9.01e-01 0.113000 -1.13e-01 6.59e-04 4.66e-01 9.97e-01
GOBP IMMUNE RESPONSE TO TUMOR CELL 28 6.07e-01 8.21e-01 0.113000 -6.02e-02 -9.51e-02 5.81e-01 3.84e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING NITROGENOUS GROUPS 27 5.76e-01 8.00e-01 0.113000 -8.78e-02 7.04e-02 4.30e-01 5.27e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS 133 8.58e-02 3.13e-01 0.113000 2.09e-02 1.11e-01 6.78e-01 2.77e-02
GOBP NEURON PROJECTION EXTENSION 153 6.67e-02 2.70e-01 0.112000 9.50e-02 6.03e-02 4.26e-02 1.98e-01
GOBP RESPONSE TO XENOBIOTIC STIMULUS 435 4.18e-04 6.82e-03 0.112000 1.07e-01 3.55e-02 1.35e-04 2.04e-01
GOMF METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 433 1.81e-04 3.48e-03 0.112000 -9.60e-02 5.85e-02 6.13e-04 3.70e-02
GOMF C ACYLTRANSFERASE ACTIVITY 20 6.81e-01 8.62e-01 0.112000 -1.12e-01 7.12e-03 3.85e-01 9.56e-01
GOMF AMP BINDING 15 7.39e-01 8.87e-01 0.112000 -4.98e-02 1.01e-01 7.39e-01 4.99e-01
Transport of Mature mRNAs Derived from Intronless Transcripts 43 4.29e-01 7.06e-01 0.112000 1.09e-01 -2.82e-02 2.17e-01 7.49e-01
GOMF NUCLEOSIDE MONOPHOSPHATE KINASE ACTIVITY 19 6.79e-01 8.61e-01 0.112000 -8.03e-02 7.86e-02 5.45e-01 5.53e-01
GOBP MONOSACCHARIDE METABOLIC PROCESS 242 1.34e-02 9.70e-02 0.112000 4.32e-02 1.04e-01 2.47e-01 5.48e-03
VLDL clearance 6 8.88e-01 9.55e-01 0.112000 3.40e-02 -1.07e-01 8.85e-01 6.50e-01
GOBP POSTSYNAPTIC CYTOSKELETON ORGANIZATION 17 7.34e-01 8.85e-01 0.112000 1.07e-01 3.38e-02 4.45e-01 8.09e-01
GOBP REGULATION OF DENDRITE DEVELOPMENT 92 1.99e-01 4.92e-01 0.112000 8.02e-02 7.86e-02 1.84e-01 1.93e-01
GOBP FATTY ACID TRANSMEMBRANE TRANSPORT 19 6.82e-01 8.62e-01 0.112000 1.00e-01 -5.07e-02 4.50e-01 7.02e-01
GOBP REGULATION OF CELL GROWTH 383 8.96e-04 1.26e-02 0.112000 1.11e-01 1.47e-02 1.84e-04 6.21e-01
GOBP POSITIVE REGULATION OF SIGNALING 1747 4.42e-14 6.79e-12 0.112000 1.12e-01 -3.90e-03 6.37e-15 7.86e-01
GOBP MITOPHAGY 63 3.14e-01 6.07e-01 0.112000 1.10e-01 2.25e-02 1.31e-01 7.58e-01
GOBP REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 237 1.47e-02 1.04e-01 0.112000 1.04e-01 4.32e-02 6.01e-03 2.52e-01
GOBP CELLULAR RESPONSE TO XENOBIOTIC STIMULUS 190 3.09e-02 1.69e-01 0.112000 1.10e-01 2.14e-02 8.83e-03 6.11e-01
GOMF CHLORIDE ION BINDING 9 8.37e-01 9.32e-01 0.112000 -3.27e-02 1.07e-01 8.65e-01 5.77e-01
GOBP NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 40 4.55e-01 7.22e-01 0.112000 -3.10e-02 1.08e-01 7.34e-01 2.38e-01
GOBP FIBROBLAST PROLIFERATION 107 1.23e-01 3.82e-01 0.112000 3.12e-02 -1.08e-01 5.77e-01 5.42e-02
GOBP POSITIVE REGULATION OF MEMBRANE PERMEABILITY 45 4.15e-01 6.96e-01 0.112000 2.55e-02 -1.09e-01 7.68e-01 2.05e-01
GOBP REGULATION OF CELLULAR COMPONENT SIZE 335 1.99e-03 2.36e-02 0.112000 1.12e-01 3.85e-03 4.25e-04 9.04e-01
GOBP POSITIVE REGULATION OF CIRCADIAN RHYTHM 18 7.13e-01 8.76e-01 0.112000 1.12e-01 5.56e-03 4.11e-01 9.67e-01
GOBP CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS 137 8.92e-02 3.19e-01 0.112000 5.43e-02 9.80e-02 2.72e-01 4.77e-02
GOCC MITOCHONDRIAL ENVELOPE 763 4.99e-07 2.12e-05 0.112000 3.23e-02 -1.07e-01 1.29e-01 4.59e-07
Acyl chain remodeling of CL 5 9.08e-01 9.65e-01 0.112000 1.46e-02 -1.11e-01 9.55e-01 6.67e-01
GOBP REGULATION OF CELL PROJECTION ORGANIZATION 649 1.23e-05 3.45e-04 0.112000 1.04e-01 4.16e-02 6.20e-06 7.08e-02
GOBP REGULATION OF BLOOD PRESSURE 175 4.42e-02 2.10e-01 0.112000 1.04e-01 4.09e-02 1.74e-02 3.51e-01
RAF/MAP kinase cascade 252 7.30e-03 6.30e-02 0.112000 1.06e-01 -3.60e-02 3.75e-03 3.25e-01
GOMF CALCIUM INDUCED CALCIUM RELEASE ACTIVITY 6 8.90e-01 9.56e-01 0.112000 -1.10e-01 2.21e-02 6.42e-01 9.25e-01
Peroxisomal lipid metabolism 27 6.00e-01 8.16e-01 0.112000 3.28e-03 -1.12e-01 9.76e-01 3.15e-01
GOBP NEURON NEURON SYNAPTIC TRANSMISSION 8 8.68e-01 9.45e-01 0.112000 -5.07e-02 -9.97e-02 8.04e-01 6.25e-01
GOBP REGULATION OF PHOSPHATASE ACTIVITY 53 3.51e-01 6.40e-01 0.112000 1.03e-01 -4.23e-02 1.93e-01 5.94e-01
GOBP CELL JUNCTION ASSEMBLY 433 3.52e-04 5.93e-03 0.112000 1.12e-01 4.32e-03 6.73e-05 8.78e-01
GOBP REGULATION OF CARBOHYDRATE METABOLIC PROCESS 176 4.73e-02 2.19e-01 0.112000 7.20e-02 8.55e-02 9.95e-02 5.05e-02
GOBP MITOTIC SPINDLE ASSEMBLY 70 2.52e-01 5.49e-01 0.112000 4.12e-02 -1.04e-01 5.51e-01 1.33e-01
GOBP AXIS SPECIFICATION 93 1.67e-01 4.51e-01 0.112000 1.10e-01 -2.18e-02 6.78e-02 7.16e-01
GOBP METHIONINE METABOLIC PROCESS 15 7.67e-01 9.01e-01 0.112000 -4.74e-02 -1.01e-01 7.50e-01 4.98e-01
GOBP CARTILAGE DEVELOPMENT 200 3.10e-02 1.70e-01 0.112000 9.27e-02 6.23e-02 2.39e-02 1.29e-01
GOCC RECYCLING ENDOSOME MEMBRANE 100 1.76e-01 4.63e-01 0.112000 6.79e-02 8.86e-02 2.41e-01 1.26e-01
GOBP NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 18 6.99e-01 8.70e-01 0.112000 5.41e-02 -9.76e-02 6.91e-01 4.74e-01
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS 160 4.51e-02 2.13e-01 0.112000 1.07e-01 -3.08e-02 1.92e-02 5.01e-01
GOBP POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION 16 7.57e-01 8.96e-01 0.111000 7.01e-02 8.66e-02 6.27e-01 5.49e-01
GOBP PROTEIN IMPORT INTO PEROXISOME MATRIX SUBSTRATE RELEASE 5 9.12e-01 9.67e-01 0.111000 1.11e-01 1.08e-02 6.68e-01 9.67e-01
GOBP CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 31 5.53e-01 7.87e-01 0.111000 1.75e-02 -1.10e-01 8.66e-01 2.89e-01
Formation of lateral plate mesoderm 5 9.10e-01 9.66e-01 0.111000 4.66e-03 -1.11e-01 9.86e-01 6.67e-01
GOBP SINGLE FERTILIZATION 161 5.31e-02 2.34e-01 0.111000 -1.11e-01 -1.29e-02 1.55e-02 7.78e-01
GOBP CAMP CATABOLIC PROCESS 9 8.51e-01 9.38e-01 0.111000 3.34e-02 1.06e-01 8.62e-01 5.81e-01
GOCC CYTOPLASMIC SIDE OF PLASMA MEMBRANE 155 6.01e-02 2.52e-01 0.111000 1.10e-01 1.66e-02 1.81e-02 7.21e-01
GOBP CELLULAR RESPONSE TO ESTROGEN STIMULUS 19 6.88e-01 8.65e-01 0.111000 -4.80e-02 1.00e-01 7.17e-01 4.49e-01
GOBP NEGATIVE REGULATION OF DENDRITE DEVELOPMENT 8 8.52e-01 9.39e-01 0.111000 7.29e-02 -8.40e-02 7.21e-01 6.81e-01
GOMF HYALURONIC ACID BINDING 24 6.20e-01 8.27e-01 0.111000 -6.34e-02 9.14e-02 5.91e-01 4.38e-01
GOBP EPIGENETIC PROGRAMMING OF GENE EXPRESSION 30 5.71e-01 7.98e-01 0.111000 1.11e-01 -1.14e-03 2.92e-01 9.91e-01
GOCC MITOCHONDRIAL MATRIX 479 1.32e-04 2.69e-03 0.111000 1.71e-02 -1.10e-01 5.21e-01 3.79e-05
GOBP RESPONSE TO MANGANESE ION 17 7.27e-01 8.82e-01 0.111000 5.28e-03 -1.11e-01 9.70e-01 4.28e-01
GOBP REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 182 2.81e-02 1.60e-01 0.111000 9.79e-02 -5.27e-02 2.27e-02 2.20e-01
GOBP RESPIRATORY BURST 32 5.67e-01 7.95e-01 0.111000 -1.05e-01 -3.65e-02 3.04e-01 7.21e-01
GOBP REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 74 2.32e-01 5.30e-01 0.111000 9.58e-02 -5.61e-02 1.54e-01 4.04e-01
Insulin receptor recycling 28 6.11e-01 8.22e-01 0.111000 1.03e-01 4.15e-02 3.46e-01 7.04e-01
GOBP RETINOL METABOLIC PROCESS 50 3.85e-01 6.69e-01 0.111000 1.09e-01 -2.29e-02 1.84e-01 7.79e-01
GOBP REGULATION OF MICROVILLUS LENGTH 7 8.73e-01 9.48e-01 0.111000 -3.87e-02 1.04e-01 8.59e-01 6.34e-01
GOMF ATP TRANSMEMBRANE TRANSPORTER ACTIVITY 12 7.88e-01 9.13e-01 0.111000 -6.85e-02 8.73e-02 6.81e-01 6.00e-01
GOBP REGULATION OF CALCIUM MEDIATED SIGNALING 95 1.57e-01 4.38e-01 0.111000 4.49e-02 -1.01e-01 4.49e-01 8.74e-02
GOMF FERROUS IRON BINDING 24 6.29e-01 8.34e-01 0.111000 1.06e-01 -3.15e-02 3.67e-01 7.89e-01
GOBP EPIDERMAL CELL DIFFERENTIATION 240 1.10e-02 8.42e-02 0.111000 -1.09e-01 1.82e-02 3.50e-03 6.27e-01
GOBP SPERM CAPACITATION 32 5.33e-01 7.73e-01 0.111000 -9.82e-02 5.16e-02 3.36e-01 6.14e-01
MyD88:MAL(TIRAP) cascade initiated on plasma membrane 106 1.22e-01 3.81e-01 0.111000 8.14e-02 -7.54e-02 1.48e-01 1.80e-01
Toll Like Receptor TLR6:TLR2 Cascade 106 1.22e-01 3.81e-01 0.111000 8.14e-02 -7.54e-02 1.48e-01 1.80e-01
GOBP REGULATION OF B CELL MEDIATED IMMUNITY 58 3.28e-01 6.19e-01 0.111000 3.06e-02 -1.07e-01 6.86e-01 1.60e-01
Regulation of PLK1 Activity at G2/M Transition 83 2.13e-01 5.08e-01 0.111000 1.11e-01 -7.29e-03 8.13e-02 9.09e-01
GOBP MITOTIC NUCLEAR MEMBRANE ORGANIZATION 10 8.28e-01 9.29e-01 0.111000 1.17e-02 -1.10e-01 9.49e-01 5.46e-01
GOBP REGULATION OF LIPID CATABOLIC PROCESS 65 3.25e-01 6.16e-01 0.111000 5.61e-02 9.56e-02 4.34e-01 1.82e-01
GOCC EXTERNAL SIDE OF PLASMA MEMBRANE 373 1.72e-03 2.10e-02 0.111000 -9.56e-02 -5.62e-02 1.52e-03 6.24e-02
GOBP REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION 25 6.16e-01 8.26e-01 0.111000 3.78e-02 -1.04e-01 7.44e-01 3.67e-01
GOBP REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING 61 3.40e-01 6.30e-01 0.111000 1.05e-01 3.44e-02 1.55e-01 6.42e-01
GOBP CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 555 7.64e-05 1.70e-03 0.111000 1.01e-01 4.45e-02 4.35e-05 7.27e-02
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY 55 3.61e-01 6.49e-01 0.111000 1.67e-03 -1.11e-01 9.83e-01 1.55e-01
GOBP METANEPHRIC EPITHELIUM DEVELOPMENT 28 6.19e-01 8.27e-01 0.111000 7.55e-02 8.11e-02 4.89e-01 4.58e-01
GOMF PATCHED BINDING 8 8.59e-01 9.42e-01 0.111000 1.09e-01 -1.98e-02 5.93e-01 9.23e-01
GOBP PYRIMIDINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS 6 8.88e-01 9.55e-01 0.111000 -9.11e-02 6.31e-02 6.99e-01 7.89e-01
GOMF TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 864 5.21e-07 2.20e-05 0.111000 9.92e-02 4.93e-02 7.36e-07 1.40e-02
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN 37 5.11e-01 7.60e-01 0.111000 1.10e-01 1.31e-02 2.47e-01 8.90e-01
GOBP PHENOL CONTAINING COMPOUND METABOLIC PROCESS 106 1.55e-01 4.35e-01 0.111000 3.51e-02 1.05e-01 5.32e-01 6.17e-02
GOBP REGULATION OF CELL DIFFERENTIATION 1553 4.45e-12 4.97e-10 0.111000 1.10e-01 1.65e-02 5.64e-13 2.79e-01
GOBP LYSOSOMAL PROTEIN CATABOLIC PROCESS 20 7.10e-01 8.75e-01 0.111000 8.15e-02 7.50e-02 5.28e-01 5.62e-01
GOBP REGULATION OF NEURON MIGRATION 44 4.68e-01 7.30e-01 0.111000 9.49e-02 5.71e-02 2.76e-01 5.12e-01
GOBP MEMBRANE DOCKING 83 2.05e-01 4.99e-01 0.111000 1.06e-01 -3.09e-02 9.42e-02 6.27e-01
GOBP VESICLE TARGETING TO FROM OR WITHIN GOLGI 32 5.42e-01 7.79e-01 0.111000 1.06e-01 -3.11e-02 2.99e-01 7.61e-01
GOCC L TYPE VOLTAGE GATED CALCIUM CHANNEL COMPLEX 12 7.90e-01 9.14e-01 0.111000 -5.87e-02 9.37e-02 7.25e-01 5.74e-01
GOBP REGULATION OF TRANSLATION INITIATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 8 8.56e-01 9.40e-01 0.111000 4.33e-02 -1.02e-01 8.32e-01 6.18e-01
PCP/CE pathway 79 2.13e-01 5.08e-01 0.111000 9.24e-02 -6.08e-02 1.56e-01 3.50e-01
GOBP REGULATION OF RECEPTOR INTERNALIZATION 62 3.41e-01 6.31e-01 0.111000 4.76e-02 9.98e-02 5.17e-01 1.74e-01
GOBP RESPONSE TO LEAD ION 19 7.00e-01 8.70e-01 0.111000 -1.49e-02 1.10e-01 9.11e-01 4.09e-01
GOBP RESPONSE TO ENDOPLASMIC RETICULUM STRESS 259 6.89e-03 6.02e-02 0.111000 1.00e-01 -4.64e-02 5.45e-03 1.98e-01
GOBP HEMOGLOBIN METABOLIC PROCESS 17 7.48e-01 8.91e-01 0.110000 6.55e-02 8.90e-02 6.40e-01 5.25e-01
GOBP REGULATION OF BINDING 221 2.09e-02 1.30e-01 0.110000 1.06e-01 3.03e-02 6.50e-03 4.38e-01
GOBP MITOCHONDRIAL MEMBRANE ORGANIZATION 113 1.22e-01 3.81e-01 0.110000 1.21e-02 -1.10e-01 8.24e-01 4.38e-02
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION 7 8.71e-01 9.47e-01 0.110000 8.32e-02 -7.26e-02 7.03e-01 7.39e-01
GOBP CELL MIGRATION INVOLVED IN GASTRULATION 13 7.76e-01 9.07e-01 0.110000 5.11e-02 -9.78e-02 7.50e-01 5.42e-01
Defective CHST6 causes MCDC1 8 8.73e-01 9.48e-01 0.110000 7.23e-02 8.34e-02 7.23e-01 6.83e-01
GOMF C X C CHEMOKINE RECEPTOR ACTIVITY 7 8.88e-01 9.55e-01 0.110000 6.87e-02 8.63e-02 7.53e-01 6.92e-01
GOMF PHOSPHATASE ACTIVITY 259 1.19e-02 8.90e-02 0.110000 9.96e-02 4.75e-02 5.79e-03 1.88e-01
GOBP REGULATION OF BILE ACID METABOLIC PROCESS 15 7.70e-01 9.04e-01 0.110000 -1.03e-01 -4.06e-02 4.92e-01 7.85e-01
GOBP CELL PROJECTION MORPHOGENESIS 636 2.06e-05 5.50e-04 0.110000 1.03e-01 3.81e-02 8.41e-06 1.01e-01
GOBP REGULATION OF EPITHELIAL CELL DIFFERENTIATION 168 4.04e-02 1.98e-01 0.110000 1.03e-01 -4.04e-02 2.18e-02 3.66e-01
NCAM signaling for neurite out-growth 62 3.00e-01 5.95e-01 0.110000 -5.53e-02 9.54e-02 4.52e-01 1.94e-01
GOMF ORGANIC ACID SODIUM SYMPORTER ACTIVITY 32 5.63e-01 7.93e-01 0.110000 1.39e-02 1.09e-01 8.91e-01 2.84e-01
GOBP ECTOPIC GERM CELL PROGRAMMED CELL DEATH 17 7.21e-01 8.80e-01 0.110000 -1.01e-01 4.30e-02 4.69e-01 7.59e-01
Glucagon-like Peptide-1 (GLP1) regulates insulin secretion 42 4.84e-01 7.43e-01 0.110000 4.51e-02 1.01e-01 6.13e-01 2.60e-01
GOBP MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE 19 7.21e-01 8.80e-01 0.110000 -4.77e-02 -9.93e-02 7.19e-01 4.54e-01
GOBP POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY 192 2.54e-02 1.50e-01 0.110000 1.00e-01 -4.54e-02 1.65e-02 2.78e-01
GOBP DENDRITE EXTENSION 35 5.32e-01 7.72e-01 0.110000 -1.10e-01 -7.60e-03 2.61e-01 9.38e-01
GOMF TYPE 5 METABOTROPIC GLUTAMATE RECEPTOR BINDING 6 8.91e-01 9.56e-01 0.110000 -4.75e-02 9.93e-02 8.40e-01 6.74e-01
GOCC PERICHROMATIN FIBRILS 6 9.03e-01 9.62e-01 0.110000 -8.44e-02 -7.06e-02 7.20e-01 7.65e-01
GOCC COATED VESICLE 304 4.27e-03 4.20e-02 0.110000 1.10e-01 2.33e-03 9.70e-04 9.44e-01
GOBP SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND 67 2.81e-01 5.78e-01 0.110000 1.05e-01 -3.25e-02 1.37e-01 6.46e-01
GOBP CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS 30 5.93e-01 8.11e-01 0.110000 3.35e-02 1.05e-01 7.51e-01 3.21e-01
GOMF STEROID DEHYDROGENASE ACTIVITY 35 5.13e-01 7.61e-01 0.110000 4.00e-02 -1.02e-01 6.82e-01 2.95e-01
GOBP PROTEIN TRANSPORT 1361 4.50e-11 4.03e-09 0.110000 1.08e-01 -1.81e-02 1.94e-11 2.63e-01
GOBP VACUOLAR TRANSPORT 166 5.70e-02 2.44e-01 0.110000 1.04e-01 3.49e-02 2.06e-02 4.38e-01
GOMF IMPORTIN ALPHA FAMILY PROTEIN BINDING 9 8.47e-01 9.36e-01 0.110000 1.42e-02 -1.09e-01 9.41e-01 5.72e-01
GOBP POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION 19 6.98e-01 8.69e-01 0.110000 3.47e-02 -1.04e-01 7.94e-01 4.32e-01
GOBP CELL PROJECTION ASSEMBLY 597 2.80e-05 7.16e-04 0.110000 1.10e-01 5.01e-03 4.71e-06 8.34e-01
GOBP REGULATION OF PLATELET AGGREGATION 29 6.12e-01 8.23e-01 0.110000 9.18e-02 6.00e-02 3.92e-01 5.76e-01
GOBP ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL COMMUNICATION 17 7.27e-01 8.82e-01 0.110000 1.07e-01 -2.58e-02 4.47e-01 8.54e-01
GOBP SALIVA SECRETION 13 7.77e-01 9.07e-01 0.110000 6.57e-02 -8.78e-02 6.82e-01 5.83e-01
GOBP EXTRACELLULAR VESICLE BIOGENESIS 25 6.18e-01 8.27e-01 0.110000 -5.37e-02 9.56e-02 6.42e-01 4.08e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL IRON ION HOMEOSTASIS 25 6.19e-01 8.27e-01 0.110000 9.66e-02 -5.18e-02 4.03e-01 6.54e-01
Amino acids regulate mTORC1 50 4.00e-01 6.82e-01 0.110000 1.09e-01 -1.09e-02 1.82e-01 8.94e-01
GOBP INTERLEUKIN 1 PRODUCTION 122 1.02e-01 3.42e-01 0.110000 -1.05e-01 3.12e-02 4.49e-02 5.52e-01
GOCC TRANS GOLGI NETWORK MEMBRANE 103 1.55e-01 4.35e-01 0.110000 1.10e-01 -3.55e-03 5.47e-02 9.50e-01
GOBP POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 1331 2.84e-10 2.28e-08 0.110000 1.07e-01 2.31e-02 5.24e-11 1.57e-01
GOBP REGULATION OF CELL DEVELOPMENT 812 8.60e-07 3.35e-05 0.110000 1.09e-01 1.07e-02 1.27e-07 6.03e-01
GOMF RNA DIRECTED DNA POLYMERASE ACTIVITY 7 8.87e-01 9.55e-01 0.110000 4.07e-02 1.02e-01 8.52e-01 6.41e-01
GOCC CENTROSOME 705 3.06e-06 1.01e-04 0.110000 1.07e-01 -2.17e-02 1.19e-06 3.26e-01
GOCC OTHER ORGANISM PART 5 9.12e-01 9.67e-01 0.110000 1.68e-02 -1.08e-01 9.48e-01 6.75e-01
GOBP ENDOSOME TO LYSOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY 17 7.48e-01 8.91e-01 0.109000 -9.95e-02 -4.57e-02 4.78e-01 7.44e-01
GOCC TERTIARY GRANULE LUMEN 54 3.55e-01 6.44e-01 0.109000 -9.26e-02 5.82e-02 2.39e-01 4.59e-01
GOBP POSITIVE REGULATION OF PROGRAMMED CELL DEATH 557 3.97e-05 9.77e-04 0.109000 1.06e-01 -2.58e-02 1.77e-05 2.98e-01
GOBP MITOTIC CYTOKINESIS 88 2.01e-01 4.94e-01 0.109000 1.09e-01 -1.07e-02 7.75e-02 8.63e-01
GOMF CYSTEINE TYPE EXOPEPTIDASE ACTIVITY 7 8.87e-01 9.55e-01 0.109000 -3.71e-02 -1.03e-01 8.65e-01 6.37e-01
GOBP REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 77 2.36e-01 5.32e-01 0.109000 3.54e-02 -1.03e-01 5.92e-01 1.17e-01
GOBP RESPONSE TO KETONE 209 1.85e-02 1.20e-01 0.109000 8.80e-02 -6.49e-02 2.84e-02 1.06e-01
Glycolysis 72 3.00e-01 5.95e-01 0.109000 8.94e-02 6.29e-02 1.90e-01 3.56e-01
GOBP NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION 24 6.54e-01 8.47e-01 0.109000 -1.18e-02 -1.09e-01 9.20e-01 3.57e-01
Bacterial Infection Pathways 67 2.78e-01 5.76e-01 0.109000 9.38e-02 -5.61e-02 1.84e-01 4.28e-01
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY 9 8.52e-01 9.39e-01 0.109000 -1.09e-01 -7.89e-03 5.72e-01 9.67e-01
GOBP NEGATIVE REGULATION OF COAGULATION 53 4.03e-01 6.85e-01 0.109000 3.43e-02 1.04e-01 6.66e-01 1.92e-01
GOBP NEGATIVE REGULATION OF PROGRAMMED NECROTIC CELL DEATH 22 6.90e-01 8.66e-01 0.109000 9.75e-02 4.92e-02 4.29e-01 6.89e-01
GOBP IMMUNOLOGICAL MEMORY FORMATION PROCESS 14 7.88e-01 9.13e-01 0.109000 4.23e-02 1.01e-01 7.84e-01 5.14e-01
GOMF GABA RECEPTOR ACTIVITY 19 7.29e-01 8.83e-01 0.109000 -7.32e-02 -8.09e-02 5.81e-01 5.41e-01
GOBP CHONDROITIN SULFATE BIOSYNTHETIC PROCESS 18 7.33e-01 8.85e-01 0.109000 2.94e-02 1.05e-01 8.29e-01 4.40e-01
GOCC ADHERENS JUNCTION 179 5.07e-02 2.27e-01 0.109000 9.35e-02 5.63e-02 3.10e-02 1.94e-01
GOCC EARLY ENDOSOME MEMBRANE 188 4.15e-02 2.02e-01 0.109000 1.02e-01 3.88e-02 1.59e-02 3.59e-01
GOCC MALE GERM CELL NUCLEUS 52 4.22e-01 7.00e-01 0.109000 -8.44e-02 -6.90e-02 2.92e-01 3.89e-01
GOBP VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 29 5.73e-01 7.99e-01 0.109000 -7.41e-02 8.00e-02 4.90e-01 4.56e-01
GOBP REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION 13 7.79e-01 9.08e-01 0.109000 -6.96e-02 8.39e-02 6.64e-01 6.00e-01
GOBP ESTABLISHMENT OF CENTROSOME LOCALIZATION 10 8.27e-01 9.29e-01 0.109000 5.31e-02 -9.52e-02 7.71e-01 6.02e-01
GOBP RESPONSE TO PAIN 36 5.51e-01 7.85e-01 0.109000 8.01e-02 7.39e-02 4.06e-01 4.43e-01
GOBP DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 219 1.69e-02 1.13e-01 0.109000 1.00e-01 -4.20e-02 1.04e-02 2.84e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 11 8.32e-01 9.30e-01 0.109000 5.82e-02 9.21e-02 7.38e-01 5.97e-01
GOMF METHYL CPG BINDING 24 6.56e-01 8.48e-01 0.109000 1.08e-01 1.10e-02 3.58e-01 9.25e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE BINDING 21 6.73e-01 8.57e-01 0.109000 9.74e-02 -4.86e-02 4.40e-01 7.00e-01
GOBP INTRACELLULAR GLUCOSE HOMEOSTASIS 161 5.74e-02 2.46e-01 0.109000 1.09e-01 -1.23e-03 1.72e-02 9.78e-01
GOBP PYRIMIDINE NUCLEOBASE METABOLIC PROCESS 20 7.18e-01 8.78e-01 0.109000 6.22e-02 8.92e-02 6.30e-01 4.90e-01
GOBP NEGATIVE REGULATION OF DNA RECOMBINATION 47 4.36e-01 7.10e-01 0.109000 1.09e-01 5.27e-03 1.98e-01 9.50e-01
GOCC AUTOPHAGOSOME 109 1.53e-01 4.32e-01 0.109000 1.06e-01 2.16e-02 5.47e-02 6.96e-01
GOBP RENAL WATER ABSORPTION 6 9.01e-01 9.61e-01 0.109000 1.07e-01 2.07e-02 6.51e-01 9.30e-01
GOCC ARYL HYDROCARBON RECEPTOR COMPLEX 8 8.76e-01 9.49e-01 0.109000 7.73e-02 7.63e-02 7.05e-01 7.08e-01
GOBP MAPK CASCADE 736 2.59e-06 8.77e-05 0.109000 1.08e-01 -1.18e-02 6.06e-07 5.87e-01
GOBP RETINA HOMEOSTASIS 54 4.01e-01 6.83e-01 0.109000 -3.73e-02 -1.02e-01 6.36e-01 1.95e-01
Prolactin receptor signaling 14 7.77e-01 9.07e-01 0.109000 1.08e-01 -9.20e-03 4.83e-01 9.52e-01
GOBP PHOTORECEPTOR CELL MAINTENANCE 43 4.83e-01 7.42e-01 0.109000 -3.61e-02 -1.02e-01 6.82e-01 2.45e-01
GOCC ANCHORING JUNCTION 863 5.59e-07 2.32e-05 0.109000 1.07e-01 1.79e-02 9.18e-08 3.71e-01
GOBP NEURON PROJECTION GUIDANCE 226 2.47e-02 1.47e-01 0.109000 8.93e-02 6.17e-02 2.07e-02 1.10e-01
GOBP PHOSPHOLIPID BIOSYNTHETIC PROCESS 243 1.10e-02 8.44e-02 0.109000 9.87e-02 -4.51e-02 8.04e-03 2.25e-01
GOBP PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS 50 3.86e-01 6.70e-01 0.109000 7.61e-02 -7.74e-02 3.52e-01 3.44e-01
GOBP REGULATION OF MITOTIC NUCLEAR DIVISION 118 1.07e-01 3.53e-01 0.108000 7.91e-02 -7.42e-02 1.38e-01 1.64e-01
GOBP NOTCH SIGNALING PATHWAY 176 5.52e-02 2.40e-01 0.108000 5.50e-02 9.34e-02 2.08e-01 3.25e-02
GOBP DETECTION OF LIPOPOLYSACCHARIDE 5 9.17e-01 9.68e-01 0.108000 1.08e-01 1.23e-02 6.77e-01 9.62e-01
GOBP POSITIVE REGULATION OF IMMATURE T CELL PROLIFERATION 5 9.16e-01 9.68e-01 0.108000 -1.02e-02 -1.08e-01 9.69e-01 6.76e-01
Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase 20 6.96e-01 8.68e-01 0.108000 1.07e-01 -1.94e-02 4.09e-01 8.81e-01
GOBP REGULATION OF NEURON PROJECTION DEVELOPMENT 422 1.06e-03 1.44e-02 0.108000 9.29e-02 5.58e-02 1.07e-03 4.93e-02
GOCC PRESPLICEOSOME 17 7.26e-01 8.82e-01 0.108000 9.24e-02 -5.66e-02 5.10e-01 6.86e-01
GOBP REGULATION OF MICROTUBULE BASED PROCESS 248 1.04e-02 8.07e-02 0.108000 9.94e-02 -4.29e-02 7.00e-03 2.44e-01
Extracellular matrix organization 311 3.74e-03 3.77e-02 0.108000 -2.30e-02 1.06e-01 4.86e-01 1.33e-03
GOBP BLOOD VESSEL MORPHOGENESIS 694 1.02e-05 2.93e-04 0.108000 1.05e-01 2.53e-02 2.27e-06 2.56e-01
GOBP REGULATION OF SYNAPSE ASSEMBLY 109 1.66e-01 4.50e-01 0.108000 9.36e-02 5.45e-02 9.15e-02 3.26e-01
GOBP INTRACELLULAR AMINO ACID HOMEOSTASIS 9 8.46e-01 9.36e-01 0.108000 9.99e-02 -4.17e-02 6.04e-01 8.29e-01
GOMF SHORT CHAIN FATTY ACYL COA DEHYDROGENASE ACTIVITY 5 9.20e-01 9.70e-01 0.108000 4.87e-02 9.67e-02 8.51e-01 7.08e-01
GOMF RNA NUCLEASE ACTIVITY 127 9.67e-02 3.34e-01 0.108000 1.02e-01 -3.71e-02 4.79e-02 4.70e-01
Netrin mediated repulsion signals 8 8.60e-01 9.42e-01 0.108000 6.82e-02 -8.40e-02 7.38e-01 6.81e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 88 1.90e-01 4.81e-01 0.108000 7.66e-02 -7.64e-02 2.14e-01 2.15e-01
GOBP NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 685 5.37e-06 1.67e-04 0.108000 1.04e-01 -2.80e-02 3.15e-06 2.12e-01
GOBP INTRACILIARY TRANSPORT 48 4.12e-01 6.93e-01 0.108000 3.93e-02 -1.01e-01 6.37e-01 2.27e-01
GOBP SULFUR AMINO ACID CATABOLIC PROCESS 9 8.63e-01 9.43e-01 0.108000 -6.73e-02 -8.45e-02 7.27e-01 6.61e-01
Host Interactions of HIV factors 115 1.18e-01 3.74e-01 0.108000 5.21e-02 -9.46e-02 3.34e-01 7.97e-02
Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) 20 7.01e-01 8.71e-01 0.108000 7.03e-03 -1.08e-01 9.57e-01 4.04e-01
GOBP POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT 50 3.91e-01 6.74e-01 0.108000 -6.67e-02 8.49e-02 4.14e-01 2.99e-01
GOBP CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 29 6.19e-01 8.27e-01 0.108000 9.76e-02 4.62e-02 3.63e-01 6.67e-01
GOBP PROTEIN INSERTION INTO ER MEMBRANE 26 6.19e-01 8.27e-01 0.108000 4.02e-02 -1.00e-01 7.23e-01 3.77e-01
GOBP CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 1147 9.94e-09 6.07e-07 0.108000 1.05e-01 2.68e-02 2.35e-09 1.26e-01
GOBP NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 92 1.94e-01 4.87e-01 0.108000 1.07e-01 -1.46e-02 7.63e-02 8.09e-01
GOCC DENSE CORE GRANULE 38 5.39e-01 7.78e-01 0.108000 8.45e-02 6.71e-02 3.67e-01 4.74e-01
GOBP CGMP METABOLIC PROCESS 16 7.70e-01 9.04e-01 0.108000 8.74e-02 6.33e-02 5.45e-01 6.61e-01
GOBP NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY 140 7.99e-02 3.00e-01 0.108000 1.05e-01 -2.66e-02 3.27e-02 5.87e-01
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL MATURATION 15 7.74e-01 9.06e-01 0.108000 2.09e-02 1.06e-01 8.88e-01 4.78e-01
GOBP REGULATION OF TISSUE REMODELING 88 2.39e-01 5.36e-01 0.108000 8.67e-02 6.41e-02 1.60e-01 2.99e-01
GOBP REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS 11 8.13e-01 9.24e-01 0.108000 8.09e-02 -7.13e-02 6.42e-01 6.82e-01
GOBP REGULATION OF PHOSPHATE TRANSPORT 7 8.92e-01 9.57e-01 0.108000 -8.67e-02 -6.40e-02 6.91e-01 7.69e-01
GOBP CALCINEURIN MEDIATED SIGNALING 47 4.15e-01 6.96e-01 0.108000 8.52e-02 -6.60e-02 3.12e-01 4.34e-01
RUNX1 regulates expression of components of tight junctions 5 9.22e-01 9.70e-01 0.108000 8.01e-02 7.21e-02 7.57e-01 7.80e-01
GOBP POSITIVE REGULATION OF BLOOD VESSEL REMODELING 6 8.95e-01 9.58e-01 0.108000 -9.66e-02 4.77e-02 6.82e-01 8.40e-01
GOMF STRUCTURAL CONSTITUENT OF MYELIN SHEATH 9 8.64e-01 9.43e-01 0.108000 8.11e-02 7.10e-02 6.74e-01 7.12e-01
GOCC SPINDLE 411 7.26e-04 1.07e-02 0.108000 1.06e-01 -1.81e-02 2.21e-04 5.29e-01
GOBP ACROSOMAL VESICLE EXOCYTOSIS 9 8.63e-01 9.43e-01 0.108000 -5.37e-02 -9.33e-02 7.80e-01 6.28e-01
GOBP RECEPTOR INTERNALIZATION 125 1.28e-01 3.91e-01 0.108000 4.36e-02 9.84e-02 3.99e-01 5.75e-02
GOBP ENDOTHELIAL CELL MIGRATION 274 8.02e-03 6.73e-02 0.108000 1.06e-01 -1.57e-02 2.42e-03 6.55e-01
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 67 3.36e-01 6.25e-01 0.108000 9.26e-02 5.47e-02 1.90e-01 4.38e-01
GOMF ADENYL NUCLEOTIDE BINDING 1565 3.71e-11 3.39e-09 0.108000 9.84e-02 4.36e-02 8.15e-11 3.99e-03
GOBP PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION 34 5.77e-01 8.01e-01 0.108000 -6.76e-02 -8.36e-02 4.95e-01 3.99e-01
GOBP ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS 21 7.09e-01 8.75e-01 0.108000 -4.88e-02 -9.58e-02 6.99e-01 4.47e-01
GOMF G PROTEIN BETA GAMMA SUBUNIT COMPLEX BINDING 21 6.96e-01 8.68e-01 0.108000 7.05e-03 1.07e-01 9.55e-01 3.95e-01
GOBP POSITIVE REGULATION OF HEMOPOIESIS 189 4.00e-02 1.97e-01 0.108000 1.07e-01 1.06e-02 1.12e-02 8.02e-01
GOBP REGULATION OF GLUCOCORTICOID BIOSYNTHETIC PROCESS 9 8.51e-01 9.38e-01 0.107000 -2.07e-02 1.05e-01 9.14e-01 5.84e-01
GOBP PROTEIN KINASE A SIGNALING 39 5.27e-01 7.69e-01 0.107000 -9.72e-02 -4.59e-02 2.94e-01 6.20e-01
GOBP LYSOSOMAL TRANSPORT 131 1.05e-01 3.50e-01 0.107000 1.07e-01 6.07e-03 3.40e-02 9.05e-01
Activation of NIMA Kinases NEK9, NEK6, NEK7 7 8.90e-01 9.56e-01 0.107000 -3.51e-02 -1.02e-01 8.72e-01 6.42e-01
GOBP REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION 13 8.06e-01 9.20e-01 0.107000 3.48e-02 1.02e-01 8.28e-01 5.26e-01
GOMF COLLAGEN BINDING 68 2.99e-01 5.94e-01 0.107000 -1.78e-02 1.06e-01 7.99e-01 1.31e-01
GOBP STRIATED MUSCLE CELL DEVELOPMENT 79 2.80e-01 5.77e-01 0.107000 6.30e-02 8.70e-02 3.33e-01 1.81e-01
GOBP RESPONSE TO ESTRADIOL 116 1.31e-01 3.95e-01 0.107000 1.07e-01 -1.05e-02 4.68e-02 8.45e-01
GOMF CARBON NITROGEN LYASE ACTIVITY 13 7.96e-01 9.17e-01 0.107000 -7.59e-03 1.07e-01 9.62e-01 5.04e-01
GOBP BLOOD COAGULATION FIBRIN CLOT FORMATION 14 7.76e-01 9.07e-01 0.107000 -1.02e-01 3.23e-02 5.07e-01 8.34e-01
GOBP HEPATOCYTE DIFFERENTIATION 14 7.97e-01 9.17e-01 0.107000 -5.75e-02 -9.06e-02 7.09e-01 5.57e-01
Metabolism of carbohydrates 276 1.15e-02 8.67e-02 0.107000 4.60e-02 9.70e-02 1.89e-01 5.55e-03
GOMF MONOATOMIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 134 8.40e-02 3.11e-01 0.107000 -8.49e-02 6.57e-02 8.98e-02 1.89e-01
GOBP NEGATIVE REGULATION OF SIGNALING 1450 5.81e-11 5.17e-09 0.107000 1.07e-01 -1.32e-03 7.89e-12 9.33e-01
GOBP FOAM CELL DIFFERENTIATION 41 4.91e-01 7.49e-01 0.107000 1.07e-01 -4.65e-04 2.35e-01 9.96e-01
GOBP MODULATION OF PROCESS OF ANOTHER ORGANISM 17 7.53e-01 8.94e-01 0.107000 -1.03e-01 -2.84e-02 4.60e-01 8.39e-01
GOBP INTERFERON BETA PRODUCTION 56 3.64e-01 6.51e-01 0.107000 3.38e-02 -1.02e-01 6.62e-01 1.88e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 92 1.92e-01 4.84e-01 0.107000 1.03e-01 -2.84e-02 8.64e-02 6.37e-01
GOBP REGULATION OF LYMPHOCYTE MIGRATION 66 3.10e-01 6.04e-01 0.107000 1.05e-01 -1.94e-02 1.38e-01 7.85e-01
GOBP GLYCEROLIPID METABOLIC PROCESS 381 1.09e-03 1.47e-02 0.107000 9.97e-02 -3.96e-02 8.36e-04 1.85e-01
GOBP PHOSPHATIDYLGLYCEROL BIOSYNTHETIC PROCESS 9 8.47e-01 9.36e-01 0.107000 9.03e-02 -5.78e-02 6.39e-01 7.64e-01
GOBP POSTSYNAPTIC MEMBRANE ORGANIZATION 38 5.27e-01 7.69e-01 0.107000 1.05e-01 2.00e-02 2.61e-01 8.31e-01
GOMF LRR DOMAIN BINDING 16 7.48e-01 8.91e-01 0.107000 3.79e-02 -1.00e-01 7.93e-01 4.87e-01
GOBP NUCLEAR MEMBRANE ORGANIZATION 45 4.45e-01 7.17e-01 0.107000 3.02e-02 -1.03e-01 7.26e-01 2.33e-01
GOBP RETINA DEVELOPMENT IN CAMERA TYPE EYE 158 8.04e-02 3.01e-01 0.107000 8.41e-02 6.64e-02 6.83e-02 1.50e-01
Metabolism of proteins 1922 7.99e-15 1.42e-12 0.107000 6.28e-02 -8.67e-02 5.25e-06 3.15e-10
GOMF PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR ACTIVITY 5 9.15e-01 9.68e-01 0.107000 2.24e-02 -1.05e-01 9.31e-01 6.85e-01
GOBP MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 47 4.52e-01 7.20e-01 0.107000 1.38e-02 1.06e-01 8.70e-01 2.08e-01
GOCC SCF UBIQUITIN LIGASE COMPLEX 66 2.95e-01 5.92e-01 0.107000 7.48e-02 -7.65e-02 2.93e-01 2.82e-01
GOBP REGULATION OF MICROTUBULE BASED MOVEMENT 53 3.90e-01 6.73e-01 0.107000 2.45e-02 -1.04e-01 7.57e-01 1.90e-01
GOBP RESPONSE TO PURINE CONTAINING COMPOUND 138 1.06e-01 3.52e-01 0.107000 9.87e-02 4.11e-02 4.52e-02 4.05e-01
GOBP MESODERMAL CELL FATE COMMITMENT 18 7.38e-01 8.87e-01 0.107000 1.06e-01 1.53e-02 4.37e-01 9.11e-01
GOCC SYNAPTIC CLEFT 22 6.67e-01 8.53e-01 0.107000 8.52e-02 -6.46e-02 4.89e-01 6.00e-01
GOBP APOPTOTIC PROCESS 1853 5.29e-14 7.88e-12 0.107000 1.01e-01 -3.41e-02 4.79e-13 1.50e-02
ABC-family proteins mediated transport 87 2.11e-01 5.06e-01 0.107000 3.28e-02 -1.02e-01 5.97e-01 1.01e-01
GOBP ACROSOME REACTION 41 4.82e-01 7.41e-01 0.107000 -1.03e-01 2.79e-02 2.53e-01 7.57e-01
GOCC SYNAPTONEMAL STRUCTURE 35 5.59e-01 7.91e-01 0.107000 1.04e-01 2.54e-02 2.88e-01 7.95e-01
Adherens junctions interactions 58 3.65e-01 6.53e-01 0.107000 1.07e-01 -8.30e-03 1.61e-01 9.13e-01
GOMF RECEPTOR SERINE THREONINE KINASE BINDING 27 6.10e-01 8.22e-01 0.107000 5.47e-02 -9.18e-02 6.23e-01 4.09e-01
GOMF ZINC ION BINDING 787 2.72e-06 9.18e-05 0.107000 1.06e-01 1.35e-02 4.30e-07 5.21e-01
GOCC SPINDLE MICROTUBULE 77 2.43e-01 5.39e-01 0.107000 8.23e-02 -6.80e-02 2.12e-01 3.02e-01
GOBP SECRETION BY TISSUE 46 4.78e-01 7.37e-01 0.107000 5.51e-02 9.15e-02 5.18e-01 2.83e-01
Cytosolic iron-sulfur cluster assembly 12 8.03e-01 9.19e-01 0.107000 -9.09e-02 5.58e-02 5.86e-01 7.38e-01
GOBP MAMMARY GLAND DEVELOPMENT 131 9.30e-02 3.27e-01 0.107000 9.27e-02 -5.29e-02 6.71e-02 2.96e-01
GOBP HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION 133 8.93e-02 3.20e-01 0.107000 9.10e-02 -5.57e-02 7.01e-02 2.67e-01
GOCC VACUOLAR MEMBRANE 470 4.54e-04 7.27e-03 0.107000 1.05e-01 1.82e-02 9.46e-05 4.98e-01
GOBP REGULATION OF MITOCHONDRION ORGANIZATION 143 8.25e-02 3.07e-01 0.107000 1.05e-01 -1.77e-02 2.99e-02 7.16e-01
GOBP REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 1429 1.61e-10 1.34e-08 0.107000 1.06e-01 1.20e-02 1.94e-11 4.46e-01
SARS-CoV-2 targets host intracellular signalling and regulatory pathways 12 8.22e-01 9.27e-01 0.107000 1.01e-01 3.44e-02 5.45e-01 8.37e-01
GOMF ALDO KETO REDUCTASE NADPH ACTIVITY 30 6.09e-01 8.22e-01 0.107000 2.52e-02 1.04e-01 8.11e-01 3.26e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL CHEMICAL HOMEOSTASIS 76 2.88e-01 5.86e-01 0.107000 1.02e-01 3.09e-02 1.24e-01 6.42e-01
GOMF DYSTROGLYCAN BINDING 10 8.33e-01 9.30e-01 0.107000 8.57e-02 -6.32e-02 6.39e-01 7.29e-01
GOMF PROTEIN KINASE C BINDING 51 4.10e-01 6.91e-01 0.107000 1.05e-01 -1.87e-02 1.95e-01 8.18e-01
GOBP POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE 128 1.12e-01 3.62e-01 0.107000 4.55e-03 -1.06e-01 9.29e-01 3.76e-02
GOMF CYTOKINE RECEPTOR ACTIVITY 88 2.27e-01 5.23e-01 0.106000 -1.06e-01 -7.03e-03 8.49e-02 9.09e-01
G alpha (q) signalling events 207 3.88e-02 1.94e-01 0.106000 7.94e-02 7.10e-02 4.91e-02 7.82e-02
GOBP RESPONSE TO ALKALOID 98 2.09e-01 5.05e-01 0.106000 9.29e-02 5.19e-02 1.12e-01 3.74e-01
GOBP CELLULAR RESPONSE TO PARATHYROID HORMONE STIMULUS 8 8.65e-01 9.43e-01 0.106000 9.13e-02 -5.47e-02 6.55e-01 7.89e-01
GOBP LYSOSOMAL LUMEN ACIDIFICATION 21 6.82e-01 8.62e-01 0.106000 6.41e-02 -8.49e-02 6.11e-01 5.01e-01
GOBP RESPONSE TO OXIDATIVE STRESS 386 2.09e-03 2.44e-02 0.106000 1.00e-01 3.49e-02 7.05e-04 2.39e-01
GOBP CERAMIDE BIOSYNTHETIC PROCESS 69 3.37e-01 6.27e-01 0.106000 7.06e-02 7.95e-02 3.11e-01 2.53e-01
GOMF FIBROBLAST GROWTH FACTOR BINDING 23 6.86e-01 8.64e-01 0.106000 2.85e-02 1.02e-01 8.13e-01 3.95e-01
GOCC RIBONUCLEOPROTEIN COMPLEX 1008 2.35e-08 1.32e-06 0.106000 6.90e-02 -8.08e-02 2.10e-04 1.43e-05
HCMV Infection 123 1.09e-01 3.57e-01 0.106000 5.42e-02 -9.14e-02 2.99e-01 8.01e-02
GOBP TOXIN METABOLIC PROCESS 15 7.79e-01 9.08e-01 0.106000 1.46e-02 1.05e-01 9.22e-01 4.81e-01
GOBP ADULT HEART DEVELOPMENT 14 8.02e-01 9.18e-01 0.106000 8.10e-02 6.87e-02 6.00e-01 6.56e-01
GOBP CHONDROITIN SULFATE METABOLIC PROCESS 25 6.75e-01 8.58e-01 0.106000 7.40e-02 7.62e-02 5.22e-01 5.10e-01
GOBP CELLULAR RESPONSE TO INTERFERON BETA 26 6.28e-01 8.33e-01 0.106000 -9.68e-02 4.36e-02 3.93e-01 7.00e-01
GOBP NEURON DEVELOPMENT 1106 3.37e-08 1.84e-06 0.106000 1.03e-01 2.76e-02 8.62e-09 1.21e-01
GOBP AMINOGLYCAN CATABOLIC PROCESS 33 5.61e-01 7.92e-01 0.106000 -1.03e-01 2.36e-02 3.04e-01 8.14e-01
GOMF TRANSITION METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 41 4.75e-01 7.35e-01 0.106000 6.46e-02 -8.41e-02 4.74e-01 3.51e-01
GOBP NEGATIVE REGULATION OF GROWTH 216 2.33e-02 1.42e-01 0.106000 1.03e-01 -2.69e-02 9.38e-03 4.95e-01
GOBP SELF PROTEOLYSIS 12 8.16e-01 9.25e-01 0.106000 1.06e-01 -8.82e-04 5.25e-01 9.96e-01
GOBP CORTICOSPINAL TRACT MORPHOGENESIS 8 8.78e-01 9.50e-01 0.106000 1.02e-01 2.87e-02 6.17e-01 8.88e-01
GOCC ENDOSOME 1010 1.40e-07 6.72e-06 0.106000 1.03e-01 2.50e-02 3.03e-08 1.80e-01
Vasopressin-like receptors 5 9.20e-01 9.70e-01 0.106000 1.05e-01 1.31e-02 6.84e-01 9.59e-01
GOCC RESPIRATORY CHAIN COMPLEX IV 22 6.90e-01 8.66e-01 0.106000 -8.72e-04 -1.06e-01 9.94e-01 3.90e-01
GOCC ACROSOMAL MEMBRANE 32 6.06e-01 8.19e-01 0.106000 -7.10e-02 -7.85e-02 4.87e-01 4.42e-01
GOBP AXONEME ASSEMBLY 96 1.91e-01 4.83e-01 0.106000 -1.04e-01 1.80e-02 7.72e-02 7.61e-01
GOBP RUFFLE ASSEMBLY 44 5.02e-01 7.54e-01 0.106000 8.43e-02 6.40e-02 3.33e-01 4.62e-01
GOBP CELLULAR COMPONENT DISASSEMBLY 521 1.42e-04 2.88e-03 0.106000 1.03e-01 -2.29e-02 5.43e-05 3.72e-01
GOBP MUSCLE SYSTEM PROCESS 449 6.29e-04 9.52e-03 0.106000 1.06e-01 5.46e-03 1.24e-04 8.43e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 86 2.12e-01 5.08e-01 0.106000 7.99e-02 -6.93e-02 2.00e-01 2.67e-01
GOMF HISTONE UBIQUITIN LIGASE ACTIVITY 10 8.51e-01 9.38e-01 0.106000 -3.04e-02 -1.01e-01 8.68e-01 5.79e-01
GOCC CONNEXIN COMPLEX 19 7.39e-01 8.87e-01 0.106000 4.42e-02 9.60e-02 7.39e-01 4.69e-01
GOBP REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 855 1.69e-06 5.98e-05 0.106000 1.01e-01 3.03e-02 4.94e-07 1.32e-01
GOBP REGULATION OF FILOPODIUM ASSEMBLY 45 4.96e-01 7.52e-01 0.106000 7.78e-02 7.15e-02 3.66e-01 4.07e-01
GOBP LIPID STORAGE 93 2.14e-01 5.09e-01 0.106000 1.05e-01 7.85e-03 7.91e-02 8.96e-01
GOBP CAMP MEDIATED SIGNALING 57 3.80e-01 6.65e-01 0.106000 -1.05e-01 8.62e-03 1.69e-01 9.10e-01
GOMF METALLOCARBOXYPEPTIDASE ACTIVITY 29 6.10e-01 8.22e-01 0.106000 -1.05e-01 1.13e-02 3.28e-01 9.16e-01
GOBP RESPONSE TO INTERLEUKIN 1 110 1.43e-01 4.15e-01 0.106000 4.44e-02 -9.58e-02 4.21e-01 8.25e-02
GOBP REGULATION OF SPROUTING ANGIOGENESIS 65 3.57e-01 6.46e-01 0.106000 4.30e-02 9.64e-02 5.49e-01 1.79e-01
Glutamate Neurotransmitter Release Cycle 24 6.85e-01 8.63e-01 0.106000 9.41e-02 4.78e-02 4.25e-01 6.85e-01
GOCC GOLGI APPARATUS SUBCOMPARTMENT 354 3.21e-03 3.38e-02 0.106000 1.05e-01 1.36e-02 7.17e-04 6.59e-01
GOBP RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM 75 3.08e-01 6.01e-01 0.106000 9.25e-02 5.07e-02 1.66e-01 4.48e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 60 3.94e-01 6.76e-01 0.106000 7.01e-02 7.89e-02 3.48e-01 2.91e-01
GOBP COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY 9 8.56e-01 9.40e-01 0.105000 -1.04e-01 1.98e-02 5.90e-01 9.18e-01
GOMF ATPASE COUPLED INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY 26 6.54e-01 8.47e-01 0.105000 1.93e-02 1.04e-01 8.65e-01 3.60e-01
GOBP NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 53 4.17e-01 6.98e-01 0.105000 -9.59e-03 -1.05e-01 9.04e-01 1.86e-01
GOBP ROUNDABOUT SIGNALING PATHWAY 5 9.24e-01 9.71e-01 0.105000 -4.93e-02 -9.32e-02 8.49e-01 7.18e-01
HS-GAG biosynthesis 28 6.43e-01 8.42e-01 0.105000 9.36e-02 4.86e-02 3.91e-01 6.56e-01
GOBP POSITIVE REGULATION OF ATP METABOLIC PROCESS 30 6.27e-01 8.33e-01 0.105000 8.11e-02 6.74e-02 4.42e-01 5.23e-01
GOBP SULFUR COMPOUND BIOSYNTHETIC PROCESS 160 8.20e-02 3.06e-01 0.105000 9.30e-02 4.98e-02 4.24e-02 2.77e-01
GOBP MHC CLASS II BIOSYNTHETIC PROCESS 19 7.38e-01 8.87e-01 0.105000 -3.62e-02 -9.90e-02 7.85e-01 4.55e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION 1627 5.17e-12 5.62e-10 0.105000 1.03e-01 -2.04e-02 3.48e-12 1.69e-01
GOBP CELLULAR RESPONSE TO FATTY ACID 33 5.75e-01 8.00e-01 0.105000 1.05e-01 -1.64e-03 2.95e-01 9.87e-01
TP53 Regulates Metabolic Genes 80 2.79e-01 5.76e-01 0.105000 1.00e-01 3.23e-02 1.21e-01 6.18e-01
GOMF NUCLEOTIDYLTRANSFERASE ACTIVITY 136 1.01e-01 3.41e-01 0.105000 1.05e-01 -9.98e-03 3.47e-02 8.41e-01
GOBP REGULATION OF TRANSLATION 428 6.25e-04 9.47e-03 0.105000 9.79e-02 -3.90e-02 5.16e-04 1.66e-01
GOBP SUBSTRATE DEPENDENT CELL MIGRATION CELL EXTENSION 8 8.83e-01 9.52e-01 0.105000 6.03e-02 8.64e-02 7.68e-01 6.72e-01
GOCC GOLGI ASSOCIATED VESICLE 89 2.51e-01 5.48e-01 0.105000 8.81e-02 5.76e-02 1.51e-01 3.47e-01
GOBP PARTURITION 14 7.92e-01 9.15e-01 0.105000 1.05e-01 2.49e-03 4.96e-01 9.87e-01
GOBP AMINO SUGAR BIOSYNTHETIC PROCESS 11 8.22e-01 9.27e-01 0.105000 -8.86e-02 5.68e-02 6.11e-01 7.44e-01
GOCC DISTAL AXON 258 1.90e-02 1.23e-01 0.105000 8.74e-02 5.85e-02 1.57e-02 1.06e-01
Opioid Signalling 89 2.54e-01 5.52e-01 0.105000 7.87e-02 6.96e-02 1.99e-01 2.56e-01
GOBP TRNA MODIFICATION 90 2.01e-01 4.94e-01 0.105000 7.48e-02 -7.38e-02 2.20e-01 2.26e-01
GOBP VASCULAR ENDOTHELIAL CELL PROLIFERATION 49 4.18e-01 6.98e-01 0.105000 8.06e-02 -6.74e-02 3.29e-01 4.14e-01
GOBP PEPTIDOGLYCAN METABOLIC PROCESS 6 9.00e-01 9.61e-01 0.105000 -9.71e-02 4.02e-02 6.80e-01 8.65e-01
GOBP SPINDLE ASSEMBLY 124 1.11e-01 3.61e-01 0.105000 8.58e-02 -6.07e-02 9.91e-02 2.43e-01
GOBP NEGATIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS 10 8.40e-01 9.33e-01 0.105000 3.69e-02 -9.83e-02 8.40e-01 5.90e-01
GOMF DNA BINDING BENDING 16 7.73e-01 9.05e-01 0.105000 1.02e-01 2.46e-02 4.79e-01 8.65e-01
GOBP CARNITINE METABOLIC PROCESS 11 8.24e-01 9.28e-01 0.105000 9.42e-02 -4.65e-02 5.89e-01 7.89e-01
GOBP REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 117 1.67e-01 4.51e-01 0.105000 7.34e-02 7.50e-02 1.70e-01 1.61e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 14 7.81e-01 9.10e-01 0.105000 -8.97e-02 5.44e-02 5.61e-01 7.24e-01
GOBP POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 46 4.63e-01 7.26e-01 0.105000 1.05e-01 -7.94e-03 2.20e-01 9.26e-01
GOBP PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS 46 4.45e-01 7.17e-01 0.105000 -9.25e-02 4.95e-02 2.78e-01 5.62e-01
GOCC STEREOCILIUM MEMBRANE 6 9.04e-01 9.62e-01 0.105000 -1.04e-01 1.43e-02 6.59e-01 9.52e-01
GOCC GAP JUNCTION 28 6.31e-01 8.34e-01 0.105000 4.62e-03 1.05e-01 9.66e-01 3.37e-01
GOBP UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY 35 5.44e-01 7.80e-01 0.105000 -3.99e-02 9.70e-02 6.83e-01 3.21e-01
GOBP UTP BIOSYNTHETIC PROCESS 10 8.38e-01 9.32e-01 0.105000 -5.89e-02 8.67e-02 7.47e-01 6.35e-01
GOBP CHOLESTEROL EFFLUX 74 2.97e-01 5.94e-01 0.105000 3.73e-03 1.05e-01 9.56e-01 1.19e-01
GOBP PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE 103 1.95e-01 4.87e-01 0.105000 2.64e-02 1.01e-01 6.43e-01 7.54e-02
GOBP POSITIVE REGULATION OF CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 200 2.97e-02 1.65e-01 0.105000 7.34e-02 -7.47e-02 7.36e-02 6.85e-02
GOMF ATPASE COUPLED TRANSMEMBRANE TRANSPORTER ACTIVITY 94 2.13e-01 5.08e-01 0.105000 -5.77e-04 1.05e-01 9.92e-01 7.95e-02
GOBP RESPONSE TO ABIOTIC STIMULUS 1086 1.84e-08 1.07e-06 0.105000 9.93e-02 -3.31e-02 3.26e-08 6.56e-02
Cardiac conduction 125 1.10e-01 3.59e-01 0.105000 -7.37e-02 7.43e-02 1.55e-01 1.52e-01
Endogenous sterols 26 6.41e-01 8.40e-01 0.105000 -1.00e-01 2.92e-02 3.75e-01 7.97e-01
GOMF ATP DEPENDENT ACTIVITY 561 1.64e-04 3.24e-03 0.105000 1.02e-01 2.49e-02 3.89e-05 3.13e-01
GOBP MITOTIC SPINDLE ELONGATION 11 8.40e-01 9.33e-01 0.105000 1.01e-01 2.71e-02 5.62e-01 8.76e-01
Cell recruitment (pro-inflammatory response) 26 6.72e-01 8.57e-01 0.105000 -6.18e-02 -8.43e-02 5.86e-01 4.57e-01
Purinergic signaling in leishmaniasis infection 26 6.72e-01 8.57e-01 0.105000 -6.18e-02 -8.43e-02 5.86e-01 4.57e-01
GOBP ANTEROGRADE AXONAL TRANSPORT 49 4.29e-01 7.06e-01 0.104000 9.65e-02 -4.01e-02 2.43e-01 6.27e-01
GOBP MITOCHONDRIAL PROTON TRANSPORTING ATP SYNTHASE COMPLEX ASSEMBLY 8 8.73e-01 9.48e-01 0.104000 1.01e-01 -2.49e-02 6.19e-01 9.03e-01
GOBP MACROMOLECULE DEACYLATION 54 4.22e-01 7.00e-01 0.104000 1.03e-01 1.78e-02 1.91e-01 8.21e-01
GOMF ENDONUCLEASE ACTIVITY 119 1.33e-01 3.98e-01 0.104000 1.01e-01 -2.80e-02 5.81e-02 5.98e-01
GOBP PROTEIN CATABOLIC PROCESS 953 1.90e-07 8.96e-06 0.104000 1.02e-01 -2.40e-02 1.08e-07 2.10e-01
GOBP RESPONSE TO LEPTIN 21 6.91e-01 8.67e-01 0.104000 7.28e-02 -7.48e-02 5.64e-01 5.53e-01
GOBP RESPONSE TO REACTIVE OXYGEN SPECIES 197 4.33e-02 2.07e-01 0.104000 1.03e-01 1.51e-02 1.25e-02 7.15e-01
GOBP RESPONSE TO NITROGEN COMPOUND 1055 9.42e-08 4.66e-06 0.104000 1.03e-01 1.36e-02 1.36e-08 4.55e-01
GOBP RESPONSE TO AMINO ACID STARVATION 54 3.88e-01 6.71e-01 0.104000 7.89e-02 -6.82e-02 3.16e-01 3.86e-01
GOCC ELONGATOR HOLOENZYME COMPLEX 6 9.00e-01 9.61e-01 0.104000 8.34e-02 -6.27e-02 7.24e-01 7.90e-01
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT 128 1.22e-01 3.81e-01 0.104000 1.04e-01 -6.15e-03 4.20e-02 9.04e-01
GOBP NEGATIVE REGULATION OF NUCLEOTIDE CATABOLIC PROCESS 18 7.34e-01 8.85e-01 0.104000 9.75e-02 -3.68e-02 4.74e-01 7.87e-01
GOCC CLATHRIN COATED VESICLE MEMBRANE 129 1.17e-01 3.73e-01 0.104000 1.03e-01 -1.39e-02 4.28e-02 7.85e-01
GOCC LATE ENDOSOME MEMBRANE 164 6.38e-02 2.62e-01 0.104000 1.02e-01 -2.34e-02 2.48e-02 6.05e-01
GOBP NON MEMBRANE BOUNDED ORGANELLE ASSEMBLY 402 1.16e-03 1.55e-02 0.104000 9.84e-02 -3.44e-02 7.13e-04 2.36e-01
GOBP RESPONSE TO HYDROGEN PEROXIDE 94 1.96e-01 4.89e-01 0.104000 8.95e-02 -5.32e-02 1.34e-01 3.73e-01
GOMF SODIUM PROTON ANTIPORTER ACTIVITY 13 8.06e-01 9.20e-01 0.104000 -1.03e-01 1.18e-02 5.19e-01 9.41e-01
GOMF NERVE GROWTH FACTOR BINDING 6 9.00e-01 9.61e-01 0.104000 -8.08e-02 6.55e-02 7.32e-01 7.81e-01
GOMF EXCITATORY EXTRACELLULAR LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY 35 5.65e-01 7.94e-01 0.104000 -1.04e-01 5.68e-04 2.87e-01 9.95e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON THE CH CH GROUP OF DONORS 60 3.80e-01 6.65e-01 0.104000 6.53e-03 1.04e-01 9.30e-01 1.64e-01
GOBP NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 400 1.15e-03 1.53e-02 0.104000 9.37e-02 -4.52e-02 1.31e-03 1.21e-01
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 24 6.60e-01 8.50e-01 0.104000 -8.99e-02 5.23e-02 4.46e-01 6.58e-01
GOMF TRANSMEMBRANE EPHRIN RECEPTOR ACTIVITY 15 7.94e-01 9.16e-01 0.104000 4.13e-02 9.54e-02 7.82e-01 5.22e-01
GOBP RETINAL CONE CELL DIFFERENTIATION 13 8.22e-01 9.27e-01 0.104000 8.08e-02 6.53e-02 6.14e-01 6.84e-01
GOBP REGULATION OF GONADOTROPIN SECRETION 12 8.13e-01 9.24e-01 0.104000 5.06e-02 -9.07e-02 7.61e-01 5.86e-01
GOBP EXECUTION PHASE OF APOPTOSIS 79 2.87e-01 5.85e-01 0.104000 1.02e-01 1.89e-02 1.17e-01 7.71e-01
GOBP POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY 126 1.14e-01 3.67e-01 0.104000 8.84e-02 -5.44e-02 8.67e-02 2.91e-01
GOBP NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION 26 6.37e-01 8.38e-01 0.104000 5.92e-02 -8.52e-02 6.01e-01 4.52e-01
GOBP FEMALE SEX DIFFERENTIATION 118 1.38e-01 4.08e-01 0.104000 9.97e-02 -2.89e-02 6.14e-02 5.88e-01
GOBP PROTEIN CONTAINING COMPLEX REMODELING 37 5.56e-01 7.89e-01 0.104000 1.48e-02 1.03e-01 8.77e-01 2.80e-01
GOBP HYDROGEN PEROXIDE METABOLIC PROCESS 50 4.52e-01 7.20e-01 0.104000 -1.03e-01 -1.34e-02 2.08e-01 8.70e-01
GOMF NUCLEASE ACTIVITY 210 2.90e-02 1.63e-01 0.104000 9.69e-02 -3.70e-02 1.55e-02 3.56e-01
GOBP MITOTIC METAPHASE CHROMOSOME ALIGNMENT 62 3.42e-01 6.32e-01 0.104000 6.27e-02 -8.27e-02 3.94e-01 2.60e-01
GOBP SPINDLE ORGANIZATION 191 4.22e-02 2.04e-01 0.104000 1.01e-01 -2.24e-02 1.58e-02 5.94e-01
GOBP ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE 75 2.77e-01 5.74e-01 0.104000 9.22e-02 -4.75e-02 1.68e-01 4.77e-01
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE MORPHOGENESIS 47 4.86e-01 7.44e-01 0.104000 3.78e-02 9.66e-02 6.54e-01 2.52e-01
GOBP GLYCEROLIPID BIOSYNTHETIC PROCESS 239 1.84e-02 1.20e-01 0.104000 9.86e-02 -3.19e-02 8.62e-03 3.96e-01
GOBP ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT 128 1.16e-01 3.70e-01 0.104000 9.85e-02 -3.23e-02 5.43e-02 5.28e-01
GOBP POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM 12 8.17e-01 9.26e-01 0.104000 9.93e-02 -2.97e-02 5.51e-01 8.59e-01
GOBP ERAD PATHWAY 109 1.52e-01 4.31e-01 0.104000 6.48e-02 -8.09e-02 2.43e-01 1.45e-01
GOCC U5 SNRNP 22 7.17e-01 8.78e-01 0.104000 8.97e-02 5.19e-02 4.67e-01 6.73e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 25 6.80e-01 8.61e-01 0.104000 -3.34e-02 -9.81e-02 7.73e-01 3.96e-01
GOBP MESODERMAL CELL FATE SPECIFICATION 13 8.01e-01 9.18e-01 0.104000 9.34e-02 -4.48e-02 5.60e-01 7.80e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN 69 3.03e-01 5.97e-01 0.104000 7.28e-02 -7.36e-02 2.96e-01 2.90e-01
GOBP VASCULATURE DEVELOPMENT 811 4.68e-06 1.50e-04 0.104000 1.01e-01 2.06e-02 8.99e-07 3.18e-01
GOBP CARBOHYDRATE TRANSPORT 137 1.19e-01 3.76e-01 0.104000 2.49e-02 1.00e-01 6.15e-01 4.23e-02
GOBP REGULATION OF SIGNALING RECEPTOR ACTIVITY 90 2.62e-01 5.58e-01 0.103000 -7.15e-02 -7.48e-02 2.41e-01 2.20e-01
GOBP NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 121 1.43e-01 4.15e-01 0.103000 1.03e-01 -1.24e-03 4.94e-02 9.81e-01
GOBP PROTON TRANSPORTING TWO SECTOR ATPASE COMPLEX ASSEMBLY 15 7.77e-01 9.07e-01 0.103000 3.13e-02 -9.86e-02 8.34e-01 5.09e-01
GOCC AZUROPHIL GRANULE LUMEN 86 2.41e-01 5.37e-01 0.103000 -1.01e-01 2.21e-02 1.06e-01 7.23e-01
Vesicle-mediated transport 642 3.95e-05 9.73e-04 0.103000 1.03e-01 -7.14e-03 8.28e-06 7.58e-01
Macroautophagy 135 9.87e-02 3.37e-01 0.103000 7.81e-02 -6.76e-02 1.17e-01 1.75e-01
GOBP INTRACELLULAR SIGNALING CASSETTE 1856 1.63e-12 1.92e-10 0.103000 1.03e-01 5.62e-03 1.75e-13 6.88e-01
GOBP SENSORY PERCEPTION OF TEMPERATURE STIMULUS 29 6.12e-01 8.23e-01 0.103000 -9.38e-02 4.33e-02 3.82e-01 6.87e-01
GOBP POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 212 3.03e-02 1.67e-01 0.103000 9.98e-02 -2.64e-02 1.23e-02 5.07e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN EXTRACELLULAR REGION 8 8.72e-01 9.48e-01 0.103000 8.95e-02 -5.15e-02 6.61e-01 8.01e-01
GOBP REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 37 5.30e-01 7.71e-01 0.103000 8.42e-02 -5.97e-02 3.75e-01 5.30e-01
GOBP PYROPTOSIS 36 5.55e-01 7.88e-01 0.103000 -1.02e-01 1.36e-02 2.88e-01 8.88e-01
GOBP PROTEIN REPAIR 7 9.00e-01 9.61e-01 0.103000 -5.23e-02 -8.90e-02 8.11e-01 6.83e-01
GOBP CELLULAR RESPONSE TO CAFFEINE 11 8.49e-01 9.37e-01 0.103000 -7.34e-02 -7.25e-02 6.73e-01 6.77e-01
SARS-CoV Infections 390 1.44e-03 1.85e-02 0.103000 5.20e-02 -8.91e-02 7.78e-02 2.53e-03
GOBP RENAL TUBULAR SECRETION 20 7.09e-01 8.75e-01 0.103000 7.43e-02 -7.16e-02 5.65e-01 5.79e-01
GOBP T HELPER 17 TYPE IMMUNE RESPONSE 48 4.55e-01 7.22e-01 0.103000 1.02e-01 -1.67e-02 2.22e-01 8.41e-01
GOBP RRNA CATABOLIC PROCESS 14 7.86e-01 9.13e-01 0.103000 6.17e-02 -8.27e-02 6.89e-01 5.92e-01
Z-decay: degradation of maternal mRNAs by zygotically expressed factors 10 8.43e-01 9.36e-01 0.103000 8.95e-02 -5.11e-02 6.24e-01 7.79e-01
Chaperonin-mediated protein folding 89 2.29e-01 5.27e-01 0.103000 2.66e-02 -9.96e-02 6.65e-01 1.04e-01
GOCC G PROTEIN COUPLED RECEPTOR COMPLEX 11 8.30e-01 9.30e-01 0.103000 -9.29e-02 4.47e-02 5.94e-01 7.97e-01
GOMF ATPASE INHIBITOR ACTIVITY 5 9.18e-01 9.69e-01 0.103000 5.15e-02 -8.93e-02 8.42e-01 7.30e-01
GOMF MISMATCH REPAIR COMPLEX BINDING 11 8.39e-01 9.33e-01 0.103000 1.03e-01 1.90e-03 5.54e-01 9.91e-01
GOBP RESPONSE TO ATP 31 6.31e-01 8.34e-01 0.103000 8.38e-02 6.00e-02 4.19e-01 5.63e-01
GOBP MULTIVESICULAR BODY ORGANIZATION 32 6.22e-01 8.29e-01 0.103000 -7.87e-02 -6.65e-02 4.41e-01 5.15e-01
TP53 Regulates Transcription of Genes Involved in Cytochrome C Release 20 7.15e-01 8.77e-01 0.103000 9.67e-02 -3.56e-02 4.54e-01 7.83e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION 48 4.61e-01 7.25e-01 0.103000 -1.03e-01 6.80e-03 2.18e-01 9.35e-01
GOBP POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION 69 3.27e-01 6.18e-01 0.103000 1.19e-02 -1.02e-01 8.64e-01 1.42e-01
FCGR activation 11 8.49e-01 9.37e-01 0.103000 -5.94e-02 -8.41e-02 7.33e-01 6.29e-01
GOBP DECIDUALIZATION 24 6.65e-01 8.52e-01 0.103000 8.84e-02 -5.28e-02 4.54e-01 6.54e-01
Regulation of insulin secretion 77 3.06e-01 5.99e-01 0.103000 2.47e-02 1.00e-01 7.07e-01 1.29e-01
GOBP REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION 101 2.20e-01 5.16e-01 0.103000 9.29e-02 4.41e-02 1.07e-01 4.44e-01
GOBP SMOOTH MUSCLE CELL APOPTOTIC PROCESS 38 5.48e-01 7.83e-01 0.103000 1.03e-01 3.42e-03 2.73e-01 9.71e-01
GOBP BONE DEVELOPMENT 205 4.85e-02 2.22e-01 0.103000 8.89e-02 5.16e-02 2.83e-02 2.03e-01
Downregulation of ERBB2:ERBB3 signaling 13 8.16e-01 9.26e-01 0.103000 1.02e-01 1.21e-02 5.24e-01 9.40e-01
GOMF EXONUCLEASE ACTIVITY 86 2.35e-01 5.32e-01 0.103000 8.89e-02 -5.15e-02 1.54e-01 4.09e-01
GOBP ORGANELLE MEMBRANE FUSION 120 1.44e-01 4.17e-01 0.103000 1.02e-01 -1.47e-02 5.45e-02 7.80e-01
GOBP SERTOLI CELL PROLIFERATION 5 9.27e-01 9.73e-01 0.103000 -9.62e-02 -3.58e-02 7.09e-01 8.90e-01
GOBP SINOATRIAL NODE DEVELOPMENT 11 8.31e-01 9.30e-01 0.103000 -9.27e-02 4.42e-02 5.95e-01 8.00e-01
GOBP MATERNAL PLACENTA DEVELOPMENT 33 5.71e-01 7.98e-01 0.103000 8.26e-02 -6.09e-02 4.11e-01 5.45e-01
GOMF QUATERNARY AMMONIUM GROUP BINDING 37 5.80e-01 8.03e-01 0.103000 6.54e-02 7.91e-02 4.91e-01 4.05e-01
GOCC EARLY ENDOSOME 424 1.73e-03 2.10e-02 0.103000 9.92e-02 2.60e-02 4.56e-04 3.59e-01
GOBP DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN 28 6.59e-01 8.50e-01 0.103000 -4.78e-02 -9.07e-02 6.61e-01 4.06e-01
GOBP CELL JUNCTION MAINTENANCE 44 4.88e-01 7.46e-01 0.103000 -2.19e-02 1.00e-01 8.02e-01 2.50e-01
GOBP BONE MORPHOGENESIS 97 2.19e-01 5.15e-01 0.103000 1.02e-01 6.23e-03 8.16e-02 9.16e-01
GOBP REGULATION OF CELLULAR LOCALIZATION 947 7.24e-07 2.88e-05 0.103000 1.02e-01 1.11e-02 1.07e-07 5.63e-01
GOCC PLASMA MEMBRANE RAFT 112 1.51e-01 4.30e-01 0.102000 5.94e-02 -8.35e-02 2.77e-01 1.27e-01
GOBP REPRODUCTIVE SYSTEM DEVELOPMENT 291 8.56e-03 7.05e-02 0.102000 9.65e-02 -3.45e-02 4.62e-03 3.11e-01
Growth hormone receptor signaling 23 7.07e-01 8.73e-01 0.102000 9.66e-02 3.41e-02 4.22e-01 7.77e-01
SARS-CoV-2 Infection 279 1.18e-02 8.87e-02 0.102000 1.26e-02 -1.02e-01 7.17e-01 3.47e-03
Activation of GABAB receptors 43 4.95e-01 7.51e-01 0.102000 -2.66e-02 9.89e-02 7.63e-01 2.62e-01
GABA B receptor activation 43 4.95e-01 7.51e-01 0.102000 -2.66e-02 9.89e-02 7.63e-01 2.62e-01
GOMF SUGAR TRANSMEMBRANE TRANSPORTER ACTIVITY 29 6.27e-01 8.33e-01 0.102000 -1.01e-01 1.38e-02 3.44e-01 8.98e-01
GOMF CORECEPTOR ACTIVITY 55 4.45e-01 7.17e-01 0.102000 8.55e-02 5.63e-02 2.73e-01 4.70e-01
GOBP PURINE NUCLEOTIDE SALVAGE 10 8.45e-01 9.36e-01 0.102000 -5.26e-02 8.78e-02 7.73e-01 6.31e-01
GOBP FEMALE MEIOTIC NUCLEAR DIVISION 39 5.17e-01 7.63e-01 0.102000 8.05e-02 -6.33e-02 3.85e-01 4.94e-01
GOBP MULTICELLULAR ORGANISMAL RESPONSE TO STRESS 94 2.09e-01 5.03e-01 0.102000 9.08e-02 -4.72e-02 1.28e-01 4.29e-01
GOBP METHIONINE BIOSYNTHETIC PROCESS 12 8.22e-01 9.27e-01 0.102000 2.68e-02 -9.88e-02 8.72e-01 5.54e-01
GOMF INORGANIC DIPHOSPHATE PHOSPHATASE ACTIVITY 5 9.29e-01 9.73e-01 0.102000 5.04e-02 8.91e-02 8.45e-01 7.30e-01
GOCC COLLAGEN CONTAINING EXTRACELLULAR MATRIX 405 1.20e-03 1.59e-02 0.102000 -6.81e-02 7.63e-02 1.86e-02 8.44e-03
GOBP TISSUE REGENERATION 79 3.13e-01 6.07e-01 0.102000 8.76e-02 5.28e-02 1.78e-01 4.17e-01
GOMF INTRACELLULARLY LIGAND GATED MONOATOMIC ION CHANNEL ACTIVITY 30 6.07e-01 8.21e-01 0.102000 -4.25e-02 9.30e-02 6.87e-01 3.78e-01
GOBP LIPOPROTEIN CATABOLIC PROCESS 15 8.01e-01 9.18e-01 0.102000 -4.60e-02 -9.13e-02 7.58e-01 5.40e-01
GOBP APOPTOTIC PROCESS IN BONE MARROW CELL 6 9.15e-01 9.68e-01 0.102000 -9.10e-02 -4.66e-02 6.99e-01 8.43e-01
GOBP DIGESTIVE SYSTEM PROCESS 105 2.00e-01 4.93e-01 0.102000 1.55e-02 1.01e-01 7.84e-01 7.35e-02
GOBP NUCLEUS ORGANIZATION 145 8.87e-02 3.19e-01 0.102000 8.61e-02 -5.52e-02 7.36e-02 2.51e-01
GOBP POSITIVE REGULATION OF LYMPHOCYTE MIGRATION 40 5.09e-01 7.59e-01 0.102000 6.46e-02 -7.93e-02 4.80e-01 3.86e-01
GOMF PURINE RIBONUCLEOTIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 20 7.35e-01 8.86e-01 0.102000 1.69e-02 1.01e-01 8.96e-01 4.35e-01
GOCC ORGANELLE ENVELOPE LUMEN 89 2.43e-01 5.39e-01 0.102000 9.45e-03 -1.02e-01 8.78e-01 9.70e-02
GOBP POSITIVE REGULATION OF CHOLESTEROL METABOLIC PROCESS 15 7.90e-01 9.14e-01 0.102000 4.78e-04 1.02e-01 9.97e-01 4.93e-01
GOMF P TYPE TRANSMEMBRANE TRANSPORTER ACTIVITY 23 7.00e-01 8.70e-01 0.102000 8.04e-03 1.02e-01 9.47e-01 3.98e-01
GOBP REGULATION OF CELL POPULATION PROLIFERATION 1690 1.22e-11 1.26e-09 0.102000 1.01e-01 -1.69e-02 5.55e-12 2.47e-01
GOBP REGULATION OF CYTOKINESIS 89 2.25e-01 5.22e-01 0.102000 8.24e-02 -6.03e-02 1.79e-01 3.26e-01
GOBP ORGANELLE ASSEMBLY 988 3.06e-07 1.36e-05 0.102000 1.02e-01 -7.74e-03 6.08e-08 6.80e-01
GOBP POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 35 6.01e-01 8.16e-01 0.102000 7.53e-02 6.89e-02 4.41e-01 4.80e-01
GOBP CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION 19 7.42e-01 8.89e-01 0.102000 2.49e-03 -1.02e-01 9.85e-01 4.42e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 18 7.69e-01 9.03e-01 0.102000 -5.85e-02 -8.36e-02 6.68e-01 5.39e-01
GOMF CYCLIC NUCLEOTIDE PHOSPHODIESTERASE ACTIVITY 26 6.49e-01 8.44e-01 0.102000 -8.87e-02 5.03e-02 4.33e-01 6.57e-01
GOBP MANGANESE ION TRANSPORT 11 8.32e-01 9.30e-01 0.102000 5.11e-02 -8.83e-02 7.69e-01 6.12e-01
GOMF RECEPTOR ANTAGONIST ACTIVITY 16 7.90e-01 9.14e-01 0.102000 8.91e-02 4.96e-02 5.37e-01 7.31e-01
GOBP NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS 12 8.18e-01 9.27e-01 0.102000 -8.67e-02 5.36e-02 6.03e-01 7.48e-01
GOBP CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 160 7.13e-02 2.80e-01 0.102000 8.99e-02 -4.81e-02 4.98e-02 2.93e-01
GOBP NEGATIVE REGULATION OF LOCOMOTION 387 3.62e-03 3.69e-02 0.102000 9.25e-02 4.28e-02 1.79e-03 1.49e-01
GOCC ENDOSOME MEMBRANE 541 3.67e-04 6.11e-03 0.102000 9.72e-02 3.04e-02 1.10e-04 2.26e-01
GOBP ESTABLISHMENT OF LOCALIZATION IN CELL 1868 1.15e-12 1.39e-10 0.102000 1.00e-01 -1.95e-02 8.05e-13 1.63e-01
GOCC CYTOPLASMIC SIDE OF LYSOSOMAL MEMBRANE 13 8.05e-01 9.20e-01 0.102000 -8.38e-02 5.77e-02 6.01e-01 7.19e-01
GOMF NUCLEOSIDE DIPHOSPHATE KINASE ACTIVITY 18 7.42e-01 8.89e-01 0.102000 -8.90e-02 4.92e-02 5.13e-01 7.18e-01
GOBP REGULATION OF TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY 14 7.91e-01 9.15e-01 0.102000 6.50e-02 -7.82e-02 6.73e-01 6.12e-01
GOBP INTRACELLULAR PROTEIN TRANSMEMBRANE TRANSPORT 30 6.16e-01 8.26e-01 0.102000 2.65e-02 -9.82e-02 8.01e-01 3.52e-01
GOBP CELLULAR RESPONSE TO UV B 12 8.19e-01 9.27e-01 0.102000 -5.98e-02 8.23e-02 7.20e-01 6.22e-01
GOBP POSITIVE REGULATION OF CELL CYCLE PROCESS 258 1.61e-02 1.10e-01 0.102000 9.74e-02 -2.90e-02 7.06e-03 4.23e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 34 5.95e-01 8.13e-01 0.102000 -1.18e-02 -1.01e-01 9.05e-01 3.08e-01
GOBP ENDOPLASMIC RETICULUM TUBULAR NETWORK FORMATION 5 9.23e-01 9.71e-01 0.102000 1.00e-01 -1.75e-02 6.98e-01 9.46e-01
GOBP OXIDATIVE DEMETHYLATION 10 8.63e-01 9.43e-01 0.102000 -3.84e-02 -9.40e-02 8.34e-01 6.07e-01
GOBP REPLACEMENT OSSIFICATION 29 6.58e-01 8.50e-01 0.102000 8.18e-02 6.01e-02 4.46e-01 5.75e-01
GOMF KINASE ACTIVATOR ACTIVITY 137 1.04e-01 3.47e-01 0.102000 8.15e-02 -6.06e-02 9.96e-02 2.21e-01
GOBP UREA CYCLE 10 8.59e-01 9.42e-01 0.102000 1.01e-01 1.30e-02 5.81e-01 9.43e-01
GOMF HEAT SHOCK PROTEIN BINDING 126 1.26e-01 3.86e-01 0.101000 8.65e-02 -5.31e-02 9.36e-02 3.03e-01
GOBP CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 299 8.07e-03 6.75e-02 0.101000 9.35e-02 -3.94e-02 5.42e-03 2.41e-01
GOBP MAGNESIUM ION HOMEOSTASIS 11 8.51e-01 9.38e-01 0.101000 9.21e-02 4.24e-02 5.97e-01 8.08e-01
GOBP POSITIVE REGULATION OF HORMONE BIOSYNTHETIC PROCESS 9 8.75e-01 9.49e-01 0.101000 -3.22e-02 -9.61e-02 8.67e-01 6.18e-01
Polymerase switching on the C-strand of the telomere 25 6.61e-01 8.51e-01 0.101000 7.83e-02 -6.44e-02 4.98e-01 5.77e-01
GOBP CALCIUM ION IMPORT 80 2.90e-01 5.87e-01 0.101000 -1.01e-01 1.14e-03 1.17e-01 9.86e-01
GOBP POSITIVE REGULATION OF HEAT GENERATION 10 8.52e-01 9.38e-01 0.101000 -9.74e-02 2.79e-02 5.94e-01 8.79e-01
GOBP NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 31 6.15e-01 8.26e-01 0.101000 -1.01e-01 1.08e-02 3.32e-01 9.17e-01
GOBP N ACETYLGLUCOSAMINE METABOLIC PROCESS 16 7.73e-01 9.05e-01 0.101000 9.68e-02 -2.97e-02 5.03e-01 8.37e-01
GOBP NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 843 1.62e-06 5.77e-05 0.101000 8.54e-02 -5.41e-02 2.51e-05 7.68e-03
GOBP POSITIVE REGULATION OF POST TRANSLATIONAL PROTEIN MODIFICATION 120 1.40e-01 4.10e-01 0.101000 5.82e-02 -8.27e-02 2.71e-01 1.18e-01
GOBP NITROGEN COMPOUND TRANSPORT 1808 5.59e-12 6.02e-10 0.101000 1.01e-01 -8.91e-03 1.20e-12 5.30e-01
GOBP REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS 25 7.00e-01 8.70e-01 0.101000 -7.79e-02 -6.43e-02 5.00e-01 5.78e-01
GOBP REGULATION OF APOPTOTIC CELL CLEARANCE 10 8.57e-01 9.40e-01 0.101000 -1.01e-01 4.67e-03 5.81e-01 9.80e-01
Kinesins 59 3.95e-01 6.77e-01 0.101000 -9.93e-02 1.84e-02 1.87e-01 8.07e-01
GOCC ROUGH ENDOPLASMIC RETICULUM 56 4.11e-01 6.92e-01 0.101000 2.59e-02 -9.76e-02 7.38e-01 2.06e-01
GOCC SPECIFIC GRANULE 155 8.09e-02 3.02e-01 0.101000 -4.99e-02 8.78e-02 2.84e-01 5.93e-02
GOBP REGULATION OF OPSIN MEDIATED SIGNALING PATHWAY 9 8.79e-01 9.50e-01 0.101000 -8.76e-02 -5.00e-02 6.49e-01 7.95e-01
GOBP POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS 8 8.79e-01 9.50e-01 0.101000 -3.92e-02 9.29e-02 8.48e-01 6.49e-01
GOBP REGULATION OF PROTEIN LOCALIZATION TO CHROMATIN 9 8.64e-01 9.43e-01 0.101000 4.80e-02 -8.87e-02 8.03e-01 6.45e-01
Resolution of Abasic Sites (AP sites) 38 5.74e-01 7.99e-01 0.101000 9.55e-02 3.23e-02 3.08e-01 7.30e-01
Mitochondrial biogenesis 88 2.37e-01 5.33e-01 0.101000 7.34e-02 -6.90e-02 2.34e-01 2.63e-01
GOBP HYPOTHALAMUS GONADOTROPHIN RELEASING HORMONE NEURON DIFFERENTIATION 7 8.97e-01 9.59e-01 0.101000 1.00e-01 -8.61e-03 6.46e-01 9.69e-01
GOBP MYELOID DENDRITIC CELL ACTIVATION 29 6.37e-01 8.38e-01 0.101000 1.33e-02 -9.99e-02 9.02e-01 3.52e-01
Killing mechanisms 11 8.35e-01 9.31e-01 0.101000 -6.74e-02 7.49e-02 6.99e-01 6.67e-01
WNT5:FZD7-mediated leishmania damping 11 8.35e-01 9.31e-01 0.101000 -6.74e-02 7.49e-02 6.99e-01 6.67e-01
GOBP SHORT CHAIN FATTY ACID METABOLIC PROCESS 16 7.82e-01 9.10e-01 0.101000 -1.01e-01 2.28e-03 4.86e-01 9.87e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON CH OH GROUP OF DONORS 130 1.21e-01 3.79e-01 0.101000 5.66e-02 -8.33e-02 2.65e-01 1.01e-01
GOBP INNER EAR RECEPTOR CELL DEVELOPMENT 47 4.70e-01 7.31e-01 0.101000 -9.24e-02 4.00e-02 2.73e-01 6.36e-01
GOBP SUPRAMOLECULAR FIBER ORGANIZATION 821 1.27e-05 3.55e-04 0.101000 8.47e-02 5.43e-02 3.69e-05 8.16e-03
EPH-ephrin mediated repulsion of cells 50 4.93e-01 7.50e-01 0.101000 7.83e-02 6.32e-02 3.38e-01 4.40e-01
RUNX1 regulates transcription of genes involved in differentiation of keratinocytes 8 8.77e-01 9.50e-01 0.101000 -6.12e-02 7.99e-02 7.64e-01 6.96e-01
Activation of NMDA receptors and postsynaptic events 86 2.48e-01 5.45e-01 0.101000 -5.25e-02 8.58e-02 4.00e-01 1.69e-01
GOBP MEMBRANE REPOLARIZATION 53 4.64e-01 7.27e-01 0.101000 9.45e-02 3.43e-02 2.34e-01 6.66e-01
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE 150 1.16e-01 3.70e-01 0.101000 -9.29e-02 -3.86e-02 4.96e-02 4.15e-01
GOBP GLUCAN METABOLIC PROCESS 81 3.14e-01 6.07e-01 0.101000 9.06e-02 4.36e-02 1.59e-01 4.97e-01
GOMF G PROTEIN COUPLED CHEMOATTRACTANT RECEPTOR ACTIVITY 25 6.92e-01 8.67e-01 0.101000 -9.76e-02 -2.42e-02 3.98e-01 8.34e-01
Polo-like kinase mediated events 16 7.82e-01 9.10e-01 0.100000 1.00e-01 -5.40e-03 4.87e-01 9.70e-01
GOBP REGULATION OF MEMBRANE REPOLARIZATION 38 5.78e-01 8.02e-01 0.100000 9.28e-02 3.84e-02 3.22e-01 6.82e-01
GOMF METAL CATION MONOATOMIC CATION ANTIPORTER ACTIVITY 39 5.38e-01 7.77e-01 0.100000 -9.46e-02 3.38e-02 3.07e-01 7.15e-01
GOBP LATERAL MESODERM DEVELOPMENT 16 7.86e-01 9.12e-01 0.100000 1.00e-01 6.55e-03 4.88e-01 9.64e-01
GOCC CUL4A RING E3 UBIQUITIN LIGASE COMPLEX 13 8.09e-01 9.22e-01 0.100000 6.83e-02 -7.37e-02 6.70e-01 6.46e-01
GOMF PROTEIN SERINE THREONINE KINASE ACTIVATOR ACTIVITY 67 3.37e-01 6.26e-01 0.100000 7.90e-02 -6.20e-02 2.63e-01 3.80e-01
GOCC PIGMENT GRANULE 109 1.85e-01 4.75e-01 0.100000 -1.62e-02 9.91e-02 7.70e-01 7.39e-02
GOBP NEGATIVE ADAPTATION OF SIGNALING PATHWAY 16 7.90e-01 9.14e-01 0.100000 -9.85e-02 -1.91e-02 4.95e-01 8.95e-01
GOBP NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT 35 6.03e-01 8.17e-01 0.100000 3.43e-02 9.43e-02 7.26e-01 3.34e-01
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane 20 7.46e-01 8.91e-01 0.100000 -2.36e-02 -9.75e-02 8.55e-01 4.50e-01
GOMF TESTOSTERONE DEHYDROGENASE NAD P ACTIVITY 10 8.53e-01 9.39e-01 0.100000 -9.31e-02 3.73e-02 6.10e-01 8.38e-01
GOMF SODIUM INDEPENDENT ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 16 7.76e-01 9.07e-01 0.100000 -3.13e-02 9.53e-02 8.28e-01 5.09e-01
GOBP STARTLE RESPONSE 27 6.83e-01 8.63e-01 0.100000 8.34e-02 5.57e-02 4.53e-01 6.16e-01
GOBP POSITIVE REGULATION OF SYNAPSE ASSEMBLY 57 4.22e-01 7.01e-01 0.100000 1.00e-01 -4.97e-04 1.90e-01 9.95e-01
GOMF METALLOENDOPEPTIDASE INHIBITOR ACTIVITY 13 8.24e-01 9.28e-01 0.100000 -9.96e-02 -1.18e-02 5.34e-01 9.41e-01
GOBP NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 65 3.55e-01 6.45e-01 0.100000 9.18e-02 -4.03e-02 2.01e-01 5.75e-01
GOBP GLUTATHIONE TRANSMEMBRANE TRANSPORT 8 8.94e-01 9.58e-01 0.100000 6.86e-02 7.30e-02 7.37e-01 7.21e-01
GOBP PONS DEVELOPMENT 11 8.56e-01 9.40e-01 0.100000 8.68e-02 5.01e-02 6.18e-01 7.74e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL 40 5.29e-01 7.71e-01 0.100000 9.18e-02 -4.02e-02 3.15e-01 6.60e-01
Muscle contraction 196 4.68e-02 2.17e-01 0.100000 -2.93e-02 9.58e-02 4.79e-01 2.07e-02
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 28 6.67e-01 8.53e-01 0.100000 3.20e-02 9.49e-02 7.69e-01 3.85e-01
GOBP REGULATION OF GLIAL CELL MIGRATION 19 7.53e-01 8.93e-01 0.100000 -7.26e-03 -9.99e-02 9.56e-01 4.51e-01
Ras activation upon Ca2+ influx through NMDA receptor 19 7.51e-01 8.93e-01 0.100000 1.00e-01 2.64e-03 4.50e-01 9.84e-01
GOCC CELL PROJECTION MEMBRANE 340 9.20e-03 7.41e-02 0.100000 7.64e-02 6.46e-02 1.55e-02 4.06e-02
Glycogen metabolism 22 7.24e-01 8.81e-01 0.100000 9.87e-02 1.63e-02 4.23e-01 8.94e-01
GOMF CHLORIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 110 1.70e-01 4.55e-01 0.100000 -7.09e-02 7.06e-02 1.99e-01 2.01e-01
GOBP VESICLE LOCALIZATION 209 4.29e-02 2.06e-01 0.100000 9.98e-02 -6.32e-03 1.29e-02 8.75e-01
GOBP NEGATIVE REGULATION OF MRNA PROCESSING 20 7.52e-01 8.93e-01 0.099900 9.15e-02 4.03e-02 4.79e-01 7.55e-01
GOBP PEPTIDYL L CYSTEINE S PALMITOYLATION 20 7.56e-01 8.95e-01 0.099900 5.68e-02 8.22e-02 6.60e-01 5.24e-01
GOBP RESPONSE TO AMINE 50 4.88e-01 7.46e-01 0.099900 9.45e-02 3.24e-02 2.48e-01 6.92e-01
GOBP POSITIVE REGULATION OF RECEPTOR INTERNALIZATION 25 6.69e-01 8.55e-01 0.099800 7.67e-02 -6.39e-02 5.07e-01 5.80e-01
GOBP REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION 12 8.26e-01 9.28e-01 0.099800 8.74e-02 -4.82e-02 6.00e-01 7.72e-01
GOBP REGULATION OF CHAPERONE MEDIATED AUTOPHAGY 8 8.93e-01 9.57e-01 0.099800 4.26e-02 9.03e-02 8.35e-01 6.58e-01
GOMF GENERAL TRANSCRIPTION INITIATION FACTOR ACTIVITY 49 4.58e-01 7.23e-01 0.099800 8.58e-02 -5.10e-02 2.99e-01 5.37e-01
GOBP THYROID HORMONE GENERATION 22 7.35e-01 8.86e-01 0.099800 8.14e-02 5.77e-02 5.09e-01 6.39e-01
GOBP NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS 115 1.95e-01 4.87e-01 0.099800 9.37e-02 3.43e-02 8.25e-02 5.25e-01
GOMF KETOSTEROID MONOOXYGENASE ACTIVITY 5 9.23e-01 9.71e-01 0.099800 5.99e-02 -7.99e-02 8.17e-01 7.57e-01
GOMF PROTEIN TYROSINE KINASE ACTIVATOR ACTIVITY 31 6.31e-01 8.34e-01 0.099800 -6.41e-03 -9.96e-02 9.51e-01 3.37e-01
GOBP POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 1079 2.27e-07 1.05e-05 0.099700 9.96e-02 4.01e-03 3.23e-08 8.24e-01
GOBP REGULATION OF LIPID STORAGE 54 4.64e-01 7.27e-01 0.099700 9.33e-02 3.52e-02 2.36e-01 6.55e-01
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION 8 8.95e-01 9.58e-01 0.099600 7.76e-02 6.26e-02 7.04e-01 7.59e-01
GOBP POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION 13 8.12e-01 9.24e-01 0.099600 7.30e-02 -6.78e-02 6.49e-01 6.72e-01
GOBP REGULATION OF MICROTUBULE BINDING 7 8.99e-01 9.61e-01 0.099600 9.92e-02 -8.86e-03 6.50e-01 9.68e-01
GOBP RESPONSE TO THYROID HORMONE 24 7.17e-01 8.78e-01 0.099500 5.92e-02 8.00e-02 6.15e-01 4.98e-01
GOMF CYTOSKELETAL PROTEIN BINDING 946 2.28e-06 7.81e-05 0.099500 9.54e-02 2.83e-02 6.57e-07 1.40e-01
GOMF 5 3 EXONUCLEASE ACTIVITY 18 7.74e-01 9.05e-01 0.099500 9.43e-02 3.17e-02 4.89e-01 8.16e-01
GOMF SECONDARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 277 1.48e-02 1.04e-01 0.099400 -2.34e-02 9.66e-02 5.03e-01 5.64e-03
Anchoring of the basal body to the plasma membrane 92 2.40e-01 5.36e-01 0.099400 9.33e-02 -3.41e-02 1.22e-01 5.72e-01
GOBP POSITIVE REGULATION OF NEUTROPHIL MIGRATION 30 6.48e-01 8.44e-01 0.099300 -9.76e-02 -1.84e-02 3.55e-01 8.61e-01
GOBP ORGANIC ACID TRANSMEMBRANE TRANSPORT 141 1.43e-01 4.15e-01 0.099300 8.39e-02 5.33e-02 8.56e-02 2.75e-01
GOCC CULLIN RING UBIQUITIN LIGASE COMPLEX 177 6.23e-02 2.58e-01 0.099300 8.67e-02 -4.85e-02 4.67e-02 2.66e-01
GOBP REGULATION OF PROTEOLYSIS 565 1.70e-04 3.33e-03 0.099300 8.84e-02 -4.52e-02 3.25e-04 6.63e-02
Regulation of pyruvate metabolism 31 6.23e-01 8.30e-01 0.099300 -2.07e-02 9.71e-02 8.42e-01 3.49e-01
GOBP SODIUM DEPENDENT PHOSPHATE TRANSPORT 12 8.26e-01 9.28e-01 0.099200 6.14e-02 -7.80e-02 7.13e-01 6.40e-01
GOBP RESPONSE TO GLUCAGON 20 7.35e-01 8.86e-01 0.099200 2.68e-02 -9.55e-02 8.35e-01 4.60e-01
GOBP REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION 22 7.31e-01 8.84e-01 0.099200 9.55e-02 2.69e-02 4.38e-01 8.27e-01
GOBP VESTIBULOCOCHLEAR NERVE FORMATION 5 9.30e-01 9.74e-01 0.099200 9.85e-02 1.14e-02 7.03e-01 9.65e-01
GOBP POSITIVE REGULATION OF PROTEIN BINDING 49 4.69e-01 7.30e-01 0.099100 9.39e-02 -3.17e-02 2.55e-01 7.01e-01
GOBP CRANIOFACIAL SUTURE MORPHOGENESIS 19 7.61e-01 8.98e-01 0.099100 9.72e-02 1.94e-02 4.63e-01 8.84e-01
GOBP POSITIVE REGULATION OF BINDING 104 2.17e-01 5.12e-01 0.099100 9.91e-02 1.87e-03 8.08e-02 9.74e-01
GOBP BIOGENIC AMINE METABOLIC PROCESS 86 2.76e-01 5.74e-01 0.099000 -1.09e-02 9.84e-02 8.61e-01 1.15e-01
SARS-CoV-2 activates/modulates innate and adaptive immune responses 118 1.63e-01 4.47e-01 0.099000 3.30e-02 -9.33e-02 5.36e-01 7.99e-02
GOBP ERK1 AND ERK2 CASCADE 314 1.07e-02 8.26e-02 0.099000 9.89e-02 5.03e-03 2.59e-03 8.78e-01
GOBP PROSTATE GLAND GROWTH 10 8.62e-01 9.43e-01 0.099000 4.34e-03 -9.89e-02 9.81e-01 5.88e-01
Erythropoietin activates Phosphoinositide-3-kinase (PI3K) 12 8.48e-01 9.36e-01 0.098900 8.34e-02 5.33e-02 6.17e-01 7.49e-01
GOMF CHONDROITIN SULFOTRANSFERASE ACTIVITY 5 9.28e-01 9.73e-01 0.098900 1.11e-02 -9.83e-02 9.66e-01 7.03e-01
Arachidonate metabolism 57 4.50e-01 7.19e-01 0.098900 -3.55e-02 -9.23e-02 6.43e-01 2.28e-01
Cobalamin (Cbl) metabolism 7 8.95e-01 9.58e-01 0.098900 7.76e-02 -6.13e-02 7.22e-01 7.79e-01
GOCC MULTIVESICULAR BODY MEMBRANE 28 6.81e-01 8.62e-01 0.098900 -5.69e-02 -8.09e-02 6.03e-01 4.58e-01
GOMF PENTOSYLTRANSFERASE ACTIVITY 53 4.49e-01 7.18e-01 0.098900 9.71e-02 -1.87e-02 2.21e-01 8.13e-01
GOBP REGULATION OF SYNAPTIC PLASTICITY 210 5.25e-02 2.33e-01 0.098900 9.50e-02 2.73e-02 1.76e-02 4.95e-01
GOCC MHC CLASS I PEPTIDE LOADING COMPLEX 8 8.87e-01 9.55e-01 0.098900 1.42e-02 -9.78e-02 9.44e-01 6.32e-01
SLC transporter disorders 94 2.38e-01 5.34e-01 0.098800 -2.95e-02 9.43e-02 6.21e-01 1.14e-01
GOBP POLYSACCHARIDE METABOLIC PROCESS 104 2.35e-01 5.32e-01 0.098800 9.21e-02 3.57e-02 1.04e-01 5.30e-01
TP53 Regulates Transcription of DNA Repair Genes 61 3.84e-01 6.69e-01 0.098800 5.58e-02 -8.15e-02 4.51e-01 2.71e-01
GOBP NEGATIVE REGULATION OF LIPASE ACTIVITY 13 8.38e-01 9.32e-01 0.098800 6.55e-02 7.40e-02 6.83e-01 6.44e-01
GOMF POLY A RNA POLYMERASE ACTIVITY 11 8.54e-01 9.40e-01 0.098700 9.72e-02 1.71e-02 5.77e-01 9.22e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPIRATION 9 8.74e-01 9.48e-01 0.098600 -9.78e-02 1.29e-02 6.11e-01 9.47e-01
GOBP RESPONSE TO INTERLEUKIN 4 34 5.97e-01 8.14e-01 0.098600 2.62e-02 -9.51e-02 7.91e-01 3.37e-01
GOBP CELL PROJECTION ORGANIZATION 1566 8.86e-10 6.56e-08 0.098500 9.74e-02 1.48e-02 1.22e-10 3.28e-01
GOBP DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS 11 8.44e-01 9.36e-01 0.098500 -3.69e-02 9.13e-02 8.32e-01 6.00e-01
GOBP MIRNA MEDIATED GENE SILENCING BY INHIBITION OF TRANSLATION 94 2.49e-01 5.46e-01 0.098500 -1.09e-02 9.79e-02 8.55e-01 1.01e-01
GOMF S ACYLTRANSFERASE ACTIVITY 27 6.92e-01 8.67e-01 0.098500 8.25e-02 5.38e-02 4.58e-01 6.29e-01
GOBP REGULATION OF EPITHELIAL CELL MIGRATION 287 1.66e-02 1.12e-01 0.098400 9.82e-02 6.26e-03 4.19e-03 8.55e-01
GOBP REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 168 8.30e-02 3.08e-01 0.098400 9.72e-02 -1.55e-02 2.98e-02 7.29e-01
GOBP RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM 37 6.07e-01 8.20e-01 0.098400 -7.57e-02 -6.28e-02 4.26e-01 5.08e-01
GOBP SPERM AXONEME ASSEMBLY 31 6.58e-01 8.50e-01 0.098300 -7.42e-02 -6.46e-02 4.75e-01 5.34e-01
GOBP POLYOL TRANSMEMBRANE TRANSPORT 10 8.73e-01 9.48e-01 0.098300 5.25e-02 8.31e-02 7.74e-01 6.49e-01
GOBP CELLULAR RESPONSE TO ALCOHOL 102 2.35e-01 5.32e-01 0.098300 9.73e-02 1.40e-02 8.96e-02 8.07e-01
GOMF TAU PROTEIN BINDING 42 5.33e-01 7.73e-01 0.098300 9.61e-02 -2.04e-02 2.81e-01 8.19e-01
GOBP REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 140 1.14e-01 3.66e-01 0.098300 7.45e-02 -6.40e-02 1.28e-01 1.91e-01
GOCC CENTRIOLAR SATELLITE 116 2.00e-01 4.93e-01 0.098300 9.36e-02 2.98e-02 8.15e-02 5.79e-01
GOBP REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 102 2.05e-01 4.99e-01 0.098200 7.56e-02 -6.28e-02 1.87e-01 2.73e-01
GOBP FERTILIZATION 197 6.28e-02 2.59e-01 0.098200 -9.67e-02 -1.74e-02 1.93e-02 6.74e-01
GOBP REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 255 2.24e-02 1.37e-01 0.098200 9.47e-02 -2.60e-02 9.24e-03 4.75e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL 28 6.76e-01 8.59e-01 0.098100 2.50e-02 9.49e-02 8.19e-01 3.85e-01
GOMF ATP HYDROLYSIS ACTIVITY 404 3.68e-03 3.72e-02 0.098100 9.65e-02 1.79e-02 8.77e-04 5.37e-01
GOBP POSITIVE REGULATION OF TRANSLATIONAL INITIATION 22 7.34e-01 8.85e-01 0.098100 9.57e-02 2.17e-02 4.37e-01 8.60e-01
GOBP SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS 15 8.16e-01 9.25e-01 0.098100 8.52e-02 4.85e-02 5.68e-01 7.45e-01
GOBP POSITIVE REGULATION OF PROTEIN UBIQUITINATION 97 2.31e-01 5.29e-01 0.098100 3.20e-02 -9.27e-02 5.86e-01 1.15e-01
TNFs bind their physiological receptors 25 7.04e-01 8.72e-01 0.098000 9.58e-02 2.04e-02 4.07e-01 8.60e-01
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION 16 7.81e-01 9.10e-01 0.098000 -5.80e-02 7.90e-02 6.88e-01 5.84e-01
GOBP PRIMARY ALCOHOL METABOLIC PROCESS 96 2.72e-01 5.70e-01 0.098000 8.69e-02 4.52e-02 1.41e-01 4.44e-01
GOBP BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS 51 4.96e-01 7.52e-01 0.098000 9.18e-02 3.42e-02 2.57e-01 6.73e-01
GOBP CHEMOREPULSION OF AXON 6 9.12e-01 9.67e-01 0.097900 8.28e-02 -5.23e-02 7.25e-01 8.25e-01
GOBP PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 111 1.85e-01 4.76e-01 0.097900 -4.13e-02 8.87e-02 4.53e-01 1.06e-01
GOBP REGULATION OF MUSCLE SYSTEM PROCESS 244 3.49e-02 1.83e-01 0.097900 9.44e-02 2.59e-02 1.11e-02 4.86e-01
GOCC MICROVILLUS 97 2.44e-01 5.40e-01 0.097900 -8.27e-03 9.75e-02 8.88e-01 9.70e-02
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS 30 6.34e-01 8.36e-01 0.097800 8.93e-02 -3.99e-02 3.97e-01 7.05e-01
GOBP PHAGOSOME MATURATION 28 6.83e-01 8.62e-01 0.097800 8.96e-02 3.92e-02 4.12e-01 7.20e-01
MTOR signalling 40 5.60e-01 7.91e-01 0.097700 9.75e-02 -6.09e-03 2.86e-01 9.47e-01
GOBP RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN 151 9.86e-02 3.37e-01 0.097700 6.58e-02 -7.22e-02 1.63e-01 1.26e-01
Post NMDA receptor activation events 75 3.25e-01 6.16e-01 0.097600 -3.32e-02 9.18e-02 6.19e-01 1.69e-01
GOBP FAT CELL DIFFERENTIATION 244 3.25e-02 1.75e-01 0.097500 9.73e-02 7.15e-03 8.86e-03 8.47e-01
Phase II - Conjugation of compounds 103 2.13e-01 5.08e-01 0.097500 8.98e-02 -3.81e-02 1.15e-01 5.04e-01
GOBP POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE 198 5.43e-02 2.38e-01 0.097500 9.43e-02 -2.47e-02 2.21e-02 5.49e-01
Mitochondrial Fatty Acid Beta-Oxidation 36 6.00e-01 8.16e-01 0.097400 9.73e-02 4.58e-03 3.12e-01 9.62e-01
GOCC DYSTROPHIN ASSOCIATED GLYCOPROTEIN COMPLEX 17 7.72e-01 9.05e-01 0.097400 -8.37e-02 4.98e-02 5.50e-01 7.22e-01
Protein folding 95 2.40e-01 5.36e-01 0.097400 4.12e-02 -8.82e-02 4.88e-01 1.37e-01
GOBP LOCALIZATION WITHIN MEMBRANE 653 1.58e-04 3.14e-03 0.097400 9.45e-02 2.33e-02 3.76e-05 3.09e-01
GOBP PROGRAMMED NECROTIC CELL DEATH 57 4.19e-01 6.99e-01 0.097400 5.85e-02 -7.78e-02 4.45e-01 3.09e-01
GOBP NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 71 3.38e-01 6.27e-01 0.097300 6.94e-02 -6.82e-02 3.12e-01 3.20e-01
GOMF PROTEIN KINASE A BINDING 50 5.12e-01 7.61e-01 0.097300 8.58e-02 4.59e-02 2.94e-01 5.75e-01
GOBP TRACHEA FORMATION 7 9.10e-01 9.66e-01 0.097300 8.82e-02 4.10e-02 6.86e-01 8.51e-01
GOBP SEX DIFFERENTIATION 268 2.02e-02 1.27e-01 0.097200 9.44e-02 -2.33e-02 7.81e-03 5.12e-01
GOMF THIOESTERASE BINDING 9 8.87e-01 9.55e-01 0.097200 -5.22e-02 -8.20e-02 7.86e-01 6.70e-01
GOBP GLYCINE TRANSPORT 14 8.14e-01 9.25e-01 0.097200 -2.11e-02 9.49e-02 8.91e-01 5.39e-01
GOBP REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 72 3.36e-01 6.26e-01 0.097200 8.13e-02 -5.32e-02 2.33e-01 4.35e-01
GOBP RESPONSE TO REDOX STATE 14 8.11e-01 9.23e-01 0.097200 9.03e-02 -3.58e-02 5.58e-01 8.17e-01
GOBP POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION 114 1.93e-01 4.85e-01 0.097100 9.63e-02 -1.29e-02 7.58e-02 8.12e-01
GOBP PHOSPHATIDYLCHOLINE METABOLIC PROCESS 74 3.31e-01 6.22e-01 0.097100 8.88e-02 -3.91e-02 1.86e-01 5.61e-01
Regulation of T cell activation by CD28 family 69 3.61e-01 6.49e-01 0.097000 9.22e-02 -3.03e-02 1.86e-01 6.63e-01
GOCC BASEMENT MEMBRANE 87 3.13e-01 6.07e-01 0.097000 4.13e-02 8.78e-02 5.05e-01 1.57e-01
GOBP ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS 311 9.38e-03 7.51e-02 0.097000 6.97e-02 -6.75e-02 3.46e-02 4.07e-02
GOMF FATTY ACID ELONGASE ACTIVITY 7 9.01e-01 9.61e-01 0.097000 9.14e-02 -3.25e-02 6.75e-01 8.82e-01
GOBP REGULATION OF CHONDROCYTE DIFFERENTIATION 52 4.54e-01 7.21e-01 0.097000 -7.01e-02 6.70e-02 3.82e-01 4.03e-01
GOBP METANEPHRIC NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION 6 9.19e-01 9.69e-01 0.097000 9.67e-02 6.74e-03 6.82e-01 9.77e-01
GPER1 signaling 45 5.55e-01 7.88e-01 0.096800 6.65e-02 7.04e-02 4.40e-01 4.14e-01
GOBP CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT 24 7.14e-01 8.77e-01 0.096800 -9.67e-02 -4.84e-03 4.12e-01 9.67e-01
Interleukin-1 family signaling 134 1.45e-01 4.18e-01 0.096800 9.50e-02 -1.86e-02 5.76e-02 7.10e-01
GOBP REGULATION OF GLIAL CELL DIFFERENTIATION 78 3.61e-01 6.49e-01 0.096700 7.47e-02 6.15e-02 2.54e-01 3.48e-01
GOBP AMMONIUM ION METABOLIC PROCESS 22 7.36e-01 8.86e-01 0.096700 6.94e-03 9.65e-02 9.55e-01 4.34e-01
GOBP SULFUR COMPOUND METABOLIC PROCESS 301 1.94e-02 1.24e-01 0.096700 8.70e-02 4.21e-02 9.38e-03 2.09e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 90 2.77e-01 5.74e-01 0.096700 1.17e-02 -9.59e-02 8.47e-01 1.16e-01
GOBP BEHAVIOR 636 1.81e-04 3.48e-03 0.096600 9.64e-02 6.18e-03 3.30e-05 7.90e-01
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS I PROTEIN COMPLEX 6 9.13e-01 9.67e-01 0.096600 6.00e-02 -7.57e-02 7.99e-01 7.48e-01
GOBP POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 26 6.81e-01 8.62e-01 0.096600 8.90e-02 -3.76e-02 4.32e-01 7.40e-01
GOMF SUPEROXIDE GENERATING NADPH OXIDASE ACTIVATOR ACTIVITY 7 9.08e-01 9.64e-01 0.096600 9.61e-02 1.03e-02 6.60e-01 9.62e-01
GOBP REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 56 4.78e-01 7.37e-01 0.096600 -8.55e-02 -4.49e-02 2.69e-01 5.61e-01
GOBP NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 61 4.04e-01 6.87e-01 0.096600 4.33e-02 -8.63e-02 5.59e-01 2.44e-01
GOBP LIPOPROTEIN BIOSYNTHETIC PROCESS 95 2.43e-01 5.39e-01 0.096600 5.00e-02 -8.26e-02 4.00e-01 1.64e-01
GOBP MYELOID CELL DEVELOPMENT 84 2.98e-01 5.94e-01 0.096600 9.47e-02 -1.87e-02 1.33e-01 7.68e-01
GOCC CHECKPOINT CLAMP COMPLEX 5 9.37e-01 9.76e-01 0.096500 -6.87e-02 -6.78e-02 7.90e-01 7.93e-01
GOBP MODIFICATION OF POSTSYNAPTIC STRUCTURE 22 7.18e-01 8.79e-01 0.096500 7.30e-02 -6.32e-02 5.53e-01 6.08e-01
GOBP CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 73 3.84e-01 6.68e-01 0.096500 4.82e-02 8.36e-02 4.77e-01 2.17e-01
GOBP REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS 30 6.37e-01 8.38e-01 0.096500 7.64e-02 -5.89e-02 4.69e-01 5.77e-01
Neurotransmitter receptors and postsynaptic signal transmission 192 5.81e-02 2.47e-01 0.096500 -4.96e-02 8.27e-02 2.36e-01 4.80e-02
GOCC CYTOPLASMIC SIDE OF MEMBRANE 195 7.03e-02 2.78e-01 0.096500 9.54e-02 1.43e-02 2.16e-02 7.30e-01
GOBP RRNA PSEUDOURIDINE SYNTHESIS 7 9.09e-01 9.65e-01 0.096500 -2.00e-02 -9.44e-02 9.27e-01 6.65e-01
GOMF EPHRIN RECEPTOR BINDING 26 6.99e-01 8.70e-01 0.096500 9.59e-02 1.04e-02 3.97e-01 9.27e-01
GOCC NEURON PROJECTION TERMINUS 122 2.07e-01 5.01e-01 0.096500 6.77e-02 6.87e-02 1.97e-01 1.90e-01
GOBP LATE ENDOSOME TO LYSOSOME TRANSPORT 21 7.61e-01 8.98e-01 0.096500 -7.63e-02 -5.90e-02 5.45e-01 6.40e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION 111 1.91e-01 4.82e-01 0.096400 5.67e-02 -7.80e-02 3.02e-01 1.56e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE 20 7.62e-01 8.99e-01 0.096400 2.00e-02 9.44e-02 8.77e-01 4.65e-01
GOBP GLUTATHIONE TRANSPORT 10 8.65e-01 9.43e-01 0.096400 9.27e-02 -2.64e-02 6.12e-01 8.85e-01
GOBP CARDIAC MUSCLE CELL ACTION POTENTIAL 81 2.97e-01 5.94e-01 0.096400 -6.54e-02 7.08e-02 3.09e-01 2.71e-01
GOBP PROTEIN DEPOLYMERIZATION 114 2.01e-01 4.94e-01 0.096300 9.60e-02 -7.97e-03 7.66e-02 8.83e-01
GOBP ENDONUCLEOLYTIC CLEAVAGE IN 5 ETS OF TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA 7 9.12e-01 9.67e-01 0.096300 4.00e-02 8.76e-02 8.54e-01 6.88e-01
GOBP PEPTIDYL SERINE MODIFICATION 268 2.85e-02 1.62e-01 0.096300 9.25e-02 2.66e-02 9.11e-03 4.53e-01
GOBP BODY FLUID SECRETION 89 2.79e-01 5.76e-01 0.096300 9.41e-02 -2.06e-02 1.25e-01 7.37e-01
Elastic fibre formation 44 5.65e-01 7.94e-01 0.096300 5.48e-02 7.91e-02 5.29e-01 3.64e-01
GOBP REGULATION OF CDC42 PROTEIN SIGNAL TRANSDUCTION 8 8.87e-01 9.55e-01 0.096300 7.04e-02 -6.57e-02 7.30e-01 7.48e-01
Interleukin-4 and Interleukin-13 signaling 103 2.51e-01 5.48e-01 0.096200 -2.38e-02 -9.32e-02 6.76e-01 1.02e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON SINGLE DONORS WITH INCORPORATION OF MOLECULAR OXYGEN 24 7.05e-01 8.72e-01 0.096200 9.08e-02 -3.18e-02 4.41e-01 7.87e-01
HIV Life Cycle 145 1.18e-01 3.74e-01 0.096200 4.75e-02 -8.37e-02 3.23e-01 8.20e-02
GOBP MONOCYTE CHEMOTAXIS 50 5.24e-01 7.66e-01 0.096100 -5.97e-02 -7.54e-02 4.66e-01 3.57e-01
GOMF PEPTIDASE ACTIVATOR ACTIVITY 57 4.30e-01 7.06e-01 0.096100 8.09e-02 -5.19e-02 2.91e-01 4.98e-01
GOBP POSITIVE REGULATION OF PHOSPHATASE ACTIVITY 25 7.02e-01 8.71e-01 0.096100 9.56e-02 -1.00e-02 4.08e-01 9.31e-01
GOBP EPITHELIAL MESENCHYMAL CELL SIGNALING 5 9.33e-01 9.75e-01 0.096100 -3.68e-03 -9.60e-02 9.89e-01 7.10e-01
GOBP B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 83 2.97e-01 5.94e-01 0.096100 8.81e-02 -3.84e-02 1.65e-01 5.45e-01
GOBP REGULATION OF VIRAL PROCESS 164 9.87e-02 3.37e-01 0.096100 9.49e-02 -1.50e-02 3.60e-02 7.41e-01
GOBP CYTOKINESIS 179 7.38e-02 2.86e-01 0.096000 8.74e-02 -3.99e-02 4.37e-02 3.58e-01
GOMF CELL CELL ADHESION MEDIATOR ACTIVITY 51 4.74e-01 7.34e-01 0.096000 -8.80e-02 3.84e-02 2.77e-01 6.35e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION 463 2.20e-03 2.54e-02 0.096000 9.41e-02 1.89e-02 5.19e-04 4.86e-01
GOBP REGULATION OF SYNAPTIC ASSEMBLY AT NEUROMUSCULAR JUNCTION 6 9.23e-01 9.71e-01 0.096000 2.34e-02 9.31e-02 9.21e-01 6.93e-01
GOBP POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS 251 3.37e-02 1.78e-01 0.096000 -1.10e-02 -9.53e-02 7.65e-01 9.28e-03
Heparan sulfate/heparin (HS-GAG) metabolism 53 4.97e-01 7.52e-01 0.095900 9.02e-02 3.28e-02 2.56e-01 6.80e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 14 8.33e-01 9.30e-01 0.095900 4.37e-02 8.54e-02 7.77e-01 5.80e-01
GOBP REGULATION OF ASTROCYTE DIFFERENTIATION 31 6.45e-01 8.42e-01 0.095900 -1.31e-02 9.50e-02 9.00e-01 3.60e-01
GOMF DNA INSERTION OR DELETION BINDING 6 9.22e-01 9.70e-01 0.095900 -1.59e-02 -9.46e-02 9.46e-01 6.88e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION CHOLINERGIC 8 9.02e-01 9.61e-01 0.095900 5.60e-02 7.79e-02 7.84e-01 7.03e-01
Activation of G protein gated Potassium channels 29 6.50e-01 8.45e-01 0.095900 -6.58e-02 6.97e-02 5.40e-01 5.16e-01
G protein gated Potassium channels 29 6.50e-01 8.45e-01 0.095900 -6.58e-02 6.97e-02 5.40e-01 5.16e-01
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits 29 6.50e-01 8.45e-01 0.095900 -6.58e-02 6.97e-02 5.40e-01 5.16e-01
GOBP REGULATION OF IMMUNOGLOBULIN PRODUCTION 70 3.55e-01 6.44e-01 0.095900 6.16e-02 -7.34e-02 3.73e-01 2.88e-01
GOMF PRERIBOSOME BINDING 8 8.90e-01 9.56e-01 0.095800 3.62e-02 -8.88e-02 8.59e-01 6.64e-01
GOBP EXTRACELLULAR MATRIX DISASSEMBLY 62 3.99e-01 6.81e-01 0.095800 -7.20e-02 6.32e-02 3.27e-01 3.89e-01
GOBP REGULATION OF SYSTEM PROCESS 552 9.96e-04 1.37e-02 0.095800 7.21e-02 6.31e-02 3.77e-03 1.12e-02
GOBP NEURON GLIAL CELL SIGNALING 5 9.28e-01 9.73e-01 0.095800 -6.89e-02 6.66e-02 7.89e-01 7.97e-01
GOBP T CELL MEDIATED IMMUNITY 126 1.97e-01 4.90e-01 0.095800 -4.85e-02 -8.26e-02 3.47e-01 1.09e-01
GOMF PHOSPHOLIPASE D ACTIVITY 6 9.17e-01 9.69e-01 0.095800 -2.81e-02 9.16e-02 9.05e-01 6.98e-01
Aryl hydrocarbon receptor signalling 7 9.13e-01 9.67e-01 0.095800 -4.36e-02 -8.53e-02 8.42e-01 6.96e-01
GOMF RDNA BINDING 9 8.91e-01 9.56e-01 0.095800 7.79e-02 5.57e-02 6.86e-01 7.72e-01
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes 29 6.74e-01 8.58e-01 0.095700 9.53e-02 9.20e-03 3.74e-01 9.32e-01
GOMF BETA 2 ADRENERGIC RECEPTOR BINDING 6 9.25e-01 9.72e-01 0.095700 4.66e-02 8.36e-02 8.43e-01 7.23e-01
Transcriptional regulation by RUNX2 104 2.16e-01 5.11e-01 0.095700 6.20e-02 -7.29e-02 2.75e-01 1.99e-01
GOBP POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 76 3.31e-01 6.22e-01 0.095600 8.57e-02 -4.25e-02 1.96e-01 5.22e-01
GOMF WW DOMAIN BINDING 22 7.36e-01 8.86e-01 0.095600 8.94e-03 -9.52e-02 9.42e-01 4.40e-01
GOCC COPII COATED ER TO GOLGI TRANSPORT VESICLE 89 2.70e-01 5.67e-01 0.095600 7.63e-02 -5.75e-02 2.13e-01 3.48e-01
GOBP THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY 13 8.30e-01 9.30e-01 0.095600 -2.92e-02 9.10e-02 8.55e-01 5.70e-01
GOBP PRIMARY AMINO COMPOUND METABOLIC PROCESS 13 8.33e-01 9.30e-01 0.095600 -1.58e-02 9.43e-02 9.21e-01 5.56e-01
GOBP NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 368 5.18e-03 4.86e-02 0.095500 8.65e-02 -4.05e-02 4.36e-03 1.82e-01
GOBP PROTEIN K48 LINKED DEUBIQUITINATION 24 7.09e-01 8.75e-01 0.095500 2.81e-02 -9.13e-02 8.12e-01 4.39e-01
GOMF CALCIUM MONOATOMIC CATION ANTIPORTER ACTIVITY 13 8.27e-01 9.29e-01 0.095500 -4.49e-02 8.42e-02 7.79e-01 5.99e-01
GOBP POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 188 7.77e-02 2.95e-01 0.095500 9.55e-02 1.78e-03 2.40e-02 9.66e-01
GOBP MAINTENANCE OF SYNAPSE STRUCTURE 24 7.21e-01 8.80e-01 0.095500 4.13e-03 9.54e-02 9.72e-01 4.19e-01
GOBP SPERM MOTILITY 140 1.36e-01 4.04e-01 0.095500 -9.07e-02 2.97e-02 6.38e-02 5.44e-01
Eicosanoid ligand-binding receptors 14 8.14e-01 9.25e-01 0.095500 6.67e-02 -6.83e-02 6.66e-01 6.58e-01
Activation of kainate receptors upon glutamate binding 29 6.54e-01 8.47e-01 0.095500 -8.01e-02 5.19e-02 4.55e-01 6.29e-01
GOBP POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE 52 5.14e-01 7.61e-01 0.095400 7.97e-02 5.26e-02 3.20e-01 5.12e-01
GOBP POSITIVE REGULATION OF MACROPHAGE MIGRATION 26 6.99e-01 8.70e-01 0.095400 2.39e-03 -9.54e-02 9.83e-01 4.00e-01
GOBP CELLULAR RESPONSE TO UV A 10 8.80e-01 9.51e-01 0.095400 -5.82e-02 -7.56e-02 7.50e-01 6.79e-01
GOBP COMMON BILE DUCT DEVELOPMENT 5 9.31e-01 9.74e-01 0.095400 3.26e-02 -8.97e-02 9.00e-01 7.28e-01
GOBP PROTEIN C LINKED GLYCOSYLATION 5 9.33e-01 9.75e-01 0.095400 -9.53e-02 3.77e-03 7.12e-01 9.88e-01
GOBP POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS 99 2.64e-01 5.61e-01 0.095400 9.48e-02 1.07e-02 1.03e-01 8.54e-01
GOBP POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 33 6.44e-01 8.42e-01 0.095300 9.37e-02 1.78e-02 3.52e-01 8.59e-01
Heme degradation 16 7.98e-01 9.17e-01 0.095300 2.01e-02 -9.32e-02 8.89e-01 5.19e-01
Metabolism of steroid hormones 35 6.08e-01 8.21e-01 0.095300 -9.15e-02 2.67e-02 3.49e-01 7.84e-01
p130Cas linkage to MAPK signaling for integrins 15 8.03e-01 9.19e-01 0.095300 7.91e-02 -5.31e-02 5.96e-01 7.22e-01
GOBP PROTEIN LOCALIZATION TO CILIUM 72 3.50e-01 6.40e-01 0.095300 5.56e-02 -7.74e-02 4.15e-01 2.56e-01
GOBP NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION 744 3.65e-05 9.12e-04 0.095200 9.15e-02 -2.63e-02 2.13e-05 2.21e-01
GOBP RESPONSE TO FOOD 38 5.92e-01 8.11e-01 0.095200 6.43e-03 -9.50e-02 9.45e-01 3.11e-01
GOMF G PROTEIN COUPLED GLUTAMATE RECEPTOR BINDING 10 8.69e-01 9.46e-01 0.095200 -1.78e-02 9.35e-02 9.22e-01 6.09e-01
GOBP LYMPHOCYTE COSTIMULATION 45 5.22e-01 7.65e-01 0.095200 4.27e-02 -8.51e-02 6.21e-01 3.23e-01
GOCC MICROBODY 143 1.25e-01 3.86e-01 0.095200 7.46e-02 -5.90e-02 1.23e-01 2.23e-01
GOBP ISOPRENOID BIOSYNTHETIC PROCESS 29 6.83e-01 8.63e-01 0.095200 -2.55e-02 -9.17e-02 8.12e-01 3.93e-01
GOBP LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS 26 7.13e-01 8.76e-01 0.095100 2.93e-02 9.05e-02 7.96e-01 4.25e-01
GOMF CYTOKINE ACTIVITY 225 4.05e-02 1.99e-01 0.095100 -8.61e-02 4.04e-02 2.61e-02 2.97e-01
GOBP GRANULOCYTE ACTIVATION 48 5.00e-01 7.53e-01 0.095000 -8.26e-02 4.70e-02 3.22e-01 5.73e-01
GOMF VITAMIN BINDING 143 1.52e-01 4.31e-01 0.095000 1.72e-02 9.34e-02 7.23e-01 5.38e-02
GOBP REGULATION OF OSTEOCLAST DEVELOPMENT 11 8.62e-01 9.42e-01 0.094900 -9.49e-02 -1.26e-03 5.86e-01 9.94e-01
GOBP ANATOMICAL STRUCTURE MATURATION 263 3.77e-02 1.91e-01 0.094900 7.47e-02 5.86e-02 3.71e-02 1.02e-01
GOBP EXCITATORY SYNAPSE ASSEMBLY 34 6.37e-01 8.38e-01 0.094900 1.28e-02 9.40e-02 8.97e-01 3.43e-01
GOBP GLYCOSYL COMPOUND METABOLIC PROCESS 81 3.48e-01 6.38e-01 0.094800 9.18e-02 2.38e-02 1.53e-01 7.11e-01
Induction of Cell-Cell Fusion 12 8.41e-01 9.34e-01 0.094800 -8.34e-02 4.51e-02 6.17e-01 7.87e-01
GOCC DYNEIN COMPLEX 52 4.72e-01 7.32e-01 0.094800 -5.31e-02 7.85e-02 5.08e-01 3.27e-01
GOCC BLOC 1 COMPLEX 15 8.04e-01 9.20e-01 0.094800 6.42e-02 -6.97e-02 6.67e-01 6.40e-01
Branched-chain amino acid catabolism 20 7.51e-01 8.92e-01 0.094800 4.29e-02 -8.45e-02 7.40e-01 5.13e-01
GOBP RESPONSE TO INTERLEUKIN 6 43 5.82e-01 8.04e-01 0.094700 5.34e-02 7.83e-02 5.45e-01 3.75e-01
Release of apoptotic factors from the mitochondria 6 9.28e-01 9.73e-01 0.094700 -6.92e-02 -6.47e-02 7.69e-01 7.84e-01
GOMF GAMMA AMINOBUTYRIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 8 8.97e-01 9.59e-01 0.094700 3.62e-03 -9.46e-02 9.86e-01 6.43e-01
GOBP REGULATION OF T CELL MEDIATED IMMUNITY 98 2.94e-01 5.91e-01 0.094600 -7.33e-02 -5.99e-02 2.10e-01 3.06e-01
GOBP RESPONSE TO FOLLICLE STIMULATING HORMONE 15 8.29e-01 9.30e-01 0.094600 6.86e-02 6.52e-02 6.45e-01 6.62e-01
GOMF PURINE NUCLEOTIDE BINDING 1884 2.69e-10 2.17e-08 0.094600 8.70e-02 3.73e-02 4.00e-10 7.41e-03
Late endosomal microautophagy 33 6.40e-01 8.40e-01 0.094600 2.08e-03 -9.46e-02 9.84e-01 3.47e-01
GOBP NEGATIVE REGULATION OF LYASE ACTIVITY 18 7.73e-01 9.05e-01 0.094600 -4.30e-02 8.42e-02 7.52e-01 5.36e-01
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects 17 8.09e-01 9.22e-01 0.094600 -6.79e-02 -6.58e-02 6.28e-01 6.39e-01
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) 17 8.09e-01 9.22e-01 0.094600 -6.79e-02 -6.58e-02 6.28e-01 6.39e-01
GOMF GALACTOSYLTRANSFERASE ACTIVITY 32 6.67e-01 8.53e-01 0.094600 4.25e-02 8.45e-02 6.78e-01 4.08e-01
GOCC AXON INITIAL SEGMENT 21 7.42e-01 8.89e-01 0.094500 -8.63e-02 3.86e-02 4.94e-01 7.59e-01
GOMF MAGNESIUM ION BINDING 217 6.81e-02 2.72e-01 0.094500 7.44e-02 5.82e-02 5.88e-02 1.40e-01
GOMF 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE ACTIVITY 8 9.04e-01 9.63e-01 0.094400 8.41e-02 4.30e-02 6.81e-01 8.33e-01
GOBP POSITIVE REGULATION OF FILOPODIUM ASSEMBLY 28 6.89e-01 8.65e-01 0.094400 9.43e-02 5.58e-03 3.88e-01 9.59e-01
GOBP REGULATION OF RESPONSE TO CYTOKINE STIMULUS 186 7.17e-02 2.81e-01 0.094400 8.21e-02 -4.66e-02 5.34e-02 2.73e-01
Neuronal System 389 4.45e-03 4.34e-02 0.094400 -3.83e-02 8.63e-02 1.95e-01 3.48e-03
GOBP EMBRYONIC AXIS SPECIFICATION 40 5.83e-01 8.05e-01 0.094400 9.43e-02 -3.70e-03 3.02e-01 9.68e-01
GOBP SECRETORY GRANULE ORGANIZATION 66 4.41e-01 7.13e-01 0.094300 7.17e-02 6.13e-02 3.14e-01 3.89e-01
GOBP NEGATIVE REGULATION OF VIRAL PROCESS 91 2.99e-01 5.94e-01 0.094300 9.42e-02 3.88e-03 1.20e-01 9.49e-01
GOBP REGULATION OF COLLAGEN METABOLIC PROCESS 41 6.01e-01 8.16e-01 0.094300 5.86e-02 7.39e-02 5.16e-01 4.13e-01
GOBP ACTOMYOSIN CONTRACTILE RING ORGANIZATION 10 8.76e-01 9.49e-01 0.094300 9.92e-03 9.37e-02 9.57e-01 6.08e-01
GOBP CELLULAR RESPONSE TO INTERLEUKIN 1 84 3.18e-01 6.10e-01 0.094200 1.49e-02 -9.30e-02 8.13e-01 1.40e-01
GOBP REGULATION OF PROTEIN K48 LINKED UBIQUITINATION 6 9.26e-01 9.72e-01 0.094200 -2.87e-02 -8.98e-02 9.03e-01 7.03e-01
GOMF GDP DISSOCIATION INHIBITOR ACTIVITY 15 8.26e-01 9.28e-01 0.094200 3.14e-02 8.88e-02 8.33e-01 5.51e-01
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 9 8.87e-01 9.55e-01 0.094200 4.05e-03 9.41e-02 9.83e-01 6.25e-01
GOBP PROTEIN PEPTIDYL PROLYL ISOMERIZATION 17 7.89e-01 9.14e-01 0.094200 3.12e-02 -8.88e-02 8.23e-01 5.26e-01
GOBP CEREBRAL CORTEX TANGENTIAL MIGRATION 5 9.31e-01 9.74e-01 0.094100 -5.35e-02 7.75e-02 8.36e-01 7.64e-01
GOBP T CELL ACTIVATION VIA T CELL RECEPTOR CONTACT WITH ANTIGEN BOUND TO MHC MOLECULE ON ANTIGEN PRESENTING CELL 10 8.82e-01 9.51e-01 0.094100 -8.54e-02 -3.96e-02 6.40e-01 8.28e-01
GOBP MODIFICATION OF SYNAPTIC STRUCTURE 27 6.79e-01 8.61e-01 0.094100 6.41e-02 -6.89e-02 5.64e-01 5.36e-01
GOCC U7 SNRNP 7 9.10e-01 9.66e-01 0.094100 8.95e-03 -9.37e-02 9.67e-01 6.68e-01
GOCC TIM23 MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE COMPLEX 14 8.20e-01 9.27e-01 0.094100 -8.36e-02 4.32e-02 5.88e-01 7.80e-01
GOBP AMYLOID BETA CLEARANCE 38 6.08e-01 8.21e-01 0.094100 -1.02e-02 -9.35e-02 9.13e-01 3.18e-01
Phenylalanine metabolism 6 9.19e-01 9.69e-01 0.094100 -8.30e-02 4.42e-02 7.25e-01 8.51e-01
GOBP EYE PHOTORECEPTOR CELL DIFFERENTIATION 49 4.97e-01 7.52e-01 0.094000 -6.07e-02 7.18e-02 4.62e-01 3.84e-01
GOCC DESMOSOME 26 7.06e-01 8.73e-01 0.094000 -4.15e-03 9.39e-02 9.71e-01 4.07e-01
Loss of Nlp from mitotic centrosomes 65 4.33e-01 7.08e-01 0.094000 9.20e-02 1.91e-02 1.99e-01 7.90e-01
Loss of proteins required for interphase microtubule organization from the centrosome 65 4.33e-01 7.08e-01 0.094000 9.20e-02 1.91e-02 1.99e-01 7.90e-01
GOBP NEGATIVE REGULATION OF CELL DIVISION 17 7.84e-01 9.12e-01 0.094000 6.97e-02 -6.30e-02 6.19e-01 6.53e-01
GOMF LIGAND GATED CALCIUM CHANNEL ACTIVITY 30 6.91e-01 8.67e-01 0.093900 7.02e-02 6.24e-02 5.06e-01 5.54e-01
GOBP POSITIVE REGULATION OF BLOOD CIRCULATION 36 6.02e-01 8.17e-01 0.093900 8.29e-02 -4.41e-02 3.89e-01 6.47e-01
GOBP GLYCEROPHOSPHOLIPID CATABOLIC PROCESS 34 6.16e-01 8.26e-01 0.093900 7.12e-02 -6.12e-02 4.73e-01 5.37e-01
GOCC GAMMA TUBULIN COMPLEX 18 7.79e-01 9.08e-01 0.093900 8.80e-02 -3.27e-02 5.18e-01 8.10e-01
GOCC CAVEOLA 81 3.20e-01 6.11e-01 0.093800 8.16e-02 -4.63e-02 2.04e-01 4.71e-01
GOMF TRANSLATION ACTIVATOR ACTIVITY 9 8.85e-01 9.54e-01 0.093800 1.20e-02 -9.30e-02 9.50e-01 6.29e-01
GOBP ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS 53 4.98e-01 7.52e-01 0.093800 4.90e-03 9.37e-02 9.51e-01 2.38e-01
GOBP REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY 182 1.08e-01 3.55e-01 0.093800 -5.92e-02 -7.27e-02 1.68e-01 9.06e-02
GOBP POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 1015 1.50e-06 5.38e-05 0.093800 8.88e-02 -3.01e-02 1.70e-06 1.05e-01
GOBP NAD METABOLIC PROCESS 63 4.25e-01 7.03e-01 0.093700 -1.90e-02 9.18e-02 7.95e-01 2.08e-01
GOBP RETINA LAYER FORMATION 23 7.52e-01 8.93e-01 0.093700 8.19e-02 4.56e-02 4.97e-01 7.05e-01
GOBP CELL MORPHOGENESIS 930 1.10e-05 3.13e-04 0.093700 9.13e-02 2.11e-02 2.36e-06 2.76e-01
GOMF STRUCTURAL CONSTITUENT OF CYTOSKELETON 104 2.31e-01 5.29e-01 0.093700 -5.44e-02 7.63e-02 3.38e-01 1.79e-01
GOBP CELL CYCLE DNA REPLICATION 43 5.86e-01 8.07e-01 0.093700 8.34e-02 4.27e-02 3.44e-01 6.28e-01
GOBP LUNG ALVEOLUS DEVELOPMENT 52 5.26e-01 7.68e-01 0.093600 8.11e-02 4.68e-02 3.11e-01 5.60e-01
GOBP NEURAL CREST FORMATION 15 8.29e-01 9.29e-01 0.093600 8.68e-02 3.51e-02 5.60e-01 8.14e-01
GOCC CELL DIVISION SITE 71 4.19e-01 6.99e-01 0.093600 7.33e-02 5.82e-02 2.85e-01 3.96e-01
GOMF CALMODULIN DEPENDENT PROTEIN KINASE ACTIVITY 24 7.45e-01 8.91e-01 0.093600 6.28e-02 6.95e-02 5.94e-01 5.56e-01
HIV Infection 211 5.36e-02 2.36e-01 0.093600 4.25e-02 -8.34e-02 2.87e-01 3.68e-02
GOBP RECEPTOR RECYCLING 45 5.75e-01 8.00e-01 0.093600 7.71e-02 5.31e-02 3.71e-01 5.38e-01
ER to Golgi Anterograde Transport 152 1.24e-01 3.84e-01 0.093600 8.80e-02 -3.19e-02 6.12e-02 4.97e-01
GOBP NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT 49 5.17e-01 7.63e-01 0.093600 1.38e-02 -9.26e-02 8.67e-01 2.62e-01
Metabolism of Angiotensinogen to Angiotensins 15 8.30e-01 9.30e-01 0.093500 -8.31e-02 -4.30e-02 5.78e-01 7.73e-01
GOBP LIPOXYGENASE PATHWAY 11 8.73e-01 9.48e-01 0.093500 4.84e-02 8.01e-02 7.81e-01 6.46e-01
Glycosphingolipid catabolism 33 6.56e-01 8.48e-01 0.093500 9.17e-02 1.85e-02 3.62e-01 8.54e-01
GOBP T CELL SELECTION 57 4.58e-01 7.23e-01 0.093500 8.88e-02 -2.91e-02 2.46e-01 7.04e-01
GOMF UBIQUITIN LIKE LIGASE SUBSTRATE ADAPTOR ACTIVITY 56 4.59e-01 7.24e-01 0.093500 4.24e-02 -8.33e-02 5.83e-01 2.81e-01
GOBP ORGANIC ACID TRANSPORT 340 1.66e-02 1.12e-01 0.093500 7.30e-02 5.84e-02 2.07e-02 6.45e-02
GOBP PYRIDINE CONTAINING COMPOUND CATABOLIC PROCESS 96 3.04e-01 5.98e-01 0.093400 3.72e-02 8.57e-02 5.29e-01 1.47e-01
GOBP VIRAL BUDDING 25 7.36e-01 8.86e-01 0.093400 -7.64e-02 -5.38e-02 5.08e-01 6.42e-01
GOBP REGULATION OF MACROPHAGE CHEMOTAXIS 28 6.78e-01 8.60e-01 0.093400 8.39e-02 -4.11e-02 4.42e-01 7.06e-01
GOBP REGULATION OF SKELETAL MUSCLE SATELLITE CELL PROLIFERATION 12 8.60e-01 9.42e-01 0.093400 -3.10e-02 -8.81e-02 8.53e-01 5.97e-01
GOBP MESENCHYMAL CELL APOPTOTIC PROCESS 15 8.09e-01 9.22e-01 0.093400 6.54e-02 -6.67e-02 6.61e-01 6.55e-01
GOMF NADPLUS PROTEIN LYSINE ADP RIBOSYLTRANSFERASE ACTIVITY 5 9.33e-01 9.75e-01 0.093400 4.26e-02 -8.31e-02 8.69e-01 7.48e-01
GOBP TRANSCRIPTION INITIATION AT RNA POLYMERASE I PROMOTER 13 8.37e-01 9.32e-01 0.093400 8.84e-02 -3.01e-02 5.81e-01 8.51e-01
GOMF MICROTUBULE BINDING 267 2.86e-02 1.62e-01 0.093400 9.19e-02 -1.63e-02 9.72e-03 6.46e-01
GOBP MACROPHAGE MIGRATION 61 4.67e-01 7.28e-01 0.093300 8.81e-02 3.08e-02 2.34e-01 6.77e-01
GOBP ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS 688 1.83e-04 3.51e-03 0.093300 9.27e-02 1.03e-02 3.39e-05 6.44e-01
GOBP POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY 18 7.80e-01 9.09e-01 0.093200 3.94e-02 -8.45e-02 7.72e-01 5.35e-01
Erythropoietin activates STAT5 7 9.10e-01 9.66e-01 0.093200 9.19e-02 -1.57e-02 6.74e-01 9.43e-01
GOBP PLATELET AGGREGATION 74 3.61e-01 6.49e-01 0.093200 3.74e-02 -8.53e-02 5.78e-01 2.04e-01
GOBP INTERLEUKIN 33 MEDIATED SIGNALING PATHWAY 7 9.19e-01 9.69e-01 0.093200 -7.08e-02 -6.05e-02 7.46e-01 7.81e-01
GOMF SOLUTE SODIUM SYMPORTER ACTIVITY 77 3.53e-01 6.42e-01 0.093200 -2.48e-02 8.98e-02 7.07e-01 1.73e-01
GOBP RESPONSE TO PROTOZOAN 29 6.93e-01 8.68e-01 0.093100 9.09e-02 2.03e-02 3.97e-01 8.50e-01
GOBP AUTOPHAGOSOME MEMBRANE DOCKING 7 9.07e-01 9.64e-01 0.093100 7.89e-02 -4.95e-02 7.18e-01 8.21e-01
Glycogen synthesis 13 8.35e-01 9.31e-01 0.093100 4.66e-02 -8.05e-02 7.71e-01 6.15e-01
GOCC BRUSH BORDER 103 2.73e-01 5.70e-01 0.093100 2.02e-02 9.09e-02 7.24e-01 1.11e-01
GOBP DENDRITIC CELL CHEMOTAXIS 23 7.57e-01 8.96e-01 0.093100 -6.99e-02 -6.14e-02 5.62e-01 6.10e-01
GOBP DETECTION OF CALCIUM ION 13 8.38e-01 9.32e-01 0.093000 8.83e-02 -2.93e-02 5.81e-01 8.55e-01
GOBP NEGATIVE REGULATION OF LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY 8 8.94e-01 9.58e-01 0.093000 -6.15e-02 6.98e-02 7.63e-01 7.32e-01
GOBP MITOTIC SPINDLE ORGANIZATION 127 1.75e-01 4.61e-01 0.093000 8.36e-02 -4.08e-02 1.04e-01 4.27e-01
SLC-mediated transmembrane transport 238 3.76e-02 1.91e-01 0.093000 -5.30e-02 7.64e-02 1.59e-01 4.23e-02
GOBP CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 115 2.06e-01 5.01e-01 0.093000 8.35e-02 -4.10e-02 1.22e-01 4.48e-01
GOBP NEUTROPHIL DEGRANULATION 13 8.53e-01 9.39e-01 0.093000 -8.07e-02 -4.61e-02 6.14e-01 7.73e-01
GOBP IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE 55 4.66e-01 7.28e-01 0.092900 5.44e-02 -7.53e-02 4.85e-01 3.34e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO STIMULUS 1706 1.20e-09 8.79e-08 0.092900 9.29e-02 -1.20e-03 1.70e-10 9.34e-01
GOBP POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS 14 8.45e-01 9.36e-01 0.092900 -6.25e-02 -6.88e-02 6.86e-01 6.56e-01
GOBP ANDROGEN METABOLIC PROCESS 29 7.04e-01 8.72e-01 0.092900 -5.23e-02 -7.68e-02 6.26e-01 4.74e-01
GOBP PENILE ERECTION 7 9.19e-01 9.69e-01 0.092900 5.78e-02 7.27e-02 7.91e-01 7.39e-01
GOCC PHAGOCYTIC CUP 28 6.82e-01 8.62e-01 0.092900 3.68e-02 -8.53e-02 7.36e-01 4.35e-01
GOMF METALLOPEPTIDASE ACTIVITY 179 9.18e-02 3.25e-01 0.092900 -2.21e-02 9.02e-02 6.10e-01 3.73e-02
GOMF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 138 1.51e-01 4.29e-01 0.092900 -4.47e-02 8.14e-02 3.65e-01 9.87e-02
GOBP CHONDROCYTE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 8 9.00e-01 9.61e-01 0.092800 -6.32e-03 9.26e-02 9.75e-01 6.50e-01
GOMF THREONINE TYPE PEPTIDASE ACTIVITY 16 8.20e-01 9.27e-01 0.092800 -8.84e-02 -2.83e-02 5.40e-01 8.45e-01
GOBP ERBB2 SIGNALING PATHWAY 23 7.35e-01 8.86e-01 0.092800 2.02e-02 -9.06e-02 8.67e-01 4.52e-01
GOBP REGULATION OF NERVOUS SYSTEM PROCESS 115 2.42e-01 5.39e-01 0.092800 3.08e-02 8.75e-02 5.68e-01 1.05e-01
Mechanical load activates signaling by PIEZO1 and integrins in osteocytes 17 8.14e-01 9.25e-01 0.092800 7.66e-02 5.24e-02 5.85e-01 7.08e-01
GOCC LEADING EDGE MEMBRANE 174 1.17e-01 3.73e-01 0.092700 8.81e-02 2.88e-02 4.49e-02 5.12e-01
Late Phase of HIV Life Cycle 132 1.61e-01 4.45e-01 0.092700 5.92e-02 -7.14e-02 2.40e-01 1.57e-01
GOBP POSITIVE REGULATION OF NUCLEASE ACTIVITY 6 9.29e-01 9.74e-01 0.092700 8.29e-02 4.14e-02 7.25e-01 8.60e-01
GOBP MONOSACCHARIDE TRANSMEMBRANE TRANSPORT 121 2.29e-01 5.27e-01 0.092700 3.77e-02 8.47e-02 4.74e-01 1.08e-01
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY 11 8.74e-01 9.48e-01 0.092600 -8.55e-02 -3.58e-02 6.24e-01 8.37e-01
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL 20 7.77e-01 9.07e-01 0.092600 9.14e-02 1.50e-02 4.79e-01 9.07e-01
GOBP EXTERNAL ENCAPSULATING STRUCTURE ORGANIZATION 324 1.67e-02 1.12e-01 0.092600 5.38e-03 9.24e-02 8.68e-01 4.23e-03
GOBP OOGENESIS 112 2.60e-01 5.57e-01 0.092600 4.69e-02 7.98e-02 3.91e-01 1.45e-01
GOCC NUCLEAR ENVELOPE 473 2.58e-03 2.88e-02 0.092600 9.25e-02 2.18e-03 5.65e-04 9.35e-01
SLBP independent Processing of Histone Pre-mRNAs 10 8.87e-01 9.55e-01 0.092500 -7.02e-02 -6.02e-02 7.01e-01 7.42e-01
Integrin cell surface interactions 83 3.40e-01 6.29e-01 0.092500 -9.21e-02 8.43e-03 1.47e-01 8.94e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS 120 2.02e-01 4.95e-01 0.092500 2.64e-02 -8.86e-02 6.17e-01 9.36e-02
GOBP N TERMINAL PROTEIN LIPIDATION 6 9.22e-01 9.70e-01 0.092500 3.54e-02 -8.54e-02 8.81e-01 7.17e-01
GOMF CARBOXY LYASE ACTIVITY 33 6.37e-01 8.38e-01 0.092500 8.12e-02 -4.42e-02 4.19e-01 6.60e-01
GOBP REGULATION OF MACROPHAGE DIFFERENTIATION 25 7.42e-01 8.89e-01 0.092400 6.10e-02 6.93e-02 5.97e-01 5.48e-01
GOMF PROCOLLAGEN PROLINE 4 DIOXYGENASE ACTIVITY 5 9.33e-01 9.75e-01 0.092400 -5.69e-02 7.28e-02 8.26e-01 7.78e-01
GOMF KINASE BINDING 749 7.10e-05 1.60e-03 0.092300 9.07e-02 -1.73e-02 2.39e-05 4.19e-01
ERBB2 Regulates Cell Motility 15 8.30e-01 9.30e-01 0.092300 -2.19e-02 -8.97e-02 8.83e-01 5.48e-01
GOMF MRNA CDS BINDING 5 9.35e-01 9.75e-01 0.092300 8.45e-02 -3.71e-02 7.43e-01 8.86e-01
GOBP ACTIVATION OF PROTEIN KINASE B ACTIVITY 20 7.61e-01 8.98e-01 0.092300 4.81e-02 -7.88e-02 7.10e-01 5.42e-01
GOBP NUCLEOBASE METABOLIC PROCESS 37 6.34e-01 8.36e-01 0.092300 8.86e-02 2.58e-02 3.51e-01 7.86e-01
GOCC XY BODY 15 8.14e-01 9.25e-01 0.092300 6.97e-02 -6.05e-02 6.40e-01 6.85e-01
Hedgehog ‘off’ state 98 2.65e-01 5.62e-01 0.092200 8.14e-02 -4.34e-02 1.64e-01 4.58e-01
GOBP NUCLEOTIDE TRANSPORT 44 5.84e-01 8.05e-01 0.092200 2.94e-02 8.74e-02 7.36e-01 3.16e-01
GOMF ACID THIOL LIGASE ACTIVITY 30 6.89e-01 8.65e-01 0.092200 1.85e-02 9.03e-02 8.61e-01 3.92e-01
GOCC MICROTUBULE CYTOSKELETON 1348 8.60e-08 4.31e-06 0.092100 9.21e-02 -2.28e-03 1.37e-08 8.88e-01
GOMF AMIDE TRANSMEMBRANE TRANSPORTER ACTIVITY 34 6.69e-01 8.55e-01 0.092100 6.72e-02 6.29e-02 4.97e-01 5.25e-01
GOBP REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL 72 3.97e-01 6.79e-01 0.092000 5.26e-03 -9.19e-02 9.38e-01 1.78e-01
GOBP CELLULAR RESPONSE TO HYDROGEN PEROXIDE 65 4.21e-01 7.00e-01 0.092000 8.71e-02 -2.98e-02 2.25e-01 6.78e-01
GOCC PLATELET ALPHA GRANULE LUMEN 60 4.45e-01 7.16e-01 0.092000 4.42e-02 -8.07e-02 5.54e-01 2.80e-01
Plasma lipoprotein remodeling 33 6.72e-01 8.57e-01 0.092000 -8.36e-02 -3.82e-02 4.06e-01 7.04e-01
Organelle biogenesis and maintenance 277 2.48e-02 1.48e-01 0.091900 8.02e-02 -4.48e-02 2.16e-02 2.00e-01
GOBP BASE CONVERSION OR SUBSTITUTION EDITING 18 8.04e-01 9.20e-01 0.091800 3.22e-02 8.60e-02 8.13e-01 5.28e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 91 2.96e-01 5.94e-01 0.091800 8.30e-02 -3.92e-02 1.71e-01 5.18e-01
GOMF FATTY ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 18 7.99e-01 9.17e-01 0.091800 1.18e-02 9.10e-02 9.31e-01 5.04e-01
GOBP ALPHA BETA T CELL PROLIFERATION 41 5.84e-01 8.05e-01 0.091700 -8.89e-02 2.28e-02 3.25e-01 8.01e-01
GOBP HOMOTYPIC CELL CELL ADHESION 96 2.99e-01 5.95e-01 0.091700 -3.42e-03 -9.17e-02 9.54e-01 1.21e-01
GOBP GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY 27 7.27e-01 8.82e-01 0.091700 -7.54e-02 -5.23e-02 4.98e-01 6.38e-01
G alpha (s) signalling events 155 1.24e-01 3.83e-01 0.091700 -7.27e-02 5.59e-02 1.18e-01 2.29e-01
GOBP LACTATE METABOLIC PROCESS 18 7.98e-01 9.17e-01 0.091700 9.13e-02 7.78e-03 5.02e-01 9.54e-01
GOBP MULTICELLULAR ORGANISMAL LEVEL HOMEOSTASIS 785 5.43e-05 1.27e-03 0.091700 9.04e-02 -1.51e-02 1.65e-05 4.71e-01
GOBP SPHINGOLIPID METABOLIC PROCESS 170 1.37e-01 4.06e-01 0.091600 5.30e-02 7.47e-02 2.33e-01 9.29e-02
GOBP REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS 91 3.41e-01 6.31e-01 0.091600 4.42e-02 8.02e-02 4.66e-01 1.86e-01
GOCC PERICENTRIC HETEROCHROMATIN 29 6.76e-01 8.59e-01 0.091600 7.25e-02 -5.59e-02 4.99e-01 6.02e-01
GOBP NEGATIVE REGULATION OF CELL DEVELOPMENT 259 3.98e-02 1.97e-01 0.091600 9.15e-02 2.24e-03 1.12e-02 9.51e-01
GOMF PROTEIN LIPID COMPLEX BINDING 31 6.65e-01 8.52e-01 0.091500 -2.91e-02 8.68e-02 7.79e-01 4.03e-01
GOBP REGULATION OF CORE PROMOTER BINDING 5 9.39e-01 9.77e-01 0.091500 -9.14e-02 3.62e-03 7.23e-01 9.89e-01
GOBP ORGANIC CATION TRANSPORT 110 2.41e-01 5.37e-01 0.091400 8.93e-02 -1.98e-02 1.06e-01 7.19e-01
GOCC PROTEIN COMPLEX INVOLVED IN CELL MATRIX ADHESION 17 8.13e-01 9.24e-01 0.091400 8.94e-02 1.94e-02 5.24e-01 8.90e-01
Axon guidance 510 1.26e-03 1.65e-02 0.091400 4.57e-02 -7.92e-02 7.75e-02 2.20e-03
GOBP CYTOSKELETON ORGANIZATION 1456 9.07e-08 4.52e-06 0.091400 8.37e-02 3.68e-02 9.08e-08 1.86e-02
GOBP DETECTION OF MECHANICAL STIMULUS 54 5.22e-01 7.65e-01 0.091400 -2.68e-02 -8.74e-02 7.33e-01 2.67e-01
GOBP VENTRICULAR SEPTUM MORPHOGENESIS 44 5.91e-01 8.10e-01 0.091400 8.56e-02 3.19e-02 3.26e-01 7.15e-01
GOMF PHOTORECEPTOR ACTIVITY 13 8.60e-01 9.42e-01 0.091300 6.51e-02 6.40e-02 6.84e-01 6.89e-01
GOBP REGULATION OF CHOLESTEROL STORAGE 19 7.95e-01 9.16e-01 0.091300 2.25e-02 8.84e-02 8.65e-01 5.05e-01
GOBP REGULATION OF LYMPHOCYTE ACTIVATION 491 1.60e-03 1.99e-02 0.091200 5.18e-02 -7.51e-02 4.92e-02 4.38e-03
GOBP RESPONSE TO VASOPRESSIN 8 9.06e-01 9.63e-01 0.091200 9.62e-03 9.07e-02 9.62e-01 6.57e-01
GOMF OPIOID RECEPTOR BINDING 7 9.10e-01 9.66e-01 0.091200 -6.99e-02 5.85e-02 7.49e-01 7.89e-01
GOBP REGULATION OF ENDOTHELIAL CELL MIGRATION 225 5.99e-02 2.52e-01 0.091200 9.10e-02 -5.52e-03 1.87e-02 8.86e-01
GOBP POSITIVE REGULATION OF CELL DIVISION 93 3.03e-01 5.97e-01 0.091100 8.91e-02 -1.93e-02 1.38e-01 7.48e-01
GOBP LIPID LOCALIZATION 497 3.34e-03 3.48e-02 0.091100 7.93e-02 4.48e-02 2.46e-03 8.70e-02
Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence 6 9.28e-01 9.73e-01 0.091100 -9.11e-02 1.49e-03 6.99e-01 9.95e-01
GOBP NEUROTRANSMITTER TRANSPORT 200 9.24e-02 3.26e-01 0.091000 2.50e-02 8.75e-02 5.42e-01 3.28e-02
GOBP REGULATION OF PROTEIN BINDING 120 2.46e-01 5.42e-01 0.091000 8.10e-02 4.14e-02 1.25e-01 4.33e-01
GOMF DYNEIN INTERMEDIATE CHAIN BINDING 35 6.41e-01 8.41e-01 0.091000 -1.07e-02 9.04e-02 9.12e-01 3.55e-01
GOBP CARBOHYDRATE METABOLIC PROCESS 542 2.02e-03 2.38e-02 0.091000 4.20e-02 8.07e-02 9.41e-02 1.31e-03
GOBP NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 129 1.94e-01 4.87e-01 0.091000 8.96e-02 -1.56e-02 7.87e-02 7.60e-01
GOBP REGULATION OF MEMBRANE LIPID DISTRIBUTION 59 4.56e-01 7.22e-01 0.090900 -5.62e-02 7.15e-02 4.55e-01 3.42e-01
GOMF CYTIDINE DEAMINASE ACTIVITY 12 8.66e-01 9.44e-01 0.090900 8.75e-02 2.45e-02 6.00e-01 8.83e-01
GOBP REGULATION OF NEURONAL SYNAPTIC PLASTICITY 54 4.93e-01 7.50e-01 0.090800 8.23e-02 -3.84e-02 2.96e-01 6.25e-01
GOBP C21 STEROID HORMONE METABOLIC PROCESS 36 6.21e-01 8.28e-01 0.090800 -7.64e-02 4.91e-02 4.28e-01 6.10e-01
GOBP DENDRITE ARBORIZATION 11 8.80e-01 9.51e-01 0.090800 -4.85e-02 -7.67e-02 7.81e-01 6.59e-01
Post-translational protein modification 1362 5.28e-08 2.72e-06 0.090800 8.26e-02 -3.76e-02 3.16e-07 1.98e-02
Centrosome maturation 77 4.08e-01 6.90e-01 0.090800 8.03e-02 4.23e-02 2.23e-01 5.21e-01
Recruitment of mitotic centrosome proteins and complexes 77 4.08e-01 6.90e-01 0.090800 8.03e-02 4.23e-02 2.23e-01 5.21e-01
GOBP POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY 239 4.57e-02 2.14e-01 0.090700 8.41e-02 -3.40e-02 2.51e-02 3.65e-01
GOBP REGULATION OF SYNAPSE STRUCTURAL PLASTICITY 7 9.23e-01 9.71e-01 0.090700 -7.20e-02 -5.51e-02 7.41e-01 8.01e-01
GOBP DETECTION OF BIOTIC STIMULUS 36 6.44e-01 8.42e-01 0.090700 -9.03e-02 -8.18e-03 3.49e-01 9.32e-01
GOBP REGULATION OF SEQUESTERING OF TRIGLYCERIDE 15 8.20e-01 9.27e-01 0.090600 -5.25e-02 7.39e-02 7.25e-01 6.20e-01
GOBP VERY LONG CHAIN FATTY ACID CATABOLIC PROCESS 6 9.27e-01 9.73e-01 0.090600 1.72e-02 -8.90e-02 9.42e-01 7.06e-01
GOMF SINGLE STRANDED RNA BINDING 79 3.87e-01 6.71e-01 0.090600 8.92e-02 1.62e-02 1.71e-01 8.04e-01
GOMF STAT FAMILY PROTEIN BINDING 11 8.66e-01 9.44e-01 0.090600 -4.08e-02 8.09e-02 8.15e-01 6.42e-01
GOCC CATENIN COMPLEX 31 6.96e-01 8.68e-01 0.090600 -8.29e-02 -3.65e-02 4.24e-01 7.25e-01
GOBP INTRACELLULAR MONOATOMIC ANION HOMEOSTASIS 10 8.91e-01 9.57e-01 0.090600 7.22e-02 5.47e-02 6.93e-01 7.65e-01
GOMF CYCLIC NUCLEOTIDE BINDING 36 6.21e-01 8.29e-01 0.090600 -5.38e-02 7.29e-02 5.76e-01 4.49e-01
GOBP UBIQUITIN DEPENDENT ENDOCYTOSIS 7 9.13e-01 9.67e-01 0.090500 3.29e-02 -8.44e-02 8.80e-01 6.99e-01
GOBP REGULATION OF T CELL ACTIVATION 374 7.70e-03 6.52e-02 0.090500 5.58e-02 -7.13e-02 6.40e-02 1.79e-02
GOBP DOUBLE STRAND BREAK REPAIR VIA CLASSICAL NONHOMOLOGOUS END JOINING 9 8.93e-01 9.57e-01 0.090500 8.98e-02 -1.15e-02 6.41e-01 9.52e-01
GOBP RIBONUCLEOSIDE METABOLIC PROCESS 35 6.35e-01 8.38e-01 0.090500 8.41e-02 -3.35e-02 3.89e-01 7.31e-01
GOBP CYTOSKELETON DEPENDENT CYTOKINESIS 116 2.34e-01 5.31e-01 0.090500 8.97e-02 -1.21e-02 9.53e-02 8.21e-01
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY 19 7.99e-01 9.17e-01 0.090500 -8.64e-02 -2.69e-02 5.14e-01 8.39e-01
Maternal to zygotic transition (MZT) 96 2.87e-01 5.84e-01 0.090500 4.08e-02 -8.07e-02 4.90e-01 1.72e-01
GOBP NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION 71 4.43e-01 7.15e-01 0.090400 7.67e-02 4.79e-02 2.64e-01 4.86e-01
GOBP SPHINGOLIPID MEDIATED SIGNALING PATHWAY 18 8.12e-01 9.24e-01 0.090400 -4.39e-02 -7.90e-02 7.47e-01 5.62e-01
GOBP ADAPTIVE IMMUNE RESPONSE 454 6.11e-03 5.46e-02 0.090400 -5.33e-02 -7.30e-02 5.17e-02 7.64e-03
GOBP REGULATION OF MYELOID CELL DIFFERENTIATION 209 6.47e-02 2.64e-01 0.090400 6.05e-02 -6.72e-02 1.32e-01 9.39e-02
GOBP CELLULAR RESPONSE TO MAGNESIUM ION 7 9.12e-01 9.67e-01 0.090400 7.45e-02 -5.13e-02 7.33e-01 8.14e-01
GOBP REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 55 5.14e-01 7.61e-01 0.090400 -1.02e-02 -8.98e-02 8.96e-01 2.49e-01
GOBP POSITIVE REGULATION OF ERBB SIGNALING PATHWAY 31 6.70e-01 8.55e-01 0.090400 3.36e-02 -8.39e-02 7.46e-01 4.19e-01
GOBP CILIUM ORGANIZATION 421 5.87e-03 5.33e-02 0.090400 9.01e-02 -6.46e-03 1.51e-03 8.20e-01
GOMF MANNOSYLTRANSFERASE ACTIVITY 24 7.61e-01 8.98e-01 0.090300 6.05e-02 6.71e-02 6.08e-01 5.69e-01
Nervous system development 534 1.04e-03 1.42e-02 0.090300 5.66e-02 -7.04e-02 2.52e-02 5.40e-03
GOBP REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT 16 8.11e-01 9.23e-01 0.090300 4.99e-02 -7.52e-02 7.30e-01 6.02e-01
GOBP RESPONSE TO ACIDIC PH 26 7.43e-01 8.89e-01 0.090300 5.28e-02 7.32e-02 6.41e-01 5.18e-01
GOBP RECEPTOR METABOLIC PROCESS 69 4.41e-01 7.13e-01 0.090200 8.81e-02 1.97e-02 2.06e-01 7.77e-01
GOBP REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 140 1.61e-01 4.43e-01 0.090200 5.78e-02 -6.92e-02 2.38e-01 1.57e-01
Defects in biotin (Btn) metabolism 8 9.00e-01 9.61e-01 0.090100 6.73e-02 -6.00e-02 7.42e-01 7.69e-01
GOBP ASTROCYTE DEVELOPMENT 43 5.80e-01 8.03e-01 0.090100 8.72e-02 -2.28e-02 3.22e-01 7.96e-01
GOMF GLUCOSE SODIUM SYMPORTER ACTIVITY 7 9.21e-01 9.70e-01 0.090100 8.73e-02 2.25e-02 6.89e-01 9.18e-01
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 79 4.09e-01 6.90e-01 0.090100 -5.47e-02 -7.16e-02 4.01e-01 2.71e-01
GOBP LATERAL SPROUTING FROM AN EPITHELIUM 10 8.78e-01 9.50e-01 0.090100 7.64e-02 -4.76e-02 6.76e-01 7.94e-01
GOBP ZYMOGEN ACTIVATION 56 5.02e-01 7.55e-01 0.090000 -5.58e-03 8.99e-02 9.42e-01 2.45e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL STORAGE 8 9.03e-01 9.62e-01 0.090000 -8.45e-02 3.11e-02 6.79e-01 8.79e-01
GOBP PIGMENT CATABOLIC PROCESS 11 8.68e-01 9.45e-01 0.090000 8.22e-02 -3.68e-02 6.37e-01 8.33e-01
GOMF TOLL LIKE RECEPTOR BINDING 14 8.52e-01 9.39e-01 0.090000 -7.62e-02 -4.79e-02 6.22e-01 7.56e-01
GOBP POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS 52 5.54e-01 7.87e-01 0.090000 7.40e-02 5.13e-02 3.56e-01 5.22e-01
GOMF LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR ACTIVITY 15 8.23e-01 9.27e-01 0.090000 -4.78e-02 7.62e-02 7.48e-01 6.09e-01
GOBP ACTIVATED T CELL PROLIFERATION 46 5.57e-01 7.89e-01 0.090000 8.54e-02 -2.83e-02 3.16e-01 7.40e-01
GOMF POTASSIUM PROTON ANTIPORTER ACTIVITY 12 8.65e-01 9.44e-01 0.089900 5.63e-03 8.98e-02 9.73e-01 5.90e-01
GOMF ARYLSULFATASE ACTIVITY 9 8.89e-01 9.55e-01 0.089900 -5.96e-02 6.73e-02 7.57e-01 7.26e-01
GOBP REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT 332 1.90e-02 1.23e-01 0.089900 8.98e-02 3.86e-03 4.90e-03 9.04e-01
GOBP CALCIUM ION EXPORT ACROSS PLASMA MEMBRANE 10 8.84e-01 9.54e-01 0.089900 8.98e-02 -5.03e-03 6.23e-01 9.78e-01
GOBP GLYCOSYL COMPOUND CATABOLIC PROCESS 34 6.60e-01 8.50e-01 0.089900 8.98e-02 -3.52e-03 3.65e-01 9.72e-01
GOBP FATTY ACYL COA METABOLIC PROCESS 37 6.19e-01 8.27e-01 0.089900 7.70e-02 -4.65e-02 4.18e-01 6.25e-01
GOBP HINDBRAIN MORPHOGENESIS 44 5.64e-01 7.93e-01 0.089900 7.14e-02 -5.46e-02 4.12e-01 5.31e-01
RAS processing 22 7.64e-01 9.00e-01 0.089900 2.00e-03 -8.99e-02 9.87e-01 4.66e-01
GOBP ALPHA BETA T CELL DIFFERENTIATION 122 2.08e-01 5.03e-01 0.089900 7.91e-02 -4.27e-02 1.31e-01 4.15e-01
Defective HLCS causes multiple carboxylase deficiency 7 9.23e-01 9.71e-01 0.089800 8.12e-02 3.84e-02 7.10e-01 8.60e-01
GOBP TETRAHYDROBIOPTERIN METABOLIC PROCESS 8 9.01e-01 9.61e-01 0.089800 -7.11e-02 5.49e-02 7.28e-01 7.88e-01
GOBP PHOSPHOLIPID METABOLIC PROCESS 373 9.96e-03 7.86e-02 0.089800 8.71e-02 -2.15e-02 3.85e-03 4.75e-01
Visual phototransduction 92 3.07e-01 6.00e-01 0.089800 -4.13e-02 7.97e-02 4.93e-01 1.87e-01
GOMF MICROTUBULE MOTOR ACTIVITY 67 4.19e-01 6.99e-01 0.089800 -6.19e-02 6.50e-02 3.81e-01 3.58e-01
GOCC NEURON PROJECTION CYTOPLASM 83 3.58e-01 6.47e-01 0.089800 8.86e-02 -1.46e-02 1.63e-01 8.18e-01
GOBP NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS 123 2.28e-01 5.25e-01 0.089700 3.01e-03 8.97e-02 9.54e-01 8.58e-02
GOCC TRANSPORTER COMPLEX 439 4.76e-03 4.57e-02 0.089700 -8.86e-02 1.45e-02 1.46e-03 6.04e-01
GOBP CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION 19 7.82e-01 9.10e-01 0.089700 7.69e-02 -4.63e-02 5.62e-01 7.27e-01
GOBP ANTERIOR POSTERIOR AXIS SPECIFICATION 55 5.10e-01 7.60e-01 0.089700 6.52e-03 -8.95e-02 9.33e-01 2.51e-01
GOMF D1 DOPAMINE RECEPTOR BINDING 6 9.31e-01 9.74e-01 0.089700 -1.23e-02 -8.89e-02 9.59e-01 7.06e-01
GOBP ASTROCYTE ACTIVATION 26 7.15e-01 8.77e-01 0.089700 4.85e-02 -7.54e-02 6.68e-01 5.06e-01
Signaling by Non-Receptor Tyrosine Kinases 54 5.01e-01 7.53e-01 0.089700 8.00e-02 -4.06e-02 3.09e-01 6.06e-01
Signaling by PTK6 54 5.01e-01 7.53e-01 0.089700 8.00e-02 -4.06e-02 3.09e-01 6.06e-01
GOBP BILE ACID SECRETION 12 8.62e-01 9.43e-01 0.089700 -1.09e-02 8.90e-02 9.48e-01 5.93e-01
GOMF HYDROLASE ACTIVITY ACTING ON GLYCOSYL BONDS 127 2.01e-01 4.94e-01 0.089700 -3.14e-02 8.40e-02 5.41e-01 1.02e-01
The phototransduction cascade 32 6.86e-01 8.64e-01 0.089600 1.57e-02 8.82e-02 8.78e-01 3.88e-01
GOBP EATING BEHAVIOR 39 6.38e-01 8.39e-01 0.089600 3.00e-02 8.44e-02 7.46e-01 3.62e-01
GOBP PURINE NUCLEOTIDE TRANSPORT 38 6.36e-01 8.38e-01 0.089500 7.86e-03 8.92e-02 9.33e-01 3.41e-01
GOBP REGULATION OF FERTILIZATION 17 8.06e-01 9.20e-01 0.089500 -3.42e-02 8.27e-02 8.07e-01 5.55e-01
GOBP RENAL SODIUM ION TRANSPORT 15 8.25e-01 9.28e-01 0.089500 7.83e-02 -4.34e-02 6.00e-01 7.71e-01
GOBP HEART FIELD SPECIFICATION 17 8.11e-01 9.23e-01 0.089500 -1.49e-02 8.82e-02 9.15e-01 5.29e-01
GOBP POSITIVE REGULATION OF MAPK CASCADE 458 3.96e-03 3.95e-02 0.089500 8.84e-02 -1.35e-02 1.18e-03 6.21e-01
GOBP POSITIVE REGULATION OF CELL ACTIVATION 368 9.47e-03 7.57e-02 0.089400 5.07e-02 -7.37e-02 9.51e-02 1.52e-02
Glucose metabolism 83 3.95e-01 6.77e-01 0.089300 4.83e-02 7.52e-02 4.47e-01 2.36e-01
GOBP REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 12 8.75e-01 9.48e-01 0.089300 6.29e-02 6.34e-02 7.06e-01 7.04e-01
GOCC PEPTIDASE COMPLEX 118 2.35e-01 5.32e-01 0.089300 1.71e-02 -8.76e-02 7.48e-01 1.00e-01
GOCC ENDOCYTIC VESICLE 329 1.97e-02 1.25e-01 0.089200 8.91e-02 -5.24e-03 5.47e-03 8.70e-01
GOCC GLUTAMATERGIC SYNAPSE 401 1.01e-02 7.93e-02 0.089200 8.75e-02 1.73e-02 2.63e-03 5.53e-01
GOBP REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 66 4.42e-01 7.14e-01 0.089200 8.67e-02 -2.09e-02 2.23e-01 7.69e-01
Cilium Assembly 189 9.47e-02 3.29e-01 0.089100 8.27e-02 -3.31e-02 4.98e-02 4.33e-01
GOBP PROTEIN LOCALIZATION TO CELL JUNCTION 102 3.20e-01 6.11e-01 0.089100 4.33e-02 7.79e-02 4.50e-01 1.74e-01
GOBP CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 92 3.39e-01 6.28e-01 0.089100 8.88e-02 7.03e-03 1.41e-01 9.07e-01
GOBP GLOMERULAR MESANGIAL CELL PROLIFERATION 13 8.52e-01 9.39e-01 0.089000 1.84e-02 -8.71e-02 9.08e-01 5.87e-01
GOMF PROTEIN DIMERIZATION ACTIVITY 1023 4.08e-06 1.31e-04 0.089000 7.63e-02 -4.59e-02 3.70e-05 1.31e-02
GOMF CARBOXYPEPTIDASE ACTIVITY 45 5.72e-01 7.99e-01 0.089000 -2.72e-02 8.47e-02 7.52e-01 3.25e-01
GOBP INTERLEUKIN 12 PRODUCTION 62 4.81e-01 7.40e-01 0.088900 -4.75e-03 -8.88e-02 9.48e-01 2.26e-01
Mitochondrial calcium ion transport 21 7.82e-01 9.10e-01 0.088900 8.85e-02 9.20e-03 4.83e-01 9.42e-01
GOBP UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS 14 8.56e-01 9.40e-01 0.088900 -7.55e-02 -4.70e-02 6.25e-01 7.61e-01
GOBP REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS 18 8.19e-01 9.27e-01 0.088900 -4.71e-02 -7.54e-02 7.29e-01 5.80e-01
Synaptic adhesion-like molecules 19 7.87e-01 9.13e-01 0.088900 -7.94e-02 3.99e-02 5.49e-01 7.63e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 6 9.27e-01 9.73e-01 0.088800 3.87e-02 -7.99e-02 8.70e-01 7.35e-01
GOBP CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS 177 1.33e-01 3.98e-01 0.088800 8.66e-02 1.97e-02 4.69e-02 6.51e-01
RNA Polymerase II Pre-transcription Events 77 3.82e-01 6.67e-01 0.088800 8.10e-02 -3.64e-02 2.19e-01 5.81e-01
GOBP OLIGOSACCHARIDE BIOSYNTHETIC PROCESS 29 6.92e-01 8.67e-01 0.088700 -5.82e-02 6.69e-02 5.87e-01 5.33e-01
GOBP CELLULAR RESPONSE TO TESTOSTERONE STIMULUS 8 9.10e-01 9.66e-01 0.088700 8.87e-02 1.28e-03 6.64e-01 9.95e-01
GOBP EPITHELIUM DEVELOPMENT 1194 1.60e-06 5.70e-05 0.088700 8.86e-02 2.11e-03 2.47e-07 9.02e-01
GOBP FLOOR PLATE DEVELOPMENT 11 8.77e-01 9.49e-01 0.088600 8.84e-02 -6.97e-03 6.12e-01 9.68e-01
GOBP NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION 21 7.89e-01 9.14e-01 0.088600 2.87e-02 8.38e-02 8.20e-01 5.06e-01
GOBP POSTSYNAPTIC SPECIALIZATION ASSEMBLY 29 7.13e-01 8.76e-01 0.088600 8.61e-03 8.82e-02 9.36e-01 4.11e-01
GOBP DOPAMINE TRANSPORT 44 5.91e-01 8.10e-01 0.088600 -8.41e-03 8.82e-02 9.23e-01 3.12e-01
GOBP INSULIN METABOLIC PROCESS 16 8.39e-01 9.33e-01 0.088500 -5.00e-02 -7.31e-02 7.29e-01 6.13e-01
GOBP MICROTUBULE DEPOLYMERIZATION 43 5.81e-01 8.04e-01 0.088500 7.07e-02 -5.32e-02 4.23e-01 5.46e-01
GOBP BONE CELL DEVELOPMENT 18 8.19e-01 9.27e-01 0.088400 4.14e-02 7.82e-02 7.61e-01 5.66e-01
GOMF SCAVENGER RECEPTOR ACTIVITY 27 7.42e-01 8.89e-01 0.088400 -7.87e-02 -4.04e-02 4.79e-01 7.16e-01
GOBP NEPHRIC DUCT FORMATION 5 9.45e-01 9.80e-01 0.088400 -8.42e-02 -2.71e-02 7.44e-01 9.17e-01
GOBP LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE 52 5.64e-01 7.93e-01 0.088400 -4.39e-02 -7.67e-02 5.84e-01 3.39e-01
GOBP THYMIC T CELL SELECTION 24 7.51e-01 8.92e-01 0.088400 -8.79e-02 9.30e-03 4.56e-01 9.37e-01
Transport to the Golgi and subsequent modification 183 1.21e-01 3.79e-01 0.088300 8.81e-02 6.65e-03 3.98e-02 8.77e-01
GOCC CYTOPLASMIC MICROTUBULE 113 2.42e-01 5.39e-01 0.088300 6.90e-02 -5.52e-02 2.05e-01 3.11e-01
GOBP NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON INTRINSIC APOPTOTIC SIGNALING PATHWAY 12 8.60e-01 9.42e-01 0.088300 6.65e-02 -5.82e-02 6.90e-01 7.27e-01
GOBP REGULATION OF HETEROTYPIC CELL CELL ADHESION 24 7.51e-01 8.92e-01 0.088300 8.78e-02 -9.40e-03 4.56e-01 9.36e-01
GOBP REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS 52 5.35e-01 7.74e-01 0.088300 -1.63e-02 8.68e-02 8.39e-01 2.79e-01
GOMF MISFOLDED PROTEIN BINDING 15 8.49e-01 9.37e-01 0.088300 -6.35e-02 -6.13e-02 6.70e-01 6.81e-01
GOBP PROSTATE GLAND MORPHOGENESIS 27 7.20e-01 8.79e-01 0.088300 2.45e-02 -8.48e-02 8.25e-01 4.46e-01
GOBP CELLULAR RESPONSE TO LIPID 592 9.43e-04 1.32e-02 0.088200 8.62e-02 -1.86e-02 3.38e-04 4.39e-01
Autophagy 149 1.56e-01 4.36e-01 0.088200 5.61e-02 -6.80e-02 2.37e-01 1.52e-01
GOBP POSITIVE REGULATION OF MOLECULAR FUNCTION 1104 2.85e-06 9.52e-05 0.088200 8.48e-02 -2.41e-02 1.96e-06 1.77e-01
GOBP STEROL HOMEOSTASIS 101 2.83e-01 5.80e-01 0.088200 -5.31e-02 7.04e-02 3.57e-01 2.22e-01
GOBP RESPONSE TO ELECTRICAL STIMULUS 44 5.80e-01 8.03e-01 0.088100 7.95e-02 -3.81e-02 3.62e-01 6.62e-01
GOBP COP9 SIGNALOSOME ASSEMBLY 5 9.44e-01 9.79e-01 0.088100 7.60e-03 8.78e-02 9.77e-01 7.34e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 171 1.46e-01 4.21e-01 0.088100 8.59e-02 1.95e-02 5.25e-02 6.61e-01
Defective B4GALT7 causes EDS, progeroid type 17 8.08e-01 9.21e-01 0.088100 -6.51e-02 5.94e-02 6.42e-01 6.72e-01
GOBP UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS 48 5.86e-01 8.06e-01 0.088100 8.35e-02 2.81e-02 3.17e-01 7.36e-01
GOBP ENDOTHELIUM DEVELOPMENT 144 2.00e-01 4.93e-01 0.088000 8.51e-02 2.27e-02 7.80e-02 6.39e-01
GOMF INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 150 1.54e-01 4.35e-01 0.088000 -6.17e-02 6.28e-02 1.92e-01 1.84e-01
GOBP PEPTIDYL AMINO ACID MODIFICATION 801 1.29e-04 2.64e-03 0.088000 8.79e-02 3.22e-03 2.33e-05 8.77e-01
GOBP CILIUM MOVEMENT 204 8.99e-02 3.21e-01 0.087900 -8.69e-02 1.34e-02 3.24e-02 7.42e-01
GOBP POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION 41 6.21e-01 8.29e-01 0.087900 8.79e-02 1.53e-03 3.30e-01 9.86e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 28 7.27e-01 8.82e-01 0.087900 1.31e-02 8.69e-02 9.04e-01 4.26e-01
GOBP REGULATION OF GLUCOSE IMPORT 58 5.29e-01 7.71e-01 0.087900 8.05e-02 3.53e-02 2.89e-01 6.42e-01
GOBP FATTY ACID CATABOLIC PROCESS 104 3.20e-01 6.11e-01 0.087900 7.99e-02 3.65e-02 1.59e-01 5.20e-01
GOBP INNER MITOCHONDRIAL MEMBRANE ORGANIZATION 41 6.01e-01 8.16e-01 0.087800 5.09e-02 -7.16e-02 5.72e-01 4.28e-01
GOMF CYCLOHYDROLASE ACTIVITY 5 9.47e-01 9.80e-01 0.087800 -7.70e-02 -4.23e-02 7.66e-01 8.70e-01
GOBP CELLULAR RESPONSE TO KETONE 101 2.92e-01 5.89e-01 0.087800 8.03e-02 -3.54e-02 1.63e-01 5.38e-01
GOBP INOSITOL TRISPHOSPHATE METABOLIC PROCESS 10 8.84e-01 9.53e-01 0.087800 -4.76e-02 7.37e-02 7.94e-01 6.86e-01
GOBP ONE CARBON METABOLIC PROCESS 37 6.55e-01 8.48e-01 0.087700 8.73e-02 8.30e-03 3.58e-01 9.30e-01
GOCC ER MEMBRANE INSERTION COMPLEX 10 8.88e-01 9.55e-01 0.087700 -8.61e-02 1.69e-02 6.37e-01 9.26e-01
GOMF CAMP RESPONSE ELEMENT BINDING PROTEIN BINDING 8 9.08e-01 9.65e-01 0.087700 8.42e-02 -2.44e-02 6.80e-01 9.05e-01
Formation of RNA Pol II elongation complex 57 5.30e-01 7.71e-01 0.087700 8.49e-02 2.18e-02 2.68e-01 7.76e-01
RNA Polymerase II Transcription Elongation 57 5.30e-01 7.71e-01 0.087700 8.49e-02 2.18e-02 2.68e-01 7.76e-01
GOBP NEGATIVE REGULATION OF PROTEIN MATURATION 26 7.56e-01 8.95e-01 0.087600 5.02e-02 7.19e-02 6.58e-01 5.26e-01
GOBP ODONTOGENESIS OF DENTIN CONTAINING TOOTH 91 3.45e-01 6.34e-01 0.087600 8.71e-02 -9.48e-03 1.51e-01 8.76e-01
GOBP VESICLE ORGANIZATION 357 1.66e-02 1.12e-01 0.087600 8.74e-02 -5.09e-03 4.54e-03 8.69e-01
GOBP REGULATION OF LIGASE ACTIVITY 7 9.17e-01 9.69e-01 0.087600 -5.27e-02 6.99e-02 8.09e-01 7.49e-01
Amino acid transport across the plasma membrane 30 7.07e-01 8.73e-01 0.087600 -5.02e-04 8.76e-02 9.96e-01 4.07e-01
GOCC OUTER MEMBRANE 233 6.15e-02 2.55e-01 0.087500 8.24e-02 -2.95e-02 3.02e-02 4.37e-01
GOMF UBIQUITIN CONJUGATING ENZYME BINDING 31 7.12e-01 8.76e-01 0.087500 8.10e-02 3.30e-02 4.35e-01 7.50e-01
GOBP XENOBIOTIC TRANSMEMBRANE TRANSPORT 17 8.33e-01 9.30e-01 0.087500 5.08e-02 7.12e-02 7.17e-01 6.11e-01
GOBP SYNAPSE ASSEMBLY 196 1.00e-01 3.40e-01 0.087500 8.60e-02 -1.60e-02 3.79e-02 6.99e-01
GOMF HEXOSE TRANSMEMBRANE TRANSPORTER ACTIVITY 25 7.44e-01 8.90e-01 0.087400 -8.54e-02 1.85e-02 4.60e-01 8.73e-01
GOBP RESPONSE TO ETHANOL 120 2.67e-01 5.63e-01 0.087400 2.32e-02 8.42e-02 6.61e-01 1.11e-01
GOCC APICAL JUNCTION COMPLEX 138 2.18e-01 5.13e-01 0.087300 8.49e-02 2.03e-02 8.49e-02 6.81e-01
GOCC TRANSCRIPTION FACTOR TFIIH HOLO COMPLEX 10 8.87e-01 9.55e-01 0.087300 8.33e-02 -2.61e-02 6.48e-01 8.86e-01
GOBP TETRAHYDROFOLATE BIOSYNTHETIC PROCESS 7 9.24e-01 9.71e-01 0.087300 1.02e-02 8.67e-02 9.63e-01 6.91e-01
GOCC ORGANELLE ENVELOPE 1207 7.90e-07 3.12e-05 0.087200 5.72e-02 -6.59e-02 8.27e-04 1.15e-04
GOMF COA LIGASE ACTIVITY 26 7.43e-01 8.89e-01 0.087200 1.94e-03 8.72e-02 9.86e-01 4.41e-01
GOMF SIGNALING RECEPTOR INHIBITOR ACTIVITY 27 7.20e-01 8.79e-01 0.087200 -4.32e-02 7.57e-02 6.98e-01 4.96e-01
GOCC H4 HISTONE ACETYLTRANSFERASE COMPLEX 37 6.36e-01 8.38e-01 0.087200 7.03e-02 -5.15e-02 4.59e-01 5.88e-01
GOMF MAP KINASE ACTIVITY 16 8.30e-01 9.30e-01 0.087100 -8.64e-02 1.14e-02 5.50e-01 9.37e-01
Iron uptake and transport 56 5.04e-01 7.56e-01 0.087100 6.85e-02 -5.38e-02 3.75e-01 4.86e-01
GOBP SUPEROXIDE METABOLIC PROCESS 64 4.97e-01 7.52e-01 0.087100 2.61e-02 8.31e-02 7.18e-01 2.50e-01
GOBP REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 73 4.45e-01 7.16e-01 0.087100 -8.57e-02 -1.58e-02 2.06e-01 8.15e-01
GOBP NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS 41 6.44e-01 8.42e-01 0.087100 4.01e-02 7.73e-02 6.57e-01 3.92e-01
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION 12 8.63e-01 9.43e-01 0.087100 6.87e-02 -5.35e-02 6.80e-01 7.48e-01
GOCC LATERAL PLASMA MEMBRANE 64 5.05e-01 7.57e-01 0.087100 7.54e-02 4.35e-02 2.97e-01 5.48e-01
GOBP CELL SURFACE RECEPTOR SIGNALING PATHWAY VIA STAT 178 1.18e-01 3.74e-01 0.087000 -4.03e-02 7.71e-02 3.54e-01 7.58e-02
GOBP POSITIVE REGULATION OF KINASE ACTIVITY 285 3.40e-02 1.79e-01 0.087000 8.01e-02 -3.40e-02 2.00e-02 3.23e-01
GOBP CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS 155 1.64e-01 4.48e-01 0.087000 8.51e-02 -1.80e-02 6.75e-02 6.98e-01
GOBP AMINE CATABOLIC PROCESS 16 8.43e-01 9.36e-01 0.086900 4.25e-02 7.58e-02 7.68e-01 5.99e-01
GOCC MHC CLASS II PROTEIN COMPLEX 15 8.38e-01 9.33e-01 0.086900 2.02e-02 -8.45e-02 8.92e-01 5.71e-01
GOBP REGULATION OF PROTEIN MODIFICATION PROCESS 1175 2.19e-06 7.53e-05 0.086900 8.51e-02 -1.76e-02 8.90e-07 3.09e-01
GOMF HYALURONONGLUCOSAMINIDASE ACTIVITY 8 9.19e-01 9.69e-01 0.086800 6.36e-02 5.91e-02 7.55e-01 7.72e-01
GOBP BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 174 1.43e-01 4.14e-01 0.086800 8.67e-02 4.35e-03 4.85e-02 9.21e-01
GOBP ENDOPLASMIC RETICULUM ORGANIZATION 95 3.18e-01 6.10e-01 0.086700 4.98e-02 -7.10e-02 4.01e-01 2.32e-01
GOBP NUCLEOSIDE DIPHOSPHATE CATABOLIC PROCESS 100 3.30e-01 6.21e-01 0.086700 1.06e-02 8.61e-02 8.54e-01 1.37e-01
GOCC PERINUCLEAR REGION OF CYTOPLASM 706 4.47e-04 7.17e-03 0.086700 8.67e-02 2.87e-03 8.69e-05 8.97e-01
GOBP POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS 25 7.68e-01 9.02e-01 0.086700 7.03e-02 5.08e-02 5.43e-01 6.60e-01
GOBP SUCCINYL COA METABOLIC PROCESS 10 8.93e-01 9.57e-01 0.086700 1.74e-03 -8.67e-02 9.92e-01 6.35e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION 34 6.62e-01 8.51e-01 0.086700 5.38e-02 -6.80e-02 5.87e-01 4.93e-01
Downregulation of ERBB2 signaling 29 7.05e-01 8.72e-01 0.086600 4.87e-02 -7.16e-02 6.50e-01 5.05e-01
AURKA Activation by TPX2 68 4.67e-01 7.29e-01 0.086600 8.65e-02 4.15e-03 2.17e-01 9.53e-01
GOBP PLATELET ACTIVATION 132 2.04e-01 4.98e-01 0.086600 6.03e-02 -6.21e-02 2.32e-01 2.18e-01
GOBP REVERSIBLE DIFFERENTIATION 11 8.91e-01 9.57e-01 0.086500 5.75e-02 6.47e-02 7.41e-01 7.10e-01
GOCC 9PLUS0 NON MOTILE CILIUM 120 2.68e-01 5.65e-01 0.086500 1.40e-02 8.54e-02 7.92e-01 1.06e-01
GOCC COMPLEX OF COLLAGEN TRIMERS 19 8.20e-01 9.27e-01 0.086500 -6.56e-02 -5.64e-02 6.21e-01 6.70e-01
GOBP CHEMOKINE PRODUCTION 101 3.02e-01 5.97e-01 0.086500 -3.66e-02 7.84e-02 5.25e-01 1.74e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL DEVELOPMENT 6 9.30e-01 9.74e-01 0.086400 -5.08e-02 6.98e-02 8.29e-01 7.67e-01
GOBP SNRNA TRANSPORT 6 9.35e-01 9.75e-01 0.086300 -2.16e-03 -8.63e-02 9.93e-01 7.14e-01
GOBP IMMUNOGLOBULIN PRODUCTION 102 2.95e-01 5.92e-01 0.086200 6.84e-02 -5.25e-02 2.32e-01 3.60e-01
GOBP GLYCOLIPID BIOSYNTHETIC PROCESS 77 4.18e-01 6.98e-01 0.086200 8.70e-03 -8.58e-02 8.95e-01 1.93e-01
GOBP MYELOID CELL DIFFERENTIATION 424 7.31e-03 6.30e-02 0.086200 7.85e-02 -3.57e-02 5.57e-03 2.08e-01
ADORA2B mediated anti-inflammatory cytokines production 42 6.34e-01 8.36e-01 0.086200 1.78e-02 8.43e-02 8.42e-01 3.44e-01
GOBP SULFUR COMPOUND CATABOLIC PROCESS 40 6.53e-01 8.47e-01 0.086200 -8.05e-02 -3.07e-02 3.78e-01 7.37e-01
GOBP DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS 103 2.97e-01 5.94e-01 0.086200 7.78e-02 -3.72e-02 1.73e-01 5.15e-01
GOBP REGULATION OF INTEGRIN ACTIVATION 17 8.22e-01 9.27e-01 0.086200 1.86e-02 -8.41e-02 8.94e-01 5.48e-01
GOBP CARBOHYDRATE CATABOLIC PROCESS 162 1.66e-01 4.50e-01 0.086100 6.70e-04 8.61e-02 9.88e-01 5.86e-02
GOMF NEUROPEPTIDE BINDING 30 7.07e-01 8.73e-01 0.086100 -8.34e-02 2.13e-02 4.29e-01 8.40e-01
GOBP POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING 42 6.32e-01 8.35e-01 0.086100 8.51e-02 1.28e-02 3.40e-01 8.86e-01
GOBP POSITIVE REGULATION OF HYDROLASE ACTIVITY 430 7.80e-03 6.58e-02 0.086000 8.38e-02 -1.94e-02 2.89e-03 4.90e-01
Cytokine Signaling in Immune system 723 2.40e-04 4.36e-03 0.086000 5.07e-02 -6.94e-02 2.03e-02 1.47e-03
GOBP REGULATION OF MESENCHYMAL CELL PROLIFERATION 33 6.75e-01 8.59e-01 0.085900 5.04e-02 -6.96e-02 6.16e-01 4.89e-01
GOBP NEGATIVE REGULATION OF BINDING 106 3.15e-01 6.08e-01 0.085900 8.53e-02 1.02e-02 1.29e-01 8.57e-01
GOBP SODIUM INDEPENDENT ORGANIC ANION TRANSPORT 15 8.36e-01 9.32e-01 0.085800 -6.30e-02 5.83e-02 6.73e-01 6.96e-01
GOMF ENDOPEPTIDASE ACTIVITY 373 1.26e-02 9.27e-02 0.085800 -6.31e-02 5.82e-02 3.63e-02 5.38e-02
GOBP CELLULAR RESPONSE TO GLUCAGON STIMULUS 11 8.82e-01 9.51e-01 0.085800 1.98e-02 -8.35e-02 9.10e-01 6.32e-01
GOMF CARD DOMAIN BINDING 16 8.43e-01 9.36e-01 0.085800 2.24e-02 8.28e-02 8.77e-01 5.66e-01
GOBP REGULATION OF MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS 7 9.20e-01 9.70e-01 0.085700 6.77e-02 -5.25e-02 7.56e-01 8.10e-01
GOMF AMINO ACID BINDING 47 6.10e-01 8.22e-01 0.085600 8.08e-02 2.82e-02 3.38e-01 7.38e-01
GOMF ENZYME REGULATOR ACTIVITY 1239 1.88e-06 6.60e-05 0.085600 8.47e-02 -1.22e-02 5.24e-07 4.71e-01
GOBP RESPONSE TO BACTERIUM 660 1.39e-03 1.79e-02 0.085500 -7.04e-02 -4.86e-02 2.02e-03 3.34e-02
GOBP MONOCARBOXYLIC ACID CATABOLIC PROCESS 128 2.70e-01 5.67e-01 0.085500 4.65e-02 7.18e-02 3.64e-01 1.61e-01
GOBP DICARBOXYLIC ACID METABOLIC PROCESS 93 3.72e-01 6.59e-01 0.085500 1.82e-02 8.35e-02 7.61e-01 1.64e-01
GOMF CELL ADHESION MOLECULE BINDING 545 2.97e-03 3.19e-02 0.085400 8.54e-02 2.85e-03 6.53e-04 9.09e-01
GOBP HORMONE TRANSPORT 315 3.99e-02 1.97e-01 0.085400 7.74e-02 3.61e-02 1.82e-02 2.71e-01
GOMF DNA POLYMERASE BINDING 21 8.02e-01 9.19e-01 0.085300 2.74e-02 8.08e-02 8.28e-01 5.21e-01
GOBP POSITIVE REGULATION OF CELL POPULATION PROLIFERATION 938 3.35e-05 8.44e-04 0.085300 8.09e-02 -2.72e-02 2.69e-05 1.57e-01
GOBP POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 154 2.07e-01 5.01e-01 0.085300 7.52e-02 4.03e-02 1.07e-01 3.88e-01
GOMF ATPASE COUPLED MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 52 5.87e-01 8.07e-01 0.085300 4.29e-02 7.37e-02 5.92e-01 3.58e-01
GOBP ACTION POTENTIAL 163 1.50e-01 4.29e-01 0.085300 -4.64e-02 7.16e-02 3.07e-01 1.15e-01
GOBP RESPONSE TO CAFFEINE 15 8.44e-01 9.36e-01 0.085300 -1.95e-02 8.30e-02 8.96e-01 5.78e-01
GOBP POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 62 5.18e-01 7.63e-01 0.085200 8.34e-02 1.75e-02 2.56e-01 8.11e-01
GOBP POSITIVE REGULATION OF T CELL MIGRATION 33 6.91e-01 8.67e-01 0.085200 1.45e-02 -8.40e-02 8.86e-01 4.04e-01
GOBP REGULATION OF BONE MINERALIZATION 77 4.50e-01 7.19e-01 0.085200 7.97e-02 3.01e-02 2.26e-01 6.48e-01
GOBP BONE RESORPTION 66 5.13e-01 7.61e-01 0.085200 6.12e-02 5.93e-02 3.90e-01 4.05e-01
GOBP NEGATIVE REGULATION OF GLUCOSE IMPORT 16 8.29e-01 9.30e-01 0.085100 5.69e-02 -6.34e-02 6.94e-01 6.61e-01
GOBP CYTOPLASMIC MICROTUBULE ORGANIZATION 58 5.12e-01 7.61e-01 0.085100 7.54e-02 -3.95e-02 3.21e-01 6.03e-01
GOBP REGULATION OF CELL ADHESION 781 2.50e-04 4.53e-03 0.085100 8.50e-02 -4.79e-03 5.38e-05 8.20e-01
GOCC TERTIARY GRANULE 158 1.65e-01 4.49e-01 0.085100 -7.88e-02 3.19e-02 8.72e-02 4.88e-01
GOBP MICROTUBULE ORGANIZING CENTER ORGANIZATION 148 1.85e-01 4.75e-01 0.085100 7.82e-02 -3.36e-02 1.01e-01 4.81e-01
Synthesis of substrates in N-glycan biosythesis 63 4.95e-01 7.51e-01 0.085100 -1.50e-02 8.37e-02 8.37e-01 2.50e-01
GOBP CELL SURFACE PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 79 4.48e-01 7.17e-01 0.085000 4.17e-02 7.41e-02 5.22e-01 2.55e-01
RHO GTPases Activate NADPH Oxidases 21 8.06e-01 9.20e-01 0.084900 3.50e-02 7.73e-02 7.81e-01 5.40e-01
GOBP PROTEIN TARGETING TO MITOCHONDRION 101 3.12e-01 6.06e-01 0.084900 4.42e-02 -7.25e-02 4.43e-01 2.08e-01
GOBP POSITIVE REGULATION OF TRANSFERASE ACTIVITY 353 1.76e-02 1.16e-01 0.084800 6.63e-02 -5.29e-02 3.22e-02 8.80e-02
GOBP RESPONSE TO RADIATION 414 9.69e-03 7.70e-02 0.084800 7.82e-02 -3.28e-02 6.31e-03 2.53e-01
GOBP PURINE RIBONUCLEOSIDE METABOLIC PROCESS 20 7.94e-01 9.16e-01 0.084800 7.20e-02 -4.48e-02 5.77e-01 7.29e-01
GOCC COHESIN COMPLEX 9 9.14e-01 9.67e-01 0.084800 -6.50e-02 -5.45e-02 7.36e-01 7.77e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 50 5.68e-01 7.96e-01 0.084700 8.00e-02 -2.81e-02 3.28e-01 7.31e-01
GOBP REGULATION OF LEUKOCYTE MEDIATED IMMUNITY 238 8.81e-02 3.17e-01 0.084700 -2.84e-02 -7.98e-02 4.50e-01 3.39e-02
GOBP MESENCHYMAL STEM CELL PROLIFERATION 10 9.04e-01 9.63e-01 0.084700 -6.70e-02 -5.18e-02 7.14e-01 7.77e-01
GRB2 events in ERBB2 signaling 16 8.33e-01 9.30e-01 0.084700 3.67e-02 -7.63e-02 7.99e-01 5.97e-01
GOBP REGULATION OF CHEMOTAXIS 200 1.20e-01 3.77e-01 0.084700 8.44e-02 6.22e-03 3.95e-02 8.80e-01
GOBP CELL JUNCTION ORGANIZATION 724 6.47e-04 9.69e-03 0.084700 8.28e-02 1.75e-02 1.47e-04 4.23e-01
GOBP NEURON PROJECTION ORGANIZATION 87 4.18e-01 6.99e-01 0.084700 6.98e-02 4.79e-02 2.60e-01 4.40e-01
GOMF ORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 258 6.14e-02 2.55e-01 0.084600 -7.73e-03 8.43e-02 8.31e-01 1.98e-02
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM 41 6.53e-01 8.47e-01 0.084600 -2.10e-02 -8.19e-02 8.16e-01 3.64e-01
GOCC MATRIX SIDE OF MITOCHONDRIAL INNER MEMBRANE 6 9.34e-01 9.75e-01 0.084600 7.48e-02 -3.93e-02 7.51e-01 8.67e-01
GOBP GTP BIOSYNTHETIC PROCESS 11 8.96e-01 9.59e-01 0.084600 -5.97e-02 -5.98e-02 7.32e-01 7.31e-01
GOMF METAL CLUSTER BINDING 71 4.67e-01 7.29e-01 0.084500 8.45e-02 8.18e-04 2.18e-01 9.90e-01
GOBP VESICLE MEDIATED TRANSPORT 1476 7.10e-07 2.86e-05 0.084500 7.97e-02 2.80e-02 2.97e-07 7.16e-02
GOBP POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 40 6.62e-01 8.51e-01 0.084500 -2.35e-02 -8.12e-02 7.97e-01 3.74e-01
Selective autophagy 84 4.11e-01 6.92e-01 0.084500 -6.80e-03 -8.42e-02 9.14e-01 1.82e-01
Other semaphorin interactions 18 8.26e-01 9.28e-01 0.084400 8.42e-02 6.51e-03 5.36e-01 9.62e-01
GOMF AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 93 3.92e-01 6.75e-01 0.084400 7.50e-02 3.86e-02 2.11e-01 5.20e-01
GOBP REGULATION OF PROTON TRANSPORT 16 8.51e-01 9.38e-01 0.084400 7.36e-02 4.13e-02 6.10e-01 7.75e-01
GOBP NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION 13 8.78e-01 9.50e-01 0.084400 4.95e-02 6.84e-02 7.57e-01 6.70e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION 57 5.48e-01 7.83e-01 0.084400 -8.39e-02 -8.63e-03 2.73e-01 9.10e-01
Class A/1 (Rhodopsin-like receptors) 313 3.15e-02 1.71e-01 0.084400 -2.65e-02 8.01e-02 4.20e-01 1.48e-02
GOBP RESPONSE TO HISTAMINE 10 9.02e-01 9.61e-01 0.084300 8.13e-02 2.23e-02 6.56e-01 9.03e-01
Fatty acyl-CoA biosynthesis 36 6.95e-01 8.68e-01 0.084300 3.42e-02 7.71e-02 7.23e-01 4.24e-01
MET activates PTK2 signaling 30 7.22e-01 8.80e-01 0.084300 8.39e-02 -8.51e-03 4.27e-01 9.36e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION 269 4.72e-02 2.19e-01 0.084300 5.55e-02 -6.34e-02 1.17e-01 7.33e-02
GOBP RELAXATION OF MUSCLE 33 6.85e-01 8.64e-01 0.084300 -5.30e-02 6.55e-02 5.98e-01 5.15e-01
GOMF LIPID BINDING 826 3.34e-04 5.69e-03 0.084300 7.47e-02 3.91e-02 2.67e-04 5.61e-02
GOMF TROPOMYOSIN BINDING 15 8.60e-01 9.42e-01 0.084200 -7.52e-02 -3.80e-02 6.14e-01 7.99e-01
GOBP NOREPINEPHRINE TRANSPORT 23 7.70e-01 9.03e-01 0.084200 4.23e-02 -7.29e-02 7.26e-01 5.45e-01
GOBP MODULATION BY HOST OF VIRAL GENOME REPLICATION 23 7.93e-01 9.15e-01 0.084200 -3.39e-02 -7.71e-02 7.78e-01 5.22e-01
Anti-inflammatory response favouring Leishmania parasite infection 73 4.60e-01 7.24e-01 0.084100 2.24e-04 8.41e-02 9.97e-01 2.14e-01
Leishmania parasite growth and survival 73 4.60e-01 7.24e-01 0.084100 2.24e-04 8.41e-02 9.97e-01 2.14e-01
GOCC AGGRESOME 33 7.20e-01 8.79e-01 0.084100 7.01e-02 4.65e-02 4.86e-01 6.44e-01
GOBP CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 119 3.05e-01 5.98e-01 0.084000 -3.65e-02 -7.57e-02 4.92e-01 1.54e-01
GOBP MICROTUBULE BASED TRANSPORT 208 1.03e-01 3.45e-01 0.084000 8.10e-02 -2.24e-02 4.40e-02 5.78e-01
GOCC CALCIUM CHANNEL COMPLEX 68 4.74e-01 7.34e-01 0.084000 -8.16e-02 2.02e-02 2.45e-01 7.73e-01
GOBP TRACHEA DEVELOPMENT 18 8.22e-01 9.27e-01 0.084000 8.26e-02 -1.54e-02 5.44e-01 9.10e-01
GOBP TYPE I INTERFERON PRODUCTION 119 2.60e-01 5.57e-01 0.084000 4.77e-02 -6.92e-02 3.69e-01 1.92e-01
GOBP POSITIVE REGULATION OF EXIT FROM MITOSIS 5 9.50e-01 9.81e-01 0.084000 -8.08e-02 -2.28e-02 7.54e-01 9.30e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE 33 7.17e-01 8.78e-01 0.084000 7.85e-02 2.99e-02 4.35e-01 7.67e-01
Lipophagy 9 9.15e-01 9.68e-01 0.084000 -6.49e-02 -5.32e-02 7.36e-01 7.82e-01
GOBP RESPONSE TO CARBOHYDRATE 233 7.62e-02 2.91e-01 0.083900 7.78e-02 -3.15e-02 4.07e-02 4.08e-01
Nucleotide salvage 20 7.96e-01 9.17e-01 0.083900 5.47e-02 -6.37e-02 6.72e-01 6.22e-01
GOBP POSITIVE REGULATION OF CELL ADHESION 473 5.52e-03 5.06e-02 0.083900 7.55e-02 -3.66e-02 4.89e-03 1.73e-01
GOBP NEGATIVE REGULATION OF PHOSPHORYLATION 306 3.47e-02 1.82e-01 0.083900 7.84e-02 -2.98e-02 1.83e-02 3.69e-01
GOCC COMMITMENT COMPLEX 5 9.50e-01 9.81e-01 0.083900 -2.40e-02 -8.04e-02 9.26e-01 7.55e-01
GOBP PYRUVATE METABOLIC PROCESS 114 2.93e-01 5.90e-01 0.083900 -1.16e-02 8.31e-02 8.30e-01 1.25e-01
GOBP REGULATION OF SARCOMERE ORGANIZATION 9 9.11e-01 9.67e-01 0.083800 1.39e-02 8.27e-02 9.42e-01 6.68e-01
GOBP POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 52 6.01e-01 8.16e-01 0.083800 6.21e-02 5.63e-02 4.39e-01 4.82e-01
GOCC GOLGI APPARATUS 1550 5.33e-07 2.24e-05 0.083800 7.68e-02 3.36e-02 4.45e-07 2.72e-02
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY 49 5.74e-01 8.00e-01 0.083800 6.64e-02 -5.11e-02 4.21e-01 5.36e-01
GOBP REGULATION OF GERMINAL CENTER FORMATION 8 9.16e-01 9.68e-01 0.083800 7.99e-02 -2.51e-02 6.96e-01 9.02e-01
GOBP RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS 208 9.82e-02 3.36e-01 0.083800 7.19e-02 -4.30e-02 7.40e-02 2.85e-01
GOBP POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS 69 4.60e-01 7.24e-01 0.083800 7.07e-02 -4.50e-02 3.10e-01 5.18e-01
Gap junction trafficking and regulation 48 5.89e-01 8.09e-01 0.083700 -2.69e-02 7.93e-02 7.47e-01 3.42e-01
GOBP POTASSIUM ION TRANSPORT 239 7.03e-02 2.78e-01 0.083700 -7.27e-02 4.14e-02 5.27e-02 2.70e-01
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS 60 5.49e-01 7.84e-01 0.083700 7.72e-02 3.22e-02 3.01e-01 6.66e-01
GOBP REGULATION OF NEUROTRANSMITTER TRANSPORT 94 3.81e-01 6.66e-01 0.083700 1.37e-02 8.25e-02 8.18e-01 1.67e-01
GOBP NEGATIVE REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS 5 9.50e-01 9.81e-01 0.083600 -8.12e-02 -2.00e-02 7.53e-01 9.38e-01
GOBP CONVERGENT EXTENSION INVOLVED IN ORGANOGENESIS 5 9.50e-01 9.81e-01 0.083500 -1.57e-02 -8.20e-02 9.52e-01 7.51e-01
GOBP ALKANESULFONATE TRANSMEMBRANE TRANSPORT 8 9.24e-01 9.71e-01 0.083500 3.94e-02 7.36e-02 8.47e-01 7.18e-01
GOBP RECEPTOR CLUSTERING 57 5.56e-01 7.89e-01 0.083500 1.07e-02 8.28e-02 8.89e-01 2.80e-01
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION 35 6.93e-01 8.68e-01 0.083400 8.34e-02 -2.39e-04 3.93e-01 9.98e-01
GOBP TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 113 2.85e-01 5.82e-01 0.083400 7.15e-02 -4.28e-02 1.89e-01 4.32e-01
GOBP NEGATIVE REGULATION OF STEROID METABOLIC PROCESS 32 6.99e-01 8.70e-01 0.083300 5.45e-02 -6.30e-02 5.94e-01 5.37e-01
Cell-Cell communication 148 2.34e-01 5.31e-01 0.083200 7.63e-02 3.34e-02 1.09e-01 4.83e-01
GOMF MODIFIED AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 30 7.47e-01 8.91e-01 0.083200 4.93e-02 6.70e-02 6.40e-01 5.25e-01
GOCC AUTOPHAGOSOME MEMBRANE 52 6.04e-01 8.19e-01 0.083200 5.06e-02 6.61e-02 5.28e-01 4.10e-01
GOBP NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION 27 7.67e-01 9.01e-01 0.083200 7.56e-02 3.48e-02 4.97e-01 7.54e-01
GOMF PROCOLLAGEN PROLINE DIOXYGENASE ACTIVITY 8 9.23e-01 9.71e-01 0.083200 7.95e-02 2.44e-02 6.97e-01 9.05e-01
C-type lectin receptors (CLRs) 126 2.46e-01 5.42e-01 0.083200 6.26e-02 -5.48e-02 2.25e-01 2.88e-01
GOMF CARBOHYDRATE TRANSMEMBRANE TRANSPORTER ACTIVITY 40 6.49e-01 8.44e-01 0.083200 -7.99e-02 2.30e-02 3.82e-01 8.01e-01
GOBP PROTECTION FROM NATURAL KILLER CELL MEDIATED CYTOTOXICITY 6 9.44e-01 9.79e-01 0.083200 -6.45e-02 -5.24e-02 7.84e-01 8.24e-01
GOBP POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 1179 7.00e-06 2.12e-04 0.083100 8.22e-02 -1.23e-02 1.99e-06 4.77e-01
GOBP CIRCADIAN SLEEP WAKE CYCLE SLEEP 16 8.49e-01 9.37e-01 0.083100 8.27e-02 8.29e-03 5.67e-01 9.54e-01
GOBP DEVELOPMENTAL PIGMENTATION 46 6.41e-01 8.40e-01 0.083100 -4.53e-02 -6.96e-02 5.95e-01 4.14e-01
GOBP SECONDARY METABOLIC PROCESS 54 5.95e-01 8.13e-01 0.083000 6.30e-02 5.41e-02 4.23e-01 4.91e-01
GOBP POSITIVE REGULATION OF PROTEOLYSIS 326 3.02e-02 1.66e-01 0.082900 7.69e-02 -3.10e-02 1.70e-02 3.36e-01
GOBP DICARBOXYLIC ACID BIOSYNTHETIC PROCESS 12 8.76e-01 9.49e-01 0.082900 -4.09e-02 7.21e-02 8.06e-01 6.65e-01
GOBP POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 21 8.16e-01 9.25e-01 0.082900 7.24e-02 4.05e-02 5.66e-01 7.48e-01
GOBP PROSTATE GLAND DEVELOPMENT 48 5.96e-01 8.14e-01 0.082800 2.64e-02 -7.85e-02 7.52e-01 3.47e-01
GOBP CARDIAC MUSCLE CONTRACTION 138 2.22e-01 5.17e-01 0.082800 -7.14e-02 4.18e-02 1.48e-01 3.96e-01
GOBP PYRIMIDINE RIBONUCLEOTIDE BIOSYNTHETIC PROCESS 22 7.95e-01 9.16e-01 0.082800 8.25e-02 -6.90e-03 5.03e-01 9.55e-01
GOCC CUL5 RING UBIQUITIN LIGASE COMPLEX 10 9.00e-01 9.61e-01 0.082700 -1.41e-02 8.15e-02 9.39e-01 6.55e-01
GOBP PLASMA MEMBRANE REPAIR 27 7.68e-01 9.02e-01 0.082700 -3.27e-02 -7.60e-02 7.69e-01 4.94e-01
GOBP GLYCOPROTEIN BIOSYNTHETIC PROCESS 315 4.90e-02 2.23e-01 0.082700 3.71e-02 7.40e-02 2.58e-01 2.40e-02
GOBP POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 132 2.65e-01 5.61e-01 0.082700 -1.07e-02 -8.20e-02 8.32e-01 1.04e-01
GOBP REGULATION OF B CELL ACTIVATION 124 2.60e-01 5.57e-01 0.082600 4.00e-02 -7.23e-02 4.41e-01 1.65e-01
GOBP AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS 93 3.72e-01 6.58e-01 0.082600 7.95e-02 -2.26e-02 1.85e-01 7.06e-01
GOBP REGULATION OF APOPTOTIC PROCESS IN BONE MARROW CELL 5 9.47e-01 9.80e-01 0.082500 -6.61e-02 4.94e-02 7.98e-01 8.48e-01
GOBP DESMOSOME ORGANIZATION 10 9.01e-01 9.61e-01 0.082500 8.22e-02 -6.46e-03 6.52e-01 9.72e-01
GOCC ATG12 ATG5 ATG16 COMPLEX 6 9.41e-01 9.77e-01 0.082500 8.23e-02 4.73e-03 7.27e-01 9.84e-01
GOBP LOCOMOTORY EXPLORATION BEHAVIOR 16 8.39e-01 9.33e-01 0.082400 5.17e-02 -6.42e-02 7.20e-01 6.57e-01
GOBP 4 HYDROXYPROLINE METABOLIC PROCESS 12 8.92e-01 9.57e-01 0.082400 7.01e-02 4.33e-02 6.74e-01 7.95e-01
GOBP POSITIVE REGULATION OF B CELL ACTIVATION 80 4.19e-01 6.99e-01 0.082400 6.83e-02 -4.60e-02 2.91e-01 4.77e-01
Interconversion of nucleotide di- and triphosphates 29 7.46e-01 8.91e-01 0.082400 5.49e-03 8.22e-02 9.59e-01 4.44e-01
GOBP TIGHT JUNCTION ORGANIZATION 80 4.40e-01 7.13e-01 0.082300 8.22e-02 -4.37e-03 2.04e-01 9.46e-01
GOBP ENDOTHELIAL CELL PROLIFERATION 196 1.34e-01 4.00e-01 0.082300 8.20e-02 -7.00e-03 4.77e-02 8.66e-01
GOBP POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS 19 8.27e-01 9.29e-01 0.082300 -8.13e-02 -1.25e-02 5.39e-01 9.25e-01
GOMF ALCOHOL TRANSMEMBRANE TRANSPORTER ACTIVITY 6 9.44e-01 9.79e-01 0.082300 -6.99e-02 -4.35e-02 7.67e-01 8.54e-01
GOBP POSITIVE REGULATION OF POTASSIUM ION TRANSPORT 41 6.58e-01 8.50e-01 0.082200 9.15e-04 -8.22e-02 9.92e-01 3.62e-01
GOMF INTRAMOLECULAR OXIDOREDUCTASE ACTIVITY 52 5.89e-01 8.09e-01 0.082200 -8.22e-02 -2.64e-05 3.05e-01 1.00e+00
GOBP UDP N ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORT 5 9.52e-01 9.82e-01 0.082200 -2.00e-02 -7.97e-02 9.38e-01 7.58e-01
GOMF UDP N ACETYLGLUCOSAMINE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 9.52e-01 9.82e-01 0.082200 -2.00e-02 -7.97e-02 9.38e-01 7.58e-01
Disease 1704 3.40e-08 1.85e-06 0.082200 5.65e-02 -5.97e-02 1.03e-04 4.18e-05
GOBP REGULATION OF MONOATOMIC ION TRANSPORT 445 1.29e-02 9.44e-02 0.082200 8.14e-02 1.16e-02 3.26e-03 6.76e-01
GOBP POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY 207 1.29e-01 3.92e-01 0.082100 8.16e-02 9.21e-03 4.30e-02 8.19e-01
GOMF PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY 16 8.44e-01 9.36e-01 0.082100 7.79e-02 -2.61e-02 5.90e-01 8.57e-01
GOBP POSITIVE REGULATION OF STEROID METABOLIC PROCESS 27 7.45e-01 8.91e-01 0.082100 -6.01e-02 5.58e-02 5.89e-01 6.16e-01
GOMF AMINO ACID PROTON SYMPORTER ACTIVITY 6 9.43e-01 9.78e-01 0.082000 1.74e-02 8.02e-02 9.41e-01 7.34e-01
G beta:gamma signalling through PI3Kgamma 25 7.63e-01 9.00e-01 0.082000 -6.99e-02 4.30e-02 5.45e-01 7.10e-01
Peptide ligand-binding receptors 188 1.51e-01 4.29e-01 0.082000 -1.52e-04 8.20e-02 9.97e-01 5.24e-02
GOBP RECEPTOR MEDIATED ENDOCYTOSIS 254 9.44e-02 3.29e-01 0.082000 5.69e-02 5.90e-02 1.18e-01 1.05e-01
GOBP REGULATION OF NEUTROPHIL MIGRATION 40 6.48e-01 8.44e-01 0.082000 -6.58e-02 4.89e-02 4.71e-01 5.92e-01
GOBP VESICLE DOCKING INVOLVED IN EXOCYTOSIS 35 7.03e-01 8.71e-01 0.082000 8.20e-02 2.12e-03 4.01e-01 9.83e-01
GOBP LEUKOTRIENE BIOSYNTHETIC PROCESS 17 8.37e-01 9.32e-01 0.082000 8.01e-02 -1.73e-02 5.67e-01 9.02e-01
GOBP ALCOHOL BIOSYNTHETIC PROCESS 136 2.35e-01 5.32e-01 0.082000 -3.66e-02 7.34e-02 4.62e-01 1.40e-01
GOBP CELL MATURATION 201 1.54e-01 4.33e-01 0.082000 6.30e-02 5.24e-02 1.24e-01 2.00e-01
GOBP ZINC ION TRANSPORT 29 7.31e-01 8.84e-01 0.081900 6.75e-02 -4.64e-02 5.29e-01 6.66e-01
GOMF LIPID TRANSPORTER ACTIVITY 164 2.11e-01 5.06e-01 0.081900 3.36e-02 7.47e-02 4.58e-01 9.86e-02
GOBP POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION 42 6.59e-01 8.50e-01 0.081900 -9.50e-03 -8.14e-02 9.15e-01 3.62e-01
GOMF ATPASE COUPLED ION TRANSMEMBRANE TRANSPORTER ACTIVITY 24 7.94e-01 9.16e-01 0.081900 7.67e-02 2.87e-02 5.15e-01 8.08e-01
GOBP ORGANELLE FISSION 485 5.96e-03 5.37e-02 0.081900 6.79e-02 -4.58e-02 1.05e-02 8.37e-02
GOBP REGULATION OF CELL ACTIVATION 615 1.53e-03 1.94e-02 0.081900 5.30e-02 -6.24e-02 2.49e-02 8.19e-03
GOCC SARCOPLASMIC RETICULUM MEMBRANE 42 6.49e-01 8.44e-01 0.081900 -1.27e-02 8.09e-02 8.87e-01 3.64e-01
GOBP POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 77 4.87e-01 7.45e-01 0.081800 6.57e-02 4.88e-02 3.19e-01 4.59e-01
GOBP ETHER METABOLIC PROCESS 26 7.63e-01 9.00e-01 0.081800 8.01e-02 -1.67e-02 4.80e-01 8.83e-01
GOMF LYSOPHOSPHATIDIC ACID PHOSPHATASE ACTIVITY 7 9.37e-01 9.76e-01 0.081800 6.26e-02 5.27e-02 7.74e-01 8.09e-01
GOBP RESPONSE TO WATER 13 8.76e-01 9.49e-01 0.081800 -6.10e-03 8.16e-02 9.70e-01 6.11e-01
GOCC CALCIUM AND CALMODULIN DEPENDENT PROTEIN KINASE COMPLEX 5 9.48e-01 9.80e-01 0.081800 -4.74e-02 6.67e-02 8.54e-01 7.96e-01
GOBP NEGATIVE REGULATION OF WOUND HEALING 74 5.01e-01 7.54e-01 0.081800 6.36e-02 5.15e-02 3.44e-01 4.44e-01
GOCC TIGHT JUNCTION 121 3.08e-01 6.01e-01 0.081700 8.01e-02 1.61e-02 1.28e-01 7.60e-01
GOBP POSITIVE REGULATION OF MEMORY T CELL DIFFERENTIATION 9 9.12e-01 9.67e-01 0.081700 -1.17e-02 8.09e-02 9.52e-01 6.74e-01
GOBP CELLULAR LIPID CATABOLIC PROCESS 234 1.13e-01 3.64e-01 0.081700 3.98e-02 7.13e-02 2.94e-01 6.01e-02
GOMF PLATELET DERIVED GROWTH FACTOR BINDING 11 8.96e-01 9.58e-01 0.081700 -2.34e-03 -8.16e-02 9.89e-01 6.39e-01
Gap junction trafficking 46 6.16e-01 8.26e-01 0.081700 -2.94e-02 7.62e-02 7.30e-01 3.71e-01
GOMF PROTEOGLYCAN BINDING 36 6.96e-01 8.68e-01 0.081600 -8.16e-02 2.79e-03 3.97e-01 9.77e-01
GOBP RESPONSE TO CHEMOKINE 96 4.04e-01 6.87e-01 0.081600 -7.40e-02 -3.46e-02 2.10e-01 5.59e-01
GOBP NEUROTRANSMITTER SECRETION 141 2.39e-01 5.36e-01 0.081600 -9.13e-03 8.11e-02 8.52e-01 9.64e-02
GOBP POSITIVE REGULATION OF CELL CELL ADHESION 318 3.50e-02 1.83e-01 0.081600 4.22e-02 -6.98e-02 1.95e-01 3.23e-02
GOBP RESPONSE TO ORGANIC CYCLIC COMPOUND 861 1.72e-04 3.35e-03 0.081600 7.74e-02 -2.57e-02 1.15e-04 2.00e-01
GOBP REGULATION OF PROGRAMMED NECROTIC CELL DEATH 37 6.77e-01 8.60e-01 0.081600 7.56e-02 -3.06e-02 4.26e-01 7.47e-01
GOBP ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS 240 8.95e-02 3.20e-01 0.081500 -7.94e-03 8.12e-02 8.32e-01 3.03e-02
Abortive elongation of HIV-1 transcript in the absence of Tat 23 8.08e-01 9.21e-01 0.081500 4.85e-02 6.54e-02 6.87e-01 5.87e-01
GOBP PROTEIN MATURATION 517 4.53e-03 4.40e-02 0.081400 4.72e-02 -6.64e-02 6.63e-02 9.81e-03
GOBP APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT 41 6.65e-01 8.52e-01 0.081400 8.14e-02 1.20e-03 3.67e-01 9.89e-01
GOBP REGULATION OF MICROVILLUS ORGANIZATION 13 8.71e-01 9.47e-01 0.081300 -4.44e-02 6.81e-02 7.81e-01 6.71e-01
GOBP REGULATION OF STRIATED MUSCLE CONTRACTION 93 3.87e-01 6.71e-01 0.081300 -7.97e-02 1.62e-02 1.84e-01 7.87e-01
GOBP REGULATION OF ADAPTIVE IMMUNE RESPONSE 204 1.45e-01 4.19e-01 0.081300 -2.36e-02 -7.77e-02 5.61e-01 5.56e-02
GOBP CELLULAR CATABOLIC PROCESS 1087 5.85e-05 1.36e-03 0.081200 7.54e-02 3.02e-02 2.72e-05 9.32e-02
Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein 77 4.82e-01 7.41e-01 0.081200 2.47e-02 7.73e-02 7.08e-01 2.41e-01
GOBP HORMONE BIOSYNTHETIC PROCESS 65 5.49e-01 7.84e-01 0.081200 -6.74e-02 -4.51e-02 3.47e-01 5.29e-01
GOBP REGULATION OF CILIUM MOVEMENT 40 6.62e-01 8.51e-01 0.081100 2.36e-02 -7.76e-02 7.96e-01 3.96e-01
GOBP REGULATION OF LOCOMOTION 1106 4.25e-05 1.03e-03 0.081100 7.88e-02 1.91e-02 9.68e-06 2.84e-01
GOMF PROTEIN DISULFIDE ISOMERASE ACTIVITY 21 8.05e-01 9.20e-01 0.081100 -7.67e-02 2.63e-02 5.43e-01 8.35e-01
GOBP SA NODE CELL TO ATRIAL CARDIAC MUSCLE CELL COMMUNICATION 11 8.90e-01 9.56e-01 0.081100 -5.37e-02 6.08e-02 7.58e-01 7.27e-01
GOBP NEGATIVE REGULATION OF TISSUE REMODELING 21 8.22e-01 9.27e-01 0.081100 -3.29e-02 -7.41e-02 7.94e-01 5.57e-01
GOBP POSITIVE REGULATION OF AMYLOID BETA CLEARANCE 8 9.28e-01 9.73e-01 0.081000 -7.42e-02 -3.26e-02 7.16e-01 8.73e-01
GOCC PROTEIN LIPID COMPLEX 38 6.74e-01 8.58e-01 0.081000 -7.57e-02 2.89e-02 4.19e-01 7.58e-01
GOCC MITOCHONDRION 1596 1.55e-07 7.36e-06 0.081000 4.73e-02 -6.58e-02 1.63e-03 1.16e-05
GOCC CUTICULAR PLATE 8 9.26e-01 9.72e-01 0.081000 7.98e-02 1.43e-02 6.96e-01 9.44e-01
GOBP POSTSYNAPTIC MEMBRANE ASSEMBLY 7 9.38e-01 9.76e-01 0.081000 -6.22e-02 -5.19e-02 7.76e-01 8.12e-01
GOCC SARCOPLASM 94 3.92e-01 6.75e-01 0.081000 -6.56e-03 8.07e-02 9.12e-01 1.76e-01
GOBP REGULATION OF RECEPTOR BINDING 16 8.52e-01 9.39e-01 0.081000 8.08e-02 -5.30e-03 5.76e-01 9.71e-01
GOBP SMALL MOLECULE CATABOLIC PROCESS 364 3.33e-02 1.77e-01 0.081000 2.24e-02 7.78e-02 4.62e-01 1.08e-02
GOMF CARBON SULFUR LYASE ACTIVITY 12 8.81e-01 9.51e-01 0.081000 5.26e-02 -6.15e-02 7.52e-01 7.12e-01
Nuclear signaling by ERBB4 32 7.46e-01 8.91e-01 0.081000 -5.07e-02 -6.31e-02 6.20e-01 5.36e-01
GOBP POSITIVE REGULATION OF IMMUNE RESPONSE 723 8.98e-04 1.26e-02 0.080900 9.04e-03 -8.04e-02 6.79e-01 2.31e-04
Drug ADME 101 3.52e-01 6.42e-01 0.080900 3.11e-02 -7.47e-02 5.89e-01 1.95e-01
GOBP NEGATIVE REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE 20 8.30e-01 9.30e-01 0.080900 7.45e-02 3.15e-02 5.64e-01 8.07e-01
GOBP POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION 25 7.79e-01 9.08e-01 0.080900 -8.46e-03 8.04e-02 9.42e-01 4.86e-01
GOBP AORTIC VALVE MORPHOGENESIS 39 6.94e-01 8.68e-01 0.080900 7.57e-02 2.84e-02 4.13e-01 7.59e-01
GOCC A BAND 39 6.85e-01 8.64e-01 0.080900 -9.04e-03 -8.04e-02 9.22e-01 3.85e-01
GOBP LIPOPROTEIN METABOLIC PROCESS 133 2.49e-01 5.46e-01 0.080900 4.36e-02 -6.81e-02 3.86e-01 1.75e-01
GOCC LATERAL ELEMENT 14 8.63e-01 9.43e-01 0.080800 6.18e-02 -5.20e-02 6.89e-01 7.36e-01
GOMF INTRAMEMBRANE LIPID TRANSPORTER ACTIVITY 41 6.67e-01 8.53e-01 0.080800 -3.00e-03 8.07e-02 9.73e-01 3.71e-01
Listeria monocytogenes entry into host cells 19 8.20e-01 9.27e-01 0.080800 6.91e-02 -4.18e-02 6.02e-01 7.52e-01
GOBP NEGATIVE REGULATION OF RNA SPLICING 24 7.78e-01 9.07e-01 0.080800 4.20e-02 -6.90e-02 7.21e-01 5.59e-01
GOBP MEDIUM CHAIN FATTY ACID BIOSYNTHETIC PROCESS 6 9.41e-01 9.77e-01 0.080800 2.04e-02 -7.82e-02 9.31e-01 7.40e-01
GOMF GLUTATHIONE TRANSMEMBRANE TRANSPORTER ACTIVITY 7 9.38e-01 9.76e-01 0.080800 4.28e-02 6.85e-02 8.45e-01 7.53e-01
GOBP APICAL JUNCTION ASSEMBLY 75 4.96e-01 7.51e-01 0.080800 7.63e-02 2.64e-02 2.53e-01 6.92e-01
GOBP DITERPENOID METABOLIC PROCESS 87 4.27e-01 7.05e-01 0.080800 8.08e-02 1.06e-03 1.93e-01 9.86e-01
GOBP ORGANOPHOSPHATE BIOSYNTHETIC PROCESS 557 3.35e-03 3.49e-02 0.080700 6.74e-02 -4.45e-02 6.53e-03 7.27e-02
GOBP REGULATION OF HEMOPOIESIS 413 1.42e-02 1.01e-01 0.080700 6.69e-02 -4.52e-02 1.97e-02 1.15e-01
GOBP AMINO ACID SALVAGE 7 9.35e-01 9.75e-01 0.080700 -7.94e-02 -1.43e-02 7.16e-01 9.48e-01
GOBP IMMUNE RESPONSE REGULATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 330 3.59e-02 1.86e-01 0.080700 2.47e-02 -7.68e-02 4.41e-01 1.64e-02
GOBP CATECHOLAMINE SECRETION 48 6.19e-01 8.27e-01 0.080700 -8.00e-02 1.07e-02 3.38e-01 8.98e-01
GOBP REGULATION OF VASCULATURE DEVELOPMENT 349 4.02e-02 1.98e-01 0.080700 7.59e-02 2.72e-02 1.48e-02 3.82e-01
GOBP INDOLE CONTAINING COMPOUND METABOLIC PROCESS 22 7.97e-01 9.17e-01 0.080700 -7.46e-02 3.07e-02 5.45e-01 8.03e-01
GOBP BROWN FAT CELL DIFFERENTIATION 53 6.17e-01 8.26e-01 0.080600 4.39e-02 6.76e-02 5.80e-01 3.94e-01
GOBP POSTSYNAPSE ASSEMBLY 41 6.86e-01 8.64e-01 0.080600 3.66e-02 7.18e-02 6.85e-01 4.26e-01
Metabolism of polyamines 44 6.58e-01 8.50e-01 0.080600 -1.47e-02 -7.93e-02 8.66e-01 3.63e-01
GOBP PURINE CONTAINING COMPOUND SALVAGE 14 8.66e-01 9.44e-01 0.080600 2.79e-02 -7.56e-02 8.56e-01 6.24e-01
GOBP MACROMOLECULE DEPALMITOYLATION 14 8.63e-01 9.43e-01 0.080600 6.23e-02 -5.11e-02 6.87e-01 7.41e-01
GOMF PALMITOYL HYDROLASE ACTIVITY 14 8.63e-01 9.43e-01 0.080600 6.23e-02 -5.11e-02 6.87e-01 7.41e-01
Signaling by Interleukins 421 1.56e-02 1.08e-01 0.080600 1.58e-02 -7.90e-02 5.79e-01 5.41e-03
GOMF LYSOPHOSPHOLIPASE ACTIVITY 26 7.86e-01 9.12e-01 0.080600 -3.18e-02 -7.40e-02 7.79e-01 5.13e-01
GOBP REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION 13 8.77e-01 9.50e-01 0.080600 -1.62e-02 7.89e-02 9.19e-01 6.22e-01
GOBP REGULATION OF INTRACELLULAR TRANSPORT 252 8.51e-02 3.12e-01 0.080500 8.03e-02 -6.18e-03 2.82e-02 8.66e-01
GOBP PROTEIN LOCALIZATION TO MITOCHONDRION 123 2.83e-01 5.80e-01 0.080500 3.28e-02 -7.35e-02 5.30e-01 1.59e-01
GOBP L AMINO ACID CATABOLIC PROCESS 64 5.49e-01 7.84e-01 0.080500 7.74e-02 2.22e-02 2.84e-01 7.59e-01
GOBP POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 75 4.99e-01 7.53e-01 0.080500 2.77e-02 7.56e-02 6.79e-01 2.58e-01
GOBP REGULATION OF PROTEIN K63 LINKED UBIQUITINATION 13 8.80e-01 9.51e-01 0.080400 3.54e-03 -8.03e-02 9.82e-01 6.16e-01
GOBP EOSINOPHIL MIGRATION 28 7.62e-01 8.99e-01 0.080400 -8.04e-02 -1.80e-03 4.62e-01 9.87e-01
GOBP MITOTIC CYTOKINETIC PROCESS 31 7.35e-01 8.86e-01 0.080300 1.19e-02 -7.94e-02 9.09e-01 4.44e-01
GOBP POSTSYNAPTIC SPECIALIZATION ORGANIZATION 45 6.53e-01 8.47e-01 0.080200 1.18e-02 7.94e-02 8.91e-01 3.57e-01
GOBP NEGATIVE REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS 10 9.14e-01 9.68e-01 0.080200 -5.44e-02 -5.89e-02 7.66e-01 7.47e-01
GOBP CEREBELLAR CORTEX DEVELOPMENT 50 5.96e-01 8.13e-01 0.080100 6.24e-02 -5.03e-02 4.45e-01 5.38e-01
GOBP DNA TEMPLATED DNA REPLICATION 160 2.00e-01 4.93e-01 0.080100 7.55e-02 -2.69e-02 9.94e-02 5.57e-01
GOBP POSTSYNAPTIC DENSITY ASSEMBLY 24 7.91e-01 9.15e-01 0.080100 -5.29e-03 8.00e-02 9.64e-01 4.98e-01
GOBP PHOSPHORYLATION 1334 7.44e-06 2.23e-04 0.080100 7.88e-02 1.46e-02 1.37e-06 3.70e-01
Toll-like Receptor Cascades 161 1.91e-01 4.83e-01 0.080000 6.31e-02 -4.93e-02 1.67e-01 2.81e-01
GOBP LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 55 5.79e-01 8.02e-01 0.080000 -1.76e-02 7.80e-02 8.22e-01 3.17e-01
GOBP B 1 B CELL DIFFERENTIATION 5 9.50e-01 9.81e-01 0.080000 -5.03e-02 6.22e-02 8.46e-01 8.10e-01
GOBP EXOCYTIC PROCESS 77 5.01e-01 7.53e-01 0.079900 6.93e-02 3.98e-02 2.93e-01 5.46e-01
Cellular hexose transport 22 8.21e-01 9.27e-01 0.079900 -6.55e-02 -4.57e-02 5.95e-01 7.11e-01
Diseases of glycosylation 139 2.40e-01 5.36e-01 0.079900 -5.88e-02 5.41e-02 2.31e-01 2.71e-01
GOMF ICOSANOID RECEPTOR ACTIVITY 14 8.66e-01 9.44e-01 0.079900 4.31e-02 -6.72e-02 7.80e-01 6.63e-01
GOBP NEGATIVE REGULATION OF VASCULAR WOUND HEALING 7 9.39e-01 9.77e-01 0.079800 5.02e-02 6.21e-02 8.18e-01 7.76e-01
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors 34 7.24e-01 8.81e-01 0.079800 7.97e-02 3.52e-03 4.21e-01 9.72e-01
GOBP REGULATION OF MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 5 9.50e-01 9.81e-01 0.079800 4.85e-02 -6.33e-02 8.51e-01 8.06e-01
GOBP POSITIVE REGULATION OF CATALYTIC ACTIVITY 802 3.92e-04 6.46e-03 0.079800 7.16e-02 -3.51e-02 5.65e-04 9.09e-02
GOBP REGULATION OF OSTEOCLAST DIFFERENTIATION 70 5.15e-01 7.62e-01 0.079700 -4.40e-03 -7.96e-02 9.49e-01 2.49e-01
Translation of Structural Proteins 9694635 55 6.03e-01 8.17e-01 0.079700 7.66e-02 2.21e-02 3.26e-01 7.77e-01
GOBP REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 147 2.65e-01 5.61e-01 0.079700 7.40e-02 2.97e-02 1.21e-01 5.35e-01
GOMF ALPHA TUBULIN BINDING 38 7.14e-01 8.77e-01 0.079700 5.55e-02 5.72e-02 5.54e-01 5.42e-01
GOBP REGULATION OF AMIDE METABOLIC PROCESS 79 4.82e-01 7.41e-01 0.079600 7.79e-02 1.64e-02 2.31e-01 8.01e-01
GOBP AUDITORY RECEPTOR CELL MORPHOGENESIS 21 8.16e-01 9.26e-01 0.079600 -7.94e-02 6.22e-03 5.29e-01 9.61e-01
GOBP IMP BIOSYNTHETIC PROCESS 10 9.03e-01 9.62e-01 0.079600 -5.42e-02 5.83e-02 7.67e-01 7.50e-01
GOBP NEGATIVE REGULATION OF PROTEOLYSIS 206 1.24e-01 3.84e-01 0.079600 5.03e-02 -6.17e-02 2.13e-01 1.27e-01
GOBP DIGESTION 131 2.78e-01 5.75e-01 0.079500 -1.84e-02 7.73e-02 7.16e-01 1.26e-01
GOBP POSITIVE REGULATION OF MAP KINASE ACTIVITY 78 4.61e-01 7.25e-01 0.079400 7.49e-02 -2.63e-02 2.52e-01 6.88e-01
GOBP PLACENTA DEVELOPMENT 145 2.31e-01 5.28e-01 0.079400 5.96e-02 -5.24e-02 2.15e-01 2.76e-01
GOCC ANAPHASE PROMOTING COMPLEX 22 8.03e-01 9.19e-01 0.079300 7.38e-02 -2.91e-02 5.49e-01 8.13e-01
GOMF OLEATE TRANSMEMBRANE TRANSPORTER ACTIVITY 6 9.49e-01 9.81e-01 0.079300 5.69e-02 5.53e-02 8.09e-01 8.15e-01
GOBP POSITIVE REGULATION OF BONE RESORPTION 19 8.45e-01 9.36e-01 0.079300 3.84e-02 6.94e-02 7.72e-01 6.01e-01
RAB geranylgeranylation 57 5.61e-01 7.92e-01 0.079300 5.08e-02 -6.09e-02 5.07e-01 4.27e-01
GOBP POSITIVE REGULATION OF TYPE II INTERFERON PRODUCTION 74 5.07e-01 7.58e-01 0.079300 -1.58e-02 -7.77e-02 8.14e-01 2.48e-01
GOBP RESPONSE TO OXYGEN CONTAINING COMPOUND 1609 9.87e-07 3.75e-05 0.079300 7.84e-02 1.19e-02 1.58e-07 4.26e-01
GOBP VESICLE MEDIATED TRANSPORT IN SYNAPSE 213 1.56e-01 4.36e-01 0.079300 4.61e-02 6.45e-02 2.46e-01 1.05e-01
GOBP MITOCHONDRION ORGANIZATION 490 7.75e-03 6.56e-02 0.079300 4.79e-02 -6.32e-02 6.97e-02 1.66e-02
GOBP CARNITINE TRANSPORT 8 9.25e-01 9.72e-01 0.079200 1.64e-02 -7.75e-02 9.36e-01 7.04e-01
Scavenging of heme from plasma 12 8.90e-01 9.56e-01 0.079200 -1.52e-02 7.77e-02 9.28e-01 6.41e-01
GOBP MEMBRANE ORGANIZATION 768 7.31e-04 1.07e-02 0.079200 7.74e-02 -1.65e-02 2.60e-04 4.35e-01
GOBP POSITIVE REGULATION OF CHOLESTEROL EFFLUX 27 7.66e-01 9.01e-01 0.079200 -7.40e-02 2.81e-02 5.06e-01 8.00e-01
GOBP REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 76 4.77e-01 7.37e-01 0.079100 7.69e-02 -1.87e-02 2.46e-01 7.78e-01
GOMF CYCLOSPORIN A BINDING 17 8.55e-01 9.40e-01 0.079100 7.80e-02 1.33e-02 5.78e-01 9.24e-01
GOMF EUKARYOTIC TRANSLATION INITIATION FACTOR 2ALPHA KINASE ACTIVITY 6 9.47e-01 9.80e-01 0.079100 -2.40e-02 -7.53e-02 9.19e-01 7.49e-01
GOBP POSITIVE REGULATION OF RECEPTOR CATABOLIC PROCESS 7 9.40e-01 9.77e-01 0.079000 6.81e-02 4.01e-02 7.55e-01 8.54e-01
GOBP PROTEIN LOCALIZATION TO EXTRACELLULAR REGION 370 3.80e-02 1.92e-01 0.079000 7.49e-02 2.49e-02 1.33e-02 4.10e-01
GOBP REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 132 3.16e-01 6.09e-01 0.078900 6.78e-02 4.03e-02 1.79e-01 4.24e-01
GOBP LACTONE METABOLIC PROCESS 13 8.90e-01 9.56e-01 0.078800 -7.49e-02 -2.45e-02 6.40e-01 8.78e-01
GOBP RECEPTOR GUANYLYL CYCLASE SIGNALING PATHWAY 10 9.04e-01 9.63e-01 0.078800 6.09e-02 -5.00e-02 7.39e-01 7.84e-01
Chondroitin sulfate biosynthesis 18 8.55e-01 9.40e-01 0.078800 5.29e-02 5.84e-02 6.98e-01 6.68e-01
GOBP BILE ACID BIOSYNTHETIC PROCESS 37 7.12e-01 8.76e-01 0.078800 1.05e-02 7.81e-02 9.12e-01 4.11e-01
GOBP REGULATION OF MITOCHONDRIAL DEPOLARIZATION 19 8.36e-01 9.31e-01 0.078800 7.85e-02 -6.21e-03 5.53e-01 9.63e-01
TRP channels 27 7.74e-01 9.06e-01 0.078800 -7.84e-02 7.50e-03 4.81e-01 9.46e-01
Processing of SMDT1 14 8.73e-01 9.48e-01 0.078800 7.57e-02 -2.17e-02 6.24e-01 8.88e-01
GOBP ENDOPLASMIC RETICULUM PLASMA MEMBRANE TETHERING 6 9.48e-01 9.80e-01 0.078700 2.96e-02 7.30e-02 9.00e-01 7.57e-01
GOBP RESPONSE TO LEUKEMIA INHIBITORY FACTOR 100 3.97e-01 6.79e-01 0.078700 7.86e-02 3.92e-03 1.74e-01 9.46e-01
GOMF MODIFIED AMINO ACID BINDING 95 4.13e-01 6.94e-01 0.078700 -6.55e-04 7.87e-02 9.91e-01 1.85e-01
GOBP REGULATION OF MESENCHYMAL STEM CELL DIFFERENTIATION 10 9.10e-01 9.66e-01 0.078600 5.04e-03 -7.85e-02 9.78e-01 6.67e-01
GOBP POSITIVE REGULATION OF HORMONE SECRETION 142 2.53e-01 5.51e-01 0.078600 7.47e-02 -2.46e-02 1.24e-01 6.12e-01
GOBP HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 12 8.93e-01 9.57e-01 0.078600 -8.92e-03 7.81e-02 9.57e-01 6.39e-01
GOBP POSITIVE REGULATION OF HORMONE METABOLIC PROCESS 15 8.65e-01 9.44e-01 0.078500 2.02e-02 -7.59e-02 8.92e-01 6.11e-01
GOCC MOTILE CILIUM 266 9.74e-02 3.35e-01 0.078500 -7.38e-02 -2.69e-02 3.84e-02 4.49e-01
GOCC SMOOTH ENDOPLASMIC RETICULUM 28 7.76e-01 9.07e-01 0.078500 -1.28e-02 -7.74e-02 9.07e-01 4.78e-01
GOMF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 62 5.87e-01 8.07e-01 0.078500 5.29e-02 5.79e-02 4.71e-01 4.30e-01
GOBP POSITIVE REGULATION OF PEPTIDASE ACTIVITY 163 2.01e-01 4.94e-01 0.078400 4.63e-02 -6.33e-02 3.08e-01 1.63e-01
RIP-mediated NFkB activation via ZBP1 16 8.65e-01 9.43e-01 0.078400 7.78e-02 9.57e-03 5.90e-01 9.47e-01
GOBP IMP METABOLIC PROCESS 17 8.64e-01 9.43e-01 0.078400 5.80e-02 5.27e-02 6.79e-01 7.07e-01
GOBP PROTEIN TARGETING TO MEMBRANE 111 3.68e-01 6.56e-01 0.078300 1.21e-02 7.74e-02 8.25e-01 1.59e-01
Diseases associated with glycosaminoglycan metabolism 38 7.21e-01 8.80e-01 0.078300 4.42e-02 6.47e-02 6.38e-01 4.90e-01
GOBP LONG CHAIN FATTY ACID METABOLIC PROCESS 103 4.16e-01 6.96e-01 0.078300 5.76e-02 5.31e-02 3.13e-01 3.52e-01
GOBP FEMALE GAMETE GENERATION 162 2.45e-01 5.41e-01 0.078200 7.20e-02 3.05e-02 1.14e-01 5.03e-01
GOMF ORGANIC HYDROXY COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY 52 6.27e-01 8.33e-01 0.078100 1.22e-02 7.71e-02 8.79e-01 3.36e-01
GOMF SULFUR COMPOUND TRANSMEMBRANE TRANSPORTER ACTIVITY 60 5.71e-01 7.98e-01 0.078100 -9.40e-03 7.75e-02 9.00e-01 2.99e-01
GOCC GAMMA TUBULIN RING COMPLEX 9 9.16e-01 9.68e-01 0.078100 3.21e-02 -7.12e-02 8.67e-01 7.12e-01
GABA receptor activation 57 5.76e-01 8.00e-01 0.078100 -3.43e-02 7.01e-02 6.55e-01 3.60e-01
GOBP PHOTORECEPTOR CELL DEVELOPMENT 51 6.06e-01 8.19e-01 0.078100 -5.11e-02 5.90e-02 5.28e-01 4.66e-01
GOBP REGULATION OF ARACHIDONIC ACID SECRETION 7 9.35e-01 9.75e-01 0.078000 2.83e-02 -7.27e-02 8.97e-01 7.39e-01
GOCC CELL SURFACE 845 5.11e-04 8.01e-03 0.078000 -7.75e-02 8.71e-03 1.29e-04 6.67e-01
Mitotic G2-G2/M phases 180 1.73e-01 4.59e-01 0.078000 5.96e-02 -5.04e-02 1.68e-01 2.44e-01
GOCC SPECIFIC GRANULE MEMBRANE 88 4.45e-01 7.17e-01 0.078000 -4.31e-03 7.78e-02 9.44e-01 2.07e-01
G beta:gamma signalling through CDC42 19 8.42e-01 9.35e-01 0.078000 -4.69e-03 -7.78e-02 9.72e-01 5.57e-01
G2/M Transition 178 1.77e-01 4.64e-01 0.077900 6.22e-02 -4.69e-02 1.52e-01 2.80e-01
GOBP RESPONSE TO MERCURY ION 10 9.19e-01 9.69e-01 0.077900 4.86e-02 6.09e-02 7.90e-01 7.39e-01
GOBP CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY 168 2.02e-01 4.95e-01 0.077900 -7.30e-02 2.73e-02 1.03e-01 5.41e-01
GOMF MRNA 3 UTR BINDING 231 1.24e-01 3.84e-01 0.077900 7.79e-02 1.41e-03 4.14e-02 9.70e-01
GOBP GLYCOSYLATION 238 1.26e-01 3.87e-01 0.077900 2.14e-02 7.49e-02 5.69e-01 4.66e-02
GOCC EARLY ENDOSOME LUMEN 5 9.57e-01 9.84e-01 0.077900 -1.89e-02 -7.55e-02 9.42e-01 7.70e-01
GOBP TRIPARTITE REGIONAL SUBDIVISION 20 8.30e-01 9.30e-01 0.077900 -1.09e-02 7.71e-02 9.33e-01 5.51e-01
GOBP REGULATION OF MONONUCLEAR CELL MIGRATION 137 2.97e-01 5.94e-01 0.077800 7.68e-02 1.29e-02 1.21e-01 7.95e-01
GOBP REGULATION OF BLOOD BRAIN BARRIER PERMEABILITY 9 9.16e-01 9.68e-01 0.077800 -6.80e-02 3.79e-02 7.24e-01 8.44e-01
GOBP POSITIVE REGULATION OF SPINDLE CHECKPOINT 13 8.89e-01 9.55e-01 0.077800 7.77e-02 4.03e-03 6.28e-01 9.80e-01
Dopamine Neurotransmitter Release Cycle 21 8.33e-01 9.30e-01 0.077800 7.30e-02 2.68e-02 5.63e-01 8.31e-01
GOBP SYNAPTIC TRANSMISSION CHOLINERGIC 32 7.36e-01 8.86e-01 0.077800 -7.18e-02 2.99e-02 4.82e-01 7.70e-01
GOBP REGULATION OF DENDRITIC CELL CHEMOTAXIS 9 9.16e-01 9.68e-01 0.077700 6.61e-02 -4.09e-02 7.31e-01 8.32e-01
GOMF TUBULIN BINDING 364 3.52e-02 1.83e-01 0.077500 7.57e-02 -1.70e-02 1.32e-02 5.78e-01
GOBP MACROPHAGE ACTIVATION 110 3.71e-01 6.58e-01 0.077500 2.41e-04 -7.75e-02 9.97e-01 1.60e-01
GOBP ODONTOBLAST DIFFERENTIATION 16 8.62e-01 9.42e-01 0.077500 7.58e-02 -1.60e-02 6.00e-01 9.12e-01
GOBP SENSORY PERCEPTION OF PAIN 79 5.08e-01 7.59e-01 0.077500 -2.75e-02 -7.24e-02 6.72e-01 2.66e-01
GOMF BMP RECEPTOR BINDING 12 9.01e-01 9.61e-01 0.077400 -1.85e-02 -7.52e-02 9.12e-01 6.52e-01
GOBP PLASMA MEMBRANE FUSION 30 7.48e-01 8.91e-01 0.077400 -5.33e-02 5.61e-02 6.13e-01 5.95e-01
FOXO-mediated transcription 65 5.48e-01 7.83e-01 0.077400 7.57e-02 -1.61e-02 2.91e-01 8.23e-01
GOBP POSITIVE REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY 10 9.11e-01 9.67e-01 0.077300 -1.71e-02 7.54e-02 9.25e-01 6.80e-01
GOBP VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT 62 5.97e-01 8.14e-01 0.077300 5.29e-02 5.63e-02 4.71e-01 4.43e-01
GOBP POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 106 3.83e-01 6.67e-01 0.077300 7.70e-02 -6.43e-03 1.71e-01 9.09e-01
GOBP REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL 38 6.93e-01 8.68e-01 0.077200 -5.84e-02 5.06e-02 5.34e-01 5.89e-01
GOBP REGULATION OF CALCIUM ION TRANSPORT 243 1.13e-01 3.65e-01 0.077200 7.71e-02 -4.28e-03 3.85e-02 9.09e-01
GOMF MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY 723 1.46e-03 1.86e-02 0.077100 -7.38e-02 2.25e-02 7.27e-04 3.02e-01
GOBP LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 34 7.52e-01 8.93e-01 0.077100 -4.07e-02 -6.55e-02 6.81e-01 5.09e-01
Interleukin-1 processing 9 9.24e-01 9.71e-01 0.077100 -7.15e-03 -7.68e-02 9.70e-01 6.90e-01
GOBP REGULATION OF TRANSFERASE ACTIVITY 606 3.45e-03 3.56e-02 0.077100 5.36e-02 -5.54e-02 2.41e-02 1.99e-02
GOBP INNATE IMMUNE RESPONSE 906 7.27e-04 1.07e-02 0.077100 -4.86e-02 -5.98e-02 1.30e-02 2.27e-03
GOBP IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE 20 8.26e-01 9.28e-01 0.077100 4.05e-02 -6.56e-02 7.54e-01 6.12e-01
Choline catabolism 6 9.51e-01 9.82e-01 0.077000 4.61e-02 6.18e-02 8.45e-01 7.93e-01
GOBP POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 312 6.02e-02 2.52e-01 0.077000 7.63e-02 -1.09e-02 2.05e-02 7.40e-01
GOBP CARBOHYDRATE HOMEOSTASIS 255 1.12e-01 3.62e-01 0.077000 7.56e-02 1.49e-02 3.77e-02 6.81e-01
GOBP CELLULAR KETONE METABOLIC PROCESS 219 1.50e-01 4.29e-01 0.077000 7.60e-02 1.22e-02 5.25e-02 7.56e-01
GOBP LYMPHOCYTE MEDIATED IMMUNITY 289 9.40e-02 3.28e-01 0.077000 -5.86e-02 -4.99e-02 8.63e-02 1.45e-01
GOBP RENAL SYSTEM PROCESS 120 3.72e-01 6.58e-01 0.077000 6.11e-02 4.68e-02 2.48e-01 3.76e-01
GOBP REGULATION OF MAP KINASE ACTIVITY 128 3.21e-01 6.12e-01 0.076900 7.69e-02 -6.48e-04 1.33e-01 9.90e-01
GOBP REGULATION OF MEMBRANE DEPOLARIZATION 46 6.72e-01 8.57e-01 0.076900 7.52e-02 1.58e-02 3.77e-01 8.53e-01
Inactivation, recovery and regulation of the phototransduction cascade 31 7.56e-01 8.96e-01 0.076900 -6.21e-03 7.66e-02 9.52e-01 4.60e-01
GOCC CELL BODY MEMBRANE 32 7.65e-01 9.01e-01 0.076800 -6.89e-02 -3.41e-02 5.00e-01 7.39e-01
GOBP XENOBIOTIC METABOLIC PROCESS 122 3.62e-01 6.50e-01 0.076800 6.86e-02 3.46e-02 1.91e-01 5.09e-01
GOBP ORGANIC ANION TRANSPORT 439 2.79e-02 1.60e-01 0.076800 3.97e-02 6.57e-02 1.53e-01 1.82e-02
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSMEMBRANE TRANSPORT 96 4.31e-01 7.07e-01 0.076800 7.66e-02 5.46e-03 1.95e-01 9.26e-01
GOBP CELLULAR RESPONSE TO OXIDISED LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS 14 8.91e-01 9.57e-01 0.076800 -5.03e-02 -5.80e-02 7.44e-01 7.07e-01
GOMF CELL ADHESION MEDIATOR ACTIVITY 67 5.63e-01 7.93e-01 0.076800 1.67e-02 7.49e-02 8.14e-01 2.89e-01
GOBP MAINTENANCE OF PROTEIN LOCATION 83 5.06e-01 7.58e-01 0.076700 5.69e-02 5.15e-02 3.70e-01 4.17e-01
GOBP SODIUM ION HOMEOSTASIS 47 6.76e-01 8.59e-01 0.076700 -6.89e-02 -3.37e-02 4.14e-01 6.89e-01
GOBP REGULATION OF NEURON PROJECTION REGENERATION 31 7.71e-01 9.04e-01 0.076700 3.06e-02 7.03e-02 7.68e-01 4.98e-01
GOMF NADP BINDING 51 6.17e-01 8.26e-01 0.076700 -4.87e-02 5.92e-02 5.47e-01 4.65e-01
GOBP REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL 12 8.93e-01 9.57e-01 0.076600 -6.08e-02 4.66e-02 7.15e-01 7.80e-01
GOBP MORPHOGENESIS OF A POLARIZED EPITHELIUM 60 5.68e-01 7.96e-01 0.076600 6.40e-02 -4.20e-02 3.91e-01 5.73e-01
GOMF PROTEASE BINDING 136 3.30e-01 6.21e-01 0.076600 -5.70e-02 -5.12e-02 2.51e-01 3.03e-01
GOBP TETRAPYRROLE METABOLIC PROCESS 59 5.73e-01 7.99e-01 0.076600 6.10e-02 -4.63e-02 4.18e-01 5.38e-01
GOBP NUCLEOTIDE SALVAGE 17 8.70e-01 9.47e-01 0.076400 5.89e-02 4.87e-02 6.74e-01 7.28e-01
GOBP RESPONSE TO NICOTINE 51 6.20e-01 8.27e-01 0.076400 -4.38e-02 6.26e-02 5.88e-01 4.39e-01
GOBP POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 721 2.17e-03 2.52e-02 0.076400 7.64e-02 5.74e-04 4.75e-04 9.79e-01
GOBP NEGATIVE REGULATION OF CELLULAR SENESCENCE 26 7.88e-01 9.14e-01 0.076400 7.30e-02 -2.23e-02 5.19e-01 8.44e-01
GOBP NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION 15 8.80e-01 9.51e-01 0.076400 7.45e-02 1.69e-02 6.17e-01 9.10e-01
GOBP LEARNING 149 2.99e-01 5.95e-01 0.076400 5.65e-02 5.13e-02 2.33e-01 2.80e-01
GOBP NEGATIVE REGULATION OF BLOOD PRESSURE 48 6.36e-01 8.38e-01 0.076400 5.36e-02 -5.44e-02 5.21e-01 5.14e-01
GOCC SEPTIN CYTOSKELETON 14 8.92e-01 9.57e-01 0.076300 -5.71e-02 -5.06e-02 7.11e-01 7.43e-01
GOCC CHROMOSOME TELOMERIC REPEAT REGION 14 8.89e-01 9.55e-01 0.076300 7.35e-02 2.06e-02 6.34e-01 8.94e-01
GOBP RESPONSE TO FATTY ACID 55 6.28e-01 8.33e-01 0.076300 7.43e-02 1.74e-02 3.41e-01 8.24e-01
GOMF MYOSIN BINDING 72 5.43e-01 7.80e-01 0.076300 7.46e-02 1.59e-02 2.74e-01 8.15e-01
Toll Like Receptor 4 (TLR4) Cascade 139 2.73e-01 5.70e-01 0.076200 5.70e-02 -5.06e-02 2.46e-01 3.03e-01
GOBP REGULATION OF CELLULAR KETONE METABOLIC PROCESS 138 3.23e-01 6.14e-01 0.076200 6.84e-02 3.35e-02 1.65e-01 4.97e-01
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 75 4.96e-01 7.51e-01 0.076200 -4.91e-02 5.82e-02 4.62e-01 3.84e-01
GOBP ACTIN FILAMENT BASED MOVEMENT 135 3.35e-01 6.25e-01 0.076100 4.06e-02 6.44e-02 4.16e-01 1.96e-01
GOBP IMMUNOLOGICAL SYNAPSE FORMATION 16 8.78e-01 9.50e-01 0.076100 -3.94e-02 -6.51e-02 7.85e-01 6.52e-01
GOBP DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS 28 7.98e-01 9.17e-01 0.076100 -5.46e-02 -5.30e-02 6.17e-01 6.27e-01
GOBP VASCULAR PROCESS IN CIRCULATORY SYSTEM 265 1.18e-01 3.73e-01 0.076000 6.65e-02 3.69e-02 6.24e-02 3.02e-01
GOBP LOCALIZATION OF CELL 6 9.49e-01 9.81e-01 0.076000 3.35e-04 -7.60e-02 9.99e-01 7.47e-01
GOBP AMMONIUM TRANSMEMBRANE TRANSPORT 13 9.00e-01 9.61e-01 0.076000 -5.42e-02 -5.33e-02 7.35e-01 7.39e-01
GOBP IMPORT INTO CELL 887 1.02e-03 1.39e-02 0.076000 4.53e-02 6.10e-02 2.21e-02 2.05e-03
GOMF PROTEIN KINASE B BINDING 10 9.23e-01 9.71e-01 0.076000 -5.31e-02 -5.43e-02 7.71e-01 7.66e-01
GOBP ENDOCYTOSIS 675 4.96e-03 4.71e-02 0.076000 6.27e-02 4.29e-02 5.48e-03 5.73e-02
GOBP POSITIVE REGULATION OF MUSCLE ADAPTATION 13 8.95e-01 9.58e-01 0.076000 1.05e-02 7.52e-02 9.48e-01 6.39e-01
GOBP OSTEOCLAST PROLIFERATION 11 9.13e-01 9.67e-01 0.075900 -7.24e-02 -2.27e-02 6.77e-01 8.96e-01
GOBP REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 511 1.37e-02 9.93e-02 0.075900 7.57e-02 5.58e-03 3.40e-03 8.29e-01
A tetrasaccharide linker sequence is required for GAG synthesis 24 8.10e-01 9.22e-01 0.075900 -6.85e-03 7.56e-02 9.54e-01 5.22e-01
GOBP STRIATED MUSCLE CELL PROLIFERATION 81 5.02e-01 7.55e-01 0.075900 7.53e-02 9.17e-03 2.41e-01 8.87e-01
GOBP REGULATION OF LYMPHOCYTE DIFFERENTIATION 212 1.41e-01 4.13e-01 0.075900 5.44e-02 -5.28e-02 1.72e-01 1.85e-01
GOBP DETECTION OF CELL DENSITY 8 9.28e-01 9.73e-01 0.075800 4.41e-02 -6.17e-02 8.29e-01 7.62e-01
GOBP CEREBELLAR CORTEX MORPHOGENESIS 35 7.26e-01 8.82e-01 0.075800 6.83e-02 -3.28e-02 4.84e-01 7.37e-01
GOBP REGULATION OF CILIUM DEPENDENT CELL MOTILITY 29 7.68e-01 9.02e-01 0.075800 6.91e-02 -3.11e-02 5.20e-01 7.72e-01
GOMF CYSTEINE TYPE ENDOPEPTIDASE INHIBITOR ACTIVITY INVOLVED IN APOPTOTIC PROCESS 17 8.54e-01 9.39e-01 0.075800 5.81e-02 -4.86e-02 6.78e-01 7.29e-01
GOBP REGULATION OF ERBB SIGNALING PATHWAY 72 5.16e-01 7.62e-01 0.075700 6.42e-02 -4.01e-02 3.46e-01 5.56e-01
GOBP REGULATION OF ALPHA BETA T CELL ACTIVATION 109 3.83e-01 6.68e-01 0.075700 1.23e-02 -7.47e-02 8.24e-01 1.78e-01
GOCC NUCLEAR UBIQUITIN LIGASE COMPLEX 45 6.63e-01 8.51e-01 0.075700 6.77e-02 -3.38e-02 4.32e-01 6.95e-01
GOBP ACTIVATION OF IMMUNE RESPONSE 530 9.18e-03 7.41e-02 0.075700 2.79e-02 -7.03e-02 2.72e-01 5.59e-03
GOBP PROTEIN CONTAINING COMPLEX LOCALIZATION 187 2.04e-01 4.99e-01 0.075700 7.55e-02 4.24e-03 7.48e-02 9.20e-01
GOBP MESENCHYMAL EPITHELIAL CELL SIGNALING 9 9.23e-01 9.71e-01 0.075700 1.66e-02 -7.38e-02 9.31e-01 7.01e-01
GOBP RESPONSE TO ESTROGEN 67 5.86e-01 8.06e-01 0.075600 4.75e-02 5.89e-02 5.01e-01 4.05e-01
GOBP MEDIUM CHAIN FATTY ACID METABOLIC PROCESS 15 8.74e-01 9.48e-01 0.075600 2.43e-02 -7.16e-02 8.70e-01 6.31e-01
GOBP NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT 139 3.10e-01 6.04e-01 0.075600 7.51e-02 8.99e-03 1.26e-01 8.55e-01
GOBP REGULATION OF LEUKOCYTE CHEMOTAXIS 117 3.41e-01 6.31e-01 0.075600 4.62e-02 -5.99e-02 3.88e-01 2.63e-01
GOBP POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN 63 5.67e-01 7.95e-01 0.075600 -7.08e-02 2.64e-02 3.31e-01 7.17e-01
GOBP LYMPHOID PROGENITOR CELL DIFFERENTIATION 24 8.11e-01 9.23e-01 0.075600 7.54e-02 -5.93e-03 5.23e-01 9.60e-01
GOBP PURINE CONTAINING COMPOUND CATABOLIC PROCESS 144 2.94e-01 5.91e-01 0.075600 3.36e-03 7.55e-02 9.45e-01 1.18e-01
GOBP POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING 20 8.31e-01 9.30e-01 0.075600 5.34e-02 -5.34e-02 6.79e-01 6.79e-01
GOBP NEGATIVE REGULATION OF PROTEIN LOCALIZATION 207 1.83e-01 4.73e-01 0.075500 7.28e-02 2.00e-02 7.09e-02 6.20e-01
NrCAM interactions 6 9.48e-01 9.81e-01 0.075500 -1.41e-02 7.42e-02 9.52e-01 7.53e-01
GOBP LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY 55 6.27e-01 8.33e-01 0.075500 -4.97e-03 -7.53e-02 9.49e-01 3.34e-01
GOBP POSITIVE REGULATION OF WOUND HEALING 64 5.60e-01 7.91e-01 0.075500 -3.27e-02 6.80e-02 6.51e-01 3.46e-01
GOBP POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS 11 9.10e-01 9.66e-01 0.075500 -1.36e-03 -7.54e-02 9.94e-01 6.65e-01
HS-GAG degradation 21 8.46e-01 9.36e-01 0.075400 -5.88e-02 -4.72e-02 6.41e-01 7.08e-01
GOBP RESPONSE TO CATECHOLAMINE 59 6.16e-01 8.26e-01 0.075400 7.24e-02 2.10e-02 3.36e-01 7.81e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS 17 8.66e-01 9.44e-01 0.075400 7.51e-02 5.79e-03 5.92e-01 9.67e-01
GOBP RETINA MORPHOGENESIS IN CAMERA TYPE EYE 64 6.00e-01 8.16e-01 0.075300 6.56e-02 3.70e-02 3.64e-01 6.08e-01
Interleukin-35 Signalling 12 9.06e-01 9.64e-01 0.075300 7.19e-02 2.22e-02 6.66e-01 8.94e-01
GOCC NUCLEAR MEMBRANE 299 8.50e-02 3.12e-01 0.075300 7.44e-02 1.11e-02 2.68e-02 7.41e-01
GOBP ENDOMEMBRANE SYSTEM ORGANIZATION 570 9.64e-03 7.67e-02 0.075200 7.45e-02 1.04e-02 2.37e-03 6.70e-01
GOCC CELL BODY 530 1.50e-02 1.05e-01 0.075200 7.06e-02 2.58e-02 5.39e-03 3.10e-01
GOCC CYTOPLASMIC SIDE OF ENDOPLASMIC RETICULUM MEMBRANE 20 8.33e-01 9.30e-01 0.075200 4.85e-02 -5.75e-02 7.07e-01 6.56e-01
GOBP LOCOMOTION 1278 5.37e-05 1.27e-03 0.075200 7.17e-02 2.25e-02 1.62e-05 1.77e-01
Interleukin-2 family signaling 39 7.16e-01 8.77e-01 0.075200 7.50e-02 -4.49e-03 4.18e-01 9.61e-01
GOBP NEGATIVE REGULATION OF TRANSLATION 200 1.71e-01 4.57e-01 0.075100 7.05e-02 -2.59e-02 8.56e-02 5.27e-01
GOBP METANEPHRIC TUBULE DEVELOPMENT 24 8.25e-01 9.28e-01 0.075100 3.39e-02 6.71e-02 7.74e-01 5.70e-01
GOBP REGULATION OF HORMONE SECRETION 252 1.29e-01 3.93e-01 0.075100 7.27e-02 1.89e-02 4.69e-02 6.05e-01
Molecules associated with elastic fibres 37 7.45e-01 8.91e-01 0.075100 6.41e-02 3.92e-02 5.00e-01 6.80e-01
Thromboxane signalling through TP receptor 24 8.17e-01 9.26e-01 0.075000 -4.52e-03 -7.49e-02 9.69e-01 5.25e-01
GOMF VOLTAGE GATED MONOATOMIC ANION CHANNEL ACTIVITY 14 8.87e-01 9.55e-01 0.075000 -7.49e-02 4.13e-03 6.27e-01 9.79e-01
Toll Like Receptor 2 (TLR2) Cascade 109 3.73e-01 6.59e-01 0.075000 5.41e-02 -5.20e-02 3.30e-01 3.48e-01
Toll Like Receptor TLR1:TLR2 Cascade 109 3.73e-01 6.59e-01 0.075000 5.41e-02 -5.20e-02 3.30e-01 3.48e-01
GOBP MONOATOMIC ANION TRANSPORT 162 2.32e-01 5.30e-01 0.075000 -4.60e-02 5.92e-02 3.13e-01 1.93e-01
GOBP NEGATIVE REGULATION OF RELAXATION OF MUSCLE 7 9.38e-01 9.77e-01 0.075000 -5.00e-02 5.59e-02 8.19e-01 7.98e-01
GOBP LUNG EPITHELIUM DEVELOPMENT 45 6.90e-01 8.66e-01 0.075000 7.38e-02 1.30e-02 3.92e-01 8.80e-01
GOBP REGULATION OF TOLL SIGNALING PATHWAY 5 9.60e-01 9.85e-01 0.074900 -1.54e-02 -7.33e-02 9.52e-01 7.76e-01
GOBP ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 540 1.59e-02 1.10e-01 0.074900 5.78e-02 4.77e-02 2.16e-02 5.81e-02
GOBP POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION 18 8.68e-01 9.46e-01 0.074900 5.61e-02 4.97e-02 6.80e-01 7.15e-01
GOCC SEH1 ASSOCIATED COMPLEX 13 8.89e-01 9.55e-01 0.074900 4.72e-02 -5.81e-02 7.68e-01 7.17e-01
GOCC ORGANELLE SUBCOMPARTMENT 1445 7.77e-06 2.32e-04 0.074800 7.30e-02 -1.65e-02 3.38e-06 2.94e-01
GOCC SPINDLE POLE 171 2.53e-01 5.51e-01 0.074800 7.15e-02 2.22e-02 1.07e-01 6.17e-01
GOBP REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE 9 9.29e-01 9.73e-01 0.074800 -7.35e-02 -1.38e-02 7.02e-01 9.43e-01
GOBP EPITHELIAL CILIUM MOVEMENT INVOLVED IN DETERMINATION OF LEFT RIGHT ASYMMETRY 11 9.06e-01 9.63e-01 0.074800 -6.47e-02 3.76e-02 7.10e-01 8.29e-01
GOCC ENDOCYTIC VESICLE MEMBRANE 189 1.83e-01 4.73e-01 0.074800 5.24e-02 -5.33e-02 2.14e-01 2.06e-01
GOMF DEACETYLASE ACTIVITY 36 7.39e-01 8.87e-01 0.074800 1.35e-03 7.48e-02 9.89e-01 4.38e-01
GOBP NEGATIVE REGULATION OF PROTEIN POLYUBIQUITINATION 8 9.30e-01 9.74e-01 0.074700 -4.72e-02 5.79e-02 8.17e-01 7.77e-01
GOMF LIGASE ACTIVITY FORMING CARBON SULFUR BONDS 39 7.17e-01 8.78e-01 0.074700 7.42e-02 -8.70e-03 4.23e-01 9.25e-01
GOBP REGULATORY T CELL DIFFERENTIATION 39 7.29e-01 8.83e-01 0.074600 -1.67e-02 -7.27e-02 8.57e-01 4.32e-01
GOMF CIS TRANS ISOMERASE ACTIVITY 38 7.44e-01 8.90e-01 0.074600 -4.57e-02 -5.90e-02 6.26e-01 5.29e-01
Transcription of the HIV genome 66 5.61e-01 7.92e-01 0.074600 2.50e-02 -7.03e-02 7.25e-01 3.23e-01
GOCC GLYCINERGIC SYNAPSE 7 9.42e-01 9.78e-01 0.074600 7.45e-02 -4.31e-03 7.33e-01 9.84e-01
GOBP SYNAPTIC VESICLE MATURATION 21 8.37e-01 9.32e-01 0.074500 6.11e-03 -7.43e-02 9.61e-01 5.56e-01
GOMF PHOSPHOLIPASE C ACTIVITY 29 7.85e-01 9.12e-01 0.074500 -7.45e-02 -4.90e-04 4.87e-01 9.96e-01
GPCR downstream signalling 603 8.72e-03 7.14e-02 0.074500 1.75e-02 7.24e-02 4.64e-01 2.39e-03
GOBP CELLULAR RESPONSE TO ALKALOID 37 7.51e-01 8.92e-01 0.074500 4.69e-02 5.78e-02 6.21e-01 5.43e-01
GOBP MYELOID LEUKOCYTE ACTIVATION 238 1.42e-01 4.14e-01 0.074500 -4.83e-03 -7.43e-02 8.98e-01 4.83e-02
GOCC APICAL PART OF CELL 451 3.01e-02 1.66e-01 0.074400 2.73e-02 6.92e-02 3.20e-01 1.17e-02
GOCC AXONEMAL MICROTUBULE 53 6.41e-01 8.41e-01 0.074400 3.38e-03 -7.43e-02 9.66e-01 3.49e-01
GOBP CARDIAC MUSCLE CELL CONTRACTION 81 4.86e-01 7.44e-01 0.074400 -5.43e-02 5.08e-02 3.98e-01 4.29e-01
GOBP POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 42 7.09e-01 8.75e-01 0.074300 7.39e-02 7.69e-03 4.07e-01 9.31e-01
GOBP DENDRITE MORPHOGENESIS 133 3.60e-01 6.48e-01 0.074300 5.64e-02 4.84e-02 2.61e-01 3.35e-01
GOMF AMINO ACID MONOATOMIC CATION SYMPORTER ACTIVITY 27 8.04e-01 9.20e-01 0.074300 1.39e-02 7.30e-02 9.00e-01 5.12e-01
GOBP SLEEP 22 8.27e-01 9.29e-01 0.074300 -7.15e-02 2.03e-02 5.62e-01 8.69e-01
Uptake and actions of bacterial toxins 28 7.80e-01 9.09e-01 0.074300 4.09e-02 -6.20e-02 7.08e-01 5.70e-01
GOBP PURINE NUCLEOBASE METABOLIC PROCESS 18 8.53e-01 9.39e-01 0.074200 6.52e-02 -3.54e-02 6.32e-01 7.95e-01
GOBP ACYL COA METABOLIC PROCESS 89 5.05e-01 7.57e-01 0.074200 5.64e-02 4.83e-02 3.58e-01 4.31e-01
GOCC I BAND 140 3.43e-01 6.32e-01 0.074200 5.36e-02 5.13e-02 2.73e-01 2.95e-01
GOBP NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION 45 6.80e-01 8.61e-01 0.074000 7.09e-02 -2.10e-02 4.10e-01 8.07e-01
GOMF NUCLEOBASE CONTAINING COMPOUND KINASE ACTIVITY 41 7.15e-01 8.77e-01 0.074000 4.29e-03 7.38e-02 9.62e-01 4.13e-01
GOBP LEUKOCYTE MEDIATED IMMUNITY 386 5.38e-02 2.36e-01 0.073900 -3.77e-02 -6.36e-02 2.03e-01 3.20e-02
GOBP GLUCOSE IMPORT 77 5.55e-01 7.88e-01 0.073900 6.09e-02 4.18e-02 3.55e-01 5.26e-01
GOCC MITOTIC COHESIN COMPLEX 5 9.60e-01 9.85e-01 0.073900 9.03e-04 7.39e-02 9.97e-01 7.75e-01
Pyruvate metabolism 46 6.69e-01 8.55e-01 0.073900 -3.72e-02 6.38e-02 6.63e-01 4.54e-01
GOBP AMINO SUGAR METABOLIC PROCESS 40 7.06e-01 8.73e-01 0.073800 -3.47e-02 6.51e-02 7.05e-01 4.76e-01
GOBP POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS 137 3.50e-01 6.40e-01 0.073700 3.46e-02 6.51e-02 4.84e-01 1.88e-01
GOBP POSITIVE REGULATION OF GENE EXPRESSION 1145 8.44e-05 1.85e-03 0.073700 6.73e-02 -3.01e-02 1.23e-04 8.64e-02
GOBP NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT 21 8.53e-01 9.39e-01 0.073700 5.26e-02 5.16e-02 6.77e-01 6.82e-01
GOBP CELLULAR RESPONSE TO ORGANIC SUBSTANCE 1898 9.36e-07 3.61e-05 0.073600 7.28e-02 1.09e-02 1.49e-07 4.31e-01
GOBP POLYSACCHARIDE CATABOLIC PROCESS 27 7.91e-01 9.15e-01 0.073600 -6.36e-02 3.71e-02 5.68e-01 7.38e-01
GOBP RESPONSE TO MINERALOCORTICOID 36 7.30e-01 8.84e-01 0.073600 4.69e-02 -5.67e-02 6.26e-01 5.56e-01
Defective B3GAT3 causes JDSSDHD 17 8.74e-01 9.48e-01 0.073600 -7.19e-02 -1.57e-02 6.08e-01 9.11e-01
GOBP OSSIFICATION 434 3.29e-02 1.75e-01 0.073500 7.31e-02 7.91e-03 9.00e-03 7.77e-01
GOBP POSITIVE REGULATION OF RESPONSE TO TUMOR CELL 14 8.99e-01 9.61e-01 0.073500 -4.47e-02 -5.84e-02 7.72e-01 7.05e-01
GOMF GDP BINDING 71 5.41e-01 7.79e-01 0.073500 3.71e-02 -6.35e-02 5.89e-01 3.55e-01
GOBP NEGATIVE REGULATION OF VIRAL LIFE CYCLE 27 7.99e-01 9.17e-01 0.073500 -1.06e-02 7.27e-02 9.24e-01 5.13e-01
GOBP PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM 70 5.74e-01 8.00e-01 0.073500 -1.22e-02 -7.24e-02 8.60e-01 2.95e-01
GOBP ORGANIC HYDROXY COMPOUND TRANSPORT 280 1.11e-01 3.61e-01 0.073400 1.12e-02 7.26e-02 7.47e-01 3.67e-02
Biosynthesis of maresins 8 9.33e-01 9.75e-01 0.073400 -3.89e-02 6.23e-02 8.49e-01 7.60e-01
GOMF STRUCTURAL MOLECULE ACTIVITY 750 4.31e-03 4.24e-02 0.073300 -5.20e-02 -5.17e-02 1.53e-02 1.60e-02
GOBP PHOTORECEPTOR CELL DIFFERENTIATION 65 5.69e-01 7.97e-01 0.073300 -4.63e-02 5.69e-02 5.18e-01 4.28e-01
GOBP PROTEIN DEGLUTAMYLATION 6 9.52e-01 9.82e-01 0.073300 -7.27e-02 9.37e-03 7.58e-01 9.68e-01
GOBP BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS 22 8.37e-01 9.32e-01 0.073200 1.87e-03 -7.32e-02 9.88e-01 5.52e-01
GOBP MITOCHONDRIAL ELECTRON TRANSPORT CYTOCHROME C TO OXYGEN 18 8.56e-01 9.40e-01 0.073200 4.75e-02 -5.57e-02 7.27e-01 6.83e-01
GOBP PROTEIN TARGETING 307 7.91e-02 2.99e-01 0.073200 7.06e-02 -1.93e-02 3.34e-02 5.61e-01
GOBP REGULATION OF NUCLEOTIDE CATABOLIC PROCESS 50 6.88e-01 8.65e-01 0.073200 5.53e-02 4.80e-02 4.99e-01 5.57e-01
GOBP REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY 23 8.24e-01 9.28e-01 0.073200 2.12e-02 -7.00e-02 8.60e-01 5.61e-01
GOBP POSITIVE REGULATION OF CYTOKINESIS 47 6.79e-01 8.61e-01 0.073200 7.23e-02 -1.13e-02 3.91e-01 8.94e-01
GOBP POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION 13 9.00e-01 9.61e-01 0.073200 -7.31e-02 3.52e-03 6.48e-01 9.82e-01
GOBP AMIDE METABOLIC PROCESS 435 4.13e-02 2.01e-01 0.073100 5.40e-02 4.93e-02 5.34e-02 7.79e-02
GOMF UDP GLUCOSYLTRANSFERASE ACTIVITY 10 9.25e-01 9.71e-01 0.073100 7.19e-02 1.30e-02 6.94e-01 9.43e-01
GOBP ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS 1697 1.35e-06 4.99e-05 0.073100 5.66e-02 -4.62e-02 1.04e-04 1.56e-03
p38MAPK events 13 9.01e-01 9.61e-01 0.073100 7.30e-02 2.57e-03 6.49e-01 9.87e-01
Interleukin receptor SHC signaling 23 8.33e-01 9.30e-01 0.073000 7.27e-02 6.76e-03 5.46e-01 9.55e-01
GOBP MITOCHONDRIAL TRANSPORT 176 2.55e-01 5.53e-01 0.073000 -1.36e-02 -7.17e-02 7.55e-01 1.01e-01
GOMF HYDROLASE ACTIVITY ACTING ON CARBON NITROGEN BUT NOT PEPTIDE BONDS IN LINEAR AMIDES 71 5.78e-01 8.02e-01 0.073000 1.84e-02 7.07e-02 7.89e-01 3.03e-01
GOBP MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY 53 6.60e-01 8.50e-01 0.073000 7.22e-02 1.09e-02 3.63e-01 8.91e-01
GOMF PROTEIN MEMBRANE ADAPTOR ACTIVITY 40 7.09e-01 8.75e-01 0.073000 -5.44e-02 4.86e-02 5.52e-01 5.95e-01
GOBP REGULATION OF NEUROTRANSMITTER SECRETION 78 5.31e-01 7.72e-01 0.072900 -8.38e-03 7.24e-02 8.98e-01 2.69e-01
GOMF SPHINGOLIPID BINDING 28 8.01e-01 9.18e-01 0.072900 5.63e-03 7.27e-02 9.59e-01 5.06e-01
GOBP NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY 37 7.50e-01 8.92e-01 0.072900 7.16e-02 1.34e-02 4.51e-01 8.88e-01
GOBP COCHLEA DEVELOPMENT 49 6.59e-01 8.50e-01 0.072900 6.14e-02 -3.93e-02 4.57e-01 6.34e-01
GOCC CORTICAL CYTOSKELETON 105 4.57e-01 7.23e-01 0.072900 3.79e-02 6.22e-02 5.02e-01 2.71e-01
GOBP ORGANONITROGEN COMPOUND CATABOLIC PROCESS 1373 3.74e-05 9.25e-04 0.072900 7.27e-02 5.31e-03 6.32e-06 7.41e-01
GOBP ACTIN MEDIATED CELL CONTRACTION 111 3.89e-01 6.72e-01 0.072800 -4.46e-02 5.75e-02 4.17e-01 2.95e-01
GOBP POSITIVE REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN 11 9.10e-01 9.66e-01 0.072800 -4.46e-02 5.75e-02 7.98e-01 7.41e-01
GOBP PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS 167 2.86e-01 5.83e-01 0.072800 2.90e-02 6.68e-02 5.19e-01 1.36e-01
GOBP POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS 84 5.19e-01 7.63e-01 0.072800 9.90e-03 7.21e-02 8.75e-01 2.53e-01
GOBP DEVELOPMENTAL MATURATION 326 8.89e-02 3.19e-01 0.072800 6.59e-02 3.09e-02 4.09e-02 3.37e-01
GOBP NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 53 6.54e-01 8.47e-01 0.072800 7.27e-02 -3.68e-03 3.60e-01 9.63e-01
GOBP REGULATION OF DNA TEMPLATED DNA REPLICATION 48 6.63e-01 8.51e-01 0.072800 5.15e-02 -5.14e-02 5.37e-01 5.38e-01
MHC class II antigen presentation 121 4.00e-01 6.82e-01 0.072700 6.88e-02 2.34e-02 1.91e-01 6.57e-01
Syndecan interactions 26 8.01e-01 9.18e-01 0.072700 4.88e-02 -5.38e-02 6.66e-01 6.35e-01
GOBP REGULATION OF RESPONSE TO OXIDATIVE STRESS 32 7.87e-01 9.13e-01 0.072700 3.33e-02 6.46e-02 7.45e-01 5.27e-01
GOMF CALMODULIN BINDING 199 2.21e-01 5.17e-01 0.072700 2.02e-02 6.98e-02 6.24e-01 8.95e-02
GOBP PHOSPHOLIPID CATABOLIC PROCESS 55 6.27e-01 8.33e-01 0.072700 -4.38e-02 5.80e-02 5.74e-01 4.57e-01
Asparagine N-linked glycosylation 300 9.63e-02 3.32e-01 0.072600 7.26e-02 3.02e-03 3.06e-02 9.28e-01
GOBP NEURAL RETINA DEVELOPMENT 80 5.38e-01 7.77e-01 0.072600 7.18e-02 1.08e-02 2.67e-01 8.68e-01
GOBP CIRCULATORY SYSTEM PROCESS 588 1.46e-02 1.03e-01 0.072600 4.51e-02 5.70e-02 6.17e-02 1.83e-02
GOBP NEGATIVE REGULATION OF TRANSFERASE ACTIVITY 208 1.74e-01 4.60e-01 0.072600 6.00e-02 -4.09e-02 1.35e-01 3.10e-01
GOBP HYALURONAN CATABOLIC PROCESS 16 8.73e-01 9.48e-01 0.072600 6.27e-02 -3.67e-02 6.64e-01 7.99e-01
GOBP NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS 55 6.51e-01 8.46e-01 0.072600 7.21e-02 8.59e-03 3.55e-01 9.12e-01
GOBP SYNAPTIC SIGNALING 756 4.42e-03 4.33e-02 0.072600 6.23e-02 3.73e-02 3.58e-03 8.11e-02
GOMF HEXOSAMINIDASE ACTIVITY 15 8.92e-01 9.57e-01 0.072500 7.03e-02 1.79e-02 6.38e-01 9.05e-01
GOCC TRANSPORT VESICLE MEMBRANE 232 1.63e-01 4.46e-01 0.072500 7.25e-02 2.93e-04 5.72e-02 9.94e-01
GOMF GLYCOLIPID BINDING 29 8.06e-01 9.20e-01 0.072400 -6.48e-02 -3.23e-02 5.46e-01 7.63e-01
GOBP MITOCHONDRIAL RIBOSOME ASSEMBLY 12 9.06e-01 9.63e-01 0.072400 2.11e-02 -6.93e-02 8.99e-01 6.78e-01
GOBP NEGATIVE REGULATION OF GENE EXPRESSION 1518 2.33e-05 6.10e-04 0.072400 6.83e-02 2.39e-02 8.57e-06 1.19e-01
GOBP NEGATIVE REGULATION OF INFLAMMATORY RESPONSE 191 2.02e-01 4.95e-01 0.072400 -4.24e-02 5.86e-02 3.12e-01 1.62e-01
GOBP DENDRITE DEVELOPMENT 223 1.89e-01 4.80e-01 0.072400 6.87e-02 2.28e-02 7.72e-02 5.58e-01
GOCC NON MOTILE CILIUM 155 3.14e-01 6.07e-01 0.072300 2.48e-02 6.80e-02 5.94e-01 1.44e-01
GOMF PHOSPHOLIPID TRANSPORTER ACTIVITY 63 6.20e-01 8.27e-01 0.072300 7.03e-02 1.67e-02 3.34e-01 8.19e-01
GOBP AMINO ACID BIOSYNTHETIC PROCESS 72 5.48e-01 7.83e-01 0.072200 4.03e-02 -5.99e-02 5.54e-01 3.80e-01
GOMF INORGANIC MOLECULAR ENTITY TRANSMEMBRANE TRANSPORTER ACTIVITY 691 3.78e-03 3.80e-02 0.072200 -6.34e-02 3.45e-02 4.51e-03 1.22e-01
GOBP NEGATIVE REGULATION OF CYCLASE ACTIVITY 15 8.92e-01 9.57e-01 0.072100 1.66e-02 7.02e-02 9.11e-01 6.38e-01
GOBP TRANS SYNAPTIC SIGNALING MODULATING SYNAPTIC TRANSMISSION 11 9.22e-01 9.70e-01 0.072100 2.82e-02 6.64e-02 8.71e-01 7.03e-01
GOBP RELAXATION OF CARDIAC MUSCLE 17 8.79e-01 9.50e-01 0.072100 7.00e-02 1.74e-02 6.17e-01 9.01e-01
GOBP NEURONAL ION CHANNEL CLUSTERING 12 9.05e-01 9.63e-01 0.072100 -6.28e-02 3.54e-02 7.06e-01 8.32e-01
GOBP SKIN EPIDERMIS DEVELOPMENT 128 3.78e-01 6.63e-01 0.072100 7.11e-02 1.19e-02 1.65e-01 8.17e-01
GOBP REGULATION OF MOLECULAR FUNCTION 1871 9.68e-07 3.70e-05 0.072100 7.01e-02 -1.65e-02 4.98e-07 2.37e-01
GOMF AMINO ACID SODIUM SYMPORTER ACTIVITY 21 8.52e-01 9.39e-01 0.072100 1.29e-02 7.09e-02 9.18e-01 5.74e-01
GOMF PDZ DOMAIN BINDING 85 5.41e-01 7.79e-01 0.072000 4.64e-02 5.51e-02 4.59e-01 3.80e-01
GOBP POSITIVE REGULATION OF CELLULAR PH REDUCTION 5 9.64e-01 9.86e-01 0.071900 3.39e-02 6.34e-02 8.96e-01 8.06e-01
GOBP REGULATION OF ENDOSOME SIZE 13 8.98e-01 9.60e-01 0.071900 -6.10e-02 3.81e-02 7.04e-01 8.12e-01
GOBP MICROTUBULE CYTOSKELETON ORGANIZATION 628 7.51e-03 6.41e-02 0.071900 7.05e-02 -1.41e-02 2.55e-03 5.48e-01
GOBP RESPIRATORY BURST INVOLVED IN INFLAMMATORY RESPONSE 9 9.37e-01 9.76e-01 0.071900 -5.86e-02 -4.17e-02 7.61e-01 8.29e-01
GOMF INTRACELLULARLY CALCIUM GATED CHLORIDE CHANNEL ACTIVITY 20 8.46e-01 9.36e-01 0.071900 -4.68e-02 5.45e-02 7.17e-01 6.73e-01
GOMF MONOATOMIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 612 8.42e-03 6.97e-02 0.071800 -7.00e-02 1.62e-02 3.11e-03 4.94e-01
GOBP REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY 42 7.38e-01 8.87e-01 0.071800 -3.98e-02 -5.97e-02 6.55e-01 5.03e-01
GOBP PHAGOCYTOSIS ENGULFMENT 47 6.96e-01 8.68e-01 0.071700 -7.17e-02 -1.97e-03 3.95e-01 9.81e-01
Regulation of HMOX1 expression and activity 5 9.60e-01 9.85e-01 0.071700 -6.32e-02 3.38e-02 8.07e-01 8.96e-01
GOMF GLYCOSAMINOGLYCAN BINDING 235 1.45e-01 4.18e-01 0.071700 -4.54e-02 5.55e-02 2.30e-01 1.43e-01
GOBP GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS 23 8.33e-01 9.30e-01 0.071700 -7.02e-02 1.46e-02 5.60e-01 9.03e-01
GOMF TRANSITION METAL ION BINDING 1051 4.34e-04 7.03e-03 0.071700 7.17e-02 7.96e-04 8.59e-05 9.65e-01
GOCC CHLORIDE CHANNEL COMPLEX 51 6.87e-01 8.64e-01 0.071600 2.36e-02 6.76e-02 7.71e-01 4.03e-01
GOBP PLASMA MEMBRANE RAFT ORGANIZATION 12 9.17e-01 9.69e-01 0.071600 3.94e-02 5.97e-02 8.13e-01 7.20e-01
GOBP POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS 26 8.23e-01 9.27e-01 0.071500 -7.02e-02 -1.36e-02 5.35e-01 9.04e-01
GOBP RESPONSE TO ANTIBIOTIC 36 7.67e-01 9.02e-01 0.071400 6.80e-02 2.20e-02 4.80e-01 8.19e-01
GOBP SPERMATID DIFFERENTIATION 215 1.86e-01 4.77e-01 0.071400 -7.02e-02 1.30e-02 7.59e-02 7.43e-01
GOBP CELLULAR LIPID METABOLIC PROCESS 990 8.18e-04 1.17e-02 0.071400 7.06e-02 1.04e-02 1.70e-04 5.81e-01
GOMF PHOSPHORIC DIESTER HYDROLASE ACTIVITY 86 5.15e-01 7.62e-01 0.071400 -7.13e-02 3.77e-03 2.53e-01 9.52e-01
GOBP POST TRANSCRIPTIONAL REGULATION OF GENE EXPRESSION 976 1.27e-03 1.67e-02 0.071300 5.82e-02 4.12e-02 2.07e-03 2.92e-02
GOCC IMMUNOLOGICAL SYNAPSE 45 7.12e-01 8.76e-01 0.071300 7.10e-02 6.44e-03 4.10e-01 9.40e-01
HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand 54 6.77e-01 8.60e-01 0.071300 -2.80e-02 -6.55e-02 7.22e-01 4.05e-01
GOBP STRIATED MUSCLE CONTRACTION 182 2.36e-01 5.32e-01 0.071200 -6.71e-02 2.39e-02 1.19e-01 5.78e-01
GOBP SENSORY PERCEPTION OF MECHANICAL STIMULUS 183 2.32e-01 5.29e-01 0.071100 3.00e-02 -6.45e-02 4.85e-01 1.32e-01
GOBP SYNAPTIC TRANSMISSION GLUTAMATERGIC 104 4.35e-01 7.10e-01 0.071100 -6.55e-02 2.78e-02 2.48e-01 6.25e-01
GOMF PHOSPHATIDYL PHOSPHOLIPASE B ACTIVITY 11 9.14e-01 9.68e-01 0.071100 -4.48e-02 5.52e-02 7.97e-01 7.51e-01
ECM proteoglycans 73 5.54e-01 7.87e-01 0.071100 -5.99e-02 3.83e-02 3.76e-01 5.71e-01
GOCC AXON 623 1.26e-02 9.23e-02 0.071000 6.62e-02 2.58e-02 4.79e-03 2.72e-01
Depolymerization of the Nuclear Lamina 14 8.92e-01 9.57e-01 0.071000 4.89e-02 -5.15e-02 7.51e-01 7.39e-01
GOBP POSITIVE REGULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION 8 9.45e-01 9.80e-01 0.071000 -5.32e-02 -4.70e-02 7.94e-01 8.18e-01
GOBP REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY 23 8.47e-01 9.36e-01 0.071000 2.50e-02 6.65e-02 8.36e-01 5.81e-01
GOBP RRNA 5 END PROCESSING 5 9.62e-01 9.86e-01 0.071000 -1.12e-02 7.01e-02 9.66e-01 7.86e-01
GOBP REGULATION OF CARBOHYDRATE CATABOLIC PROCESS 60 6.56e-01 8.49e-01 0.071000 5.15e-02 4.88e-02 4.90e-01 5.13e-01
GOBP CHLORIDE TRANSPORT 116 3.91e-01 6.74e-01 0.070900 -5.53e-02 4.44e-02 3.03e-01 4.09e-01
GOBP NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 1189 3.11e-04 5.36e-03 0.070900 6.51e-02 2.81e-02 1.56e-04 1.02e-01
GOCC EXTRINSIC COMPONENT OF PLASMA MEMBRANE 99 4.93e-01 7.50e-01 0.070800 2.66e-02 6.56e-02 6.48e-01 2.59e-01
GOMF CARNITINE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 9.61e-01 9.85e-01 0.070700 3.67e-02 -6.05e-02 8.87e-01 8.15e-01
GOBP COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 53 6.75e-01 8.58e-01 0.070700 7.05e-02 5.84e-03 3.75e-01 9.41e-01
GOBP INORGANIC ANION TRANSMEMBRANE TRANSPORT 123 3.73e-01 6.59e-01 0.070700 -5.78e-02 4.08e-02 2.69e-01 4.35e-01
GOMF PHOSPHATIDYLSERINE BINDING 66 6.12e-01 8.23e-01 0.070600 4.46e-03 7.05e-02 9.50e-01 3.22e-01
GOBP RENAL RESPONSE TO BLOOD FLOW INVOLVED IN CIRCULATORY RENIN ANGIOTENSIN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE 7 9.50e-01 9.81e-01 0.070600 6.97e-02 1.12e-02 7.49e-01 9.59e-01
GOBP OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS 21 8.59e-01 9.42e-01 0.070600 6.82e-02 1.83e-02 5.88e-01 8.85e-01
GOMF CHEMOKINE RECEPTOR BINDING 63 6.46e-01 8.43e-01 0.070600 -4.96e-02 -5.03e-02 4.96e-01 4.90e-01
GOCC NUCLEAR LAMINA 10 9.23e-01 9.71e-01 0.070600 -5.34e-02 4.61e-02 7.70e-01 8.01e-01
GOBP POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 1633 1.82e-05 4.89e-04 0.070500 6.81e-02 1.80e-02 4.45e-06 2.26e-01
GOBP NECROPTOTIC PROCESS 45 7.02e-01 8.71e-01 0.070400 6.49e-02 -2.75e-02 4.51e-01 7.50e-01
GOBP REGULATION OF TRANSMEMBRANE TRANSPORT 465 3.62e-02 1.87e-01 0.070400 6.94e-02 1.16e-02 1.03e-02 6.68e-01
GOMF TRANSPORTER REGULATOR ACTIVITY 145 3.68e-01 6.56e-01 0.070400 5.52e-02 4.36e-02 2.51e-01 3.65e-01
GOBP VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION 38 7.50e-01 8.92e-01 0.070300 6.98e-02 -8.93e-03 4.57e-01 9.24e-01
GOBP PIGMENTATION 107 4.36e-01 7.10e-01 0.070200 6.55e-02 -2.53e-02 2.42e-01 6.51e-01
GOMF 3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 22 8.45e-01 9.36e-01 0.070200 -6.80e-02 1.73e-02 5.81e-01 8.88e-01
GOBP PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS 31 8.04e-01 9.20e-01 0.070200 2.62e-02 6.51e-02 8.01e-01 5.31e-01
GOBP COLLAGEN BIOSYNTHETIC PROCESS 46 7.24e-01 8.81e-01 0.070100 2.54e-02 6.54e-02 7.66e-01 4.43e-01
GOBP REGULATION OF PEPTIDYL CYSTEINE S NITROSYLATION 10 9.24e-01 9.71e-01 0.070100 -4.13e-02 5.66e-02 8.21e-01 7.56e-01
GOBP REGULATION OF NUCLEAR DIVISION 146 3.18e-01 6.10e-01 0.070000 5.72e-02 -4.04e-02 2.32e-01 4.00e-01
Stimuli-sensing channels 101 4.56e-01 7.22e-01 0.070000 -6.26e-02 3.13e-02 2.77e-01 5.87e-01
GOBP CELLULAR HYPOTONIC RESPONSE 11 9.22e-01 9.70e-01 0.070000 6.99e-02 -3.19e-03 6.88e-01 9.85e-01
GOBP LUNG SACCULE DEVELOPMENT 10 9.27e-01 9.73e-01 0.069900 -6.90e-02 1.12e-02 7.06e-01 9.51e-01
TP53 Regulates Transcription of Cell Cycle Genes 47 6.92e-01 8.67e-01 0.069800 3.81e-02 -5.85e-02 6.51e-01 4.88e-01
GOBP PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS 86 5.50e-01 7.85e-01 0.069800 6.46e-02 2.65e-02 3.00e-01 6.71e-01
GOCC OUTER MITOCHONDRIAL MEMBRANE PROTEIN COMPLEX 21 8.55e-01 9.40e-01 0.069800 7.71e-03 -6.94e-02 9.51e-01 5.82e-01
GOCC CILIARY BASE 45 7.33e-01 8.85e-01 0.069800 3.03e-02 6.29e-02 7.25e-01 4.66e-01
GOBP LYMPHOCYTE MIGRATION 99 4.99e-01 7.53e-01 0.069800 6.69e-02 1.98e-02 2.50e-01 7.33e-01
G alpha (i) signalling events 304 1.08e-01 3.55e-01 0.069800 -5.40e-03 6.95e-02 8.71e-01 3.70e-02
GOCC AXONEMAL A TUBULE INNER SHEATH 23 8.47e-01 9.36e-01 0.069700 -6.83e-03 -6.94e-02 9.55e-01 5.65e-01
GOBP CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 296 1.05e-01 3.49e-01 0.069700 2.82e-02 -6.37e-02 4.03e-01 5.93e-02
GOCC CONDENSED NUCLEAR CHROMOSOME 74 5.61e-01 7.92e-01 0.069700 5.52e-02 -4.25e-02 4.11e-01 5.27e-01
GOBP CHONDROCYTE DEVELOPMENT 32 7.97e-01 9.17e-01 0.069700 6.80e-02 1.54e-02 5.06e-01 8.80e-01
GOBP HOMOCYSTEINE METABOLIC PROCESS 12 9.22e-01 9.70e-01 0.069700 4.86e-02 4.99e-02 7.70e-01 7.65e-01
GOBP LIPID HOMEOSTASIS 175 2.56e-01 5.53e-01 0.069700 -4.54e-02 5.29e-02 3.00e-01 2.28e-01
GOBP POSITIVE REGULATION OF CHEMOKINE PRODUCTION 70 5.82e-01 8.04e-01 0.069700 -6.23e-02 3.12e-02 3.67e-01 6.52e-01
GOBP MYOBLAST FUSION 46 7.28e-01 8.83e-01 0.069600 6.32e-02 2.93e-02 4.59e-01 7.31e-01
GOBP PLASMA MEMBRANE ORGANIZATION 161 3.37e-01 6.26e-01 0.069600 3.81e-02 5.82e-02 4.04e-01 2.03e-01
GOMF BETA TUBULIN BINDING 37 7.49e-01 8.92e-01 0.069500 5.15e-02 -4.66e-02 5.87e-01 6.24e-01
GOBP PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS 17 8.76e-01 9.49e-01 0.069500 5.51e-02 -4.23e-02 6.94e-01 7.63e-01
GOCC SOMATODENDRITIC COMPARTMENT 802 4.85e-03 4.64e-02 0.069500 6.39e-02 2.73e-02 2.09e-03 1.89e-01
GOBP HYALURONAN METABOLIC PROCESS 33 7.98e-01 9.17e-01 0.069500 3.27e-02 6.13e-02 7.45e-01 5.42e-01
Aggrephagy 40 7.53e-01 8.94e-01 0.069400 -6.86e-02 -1.04e-02 4.53e-01 9.10e-01
GOBP NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS 28 8.28e-01 9.29e-01 0.069400 4.67e-02 5.13e-02 6.69e-01 6.38e-01
GOBP POSITIVE REGULATION OF RESPONSE TO TYPE II INTERFERON 6 9.55e-01 9.83e-01 0.069300 4.21e-02 -5.51e-02 8.58e-01 8.15e-01
GOBP FAT SOLUBLE VITAMIN METABOLIC PROCESS 47 6.95e-01 8.68e-01 0.069300 4.38e-02 -5.38e-02 6.04e-01 5.24e-01
GOBP MAMMARY GLAND MORPHOGENESIS 45 7.12e-01 8.76e-01 0.069300 6.60e-02 -2.10e-02 4.43e-01 8.07e-01
GOBP AMELOGENESIS 25 8.36e-01 9.32e-01 0.069300 -5.10e-03 -6.91e-02 9.65e-01 5.50e-01
GOCC EXTRINSIC COMPONENT OF CYTOPLASMIC SIDE OF PLASMA MEMBRANE 48 7.25e-01 8.82e-01 0.069200 5.39e-02 4.35e-02 5.18e-01 6.02e-01
GOBP GLYCOPROTEIN METABOLIC PROCESS 373 8.14e-02 3.04e-01 0.069200 2.64e-02 6.39e-02 3.81e-01 3.40e-02
GOCC EXOCYTIC VESICLE 227 2.10e-01 5.05e-01 0.069100 6.71e-02 1.64e-02 8.14e-02 6.71e-01
GOMF PROTEIN TYROSINE THREONINE PHOSPHATASE ACTIVITY 9 9.41e-01 9.77e-01 0.069100 -3.48e-02 -5.97e-02 8.57e-01 7.57e-01
GOBP POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 31 7.98e-01 9.17e-01 0.069100 -5.21e-03 6.89e-02 9.60e-01 5.07e-01
GOBP CARBOHYDRATE BIOSYNTHETIC PROCESS 200 2.64e-01 5.61e-01 0.069000 3.68e-02 5.84e-02 3.70e-01 1.54e-01
GOBP DEFENSE RESPONSE TO OTHER ORGANISM 1162 6.51e-04 9.73e-03 0.069000 -5.31e-02 -4.41e-02 2.28e-03 1.13e-02
GOBP CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS 40 7.58e-01 8.96e-01 0.069000 6.73e-02 1.53e-02 4.62e-01 8.67e-01
GOMF MDM2 MDM4 FAMILY PROTEIN BINDING 11 9.30e-01 9.74e-01 0.068900 -5.33e-02 -4.38e-02 7.60e-01 8.02e-01
GOBP PEPTIDYL METHIONINE MODIFICATION 11 9.19e-01 9.69e-01 0.068900 -4.22e-02 5.45e-02 8.08e-01 7.54e-01
GOBP REGULATION OF CARTILAGE DEVELOPMENT 71 5.97e-01 8.14e-01 0.068900 -9.18e-03 6.83e-02 8.94e-01 3.20e-01
GOBP MALATE METABOLIC PROCESS 9 9.37e-01 9.76e-01 0.068900 6.88e-02 -4.59e-03 7.21e-01 9.81e-01
GOBP REGULATION OF SENSORY PERCEPTION 17 8.88e-01 9.55e-01 0.068900 -1.14e-02 -6.79e-02 9.35e-01 6.28e-01
GOBP ORGANIC ACID CATABOLIC PROCESS 242 1.93e-01 4.84e-01 0.068900 1.84e-02 6.64e-02 6.22e-01 7.54e-02
GOBP REGULATION OF MACROPHAGE MIGRATION 45 7.40e-01 8.88e-01 0.068900 6.00e-02 3.39e-02 4.87e-01 6.94e-01
GOBP ICOSANOID BIOSYNTHETIC PROCESS 55 6.61e-01 8.51e-01 0.068800 6.23e-02 -2.93e-02 4.24e-01 7.07e-01
GOMF INSULIN LIKE GROWTH FACTOR BINDING 19 8.78e-01 9.50e-01 0.068800 6.59e-02 1.98e-02 6.19e-01 8.81e-01
GOMF AMYLOID BETA BINDING 80 5.73e-01 7.99e-01 0.068800 -6.80e-02 -1.05e-02 2.93e-01 8.71e-01
GOBP RESPONSE TO LIPID 896 1.55e-03 1.94e-02 0.068800 6.25e-02 -2.87e-02 1.51e-03 1.45e-01
GOBP PARACRINE SIGNALING 7 9.53e-01 9.82e-01 0.068800 -1.60e-02 -6.69e-02 9.41e-01 7.59e-01
GOBP PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS 39 7.47e-01 8.91e-01 0.068800 6.38e-02 -2.56e-02 4.90e-01 7.82e-01
GOMF MAP KINASE TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY 11 9.20e-01 9.70e-01 0.068800 -6.14e-02 3.09e-02 7.24e-01 8.59e-01
GOBP MESENCHYMAL STEM CELL DIFFERENTIATION 12 9.21e-01 9.70e-01 0.068700 -6.69e-02 -1.56e-02 6.88e-01 9.25e-01
GOBP NEGATIVE REGULATION OF PROTEIN SECRETION 72 6.11e-01 8.23e-01 0.068700 1.79e-02 6.63e-02 7.93e-01 3.30e-01
GOBP CELL REDOX HOMEOSTASIS 38 7.71e-01 9.04e-01 0.068600 -1.69e-02 -6.65e-02 8.57e-01 4.78e-01
GOCC TRANSCRIPTION FACTOR TFIID COMPLEX 30 7.96e-01 9.17e-01 0.068600 4.39e-02 -5.28e-02 6.78e-01 6.17e-01
GOBP RESPONSE TO MITOCHONDRIAL DEPOLARISATION 19 8.70e-01 9.46e-01 0.068600 1.62e-02 -6.66e-02 9.03e-01 6.15e-01
GOMF PROTON TRANSMEMBRANE TRANSPORTER ACTIVITY 164 3.04e-01 5.98e-01 0.068600 1.58e-02 -6.67e-02 7.28e-01 1.40e-01
GOBP POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND 10 9.32e-01 9.75e-01 0.068600 3.44e-03 6.85e-02 9.85e-01 7.08e-01
GOBP REGULATION OF DENDRITE EXTENSION 26 8.35e-01 9.31e-01 0.068500 -6.79e-02 -9.04e-03 5.49e-01 9.36e-01
GOBP VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION 59 6.47e-01 8.44e-01 0.068500 6.52e-02 -2.13e-02 3.87e-01 7.78e-01
GOBP SODIUM ION TRANSMEMBRANE TRANSPORT 179 2.60e-01 5.57e-01 0.068500 -5.34e-02 4.29e-02 2.18e-01 3.22e-01
GOBP MAST CELL CYTOKINE PRODUCTION 6 9.56e-01 9.84e-01 0.068500 6.34e-02 -2.60e-02 7.88e-01 9.12e-01
GOBP REGULATION OF HYDROLASE ACTIVITY 673 8.45e-03 6.99e-02 0.068500 6.64e-02 -1.69e-02 3.33e-03 4.56e-01
GOBP PLACENTA BLOOD VESSEL DEVELOPMENT 31 7.99e-01 9.17e-01 0.068500 1.30e-02 -6.72e-02 9.00e-01 5.17e-01
Adaptive Immune System 720 5.15e-03 4.84e-02 0.068400 4.17e-02 -5.43e-02 5.67e-02 1.31e-02
GOBP REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST 40 7.42e-01 8.89e-01 0.068400 -3.05e-02 6.13e-02 7.39e-01 5.03e-01
GOBP CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES 22 8.66e-01 9.44e-01 0.068400 4.81e-02 4.86e-02 6.96e-01 6.93e-01
GOBP OVARIAN FOLLICLE DEVELOPMENT 55 6.80e-01 8.61e-01 0.068200 6.82e-02 -1.17e-03 3.81e-01 9.88e-01
GOBP VIRAL PROCESS 412 5.13e-02 2.29e-01 0.068200 6.44e-02 -2.27e-02 2.50e-02 4.29e-01
Defective B3GALT6 causes EDSP2 and SEMDJL1 17 8.88e-01 9.55e-01 0.068200 -6.82e-02 -1.41e-03 6.26e-01 9.92e-01
GOBP LIPID METABOLIC PROCESS 1350 1.77e-04 3.44e-03 0.068200 6.69e-02 1.31e-02 3.69e-05 4.19e-01
Signaling by PDGF 57 6.84e-01 8.63e-01 0.068200 6.42e-02 2.29e-02 4.02e-01 7.65e-01
GOBP REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS 38 7.52e-01 8.93e-01 0.068200 -5.25e-02 4.35e-02 5.75e-01 6.43e-01
Defects in vitamin and cofactor metabolism 21 8.55e-01 9.40e-01 0.068100 5.78e-02 -3.60e-02 6.46e-01 7.75e-01
GOMF MOLECULAR FUNCTION ACTIVATOR ACTIVITY 1073 8.70e-04 1.23e-02 0.068000 6.78e-02 5.18e-03 1.74e-04 7.74e-01
Platelet activation, signaling and aggregation 249 1.64e-01 4.48e-01 0.068000 6.27e-02 -2.63e-02 8.84e-02 4.75e-01
GOMF HYDROLASE ACTIVITY HYDROLYZING O GLYCOSYL COMPOUNDS 89 5.31e-01 7.72e-01 0.067900 -1.22e-02 6.68e-02 8.42e-01 2.76e-01
GOBP ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 166 3.36e-01 6.25e-01 0.067900 -2.32e-02 -6.38e-02 6.07e-01 1.56e-01
GOBP SENSORY PERCEPTION OF LIGHT STIMULUS 207 2.57e-01 5.54e-01 0.067700 2.07e-02 6.45e-02 6.08e-01 1.10e-01
GOBP HEMOPOIESIS 928 1.67e-03 2.05e-02 0.067700 6.46e-02 -2.01e-02 8.47e-04 3.00e-01
GOMF CHEMOATTRACTANT ACTIVITY 34 7.81e-01 9.10e-01 0.067600 2.78e-02 -6.17e-02 7.79e-01 5.34e-01
GOBP REGULATION OF SUPEROXIDE METABOLIC PROCESS 28 8.22e-01 9.27e-01 0.067600 -6.70e-02 8.94e-03 5.39e-01 9.35e-01
GOBP T CELL DIFFERENTIATION 307 1.09e-01 3.56e-01 0.067600 5.84e-02 -3.40e-02 7.82e-02 3.05e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS 8 9.43e-01 9.79e-01 0.067600 3.29e-02 -5.91e-02 8.72e-01 7.72e-01
Chondroitin sulfate/dermatan sulfate metabolism 46 7.33e-01 8.85e-01 0.067600 8.42e-03 6.71e-02 9.21e-01 4.31e-01
GOBP POSITIVE REGULATION OF B CELL PROLIFERATION 43 7.28e-01 8.83e-01 0.067600 -4.44e-02 5.09e-02 6.14e-01 5.64e-01
GOCC NEURONAL DENSE CORE VESICLE 25 8.32e-01 9.30e-01 0.067500 5.05e-02 -4.48e-02 6.62e-01 6.98e-01
GOBP NEGATIVE REGULATION OF PEPTIDE SECRETION 45 7.20e-01 8.79e-01 0.067500 5.80e-02 -3.44e-02 5.01e-01 6.89e-01
GOCC PRESYNAPTIC ACTIVE ZONE MEMBRANE 31 7.98e-01 9.17e-01 0.067400 3.32e-02 -5.87e-02 7.49e-01 5.72e-01
Diseases associated with the TLR signaling cascade 29 8.09e-01 9.22e-01 0.067400 3.88e-02 -5.51e-02 7.18e-01 6.07e-01
Diseases of Immune System 29 8.09e-01 9.22e-01 0.067400 3.88e-02 -5.51e-02 7.18e-01 6.07e-01
GOBP LUTEINIZATION 12 9.17e-01 9.69e-01 0.067400 -6.23e-02 2.57e-02 7.09e-01 8.78e-01
GOBP NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY 25 8.50e-01 9.37e-01 0.067300 -2.19e-02 -6.36e-02 8.49e-01 5.82e-01
GOMF PHOSPHATIDYLETHANOLAMINE FLIPPASE ACTIVITY 5 9.68e-01 9.89e-01 0.067300 -5.90e-02 -3.23e-02 8.19e-01 9.00e-01
GOBP MECHANORECEPTOR DIFFERENTIATION 70 6.02e-01 8.17e-01 0.067200 -3.76e-02 5.57e-02 5.87e-01 4.20e-01
GOBP POSITIVE REGULATION OF PROTEIN MATURATION 26 8.33e-01 9.30e-01 0.067200 -1.48e-02 6.55e-02 8.96e-01 5.63e-01
Signaling by GPCR 674 1.39e-02 1.00e-01 0.067200 1.82e-02 6.46e-02 4.19e-01 4.22e-03
GOBP GRANULOCYTE DIFFERENTIATION 39 7.75e-01 9.06e-01 0.067100 -6.51e-02 -1.63e-02 4.82e-01 8.60e-01
GOBP FIBROBLAST GROWTH FACTOR PRODUCTION 10 9.34e-01 9.75e-01 0.067100 6.70e-02 -2.96e-03 7.14e-01 9.87e-01
GOCC CYTOPLASMIC DYNEIN COMPLEX 22 8.71e-01 9.47e-01 0.067100 5.47e-02 3.88e-02 6.57e-01 7.53e-01
GOCC DENDRITIC TREE 590 2.69e-02 1.56e-01 0.067000 5.32e-02 4.08e-02 2.72e-02 9.07e-02
GOBP NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION 110 4.93e-01 7.50e-01 0.067000 2.25e-02 6.31e-02 6.83e-01 2.53e-01
GOCC PRC1 COMPLEX 18 8.90e-01 9.56e-01 0.067000 2.05e-02 6.38e-02 8.80e-01 6.40e-01
GOMF ANTIPORTER ACTIVITY 128 4.17e-01 6.97e-01 0.066900 -8.39e-03 6.64e-02 8.70e-01 1.94e-01
GOBP MEMBRANE FUSION 177 3.01e-01 5.96e-01 0.066900 6.66e-02 -5.91e-03 1.26e-01 8.92e-01
GOBP POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS 1044 8.28e-04 1.19e-02 0.066900 2.91e-02 -6.02e-02 1.12e-01 1.00e-03
GPCR ligand binding 445 4.36e-02 2.08e-01 0.066900 -3.50e-02 5.70e-02 2.06e-01 3.92e-02
GOBP NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS 268 1.49e-01 4.25e-01 0.066800 5.48e-02 -3.82e-02 1.22e-01 2.81e-01
GOBP REGULATION OF OSTEOBLAST DIFFERENTIATION 151 3.71e-01 6.58e-01 0.066800 6.63e-02 8.06e-03 1.60e-01 8.64e-01
GOCC SECONDARY LYSOSOME 20 8.80e-01 9.51e-01 0.066800 6.19e-02 2.50e-02 6.32e-01 8.46e-01
Pregnenolone biosynthesis 12 9.28e-01 9.73e-01 0.066700 5.23e-02 4.14e-02 7.54e-01 8.04e-01
GOBP ADENYLATE CYCLASE ACTIVATING DOPAMINE RECEPTOR SIGNALING PATHWAY 10 9.32e-01 9.75e-01 0.066600 6.24e-02 -2.33e-02 7.32e-01 8.99e-01
Diseases of carbohydrate metabolism 31 8.13e-01 9.25e-01 0.066600 -6.66e-02 -8.86e-04 5.21e-01 9.93e-01
GOBP RESPONSE TO GONADOTROPIN 27 8.45e-01 9.36e-01 0.066600 3.68e-02 5.55e-02 7.40e-01 6.18e-01
GOBP REGULATION OF AMINE METABOLIC PROCESS 29 8.22e-01 9.27e-01 0.066500 6.64e-02 -4.78e-03 5.36e-01 9.64e-01
GOCC POSTSYNAPTIC MEMBRANE 261 1.63e-01 4.47e-01 0.066500 -6.12e-02 2.61e-02 8.87e-02 4.67e-01
GOMF ANTIOXIDANT ACTIVITY 82 5.63e-01 7.93e-01 0.066500 -2.78e-02 6.04e-02 6.64e-01 3.44e-01
GOBP POSITIVE REGULATION OF COAGULATION 30 8.23e-01 9.27e-01 0.066500 1.01e-02 6.57e-02 9.24e-01 5.33e-01
GOCC VESICLE MEMBRANE 1199 8.40e-04 1.20e-02 0.066500 5.79e-02 3.26e-02 7.32e-04 5.70e-02
GOBP NEUROMUSCULAR SYNAPTIC TRANSMISSION 28 8.19e-01 9.27e-01 0.066500 5.06e-02 -4.31e-02 6.43e-01 6.93e-01
GOBP INSULIN SECRETION 195 2.81e-01 5.78e-01 0.066500 6.61e-02 6.44e-03 1.11e-01 8.77e-01
GOMF APOLIPOPROTEIN BINDING 17 8.97e-01 9.59e-01 0.066500 -2.05e-02 -6.32e-02 8.84e-01 6.52e-01
GOMF PHOSPHORIC ESTER HYDROLASE ACTIVITY 346 1.20e-01 3.77e-01 0.066400 5.70e-02 3.41e-02 6.84e-02 2.76e-01
Transferrin endocytosis and recycling 29 8.23e-01 9.27e-01 0.066400 6.63e-02 -4.26e-03 5.37e-01 9.68e-01
GOBP OSTEOCLAST FUSION 6 9.63e-01 9.86e-01 0.066400 -6.35e-02 -1.94e-02 7.88e-01 9.34e-01
GOMF HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES 763 7.64e-03 6.49e-02 0.066400 6.63e-02 1.52e-03 1.82e-03 9.43e-01
GOBP POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION 22 8.61e-01 9.42e-01 0.066300 -1.23e-02 6.52e-02 9.21e-01 5.97e-01
GOBP REACTIVE NITROGEN SPECIES METABOLIC PROCESS 84 5.70e-01 7.97e-01 0.066300 6.59e-02 -6.74e-03 2.96e-01 9.15e-01
ADP signalling through P2Y purinoceptor 12 22 8.72e-01 9.48e-01 0.066200 -5.88e-02 -3.04e-02 6.33e-01 8.05e-01
GOBP DENDRITIC SPINE MORPHOGENESIS 54 6.86e-01 8.64e-01 0.066200 -5.81e-02 3.16e-02 4.60e-01 6.88e-01
GOBP PURINE DEOXYRIBONUCLEOTIDE CATABOLIC PROCESS 10 9.33e-01 9.75e-01 0.066100 2.91e-02 -5.94e-02 8.73e-01 7.45e-01
GOBP NEGATIVE REGULATION OF MONOATOMIC ION TRANSPORT 123 4.66e-01 7.28e-01 0.066100 6.07e-02 2.63e-02 2.45e-01 6.14e-01
GOBP REGULATION OF CATALYTIC ACTIVITY 1302 1.79e-04 3.46e-03 0.066100 5.43e-02 -3.78e-02 1.01e-03 2.20e-02
Class B/2 (Secretin family receptors) 93 5.61e-01 7.92e-01 0.066000 -2.44e-02 -6.14e-02 6.84e-01 3.06e-01
GOMF HEPARIN BINDING 169 3.16e-01 6.08e-01 0.066000 -2.20e-02 6.23e-02 6.22e-01 1.63e-01
GOBP POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 130 4.20e-01 6.99e-01 0.066000 6.52e-02 -9.99e-03 1.99e-01 8.44e-01
GOBP POSITIVE REGULATION OF DEPHOSPHORYLATION 51 7.09e-01 8.75e-01 0.066000 6.48e-02 -1.26e-02 4.24e-01 8.76e-01
GOBP TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR 10 9.40e-01 9.77e-01 0.066000 5.70e-02 3.33e-02 7.55e-01 8.56e-01
Platelet homeostasis 84 6.01e-01 8.16e-01 0.065900 4.92e-02 4.40e-02 4.36e-01 4.86e-01
GOBP NEGATIVE REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS 6 9.60e-01 9.85e-01 0.065900 1.34e-02 -6.46e-02 9.55e-01 7.84e-01
GOBP VIRAL LIFE CYCLE 309 1.22e-01 3.81e-01 0.065900 6.09e-02 -2.54e-02 6.58e-02 4.43e-01
GOBP RESPONSE TO MECHANICAL STIMULUS 216 2.57e-01 5.54e-01 0.065900 6.44e-02 1.37e-02 1.03e-01 7.28e-01
GOBP POSTSYNAPTIC SIGNAL TRANSDUCTION 48 7.47e-01 8.91e-01 0.065800 -5.60e-02 -3.45e-02 5.02e-01 6.79e-01
GOBP POSITIVE REGULATION OF T CELL PROLIFERATION 98 5.48e-01 7.83e-01 0.065800 -2.65e-02 -6.02e-02 6.50e-01 3.03e-01
GOBP CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION 32 8.24e-01 9.28e-01 0.065700 4.85e-02 4.44e-02 6.35e-01 6.64e-01
GOBP INORGANIC ANION TRANSPORT 162 3.32e-01 6.22e-01 0.065700 -6.02e-02 2.64e-02 1.86e-01 5.62e-01
GOBP CYTOKINETIC PROCESS 46 7.31e-01 8.84e-01 0.065700 6.12e-02 -2.40e-02 4.73e-01 7.78e-01
GOBP MAST CELL MIGRATION 14 9.15e-01 9.68e-01 0.065700 1.17e-02 6.46e-02 9.40e-01 6.75e-01
GOBP REGULATION OF CELLULAR RESPONSE TO OXIDATIVE STRESS 20 8.78e-01 9.50e-01 0.065700 -2.74e-05 6.57e-02 1.00e+00 6.11e-01
GOBP VACUOLAR ACIDIFICATION 33 7.95e-01 9.16e-01 0.065600 4.77e-02 -4.50e-02 6.35e-01 6.55e-01
GOBP NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY 14 9.19e-01 9.69e-01 0.065600 4.93e-02 4.32e-02 7.49e-01 7.79e-01
GOBP RESPONSE TO HYDROSTATIC PRESSURE 7 9.56e-01 9.84e-01 0.065600 -6.54e-02 -5.03e-03 7.65e-01 9.82e-01
GOBP UNSATURATED FATTY ACID METABOLIC PROCESS 109 4.80e-01 7.39e-01 0.065600 6.23e-02 -2.05e-02 2.61e-01 7.12e-01
GOBP SYNAPSE ORGANIZATION 459 5.48e-02 2.39e-01 0.065400 6.54e-02 -8.87e-04 1.64e-02 9.74e-01
GOBP POSITIVE REGULATION OF LIPID STORAGE 27 8.41e-01 9.34e-01 0.065400 6.54e-02 9.93e-04 5.56e-01 9.93e-01
GOMF ATP DEPENDENT PEPTIDASE ACTIVITY 7 9.59e-01 9.85e-01 0.065300 3.68e-02 5.40e-02 8.66e-01 8.05e-01
GOBP MALE GENITALIA DEVELOPMENT 23 8.55e-01 9.40e-01 0.065300 3.02e-02 -5.79e-02 8.02e-01 6.30e-01
GOBP NEGATIVE REGULATION OF T CELL CYTOKINE PRODUCTION 10 9.39e-01 9.77e-01 0.065300 -1.15e-02 -6.43e-02 9.50e-01 7.25e-01
Innate Immune System 989 3.56e-03 3.64e-02 0.065300 -5.05e-02 -4.14e-02 7.15e-03 2.77e-02
GOBP MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE 43 7.45e-01 8.91e-01 0.065300 -5.34e-02 3.76e-02 5.45e-01 6.70e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL FUSION 5 9.67e-01 9.88e-01 0.065300 -6.07e-02 2.41e-02 8.14e-01 9.26e-01
GOBP SUBSTRATE DEPENDENT CELL MIGRATION 25 8.45e-01 9.36e-01 0.065200 6.09e-02 -2.34e-02 5.98e-01 8.40e-01
GOBP NEGATIVE REGULATION OF MEMBRANE DEPOLARIZATION 7 9.54e-01 9.83e-01 0.065200 -6.23e-02 1.92e-02 7.75e-01 9.30e-01
GOMF TRANSCRIPTION ELONGATION FACTOR ACTIVITY 7 9.53e-01 9.82e-01 0.065200 4.66e-02 -4.55e-02 8.31e-01 8.35e-01
GOBP REGULATION OF LEUKOCYTE DIFFERENTIATION 322 1.18e-01 3.73e-01 0.065100 5.95e-02 -2.64e-02 6.63e-02 4.15e-01
Neurotoxicity of clostridium toxins 10 9.39e-01 9.77e-01 0.065100 6.49e-02 4.34e-03 7.22e-01 9.81e-01
GOBP PROTEIN HOMOTETRAMERIZATION 60 7.01e-01 8.70e-01 0.065100 3.94e-02 5.18e-02 5.98e-01 4.88e-01
GOBP NEGATIVE REGULATION OF SECRETION 163 3.70e-01 6.58e-01 0.065000 6.27e-02 1.72e-02 1.67e-01 7.05e-01
GOMF BETA CATENIN BINDING 101 5.41e-01 7.79e-01 0.065000 6.22e-02 1.89e-02 2.80e-01 7.43e-01
GOBP DETERMINATION OF LEFT RIGHT ASYMMETRY IN LATERAL MESODERM 8 9.47e-01 9.80e-01 0.064900 -4.56e-02 4.62e-02 8.23e-01 8.21e-01
Negative regulation of NMDA receptor-mediated neuronal transmission 20 8.73e-01 9.48e-01 0.064900 4.57e-02 -4.61e-02 7.24e-01 7.21e-01
GOMF ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 177 3.39e-01 6.29e-01 0.064900 1.40e-02 6.34e-02 7.48e-01 1.46e-01
Nuclear Envelope (NE) Reassembly 73 6.16e-01 8.26e-01 0.064900 2.40e-02 -6.02e-02 7.23e-01 3.74e-01
GOBP REGULATION OF MEIOTIC CELL CYCLE PHASE TRANSITION 11 9.32e-01 9.75e-01 0.064800 2.39e-03 -6.48e-02 9.89e-01 7.10e-01
GOBP NEGATIVE REGULATION OF LIPID STORAGE 22 8.79e-01 9.50e-01 0.064800 4.06e-02 5.05e-02 7.41e-01 6.82e-01
GOBP SUPEROXIDE ANION GENERATION 37 7.88e-01 9.13e-01 0.064800 -8.48e-03 6.42e-02 9.29e-01 4.99e-01
GOBP POSITIVE REGULATION OF LOCOMOTION 608 2.34e-02 1.43e-01 0.064800 6.47e-02 -1.79e-03 6.41e-03 9.40e-01
GOBP SYMBIONT ENTRY INTO HOST 159 3.97e-01 6.79e-01 0.064700 4.24e-02 4.89e-02 3.57e-01 2.87e-01
GOBP CMP METABOLIC PROCESS 8 9.48e-01 9.80e-01 0.064700 -5.69e-02 3.07e-02 7.80e-01 8.80e-01
GOBP PROTEIN KINASE C SIGNALING 35 8.02e-01 9.18e-01 0.064700 -6.88e-04 6.47e-02 9.94e-01 5.08e-01
GOCC CELL CELL CONTACT ZONE 72 6.42e-01 8.41e-01 0.064600 8.10e-03 6.41e-02 9.05e-01 3.47e-01
GOCC ENDOPLASMIC RETICULUM GOLGI INTERMEDIATE COMPARTMENT MEMBRANE 76 6.19e-01 8.27e-01 0.064600 6.46e-02 -2.35e-03 3.30e-01 9.72e-01
GOBP REGULATION OF PROTEIN TRANSPORT 421 7.53e-02 2.90e-01 0.064600 6.46e-02 2.18e-03 2.31e-02 9.39e-01
GOBP REGULATION OF KETONE BIOSYNTHETIC PROCESS 21 8.69e-01 9.46e-01 0.064600 -3.59e-02 5.37e-02 7.76e-01 6.70e-01
GOBP EPITHELIAL CELL DEVELOPMENT 211 2.87e-01 5.84e-01 0.064500 6.05e-02 2.24e-02 1.30e-01 5.75e-01
GOBP AMP BIOSYNTHETIC PROCESS 12 9.27e-01 9.73e-01 0.064500 -6.45e-02 3.58e-04 6.99e-01 9.98e-01
GOBP NEGATIVE REGULATION OF AMINE TRANSPORT 27 8.35e-01 9.31e-01 0.064500 3.66e-02 -5.31e-02 7.42e-01 6.33e-01
Developmental Biology 1331 2.27e-04 4.20e-03 0.064400 4.65e-02 -4.46e-02 4.44e-03 6.33e-03
GOBP CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 270 1.91e-01 4.83e-01 0.064400 6.43e-02 3.24e-03 6.91e-02 9.27e-01
GOMF THIOLESTER HYDROLASE ACTIVITY 40 7.74e-01 9.05e-01 0.064300 -1.36e-02 6.29e-02 8.82e-01 4.91e-01
GOBP NEGATIVE REGULATION OF OSTEOBLAST PROLIFERATION 15 9.04e-01 9.63e-01 0.064300 -4.73e-02 4.36e-02 7.51e-01 7.70e-01
GOCC PLATELET ALPHA GRANULE 82 5.87e-01 8.07e-01 0.064300 2.11e-02 -6.08e-02 7.41e-01 3.42e-01
GOBP UTERUS DEVELOPMENT 25 8.54e-01 9.39e-01 0.064300 -6.76e-03 6.40e-02 9.53e-01 5.80e-01
GOMF DNA CLAMP LOADER ACTIVITY 9 9.49e-01 9.81e-01 0.064300 -5.19e-02 -3.80e-02 7.88e-01 8.44e-01
Diseases of metabolism 250 1.95e-01 4.87e-01 0.064200 -5.52e-02 3.28e-02 1.33e-01 3.72e-01
GOCC CHROMOCENTER 13 9.20e-01 9.70e-01 0.064200 6.30e-02 -1.24e-02 6.94e-01 9.39e-01
GOBP REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE 35 8.13e-01 9.24e-01 0.064100 2.02e-02 6.08e-02 8.36e-01 5.33e-01
GOBP REGULATION OF RESPONSE TO STRESS 1376 2.07e-04 3.87e-03 0.064100 5.60e-02 -3.11e-02 4.93e-04 5.30e-02
GOBP CELL CELL JUNCTION ORGANIZATION 208 3.03e-01 5.97e-01 0.064000 5.56e-02 3.17e-02 1.67e-01 4.31e-01
GOBP NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION 74 6.52e-01 8.46e-01 0.064000 3.11e-02 5.60e-02 6.44e-01 4.05e-01
GOMF CERAMIDE BINDING 19 8.93e-01 9.57e-01 0.064000 1.62e-02 6.19e-02 9.03e-01 6.40e-01
GOBP RESPONSE TO INTERLEUKIN 18 12 9.24e-01 9.71e-01 0.064000 -5.58e-02 3.13e-02 7.38e-01 8.51e-01
GOMF CHEMOKINE BINDING 31 8.26e-01 9.28e-01 0.063900 -6.39e-02 -1.90e-04 5.38e-01 9.99e-01
GOCC NUCLEAR OUTER MEMBRANE ENDOPLASMIC RETICULUM MEMBRANE NETWORK 1170 7.62e-04 1.11e-02 0.063900 5.89e-02 -2.49e-02 6.92e-04 1.51e-01
GOBP NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION 16 9.07e-01 9.64e-01 0.063900 -6.37e-02 -4.81e-03 6.59e-01 9.73e-01
GOCC CELL CELL JUNCTION 487 6.47e-02 2.64e-01 0.063900 5.45e-02 3.32e-02 3.92e-02 2.09e-01
GOBP LEUKOCYTE CELL CELL ADHESION 407 7.18e-02 2.81e-01 0.063800 4.43e-02 -4.60e-02 1.25e-01 1.12e-01
GOBP ALCOHOL METABOLIC PROCESS 354 1.38e-01 4.07e-01 0.063800 4.62e-02 4.40e-02 1.35e-01 1.55e-01
GOBP REGULATION OF GLYCOPROTEIN METABOLIC PROCESS 57 7.06e-01 8.73e-01 0.063800 -6.38e-02 -8.45e-04 4.05e-01 9.91e-01
GOMF ALCOHOL BINDING 88 6.03e-01 8.17e-01 0.063800 5.73e-02 2.79e-02 3.52e-01 6.51e-01
GOBP RECEPTOR CATABOLIC PROCESS 27 8.45e-01 9.36e-01 0.063800 6.32e-02 -8.25e-03 5.70e-01 9.41e-01
GOBP PROSTANOID METABOLIC PROCESS 50 7.20e-01 8.79e-01 0.063800 4.65e-02 -4.37e-02 5.70e-01 5.93e-01
GOBP CHEMOSENSORY BEHAVIOR 19 8.83e-01 9.52e-01 0.063800 4.69e-02 -4.31e-02 7.23e-01 7.45e-01
GOBP DETECTION OF ABIOTIC STIMULUS 135 4.30e-01 7.06e-01 0.063700 -6.26e-02 1.20e-02 2.09e-01 8.09e-01
GOBP POSITIVE REGULATION OF PHOSPHORYLATION 590 3.32e-02 1.77e-01 0.063700 6.21e-02 1.41e-02 9.91e-03 5.59e-01
GOBP REGULATION OF MONOCYTE CHEMOTAXIS 26 8.47e-01 9.36e-01 0.063700 -6.03e-02 2.05e-02 5.94e-01 8.56e-01
GOBP TROPHOBLAST GIANT CELL DIFFERENTIATION 12 9.24e-01 9.71e-01 0.063700 -4.68e-02 4.33e-02 7.79e-01 7.95e-01
GOBP POSITIVE REGULATION OF TRANSPORT 806 8.19e-03 6.83e-02 0.063700 6.35e-02 -4.98e-03 2.18e-03 8.10e-01
GOBP REGULATION OF KINASE ACTIVITY 503 4.04e-02 1.99e-01 0.063700 5.32e-02 -3.51e-02 4.12e-02 1.78e-01
GOBP CELL MOTILITY 1764 6.30e-05 1.45e-03 0.063700 6.27e-02 1.10e-02 1.21e-05 4.45e-01
GOBP REGULATION OF MEIOTIC NUCLEAR DIVISION 35 7.99e-01 9.17e-01 0.063700 -5.88e-02 2.44e-02 5.47e-01 8.03e-01
GOBP POSITIVE REGULATION OF I KAPPAB PHOSPHORYLATION 6 9.65e-01 9.87e-01 0.063600 -6.30e-02 -9.31e-03 7.89e-01 9.69e-01
GOCC VACUOLE 817 8.70e-03 7.13e-02 0.063500 6.34e-02 4.20e-03 2.07e-03 8.38e-01
GOCC ACROSOMAL VESICLE 142 4.51e-01 7.19e-01 0.063500 -4.91e-02 -4.03e-02 3.12e-01 4.08e-01
GOBP REGULATION OF PHOSPHORYLATION 950 3.71e-03 3.74e-02 0.063500 6.33e-02 -5.11e-03 9.43e-04 7.90e-01
GOBP SIGNAL RELEASE 472 7.38e-02 2.86e-01 0.063500 5.00e-02 3.91e-02 6.25e-02 1.46e-01
GOMF CALCIUM ION BINDING 679 2.04e-02 1.29e-01 0.063500 1.17e-02 6.24e-02 6.03e-01 5.58e-03
GOCC CILIARY PLASM 178 3.58e-01 6.47e-01 0.063500 -1.95e-02 -6.04e-02 6.53e-01 1.65e-01
GOBP GENERATION OF PRECURSOR METABOLITES AND ENERGY 435 6.69e-02 2.70e-01 0.063400 6.00e-02 -2.07e-02 3.20e-02 4.59e-01
GOBP POSITIVE REGULATION OF PROTEIN TRANSPORT 241 2.22e-01 5.18e-01 0.063400 6.09e-02 -1.77e-02 1.03e-01 6.35e-01
GOBP REGULATION OF PROTEIN MATURATION 65 6.66e-01 8.53e-01 0.063400 6.14e-02 -1.57e-02 3.92e-01 8.27e-01
GOBP LONG TERM MEMORY 37 8.01e-01 9.18e-01 0.063400 6.33e-02 2.43e-03 5.05e-01 9.80e-01
GOBP BILE ACID METABOLIC PROCESS 50 7.55e-01 8.95e-01 0.063300 3.55e-02 5.24e-02 6.64e-01 5.21e-01
GOMF PHOSPHATIDYLSERINE FLOPPASE ACTIVITY 8 9.52e-01 9.82e-01 0.063300 6.30e-02 -6.21e-03 7.58e-01 9.76e-01
GOBP REGULATION OF ANTIMICROBIAL PEPTIDE PRODUCTION 9 9.51e-01 9.82e-01 0.063200 -4.50e-02 -4.44e-02 8.15e-01 8.17e-01
GOBP MITOCHONDRIAL GENOME MAINTENANCE 30 8.31e-01 9.30e-01 0.063200 1.06e-02 -6.23e-02 9.20e-01 5.55e-01
GOBP VITAMIN METABOLIC PROCESS 112 4.87e-01 7.45e-01 0.063200 4.33e-02 -4.60e-02 4.28e-01 4.01e-01
GOMF PHOSPHATASE INHIBITOR ACTIVITY 46 7.65e-01 9.01e-01 0.063200 -1.42e-02 -6.16e-02 8.68e-01 4.70e-01
GOBP COGNITION 305 1.64e-01 4.48e-01 0.063200 6.32e-02 2.88e-04 5.78e-02 9.93e-01
G-protein beta:gamma signalling 30 8.25e-01 9.28e-01 0.063200 -3.65e-02 5.16e-02 7.30e-01 6.25e-01
GOMF DNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS 9 9.45e-01 9.80e-01 0.063200 2.26e-02 -5.90e-02 9.07e-01 7.59e-01
GOBP NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY 21 8.79e-01 9.50e-01 0.063100 9.21e-03 -6.24e-02 9.42e-01 6.21e-01
GOBP PROTEIN LOCALIZATION TO NUCLEAR ENVELOPE 13 9.21e-01 9.70e-01 0.063000 3.25e-02 -5.40e-02 8.39e-01 7.36e-01
Transmission across Chemical Synapses 255 2.13e-01 5.08e-01 0.062900 -1.22e-02 6.18e-02 7.38e-01 8.95e-02
GOBP GLIAL CELL ACTIVATION 58 7.11e-01 8.76e-01 0.062800 -4.99e-03 -6.26e-02 9.48e-01 4.09e-01
GOMF INITIATOR METHIONYL AMINOPEPTIDASE ACTIVITY 5 9.70e-01 9.89e-01 0.062800 6.07e-02 -1.63e-02 8.14e-01 9.50e-01
GOMF MOLECULAR SEQUESTERING ACTIVITY 44 7.67e-01 9.02e-01 0.062800 -6.32e-03 6.24e-02 9.42e-01 4.74e-01
GOBP REGULATION OF REGULATED SECRETORY PATHWAY 104 5.17e-01 7.63e-01 0.062700 4.68e-02 -4.18e-02 4.09e-01 4.62e-01
GOBP HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS 52 7.32e-01 8.85e-01 0.062700 -5.21e-03 6.25e-02 9.48e-01 4.35e-01
GOBP REGULATION OF MODIFICATION OF POSTSYNAPTIC STRUCTURE 10 9.45e-01 9.80e-01 0.062700 5.73e-02 2.56e-02 7.54e-01 8.89e-01
GOBP POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY 28 8.40e-01 9.33e-01 0.062700 5.75e-02 -2.50e-02 5.99e-01 8.19e-01
GOMF GLYCOSYLTRANSFERASE ACTIVITY 266 2.33e-01 5.31e-01 0.062700 5.38e-02 3.20e-02 1.31e-01 3.68e-01
GOBP REGULATION OF HEART RATE 100 5.79e-01 8.02e-01 0.062600 4.99e-02 3.78e-02 3.88e-01 5.14e-01
GOBP REGULATION OF PRIMARY MIRNA PROCESSING 5 9.70e-01 9.89e-01 0.062600 1.50e-02 -6.08e-02 9.54e-01 8.14e-01
Nef mediated downregulation of MHC class I complex cell surface expression 9 9.50e-01 9.81e-01 0.062600 1.35e-02 6.11e-02 9.44e-01 7.51e-01
GOBP PEPTIDE TRANSPORT 253 2.35e-01 5.32e-01 0.062600 6.20e-02 8.67e-03 8.97e-02 8.12e-01
GOBP NEGATIVE REGULATION OF PHOTORECEPTOR CELL DIFFERENTIATION 6 9.64e-01 9.86e-01 0.062500 2.23e-02 -5.84e-02 9.24e-01 8.04e-01
GOBP POSITIVE REGULATION OF NEUROTRANSMITTER UPTAKE 6 9.64e-01 9.86e-01 0.062500 5.96e-02 -1.86e-02 8.00e-01 9.37e-01
Phosphorylation of the APC/C 20 8.82e-01 9.52e-01 0.062500 5.27e-02 -3.35e-02 6.83e-01 7.96e-01
GOBP POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 663 2.71e-02 1.57e-01 0.062500 5.89e-02 2.09e-02 9.73e-03 3.59e-01
GOBP REGULATION OF DEFENSE RESPONSE TO FUNGUS 5 9.72e-01 9.90e-01 0.062500 1.09e-02 6.15e-02 9.66e-01 8.12e-01
Translocation of SLC2A4 (GLUT4) to the plasma membrane 70 6.82e-01 8.62e-01 0.062400 3.53e-02 5.15e-02 6.10e-01 4.56e-01
GOMF GAP JUNCTION CHANNEL ACTIVITY 22 8.81e-01 9.51e-01 0.062400 1.00e-02 6.16e-02 9.35e-01 6.17e-01
Metabolism 2055 1.25e-05 3.49e-04 0.062400 6.08e-02 -1.39e-02 5.43e-06 2.97e-01
GOBP NEGATIVE REGULATION OF TRANSPORT 438 8.71e-02 3.16e-01 0.062400 6.09e-02 1.34e-02 2.88e-02 6.30e-01
Organic cation transport 10 9.47e-01 9.80e-01 0.062400 3.95e-02 4.83e-02 8.29e-01 7.91e-01
GOBP NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE 17 9.12e-01 9.67e-01 0.062300 -4.58e-02 -4.22e-02 7.44e-01 7.63e-01
GOCC PORE COMPLEX 24 8.61e-01 9.42e-01 0.062300 -5.38e-02 3.14e-02 6.48e-01 7.90e-01
GOBP POSITIVE REGULATION OF SECRETION 307 1.68e-01 4.53e-01 0.062300 6.22e-02 -2.70e-03 6.08e-02 9.35e-01
GOBP POSITIVE REGULATION OF PROTEIN IMPORT INTO NUCLEUS 39 7.94e-01 9.16e-01 0.062200 6.17e-02 -7.48e-03 5.05e-01 9.36e-01
MASTL Facilitates Mitotic Progression 10 9.39e-01 9.77e-01 0.062200 4.11e-02 -4.66e-02 8.22e-01 7.99e-01
GOBP CYCLIC NUCLEOTIDE CATABOLIC PROCESS 14 9.16e-01 9.68e-01 0.062100 -4.92e-02 3.80e-02 7.50e-01 8.06e-01
GOCC GOLGI MEMBRANE 655 2.48e-02 1.48e-01 0.062100 6.21e-02 -1.90e-04 6.72e-03 9.93e-01
GOCC AXONEMAL B TUBULE INNER SHEATH 11 9.35e-01 9.75e-01 0.062100 -5.68e-02 2.50e-02 7.44e-01 8.86e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTRASPECIES INTERACTION BETWEEN ORGANISMS 49 7.46e-01 8.91e-01 0.062000 6.02e-02 -1.49e-02 4.66e-01 8.57e-01
Early SARS-CoV-2 Infection Events 34 8.34e-01 9.30e-01 0.062000 -4.46e-02 -4.30e-02 6.53e-01 6.64e-01
GOBP REGULATION OF HORMONE LEVELS 524 5.90e-02 2.49e-01 0.061900 5.88e-02 1.94e-02 2.12e-02 4.47e-01
GOMF PROTEIN KINASE A REGULATORY SUBUNIT BINDING 24 8.72e-01 9.47e-01 0.061900 6.18e-02 4.29e-03 6.00e-01 9.71e-01
GOBP REGULATION OF AEROBIC RESPIRATION 30 8.37e-01 9.32e-01 0.061900 6.05e-02 -1.27e-02 5.66e-01 9.04e-01
Glucagon signaling in metabolic regulation 32 8.42e-01 9.35e-01 0.061900 3.36e-02 5.20e-02 7.42e-01 6.11e-01
GOBP POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION 15 9.13e-01 9.67e-01 0.061800 -2.74e-02 5.54e-02 8.54e-01 7.10e-01
GOBP INTRACELLULAR PHOSPHATE ION HOMEOSTASIS 10 9.44e-01 9.79e-01 0.061700 6.02e-04 6.17e-02 9.97e-01 7.35e-01
GOMF MRF BINDING 5 9.73e-01 9.90e-01 0.061700 5.72e-02 2.31e-02 8.25e-01 9.29e-01
GOBP WATER SOLUBLE VITAMIN METABOLIC PROCESS 61 6.92e-01 8.67e-01 0.061700 5.64e-02 -2.50e-02 4.46e-01 7.36e-01
GOBP INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS 26 8.60e-01 9.42e-01 0.061600 6.16e-03 -6.13e-02 9.57e-01 5.89e-01
GOBP XENOBIOTIC TRANSPORT 60 7.06e-01 8.73e-01 0.061500 -8.38e-03 6.10e-02 9.11e-01 4.14e-01
GOBP RESPIRATORY SYSTEM PROCESS 42 7.84e-01 9.11e-01 0.061400 6.07e-02 -8.95e-03 4.96e-01 9.20e-01
Biological oxidations 211 2.89e-01 5.86e-01 0.061400 5.79e-02 -2.05e-02 1.47e-01 6.08e-01
GOBP DETERMINATION OF LIVER LEFT RIGHT ASYMMETRY 5 9.73e-01 9.90e-01 0.061300 6.02e-02 1.18e-02 8.16e-01 9.64e-01
GOBP OSTEOBLAST DIFFERENTIATION 254 2.48e-01 5.45e-01 0.061300 6.06e-02 9.14e-03 9.61e-02 8.02e-01
GOBP PODOCYTE CELL MIGRATION 7 9.64e-01 9.86e-01 0.061300 4.31e-02 4.36e-02 8.44e-01 8.42e-01
GOBP NEGATIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE 10 9.45e-01 9.80e-01 0.061300 -3.85e-03 -6.12e-02 9.83e-01 7.38e-01
GOBP ADHERENS JUNCTION MAINTENANCE 7 9.64e-01 9.86e-01 0.061300 4.91e-02 3.67e-02 8.22e-01 8.67e-01
GOBP NEGATIVE REGULATION OF MOLECULAR FUNCTION 696 2.39e-02 1.45e-01 0.061300 6.06e-02 9.34e-03 6.46e-03 6.75e-01
Synthesis of 15-eicosatetraenoic acid derivatives 6 9.66e-01 9.88e-01 0.061300 -6.11e-02 3.76e-03 7.95e-01 9.87e-01
GOBP HYPOTONIC RESPONSE 13 9.25e-01 9.72e-01 0.061300 5.52e-02 -2.65e-02 7.30e-01 8.69e-01
GOBP NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT 34 8.37e-01 9.32e-01 0.061200 4.55e-02 4.09e-02 6.46e-01 6.80e-01
GOBP LYMPHOCYTE ACTIVATION 766 1.19e-02 8.90e-02 0.061200 2.86e-02 -5.41e-02 1.78e-01 1.08e-02
GOMF PROTEIN HOMODIMERIZATION ACTIVITY 684 2.35e-02 1.43e-01 0.061200 6.12e-02 -8.85e-04 6.38e-03 9.69e-01
Intra-Golgi and retrograde Golgi-to-ER traffic 198 3.15e-01 6.08e-01 0.061200 5.80e-02 -1.95e-02 1.60e-01 6.36e-01
GOCC DENDRITE MEMBRANE 36 8.04e-01 9.20e-01 0.061200 4.35e-02 -4.30e-02 6.51e-01 6.55e-01
GOMF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR BINDING 12 9.39e-01 9.77e-01 0.061100 3.02e-02 5.31e-02 8.56e-01 7.50e-01
GOMF TETRAPYRROLE BINDING 144 4.38e-01 7.12e-01 0.061100 -6.02e-02 1.07e-02 2.13e-01 8.25e-01
GOMF MRNA BINDING 576 4.15e-02 2.02e-01 0.061100 6.10e-02 -3.10e-03 1.23e-02 8.99e-01
GOBP ENDOCHONDRAL BONE MORPHOGENESIS 57 7.10e-01 8.75e-01 0.061100 4.41e-02 -4.22e-02 5.64e-01 5.82e-01
GOBP POSITIVE REGULATION OF CYCLASE ACTIVITY 35 8.34e-01 9.30e-01 0.061000 4.24e-02 4.39e-02 6.64e-01 6.53e-01
GOBP REGULATION OF IMMUNE RESPONSE 900 8.86e-03 7.24e-02 0.061000 -1.03e-02 -6.01e-02 6.01e-01 2.22e-03
GOMF CAMP BINDING 22 8.81e-01 9.51e-01 0.061000 -1.01e-02 6.02e-02 9.35e-01 6.25e-01
GOMF HEXOSYLTRANSFERASE ACTIVITY 193 3.71e-01 6.58e-01 0.060900 4.07e-02 4.54e-02 3.30e-01 2.77e-01
GOCC PRESYNAPTIC ACTIVE ZONE 76 6.65e-01 8.52e-01 0.060900 1.55e-02 5.89e-02 8.16e-01 3.74e-01
GOBP REGULATION OF URINE VOLUME 21 8.89e-01 9.55e-01 0.060900 1.57e-03 -6.09e-02 9.90e-01 6.29e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 21 8.95e-01 9.58e-01 0.060900 5.61e-02 2.37e-02 6.56e-01 8.51e-01
GOBP POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS 25 8.79e-01 9.50e-01 0.060800 4.42e-02 4.19e-02 7.02e-01 7.17e-01
GOBP SYNAPTIC TRANSMISSION GABAERGIC 58 7.31e-01 8.84e-01 0.060800 -1.24e-02 -5.96e-02 8.70e-01 4.33e-01
GOBP FATTY ACID METABOLIC PROCESS 387 1.29e-01 3.92e-01 0.060800 5.91e-02 1.46e-02 4.61e-02 6.23e-01
G beta:gamma signalling through BTK 17 9.16e-01 9.68e-01 0.060800 -3.66e-02 -4.85e-02 7.94e-01 7.29e-01
GOBP NEUTROPHIL MIGRATION 100 5.52e-01 7.86e-01 0.060800 -4.74e-02 3.80e-02 4.13e-01 5.11e-01
GOBP REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 183 3.63e-01 6.51e-01 0.060600 3.91e-03 -6.04e-02 9.27e-01 1.59e-01
GOBP MEMBRANE FISSION 44 7.98e-01 9.17e-01 0.060500 3.57e-02 4.89e-02 6.82e-01 5.75e-01
GOMF NEUROPEPTIDE RECEPTOR ACTIVITY 43 7.76e-01 9.07e-01 0.060500 4.79e-02 -3.69e-02 5.87e-01 6.75e-01
GOBP NEGATIVE REGULATION OF T CELL DIFFERENTIATION 48 7.72e-01 9.05e-01 0.060400 -5.99e-02 -8.39e-03 4.73e-01 9.20e-01
GOMF PROTEIN CARBOXYL O METHYLTRANSFERASE ACTIVITY 6 9.67e-01 9.88e-01 0.060400 9.22e-03 -5.97e-02 9.69e-01 8.00e-01
GOBP CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION 39 8.20e-01 9.27e-01 0.060400 4.59e-02 3.93e-02 6.20e-01 6.71e-01
GOBP NEGATIVE REGULATION OF MACROPHAGE APOPTOTIC PROCESS 8 9.58e-01 9.85e-01 0.060400 1.25e-02 5.91e-02 9.51e-01 7.72e-01
GOBP REGULATION OF COAGULATION 74 6.64e-01 8.51e-01 0.060400 -4.98e-03 6.02e-02 9.41e-01 3.71e-01
GOBP CHAPERONE MEDIATED AUTOPHAGY 14 9.21e-01 9.70e-01 0.060300 -4.73e-02 3.74e-02 7.59e-01 8.08e-01
GOBP PYRIMIDINE NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS 6 9.67e-01 9.88e-01 0.060200 -1.65e-02 5.79e-02 9.44e-01 8.06e-01
Purine salvage 11 9.39e-01 9.77e-01 0.060200 5.68e-02 -1.99e-02 7.44e-01 9.09e-01
GOMF SYNTAXIN 1 BINDING 19 9.06e-01 9.63e-01 0.060200 2.05e-02 5.66e-02 8.77e-01 6.69e-01
GOBP REGULATION OF BLOOD CIRCULATION 252 2.85e-01 5.82e-01 0.060100 4.34e-02 4.15e-02 2.36e-01 2.56e-01
GOBP AMINE METABOLIC PROCESS 106 5.77e-01 8.01e-01 0.060000 1.69e-02 5.76e-02 7.64e-01 3.05e-01
GOBP POSITIVE REGULATION OF INTEGRIN ACTIVATION 11 9.46e-01 9.80e-01 0.060000 -3.80e-02 -4.65e-02 8.27e-01 7.90e-01
GOBP NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 27 8.61e-01 9.42e-01 0.059900 5.89e-02 -1.09e-02 5.96e-01 9.22e-01
GOBP NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 20 9.04e-01 9.63e-01 0.059900 -5.16e-02 -3.03e-02 6.89e-01 8.15e-01
Cytochrome P450 - arranged by substrate type 64 7.18e-01 8.78e-01 0.059900 -5.77e-02 -1.61e-02 4.25e-01 8.24e-01
GOBP POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT 6 9.70e-01 9.89e-01 0.059800 2.01e-02 5.64e-02 9.32e-01 8.11e-01
GOBP DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN 19 8.98e-01 9.60e-01 0.059800 -5.50e-02 2.35e-02 6.78e-01 8.59e-01
GOCC TRANSPORT VESICLE 414 1.01e-01 3.42e-01 0.059800 5.68e-02 -1.89e-02 4.76e-02 5.09e-01
GOBP MONOCARBOXYLIC ACID TRANSPORT 179 4.01e-01 6.83e-01 0.059800 5.63e-02 2.01e-02 1.94e-01 6.43e-01
GOBP REGULATION OF INFLAMMATORY RESPONSE 410 9.88e-02 3.37e-01 0.059700 -4.92e-02 3.39e-02 8.76e-02 2.38e-01
GOBP MICROTUBULE BASED PROCESS 909 7.27e-03 6.29e-02 0.059700 5.51e-02 -2.30e-02 4.88e-03 2.39e-01
GOBP RESPONSE TO INTERFERON BETA 33 8.35e-01 9.31e-01 0.059700 -5.91e-02 8.55e-03 5.57e-01 9.32e-01
GOCC MEMBRANE MICRODOMAIN 282 2.17e-01 5.12e-01 0.059700 5.89e-02 -9.71e-03 8.90e-02 7.79e-01
GOCC MYELIN SHEATH ADAXONAL REGION 6 9.66e-01 9.87e-01 0.059600 -3.76e-02 4.63e-02 8.73e-01 8.44e-01
Ion homeostasis 52 7.45e-01 8.91e-01 0.059600 -5.39e-02 2.55e-02 5.01e-01 7.50e-01
GOBP MAINTENANCE OF LOCATION 329 1.92e-01 4.83e-01 0.059600 5.58e-02 2.08e-02 8.17e-02 5.16e-01
GOCC CONTRACTILE MUSCLE FIBER 243 3.02e-01 5.97e-01 0.059400 3.07e-02 5.09e-02 4.10e-01 1.72e-01
GOMF SMALL MOLECULE SENSOR ACTIVITY 48 7.63e-01 8.99e-01 0.059400 5.16e-02 -2.94e-02 5.36e-01 7.24e-01
GOBP POSITIVE REGULATION OF VASOCONSTRICTION 31 8.45e-01 9.36e-01 0.059300 -1.01e-02 5.84e-02 9.22e-01 5.73e-01
Metal ion SLC transporters 23 8.91e-01 9.57e-01 0.059300 -2.54e-02 -5.36e-02 8.33e-01 6.57e-01
GOBP NEGATIVE CHEMOTAXIS 46 7.98e-01 9.17e-01 0.059300 4.26e-02 4.13e-02 6.17e-01 6.28e-01
GOBP ENDOTHELIAL CELL MORPHOGENESIS 9 9.52e-01 9.82e-01 0.059300 -1.30e-02 5.78e-02 9.46e-01 7.64e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PEROXIDE AS ACCEPTOR 56 7.29e-01 8.84e-01 0.059200 -3.31e-02 4.91e-02 6.68e-01 5.25e-01
GOCC DENDRITIC SHAFT 40 8.04e-01 9.20e-01 0.059200 -1.45e-02 5.74e-02 8.74e-01 5.30e-01
GOCC CLATHRIN COATED ENDOCYTIC VESICLE MEMBRANE 69 6.78e-01 8.60e-01 0.059100 4.00e-02 -4.35e-02 5.65e-01 5.32e-01
Maturation of spike protein 9694548 35 8.22e-01 9.27e-01 0.059100 -3.25e-02 4.93e-02 7.40e-01 6.13e-01
GOCC SYNAPTIC VESICLE MEMBRANE 130 5.21e-01 7.64e-01 0.059100 5.64e-02 1.76e-02 2.67e-01 7.29e-01
GOMF VITAMIN TRANSMEMBRANE TRANSPORTER ACTIVITY 34 8.47e-01 9.36e-01 0.059000 3.63e-02 4.66e-02 7.14e-01 6.38e-01
GOBP CELLULAR METABOLIC COMPOUND SALVAGE 32 8.44e-01 9.36e-01 0.059000 5.90e-02 -2.92e-03 5.64e-01 9.77e-01
GOMF RNA ENDONUCLEASE ACTIVITY PRODUCING 3 PHOSPHOMONOESTERS 7 9.64e-01 9.86e-01 0.059000 1.18e-03 -5.90e-02 9.96e-01 7.87e-01
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION 10 9.53e-01 9.82e-01 0.058900 -4.44e-02 -3.88e-02 8.08e-01 8.32e-01
GOBP PARKIN MEDIATED STIMULATION OF MITOPHAGY IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION 5 9.76e-01 9.91e-01 0.058900 -3.48e-02 -4.76e-02 8.93e-01 8.54e-01
GOBP SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT 41 8.16e-01 9.25e-01 0.058900 -5.51e-02 -2.08e-02 5.42e-01 8.18e-01
GOMF DNA METHYLTRANSFERASE ACTIVITY 7 9.63e-01 9.86e-01 0.058900 -9.25e-03 5.81e-02 9.66e-01 7.90e-01
GOBP MONOCYTE DIFFERENTIATION 34 8.41e-01 9.34e-01 0.058900 9.36e-03 5.81e-02 9.25e-01 5.58e-01
GOBP REGULATION OF CARDIAC CONDUCTION 26 8.80e-01 9.51e-01 0.058800 5.30e-02 2.55e-02 6.40e-01 8.22e-01
GOBP NUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 18 9.14e-01 9.68e-01 0.058800 1.88e-02 5.57e-02 8.90e-01 6.82e-01
GOBP NEGATIVE REGULATION OF ATP DEPENDENT ACTIVITY 17 9.10e-01 9.66e-01 0.058700 4.66e-02 -3.57e-02 7.39e-01 7.99e-01
GOBP SKIN DEVELOPMENT 312 1.85e-01 4.75e-01 0.058700 -5.36e-02 2.39e-02 1.03e-01 4.68e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 52 7.59e-01 8.97e-01 0.058700 5.79e-02 -9.45e-03 4.70e-01 9.06e-01
GOMF DNA DEMETHYLASE ACTIVITY 5 9.76e-01 9.91e-01 0.058700 2.71e-02 5.20e-02 9.17e-01 8.40e-01
GOBP REGULATION OF PH 97 5.84e-01 8.06e-01 0.058700 -3.74e-02 4.52e-02 5.24e-01 4.42e-01
GOMF GROWTH FACTOR RECEPTOR BINDING 135 5.04e-01 7.56e-01 0.058600 6.24e-03 5.83e-02 9.00e-01 2.42e-01
GOMF ARRESTIN FAMILY PROTEIN BINDING 9 9.53e-01 9.82e-01 0.058600 5.68e-02 -1.44e-02 7.68e-01 9.40e-01
GOBP REGULATION OF DENDRITIC SPINE MORPHOGENESIS 41 7.97e-01 9.17e-01 0.058600 -3.52e-02 4.69e-02 6.97e-01 6.03e-01
GOCC NETWORK FORMING COLLAGEN TRIMER 6 9.67e-01 9.88e-01 0.058600 -3.72e-02 4.53e-02 8.75e-01 8.48e-01
GOMF DNA N GLYCOSYLASE ACTIVITY 14 9.29e-01 9.73e-01 0.058600 -5.80e-02 8.27e-03 7.07e-01 9.57e-01
GOBP REGULATION OF HORMONE METABOLIC PROCESS 39 8.06e-01 9.20e-01 0.058500 3.99e-02 -4.29e-02 6.67e-01 6.43e-01
GOBP BONE REMODELING 90 6.44e-01 8.42e-01 0.058500 2.13e-02 5.45e-02 7.27e-01 3.71e-01
GOBP AMYLOID FIBRIL FORMATION 38 8.16e-01 9.25e-01 0.058500 5.63e-02 -1.60e-02 5.48e-01 8.64e-01
GOBP POSITIVE REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY 40 8.05e-01 9.20e-01 0.058500 2.36e-02 -5.35e-02 7.96e-01 5.58e-01
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE CATABOLIC PROCESS 14 9.35e-01 9.75e-01 0.058500 -4.77e-02 -3.38e-02 7.57e-01 8.27e-01
GOCC EXTRINSIC COMPONENT OF MEMBRANE 170 4.32e-01 7.07e-01 0.058400 5.69e-02 1.35e-02 2.01e-01 7.62e-01
GOBP REGULATION OF PEPTIDASE ACTIVITY 287 2.16e-01 5.11e-01 0.058400 2.35e-02 -5.34e-02 4.93e-01 1.19e-01
GOBP TERPENOID METABOLIC PROCESS 98 6.18e-01 8.27e-01 0.058300 5.61e-02 1.60e-02 3.37e-01 7.84e-01
GOMF PROTEIN FOLDING CHAPERONE BINDING 129 4.93e-01 7.50e-01 0.058300 3.99e-02 -4.25e-02 4.34e-01 4.04e-01
GOBP REGULATION OF PHOSPHOLIPASE ACTIVITY 48 7.69e-01 9.03e-01 0.058300 4.74e-02 -3.40e-02 5.70e-01 6.84e-01
Glutathione synthesis and recycling 12 9.40e-01 9.77e-01 0.058300 -4.28e-03 5.82e-02 9.80e-01 7.27e-01
GOMF PHOSPHOLIPID SCRAMBLASE ACTIVITY 15 9.21e-01 9.70e-01 0.058300 -4.16e-02 4.08e-02 7.80e-01 7.85e-01
Transport of bile salts and organic acids, metal ions and amine compounds 82 6.50e-01 8.45e-01 0.058300 -5.71e-02 1.14e-02 3.71e-01 8.58e-01
GOBP DETOXIFICATION 157 4.29e-01 7.06e-01 0.058200 -2.78e-02 5.11e-02 5.48e-01 2.69e-01
GOBP REGULATION OF SECRETION 588 6.36e-02 2.62e-01 0.058200 5.26e-02 2.48e-02 2.93e-02 3.04e-01
Recruitment of NuMA to mitotic centrosomes 89 6.57e-01 8.49e-01 0.058200 4.51e-02 3.68e-02 4.62e-01 5.49e-01
Post-translational protein phosphorylation 100 5.86e-01 8.07e-01 0.058100 -2.31e-02 5.33e-02 6.90e-01 3.57e-01
GOBP THYROID HORMONE METABOLIC PROCESS 28 8.65e-01 9.44e-01 0.058100 -7.27e-03 5.77e-02 9.47e-01 5.97e-01
Signal amplification 33 8.55e-01 9.40e-01 0.058000 -5.12e-02 -2.74e-02 6.11e-01 7.86e-01
The role of Nef in HIV-1 replication and disease pathogenesis 27 8.81e-01 9.51e-01 0.058000 3.80e-02 4.38e-02 7.33e-01 6.94e-01
GOBP GLIAL CELL DERIVED NEUROTROPHIC FACTOR RECEPTOR SIGNALING PATHWAY 15 9.32e-01 9.75e-01 0.057900 -3.68e-02 -4.46e-02 8.05e-01 7.65e-01
GOBP REGULATION OF BROWN FAT CELL DIFFERENTIATION 24 8.93e-01 9.57e-01 0.057800 4.88e-02 3.10e-02 6.79e-01 7.93e-01
GOBP DETECTION OF BACTERIUM 16 9.21e-01 9.70e-01 0.057800 -5.74e-02 7.08e-03 6.91e-01 9.61e-01
GOBP DETECTION OF MOLECULE OF BACTERIAL ORIGIN 13 9.34e-01 9.75e-01 0.057800 -5.39e-02 2.08e-02 7.37e-01 8.97e-01
GOBP POSITIVE REGULATION OF GONADOTROPIN SECRETION 7 9.66e-01 9.87e-01 0.057700 5.77e-02 3.25e-03 7.92e-01 9.88e-01
GOBP MONOATOMIC ANION HOMEOSTASIS 20 9.06e-01 9.64e-01 0.057700 8.17e-03 5.72e-02 9.50e-01 6.58e-01
GOBP REGENERATION 192 3.90e-01 6.73e-01 0.057700 5.74e-02 5.59e-03 1.70e-01 8.94e-01
GOBP SYNAPTIC TRANSMISSION DOPAMINERGIC 28 8.73e-01 9.48e-01 0.057700 1.16e-02 5.65e-02 9.16e-01 6.05e-01
GOBP EXPORT FROM CELL 881 1.91e-02 1.23e-01 0.057700 4.83e-02 3.16e-02 1.50e-02 1.12e-01
Signalling to RAS 20 9.08e-01 9.65e-01 0.057700 5.56e-02 1.55e-02 6.67e-01 9.05e-01
GOBP REGULATION OF LEUKOCYTE ADHESION TO ARTERIAL ENDOTHELIAL CELL 5 9.77e-01 9.91e-01 0.057700 -4.89e-02 -3.05e-02 8.50e-01 9.06e-01
GOBP REGULATION OF LIPID METABOLIC PROCESS 314 2.37e-01 5.33e-01 0.057600 4.49e-02 3.62e-02 1.71e-01 2.71e-01
GOMF ENDONUCLEASE ACTIVITY ACTIVE WITH EITHER RIBO OR DEOXYRIBONUCLEIC ACIDS AND PRODUCING 3 PHOSPHOMONOESTERS 17 9.17e-01 9.68e-01 0.057600 5.68e-02 -9.44e-03 6.85e-01 9.46e-01
GOBP XENOBIOTIC EXPORT FROM CELL 26 8.70e-01 9.46e-01 0.057600 -3.85e-02 4.28e-02 7.34e-01 7.05e-01
GOCC SCHAFFER COLLATERAL CA1 SYNAPSE 89 6.46e-01 8.43e-01 0.057500 5.73e-02 4.99e-03 3.50e-01 9.35e-01
GOBP POSITIVE REGULATION OF SPINDLE ASSEMBLY 7 9.65e-01 9.87e-01 0.057500 6.85e-03 -5.71e-02 9.75e-01 7.94e-01
GOBP GLUTAMATE METABOLIC PROCESS 33 8.46e-01 9.36e-01 0.057500 -6.54e-03 5.71e-02 9.48e-01 5.70e-01
GOMF ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 428 1.19e-01 3.76e-01 0.057500 -6.97e-03 5.70e-02 8.05e-01 4.30e-02
GOBP REGULATION OF MICROVILLUS ASSEMBLY 6 9.69e-01 9.89e-01 0.057500 -5.11e-02 2.62e-02 8.28e-01 9.12e-01
GOBP MYELOID LEUKOCYTE MEDIATED IMMUNITY 105 5.90e-01 8.09e-01 0.057400 5.70e-03 -5.71e-02 9.20e-01 3.12e-01
Formation of the Early Elongation Complex 32 8.60e-01 9.42e-01 0.057400 5.36e-02 2.04e-02 6.00e-01 8.42e-01
Formation of the HIV-1 Early Elongation Complex 32 8.60e-01 9.42e-01 0.057400 5.36e-02 2.04e-02 6.00e-01 8.42e-01
GOBP NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 52 7.68e-01 9.02e-01 0.057400 -1.05e-02 5.64e-02 8.96e-01 4.82e-01
GOBP CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS 264 2.71e-01 5.68e-01 0.057300 -4.47e-03 5.71e-02 9.00e-01 1.10e-01
GOMF DISULFIDE OXIDOREDUCTASE ACTIVITY 40 8.14e-01 9.25e-01 0.057300 -5.51e-02 1.58e-02 5.47e-01 8.63e-01
GOCC NEURON PROJECTION 1260 4.12e-03 4.08e-02 0.057300 4.86e-02 3.03e-02 3.71e-03 7.05e-02
GOBP PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS 14 9.29e-01 9.73e-01 0.057300 -3.65e-02 4.41e-02 8.13e-01 7.75e-01
GOBP POLYOL METABOLIC PROCESS 101 6.29e-01 8.34e-01 0.057200 4.85e-02 3.04e-02 4.00e-01 5.97e-01
GOCC PRESYNAPTIC MEMBRANE 161 4.34e-01 7.08e-01 0.057200 -2.66e-02 5.07e-02 5.61e-01 2.67e-01
GOBP REGULATION OF HOMOTYPIC CELL CELL ADHESION 36 8.31e-01 9.30e-01 0.057100 5.35e-02 -2.01e-02 5.79e-01 8.35e-01
GOMF CARBON CARBON LYASE ACTIVITY 51 7.93e-01 9.15e-01 0.057100 4.24e-02 3.83e-02 6.00e-01 6.36e-01
GOMF GTPASE ACTIVITY 303 2.11e-01 5.06e-01 0.057100 5.14e-02 -2.50e-02 1.24e-01 4.54e-01
GOCC EXTERNAL SIDE OF APICAL PLASMA MEMBRANE 6 9.70e-01 9.89e-01 0.057100 5.39e-02 -1.89e-02 8.19e-01 9.36e-01
GOBP REGULATION OF HISTAMINE SECRETION BY MAST CELL 6 9.69e-01 9.89e-01 0.057000 -4.10e-02 3.97e-02 8.62e-01 8.66e-01
GOBP T CELL PROLIFERATION 204 3.79e-01 6.65e-01 0.057000 -8.28e-03 -5.64e-02 8.38e-01 1.65e-01
GOBP CDC42 PROTEIN SIGNAL TRANSDUCTION 16 9.25e-01 9.71e-01 0.057000 5.70e-02 -3.14e-04 6.93e-01 9.98e-01
GOMF ENZYME INHIBITOR ACTIVITY 379 1.74e-01 4.60e-01 0.057000 -5.45e-02 -1.66e-02 6.84e-02 5.79e-01
GOBP ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS 303 2.55e-01 5.52e-01 0.056900 -2.90e-02 -4.90e-02 3.86e-01 1.42e-01
GOBP DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS 14 9.29e-01 9.74e-01 0.056900 -3.62e-02 4.39e-02 8.15e-01 7.76e-01
GOBP REGULATION OF PROTEIN SECRETION 261 3.11e-01 6.04e-01 0.056800 4.66e-02 3.25e-02 1.95e-01 3.66e-01
GOBP POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION 88 6.33e-01 8.35e-01 0.056800 4.09e-02 -3.94e-02 5.07e-01 5.23e-01
GOBP REGULATION OF ANGIOTENSIN LEVELS IN BLOOD 8 9.60e-01 9.85e-01 0.056800 -5.47e-02 1.53e-02 7.89e-01 9.40e-01
GOBP REGULATION OF TRANSPORT 1559 1.20e-03 1.59e-02 0.056800 5.38e-02 1.82e-02 3.93e-04 2.31e-01
GOBP TAXIS 440 1.43e-01 4.15e-01 0.056700 4.44e-02 3.52e-02 1.10e-01 2.05e-01
COPI-independent Golgi-to-ER retrograde traffic 51 7.96e-01 9.16e-01 0.056700 3.63e-02 4.35e-02 6.54e-01 5.91e-01
GOMF MITOCHONDRIAL RIBOSOME BINDING 9 9.60e-01 9.85e-01 0.056600 5.17e-02 2.32e-02 7.88e-01 9.04e-01
GOBP MICROTUBULE BUNDLE FORMATION 125 5.24e-01 7.66e-01 0.056600 -4.18e-02 3.82e-02 4.20e-01 4.60e-01
GOCC PLATELET ALPHA GRANULE MEMBRANE 16 9.24e-01 9.71e-01 0.056600 -1.18e-02 5.54e-02 9.35e-01 7.01e-01
GOBP POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION 64 7.51e-01 8.92e-01 0.056600 4.49e-02 3.45e-02 5.35e-01 6.33e-01
GOBP L LEUCINE CATABOLIC PROCESS 6 9.73e-01 9.90e-01 0.056500 2.13e-02 5.23e-02 9.28e-01 8.24e-01
GOBP RESPONSE TO TYPE I INTERFERON 84 6.49e-01 8.45e-01 0.056500 4.16e-02 -3.82e-02 5.10e-01 5.45e-01
GOBP CELL ACTIVATION 1077 5.15e-03 4.84e-02 0.056400 3.47e-02 -4.45e-02 5.48e-02 1.36e-02
GOBP REGULATION OF PEPTIDE TRANSPORT 196 3.89e-01 6.73e-01 0.056400 5.62e-02 -5.03e-03 1.75e-01 9.03e-01
GOCC SARCOLEMMA 136 4.99e-01 7.53e-01 0.056400 -3.92e-02 4.05e-02 4.30e-01 4.14e-01
GOBP STEROID METABOLIC PROCESS 315 2.50e-01 5.48e-01 0.056300 3.18e-02 4.65e-02 3.32e-01 1.56e-01
GOBP MEMORY 122 5.40e-01 7.79e-01 0.056300 2.65e-02 -4.97e-02 6.13e-01 3.43e-01
GOBP DEFENSE RESPONSE TO VIRUS 297 2.36e-01 5.33e-01 0.056200 5.45e-02 -1.35e-02 1.06e-01 6.88e-01
GOMF RACEMASE AND EPIMERASE ACTIVITY 17 9.27e-01 9.73e-01 0.056200 2.66e-02 4.95e-02 8.49e-01 7.24e-01
Defects in cobalamin (B12) metabolism 13 9.37e-01 9.76e-01 0.056200 5.20e-02 -2.12e-02 7.46e-01 8.94e-01
GOBP IMMUNE RESPONSE REGULATING SIGNALING PATHWAY 515 8.25e-02 3.07e-01 0.056100 1.76e-02 -5.33e-02 4.95e-01 3.83e-02
GOCC GERM CELL NUCLEUS 68 7.40e-01 8.88e-01 0.056100 -2.95e-02 -4.78e-02 6.74e-01 4.96e-01
GOCC PRESYNAPSE 547 9.21e-02 3.25e-01 0.056100 5.01e-02 2.54e-02 4.52e-02 3.10e-01
GOBP NEGATIVE REGULATION OF LAMELLIPODIUM ORGANIZATION 7 9.65e-01 9.87e-01 0.056100 -3.89e-02 4.04e-02 8.58e-01 8.53e-01
GOBP RETINAL ROD CELL DIFFERENTIATION 16 9.25e-01 9.71e-01 0.056100 1.37e-02 -5.44e-02 9.24e-01 7.07e-01
GOBP CELL CELL SIGNALING 1255 5.06e-03 4.79e-02 0.056100 5.03e-02 2.47e-02 2.71e-03 1.41e-01
GOBP NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE 87 6.79e-01 8.61e-01 0.056100 -2.41e-02 -5.06e-02 6.98e-01 4.14e-01
GOMF PHOSPHOTRANSFERASE ACTIVITY PHOSPHATE GROUP AS ACCEPTOR 35 8.43e-01 9.36e-01 0.056000 -1.17e-02 5.48e-02 9.05e-01 5.75e-01
GOCC GATOR2 COMPLEX 9 9.58e-01 9.85e-01 0.056000 2.96e-03 -5.60e-02 9.88e-01 7.71e-01
GOBP REGULATION OF PHOSPHORUS METABOLIC PROCESS 1100 6.56e-03 5.79e-02 0.056000 5.57e-02 -6.19e-03 1.82e-03 7.29e-01
GOBP REGULATION OF POTASSIUM ION TRANSPORT 97 6.29e-01 8.34e-01 0.056000 5.58e-02 -4.88e-03 3.42e-01 9.34e-01
GOBP PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 220 3.53e-01 6.42e-01 0.056000 5.17e-03 -5.57e-02 8.95e-01 1.54e-01
GOBP POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEOLUS 5 9.77e-01 9.91e-01 0.056000 5.58e-02 3.95e-03 8.29e-01 9.88e-01
GOBP POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 82 6.94e-01 8.68e-01 0.055900 -1.97e-02 -5.23e-02 7.57e-01 4.13e-01
GOBP SYNCYTIUM FORMATION 64 7.26e-01 8.82e-01 0.055900 2.86e-02 -4.80e-02 6.92e-01 5.07e-01
GOBP REGULATION OF IMMUNE SYSTEM PROCESS 1511 9.02e-04 1.27e-02 0.055800 2.56e-02 -4.96e-02 9.66e-02 1.26e-03
GOBP MUSCLE CONTRACTION 344 1.98e-01 4.92e-01 0.055800 5.55e-02 -6.22e-03 7.70e-02 8.43e-01
GOMF EFFLUX TRANSMEMBRANE TRANSPORTER ACTIVITY 15 9.36e-01 9.76e-01 0.055800 3.00e-02 4.71e-02 8.41e-01 7.52e-01
GOBP NEGATIVE REGULATION OF KINASE ACTIVITY 176 4.24e-01 7.03e-01 0.055800 5.22e-02 -1.95e-02 2.32e-01 6.56e-01
GOMF MUTSALPHA COMPLEX BINDING 7 9.70e-01 9.89e-01 0.055700 4.49e-02 3.30e-02 8.37e-01 8.80e-01
GOBP NEGATIVE REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 51 7.80e-01 9.09e-01 0.055700 1.66e-02 -5.32e-02 8.38e-01 5.11e-01
GOBP IRON ION TRANSPORT 52 7.99e-01 9.17e-01 0.055700 3.67e-02 4.18e-02 6.47e-01 6.02e-01
GOBP VERY LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS 13 9.38e-01 9.76e-01 0.055600 5.02e-02 -2.38e-02 7.54e-01 8.82e-01
GOMF LIPASE ACTIVITY 133 5.19e-01 7.63e-01 0.055600 -4.81e-02 2.79e-02 3.38e-01 5.78e-01
GOBP MACROPHAGE DIFFERENTIATION 62 7.65e-01 9.01e-01 0.055600 4.39e-02 3.40e-02 5.50e-01 6.43e-01
GOBP REGULATION OF NITRIC OXIDE METABOLIC PROCESS 63 7.34e-01 8.85e-01 0.055500 4.89e-02 -2.63e-02 5.02e-01 7.18e-01
GOBP REGULATION OF SPINDLE ORGANIZATION 45 8.00e-01 9.17e-01 0.055500 4.21e-02 -3.62e-02 6.25e-01 6.75e-01
GOMF CYTOSKELETAL MOTOR ACTIVITY 111 6.10e-01 8.22e-01 0.055500 1.41e-02 5.37e-02 7.97e-01 3.29e-01
GOBP POSITIVE REGULATION OF REPRODUCTIVE PROCESS 88 6.52e-01 8.46e-01 0.055200 -2.79e-02 4.76e-02 6.51e-01 4.40e-01
GOBP ENDOSOME TO LYSOSOME TRANSPORT 70 7.34e-01 8.85e-01 0.055100 5.37e-02 1.22e-02 4.37e-01 8.60e-01
GOBP CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 57 7.76e-01 9.07e-01 0.055000 -9.42e-03 -5.42e-02 9.02e-01 4.79e-01
GOBP HAIR CELL DIFFERENTIATION 54 7.82e-01 9.10e-01 0.055000 -7.99e-04 5.50e-02 9.92e-01 4.85e-01
GOCC VESICLE LUMEN 311 2.66e-01 5.62e-01 0.055000 -5.08e-02 -2.10e-02 1.24e-01 5.24e-01
GOBP REGULATION OF INSULIN SECRETION 164 4.72e-01 7.32e-01 0.054900 5.47e-02 -5.13e-03 2.27e-01 9.10e-01
GOBP POSITIVE REGULATION OF INSULIN SECRETION 85 6.62e-01 8.51e-01 0.054900 4.21e-02 -3.53e-02 5.03e-01 5.73e-01
GOBP REGULATION OF LIPASE ACTIVITY 65 7.55e-01 8.95e-01 0.054900 -1.78e-02 -5.19e-02 8.03e-01 4.69e-01
GOBP CELL CELL ADHESION 937 1.41e-02 1.01e-01 0.054900 5.16e-02 -1.88e-02 7.49e-03 3.30e-01
GOBP NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 45 8.05e-01 9.20e-01 0.054900 2.72e-02 -4.76e-02 7.52e-01 5.80e-01
GOBP REGULATION OF RESPONSE TO DRUG 16 9.25e-01 9.72e-01 0.054900 -4.35e-02 3.35e-02 7.63e-01 8.17e-01
GOBP REGULATION OF INNATE IMMUNE RESPONSE 430 1.44e-01 4.18e-01 0.054800 4.31e-03 -5.47e-02 8.78e-01 5.18e-02
GOBP T CELL ACTIVATION 551 7.54e-02 2.90e-01 0.054800 2.69e-02 -4.77e-02 2.80e-01 5.53e-02
GOBP POSITIVE REGULATION OF RESPONSE TO WOUNDING 76 7.03e-01 8.71e-01 0.054800 -1.12e-02 5.36e-02 8.66e-01 4.19e-01
Late SARS-CoV-2 Infection Events 67 7.54e-01 8.95e-01 0.054700 4.80e-02 2.62e-02 4.97e-01 7.10e-01
GOMF PHOSPHATIDYLETHANOLAMINE BINDING 17 9.21e-01 9.70e-01 0.054600 4.09e-02 -3.61e-02 7.70e-01 7.97e-01
GOMF FATTY ACID BINDING 48 8.18e-01 9.27e-01 0.054600 4.59e-02 2.95e-02 5.82e-01 7.24e-01
GOBP MAMMARY GLAND DUCT MORPHOGENESIS 31 8.71e-01 9.47e-01 0.054500 5.45e-02 2.68e-03 6.00e-01 9.79e-01
Diseases of mitotic cell cycle 37 8.39e-01 9.33e-01 0.054400 4.70e-02 -2.74e-02 6.21e-01 7.73e-01
GOBP ORGANOPHOSPHATE METABOLIC PROCESS 981 1.38e-02 9.94e-02 0.054400 5.36e-02 -9.35e-03 4.49e-03 6.20e-01
GOBP REGULATION OF IMMUNE EFFECTOR PROCESS 377 1.99e-01 4.93e-01 0.054300 -8.62e-03 -5.37e-02 7.74e-01 7.36e-02
Leishmania infection 155 5.18e-01 7.63e-01 0.054300 5.22e-02 1.52e-02 2.62e-01 7.44e-01
Parasitic Infection Pathways 155 5.18e-01 7.63e-01 0.054300 5.22e-02 1.52e-02 2.62e-01 7.44e-01
GOBP TOLL LIKE RECEPTOR SIGNALING PATHWAY 72 7.29e-01 8.83e-01 0.054300 -3.46e-03 -5.42e-02 9.59e-01 4.27e-01
GOMF ENDOPEPTIDASE ACTIVATOR ACTIVITY 19 9.15e-01 9.68e-01 0.054300 -4.84e-02 2.46e-02 7.15e-01 8.53e-01
GOBP TRANSMISSION OF NERVE IMPULSE 73 7.19e-01 8.79e-01 0.054200 -8.58e-03 5.35e-02 8.99e-01 4.29e-01
GOBP ATP METABOLIC PROCESS 205 3.91e-01 6.74e-01 0.054100 1.91e-02 -5.06e-02 6.37e-01 2.12e-01
GOBP POSITIVE REGULATION OF LIPID TRANSPORT 86 6.69e-01 8.55e-01 0.054100 2.68e-02 -4.70e-02 6.68e-01 4.51e-01
GOBP REGULATION OF MITOTIC CENTROSOME SEPARATION 9 9.63e-01 9.86e-01 0.054100 -2.11e-02 -4.98e-02 9.13e-01 7.96e-01
Sulfide oxidation to sulfate 5 9.77e-01 9.91e-01 0.054000 -4.04e-02 3.58e-02 8.76e-01 8.90e-01
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 82 7.15e-01 8.77e-01 0.054000 4.66e-02 2.73e-02 4.66e-01 6.69e-01
GOBP REGULATION OF CELL CELL ADHESION 486 1.09e-01 3.57e-01 0.054000 4.78e-02 -2.52e-02 7.14e-02 3.42e-01
GOBP REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION 113 5.89e-01 8.09e-01 0.054000 3.52e-02 -4.09e-02 5.18e-01 4.52e-01
GOBP PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS 16 9.33e-01 9.75e-01 0.053900 5.38e-02 3.83e-03 7.09e-01 9.79e-01
GOBP FOLLICLE STIMULATING HORMONE SECRETION 8 9.67e-01 9.88e-01 0.053900 -1.14e-02 -5.27e-02 9.55e-01 7.96e-01
GOMF PEPTIDE ANTIGEN BINDING 35 8.58e-01 9.41e-01 0.053900 -3.92e-06 -5.39e-02 1.00e+00 5.81e-01
Respiratory syncytial virus (RSV) attachment and entry 21 9.17e-01 9.69e-01 0.053900 -2.33e-02 -4.86e-02 8.54e-01 7.00e-01
GOCC ACTIN BASED CELL PROJECTION 221 4.12e-01 6.93e-01 0.053900 3.65e-02 3.96e-02 3.50e-01 3.10e-01
GOBP BRANCHED CHAIN AMINO ACID CATABOLIC PROCESS 21 9.06e-01 9.64e-01 0.053800 3.60e-02 -4.00e-02 7.75e-01 7.51e-01
GOBP REGULATION OF RUFFLE ASSEMBLY 31 8.82e-01 9.52e-01 0.053800 3.06e-02 4.42e-02 7.68e-01 6.70e-01
GOBP ASCENDING AORTA DEVELOPMENT 5 9.80e-01 9.92e-01 0.053800 4.48e-02 2.97e-02 8.62e-01 9.08e-01
GOBP PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS 29 8.87e-01 9.55e-01 0.053700 5.02e-02 1.91e-02 6.40e-01 8.59e-01
GOMF GROWTH FACTOR ACTIVITY 152 5.22e-01 7.65e-01 0.053700 3.79e-03 5.36e-02 9.36e-01 2.54e-01
GOCC NEUROMUSCULAR JUNCTION 72 7.22e-01 8.80e-01 0.053600 1.88e-02 -5.02e-02 7.83e-01 4.61e-01
GOCC MICROTUBULE 460 1.46e-01 4.22e-01 0.053600 5.33e-02 5.87e-03 5.01e-02 8.29e-01
Energy dependent regulation of mTOR by LKB1-AMPK 28 8.94e-01 9.58e-01 0.053600 3.88e-02 3.70e-02 7.22e-01 7.35e-01
GOBP REGULATION OF BONE RESORPTION 43 8.35e-01 9.31e-01 0.053600 1.04e-02 5.25e-02 9.06e-01 5.51e-01
GOCC CUL2 RING UBIQUITIN LIGASE COMPLEX 23 9.03e-01 9.62e-01 0.053500 5.27e-02 -9.34e-03 6.62e-01 9.38e-01
GOMF MISMATCHED DNA BINDING 14 9.37e-01 9.76e-01 0.053500 4.44e-02 -2.99e-02 7.74e-01 8.46e-01
GOBP REGULATION OF TRANS SYNAPTIC SIGNALING 477 1.54e-01 4.33e-01 0.053500 3.12e-02 4.34e-02 2.43e-01 1.04e-01
GOBP RESPONSE TO VIRUS 396 1.68e-01 4.53e-01 0.053500 4.58e-02 -2.76e-02 1.18e-01 3.46e-01
GOBP DE NOVO AMP BIOSYNTHETIC PROCESS 8 9.64e-01 9.86e-01 0.053400 -3.63e-02 3.92e-02 8.59e-01 8.48e-01
GOMF MONOATOMIC ANION CHANNEL ACTIVITY 90 6.66e-01 8.53e-01 0.053300 -4.81e-02 2.31e-02 4.31e-01 7.05e-01
GOBP CELL CELL JUNCTION ASSEMBLY 151 5.16e-01 7.62e-01 0.053300 5.21e-02 -1.12e-02 2.69e-01 8.13e-01
GOBP RIBOSE PHOSPHATE METABOLIC PROCESS 446 1.50e-01 4.28e-01 0.053300 5.30e-02 -5.20e-03 5.50e-02 8.51e-01
GOBP NEGATIVE REGULATION OF T CELL PROLIFERATION 69 7.35e-01 8.86e-01 0.053300 -5.01e-02 1.80e-02 4.71e-01 7.96e-01
GOCC M BAND 27 8.91e-01 9.57e-01 0.053200 2.96e-04 -5.32e-02 9.98e-01 6.32e-01
GOBP REGULATION OF FEMALE GONAD DEVELOPMENT 7 9.73e-01 9.90e-01 0.053200 3.06e-02 4.35e-02 8.88e-01 8.42e-01
GOBP NEGATIVE REGULATION OF HEMOPOIESIS 113 6.39e-01 8.40e-01 0.053100 -2.73e-02 -4.55e-02 6.16e-01 4.03e-01
GOBP ORGANOPHOSPHATE CATABOLIC PROCESS 229 3.66e-01 6.53e-01 0.053100 -1.61e-02 5.06e-02 6.75e-01 1.87e-01
GOMF RETINOL BINDING 16 9.30e-01 9.74e-01 0.053100 -3.28e-02 4.17e-02 8.20e-01 7.73e-01
GOBP ESTABLISHMENT OF ENDOTHELIAL BARRIER 51 8.19e-01 9.27e-01 0.053000 3.67e-02 3.83e-02 6.50e-01 6.36e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERSPECIES INTERACTION BETWEEN ORGANISMS 1628 2.72e-03 2.99e-02 0.052900 -3.56e-02 -3.92e-02 1.67e-02 8.38e-03
GOBP LOCOMOTOR RHYTHM 16 9.37e-01 9.76e-01 0.052900 1.16e-02 5.17e-02 9.36e-01 7.21e-01
GOCC SYNAPTIC MEMBRANE 375 1.89e-01 4.80e-01 0.052900 -3.15e-02 4.25e-02 2.96e-01 1.57e-01
GOBP BONE GROWTH 31 8.70e-01 9.46e-01 0.052800 2.88e-02 -4.43e-02 7.81e-01 6.69e-01
ZBP1(DAI) mediated induction of type I IFNs 20 9.19e-01 9.69e-01 0.052800 5.28e-02 -2.63e-03 6.83e-01 9.84e-01
GOBP TRANSITION METAL ION TRANSPORT 93 6.81e-01 8.62e-01 0.052800 5.25e-02 5.50e-03 3.81e-01 9.27e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS 24 9.11e-01 9.66e-01 0.052700 4.32e-02 3.03e-02 7.14e-01 7.97e-01
GOCC GTPASE COMPLEX 38 8.63e-01 9.43e-01 0.052700 3.23e-02 4.17e-02 7.30e-01 6.57e-01
GOBP SYNAPTIC VESICLE EXOCYTOSIS 91 6.86e-01 8.64e-01 0.052700 2.77e-03 5.26e-02 9.64e-01 3.86e-01
GOBP SPERM FLAGELLUM ASSEMBLY 47 8.26e-01 9.28e-01 0.052700 -5.18e-02 -9.58e-03 5.39e-01 9.10e-01
GOBP MALE GAMETE GENERATION 590 9.45e-02 3.29e-01 0.052600 -5.23e-02 -4.98e-03 2.99e-02 8.36e-01
GOBP SMALL MOLECULE METABOLIC PROCESS 1746 1.90e-03 2.27e-02 0.052500 4.58e-02 2.56e-02 1.46e-03 7.52e-02
GOBP CELL CHEMOTAXIS 302 3.06e-01 5.99e-01 0.052500 5.02e-02 1.53e-02 1.34e-01 6.48e-01
GOCC AZUROPHIL GRANULE MEMBRANE 56 8.07e-01 9.20e-01 0.052400 3.94e-02 3.46e-02 6.10e-01 6.54e-01
Ion transport by P-type ATPases 51 8.20e-01 9.27e-01 0.052400 4.65e-02 2.41e-02 5.66e-01 7.65e-01
GOBP POSITIVE REGULATION OF PEPTIDE SECRETION 112 6.10e-01 8.22e-01 0.052400 3.21e-02 -4.14e-02 5.58e-01 4.49e-01
GOBP STEROID BIOSYNTHETIC PROCESS 178 4.60e-01 7.24e-01 0.052400 -2.54e-02 4.58e-02 5.59e-01 2.92e-01
GOBP NITROGEN CYCLE METABOLIC PROCESS 12 9.55e-01 9.83e-01 0.052400 -4.28e-02 -3.02e-02 7.97e-01 8.56e-01
GOBP SECRETION 937 3.11e-02 1.70e-01 0.052300 4.53e-02 2.62e-02 1.87e-02 1.75e-01
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC CLASS II PROTEIN COMPLEX 14 9.48e-01 9.80e-01 0.052200 -4.12e-02 -3.21e-02 7.90e-01 8.35e-01
GOBP POSITIVE REGULATION OF MHC CLASS I BIOSYNTHETIC PROCESS 6 9.77e-01 9.91e-01 0.052200 -3.38e-02 -3.98e-02 8.86e-01 8.66e-01
GOBP ALPHA BETA T CELL ACTIVATION 172 4.88e-01 7.46e-01 0.052200 8.49e-03 -5.15e-02 8.48e-01 2.44e-01
GOBP NEURONAL ACTION POTENTIAL 34 8.78e-01 9.50e-01 0.052100 4.48e-02 2.66e-02 6.51e-01 7.88e-01
NPAS4 regulates expression of target genes 20 9.19e-01 9.69e-01 0.052100 5.02e-02 -1.41e-02 6.98e-01 9.13e-01
GOBP IMMUNE EFFECTOR PROCESS 621 9.89e-02 3.37e-01 0.052100 -2.64e-02 -4.49e-02 2.61e-01 5.59e-02
GOBP RESPONSE TO LIGHT STIMULUS 304 2.98e-01 5.94e-01 0.052100 5.19e-02 4.53e-03 1.20e-01 8.92e-01
GOBP T CELL CYTOKINE PRODUCTION 36 8.54e-01 9.39e-01 0.052100 -3.41e-02 3.94e-02 7.23e-01 6.82e-01
GOBP EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT 10 9.57e-01 9.84e-01 0.051900 -3.99e-02 3.33e-02 8.27e-01 8.55e-01
GOBP REGULATION OF RRNA PROCESSING 16 9.33e-01 9.75e-01 0.051900 4.58e-02 -2.43e-02 7.51e-01 8.66e-01
GOBP LIPID BIOSYNTHETIC PROCESS 709 7.03e-02 2.78e-01 0.051900 4.88e-02 1.76e-02 2.69e-02 4.23e-01
GOBP POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS 16 9.36e-01 9.76e-01 0.051900 4.79e-03 -5.16e-02 9.74e-01 7.21e-01
GOBP ORGANOPHOSPHATE ESTER TRANSPORT 151 5.66e-01 7.94e-01 0.051800 2.53e-02 4.52e-02 5.91e-01 3.38e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS 99 6.86e-01 8.64e-01 0.051800 4.72e-02 2.14e-02 4.17e-01 7.13e-01
GOBP NEGATIVE REGULATION OF CALCIUM ION TRANSPORT 67 7.49e-01 8.92e-01 0.051800 4.29e-02 -2.90e-02 5.44e-01 6.81e-01
GOCC CILIARY ROOTLET 14 9.42e-01 9.78e-01 0.051800 2.22e-02 -4.68e-02 8.85e-01 7.62e-01
GOCC MICROBODY LUMEN 51 8.13e-01 9.24e-01 0.051800 5.17e-02 -2.36e-03 5.23e-01 9.77e-01
GOBP CELL ADHESION 1475 4.64e-03 4.47e-02 0.051700 5.04e-02 1.17e-02 1.21e-03 4.52e-01
GOBP NEGATIVE REGULATION OF FIBROBLAST MIGRATION 12 9.56e-01 9.83e-01 0.051700 2.54e-02 4.50e-02 8.79e-01 7.87e-01
GOBP NEGATIVE REGULATION OF ENDOCYTOSIS 75 7.32e-01 8.84e-01 0.051700 -1.38e-02 4.98e-02 8.36e-01 4.56e-01
GOCC INTERCELLULAR BRIDGE 90 7.14e-01 8.76e-01 0.051700 4.45e-02 2.63e-02 4.66e-01 6.67e-01
COPI-mediated anterograde transport 100 6.61e-01 8.51e-01 0.051500 4.96e-02 -1.41e-02 3.92e-01 8.07e-01
Golgi Cisternae Pericentriolar Stack Reorganization 14 9.49e-01 9.81e-01 0.051500 4.37e-02 2.73e-02 7.77e-01 8.60e-01
Metabolism of steroids 149 5.77e-01 8.01e-01 0.051500 3.97e-02 3.29e-02 4.03e-01 4.88e-01
GOCC SECRETORY GRANULE MEMBRANE 307 2.74e-01 5.71e-01 0.051500 -4.15e-02 3.05e-02 2.11e-01 3.59e-01
GOBP ICOSANOID METABOLIC PROCESS 117 6.37e-01 8.38e-01 0.051500 5.04e-02 1.05e-02 3.46e-01 8.44e-01
GOMF HORMONE ACTIVITY 122 5.99e-01 8.16e-01 0.051400 -4.56e-02 2.38e-02 3.85e-01 6.50e-01
GOBP RESPONSE TO WOUNDING 552 1.24e-01 3.84e-01 0.051400 5.06e-02 8.68e-03 4.20e-02 7.27e-01
GOBP OLEFINIC COMPOUND METABOLIC PROCESS 156 5.59e-01 7.91e-01 0.051300 4.65e-02 2.16e-02 3.16e-01 6.41e-01
GOBP PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS 23 9.13e-01 9.67e-01 0.051300 5.13e-02 1.75e-03 6.70e-01 9.88e-01
GOCC POSTSYNAPTIC SPECIALIZATION INTRACELLULAR COMPONENT 19 9.32e-01 9.74e-01 0.051300 -4.62e-02 -2.21e-02 7.27e-01 8.68e-01
GOBP POSITIVE REGULATION OF VASCULAR PERMEABILITY 17 9.31e-01 9.74e-01 0.051200 -4.56e-02 2.32e-02 7.45e-01 8.68e-01
GOBP PROTEIN HOMOOLIGOMERIZATION 192 4.98e-01 7.52e-01 0.051200 3.70e-02 3.54e-02 3.77e-01 3.98e-01
GOBP RESPONSE TO ACTIVITY 77 7.48e-01 8.91e-01 0.051200 4.89e-02 1.52e-02 4.59e-01 8.17e-01
GOMF IRON ION BINDING 146 5.78e-01 8.02e-01 0.051100 -1.48e-02 -4.89e-02 7.58e-01 3.07e-01
GOCC CASPASE COMPLEX 10 9.60e-01 9.85e-01 0.051100 -1.15e-02 4.98e-02 9.50e-01 7.85e-01
GOMF N N DIMETHYLANILINE MONOOXYGENASE ACTIVITY 5 9.81e-01 9.92e-01 0.051000 4.87e-02 1.52e-02 8.50e-01 9.53e-01
GOBP POSITIVE REGULATION OF LYASE ACTIVITY 36 8.63e-01 9.43e-01 0.051000 4.79e-02 -1.75e-02 6.19e-01 8.55e-01
GOCC SUPRAMOLECULAR POLYMER 1007 2.24e-02 1.37e-01 0.051000 -3.13e-03 5.09e-02 8.66e-01 6.30e-03
GOBP OSTEOBLAST DEVELOPMENT 17 9.40e-01 9.77e-01 0.050900 -3.86e-02 -3.32e-02 7.83e-01 8.13e-01
GOBP CARBOHYDRATE IMPORT ACROSS PLASMA MEMBRANE 6 9.76e-01 9.91e-01 0.050900 4.94e-02 -1.23e-02 8.34e-01 9.58e-01
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE 494 1.51e-01 4.30e-01 0.050900 3.52e-04 -5.09e-02 9.89e-01 5.28e-02
GOBP CHOLESTEROL STORAGE 25 9.13e-01 9.67e-01 0.050900 -2.94e-02 -4.15e-02 7.99e-01 7.20e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION 92 6.90e-01 8.66e-01 0.050800 -4.88e-02 1.44e-02 4.19e-01 8.11e-01
GOBP ENAMEL MINERALIZATION 20 9.20e-01 9.70e-01 0.050800 2.76e-02 -4.27e-02 8.31e-01 7.41e-01
GOBP NEGATIVE REGULATION OF CELL ADHESION 299 3.43e-01 6.32e-01 0.050800 4.35e-02 2.61e-02 1.96e-01 4.37e-01
GOBP RESPONSE TO ALCOHOL 253 4.00e-01 6.82e-01 0.050700 4.58e-02 2.19e-02 2.10e-01 5.48e-01
GOCC SIDE OF MEMBRANE 691 8.90e-02 3.19e-01 0.050600 -4.33e-02 -2.62e-02 5.21e-02 2.41e-01
GOBP TYPE II INTERFERON PRODUCTION 113 6.40e-01 8.40e-01 0.050600 -4.97e-02 9.41e-03 3.61e-01 8.63e-01
GOBP REGULATION OF HORMONE BIOSYNTHETIC PROCESS 24 9.18e-01 9.69e-01 0.050600 -3.25e-02 -3.88e-02 7.83e-01 7.42e-01
GOBP ENDOLYSOSOMAL TOLL LIKE RECEPTOR SIGNALING PATHWAY 45 8.32e-01 9.30e-01 0.050600 2.51e-02 -4.39e-02 7.71e-01 6.10e-01
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST 29 8.88e-01 9.55e-01 0.050500 -4.36e-02 2.55e-02 6.84e-01 8.12e-01
GOMF HYDROLASE ACTIVITY ACTING ON ESTER BONDS 729 7.55e-02 2.90e-01 0.050500 4.77e-02 1.66e-02 2.84e-02 4.46e-01
GOMF SIGNALING RECEPTOR REGULATOR ACTIVITY 518 1.26e-01 3.86e-01 0.050400 -3.78e-02 3.33e-02 1.41e-01 1.94e-01
GOCC BLEB 9 9.68e-01 9.88e-01 0.050300 -4.70e-02 -1.79e-02 8.07e-01 9.26e-01
GOBP SEQUESTERING OF TRIGLYCERIDE 18 9.30e-01 9.74e-01 0.050300 -4.40e-02 2.44e-02 7.47e-01 8.58e-01
GOMF ADP PHOSPHATASE ACTIVITY 6 9.76e-01 9.91e-01 0.050300 -4.47e-02 2.31e-02 8.50e-01 9.22e-01
GOBP PROTEOLYSIS 1529 3.40e-03 3.52e-02 0.050300 4.71e-02 -1.77e-02 2.11e-03 2.48e-01
GOMF STEROID BINDING 103 6.88e-01 8.65e-01 0.050300 4.81e-02 1.47e-02 3.99e-01 7.97e-01
GOBP ENDOSOME ORGANIZATION 94 6.92e-01 8.67e-01 0.050200 1.13e-02 -4.89e-02 8.50e-01 4.12e-01
GOBP PEPTIDYL CYSTEINE MODIFICATION 40 8.69e-01 9.46e-01 0.050200 -3.35e-02 -3.74e-02 7.14e-01 6.82e-01
GOBP ADHERENS JUNCTION ORGANIZATION 57 8.14e-01 9.25e-01 0.050200 1.81e-02 4.68e-02 8.14e-01 5.41e-01
GOBP RESPONSE TO COPPER ION 34 8.84e-01 9.53e-01 0.050200 -4.80e-02 -1.47e-02 6.28e-01 8.82e-01
GOBP TETRAHYDROFOLATE METABOLIC PROCESS 18 9.34e-01 9.75e-01 0.050200 -5.01e-02 2.64e-03 7.13e-01 9.85e-01
GOMF TAURINE TRANSMEMBRANE TRANSPORTER ACTIVITY 5 9.82e-01 9.93e-01 0.050100 -4.84e-02 -1.28e-02 8.51e-01 9.61e-01
Strand-asynchronous mitochondrial DNA replication 10 9.64e-01 9.86e-01 0.050100 7.53e-03 4.95e-02 9.67e-01 7.86e-01
GOBP REGULATION OF STEROID BIOSYNTHETIC PROCESS 79 7.35e-01 8.86e-01 0.050100 -4.86e-02 1.22e-02 4.56e-01 8.51e-01
GOBP INTERLEUKIN 2 PRODUCTION 61 8.07e-01 9.20e-01 0.050000 -4.32e-02 -2.52e-02 5.59e-01 7.34e-01
GOBP APOPTOTIC CELL CLEARANCE 47 8.37e-01 9.32e-01 0.050000 -4.99e-02 3.09e-03 5.54e-01 9.71e-01
GOBP INNATE IMMUNE RESPONSE ACTIVATING CELL SURFACE RECEPTOR SIGNALING PATHWAY 97 7.13e-01 8.76e-01 0.050000 4.03e-02 2.96e-02 4.93e-01 6.14e-01
GOBP POST TRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE 14 9.45e-01 9.80e-01 0.049900 -4.07e-02 2.89e-02 7.92e-01 8.52e-01
GOBP NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION 160 5.62e-01 7.92e-01 0.049900 -1.23e-02 -4.84e-02 7.89e-01 2.91e-01
GOBP REGULATION OF ADENYLATE CYCLASE ACTIVITY 42 8.51e-01 9.38e-01 0.049900 4.92e-02 -8.51e-03 5.81e-01 9.24e-01
GOBP POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS 383 2.27e-01 5.24e-01 0.049900 1.82e-02 -4.65e-02 5.42e-01 1.19e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 40 8.69e-01 9.46e-01 0.049900 2.40e-02 4.37e-02 7.93e-01 6.32e-01
GOMF TRANSPORTER ACTIVITY 1173 1.20e-02 8.92e-02 0.049800 -4.19e-02 2.69e-02 1.56e-02 1.21e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 54 8.28e-01 9.29e-01 0.049700 2.38e-02 4.37e-02 7.62e-01 5.79e-01
GOBP PROTEIN COMPLEX OLIGOMERIZATION 256 4.03e-01 6.86e-01 0.049700 4.79e-02 1.32e-02 1.87e-01 7.15e-01
GOCC VACUOLAR PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN 9 9.65e-01 9.87e-01 0.049700 1.92e-02 -4.58e-02 9.21e-01 8.12e-01
GOBP PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT 24 9.09e-01 9.65e-01 0.049700 3.07e-02 -3.90e-02 7.94e-01 7.41e-01
Aberrant regulation of mitotic cell cycle due to RB1 defects 36 8.67e-01 9.45e-01 0.049600 3.44e-02 -3.57e-02 7.21e-01 7.11e-01
GOBP CELLULAR ALDEHYDE METABOLIC PROCESS 76 7.66e-01 9.01e-01 0.049600 4.62e-02 1.80e-02 4.87e-01 7.86e-01
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE 30 8.91e-01 9.57e-01 0.049500 -4.78e-02 1.31e-02 6.50e-01 9.02e-01
GOBP INFLAMMATORY RESPONSE 856 3.89e-02 1.94e-01 0.049500 -2.75e-02 4.12e-02 1.72e-01 4.09e-02
GOBP MITOCHONDRIAL DEPOLARIZATION 24 9.15e-01 9.68e-01 0.049500 -2.71e-03 4.94e-02 9.82e-01 6.75e-01
GOBP CELLULAR RESPONSE TO GONADOTROPIN STIMULUS 17 9.35e-01 9.75e-01 0.049500 -3.94e-02 3.00e-02 7.79e-01 8.30e-01
GOBP INTRACELLULAR PH REDUCTION 52 8.14e-01 9.25e-01 0.049500 3.25e-02 -3.73e-02 6.85e-01 6.42e-01
GOCC SYNAPSE 1414 7.99e-03 6.70e-02 0.049500 4.93e-02 3.40e-03 1.88e-03 8.31e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO TUMOR CELL 8 9.71e-01 9.90e-01 0.049300 -4.92e-02 -4.14e-03 8.10e-01 9.84e-01
GOBP INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS 64 7.91e-01 9.14e-01 0.049300 2.22e-03 -4.92e-02 9.76e-01 4.96e-01
GOBP ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY 55 8.22e-01 9.27e-01 0.049300 4.87e-02 7.59e-03 5.32e-01 9.22e-01
GOBP BENZENE CONTAINING COMPOUND METABOLIC PROCESS 26 9.11e-01 9.67e-01 0.049200 -7.38e-03 -4.87e-02 9.48e-01 6.67e-01
GOMF ATPASE ACTIVATOR ACTIVITY 25 9.17e-01 9.69e-01 0.049200 -1.80e-02 -4.58e-02 8.76e-01 6.92e-01
GOBP RESPONSE TO PH 40 8.74e-01 9.48e-01 0.049200 3.53e-02 3.43e-02 7.00e-01 7.07e-01
GOCC VACUOLAR LUMEN 167 5.23e-01 7.66e-01 0.049200 -3.82e-02 3.09e-02 3.94e-01 4.90e-01
GOBP DEOXYRIBONUCLEOSIDE METABOLIC PROCESS 11 9.60e-01 9.85e-01 0.049200 -7.17e-03 4.86e-02 9.67e-01 7.80e-01
GOCC TERMINAL BOUTON 44 8.44e-01 9.36e-01 0.049000 -2.50e-02 4.22e-02 7.74e-01 6.28e-01
GOMF G PROTEIN COUPLED RECEPTOR BINDING 274 4.01e-01 6.83e-01 0.049000 2.72e-02 4.08e-02 4.39e-01 2.45e-01
GOBP EPIGENETIC PROGRAMMING IN THE ZYGOTIC PRONUCLEI 14 9.51e-01 9.82e-01 0.049000 4.87e-02 5.23e-03 7.52e-01 9.73e-01
GOBP ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE 256 4.08e-01 6.90e-01 0.048900 4.85e-02 6.65e-03 1.82e-01 8.55e-01
GOCC MRNA EDITING COMPLEX 6 9.79e-01 9.92e-01 0.048900 4.89e-02 -1.03e-03 8.36e-01 9.96e-01
GOMF FLAP ENDONUCLEASE ACTIVITY 6 9.79e-01 9.92e-01 0.048900 7.94e-03 4.82e-02 9.73e-01 8.38e-01
GOMF GROWTH FACTOR BINDING 130 6.45e-01 8.42e-01 0.048900 4.41e-02 2.10e-02 3.85e-01 6.79e-01
Cell-cell junction organization 88 7.25e-01 8.82e-01 0.048900 4.84e-02 -6.69e-03 4.32e-01 9.14e-01
GOCC ENDOPLASMIC RETICULUM LUMEN 295 3.32e-01 6.23e-01 0.048800 -1.89e-02 4.50e-02 5.77e-01 1.83e-01
GOCC POLYMERIC CYTOSKELETAL FIBER 762 6.42e-02 2.63e-01 0.048800 -1.38e-02 4.68e-02 5.17e-01 2.79e-02
GOMF LEUCINE ZIPPER DOMAIN BINDING 11 9.63e-01 9.86e-01 0.048800 -1.07e-02 -4.76e-02 9.51e-01 7.85e-01
GOBP LEUKOCYTE CHEMOTAXIS 226 4.29e-01 7.06e-01 0.048700 4.32e-02 -2.24e-02 2.63e-01 5.62e-01
GOBP PHOSPHOLIPID TRANSPORT 101 7.17e-01 8.78e-01 0.048600 3.71e-02 3.15e-02 5.20e-01 5.84e-01
GOBP INTRACELLULAR IRON ION HOMEOSTASIS 66 7.79e-01 9.08e-01 0.048600 2.74e-02 -4.01e-02 7.00e-01 5.74e-01
GOBP REGULATION OF SMALL MOLECULE METABOLIC PROCESS 319 3.54e-01 6.44e-01 0.048500 3.88e-02 2.92e-02 2.34e-01 3.70e-01
GOBP REGULATION OF LIPOPROTEIN LIPASE ACTIVITY 14 9.55e-01 9.83e-01 0.048500 -4.27e-02 -2.29e-02 7.82e-01 8.82e-01
GOBP AMIDE TRANSPORT 308 3.55e-01 6.45e-01 0.048500 4.67e-02 1.30e-02 1.59e-01 6.95e-01
GOBP KETONE BIOSYNTHETIC PROCESS 47 8.57e-01 9.40e-01 0.048400 -3.98e-02 -2.76e-02 6.37e-01 7.43e-01
GOBP POSITIVE REGULATION OF COA TRANSFERASE ACTIVITY 8 9.71e-01 9.89e-01 0.048400 -2.03e-02 4.40e-02 9.21e-01 8.29e-01
RHO GTPases activate IQGAPs 30 9.00e-01 9.61e-01 0.048300 -4.83e-02 5.42e-04 6.47e-01 9.96e-01
GOBP POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION 44 8.56e-01 9.40e-01 0.048300 4.82e-02 -2.67e-03 5.80e-01 9.76e-01
GOBP MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION 29 9.05e-01 9.63e-01 0.048300 -6.00e-03 -4.79e-02 9.55e-01 6.55e-01
GOBP CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE 63 8.04e-01 9.20e-01 0.048200 4.81e-02 4.07e-03 5.09e-01 9.55e-01
Mitochondrial Uncoupling 6 9.81e-01 9.92e-01 0.048200 4.03e-02 2.64e-02 8.64e-01 9.11e-01
GOBP FC EPSILON RECEPTOR SIGNALING PATHWAY 24 9.18e-01 9.69e-01 0.048200 4.78e-02 -5.93e-03 6.85e-01 9.60e-01
GOBP HOMEOSTATIC PROCESS 1676 5.28e-03 4.91e-02 0.048100 4.71e-02 9.44e-03 1.31e-03 5.20e-01
GOMF ADENYLATE KINASE ACTIVITY 9 9.70e-01 9.89e-01 0.048100 7.55e-03 4.75e-02 9.69e-01 8.05e-01
GOBP PEPTIDYL TYROSINE DEPHOSPHORYLATION 30 8.94e-01 9.58e-01 0.048000 -2.88e-02 3.85e-02 7.85e-01 7.15e-01
GOBP RESPONSE TO ALDOSTERONE 17 9.44e-01 9.79e-01 0.048000 -4.73e-02 -8.14e-03 7.36e-01 9.54e-01
GOBP REGULATION OF MRNA 3 END PROCESSING 9 9.68e-01 9.88e-01 0.048000 -1.19e-02 4.65e-02 9.51e-01 8.09e-01
GOBP POSITIVE CHEMOTAXIS 62 8.06e-01 9.20e-01 0.048000 -2.71e-03 4.79e-02 9.71e-01 5.14e-01
GOCC PLASMA MEMBRANE REGION 1223 2.26e-02 1.38e-01 0.047900 1.86e-02 4.42e-02 2.72e-01 9.36e-03
GOBP PROTEIN TARGETING TO VACUOLE INVOLVED IN AUTOPHAGY 5 9.82e-01 9.93e-01 0.047900 -2.63e-02 4.00e-02 9.19e-01 8.77e-01
GOBP CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS 633 1.34e-01 4.00e-01 0.047900 4.40e-02 1.89e-02 5.90e-02 4.16e-01
GOBP GLYCEROLIPID CATABOLIC PROCESS 64 8.00e-01 9.18e-01 0.047900 -4.77e-02 4.10e-03 5.09e-01 9.55e-01
GOBP POSITIVE REGULATION OF TRANSMISSION OF NERVE IMPULSE 7 9.76e-01 9.91e-01 0.047800 2.94e-03 4.77e-02 9.89e-01 8.27e-01
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION 25 9.23e-01 9.71e-01 0.047800 3.62e-02 3.12e-02 7.54e-01 7.87e-01
GOBP REGULATION OF LIPID TRANSPORT 153 6.15e-01 8.26e-01 0.047800 3.07e-02 3.67e-02 5.13e-01 4.34e-01
GOBP TYROSINE PHOSPHORYLATION OF STAT PROTEIN 77 7.60e-01 8.98e-01 0.047800 -4.58e-02 1.36e-02 4.87e-01 8.36e-01
GOBP REGULATION OF CALCIUM ION IMPORT 46 8.62e-01 9.43e-01 0.047800 -2.26e-02 -4.21e-02 7.91e-01 6.21e-01
GOMF ADP RIBOSE DIPHOSPHATASE ACTIVITY 6 9.78e-01 9.92e-01 0.047700 4.24e-02 -2.20e-02 8.57e-01 9.26e-01
GOBP NEUTROPHIL ACTIVATION INVOLVED IN IMMUNE RESPONSE 20 9.37e-01 9.76e-01 0.047700 -1.98e-02 -4.35e-02 8.78e-01 7.37e-01
GOBP CARDIOLIPIN BIOSYNTHETIC PROCESS 7 9.78e-01 9.91e-01 0.047600 -4.36e-02 -1.93e-02 8.42e-01 9.29e-01
GOBP PROSTATIC BUD FORMATION 8 9.71e-01 9.90e-01 0.047600 2.90e-02 -3.77e-02 8.87e-01 8.53e-01
GOBP NEURONAL SIGNAL TRANSDUCTION 7 9.75e-01 9.91e-01 0.047600 -4.36e-02 1.90e-02 8.42e-01 9.31e-01
Presynaptic function of Kainate receptors 21 9.28e-01 9.73e-01 0.047500 -4.50e-02 1.52e-02 7.21e-01 9.04e-01
GOCC CLATHRIN COATED ENDOCYTIC VESICLE 87 7.44e-01 8.90e-01 0.047500 4.75e-02 -1.13e-03 4.44e-01 9.86e-01
GOMF FRIZZLED BINDING 36 8.93e-01 9.57e-01 0.047500 3.34e-02 3.38e-02 7.29e-01 7.26e-01
GOBP CELLULAR OXIDANT DETOXIFICATION 93 7.16e-01 8.78e-01 0.047400 -2.29e-02 4.15e-02 7.02e-01 4.89e-01
GOMF GLYCINE TRANSMEMBRANE TRANSPORTER ACTIVITY 9 9.71e-01 9.90e-01 0.047400 4.62e-02 1.05e-02 8.10e-01 9.57e-01
Long-term potentiation 22 9.33e-01 9.75e-01 0.047400 -3.80e-02 -2.83e-02 7.58e-01 8.19e-01
GOBP PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS 44 8.66e-01 9.44e-01 0.047400 4.60e-02 1.14e-02 5.98e-01 8.96e-01
GOBP REGULATION OF ESTABLISHMENT OF PLANAR POLARITY 14 9.53e-01 9.82e-01 0.047300 4.72e-02 -4.17e-03 7.60e-01 9.78e-01
GOBP REGULATION OF CELLULAR RESPIRATION 45 8.52e-01 9.39e-01 0.047300 4.22e-02 -2.13e-02 6.24e-01 8.04e-01
GOMF PROTEIN TYROSINE SERINE THREONINE PHOSPHATASE ACTIVITY 25 9.24e-01 9.71e-01 0.047200 -4.12e-02 -2.30e-02 7.21e-01 8.42e-01
GOCC ENDOPEPTIDASE COMPLEX 85 7.66e-01 9.01e-01 0.047200 -2.25e-02 -4.15e-02 7.20e-01 5.09e-01
GOBP NEGATIVE REGULATION OF REPRODUCTIVE PROCESS 71 7.75e-01 9.06e-01 0.047200 -3.52e-02 3.14e-02 6.08e-01 6.47e-01
GOBP CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS 14 9.54e-01 9.82e-01 0.047100 -3.72e-03 4.70e-02 9.81e-01 7.61e-01
GOCC FICOLIN 1 RICH GRANULE LUMEN 121 6.52e-01 8.46e-01 0.047100 2.25e-02 -4.14e-02 6.69e-01 4.31e-01
GOBP PEPTIDYL TYROSINE MODIFICATION 257 4.54e-01 7.21e-01 0.047100 3.78e-02 2.81e-02 2.97e-01 4.38e-01
GOCC NUCLEAR INNER MEMBRANE 54 8.32e-01 9.30e-01 0.047100 4.67e-02 -6.02e-03 5.53e-01 9.39e-01
GOBP REGULATION OF CYCLASE ACTIVITY 51 8.54e-01 9.39e-01 0.047100 2.98e-02 3.64e-02 7.12e-01 6.53e-01
GOBP PROTEIN PROCESSING 230 4.62e-01 7.25e-01 0.047000 4.66e-02 -6.29e-03 2.24e-01 8.69e-01
GOBP PHOTOTRANSDUCTION VISIBLE LIGHT 17 9.41e-01 9.77e-01 0.047000 -3.25e-02 3.40e-02 8.17e-01 8.08e-01
GOBP REGULATION OF VESICLE MEDIATED TRANSPORT 490 2.28e-01 5.26e-01 0.046900 3.69e-02 2.90e-02 1.62e-01 2.71e-01
GOBP NEGATIVE REGULATION OF PROTEIN BINDING 68 8.06e-01 9.20e-01 0.046900 4.46e-02 1.44e-02 5.24e-01 8.38e-01
GOBP RETINAL GANGLION CELL AXON GUIDANCE 22 9.34e-01 9.75e-01 0.046800 4.20e-02 2.08e-02 7.33e-01 8.66e-01
GOBP ORGANIC ACID METABOLIC PROCESS 901 7.09e-02 2.79e-01 0.046800 3.60e-02 2.99e-02 6.66e-02 1.28e-01
Protein-protein interactions at synapses 78 7.64e-01 9.00e-01 0.046700 -1.79e-02 4.31e-02 7.85e-01 5.10e-01
GOBP BEHAVIORAL RESPONSE TO COCAINE 16 9.47e-01 9.80e-01 0.046700 8.88e-03 -4.58e-02 9.51e-01 7.51e-01
GOMF PEPTIDE RECEPTOR ACTIVITY 120 6.80e-01 8.61e-01 0.046700 5.34e-03 4.63e-02 9.19e-01 3.81e-01
GOBP WOUND HEALING 416 2.82e-01 5.79e-01 0.046600 4.25e-02 1.91e-02 1.37e-01 5.05e-01
GOBP NEGATIVE REGULATION OF CELL ACTIVATION 210 5.03e-01 7.55e-01 0.046500 3.39e-03 -4.64e-02 9.33e-01 2.46e-01
GOBP REGULATION OF MEMBRANE LIPID METABOLIC PROCESS 20 9.37e-01 9.76e-01 0.046500 4.65e-02 -8.26e-04 7.19e-01 9.95e-01
GOBP VITAMIN D3 METABOLIC PROCESS 7 9.79e-01 9.92e-01 0.046500 3.98e-02 2.39e-02 8.55e-01 9.13e-01
GOBP ACTIVATION OF JANUS KINASE ACTIVITY 13 9.59e-01 9.85e-01 0.046300 2.82e-03 4.62e-02 9.86e-01 7.73e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS II 28 9.17e-01 9.68e-01 0.046300 4.47e-02 1.20e-02 6.82e-01 9.12e-01
Abacavir ADME 8 9.73e-01 9.90e-01 0.046300 4.18e-02 -2.00e-02 8.38e-01 9.22e-01
GOMF PEPTIDASE ACTIVITY 557 1.65e-01 4.49e-01 0.046300 -8.92e-03 4.54e-02 7.19e-01 6.70e-02
MAPK targets/ Nuclear events mediated by MAP kinases 29 9.13e-01 9.67e-01 0.046100 4.59e-02 4.55e-03 6.69e-01 9.66e-01
GOBP NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS 171 5.71e-01 7.98e-01 0.046000 -1.10e-02 4.47e-02 8.04e-01 3.13e-01
GOMF UDP GLYCOSYLTRANSFERASE ACTIVITY 141 6.58e-01 8.50e-01 0.046000 3.97e-02 2.33e-02 4.16e-01 6.32e-01
GOBP REGULATION OF I KAPPAB PHOSPHORYLATION 8 9.75e-01 9.91e-01 0.045900 4.56e-02 5.92e-03 8.23e-01 9.77e-01
GOBP NEGATIVE REGULATION OF PEPTIDASE ACTIVITY 118 7.07e-01 8.73e-01 0.045900 -2.82e-02 -3.62e-02 5.96e-01 4.97e-01
GOBP SYNAPTIC VESICLE LOCALIZATION 55 8.33e-01 9.30e-01 0.045700 2.08e-02 -4.07e-02 7.90e-01 6.01e-01
GOBP REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS 50 8.60e-01 9.42e-01 0.045700 4.42e-02 1.16e-02 5.89e-01 8.87e-01
GOBP ATP TRANSPORT 19 9.39e-01 9.77e-01 0.045700 -1.98e-02 4.12e-02 8.81e-01 7.56e-01
GOBP REGULATION OF T HELPER 1 CELL DIFFERENTIATION 11 9.67e-01 9.88e-01 0.045700 1.03e-02 4.45e-02 9.53e-01 7.98e-01
GOBP REGULATION OF PROTEIN IMPORT INTO NUCLEUS 57 8.26e-01 9.28e-01 0.045700 3.74e-02 -2.62e-02 6.25e-01 7.33e-01
GOBP EPIDERMIS DEVELOPMENT 376 2.90e-01 5.87e-01 0.045500 -3.54e-02 2.85e-02 2.38e-01 3.42e-01
Epithelial-Mesenchymal Transition (EMT) during gastrulation 7 9.80e-01 9.92e-01 0.045500 3.74e-02 2.58e-02 8.64e-01 9.06e-01
GOBP RESPONSE TO OXYGEN RADICAL 26 9.19e-01 9.69e-01 0.045400 4.27e-02 -1.55e-02 7.06e-01 8.91e-01
Cell surface interactions at the vascular wall 129 6.61e-01 8.51e-01 0.045400 1.15e-02 -4.39e-02 8.21e-01 3.89e-01
GOBP REGULATION OF CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 107 7.20e-01 8.79e-01 0.045400 4.54e-02 1.91e-03 4.17e-01 9.73e-01
GOBP REGULATION OF METANEPHROS DEVELOPMENT 5 9.85e-01 9.94e-01 0.045300 -4.53e-02 9.40e-04 8.61e-01 9.97e-01
GOBP URATE METABOLIC PROCESS 12 9.62e-01 9.86e-01 0.045300 -1.13e-02 4.39e-02 9.46e-01 7.92e-01
GOBP RESPONSE TO STEROL 35 9.00e-01 9.61e-01 0.045300 9.10e-03 4.44e-02 9.26e-01 6.50e-01
GOBP REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE 33 8.98e-01 9.60e-01 0.045300 1.89e-02 -4.12e-02 8.51e-01 6.82e-01
Neutrophil degranulation 458 2.50e-01 5.47e-01 0.045100 -4.51e-02 2.20e-03 9.83e-02 9.36e-01
GOBP CERAMIDE TRANSPORT 17 9.48e-01 9.80e-01 0.045100 1.05e-02 -4.39e-02 9.40e-01 7.54e-01
GOBP HIPPOCAMPAL NEURON APOPTOTIC PROCESS 6 9.81e-01 9.92e-01 0.045100 -2.02e-02 4.04e-02 9.32e-01 8.64e-01
GOBP B CELL ACTIVATION 261 4.45e-01 7.17e-01 0.045100 7.18e-03 -4.45e-02 8.42e-01 2.15e-01
GOCC CEREBELLAR MOSSY FIBER 7 9.80e-01 9.92e-01 0.045000 1.62e-02 4.20e-02 9.41e-01 8.47e-01
Golgi-to-ER retrograde transport 132 6.81e-01 8.62e-01 0.045000 4.31e-02 1.29e-02 3.93e-01 7.97e-01
GOBP ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS 44 8.79e-01 9.50e-01 0.044900 -1.03e-02 -4.37e-02 9.06e-01 6.16e-01
GOMF LIGASE ACTIVITY FORMING CARBON NITROGEN BONDS 49 8.65e-01 9.44e-01 0.044900 4.42e-02 7.80e-03 5.92e-01 9.25e-01
GOBP ENDOTHELIAL CELL DEVELOPMENT 65 8.33e-01 9.30e-01 0.044900 2.89e-02 3.43e-02 6.87e-01 6.32e-01
GOMF POTASSIUM CHANNEL REGULATOR ACTIVITY 46 8.75e-01 9.48e-01 0.044800 4.34e-02 1.10e-02 6.10e-01 8.97e-01
Lysine catabolism 12 9.67e-01 9.88e-01 0.044800 -2.50e-02 -3.72e-02 8.81e-01 8.24e-01
GOBP ISOPRENOID TRANSPORT 5 9.86e-01 9.95e-01 0.044800 -2.50e-02 -3.71e-02 9.23e-01 8.86e-01
GOBP EPITHELIAL CELL DIFFERENTIATION 724 1.23e-01 3.82e-01 0.044700 4.47e-02 2.48e-03 4.07e-02 9.09e-01
GOBP FOLIC ACID METABOLIC PROCESS 14 9.60e-01 9.85e-01 0.044700 -1.07e-02 -4.34e-02 9.45e-01 7.79e-01
GOBP POSITIVE REGULATION OF FAT CELL DIFFERENTIATION 67 8.23e-01 9.27e-01 0.044700 -9.12e-03 -4.37e-02 8.97e-01 5.36e-01
GOBP INTESTINAL EPITHELIAL CELL DEVELOPMENT 17 9.53e-01 9.82e-01 0.044700 -3.92e-02 -2.13e-02 7.79e-01 8.79e-01
PKR-mediated signaling 70 8.01e-01 9.18e-01 0.044600 4.05e-02 -1.88e-02 5.58e-01 7.86e-01
GOBP LIPOSACCHARIDE METABOLIC PROCESS 111 7.01e-01 8.70e-01 0.044600 2.82e-02 -3.45e-02 6.08e-01 5.30e-01
GOBP CALMODULIN DEPENDENT KINASE SIGNALING PATHWAY 12 9.62e-01 9.86e-01 0.044600 -3.63e-02 2.59e-02 8.28e-01 8.76e-01
GOBP POSITIVE REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE 20 9.46e-01 9.80e-01 0.044600 2.75e-02 3.51e-02 8.31e-01 7.86e-01
GOBP MYELOID LEUKOCYTE MIGRATION 228 5.30e-01 7.71e-01 0.044500 1.97e-02 3.99e-02 6.09e-01 2.99e-01
GOBP OLIGOSACCHARIDE METABOLIC PROCESS 62 8.31e-01 9.30e-01 0.044500 -1.23e-03 4.45e-02 9.87e-01 5.45e-01
GOCC FEMALE GERM CELL NUCLEUS 17 9.50e-01 9.81e-01 0.044400 5.52e-03 -4.41e-02 9.69e-01 7.53e-01
GOBP RESPONSE TO ISOQUINOLINE ALKALOID 13 9.60e-01 9.85e-01 0.044400 -4.06e-02 1.79e-02 8.00e-01 9.11e-01
GOBP REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 96 7.59e-01 8.97e-01 0.044300 4.35e-02 8.63e-03 4.62e-01 8.84e-01
GOBP NEGATIVE REGULATION OF LIPOPROTEIN METABOLIC PROCESS 5 9.85e-01 9.94e-01 0.044300 1.29e-02 -4.24e-02 9.60e-01 8.70e-01
GOBP POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 33 9.01e-01 9.61e-01 0.044300 -3.46e-02 2.77e-02 7.31e-01 7.83e-01
GOBP ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 6 9.83e-01 9.94e-01 0.044200 -3.97e-02 -1.95e-02 8.66e-01 9.34e-01
GOMF PROTEIN BINDING INVOLVED IN HETEROTYPIC CELL CELL ADHESION 12 9.63e-01 9.86e-01 0.044200 -2.73e-02 3.48e-02 8.70e-01 8.35e-01
GOBP REGULATION OF ACTIVATION OF JANUS KINASE ACTIVITY 8 9.76e-01 9.91e-01 0.044200 -4.39e-02 5.15e-03 8.30e-01 9.80e-01
GOBP NEUTRAL LIPID BIOSYNTHETIC PROCESS 49 8.70e-01 9.47e-01 0.044200 1.14e-02 4.27e-02 8.90e-01 6.05e-01
GOBP REGULATION OF RESPONSE TO BIOTIC STIMULUS 515 2.08e-01 5.03e-01 0.044100 2.16e-02 -3.85e-02 4.02e-01 1.35e-01
GOBP REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION 125 6.77e-01 8.60e-01 0.044100 3.64e-02 -2.49e-02 4.82e-01 6.31e-01
GOBP MONOCARBOXYLIC ACID METABOLIC PROCESS 616 1.87e-01 4.78e-01 0.044100 4.16e-02 1.48e-02 7.82e-02 5.31e-01
GOMF UBIQUINONE BINDING 5 9.86e-01 9.95e-01 0.044100 -2.07e-02 -3.89e-02 9.36e-01 8.80e-01
GOBP POSITIVE REGULATION OF CYTOKINE PRODUCTION 485 2.66e-01 5.62e-01 0.043900 -4.21e-02 -1.24e-02 1.12e-01 6.40e-01
Prostacyclin signalling through prostacyclin receptor 19 9.47e-01 9.80e-01 0.043900 -4.37e-02 -4.08e-03 7.42e-01 9.75e-01
GOBP CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC 111 7.28e-01 8.83e-01 0.043800 3.15e-03 4.37e-02 9.54e-01 4.26e-01
GOBP SECONDARY METABOLITE BIOSYNTHETIC PROCESS 24 9.31e-01 9.74e-01 0.043800 -4.30e-02 7.92e-03 7.15e-01 9.46e-01
GOMF THIAMINE PYROPHOSPHATE BINDING 7 9.79e-01 9.92e-01 0.043700 -2.05e-02 3.86e-02 9.25e-01 8.59e-01
GOCC MICROTUBULE ASSOCIATED COMPLEX 149 6.73e-01 8.57e-01 0.043700 3.46e-02 2.68e-02 4.66e-01 5.73e-01
GOCC PROTON TRANSPORTING V TYPE ATPASE V1 DOMAIN 12 9.67e-01 9.88e-01 0.043600 1.15e-02 4.21e-02 9.45e-01 8.01e-01
GOMF MANGANESE ION TRANSMEMBRANE TRANSPORTER ACTIVITY 9 9.76e-01 9.91e-01 0.043600 4.10e-02 1.48e-02 8.31e-01 9.39e-01
ROS and RNS production in phagocytes 33 9.11e-01 9.67e-01 0.043500 -4.37e-03 -4.33e-02 9.65e-01 6.67e-01
GOBP POSTSYNAPSE TO NUCLEUS SIGNALING PATHWAY 6 9.82e-01 9.93e-01 0.043500 3.81e-02 -2.10e-02 8.71e-01 9.29e-01
GOBP MULTI MULTICELLULAR ORGANISM PROCESS 199 5.46e-01 7.82e-01 0.043500 2.86e-02 -3.28e-02 4.87e-01 4.25e-01
GOBP NEUROMUSCULAR PROCESS CONTROLLING POSTURE 18 9.52e-01 9.82e-01 0.043500 -4.18e-02 -1.19e-02 7.59e-01 9.31e-01
GOCC GABA ERGIC SYNAPSE 73 8.22e-01 9.27e-01 0.043400 4.03e-02 1.59e-02 5.51e-01 8.14e-01
Biotin transport and metabolism 10 9.73e-01 9.90e-01 0.043300 4.19e-02 1.10e-02 8.18e-01 9.52e-01
GOCC BASAL PART OF CELL 300 4.58e-01 7.23e-01 0.043300 2.41e-02 3.60e-02 4.73e-01 2.83e-01
Neurexins and neuroligins 52 8.57e-01 9.41e-01 0.043300 -4.02e-02 1.60e-02 6.16e-01 8.42e-01
GOBP REGULATION OF NEUTROPHIL DEGRANULATION 8 9.79e-01 9.92e-01 0.043300 3.28e-02 2.83e-02 8.73e-01 8.90e-01
GOBP NEGATIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS 16 9.55e-01 9.83e-01 0.043200 5.35e-03 -4.29e-02 9.70e-01 7.66e-01
GOBP ACTIVATION OF INNATE IMMUNE RESPONSE 291 4.20e-01 6.99e-01 0.043200 2.82e-02 -3.28e-02 4.08e-01 3.36e-01
GOBP ACTIVATION OF ADENYLATE CYCLASE ACTIVITY 23 9.40e-01 9.77e-01 0.043200 -4.05e-02 -1.51e-02 7.37e-01 9.00e-01
GOBP INTESTINAL EPITHELIAL CELL DIFFERENTIATION 27 9.31e-01 9.74e-01 0.043200 -1.84e-02 -3.91e-02 8.69e-01 7.25e-01
GOBP PROTEIN N LINKED GLYCOSYLATION 70 8.34e-01 9.30e-01 0.043100 -2.74e-02 -3.33e-02 6.92e-01 6.30e-01
GOMF ALPHA CATENIN BINDING 10 9.74e-01 9.90e-01 0.043000 -4.11e-02 -1.27e-02 8.22e-01 9.45e-01
GOBP CELLULAR RESPONSE TO TOXIC SUBSTANCE 129 7.17e-01 8.78e-01 0.043000 2.58e-02 3.44e-02 6.12e-01 5.00e-01
GOBP PHOSPHATE ION TRANSPORT 27 9.31e-01 9.74e-01 0.043000 -1.69e-02 -3.96e-02 8.80e-01 7.22e-01
GOBP NEGATIVE REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 8 9.77e-01 9.91e-01 0.042900 2.28e-02 -3.64e-02 9.11e-01 8.59e-01
GOBP RESPONSE TO ACETYLCHOLINE 46 8.88e-01 9.55e-01 0.042800 -3.47e-02 -2.51e-02 6.84e-01 7.68e-01
GOBP MALE MEIOSIS I 28 9.30e-01 9.74e-01 0.042800 -2.19e-02 -3.68e-02 8.41e-01 7.36e-01
GOBP MYELOID LEUKOCYTE DIFFERENTIATION 231 5.31e-01 7.72e-01 0.042800 4.28e-02 -6.29e-04 2.63e-01 9.87e-01
GOCC PLASMA MEMBRANE PROTEIN COMPLEX 579 1.97e-01 4.90e-01 0.042800 -1.41e-02 4.04e-02 5.63e-01 9.68e-02
GOBP SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING 37 9.08e-01 9.65e-01 0.042700 -1.60e-02 -3.95e-02 8.66e-01 6.77e-01
GOBP NEURON CELLULAR HOMEOSTASIS 60 8.47e-01 9.36e-01 0.042600 -4.41e-03 4.24e-02 9.53e-01 5.70e-01
GOMF MAP KINASE PHOSPHATASE ACTIVITY 15 9.59e-01 9.85e-01 0.042600 -4.17e-02 8.71e-03 7.80e-01 9.53e-01
GOBP MODIFIED AMINO ACID TRANSPORT 40 9.04e-01 9.63e-01 0.042400 -2.56e-02 -3.38e-02 7.80e-01 7.11e-01
GOCC EXCITATORY SYNAPSE 58 8.45e-01 9.36e-01 0.042400 3.25e-02 -2.72e-02 6.69e-01 7.20e-01
GOBP POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 621 1.83e-01 4.73e-01 0.042400 1.18e-02 -4.07e-02 6.16e-01 8.33e-02
GOBP LYMPHOCYTE DIFFERENTIATION 418 3.07e-01 6.00e-01 0.042400 3.59e-02 -2.25e-02 2.08e-01 4.31e-01
GOBP POSITIVE REGULATION OF LIPID LOCALIZATION 111 7.26e-01 8.82e-01 0.042300 2.84e-02 -3.13e-02 6.05e-01 5.68e-01
GOBP XENOBIOTIC CATABOLIC PROCESS 24 9.36e-01 9.76e-01 0.042300 -4.15e-02 8.10e-03 7.25e-01 9.45e-01
G alpha (z) signalling events 48 8.75e-01 9.48e-01 0.042300 1.02e-02 -4.11e-02 9.03e-01 6.23e-01
Uptake and function of anthrax toxins 11 9.72e-01 9.90e-01 0.042300 4.05e-02 1.22e-02 8.16e-01 9.44e-01
GOBP NEGATIVE REGULATION OF IMMUNE RESPONSE 192 6.13e-01 8.24e-01 0.042200 -4.01e-02 -1.33e-02 3.38e-01 7.51e-01
GOBP NEGATIVE REGULATION OF CATALYTIC ACTIVITY 420 3.06e-01 5.99e-01 0.042200 3.40e-02 -2.50e-02 2.32e-01 3.80e-01
GOBP NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION 11 9.71e-01 9.90e-01 0.042200 3.26e-03 4.21e-02 9.85e-01 8.09e-01
GOBP OLIGOSACCHARIDE CATABOLIC PROCESS 15 9.63e-01 9.86e-01 0.042200 3.55e-02 2.27e-02 8.12e-01 8.79e-01
GOBP LEUKOCYTE PROLIFERATION 335 4.40e-01 7.13e-01 0.042100 -3.42e-02 -2.46e-02 2.82e-01 4.39e-01
GOBP NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS 110 7.31e-01 8.84e-01 0.042000 2.77e-02 -3.17e-02 6.16e-01 5.66e-01
GOMF ACTIVE MONOATOMIC ION TRANSMEMBRANE TRANSPORTER ACTIVITY 265 4.97e-01 7.52e-01 0.041900 -1.67e-03 4.19e-02 9.63e-01 2.40e-01
GOBP REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS 53 8.76e-01 9.49e-01 0.041800 3.83e-02 1.68e-02 6.29e-01 8.33e-01
GOMF FLIPPASE ACTIVITY 15 9.62e-01 9.86e-01 0.041800 4.14e-02 5.57e-03 7.81e-01 9.70e-01
GOBP REGULATION OF GRANULOCYTE CHEMOTAXIS 49 8.81e-01 9.51e-01 0.041700 4.15e-02 4.18e-03 6.15e-01 9.60e-01
GOBP POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS 17 9.56e-01 9.84e-01 0.041500 -3.93e-03 4.14e-02 9.78e-01 7.68e-01
Synthesis, secretion, and deacylation of Ghrelin 19 9.52e-01 9.82e-01 0.041500 -1.88e-03 -4.14e-02 9.89e-01 7.55e-01
GOBP CARBOHYDRATE DERIVATIVE METABOLIC PROCESS 1051 9.05e-02 3.22e-01 0.041400 2.81e-02 3.05e-02 1.24e-01 9.46e-02
GOBP NEUTROPHIL MEDIATED IMMUNITY 37 9.07e-01 9.64e-01 0.041400 -4.09e-02 6.08e-03 6.67e-01 9.49e-01
Diseases associated with N-glycosylation of proteins 19 9.56e-01 9.83e-01 0.041200 3.48e-02 2.21e-02 7.93e-01 8.68e-01
GOMF PROTEIN TYROSINE PHOSPHATASE ACTIVITY 97 7.84e-01 9.11e-01 0.041100 4.10e-02 3.13e-03 4.85e-01 9.58e-01
GOMF CYCLASE ACTIVATOR ACTIVITY 11 9.73e-01 9.90e-01 0.041100 -7.61e-03 -4.04e-02 9.65e-01 8.17e-01
GOBP NEGATIVE REGULATION OF LIPID METABOLIC PROCESS 108 7.62e-01 8.99e-01 0.041100 -2.20e-03 -4.10e-02 9.69e-01 4.62e-01
GOCC SUPRAMOLECULAR COMPLEX 1357 4.60e-02 2.14e-01 0.041100 3.84e-02 1.45e-02 1.76e-02 3.69e-01
GOCC FILOPODIUM TIP 18 9.53e-01 9.82e-01 0.041000 3.55e-02 -2.06e-02 7.95e-01 8.80e-01
GOBP MYELOID DENDRITIC CELL DIFFERENTIATION 20 9.48e-01 9.80e-01 0.041000 1.94e-02 -3.61e-02 8.81e-01 7.80e-01
GOBP CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS 10 9.76e-01 9.91e-01 0.041000 -3.97e-02 -1.02e-02 8.28e-01 9.56e-01
GOBP PYRIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS 28 9.29e-01 9.74e-01 0.040900 -1.24e-02 3.90e-02 9.10e-01 7.21e-01
GOMF PHOSPHATIDYLINOSITOL 3 KINASE REGULATOR ACTIVITY 11 9.73e-01 9.90e-01 0.040800 3.80e-03 4.07e-02 9.83e-01 8.15e-01
GOBP PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 20 9.54e-01 9.83e-01 0.040800 -3.53e-02 -2.03e-02 7.85e-01 8.75e-01
GOBP PROSTANOID BIOSYNTHETIC PROCESS 30 9.32e-01 9.75e-01 0.040700 3.50e-02 2.08e-02 7.40e-01 8.43e-01
Fatty acid metabolism 169 6.49e-01 8.45e-01 0.040700 3.96e-02 -9.31e-03 3.74e-01 8.35e-01
GOMF MAP KINASE KINASE ACTIVITY 15 9.66e-01 9.87e-01 0.040700 2.93e-02 2.82e-02 8.44e-01 8.50e-01
GOBP PROTEIN K29 LINKED UBIQUITINATION 11 9.73e-01 9.90e-01 0.040500 -4.04e-02 -2.68e-03 8.16e-01 9.88e-01
GOBP SKELETAL MUSCLE SATELLITE CELL DIFFERENTIATION 13 9.70e-01 9.89e-01 0.040500 -1.49e-02 -3.76e-02 9.26e-01 8.14e-01
GOBP L AMINO ACID BIOSYNTHETIC PROCESS 56 8.75e-01 9.49e-01 0.040500 -1.01e-02 -3.92e-02 8.96e-01 6.12e-01
GOMF CROSSOVER JUNCTION DNA ENDONUCLEASE ACTIVITY 7 9.82e-01 9.93e-01 0.040400 3.45e-02 -2.11e-02 8.74e-01 9.23e-01
GOBP MITOCHONDRION DISTRIBUTION 17 9.60e-01 9.85e-01 0.040400 -3.95e-02 -8.24e-03 7.78e-01 9.53e-01
GOBP PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION 305 4.99e-01 7.53e-01 0.040400 3.61e-02 1.81e-02 2.78e-01 5.87e-01
GOBP REGULATION OF CARDIAC MUSCLE CONTRACTION 73 8.47e-01 9.36e-01 0.040300 -2.41e-02 -3.23e-02 7.22e-01 6.33e-01
GOBP REGULATION OF RESPONSE TO TUMOR CELL 24 9.46e-01 9.80e-01 0.040200 -1.50e-02 -3.73e-02 8.99e-01 7.52e-01
GOBP POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION 29 9.33e-01 9.75e-01 0.040200 -4.92e-03 -3.99e-02 9.63e-01 7.10e-01
GOBP PROTEIN AUTOPROCESSING 27 9.35e-01 9.75e-01 0.040100 -5.73e-03 3.97e-02 9.59e-01 7.21e-01
GOBP LIPID CATABOLIC PROCESS 342 4.69e-01 7.30e-01 0.040100 2.53e-02 3.11e-02 4.21e-01 3.24e-01
GOBP LEUKOCYTE MIGRATION 382 4.25e-01 7.03e-01 0.040000 3.64e-02 1.66e-02 2.22e-01 5.76e-01
GOBP DEFENSE RESPONSE 1762 2.47e-02 1.48e-01 0.040000 -3.69e-02 -1.54e-02 1.02e-02 2.82e-01
GOBP POLYOL BIOSYNTHETIC PROCESS 59 8.69e-01 9.46e-01 0.039900 2.09e-03 3.98e-02 9.78e-01 5.97e-01
GOBP NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS 25 9.44e-01 9.79e-01 0.039900 3.84e-02 1.09e-02 7.40e-01 9.25e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO WOUNDING 97 8.03e-01 9.19e-01 0.039800 3.67e-02 1.55e-02 5.32e-01 7.91e-01
GOCC SECRETORY GRANULE 865 1.31e-01 3.96e-01 0.039800 -3.93e-02 6.26e-03 4.97e-02 7.54e-01
GOBP NEUROINFLAMMATORY RESPONSE 84 8.10e-01 9.22e-01 0.039800 3.55e-02 -1.80e-02 5.74e-01 7.76e-01
Factors involved in megakaryocyte development and platelet production 148 7.03e-01 8.71e-01 0.039700 -3.96e-02 2.48e-03 4.05e-01 9.59e-01
GOBP ENDOSOME TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY 40 9.16e-01 9.68e-01 0.039700 2.40e-02 3.16e-02 7.92e-01 7.30e-01
GOMF TRANSLATION REGULATOR ACTIVITY 380 4.39e-01 7.12e-01 0.039700 2.35e-02 3.20e-02 4.32e-01 2.84e-01
GOBP GONADOTROPIN SECRETION 18 9.55e-01 9.83e-01 0.039600 2.63e-02 -2.96e-02 8.47e-01 8.28e-01
Response to elevated platelet cytosolic Ca2+ 122 7.51e-01 8.92e-01 0.039600 -4.78e-04 -3.96e-02 9.93e-01 4.50e-01
GOBP NEURON PROJECTION ARBORIZATION 32 9.32e-01 9.74e-01 0.039400 3.63e-02 1.54e-02 7.22e-01 8.80e-01
GOMF CYTOKINE BINDING 134 7.46e-01 8.91e-01 0.039400 1.80e-02 3.50e-02 7.19e-01 4.84e-01
GOBP VISUAL BEHAVIOR 56 8.86e-01 9.55e-01 0.039300 2.92e-02 2.63e-02 7.05e-01 7.34e-01
GOMF PHOSPHOLIPASE ACTIVITY 107 7.94e-01 9.16e-01 0.039300 -3.20e-02 -2.28e-02 5.68e-01 6.83e-01
GOBP REGULATION OF LEUKOCYTE MIGRATION 220 6.19e-01 8.27e-01 0.039200 3.63e-02 1.48e-02 3.53e-01 7.06e-01
GOCC H4 H2A HISTONE ACETYLTRANSFERASE COMPLEX 26 9.45e-01 9.80e-01 0.039100 -1.76e-02 -3.50e-02 8.76e-01 7.58e-01
GOBP POSITIVE REGULATION OF MEIOTIC CELL CYCLE 28 9.34e-01 9.75e-01 0.039100 -1.92e-02 3.41e-02 8.61e-01 7.55e-01
Immune System 1913 1.95e-02 1.24e-01 0.039100 -5.35e-03 -3.87e-02 6.99e-01 5.10e-03
Metabolism of water-soluble vitamins and cofactors 125 7.70e-01 9.03e-01 0.038800 2.77e-02 2.72e-02 5.93e-01 5.99e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION 27 9.40e-01 9.77e-01 0.038800 -3.88e-02 1.37e-03 7.27e-01 9.90e-01
GOBP REGULATION OF SKELETAL MUSCLE CONTRACTION BY CALCIUM ION SIGNALING 7 9.85e-01 9.94e-01 0.038800 -2.01e-02 -3.32e-02 9.26e-01 8.79e-01
GOBP HORMONE METABOLIC PROCESS 231 5.74e-01 7.99e-01 0.038800 3.09e-02 -2.35e-02 4.19e-01 5.39e-01
GOBP CALCIUM ION TRANSMEMBRANE TRANSPORT 329 5.03e-01 7.55e-01 0.038700 3.38e-02 1.90e-02 2.92e-01 5.54e-01
GOBP CAVEOLA ASSEMBLY 6 9.86e-01 9.95e-01 0.038700 -1.33e-02 3.64e-02 9.55e-01 8.77e-01
GOBP EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION 13 9.71e-01 9.89e-01 0.038700 -3.86e-02 2.82e-03 8.10e-01 9.86e-01
GOBP POSITIVE REGULATION OF CHEMOTAXIS 137 7.25e-01 8.82e-01 0.038700 1.33e-02 -3.63e-02 7.87e-01 4.63e-01
GOBP PROTON TRANSMEMBRANE TRANSPORT 143 7.31e-01 8.84e-01 0.038700 -6.31e-03 -3.82e-02 8.96e-01 4.31e-01
GOBP T HELPER 1 TYPE IMMUNE RESPONSE 48 9.00e-01 9.61e-01 0.038600 5.53e-03 3.82e-02 9.47e-01 6.47e-01
GOBP NEURON RECOGNITION 46 8.97e-01 9.59e-01 0.038600 -1.39e-02 3.60e-02 8.70e-01 6.72e-01
Basigin interactions 24 9.48e-01 9.81e-01 0.038600 -4.54e-03 -3.83e-02 9.69e-01 7.45e-01
GOBP MRNA PSEUDOURIDINE SYNTHESIS 8 9.83e-01 9.93e-01 0.038600 -3.76e-02 -8.61e-03 8.54e-01 9.66e-01
GOBP REGULATION OF TRIGLYCERIDE METABOLIC PROCESS 44 9.05e-01 9.63e-01 0.038500 -4.74e-03 3.82e-02 9.57e-01 6.61e-01
GOBP POSITIVE REGULATION OF PROTEIN SECRETION 145 7.34e-01 8.85e-01 0.038400 3.72e-02 9.75e-03 4.40e-01 8.39e-01
Detoxification of Reactive Oxygen Species 33 9.26e-01 9.72e-01 0.038400 -1.69e-02 3.45e-02 8.67e-01 7.32e-01
GOBP PROTEIN ACTIVATION CASCADE 18 9.59e-01 9.85e-01 0.038300 3.65e-02 -1.17e-02 7.89e-01 9.31e-01
GOCC LYSOSOMAL LUMEN 91 8.30e-01 9.30e-01 0.038300 2.34e-02 3.03e-02 6.99e-01 6.17e-01
GOBP UDP GLUCOSE METABOLIC PROCESS 6 9.88e-01 9.95e-01 0.038300 3.01e-02 2.37e-02 8.99e-01 9.20e-01
GOBP NEGATIVE REGULATION OF B CELL PROLIFERATION 15 9.67e-01 9.88e-01 0.038100 -3.61e-03 3.79e-02 9.81e-01 7.99e-01
GOBP PROTEIN K11 LINKED DEUBIQUITINATION 9 9.80e-01 9.92e-01 0.038100 -9.23e-03 3.70e-02 9.62e-01 8.48e-01
G-protein activation 24 9.50e-01 9.81e-01 0.037900 -3.79e-02 -9.02e-04 7.48e-01 9.94e-01
GOBP PROTEIN TETRAMERIZATION 92 8.19e-01 9.27e-01 0.037800 3.76e-02 -3.63e-03 5.33e-01 9.52e-01
L1CAM interactions 111 7.82e-01 9.10e-01 0.037800 -3.67e-02 8.92e-03 5.04e-01 8.71e-01
GOBP RESPONSE TO AMYLOID BETA 55 8.92e-01 9.57e-01 0.037700 3.72e-02 6.36e-03 6.33e-01 9.35e-01
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT 36 9.27e-01 9.73e-01 0.037700 -3.75e-02 -3.68e-03 6.97e-01 9.69e-01
GOBP DENDRITIC CELL DIFFERENTIATION 44 9.17e-01 9.68e-01 0.037700 -2.36e-02 -2.94e-02 7.87e-01 7.36e-01
GOBP GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS 15 9.69e-01 9.89e-01 0.037600 6.81e-03 3.70e-02 9.64e-01 8.04e-01
GOBP REGULATION OF HEART CONTRACTION 201 6.75e-01 8.58e-01 0.037600 2.49e-02 2.82e-02 5.43e-01 4.91e-01
GOBP NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS 514 3.61e-01 6.49e-01 0.037600 -1.22e-02 -3.55e-02 6.36e-01 1.68e-01
GOMF PEPTIDE BINDING 243 5.80e-01 8.03e-01 0.037500 3.04e-02 -2.19e-02 4.14e-01 5.56e-01
Defective EXT1 causes exostoses 1, TRPS2 and CHDS 12 9.73e-01 9.90e-01 0.037500 -1.99e-02 3.18e-02 9.05e-01 8.49e-01
Defective EXT2 causes exostoses 2 12 9.73e-01 9.90e-01 0.037500 -1.99e-02 3.18e-02 9.05e-01 8.49e-01
GOCC CYTOPLASMIC REGION 295 5.22e-01 7.65e-01 0.037500 3.40e-02 -1.57e-02 3.15e-01 6.42e-01
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION 359 4.81e-01 7.40e-01 0.037400 4.79e-03 3.71e-02 8.76e-01 2.27e-01
GOBP GALACTOLIPID METABOLIC PROCESS 9 9.82e-01 9.93e-01 0.037400 5.01e-03 3.71e-02 9.79e-01 8.47e-01
GOBP SPONTANEOUS NEUROTRANSMITTER SECRETION 8 9.84e-01 9.94e-01 0.037400 2.87e-02 2.39e-02 8.88e-01 9.07e-01
Mitochondrial unfolded protein response (UPRmt) 18 9.65e-01 9.87e-01 0.037300 1.74e-02 3.30e-02 8.98e-01 8.08e-01
GOBP RESPONSE TO PARATHYROID HORMONE 10 9.81e-01 9.92e-01 0.037300 -3.00e-02 -2.22e-02 8.70e-01 9.03e-01
GOBP MOTILE CILIUM ASSEMBLY 70 8.55e-01 9.40e-01 0.037300 -2.60e-02 2.68e-02 7.07e-01 6.99e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN INTERACTION WITH HOST 198 6.82e-01 8.62e-01 0.037300 3.10e-02 2.08e-02 4.53e-01 6.15e-01
GOBP NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA 19 9.64e-01 9.86e-01 0.037100 -2.23e-02 -2.97e-02 8.66e-01 8.23e-01
GOBP ASPARTATE METABOLIC PROCESS 8 9.83e-01 9.94e-01 0.037100 -7.19e-04 3.71e-02 9.97e-01 8.56e-01
Plasma lipoprotein assembly, remodeling, and clearance 74 8.58e-01 9.41e-01 0.037100 3.71e-02 8.80e-04 5.81e-01 9.90e-01
GOCC T TUBULE 52 8.92e-01 9.57e-01 0.037100 -1.85e-02 3.21e-02 8.17e-01 6.89e-01
GOBP FC GAMMA RECEPTOR SIGNALING PATHWAY 31 9.42e-01 9.78e-01 0.037000 2.21e-02 2.97e-02 8.31e-01 7.75e-01
GOBP NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS 251 5.80e-01 8.03e-01 0.037000 1.82e-02 -3.22e-02 6.19e-01 3.80e-01
GOCC POSTSYNAPSE 626 3.06e-01 5.99e-01 0.037000 3.37e-02 1.53e-02 1.50e-01 5.14e-01
GOBP NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 13 9.72e-01 9.90e-01 0.037000 3.29e-02 -1.69e-02 8.37e-01 9.16e-01
GOBP ACROSOME ASSEMBLY 30 9.36e-01 9.76e-01 0.036900 -2.58e-02 2.64e-02 8.07e-01 8.02e-01
GOMF COPPER ION BINDING 58 8.91e-01 9.56e-01 0.036800 -5.02e-03 -3.65e-02 9.47e-01 6.31e-01
GOCC NEURON PROJECTION MEMBRANE 56 8.85e-01 9.54e-01 0.036700 -2.97e-02 2.16e-02 7.00e-01 7.80e-01
GOMF CHLORIDE CHANNEL ACTIVITY 74 8.53e-01 9.39e-01 0.036700 -1.87e-02 3.15e-02 7.81e-01 6.39e-01
GOBP TRANSPORT OF VIRUS 21 9.61e-01 9.86e-01 0.036600 3.25e-02 1.69e-02 7.97e-01 8.93e-01
GOBP GRANULOCYTE MIGRATION 144 7.35e-01 8.86e-01 0.036500 -2.61e-02 2.55e-02 5.89e-01 5.98e-01
GOBP NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 41 9.17e-01 9.68e-01 0.036400 1.83e-02 -3.15e-02 8.39e-01 7.27e-01
GOCC CLUSTER OF ACTIN BASED CELL PROJECTIONS 161 7.11e-01 8.75e-01 0.036400 -2.82e-02 2.29e-02 5.37e-01 6.15e-01
GOBP REGULATION OF WOUND HEALING 134 7.68e-01 9.02e-01 0.036400 1.32e-03 3.63e-02 9.79e-01 4.68e-01
GOBP NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS 19 9.62e-01 9.86e-01 0.036400 -3.59e-02 5.97e-03 7.87e-01 9.64e-01
Unblocking of NMDA receptors, glutamate binding and activation 19 9.61e-01 9.85e-01 0.036300 3.23e-02 -1.67e-02 8.08e-01 9.00e-01
GOBP INTERFERON MEDIATED SIGNALING PATHWAY 100 8.21e-01 9.27e-01 0.036300 -2.09e-03 -3.63e-02 9.71e-01 5.31e-01
GOBP REGULATION OF SYNAPTIC VESICLE RECYCLING 24 9.51e-01 9.82e-01 0.036300 3.36e-02 -1.39e-02 7.76e-01 9.06e-01
GOBP POSITIVE REGULATION OF EXOCYTOSIS 72 8.61e-01 9.42e-01 0.036300 1.40e-02 -3.35e-02 8.38e-01 6.23e-01
GOMF ORGANIC ACID BINDING 202 6.73e-01 8.57e-01 0.036200 -3.44e-04 3.62e-02 9.93e-01 3.75e-01
GOBP PROTEIN PALMITOYLATION 28 9.47e-01 9.80e-01 0.036200 4.36e-03 3.59e-02 9.68e-01 7.42e-01
GOBP CELLULAR RESPONSE TO INORGANIC SUBSTANCE 205 6.83e-01 8.62e-01 0.036200 1.24e-02 3.40e-02 7.60e-01 4.02e-01
GOBP REGULATION OF ATRIAL CARDIAC MUSCLE CELL MEMBRANE DEPOLARIZATION 10 9.81e-01 9.92e-01 0.036100 -3.51e-02 -8.63e-03 8.48e-01 9.62e-01
GOBP NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 60 8.86e-01 9.55e-01 0.036100 3.54e-02 -7.18e-03 6.35e-01 9.23e-01
GOBP ORGANIC ACID BIOSYNTHETIC PROCESS 319 5.37e-01 7.76e-01 0.036000 3.59e-02 -2.68e-03 2.70e-01 9.34e-01
GOBP REGULATORY NCRNA PROCESSING 69 8.79e-01 9.50e-01 0.036000 3.41e-02 1.17e-02 6.25e-01 8.66e-01
GOBP TRIGLYCERIDE METABOLIC PROCESS 104 8.23e-01 9.27e-01 0.036000 -3.46e-02 -1.00e-02 5.42e-01 8.60e-01
GOBP REGULATION OF OXIDATIVE PHOSPHORYLATION 21 9.60e-01 9.85e-01 0.035800 3.56e-02 -3.91e-03 7.78e-01 9.75e-01
Platelet degranulation 117 8.00e-01 9.18e-01 0.035700 9.02e-06 -3.57e-02 1.00e+00 5.05e-01
GOBP AMINE TRANSPORT 92 8.44e-01 9.36e-01 0.035600 8.20e-03 3.46e-02 8.92e-01 5.66e-01
GOBP REGULATION OF KERATINOCYTE DIFFERENTIATION 39 9.29e-01 9.74e-01 0.035600 3.54e-02 2.77e-03 7.02e-01 9.76e-01
GOBP REGULATION OF B CELL PROLIFERATION 62 8.83e-01 9.52e-01 0.035500 -1.74e-02 3.09e-02 8.13e-01 6.74e-01
GOBP TOLL SIGNALING PATHWAY 11 9.81e-01 9.92e-01 0.035500 3.05e-02 1.81e-02 8.61e-01 9.17e-01
GOBP VESICLE FUSION TO PLASMA MEMBRANE 24 9.54e-01 9.83e-01 0.035500 3.50e-02 -5.77e-03 7.67e-01 9.61e-01
GOMF SIRNA BINDING 9 9.84e-01 9.94e-01 0.035400 -3.04e-02 -1.81e-02 8.74e-01 9.25e-01
GOMF HSP70 PROTEIN BINDING 50 9.16e-01 9.68e-01 0.035300 -2.21e-02 -2.76e-02 7.87e-01 7.36e-01
GOBP REGULATION OF ATP DEPENDENT ACTIVITY 60 8.89e-01 9.56e-01 0.035300 1.02e-02 -3.38e-02 8.91e-01 6.51e-01
GOBP CATECHOLAMINE TRANSPORT 63 8.92e-01 9.57e-01 0.035300 -3.42e-02 -8.88e-03 6.39e-01 9.03e-01
GOBP RESPONSE TO TUMOR NECROSIS FACTOR 232 6.45e-01 8.42e-01 0.035300 3.50e-02 -4.47e-03 3.59e-01 9.07e-01
GOBP REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY 165 7.42e-01 8.89e-01 0.035200 3.46e-02 6.38e-03 4.43e-01 8.88e-01
GOBP POSITIVE REGULATION OF ENDOCYTOSIS 147 7.50e-01 8.92e-01 0.035200 -3.23e-02 1.41e-02 4.99e-01 7.68e-01
GOBP WOUND HEALING SPREADING OF EPIDERMAL CELLS 26 9.55e-01 9.83e-01 0.034900 8.66e-03 3.38e-02 9.39e-01 7.65e-01
GOBP LEUKOCYTE DIFFERENTIATION 605 3.36e-01 6.25e-01 0.034900 3.49e-02 -2.05e-03 1.43e-01 9.31e-01
GOBP REGULATION OF FAT CELL DIFFERENTIATION 141 7.59e-01 8.97e-01 0.034900 2.22e-02 -2.69e-02 6.48e-01 5.81e-01
Protein hydroxylation 17 9.70e-01 9.89e-01 0.034900 9.13e-03 3.37e-02 9.48e-01 8.10e-01
GOBP CELLULAR RESPONSE TO ETHANOL 12 9.80e-01 9.92e-01 0.034900 2.93e-02 1.89e-02 8.60e-01 9.10e-01
GOBP CELLULAR RESPONSE TO PH 25 9.58e-01 9.85e-01 0.034900 -2.33e-02 -2.60e-02 8.40e-01 8.22e-01
Metabolic disorders of biological oxidation enzymes 33 9.45e-01 9.80e-01 0.034800 -3.03e-02 -1.71e-02 7.63e-01 8.65e-01
GOMF CALCIUM CHANNEL REGULATOR ACTIVITY 49 9.16e-01 9.68e-01 0.034800 3.47e-02 2.79e-03 6.75e-01 9.73e-01
GOBP NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 128 8.00e-01 9.18e-01 0.034800 3.35e-02 9.44e-03 5.13e-01 8.54e-01
GOBP DEOXYRIBONUCLEOTIDE METABOLIC PROCESS 42 9.26e-01 9.72e-01 0.034700 -3.46e-02 3.38e-03 6.98e-01 9.70e-01
GOBP GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS 71 8.85e-01 9.54e-01 0.034700 3.27e-02 1.16e-02 6.34e-01 8.66e-01
GOBP POSITIVE REGULATION OF ARTERY MORPHOGENESIS 6 9.90e-01 9.96e-01 0.034600 1.28e-02 3.22e-02 9.57e-01 8.91e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II 34 9.38e-01 9.76e-01 0.034500 1.48e-02 -3.11e-02 8.81e-01 7.54e-01
GOBP REGULATION OF T CELL PROLIFERATION 172 7.42e-01 8.89e-01 0.034400 -4.79e-03 -3.41e-02 9.14e-01 4.41e-01
GOBP NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE 43 9.21e-01 9.70e-01 0.034300 2.23e-02 -2.61e-02 8.00e-01 7.67e-01
Insulin processing 24 9.60e-01 9.85e-01 0.034200 7.97e-03 3.33e-02 9.46e-01 7.78e-01
GOMF DEATH RECEPTOR ACTIVITY 11 9.80e-01 9.92e-01 0.034200 2.84e-02 -1.90e-02 8.70e-01 9.13e-01
GOBP NON PROTEINOGENIC AMINO ACID METABOLIC PROCESS 71 8.81e-01 9.51e-01 0.034100 5.11e-03 -3.38e-02 9.41e-01 6.23e-01
GOBP NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 32 9.42e-01 9.78e-01 0.034000 -2.35e-02 2.47e-02 8.18e-01 8.09e-01
GOBP REGULATION OF LIPID LOCALIZATION 184 7.37e-01 8.87e-01 0.034000 9.23e-03 3.27e-02 8.29e-01 4.45e-01
GOCC AZUROPHIL GRANULE 149 7.74e-01 9.05e-01 0.033900 -3.39e-02 -6.91e-04 4.75e-01 9.88e-01
GOBP LIGAND GATED ION CHANNEL SIGNALING PATHWAY 30 9.49e-01 9.81e-01 0.033900 -1.33e-03 3.39e-02 9.90e-01 7.48e-01
GOBP REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE 12 9.79e-01 9.92e-01 0.033900 -3.28e-02 8.32e-03 8.44e-01 9.60e-01
GOBP POSITIVE REGULATION OF DENDRITE DEVELOPMENT 15 9.76e-01 9.91e-01 0.033900 2.12e-02 2.64e-02 8.87e-01 8.59e-01
GOBP INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY 7 9.88e-01 9.95e-01 0.033900 -2.80e-03 3.37e-02 9.90e-01 8.77e-01
GOBP REGULATION OF BODY FLUID LEVELS 357 5.47e-01 7.82e-01 0.033800 3.38e-02 2.99e-04 2.73e-01 9.92e-01
GOBP MEIOTIC CHROMOSOME SEGREGATION 91 8.56e-01 9.40e-01 0.033700 3.37e-02 7.21e-04 5.78e-01 9.91e-01
Sensory processing of sound by inner hair cells of the cochlea 63 9.04e-01 9.63e-01 0.033600 -1.44e-02 -3.04e-02 8.43e-01 6.77e-01
GOCC AXONEMAL OUTER DOUBLET 37 9.40e-01 9.77e-01 0.033600 -5.77e-03 -3.31e-02 9.52e-01 7.27e-01
GOMF TRANSMEMBRANE TRANSPORTER BINDING 128 7.97e-01 9.17e-01 0.033600 -1.16e-02 3.15e-02 8.21e-01 5.38e-01
GOBP CELLULAR RESPONSE TO OXYGEN RADICAL 22 9.65e-01 9.87e-01 0.033500 -9.54e-03 -3.21e-02 9.38e-01 7.94e-01
GOBP PURINE NUCLEOSIDE METABOLIC PROCESS 25 9.56e-01 9.84e-01 0.033500 3.02e-02 -1.44e-02 7.94e-01 9.01e-01
GOBP HOMOLOGOUS CHROMOSOME SEGREGATION 65 8.99e-01 9.61e-01 0.033500 6.98e-03 3.27e-02 9.22e-01 6.48e-01
GOBP PURINE CONTAINING COMPOUND METABOLIC PROCESS 532 4.20e-01 6.99e-01 0.033400 3.34e-02 1.21e-03 1.88e-01 9.62e-01
GOBP POSITIVE REGULATION OF ATP DEPENDENT ACTIVITY 38 9.42e-01 9.78e-01 0.033400 -1.91e-02 -2.74e-02 8.39e-01 7.70e-01
GOBP SEQUESTERING OF CALCIUM ION 133 7.97e-01 9.17e-01 0.033300 3.27e-02 -6.17e-03 5.15e-01 9.02e-01
GOBP REGULATION OF VESICLE FUSION 23 9.64e-01 9.86e-01 0.033200 8.23e-03 3.21e-02 9.46e-01 7.90e-01
GOBP HEART PROCESS 251 6.67e-01 8.53e-01 0.033100 2.49e-03 3.30e-02 9.46e-01 3.68e-01
GOBP MITOCHONDRIAL TRANSMEMBRANE TRANSPORT 93 8.61e-01 9.42e-01 0.033100 -5.19e-03 -3.27e-02 9.31e-01 5.86e-01
GOBP MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS 217 7.19e-01 8.79e-01 0.033100 2.75e-02 1.83e-02 4.85e-01 6.42e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE MIGRATION 143 7.93e-01 9.15e-01 0.033000 -1.48e-03 -3.30e-02 9.76e-01 4.96e-01
GOBP LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE 206 7.09e-01 8.75e-01 0.033000 5.95e-03 -3.25e-02 8.83e-01 4.22e-01
GOBP MALE MEIOTIC NUCLEAR DIVISION 54 9.12e-01 9.67e-01 0.032900 -3.02e-02 1.28e-02 7.01e-01 8.70e-01
Purine catabolism 17 9.71e-01 9.90e-01 0.032900 1.57e-02 -2.89e-02 9.11e-01 8.37e-01
GOBP MULTIVESICULAR BODY SORTING PATHWAY 47 9.31e-01 9.74e-01 0.032800 3.03e-02 1.25e-02 7.19e-01 8.82e-01
GOBP MEMBRANE BIOGENESIS 61 9.13e-01 9.67e-01 0.032700 -2.41e-02 -2.22e-02 7.45e-01 7.65e-01
GOBP NEUTROPHIL CHEMOTAXIS 81 8.70e-01 9.46e-01 0.032700 -2.03e-02 2.57e-02 7.52e-01 6.90e-01
Biosynthesis of DHA-derived SPMs 17 9.74e-01 9.91e-01 0.032500 3.14e-02 8.32e-03 8.23e-01 9.53e-01
GOBP RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 350 6.01e-01 8.16e-01 0.032400 -1.84e-02 -2.67e-02 5.54e-01 3.91e-01
GOBP TISSUE HOMEOSTASIS 254 6.74e-01 8.58e-01 0.032400 3.24e-02 1.24e-03 3.74e-01 9.73e-01
GOBP CLUSTERING OF VOLTAGE GATED SODIUM CHANNELS 6 9.91e-01 9.97e-01 0.032400 2.05e-02 2.50e-02 9.31e-01 9.15e-01
GOMF ASPARTIC TYPE PEPTIDASE ACTIVITY 26 9.63e-01 9.86e-01 0.032300 2.13e-02 2.43e-02 8.51e-01 8.30e-01
Biosynthesis of specialized proresolving mediators (SPMs) 19 9.69e-01 9.89e-01 0.032300 1.54e-02 -2.84e-02 9.07e-01 8.30e-01
GOCC PROTON TRANSPORTING V TYPE ATPASE COMPLEX 26 9.57e-01 9.84e-01 0.032300 2.48e-02 -2.07e-02 8.27e-01 8.55e-01
GOBP NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS 639 3.76e-01 6.62e-01 0.032200 3.21e-02 -1.94e-03 1.66e-01 9.33e-01
Lysosome Vesicle Biogenesis 33 9.52e-01 9.82e-01 0.032100 3.12e-02 7.41e-03 7.56e-01 9.41e-01
GOMF ISOPRENOID BINDING 45 9.35e-01 9.75e-01 0.032000 3.09e-02 8.41e-03 7.20e-01 9.22e-01
GOBP MONONUCLEAR CELL DIFFERENTIATION 507 4.56e-01 7.22e-01 0.032000 3.15e-02 -5.87e-03 2.25e-01 8.21e-01
GOBP HETEROTYPIC CELL CELL ADHESION 62 9.09e-01 9.66e-01 0.032000 3.20e-02 4.75e-04 6.63e-01 9.95e-01
GOMF CARGO RECEPTOR ACTIVITY 72 9.03e-01 9.62e-01 0.031900 -2.25e-02 -2.26e-02 7.41e-01 7.40e-01
GOBP B CELL MEDIATED IMMUNITY 130 8.33e-01 9.30e-01 0.031900 -2.24e-02 -2.26e-02 6.59e-01 6.56e-01
GOBP REGULATION OF ENDODERMAL CELL DIFFERENTIATION 7 9.89e-01 9.96e-01 0.031800 3.16e-02 -3.74e-03 8.85e-01 9.86e-01
GOBP DENDRITIC CELL MIGRATION 30 9.55e-01 9.83e-01 0.031700 3.01e-03 -3.16e-02 9.77e-01 7.65e-01
GOBP T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE 121 8.46e-01 9.36e-01 0.031500 -2.31e-02 -2.13e-02 6.60e-01 6.85e-01
GOBP POSITIVE REGULATION OF DNA REPLICATION 42 9.35e-01 9.75e-01 0.031500 2.65e-02 -1.69e-02 7.66e-01 8.50e-01
GOBP REGULATION OF FLAGELLATED SPERM MOTILITY 20 9.69e-01 9.89e-01 0.031400 2.19e-02 -2.25e-02 8.65e-01 8.61e-01
GOCC KINESIN COMPLEX 47 9.36e-01 9.76e-01 0.031300 2.93e-02 1.12e-02 7.28e-01 8.94e-01
GOBP POSITIVE REGULATION OF BLOOD PRESSURE 31 9.57e-01 9.84e-01 0.031300 -2.94e-02 -1.09e-02 7.77e-01 9.17e-01
GOCC GOLGI TRANS CISTERNA 9 9.87e-01 9.95e-01 0.031300 3.41e-03 -3.11e-02 9.86e-01 8.72e-01
GOBP CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM 396 5.58e-01 7.90e-01 0.031100 -5.19e-03 3.07e-02 8.59e-01 2.94e-01
Transport of small molecules 693 3.63e-01 6.51e-01 0.031100 -7.54e-03 3.02e-02 7.35e-01 1.76e-01
GOBP MONONUCLEAR CELL MIGRATION 216 7.36e-01 8.86e-01 0.031000 3.09e-02 2.41e-03 4.34e-01 9.51e-01
GOBP REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS 21 9.68e-01 9.88e-01 0.030900 2.38e-02 -1.97e-02 8.50e-01 8.76e-01
GOBP REGULATION OF EXOCYTOSIS 159 7.92e-01 9.15e-01 0.030800 3.00e-02 -7.21e-03 5.14e-01 8.75e-01
GOCC ESCRT COMPLEX 29 9.60e-01 9.85e-01 0.030500 -1.71e-03 3.05e-02 9.87e-01 7.76e-01
GOBP RESPONSE TO INORGANIC SUBSTANCE 492 5.10e-01 7.60e-01 0.030500 3.05e-02 8.42e-04 2.46e-01 9.74e-01
GOBP REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY 20 9.74e-01 9.91e-01 0.030500 1.61e-02 2.59e-02 9.01e-01 8.41e-01
GOBP MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY 16 9.76e-01 9.91e-01 0.030500 1.76e-02 -2.49e-02 9.03e-01 8.63e-01
GOBP CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN 226 7.27e-01 8.83e-01 0.030500 -3.03e-02 3.33e-03 4.33e-01 9.31e-01
GOBP REGULATION OF MUSCLE CONTRACTION 165 8.07e-01 9.21e-01 0.030400 1.55e-02 2.62e-02 7.31e-01 5.62e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN NAD P H AS ONE DONOR AND INCORPORATION OF ONE ATOM OF OXYGEN 38 9.45e-01 9.80e-01 0.030400 -2.42e-02 1.84e-02 7.96e-01 8.44e-01
GOBP POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT 36 9.50e-01 9.81e-01 0.030200 2.93e-02 -7.53e-03 7.61e-01 9.38e-01
Phase I - Functionalization of compounds 102 8.62e-01 9.43e-01 0.030200 2.68e-02 -1.40e-02 6.41e-01 8.07e-01
GOBP CALCIUM MEDIATED SIGNALING 220 7.38e-01 8.87e-01 0.030200 4.04e-03 -2.99e-02 9.18e-01 4.45e-01
GOMF PHOSPHATE ION BINDING 11 9.84e-01 9.94e-01 0.030100 -2.80e-02 1.08e-02 8.72e-01 9.50e-01
GOBP PHOSPHATE ION TRANSMEMBRANE TRANSPORT 14 9.80e-01 9.92e-01 0.030000 1.51e-02 -2.60e-02 9.22e-01 8.66e-01
GOBP POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION 157 8.21e-01 9.27e-01 0.030000 -2.32e-02 -1.91e-02 6.17e-01 6.79e-01
Ion channel transport 172 7.85e-01 9.12e-01 0.029800 -1.51e-02 2.56e-02 7.32e-01 5.62e-01
GOBP ISOPRENOID METABOLIC PROCESS 134 8.39e-01 9.33e-01 0.029800 2.96e-02 2.80e-03 5.54e-01 9.55e-01
GOCC SARCOPLASMIC RETICULUM 74 9.05e-01 9.63e-01 0.029500 -5.76e-03 2.90e-02 9.32e-01 6.67e-01
GOBP NEGATIVE REGULATION OF T CELL MEDIATED IMMUNE RESPONSE TO TUMOR CELL 5 9.93e-01 9.98e-01 0.029500 1.44e-02 -2.57e-02 9.56e-01 9.21e-01
G beta:gamma signalling through PLC beta 20 9.73e-01 9.90e-01 0.029300 -2.52e-02 1.50e-02 8.45e-01 9.08e-01
GOBP REGULATION OF T CELL MIGRATION 47 9.45e-01 9.80e-01 0.029300 2.40e-02 1.68e-02 7.76e-01 8.42e-01
Retinoid metabolism and transport 42 9.44e-01 9.79e-01 0.029200 -2.26e-02 1.85e-02 8.00e-01 8.35e-01
GOMF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY 27 9.66e-01 9.87e-01 0.029200 2.86e-04 -2.92e-02 9.98e-01 7.93e-01
GOBP CHEMICAL HOMEOSTASIS 1016 3.18e-01 6.10e-01 0.029100 1.87e-02 2.23e-02 3.13e-01 2.30e-01
GOBP SODIUM ION TRANSPORT 237 7.30e-01 8.84e-01 0.028800 -2.08e-02 1.99e-02 5.82e-01 5.98e-01
Intraflagellar transport 51 9.40e-01 9.77e-01 0.028800 -3.45e-03 -2.86e-02 9.66e-01 7.24e-01
GOBP SYNAPTIC VESICLE MEMBRANE ORGANIZATION 27 9.69e-01 9.89e-01 0.028800 2.52e-02 1.39e-02 8.21e-01 9.01e-01
GOBP BIOLOGICAL PROCESS INVOLVED IN SYMBIOTIC INTERACTION 297 7.01e-01 8.70e-01 0.028700 -2.83e-02 -4.97e-03 4.01e-01 8.83e-01
GOBP NEGATIVE REGULATION OF VASCULAR PERMEABILITY 18 9.79e-01 9.92e-01 0.028700 2.21e-02 1.83e-02 8.71e-01 8.93e-01
GOMF MHC CLASS I PROTEIN COMPLEX BINDING 6 9.92e-01 9.98e-01 0.028600 -5.02e-03 2.82e-02 9.83e-01 9.05e-01
GOBP NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS 120 8.60e-01 9.42e-01 0.028600 -2.82e-02 4.86e-03 5.94e-01 9.27e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON PAIRED DONORS WITH INCORPORATION OR REDUCTION OF MOLECULAR OXYGEN 171 8.05e-01 9.20e-01 0.028400 -1.06e-02 2.64e-02 8.12e-01 5.51e-01
GOBP MONOATOMIC ION TRANSMEMBRANE TRANSPORT 969 3.01e-01 5.96e-01 0.028400 -2.38e-02 1.55e-02 2.09e-01 4.15e-01
GOBP REGULATION OF ACTIN FILAMENT BASED MOVEMENT 39 9.51e-01 9.82e-01 0.028400 -1.47e-02 2.42e-02 8.74e-01 7.93e-01
Tight junction interactions 28 9.69e-01 9.89e-01 0.028200 -1.69e-02 -2.26e-02 8.77e-01 8.36e-01
GOBP MEIOTIC CELL CYCLE PROCESS 212 7.65e-01 9.01e-01 0.028100 2.06e-02 -1.90e-02 6.05e-01 6.33e-01
GOMF SIGNALING RECEPTOR BINDING 1409 2.21e-01 5.17e-01 0.028000 2.73e-02 6.24e-03 8.61e-02 6.95e-01
GOBP MAINTENANCE OF LOCATION IN CELL 220 7.73e-01 9.05e-01 0.028000 2.80e-02 -4.12e-04 4.75e-01 9.92e-01
GOBP RESPONSE TO AMMONIUM ION 6 9.93e-01 9.98e-01 0.028000 2.79e-02 2.17e-03 9.06e-01 9.93e-01
TYSND1 cleaves peroxisomal proteins 7 9.92e-01 9.98e-01 0.027900 -1.84e-02 -2.10e-02 9.33e-01 9.23e-01
GOBP TRANSFORMING GROWTH FACTOR BETA PRODUCTION 32 9.61e-01 9.85e-01 0.027900 -2.15e-02 1.77e-02 8.33e-01 8.62e-01
GOBP RESPONSE TO ARSENIC CONTAINING SUBSTANCE 30 9.66e-01 9.87e-01 0.027600 2.74e-02 -3.14e-03 7.95e-01 9.76e-01
GOBP REGULATION OF XENOBIOTIC DETOXIFICATION BY TRANSMEMBRANE EXPORT ACROSS THE PLASMA MEMBRANE 12 9.87e-01 9.95e-01 0.027500 -7.52e-03 -2.65e-02 9.64e-01 8.74e-01
GOBP NUCLEOSIDE METABOLIC PROCESS 55 9.36e-01 9.76e-01 0.027500 2.45e-02 -1.24e-02 7.53e-01 8.73e-01
GOBP MEIOTIC CELL CYCLE 279 7.16e-01 8.78e-01 0.027400 2.29e-02 -1.51e-02 5.10e-01 6.64e-01
GOBP REGULATION OF STEROID METABOLIC PROCESS 101 8.85e-01 9.54e-01 0.027400 -1.67e-02 2.18e-02 7.72e-01 7.05e-01
GOBP B CELL DIFFERENTIATION 145 8.56e-01 9.40e-01 0.027400 -9.11e-03 -2.58e-02 8.50e-01 5.91e-01
GOBP MEMBRANE LIPID BIOSYNTHETIC PROCESS 149 8.52e-01 9.39e-01 0.027400 2.61e-02 8.26e-03 5.83e-01 8.62e-01
GOBP ADENYLATE CYCLASE INHIBITING DOPAMINE RECEPTOR SIGNALING PATHWAY 5 9.94e-01 9.98e-01 0.027300 -1.52e-03 2.73e-02 9.95e-01 9.16e-01
GOBP REGULATION OF REPRODUCTIVE PROCESS 198 8.02e-01 9.18e-01 0.027300 -2.73e-02 3.70e-04 5.08e-01 9.93e-01
GOBP TRNA WOBBLE BASE MODIFICATION 20 9.78e-01 9.92e-01 0.027300 5.21e-04 -2.73e-02 9.97e-01 8.33e-01
GOMF CAMP DEPENDENT PROTEIN KINASE INHIBITOR ACTIVITY 10 9.89e-01 9.96e-01 0.027200 -2.70e-02 3.40e-03 8.82e-01 9.85e-01
GOBP GROOMING BEHAVIOR 18 9.81e-01 9.92e-01 0.027100 2.54e-02 9.61e-03 8.52e-01 9.44e-01
GOCC AUTOLYSOSOME 13 9.87e-01 9.95e-01 0.027100 2.25e-02 1.52e-02 8.88e-01 9.25e-01
GOCC POSTSYNAPTIC SPECIALIZATION 335 7.04e-01 8.72e-01 0.027000 -2.63e-02 -6.28e-03 4.08e-01 8.43e-01
GOMF RNA POLYMERASE III TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING 8 9.91e-01 9.97e-01 0.026900 2.69e-02 -9.24e-04 8.95e-01 9.96e-01
GOBP SULFUR COMPOUND TRANSPORT 62 9.31e-01 9.74e-01 0.026900 -1.09e-02 2.46e-02 8.82e-01 7.38e-01
GOBP NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 62 9.40e-01 9.77e-01 0.026800 -2.10e-02 -1.67e-02 7.75e-01 8.21e-01
GOMF PRIMARY ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 147 8.45e-01 9.36e-01 0.026700 2.16e-02 -1.57e-02 6.51e-01 7.42e-01
GOMF OXIDOREDUCTASE ACTIVITY ACTING ON A SULFUR GROUP OF DONORS 55 9.44e-01 9.79e-01 0.026700 -4.90e-03 -2.62e-02 9.50e-01 7.37e-01
GOBP IMPORT INTO THE MITOCHONDRION 49 9.52e-01 9.82e-01 0.026500 -2.51e-02 -8.60e-03 7.61e-01 9.17e-01
GOBP MEMBRANE LIPID METABOLIC PROCESS 217 8.06e-01 9.20e-01 0.026500 2.43e-02 1.06e-02 5.38e-01 7.87e-01
GOBP SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING 5 9.95e-01 9.98e-01 0.026500 -5.76e-03 2.59e-02 9.82e-01 9.20e-01
GOCC CILIUM 733 4.68e-01 7.30e-01 0.026500 2.64e-02 -2.34e-03 2.24e-01 9.14e-01
GOMF LIGAND GATED MONOATOMIC ANION CHANNEL ACTIVITY 43 9.53e-01 9.82e-01 0.026500 1.79e-02 -1.95e-02 8.39e-01 8.25e-01
GOBP NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE 34 9.63e-01 9.86e-01 0.026300 2.09e-02 -1.59e-02 8.33e-01 8.73e-01
GOBP ADENINE TRANSPORT 5 9.94e-01 9.98e-01 0.026300 -2.20e-02 1.44e-02 9.32e-01 9.56e-01
GOMF OXIDOREDUCTASE ACTIVITY 682 5.24e-01 7.66e-01 0.026200 2.41e-02 1.00e-02 2.82e-01 6.55e-01
GOBP NEGATIVE REGULATION OF HORMONE SECRETION 66 9.39e-01 9.77e-01 0.026100 2.15e-02 1.48e-02 7.63e-01 8.35e-01
GOBP AMINO ACID CATABOLIC PROCESS 98 9.13e-01 9.67e-01 0.025900 1.92e-02 1.74e-02 7.42e-01 7.66e-01
GOBP CIRCADIAN SLEEP WAKE CYCLE 22 9.77e-01 9.91e-01 0.025900 -1.14e-02 2.32e-02 9.26e-01 8.50e-01
GOBP PURINE DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS 5 9.95e-01 9.98e-01 0.025900 1.11e-02 2.34e-02 9.66e-01 9.28e-01
Biosynthesis of E-series 18(S)-resolvins 5 9.95e-01 9.98e-01 0.025800 -1.54e-02 2.08e-02 9.52e-01 9.36e-01
GOBP REGULATION OF RESPONSE TO WOUNDING 172 8.49e-01 9.37e-01 0.025800 9.23e-03 2.41e-02 8.35e-01 5.85e-01
Miscellaneous transport and binding events 24 9.75e-01 9.91e-01 0.025700 -2.47e-02 7.17e-03 8.34e-01 9.52e-01
GOBP REGULATION OF MEMBRANE POTENTIAL 445 6.29e-01 8.34e-01 0.025600 -1.76e-02 1.86e-02 5.24e-01 5.01e-01
GOMF WIDE PORE CHANNEL ACTIVITY 33 9.68e-01 9.88e-01 0.025600 2.56e-02 -4.80e-04 7.99e-01 9.96e-01
GOBP FATTY ACID BIOSYNTHETIC PROCESS 159 8.64e-01 9.43e-01 0.025600 1.21e-02 2.26e-02 7.93e-01 6.23e-01
Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation 51 9.48e-01 9.80e-01 0.025600 1.40e-02 -2.15e-02 8.63e-01 7.91e-01
GOBP EXCRETION 30 9.71e-01 9.89e-01 0.025500 1.63e-03 -2.55e-02 9.88e-01 8.09e-01
GOBP STEROID CATABOLIC PROCESS 24 9.77e-01 9.91e-01 0.025500 -3.13e-03 -2.53e-02 9.79e-01 8.30e-01
GOCC BASOLATERAL PLASMA MEMBRANE 249 7.93e-01 9.15e-01 0.025500 7.47e-03 2.44e-02 8.39e-01 5.07e-01
GOCC SECRETORY VESICLE 1032 3.66e-01 6.54e-01 0.025500 -2.45e-02 7.21e-03 1.84e-01 6.95e-01
GOBP AUDITORY RECEPTOR CELL DEVELOPMENT 26 9.74e-01 9.91e-01 0.025400 -2.50e-02 4.52e-03 8.26e-01 9.68e-01
GOBP PROGESTERONE METABOLIC PROCESS 16 9.84e-01 9.94e-01 0.025400 -2.50e-02 4.46e-03 8.63e-01 9.75e-01
GOBP NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 38 9.64e-01 9.86e-01 0.025300 -3.01e-04 -2.53e-02 9.97e-01 7.88e-01
GOCC MEMBRANE PROTEIN COMPLEX 1214 3.11e-01 6.04e-01 0.025100 2.00e-02 -1.51e-02 2.40e-01 3.74e-01
Sensory processing of sound 70 9.40e-01 9.77e-01 0.025100 -1.62e-02 -1.91e-02 8.15e-01 7.82e-01
GOBP LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY 26 9.77e-01 9.91e-01 0.025000 2.07e-02 1.40e-02 8.55e-01 9.01e-01
GOBP NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 71 9.31e-01 9.74e-01 0.025000 -1.47e-02 2.02e-02 8.31e-01 7.68e-01
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) 117 8.92e-01 9.57e-01 0.025000 -2.37e-02 7.97e-03 6.58e-01 8.82e-01
GOBP GMP METABOLIC PROCESS 25 9.75e-01 9.91e-01 0.024900 2.17e-02 -1.24e-02 8.51e-01 9.15e-01
GOBP SMALL MOLECULE BIOSYNTHETIC PROCESS 576 6.17e-01 8.26e-01 0.024800 1.38e-02 2.05e-02 5.71e-01 4.00e-01
GOBP REGULATION OF BILE ACID SECRETION 6 9.94e-01 9.98e-01 0.024700 -1.21e-02 2.16e-02 9.59e-01 9.27e-01
GOBP L LEUCINE METABOLIC PROCESS 8 9.93e-01 9.98e-01 0.024700 -1.11e-02 -2.20e-02 9.57e-01 9.14e-01
GOBP BIOMINERAL TISSUE DEVELOPMENT 170 8.49e-01 9.37e-01 0.024600 -2.16e-02 1.19e-02 6.28e-01 7.90e-01
GOBP RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS 31 9.73e-01 9.90e-01 0.024600 2.41e-02 4.97e-03 8.16e-01 9.62e-01
Mucopolysaccharidoses 10 9.91e-01 9.97e-01 0.024600 2.25e-02 9.84e-03 9.02e-01 9.57e-01
GOMF ACETYL COA C ACYLTRANSFERASE ACTIVITY 7 9.94e-01 9.98e-01 0.024600 -1.80e-02 -1.67e-02 9.34e-01 9.39e-01
GOBP PLASMA LIPOPROTEIN PARTICLE CLEARANCE 54 9.49e-01 9.81e-01 0.024500 -1.81e-02 1.65e-02 8.18e-01 8.34e-01
GOBP T CELL MIGRATION 66 9.46e-01 9.80e-01 0.024500 -1.94e-02 -1.50e-02 7.85e-01 8.33e-01
GOCC PROTON TRANSPORTING V TYPE ATPASE V0 DOMAIN 11 9.90e-01 9.96e-01 0.024200 2.34e-02 -6.29e-03 8.93e-01 9.71e-01
GOBP ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGEN 46 9.58e-01 9.84e-01 0.024200 1.99e-02 -1.37e-02 8.15e-01 8.72e-01
GOBP POSITIVE REGULATION OF AMIDE METABOLIC PROCESS 30 9.75e-01 9.91e-01 0.024000 5.20e-03 2.35e-02 9.61e-01 8.24e-01
GOBP BONE MINERALIZATION 120 9.06e-01 9.64e-01 0.024000 2.20e-02 9.53e-03 6.77e-01 8.57e-01
GOCC SHELTERIN COMPLEX 7 9.94e-01 9.98e-01 0.024000 0.00e+00 2.40e-02 1.00e+00 9.12e-01
GOBP RESPONSE TO TOXIC SUBSTANCE 255 7.91e-01 9.15e-01 0.023900 -1.74e-02 1.64e-02 6.32e-01 6.52e-01
GOBP MONOAMINE TRANSPORT 74 9.38e-01 9.77e-01 0.023900 1.57e-04 -2.39e-02 9.98e-01 7.22e-01
GOBP POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE PROTEIN KINASE B SIGNAL TRANSDUCTION 183 8.49e-01 9.37e-01 0.023900 8.93e-03 -2.22e-02 8.35e-01 6.05e-01
GOBP PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS 30 9.77e-01 9.91e-01 0.023800 -1.79e-02 -1.56e-02 8.65e-01 8.83e-01
GOBP PHAGOCYTOSIS 231 8.21e-01 9.27e-01 0.023700 -2.35e-02 2.68e-03 5.38e-01 9.44e-01
GOBP NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY 31 9.76e-01 9.91e-01 0.023700 2.02e-02 1.23e-02 8.46e-01 9.05e-01
GOBP NEGATIVE REGULATION OF MEIOTIC CELL CYCLE 18 9.85e-01 9.94e-01 0.023600 2.36e-02 -1.56e-03 8.63e-01 9.91e-01
GOBP REGULATION OF VASCULAR PERMEABILITY 49 9.57e-01 9.84e-01 0.023600 -1.39e-02 1.91e-02 8.67e-01 8.17e-01
GOBP REGULATION OF ENDOCYTOSIS 285 8.06e-01 9.20e-01 0.023400 1.80e-02 1.49e-02 6.00e-01 6.66e-01
GOBP REGULATION OF RESPONSE TO EXTERNAL STIMULUS 1073 4.27e-01 7.04e-01 0.023300 2.31e-02 -3.29e-03 2.02e-01 8.56e-01
G1/S-Specific Transcription 28 9.76e-01 9.91e-01 0.023300 1.81e-02 -1.46e-02 8.68e-01 8.93e-01
GOMF PROTEIN CONTAINING COMPLEX DESTABILIZING ACTIVITY 15 9.88e-01 9.95e-01 0.023300 7.09e-04 -2.33e-02 9.96e-01 8.76e-01
Metabolism of vitamins and cofactors 194 8.49e-01 9.37e-01 0.023100 2.15e-02 -8.59e-03 6.06e-01 8.37e-01
GOBP POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION 70 9.47e-01 9.80e-01 0.023100 -5.61e-03 -2.24e-02 9.35e-01 7.45e-01
GOBP PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS 25 9.80e-01 9.92e-01 0.023000 2.32e-03 -2.29e-02 9.84e-01 8.43e-01
GOBP PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS 50 9.58e-01 9.85e-01 0.023000 -1.43e-02 1.80e-02 8.61e-01 8.25e-01
GOBP MEIOSIS I CELL CYCLE PROCESS 135 9.05e-01 9.63e-01 0.022900 -1.11e-02 -2.01e-02 8.24e-01 6.87e-01
GOBP FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS 28 9.78e-01 9.92e-01 0.022800 9.89e-04 2.28e-02 9.93e-01 8.35e-01
GOBP CELLULAR RESPONSE TO CGMP 7 9.94e-01 9.98e-01 0.022800 -4.11e-03 2.24e-02 9.85e-01 9.18e-01
GOBP REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN REGULATION OF CONTRACTION 7 9.94e-01 9.98e-01 0.022800 4.39e-03 -2.24e-02 9.84e-01 9.18e-01
GOMF EXOGENOUS PROTEIN BINDING 79 9.38e-01 9.76e-01 0.022800 7.41e-03 -2.16e-02 9.09e-01 7.40e-01
Adrenaline,noradrenaline inhibits insulin secretion 28 9.80e-01 9.92e-01 0.022800 1.85e-02 1.33e-02 8.65e-01 9.03e-01
GOBP REGULATION OF LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE 22 9.84e-01 9.94e-01 0.022800 1.29e-02 1.88e-02 9.16e-01 8.79e-01
GOBP PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS 34 9.74e-01 9.91e-01 0.022600 -1.86e-03 2.25e-02 9.85e-01 8.20e-01
GOBP DENDRITIC SPINE DEVELOPMENT 88 9.31e-01 9.74e-01 0.022400 -1.40e-02 1.75e-02 8.20e-01 7.77e-01
GOBP GOLGI DISASSEMBLY 6 9.95e-01 9.98e-01 0.022400 2.13e-04 -2.24e-02 9.99e-01 9.24e-01
Metabolism of fat-soluble vitamins 46 9.69e-01 9.89e-01 0.022200 -1.39e-02 -1.74e-02 8.71e-01 8.38e-01
GOBP CARDIAC CONDUCTION 95 9.36e-01 9.76e-01 0.022200 9.34e-03 2.01e-02 8.75e-01 7.35e-01
GOMF PROTEIN HORMONE RECEPTOR ACTIVITY 20 9.86e-01 9.95e-01 0.022100 -1.60e-02 -1.53e-02 9.02e-01 9.05e-01
GOMF GUANYL RIBONUCLEOTIDE BINDING 368 7.60e-01 8.98e-01 0.022100 2.18e-02 -3.88e-03 4.73e-01 8.98e-01
GOBP CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION 31 9.76e-01 9.91e-01 0.022100 1.47e-02 -1.65e-02 8.87e-01 8.74e-01
GOBP NEGATIVE REGULATION OF CELL CELL ADHESION 197 8.75e-01 9.49e-01 0.022100 1.63e-02 1.49e-02 6.93e-01 7.18e-01
Synthesis of bile acids and bile salts via 24-hydroxycholesterol 13 9.91e-01 9.97e-01 0.022000 -1.15e-02 -1.88e-02 9.43e-01 9.07e-01
GOBP MICROTUBULE BASED MOVEMENT 417 7.38e-01 8.87e-01 0.022000 2.18e-02 -2.67e-03 4.44e-01 9.25e-01
GOBP TRANSMEMBRANE TRANSPORT 1509 3.35e-01 6.25e-01 0.021900 -1.54e-02 1.56e-02 3.16e-01 3.13e-01
GOBP PROTEIN HEXAMERIZATION 9 9.93e-01 9.98e-01 0.021900 4.45e-03 -2.15e-02 9.82e-01 9.11e-01
Endosomal Sorting Complex Required For Transport (ESCRT) 31 9.79e-01 9.92e-01 0.021900 -1.84e-02 -1.18e-02 8.59e-01 9.09e-01
GOMF SULFUR COMPOUND BINDING 260 8.43e-01 9.35e-01 0.021800 1.63e-02 1.45e-02 6.51e-01 6.86e-01
GOBP POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION 97 9.30e-01 9.74e-01 0.021800 8.39e-03 -2.01e-02 8.86e-01 7.33e-01
GOBP MONOATOMIC ION TRANSPORT 1183 4.35e-01 7.10e-01 0.021600 -1.96e-02 9.22e-03 2.57e-01 5.93e-01
GOMF SCAFFOLD PROTEIN BINDING 66 9.52e-01 9.82e-01 0.021500 -1.53e-02 1.51e-02 8.29e-01 8.32e-01
GOBP DNA DEAMINATION 13 9.91e-01 9.97e-01 0.021500 5.37e-03 -2.08e-02 9.73e-01 8.97e-01
GOBP CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL 182 8.89e-01 9.55e-01 0.021400 1.91e-02 9.70e-03 6.56e-01 8.21e-01
GOBP REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 30 9.79e-01 9.92e-01 0.021400 -2.11e-02 3.93e-03 8.42e-01 9.70e-01
GOCC FICOLIN 1 RICH GRANULE 180 8.87e-01 9.55e-01 0.021400 -2.10e-02 -4.02e-03 6.26e-01 9.26e-01
Metabolism of nucleotides 92 9.44e-01 9.79e-01 0.021300 -1.60e-02 -1.40e-02 7.90e-01 8.16e-01
GOBP INTERLEUKIN 6 PRODUCTION 164 8.99e-01 9.61e-01 0.021300 -5.99e-03 -2.04e-02 8.95e-01 6.52e-01
GOCC APICOLATERAL PLASMA MEMBRANE 23 9.84e-01 9.94e-01 0.021200 -1.97e-02 7.78e-03 8.70e-01 9.48e-01
GOBP ACTIVATION OF PROTEIN KINASE ACTIVITY 76 9.47e-01 9.80e-01 0.021100 1.48e-02 -1.51e-02 8.24e-01 8.20e-01
HIV elongation arrest and recovery 33 9.77e-01 9.91e-01 0.021100 -9.92e-03 1.86e-02 9.21e-01 8.53e-01
Pausing and recovery of HIV elongation 33 9.77e-01 9.91e-01 0.021100 -9.92e-03 1.86e-02 9.21e-01 8.53e-01
GOBP NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS 28 9.81e-01 9.92e-01 0.021100 -2.07e-02 3.86e-03 8.49e-01 9.72e-01
GOBP AMINO ACID METABOLIC PROCESS 285 8.20e-01 9.27e-01 0.021100 1.91e-02 -8.82e-03 5.78e-01 7.98e-01
GOMF PROTEIN SEQUESTERING ACTIVITY 27 9.82e-01 9.93e-01 0.021000 -2.09e-02 1.26e-03 8.51e-01 9.91e-01
GOBP REGULATED EXOCYTOSIS 211 8.79e-01 9.50e-01 0.020900 -1.07e-02 -1.80e-02 7.89e-01 6.53e-01
GOBP MAINTENANCE OF PROTEIN LOCATION IN CELL 63 9.57e-01 9.84e-01 0.020900 -8.93e-03 1.89e-02 9.02e-01 7.95e-01
GOMF N ACETYLGLUCOSAMINE 6 O SULFOTRANSFERASE ACTIVITY 6 9.96e-01 9.98e-01 0.020600 -1.82e-02 9.72e-03 9.38e-01 9.67e-01
GOBP REGULATION OF PROTEIN POLYUBIQUITINATION 26 9.83e-01 9.94e-01 0.020500 4.14e-03 -2.01e-02 9.71e-01 8.59e-01
GOBP GLYCOSAMINOGLYCAN CATABOLIC PROCESS 27 9.84e-01 9.94e-01 0.020500 -1.76e-02 -1.04e-02 8.74e-01 9.25e-01
GOBP NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION 144 9.16e-01 9.68e-01 0.020400 2.01e-02 3.18e-03 6.76e-01 9.48e-01
GOBP CELLULAR HOMEOSTASIS 799 6.23e-01 8.30e-01 0.020300 2.02e-02 2.16e-03 3.31e-01 9.17e-01
GOMF GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE NADPLUS NON PHOSPHORYLATING ACTIVITY 7 9.96e-01 9.98e-01 0.020100 2.74e-03 1.99e-02 9.90e-01 9.27e-01
GOCC NEURON SPINE 167 8.98e-01 9.60e-01 0.020100 1.76e-02 -9.64e-03 6.94e-01 8.30e-01
GOBP CELLULAR RESPONSE TO BIOTIC STIMULUS 251 8.68e-01 9.45e-01 0.020000 -7.51e-03 -1.85e-02 8.38e-01 6.13e-01
GOBP TRNA PSEUDOURIDINE SYNTHESIS 6 9.97e-01 9.99e-01 0.019600 -2.56e-03 -1.94e-02 9.91e-01 9.34e-01
GOBP NUCLEOTIDE SUGAR METABOLIC PROCESS 38 9.78e-01 9.92e-01 0.019600 2.47e-03 -1.94e-02 9.79e-01 8.36e-01
GOBP TRIGLYCERIDE BIOSYNTHETIC PROCESS 41 9.75e-01 9.91e-01 0.019400 -1.35e-02 1.40e-02 8.81e-01 8.77e-01
GOBP CALCIUM ION REGULATED EXOCYTOSIS 63 9.63e-01 9.86e-01 0.019200 -1.24e-02 1.47e-02 8.65e-01 8.40e-01
GOBP REGULATION OF LIPID BIOSYNTHETIC PROCESS 179 9.04e-01 9.63e-01 0.019200 -1.91e-02 2.16e-03 6.59e-01 9.60e-01
ADP signalling through P2Y purinoceptor 1 25 9.85e-01 9.94e-01 0.019100 -1.14e-02 1.54e-02 9.22e-01 8.94e-01
GOMF CARBOXYLIC ESTER HYDROLASE ACTIVITY 150 9.19e-01 9.69e-01 0.019100 -1.84e-02 4.88e-03 6.97e-01 9.18e-01
GOMF MOLECULAR FUNCTION INHIBITOR ACTIVITY 489 7.77e-01 9.07e-01 0.019000 -3.17e-03 -1.87e-02 9.04e-01 4.79e-01
GOBP DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS 24 9.87e-01 9.95e-01 0.018800 2.95e-03 -1.86e-02 9.80e-01 8.75e-01
GOBP POLYPRENOL METABOLIC PROCESS 25 9.87e-01 9.95e-01 0.018800 1.88e-02 -3.56e-04 8.71e-01 9.98e-01
GOBP RESPONSE TO UV A 13 9.93e-01 9.98e-01 0.018600 -1.67e-03 -1.85e-02 9.92e-01 9.08e-01
GOBP GLUTAMINE METABOLIC PROCESS 26 9.86e-01 9.95e-01 0.018500 1.70e-02 -7.50e-03 8.81e-01 9.47e-01
GOBP RHYTHMIC BEHAVIOR 46 9.78e-01 9.92e-01 0.018400 7.87e-03 1.67e-02 9.26e-01 8.45e-01
GOMF CYTOKINE RECEPTOR BINDING 254 8.72e-01 9.47e-01 0.018400 -1.54e-02 1.02e-02 6.73e-01 7.80e-01
Hemostasis 577 7.55e-01 8.95e-01 0.018400 1.82e-02 2.83e-03 4.55e-01 9.07e-01
GOBP RESPONSE TO UV B 21 9.90e-01 9.96e-01 0.018300 -1.78e-02 -4.41e-03 8.88e-01 9.72e-01
GOCC RECEPTOR COMPLEX 387 8.32e-01 9.30e-01 0.018300 5.55e-03 1.75e-02 8.51e-01 5.56e-01
GOBP NEGATIVE REGULATION OF HYDROLASE ACTIVITY 182 9.13e-01 9.67e-01 0.018100 1.60e-03 -1.81e-02 9.70e-01 6.74e-01
GOBP POSITIVE REGULATION OF DEFENSE RESPONSE TO BACTERIUM 14 9.93e-01 9.98e-01 0.018100 7.39e-03 -1.65e-02 9.62e-01 9.15e-01
GOBP ALPHA KETOGLUTARATE TRANSPORT 7 9.97e-01 9.99e-01 0.018000 1.23e-02 1.32e-02 9.55e-01 9.52e-01
GOBP REGULATION OF SKELETAL MUSCLE CELL PROLIFERATION 15 9.93e-01 9.98e-01 0.018000 -6.81e-03 -1.67e-02 9.64e-01 9.11e-01
GOBP REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 141 9.30e-01 9.74e-01 0.017900 -1.17e-02 1.36e-02 8.10e-01 7.81e-01
GOMF FIBRINOGEN BINDING 6 9.97e-01 9.99e-01 0.017900 -9.41e-03 -1.52e-02 9.68e-01 9.49e-01
GOBP POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 109 9.46e-01 9.80e-01 0.017800 1.20e-02 -1.31e-02 8.29e-01 8.13e-01
GOCC PLASMA MEMBRANE SIGNALING RECEPTOR COMPLEX 183 9.22e-01 9.70e-01 0.017600 -1.68e-02 -5.53e-03 6.96e-01 8.97e-01
GOBP NEGATIVE REGULATION OF DEFENSE RESPONSE 280 8.71e-01 9.47e-01 0.017600 -1.28e-02 1.20e-02 7.12e-01 7.29e-01
GOBP REGULATION OF NUCLEOTIDE METABOLIC PROCESS 86 9.63e-01 9.86e-01 0.017500 -6.41e-03 -1.63e-02 9.18e-01 7.94e-01
GOBP REACTIVE OXYGEN SPECIES METABOLIC PROCESS 220 9.04e-01 9.63e-01 0.017200 1.65e-02 -4.75e-03 6.72e-01 9.03e-01
Pyroptosis 27 9.87e-01 9.95e-01 0.017200 1.46e-02 -9.12e-03 8.96e-01 9.35e-01
GOMF ISOMERASE ACTIVITY 165 9.34e-01 9.75e-01 0.017200 -7.20e-03 -1.56e-02 8.73e-01 7.30e-01
GOCC DENDRITE CYTOPLASM 26 9.89e-01 9.96e-01 0.017100 -1.64e-02 -5.15e-03 8.85e-01 9.64e-01
Pausing and recovery of Tat-mediated HIV elongation 31 9.86e-01 9.95e-01 0.017000 -4.13e-03 1.64e-02 9.68e-01 8.74e-01
Tat-mediated HIV elongation arrest and recovery 31 9.86e-01 9.95e-01 0.017000 -4.13e-03 1.64e-02 9.68e-01 8.74e-01
GOBP ARACHIDONIC ACID METABOLIC PROCESS 55 9.75e-01 9.91e-01 0.016900 -9.33e-03 1.41e-02 9.05e-01 8.57e-01
GOBP REGULATION OF DENDRITIC SPINE DEVELOPMENT 53 9.76e-01 9.91e-01 0.016800 -1.13e-02 1.24e-02 8.87e-01 8.76e-01
GOBP REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 209 9.22e-01 9.70e-01 0.016700 8.16e-03 1.46e-02 8.39e-01 7.17e-01
GOBP DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 938 6.93e-01 8.68e-01 0.016700 1.64e-02 3.05e-03 3.95e-01 8.74e-01
GOBP POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 21 9.92e-01 9.98e-01 0.016600 1.00e-02 1.32e-02 9.37e-01 9.17e-01
GOBP SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE TRANSLOCATION 8 9.97e-01 9.99e-01 0.016500 -8.59e-03 -1.41e-02 9.66e-01 9.45e-01
GOBP POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY 129 9.46e-01 9.80e-01 0.016300 -1.17e-02 1.14e-02 8.18e-01 8.23e-01
GOBP REGULATION OF PHOSPHOLIPASE C ACTIVITY 34 9.86e-01 9.95e-01 0.016300 7.28e-03 -1.46e-02 9.41e-01 8.83e-01
GOBP POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 161 9.39e-01 9.77e-01 0.016100 1.60e-02 -1.38e-03 7.25e-01 9.76e-01
GOBP REGULATION OF PROTEIN AUTOPHOSPHORYLATION 35 9.87e-01 9.95e-01 0.016000 1.55e-02 3.95e-03 8.74e-01 9.68e-01
GOCC PERIKARYON 144 9.47e-01 9.80e-01 0.016000 2.34e-03 1.58e-02 9.61e-01 7.43e-01
GOBP ALPHA AMINO ACID METABOLIC PROCESS 205 9.32e-01 9.74e-01 0.015800 -1.14e-02 -1.09e-02 7.79e-01 7.88e-01
GOBP REGULATION OF NEUTROPHIL CHEMOTAXIS 31 9.88e-01 9.96e-01 0.015700 9.80e-04 -1.57e-02 9.92e-01 8.80e-01
GOBP CALCIUM ION HOMEOSTASIS 318 8.85e-01 9.54e-01 0.015700 1.45e-02 -5.91e-03 6.56e-01 8.56e-01
GOBP REPRODUCTIVE PROCESS 1435 6.09e-01 8.22e-01 0.015400 1.49e-02 -3.87e-03 3.45e-01 8.06e-01
GOBP POSITIVE REGULATION OF SEQUESTERING OF TRIGLYCERIDE 9 9.97e-01 9.99e-01 0.015400 6.78e-03 -1.38e-02 9.72e-01 9.43e-01
GOBP NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION 22 9.92e-01 9.98e-01 0.015300 1.52e-02 -1.85e-03 9.02e-01 9.88e-01
GOBP RESPONSE TO CYTOKINE 918 7.21e-01 8.80e-01 0.015300 6.48e-03 -1.38e-02 7.39e-01 4.77e-01
GOBP OSTEOCLAST DIFFERENTIATION 106 9.64e-01 9.86e-01 0.015300 1.53e-02 3.57e-04 7.86e-01 9.95e-01
GOBP T CELL DIFFERENTIATION IN THYMUS 85 9.72e-01 9.90e-01 0.015300 -1.45e-02 -4.86e-03 8.18e-01 9.38e-01
GOBP MICROTUBULE SEVERING 9 9.97e-01 9.99e-01 0.015100 -5.23e-03 -1.42e-02 9.78e-01 9.41e-01
GOBP GRANULOCYTE CHEMOTAXIS 121 9.62e-01 9.86e-01 0.015100 1.04e-02 1.09e-02 8.43e-01 8.36e-01
GOBP REGULATION OF LYSOSOMAL LUMEN PH 28 9.90e-01 9.96e-01 0.015100 1.12e-02 -1.01e-02 9.18e-01 9.26e-01
GOBP NEGATIVE REGULATION OF DNA REPLICATION 25 9.92e-01 9.98e-01 0.014800 -4.41e-03 -1.42e-02 9.70e-01 9.02e-01
GOMF PROTEIN TYROSINE KINASE BINDING 120 9.62e-01 9.86e-01 0.014700 1.47e-02 3.37e-04 7.81e-01 9.95e-01
GOBP REGULATION OF VESICLE SIZE 20 9.94e-01 9.98e-01 0.014500 7.74e-03 1.23e-02 9.52e-01 9.24e-01
GOBP NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION 9 9.97e-01 9.99e-01 0.014500 1.38e-02 4.57e-03 9.43e-01 9.81e-01
GOMF CHEMOKINE ACTIVITY 46 9.85e-01 9.94e-01 0.014500 -1.38e-02 4.36e-03 8.71e-01 9.59e-01
GOBP PEPTIDE ANTIGEN ASSEMBLY WITH MHC PROTEIN COMPLEX 19 9.94e-01 9.98e-01 0.014500 -1.14e-02 -8.97e-03 9.32e-01 9.46e-01
GOBP EPITHELIAL CELL MORPHOGENESIS 30 9.90e-01 9.97e-01 0.014400 -1.43e-02 2.18e-03 8.92e-01 9.84e-01
GOBP SEXUAL REPRODUCTION 1011 7.45e-01 8.91e-01 0.014400 -1.42e-02 -2.13e-03 4.45e-01 9.09e-01
GOBP REGULATION OF ATP METABOLIC PROCESS 68 9.79e-01 9.92e-01 0.014200 3.29e-03 -1.38e-02 9.63e-01 8.44e-01
GOBP CYTOKINE MEDIATED SIGNALING PATHWAY 501 8.70e-01 9.46e-01 0.014100 -1.32e-02 -5.07e-03 6.14e-01 8.46e-01
GOBP REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN 15 9.96e-01 9.98e-01 0.013800 3.39e-03 1.34e-02 9.82e-01 9.28e-01
GOBP L AMINO ACID METABOLIC PROCESS 171 9.52e-01 9.82e-01 0.013700 1.34e-02 -2.77e-03 7.62e-01 9.50e-01
GOBP REGULATION OF LYASE ACTIVITY 55 9.85e-01 9.94e-01 0.013700 1.34e-02 2.72e-03 8.63e-01 9.72e-01
GOBP MAINTENANCE OF BLOOD BRAIN BARRIER 37 9.90e-01 9.96e-01 0.013600 1.33e-02 -2.54e-03 8.88e-01 9.79e-01
GOBP ESTABLISHMENT OF TISSUE POLARITY 36 9.90e-01 9.96e-01 0.013400 7.48e-03 -1.11e-02 9.38e-01 9.08e-01
GOBP REGULATION OF DEOXYRIBONUCLEASE ACTIVITY 10 9.97e-01 9.99e-01 0.013300 1.25e-02 4.69e-03 9.45e-01 9.80e-01
GOCC INTERCALATED DISC 50 9.87e-01 9.95e-01 0.013100 1.26e-02 -3.50e-03 8.77e-01 9.66e-01
GOBP HEMOSTASIS 223 9.41e-01 9.77e-01 0.013100 1.12e-02 -6.74e-03 7.73e-01 8.62e-01
GOMF AMIDE BINDING 236 9.44e-01 9.79e-01 0.013000 -2.94e-03 -1.27e-02 9.38e-01 7.37e-01
GOBP CALCIUM ION TRANSPORT 420 9.06e-01 9.63e-01 0.012900 1.22e-02 4.32e-03 6.69e-01 8.79e-01
GOBP SULFUR AMINO ACID METABOLIC PROCESS 31 9.93e-01 9.98e-01 0.012800 -1.20e-02 -4.68e-03 9.08e-01 9.64e-01
GOBP MEMBRANE DEPOLARIZATION 91 9.79e-01 9.92e-01 0.012700 -1.25e-02 -2.11e-03 8.36e-01 9.72e-01
GOBP MONOATOMIC CATION TRANSMEMBRANE TRANSPORT 811 8.16e-01 9.26e-01 0.012700 -6.93e-03 1.06e-02 7.37e-01 6.06e-01
GOBP FC RECEPTOR SIGNALING PATHWAY 53 9.87e-01 9.95e-01 0.012300 1.04e-02 -6.58e-03 8.96e-01 9.34e-01
GOBP IRON ION TRANSMEMBRANE TRANSPORT 19 9.96e-01 9.98e-01 0.012000 -3.08e-03 -1.15e-02 9.81e-01 9.31e-01
GOBP NEGATIVE REGULATION OF NON CANONICAL NF KAPPAB SIGNAL TRANSDUCTION 34 9.92e-01 9.98e-01 0.011900 -5.05e-03 1.08e-02 9.59e-01 9.13e-01
GOBP POSITIVE REGULATION OF AMYLOID BETA FORMATION 20 9.96e-01 9.98e-01 0.011600 -1.69e-03 1.15e-02 9.90e-01 9.29e-01
GOBP ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 255 9.56e-01 9.83e-01 0.011300 -8.21e-03 -7.81e-03 8.21e-01 8.30e-01
GOBP TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION 185 9.64e-01 9.86e-01 0.011300 -1.04e-02 4.39e-03 8.08e-01 9.18e-01
GOBP NEGATIVE REGULATION OF AXON EXTENSION 28 9.95e-01 9.98e-01 0.011000 -3.40e-03 1.05e-02 9.75e-01 9.23e-01
GOBP NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 413 9.34e-01 9.75e-01 0.011000 8.38e-03 7.09e-03 7.70e-01 8.05e-01
GOBP NEUTRAL LIPID METABOLIC PROCESS 130 9.79e-01 9.92e-01 0.010900 8.82e-03 6.43e-03 8.62e-01 8.99e-01
GOMF AMMONIUM TRANSMEMBRANE TRANSPORTER ACTIVITY 12 9.98e-01 9.99e-01 0.010900 -3.84e-03 -1.01e-02 9.82e-01 9.51e-01
GOBP NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION 15 9.97e-01 9.99e-01 0.010700 -1.07e-02 5.78e-05 9.43e-01 1.00e+00
GOMF ACID PHOSPHATASE ACTIVITY 9 9.99e-01 9.99e-01 0.009940 9.30e-03 -3.48e-03 9.61e-01 9.86e-01
GOBP EXOCYTOSIS 330 9.55e-01 9.83e-01 0.009890 9.64e-03 2.23e-03 7.63e-01 9.44e-01
GOBP NLS BEARING PROTEIN IMPORT INTO NUCLEUS 19 9.97e-01 9.99e-01 0.009690 -8.61e-03 4.45e-03 9.48e-01 9.73e-01
GOBP REGULATION OF EPIDERMIS DEVELOPMENT 65 9.91e-01 9.97e-01 0.009600 3.17e-03 -9.06e-03 9.65e-01 8.99e-01
GOBP POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION 26 9.96e-01 9.99e-01 0.009490 9.06e-03 -2.83e-03 9.36e-01 9.80e-01
Peptide hormone metabolism 81 9.88e-01 9.96e-01 0.009460 -5.42e-03 7.75e-03 9.33e-01 9.04e-01
GOBP FOLIC ACID CONTAINING COMPOUND BIOSYNTHETIC PROCESS 9 9.99e-01 9.99e-01 0.009230 9.18e-03 9.28e-04 9.62e-01 9.96e-01
GOBP MULTICELLULAR ORGANISMAL REPRODUCTIVE PROCESS 893 9.02e-01 9.61e-01 0.009080 8.88e-03 1.88e-03 6.52e-01 9.24e-01
GOBP REGULATION OF LEUKOCYTE PROLIFERATION 256 9.73e-01 9.90e-01 0.008820 -4.47e-03 -7.60e-03 9.02e-01 8.34e-01
GOBP SKELETAL MUSCLE FIBER DIFFERENTIATION 12 9.99e-01 9.99e-01 0.008680 1.71e-03 -8.51e-03 9.92e-01 9.59e-01
GOBP REGULATION OF BONE REMODELING 51 9.95e-01 9.98e-01 0.008460 4.41e-03 7.22e-03 9.57e-01 9.29e-01
GOBP SYNAPTIC VESICLE LUMEN ACIDIFICATION 15 9.98e-01 9.99e-01 0.008390 4.04e-03 -7.35e-03 9.78e-01 9.61e-01
GOBP REGULATION OF DEFENSE RESPONSE 810 9.18e-01 9.69e-01 0.008250 7.09e-03 -4.21e-03 7.32e-01 8.39e-01
GOBP REGULATION OF MEIOTIC CELL CYCLE 68 9.94e-01 9.98e-01 0.008080 -5.49e-03 -5.93e-03 9.38e-01 9.33e-01
GOBP MEMBRANE INVAGINATION 63 9.94e-01 9.98e-01 0.007980 -4.69e-03 6.46e-03 9.49e-01 9.29e-01
GOBP CELLULAR RESPONSE TO AMMONIUM ION 5 1.00e+00 1.00e+00 0.007870 -6.34e-03 -4.66e-03 9.80e-01 9.86e-01
Assembly of active LPL and LIPC lipase complexes 18 9.98e-01 9.99e-01 0.007820 6.86e-03 3.75e-03 9.60e-01 9.78e-01
GOBP INORGANIC ION HOMEOSTASIS 515 9.53e-01 9.82e-01 0.007740 7.12e-03 -3.05e-03 7.82e-01 9.06e-01
Metabolism of folate and pterines 17 9.98e-01 9.99e-01 0.007510 -4.55e-03 5.97e-03 9.74e-01 9.66e-01
GOBP RESPONSE TO CALCIUM ION 125 9.89e-01 9.96e-01 0.007330 5.82e-03 -4.46e-03 9.11e-01 9.31e-01
GOMF PROTEIN PHOSPHATASE 1 BINDING 25 9.98e-01 9.99e-01 0.006850 4.17e-03 5.44e-03 9.71e-01 9.62e-01
GOCC MULTIVESICULAR BODY 65 9.96e-01 9.98e-01 0.006600 2.66e-03 -6.04e-03 9.70e-01 9.33e-01
COPI-dependent Golgi-to-ER retrograde traffic 98 9.94e-01 9.98e-01 0.006410 -6.34e-03 9.43e-04 9.14e-01 9.87e-01
GOBP RESPONSE TO AXON INJURY 81 9.95e-01 9.98e-01 0.006360 5.51e-03 3.17e-03 9.32e-01 9.61e-01
GOBP AMINOPHOSPHOLIPID TRANSLOCATION 6 1.00e+00 1.00e+00 0.006040 4.37e-03 4.17e-03 9.85e-01 9.86e-01
GOMF AMINOPHOSPHOLIPID FLIPPASE ACTIVITY 6 1.00e+00 1.00e+00 0.006040 4.37e-03 4.17e-03 9.85e-01 9.86e-01
GOBP MONOATOMIC CATION TRANSPORT 990 9.59e-01 9.85e-01 0.005370 -5.35e-03 4.92e-04 7.76e-01 9.79e-01
GOBP POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 151 9.93e-01 9.98e-01 0.005330 3.34e-03 -4.15e-03 9.44e-01 9.30e-01
Disorders of transmembrane transporters 158 9.93e-01 9.98e-01 0.005260 5.26e-03 3.90e-05 9.09e-01 9.99e-01
GOBP RESPONSE TO METAL ION 330 9.86e-01 9.95e-01 0.005260 -2.43e-04 5.25e-03 9.94e-01 8.70e-01
Formation of HIV elongation complex in the absence of HIV Tat 44 9.98e-01 9.99e-01 0.005250 -4.91e-03 1.86e-03 9.55e-01 9.83e-01
GOBP REGULATION OF MYOBLAST FUSION 20 9.99e-01 1.00e+00 0.004570 3.73e-03 2.65e-03 9.77e-01 9.84e-01
GOCC NEURON TO NEURON SYNAPSE 349 9.91e-01 9.97e-01 0.004110 -3.56e-03 2.06e-03 9.09e-01 9.47e-01
GOBP GAMETE GENERATION 743 9.83e-01 9.94e-01 0.003840 -1.85e-03 3.37e-03 9.32e-01 8.76e-01
GOBP MONOATOMIC ION HOMEOSTASIS 589 9.89e-01 9.96e-01 0.003650 -3.06e-03 -1.99e-03 8.99e-01 9.34e-01
GOBP CELLULAR RESPONSE TO CALCIUM ION 69 9.99e-01 9.99e-01 0.003330 -3.14e-03 1.11e-03 9.64e-01 9.87e-01
GOBP CYTOKINE PRODUCTION 841 9.96e-01 9.98e-01 0.001900 -5.22e-05 -1.90e-03 9.98e-01 9.26e-01
Formation of HIV-1 elongation complex containing HIV-1 Tat 42 1.00e+00 1.00e+00 0.000678 -3.90e-04 -5.55e-04 9.97e-01 9.95e-01
HIV Transcription Elongation 42 1.00e+00 1.00e+00 0.000678 -3.90e-04 -5.55e-04 9.97e-01 9.95e-01
Tat-mediated elongation of the HIV-1 transcript 42 1.00e+00 1.00e+00 0.000678 -3.90e-04 -5.55e-04 9.97e-01 9.95e-01


Detailed Gene set reports


GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB
GOBP ANTIGEN PROCESSING AND PRESENTATION ENDOGENOUS LIPID ANTIGEN VIA MHC CLASS IB
metric value
setSize 5
pMANOVA 0.000868
p.adjustMANOVA 0.0123
s.dist 1
s.cancer -0.808
s.incidence -0.594
p.cancer 0.00175
p.incidence 0.0215



Top 20 genes
Gene cancer incidence
CD1E -9824 -10624
CD1C -8994 -10649
CD1B -9809 -3665
CD1D -2133 -7113

Click HERE to show all gene set members

All member genes
cancer incidence
CD1A -8875 398
CD1B -9809 -3665
CD1C -8994 -10649
CD1D -2133 -7113
CD1E -9824 -10624



GOMF LIPID ANTIGEN BINDING
GOMF LIPID ANTIGEN BINDING
metric value
setSize 5
pMANOVA 0.000868
p.adjustMANOVA 0.0123
s.dist 1
s.cancer -0.808
s.incidence -0.594
p.cancer 0.00175
p.incidence 0.0215



Top 20 genes
Gene cancer incidence
CD1E -9824 -10624
CD1C -8994 -10649
CD1B -9809 -3665
CD1D -2133 -7113

Click HERE to show all gene set members

All member genes
cancer incidence
CD1A -8875 398
CD1B -9809 -3665
CD1C -8994 -10649
CD1D -2133 -7113
CD1E -9824 -10624



GOBP FOREBRAIN NEURON FATE COMMITMENT
GOBP FOREBRAIN NEURON FATE COMMITMENT
metric value
setSize 7
pMANOVA 0.000111
p.adjustMANOVA 0.00236
s.dist 0.906
s.cancer 0.841
s.incidence -0.338
p.cancer 0.000116
p.incidence 0.122



Top 20 genes
Gene cancer incidence
ASCL1 11490 -9360
PAX6 10773 -6785
GATA2 10708 -5348
BCL11B 9606 -2845
TBR1 9851 -2282
FEZF2 11845 -1094

Click HERE to show all gene set members

All member genes
cancer incidence
ASCL1 11490 -9360
BCL11B 9606 -2845
FEZF2 11845 -1094
GATA2 10708 -5348
NKX2-1 6739 3034
PAX6 10773 -6785
TBR1 9851 -2282



GOBP SPINAL CORD OLIGODENDROCYTE CELL DIFFERENTIATION
GOBP SPINAL CORD OLIGODENDROCYTE CELL DIFFERENTIATION
metric value
setSize 5
pMANOVA 0.0016
p.adjustMANOVA 0.0199
s.dist 0.893
s.cancer 0.702
s.incidence -0.552
p.cancer 0.00659
p.incidence 0.0325



Top 20 genes
Gene cancer incidence
ASCL1 11490 -9360
OLIG2 11487 -7027
NKX2-2 11541 -6681
SOX13 6779 -2832
SOX6 1783 -3483

Click HERE to show all gene set members

All member genes
cancer incidence
ASCL1 11490 -9360
NKX2-2 11541 -6681
OLIG2 11487 -7027
SOX13 6779 -2832
SOX6 1783 -3483



GOMF HEMOGLOBIN ALPHA BINDING
GOMF HEMOGLOBIN ALPHA BINDING
metric value
setSize 5
pMANOVA 0.0028
p.adjustMANOVA 0.0305
s.dist 0.886
s.cancer -0.885
s.incidence -0.0367
p.cancer 0.00061
p.incidence 0.887



Top 20 genes
Gene cancer incidence
HBD -7255 -6257
HBG2 -9625 -4389
HBB -8689 -3760

Click HERE to show all gene set members

All member genes
cancer incidence
HBB -8689 -3760
HBD -7255 -6257
HBE1 -9925 8110
HBG1 -8350 5154
HBG2 -9625 -4389



GOBP MESENCHYME MIGRATION
GOBP MESENCHYME MIGRATION
metric value
setSize 5
pMANOVA 0.00283
p.adjustMANOVA 0.0307
s.dist 0.867
s.cancer 0.842
s.incidence -0.207
p.cancer 0.00111
p.incidence 0.422



Top 20 genes
Gene cancer incidence
FOXF1 10312 -7102
ACTG2 11662 -3905
ACTC1 7586 -4460

Click HERE to show all gene set members

All member genes
cancer incidence
ACTA1 11367 3998
ACTA2 9871 980
ACTC1 7586 -4460
ACTG2 11662 -3905
FOXF1 10312 -7102



GOMF 3 KETO STEROL REDUCTASE ACTIVITY
GOMF 3 KETO STEROL REDUCTASE ACTIVITY
metric value
setSize 5
pMANOVA 0.00476
p.adjustMANOVA 0.0457
s.dist 0.822
s.cancer 0.297
s.incidence -0.766
p.cancer 0.249
p.incidence 0.003



Top 20 genes
Gene cancer incidence
HSD17B7 10270 -7088
HSD3B1 5063 -9088
DHRS11 4419 -8084
CBR3 1230 -8143

Click HERE to show all gene set members

All member genes
cancer incidence
CBR3 1230 -8143
DHRS11 4419 -8084
DHRS4 -45 -8719
HSD17B7 10270 -7088
HSD3B1 5063 -9088



Beta defensins
Beta defensins
metric value
setSize 26
pMANOVA 3.88e-11
p.adjustMANOVA 3.5e-09
s.dist 0.809
s.cancer -0.694
s.incidence -0.416
p.cancer 9.13e-10
p.incidence 0.000243



Top 20 genes
Gene cancer incidence
DEFB118 -9973 -10312
DEFB129 -9823 -10041
DEFB135 -9575 -10262
DEFB125 -9748 -10046
DEFB119 -10001 -8789
DEFB114 -9806 -8595
DEFB110 -9346 -8709
DEFB115 -9295 -8203
DEFB124 -9941 -7417
DEFB121 -9733 -7460
DEFB128 -8193 -7761
DEFB127 -6677 -8512
DEFB132 -8390 -2969
DEFB116 -9435 -2356
DEFB133 -9002 -2374

Click HERE to show all gene set members

All member genes
cancer incidence
CCR2 -3604.0 1657.0
CCR6 -2752.0 48.0
DEFB1 2448.0 -10581.0
DEFB104A -2098.5 2891.5
DEFB110 -9346.0 -8709.0
DEFB113 -8489.0 6913.0
DEFB114 -9806.0 -8595.0
DEFB115 -9295.0 -8203.0
DEFB116 -9435.0 -2356.0
DEFB118 -9973.0 -10312.0
DEFB119 -10001.0 -8789.0
DEFB121 -9733.0 -7460.0
DEFB123 -9063.0 1152.0
DEFB124 -9941.0 -7417.0
DEFB125 -9748.0 -10046.0
DEFB126 -9651.0 2952.0
DEFB127 -6677.0 -8512.0
DEFB128 -8193.0 -7761.0
DEFB129 -9823.0 -10041.0
DEFB132 -8390.0 -2969.0
DEFB133 -9002.0 -2374.0
DEFB134 -9535.0 6609.0
DEFB135 -9575.0 -10262.0
DEFB136 827.0 -9950.0
TLR1 10008.0 -6576.0
TLR2 -2427.0 4871.0



GOMF CCR6 CHEMOKINE RECEPTOR BINDING
GOMF CCR6 CHEMOKINE RECEPTOR BINDING
metric value
setSize 5
pMANOVA 0.0111
p.adjustMANOVA 0.0846
s.dist 0.798
s.cancer -0.698
s.incidence -0.387
p.cancer 0.00685
p.incidence 0.134



Top 20 genes
Gene cancer incidence
DEFB114 -9806 -8595
DEFB110 -9346 -8709
DEFB133 -9002 -2374

Click HERE to show all gene set members

All member genes
cancer incidence
CCL20 -7907 9945
DEFB1 2448 -10581
DEFB110 -9346 -8709
DEFB114 -9806 -8595
DEFB133 -9002 -2374



GOMF OLFACTORY RECEPTOR ACTIVITY
GOMF OLFACTORY RECEPTOR ACTIVITY
metric value
setSize 338
pMANOVA 1.22e-137
p.adjustMANOVA 1.49e-133
s.dist 0.794
s.cancer -0.788
s.incidence -0.0975
p.cancer 8.66e-139
p.incidence 0.00206



Top 20 genes
Gene cancer incidence
OR10T2 -9998 -10706
OR5A2 -9958 -10661
OR2M7 -10009 -10563
OR4A47 -9954 -10617
OR10AG1 -9802 -10579
OR4C46 -9869 -10370
OR2G6 -9745 -10491
OR56B4 -10027 -10147
OR5AR1 -9988 -10160
OR10K1 -9797 -10324
OR4S1 -9854 -10235
OR5AC2 -9977 -10092
OR52D1 -9953 -10037
OR4C3 -9276 -10728
OR5A1 -9661 -10279
OR2AK2 -9597 -10319
OR2B3 -9549 -10353
OR10G9 -9790 -10098
OR52A5 -9430 -10450
OR6C65 -9830 -9990

Click HERE to show all gene set members

All member genes
cancer incidence
GPR148 -1461.0 1712.0
OR10A2 -8464.0 -5935.0
OR10A3 -9853.0 10242.0
OR10A4 -8177.0 -3723.0
OR10A5 -6694.0 9675.0
OR10A6 -8637.0 -7497.0
OR10A7 -9569.0 10042.0
OR10AD1 -9069.0 1784.0
OR10AG1 -9802.0 -10579.0
OR10C1 -9527.0 6402.0
OR10G2 -8122.0 -8148.0
OR10G3 2996.0 10170.0
OR10G4 -9727.0 266.0
OR10G7 -8477.0 -10094.0
OR10G8 -8912.0 -8988.0
OR10G9 -9790.0 -10098.0
OR10H1 -8942.0 -9228.0
OR10H2 -9768.0 -3426.0
OR10H3 -5916.0 -8996.0
OR10H4 -6175.0 -6202.0
OR10H5 -9593.0 -7196.0
OR10J1 -9838.0 8789.0
OR10J3 -10013.0 10089.0
OR10J5 -9493.0 4414.0
OR10K1 -9797.0 -10324.0
OR10K2 -9964.0 2970.0
OR10P1 -9675.0 9996.0
OR10Q1 9880.0 5400.0
OR10S1 -9990.0 -2537.0
OR10T2 -9998.0 -10706.0
OR10V1 10766.0 -7331.0
OR10W1 6028.0 -10029.0
OR10X1 -9863.0 -850.0
OR10Z1 -10011.0 3262.0
OR11A1 -8524.0 6374.0
OR11G2 -6846.0 223.0
OR11H4 -8274.0 -10016.0
OR11H6 -9366.0 -6068.0
OR11L1 -6769.0 10218.0
OR12D2 -9423.0 -7871.0
OR12D3 -7169.0 -7949.0
OR13A1 -8329.0 3141.0
OR13C2 -8740.0 2872.0
OR13C3 -5709.0 7390.0
OR13C4 -8505.0 -9274.0
OR13C8 -3999.0 -10161.0
OR13C9 -9570.0 3011.0
OR13D1 -9519.0 -7958.0
OR13F1 -8583.0 -10372.0
OR13G1 -9913.0 -3465.0
OR13J1 -2015.0 -6841.0
OR14A16 -7355.0 3813.0
OR14C36 -9947.0 -3594.0
OR14I1 -9531.0 -4078.0
OR14J1 -9284.0 -5037.0
OR1A1 -7332.0 -2231.0
OR1A2 -8440.0 -10614.0
OR1B1 -9539.0 -7910.0
OR1C1 -9749.0 -9481.0
OR1D2 -1933.0 4074.0
OR1E1 -6822.0 -4017.0
OR1E2 -9084.0 -10703.0
OR1F1 -8800.0 8682.0
OR1F2P -9125.0 -9879.0
OR1G1 -9440.0 4298.0
OR1I1 -4315.0 -1341.0
OR1J1 -4382.0 10978.0
OR1J2 -8746.0 3946.0
OR1J4 -9012.0 8278.0
OR1K1 -8703.0 -660.0
OR1L1 -9615.0 -7615.0
OR1L3 -8458.0 -10292.0
OR1L4 -9740.0 -9123.0
OR1L6 -2720.0 9209.0
OR1L8 -8236.0 6976.0
OR1M1 -9000.0 -1931.0
OR1N1 -8581.0 -2476.0
OR1N2 -9198.0 -4888.0
OR1Q1 -8269.0 -755.0
OR1S1 8391.0 7433.0
OR1S2 9595.0 -676.0
OR2A12 -7999.0 10106.0
OR2A14 -9192.0 -9497.0
OR2A2 -9588.0 9857.0
OR2A5 -8838.0 10411.0
OR2AE1 -9428.0 8252.0
OR2AG1 -9204.0 1039.0
OR2AG2 -7805.0 3379.0
OR2AK2 -9597.0 -10319.0
OR2AP1 -9515.0 -9724.0
OR2AT4 -9188.0 8822.0
OR2B11 -9086.0 10861.0
OR2B2 -9282.0 426.0
OR2B3 -9549.0 -10353.0
OR2B6 -8351.0 8678.0
OR2C1 -6186.0 -4785.0
OR2C3 -5910.0 9185.0
OR2D2 -8522.0 -7075.0
OR2D3 -4878.0 -6341.0
OR2F1 -8920.0 -3034.0
OR2F2 -7814.0 -7715.0
OR2G2 -7785.0 8211.0
OR2G3 -9711.0 -4966.0
OR2G6 -9745.0 -10491.0
OR2H1 -9140.0 -6086.0
OR2H2 10590.0 10890.0
OR2J2 -8888.0 -8698.0
OR2K2 -7695.0 -4440.0
OR2L13 -8609.0 -5404.0
OR2L2 -7167.0 2643.0
OR2L3 -9355.0 -8368.0
OR2L5 -8719.0 776.0
OR2L8 -9553.0 -5682.0
OR2M2 -9875.0 -4098.0
OR2M3 -9782.0 4907.0
OR2M4 -9732.0 -8967.0
OR2M5 -8133.0 6209.0
OR2M7 -10009.0 -10563.0
OR2S2 1454.0 10705.0
OR2T1 -7320.0 -2860.0
OR2T11 2415.0 126.0
OR2T12 -6858.0 3303.0
OR2T27 -8726.0 -9609.0
OR2T3 -9057.0 10724.0
OR2T33 -9042.0 5178.0
OR2T4 -6994.0 4046.0
OR2T6 -9917.0 5485.0
OR2T8 -8072.0 -3848.0
OR2V1 -9456.0 -5518.0
OR2V2 -4912.0 10159.0
OR2W1 -9427.0 -7573.0
OR2W3 -9183.0 9747.0
OR2W5P -7715.0 -10328.0
OR2Y1 -8639.0 2587.0
OR2Z1 -8542.0 4681.0
OR3A1 -1366.0 8549.0
OR3A2 -7888.0 -7386.0
OR3A3 -9137.0 4677.0
OR4A15 -8412.0 3178.0
OR4A16 -9474.0 -10347.0
OR4A47 -9954.0 -10617.0
OR4A5 -5999.0 -10629.0
OR4B1 -9753.0 -9593.0
OR4C12 -9942.0 -8519.0
OR4C15 -8216.0 -1911.0
OR4C16 -9787.0 -4184.0
OR4C3 -9276.0 -10728.0
OR4C45 4426.0 -2206.0
OR4C46 -9869.0 -10370.0
OR4C6 -9764.0 -9293.0
OR4D1 -9822.0 3644.0
OR4D10 -7930.0 10155.0
OR4D11 -9818.0 -6471.0
OR4D2 -9561.0 9189.0
OR4D5 -8684.0 -8847.0
OR4D6 -9660.0 3506.0
OR4D9 -7494.0 -3028.0
OR4E2 -7106.0 8010.0
OR4F15 -7871.0 5839.0
OR4F6 -8837.0 -4892.0
OR4K1 -8380.0 10526.0
OR4K13 -6797.0 10417.0
OR4K14 -4041.0 10985.0
OR4K15 -7205.0 -8243.0
OR4K17 -9473.0 -8041.0
OR4K2 -5012.0 -8332.0
OR4K5 -9721.0 183.0
OR4L1 -6817.0 -4481.0
OR4M1 -3073.0 -7830.0
OR4N2 -7438.0 -9842.0
OR4N5 -5909.0 3551.0
OR4S1 -9854.0 -10235.0
OR4X1 -9373.0 -10270.0
OR51A2 -8741.0 -8871.0
OR51A7 -9880.0 -7857.0
OR51B2 -9193.0 -2036.0
OR51B4 -9984.0 -8377.0
OR51B5 -9752.0 -3154.0
OR51B6 -9901.0 -6618.0
OR51D1 -5300.0 -9933.0
OR51E1 -3918.0 6782.0
OR51E2 -252.0 -551.0
OR51F1 -9083.0 700.0
OR51F2 -6676.0 3595.0
OR51G1 -9616.0 9324.0
OR51G2 -9606.0 7295.0
OR51I1 -9959.0 -3664.0
OR51I2 -8130.0 -2251.0
OR51L1 -9817.0 -2075.0
OR51M1 -9904.0 -9799.0
OR51Q1 -8339.0 -7246.0
OR51S1 -8983.0 7927.0
OR51T1 -9124.0 -8828.0
OR51V1 -8075.0 5067.0
OR52A1 -8820.0 -8955.0
OR52A4P -9303.0 1390.0
OR52A5 -9430.0 -10450.0
OR52B2 -8761.0 521.0
OR52B4 -8681.0 5871.0
OR52B6 -9117.0 10877.0
OR52D1 -9953.0 -10037.0
OR52E2 -9795.0 4085.0
OR52E4 -9840.0 6051.0
OR52E6 -9532.0 7266.0
OR52E8 -7920.0 9213.0
OR52H1 -9080.0 4434.0
OR52I1 5073.0 9984.0
OR52I2 -6156.0 5814.0
OR52J3 -9371.0 -4640.0
OR52K1 -7849.0 -8586.0
OR52K2 -7804.0 -7404.0
OR52L1 -8359.0 11049.0
OR52M1 7596.0 2184.0
OR52N1 -9166.0 -5728.0
OR52N2 -9309.0 -1748.0
OR52R1 -6133.0 -3017.0
OR52W1 4417.0 10541.0
OR56A1 -10018.0 -5130.0
OR56A3 -9989.0 10277.0
OR56A4 -8964.0 -9377.0
OR56A5 -8165.0 -10367.0
OR56B1 -9960.0 4515.0
OR56B4 -10027.0 -10147.0
OR5A1 -9661.0 -10279.0
OR5A2 -9958.0 -10661.0
OR5AC2 -9977.0 -10092.0
OR5AK2 -6105.0 -7156.0
OR5AN1 -9931.0 -4825.0
OR5AP2 -8235.0 9834.0
OR5AR1 -9988.0 -10160.0
OR5AS1 -9407.0 5284.0
OR5AU1 -9690.0 -3584.0
OR5B12 -9082.0 2723.0
OR5B17 -8707.0 -10306.0
OR5B2 -8355.0 5230.0
OR5B21 -8299.0 4421.0
OR5B3 -5603.0 -3835.0
OR5C1 -6413.0 11070.0
OR5D13 -9090.0 9592.0
OR5D14 -9885.0 -9666.0
OR5D16 -8557.0 -10102.0
OR5D18 -7680.0 -1967.0
OR5F1 -6470.0 6252.0
OR5H15 -9218.0 6200.0
OR5H2 -6979.0 -574.0
OR5H6 -10000.0 -2293.0
OR5I1 -9907.0 -2333.0
OR5J2 -10031.0 -3085.0
OR5K1 -7374.0 -3918.0
OR5K2 -9313.0 9267.0
OR5K3 -9560.0 -8803.0
OR5K4 -4959.0 -10259.0
OR5L1 -8976.0 -10357.0
OR5L2 -7476.0 -4600.0
OR5M1 -9397.0 9981.0
OR5M10 1286.0 9824.0
OR5M11 3179.0 4737.0
OR5M3 -9581.0 -9418.0
OR5M8 -7759.0 9947.0
OR5M9 -7661.0 10386.0
OR5P2 -9498.0 -9334.0
OR5P3 -9015.0 9612.0
OR5T1 -9974.0 -9328.0
OR5T2 -9895.0 -2530.0
OR5V1 -9645.0 5954.0
OR5W2 -9155.0 5382.0
OR6A2 -9041.0 11011.0
OR6B1 -7936.0 6239.0
OR6B2 -8315.0 8685.0
OR6B3 -8745.0 -10264.0
OR6C1 -6434.0 10736.0
OR6C2 -9357.0 -8311.0
OR6C3 -9121.0 -1732.0
OR6C4 -8979.0 -100.0
OR6C6 -8498.0 11039.0
OR6C65 -9830.0 -9990.0
OR6C68 -3498.0 3435.0
OR6C70 -6651.0 10054.0
OR6C74 -9859.0 -5447.0
OR6C75 -8851.0 -3525.0
OR6C76 -5241.0 -1786.0
OR6F1 -9259.0 10284.0
OR6K2 -9785.0 1065.0
OR6K3 -9946.0 -6085.0
OR6K6 -8715.0 -3620.0
OR6M1 -8407.0 9810.0
OR6N1 -9398.0 4764.0
OR6N2 -9881.0 6093.0
OR6P1 -9579.0 4481.0
OR6Q1 -8778.0 -10767.0
OR6S1 2461.0 -8001.0
OR6T1 -8226.0 9736.0
OR6V1 8382.0 5592.0
OR6X1 -6196.0 -7881.0
OR6Y1 -9976.0 9166.0
OR7A10 -3286.0 7314.0
OR7A17 -786.0 -10434.0
OR7A5 -9115.0 -7899.0
OR7C1 -3413.0 8656.0
OR7C2 -5230.0 5306.0
OR7D2 -7347.0 -7531.0
OR7D4 -9487.0 -6966.0
OR7E24 -1488.0 11003.0
OR7G1 -6349.0 -10701.0
OR7G2 -8634.0 -2982.0
OR7G3 -9344.0 8561.0
OR8A1 -9915.0 -6699.0
OR8B12 -9970.0 -1866.0
OR8B2 -9738.0 -9935.0
OR8B4 -9663.0 -9632.0
OR8B8 -8622.0 10641.0
OR8D1 -8628.0 -669.0
OR8D2 -9674.0 -7035.0
OR8D4 -6013.0 -10145.0
OR8G1 -9605.0 -2692.0
OR8G2P -9452.0 -4049.0
OR8G5 -9889.0 2669.0
OR8H1 -7582.0 -10329.0
OR8H3 -10019.0 11080.0
OR8I2 -5434.0 11008.0
OR8J1 -9995.0 10020.0
OR8J3 -9609.0 9958.0
OR8K1 -8582.0 -3228.0
OR8K3 -8537.0 10261.0
OR8K5 -9621.0 -4361.0
OR8S1 -8945.0 10101.0
OR8U1 -9250.0 -1680.0
OR8U3 -9999.0 -6107.0
OR8U8 -9217.0 552.0
OR9A2 -9335.0 7328.0
OR9A4 -7179.0 -7512.0
OR9G1 -8866.5 -7172.5
OR9G4 -8952.0 -10615.0
OR9G9 -8866.5 -7172.5
OR9I1 5197.0 -3824.0
OR9K2 -8662.0 7241.0
OR9Q1 5052.0 -8799.0
OR9Q2 2265.0 -5681.0



GOMF TYPE I INTERFERON RECEPTOR BINDING
GOMF TYPE I INTERFERON RECEPTOR BINDING
metric value
setSize 14
pMANOVA 1.39e-06
p.adjustMANOVA 5.09e-05
s.dist 0.791
s.cancer -0.784
s.incidence 0.11
p.cancer 3.81e-07
p.incidence 0.474



Top 20 genes
Gene cancer incidence
IFNA14 -9502 10927
IFNW1 -8341 10269
IFNA6 -8185 9926
IFNA13 -9511 6663
IFNA7 -9789 5859
IFNA5 -5835 9052
IFNE -7737 4791
IFNA2 -9808 3407

Click HERE to show all gene set members

All member genes
cancer incidence
IFNA1 -8990 -9764
IFNA13 -9511 6663
IFNA14 -9502 10927
IFNA16 -10014 -10376
IFNA2 -9808 3407
IFNA21 -9530 -10696
IFNA5 -5835 9052
IFNA6 -8185 9926
IFNA7 -9789 5859
IFNA8 -10003 -10773
IFNB1 -8744 -5148
IFNE -7737 4791
IFNK 8808 5224
IFNW1 -8341 10269



GOBP NEURAL PLATE REGIONALIZATION
GOBP NEURAL PLATE REGIONALIZATION
metric value
setSize 6
pMANOVA 0.00432
p.adjustMANOVA 0.0425
s.dist 0.79
s.cancer 0.764
s.incidence 0.199
p.cancer 0.00118
p.incidence 0.399



Top 20 genes
Gene cancer incidence
SSBP3 9105 9388
BMPR1A 10489 6270
CELSR2 4749 9636
TBX18 11226 3591

Click HERE to show all gene set members

All member genes
cancer incidence
BMPR1A 10489 6270
CELSR2 4749 9636
FUZ 11000 -6411
NOG 9264 -8347
SSBP3 9105 9388
TBX18 11226 3591



GOMF ODORANT BINDING
GOMF ODORANT BINDING
metric value
setSize 99
pMANOVA 4.05e-40
p.adjustMANOVA 2.93e-37
s.dist 0.787
s.cancer -0.78
s.incidence -0.106
p.cancer 3.39e-41
p.incidence 0.0694



Top 20 genes
Gene cancer incidence
OR10T2 -9998 -10706
OR5A2 -9958 -10661
OR5AR1 -9988 -10160
OR10K1 -9797 -10324
OR5AC2 -9977 -10092
OR5A1 -9661 -10279
OR8B2 -9738 -9935
OR5D14 -9885 -9666
OR9G4 -8952 -10615
OR8B4 -9663 -9632
OR5T1 -9974 -9328
OR5L1 -8976 -10357
OR5M3 -9581 -9418
OR6B3 -8745 -10264
OR5B17 -8707 -10306
OR5P2 -9498 -9334
OR5D16 -8557 -10102
OR5K3 -9560 -8803
OR8H1 -7582 -10329
OR12D2 -9423 -7871

Click HERE to show all gene set members

All member genes
cancer incidence
GPR148 -1461 1712
OBP2A -7937 8449
OBP2B -7006 -9145
OR10J1 -9838 8789
OR10J3 -10013 10089
OR10K1 -9797 -10324
OR10K2 -9964 2970
OR10Q1 9880 5400
OR10T2 -9998 -10706
OR10V1 10766 -7331
OR10W1 6028 -10029
OR10Z1 -10011 3262
OR11L1 -6769 10218
OR12D2 -9423 -7871
OR12D3 -7169 -7949
OR13A1 -8329 3141
OR13G1 -9913 -3465
OR14A16 -7355 3813
OR14C36 -9947 -3594
OR14I1 -9531 -4078
OR14J1 -9284 -5037
OR1K1 -8703 -660
OR2C1 -6186 -4785
OR4E2 -7106 8010
OR5A1 -9661 -10279
OR5A2 -9958 -10661
OR5AC2 -9977 -10092
OR5AK2 -6105 -7156
OR5AN1 -9931 -4825
OR5AP2 -8235 9834
OR5AR1 -9988 -10160
OR5AS1 -9407 5284
OR5AU1 -9690 -3584
OR5B12 -9082 2723
OR5B17 -8707 -10306
OR5B2 -8355 5230
OR5B21 -8299 4421
OR5B3 -5603 -3835
OR5C1 -6413 11070
OR5D13 -9090 9592
OR5D14 -9885 -9666
OR5D16 -8557 -10102
OR5D18 -7680 -1967
OR5F1 -6470 6252
OR5H15 -9218 6200
OR5H2 -6979 -574
OR5H6 -10000 -2293
OR5I1 -9907 -2333
OR5J2 -10031 -3085
OR5K1 -7374 -3918
OR5K2 -9313 9267
OR5K3 -9560 -8803
OR5K4 -4959 -10259
OR5L1 -8976 -10357
OR5L2 -7476 -4600
OR5M1 -9397 9981
OR5M10 1286 9824
OR5M11 3179 4737
OR5M3 -9581 -9418
OR5M8 -7759 9947
OR5M9 -7661 10386
OR5P2 -9498 -9334
OR5P3 -9015 9612
OR5T1 -9974 -9328
OR5T2 -9895 -2530
OR5W2 -9155 5382
OR6B2 -8315 8685
OR6B3 -8745 -10264
OR6K2 -9785 1065
OR6K3 -9946 -6085
OR6K6 -8715 -3620
OR6N2 -9881 6093
OR8A1 -9915 -6699
OR8B12 -9970 -1866
OR8B2 -9738 -9935
OR8B4 -9663 -9632
OR8B8 -8622 10641
OR8D1 -8628 -669
OR8D2 -9674 -7035
OR8D4 -6013 -10145
OR8G1 -9605 -2692
OR8G2P -9452 -4049
OR8G5 -9889 2669
OR8H1 -7582 -10329
OR8H3 -10019 11080
OR8I2 -5434 11008
OR8J1 -9995 10020
OR8J3 -9609 9958
OR8K1 -8582 -3228
OR8K3 -8537 10261
OR8K5 -9621 -4361
OR8U1 -9250 -1680
OR8U3 -9999 -6107
OR8U8 -9217 552
OR9G4 -8952 -10615
OR9I1 5197 -3824
OR9K2 -8662 7241
OR9Q1 5052 -8799
OR9Q2 2265 -5681



GOBP CARDIAC SEPTUM CELL DIFFERENTIATION
GOBP CARDIAC SEPTUM CELL DIFFERENTIATION
metric value
setSize 5
pMANOVA 0.0112
p.adjustMANOVA 0.0853
s.dist 0.784
s.cancer 0.765
s.incidence 0.174
p.cancer 0.00306
p.incidence 0.501



Top 20 genes
Gene cancer incidence
KCNJ8 11437 9217
BMPR1A 10489 6270
TBX5 11380 376

Click HERE to show all gene set members

All member genes
cancer incidence
BMPR1A 10489 6270
KCNJ8 11437 9217
MAML1 2127 -4064
NKX2-5 11119 -1400
TBX5 11380 376



Expression and translocation of olfactory receptors
Expression and translocation of olfactory receptors
metric value
setSize 339
pMANOVA 3.53e-134
p.adjustMANOVA 2.17e-130
s.dist 0.783
s.cancer -0.777
s.incidence -0.093
p.cancer 2.2e-135
p.incidence 0.00326



Top 20 genes
Gene cancer incidence
OR10T2 -9998 -10706
OR5A2 -9958 -10661
OR2M7 -10009 -10563
OR4A47 -9954 -10617
OR10AG1 -9802 -10579
OR4C46 -9869 -10370
OR2G6 -9745 -10491
OR56B4 -10027 -10147
OR5AR1 -9988 -10160
OR10K1 -9797 -10324
OR4S1 -9854 -10235
OR5AC2 -9977 -10092
OR52D1 -9953 -10037
OR4C3 -9276 -10728
OR5A1 -9661 -10279
OR2AK2 -9597 -10319
OR2B3 -9549 -10353
OR10G9 -9790 -10098
OR52A5 -9430 -10450
OR6C65 -9830 -9990

Click HERE to show all gene set members

All member genes
cancer incidence
EBF1 -7039.0 -6118.0
LDB1 8627.0 -5276.0
LHX2 8572.0 1914.0
OR10A2 -8464.0 -5935.0
OR10A3 -9853.0 10242.0
OR10A4 -8177.0 -3723.0
OR10A5 -6694.0 9675.0
OR10A6 -8637.0 -7497.0
OR10A7 -9569.0 10042.0
OR10AD1 -9069.0 1784.0
OR10AG1 -9802.0 -10579.0
OR10C1 -9527.0 6402.0
OR10G2 -8122.0 -8148.0
OR10G3 2996.0 10170.0
OR10G4 -9727.0 266.0
OR10G7 -8477.0 -10094.0
OR10G8 -8912.0 -8988.0
OR10G9 -9790.0 -10098.0
OR10H1 -8942.0 -9228.0
OR10H2 -9768.0 -3426.0
OR10H3 -5916.0 -8996.0
OR10H4 -6175.0 -6202.0
OR10H5 -9593.0 -7196.0
OR10J1 -9838.0 8789.0
OR10J3 -10013.0 10089.0
OR10J5 -9493.0 4414.0
OR10K1 -9797.0 -10324.0
OR10K2 -9964.0 2970.0
OR10P1 -9675.0 9996.0
OR10Q1 9880.0 5400.0
OR10S1 -9990.0 -2537.0
OR10T2 -9998.0 -10706.0
OR10V1 10766.0 -7331.0
OR10W1 6028.0 -10029.0
OR10X1 -9863.0 -850.0
OR10Z1 -10011.0 3262.0
OR11A1 -8524.0 6374.0
OR11G2 -6846.0 223.0
OR11H4 -8274.0 -10016.0
OR11H6 -9366.0 -6068.0
OR11L1 -6769.0 10218.0
OR12D2 -9423.0 -7871.0
OR12D3 -7169.0 -7949.0
OR13A1 -8329.0 3141.0
OR13C2 -8740.0 2872.0
OR13C3 -5709.0 7390.0
OR13C4 -8505.0 -9274.0
OR13C8 -3999.0 -10161.0
OR13C9 -9570.0 3011.0
OR13D1 -9519.0 -7958.0
OR13F1 -8583.0 -10372.0
OR13G1 -9913.0 -3465.0
OR13J1 -2015.0 -6841.0
OR14A16 -7355.0 3813.0
OR14C36 -9947.0 -3594.0
OR14I1 -9531.0 -4078.0
OR14J1 -9284.0 -5037.0
OR1A1 -7332.0 -2231.0
OR1A2 -8440.0 -10614.0
OR1B1 -9539.0 -7910.0
OR1C1 -9749.0 -9481.0
OR1D2 -1933.0 4074.0
OR1E1 -6822.0 -4017.0
OR1E2 -9084.0 -10703.0
OR1F1 -8800.0 8682.0
OR1G1 -9440.0 4298.0
OR1I1 -4315.0 -1341.0
OR1J1 -4382.0 10978.0
OR1J2 -8746.0 3946.0
OR1J4 -9012.0 8278.0
OR1K1 -8703.0 -660.0
OR1L1 -9615.0 -7615.0
OR1L3 -8458.0 -10292.0
OR1L4 -9740.0 -9123.0
OR1L6 -2720.0 9209.0
OR1L8 -8236.0 6976.0
OR1M1 -9000.0 -1931.0
OR1N1 -8581.0 -2476.0
OR1N2 -9198.0 -4888.0
OR1Q1 -8269.0 -755.0
OR1S1 8391.0 7433.0
OR1S2 9595.0 -676.0
OR2A12 -7999.0 10106.0
OR2A14 -9192.0 -9497.0
OR2A2 -9588.0 9857.0
OR2A5 -8838.0 10411.0
OR2AE1 -9428.0 8252.0
OR2AG1 -9204.0 1039.0
OR2AG2 -7805.0 3379.0
OR2AK2 -9597.0 -10319.0
OR2AP1 -9515.0 -9724.0
OR2AT4 -9188.0 8822.0
OR2B11 -9086.0 10861.0
OR2B2 -9282.0 426.0
OR2B3 -9549.0 -10353.0
OR2B6 -8351.0 8678.0
OR2C1 -6186.0 -4785.0
OR2C3 -5910.0 9185.0
OR2D2 -8522.0 -7075.0
OR2D3 -4878.0 -6341.0
OR2F1 -8920.0 -3034.0
OR2F2 -7814.0 -7715.0
OR2G2 -7785.0 8211.0
OR2G3 -9711.0 -4966.0
OR2G6 -9745.0 -10491.0
OR2H1 -9140.0 -6086.0
OR2H2 10590.0 10890.0
OR2J2 -8888.0 -8698.0
OR2K2 -7695.0 -4440.0
OR2L13 -8609.0 -5404.0
OR2L2 -7167.0 2643.0
OR2L3 -9355.0 -8368.0
OR2L5 -8719.0 776.0
OR2L8 -9553.0 -5682.0
OR2M2 -9875.0 -4098.0
OR2M3 -9782.0 4907.0
OR2M4 -9732.0 -8967.0
OR2M5 -8133.0 6209.0
OR2M7 -10009.0 -10563.0
OR2S2 1454.0 10705.0
OR2T1 -7320.0 -2860.0
OR2T11 2415.0 126.0
OR2T12 -6858.0 3303.0
OR2T27 -8726.0 -9609.0
OR2T3 -9057.0 10724.0
OR2T33 -9042.0 5178.0
OR2T4 -6994.0 4046.0
OR2T6 -9917.0 5485.0
OR2T8 -8072.0 -3848.0
OR2V1 -9456.0 -5518.0
OR2V2 -4912.0 10159.0
OR2W1 -9427.0 -7573.0
OR2W3 -9183.0 9747.0
OR2Y1 -8639.0 2587.0
OR2Z1 -8542.0 4681.0
OR3A1 -1366.0 8549.0
OR3A2 -7888.0 -7386.0
OR3A3 -9137.0 4677.0
OR4A15 -8412.0 3178.0
OR4A16 -9474.0 -10347.0
OR4A47 -9954.0 -10617.0
OR4A5 -5999.0 -10629.0
OR4B1 -9753.0 -9593.0
OR4C12 -9942.0 -8519.0
OR4C15 -8216.0 -1911.0
OR4C16 -9787.0 -4184.0
OR4C3 -9276.0 -10728.0
OR4C45 4426.0 -2206.0
OR4C46 -9869.0 -10370.0
OR4C6 -9764.0 -9293.0
OR4D1 -9822.0 3644.0
OR4D10 -7930.0 10155.0
OR4D11 -9818.0 -6471.0
OR4D2 -9561.0 9189.0
OR4D5 -8684.0 -8847.0
OR4D6 -9660.0 3506.0
OR4D9 -7494.0 -3028.0
OR4E2 -7106.0 8010.0
OR4F15 -7871.0 5839.0
OR4F6 -8837.0 -4892.0
OR4K1 -8380.0 10526.0
OR4K13 -6797.0 10417.0
OR4K14 -4041.0 10985.0
OR4K15 -7205.0 -8243.0
OR4K17 -9473.0 -8041.0
OR4K2 -5012.0 -8332.0
OR4K5 -9721.0 183.0
OR4L1 -6817.0 -4481.0
OR4M1 -3073.0 -7830.0
OR4N2 -7438.0 -9842.0
OR4N5 -5909.0 3551.0
OR4S1 -9854.0 -10235.0
OR4X1 -9373.0 -10270.0
OR51A2 -8741.0 -8871.0
OR51A7 -9880.0 -7857.0
OR51B2 -9193.0 -2036.0
OR51B4 -9984.0 -8377.0
OR51B5 -9752.0 -3154.0
OR51B6 -9901.0 -6618.0
OR51D1 -5300.0 -9933.0
OR51E1 -3918.0 6782.0
OR51E2 -252.0 -551.0
OR51F1 -9083.0 700.0
OR51F2 -6676.0 3595.0
OR51G1 -9616.0 9324.0
OR51G2 -9606.0 7295.0
OR51I1 -9959.0 -3664.0
OR51I2 -8130.0 -2251.0
OR51L1 -9817.0 -2075.0
OR51M1 -9904.0 -9799.0
OR51Q1 -8339.0 -7246.0
OR51S1 -8983.0 7927.0
OR51T1 -9124.0 -8828.0
OR51V1 -8075.0 5067.0
OR52A1 -8820.0 -8955.0
OR52A4P -9303.0 1390.0
OR52A5 -9430.0 -10450.0
OR52B2 -8761.0 521.0
OR52B6 -9117.0 10877.0
OR52D1 -9953.0 -10037.0
OR52E2 -9795.0 4085.0
OR52E4 -9840.0 6051.0
OR52E6 -9532.0 7266.0
OR52E8 -7920.0 9213.0
OR52H1 -9080.0 4434.0
OR52I1 5073.0 9984.0
OR52I2 -6156.0 5814.0
OR52J3 -9371.0 -4640.0
OR52K1 -7849.0 -8586.0
OR52K2 -7804.0 -7404.0
OR52L1 -8359.0 11049.0
OR52M1 7596.0 2184.0
OR52N1 -9166.0 -5728.0
OR52N2 -9309.0 -1748.0
OR52R1 -6133.0 -3017.0
OR52W1 4417.0 10541.0
OR56A1 -10018.0 -5130.0
OR56A3 -9989.0 10277.0
OR56A4 -8964.0 -9377.0
OR56A5 -8165.0 -10367.0
OR56B1 -9960.0 4515.0
OR56B4 -10027.0 -10147.0
OR5A1 -9661.0 -10279.0
OR5A2 -9958.0 -10661.0
OR5AC2 -9977.0 -10092.0
OR5AK2 -6105.0 -7156.0
OR5AN1 -9931.0 -4825.0
OR5AP2 -8235.0 9834.0
OR5AR1 -9988.0 -10160.0
OR5AS1 -9407.0 5284.0
OR5AU1 -9690.0 -3584.0
OR5B12 -9082.0 2723.0
OR5B17 -8707.0 -10306.0
OR5B2 -8355.0 5230.0
OR5B21 -8299.0 4421.0
OR5B3 -5603.0 -3835.0
OR5C1 -6413.0 11070.0
OR5D13 -9090.0 9592.0
OR5D14 -9885.0 -9666.0
OR5D16 -8557.0 -10102.0
OR5D18 -7680.0 -1967.0
OR5F1 -6470.0 6252.0
OR5H15 -9218.0 6200.0
OR5H2 -6979.0 -574.0
OR5H6 -10000.0 -2293.0
OR5I1 -9907.0 -2333.0
OR5J2 -10031.0 -3085.0
OR5K1 -7374.0 -3918.0
OR5K2 -9313.0 9267.0
OR5K3 -9560.0 -8803.0
OR5K4 -4959.0 -10259.0
OR5L1 -8976.0 -10357.0
OR5L2 -7476.0 -4600.0
OR5M1 -9397.0 9981.0
OR5M10 1286.0 9824.0
OR5M11 3179.0 4737.0
OR5M3 -9581.0 -9418.0
OR5M8 -7759.0 9947.0
OR5M9 -7661.0 10386.0
OR5P2 -9498.0 -9334.0
OR5P3 -9015.0 9612.0
OR5T1 -9974.0 -9328.0
OR5T2 -9895.0 -2530.0
OR5V1 -9645.0 5954.0
OR5W2 -9155.0 5382.0
OR6A2 -9041.0 11011.0
OR6B1 -7936.0 6239.0
OR6B2 -8315.0 8685.0
OR6B3 -8745.0 -10264.0
OR6C1 -6434.0 10736.0
OR6C2 -9357.0 -8311.0
OR6C3 -9121.0 -1732.0
OR6C4 -8979.0 -100.0
OR6C6 -8498.0 11039.0
OR6C65 -9830.0 -9990.0
OR6C68 -3498.0 3435.0
OR6C70 -6651.0 10054.0
OR6C74 -9859.0 -5447.0
OR6C75 -8851.0 -3525.0
OR6C76 -5241.0 -1786.0
OR6F1 -9259.0 10284.0
OR6K2 -9785.0 1065.0
OR6K3 -9946.0 -6085.0
OR6K6 -8715.0 -3620.0
OR6M1 -8407.0 9810.0
OR6N1 -9398.0 4764.0
OR6N2 -9881.0 6093.0
OR6P1 -9579.0 4481.0
OR6Q1 -8778.0 -10767.0
OR6S1 2461.0 -8001.0
OR6T1 -8226.0 9736.0
OR6V1 8382.0 5592.0
OR6X1 -6196.0 -7881.0
OR6Y1 -9976.0 9166.0
OR7A10 -3286.0 7314.0
OR7A17 -786.0 -10434.0
OR7A5 -9115.0 -7899.0
OR7C1 -3413.0 8656.0
OR7C2 -5230.0 5306.0
OR7D2 -7347.0 -7531.0
OR7D4 -9487.0 -6966.0
OR7E24 -1488.0 11003.0
OR7G1 -6349.0 -10701.0
OR7G2 -8634.0 -2982.0
OR7G3 -9344.0 8561.0
OR8A1 -9915.0 -6699.0
OR8B12 -9970.0 -1866.0
OR8B2 -9738.0 -9935.0
OR8B4 -9663.0 -9632.0
OR8B8 -8622.0 10641.0
OR8D1 -8628.0 -669.0
OR8D2 -9674.0 -7035.0
OR8D4 -6013.0 -10145.0
OR8G1 -9605.0 -2692.0
OR8G5 -9889.0 2669.0
OR8H1 -7582.0 -10329.0
OR8H3 -10019.0 11080.0
OR8I2 -5434.0 11008.0
OR8J1 -9995.0 10020.0
OR8J3 -9609.0 9958.0
OR8K1 -8582.0 -3228.0
OR8K3 -8537.0 10261.0
OR8K5 -9621.0 -4361.0
OR8S1 -8945.0 10101.0
OR8U1 -9250.0 -1680.0
OR8U3 -9999.0 -6107.0
OR8U8 -9217.0 552.0
OR9A2 -9335.0 7328.0
OR9A4 -7179.0 -7512.0
OR9G1 -8866.5 -7172.5
OR9G4 -8952.0 -10615.0
OR9G9 -8866.5 -7172.5
OR9I1 5197.0 -3824.0
OR9K2 -8662.0 7241.0
OR9Q1 5052.0 -8799.0
OR9Q2 2265.0 -5681.0
REEP1 1330.0 -3012.0
RTP1 -7938.0 9859.0
RTP2 -7678.0 1725.0



GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION
GOBP POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION
metric value
setSize 5
pMANOVA 0.0125
p.adjustMANOVA 0.0922
s.dist 0.782
s.cancer 0.727
s.incidence 0.288
p.cancer 0.00486
p.incidence 0.265



Top 20 genes
Gene cancer incidence
SOX15 10106 9791
CAPN3 8907 10686
PPARD 5513 7324

Click HERE to show all gene set members

All member genes
cancer incidence
CAPN3 8907 10686
HOPX 8192 -2347
MYOD1 11771 -8825
PPARD 5513 7324
SOX15 10106 9791



GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY
GOBP ADENYLATE CYCLASE INHIBITING SEROTONIN RECEPTOR SIGNALING PATHWAY
metric value
setSize 7
pMANOVA 0.00258
p.adjustMANOVA 0.0287
s.dist 0.775
s.cancer 0.691
s.incidence 0.35
p.cancer 0.00154
p.incidence 0.109



Top 20 genes
Gene cancer incidence
DRD4 11540 8938
HTR1B 11476 6989
HTR1E 9826 4622
HTR1F 2550 7799
HTR1A 11302 676
HTR5A 1901 2622

Click HERE to show all gene set members

All member genes
cancer incidence
DRD4 11540 8938
HTR1A 11302 676
HTR1B 11476 6989
HTR1D 10914 -3572
HTR1E 9826 4622
HTR1F 2550 7799
HTR5A 1901 2622



GOMF ARYL SULFOTRANSFERASE ACTIVITY
GOMF ARYL SULFOTRANSFERASE ACTIVITY
metric value
setSize 7
pMANOVA 0.00264
p.adjustMANOVA 0.0293
s.dist 0.774
s.cancer 0.683
s.incidence 0.365
p.cancer 0.00176
p.incidence 0.0948



Top 20 genes
Gene cancer incidence
SULT1C4 10940 9779
SULT1A2 10467 9783
SULT1A1 8714 10804
SULT1E1 9336 2052
SULT1B1 2450 6332

Click HERE to show all gene set members

All member genes
cancer incidence
SULT1A1 8714 10804
SULT1A2 10467 9783
SULT1B1 2450 6332
SULT1C2 6650 -6715
SULT1C3 10306 -2852
SULT1C4 10940 9779
SULT1E1 9336 2052



GOBP NORADRENERGIC NEURON DIFFERENTIATION
GOBP NORADRENERGIC NEURON DIFFERENTIATION
metric value
setSize 10
pMANOVA 0.000116
p.adjustMANOVA 0.00244
s.dist 0.771
s.cancer 0.77
s.incidence -0.0531
p.cancer 2.5e-05
p.incidence 0.771



Top 20 genes
Gene cancer incidence
ASCL1 11490 -9360
SOX4 8834 -8171
PHOX2B 10582 -5725
EDN1 11626 -3238

Click HERE to show all gene set members

All member genes
cancer incidence
ASCL1 11490 -9360
EDN1 11626 -3238
EDNRA 3677 4086
HAND2 11651 981
INSM1 9810 1288
PHOX2A 11227 9033
PHOX2B 10582 -5725
RNF220 3077 3958
SOX11 11629 3064
SOX4 8834 -8171



Olfactory Signaling Pathway
Olfactory Signaling Pathway
metric value
setSize 346
pMANOVA 4.94e-133
p.adjustMANOVA 2.02e-129
s.dist 0.771
s.cancer -0.767
s.incidence -0.0834
p.cancer 2.34e-134
p.incidence 0.00769



Top 20 genes
Gene cancer incidence
OR10T2 -9998 -10706
OR5A2 -9958 -10661
OR2M7 -10009 -10563
OR4A47 -9954 -10617
OR10AG1 -9802 -10579
OR4C46 -9869 -10370
OR2G6 -9745 -10491
OR56B4 -10027 -10147
OR5AR1 -9988 -10160
OR10K1 -9797 -10324
OR4S1 -9854 -10235
OR5AC2 -9977 -10092
OR52D1 -9953 -10037
OR4C3 -9276 -10728
OR5A1 -9661 -10279
OR2AK2 -9597 -10319
OR2B3 -9549 -10353
OR10G9 -9790 -10098
OR52A5 -9430 -10450
OR6C65 -9830 -9990

Click HERE to show all gene set members

All member genes
cancer incidence
ADCY3 7415.0 9539.0
ANO2 -8001.0 -3383.0
CNGA4 -9205.0 10424.0
CNGB1 -6389.0 5156.0
EBF1 -7039.0 -6118.0
GNAL -28.0 -486.0
GNB1 10405.0 6319.0
GNG13 -5526.0 2513.0
LDB1 8627.0 -5276.0
LHX2 8572.0 1914.0
OR10A2 -8464.0 -5935.0
OR10A3 -9853.0 10242.0
OR10A4 -8177.0 -3723.0
OR10A5 -6694.0 9675.0
OR10A6 -8637.0 -7497.0
OR10A7 -9569.0 10042.0
OR10AD1 -9069.0 1784.0
OR10AG1 -9802.0 -10579.0
OR10C1 -9527.0 6402.0
OR10G2 -8122.0 -8148.0
OR10G3 2996.0 10170.0
OR10G4 -9727.0 266.0
OR10G7 -8477.0 -10094.0
OR10G8 -8912.0 -8988.0
OR10G9 -9790.0 -10098.0
OR10H1 -8942.0 -9228.0
OR10H2 -9768.0 -3426.0
OR10H3 -5916.0 -8996.0
OR10H4 -6175.0 -6202.0
OR10H5 -9593.0 -7196.0
OR10J1 -9838.0 8789.0
OR10J3 -10013.0 10089.0
OR10J5 -9493.0 4414.0
OR10K1 -9797.0 -10324.0
OR10K2 -9964.0 2970.0
OR10P1 -9675.0 9996.0
OR10Q1 9880.0 5400.0
OR10S1 -9990.0 -2537.0
OR10T2 -9998.0 -10706.0
OR10V1 10766.0 -7331.0
OR10W1 6028.0 -10029.0
OR10X1 -9863.0 -850.0
OR10Z1 -10011.0 3262.0
OR11A1 -8524.0 6374.0
OR11G2 -6846.0 223.0
OR11H4 -8274.0 -10016.0
OR11H6 -9366.0 -6068.0
OR11L1 -6769.0 10218.0
OR12D2 -9423.0 -7871.0
OR12D3 -7169.0 -7949.0
OR13A1 -8329.0 3141.0
OR13C2 -8740.0 2872.0
OR13C3 -5709.0 7390.0
OR13C4 -8505.0 -9274.0
OR13C8 -3999.0 -10161.0
OR13C9 -9570.0 3011.0
OR13D1 -9519.0 -7958.0
OR13F1 -8583.0 -10372.0
OR13G1 -9913.0 -3465.0
OR13J1 -2015.0 -6841.0
OR14A16 -7355.0 3813.0
OR14C36 -9947.0 -3594.0
OR14I1 -9531.0 -4078.0
OR14J1 -9284.0 -5037.0
OR1A1 -7332.0 -2231.0
OR1A2 -8440.0 -10614.0
OR1B1 -9539.0 -7910.0
OR1C1 -9749.0 -9481.0
OR1D2 -1933.0 4074.0
OR1E1 -6822.0 -4017.0
OR1E2 -9084.0 -10703.0
OR1F1 -8800.0 8682.0
OR1G1 -9440.0 4298.0
OR1I1 -4315.0 -1341.0
OR1J1 -4382.0 10978.0
OR1J2 -8746.0 3946.0
OR1J4 -9012.0 8278.0
OR1K1 -8703.0 -660.0
OR1L1 -9615.0 -7615.0
OR1L3 -8458.0 -10292.0
OR1L4 -9740.0 -9123.0
OR1L6 -2720.0 9209.0
OR1L8 -8236.0 6976.0
OR1M1 -9000.0 -1931.0
OR1N1 -8581.0 -2476.0
OR1N2 -9198.0 -4888.0
OR1Q1 -8269.0 -755.0
OR1S1 8391.0 7433.0
OR1S2 9595.0 -676.0
OR2A12 -7999.0 10106.0
OR2A14 -9192.0 -9497.0
OR2A2 -9588.0 9857.0
OR2A5 -8838.0 10411.0
OR2AE1 -9428.0 8252.0
OR2AG1 -9204.0 1039.0
OR2AG2 -7805.0 3379.0
OR2AK2 -9597.0 -10319.0
OR2AP1 -9515.0 -9724.0
OR2AT4 -9188.0 8822.0
OR2B11 -9086.0 10861.0
OR2B2 -9282.0 426.0
OR2B3 -9549.0 -10353.0
OR2B6 -8351.0 8678.0
OR2C1 -6186.0 -4785.0
OR2C3 -5910.0 9185.0
OR2D2 -8522.0 -7075.0
OR2D3 -4878.0 -6341.0
OR2F1 -8920.0 -3034.0
OR2F2 -7814.0 -7715.0
OR2G2 -7785.0 8211.0
OR2G3 -9711.0 -4966.0
OR2G6 -9745.0 -10491.0
OR2H1 -9140.0 -6086.0
OR2H2 10590.0 10890.0
OR2J2 -8888.0 -8698.0
OR2K2 -7695.0 -4440.0
OR2L13 -8609.0 -5404.0
OR2L2 -7167.0 2643.0
OR2L3 -9355.0 -8368.0
OR2L5 -8719.0 776.0
OR2L8 -9553.0 -5682.0
OR2M2 -9875.0 -4098.0
OR2M3 -9782.0 4907.0
OR2M4 -9732.0 -8967.0
OR2M5 -8133.0 6209.0
OR2M7 -10009.0 -10563.0
OR2S2 1454.0 10705.0
OR2T1 -7320.0 -2860.0
OR2T11 2415.0 126.0
OR2T12 -6858.0 3303.0
OR2T27 -8726.0 -9609.0
OR2T3 -9057.0 10724.0
OR2T33 -9042.0 5178.0
OR2T4 -6994.0 4046.0
OR2T6 -9917.0 5485.0
OR2T8 -8072.0 -3848.0
OR2V1 -9456.0 -5518.0
OR2V2 -4912.0 10159.0
OR2W1 -9427.0 -7573.0
OR2W3 -9183.0 9747.0
OR2Y1 -8639.0 2587.0
OR2Z1 -8542.0 4681.0
OR3A1 -1366.0 8549.0
OR3A2 -7888.0 -7386.0
OR3A3 -9137.0 4677.0
OR4A15 -8412.0 3178.0
OR4A16 -9474.0 -10347.0
OR4A47 -9954.0 -10617.0
OR4A5 -5999.0 -10629.0
OR4B1 -9753.0 -9593.0
OR4C12 -9942.0 -8519.0
OR4C15 -8216.0 -1911.0
OR4C16 -9787.0 -4184.0
OR4C3 -9276.0 -10728.0
OR4C45 4426.0 -2206.0
OR4C46 -9869.0 -10370.0
OR4C6 -9764.0 -9293.0
OR4D1 -9822.0 3644.0
OR4D10 -7930.0 10155.0
OR4D11 -9818.0 -6471.0
OR4D2 -9561.0 9189.0
OR4D5 -8684.0 -8847.0
OR4D6 -9660.0 3506.0
OR4D9 -7494.0 -3028.0
OR4E2 -7106.0 8010.0
OR4F15 -7871.0 5839.0
OR4F6 -8837.0 -4892.0
OR4K1 -8380.0 10526.0
OR4K13 -6797.0 10417.0
OR4K14 -4041.0 10985.0
OR4K15 -7205.0 -8243.0
OR4K17 -9473.0 -8041.0
OR4K2 -5012.0 -8332.0
OR4K5 -9721.0 183.0
OR4L1 -6817.0 -4481.0
OR4M1 -3073.0 -7830.0
OR4N2 -7438.0 -9842.0
OR4N5 -5909.0 3551.0
OR4S1 -9854.0 -10235.0
OR4X1 -9373.0 -10270.0
OR51A2 -8741.0 -8871.0
OR51A7 -9880.0 -7857.0
OR51B2 -9193.0 -2036.0
OR51B4 -9984.0 -8377.0
OR51B5 -9752.0 -3154.0
OR51B6 -9901.0 -6618.0
OR51D1 -5300.0 -9933.0
OR51E1 -3918.0 6782.0
OR51E2 -252.0 -551.0
OR51F1 -9083.0 700.0
OR51F2 -6676.0 3595.0
OR51G1 -9616.0 9324.0
OR51G2 -9606.0 7295.0
OR51I1 -9959.0 -3664.0
OR51I2 -8130.0 -2251.0
OR51L1 -9817.0 -2075.0
OR51M1 -9904.0 -9799.0
OR51Q1 -8339.0 -7246.0
OR51S1 -8983.0 7927.0
OR51T1 -9124.0 -8828.0
OR51V1 -8075.0 5067.0
OR52A1 -8820.0 -8955.0
OR52A4P -9303.0 1390.0
OR52A5 -9430.0 -10450.0
OR52B2 -8761.0 521.0
OR52B6 -9117.0 10877.0
OR52D1 -9953.0 -10037.0
OR52E2 -9795.0 4085.0
OR52E4 -9840.0 6051.0
OR52E6 -9532.0 7266.0
OR52E8 -7920.0 9213.0
OR52H1 -9080.0 4434.0
OR52I1 5073.0 9984.0
OR52I2 -6156.0 5814.0
OR52J3 -9371.0 -4640.0
OR52K1 -7849.0 -8586.0
OR52K2 -7804.0 -7404.0
OR52L1 -8359.0 11049.0
OR52M1 7596.0 2184.0
OR52N1 -9166.0 -5728.0
OR52N2 -9309.0 -1748.0
OR52R1 -6133.0 -3017.0
OR52W1 4417.0 10541.0
OR56A1 -10018.0 -5130.0
OR56A3 -9989.0 10277.0
OR56A4 -8964.0 -9377.0
OR56A5 -8165.0 -10367.0
OR56B1 -9960.0 4515.0
OR56B4 -10027.0 -10147.0
OR5A1 -9661.0 -10279.0
OR5A2 -9958.0 -10661.0
OR5AC2 -9977.0 -10092.0
OR5AK2 -6105.0 -7156.0
OR5AN1 -9931.0 -4825.0
OR5AP2 -8235.0 9834.0
OR5AR1 -9988.0 -10160.0
OR5AS1 -9407.0 5284.0
OR5AU1 -9690.0 -3584.0
OR5B12 -9082.0 2723.0
OR5B17 -8707.0 -10306.0
OR5B2 -8355.0 5230.0
OR5B21 -8299.0 4421.0
OR5B3 -5603.0 -3835.0
OR5C1 -6413.0 11070.0
OR5D13 -9090.0 9592.0
OR5D14 -9885.0 -9666.0
OR5D16 -8557.0 -10102.0
OR5D18 -7680.0 -1967.0
OR5F1 -6470.0 6252.0
OR5H15 -9218.0 6200.0
OR5H2 -6979.0 -574.0
OR5H6 -10000.0 -2293.0
OR5I1 -9907.0 -2333.0
OR5J2 -10031.0 -3085.0
OR5K1 -7374.0 -3918.0
OR5K2 -9313.0 9267.0
OR5K3 -9560.0 -8803.0
OR5K4 -4959.0 -10259.0
OR5L1 -8976.0 -10357.0
OR5L2 -7476.0 -4600.0
OR5M1 -9397.0 9981.0
OR5M10 1286.0 9824.0
OR5M11 3179.0 4737.0
OR5M3 -9581.0 -9418.0
OR5M8 -7759.0 9947.0
OR5M9 -7661.0 10386.0
OR5P2 -9498.0 -9334.0
OR5P3 -9015.0 9612.0
OR5T1 -9974.0 -9328.0
OR5T2 -9895.0 -2530.0
OR5V1 -9645.0 5954.0
OR5W2 -9155.0 5382.0
OR6A2 -9041.0 11011.0
OR6B1 -7936.0 6239.0
OR6B2 -8315.0 8685.0
OR6B3 -8745.0 -10264.0
OR6C1 -6434.0 10736.0
OR6C2 -9357.0 -8311.0
OR6C3 -9121.0 -1732.0
OR6C4 -8979.0 -100.0
OR6C6 -8498.0 11039.0
OR6C65 -9830.0 -9990.0
OR6C68 -3498.0 3435.0
OR6C70 -6651.0 10054.0
OR6C74 -9859.0 -5447.0
OR6C75 -8851.0 -3525.0
OR6C76 -5241.0 -1786.0
OR6F1 -9259.0 10284.0
OR6K2 -9785.0 1065.0
OR6K3 -9946.0 -6085.0
OR6K6 -8715.0 -3620.0
OR6M1 -8407.0 9810.0
OR6N1 -9398.0 4764.0
OR6N2 -9881.0 6093.0
OR6P1 -9579.0 4481.0
OR6Q1 -8778.0 -10767.0
OR6S1 2461.0 -8001.0
OR6T1 -8226.0 9736.0
OR6V1 8382.0 5592.0
OR6X1 -6196.0 -7881.0
OR6Y1 -9976.0 9166.0
OR7A10 -3286.0 7314.0
OR7A17 -786.0 -10434.0
OR7A5 -9115.0 -7899.0
OR7C1 -3413.0 8656.0
OR7C2 -5230.0 5306.0
OR7D2 -7347.0 -7531.0
OR7D4 -9487.0 -6966.0
OR7E24 -1488.0 11003.0
OR7G1 -6349.0 -10701.0
OR7G2 -8634.0 -2982.0
OR7G3 -9344.0 8561.0
OR8A1 -9915.0 -6699.0
OR8B12 -9970.0 -1866.0
OR8B2 -9738.0 -9935.0
OR8B4 -9663.0 -9632.0
OR8B8 -8622.0 10641.0
OR8D1 -8628.0 -669.0
OR8D2 -9674.0 -7035.0
OR8D4 -6013.0 -10145.0
OR8G1 -9605.0 -2692.0
OR8G5 -9889.0 2669.0
OR8H1 -7582.0 -10329.0
OR8H3 -10019.0 11080.0
OR8I2 -5434.0 11008.0
OR8J1 -9995.0 10020.0
OR8J3 -9609.0 9958.0
OR8K1 -8582.0 -3228.0
OR8K3 -8537.0 10261.0
OR8K5 -9621.0 -4361.0
OR8S1 -8945.0 10101.0
OR8U1 -9250.0 -1680.0
OR8U3 -9999.0 -6107.0
OR8U8 -9217.0 552.0
OR9A2 -9335.0 7328.0
OR9A4 -7179.0 -7512.0
OR9G1 -8866.5 -7172.5
OR9G4 -8952.0 -10615.0
OR9G9 -8866.5 -7172.5
OR9I1 5197.0 -3824.0
OR9K2 -8662.0 7241.0
OR9Q1 5052.0 -8799.0
OR9Q2 2265.0 -5681.0
REEP1 1330.0 -3012.0
RTP1 -7938.0 9859.0
RTP2 -7678.0 1725.0



GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY
GOMF INHIBITORY MHC CLASS I RECEPTOR ACTIVITY
metric value
setSize 9
pMANOVA 0.000397
p.adjustMANOVA 0.00651
s.dist 0.769
s.cancer -0.758
s.incidence -0.134
p.cancer 8.26e-05
p.incidence 0.488



Top 20 genes
Gene cancer incidence
LILRA4 -7917 -10291
LILRA2 -8117 -9669
LILRB1 -8796 -4558
LILRB4 -7927 -4934
LILRA5 -4296 -2492
LILRA1 -8902 -52

Click HERE to show all gene set members

All member genes
cancer incidence
KIR3DL1 -9687 9192
LILRA1 -8902 -52
LILRA2 -8117 -9669
LILRA3 -2397 9385
LILRA4 -7917 -10291
LILRA5 -4296 -2492
LILRB1 -8796 -4558
LILRB2 -8320 1815
LILRB4 -7927 -4934



GOBP REGULATION OF GLUCOSYLCERAMIDE CATABOLIC PROCESS
GOBP REGULATION OF GLUCOSYLCERAMIDE CATABOLIC PROCESS
metric value
setSize 5
pMANOVA 0.0157
p.adjustMANOVA 0.109
s.dist 0.76
s.cancer 0.256
s.incidence 0.716
p.cancer 0.322
p.incidence 0.00559



Top 20 genes
Gene cancer incidence
MIR195 11477 9965
MIR16-1 9000 9132
SCARB2 5732 4553
PRKCD 1070 5987

Click HERE to show all gene set members

All member genes
cancer incidence
MIR127 -8619 10438
MIR16-1 9000 9132
MIR195 11477 9965
PRKCD 1070 5987
SCARB2 5732 4553



GOBP NEURAL FOLD FORMATION
GOBP NEURAL FOLD FORMATION
metric value
setSize 7
pMANOVA 0.00255
p.adjustMANOVA 0.0285
s.dist 0.756
s.cancer -0.0528
s.incidence -0.754
p.cancer 0.809
p.incidence 0.000549



Top 20 genes
Gene cancer incidence
BMP5 -8189 -10118
OVOL2 -3997 -9234
CECR2 -1676 -5116

Click HERE to show all gene set members

All member genes
cancer incidence
BMP5 -8189 -10118
BMP7 1127 -9205
CECR2 -1676 -5116
HIF1A 3202 -6142
LUZP1 8176 -7126
NODAL 3807 -9690
OVOL2 -3997 -9234



GOMF HISTONE H3K36 TRIMETHYLTRANSFERASE ACTIVITY
GOMF HISTONE H3K36 TRIMETHYLTRANSFERASE ACTIVITY
metric value
setSize 5
pMANOVA 0.0176
p.adjustMANOVA 0.116
s.dist 0.753
s.cancer 0.685
s.incidence 0.313
p.cancer 0.00797
p.incidence 0.226



Top 20 genes
Gene cancer incidence
NSD2 7201 7541
PRDM9 9011 4842
SETD5 9130 2600
SETD2 7012 1959
ASH1L 9830 1070

Click HERE to show all gene set members

All member genes
cancer incidence
ASH1L 9830 1070
NSD2 7201 7541
PRDM9 9011 4842
SETD2 7012 1959
SETD5 9130 2600



GOMF AMINOACYL TRNA HYDROLASE ACTIVITY
GOMF AMINOACYL TRNA HYDROLASE ACTIVITY
metric value
setSize 5
pMANOVA 0.0174
p.adjustMANOVA 0.115
s.dist 0.753
s.cancer -0.28
s.incidence -0.699
p.cancer 0.279
p.incidence 0.00682



Top 20 genes
Gene cancer incidence
PTRH1 -4460 -9542
PTRHD1 -5191 -6676
PTRH2 -3820 -7950
MRPL58 -767 -8398

Click HERE to show all gene set members

All member genes
cancer incidence
ETF1 3550 -4846
MRPL58 -767 -8398
PTRH1 -4460 -9542
PTRH2 -3820 -7950
PTRHD1 -5191 -6676



GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX
GOCC ATP BINDING CASSETTE ABC TRANSPORTER COMPLEX
metric value
setSize 6
pMANOVA 0.00594
p.adjustMANOVA 0.0537
s.dist 0.749
s.cancer -0.0561
s.incidence 0.747
p.cancer 0.812
p.incidence 0.00154



Top 20 genes
Gene cancer incidence
ABCA2 -3535 9854
ABCG5 -49 9550

Click HERE to show all gene set members

All member genes
cancer incidence
ABCA2 -3535 9854
ABCB6 1224 7928
ABCB8 186 9207
ABCD4 2962 4031
ABCG5 -49 9550
ABCG8 1093 9553



GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT
GOBP VOLUNTARY MUSCULOSKELETAL MOVEMENT
metric value
setSize 7
pMANOVA 0.00386
p.adjustMANOVA 0.0386
s.dist 0.748
s.cancer 0.335
s.incidence 0.669
p.cancer 0.125
p.incidence 0.00218



Top 20 genes
Gene cancer incidence
MAP1A 11347 9182
MTOR 10822 7373
HIPK2 6775 8074
VTI1A 3002 6561
ITPR1 938 4874
XRCC1 430 9462

Click HERE to show all gene set members

All member genes
cancer incidence
HIPK2 6775 8074
ITPR1 938 4874
MAP1A 11347 9182
MTOR 10822 7373
VPS35 -1116 6982
VTI1A 3002 6561
XRCC1 430 9462



GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION
GOBP REGULATION OF SKELETAL MUSCLE TISSUE REGENERATION
metric value
setSize 8
pMANOVA 0.00115
p.adjustMANOVA 0.0154
s.dist 0.746
s.cancer 0.745
s.incidence -0.0379
p.cancer 0.000261
p.incidence 0.853



Top 20 genes
Gene cancer incidence
MYOD1 11771 -8825
MYOZ1 11262 -8112
GJD4 5543 -7186
SPAAR 11468 -3266
HOPX 8192 -2347

Click HERE to show all gene set members

All member genes
cancer incidence
CAPN3 8907 10686
GJD4 5543 -7186
HOPX 8192 -2347
MYOD1 11771 -8825
MYOZ1 11262 -8112
PPARD 5513 7324
SOX15 10106 9791
SPAAR 11468 -3266



GOMF HEXOKINASE ACTIVITY
GOMF HEXOKINASE ACTIVITY
metric value
setSize 5
pMANOVA 0.0117
p.adjustMANOVA 0.0883
s.dist 0.746
s.cancer -0.337
s.incidence 0.666
p.cancer 0.192
p.incidence 0.00995



Top 20 genes
Gene cancer incidence
HK3 -8416 8408
HK2 -4268 9970
HKDC1 -1661 9175
GCK -6885 1458

Click HERE to show all gene set members

All member genes
cancer incidence
GCK -6885 1458
HK1 7408 8325
HK2 -4268 9970
HK3 -8416 8408
HKDC1 -1661 9175



Developmental Cell Lineages
Developmental Cell Lineages
metric value
setSize 5
pMANOVA 0.0188
p.adjustMANOVA 0.122
s.dist 0.746
s.cancer 0.688
s.incidence 0.288
p.cancer 0.00773
p.incidence 0.265



Top 20 genes
Gene cancer incidence
FGF4 10454 8689
FGF7 7478 7931
FGF2 8761 5298
FGF10 10844 2961

Click HERE to show all gene set members

All member genes
cancer incidence
EGF 4792 -8230
FGF10 10844 2961
FGF2 8761 5298
FGF4 10454 8689
FGF7 7478 7931



Developmental Lineage of Pancreatic Acinar Cells
Developmental Lineage of Pancreatic Acinar Cells
metric value
setSize 5
pMANOVA 0.0188
p.adjustMANOVA 0.122
s.dist 0.746
s.cancer 0.688
s.incidence 0.288
p.cancer 0.00773
p.incidence 0.265



Top 20 genes
Gene cancer incidence
FGF4 10454 8689
FGF7 7478 7931
FGF2 8761 5298
FGF10 10844 2961

Click HERE to show all gene set members

All member genes
cancer incidence
EGF 4792 -8230
FGF10 10844 2961
FGF2 8761 5298
FGF4 10454 8689
FGF7 7478 7931



GOCC OUTER DENSE FIBER
GOCC OUTER DENSE FIBER
metric value
setSize 6
pMANOVA 0.00469
p.adjustMANOVA 0.0451
s.dist 0.745
s.cancer -0.402
s.incidence 0.628
p.cancer 0.0878
p.incidence 0.00777



Top 20 genes
Gene cancer incidence
CIMAP1A -9152 9663
ODF1 -7173 10317
TMEM232 -6749 5536

Click HERE to show all gene set members

All member genes
cancer incidence
AK1 3652 9623
CIMAP1A -9152 9663
FLACC1 3319 10305
ODF1 -7173 10317
RSPH1 -4785 -3144
TMEM232 -6749 5536



GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS
GOBP NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OSMOTIC STRESS
metric value
setSize 5
pMANOVA 0.0195
p.adjustMANOVA 0.124
s.dist 0.745
s.cancer 0.67
s.incidence 0.324
p.cancer 0.00945
p.incidence 0.209



Top 20 genes
Gene cancer incidence
ARHGEF2 9631 6666
PTGS2 3505 7153
EPO 11716 1303
YBX3 5573 2369
BDKRB2 10938 1150

Click HERE to show all gene set members

All member genes
cancer incidence
ARHGEF2 9631 6666
BDKRB2 10938 1150
EPO 11716 1303
PTGS2 3505 7153
YBX3 5573 2369



GOBP SENSORY PERCEPTION OF SMELL
GOBP SENSORY PERCEPTION OF SMELL
metric value
setSize 364
pMANOVA 5.2e-129
p.adjustMANOVA 1.59e-125
s.dist 0.742
s.cancer -0.736
s.incidence -0.0943
p.cancer 4.18e-130
p.incidence 0.00199



Top 20 genes
Gene cancer incidence
OR10T2 -9998 -10706
OR5A2 -9958 -10661
OR2M7 -10009 -10563
OR4A47 -9954 -10617
OR10AG1 -9802 -10579
OR4C46 -9869 -10370
OR2G6 -9745 -10491
OR56B4 -10027 -10147
OR5AR1 -9988 -10160
OR10K1 -9797 -10324
OR4S1 -9854 -10235
OR5AC2 -9977 -10092
OR52D1 -9953 -10037
OR4C3 -9276 -10728
OR5A1 -9661 -10279
OR2AK2 -9597 -10319
OR2B3 -9549 -10353
OR10G9 -9790 -10098
OR52A5 -9430 -10450
OR6C65 -9830 -9990

Click HERE to show all gene set members

All member genes
cancer incidence
ADCY3 7415.0 9539.0
B2M 931.0 -7866.0
B3GNT2 2930.0 1662.0
BBS1 10572.0 -4293.0
BBS4 3538.0 6393.0
BEST2 -7956.0 -6685.0
CFAP69 568.0 -2689.0
CNGA4 -9205.0 10424.0
CNGB1 -6389.0 5156.0
DRD2 -878.0 -6113.0
FZD2 6487.0 1333.0
GFY -1817.0 3907.0
GJB4 111.0 10880.0
GPR148 -1461.0 1712.0
MKKS -24.0 -6926.0
NAV2 4230.0 4.0
NXNL2 -4427.0 -5227.0
OBP2A -7937.0 8449.0
OBP2B -7006.0 -9145.0
OMP 4066.0 -6817.0
OR10A2 -8464.0 -5935.0
OR10A3 -9853.0 10242.0
OR10A4 -8177.0 -3723.0
OR10A5 -6694.0 9675.0
OR10A6 -8637.0 -7497.0
OR10A7 -9569.0 10042.0
OR10AD1 -9069.0 1784.0
OR10AG1 -9802.0 -10579.0
OR10C1 -9527.0 6402.0
OR10G2 -8122.0 -8148.0
OR10G3 2996.0 10170.0
OR10G4 -9727.0 266.0
OR10G7 -8477.0 -10094.0
OR10G8 -8912.0 -8988.0
OR10G9 -9790.0 -10098.0
OR10H1 -8942.0 -9228.0
OR10H2 -9768.0 -3426.0
OR10H3 -5916.0 -8996.0
OR10H4 -6175.0 -6202.0
OR10H5 -9593.0 -7196.0
OR10J1 -9838.0 8789.0
OR10J3 -10013.0 10089.0
OR10J5 -9493.0 4414.0
OR10K1 -9797.0 -10324.0
OR10K2 -9964.0 2970.0
OR10P1 -9675.0 9996.0
OR10Q1 9880.0 5400.0
OR10S1 -9990.0 -2537.0
OR10T2 -9998.0 -10706.0
OR10V1 10766.0 -7331.0
OR10W1 6028.0 -10029.0
OR10X1 -9863.0 -850.0
OR10Z1 -10011.0 3262.0
OR11A1 -8524.0 6374.0
OR11G2 -6846.0 223.0
OR11H4 -8274.0 -10016.0
OR11H6 -9366.0 -6068.0
OR11L1 -6769.0 10218.0
OR12D2 -9423.0 -7871.0
OR12D3 -7169.0 -7949.0
OR13A1 -8329.0 3141.0
OR13C2 -8740.0 2872.0
OR13C3 -5709.0 7390.0
OR13C4 -8505.0 -9274.0
OR13C8 -3999.0 -10161.0
OR13C9 -9570.0 3011.0
OR13D1 -9519.0 -7958.0
OR13F1 -8583.0 -10372.0
OR13G1 -9913.0 -3465.0
OR13J1 -2015.0 -6841.0
OR14A16 -7355.0 3813.0
OR14C36 -9947.0 -3594.0
OR14I1 -9531.0 -4078.0
OR14J1 -9284.0 -5037.0
OR1A1 -7332.0 -2231.0
OR1A2 -8440.0 -10614.0
OR1B1 -9539.0 -7910.0
OR1C1 -9749.0 -9481.0
OR1D2 -1933.0 4074.0
OR1E1 -6822.0 -4017.0
OR1E2 -9084.0 -10703.0
OR1F1 -8800.0 8682.0
OR1F2P -9125.0 -9879.0
OR1G1 -9440.0 4298.0
OR1I1 -4315.0 -1341.0
OR1J1 -4382.0 10978.0
OR1J2 -8746.0 3946.0
OR1J4 -9012.0 8278.0
OR1K1 -8703.0 -660.0
OR1L1 -9615.0 -7615.0
OR1L3 -8458.0 -10292.0
OR1L4 -9740.0 -9123.0
OR1L6 -2720.0 9209.0
OR1L8 -8236.0 6976.0
OR1M1 -9000.0 -1931.0
OR1N1 -8581.0 -2476.0
OR1N2 -9198.0 -4888.0
OR1Q1 -8269.0 -755.0
OR1S1 8391.0 7433.0
OR1S2 9595.0 -676.0
OR2A12 -7999.0 10106.0
OR2A14 -9192.0 -9497.0
OR2A2 -9588.0 9857.0
OR2A5 -8838.0 10411.0
OR2AE1 -9428.0 8252.0
OR2AG1 -9204.0 1039.0
OR2AG2 -7805.0 3379.0
OR2AK2 -9597.0 -10319.0
OR2AP1 -9515.0 -9724.0
OR2AT4 -9188.0 8822.0
OR2B11 -9086.0 10861.0
OR2B2 -9282.0 426.0
OR2B3 -9549.0 -10353.0
OR2B6 -8351.0 8678.0
OR2C1 -6186.0 -4785.0
OR2C3 -5910.0 9185.0
OR2D2 -8522.0 -7075.0
OR2D3 -4878.0 -6341.0
OR2F1 -8920.0 -3034.0
OR2F2 -7814.0 -7715.0
OR2G2 -7785.0 8211.0
OR2G3 -9711.0 -4966.0
OR2G6 -9745.0 -10491.0
OR2H1 -9140.0 -6086.0
OR2H2 10590.0 10890.0
OR2J2 -8888.0 -8698.0
OR2K2 -7695.0 -4440.0
OR2L13 -8609.0 -5404.0
OR2L2 -7167.0 2643.0
OR2L3 -9355.0 -8368.0
OR2L5 -8719.0 776.0
OR2L8 -9553.0 -5682.0
OR2M2 -9875.0 -4098.0
OR2M3 -9782.0 4907.0
OR2M4 -9732.0 -8967.0
OR2M5 -8133.0 6209.0
OR2M7 -10009.0 -10563.0
OR2S2 1454.0 10705.0
OR2T1 -7320.0 -2860.0
OR2T11 2415.0 126.0
OR2T12 -6858.0 3303.0
OR2T27 -8726.0 -9609.0
OR2T3 -9057.0 10724.0
OR2T33 -9042.0 5178.0
OR2T4 -6994.0 4046.0
OR2T6 -9917.0 5485.0
OR2T8 -8072.0 -3848.0
OR2V1 -9456.0 -5518.0
OR2V2 -4912.0 10159.0
OR2W1 -9427.0 -7573.0
OR2W3 -9183.0 9747.0
OR2W5P -7715.0 -10328.0
OR2Y1 -8639.0 2587.0
OR2Z1 -8542.0 4681.0
OR3A1 -1366.0 8549.0
OR3A2 -7888.0 -7386.0
OR3A3 -9137.0 4677.0
OR4A15 -8412.0 3178.0
OR4A16 -9474.0 -10347.0
OR4A47 -9954.0 -10617.0
OR4A5 -5999.0 -10629.0
OR4B1 -9753.0 -9593.0
OR4C12 -9942.0 -8519.0
OR4C15 -8216.0 -1911.0
OR4C16 -9787.0 -4184.0
OR4C3 -9276.0 -10728.0
OR4C45 4426.0 -2206.0
OR4C46 -9869.0 -10370.0
OR4C6 -9764.0 -9293.0
OR4D1 -9822.0 3644.0
OR4D10 -7930.0 10155.0
OR4D11 -9818.0 -6471.0
OR4D2 -9561.0 9189.0
OR4D5 -8684.0 -8847.0
OR4D6 -9660.0 3506.0
OR4D9 -7494.0 -3028.0
OR4E2 -7106.0 8010.0
OR4F15 -7871.0 5839.0
OR4F6 -8837.0 -4892.0
OR4K1 -8380.0 10526.0
OR4K13 -6797.0 10417.0
OR4K14 -4041.0 10985.0
OR4K15 -7205.0 -8243.0
OR4K17 -9473.0 -8041.0
OR4K2 -5012.0 -8332.0
OR4K5 -9721.0 183.0
OR4L1 -6817.0 -4481.0
OR4M1 -3073.0 -7830.0
OR4N2 -7438.0 -9842.0
OR4N5 -5909.0 3551.0
OR4S1 -9854.0 -10235.0
OR4X1 -9373.0 -10270.0
OR51A2 -8741.0 -8871.0
OR51A7 -9880.0 -7857.0
OR51B2 -9193.0 -2036.0
OR51B4 -9984.0 -8377.0
OR51B5 -9752.0 -3154.0
OR51B6 -9901.0 -6618.0
OR51D1 -5300.0 -9933.0
OR51E1 -3918.0 6782.0
OR51E2 -252.0 -551.0
OR51F1 -9083.0 700.0
OR51F2 -6676.0 3595.0
OR51G1 -9616.0 9324.0
OR51G2 -9606.0 7295.0
OR51I1 -9959.0 -3664.0
OR51I2 -8130.0 -2251.0
OR51L1 -9817.0 -2075.0
OR51M1 -9904.0 -9799.0
OR51Q1 -8339.0 -7246.0
OR51S1 -8983.0 7927.0
OR51T1 -9124.0 -8828.0
OR51V1 -8075.0 5067.0
OR52A1 -8820.0 -8955.0
OR52A4P -9303.0 1390.0
OR52A5 -9430.0 -10450.0
OR52B2 -8761.0 521.0
OR52B4 -8681.0 5871.0
OR52B6 -9117.0 10877.0
OR52D1 -9953.0 -10037.0
OR52E2 -9795.0 4085.0
OR52E4 -9840.0 6051.0
OR52E6 -9532.0 7266.0
OR52E8 -7920.0 9213.0
OR52H1 -9080.0 4434.0
OR52I1 5073.0 9984.0
OR52I2 -6156.0 5814.0
OR52J3 -9371.0 -4640.0
OR52K1 -7849.0 -8586.0
OR52K2 -7804.0 -7404.0
OR52L1 -8359.0 11049.0
OR52M1 7596.0 2184.0
OR52N1 -9166.0 -5728.0
OR52N2 -9309.0 -1748.0
OR52R1 -6133.0 -3017.0
OR52W1 4417.0 10541.0
OR56A1 -10018.0 -5130.0
OR56A3 -9989.0 10277.0
OR56A4 -8964.0 -9377.0
OR56A5 -8165.0 -10367.0
OR56B1 -9960.0 4515.0
OR56B4 -10027.0 -10147.0
OR5A1 -9661.0 -10279.0
OR5A2 -9958.0 -10661.0
OR5AC2 -9977.0 -10092.0
OR5AK2 -6105.0 -7156.0
OR5AN1 -9931.0 -4825.0
OR5AP2 -8235.0 9834.0
OR5AR1 -9988.0 -10160.0
OR5AS1 -9407.0 5284.0
OR5AU1 -9690.0 -3584.0
OR5B12 -9082.0 2723.0
OR5B17 -8707.0 -10306.0
OR5B2 -8355.0 5230.0
OR5B21 -8299.0 4421.0
OR5B3 -5603.0 -3835.0
OR5C1 -6413.0 11070.0
OR5D13 -9090.0 9592.0
OR5D14 -9885.0 -9666.0
OR5D16 -8557.0 -10102.0
OR5D18 -7680.0 -1967.0
OR5F1 -6470.0 6252.0
OR5H15 -9218.0 6200.0
OR5H2 -6979.0 -574.0
OR5H6 -10000.0 -2293.0
OR5I1 -9907.0 -2333.0
OR5J2 -10031.0 -3085.0
OR5K1 -7374.0 -3918.0
OR5K2 -9313.0 9267.0
OR5K3 -9560.0 -8803.0
OR5K4 -4959.0 -10259.0
OR5L1 -8976.0 -10357.0
OR5L2 -7476.0 -4600.0
OR5M1 -9397.0 9981.0
OR5M10 1286.0 9824.0
OR5M11 3179.0 4737.0
OR5M3 -9581.0 -9418.0
OR5M8 -7759.0 9947.0
OR5M9 -7661.0 10386.0
OR5P2 -9498.0 -9334.0
OR5P3 -9015.0 9612.0
OR5T1 -9974.0 -9328.0
OR5T2 -9895.0 -2530.0
OR5V1 -9645.0 5954.0
OR5W2 -9155.0 5382.0
OR6A2 -9041.0 11011.0
OR6B1 -7936.0 6239.0
OR6B2 -8315.0 8685.0
OR6B3 -8745.0 -10264.0
OR6C1 -6434.0 10736.0
OR6C2 -9357.0 -8311.0
OR6C3 -9121.0 -1732.0
OR6C4 -8979.0 -100.0
OR6C6 -8498.0 11039.0
OR6C65 -9830.0 -9990.0
OR6C68 -3498.0 3435.0
OR6C70 -6651.0 10054.0
OR6C74 -9859.0 -5447.0
OR6C75 -8851.0 -3525.0
OR6C76 -5241.0 -1786.0
OR6F1 -9259.0 10284.0
OR6K2 -9785.0 1065.0
OR6K3 -9946.0 -6085.0
OR6K6 -8715.0 -3620.0
OR6M1 -8407.0 9810.0
OR6N1 -9398.0 4764.0
OR6N2 -9881.0 6093.0
OR6P1 -9579.0 4481.0
OR6Q1 -8778.0 -10767.0
OR6S1 2461.0 -8001.0
OR6T1 -8226.0 9736.0
OR6V1 8382.0 5592.0
OR6X1 -6196.0 -7881.0
OR6Y1 -9976.0 9166.0
OR7A10 -3286.0 7314.0
OR7A17 -786.0 -10434.0
OR7A5 -9115.0 -7899.0
OR7C1 -3413.0 8656.0
OR7C2 -5230.0 5306.0
OR7D2 -7347.0 -7531.0
OR7D4 -9487.0 -6966.0
OR7E24 -1488.0 11003.0
OR7G1 -6349.0 -10701.0
OR7G2 -8634.0 -2982.0
OR7G3 -9344.0 8561.0
OR8A1 -9915.0 -6699.0
OR8B12 -9970.0 -1866.0
OR8B2 -9738.0 -9935.0
OR8B4 -9663.0 -9632.0
OR8B8 -8622.0 10641.0
OR8D1 -8628.0 -669.0
OR8D2 -9674.0 -7035.0
OR8D4 -6013.0 -10145.0
OR8G1 -9605.0 -2692.0
OR8G2P -9452.0 -4049.0
OR8G5 -9889.0 2669.0
OR8H1 -7582.0 -10329.0
OR8H3 -10019.0 11080.0
OR8I2 -5434.0 11008.0
OR8J1 -9995.0 10020.0
OR8J3 -9609.0 9958.0
OR8K1 -8582.0 -3228.0
OR8K3 -8537.0 10261.0
OR8K5 -9621.0 -4361.0
OR8S1 -8945.0 10101.0
OR8U1 -9250.0 -1680.0
OR8U3 -9999.0 -6107.0
OR8U8 -9217.0 552.0
OR9A2 -9335.0 7328.0
OR9A4 -7179.0 -7512.0
OR9G1 -8866.5 -7172.5
OR9G4 -8952.0 -10615.0
OR9G9 -8866.5 -7172.5
OR9I1 5197.0 -3824.0
OR9K2 -8662.0 7241.0
OR9Q1 5052.0 -8799.0
OR9Q2 2265.0 -5681.0
PDE4A 7953.0 1839.0
SLC24A4 -145.0 7734.0
SLC6A3 289.0 1117.0
SYT10 10266.0 -7197.0
TTC8 654.0 -1588.0
UBR3 4852.0 -3858.0
UGT2A1 -6773.0 -9953.0



GOBP CEREBRAL CORTEX REGIONALIZATION
GOBP CEREBRAL CORTEX REGIONALIZATION
metric value
setSize 7
pMANOVA 0.00327
p.adjustMANOVA 0.0342
s.dist 0.738
s.cancer 0.737
s.incidence 0.0165
p.cancer 0.000727
p.incidence 0.94



Top 20 genes
Gene cancer incidence
ADGRG1 10468 9193
EMX1 2654 5420
DMRTA2 10910 1269

Click HERE to show all gene set members

All member genes
cancer incidence
ADGRG1 10468 9193
DMRTA2 10910 1269
EMX1 2654 5420
EMX2 10433 -5082
EOMES 9915 -341
PAX6 10773 -6785
TRA2B 7911 -1196



GOBP REGULATION OF OOCYTE MATURATION
GOBP REGULATION OF OOCYTE MATURATION
metric value
setSize 7
pMANOVA 0.00517
p.adjustMANOVA 0.0486
s.dist 0.732
s.cancer 0.438
s.incidence 0.587
p.cancer 0.0448
p.incidence 0.00715



Top 20 genes
Gene cancer incidence
NPR2 10039 10022
BNC1 11712 7002
NPPC 10747 6529
WEE2 2829 9879
SHB 5452 4183
SIRT2 1426 765

Click HERE to show all gene set members

All member genes
cancer incidence
AURKA -2112 7865
BNC1 11712 7002
NPPC 10747 6529
NPR2 10039 10022
SHB 5452 4183
SIRT2 1426 765
WEE2 2829 9879



GOBP EPOXIDE METABOLIC PROCESS
GOBP EPOXIDE METABOLIC PROCESS
metric value
setSize 5
pMANOVA 0.0235
p.adjustMANOVA 0.143
s.dist 0.732
s.cancer 0.589
s.incidence 0.435
p.cancer 0.0227
p.incidence 0.0924



Top 20 genes
Gene cancer incidence
ALOX12 8688 10495
EPHX1 9240 8573
EPHX3 10366 6725
ALOX5 868 5392

Click HERE to show all gene set members

All member genes
cancer incidence
ALOX12 8688 10495
ALOX5 868 5392
EPHX1 9240 8573
EPHX2 7728 -6505
EPHX3 10366 6725



GOBP MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION
GOBP MEIOTIC CELL CYCLE PROCESS INVOLVED IN OOCYTE MATURATION
metric value
setSize 6
pMANOVA 0.0112
p.adjustMANOVA 0.0854
s.dist 0.731
s.cancer 0.559
s.incidence 0.471
p.cancer 0.0176
p.incidence 0.0457



Top 20 genes
Gene cancer incidence
NPR2 10039 10022
NPPC 10747 6529
PPP2R1A 6429 8629
EDNRA 3677 4086

Click HERE to show all gene set members

All member genes
cancer incidence
EDN1 11626 -3238
EDNRA 3677 4086
NPPC 10747 6529
NPR2 10039 10022
PPP2R1A 6429 8629
YTHDF2 -161 5981



GOBP PROTEIN O LINKED FUCOSYLATION
GOBP PROTEIN O LINKED FUCOSYLATION
metric value
setSize 5
pMANOVA 0.0169
p.adjustMANOVA 0.113
s.dist 0.73
s.cancer -0.0774
s.incidence 0.726
p.cancer 0.764
p.incidence 0.00492



Top 20 genes
Gene cancer incidence
SLC35C1 -5854 8959
POFUT1 -3043 7815
B3GLCT -1365 8085

Click HERE to show all gene set members

All member genes
cancer incidence
B3GLCT -1365 8085
POFUT1 -3043 7815
POFUT2 267 7610
SLC35C1 -5854 8959
SLC35C2 10396 8186



GOBP FAS SIGNALING PATHWAY
GOBP FAS SIGNALING PATHWAY
metric value
setSize 8
pMANOVA 0.00108
p.adjustMANOVA 0.0146
s.dist 0.73
s.cancer 0.638
s.incidence -0.354
p.cancer 0.00176
p.incidence 0.0825



Top 20 genes
Gene cancer incidence
CASP8AP2 10385 -8279
MIR27A 8646 -8850
FAS 7805 -9087
MIR23A 7930 -6959
SP100 11009 -3959

Click HERE to show all gene set members

All member genes
cancer incidence
CASP8AP2 10385 -8279
FAS 7805 -9087
MIR23A 7930 -6959
MIR27A 8646 -8850
SMAD5 6250 2185
SP100 11009 -3959
TMBIM1 1114 3344
ZDHHC7 10251 1922



GOBP ALANINE METABOLIC PROCESS
GOBP ALANINE METABOLIC PROCESS
metric value
setSize 5
pMANOVA 0.0141
p.adjustMANOVA 0.101
s.dist 0.726
s.cancer -0.48
s.incidence 0.545
p.cancer 0.063
p.incidence 0.0349



Top 20 genes
Gene cancer incidence
DAO -6350 10187
GPT -5863 8947
AGXT -3980 9603
AGXT2 -6866 1680

Click HERE to show all gene set members

All member genes
cancer incidence
AGXT -3980 9603
AGXT2 -6866 1680
DAO -6350 10187
GPT -5863 8947
GPT2 1391 292



GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY
GOMF HISTONE H3K4 TRIMETHYLTRANSFERASE ACTIVITY
metric value
setSize 10
pMANOVA 0.000635
p.adjustMANOVA 0.00959
s.dist 0.725
s.cancer 0.56
s.incidence 0.462
p.cancer 0.00218
p.incidence 0.0115



Top 20 genes
Gene cancer incidence
KMT2D 9637 10824
KMT2C 10441 8531
PRDM9 9011 4842
SMYD1 10903 3413
SETD1A 3553 7338
SMYD3 5045 4727
SETD1B 3957 4905
SMYD2 8921 274

Click HERE to show all gene set members

All member genes
cancer incidence
KMT2A 9717 -3350
KMT2B -597 10807
KMT2C 10441 8531
KMT2D 9637 10824
PRDM9 9011 4842
SETD1A 3553 7338
SETD1B 3957 4905
SMYD1 10903 3413
SMYD2 8921 274
SMYD3 5045 4727



GOBP GLIAL CELL FATE SPECIFICATION
GOBP GLIAL CELL FATE SPECIFICATION
metric value
setSize 7
pMANOVA 0.00268
p.adjustMANOVA 0.0296
s.dist 0.724
s.cancer 0.589
s.incidence -0.422
p.cancer 0.00697
p.incidence 0.0534



Top 20 genes
Gene cancer incidence
ASCL1 11490 -9360
OLIG2 11487 -7027
NKX2-2 11541 -6681
PAX6 10773 -6785
NFIB 4980 -6

Click HERE to show all gene set members

All member genes
cancer incidence
ASCL1 11490 -9360
NFIA 9688 1016
NFIB 4980 -6
NKX2-2 11541 -6681
OLIG2 11487 -7027
PAX6 10773 -6785
SOX9 -8290 -2285



GOBP NEURAL PLATE PATTERN SPECIFICATION
GOBP NEURAL PLATE PATTERN SPECIFICATION
metric value
setSize 8
pMANOVA 0.00237
p.adjustMANOVA 0.0268
s.dist 0.721
s.cancer 0.698
s.incidence 0.179
p.cancer 0.000628
p.incidence 0.38



Top 20 genes
Gene cancer incidence
SSBP3 9105 9388
BMPR1A 10489 6270
CELSR2 4749 9636
TBX18 11226 3591
PTCH1 9315 2830
C2CD3 3468 152

Click HERE to show all gene set members

All member genes
cancer incidence
BMPR1A 10489 6270
C2CD3 3468 152
CELSR2 4749 9636
FUZ 11000 -6411
NOG 9264 -8347
PTCH1 9315 2830
SSBP3 9105 9388
TBX18 11226 3591



GOCC ALPHA BETA T CELL RECEPTOR COMPLEX
GOCC ALPHA BETA T CELL RECEPTOR COMPLEX
metric value
setSize 5
pMANOVA 0.0215
p.adjustMANOVA 0.133
s.dist 0.719
s.cancer -0.0715
s.incidence -0.715
p.cancer 0.782
p.incidence 0.00559



Top 20 genes
Gene cancer incidence
CD3E -2484 -10313

Click HERE to show all gene set members

All member genes
cancer incidence
CD247 -3761 2337
CD3D 1059 -10567
CD3E -2484 -10313
CD3G 4561 -10611
PTPN6 1352 -9179



GOMF TYPE 2 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING
GOMF TYPE 2 FIBROBLAST GROWTH FACTOR RECEPTOR BINDING
metric value
setSize 5
pMANOVA 0.0263
p.adjustMANOVA 0.154
s.dist 0.718
s.cancer 0.617
s.incidence 0.368
p.cancer 0.0169
p.incidence 0.154



Top 20 genes
Gene cancer incidence
FGF17 10701 8279
FGF7 7478 7931
FGF8 11136 3377
FGF10 10844 2961

Click HERE to show all gene set members

All member genes
cancer incidence
FGF10 10844 2961
FGF17 10701 8279
FGF18 -1719 -1500
FGF7 7478 7931
FGF8 11136 3377



Ficolins bind to repetitive carbohydrate structures on the target cell surface
Ficolins bind to repetitive carbohydrate structures on the target cell surface
metric value
setSize 5
pMANOVA 0.0191
p.adjustMANOVA 0.123
s.dist 0.717
s.cancer -0.709
s.incidence 0.104
p.cancer 0.006
p.incidence 0.688



Top 20 genes
Gene cancer incidence
FCN1 -8862 9907
FCN3 -5263 6353
MASP2 -2269 4970

Click HERE to show all gene set members

All member genes
cancer incidence
FCN1 -8862 9907
FCN2 -9299 -9796
FCN3 -5263 6353
MASP1 -8538 -4878
MASP2 -2269 4970



GOCC INNER DYNEIN ARM
GOCC INNER DYNEIN ARM
metric value
setSize 5
pMANOVA 0.0273
p.adjustMANOVA 0.157
s.dist 0.716
s.cancer 0.409
s.incidence 0.588
p.cancer 0.113
p.incidence 0.0228



Top 20 genes
Gene cancer incidence
DNHD1 10415 10086
DNAH1 3994 10285
DNAH7 3151 8740

Click HERE to show all gene set members

All member genes
cancer incidence
DNAH1 3994 10285
DNAH2 -1515 4076
DNAH7 3151 8740
DNAI3 11008 -104
DNHD1 10415 10086



GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER
GOCC EQUATORIAL MICROTUBULE ORGANIZING CENTER
metric value
setSize 5
pMANOVA 0.0277
p.adjustMANOVA 0.159
s.dist 0.712
s.cancer 0.345
s.incidence 0.623
p.cancer 0.182
p.incidence 0.0158



Top 20 genes
Gene cancer incidence
TUBGCP3 7303 8809
TUBGCP4 6596 8529
TUBGCP6 4800 8275
TUBGCP2 1315 9359
TUBGCP5 3507 53

Click HERE to show all gene set members

All member genes
cancer incidence
TUBGCP2 1315 9359
TUBGCP3 7303 8809
TUBGCP4 6596 8529
TUBGCP5 3507 53
TUBGCP6 4800 8275



GOBP REGULATION OF LUNG BLOOD PRESSURE
GOBP REGULATION OF LUNG BLOOD PRESSURE
metric value
setSize 5
pMANOVA 0.0278
p.adjustMANOVA 0.159
s.dist 0.712
s.cancer 0.618
s.incidence 0.354
p.cancer 0.0166
p.incidence 0.171



Top 20 genes
Gene cancer incidence
MIR199A1 11876 10096
SMAD3 10428 6540
BMPR2 6305 2589
MIR27B 10960 840

Click HERE to show all gene set members

All member genes
cancer incidence
BMPR2 6305 2589
GCH1 -1048 173
MIR199A1 11876 10096
MIR27B 10960 840
SMAD3 10428 6540



Here is the session info with all the versions of packages used.

sessionInfo()
## R version 4.4.1 (2024-06-14)
## Platform: x86_64-pc-linux-gnu
## Running under: Ubuntu 22.04.5 LTS
## 
## Matrix products: default
## BLAS:   /usr/lib/x86_64-linux-gnu/blas/libblas.so.3.10.0 
## LAPACK: /usr/lib/x86_64-linux-gnu/lapack/liblapack.so.3.10.0
## 
## locale:
##  [1] LC_CTYPE=en_US.UTF-8       LC_NUMERIC=C              
##  [3] LC_TIME=en_US.UTF-8        LC_COLLATE=en_US.UTF-8    
##  [5] LC_MONETARY=en_US.UTF-8    LC_MESSAGES=en_US.UTF-8   
##  [7] LC_PAPER=en_US.UTF-8       LC_NAME=C                 
##  [9] LC_ADDRESS=C               LC_TELEPHONE=C            
## [11] LC_MEASUREMENT=en_US.UTF-8 LC_IDENTIFICATION=C       
## 
## time zone: Australia/Melbourne
## tzcode source: system (glibc)
## 
## attached base packages:
## [1] parallel  stats4    stats     graphics  grDevices utils     datasets 
## [8] methods   base     
## 
## other attached packages:
##  [1] pkgload_1.4.0                                      
##  [2] GGally_2.2.1                                       
##  [3] ggplot2_3.5.1                                      
##  [4] reshape2_1.4.4                                     
##  [5] gtools_3.9.5                                       
##  [6] tibble_3.2.1                                       
##  [7] dplyr_1.1.4                                        
##  [8] echarts4r_0.4.5                                    
##  [9] gplots_3.2.0                                       
## [10] eulerr_7.0.2                                       
## [11] RhpcBLASctl_0.23-42                                
## [12] beeswarm_0.4.0                                     
## [13] vioplot_0.5.0                                      
## [14] zoo_1.8-12                                         
## [15] sm_2.2-6.0                                         
## [16] kableExtra_1.4.0                                   
## [17] IlluminaHumanMethylationEPICanno.ilm10b4.hg19_0.6.0
## [18] IlluminaHumanMethylation450kanno.ilmn12.hg19_0.6.1 
## [19] minfi_1.50.0                                       
## [20] bumphunter_1.46.0                                  
## [21] locfit_1.5-9.10                                    
## [22] iterators_1.0.14                                   
## [23] foreach_1.5.2                                      
## [24] Biostrings_2.72.1                                  
## [25] XVector_0.44.0                                     
## [26] SummarizedExperiment_1.34.0                        
## [27] Biobase_2.64.0                                     
## [28] MatrixGenerics_1.16.0                              
## [29] matrixStats_1.4.1                                  
## [30] GenomicRanges_1.56.2                               
## [31] GenomeInfoDb_1.40.1                                
## [32] IRanges_2.38.1                                     
## [33] S4Vectors_0.42.1                                   
## [34] BiocGenerics_0.50.0                                
## [35] HGNChelper_0.8.15                                  
## [36] mitch_1.19.3                                       
## 
## loaded via a namespace (and not attached):
##   [1] splines_4.4.1             later_1.4.0              
##   [3] BiocIO_1.14.0             bitops_1.0-9             
##   [5] polyclip_1.10-7           preprocessCore_1.66.0    
##   [7] XML_3.99-0.17             lifecycle_1.0.4          
##   [9] lattice_0.22-6            MASS_7.3-61              
##  [11] base64_2.0.2              scrime_1.3.5             
##  [13] magrittr_2.0.3            sass_0.4.9               
##  [15] limma_3.60.6              rmarkdown_2.29           
##  [17] jquerylib_0.1.4           yaml_2.3.10              
##  [19] httpuv_1.6.15             doRNG_1.8.6              
##  [21] askpass_1.2.1             DBI_1.2.3                
##  [23] RColorBrewer_1.1-3        abind_1.4-8              
##  [25] zlibbioc_1.50.0           quadprog_1.5-8           
##  [27] purrr_1.0.2               RCurl_1.98-1.16          
##  [29] GenomeInfoDbData_1.2.12   genefilter_1.86.0        
##  [31] annotate_1.82.0           svglite_2.1.3            
##  [33] DelayedMatrixStats_1.26.0 codetools_0.2-20         
##  [35] DelayedArray_0.30.1       xml2_1.3.6               
##  [37] tidyselect_1.2.1          farver_2.1.2             
##  [39] UCSC.utils_1.0.0          beanplot_1.3.1           
##  [41] illuminaio_0.46.0         GenomicAlignments_1.40.0 
##  [43] jsonlite_1.8.9            multtest_2.60.0          
##  [45] survival_3.7-0            systemfonts_1.1.0        
##  [47] polylabelr_0.3.0          tools_4.4.1              
##  [49] Rcpp_1.0.13-1             glue_1.8.0               
##  [51] gridExtra_2.3             SparseArray_1.4.8        
##  [53] xfun_0.49                 HDF5Array_1.32.1         
##  [55] withr_3.0.2               fastmap_1.2.0            
##  [57] rhdf5filters_1.16.0       fansi_1.0.6              
##  [59] openssl_2.2.2             caTools_1.18.3           
##  [61] digest_0.6.37             R6_2.5.1                 
##  [63] mime_0.12                 colorspace_2.1-1         
##  [65] RSQLite_2.3.8             utf8_1.2.4               
##  [67] tidyr_1.3.1               generics_0.1.3           
##  [69] data.table_1.16.2         rtracklayer_1.64.0       
##  [71] httr_1.4.7                htmlwidgets_1.6.4        
##  [73] S4Arrays_1.4.1            ggstats_0.7.0            
##  [75] pkgconfig_2.0.3           gtable_0.3.6             
##  [77] blob_1.2.4                siggenes_1.78.0          
##  [79] htmltools_0.5.8.1         scales_1.3.0             
##  [81] png_0.1-8                 knitr_1.49               
##  [83] rstudioapi_0.17.1         tzdb_0.4.0               
##  [85] rjson_0.2.23              nlme_3.1-166             
##  [87] curl_6.0.1                cachem_1.1.0             
##  [89] rhdf5_2.48.0              stringr_1.5.1            
##  [91] KernSmooth_2.23-24        AnnotationDbi_1.66.0     
##  [93] restfulr_0.0.15           GEOquery_2.72.0          
##  [95] pillar_1.9.0              grid_4.4.1               
##  [97] reshape_0.8.9             vctrs_0.6.5              
##  [99] promises_1.3.1            xtable_1.8-4             
## [101] evaluate_1.0.1            readr_2.1.5              
## [103] GenomicFeatures_1.56.0    cli_3.6.3                
## [105] compiler_4.4.1            Rsamtools_2.20.0         
## [107] rlang_1.1.4               crayon_1.5.3             
## [109] rngtools_1.5.2            labeling_0.4.3           
## [111] nor1mix_1.3-3             mclust_6.1.1             
## [113] plyr_1.8.9                stringi_1.8.4            
## [115] viridisLite_0.4.2         BiocParallel_1.38.0      
## [117] munsell_0.5.1             Matrix_1.7-1             
## [119] hms_1.1.3                 sparseMatrixStats_1.16.0 
## [121] bit64_4.5.2               Rhdf5lib_1.26.0          
## [123] KEGGREST_1.44.1           statmod_1.5.0            
## [125] shiny_1.9.1               memoise_2.0.1.9000       
## [127] bslib_0.8.0               bit_4.5.0                
## [129] splitstackshape_1.4.8

END of report